PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Koag, MC; Lai, L; Lee, S				Koag, Myong-Chul; Lai, Lara; Lee, Seongmin			Structural Basis for the Inefficient Nucleotide Incorporation Opposite Cisplatin-DNA Lesion by Human DNA Polymerase beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-MECHANISMS; CRYSTAL-STRUCTURES; EXCISION-REPAIR; GPG ADDUCTS; ETA; BYPASS; OXALIPLATIN; FIDELITY; DAMAGE; CELLS	Human DNA polymerase beta (pol beta) has been suggested to play a role in cisplatin resistance, especially in pol beta-overexpressing cancer cells. Pol beta has been shown to accurately albeit slowly bypass the cisplatin-1,2-d(GpG) (Pt-GG) intramolecular crosslink in vitro. Currently, the structural basis for the inefficient Pt-GG bypass mechanism of pol beta is unknown. To gain structural insights into the mechanism, we determined two ternary structures of pol beta incorporating dCTP opposite the templating Pt-GG lesion in the presence of the active site Mg2+ or Mn2+. The Mg2+ -bound structure shows that the bulky Pt-GG adduct is accommodated in the pol beta active site without any steric hindrance. In addition, both guanines of the Pt-GG lesion form Watson-Crick base pairing with the primer terminus dC and the incoming dCTP, providing the structural basis for the accurate bypass of the Pt-GG adduct by pol beta. The Mn2+ -bound structure shows that pol beta adopts a catalytically suboptimal semiclosed conformation during the insertion of dCTP opposite the templating Pt-GG, explaining the inefficient replication across the Pt-GG lesion by pol beta. Overall, our studies provide the first structural insights into the mechanism of the potential pol beta mediated cisplatin resistance.	[Koag, Myong-Chul; Lai, Lara; Lee, Seongmin] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Lee, S (corresponding author), Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA.	SeongminLee@austin.utexas.edu	Lee, Seongmin/AAR-2499-2021		Office of Science, Office of Basic Energy Sciences of the United States Department of Energy [DE-AC02-05CH11231]	Office of Science, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE))	Instrumentation and technical assistance for this work were provided by the Macro molecular Crystallography Facility with financial support from the College of Natural Sciences, the Office of the Executive Vice President and Provost, and the Institute for Cellular and Molecular Biology at the University of Texas at Austin, The Berkeley Center for Structural Biology is supported in part by the National Institute of General Medical Sciences. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences of the United States Department of Energy under Contract DE-AC02-05CH11231.	Alt A, 2007, SCIENCE, V318, P967, DOI 10.1126/science.1148242; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Bergoglio V, 2001, ONCOGENE, V20, P6181, DOI 10.1038/sj.onc.1204743; Boudsocq F, 2005, MOL PHARMACOL, V67, P1485, DOI 10.1124/mol.104.001776; Canitrot Y, 1999, FASEB J, V13, P1107, DOI 10.1096/fasebj.13.9.1107; Canitrot Y, 1998, P NATL ACAD SCI USA, V95, P12586, DOI 10.1073/pnas.95.21.12586; Canitrot Y, 2000, FASEB J, V14, P1765, DOI 10.1096/fj.99-1063com; Chamberlain BT, 2012, CHEMBIOCHEM, V13, P528, DOI 10.1002/cbic.201100738; Chaney SG, 2005, CRIT REV ONCOL HEMAT, V53, P3, DOI 10.1016/j.critrevonc.2004.08.008; Clausen AR, 2013, P NATL ACAD SCI USA, V110, P16802, DOI 10.1073/pnas.1309119110; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; ELDEIRY WS, 1984, P NATL ACAD SCI-BIOL, V81, P7378, DOI 10.1073/pnas.81.23.7378; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freudenthal BD, 2013, CELL, V154, P157, DOI 10.1016/j.cell.2013.05.048; Gregory MT, 2014, P NATL ACAD SCI USA, V111, P9133, DOI 10.1073/pnas.1405739111; HOFFMANN JS, 1995, P NATL ACAD SCI USA, V92, P5356, DOI 10.1073/pnas.92.12.5356; HORTON JK, 1995, NUCLEIC ACIDS RES, V23, P3810, DOI 10.1093/nar/23.19.3810; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; Koag MC, 2014, J AM CHEM SOC, V136, P5709, DOI 10.1021/ja500172d; KRAKER AJ, 1988, CANCER LETT, V38, P307, DOI 10.1016/0304-3835(88)90022-5; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Reissner T, 2010, ANGEW CHEM INT EDIT, V49, P3077, DOI 10.1002/anie.201000414; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Srivastava DK, 1999, CARCINOGENESIS, V20, P1049, DOI 10.1093/carcin/20.6.1049; TABOR S, 1989, P NATL ACAD SCI USA, V86, P4076, DOI 10.1073/pnas.86.11.4076; Ummat A, 2012, NAT STRUCT MOL BIOL, V19, P628, DOI 10.1038/nsmb.2295; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Vaisman A, 2000, J BIOL CHEM, V275, P13017, DOI 10.1074/jbc.275.17.13017; Vaisman A, 2000, BIOCHEMISTRY-US, V39, P4575, DOI 10.1021/bi000130k; Wang D, 2003, BIOCHEMISTRY-US, V42, P6747, DOI 10.1021/bi034264k; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong JHY, 2010, EMBO J, V29, P2059, DOI 10.1038/emboj.2010.101; Xie K, 2010, P NATL ACAD SCI USA, V107, P20792, DOI 10.1073/pnas.1011412107; Zhao Y, 2012, P NATL ACAD SCI USA, V109, P7269, DOI 10.1073/pnas.1202681109	37	6	6	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31341	31348		10.1074/jbc.M114.605451	http://dx.doi.org/10.1074/jbc.M114.605451			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25237188	Green Published, hybrid			2022-12-25	WOS:000344549900038
J	Honda, RP; Yamaguchi, K; Kuwata, K				Honda, Ryo P.; Yamaguchi, Kei-ichi; Kuwata, Kazuo			Acid-induced Molten Globule State of a Prion Protein CRUCIAL ROLE OF STRAND 1-HELIX 1-STRAND 2 SEGMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; CONVERSION; MOUSE; FIBRILLIZATION; STABILITY; EXCHANGE; HELIX-1; HAMSTER; HELICES; PH	The conversion of a cellular prion protein (PrPC) to its pathogenic isoform (PrPSc) is a critical event in the pathogenesis of prion diseases. Pathogenic conversion is usually associated with the oligomerization process; therefore, the conformational characteristics of the pre-oligomer state may provide insights into the conversion process. Previous studies indicate that PrPC is prone to oligomer formation at low pH, but the conformation of the pre-oligomer state remains unknown. In this study, we systematically analyzed the acid-induced conformational changes of PrPC and discovered a unique acid-induced molten globule state at pH 2.0 termed the "A-state." We characterized the structure of the A-state using far/near-UV CD, 1-anilino- 8-naphthalene sulfonate fluorescence, size exclusion chromatography, and NMR. Deuterium exchange experiments with NMR detection revealed its first unique structure ever reported thus far; i.e. the Strand 1-Helix 1-Strand 2 segment at the N terminus was preferentially unfolded, whereas the Helix 2-Helix 3 segment at the C terminus remained marginally stable. This conformational change could be triggered by the protonation of Asp(144), Asp(147), and Glu(196), followed by disruption of key salt bridges in PrPC. Moreover, the initial population of the A-state at low pH (pH 2.0-5.0) was well correlated with the rate of the beta-rich oligomer formation, suggesting that the A-state is the pre-oligomer state. Thus, the specific conformation of the A-state would provide crucial insights into the mechanisms of oligomerization and further pathogenic conversion as well as facilitating the design of novel medical chaperones for treating prion diseases.	[Honda, Ryo P.; Kuwata, Kazuo] Gifu Univ, Sch Med, Gifu 5011193, Japan; [Kuwata, Kazuo] Gifu Univ, Grad Sch Med, Dept Gene & Dev, Gifu 5011193, Japan; [Yamaguchi, Kei-ichi; Kuwata, Kazuo] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu 5011194, Japan	Gifu University; Gifu University; Gifu University	Kuwata, K (corresponding author), Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, 1-1 Yanagido, Gifu 5011194, Japan.	kuwata@gifu-u.ac.jp			Ministry of Health, Labor, and Welfare of Japan (Research on Measures for Intractable Diseases (Prion Disease and Slow Virus Infections and Development of Low Molecular Weight Medical Chaperone Therapeutics for Prion Diseases)); Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Health, Labor, and Welfare of Japan (Research on Measures for Intractable Diseases (Prion Disease and Slow Virus Infections and Development of Low Molecular Weight Medical Chaperone Therapeutics for Prion Diseases)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Health, Labor, and Welfare of Japan (Research on Measures for Intractable Diseases (Prion Disease and Slow Virus Infections and Development of Low Molecular Weight Medical Chaperone Therapeutics for Prion Diseases)) and from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (grants-in-aid for scientific research and the X-ray Free Electron Laser (XFEL) Program).	Abskharon RNN, 2014, J AM CHEM SOC, V136, P937, DOI 10.1021/ja407527p; Adrover M, 2010, J BIOL CHEM, V285, P21004, DOI 10.1074/jbc.M110.111815; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; Bae SH, 2009, BIOCHEMISTRY-US, V48, P8120, DOI 10.1021/bi900923b; Bjorndahl TC, 2011, BIOCHEMISTRY-US, V50, P1162, DOI 10.1021/bi101435c; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Chakroun N, 2010, FASEB J, V24, P3222, DOI 10.1096/fj.09-153924; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; COVINGTON AK, 1968, ANAL CHEM, V40, P700, DOI 10.1021/ac60260a013; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; Ishikawa T, 2010, J CHEM THEORY COMPUT, V6, P538, DOI 10.1021/ct900456v; Jain S, 2008, J MOL BIOL, V382, P1228, DOI 10.1016/j.jmb.2008.07.052; Jain S, 2011, BIOCHEMISTRY-US, V50, P1153, DOI 10.1021/bi101757x; Jain S, 2010, BIOCHEMISTRY-US, V49, P7615, DOI 10.1021/bi100745j; JENG MF, 1990, BIOCHEMISTRY-US, V29, P10433, DOI 10.1021/bi00498a001; Julien O, 2011, BIOCHEMISTRY-US, V50, P7536, DOI 10.1021/bi200731e; Karp DA, 2007, BIOPHYS J, V92, P2041, DOI 10.1529/biophysj.106.090266; Katou H, 2001, J MOL BIOL, V310, P471, DOI 10.1006/jmbi.2001.4777; Kuwata K, 2004, BIOCHEMISTRY-US, V43, P4439, DOI 10.1021/bi036123o; Kuwata K, 2007, P NATL ACAD SCI USA, V104, P11921, DOI 10.1073/pnas.0702671104; Kuwata K, 2013, CURR TOP MED CHEM, V13, P2432; Masel J, 2005, J MOL BIOL, V345, P1243, DOI 10.1016/j.jmb.2004.10.088; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; MorozovaRoche LA, 1997, J MOL BIOL, V268, P903, DOI 10.1006/jmbi.1997.0996; Morrissey MP, 1999, P NATL ACAD SCI USA, V96, P11293, DOI 10.1073/pnas.96.20.11293; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pastore M, 2005, AM J PATHOL, V167, P1729, DOI 10.1016/S0002-9440(10)61254-0; Peoc'h K, 2000, HUM MUTAT, V15; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Redfield C, 2004, METHODS, V34, P121, DOI 10.1016/j.ymeth.2004.03.009; Rezaei H, 2002, J MOL BIOL, V322, P799, DOI 10.1016/S0022-2836(02)00856-2; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Singh J, 2012, J MOL BIOL, V423, P217, DOI 10.1016/j.jmb.2012.06.040; Speare JO, 2003, J BIOL CHEM, V278, P12522, DOI 10.1074/jbc.M211599200; Sreerama N, 1999, PROTEIN SCI, V8, P370; Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m; Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499; Ziegler J, 2003, J BIOL CHEM, V278, P50175, DOI 10.1074/jbc.M305234200	45	35	35	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30355	30363		10.1074/jbc.M114.559450	http://dx.doi.org/10.1074/jbc.M114.559450			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25217639	Green Published, hybrid			2022-12-25	WOS:000344549700018
J	Li, L; Yao, YC; Fang, SH; Ma, CQ; Cen, Y; Xu, ZM; Dai, ZY; Li, C; Li, S; Zhang, T; Hong, HH; Qi, WW; Zhou, T; Li, CY; Yang, X; Gao, GQ				Li, Lei; Yao, Ya-Chao; Fang, Shu-Huan; Ma, Cai-Qi; Cen, Yi; Xu, Zu-Min; Dai, Zhi-Yu; Li, Cen; Li, Shuai; Zhang, Ting; Hong, Hong-Hai; Qi, Wei-Wei; Zhou, Ti; Li, Chao-Yang; Yang, Xia; Gao, Guo-Quan			Pigment Epithelial-derived Factor (PEDF)-triggered Lung Cancer Cell Apoptosis Relies on p53 Protein-driven Fas Ligand (Fas-L) Up-regulation and Fas Protein Cell Surface Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53-MEDIATED APOPTOSIS; SIGNALING PATHWAYS; ENDOTHELIAL-CELLS; MELANOMA-CELLS; GENE-TRANSFER; GROWTH; EXPRESSION; PEDF; ANGIOGENESIS; CD95	Pigment epithelium-derived factor (PEDF), a potent antiangiogenesis agent, has recently attracted attention for targeting tumor cells in several types of tumors. However, less is known about the apoptosis-inducing effect of PEDF on human lung cancer cells and the underlying molecular events. Here we report that PEDF has a growth-suppressive and proapoptotic effect on lung cancer xenografts. Accordingly, in vitro, PEDF apparently induced apoptosis in A549 and Calu-3 cells, predominantly via the Fas-L/Fas death signaling pathway. Interestingly, A549 and Calu-3 cells are insensitive to the Fas-L/Fas apoptosis pathway because of the low level of cell surface Fas. Our results revealed that, in addition to the enhancement of Fas-L expression, PEDF increased the sensitivity of A549 and Calu-3 cells to Fas-L-mediated apoptosis by triggering the translocation of Fas protein to the plasma membrane in a p53- and FAP-1-dependent manner. Similarly, the up-regulation of Fas-L by PEDF was also mediated by p53. Furthermore, peroxisome proliferator-activated receptor gamma was determined to be the upstream regulator of p53. Together, these findings uncover a novel mechanism of tumor cell apoptosis induced by PEDF and provide a potential therapeutic strategy for tumors that are insensitive to Fas-L/Fas-dependent apoptosis because of a low level of cell surface Fas.	[Li, Lei; Ma, Cai-Qi; Cen, Yi; Dai, Zhi-Yu; Li, Cen; Li, Shuai; Zhang, Ting; Hong, Hong-Hai; Qi, Wei-Wei; Zhou, Ti; Yang, Xia; Gao, Guo-Quan] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou 510080, Guangdong, Peoples R China; [Li, Chao-Yang] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510060, Guangdong, Peoples R China; [Li, Lei] Guangzhou Med Univ, Dept Reprod Med Ctr, Key Lab Reprod Med Guangdong Prov, Affiliated Hosp 3, Guangzhou 510150, Guangdong, Peoples R China; [Yao, Ya-Chao] Guangdong 2 Prov Peoples Hosp, Lab Ctr, Guangzhou 510317, Guangdong, Peoples R China; [Fang, Shu-Huan] Guangzhou Univ Chinese Med, DME Ctr, Clin Pharmacol Inst, Guangzhou 510405, Guangdong, Peoples R China; [Xu, Zu-Min] Guangdong Med Coll, Affiliated Hosp, Ctr Canc, Zhanjiang 524000, Peoples R China; [Yang, Xia] Sun Yat Sen Univ, Minist Educ, China Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China; [Gao, Guo-Quan] Sun Yat Sen Univ, Dept Educ Guangdong Prov, Key Lab Funct Mol Marine Microorganisms, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University; Guangzhou University of Chinese Medicine; Guangdong Medical University; Sun Yat Sen University; Sun Yat Sen University	Li, CY (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510060, Guangdong, Peoples R China.	clioffice@yahoo.cn; yangxia@mail.sysu.edu.cn; gaogq@mail.sysu.edu.cn	Li, Chao/GSM-8117-2022; Dai, Zhiyu/H-3453-2019	Li, Chao/0000-0001-6110-6210; Dai, Zhiyu/0000-0002-2945-7923	National Nature Science Foundation of China [30971208, 30973449, 81070746, 81172163, 81272338, 81272515, 81200706, 81400639]; National Key Sci-Tech Special Project of China [2009ZX09103-642, 2013ZX09102-053]; Program for Doctoral Station in University Grants [20100171110049, 2011M501364, 20120171110053]; Key Project of Nature Science Foundation of Guangdong Province, China [10251008901000009]; Key Sci-tech Research Project of Guangdong Province, China [2011B031200006]; Guandong Natural Science Fund [10151008901000007, S2012010009250, S2012040006986]; Key Sci-tech Research Project of Guangzhou Municipality, China [2011Y1-00017-8, 12A52061519]; Changjiang Scholars and Innovative Research Team in University 985 project PCSIRT [0947]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Sci-Tech Special Project of China; Program for Doctoral Station in University Grants; Key Project of Nature Science Foundation of Guangdong Province, China; Key Sci-tech Research Project of Guangdong Province, China; Guandong Natural Science Fund; Key Sci-tech Research Project of Guangzhou Municipality, China; Changjiang Scholars and Innovative Research Team in University 985 project PCSIRT	This study was supported by National Nature Science Foundation of China Grants 30971208, 30973449, 81070746, 81172163, 81272338, 81272515, 81200706, and 81400639; by National Key Sci-Tech Special Project of China Grants 2009ZX09103-642 and 2013ZX09102-053; by Program for Doctoral Station in University Grants 20100171110049, 2011M501364, and 20120171110053; by Key Project of Nature Science Foundation of Guangdong Province, China, Grant 10251008901000009; by Key Sci-tech Research Project of Guangdong Province, China, Grant 2011B031200006; by Guandong Natural Science Fund Grant 10151008901000007, S2012010009250, and S2012040006986; by Key Sci-tech Research Project of Guangzhou Municipality, China, Grants 2011Y1-00017-8 and 12A52061519; and by Changjiang Scholars and Innovative Research Team in University 985 project PCSIRT 0947.	Abe R, 2004, AM J PATHOL, V164, P1225, DOI 10.1016/S0002-9440(10)63210-5; Beltinger C, 1999, P NATL ACAD SCI USA, V96, P8699, DOI 10.1073/pnas.96.15.8699; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Bonofiglio D, 2009, BREAST CANCER RES TR, V113, P423, DOI 10.1007/s10549-008-9944-1; Broadhead ML, 2009, EXPERT OPIN THER TAR, V13, P1429, DOI 10.1517/14728220903307475; Buque A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-25; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Chen Jin-Feng, 2009, Zhonghua Yi Xue Za Zhi, V89, P485; Chen JF, 2009, INT J ONCOL, V35, P159, DOI 10.3892/ijo_00000324; Chen M, 2002, APOPTOSIS, V7, P313, DOI 10.1023/A:1016167228059; Crowe S, 2009, CELL METAB, V10, P40, DOI 10.1016/j.cmet.2009.06.001; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Ehrenschwender M, 2009, ADV EXP MED BIOL, V647, P64, DOI 10.1007/978-0-387-89520-8_5; Ek ETH, 2007, CANCER GENE THER, V14, P616, DOI 10.1038/sj.cgt.7701044; Ek ETH, 2006, MOL CANCER THER, V5, P1641, DOI 10.1158/1535-7163.MCT-06-0107; Guan M, 2004, CANCER GENE THER, V11, P325, DOI 10.1038/sj.cgt.7700675; Guan M, 2007, CANCER BIOL THER, V6, P419, DOI 10.4161/cbt.6.3.3757; Haynes AP, 2002, BRIT J HAEMATOL, V118, P488, DOI 10.1046/j.1365-2141.2002.03643.x; He SS, 2012, ONCOL REP, V27, P1142, DOI 10.3892/or.2012.1621; Ho TC, 2007, CARDIOVASC RES, V76, P213, DOI 10.1016/j.cardiores.2007.06.032; Ho TC, 2009, AM J PHYSIOL-CELL PH, V296, pC273, DOI 10.1152/ajpcell.00432.2008; Irie S, 2001, DNA SEQUENCE, V11, P519, DOI 10.3109/10425170109041336; Ivanov VN, 2003, MOL CELL BIOL, V23, P3623, DOI 10.1128/MCB.23.10.3623-3635.2003; Kawasaki M, 2000, EUR J CANCER, V36, P656, DOI 10.1016/S0959-8049(99)00332-9; Lee SH, 1999, ONCOGENE, V18, P3754, DOI 10.1038/sj.onc.1202769; Li L, 2012, INT J PHARMACEUT, V438, P1, DOI 10.1016/j.ijpharm.2012.08.043; Lin CS, 2010, CLIN VACCINE IMMUNOL, V17, P1548, DOI 10.1128/CVI.00064-10; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Muller M, 1997, J CLIN INVEST, V99, P403, DOI 10.1172/JCI119174; Munsch D, 2000, J BIOL CHEM, V275, P3867, DOI 10.1074/jbc.275.6.3867; Muschen M, 2000, J MOL MED-JMM, V78, P312, DOI 10.1007/s001090000112; Nambu Y, 1998, J CLIN INVEST, V101, P1102, DOI 10.1172/JCI1692; OWENSCHAUB LB, 1994, CANCER RES, V54, P1580; Peter ME, 2005, BBA-REV CANCER, V1755, P25, DOI 10.1016/j.bbcan.2005.01.001; Pratesi G, 1999, BRIT J CANCER, V80, P1912, DOI 10.1038/sj.bjc.6690620; Rho JK, 2007, CANCER RES, V67, P1163, DOI 10.1158/0008-5472.CAN-06-2037; Roy J, 2010, CAN J PHYSIOL PHARM, V88, P353, DOI 10.1139/Y09-134; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Sodeman T, 2000, AM J PHYSIOL-GASTR L, V278, pG992, DOI 10.1152/ajpgi.2000.278.6.G992; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Stellmach V, 2001, P NATL ACAD SCI USA, V98, P2593, DOI 10.1073/pnas.031252398; Ungefroren H, 2001, J CELL SCI, V114, P2735; Viard-Leveugle I, 2003, J PATHOL, V201, P268, DOI 10.1002/path.1428; Villa-Morales M, 2012, EXPERT OPIN THER TAR, V16, P85, DOI 10.1517/14728222.2011.628937; Volpert OV, 2002, NAT MED, V8, P349, DOI 10.1038/nm0402-349; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; WELLER M, 1995, CANCER RES, V55, P2936; Xu G, 2007, LARYNGOSCOPE, V117, P960, DOI 10.1097/mlg.0b013e318041549c; Yamada T, 2006, FEBS LETT, V580, P4387, DOI 10.1016/j.febslet.2006.07.003; Yang HS, 2009, CANCER SCI, V100, P2419, DOI 10.1111/j.1349-7006.2009.01332.x; Zhang SX, 2006, FASEB J, V20, P323, DOI 10.1096/fj.05-4313fje; Zheng J, 2012, ALLERGY, V67, P362, DOI 10.1111/j.1398-9995.2011.02776.x	52	23	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30785	30799		10.1074/jbc.M114.590000	http://dx.doi.org/10.1074/jbc.M114.590000			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25225287	Green Published, hybrid			2022-12-25	WOS:000344549700053
J	Wu, CC; Wang, CK; Chen, YC; Lin, TH; Jinn, TR; Lin, CT				Wu, Chien-Chen; Wang, Chien-Kuo; Chen, Yu-Ching; Lin, Tien-Huang; Jinn, Tzyy-Rong; Lin, Ching-Ting			IscR Regulation of Capsular Polysaccharide Biosynthesis and Iron-Acquisition Systems in Klebsiella pneumoniae CG43	PLOS ONE			English	Article							ESCHERICHIA-COLI; OXIDATIVE STRESS; GENE-EXPRESSION; DNA-BINDING; CLUSTER; IDENTIFICATION; MUTAGENESIS; REDUCTION; PROMOTERS; PATHOGENS	IscR, an Fe-S cluster-containing transcriptional factor, regulates genes involved in various cellular processes. In response to environmental stimuli such as oxidative stress and iron levels, IscR switches between its holo and apo forms to regulate various targets. IscR binding sequences are classified into two types:the type 1 IscR box that is specific for holo-IscR binding, and the type 2 IscR box that binds holo- and apo-IscR. Studying Klebsiella pneumoniae CG43S3, we have previously shown that iron availability regulates capsular polysaccharide (CPS) biosynthesis and iron-acquisition systems. The present study investigated whether IscR is involved in this regulation. Compared with that in CG43S3, the amount of CPS was decreased in AP001 (Delta iscR) or AP002 (iscR(3CA)), a CG43S3-derived strain expressing mutated IscR mimicked apo-IscR, suggesting that only holo-IscR activates CPS biosynthesis. Furthermore, a promoter-reporter assay verified that the transcription of cps genes was reduced in AP001 and AP002. Purified IscR::His(6), but not IscR(3CA)::His(6), was also found to bind the predicted type 1 IscR box specifically in the cps promoter. Furthermore, reduced siderophore production was observed in AP004 (Delta fur-Delta iscR) but not in AP005 (Delta fur-iscR(3CA)), implying that apo-IscR activates iron acquisition. Compared with those in AP004, mRNA levels of three putative iron acquisition systems (fhu, iuc, and sit) were increased in AP005, and both purified IscR::His(6) and IscR(3CA)::His(6) bound the predicted type 2 IscR box in the fhuA, iucA, and sitA promoters, whereas IscR(3CA)::His(6) displayed a lower affinity. Finally, we analyzed the effect of external iron levels on iscR expression. The transcription of iscR was increased under iron-depleted conditions as well as in AP001 and AP002, suggesting an auto-repression exerted by apoIscR. Our results show that in K. pneumoniae, IscR plays a dual role in the regulation of CPS biosynthesis and iron-acquisition systems in response to environmental iron availability.	[Wu, Chien-Chen] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Wang, Chien-Kuo] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Chen, Yu-Ching] Asia Univ, Dept Biomed Informat, Taichung, Taiwan; [Lin, Tien-Huang] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Div Urol, Taichung, Taiwan; [Lin, Tien-Huang; Jinn, Tzyy-Rong; Lin, Ching-Ting] China Med Univ, Sch Chinese Med, Grad Inst Chinese Med, Taichung, Taiwan	National Yang Ming Chiao Tung University; Asia University Taiwan; Asia University Taiwan; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; China Medical University Taiwan	Lin, CT (corresponding author), China Med Univ, Sch Chinese Med, Grad Inst Chinese Med, Taichung, Taiwan.	gingting@mail.cmu.edu.tw			National Science Council [NSC 99-2320-B-039-002MY3, NSC 102-2320-B-039-042-]; China Medical University [CMU99-ASIA-07, CMU100-ASIA-12]; Taichung Tzuchi Hospital, The Buddhist Tzu Chi Medical Foundation [TTCRD-10218]	National Science Council(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University); Taichung Tzuchi Hospital, The Buddhist Tzu Chi Medical Foundation	The work is supported by the grants from National Science Council (NSC 99-2320-B-039-002MY3 and NSC 102-2320-B-039-042-), China Medical University (CMU99-ASIA-07 and CMU100-ASIA-12), and Taichung Tzuchi Hospital, The Buddhist Tzu Chi Medical Foundation (TTCRD-10218). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; ARAKAWA Y, 1995, J BACTERIOL, V177, P1788, DOI 10.1128/jb.177.7.1788-1796.1995; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Boddicker JD, 2006, INFECT IMMUN, V74, P4590, DOI 10.1128/IAI.00129-06; Cheng HY, 2010, J BACTERIOL, V192, P3144, DOI 10.1128/JB.00031-10; Neto JFD, 2009, NUCLEIC ACIDS RES, V37, P4812, DOI 10.1093/nar/gkp509; DOMENICO P, 1989, INFECT IMMUN, V57, P3778, DOI 10.1128/IAI.57.12.3778-3782.1989; Favre-Bonte S, 1999, INFECT IMMUN, V67, P554, DOI 10.1128/IAI.67.2.554-561.1999; Giel JL, 2013, MOL MICROBIOL, V87, P478, DOI 10.1111/mmi.12052; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Griffith KL, 2001, MOL MICROBIOL, V40, P1141, DOI 10.1046/j.1365-2958.2001.02456.x; HAN SHB, 1995, WESTERN J MED, V162, P220; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Huang SH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-148; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0; Lai YC, 2001, INFECT IMMUN, V69, P7140, DOI 10.1128/IAI.69.11.7140-7145.2001; Lai YC, 2003, J BACTERIOL, V185, P788, DOI 10.1128/JB.185.3.788-800.2003; Lau YJ, 2000, J CLIN MICROBIOL, V38, P412; Lim JG, 2014, INFECT IMMUN, V82, P569, DOI 10.1128/IAI.01141-13; Lin CT, 2006, J BIOCHEM, V140, P429, DOI 10.1093/jb/mvj168; Lin CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054430; Lin CT, 2011, MICROBIOL-SGM, V157, P419, DOI 10.1099/mic.0.044065-0; Lin JC, 2004, MICROBES INFECT, V6, P1191, DOI 10.1016/j.micinf.2004.06.003; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Moranta D, 2010, INFECT IMMUN, V78, P1135, DOI 10.1128/IAI.00940-09; Nesbit AD, 2009, J MOL BIOL, V387, P28, DOI 10.1016/j.jmb.2009.01.055; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Pullan ST, 2007, J BACTERIOL, V189, P1845, DOI 10.1128/JB.01354-06; Py B, 2011, CURR OPIN MICROBIOL, V14, P218, DOI 10.1016/j.mib.2011.01.004; Rajagopalan S, 2013, NAT STRUCT MOL BIOL, V20, P740, DOI 10.1038/nsmb.2568; Regueiro V, 2006, MICROBIOL-SGM, V152, P555, DOI 10.1099/mic.0.28285-0; Sahly H, 2000, INFECT IMMUN, V68, P6744, DOI 10.1128/IAI.68.12.6744-6749.2000; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Wu CC, 2012, MICROBIOL-SGM, V158, P1045, DOI 10.1099/mic.0.053801-0; Yang YS, 2009, J CLIN MICROBIOL, V47, P3336, DOI 10.1128/JCM.00918-09; Yeo WS, 2006, MOL MICROBIOL, V61, P206, DOI 10.1111/j.1365-2958.2006.05220.x	43	12	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107812	10.1371/journal.pone.0107812	http://dx.doi.org/10.1371/journal.pone.0107812			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25237815	Green Submitted, Green Published, gold			2022-12-25	WOS:000342491600051
J	Chakraborty, S; Deb, A; Maji, RK; Saha, S; Ghosh, Z				Chakraborty, Sohini; Deb, Aritra; Maji, Ranjan Kumar; Saha, Sudipto; Ghosh, Zhumur			LncRBase: An Enriched Resource for lncRNA Information	PLOS ONE			English	Article							LONG NONCODING RNAS; INTEGRATIVE ANNOTATION; MICROARRAY DATA; CPG-ISLANDS; EXPRESSION; GENOME; DATABASE; REVEALS; ALIGNMENT; TRANSCRIPTOME	Long noncoding RNAs (lncRNAs) are noncoding transcripts longer than 200 nucleotides, which show evidence of pervasive transcription and participate in a plethora of cellular regulatory processes. Although several noncoding transcripts have been functionally annotated as lncRNAs within the genome, not all have been proven to fulfill the criteria for a functional regulator and further analyses have to be done in order to include them in a functional cohort. LncRNAs are being classified and reclassified in an ongoing annotation process, and the challenge is fraught with ambiguity, as newer evidences of their biogenesis and functional implication come into light. In our effort to understand the complexity of this still enigmatic biomolecule, we have developed a new database entitled "LncRBase'' where we have classified and characterized lncRNAs in human and mouse. It is an extensive resource of human and mouse lncRNA transcripts belonging to fourteen distinct subtypes, with a total of 83,201 entries for mouse and 133,361 entries for human: among these, we have newly annotated 8,507 mouse and 14,813 human non coding RNA transcripts (from UCSC and H-InvDB 8.0) as lncRNAs. We have especially considered protein coding gene loci which act as hosts for non coding transcripts. LncRBase includes different lncRNA transcript variants of protein coding genes within LncRBase. LncRBase provides information about the genomic context of different lncRNA subtypes, their interaction with small non coding RNAs (ncRNAs) viz. piwi interacting RNAs (piRNAs) and microRNAs (miRNAs) and their mode of regulation, via association with diverse other genomic elements. Adequate knowledge about genomic origin and molecular features of lncRNAs is essential to understand their functional and behavioral complexities. Overall, LncRBase provides a thorough study on various aspects of lncRNA origin and function and a user-friendly interface to search for lncRNA information. LncRBase is available at http://bicresources.jcbose.ac.in/zhumur/lncrbase.	[Chakraborty, Sohini; Deb, Aritra; Maji, Ranjan Kumar; Saha, Sudipto; Ghosh, Zhumur] Bose Inst, Bioinformat Ctr, Kolkata, India	Department of Science & Technology (India); Bose Institute	Ghosh, Z (corresponding author), Bose Inst, Bioinformat Ctr, Kolkata, India.	zhumur@jcbose.ac.in	Chakraborty, Sohini/ABA-4937-2021; Saha, Sudipto/AAF-1034-2020	Chakraborty, Sohini/0000-0002-6339-7792; Saha, Sudipto/0000-0001-9433-8894; Maji, Ranjan Kumar/0000-0002-9559-1661	Council of Scientific and Industrial Research (CSIR); Department of Biotechnology (DBT)	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India)	This work was supported by Council of Scientific and Industrial Research (CSIR) and Department of Biotechnology (DBT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Bao JQ, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.113308; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beaulieu YB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003078; Bhartiya D, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat034; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cao WJ, 2013, WORLD J GASTROENTERO, V19, P3658, DOI 10.3748/wjg.v19.i23.3658; Cartault F, 2012, P NATL ACAD SCI USA, V109, P4980, DOI 10.1073/pnas.1111596109; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Chew GL, 2013, DEVELOPMENT, V140, P2828, DOI 10.1242/dev.098343; Cooper C, 2011, BIOCHIMIE, V93, P1973, DOI 10.1016/j.biochi.2011.07.002; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dinger ME, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000176; Erdmann VA, 1999, NUCLEIC ACIDS RES, V27, P192, DOI 10.1093/nar/27.1.192; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Han H, 2011, HUM MOL GENET, V20, P4299, DOI 10.1093/hmg/ddr356; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Huang XA, 2013, DEV CELL, V24, P502, DOI 10.1016/j.devcel.2013.01.023; Jalali S., 2013, PLOS ONE PLOS ONE, V8; Jalali S, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-25; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Liao Q, 2011, NUCLEIC ACIDS RES, V39, P3864, DOI 10.1093/nar/gkq1348; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Lu XY, 2014, NAT STRUCT MOL BIOL, V21, P423, DOI 10.1038/nsmb.2799; Maeda N, 2006, PLOS GENET, V2, P498, DOI 10.1371/journal.pgen.0020062; Mattick JS, 2003, BIOESSAYS, V25, P930, DOI 10.1002/bies.10332; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Michelhaugh SK, 2011, J NEUROCHEM, V116, P459, DOI 10.1111/j.1471-4159.2010.07126.x; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Nordstrom KJV, 2009, GENOMICS, V94, P169, DOI 10.1016/j.ygeno.2009.05.012; Novikova IV, 2013, INT J MOL SCI, V14, P23672, DOI 10.3390/ijms141223672; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Rossi JJ, 2011, EMBO J, V30, P4340, DOI 10.1038/emboj.2011.373; Royo H, 2008, BIOL CELL, V100, P149, DOI 10.1042/BC20070126; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Skinner Mitchell E, 2010, Curr Protoc Bioinformatics, VChapter 9, DOI 10.1002/0471250953.bi0913s32; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ulveling D, 2011, BIOCHIMIE, V93, P2024, DOI 10.1016/j.biochi.2011.06.019; Ulveling D, 2011, BIOCHIMIE, V93, P633, DOI 10.1016/j.biochi.2010.11.004; van Wolfswinkel JC, 2010, J CELL SCI, V123, P1825, DOI 10.1242/jcs.061713; Volders PJ, 2013, NUCLEIC ACIDS RES, V41, pD246, DOI 10.1093/nar/gks915; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Xie C, 2013, NUCL ACIDS RES; Yamasaki C, 2008, NUCLEIC ACIDS RES, V36, pD793, DOI 10.1093/nar/gkm999; Yang JH, 2010, NUCLEIC ACIDS RES, V38, pD123, DOI 10.1093/nar/gkp943; Zhang Y, 2010, RNA, V16, P1889, DOI 10.1261/rna.2226910; Zilliox MJ, 2007, NAT METHODS, V4, P911, DOI 10.1038/NMETH1102	69	44	46	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e108010	10.1371/journal.pone.0108010	http://dx.doi.org/10.1371/journal.pone.0108010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233092	gold, Green Published, Green Submitted			2022-12-25	WOS:000342921200073
J	Perisic, O; Lu, H				Perisic, Ognjen; Lu, Hui			On the Improvement of Free-Energy Calculation from Steered Molecular Dynamics Simulations Using Adaptive Stochastic Perturbation Protocols	PLOS ONE			English	Article							TITIN IMMUNOGLOBULIN DOMAINS; NONEQUILIBRIUM MEASUREMENTS; MECHANICAL STABILITY; JARZYNSKIS EQUALITY; FORCE SPECTROSCOPY; HYSTERESIS; PROTEINS; KINETICS	The potential of mean force (PMF) calculation in single molecule manipulation experiments performed via the steered molecular dynamics (SMD) technique is a computationally very demanding task because the analyzed system has to be perturbed very slowly to be kept close to equilibrium. Faster perturbations, far from equilibrium, increase dissipation and move the average work away from the underlying free energy profile, and thus introduce a bias into the PMF estimate. The Jarzynski equality offers a way to overcome the bias problem by being able to produce an exact estimate of the free energy difference, regardless of the perturbation regime. However, with a limited number of samples and high dissipation the Jarzynski equality also introduces a bias. In our previous work, based on the Brownian motion formalism, we introduced three stochastic perturbation protocols aimed at improving the PMF calculation with the Jarzynski equality in single molecule manipulation experiments and analogous computer simulations. This paper describes the PMF reconstruction results based on full-atom molecular dynamics simulations, obtained with those three protocols. We also want to show that the protocols are applicable with the second-order cumulant expansion formula. Our protocols offer a very noticeable improvement over the simple constant velocity pulling. They are able to produce an acceptable estimate of PMF with a significantly reduced bias, even with very fast perturbation regimes. Therefore, the protocols can be adopted as practical and efficient tools for the analysis of mechanical properties of biological molecules.	[Perisic, Ognjen; Lu, Hui] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Shanghai Inst Med Genet, Shanghai 200030, Peoples R China; [Perisic, Ognjen; Lu, Hui] Univ Illinois, Dept Bioengn, Chicago, IL USA	Shanghai Jiao Tong University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Perisic, O (corresponding author), Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Shanghai Inst Med Genet, Shanghai 200030, Peoples R China.	ognjen.perisic@gmail.com; huilu@uic.edu	Lu, Hui/K-3264-2019; Perišić, Ognjen/ABD-5742-2020	Perisic, Ognjen/0000-0002-6855-3985; Lu, Hui/0000-0001-8347-0830	National Natural Science Foundation of China [31071167]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The project was funded by the National Natural Science Foundation of China, grant No. 31071167. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R.L.., 2003, SIGNAL ANAL TIME FRE, P482; Athanasios P, 1991, PROBABILITY RANDOM V; Balsera M, 1997, BIOPHYS J, V73, P1281, DOI 10.1016/S0006-3495(97)78161-X; Bracewell RN, 2000, FOURIER TRANSFORM IT; Braun O, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.158105; CALLEN HB, 1951, PHYS REV, V83, P34, DOI 10.1103/PhysRev.83.34; FERRENBERG AM, 1989, PHYS REV LETT, V63, P1195, DOI 10.1103/PhysRevLett.63.1195; Gardiner C. W., 1983, HDB STOCHASTIC METHO; Genchev GZ, 2009, CELL BIOCHEM BIOPHYS, V55, P141, DOI 10.1007/s12013-009-9064-5; Harvey S.C., 1988, DYNAMICS PROTEINS NU; HERMANS J, 1991, J PHYS CHEM-US, V95, P9029, DOI 10.1021/j100176a002; Hummer G, 2001, P NATL ACAD SCI USA, V98, P3658, DOI 10.1073/pnas.071034098; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Kou SC, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.180603; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Kuo TL, 2010, P NATL ACAD SCI USA, V107, P11336, DOI 10.1073/pnas.1006517107; Levy Y, 2001, P NATL ACAD SCI USA, V98, P2188, DOI 10.1073/pnas.041611998; Liphardt J, 2002, SCIENCE, V296, P1832, DOI 10.1126/science.1071152; Lu H, 1999, CHEM PHYS, V247, P141, DOI 10.1016/S0301-0104(99)00164-0; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maragakis P, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2937892; Oberhofer H, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061106; Palassini M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.060601; Park S, 2004, J CHEM PHYS, V120, P5946, DOI 10.1063/1.1651473; Park S, 2003, J CHEM PHYS, V119, P3559, DOI 10.1063/1.1590311; Perisic O, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.013303; Perisic O, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.056705; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Reif F., 1965, FUNDAMENTALS STAT TH; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Sharma D, 2008, BIOPHYS J, V95, P3935, DOI 10.1529/biophysj.108.134072; Sharma D, 2007, P NATL ACAD SCI USA, V104, P9278, DOI 10.1073/pnas.0700351104; Shiavi R., 1999, INTRO APPL STAT SIGN; Van Kampen N. G., 1992, STOCHASTIC PROCESSES; WOOD RH, 1991, J PHYS CHEM-US, V95, P6670, DOI 10.1021/j100170a054; Zuckerman DM, 2004, J STAT PHYS, V114, P1303, DOI 10.1023/B:JOSS.0000013961.84860.5b; Zuckerman DM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.180602	39	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e101810	10.1371/journal.pone.0101810	http://dx.doi.org/10.1371/journal.pone.0101810			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232859	Green Published, Green Submitted, gold			2022-12-25	WOS:000342921200002
J	Ueyama, K; Mori, K; Shoji, T; Omata, H; Gehlbach, PL; Brough, DE; Wei, LL; Yoneya, S				Ueyama, Kazuhiro; Mori, Keisuke; Shoji, Takuhei; Omata, Hidekazu; Gehlbach, Peter L.; Brough, Douglas E.; Wei, Lisa L.; Yoneya, Shin			Ocular Localization and Transduction by Adenoviral Vectors Are Serotype-Dependent and Can Be Modified by Inclusion of RGD Fiber Modifications	PLOS ONE			English	Article							MEDIATED GENE-TRANSFER; EPITHELIUM-DERIVED FACTOR; TRANSGENE EXPRESSION; IN-VIVO; INTEGRIN ALPHA(V)BETA(3); COMPLEMENT ACTIVATION; IMMUNE-RESPONSES; PROTEIN CD46; CELLS; RECEPTOR	Purpose: To evaluate localization and transgene expression from adenoviral vector of serotypes 5, 35, and 28, +/- an RGD motif in the fiber following intravitreal or subretinal administration. Methods: Ocular transduction by adenoviral vector serotypes +/- RGD was studied in the eyes of mice receiving an intravitreous or subretinal injection. Each serotype expressed a CMV-GFP expression cassette and histological sections of eyes were examined. Transgene expression levels were examined using luciferase (Luc) regulated by the CMV promoter. Results: GFP localization studies revealed that serotypes 5 and 28 given intravitreously transduced corneal endothelial, trabecular, and iris cells. Intravitreous delivery of the unmodified Ad35 serotype transduced only trabecular meshwork cells, but, the modification of the RGD motif into the fiber of the Ad35 viral vector base expanded transduction to corneal endothelial and iris cells. Incorporation of the RGD motif into the fiber knob with deletion of RGD from the penton base did not affect the transduction ability of the Ad5 vector base. Subretinal studies showed that RGD in the Ad5 knob shifted transduction from RPE cells to photoreceptor cells. Using a CMV-Luc expression cassette, intravitreous delivery of all the tested vectors, such as Ad5-, Ad35- and Ad28- resulted in an initial rapid induction of luciferase activity that thereafter declined. Subretinal administration of vectors showed a marked difference in transgene activity. Ad35-Luc gene expression peaked at 7 days and remained elevated for 6 months. Ad28-Luc expression was high after 1 day and remained sustained for one month. Conclusions: Different adenoviral vector serotypes 6 modifications transduce different cells within the eye. Transgene expression can be brief or extended and is serotype and delivery route dependent. Thus, adenoviral vectors provide a versatile platform for the delivery of therapeutic agents for ocular diseases.	[Ueyama, Kazuhiro; Mori, Keisuke; Shoji, Takuhei; Omata, Hidekazu; Yoneya, Shin] Saitama Med Univ, Dept Ophthalmol, Iruma, Saitama, Japan; [Gehlbach, Peter L.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Brough, Douglas E.; Wei, Lisa L.] GenVec Inc, Gaithersburg, MD USA; [Wei, Lisa L.] NEI, Bethesda, MD 20892 USA	Saitama Medical University; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Ueyama, K (corresponding author), Saitama Med Univ, Dept Ophthalmol, Iruma, Saitama, Japan.	thecollectors20060211@yahoo.co.jp	Shoji, Takuhei/W-1856-2017	Shoji, Takuhei/0000-0002-5464-2573				BARR D, 1995, GENE THER, V2, P151; Bennett J, 2000, MOL THER, V1, P501, DOI 10.1006/mthe.2000.0080; Bennett J, 2003, GENE THER, V10, P977, DOI 10.1038/sj.gt.3302030; Bennett J, 1994, INVEST OPHTH VIS SCI, V35, P235; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Brough DE, 1996, J VIROL, V70, P6497, DOI 10.1128/JVI.70.9.6497-6501.1996; Butman BT, 2006, DEV BIOLOGICALS, V123, P225; Campochiaro PA, 2006, HUM GENE THER, V17, P167, DOI 10.1089/hum.2006.17.167; Cashman SM, 2007, MOL THER, V15, P1640, DOI 10.1038/sj.mt.6300203; Chevez-Barrios P, 2005, J CLIN ONCOL, V23, P7927, DOI 10.1200/JCO.2004.00.1883; Einfeld DA, 2001, J VIROL, V75, P11284, DOI 10.1128/JVI.75.23.11284-11291.2001; Gaggar A, 2003, NAT MED, V9, P1408, DOI 10.1038/nm952; Hamilton MM, 2008, MOL VIS, V14, P2535; Hauswirth WW, 2000, INVEST OPHTH VIS SCI, V41, P2821; HENRY LJ, 1994, J VIROL, V68, P5239, DOI 10.1128/JVI.68.8.5239-5246.1994; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; JOMARY C, 1994, FEBS LETT, V347, P117, DOI 10.1016/0014-5793(94)00512-5; Law LK, 2005, MOL THER, V12, P599, DOI 10.1016/j.ymthe.2005.05.017; Lemiale F, 2007, VACCINE, V25, P2074, DOI 10.1016/j.vaccine.2006.11.025; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; Liu J, 2008, MOL VIS, V14, P2087; Luna J, 1996, LAB INVEST, V75, P563; Mallam JN, 2004, INVEST OPHTH VIS SCI, V45, P1680, DOI 10.1167/iovs.03-0730; MASHHOUR B, 1994, GENE THER, V1, P122; MATHIAS P, 1994, J VIROL, V68, P6811, DOI 10.1128/JVI.68.10.6811-6814.1994; McLaughlin BJ, 2003, INVEST OPHTH VIS SCI, V44, P3669, DOI 10.1167/iovs.02-0813; McVey D, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-276; Mori K, 2002, INVEST OPHTH VIS SCI, V43, P1610; Mori K, 2001, J CELL PHYSIOL, V188, P253, DOI 10.1002/jcp.1114; Mudhakir D, 2009, AAPS J, V11, P65, DOI 10.1208/s12248-009-9080-9; Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004; OGLESBY TJ, 1992, J EXP MED, V175, P1547, DOI 10.1084/jem.175.6.1547; RAABE T, 1995, EMBO J, V14, P2509, DOI 10.1002/j.1460-2075.1995.tb07248.x; Reynolds PN, 1999, GENE THER, V6, P1336, DOI 10.1038/sj.gt.3300941; Roelvink PW, 1998, J VIROL, V72, P7909, DOI 10.1128/JVI.72.10.7909-7915.1998; Schagen FHE, 2004, CRIT REV ONCOL HEMAT, V50, P51, DOI 10.1016/S1040-8428(03)00172-0; Sweigard JH, 2010, INVEST OPHTH VIS SCI, V51, P2219, DOI 10.1167/iovs.09-4367; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Yang P, 2009, INVEST OPHTH VIS SCI, V50, P3473, DOI 10.1167/iovs.08-3202; Yang Y, 1996, GENE THER, V3, P137	40	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e108071	10.1371/journal.pone.0108071	http://dx.doi.org/10.1371/journal.pone.0108071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232844	Green Published, Green Submitted, gold			2022-12-25	WOS:000342921200078
J	Bonfim-Mendonca, PD; Ratti, BA; Godoy, JDR; Negri, M; de Lima, NCA; Fiorini, A; Hatanaka, E; Consolaro, MEL; Silva, SD; Svidzinski, TIE				Bonfim-Mendonca, Patricia de Souza; Ratti, Bianca Altrao; Ribeiro Godoy, Janine da Silva; Negri, Melyssa; Alves de Lima, Nayara Cristina; Fiorini, Adriana; Hatanaka, Elaine; Lopes Consolaro, Marcia Edilaine; Silva, Sueli de Oliveira; Estivalet Svidzinski, Terezinha Inez			beta-Glucan Induces Reactive Oxygen Species Production in Human Neutrophils to Improve the Killing of Candida albicans and Candida glabrata Isolates from Vulvovaginal Candidiasis	PLOS ONE			English	Article							OXIDATIVE BURST; HUMAN MONOCYTES; FLOW-CYTOMETRY; MYELOPEROXIDASE; LAMINARIN; CELLS; SUPEROXIDE; PREVALENCE; PHAGOSOME; VAGINITIS	Vulvovaginal candidiasis (VVC) is among the most prevalent vaginal diseases. Candida albicans is still the most prevalent species associated with this pathology, however, the prevalence of other Candida species, such as C. glabrata, is increasing. The pathogenesis of these infections has been intensely studied, nevertheless, no consensus has been reached on the pathogenicity of VVC. In addition, inappropriate treatment or the presence of resistant strains can lead to RVVC (vulvovaginal candidiasis recurrent). Immunomodulation therapy studies have become increasingly promising, including with the beta-glucans. Thus, in the present study, we evaluated microbicidal activity, phagocytosis, intracellular oxidant species production, oxygen consumption, myeloperoxidase (MPO) activity, and the release of tumor necrosis factor alpha (TNF-alpha), interleukin-8 (IL-8), IL-1 beta, and IL-1Ra in neutrophils previously treated or not with beta-glucan. In all of the assays, human neutrophils were challenged with C. albicans and C. glabrata isolated from vulvovaginal candidiasis. beta-glucan significantly increased oxidant species production, suggesting that beta-glucan may be an efficient immunomodulator that triggers an increase in the microbicidal response of neutrophils for both of the species isolated from vulvovaginal candidiasis. The effects of beta-glucan appeared to be mainly related to the activation of reactive oxygen species and modulation of cytokine release.	[Bonfim-Mendonca, Patricia de Souza; Ribeiro Godoy, Janine da Silva; Negri, Melyssa; Fiorini, Adriana; Lopes Consolaro, Marcia Edilaine; Estivalet Svidzinski, Terezinha Inez] Univ Estadual Maringa, Dept Anal Clin & Biomed, Maringa, Parana, Brazil; [Ratti, Bianca Altrao; Alves de Lima, Nayara Cristina; Silva, Sueli de Oliveira] Univ Estadual Maringa, Dept Ciencias Basicas Saude, Maringa, Parana, Brazil; [Hatanaka, Elaine] Univ Cruzeiro Sul, Inst Ciencias Atividade Fis & Esporte, Sao Paulo, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Cruzeiro do Sul	Svidzinski, TIE (corresponding author), Univ Estadual Maringa, Dept Anal Clin & Biomed, Maringa, Parana, Brazil.	terezinha.svidzinski@gmail.com	Hatanaka Dermargos, Elaine/HHZ-1180-2022; Hatanaka, Elaine/AFL-1791-2022; Consolaro, Marcia EL/I-4932-2014; Hatanaka, Elaine/D-6337-2012; Lautenschlager, Sueli OS/P-2164-2017	Hatanaka, Elaine/0000-0002-9716-1163; Consolaro, Marcia EL/0000-0001-9102-4865; Lautenschlager, Sueli OS/0000-0001-9303-0804	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [320]; Fundacao Araucaria, Programa de Pos Graduacao em Ciencias da Saude, Universidade Estadual de Maringa; Complexo de Centrais de Apoio a Pesquisa-UEM	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Araucaria, Programa de Pos Graduacao em Ciencias da Saude, Universidade Estadual de Maringa; Complexo de Centrais de Apoio a Pesquisa-UEM	This research is supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - gant number 320, Edital 10/2009, Fundacao Araucaria, Programa de Pos Graduacao em Ciencias da Saude, Universidade Estadual de Maringa and Complexo de Centrais de Apoio a Pesquisa-UEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babic M, 2010, BOSNIAN J BASIC MED, V10, P89, DOI 10.17305/bjbms.2010.2744; Barsanti L, 2011, NAT PROD REP, V28, P457, DOI 10.1039/c0np00018c; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Brown GD, 2003, IMMUNITY, V19, P311, DOI 10.1016/S1074-7613(03)00233-4; Buitron-Garcia-Figueroa R, 2009, CIR CIR, V77, P423; Chai LYA, 2009, MED MYCOL, V47, P227, DOI 10.1080/13693780802209082; Colombo AL, 2013, BRAZ J INFECT DIS, V17, P283, DOI 10.1016/j.bjid.2013.02.001; Dypbukt JM, 2005, FREE RADICAL BIO MED, V39, P1468, DOI 10.1016/j.freeradbiomed.2005.07.008; EDWARDS SW, 1987, J GEN MICROBIOL, V133, P3591; Estabrook R. W., 1967, METHODS ENZYMOLOGY, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4; Fidel PL, 2007, AM J REPROD IMMUNOL, V57, P2, DOI 10.1111/j.1600-0897.2006.00450.x; Fidel Paul L Jr, 2011, Curr Infect Dis Rep, V13, P102, DOI 10.1007/s11908-010-0143-y; Fidel PL, 1999, INFECT IMMUN, V67, P3135, DOI 10.1128/IAI.67.6.3135-3140.1999; Foxman B, 2000, SEX TRANSM DIS, V27, P230, DOI 10.1097/00007435-200004000-00009; Foxman B, 2013, J LOW GENIT TRACT DI, V17, P340, DOI 10.1097/LGT.0b013e318273e8cf; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gow NAR, 2002, CURR OPIN MICROBIOL, V5, P366, DOI 10.1016/S1369-5274(02)00338-7; Grigoriou O, 2006, EUR J OBSTET GYN R B, V126, P121, DOI 10.1016/j.ejogrb.2005.09.015; Hong E, 2014, J LOW GENIT TRACT DI, V18, P31, DOI 10.1097/LGT.0b013e318287aced; Jaeger M, 2013, CURR INFECT DIS REP, V15, P136, DOI 10.1007/s11908-013-0319-3; Kaur R, 2005, CURR OPIN MICROBIOL, V8, P378, DOI 10.1016/j.mib.2005.06.012; Kennedy Melissa A, 2010, Curr Infect Dis Rep, V12, P465, DOI 10.1007/s11908-010-0137-9; Leal CAM, 2011, REDOX REP, V16, P230, DOI 10.1179/1351000211Y.0000000013; Lee JY, 2012, MOLECULES, V17, P5404, DOI 10.3390/molecules17055404; Liu L, 2013, APPL MICROBIOL BIOT, V97, P2551, DOI 10.1007/s00253-012-4368-6; Lopes Consolaro Marcia Edilaine, 2004, Rev Iberoam Micol, V21, P202; Naglik JR, 2011, MICROBES INFECT, V13, P963, DOI 10.1016/j.micinf.2011.06.009; Nakagawa Y, 2003, J INFECT DIS, V187, P710, DOI 10.1086/368334; Neyrinck AM, 2007, INT IMMUNOPHARMACOL, V7, P1497, DOI 10.1016/j.intimp.2007.06.011; Nordenfelt P, 2011, J LEUKOCYTE BIOL, V90, P271, DOI 10.1189/jlb.0810457; Pang ZC, 2005, BIOSCI BIOTECH BIOCH, V69, P553, DOI 10.1271/bbb.69.553; Pascon Renata C, 2011, Enzyme Res, V2011, P679624, DOI 10.4061/2011/679624; Prokopowicz Z, 2012, ARCH IMMUNOL THER EX, V60, P43, DOI 10.1007/s00005-011-0156-8; Rebecchi IMM, 2000, CELL BIOCHEM FUNCT, V18, P127, DOI 10.1002/(SICI)1099-0844(200006)18:2<127::AID-CBF865>3.3.CO;2-M; Roetzer A, 2011, FEMS MICROBIOL LETT, V314, P1, DOI 10.1111/j.1574-6968.2010.02102.x; Rosa MI, 2013, EUR J OBSTET GYN R B, V167, P132, DOI 10.1016/j.ejogrb.2012.12.001; Shukla AK, 2012, EUR J MED CHEM, V54, P49, DOI 10.1016/j.ejmech.2012.04.034; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Spanu T, 2012, J CLIN MICROBIOL, V50, P176, DOI 10.1128/JCM.05742-11; STEVENS P, 1984, MICROCHEM J, V30, P135, DOI 10.1016/0026-265X(84)90034-1; Thompson DS, 2011, EUKARYOT CELL, V10, P1173, DOI 10.1128/EC.05085-11; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Wakshull E, 1999, IMMUNOPHARMACOLOGY, V41, P89, DOI 10.1016/S0162-3109(98)00059-9; Walrand S, 2003, CLIN CHIM ACTA, V331, P103, DOI 10.1016/S0009-8981(03)00086-X; WHITEOWEN C, 1992, J CLIN MICROBIOL, V30, P2071, DOI 10.1128/JCM.30.8.2071-2076.1992; Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200	47	21	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107805	10.1371/journal.pone.0107805	http://dx.doi.org/10.1371/journal.pone.0107805			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229476	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900076
J	Djeddi, D; Cantin, D; Samson, N; Praud, JP				Djeddi, Djamal; Cantin, Danny; Samson, Nathalie; Praud, Jean-Paul			Nasal Continuous Positive Airway Pressure Inhibits Gastroesophageal Reflux in Newborn Lambs	PLOS ONE			English	Article							LOWER ESOPHAGEAL SPHINCTER; INFANT-DEATH-SYNDROME; APNEA; CPAP; MECHANISMS; PRETERM; MUSCLE; CONTRACTION; RELAXATION; RELEVANCE	Background: Using esophageal pHmetry, nasal CPAP (nCPAP) has been shown to decrease acid gastroesophageal reflux (GER) in adult humans. Although both GER (mainly non-acid) and nCPAP use are very frequent in newborns, the effect of nCPAP on GER in early life is unknown. Having recently shown that the newborn lamb is a unique model for studying neonatal GER, our main objective was to assess the effect of nCPAP on GER in newborn lambs. Methods: Eight newborn lambs, aged 2-3 days, were studied. Continuous esophageal pH-Impedance monitoring and polysomnography were performed for six hours during both spontaneous breathing and nCPAP application at 6 cmH(2)O (nCPAP6), in a randomized order. Results were compared in the two experimental conditions, as well as without CPAP during the following 6 hours. Results: i) nCPAP(6) virtually abolished GER [mean +/- SD reflux number for 6 h = 9.1 +/- 8.6 without nCPAP(6) vs. 0.6 +/- 1 with nCPAP(6), P<0.05]; ii) GER number was also reduced during the 6 h-period following nCPAP6 application (18 +/- 16 without nCPAP(6) vs. 7 +/- 8.1 with nCPAP(6,) P<0.05); iii) nCPAP(6) decreased the depth and duration of lower esophageal sphincter relaxation. Conclusions: nCPAP inhibits GER in the newborn lamb. Further clinical studies using different levels of nasal CPAP are needed to confirm this result in human infants.	[Djeddi, Djamal; Cantin, Danny; Samson, Nathalie; Praud, Jean-Paul] Univ Sherbrooke, Neonatal Resp Res Unit, Dept Pediat, Sherbrooke, PQ J1K 2R1, Canada; [Djeddi, Djamal; Cantin, Danny; Samson, Nathalie; Praud, Jean-Paul] Univ Sherbrooke, Neonatal Resp Res Unit, Dept Physiol, Sherbrooke, PQ J1K 2R1, Canada; [Djeddi, Djamal] Amiens Univ, Med Ctr, Dept Pediat, Amiens, France	University of Sherbrooke; University of Sherbrooke; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Djeddi, D (corresponding author), Univ Sherbrooke, Neonatal Resp Res Unit, Dept Pediat, Sherbrooke, PQ J1K 2R1, Canada.	Djeddi.Djamal-Dine@chu-amiens.fr		Djeddi, Djamal-Dine/0000-0002-9513-0275				Babaei A, 2008, GASTROENTEROLOGY, V134, P1322, DOI 10.1053/j.gastro.2008.02.031; Bernier A, 2012, J APPL PHYSIOL, V112, P1984, DOI 10.1152/japplphysiol.01559.2011; Boudaa N, 2013, J APPL PHYSIOL, V114, P637, DOI 10.1152/japplphysiol.00599.2012; Cavusoglu H, 2009, J NEUROSURG-SPINE, V11, P547, DOI 10.3171/2009.6.SPINE09216; Czinn SJ, 2013, PEDIATR DRUGS, V15, P19, DOI 10.1007/s40272-012-0004-2; Djeddi D, 2013, J PEDIATR GASTR NUTR, V57, P188, DOI 10.1097/MPG.0b013e318292b3b2; Djeddi D, 2012, J PEDIATR GASTR NUTR, V55, P745, DOI 10.1097/MPG.0b013e318263cae0; Farre R, 2008, BRIT J PHARMACOL, V153, P858, DOI 10.1038/sj.bjp.0707572; Fournier MR, 1999, J OTOLARYNGOL, V28, P142; Green BT, 2003, ARCH INTERN MED, V163, P41, DOI 10.1001/archinte.163.1.41; Ing Alvin J., 2000, American Journal of Medicine, V108, p120S; KERR P, 1992, CHEST, V101, P1539, DOI 10.1378/chest.101.6.1539; KERR P, 1993, J CLIN GASTROENTEROL, V17, P276, DOI 10.1097/00004836-199312000-00002; Kim HR, 2005, CAN J PHYSIOL PHARM, V83, P811, DOI 10.1139/Y05-060; Laptook AR, 2005, PEDIATRICS, V115, P673, DOI 10.1542/peds.2004-0667; Leiter JC, 2007, RESP PHYSIOL NEUROBI, V159, P127, DOI 10.1016/j.resp.2007.05.014; Mahmoud RA, 2011, PAEDIATR RESPIR REV, V12, P196, DOI 10.1016/j.prrv.2010.12.001; Mittal RK, 2013, J NEUROGASTROENTEROL, V19, P126, DOI 10.5056/jnm.2013.19.2.126; Mittal RK, 2005, NEUROGASTROENT MOTIL, V17, P187, DOI 10.1111/j.1365-2982.2004.00600.x; Pandolifino JE, 2006, GASTROENTEROLOGY, V131, P1725, DOI 10.1053/j.gastro.2006.09.009; Pfannkuche H, 2003, J ANAT; Praud JP, 2010, PAEDIATR RESPIR REV, V11, P208, DOI 10.1016/j.prrv.2010.07.001; Ramanathan R, 2010, J PERINATOL, V30, pS67, DOI 10.1038/jp.2010.99; Roehr CC, 2007, EUR J MED RES, V12, P139; ROSEN CL, 1986, AM J DIS CHILD, V140, P547, DOI 10.1001/archpedi.1986.02140200057027; Samson N, 2005, J APPL PHYSIOL, V99, P1636, DOI 10.1152/japplphysiol.00464.2005; Shepherd K, 2011, SLEEP BREATH, V15, P561, DOI 10.1007/s11325-010-0404-x; Shepherd KL, 2007, AM J PHYSIOL-GASTR L, V292, pG1200, DOI 10.1152/ajpgi.00476.2006; SHOENUT JP, 1994, CHEST, V106, P738, DOI 10.1378/chest.106.3.738; Staiano A, 2007, GASTROENTEROLOGY, V132, P1718, DOI 10.1053/j.gastro.2007.03.042; Tawk M, 2006, CHEST, V130, P1003, DOI 10.1378/chest.130.4.1003; Thach B, 2008, EMBO REP, V9, P114, DOI 10.1038/sj.embor.7401163; Vandenplas Y, 2009, J PEDIATR GASTR NUTR, V49, P498, DOI 10.1097/MPG.0b013e3181b7f563	33	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107736	10.1371/journal.pone.0107736	http://dx.doi.org/10.1371/journal.pone.0107736			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226514	gold, Green Submitted, Green Published			2022-12-25	WOS:000344317700078
J	Mishra, NN; Bayer, AS; Weidenmaier, C; Grau, T; Wanner, S; Stefani, S; Cafiso, V; Bertuccio, T; Yeaman, MR; Nast, CC; Yang, SJ				Mishra, Nagendra N.; Bayer, Arnold S.; Weidenmaier, Christopher; Grau, Timo; Wanner, Stefanie; Stefani, Stefania; Cafiso, Viviana; Bertuccio, Taschia; Yeaman, Michael R.; Nast, Cynthia C.; Yang, Soo-Jin			Phenotypic and Genotypic Characterization of Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus Strains: Relative Roles of mprF and dlt Operons	PLOS ONE			English	Article							CATIONIC ANTIMICROBIAL PEPTIDES; PLATELET MICROBICIDAL PROTEINS; 2-COMPONENT REGULATORY SYSTEM; CELL-MEMBRANE; IN-VIVO; ENTEROCOCCUS-FAECIUM; TEICHOIC-ACIDS; ENDOCARDITIS; MECHANISMS; NONSUSCEPTIBILITY	Development of in vivo daptomycin resistance (DAP-R) among Staphylococcus aureus clinical isolates, in association with clinical treatment failures, has become a major therapeutic problem. This issue is especially relevant to methicillin-resistant S. aureus (MRSA) strains in the context of invasive endovascular infections. In the current study, we used three wellcharacterized and clinically-derived DAP-susceptible (DAP-S) vs. resistant (DAP-R) MRSA strain-pairs to elucidate potential genotypic mechanisms of the DAP-R phenotype. In comparison to the DAP-S parental strains, DAP-R isolates demonstrated (i) altered expression of two key determinants of net positive surface charge, either during exponential or stationary growth phases (i.e., dysregulation of dltA and mprF), (ii) a significant increase in the D-alanylated wall teichoic acid (WTA) content in DAP-R strains, reflecting DltA gain-in-function; (iii) heightened elaboration of lysinylated-phosphatidylglyderol (L-PG) in DAP-R strains, reflecting MprF gain-in-function; (iv) increased cell membrane (CM) fluidity, and (v) significantly reduced susceptibility to prototypic cationic host defense peptides of platelet and leukocyte origins. In the tested DAP-R strains, genes conferring positive surface charge were dysregulated, and their functionality altered. However, there were no correlations between relative surface positive charge or cell wall thickness and the observed DAP-R phenotype. Thus, charge repulsion mechanisms via altered surface charge may not be sufficient to explain the DAP-R outcome. Instead, changes in the compositional or biophysical order of the DAP CM target of such DAP-R strains (i.e., increased fluidity) may be essential to this phenotype. Taken together, DAP-R in S. aureus appears to involve multi-factorial and strain-specific adaptive mechanisms.	[Mishra, Nagendra N.; Bayer, Arnold S.; Yeaman, Michael R.; Yang, Soo-Jin] Harbor UCLA Med Ctr, Div Infect Dis, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Mishra, Nagendra N.; Bayer, Arnold S.; Yeaman, Michael R.; Nast, Cynthia C.; Yang, Soo-Jin] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Weidenmaier, Christopher; Grau, Timo; Wanner, Stefanie] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany; [Weidenmaier, Christopher] German Ctr Infect Res DZIF, Tubingen, Germany; [Stefani, Stefania; Cafiso, Viviana; Bertuccio, Taschia] Univ Catania, Dept Biomed Sci Microbiol, Catania, Italy; [Yeaman, Michael R.] Harbor UCLA Med Ctr, Div Mol Med, Torrance, CA 90509 USA; [Nast, Cynthia C.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Eberhard Karls University of Tubingen; German Center for Infection Research; University of Catania; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Cedars Sinai Medical Center	Yang, SJ (corresponding author), Harbor UCLA Med Ctr, Div Infect Dis, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA.	sjyang@ucla.edu	Stefani, Stefania/K-8075-2016	Stefani, Stefania/0000-0003-1594-7427; Cafiso, Viviana/0000-0002-0785-7934; Weidenmaier, Christopher/0000-0003-4107-739X	National Institutes of Health [AI-39108-15, AI-111611]; U.S. Department of Defense [W81XWH-12-2-0101]; American Heart Association [12BGIA11780035]; German Research Foundation [TR-SFB34, SFB766]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039108] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); American Heart Association(American Heart Association); German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in-part by grants from National Institutes of Health (AI-39108-15 to A. S. B and AI-111611 to MRY), the U.S. Department of Defense (W81XWH-12-2-0101 to MRY), the American Heart Association (12BGIA11780035 to SJY), and the German Research Foundation (TR-SFB34 and SFB766 to CW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBORN WE, 1991, ANTIMICROB AGENTS CH, V35, P2282, DOI 10.1128/AAC.35.11.2282; Arias CA, 2007, CLIN INFECT DIS, V45, P1343, DOI 10.1086/522656; Arias CA, 2011, NEW ENGL J MED, V365, P892, DOI 10.1056/NEJMoa1011138; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Bayer AS, 2013, ANN NY ACAD SCI, V1277, P139, DOI 10.1111/j.1749-6632.2012.06819.x; Beranova J, 2008, BBA-BIOMEMBRANES, V1778, P445, DOI 10.1016/j.bbamem.2007.11.012; Bertsche U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067398; Bertsche U, 2011, ANTIMICROB AGENTS CH, V55, P3922, DOI 10.1128/AAC.01226-10; Boucher HW, 2007, CLIN INFECT DIS, V45, P601, DOI 10.1086/520655; Cafiso V, 2014, INT J ANTIMICROB AG, V43, P26, DOI 10.1016/j.ijantimicag.2013.10.001; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P707; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Cui LZ, 2006, ANTIMICROB AGENTS CH, V50, P1079, DOI 10.1128/AAC.50.3.1079-1082.2006; DYER DW, 1983, APPL ENVIRON MICROB, V46, P283, DOI 10.1128/AEM.46.1.283-285.1983; Ernst CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000660; GANZ T, 1990, EUR J HAEMATOL, V44, P1; Hayden MK, 2005, J CLIN MICROBIOL, V43, P5285, DOI 10.1128/JCM.43.10.5285-5287.2005; Humphries RM, 2013, CLIN MICROBIOL REV, V26, P759, DOI 10.1128/CMR.00030-13; Jones T, 2008, ANTIMICROB AGENTS CH, V52, P269, DOI 10.1128/AAC.00719-07; Joson J, 2011, J ANTIMICROB CHEMOTH, V66, P2186, DOI 10.1093/jac/dkr234; Kaatz GW, 2006, INT J ANTIMICROB AG, V28, P280, DOI 10.1016/j.ijantimicag.2006.05.030; Kelesidis T, 2013, J ANTIMICROB CHEMOTH, V68, P1926, DOI 10.1093/jac/dkt117; Keynan Y, 2013, CRIT CARE CLIN, V29, P547, DOI 10.1016/j.ccc.2013.03.008; Kilelee E, 2010, ANTIMICROB AGENTS CH, V54, P4476, DOI 10.1128/AAC.00191-10; Kristian SA, 2005, J BACTERIOL, V187, P6719, DOI 10.1128/JB.187.19.6719-6725.2005; Marco F, 2008, ANTIMICROB AGENTS CH, V52, P2538, DOI 10.1128/AAC.00510-07; Mishra NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071151; Mishra NN, 2013, ANTIMICROB AGENTS CH, V57, P1082, DOI 10.1128/AAC.02182-12; Mishra NN, 2012, J INFECT DIS, V206, P1160, DOI 10.1093/infdis/jis482; Mishra NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043958; Mishra NN, 2011, ANTIMICROB AGENTS CH, V55, P4012, DOI 10.1128/AAC.00223-11; Mishra NN, 2011, ANTIMICROB AGENTS CH, V55, P526, DOI 10.1128/AAC.00680-10; Mishra NN, 2009, ANTIMICROB AGENTS CH, V53, P2312, DOI 10.1128/AAC.01682-08; Murthy MH, 2008, J MED MICROBIOL, V57, P1036, DOI 10.1099/jmm.0.2008/000588-0; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Pillai SK, 2007, ANTIMICROB AGENTS CH, V51, P2223, DOI 10.1128/AAC.00202-07; Sakoulas G, 2009, CLIN MICROBIOL INFEC, V15, P11, DOI 10.1111/j.1469-0691.2009.03054.x; Schriever CA, 2005, AM J HEALTH-SYST PH, V62, P1145, DOI 10.1093/ajhp/62.11.1145; Sieprawska-Lupa M, 2004, ANTIMICROB AGENTS CH, V48, P4673, DOI 10.1128/AAC.48.12.4673-4679.2004; Silverman JA, 2003, ANTIMICROB AGENTS CH, V47, P2538, DOI 10.1128/AAC.47.8.2538-2544.2003; Skiest DJ, 2006, J CLIN MICROBIOL, V44, P655, DOI 10.1128/JCM.44.2.655-656.2006; Tran TT, 2013, MBIO, V4, DOI 10.1128/mBio.00281-13; Weidenmaier C, 2005, INFECT IMMUN, V73, P8033, DOI 10.1128/IAI.73.12.8033-8038.2005; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Yang SJ, 2013, ANTIMICROB AGENTS CH, V57, P5658, DOI 10.1128/AAC.01184-13; Yang SJ, 2013, ANTIMICROB AGENTS CH, V57, P3875, DOI 10.1128/AAC.00412-13; Yang SJ, 2012, INFECT IMMUN, V80, P74, DOI 10.1128/IAI.05669-11; Yang SJ, 2010, ANTIMICROB AGENTS CH, V54, P3079, DOI 10.1128/AAC.00122-10; Yang SJ, 2009, J INFECT DIS, V200, P1916, DOI 10.1086/648473; Yang SJ, 2009, ANTIMICROB AGENTS CH, V53, P2636, DOI 10.1128/AAC.01415-08; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yeaman MR, 1998, J CLIN INVEST, V101, P178, DOI 10.1172/JCI562; Yeaman MR, 2002, ANTIMICROB AGENTS CH, V46, P3883, DOI 10.1128/AAC.46.12.3883-3891.2002; YEAMAN MR, 1992, INFECT IMMUN, V60, P1202, DOI 10.1128/IAI.60.3.1202-1209.1992	54	76	78	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107426	10.1371/journal.pone.0107426	http://dx.doi.org/10.1371/journal.pone.0107426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226591	gold, Green Published, Green Submitted			2022-12-25	WOS:000344317700055
J	Van Kammen, K; Boonstra, A; Reinders-Messelink, H; den Otter, R				Van Kammen, Klaske; Boonstra, Annemarijke; Reinders-Messelink, Heleen; den Otter, Rob			The Combined Effects of Body Weight Support and Gait Speed on Gait Related Muscle Activity: A Comparison between Walking in the Lokomat Exoskeleton and Regular Treadmill Walking	PLOS ONE			English	Article							ACTIVATION PATTERNS; PARAPLEGIC PATIENTS; STROKE PATIENTS; ADAPTATION; MASS; REHABILITATION; ORTHOSIS; RECOVERY; FORCES; LENGTH	Background: For the development of specialized training protocols for robot assisted gait training, it is important to understand how the use of exoskeletons alters locomotor task demands, and how the nature and magnitude of these changes depend on training parameters. Therefore, the present study assessed the combined effects of gait speed and body weight support (BWS) on muscle activity, and compared these between treadmill walking and walking in the Lokomat exoskeleton. Methods: Ten healthy participants walked on a treadmill and in the Lokomat, with varying levels of BWS (0% and 50% of the participants' body weight) and gait speed (0.8, 1.8, and 2.8 km/h), while temporal step characteristics and muscle activity from Erector Spinae, Gluteus Medius, Vastus Lateralis, Biceps Femoris, Gastrocnemius Medialis, and Tibialis Anterior muscles were recorded. Results: The temporal structure of the stepping pattern was altered when participants walked in the Lokomat or when BWS was provided (i.e. the relative duration of the double support phase was reduced, and the single support phase prolonged), but these differences normalized as gait speed increased. Alternations in muscle activity were characterized by complex interactions between walking conditions and training parameters: Differences between treadmill walking and walking in the exoskeleton were most prominent at low gait speeds, and speed effects were attenuated when BWS was provided. Conclusion: Walking in the Lokomat exoskeleton without movement guidance alters the temporal step regulation and the neuromuscular control of walking, although the nature and magnitude of these effects depend on complex interactions with gait speed and BWS. If normative neuromuscular control of gait is targeted during training, it is recommended that very low speeds and high levels of BWS should be avoided when possible.	[Van Kammen, Klaske; den Otter, Rob] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Boonstra, Annemarijke; Reinders-Messelink, Heleen] Rehabil Ctr Revalidatie Friesland, Beetsterzwaag, Netherlands	University of Groningen	den Otter, R (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	a.r.den.otter@umcg.nl						Aguirre-Ollinger G, 2011, INT J ROBOT RES, V30, P486, DOI 10.1177/0278364910385730; ANDRIACCHI TP, 1977, J BIOMECH, V10, P261, DOI 10.1016/0021-9290(77)90049-5; [Anonymous], 1999, SENIAM DELIV; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bohannon RW, 1989, CLIN REHABIL, V3, P47; Bonnard M, 2000, J MOTOR BEHAV, V32, P200, DOI 10.1080/00222890009601371; Browning RC, 2007, MED SCI SPORT EXER, V39, P515, DOI 10.1249/mss.0b013e31802b3562; Buurke JH, 2005, GAIT POSTURE, V22, P164, DOI 10.1016/j.gaitpost.2004.09.003; CAVAGNA GA, 1986, J PHYSIOL-LONDON, V373, P235, DOI 10.1113/jphysiol.1986.sp016044; Coenen P, 2012, J REHABIL MED, V44, P331, DOI 10.2340/16501977-0954; Colombo G, 2000, J REHABIL RES DEV, V37, P693; Colombo G, 2001, SPINAL CORD, V39, P252, DOI 10.1038/sj.sc.3101154; De Bujanda E, 2003, J REHABIL MED, V35, P259, DOI 10.1080/16501970310012428; Den Otter AR, 2007, GAIT POSTURE, V25, P342, DOI 10.1016/j.gaitpost.2006.04.007; den Otter AR, 2004, GAIT POSTURE, V19, P270, DOI 10.1016/S0966-6362(03)00071-7; Dietz V, 1998, SPINAL CORD, V36, P380, DOI 10.1038/sj.sc.3100590; Duschau-Wicke A, 2010, IEEE T NEUR SYS REH, V18, P38, DOI 10.1109/TNSRE.2009.2033061; Duysens J, 2000, PHYSIOL REV, V80, P83, DOI 10.1152/physrev.2000.80.1.83; DUYSENS J, 1980, BRAIN RES, V187, P321, DOI 10.1016/0006-8993(80)90206-1; FINCH L, 1991, PHYS THER, V71, P842, DOI 10.1093/ptj/71.11.842; Gizzi L, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-76; Hidler JM, 2005, CLIN BIOMECH, V20, P184, DOI 10.1016/j.clinbiomech.2004.09.016; Higginson JS, 2006, J BIOMECH, V39, P1769, DOI 10.1016/j.jbiomech.2005.05.032; Hof AL, 2002, GAIT POSTURE, V16, P78, DOI 10.1016/S0966-6362(01)00206-5; Honeine JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052943; Hornby TG, 2008, STROKE, V39, P1786, DOI 10.1161/STROKEAHA.107.504779; Ivanenko YP, 2002, J NEUROPHYSIOL, V87, P3070, DOI 10.1152/jn.2002.87.6.3070; Kuo AD, 2001, J BIOMECH ENG-T ASME, V123, P264, DOI 10.1115/1.1372322; Kwakkel G, 2004, RESTOR NEUROL NEUROS, V22, P281; Kwakkel G, 1997, STROKE, V28, P1550, DOI 10.1161/01.STR.28.8.1550; LEONARD CT, 1991, DEV MED CHILD NEUROL, V33, P567; Louwerens JWK, 1995, ACTA ORTHOP SCAND, V66, P517, DOI 10.3109/17453679509002306; Mayr A, 2007, NEUROREHAB NEURAL RE, V21, P307, DOI 10.1177/1545968307300697; Moreno JC, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-79; Neptune RR, 2008, GAIT POSTURE, V28, P135, DOI 10.1016/j.gaitpost.2007.11.004; NILSSON J, 1989, ACTA PHYSIOL SCAND, V136, P217, DOI 10.1111/j.1748-1716.1989.tb08655.x; Noble JW, 2006, EXP BRAIN RES, V169, P482, DOI 10.1007/s00221-005-0162-3; Orendurff MS, 2004, J REHABIL RES DEV, V41, P829, DOI 10.1682/JRRD.2003.10.0150; Perry J., 1992, GAIT ANAL NORMAL PAT; Riener R, 2010, J HEALTHC ENG, V1, P197, DOI 10.1260/2040-2295.1.2.197; Royer TD, 2005, MED SCI SPORT EXER, V37, P649, DOI 10.1249/01.MSS.0000159007.56083.96; Teasell Robert W, 2003, Top Stroke Rehabil, V10, P29; Threlkeld AJ, 2003, GAIT POSTURE, V17, P235, DOI 10.1016/S0966-6362(02)00105-4; Varraine E, 2000, EXP BRAIN RES, V130, P248, DOI 10.1007/s002219900234; White SG, 2002, CLIN BIOMECH, V17, P177, DOI 10.1016/S0268-0033(02)00007-4; Wolpert DM, 2001, TRENDS COGN SCI, V5, P487, DOI 10.1016/S1364-6613(00)01773-3; World Medical Association, 2013, JAMA J AM MED ASS	47	36	36	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107323	10.1371/journal.pone.0107323	http://dx.doi.org/10.1371/journal.pone.0107323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226302	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700044
J	Zhang, Y; Li, Y; Lin, CW; Ding, J; Liao, GQ; Tang, B				Zhang, Yi; Li, Yang; Lin, Changwei; Ding, Jie; Liao, Guoqing; Tang, Bo			Aberrant Upregulation of 14-3-3 sigma and EZH2 Expression Serves as an Inferior Prognostic Biomarker for Hepatocellular Carcinoma	PLOS ONE			English	Article							BREAST-CANCER; PROTEIN; GENE	Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world. It is of important significance to find biomarkers for the prognostic monitoring of HCC. The 14-3-3 sigma and EZH2 proteins are involved in cell cycle regulation and epigenetic silencing. We herein examined the significance of 14-3-3 sigma and EZH2 in HCC (n = 167) by immunohistochemistry, RT-PCR and qRT-PCR. The correlation between 14-3-3s and EZH2 expression and patients' clinicopathologic features were examined, as was the correlation between 14-3-3 sigma and EZH2 expression and the prognosis of HCC patients. We found that 14-3-3 sigma and EZH2 were highly expressed in HCC (71% and 90%), the expression of EZH2, but not 14-3-3 sigma, is associated with vascular invasion and tumor differentiation (p<0.01). The coexistence of 14-3-3 sigma and EZH2 overexpression is associated with a relatively unfavorable prognosis (p<0.01), suggesting that aberrant upregulation of 14-3-3 sigma and EZH2 expression serves as an inferior prognostic biomarker for HCC.	[Zhang, Yi; Liao, Guoqing] Cent S Univ, Xiangya Hosp, Dept Gastrointestinal Surg, Changsha, Hunan, Peoples R China; [Lin, Changwei] Cent S Univ, Xiangya Hosp 3, Dept Gastrointestinal Surg, Changsha, Hunan, Peoples R China; [Ding, Jie] Guizhou Prov Peoples Hosp, Dept Gastrointestinal Surg, Guiyang, Peoples R China; [Li, Yang; Tang, Bo] Guilin Med Univ, Affiliated Hosp, Dept Hepatobiliary Surg, Guilin, Peoples R China	Central South University; Central South University; Guilin Medical University	Liao, GQ (corresponding author), Cent S Univ, Xiangya Hosp, Dept Gastrointestinal Surg, Changsha, Hunan, Peoples R China.	liaoguoqing@medmail.com.cn; dytangbo@163.com		Liao, Guo-Qing/0000-0002-5967-0282; Zhang, Yi/0000-0001-9357-1205	National Natural Science Foundation of China [81360367]; Science and technology research projects focused on universities in Guangxi [2013ZD046]; Guangxi Health Department; National Natural Science Foundation of Hunan province [08JJ5009, Z2013464]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and technology research projects focused on universities in Guangxi; Guangxi Health Department; National Natural Science Foundation of Hunan province(Natural Science Foundation of Hunan Province)	This research was supported by the National Natural Science Foundation of China (81360367), Science and technology research projects focused on universities in Guangxi (2013ZD046), Guangxi Health Department self-funded project, and the National Natural Science Foundation of Hunan province (08JJ5009) (Z2013464). The funders participated in study design, data collection and analysis.	Au SLK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068226; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cardoso C, 2000, EUR J HUM GENET, V8, P174, DOI 10.1038/sj.ejhg.5200439; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Gheibi A, 2012, Adv Biomed Res, V1, P80, DOI 10.4103/2277-9175.102990; Hajosi-Kalcakosz S, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-86; Iwata N, 2000, ONCOGENE, V19, P5298, DOI 10.1038/sj.onc.1203898; Kino T, 2005, J VIROL, V79, P2780, DOI 10.1128/JVI.79.5.2780-2787.2005; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Laronga C, 2000, J BIOL CHEM, V275, P23106, DOI 10.1074/jbc.M905616199; Luo J, 2010, MED ONCOL, V27, P791, DOI 10.1007/s12032-009-9287-8; Okuda K, 2000, J HEPATOL, V32, P225, DOI 10.1016/S0168-8278(00)80428-6; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; Sasaki M, 2008, LAB INVEST, V88, P873, DOI 10.1038/labinvest.2008.52; Sewalt RGAB, 1998, MOL CELL BIOL, V18, P3586, DOI 10.1128/MCB.18.6.3586; Sudo T, 2005, BRIT J CANCER, V92, P1754, DOI 10.1038/sj.bjc.6602531; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Zhou WH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-397; Zurita M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-217	20	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107251	10.1371/journal.pone.0107251	http://dx.doi.org/10.1371/journal.pone.0107251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226601	Green Published, gold, Green Submitted			2022-12-25	WOS:000344317700039
J	Ssengooba, W; Nakiyingi, L; Armstrong, DT; Cobelens, FG; Alland, D; Manabe, YC; Dorman, SE; Ellner, JJ; Joloba, ML				Ssengooba, Willy; Nakiyingi, Lydia; Armstrong, Derek T.; Cobelens, Frank G.; Alland, David; Manabe, Yukari C.; Dorman, Susan E.; Ellner, Jerrold J.; Joloba, Moses L.			Clinical Utility of a Novel Molecular Assay in Various Combination Strategies with Existing Methods for Diagnosis of HIV-Related Tuberculosis in Uganda	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; SMEAR MICROSCOPY; MTB/RIF; FLUORESCENCE; PERFORMANCE; SENSITIVITY	Background: Low income, high-tuberculosis burden, countries are considering selective deployment of Xpert MTB/RIF assay (Xpert) due to high cost per test. We compared the diagnostic gain of the Xpert add-on strategy with Xpert replacement strategy for pulmonary tuberculosis diagnosis among HIV-infected adults to inform its implementation. Methods: The first diagnostic sputum sample of 424 HIV-infected adults (67% with CD4 counts <= 200/mm(3)) suspected for tuberculosis was tested by direct Ziehl-Neelsen (DZN) and direct fluorescent microscopy (DFM); concentrated fluorescent microscopy (CFM); Lowenstein-Jensen (LJ) and Mycobacterial Growth Indicator Tube (MGIT) culture; and Xpert. Overall diagnostic yield and sensitivity were calculated using MGIT as reference comparator. The sensitivity of Xpert in an add-on strategy was calculated as the number of smear negative but Xpert positive participants among MGIT positive participants. Results: A total of 123 (29.0%) participants were MGIT culture positive for Mycobacterium tuberculosis. The sensitivity (95% confidence interval) was 31.7% (23.6-40.7%) for DZN, 35.0% (26.5-44.0%) for DFM, 43.9% (34.9-53.1%) for CFM, 76.4% (67.9-83.6) for Xpert and 81.3% (73.2-87.7%) for LJ culture. Add-on strategy Xpert showed an incremental sensitivity of 44.7% (35.7-53.9%) when added to DZN, 42.3% (33.4-51.5%) to DFM and 35.0% (26.5-44.0%) to CFM. This translated to an overall sensitivity of 76.4%, 77.3% and 79.0% for add-on strategies based on DZN, DFM and CFM, respectively, compared to 76.4% for Xpert done independently. From replacement to add-on strategy, the number of Xpert cartridges needed was reduced by approximately 10%. Conclusions: Among HIV-infected TB suspects, doing smear microscopy prior to Xpert assay in add-on fashion only identifies a few additional TB cases.	[Ssengooba, Willy; Joloba, Moses L.] Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda; [Ssengooba, Willy; Nakiyingi, Lydia; Manabe, Yukari C.; Joloba, Moses L.] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Armstrong, Derek T.; Manabe, Yukari C.; Dorman, Susan E.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Ssengooba, Willy; Cobelens, Frank G.] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Ssengooba, Willy; Cobelens, Frank G.] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands; [Cobelens, Frank G.] KNCV TB Fdn, The Hague, Netherlands; [Alland, David; Ellner, Jerrold J.] Boston Univ, Sch Med, Boston Med Ctr, Boston, MA 02118 USA	Makerere University; Makerere University; Johns Hopkins University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; KNCV Tuberculosis Foundation; Boston Medical Center; Boston University	Ssengooba, W (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda.	willyssengooba@gmail.com	Ssengooba, Willy/AAG-1202-2020; Ssengooba, Willy/ABE-2168-2020; Nakiyingi, Lydia/ABG-7669-2020	Ssengooba, Willy/0000-0002-1643-110X; Ssengooba, Willy/0000-0002-1643-110X; Nakiyingi, Lydia/0000-0001-7263-3198; Cobelens, Frank/0000-0002-4367-1133; Joloba, Moses/0000-0002-0334-9983	National Institute of Allergy and Infectious Diseases; National Institutes of Health; Department of Health and Human Services [HHSN2722000900050C]; FOGARTY INTERNATIONAL CENTER [D43TW009771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI104830, P30AI094189] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract no. HHSN2722000900050C "TB Clinical Diagnostics Research Consortium''. Additional support was provided by Erasmus Mundus Joint Doctorate Program of the European Union to WS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072556; Albert H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015206; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Cattamanchi A, 2009, INT J TUBERC LUNG D, V13, P1130; CDC, 1985, PUBL HLTH MYC GUID L; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Cobelens F, 2012, J INFECT DIS, V205, pS191, DOI 10.1093/infdis/jis188; Cohen GM, 2007, AIDS, V21, pS81, DOI 10.1097/01.aids.0000279710.47298.5c; Creswell J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-2; Cuevas L E, 2011, PLOS MED, V8; Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030; Joloba M, 2013, LAB SERVICES UGANDA; Marlowe EM, 2011, J CLIN MICROBIOL, V49, P1621, DOI 10.1128/JCM.02214-10; McCarthy KD, 2012, AM J RESP CRIT CARE, V185, P981, DOI 10.1164/rccm.201107-1327OC; Monkongdee P, 2009, AM J RESP CRIT CARE, V180, P903, DOI 10.1164/rccm.200905-0692OC; Moure R, 2011, J CLIN MICROBIOL, V49, P1137, DOI 10.1128/JCM.01831-10; Muchwa Christopher, 2012, BMC Res Notes, V5, P44, DOI 10.1186/1756-0500-5-44; Nakiyingi L, 2014, J ACQUIR IMMUNE 0326; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Ramsay A, 2009, J TROP MED-US, V2009, DOI 10.1155/2009/398767; Ssengooba W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037650; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392; Turnbull ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027125; Van Deun A, 2008, INT J TUBERC LUNG D, V12, P1009; Van Deun A, 2007, PRIORITIES TUBERCULO, P11; van Zyl-Smit RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028815; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2013, TUB DIAGN XPERT MTB; World Health Organization, 2011, WHOHTMTB20112; World Health Organization, 2007, TB DIAGN LAB STRENGT; World Health Organization, 2006, TUB COAL TECHN ASS	36	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107595	10.1371/journal.pone.0107595	http://dx.doi.org/10.1371/journal.pone.0107595			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222866	Green Submitted, Green Published, gold			2022-12-25	WOS:000341774800086
J	Wang, K				Wang, Kai			Testing Genetic Association by Regressing Genotype over Multiple Phenotypes	PLOS ONE			English	Article								Complex disorders are typically characterized by multiple phenotypes. Analyzing these phenotypes jointly is expected to be more powerful than dealing with one of them at a time. A recent approach (O'Reilly et al. 2012) is to regress the genotype at a SNP marker on multiple phenotypes and apply the proportional odds model. In the current research, we introduce an explicit expression for the score test statistic and its non-centrality parameter that determines its power. Same simulation studies as those reported in Galesloot et al. (2014) were conducted to assess its performance. We demonstrate by theoretical arguments and simulation studies that, despite its potential usefulness for multiple phenotypes, the proportional odds model method can be less powerful than regular methods for univariate traits. We also introduce an implementation of the proposed score statistic in an R package named iGasso.	Univ Iowa, Dept Biostat, Iowa City, IA 52242 USA	University of Iowa	Wang, K (corresponding author), Univ Iowa, Dept Biostat, Iowa City, IA 52242 USA.	kai-wang@uiowa.edu			National Institute for Environmental Health Sciences through the University of Iowa Environmental Health Sciences Research Center, NIEHS/NIH [P30 ES05605]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Institute for Environmental Health Sciences through the University of Iowa Environmental Health Sciences Research Center, NIEHS/NIH; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research is funded by the National Institute for Environmental Health Sciences through the University of Iowa Environmental Health Sciences Research Center, NIEHS/NIH P30 ES05605. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; Galesloot TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095923; O'Reilly PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034861; Wang K, 2011, GENETIC ANAL WORKSHO, V17, pS60; Xu X, 2003, BIOSTATISTICS, V4, P223, DOI 10.1093/biostatistics/4.2.223; Yang QO, 2010, GENET EPIDEMIOL, V34, P444, DOI 10.1002/gepi.20497; Zhu WS, 2009, J KOREAN STAT SOC, V38, P1, DOI 10.1016/j.jkss.2008.10.006	7	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e106918	10.1371/journal.pone.0106918	http://dx.doi.org/10.1371/journal.pone.0106918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25221983	gold, Green Published			2022-12-25	WOS:000341774800032
J	Gao, M; Liu, Y; Xiao, Y; Han, GC; Jia, L; Wang, LQ; Lei, T; Huang, YF				Gao, Min; Liu, Yong; Xiao, Yang; Han, Gencheng; Jia, Liang; Wang, Liqiang; Lei, Tian; Huang, Yifei			Prolonging Survival of Corneal Transplantation by Selective Sphingosine-1-Phosphate Receptor 1 Agonist	PLOS ONE			English	Article							CYCLOSPORINE-A; SYSTEMIC CYCLOSPORINE; ALLOGRAFT-REJECTION; MYCOPHENOLATE-MOFETIL; FTY720; GRAFT; MICE; CELLS; MODEL; KERATOPLASTY	Corneal transplantation is the most used therapy for eye disorders. Although the cornea is somewhat an immune privileged organ, immune rejection is still the major problem that reduces the success rate. Therefore, effective chemical drugs that regulate immunoreactions are needed to improve the outcome of corneal transplantations. Here, a sphingosine-1-phosphate receptor 1 (S1P1) selective agonist was systematically evaluated in mouse allogeneic corneal transplantation and compared with the commonly used immunosuppressive agents. Compared with CsA and the non-selective sphingosine 1-phosphate (S1P) receptor agonist FTY720, the S1P1 selective agonist can prolong the survival corneal transplantation for more than 30 days with a low immune response. More importantly, the optimal dose of the S1P1 selective agonist was much less than non-selective S1P receptor agonist FTY720, which would reduce the dose-dependent toxicity in drug application. Then we analyzed the mechanisms of the selected S1P1 selective agonist on the immunosuppression. The results shown that the S1P1 selective agonist could regulate the distribution of the immune cells with less CD4+ T cells and enhanced Treg cells in the allograft, moreover the expression of anti-inflammatory cytokines TGF-beta 1 and IL-10 unregulated which can reduce the immunoreactions. These findings suggest that S1P1 selective agonist may be a more appropriate immunosuppressive compound to effectively prolong mouse allogeneic corneal grafts survival.	[Gao, Min; Jia, Liang; Wang, Liqiang; Lei, Tian; Huang, Yifei] Chinese Peoples Liberat Army Gen Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Gao, Min; Xiao, Yang] Capital Med Univ, Beijing Chaoyang Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Liu, Yong] Chinese PLA Air Force Gen Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Han, Gencheng] Chinese Acad Med Sci, Inst Basic Med Sci, Immunol Lab, Beijing 100730, Peoples R China	Chinese People's Liberation Army General Hospital; Capital Medical University; Air Force General Hospital PLA; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Huang, YF (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Ophthalmol, Beijing, Peoples R China.	301yk@sina.com	Jia, Liang/ABD-6360-2020; Huang, Yifei/ABE-7566-2020; Huang, Yifei/ABE-4692-2020	Huang, Yifei/0000-0002-7089-6426	National Sciences Fund [81170830]; National Key Basic Research Program [2013CB967001]	National Sciences Fund; National Key Basic Research Program(National Basic Research Program of China)	This work was supported by National Sciences Fund (No. 81170830) and National Key Basic Research Program (No. 2013CB967001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cunnusamy K, 2010, INVEST OPHTH VIS SCI, V51, P6566, DOI 10.1167/iovs.10-6161; DelCastillo JMB, 1995, DOC OPHTHALMOL, V91, P49; Fu Hongmei, 2008, Transplant Rev (Orlando), V22, P105, DOI 10.1016/j.trre.2007.12.005; Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005; He XH, 2012, BIOORG MED CHEM LETT, V22, P553, DOI 10.1016/j.bmcl.2011.10.088; Holthoff JH, 2012, KIDNEY INT, V81, P370, DOI 10.1038/ki.2011.347; Igarashi J, 2003, P NATL ACAD SCI USA, V100, P10664, DOI 10.1073/pnas.1934494100; Inoue K, 2001, JPN J OPHTHALMOL, V45, P378, DOI 10.1016/S0021-5155(01)00339-2; Jia L, 2014, CORNEA, V33, P398, DOI 10.1097/ICO.0000000000000077; Kitamura M, 1997, NEPHROL DIAL TRANSPL, V12, P669, DOI 10.1093/ndt/12.4.669; Larkin DFP, 1997, CLIN EXP IMMUNOL, V107, P381, DOI 10.1111/j.1365-2249.1997.279-ce1171.x; Le Discorde M, 2003, HUM IMMUNOL, V64, P1039, DOI 10.1016/j.humimm.2003.08.346; Li QY, 2010, IMMUNOPHARM IMMUNOT, V32, P680, DOI 10.3109/08923971003674433; Liu Y, 2012, MOL VIS, V18, P624; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Mayer K, 2004, BRIT J OPHTHALMOL, V88, P915, DOI 10.1136/bjo.2003.034017; Niederkorn JY, 2006, TRANSPLANTATION, V81, P1171, DOI 10.1097/01.tp.0000203140.70742.cb; Pietra BA, 2000, J CLIN INVEST, V106, P1003, DOI 10.1172/JCI10467; Reinhard T, 2001, GRAEF ARCH CLIN EXP, V239, P367, DOI 10.1007/s004170100285; Reis A, 1998, BRIT J OPHTHALMOL, V82, P700, DOI 10.1136/bjo.82.6.700; Saab G, 2008, ARCH OPHTHALMOL-CHIC, V126, P140, DOI 10.1001/archophthalmol.2007.23; Shimazaki J, 2011, AM J OPHTHALMOL, V152, P33, DOI 10.1016/j.ajo.2011.01.019; Sit M, 2001, CORNEA, V20, P129, DOI 10.1097/00003226-200103000-00002; STREILEIN JW, 1979, NATURE, V282, P326, DOI 10.1038/282326a0; Stuart PM, 1997, J CLIN INVEST, V99, P396, DOI 10.1172/JCI119173; Tamura A, 2000, SURGERY, V127, P47, DOI 10.1067/msy.2000.100884; WHITE DJG, 1979, TRANSPLANTATION, V27, P55, DOI 10.1097/00007890-197901000-00014; WILLIAMS KA, 1995, EYE, V9, P219, DOI 10.1038/eye.1995.43; Wolf AM, 2009, J IMMUNOL, V183, P3751, DOI 10.4049/jimmunol.0901011; Yang ZD, 2003, CLIN IMMUNOL, V107, P30, DOI 10.1016/S1521-6616(02)00054-2; Zhu J, 2014, ACTA OPHTHALMOL, V92, pE12, DOI 10.1111/aos.12237	31	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e105693	10.1371/journal.pone.0105693	http://dx.doi.org/10.1371/journal.pone.0105693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216235	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774300003
J	Gonzalez, WG; Pham, K; Miksovska, J				Gonzalez, Walter G.; Pham, Khoa; Miksovska, Jaroslava			Modulation of the Voltage-gated Potassium Channel (Kv4.3) and the Auxiliary Protein (KChIP3) Interactions by the Current Activator NS5806	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium-binding Protein; Fluorescence Resonance Energy Transfer (FRET); Isothermal Titration Calorimetry (ITC); Potassium Channel; Protein Drug Interaction; KChIP; Kv4; NCS; NS5806; Calsenilin	CALCIUM-BINDING PROTEIN; K+ CHANNELS; DNA-BINDING; TERMINAL DOMAINS; HEART-FAILURE; ION CHANNELS; INACTIVATION; DREAM; EXPRESSION; SUBUNITS	KChIP3 (potassium channel interacting protein 3) is a calcium-binding protein that binds at the N terminus of the Kv4 voltage-gated potassium channel through interactions at two contact sites and has been shown to regulate potassium current gating kinetics as well as channel trafficking in cardiac and neuronal cells. Using fluorescence spectroscopy, isothermal calorimetry, and docking simulations we show that the novel potassium current activator, NS5806, binds at a hydrophobic site on the C terminus of KChIP3 in a calcium-dependent manner, with an equilibrium dissociation constant of 2-5 m in the calcium-bound form. We further determined that the association between KChIP3 and the hydrophobic N terminus of Kv4.3 is calcium-dependent, with an equilibrium dissociation constant in the apo-state of 70 +/- 3 m and 2.7 +/- 0.1 m in the calcium-bound form. NS5806 increases the affinity between KChIP3 and the N terminus of Kv4.3 (K-d = 1.9 +/- 0.1 m) in the presence and absence of calcium. Mutation of Tyr-174 or Phe-218 on KChIP3 abolished the enhancement of Kv4.3 site 1 binding in the apo-state, highlighting the role of these residues in drug and K4.3 binding. Kinetic studies show that NS5806 decreases the rate of dissociation between KChIP3 and the N terminus of K(V)4.3. Overall, these studies support the idea that NS5806 directly interacts with KChIP3 and modulates the interactions between this calcium-binding protein and the T1 domain of the Kv4.3 channels through reorientation of helix 10 on KChIP3.	[Gonzalez, Walter G.; Pham, Khoa; Miksovska, Jaroslava] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA	State University System of Florida; Florida International University	Miksovska, J (corresponding author), Florida Int Univ, Dept Chem & Biochem, 11200 SW 8th St, Miami, FL 33199 USA.	miksovsk@fiu.edu		Gonzalez, Walter/0000-0003-1310-9323; Pham, Khoa/0000-0001-7449-1226	National Institutes of Health [R25 GM061347]; National Science Foundation [MCB 1021831]; James and Esther King eBiomedical Research Program, Florida Department of Health; Div Of Molecular and Cellular Bioscience [1021831] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); James and Esther King eBiomedical Research Program, Florida Department of Health; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R25 GM061347 (NIGMS; to W. G. G.). This work was also supported by National Science Foundation (MCB 1021831) and the James and Esther King eBiomedical Research Program, Florida Department of Health.	Adams SR, 2008, NAT PROTOC, V3, P1527, DOI 10.1038/nprot.2008.144; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Anderson D, 2010, NAT NEUROSCI, V13, P333, DOI 10.1038/nn.2493; Bahring R, 2011, J PHYSIOL-LONDON, V589, P461, DOI 10.1113/jphysiol.2010.191965; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; BEECHEM JM, 1989, CHEM PHYS LIPIDS, V50, P237, DOI 10.1016/0009-3084(89)90052-2; Bourdeau ML, 2011, NEUROSCIENCE, V176, P173, DOI 10.1016/j.neuroscience.2010.11.051; Bowlby MR, 2005, BIOORGAN MED CHEM, V13, P6112, DOI 10.1016/j.bmc.2005.06.042; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Calloe K, 2010, J MOL CELL CARDIOL, V48, P191, DOI 10.1016/j.yjmcc.2009.07.017; Calloe K, 2009, CARDIOVASC RES, V81, P686, DOI 10.1093/cvr/cvn339; Callsen B, 2005, J PHYSIOL-LONDON, V568, P397, DOI 10.1113/jphysiol.2005.094359; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Chuang S, 2008, J MED CHEM, V51, P3755, DOI 10.1021/jm701192w; Cordeiro JM, 2012, J MOL CELL CARDIOL, V52, P1291, DOI 10.1016/j.yjmcc.2012.03.001; Craig TA, 2002, J BIOL CHEM, V277, P10955, DOI 10.1074/jbc.M109660200; Cui YY, 2008, NEUROCHEM RES, V33, P2078, DOI 10.1007/s11064-008-9688-7; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; Foeger NC, 2010, J BIOL CHEM, V285, P33413, DOI 10.1074/jbc.M110.145185; Gebauer M, 2004, BIOPHYS J, V86, P210, DOI 10.1016/S0006-3495(04)74097-7; Gonzalez WG, 2014, BBA-PROTEINS PROTEOM, V1844, P1472, DOI 10.1016/j.bbapap.2014.05.004; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Jerng HH, 1999, J GEN PHYSIOL, V113, P641, DOI 10.1085/jgp.113.5.641; Jerng HH, 1997, BIOPHYS J, V72, P163, DOI 10.1016/S0006-3495(97)78655-7; Kaab S, 1998, CIRCULATION, V98, P1383, DOI 10.1161/01.CIR.98.14.1383; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kunjilwar K, 2013, J NEUROCHEM, V126, P462, DOI 10.1111/jnc.12309; Lakowicz J. R., 2010, PRINCIPLES FLUORESCE, P372; Lang F, 2007, METHOD ENZYMOL, V428, P209, DOI 10.1016/S0076-6879(07)28011-5; Li MN, 2014, ANAL BIOCHEM, V449, P99, DOI 10.1016/j.ab.2013.12.015; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; Lundby A, 2010, BRIT J PHARMACOL, V160, P2028, DOI 10.1111/j.1476-5381.2010.00859.x; Lusin JD, 2008, BIOCHEMISTRY-US, V47, P2252, DOI 10.1021/bi7017267; Martens JR, 1999, TRENDS CARDIOVAS MED, V9, P253, DOI 10.1016/S1050-1738(00)00037-2; Martin MP, 2012, CHEMBIOCHEM, V13, P2128, DOI 10.1002/cbic.201200316; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Niwa N, 2010, J MOL CELL CARDIOL, V48, P12, DOI 10.1016/j.yjmcc.2009.07.013; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Osawa M, 2001, J BIOL CHEM, V276, P41005, DOI 10.1074/jbc.M105842200; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Scannevin RH, 2004, NEURON, V41, P587, DOI 10.1016/S0896-6273(04)00049-2; Song WJ, 1998, J NEUROSCI, V18, P3124; Szabo I, 2010, FEBS LETT, V584, P2049, DOI 10.1016/j.febslet.2010.01.038; Wang GY, 2006, J GEN PHYSIOL, V127, P391, DOI 10.1085/jgp.200509442; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Wang K., 2009, STRUCTURE FUNCTION M, P343; Witzel K, 2012, NEUROPHARMACOLOGY, V63, P1389, DOI 10.1016/j.neuropharm.2012.08.017; Yu LP, 2007, PROTEIN SCI, V16, P2502, DOI 10.1110/ps.072928007; Zhou W, 2004, NEURON, V41, P573, DOI 10.1016/S0896-6273(04)00045-5; Zicha S, 2004, J PHYSIOL-LONDON, V561, P735, DOI 10.1113/jphysiol.2004.075861	53	26	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32201	32213		10.1074/jbc.M114.577528	http://dx.doi.org/10.1074/jbc.M114.577528			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25228688	Green Published, hybrid			2022-12-25	WOS:000345314700047
J	Dasgupta, M; Unal, H; Willard, B; Yang, JB; Karnik, SS; Stark, GR				Dasgupta, Maupali; Unal, Hamiyet; Willard, Belinda; Yang, Jinbo; Karnik, Sadashiva S.; Stark, George R.			Critical Role for Lysine 685 in Gene Expression Mediated by Transcription Factor Unphosphorylated STAT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATES TRANSCRIPTION; SERINE PHOSPHORYLATION; ACETYLATION; METHYLATION; INHIBITION; CELLS; DNA; INDUCTION; COMPLEX; BINDING	STAT3 is a pleiotropic transcription factor that is activated by the phosphorylation of tyrosine 705 in response to many cytokines and growth factors. STAT3 without Tyr-705 phosphorylation (U-STAT3) is also a potent transcription factor, and its concentration in cells increases greatly in response to STAT3 activation because the STAT3 gene can be driven by phosphorylated STAT3 dimers. We have now searched for post-translational modifications of U-STAT3 that might have a critical role in its function. An analysis by mass spectroscopy indicated that U-STAT3 is acetylated on Lys-685, and the integrity of Lys-685 is required for the expression of most U-STAT3-dependent genes. In contrast, we found only a very minor role for Lys-685 in gene expression induced in response to tyrosine-phosphorylated STAT3. U-STAT3 plays an important role in angiotensin II-induced gene expression and in the consequent development of cardiac hypertrophy and dysfunction. Mutation of Lys-685 inhibits this function of STAT3, providing new information on the role of U-STAT3 in augmenting the development of heart failure.	[Dasgupta, Maupali; Yang, Jinbo; Stark, George R.] Cleveland Clin, Dept Mol Genet, Cleveland, OH 44195 USA; [Unal, Hamiyet; Karnik, Sadashiva S.] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Willard, Belinda] Cleveland Clin, Mass Spectrometry Lab Prot Sequencing, Lerner Res Inst, Cleveland, OH 44195 USA; [Yang, Jinbo] Lanzhou Univ, Sch Life Sci, Lanzhou 73000, Gansu, Peoples R China	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Lanzhou University	Stark, GR (corresponding author), Cleveland Clin, Dept Mol Genet, Cleveland, OH 44195 USA.	starkg@ccf.org	Karnik, Sadashiva/Y-2477-2019	Karnik, Sadashiva/0000-0003-0746-2753	National Institutes of Health [CA062220]; National Institutes of Health Shared Instrument Grant [1S10RR031537-01]; NATIONAL CANCER INSTITUTE [P01CA062220] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Shared Instrument Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA062220 (to G. R. S.) and National Institutes of Health Shared Instrument Grant 1S10RR031537-01 (to B. W.) for purchasing the Orbitrap Elite instrument.	AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bourguignon LYW, 2012, ONCOGENE, V31, P149, DOI 10.1038/onc.2011.222; Brinkman JA, 2009, J MAMMARY GLAND BIOL, V14, P67, DOI 10.1007/s10911-009-9113-0; Courapied S, 2010, J BIOL CHEM, V285, P26765, DOI 10.1074/jbc.M109.092304; Hazan-Halevy I, 2010, BLOOD, V115, P2852, DOI 10.1182/blood-2009-10-230060; Icardi L, 2012, P NATL ACAD SCI USA, V109, P12058, DOI 10.1073/pnas.1206458109; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Lee H, 2012, P NATL ACAD SCI USA, V109, P7765, DOI 10.1073/pnas.1205132109; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Liu HT, 2003, BLOOD, V102, P344, DOI 10.1182/blood-2002-11-3396; Mori T, 2006, CANCER RES, V66, P6692, DOI 10.1158/0008-5472.CAN-06-0801; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; O'Shea JJ, 2005, SCIENCE, V307, P217, DOI 10.1126/science.1108164; Pena G, 2010, EUR J IMMUNOL, V40, P2580, DOI 10.1002/eji.201040540; Perry E, 2004, ONCOGENE, V23, P8908, DOI 10.1038/sj.onc.1208149; Ray S, 2005, GASTROENTEROLOGY, V129, P1616, DOI 10.1053/j.gastro.2005.07.055; Ray S, 2014, CELL SIGNAL, V26, P1445, DOI 10.1016/j.cellsig.2014.03.007; Samraj AK, 2014, J CEREBR BLOOD F MET, V34, P759, DOI 10.1038/jcbfm.2014.15; Stark GR, 2011, CELL RES, V21, P375, DOI 10.1038/cr.2010.174; Tanaka T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001637; Waitkus MS, 2014, MOL CELL BIOL, V34, P1800, DOI 10.1128/MCB.00034-14; Wang R, 2005, J BIOL CHEM, V280, P11528, DOI 10.1074/jbc.M413930200; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yang J, 2005, CANCER RES, V65, P939; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Yue H, 2010, CARDIOVASC RES, V85, P90, DOI 10.1093/cvr/cvp285	29	41	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30763	30771		10.1074/jbc.M114.603894	http://dx.doi.org/10.1074/jbc.M114.603894			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25217633	Green Published, hybrid			2022-12-25	WOS:000344549700051
J	Kalakech, H; Hibert, P; Prunier-Mirebeau, D; Tamareille, S; Letournel, F; Macchi, L; Pinet, F; Furber, A; Prunier, F				Kalakech, Hussein; Hibert, Pierre; Prunier-Mirebeau, Delphine; Tamareille, Sophie; Letournel, Franck; Macchi, Laurent; Pinet, Florence; Furber, Alain; Prunier, Fabrice			RISK and SAFE Signaling Pathway Involvement in Apolipoprotein A-I-Induced Cardioprotection	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; ISCHEMIA-REPERFUSION INJURY; ISCHEMIA/REPERFUSION INJURY; POSTCONDITIONING PROTECTS; CHOLESTEROL LEVELS; HDL; MECHANISMS; HEART; MYOCARDIUM; SURGERY	Recent findings indicate that apolipoprotein A-I (ApoA-I) may be a protective humoral mediator involved in remote ischemic preconditioning (RIPC). This study sought to determine if ApoA-I mediates its protective effects via the RISK and SAFE signaling pathways implicated in RIPC. Wistar rats were allocated to one of the following groups. Control: rats were subjected to myocardial ischemia/reperfusion (I/R) without any further intervention; RIPC: four cycles of limb I/R were applied prior to myocardial ischemia; ApoA-I: 10 mg/Kg of ApoA-I were intravenously injected prior to myocardial ischemia; ApoA-I + inhibitor: pharmacological inhibitors of RISK/SAFE pro-survival kinase (Akt, ERK1/2 and STAT-3) were administered prior to ApoA-I injection. Infarct size was significantly reduced in the RIPC group compared to Control. Similarly, ApoA-I injection efficiently protected the heart, recapitulating RIPC-induced cardioprotection. The ApoA-I protective effect was associated with Akt and GSK-3b phosphorylation and substantially inhibited by pretreatment with Akt and ERK1/2 inhibitors. Pretreatment with ApoA-I in a rat model of I/R recapitulates RIPC-induced cardioprotection and shares some similar molecular mechanisms with those of RIPC-involved protection of the heart.	[Kalakech, Hussein; Hibert, Pierre; Prunier-Mirebeau, Delphine; Tamareille, Sophie; Letournel, Franck; Macchi, Laurent; Furber, Alain; Prunier, Fabrice] LUNAM Univ, Angers, France; [Kalakech, Hussein; Hibert, Pierre; Tamareille, Sophie; Macchi, Laurent; Furber, Alain; Prunier, Fabrice] Univ Angers, Lab Cardioprotect Remodelage & Thrombose, Angers, France; [Prunier-Mirebeau, Delphine] Univ Angers, INSERM U771, CNRS UMR 6214, CHU Angers,Dept Biochim & Genet, Angers, France; [Letournel, Franck] CHU Angers, Lab Neurobiol Neuropathol, UPRES EA3143, Inst Biol Sante PBH, Angers, France; [Pinet, Florence] Univ Lille Nord France, Inst Pasteur Lille, INSERM, U744, Lille, France; [Furber, Alain; Prunier, Fabrice] CHU Angers, Serv Cardiol, Angers, France	Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Prunier, F (corresponding author), LUNAM Univ, Angers, France.	faprunier@chu-angers.fr	Prunier, Fabrice/A-5210-2011; Prunier, Delphine/K-3301-2015; Pinet, Florence/F-2892-2013; Letournel, Franck/K-4263-2015; Tamareille, Sophie/K-1770-2015	Pinet, Florence/0000-0002-5471-1487; Tamareille, Sophie/0000-0001-8563-6558; letournel, franck/0000-0003-2925-4453	Fondation Coeur Recherche; French Ministry of Education and Research	Fondation Coeur Recherche; French Ministry of Education and Research	This work was supported in part by a grant from the Fondation Coeur & Recherche. HK was given support by a fellowship from the French Ministry of Education and Research. Those awarding the funding had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Birnbaum Y, 1997, CIRCULATION, V96, P1641, DOI 10.1161/01.CIR.96.5.1641; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Calabresi L, 2003, CIRC RES, V92, P330, DOI 10.1161/01.RES.0000054201.60308.1A; Cheung MMH, 2006, J AM COLL CARDIOL, V47, P2277, DOI 10.1016/j.jacc.2006.01.066; Degoma EM, 2008, J AM COLL CARDIOL, V51, P2199, DOI 10.1016/j.jacc.2008.03.016; Dickson EW, 1999, AM J PHYSIOL-HEART C, V277, pH2451, DOI 10.1152/ajpheart.1999.277.6.H2451; Frias Miguel A, 2012, JAKSTAT, V1, P92, DOI 10.4161/jkst.19754; Frias MA, 2013, ATHEROSCLEROSIS, V228, P110, DOI 10.1016/j.atherosclerosis.2013.02.003; Frias MA, 2010, CARDIOVASC RES, V85, P118, DOI 10.1093/cvr/cvp289; Frias MA, 2009, CARDIOVASC RES, V82, P313, DOI 10.1093/cvr/cvp024; Getz GS, 2010, CURR PHARM DESIGN, V16, P3173; Gho BCG, 1996, CIRCULATION, V94, P2193, DOI 10.1161/01.CIR.94.9.2193; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; Gu SS, 2007, LIFE SCI, V81, P702, DOI 10.1016/j.lfs.2007.06.021; Hafiane A, 2013, CHOLESTEROL, DOI 10.1155/2013/891403; Hausenloy DJ, 2012, CLIN RES CARDIOL, V101, P339, DOI 10.1007/s00392-011-0397-x; Hausenloy DJ, 2011, NAT REV CARDIOL, V8, P619, DOI 10.1038/nrcardio.2011.85; Hausenloy DJ, 2011, ANTIOXID REDOX SIGN, V14, P893, DOI 10.1089/ars.2010.3360; Hausenloy DJ, 2008, CARDIOVASC RES, V79, P377, DOI 10.1093/cvr/cvn114; Hepponstall M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048284; Heusch G, 2002, J MOL CELL CARDIOL, V34, P1279, DOI 10.1006/jmcc.2002.2093; Hibert P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077211; Hoole SP, 2009, CIRCULATION, V119, P820, DOI 10.1161/CIRCULATIONAHA.108.809723; Huffman LC, 2008, AM J PHYSIOL-HEART C, V294, pH257, DOI 10.1152/ajpheart.00769.2007; Imaizumi S, 2008, J AM COLL CARDIOL, V51, P1604, DOI 10.1016/j.jacc.2007.12.040; Kanoria S, 2007, TRANSPLANTATION, V84, P445, DOI 10.1097/01.tp.0000228235.55419.e8; Kharbanda RK, 2009, LANCET, V374, P1557, DOI 10.1016/S0140-6736(09)61421-5; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kloner RA, 2009, CIRCULATION, V119, P776, DOI 10.1161/CIRCULATIONAHA.108.832832; Konstantinov IE, 2005, TRANSPLANTATION, V79, P1691, DOI 10.1097/01.TP.0000159137.76400.5D; Konstantinov IE, 2004, PHYSIOL GENOMICS, V19, P143, DOI 10.1152/physiolgenomics.00046.2004; Lacerda L, 2009, CARDIOVASC RES, V84, P201, DOI 10.1093/cvr/cvp274; Li J, 2011, CLIN SCI, V120, P451, DOI 10.1042/CS20100466; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; Luscher TF, 2014, CIRC RES, V114, P171, DOI 10.1161/CIRCRESAHA.114.300935; Nicholls SJ, 2005, CIRCULATION, V111, P1543, DOI 10.1161/01.CIR.0000159351.95399.50; O'Connell BJ, 2001, CIRCULATION, V104, P1978, DOI 10.1161/hc3901.096667; Olsson AG, 2005, EUR HEART J, V26, P890, DOI 10.1093/eurheartj/ehi186; Pell TJ, 1998, AM J PHYSIOL-HEART C, V275, pH1542, DOI 10.1152/ajpheart.1998.275.5.H1542; Piper HM, 1998, CARDIOVASC RES, V38, P291, DOI 10.1016/S0008-6363(98)00033-9; Prunier F, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-013-0400-y; Puranik R, 2008, ATHEROSCLEROSIS, V196, P240, DOI 10.1016/j.atherosclerosis.2007.05.008; Saemann MD, 2010, EUR J CLIN INVEST, V40, P1131, DOI 10.1111/j.1365-2362.2010.02361.x; Saxena P, 2010, J CARDIAC SURG, V25, P127, DOI 10.1111/j.1540-8191.2009.00820.x; Schmidt MR, 2013, CIRC RES, V113, P1278, DOI 10.1161/CIRCRESAHA.113.302942; Shi N, 2008, J BIOMED SCI, V15, P577, DOI 10.1007/s11373-008-9258-7; Shi WW, 2012, CARDIOVASC RES, V94, P206, DOI 10.1093/cvr/cvs088; Shimizu M, 2010, J SURG RES, V158, P155, DOI 10.1016/j.jss.2008.08.010; Shimizu M, 2009, CLIN SCI, V117, P191, DOI 10.1042/CS20080523; Tamareille S, 2011, BASIC RES CARDIOL, V106, P1329, DOI 10.1007/s00395-011-0210-z; Tao R, 2010, AM J PHYSIOL-HEART C, V298, pH1022, DOI 10.1152/ajpheart.00902.2009; Theilmeier G, 2006, CIRCULATION, V114, P1403, DOI 10.1161/CIRCULATIONAHA.105.607135; Thielmann M, 2013, LANCET, V382, P597, DOI 10.1016/S0140-6736(13)61450-6; Tsang A, 2004, CIRC RES, V95, P230, DOI 10.1161/01.RES.0000138303.76488.fe; Veighey K, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/620681; Wei M, 2011, CIRC RES, V108, P1220, DOI 10.1161/CIRCRESAHA.110.236190; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhu XW, 2012, ANNU REV NUTR, V32, P161, DOI 10.1146/annurev-nutr-071811-150709	59	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107950	10.1371/journal.pone.0107950	http://dx.doi.org/10.1371/journal.pone.0107950			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25237809	Green Published, Green Submitted, gold			2022-12-25	WOS:000342491600067
J	Greenlee, JJ; Kunkle, RA; Richt, JA; Nicholson, EM; Hamir, AN				Greenlee, Justin J.; Kunkle, Robert A.; Richt, Juergen A.; Nicholson, Eric M.; Hamir, Amir N.			Lack of Prion Accumulation in Lymphoid Tissues of PRNP ARQ/ARR Sheep Intracranially Inoculated with the Agent of Scrapie	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; CERVUS-ELAPHUS-NELSONI; EXPERIMENTAL TRANSMISSION; NATURAL SCRAPIE; SUFFOLK SHEEP; PRP GENOTYPE; INTRACEREBRAL INOCULATION; PRECLINICAL DIAGNOSIS; PROTEIN GENE; ELK	Sheep scrapie is a transmissible spongiform encephalopathy that can be transmitted horizontally. The prion protein gene (PRNP) profoundly influences the susceptibility of sheep to the scrapie agent and the tissue levels and distribution of PrP Sc in affected sheep. The purpose of this study was to compare the survival time and PrPSc tissue distribution in sheep with highly resistant and highly susceptible PRNP genotypes after intracranial inoculation of the agent of scrapie. Five sheep each of genotype VRQ/VRQ, VRQ/ARR or ARQ/ARR were inoculated. Sheep were euthanized when clinical signs of scrapie became severe. Clinical signs, microscopic lesions, and western blot profiles were uniform across genotypes and consistent with manifestations of classical scrapie. Mean survival time differences were associated with the 171 polymorphic site with VRQ/VRQ sheep surviving 18 months, whereas VRQ/ARR and ARQ/ARR sheep survived 60 and 56 months, respectively. Labeling of PrP Sc by immunohistochemistry revealed similar accumulations in central nervous system tissues regardless of host genotype. Immunoreactivity for PrPSc in lymphoid tissue was consistently abundant in VRQ/VRQ, present but confined to tonsil or retropharyngeal lymph node in 4/5 VRQ/ARR, and totally absent in ARQ/ARR sheep. The results of this study demonstrate the susceptibility of sheep with the ARQ/ARR genotype to scrapie by the intracranial inoculation route with PrPSc accumulation in CNS tissues, but prolonged incubation times and lack of PrP Sc in lymphoid tissue.	[Greenlee, Justin J.; Kunkle, Robert A.; Richt, Juergen A.; Nicholson, Eric M.; Hamir, Amir N.] ARS, Virus & Pr Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA	United States Department of Agriculture (USDA)	Greenlee, JJ (corresponding author), ARS, Virus & Pr Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA.	justin.greenlee@ars.usda.gov	Greenlee, Justin/Y-5732-2019; Richt, Juergen/AAL-3632-2020	Greenlee, Justin/0000-0003-2202-3054; 				Bartz JC, 2005, J VIROL, V79, P11858, DOI 10.1128/JVI.79.18.11858-11863.2005; BELT PBGM, 1995, J GEN VIROL, V76, P509, DOI 10.1099/0022-1317-76-3-509; Cosseddu GM, 2007, REV SCI TECH OIE, V26, P657, DOI 10.20506/rst.26.3.1774; CUTLIP RC, 1994, J INFECT DIS, V169, P814, DOI 10.1093/infdis/169.4.814; Cutlip RC, 2001, CAN J VET RES, V65, P131; Dawson M, 1998, VET REC, V142, P623; Diaz C, 2005, J GEN VIROL, V86, P849, DOI 10.1099/vir.0.80412-0; Espenes A, 2006, J COMP PATHOL, V134, P115, DOI 10.1016/j.jcpa.2005.08.001; Gonzalez L, 2008, VET REC, V162, P397, DOI 10.1136/vr.162.13.397; Gonzalez L, 2014, J COMP PATHOL, V150, P57, DOI 10.1016/j.jcpa.2013.10.001; Gonzalez L, 2002, J COMP PATHOL, V126, P17, DOI 10.1053/jcpa.2001.0516; Greenlee JJ, 2012, J VET DIAGN INVEST, V24, P1087, DOI 10.1177/1040638712461249; Greenlee JJ, 2012, J VET DIAGN INVEST, V24, P554, DOI 10.1177/1040638712440993; Groschup MH, 2007, EMERG INFECT DIS, V13, P1201, DOI 10.3201/eid1308.070077; Hamir AN, 2008, VET PATHOL, V45, P7, DOI 10.1354/vp.45-1-7; Hamir AN, 2009, VET PATHOL, V46, P1205, DOI 10.1354/vp.08-VP-0258-H-FL; Hamir AN, 2009, VET PATHOL, V46, P39, DOI 10.1354/vp.46-1-39; Hamir AN, 2009, J VET DIAGN INVEST, V21, P64, DOI 10.1177/104063870902100110; Hamir AN, 2005, J VET DIAGN INVEST, V17, P3, DOI 10.1177/104063870501700103; Hamir AN, 2004, J VET DIAGN INVEST, V16, P316, DOI 10.1177/104063870401600410; Hamir AN, 2003, VET REC, V153, P121, DOI 10.1136/vr.153.4.121; Hamir AN, 2003, VET PATHOL, V40, P81, DOI 10.1354/vp.40-1-81; Hamir AN, 2002, CAN J VET RES, V66, P289; Harnir AN, 2008, CAN J VET RES, V72, P63; Heggebo R, 2003, J COMP PATHOL, V128, P172, DOI 10.1053/jcpa.2002.0625; Hunter N, 1997, VET REC, V140, P59, DOI 10.1136/vr.140.3.59; Hunter N, 1997, VET REC, V141, P137, DOI 10.1136/vr.141.6.137; Hunter N, 1996, ARCH VIROL, V141, P809, DOI 10.1007/BF01718157; Jacobs JG, 2011, J VIROL, V85, P12537, DOI 10.1128/JVI.00448-11; Jeffrey M, 2002, J COMP PATHOL, V127, P264, DOI 10.1053/jcpa.2002.0592; Jeffrey M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091026; Ligios C, 2006, ARCH VIROL, V151, P207, DOI 10.1007/s00705-006-0759-2; O'Rourke KI, 2000, J CLIN MICROBIOL, V38, P3254, DOI 10.1128/JCM.38.9.3254-3259.2000; ORourke KI, 1997, J GEN VIROL, V78, P975, DOI 10.1099/0022-1317-78-4-975; Prusiner Stanley B., 2004, VVolume 41, P545; Ryder SJ, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-9; Schreuder BEC, 1998, VET REC, V142, P564, DOI 10.1136/vr.142.21.564; Somerville RA, 1997, J GEN VIROL, V78, P2389, DOI 10.1099/0022-1317-78-9-2389; Tranulis MA, 2002, APMIS, V110, P33, DOI 10.1034/j.1600-0463.2002.100105.x; Warner RG, 2006, VET REC, V159, P473, DOI 10.1136/vr.159.15.473; Wells GAH, 2003, J GEN VIROL, V84, P1021, DOI 10.1099/vir.0.18788-0	41	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e108029	10.1371/journal.pone.0108029	http://dx.doi.org/10.1371/journal.pone.0108029			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233232	Green Submitted, Green Published, gold			2022-12-25	WOS:000342921200074
J	Ndlangisa, KM; du Plessis, M; Wolter, N; de Gouveia, L; Klugman, KP; von Gottberg, A				Ndlangisa, Kedibone M.; du Plessis, Mignon; Wolter, Nicole; de Gouveia, Linda; Klugman, Keith P.; von Gottberg, Anne		GERMS SA	Population Snapshot of Streptococcus pneumoniae Causing Invasive Disease in South Africa Prior to Introduction of Pneumococcal Conjugate Vaccines	PLOS ONE			English	Article							SEROTYPE 19A; UNITED-STATES; GENETIC-STRUCTURE; TEMPORAL TRENDS; CHILDREN; CLONES; EPIDEMIOLOGY; VACCINATION; MENINGITIS; INFECTIONS	We determined the sequence types of isolates that caused invasive pneumococcal disease (IPD) prior to routine use of pneumococcal conjugate vaccines (PCV) in South Africa. PCV-13 serotypes and 6C isolates collected in 2007 (1 461/2 437, 60%) from patients of all ages as part of on-going, national, laboratory-based surveillance for IPD, were selected for genetic characterization. In addition, all 134 non-PCV isolates from children <2 years were selected for characterization. Sequence type diversity by serotype and age category (children <5 years vs. individuals >= 5 years) was assessed for PCV serotypes using Simpson's index of diversity. Similar genotypes circulated among isolates from children and adults and the majority of serotypes were heterogeneous. While globally disseminated clones were common among some serotypes (e.g., serotype 1 [clonal complex (CC) 217, 98% of all serotype 1] and 14 [CC230, 43%)]), some were represented mainly by clonal complexes rarely reported elsewhere (e.g., serotype 3 [CC458, 60%] and 19A [CC2062, 83%]). In children <2 years, serotype 15B and 8 were the most common serotypes among non-PCV isolates (16% [22/134] and 15% [20/134] isolates, respectively). Sequence type 7052 and 53 were most common among serotypes 15B and 8 isolates and accounted for 58% (7/12) and 64% (9/14) of the isolates, respectively. Serotype 19F, 14, 19A and 15B had the highest proportions of penicillin non-susceptible isolates. Genotypes rarely reported in other parts of the world but common among some of our serotypes highlight the importance of our data as these genotypes may emerge post PCV introduction.	[Ndlangisa, Kedibone M.; du Plessis, Mignon; Wolter, Nicole; de Gouveia, Linda; Klugman, Keith P.; von Gottberg, Anne] NICD, CRDM, Johannesburg, South Africa; [Ndlangisa, Kedibone M.; du Plessis, Mignon; Wolter, Nicole; von Gottberg, Anne] Univ Witwatersrand, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Ndlangisa, Kedibone M.; du Plessis, Mignon; Wolter, Nicole; de Gouveia, Linda; von Gottberg, Anne] MRC, Johannesburg, South Africa; [Klugman, Keith P.] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Klugman, Keith P.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA	National Institute for Communicable Diseases (NICD); University of Witwatersrand; Emory University; Rollins School Public Health; Emory University	Ndlangisa, KM (corresponding author), NICD, CRDM, Johannesburg, South Africa.	kedibonen@nicd.ac.za		du Plessis, Mignon/0000-0001-9186-0679; von Gottberg, Anne/0000-0002-0243-7455	National Health Laboratory Service; Centers for Disease Control and Prevention (CDC); National Centre for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP); Global AIDS Program [U62/PSO022901]; Pfizer Vaccines Research	National Health Laboratory Service; Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Centre for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP); Global AIDS Program; Pfizer Vaccines Research	This work was funded by the National Health Laboratory Service, Centers for Disease Control and Prevention (CDC), National Centre for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Global AIDS Program Cooperative Agreement U62/PSO022901. (The contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC). Molecular characterization of isolates was funded by Pfizer Vaccines Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen DM, MULTILOCUS SEQUENCE; Antonio M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-81; AUSTRIAN R, 1976, MT SINAI J MED, V43, P699; Beall B, 2006, J CLIN MICROBIOL, V44, P999, DOI 10.1128/JCM.44.3.999-1017.2006; Beall BW, 2011, J INFECT DIS, V203, P1360, DOI 10.1093/infdis/jir052; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Brueggemann AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081539; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Choi EH, 2008, EMERG INFECT DIS, V14, P275, DOI 10.3201/eid1402.070807; Clinical and Laboratory Institute, 2007, PERF STAND ANT SUSC, P64; Dagan R, 2009, J INFECT DIS, V199, P776, DOI 10.1086/597044; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feldman C, 1999, CHEST, V116, P107, DOI 10.1378/chest.116.1.107; Fenoll A, 2009, J CLIN MICROBIOL, V47, P1012, DOI 10.1128/JCM.01454-08; Gonzalez BE, 2006, PEDIATR INFECT DIS J, V25, P301, DOI 10.1097/01.inf.0000207484.52850.38; Harboe ZB, 2010, CLIN INFECT DIS, V50, P329, DOI 10.1086/649872; Huebner RE, 1999, S AFR MED J, V89, P924; Jefferies JM, 2010, J CLIN MICROBIOL, V48, P87, DOI 10.1128/JCM.01485-09; Jones N, 1998, AIDS, V12, P2177, DOI 10.1097/00002030-199816000-00013; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; Madhi SA, 2000, PEDIATR INFECT DIS J, V19, P1141, DOI 10.1097/00006454-200012000-00004; Madhi SA, 2012, VACCINE, V30, pC21, DOI 10.1016/j.vaccine.2012.05.055; Mahjoub-Messai F, 2009, J CLIN MICROBIOL, V47, P837, DOI 10.1128/JCM.01547-08; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; Mothibeli KM, 2010, J CLIN MICROBIOL, V48, P184, DOI 10.1128/JCM.01011-09; Mothibeli KM, 2006, NAT I COMM DIS NICD; Munoz-Almagro C, 2008, CLIN INFECT DIS, V46, P174, DOI 10.1086/524660; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Picazo J, 2011, VACCINE, V29, P1770, DOI 10.1016/j.vaccine.2010.12.114; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Porat N, 2008, PEDIATR INFECT DIS J, V27, P709, DOI 10.1097/INF.0b013e31816fca86; Shin J, 2011, J ANTIMICROB CHEMOTH, V66, P1001, DOI 10.1093/jac/dkr048; Smith AM, 1997, MICROB DRUG RESIST, V3, P385, DOI 10.1089/mdr.1997.3.385; Tyrrell GJ, 2009, VACCINE, V27, P3553, DOI 10.1016/j.vaccine.2009.03.063; von Gottberg A, 2013, VACCINE, V31, P4200, DOI 10.1016/j.vaccine.2013.04.077; Wasfy MO, 2005, J ANTIMICROB CHEMOTH, V55, P958, DOI 10.1093/jac/dki101	39	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107666	10.1371/journal.pone.0107666	http://dx.doi.org/10.1371/journal.pone.0107666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233455	gold, Green Published, Green Submitted			2022-12-25	WOS:000342921200042
J	O'Reilly, CE; Taylor, EV; Ayers, T; Fantu, R; Abayneh, SA; Marston, B; Molla, YB; Sewnet, T; Abebe, F; Hoekstra, RM; Quick, R				O'Reilly, Ciara E.; Taylor, Ethel V.; Ayers, Tracy; Fantu, Ribka; Abayneh, Sisay Alemayehu; Marston, Barbara; Molla, Yordanos B.; Sewnet, Tegene; Abebe, Fitsum; Hoekstra, Robert M.; Quick, Robert			Improved Health among People Living with HIV/AIDS Who Received Packages of Proven Preventive Health Interventions, Amhara, Ethiopia	PLOS ONE			English	Article							POINT-OF-USE; USE WATER-TREATMENT; HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED ADULTS; COTRIMOXAZOLE PROPHYLAXIS; ANTIRETROVIRAL THERAPY; TREATING COINFECTIONS; COST-EFFECTIVENESS; VIRAL LOAD; DIARRHEA	In 2009, basic care packages (BCP) containing health products were distributed to HIV-infected persons in Ethiopia who were clients of antiretroviral therapy clinics. To measure health impact, we enrolled clients from an intervention hospital and comparison hospital, and then conducted a baseline survey, and 7 bi-weekly home visits. We enrolled 405 intervention group clients and 344 comparison clients. Intervention clients were more likely than comparison clients to have detectable chlorine in stored water (40% vs. 1%, p<0.001), soap (51% vs. 36%, p<0.001), and a BCP water container (65% vs. 0%, p<0.001) at every home visit. Intervention clients were less likely than comparison clients to report illness (44% vs. 67%, p<0.001) or health facility visits for illness (74% vs. 95%, p<0.001), and had lower median illness scores (1.0 vs. 3.0, p<0.05). Participation in the BCP program appeared to improve reported health outcomes.	[O'Reilly, Ciara E.; Taylor, Ethel V.; Ayers, Tracy; Hoekstra, Robert M.; Quick, Robert] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30333 USA; [Taylor, Ethel V.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Fantu, Ribka; Abayneh, Sisay Alemayehu] Ctr Dis Control & Prevent, Addis Ababa, Ethiopia; [Marston, Barbara] Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA USA; [Molla, Yordanos B.; Sewnet, Tegene; Abebe, Fitsum] Michael Dejene Publ Hlth Consultancy Serv, Addis Ababa, Ethiopia	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	O'Reilly, CE (corresponding author), Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30333 USA.	bwf1@cdc.gov		Ayers, Tracy/0000-0003-4140-3263; Hoekstra, Robert Michael/0000-0002-0340-8015	US President's Emergency Plan for AIDS Relief; Global AIDS Program; Centers for Disease Control and Prevention, Ethiopia; U.S. Agency for International Development through an Inter-Agency Agreement; U.S. Centers for Disease Control and Prevention; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T35OD010991] Funding Source: NIH RePORTER	US President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Global AIDS Program; Centers for Disease Control and Prevention, Ethiopia; U.S. Agency for International Development through an Inter-Agency Agreement(United States Agency for International Development (USAID)); U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for the study was provided by the US President's Emergency Plan for AIDS Relief, Global AIDS Program, and Centers for Disease Control and Prevention, Ethiopia. Additional support for technical assistance was provided by the U.S. Agency for International Development through an Inter-Agency Agreement with the U.S. Centers for Disease Control and Prevention. Michael Dejene Public Health Consultancy Services was formally contracted by the Centers for Disease Control and Prevention, Ethiopia to carry out the data collection component of this study only. Co-authors YM, TS, and FA were employed by Michael Dejene Public Health Consultancy Services, Addis Ababa, Ethiopia.	Abebe LS, 2014, J WATER HEALTH, V12, P288, DOI 10.2166/wh.2013.185; Arnold B, 2009, INT J EPIDEMIOL, V38, P1651, DOI 10.1093/ije/dyp241; Arnold BF, 2007, AM J TROP MED HYG, V76, P354, DOI 10.4269/ajtmh.2007.76.354; Barnabas RV, 2011, AIDS, V25, P1559, DOI 10.1097/QAD.0b013e3283491e3e; Barzilay EJ, 2011, AIDS CARE, V23, P330, DOI 10.1080/09540121.2010.507749; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brink AK, 2002, J INFECTION, V45, P99, DOI 10.1053/jinf.2002.1002; COLEBUNDERS R, 1987, AM J GASTROENTEROL, V82, P859; Colford John M. Jr, 2005, Journal of Water and Health, V3, P173; Colindres R, 2008, AIDS CARE, V20, P139, DOI 10.1080/09540120701506804; Doocy S, 2006, TROP MED INT HEALTH, V11, P1542, DOI 10.1111/j.1365-3156.2006.01704.x; Federal Ministry of Health, 2006, GUID COTR PROPH HIV; Federal Ministry of Health HIV/AIDS Prevention and Control Office, 2006, AIDS ETH; Federal Ministry of Health HIV/AIDS Prevention and Control Office, 2010, ART UPD OCT 8 2009 P; Fletcher RH, 2005, RANDOMIZED CONTROL T, P128; Freeman MC, 2009, J WATER HEALTH, V7, P527, DOI 10.2166/wh.2009.063; Grant A D, 1997, AIDS, V11 Suppl B, pS43; Hoffmann CJ, 2010, AIDS, V24, P1709, DOI 10.1097/QAD.0b013e32833ac6bc; Kaplan JE, 1996, AM J TROP MED HYG, V55, P1; Lowrance D, 2007, JAIDS-J ACQ IMM DEF, V46, P56; Luby SP, 2008, AM J TROP MED HYG, V78, P382, DOI 10.4269/ajtmh.2008.78.382; Lule JR, 2005, AM J TROP MED HYG, V73, P926, DOI 10.4269/ajtmh.2005.73.926; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Mermin J, 2005, TROP MED INT HEALTH, V10, P961, DOI 10.1111/j.1365-3156.2005.01488.x; Modjarrad K, 2008, AIDS, V22, P2179, DOI 10.1097/QAD.0b013e328312c756; Modjarrad K, 2011, LANCET INFECT DIS, V11, P81, DOI 10.1016/S1473-3099(11)70013-5; Modjarrad K, 2010, LANCET INFECT DIS, V10, P455, DOI 10.1016/S1473-3099(10)70093-1; Olembo Lynette, 2004, SAFE WATER SYSTEMS E; Peletz R, 2013, AIDS, V27, P2593, DOI 10.1097/QAD.0b013e3283633a5f; Pitter C, 2007, JAIDS-J ACQ IMM DEF, V44, P336, DOI 10.1097/QAI.0b013e31802f12b5; Sheth AN, 2010, AM J TROP MED HYG, V83, P1315, DOI 10.4269/ajtmh.2010.10-0211; Shrestha RK, 2006, AM J TROP MED HYG, V74, P884, DOI 10.4269/ajtmh.2006.74.884; Stockman LJ, 2007, EMERG INFECT DIS, V13, P1077, DOI 10.3201/eid1307.060767; The US President's Emergency Plan for AIDS Relief, 2009, ETH 2009 COUNTR OP P, P1; The US President's Emergency Plan for AIDS Relief, 2009, 5 YEAR STRAT, P1; Walker AS, 2010, LANCET, V375, P1278, DOI 10.1016/S0140-6736(10)60057-8; World Health Organization, 2007, PROM SAF MED CHILDR, P1	37	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107662	10.1371/journal.pone.0107662	http://dx.doi.org/10.1371/journal.pone.0107662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233345	Green Published, Green Submitted, gold			2022-12-25	WOS:000342921200041
J	Zaman, RT; Kosuge, H; Pratx, G; Carpenter, C; Xing, L; McConnell, MV				Zaman, Raiyan T.; Kosuge, Hisanori; Pratx, Guillem; Carpenter, Colin; Xing, Lei; McConnell, Michael V.			Fiber-Optic System for Dual-Modality Imaging of Glucose Probes F-18-FDG and 6-NBDG in Atherosclerotic Plaques	PLOS ONE			English	Article							HEART-DISEASE; MACROPHAGES; FEASIBILITY; PREVENTION; CATHETER; ANALOG; PET	Background: Atherosclerosis is a progressive inflammatory condition that underlies coronary artery disease (CAD)-the leading cause of death in the United States. Thus, the ultimate goal of this research is to advance our understanding of human CAD by improving the characterization of metabolically active vulnerable plaques within the coronary arteries using a novel catheter-based imaging system. The aims of this study include (1) developing a novel fiber-optic imaging system with a scintillator to detect both F-18 and fluorescent glucose probes, and (2) validating the system on ex vivo murine plaques. Methods: A novel design implements a flexible fiber-optic catheter consisting of both a radio-luminescence and a fluorescence imaging system to detect radionuclide F-18-fluorodeoxyglucose (F-18-FDG) and the fluorescent analog 6-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl) amino)-6-Deoxyglucose (6-NBDG), respectively. Murine macrophage-rich atherosclerotic carotid plaques were imaged ex vivo after intravenous delivery of F-18-FDG or 6-NBDG. Confirmatory optical imaging by IVIS-200 and autoradiography were also performed. Results: Our fiber-optic imaging system successfully visualized both F-18-FDG and 6-NBDG probes in atherosclerotic plaques. For F-18-FDG, the ligated left carotid arteries (LCs) exhibited 4.9-fold higher radioluminescence signal intensity compared to the non-ligated right carotid arteries (RCs) (2.6 x 10(4) +/- 1.4 x 10(3) vs. 5.4 x 10(3) +/- 1.3 x 10(3) A.U., P = 0.008). Similarly, for 6-NBDG, the ligated LCs emitted 4.3-fold brighter fluorescent signals than the control RCs (1.6 x 10(2) +/- 2.7 x 10(1) vs. 3.8 x 10(1) +/- 5.9 A.U., P = 0.002). The higher uptake of both F-18-FDG and 6-NBDG in ligated LCs were confirmed with the IVIS-200 system. Autoradiography further verified the higher uptake of F-18-FDG by the LCs. Conclusions: This novel fiber-optic imaging system was sensitive to both radionuclide and fluorescent glucose probes taken up by murine atherosclerotic plaques. In addition, 6-NBDG is a promising novel fluorescent probe for detecting macrophage-rich atherosclerotic plaques.	[Zaman, Raiyan T.; Kosuge, Hisanori; McConnell, Michael V.] Stanford Univ, Div Cardiovasc Med, Sch Med, Stanford, CA 94305 USA; [Zaman, Raiyan T.; Pratx, Guillem; Carpenter, Colin; Xing, Lei] Stanford Univ, Div Radiat Phys, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Zaman, RT (corresponding author), Stanford Univ, Div Cardiovasc Med, Sch Med, Stanford, CA 94305 USA.	rtzaman@stanford.edu	Pratx, Guillem/AAK-8006-2020	McConnell, Michael/0000-0001-8743-0932; Xing, Lei/0000-0003-2536-5359; Pratx, Guillem/0000-0002-0247-6470	NIH T32 Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford [T32EB009035]; Western States Affiliated American Heart Association Postdoctoral Fellowship [13POST17290051]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009035] Funding Source: NIH RePORTER	NIH T32 Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Western States Affiliated American Heart Association Postdoctoral Fellowship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	1. NIH T32 Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford (T32EB009035); 2. Western States Affiliated American Heart Association Postdoctoral Fellowship (13POST17290051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros LF, 2009, J NEUROCHEM, V109, P94, DOI 10.1111/j.1471-4159.2009.05885.x; Calfon MA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3280282; Chen IY, 2011, CIRCULATION, V123, P425, DOI 10.1161/CIRCULATIONAHA.109.916338; Cherry S., 2012, PHYS NUCL MED; Dimastromatteo J, 2013, J NUCL MED; Funk T, 2004, MED PHYS, V31, P2680, DOI 10.1118/1.1781553; Gaeta C, 2011, EUR J NUCL MED MOL I, V38, P2018, DOI 10.1007/s00259-011-1873-2; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hyafil F, 2007, NAT MED, V13, P636, DOI 10.1038/nm1571; Inglese E, 2007, J NUCL MED, V48, P1662, DOI 10.2967/jnumed.107.041574; Jaffer FA, 2008, CIRCULATION, V118, P1802, DOI 10.1161/CIRCULATIONAHA.108.785881; Jaffer FA, 2007, CIRCULATION, V116, P1052, DOI 10.1161/CIRCULATIONAHA.106.647164; Jaffer FA, 2009, ARTERIOSCL THROM VAS, V29, P1017, DOI 10.1161/ATVBAHA.108.165530; Jung DW, 2011, MOL BIOSYST, V7, P346, DOI 10.1039/c0mb00089b; Kosuge H, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002568; Kosuge H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014523; Mallas G, 2012, PHYS MED BIOL, V57, P6395, DOI 10.1088/0031-9155/57/20/6395; MCLACHLAN SJ, 1994, JMRI-J MAGN RESON IM, V4, P301, DOI 10.1002/jmri.1880040313; Menezes LJ, 2011, J NUCL MED, V52, P1698, DOI 10.2967/jnumed.111.093724; Menezes LJ, 2010, ATHEROSCLEROSIS, V211, P136, DOI 10.1016/j.atherosclerosis.2010.01.012; Nahrendorf M, 2008, CIRCULATION, V117, P379, DOI 10.1161/CIRCULATIONAHA.107.741181; O'Neil RG, 2005, MOL IMAGING BIOL, V7, P388, DOI 10.1007/s11307-005-0011-6; Ogawa M, 2012, J NUCL MED, V53, P55, DOI 10.2967/jnumed.111.092866; Pennant M, 2010, AM J EPIDEMIOL, V172, P501, DOI 10.1093/aje/kwq171; Rogers IS, 2010, JACC-CARDIOVASC IMAG, V3, P388, DOI 10.1016/j.jcmg.2010.01.004; Shikhaliev PM, 2006, PHYS MED BIOL, V51, P963, DOI 10.1088/0031-9155/51/4/014; SPEIZER L, 1985, BIOCHIM BIOPHYS ACTA, V815, P75, DOI 10.1016/0005-2736(85)90476-6; Stabin MG, 1999, APPL RADIAT ISOTOPES, V50, P73, DOI 10.1016/S0969-8043(98)00023-2; Tahara N, 2014, NAT MED, V20, P215, DOI 10.1038/nm.3437; Tang TY, 2009, J AM COLL CARDIOL, V53, P2039, DOI 10.1016/j.jacc.2009.03.018; Terashima M, 2011, BIOMATERIALS, V32, P1430, DOI 10.1016/j.biomaterials.2010.09.029; Uchida M, 2011, ACS NANO, V5, P2493, DOI 10.1021/nn102863y; Waxman S, 2006, CIRCULATION, V114, P2390, DOI 10.1161/CIRCULATIONAHA.105.540013; Weber MJ, 2004, NUCL INSTRUM METH A, V527, P9, DOI 10.1016/j.nima.2004.03.009; Yamaguchi Y, 2004, IEEE NUCL SCI CONF R, P2463, DOI 10.1109/NSSMIC.2003.1352392; Yoo H, 2011, NAT MED, V17, P1680, DOI 10.1038/nm.2555; Yoshioka K, 1996, BBA-GEN SUBJECTS, V1289, P5, DOI 10.1016/0304-4165(95)00153-0; Zhang Zhuangyu, 2006, BMC Nucl Med, V6, P3, DOI 10.1186/1471-2385-6-3	38	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e108108	10.1371/journal.pone.0108108	http://dx.doi.org/10.1371/journal.pone.0108108			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233472	Green Published, gold, Green Submitted			2022-12-25	WOS:000342921200083
J	Balestri, M; Barresi, M; Campera, M; Serra, V; Ramanamanjato, JB; Heistermann, M; Donati, G				Balestri, Michela; Barresi, Marta; Campera, Marco; Serra, Valentina; Ramanamanjato, Jean Baptiste; Heistermann, Michael; Donati, Giuseppe			Habitat Degradation and Seasonality Affect Physiological Stress Levels of Eulemur collaris in Littoral Forest Fragments	PLOS ONE			English	Article							FECAL GLUCOCORTICOID LEVELS; FREE-RANGING MALE; LEMURS LEMUR-CATTA; CORTISOL-LEVELS; ADRENOCORTICAL ACTIVITY; PROPITHECUS-DIADEMA; EASTERN MADAGASCAR; LOXODONTA-AFRICANA; SOCIAL-DOMINANCE; HUMAN-PREGNANCY	The littoral forest on sandy soil is among the most threatened habitats in Madagascar and, as such, it represents a hot-spot within a conservation hot-spot. Assessing the health of the resident lemur fauna is not only critical for the long-term viability of these populations, but also necessary for the future re-habilitation of this unique habitat. Since the Endangered collared brown lemur, Eulemur collaris, is the largest seed disperser of the Malagasy south-eastern littoral forest its survival in this habitat is crucial. In this study we compared fecal glucocorticoid metabolite (fGCM) levels, a measure of physiological stress and potential early indicator of population health, between groups of collared brown lemurs living in a degraded forest fragment and groups occurring in a more preserved area. For this, we analysed 279 fecal samples collected year-round from 4 groups of collared brown lemurs using a validated 11-oxoetiocholanolone enzyme immunoassay and tested if fGCM levels were influenced by reproductive stages, phenological seasons, sex, and habitat degradation. The lemurs living in the degraded forest had significantly higher fGCM levels than those living in the more preserved area. In particular, the highest fGCM levels were found during the mating season in all animals and in females during gestation in the degraded forest. Since mating and gestation are both occurring during the lean season in the littoral forest, these results likely reflect a combination of ecological and reproductive pressures. Our findings provide a clear indication that habitat degradation has additive effects to the challenges found in the natural habitat. Since increased stress hormone output may have long-term negative effects on population health and reproduction, our data emphasize the need for and may add to the development of effective conservation plans for the species.	[Balestri, Michela; Campera, Marco; Donati, Giuseppe] Oxford Brookes Univ, Dept Social Sci, Oxford OX3 0BP, England; [Balestri, Michela; Barresi, Marta; Campera, Marco; Serra, Valentina] Univ Pisa, Dept Biol, Pisa, Italy; [Ramanamanjato, Jean Baptiste] QIT Madagascar Minerals, Rio Tinto, Tolagnaro, Madagascar; [Heistermann, Michael] Leibniz Inst Primate Res, German Primate Ctr, Endocrinol Lab, Gottingen, Germany	Oxford Brookes University; University of Pisa; Rio Tinto; Deutsches Primatenzentrum (DPZ)	Donati, G (corresponding author), Oxford Brookes Univ, Dept Social Sci, Oxford OX3 0BP, England.	gdonati@brookes.ac.uk		Donati, Giuseppe/0000-0002-4803-0642; Serra, Valentina/0000-0002-2887-993X; Campera, Marco/0000-0003-2643-8329	Rufford Small Grant [8953-2]; Oxford Brookes University (Mentoring Scheme: HRSU-ASQL)	Rufford Small Grant; Oxford Brookes University (Mentoring Scheme: HRSU-ASQL)	This work received funding from a Rufford Small Grant (Reference number: 8953-2) and Oxford Brookes University (Mentoring Scheme: HRSU-ASQL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht ED, 1998, CONT ENDOCRINOL, V9, P319; Behie AM, 2010, AM J PRIMATOL, V72, P600, DOI 10.1002/ajp.20813; Bergman TJ, 2005, ANIM BEHAV, V70, P703, DOI 10.1016/j.anbehav.2004.12.017; Blickley JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050462; Bollen A, 2006, ORYX, V40, P57, DOI 10.1017/S0030605306000111; Bollen A, 2005, BIOTROPICA, V37, P32, DOI 10.1111/j.1744-7429.2005.04094.x; Bollen A, 2004, J TROP ECOL, V20, P599, DOI 10.1017/S0266467404001853; Bonier F, 2009, TRENDS ECOL EVOL, V24, P634, DOI 10.1016/j.tree.2009.04.013; Boonstra R, 2013, FUNCT ECOL, V27, P11, DOI 10.1111/1365-2435.12008; Breuner CW, 2008, GEN COMP ENDOCR, V157, P288, DOI 10.1016/j.ygcen.2008.05.017; Busch DS, 2009, BIOL CONSERV, V142, P2844, DOI 10.1016/j.biocon.2009.08.013; Cameron JL, 1997, SEMIN REPROD ENDOCR, V15, P37, DOI 10.1055/s-2008-1067966; Campera M, 2014, INT J PRIMATOL, V35, P957, DOI 10.1007/s10764-014-9780-6; Carnegie SD, 2011, AM J PRIMATOL, V73, P861, DOI 10.1002/ajp.20954; Cavigelli SA, 1999, ANIM BEHAV, V43, P166; Cavigelli SA, 2012, HORM BEHAV, V62, P295, DOI 10.1016/j.yhbeh.2012.07.006; Chapman CA, 2007, AM J PHYS ANTHROPOL, V134, P240, DOI 10.1002/ajpa.20664; Chapman CA, 2006, AM J PHYS ANTHROPOL, V131, P525, DOI 10.1002/ajpa.20477; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Clinchy M, 2013, FUNCT ECOL, V27, P56, DOI 10.1111/1365-2435.12007; Coe CL, 2014, FRONT NEUROENDOCRINO; Consiglio T, 2006, CONSERV BIOL, V20, P1799, DOI 10.1111/j.1523-1739.2006.00562.x; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; Creel S, 2003, ANIMAL SOCIAL COMPLEXITY, P153; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; Creel S, 2013, FUNCT ECOL, V27, P66, DOI 10.1111/j.1365-2435.2012.02029.x; Dantzer B, 2010, GEN COMP ENDOCR, V167, P279, DOI 10.1016/j.ygcen.2010.03.024; Dewar RE, 2007, P NATL ACAD SCI USA, V104, P13723, DOI 10.1073/pnas.0704346104; Dhabhar F, 2000, PSYCHONEUROIMMUNOLOG, P301; DONATI G, 2002, THESIS U PISA; Donati G, 2007, BEHAV ECOL SOCIOBIOL, V61, P1237, DOI 10.1007/s00265-007-0354-x; Donati G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019807; Donati Giuseppe, 2007, P237; Donati G, 2009, ANIM BEHAV, V77, P317, DOI 10.1016/j.anbehav.2008.09.033; Dufour DL, 2002, AM J HUM BIOL, V14, P584, DOI 10.1002/ajhb.10071; Dunn JC, 2013, INT J PRIMATOL, V34, P246, DOI 10.1007/s10764-013-9657-0; Erkert HG, 2006, FOLIA PRIMATOL, V77, P87, DOI 10.1159/000089697; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fichtel C, 2007, HORM BEHAV, V51, P640, DOI 10.1016/j.yhbeh.2007.03.005; Francis CD, 2013, FRONT ECOL ENVIRON, V11, P305, DOI 10.1890/120183; Furtbauer I, 2014, PSYCHONEUROENDOCRINO, V48, P19, DOI 10.1016/j.psyneuen.2014.05.022; Ganswindt A, 2003, GEN COMP ENDOCR, V134, P156, DOI 10.1016/S0016-6480(03)00251-X; Ganzhorn J. U., 2007, BIODIVERSITY ECOLOGY, V11; Ganzhorn Joerg U., 2007, P223; Ganzhorn JU, 1999, CONSERV BIOL, V13, P794, DOI 10.1046/j.1523-1739.1999.98245.x; Gesquiere LR, 2011, AM J PHYS ANTHROPOL, V144, P169, DOI 10.1002/ajpa.21374; Gould L, 2005, AM J PRIMATOL, V67, P5, DOI 10.1002/ajp.20166; Gould L, 1999, INT J PRIMATOL, V20, P69, DOI 10.1023/A:1020584200807; Goymann W, 2012, METHODS ECOL EVOL, V3, P757, DOI 10.1111/j.2041-210X.2012.00203.x; Hamalainen A, 2014, GEN COMP ENDOCR, V195, P68, DOI 10.1016/j.ygcen.2013.10.017; Hamlin HJ, 2011, BIOL REPROD, V85, P1108, DOI 10.1095/biolreprod.111.092692; Heistermann M, 2006, AM J PRIMATOL, V68, P257, DOI 10.1002/ajp.20222; Heistermann M, 2004, INT J PRIMATOL, V25, P689, DOI 10.1023/B:IJOP.0000023581.17889.0f; Higham JP, 2013, BEHAV ECOL SOCIOBIOL, V67, P19, DOI 10.1007/s00265-012-1420-6; Hodges J. Keith, 2011, P353; Hoffman CL, 2010, AM J PRIMATOL, V72, P559, DOI 10.1002/ajp.20793; Homan RN, 2003, ANIM CONSERV, V6, P11, DOI 10.1017/S13679430030032; Hunt KE, 2003, PHYSIOL BIOCHEM ZOOL, V76, P918, DOI 10.1086/380209; Irwin MT, 2008, BIOTROPICA, V40, P231, DOI 10.1111/j.1744-7429.2007.00368.x; Irwin MT, 2007, AM J PRIMATOL, V69, P434, DOI 10.1002/ajp.20360; Jachowski DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031818; Johnson CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070383; Johnstone CP, 2012, J COMP PHYSIOL B, V182, P861, DOI 10.1007/s00360-012-0656-9; Keay JM, 2006, J ZOO WILDLIFE MED, V37, P234, DOI 10.1638/05-050.1; Khan MZ, 2002, GEN COMP ENDOCR, V128, P57, DOI 10.1016/S0016-6480(02)00063-1; Kraus C, 1999, PHYSIOL BEHAV, V66, P855, DOI 10.1016/S0031-9384(99)00024-4; Lane J, 2006, ANIM WELFARE, V15, P331; Lazdane K, 2014, ITAL J ZOOL, V81, P374, DOI 10.1080/11250003.2014.915993; Lee P. C., 1996, Evolutionary Anthropology, V5, P87, DOI 10.1002/(SICI)1520-6505(1996)5:3<87::AID-EVAN4>3.0.CO;2-T; Lindburg DG, 2001, ZOO BIOL, V20, P537, DOI 10.1002/zoo.10027; Lynch JW, 2002, HORM BEHAV, V41, P275, DOI 10.1006/hbeh.2002.1772; Madliger CL, 2014, CONSERV BIOL, V28, P283, DOI 10.1111/cobi.12185; Marra PP, 1998, OECOLOGIA, V116, P284, DOI 10.1007/s004420050590; Martinez-Mota R, 2007, ANIM CONSERV, V10, P374, DOI 10.1111/j.1469-1795.2007.00122.x; McLean M, 1999, TRENDS ENDOCRIN MET, V10, P174, DOI 10.1016/S1043-2760(98)00146-5; Mittermeier R.A., 2010, LEMURS MADAGASCAR; Mooring MS, 2006, HORM BEHAV, V49, P369, DOI 10.1016/j.yhbeh.2005.08.008; Muller MN, 2004, BEHAV ECOL SOCIOBIOL, V55, P332, DOI 10.1007/s00265-003-0713-1; Munshi-South J, 2008, DIVERS DISTRIB, V14, P995, DOI 10.1111/j.1472-4642.2008.00509.x; Ostner J, 2008, BEHAV ECOL SOCIOBIOL, V62, P627, DOI 10.1007/s00265-007-0487-y; Overdorff DJ, 1999, AM J PHYS ANTHROPOL, V108, P295, DOI 10.1002/(SICI)1096-8644(199903)108:3<295::AID-AJPA5>3.3.CO;2-H; Owen MA, 2005, URSUS, V16, P208, DOI 10.2192/1537-6176(2005)016[0208:SADDOG]2.0.CO;2; Palme R, 2005, ANN NY ACAD SCI, V1040, P162, DOI 10.1196/annals.1327.021; Pereira ME, 1997, BEHAVIOUR, V134, P225, DOI 10.1163/156853997X00467; Pride E, 2005, BEHAV ECOL, V16, P550, DOI 10.1093/beheco/ari025; Pride RE, 2005, BIOL LETT-UK, V1, P60, DOI 10.1098/rsbl.2004.0245; Pride RE, 2005, INT J PRIMATOL, V26, P295, DOI 10.1007/s10764-005-2926-9; Rabenantoandro J., 2007, BIODIVERSITY ECOLOGY, P65; Rangel-Negrin A, 2009, ANIM CONSERV, V12, P496, DOI 10.1111/j.1469-1795.2009.00280.x; Ratsimbazafy Jonah H., 2002, Lemur News, V7, P7; Reeder DM, 2004, GEN COMP ENDOCR, V136, P260, DOI 10.1016/j.ygcen.2003.12.020; Rimbach R, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot031; Rimbach R, 2013, GEN COMP ENDOCR, V191, P13, DOI 10.1016/j.ygcen.2013.05.010; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Rosetta L, 2011, AM J PHYS ANTHROPOL, V144, P661, DOI 10.1002/ajpa.21475; Sands J, 2004, ANIM BEHAV, V67, P387, DOI 10.1016/j.anbehav.2003.03.019; Sapolsky R.M., 2002, BEHAV ENDOCRINOLOGY, V2nd, P409; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SAPOLSKY RM, 1986, AM J PRIMATOL, V11, P217, DOI 10.1002/ajp.1350110303; Sayre RW, 1996, THESIS U N DAKOTA; SCHILLING A, 1984, J ENDOCRINOL, V102, P143, DOI 10.1677/joe.0.1020143; Schiml P, 1999, AM J PRIMATOL, V47, P93, DOI 10.1002/(SICI)1098-2345(1999)47:2<93::AID-AJP1>3.0.CO;2-S; Schiml PA, 1996, PHYSIOL BEHAV, V60, P1105, DOI 10.1016/0031-9384(96)00134-5; Schwitzer C, 2014, SCIENCE, V343, P842, DOI 10.1126/science.1245783; Starling AP, 2010, HORM BEHAV, V57, P76, DOI 10.1016/j.yhbeh.2009.09.016; Strier KB, 1999, HORM BEHAV, V35, P125, DOI 10.1006/hbeh.1998.1505; TECOT S, 2013, DEV PRIMATOLOGY PROG, P185; Tilden CD, 1997, AM J PRIMATOL, V41, P195; Tilden C, 2008, DEV PRIMATOL-PROG PR, P311, DOI 10.1007/978-0-387-73896-3_20; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020; WASSER SK, 1993, J REPROD FERTIL, V97, P569, DOI 10.1530/jrf.0.0970569; Wingfield J.C., 2001, HANDBK PHYSL, P211, DOI [10.1002/cphy.cp070411, DOI 10.1002/CPHY.CP070411]; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Wingfield JC, 2013, FUNCT ECOL, V27, P37, DOI 10.1111/1365-2435.12039; Wingfield John C., 1997, P95; Wright PC, 1999, YEARB PHYS ANTHROPOL, V42, P31; Wright PC, 2005, TROPICAL FRUITS AND FRUGIVORES: THE SEARCH FOR STRONG INTERACTORS, P121, DOI 10.1007/1-4020-3833-X_7	118	37	38	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107698	10.1371/journal.pone.0107698	http://dx.doi.org/10.1371/journal.pone.0107698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229944	Green Submitted, gold, Green Published			2022-12-25	WOS:000342123900060
J	Wolf, WA; Martin, JL; Kartje, GL; Farrer, RG				Wolf, William A.; Martin, Jody L.; Kartje, Gwendolyn L.; Farrer, Robert G.			Evidence for Fibroblast Growth Factor-2 as a Mediator of Amphetamine-Enhanced Motor Improvement following Stroke	PLOS ONE			English	Article							TRANSIENT FOREBRAIN ISCHEMIA; FOCAL CEREBRAL INFARCTION; CENTRAL-NERVOUS-SYSTEM; NEURITE OUTGROWTH; FUNCTIONAL RECOVERY; FACTOR BFGF; RAT; NEURONS; EXPRESSION; BRAIN	Previously we have shown that addition of amphetamine to physical therapy results in enhanced motor improvement following stroke in rats, which was associated with the formation of new motor pathways from cortical projection neurons of the contralesional cortex. It is unclear what mechanisms are involved, but amphetamine is known to induce the neuronal release of catecholamines as well as upregulate fibroblast growth factor-2 (FGF-2) expression in the brain. Since FGF-2 has been widely documented to stimulate neurite outgrowth, the present studies were undertaken to provide evidence for FGF-2 as a neurobiological mechanism underlying amphetamine-induced neuroplasticity. In the present study rats that received amphetamine plus physical therapy following permanent middle cerebral artery occlusion exhibited significantly greater motor improvement over animals receiving physical therapy alone. Amphetamine plus physical therapy also significantly increased the number of FGF-2 expressing pyramidal neurons of the contralesional cortex at 2 weeks post-stroke and resulted in significant axonal outgrowth from these neurons at 8 weeks post-stroke. Since amphetamine is a known releaser of norepinephrine, in vitro analyses focused on whether noradrenergic stimulation could lead to neurite outgrowth in a manner requiring FGF-2 activity. Primary cortical neurons did not respond to direct stimulation by norepinephrine or amphetamine with increased neurite outgrowth. However, conditioned media from astrocytes exposed to norepinephrine or isoproterenol (a beta adrenergic agonist) significantly increased neurite outgrowth when applied to neuronal cultures. Adrenergic agonists also upregulated FGF-2 expression in astrocytes. Pharmacological analysis indicated that beta receptors and alpha1, but not alpha2, receptors were involved in both effects. Antibody neutralization studies demonstrated that FGF-2 was a critical contributor to neurite outgrowth induced by astrocyte-conditioned media. Taken together the present results suggest that noradrenergic activation, when combined with physical therapy, can improve motor recovery following ischemic damage by stimulating the formation of new neural pathways in an FGF-2-dependent manner.	[Wolf, William A.; Kartje, Gwendolyn L.; Farrer, Robert G.] Edward Hines Jr VA Hosp, Res Serv, Hines, IL 60141 USA; [Kartje, Gwendolyn L.] Edward Hines Jr VA Hosp, Neurol Serv, Hines, IL USA; [Martin, Jody L.] Loyola Univ, Dept Cell & Mol Physiol, Maywood, IL 60153 USA; [Kartje, Gwendolyn L.] Loyola Univ, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Wolf, William A.; Farrer, Robert G.] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Loyola University Chicago; Loyola University Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wolf, WA (corresponding author), Edward Hines Jr VA Hosp, Res Serv, Hines, IL 60141 USA.	william.wolf@va.gov			Department of Veterans Affairs, Veterans Health Administration; Office of Research and Development, Biomedical Laboratory Research and Development and Public Health Service [HD 44772]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044772] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration(US Department of Veterans Affairs); Office of Research and Development, Biomedical Laboratory Research and Development and Public Health Service; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development and Public Health Service Grant HD 44772 (WAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer C, 2002, ADV EXP MED BIOL, V513, P335; American Heart Association, 2010, HEART DIS STROK STAT; Ang ET, 2007, CURR MED CHEM, V14, P2564, DOI 10.2174/092986707782023280; Bachis A, 2008, NEUROPHARMACOLOGY, V55, P1114, DOI 10.1016/j.neuropharm.2008.07.014; Beltran EJ, 2010, BRAIN RES, V1346, P174, DOI 10.1016/j.brainres.2010.05.063; Biernaskie J, 2001, J NEUROSCI, V21, P5272, DOI 10.1523/JNEUROSCI.21-14-05272.2001; Bilge C, 2008, EUR J PHYS REHAB MED, V44, P13; Bogousslavsky J, 2002, CEREBROVASC DIS, V14, P239, DOI 10.1159/000065683; Calautti C, 2003, STROKE, V34, P1553, DOI 10.1161/01.STR.0000071761.36075.A6; Chen MJ, 2009, HIPPOCAMPUS; Chen Y, 2006, ANN PHARMACOTHER, V40, P2115, DOI 10.1345/aph.1H389; Cheung VCK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061496; Day JS, 2014, NEUROPHARMACOLOGY, V77, P234, DOI 10.1016/j.neuropharm.2013.09.027; Detillieux KA, 1999, AM J PHYSIOL-HEART C, V276, pH826, DOI 10.1152/ajpheart.1999.276.3.H826; Feeney DM, 2004, RESTOR NEUROL NEUROS, V22, P175; Feeney DM, 1997, ADV NEUROL, V73, P383; Flores C, 2000, J NEUROSCI, V20; Flores C, 1998, J NEUROSCI, V18, P9547; Flores C, 2000, NEUROSCIENCE, V98, P287, DOI 10.1016/S0306-4522(00)00115-9; Forrester LW, 2008, J REHABIL RES DEV, V45, P205, DOI 10.1682/JRRD.2007.02.0034; Gilardino A, 2009, J NEUROSCI RES, V87, P2951, DOI 10.1002/jnr.22116; Gilmour G, 2005, BEHAV BRAIN RES, V165, P98, DOI 10.1016/j.bbr.2005.06.027; Gladstone DJ, 2000, CAN J NEUROL SCI, V27, P97; Gobert A, 2004, J NEUROSCI METH, V140, P141, DOI 10.1016/j.jneumeth.2004.04.040; Goldstein Larry B, 2003, Adv Neurol, V92, P447; Goldstein Larry B, 2003, Phys Med Rehabil Clin N Am, V14, pS125, DOI 10.1016/S1047-9651(02)00060-8; Goldstein LB, 2009, STROKE, V40, pS133, DOI 10.1161/STROKEAHA.108.533703; GOLDSTEIN LB, 1990, BEHAV NEUROSCI, V104, P320, DOI 10.1037/0735-7044.104.2.320; Harvey Richard L, 2003, Phys Med Rehabil Clin N Am, V14, pS1, DOI 10.1016/S1047-9651(02)00062-1; Hausott B, 2008, NEUROSCIENCE, V153, P461, DOI 10.1016/j.neuroscience.2008.01.083; Jakala P, 2012, EXPERT OPIN BIOL TH, V12, P267, DOI 10.1517/14712598.2012.656086; Jeon CY, 2010, J CELL PHYSIOL, V224, P786, DOI 10.1002/jcp.22184; Kajitani N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051197; Kawamata T, 1996, J CEREBR BLOOD F MET, V16, P542, DOI 10.1097/00004647-199607000-00003; Kawamata T, 1997, P NATL ACAD SCI USA, V94, P8179, DOI 10.1073/pnas.94.15.8179; KROBERT KA, 1994, J NEUROCHEM, V62, P2233; Kuczenski R, 1997, J NEUROCHEM, V68, P2032; KUCZENSKI R, 1995, J NEUROSCI, V15, P1308; Kwon JH, 1998, EUR J NEUROSCI, V10, P2776, DOI 10.1046/j.1460-9568.1998.00315.x; Li Q, 2002, EXP NEUROL, V177, P531, DOI 10.1006/exnr.2002.7994; Ma YP, 2008, NEUROSCI LETT, V437, P93, DOI 10.1016/j.neulet.2008.04.003; Mallei A, 2002, MOL PHARMACOL, V61, P1017, DOI 10.1124/mol.61.5.1017; Martinsson L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002090.pub2; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Ou-Yang W, 2000, ACTA PHARMACOL SIN, V21, P296; Paciaroni M, 2011, EXPERT OPIN BIOL TH, V11, P1533, DOI 10.1517/14712598.2011.616888; Papadopoulos CM, 2009, STROKE, V40, P294, DOI 10.1161/STROKEAHA.108.519769; Phillips JP, 2003, J HEAD TRAUMA REHAB, V18, P342, DOI 10.1097/00001199-200307000-00005; Reilly JF, 1996, EXP NEUROL, V140, P139, DOI 10.1006/exnr.1996.0124; Ren JM, 2005, CNS NEUROL DISORD-DR, V4, P121, DOI 10.2174/1568007053544101; Riva MA, 1998, MOL BRAIN RES, V57, P38, DOI 10.1016/S0169-328X(98)00059-X; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Rosser N, 2008, NEUROREHABILITATION, V23, P95; Rothman RB, 2001, SYNAPSE, V39, P32, DOI 10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3; Rowntree S, 1997, EUR J NEUROSCI, V9, P2432, DOI 10.1111/j.1460-9568.1997.tb01660.x; Shaw-Lutchman TZ, 2003, SYNAPSE, V48, P10, DOI 10.1002/syn.10172; Sugimori H, 2001, NEUROSCI LETT, V300, P13, DOI 10.1016/S0304-3940(01)01549-X; TAKAMI K, 1993, EXP BRAIN RES, V97, P185; TAKAMI K, 1992, EXP BRAIN RES, V90, P1; Teasell R, 2006, CAN J NEUROL SCI, V33, P357, DOI 10.1017/S0317167100005308; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; Walker-Batson D, 2013, EUR J PHYS REHAB MED, V49, P251; Zamburlin P, 2013, PFLUG ARCH EUR J PHY, V465, P1355, DOI 10.1007/s00424-013-1257-5; Zittel S, 2007, J NEUROL, V254, P197, DOI 10.1007/s00415-006-0326-5	65	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e108031	10.1371/journal.pone.0108031	http://dx.doi.org/10.1371/journal.pone.0108031			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229819	Green Published, Green Submitted, gold			2022-12-25	WOS:000342123900093
J	Frankenfeld, SP; Oliveira, LP; Ortenzi, VH; Rego-Monteiro, ICC; Chaves, EA; Ferreira, AC; Leitao, AC; Carvalho, DP; Fortunato, RS				Frankenfeld, Stephan P.; Oliveira, Leonardo P.; Ortenzi, Victor H.; Rego-Monteiro, Igor C. C.; Chaves, Elen A.; Ferreira, Andrea C.; Leitao, Alvaro C.; Carvalho, Denise P.; Fortunato, Rodrigo S.			The Anabolic Androgenic Steroid Nandrolone Decanoate Disrupts Redox Homeostasis in Liver, Heart and Kidney of Male Wistar Rats	PLOS ONE			English	Article							DAMAGE	The abuse of anabolic androgenic steroids (AAS) may cause side effects in several tissues. Oxidative stress is linked to the pathophysiology of most of these alterations, being involved in fibrosis, cellular proliferation, tumorigenesis, amongst others. Thus, the aim of this study was to determine the impact of supraphysiological doses of nandrolone decanoate (DECA) on the redox balance of liver, heart and kidney. Wistar male rats were treated with intramuscular injections of vehicle or DECA (1 mg. 100 g(-1) body weight) once a week for 8 weeks. The activity and mRNA levels of NADPH Oxidase (NOX), and the activity of catalase, glutathione peroxidase (GPx) and total superoxide dismutase (SOD), as well as the reduced thiol and carbonyl residue proteins, were measured in liver, heart and kidney. DECA treatment increased NOX activity in heart and liver, but NOX2 mRNA levels were only increased in heart. Liver catalase and SOD activities were decreased in the DECA-treated group, but only catalase activity was decreased in the kidney. No differences were detected in GPx activity. Thiol residues were decreased in the liver and kidney of treated animals in comparison to the control group, while carbonyl residues were increased in the kidney after the treatment. Taken together, our results show that chronically administered DECA is able to disrupt the cellular redox balance, leading to an oxidative stress state.	[Frankenfeld, Stephan P.; Rego-Monteiro, Igor C. C.; Leitao, Alvaro C.; Fortunato, Rodrigo S.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Radiobiol Mol, BR-21941 Rio De Janeiro, Brazil; [Oliveira, Leonardo P.; Chaves, Elen A.] Univ Fed Rio de Janeiro, Escola Educ Fis & Desportos, Lab Biol Exercicio, Rio De Janeiro, Brazil; [Ortenzi, Victor H.; Carvalho, Denise P.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Fisiol Endocrina Doris Rosenthal, BR-21941 Rio De Janeiro, Brazil; [Ferreira, Andrea C.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Polo Xerem Lab Fisiol Endocrina Doris Rosenthal, BR-21941 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Fortunato, RS (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Radiobiol Mol, BR-21941 Rio De Janeiro, Brazil.	rodrigof@biof.ufrj.br	Fortunato, Rodrigo/AAM-9931-2020; Carvalho, Denise P/H-6306-2012; Frankenfeld, Stephan/AAK-4714-2021; /E-3415-2012; Fortunato, Rodrigo/F-2020-2014	Carvalho, Denise P/0000-0001-6933-6424; /0000-0001-7300-2718; Fortunato, Rodrigo/0000-0003-3497-8173	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Aguirre J, 2010, FREE RADICAL BIO MED, V49, P1342, DOI 10.1016/j.freeradbiomed.2010.07.027; Anderson SJ, 1997, PEDIATRICS, V99, P904; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaves EA, 2006, J STEROID BIOCHEM, V99, P223, DOI 10.1016/j.jsbmb.2006.01.004; Crapo JD, 1977, METHOD ENZYMOL, V3, P382; D'Errico S, 2011, MINI-REV MED CHEM, V11, P446, DOI 10.2174/138955711795445934; Do Carmo EC, 2011, MED SCI SPORT EXER, V43, P1836, DOI 10.1249/MSS.0b013e318217e8b6; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Fortunato RS, 2010, J CLIN ENDOCR METAB, V95, P5403, DOI 10.1210/jc.2010-1085; Fortunato RS, 2006, MED SCI SPORT EXER, V38, P256, DOI 10.1249/01.mss.0000183357.19743.51; Frankenfeld SP, 2014, J ENDOCRINOL, V220, P143, DOI 10.1530/JOE-13-0259; Giorgio Marco, 2007, Nat Rev Mol Cell Biol, V8, P722, DOI 10.1038/nrm2240; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Joyce J A, 1991, AANA J, V59, P139; Juhn MS, 2003, SPORTS MED, V33, P921, DOI 10.2165/00007256-200333120-00004; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Maior AS, 2013, SCAND J MED SCI SPOR, V23, P548, DOI 10.1111/j.1600-0838.2011.01436.x; Neto SRM, 2013, ACTA PHYSIOL, V208, P166, DOI 10.1111/apha.12056; Mochizuki RM, 1998, PHYSICIAN SPORTSMED, V16, P109; Neri M, 2011, MINI-REV MED CHEM, V11, P430, DOI 10.2174/138955711795445916; Pey A, 2003, J STEROID BIOCHEM, V87, P269, DOI 10.1016/j.jsbmb.2003.09.001; Pozzi R, 2013, ARCH ENVIRON CON TOX, V64, P514, DOI 10.1007/s00244-012-9848-2; SABORIDO A, 1993, MED SCI SPORT EXER, V25, P815, DOI 10.1249/00005768-199307000-00010; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shahidi NT, 2001, CLIN THER, V23, P1355, DOI 10.1016/S0149-2918(01)80114-4; Sullivan ML, 1998, PROG CARDIOVASC DIS, V41, P1, DOI 10.1016/S0033-0620(98)80019-4; YESALIS CE, 1995, SPORTS MED, V19, P326, DOI 10.2165/00007256-199519050-00003	31	44	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e102699	10.1371/journal.pone.0102699	http://dx.doi.org/10.1371/journal.pone.0102699			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225984	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700002
J	Fujiwara, K; Ohuchida, K; Sada, M; Horioka, K; Ulrich, CD; Shindo, K; Ohtsuka, T; Takahata, S; Mizumoto, K; Oda, Y; Tanaka, M				Fujiwara, Kenji; Ohuchida, Kenoki; Sada, Masafumi; Horioka, Kohei; Ulrich, Charles D., III; Shindo, Koji; Ohtsuka, Takao; Takahata, Shunichi; Mizumoto, Kazuhiro; Oda, Yoshinao; Tanaka, Masao			CD166/ALCAM Expression Is Characteristic of Tumorigenicity and Invasive and Migratory Activities of Pancreatic Cancer Cells	PLOS ONE			English	Article							STEM-LIKE CELLS; ADHESION MOLECULE; STELLATE CELLS; PROGENITOR CELLS; CARCINOMA CELLS; ALCAM; ALCAM/CD166; SURVIVAL; MARKER; GROWTH	Background: CD166, also known as activated leukocyte cell adhesion molecule (ALCAM), is expressed by various cells in several tissues including cancer. However, the role of CD166 in malignant tumors is controversial, especially in pancreatic cancer. This study aimed to clarify the role and significance of CD166 expression in pancreatic cancer. Methods: We performed immunohistochemistry and flow cytometry to analyze the expression of CD166 in surgical pancreatic tissues and pancreatic cancer cell lines. The differences between isolated CD166+ and CD166- pancreatic cancer cells were analyzed by invasion and migration assays, and in mouse xenograft models. We also performed quantitative RT-PCR and microarray analyses to evaluate the expression levels of CD166 and related genes in cultured cells. Results: Immunohistochemistry revealed high expression of CD166 in pancreatic cancer tissues (12.2%; 12/98) compared with that in normal pancreas controls (0%; 0/17) (p = 0.0435). Flow cytometry indicated that CD166 was expressed in 33.8-70.2% of cells in surgical pancreatic tissues and 0-99.5% of pancreatic cancer cell lines. Invasion and migration assays demonstrated that CD166-pancreatic cancer cells showed stronger invasive and migratory activities than those of CD166+ cancer cells (p<0.05). On the other hand, CD166+ Panc-1 cells showed a significantly stronger colony formation activity than that of CD166-Panc-1 cells (p<0.05). In vivo analysis revealed that CD166+ cells elicited significantly greater tumor growth than that of CD166-cells (p<0.05) in both subcutaneous and orthotopic mouse tumor models. mRNA expression of the epithelial-mesenchymal transition activator Zeb1 was over-expressed in CD166-cells (p<0.001). Microarray analysis showed that TSPAN8 and BST2 were over-expressed in CD166+ cells, while BMP7 and Col6A1 were over-expressed in CD166-cells. Conclusions: CD166+ pancreatic cancer cells are strongly tumorigenic, while CD166-pancreatic cancer cells exhibit comparatively stronger invasive and migratory activities. These findings suggest that CD166 expression is related to different functions in pancreatic cancer cells.	[Fujiwara, Kenji; Ohuchida, Kenoki; Sada, Masafumi; Horioka, Kohei; Ulrich, Charles D., III; Shindo, Koji; Ohtsuka, Takao; Takahata, Shunichi; Mizumoto, Kazuhiro; Tanaka, Masao] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 812, Japan; [Shindo, Koji; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 812, Japan; [Shindo, Koji] Japan Soc Promot Sci, Tokyo, Japan; [Mizumoto, Kazuhiro] Kyushu Univ Hosp, Ctr Canc, Fukuoka 812, Japan	Kyushu University; Kyushu University; Japan Society for the Promotion of Science; Kyushu University	Ohuchida, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 812, Japan.	kenoki@surg1.med.kyushu-u.ac.jp	Fujiwara, Kenji/AAI-8431-2021	Fujiwara, Kenji/0000-0001-5900-9382; Ohuchida, Kenoki/0000-0003-4792-1168	Ministry of Education, Culture, Sports, Science and Technology of Japan [23390327, 24390318, 24390319, 25670584, 25670585, 25670586, 241237]; Fukuoka Foundation for Sound Health; Grants-in-Aid for Scientific Research [25670586, 13J03692, 24390318, 24592032] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fukuoka Foundation for Sound Health(Fukuoka Foundation for Sound Health); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant number: 23390327, 24390318, 24390319, 25670584, 25670585, 25670586, 241237) and the Fukuoka Foundation for Sound Health (http://www.jsps.go.jp/english/e-grants/) (http://www.sukoken.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Chiu KH, 2011, J PROTEOME RES, V10, P1110, DOI 10.1021/pr1008724; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Eguchi D, 2013, SURGERY, V154, P573, DOI 10.1016/j.surg.2013.03.010; Gu GP, 2012, J CELL BIOCHEM, V113, P1013, DOI 10.1002/jcb.23433; Hong X, 2010, J SURG ONCOL, V101, P564, DOI 10.1002/jso.21538; Hori Y, 2013, ADV EXP MED BIOL, V777, P185, DOI 10.1007/978-1-4614-5894-4_12; Ikeda K, 2004, J BIOL CHEM, V279, P55315, DOI 10.1074/jbc.M407776200; Ikenaga N, 2010, GASTROENTEROLOGY, V139, P1041, DOI 10.1053/j.gastro.2010.05.084; Kahlert C, 2009, BRIT J CANCER, V101, P457, DOI 10.1038/sj.bjc.6605136; Kijima N, 2012, NEURO-ONCOLOGY, V14, P1254, DOI 10.1093/neuonc/nor202; Kozono S, 2013, CANCER RES, V73, P2345, DOI 10.1158/0008-5472.CAN-12-3180; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu J, 2012, FRONT BIOSCI-LANDMRK, V17, P2541, DOI 10.2741/4069; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Notting I, 2007, INVEST OPHTH VIS SCI, V48, P4882, DOI 10.1167/iovs.07-0505; Ohneda O, 2001, BLOOD, V98, P2134, DOI 10.1182/blood.V98.7.2134; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rosso O, 2007, MOL CANCER RES, V5, P1246, DOI 10.1158/1541-7786.MCR-07-0060; Sakai H, 2012, CLIN EXP METASTAS, V29, P327, DOI 10.1007/s10585-012-9453-9; Sato N, 2001, CANCER, V91, P496, DOI 10.1002/1097-0142(20010201)91:3<496::AID-CNCR1028>3.0.CO;2-0; Swart GWM, 2002, EUR J CELL BIOL, V81, P313, DOI 10.1078/0171-9335-00256; Tachezy M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039018; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wang HB, 2013, INT J CANCER, V133, P416, DOI 10.1002/ijc.28044; Weidle Ulrich H., 2010, Cancer Genomics & Proteomics, V7, P231; Yan M, 2013, MOL CELL PROTEOMICS, V12, P3271, DOI 10.1074/mcp.M112.025460; Zhang L, 1999, CANCER LETT, V142, P129, DOI 10.1016/S0304-3835(99)00107-X	31	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107247	10.1371/journal.pone.0107247	http://dx.doi.org/10.1371/journal.pone.0107247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25221999	gold, Green Submitted, Green Published			2022-12-25	WOS:000341774800056
J	Rodriguez, F; Lillington, J; Johnson, S; Timmel, CR; Lea, SM; Berks, BC				Rodriguez, Fernanda; Lillington, James; Johnson, Steven; Timmel, Christiane R.; Lea, Susan M.; Berks, Ben C.			Crystal Structure of the Bacillus subtilis Phosphodiesterase PhoD Reveals an Iron and Calcium-containing Active Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURPLE ACID-PHOSPHATASES; CHROMOFUSCUS PHOSPHOLIPASE-D; BINUCLEAR METALLOHYDROLASES; ALKALINE-PHOSPHATASES; EXPRESSION; COMPLEX; LOCALIZATION; SCATTERING; SOFTWARE; PROGRAM	The PhoD family of extra-cytoplasmic phosphodiesterases are among the most commonly occurring bacterial phosphatases. The exemplars for this family are the PhoD protein of Bacillus subtilis and the phospholipase D of Streptomyces chromofuscus. We present the crystal structure of B. subtilis PhoD. PhoD is most closely related to purple acid phosphatases (PAPs) with both types of enzyme containing a tyrosinate-ligated Fe3+ ion. However, the PhoD active site diverges from that found in PAPs and uses two Ca2+ ions instead of the single extra Fe2+, Mn2+, or Zn2+ ion present in PAPs. The PhoD crystals contain a phosphate molecule that coordinates all three active site metal ions and that is proposed to represent a product complex. A C-terminal helix lies over the active site and controls access to the catalytic center. The structure of PhoD defines a new phosphatase active site architecture based on Fe3+ and Ca2+ ions.	[Rodriguez, Fernanda; Berks, Ben C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Lillington, James; Johnson, Steven; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Lillington, James; Timmel, Christiane R.] Univ Oxford, Inorgan Chem Lab, Oxford OX1 3QR, England	University of Oxford; University of Oxford; University of Oxford	Lea, SM (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	susan.lea@path.ox.ac.uk; ben.berks@bioch.ox.ac.uk	Lea, Susan M/B-7678-2009; Johnson, Steven J/F-9182-2016; Timmel, Christiane/GLU-4087-2022	Lea, Susan M/0000-0001-9287-8053; Johnson, Steven J/0000-0002-7877-3543; Berks, Ben/0000-0001-9685-4067; Timmel, Christiane/0000-0003-1828-7700	European Molecular Biology Organization (EMBO) Fellowship; E.P. Abrahams Cephalosporin Trust Fund; Engineering and Physical Sciences Research Council; Oxford Martin School Vaccine Design Institute; Medical Research Council (MRC) Programme [G0900888]; EPSRC [EP/D048559/1, EP/L011972/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D048559/1, EP/L011972/1] Funding Source: researchfish	European Molecular Biology Organization (EMBO) Fellowship(European Molecular Biology Organization (EMBO)); E.P. Abrahams Cephalosporin Trust Fund; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Oxford Martin School Vaccine Design Institute; Medical Research Council (MRC) Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by an European Molecular Biology Organization (EMBO) Fellowship and by the E.P. Abrahams Cephalosporin Trust Fund.; Recipient of a studentship from the Engineering and Physical Sciences Research Council and also received funding from the Oxford Martin School Vaccine Design Institute (of which S. M. L. is Co-director).; Funded by Medical Research Council (MRC) Programme Grant G0900888 (to S. M. L.).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Benini S, 2001, J BIOL INORG CHEM, V6, P778, DOI 10.1007/s007750100254; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cox RS, 2007, J AM CHEM SOC, V129, P9550, DOI 10.1021/ja072647q; CROMER DT, 1983, J APPL CRYSTALLOGR, V16, P437, DOI 10.1107/S0021889883010791; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dermol U, 2011, J MOL BIOL, V412, P481, DOI 10.1016/j.jmb.2011.07.060; Eder S, 1996, MICROBIOL-SGM, V142, P2041, DOI 10.1099/13500872-142-8-2041; Ely F, 2012, J INORG BIOCHEM, V106, P19, DOI 10.1016/j.jinorgbio.2011.09.015; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feder D, 2012, CHEM BIOL DRUG DES, V80, P665, DOI 10.1111/cbdd.12001; Ferrer M, 2008, P NATL ACAD SCI USA, V105, P8878, DOI 10.1073/pnas.0800071105; GABER BP, 1979, J BIOL CHEM, V254, P8340; Guddat LW, 1999, STRUCT FOLD DES, V7, P757, DOI 10.1016/S0969-2126(99)80100-2; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jackson CJ, 2007, J MOL BIOL, V367, P1047, DOI 10.1016/j.jmb.2007.01.032; Jongbloed JDH, 2000, J BIOL CHEM, V275, P41350, DOI 10.1074/jbc.M004887200; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Lassila JK, 2011, ANNU REV BIOCHEM, V80, P669, DOI 10.1146/annurev-biochem-060409-092741; Luo HW, 2009, P NATL ACAD SCI USA, V106, P21219, DOI 10.1073/pnas.0907586106; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Matange N, 2014, J BIOL CHEM, V289, P22470, DOI 10.1074/jbc.M114.578328; Miller DJ, 2007, PROTEIN SCI, V16, P1338, DOI 10.1110/ps.072764907; Mitic N, 2006, CHEM REV, V106, P3338, DOI 10.1021/cr050318f; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oganesyan VS, 2000, J CHEM PHYS, V113, P5003, DOI 10.1063/1.1289531; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schenk G, 2000, GENE, V255, P419, DOI 10.1016/S0378-1119(00)00305-X; Schenk G, 2005, P NATL ACAD SCI USA, V102, P273, DOI 10.1073/pnas.0407239102; Schenk G, 2012, ACCOUNTS CHEM RES, V45, P1593, DOI 10.1021/ar300067g; SCHLOSNAGLE DC, 1974, J BIOL CHEM, V249, P7574; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; YAMANE K, 1978, J BACTERIOL, V134, P100, DOI 10.1128/JB.134.1.100-107.1978; Yang HY, 2004, BBA-PROTEINS PROTEOM, V1703, P43, DOI 10.1016/j.bbapap.2004.09.014; Yong SC, 2014, SCIENCE, V345, P1170, DOI 10.1126/science.1254237; Zambonelli C, 2003, J BIOL CHEM, V278, P52282, DOI 10.1074/jbc.M310252200; Zambonelli C, 2003, J BIOL CHEM, V278, P13706, DOI 10.1074/jbc.M210363200	47	36	37	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					30889	30899		10.1074/jbc.M114.604892	http://dx.doi.org/10.1074/jbc.M114.604892			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25217636	hybrid, Green Published			2022-12-25	WOS:000344549900002
J	Wei, ZQ; Salmon, RM; Upton, PD; Morrell, NW; Li, W				Wei, Zhenquan; Salmon, Richard M.; Upton, Paul D.; Morrell, Nicholas W.; Li, Wei			Regulation of Bone Morphogenetic Protein 9 (BMP9) by Redox-dependent Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; MESENCHYMAL STEM-CELLS; RECEPTOR-LIKE KINASE-1; PULMONARY-HYPERTENSION; ENDOTHELIAL-CELLS; FUNCTIONAL-ANALYSIS; GENE DELIVERY; II RECEPTOR; 1 ALK1; MUTATIONS	BMP9, a member of the TGF beta superfamily, is a homodimer that forms a signaling complex with two type I and two type II receptors. Signaling through high-affinity activin receptor-like kinase 1 (ALK1) in endothelial cells, circulating BMP9 acts as a vascular quiescence factor, maintaining endothelial homeostasis. BMP9 is also the most potent BMP for inducing osteogenic signaling in mesenchymal stem cells in vitro and promoting bone formation in vivo. This activity requires ALK1, the lower affinity type I receptor ALK2, and higher concentrations of BMP9. In adults, BMP9 is constitutively expressed in hepatocytes and secreted into the circulation. Optimum concentrations of BMP9 are essential to maintain the highly specific endothelial-protective function. Factors regulating BMP9 stability and activity remain unknown. Here, we showed by chromatography and a 1.9 angstrom crystal structure that stable BMP9 dimers could form either with (D-form) or without (M-form) an intermolecular disulfide bond. Although both forms of BMP9 were capable of binding to the prodomain and ALK1, the M-form demonstrated less sustained induction of Smad1/5/8 phosphorylation. The two forms could be converted into each other by changing the redox potential, and this redox switch caused a major alteration in BMP9 stability. The M-form displayed greater susceptibility to redox-dependent cleavage by proteases present in serum. This study provides a mechanism for the regulation of circulating BMP9 concentrations and may provide new rationales for approaches to modify BMP9 levels for therapeutic purposes.	[Wei, Zhenquan; Salmon, Richard M.; Upton, Paul D.; Morrell, Nicholas W.; Li, Wei] Univ Cambridge, Dept Med, Sch Clin Med, Addenbrookes Hosp, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Morrell, NW (corresponding author), Univ Cambridge, Dept Med, Sch Clin Med, Addenbrookes Hosp, Box 157,Hills Rd, Cambridge CB2 0QQ, England.	nwm23@cam.ac.uk; wl225@cam.ac.uk	wei, wei/HHR-8613-2022	Morrell, Nicholas/0000-0001-5700-9792; Salmon, Richard/0000-0001-6327-5341	British Heart Foundation [PG/12/54/29734, CH/09/001/25945]; British Heart Foundation [RG/13/4/30107] Funding Source: researchfish; Medical Research Council [G1000847, G0800784, MR/K020919/1] Funding Source: researchfish; MRC [G1000847, MR/K020919/1, G0800784] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the British Heart Foundation Grants PG/12/54/29734 (to W. L.) and CH/09/001/25945 (to N. W. M.).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Bidart M, 2012, CELL MOL LIFE SCI, V69, P313, DOI 10.1007/s00018-011-0751-1; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Burke RM, 2013, P NATL ACAD SCI USA, V110, P19567, DOI 10.1073/pnas.1319297110; Burton VJ, 2011, BLOOD, V118, P4750, DOI 10.1182/blood-2011-05-347393; Burton VJ, 2011, BLOOD, V117, P333, DOI 10.1182/blood-2010-05-285973; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Degnin C, 2004, MOL BIOL CELL, V15, P5012, DOI 10.1091/mbc.E04-08-0673; Dunmore BJ, 2013, HUM MOL GENET, V22, P3667, DOI 10.1093/hmg/ddt216; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Harrison RE, 2003, J MED GENET, V40, P865, DOI 10.1136/jmg.40.12.865; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; Isaacs MJ, 2010, MOL ENDOCRINOL, V24, P1469, DOI 10.1210/me.2009-0496; Jerkic M, 2011, CARDIOVASC RES, V92, P375, DOI 10.1093/cvr/cvr232; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; JONES WK, 1994, GROWTH FACTORS, V11, P215, DOI 10.3109/08977199409046919; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kelley R, 2009, J CELL BIOL, V184, P597, DOI 10.1083/jcb.200808064; Knaus P, 2001, BIOL CHEM, V382, P1189, DOI 10.1515/BC.2001.149; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; LIU F, 1995, MOL CELL BIOL, V15, P3479; Lopez-Coviella I, 2000, SCIENCE, V289, P313, DOI 10.1126/science.289.5477.313; Luo JY, 2010, J BIOL CHEM, V285, P29588, DOI 10.1074/jbc.M110.130518; Luther G, 2011, CURR GENE THER, V11, P229; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morrell Nicholas W, 2006, Proc Am Thorac Soc, V3, P680, DOI 10.1513/pats.200605-118SF; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Reynolds AM, 2012, EUR RESPIR J, V39, P329, DOI 10.1183/09031936.00187310; Ricard N, 2012, BLOOD, V119, P6162, DOI 10.1182/blood-2012-01-407593; Ricard N, 2010, BLOOD, V116, P1604, DOI 10.1182/blood-2010-03-276881; Rossi R, 2002, CLIN CHEM, V48, P742; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Seemann P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000747; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Spoelgen R, 2005, DEVELOPMENT, V132, P405, DOI 10.1242/dev.01580; Teichert-Kuliszewska K, 2006, CIRC RES, V98, P209, DOI 10.1161/01.RES.0000200180.01710.e6; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Townson SA, 2012, J BIOL CHEM, V287, P27313, DOI 10.1074/jbc.M112.377960; Trembath RC, 2001, NEW ENGL J MED, V345, P325, DOI 10.1056/NEJM200108023450503; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881; van Baardewijk LJ, 2013, INT ORTHOP, V37, P523, DOI 10.1007/s00264-012-1750-z; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wooderchak-Donahue WL, 2013, AM J HUM GENET, V93, P530, DOI 10.1016/j.ajhg.2013.07.004; Yao YC, 2012, BLOOD, V119, P5037, DOI 10.1182/blood-2011-10-385906; Yoshimatsu Y, 2013, P NATL ACAD SCI USA, V110, P18940, DOI 10.1073/pnas.1310479110; Zhou AW, 2010, NATURE, V468, P108, DOI 10.1038/nature09505	51	30	31	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31150	31159		10.1074/jbc.M114.579771	http://dx.doi.org/10.1074/jbc.M114.579771			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25237187	Green Published, hybrid			2022-12-25	WOS:000344549900023
J	Masson, P; Hulo, C; de Castro, E; Foulger, R; Poux, S; Bridge, A; Lomax, J; Bougueleret, L; Xenarios, I; Le Mercier, P				Masson, Patrick; Hulo, Chantal; de Castro, Edouard; Foulger, Rebecca; Poux, Sylvain; Bridge, Alan; Lomax, Jane; Bougueleret, Lydie; Xenarios, Ioannis; Le Mercier, Philippe			An Integrated Ontology Resource to Explore and Study Host-Virus Relationships	PLOS ONE			English	Article							ANTIVIRAL SIGNALING PROTEIN; INNATE IMMUNE-RESPONSE; VIRAL-RNA; X PROTEIN; RIG-I; INFECTION; ANTIGEN; TYPE-1; DEGRADATION; SUPPRESSION	Our growing knowledge of viruses reveals how these pathogens manage to evade innate host defenses. A global scheme emerges in which many viruses usurp key cellular defense mechanisms and often inhibit the same components of antiviral signaling. To accurately describe these processes, we have generated a comprehensive dictionary for eukaryotic host-virus interactions. This controlled vocabulary has been detailed in 57 ViralZone resource web pages which contain a global description of all molecular processes. In order to annotate viral gene products with this vocabulary, an ontology has been built in a hierarchy of UniProt Knowledgebase (UniProtKB) keyword terms and corresponding Gene Ontology (GO) terms have been developed in parallel. The results are 65 UniProtKB keywords related to 57 GO terms, which have been used in 14,390 manual annotations; 908,723 automatic annotations and propagated to an estimation of 922,941 GO annotations. ViralZone pages, UniProtKB keywords and GO terms provide complementary tools to users, and the three resources have been linked to each other through host-virus vocabulary.	[Masson, Patrick; Hulo, Chantal; de Castro, Edouard; Poux, Sylvain; Bridge, Alan; Bougueleret, Lydie; Xenarios, Ioannis; Le Mercier, Philippe] Univ Geneva, Sch Med, Swiss Inst Bioinformat, CMU, CH-1211 Geneva, Switzerland; [Foulger, Rebecca; Lomax, Jane] European Bioinformat Inst, European Mol Biol Lab, Hinxton, England	Swiss Institute of Bioinformatics; University of Geneva; European Molecular Biology Laboratory (EMBL)	Le Mercier, P (corresponding author), Univ Geneva, Sch Med, Swiss Inst Bioinformat, CMU, CH-1211 Geneva, Switzerland.	philippe.lemercier@isb-sib.ch	Masson, Patrick/AAA-7213-2019; Lomax, Jane/H-2788-2019; Xenarios, Ioannis/ABD-5045-2021; Bridge, Alan/U-4209-2018	Masson, Patrick/0000-0002-7837-3662; Lomax, Jane/0000-0001-8865-4321; Xenarios, Ioannis/0000-0002-3413-6841; Foulger, Rebecca/0000-0001-8682-8754; Le Mercier, Philippe/0000-0001-8528-090X; Bridge, Alan/0000-0003-2148-9135; de Castro, Edouard/0000-0001-5436-7383; Masson, Patrick/0000-0001-7646-0052; Poux, Sylvain/0000-0001-7299-6685	Swiss Federal Government through the state Secretariat for Education, Research and Innovation (SERI); National Institute of Health (NIH) [1 U41 HG006104]; European Molecular Biology Laboratory (EMBL) core funds; NIH NHGRI grant [HG 002273]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG002273, U41HG006104] Funding Source: NIH RePORTER	Swiss Federal Government through the state Secretariat for Education, Research and Innovation (SERI); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Laboratory (EMBL) core funds; NIH NHGRI grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This activity of the Swiss-Prot group is supported by the Swiss Federal Government through the state Secretariat for Education, Research and Innovation (SERI), and by the National Institute of Health (NIH) grant 1 U41 HG006104. JL was funded by European Molecular Biology Laboratory (EMBL) core funds and RF was funded by NIH NHGRI grant HG 002273. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhrymuk I, 2012, J VIROL, V86, P7180, DOI 10.1128/JVI.00541-12; Aranda M, 1998, VIROLOGY, V243, P261, DOI 10.1006/viro.1998.9032; Balvay L, 2009, BBA-GENE REGUL MECH, V1789, P542, DOI 10.1016/j.bbagrm.2009.07.005; Benhenda S, 2009, ADV CANCER RES, V103, P75, DOI 10.1016/S0065-230X(09)03004-8; Birch EW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002746; Bishop KN, 2004, SCIENCE, V305, P645, DOI 10.1126/science.1100658; Brennan K, 2010, CURR OPIN MICROBIOL, V13, P503, DOI 10.1016/j.mib.2010.05.007; Brister JR, 2012, VIROLOGY, V434, P175, DOI 10.1016/j.virol.2012.09.027; Castello A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007997; Csorba T, 2009, ADV VIRUS RES, V75, P35, DOI 10.1016/S0065-3527(09)07502-2; de Breyne S, 2008, VIROLOGY, V378, P118, DOI 10.1016/j.virol.2008.05.019; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Dixit E, 2013, ADV IMMUNOL, V117, P99, DOI 10.1016/B978-0-12-410524-9.00004-9; Dong XN, 2013, J INNATE IMMUN, V5, P480, DOI 10.1159/000346388; Duan CG, 2012, PLANT CELL, V24, P259, DOI 10.1105/tpc.111.092718; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Fusaro AF, 2012, VIROLOGY, V426, P178, DOI 10.1016/j.virol.2012.01.026; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Geoffroy MC, 2011, J INTERF CYTOK RES, V31, P145, DOI 10.1089/jir.2010.0111; Gobeil PAM, 2012, MBIO, V3, DOI 10.1128/mBio.00267-12; Horst D, 2011, CURR OPIN IMMUNOL, V23, P96, DOI 10.1016/j.coi.2010.11.005; Hume AJ, 2008, SCIENCE, V320, P797, DOI 10.1126/science.1152095; Johnston JB, 2005, J VIROL, V79, P10750, DOI 10.1128/JVI.79.16.10750-10763.2005; Jugovic P, 1998, J VIROL, V72, P5076, DOI 10.1128/JVI.72.6.5076-5084.1998; Lee A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0503; Lee C, 2002, REV MED VIROL, V12, P81, DOI 10.1002/rmv.340; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Nascimento R, 2009, ARCH VIROL, V154, P1143, DOI 10.1007/s00705-009-0420-y; Oh Ji Eun, 2013, Immune Netw, V13, P1, DOI 10.4110/in.2013.13.1.1; Parker GA, 1996, ONCOGENE, V13, P2541; Penfold MET, 1999, P NATL ACAD SCI USA, V96, P9839, DOI 10.1073/pnas.96.17.9839; Rose KM, 2004, TRENDS MOL MED, V10, P291, DOI 10.1016/j.molmed.2004.04.008; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Seet BT, 2002, J LEUKOCYTE BIOL, V72, P24; Shi JY, 2012, ACTA BIOCH BIOPH SIN, V44, P375, DOI 10.1093/abbs/gms010; Singh G, 2009, FASEB J, V23, P1845, DOI 10.1096/fj.08-125120; Song CZ, 1997, MOL CELL BIOL, V17, P2186, DOI 10.1128/MCB.17.4.2186; The Gene Ontology C, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI [10.1093/nar/gkp1018, DOI 10.1093/NAR/GKP1018]; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Vogt C, 2008, J VIROL, V82, P11446, DOI 10.1128/JVI.01284-08; Wack A, 2011, CURR OPIN VIROL, V1, P184, DOI 10.1016/j.coviro.2011.05.015; Wei CW, 2010, J IMMUNOL, V185, P1158, DOI 10.4049/jimmunol.0903874; Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104	45	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e108075	10.1371/journal.pone.0108075	http://dx.doi.org/10.1371/journal.pone.0108075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233094	Green Published, gold, Green Submitted			2022-12-25	WOS:000342921200080
J	Mwau, M; Kadima, S; Mwende, J; Adhiambo, M; Akinyi, C; Prescott, M; Lusike, J; Hungu, J; Vojnov, L				Mwau, Matilu; Kadima, Silvia; Mwende, Joy; Adhiambo, Maureen; Akinyi, Catherine; Prescott, Marta; Lusike, Judi; Hungu, Jackson; Vojnov, Lara			Technical Performance Evaluation of the MyT4 Point of Care Technology for CD4+T Cell Enumeration	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; LYMPHOCYTE COUNTS; PREDICTORS; ANALYZER; CLINICS; UGANDA; HEALTH; TESTS; RISK	Objective: Though absolute CD4+ T cell enumeration is the primary gateway to antiretroviral therapy initiation for HIV-positive patients in all developing countries, patient access to this critical diagnostic test is relatively poor. We technically evaluated the performance of a newly developed point-of-care CD4+ T cell technology, the MyT4, compared with conventional CD4+ T cell testing technologies. Design: Over 250 HIV-positive patients were consecutively enrolled and their blood tested on the MyT4, BD FACSCalibur, and BD FACSCount. Results: Compared with the BD FACSCount, the MyT4 had an r(2) of 0.7269 and a mean bias of -23.37 cells/mu l. Compared with the BD FACSCalibur, the MyT4 had an r(2) of 0.5825 and a mean bias of 246.58 cells/ml. Kenya currently uses a CD4+ T cell test threshold of 350 cells/ml to determine patient eligibility for antiretroviral therapy. At this threshold, the MyT4 had a sensitivity of 95.3% (95% CI: 88.4-98.7%) and a specificity of 87.9% (95% CI: 82.3-92.3%) compared with the BD FACSCount and sensitivity and specificity of 88.2% (95% CI: 79.4-94.2%) and 84.2% (95% CI: 78.2-89.2%), respectively, compared with the BD FACSCalibur. Finally, the MyT4 had a coefficient of variation of 12.80% compared with 14.03% for the BD FACSCalibur. Conclusions: We conclude that the MyT4 performed well at the current 350 cells/ml ART initiation eligibility threshold when used by lower cadres of health care facility staff in rural clinics compared to conventional CD4+ T cell technologies.	[Mwau, Matilu; Mwende, Joy; Adhiambo, Maureen; Akinyi, Catherine] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Kadima, Silvia; Prescott, Marta; Lusike, Judi; Hungu, Jackson; Vojnov, Lara] Clinton Hlth Access Initiat, Nairobi, Kenya	Kenya Medical Research Institute	Mwau, M (corresponding author), Kenya Govt Med Res Ctr, Nairobi, Kenya.	matilu.mwau@gmail.com		Hungu, Jackson/0000-0002-9058-5027; Vojnov, Lara/0000-0003-0488-1012	UNITAID	UNITAID	This work was supported by UNITAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; Hulgan T, 2007, J INFECT DIS, V195, P425, DOI 10.1086/510536; Jani IV, 2013, NEW ENGL J MED, V368, P2319, DOI 10.1056/NEJMsb1214197; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Kagaayi J, 2007, AIDS, V21, P1208, DOI 10.1097/QAD.0b013e32810c8dce; Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034319; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Mwau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067612; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; Post FA, 1996, QJM-MON J ASSOC PHYS, V89, P505; UNAIDS, 2011, POL DECL HIV AIDS IN; UNITAID, 2013, HIV AIDS DIAGN TECHN; World Health Organisation, 2021, CONSOLIDATED GUIDELI; Wynberg E, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18809	17	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107410	10.1371/journal.pone.0107410	http://dx.doi.org/10.1371/journal.pone.0107410			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229408	Green Submitted, Green Published, gold			2022-12-25	WOS:000342123900041
J	Valente-dos-Santos, J; Coelho-e-Silva, MJ; Machado-Rodrigues, AM; Elferink-Gemser, MT; Malina, RM; Petroski, EL; Minderico, CS; Silva, AM; Baptista, F; Sardinha, LB				Valente-dos-Santos, Joao; Coelho-e-Silva, Manuel J.; Machado-Rodrigues, Aristides M.; Elferink-Gemser, Marije T.; Malina, Robert M.; Petroski, Edio L.; Minderico, Claudia S.; Silva, Analiza M.; Baptista, Fatima; Sardinha, Luis B.			Prediction Equation for Lower Limbs Lean Soft Tissue in Circumpubertal Boys Using Anthropometry and Biological Maturation	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; SKELETAL-MUSCLE MASS; HUMAN-BODY COMPOSITION; BIOELECTRICAL-IMPEDANCE ANALYSIS; FAT-FREE MASS; EXERCISE PERFORMANCE; PHYSICAL-ACTIVITY; CROSS-VALIDATION; AEROBIC FITNESS; SPORTS-MEDICINE	Lean soft tissue (LST), a surrogate of skeletal muscle mass, is largely limited to appendicular body regions. Simple and accurate methods to estimate lower limbs LST are often used in attempts to partition out the influence of body size on performance outputs. The aim of the current study was to develop and cross-validate a new model to predict lower limbs LST in boys aged 10-13 years, using dual-energy X-ray absorptiometry (DXA) as the reference method. Total body and segmental (lower limbs) composition were assessed with a Hologic Explorer-W QDR DXA scanner in a cross-sectional sample of 75 Portuguese boys (144.8 +/- 6.4 cm; 40.2 +/- 9.0 kg). Skinfolds were measured at the anterior and posterior mid-thigh, and medial calf. Circumferences were measured at the proximal, mid and distal thigh. Leg length was estimated as stature minus sitting height. Current stature expressed as a percentage of attained predicted mature stature (PMS) was used as an estimate of biological maturity status. Backward proportional allometric models were used to identify the model with the best statistical fit: ln (lower limbs LST) = 0.838x ln (body mass) +0.476x ln (leg length) - 0.135x ln (mid-thigh circumference) - 0.053x ln (anterior mid-thigh skinfold) - 0.098x ln (medial calf skinfold) - 2.680+0.010x (percentage of attained PMS) (R = 0.95). The obtained equation was cross-validated using the predicted residuals sum of squares statistics (PRESS) method (R-2 (PRESS) = 0.90). Deming repression analysis between predicted and current lower limbs LST showed a standard error of estimation of 0.52 kg (95% limits of agreement: 0.77 to -1.27 kg). The new model accurately predicts lower limbs LST in circumpubertal boys.	[Valente-dos-Santos, Joao; Coelho-e-Silva, Manuel J.; Machado-Rodrigues, Aristides M.] Univ Coimbra, Fac Sport Sci & Phys Educ, Coimbra, Portugal; [Elferink-Gemser, Marije T.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Elferink-Gemser, Marije T.] HAN Univ Appl Sci, Inst Studies Sports & Exercise, Nijmegen, Netherlands; [Malina, Robert M.] Univ Texas Austin, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA; [Malina, Robert M.] Tarleton State Univ, Dept Kinesiol, Stephenville, TX USA; [Petroski, Edio L.] Univ Fed Santa Catarina, Res Ctr Kinanthropometry & Human Performance, Florianopolis, SC, Brazil; [Minderico, Claudia S.; Silva, Analiza M.; Baptista, Fatima; Sardinha, Luis B.] Univ Lisbon, Fac Motricidade Humana, CIPER, Exercise & Hlth Lab, Cruz Quebrada, Portugal	Universidade de Coimbra; University of Groningen; University of Texas System; University of Texas Austin; Texas A&M University System; Tarleton State University; Universidade Federal de Santa Catarina (UFSC); Universidade de Lisboa	Coelho-e-Silva, MJ (corresponding author), Univ Coimbra, Fac Sport Sci & Phys Educ, Coimbra, Portugal.	mjcesilva@hotmail.com	Sardinha, Luís B./ABG-5389-2020; Baptista, Fátima/N-4043-2013; Sardinha, Luís Bettencourt/F-2641-2013; Valente-dos-Santos, Joao/ABE-3220-2020; Silva, Analiza M/C-9858-2010; Silva, Manuel Coelho E/O-2604-2019; Coelho-e-Silva, Manuel J/V-1645-2017	Sardinha, Luís B./0000-0002-6230-6027; Baptista, Fátima/0000-0002-0214-5401; Sardinha, Luís Bettencourt/0000-0002-6230-6027; Valente-dos-Santos, Joao/0000-0003-0980-0269; Silva, Analiza M/0000-0002-8984-8600; Silva, Manuel Coelho E/0000-0003-4512-7331; Coelho-e-Silva, Manuel J/0000-0003-4512-7331; Machado-Rodrigues, Aristides/0000-0002-7169-8034; Minderico, Claudia Sofia/0000-0002-3621-9501	Portuguese Foundation for Science and Technology [SFRH/BD/64648/2009, PTDC/DTP-DES/1178/2012]; CAPES [BEX0951/10-2]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Authors were partially supported by the Portuguese Foundation for Science and Technology (SFRH/BD/64648/2009; PTDC/DTP-DES/1178/2012) and CAPES (BEX0951/10-2). No other current funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt, 1923, PEDIATRICS, P257; Armstrong N, 2013, PEDIATR EXERC SCI, V25, P548, DOI 10.1123/pes.25.4.548; Batterham AM, 1997, MED SCI SPORT EXER, V29, P181, DOI 10.1097/00005768-199702000-00003; BAYLEY N, 1952, J PEDIATR-US, V40, P423, DOI 10.1016/S0022-3476(52)80205-7; BIELICKI T, 1984, ANN HUM BIOL, V11, P201, DOI 10.1080/03014468400007071; Bland JM, 2012, ANESTHESIOLOGY, V116, P182, DOI 10.1097/ALN.0b013e31823d7784; Coelho-e-Silva MJ, 2013, EUR J SPORT SCI, V13, P527, DOI 10.1080/17461391.2013.767945; DAVIES CTM, 1972, HUM BIOL, V44, P195; DOCHERTY D, 1991, INT J SPORTS MED, V12, P525, DOI 10.1055/s-2007-1024728; Dore E, 2001, EUR J APPL PHYSIOL, V84, P476, DOI 10.1007/s004210100385; Ellis KJ, 2000, PHYSIOL REV, V80, P649, DOI 10.1152/physrev.2000.80.2.649; Evans EM, 2005, MED SCI SPORT EXER, V37, P2006, DOI 10.1249/01.mss.0000176682.54071.5c; Fuller NJ, 2002, INT J OBESITY, V26, P692, DOI 10.1038/sj.ijo.0801989; Goran MI, 1998, PEDIATRICS, V101, P505; Heymsfield SB, 1997, ANNU REV NUTR, V17, P527, DOI 10.1146/annurev.nutr.17.1.527; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52; HINKLEY DV, 1977, TECHNOMETRICS, V19, P285, DOI 10.2307/1267698; HOLIDAY DB, 1995, MED SCI SPORT EXER, V27, P612; Holmes JD, 2005, J APPL BIOMECH, V21, P371, DOI 10.1123/jab.21.4.371; HOPKINS WG, 2004, SPORTSCIENCE, V8, P42; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Jones P. R., 1969, J PHYSIOL-LONDON, V204, P63, DOI [10.1113/jphysiol.1969.sp008898, DOI 10.1113/JPHYSIOL.1969.SP008898]; Kemper HCG, 2013, PEDIATR EXERC SCI, V25, P524, DOI 10.1123/pes.25.4.524; KHAMIS HJ, 1994, PEDIATRICS, V94, P504; Kim J, 2006, AM J CLIN NUTR, V84, P1014, DOI 10.1093/ajcn/84.5.1014; Kuczmarski RJ, 2002, SERIES-J SPAN ECON, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Kulkarni B, 2013, J APPL PHYSIOL, V115, P1156, DOI 10.1152/japplphysiol.00777.2013; Leahy S, 2012, EUR J APPL PHYSIOL, V112, P589, DOI 10.1007/s00421-011-2010-4; Lee R C, 2000, Am J Clin Nutr, V72, P796; Lee RC, 2001, CAN J APPL PHYSIOL, V26, P102, DOI 10.1139/h01-008; Lee SY, 2008, CURR OPIN CLIN NUTR, V11, P566, DOI 10.1097/MCO.0b013e32830b5f23; LOHMAN TG, 1986, EXERCISE SPORT SCI R, V14, P325; Lohman TG, 1988, ANTHROPOMETRIC STAND, P177, DOI DOI 10.1002/AJHB.1310040323; Ludbrook J, 2002, CLIN EXP PHARMACOL P, V29, P527, DOI 10.1046/j.1440-1681.2002.03686.x; LUKASKI HC, 1987, AM J CLIN NUTR, V46, P537, DOI 10.1093/ajcn/46.4.537; Machado D, 2013, J OBES, V2013, DOI 10.1155/2013/428135; Malina R.M., 1996, HUMAN BODY COMPOSITI, P217; Malina R.M., 1995, PHYSL ASSESSMENT HUM, P205; Malina RM., 2004, GROWTH MATURATION PH, V2nd Ed, P728; Malina RM, 2007, CLIN J SPORT MED, V17, P362, DOI 10.1097/JSM.0b013e31815400f4; Malina RM, 2014, J SPORT SCI, V32, P1374, DOI 10.1080/02640414.2014.889846; Malina RM, 2014, J SPORT SCI, V32, P424, DOI 10.1080/02640414.2013.828850; Malina RM, 2012, J SPORT SCI, V30, P1705, DOI 10.1080/02640414.2011.639382; Martin AD, 1998, ANTHROPOMETRIC STAND, P9; Martin RJF, 2004, MED SCI SPORT EXER, V36, P498, DOI 10.1249/01.MSS.0000117162.20314.6B; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; NEVILL AM, 1994, APPL STAT-J ROY ST C, V43, P653, DOI 10.2307/2986263; Nevill AM, 1997, BRIT J SPORT MED, V31, P314, DOI 10.1136/bjsm.31.4.314; NEVILL AM, 1992, EUR J APPL PHYSIOL, V65, P110, DOI 10.1007/BF00705066; Padez C, 2003, ANN HUM BIOL, V30, P262, DOI 10.1080/0301446031000064530; Pietrobelli A, 1996, AM J PHYSIOL-ENDOC M, V271, pE941, DOI 10.1152/ajpendo.1996.271.6.E941; Quiterio AL, 2009, MED SCI SPORT EXER, V41, P828, DOI 10.1249/MSS.0b013e31818ffe4b; RICKER WE, 1973, J FISH RES BOARD CAN, V30, P409, DOI 10.1139/f73-072; ROCHE AF, 1983, RES Q EXERCISE SPORT, V54, P364, DOI 10.1080/02701367.1983.10605321; Salinari S, 2002, AM J PHYSIOL-ENDOC M, V282, pE960, DOI 10.1152/ajpendo.00109.2001; SLINKER BK, 1985, AM J PHYSIOL, V249, pR1, DOI 10.1152/ajpregu.1985.249.1.R1; Snyder WS, 1975, ICRP PUBL, V23, P40; Tanner JM, 1962, GROWTH ADOLESCENCE, P325; Tolfrey K, 2006, J APPL PHYSIOL, V100, P1851, DOI 10.1152/japplphysiol.01213.2005; Valente-dos-Santos J, 2013, APPL PHYSIOL NUTR ME, V38, P390, DOI 10.1139/apnm-2012-0178; VANPRAAGH E, 1990, PEDIATR EXERC SCI, V2, P336; Vincent WJ, 2005, STAT KINESIOLOGY, P511; Visser M, 1999, J APPL PHYSIOL, V87, P1513, DOI 10.1152/jappl.1999.87.4.1513; Wang ZM, 1996, J APPL PHYSIOL, V80, P824, DOI 10.1152/jappl.1996.80.3.824; Wang ZM, 2003, AM J CLIN NUTR, V77, P76, DOI 10.1093/ajcn/77.1.76; Wells JCK, 1999, AM J CLIN NUTR, V69, P904; Wells JCK, 2010, AM J CLIN NUTR, V91, P610, DOI 10.3945/ajcn.2009.28428; Welsman JR, 1997, EUR J APPL PHYSIOL O, V76, P92, DOI 10.1007/s004210050218; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	69	5	5	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107219	10.1371/journal.pone.0107219	http://dx.doi.org/10.1371/journal.pone.0107219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229472	Green Published, Green Submitted, gold			2022-12-25	WOS:000342123900032
J	Eliash, N; Singh, NK; Kamer, Y; Pinnelli, GR; Plettner, E; Soroker, V				Eliash, Nurit; Singh, Nitin Kumar; Kamer, Yosef; Pinnelli, Govardhana Reddy; Plettner, Erika; Soroker, Victoria			Can We Disrupt the Sensing of Honey Bees by the Bee Parasite Varroa destructor?	PLOS ONE			English	Article							MITE VARROA; ANTENNAL RESPONSES; TRICHOPLUSIA-NI; CABBAGE-LOOPER; BEHAVIOR; SEMIOCHEMICALS; PREFERENCES; JACOBSONI; DISCOVERY; BINDING	Background: The ectoparasitic mite, Varroa destructor, is considered to be one of the most significant threats to apiculture around the world. Chemical cues are known to play a significant role in the host-finding behavior of Varroa. The mites distinguish between bees from different task groups, and prefer nurses over foragers. We examined the possibility of disrupting the Varroa - honey bee interaction by targeting the mite's olfactory system. In particular, we examined the effect of volatile compounds, ethers of cis 5-(2'-hydroxyethyl) cyclopent-2-en-1-ol or of dihydroquinone, resorcinol or catechol. We tested the effect of these compounds on the Varroa chemosensory organ by electrophysiology and on behavior in a choice bioassay. The electrophysiological studies were conducted on the isolated foreleg. In the behavioral bioassay, the mite's preference between a nurse and a forager bee was evaluated. Principal findings: We found that in the presence of some compounds, the response of the Varroa chemosensory organ to honey bee headspace volatiles significantly decreased. This effect was dose dependent and, for some of the compounds, long lasting (>1 min). Furthermore, disruption of the Varroa volatile detection was accompanied by a reversal of the mite's preference from a nurse to a forager bee. Long-term inhibition of the electrophysiological responses of mites to the tested compounds was a good predictor for an alteration in the mite's host preference. Conclusions: These data indicate the potential of the selected compounds to disrupt the Varroa - honey bee associations, thus opening new avenues for Varroa control.	[Eliash, Nurit; Singh, Nitin Kumar; Kamer, Yosef; Soroker, Victoria] Agr Res Org, Volcani Ctr, Inst Plant Protect, IL-50250 Bet Dagan, Israel; [Pinnelli, Govardhana Reddy; Plettner, Erika] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Simon Fraser University	Plettner, E (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.	plettner@sfu.ca; sorokerv@volcani.agri.gov.il	Soroker, Victoria/AAO-1632-2020		Natural Sciences and Engineering Research Council of Canada [STPGP/396484-2010]; Israeli Honey Board; ICA Foundation [ICA- 131-1740]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Israeli Honey Board; ICA Foundation	Natural Sciences and Engineering Research Council of Canada; Strategic Project Grant STPGP/396484-2010; http://www.nserc-crsng.gc.ca/index_eng.asp; EP. Israeli Honey Board; http://www.honey.org.il/; VS. ICA Foundation; ICA- 131-1740; http://www.ica-is.org.il/en; VS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar Y, 2007, J AGR FOOD CHEM, V55, P10323, DOI 10.1021/jf071636d; Akhtar Y, 2010, J AGR FOOD CHEM, V58, P4983, DOI 10.1021/jf9045123; [Anonymous], 2001, MITES HONEY BEE; Bowen-Walker PL, 2001, ENTOMOL EXP APPL, V101, P207, DOI 10.1023/A:1019254727879; Chen H, 2012, TETRAHEDRON LETT, V53, P2059, DOI 10.1016/j.tetlet.2012.02.020; Chen H, 2010, BIOORGAN MED CHEM, V18, P2920, DOI 10.1016/j.bmc.2010.02.061; Chen H, 2009, TETRAHEDRON-ASYMMETR, V20, P449, DOI 10.1016/j.tetasy.2009.02.007; de Miranda J. R., 2011, VARROA STILL PROBLEM, P11; Del Piccolo F, 2010, PARASITOLOGY, V137, P967, DOI 10.1017/S0031182009991867; Dillier FX, 2006, REV SUISSE ZOOL, V113, P857, DOI 10.5962/bhl.part.80381; DILLIER FX, 2001, SCHWEIZERISCHE BIENE, V124, P28; Eliash N., 2012, P 19 C INT ACT AP OX, P111; Eliash N., 2012, THESIS HEBREW U JERU; Endris J. J., 1993, Apidologie, V24, P488; Genersch E, 2010, APPL MICROBIOL BIOT, V87, P87, DOI 10.1007/s00253-010-2573-8; Gong YM, 2011, CHEM SENSES, V36, P291, DOI 10.1093/chemse/bjq130; Kather R, 2011, J CHEM ECOL, V37, P205, DOI 10.1007/s10886-011-9909-4; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Kralj J, 2007, J COMP PHYSIOL A, V193, P363, DOI 10.1007/s00359-006-0192-8; Kralj J, 2006, APIDOLOGIE, V37, P577, DOI 10.1051/apido:2006040; KRAUS B, 1994, EXP APPL ACAROL, V18, P435, DOI 10.1007/BF00051525; KRAUS B, 1993, J APICULT RES, V32, P57, DOI 10.1080/00218839.1993.11101288; Kuenen LPS, 1997, J INSECT BEHAV, V10, P213, DOI 10.1007/BF02765554; LE CONTE Y, 1989, SCIENCE, V245, P638, DOI 10.1126/science.245.4918.638; Merrill CE, 2002, P NATL ACAD SCI USA, V99, P1633, DOI 10.1073/pnas.022505499; Milani N., 1989, P71; Nazzi F, 2001, APIDOLOGIE, V32, P149, DOI 10.1051/apido:2001120; Oldroyd BP, 1999, TRENDS ECOL EVOL, V14, P312, DOI 10.1016/S0169-5347(99)01613-4; Paduraru PA, 2008, J COMB CHEM, V10, P123, DOI 10.1021/cc700139y; Pernal SF, 2005, EXP APPL ACAROL, V37, P1, DOI 10.1007/s10493-005-1117-x; Plettner E, 2010, J AGR FOOD CHEM, V58, P3708, DOI 10.1021/jf904139e; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Rytz R, 2013, INSECT BIOCHEM MOLEC, V43, P888, DOI 10.1016/j.ibmb.2013.02.007; Vereecken NJ, 2010, CAN J ZOOL, V88, P725, DOI 10.1139/Z10-040; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; Wyatt T. D., 2003, PHEROMONES ANIMAL BE, P391, DOI [DOI 10.1017/CBO9780511615061, 10.1017/CBO9780511615061]; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; ZIMMERMANN B, 1992, CELL TISSUE RES, V270, P365, DOI 10.1007/BF00328020	38	20	23	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e106889	10.1371/journal.pone.0106889	http://dx.doi.org/10.1371/journal.pone.0106889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226388	Green Submitted, Green Published, gold			2022-12-25	WOS:000344317700021
J	Herting, G; Tao, J; Sjostedt, C; Wallinder, IO				Herting, Gunilla; Tao Jiang; Sjostedt, Carin; Wallinder, Inger Odnevall			Release of Si from Silicon, a Ferrosilicon (FeSi) Alloy and a Synthetic Silicate Mineral in Simulated Biological Media	PLOS ONE			English	Article							AMORPHOUS SILICA; DISSOLUTION KINETICS; REDUCTIVE DISSOLUTION; FERROCHROMIUM ALLOY; QUARTZ DISSOLUTION; CHLORIDE SOLUTIONS; ORGANIC-ACIDS; PURE METALS; PARTICLES; SOLUBILITY	Unique quantitative bioaccessibility data has been generated, and the influence of surface/material and test media characteristics on the elemental release process were assessed for silicon containing materials in specific synthetic body fluids at certain time periods at a fixed loading. The metal release test protocol, elaborated by the KTH team, has previously been used for classification, ranking, and screening of different alloys and metals. Time resolved elemental release of Si, Fe and Al from particles, sized less than 50 mm, of two grades of metallurgical silicon (high purity silicon, SiHG, low purity silicon, SiLG), an alloy (ferrosilicon, FeSi) and a mineral (aluminium silicate, AlSi) has been investigated in synthetic body fluids of varying pH, composition and complexation capacity, simple models of for example dermal contact and digestion scenarios. Individual methods for analysis of released Si (as silicic acid, Si(OH)(4)) in synthetic body fluids using GF-AAS were developed for each fluid including optimisation of solution pH and graphite furnace parameters. The release of Si from the two metallurgical silicon grades was strongly dependent on both pH and media composition with the highest release in pH neutral media. No similar effect was observed for the FeSi alloy or the aluminium silicate mineral. Surface adsorption of phosphate and lactic acid were believed to hinder the release of Si whereas the presence of citric acid enhanced the release as a result of surface complexation. An increased presence of Al and Fe in the material (low purity metalloid, alloy or mineral) resulted in a reduced release of Si in pH neutral media. The release of Si was enhanced for all materials with Al at their outermost surface in acetic media.	[Herting, Gunilla; Tao Jiang; Sjostedt, Carin; Wallinder, Inger Odnevall] KTH Royal Inst Technol, Div Surface & Corros Sci, Sch Chem Sci & Engn, Stockholm, Sweden	Royal Institute of Technology	Herting, G (corresponding author), KTH Royal Inst Technol, Div Surface & Corros Sci, Sch Chem Sci & Engn, Stockholm, Sweden.	herting@kth.se	Wallinder, Inger Odnevall/Q-6875-2017	Herting, Gunilla/0000-0002-2123-2201; Odnevall, Inger/0000-0003-2206-0082; Sjostedt, Carin/0000-0001-6490-1658	silicon and ferrosilicon consortium	silicon and ferrosilicon consortium	The research reported in this article was funded by the silicon and ferrosilicon consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFONSO MD, 1990, J COLLOID INTERF SCI, V138, P74; ALEXANDER GB, 1954, J PHYS CHEM-US, V58, P453, DOI 10.1021/j150516a002; Amirbahman A, 1997, J COLLOID INTERF SCI, V194, P194, DOI 10.1006/jcis.1997.5116; Atkins PW, 1992, GEN CHEM; BAUMANN H., 1955, Beitrage z. Silikose-Forschung, P45; BENNETT PC, 1988, GEOCHIM COSMOCHIM AC, V52, P1521, DOI 10.1016/0016-7037(88)90222-0; BENNETT PC, 1991, GEOCHIM COSMOCHIM AC, V55, P1781, DOI 10.1016/0016-7037(91)90023-X; BERGSTROM L, 1990, COLLOID SURFACE, V49, P183, DOI 10.1016/0166-6622(90)80101-9; Borm P, 2006, TOXICOL SCI, V90, P23, DOI 10.1093/toxsci/kfj084; Bouallou M, 1998, LANGMUIR, V14, P1072, DOI 10.1021/la970750v; Brown SC, 2007, ADV POWDER TECHNOL, V18, P69, DOI 10.1163/156855207779768214; Butcher DJ, 1998, PRACTICAL GUIDE GRAP; Carbonaro RF, 2008, GEOCHIM COSMOCHIM AC, V72, P3241, DOI 10.1016/j.gca.2008.04.010; CHOI I, 1972, J COLLOID INTERF SCI, V40, P253, DOI 10.1016/0021-9797(72)90014-8; Clouter A, 2001, TOXICOL SCI, V63, P90, DOI 10.1093/toxsci/63.1.90; de Meringo A, 1994, ENV HLTH PERSPECT, V102; DEMERINGO A, 1994, ENVIRON HEALTH PERSP, V102, P47, DOI 10.2307/3432058; DEMPSTER PB, 1952, NATURE, V169, P538, DOI 10.1038/169538b0; Denny JJ, 1939, CAN MED ASSOC J, V40, P213; DOVE PM, 1990, GEOCHIM COSMOCHIM AC, V54, P955, DOI 10.1016/0016-7037(90)90431-J; Dove PM, 1997, GEOCHIM COSMOCHIM AC, V61, P3329, DOI 10.1016/S0016-7037(97)00217-2; Dove PM, 2008, P NATL ACAD SCI; EN1811, 1998, EN1811; Fornero E, 2009, SCI TOTAL ENVIRON, V407, P1010, DOI 10.1016/j.scitotenv.2008.10.021; Gerard F, 2002, GEODERMA, V107, P197, DOI 10.1016/S0016-7061(01)00149-5; Gustafsson JP, 2013, VISUAL MINTEQ 3 0; Hedberg Y, 2011, BIOMETALS, V24, P1099, DOI 10.1007/s10534-011-9469-7; Hedberg Yolanda, 2010, Integrated Environmental Assessment and Management, V6, P456, DOI 10.1002/ieam.66; Herting G, 2007, CORROS SCI, V49, P103, DOI 10.1016/j.corsci.2006.05.008; Icenhower JP, 2000, GEOCHIM COSMOCHIM AC, V64, P4193, DOI 10.1016/S0016-7037(00)00487-7; Iler R. K, 1979, CHEM SILICA; ILER RK, 1973, J COLLOID INTERF SCI, V43, P399, DOI 10.1016/0021-9797(73)90386-X; Jiang T, 2012, ISRN CORROS, V2012, P10; Kisa M, 2007, OXIDATION SILICON GE; Larson RR, 2010, OPEN TOXICOL J, V4, P51, DOI DOI 10.2174/1874340401004010051; LEDOUX RL, 1966, J COLLOID INTERF SCI, V21, P127, DOI 10.1016/0095-8522(66)90029-8; LEWIN JC, 1961, GEOCHIM COSMOCHIM AC, V21, P182, DOI 10.1016/S0016-7037(61)80054-9; MARSHALL WL, 1980, GEOCHIM COSMOCHIM AC, V44, P915, DOI 10.1016/0016-7037(80)90281-1; Midander K, 2007, CONTACT DERMATITIS, V56, P325, DOI 10.1111/j.1600-0536.2007.01115.x; Midander Klara, 2010, Integrated Environmental Assessment and Management, V6, P441, DOI 10.1002/ieam.32; Midander K, 2009, SMALL, V5, P389, DOI 10.1002/smll.200801220; Nesse WD, 2009, INTRO MINERALOGY; Norlin A, 2002, BIOMOL ENG, V19, P67, DOI 10.1016/S1389-0344(02)00013-8; OHMAN LO, 1991, ACTA CHEM SCAND, V45, P335, DOI 10.3891/acta.chem.scand.45-0335; OKAMOTO G, 1957, GEOCHIM COSMOCHIM AC, V12, P123, DOI 10.1016/0016-7037(57)90023-6; Pak TM, 2003, CHEM GEOL, V200, P377, DOI 10.1016/S0009-2541(03)00211-0; PANDURANGI RS, 1990, ENVIRON HEALTH PERSP, V86, P327, DOI 10.2307/3430972; PerkinElmerPrecisely, 2003, WINLAB 32 AA 6 2 0 0; Prazeres DMF, 2011, PLASMID BIOPHARMACEUTICALS: BASICS, APPLICATIONS, AND MANUFACTURING, P1, DOI 10.1002/9780470939918; RIMSTIDT JD, 1980, GEOCHIM COSMOCHIM AC, V44, P1683, DOI 10.1016/0016-7037(80)90220-3; Roelofs F, 2004, J PHYS CHEM B, V108, P11308, DOI 10.1021/jp048767r; Schwertmann U, 2000, IRON OXIDES LAB PREC; Smith RM, 1998, NIST CRITICALLY SELE; Stopford W, 2003, J ENVIRON MONITOR, V5, P675, DOI 10.1039/b302257a; Tanaka M, 2003, J TRACE MICROPROBE T, V21, P561, DOI 10.1081/TMA-120025806; VOGELSBERGER W, 1992, J CHEM SOC FARADAY T, V88, P473, DOI 10.1039/ft9928800473; WELCH SA, 1993, GEOCHIM COSMOCHIM AC, V57, P2725, DOI 10.1016/0016-7037(93)90386-B; ZHANG Y, 1985, LANGMUIR, V1, P201, DOI 10.1021/la00062a004	58	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107668	10.1371/journal.pone.0107668	http://dx.doi.org/10.1371/journal.pone.0107668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225879	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700073
J	Matson, PG; Washburn, L; Martz, TR; Hofmann, GE				Matson, Paul G.; Washburn, Libe; Martz, Todd R.; Hofmann, Gretchen E.			Abiotic versus Biotic Drivers of Ocean pH Variation under Fast Sea Ice in McMurdo Sound, Antarctica	PLOS ONE			English	Article							ROSS SEA; SOUTHERN-OCEAN; MICROBIAL COMMUNITIES; PRIMARY PRODUCTIVITY; CAPE EVANS; PHOTOSYNTHESIS; PATTERNS; ACIDIFICATION; TEMPERATURE; CIRCULATION	Ocean acidification is expected to have a major effect on the marine carbonate system over the next century, particularly in high latitude seas. Less appreciated is natural environmental variation within these systems, particularly in terms of pH, and how this natural variation may inform laboratory experiments. In this study, we deployed sensor-equipped moorings at 20 m depths at three locations in McMurdo Sound, comprising deep (bottom depth>200 m: Hut Point Peninsula) and shallow environments (bottom depth similar to 25 m: Cape Evans and New Harbor). Our sensors recorded high-frequency variation in pH (Hut Point and Cape Evans only), tide (Cape Evans and New Harbor), and water mass properties (temperature and salinity) during spring and early summer 2011. These collective observations showed that (1) pH differed spatially both in terms of mean pH (Cape Evans: 8.009 +/- 0.015; Hut Point: 8.020 +/- 0.007) and range of pH (Cape Evans: 0.090; Hut Point: 0.036), and (2) pH was not related to the mixing of two water masses, suggesting that the observed pH variation is likely not driven by this abiotic process. Given the large daily fluctuation in pH at Cape Evans, we developed a simple mechanistic model to explore the potential for biotic processes - in this case algal photosynthesis - to increase pH by fixing carbon from the water column. For this model, we incorporated published photosynthetic parameters for the three dominant algal functional groups found at Cape Evans (benthic fleshy red macroalgae, crustose coralline algae, and sea ice algal communities) to estimate oxygen produced/carbon fixed from the water column underneath fast sea ice and the resulting pH change. These results suggest that biotic processes may be a primary driver of pH variation observed under fast sea ice at Cape Evans and potentially at other shallow sites in McMurdo Sound.	[Matson, Paul G.; Hofmann, Gretchen E.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Washburn, Libe] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA; [Martz, Todd R.] Univ Calif San Diego, Scripps Inst Oceanog, Geosci Res Div, La Jolla, CA 92093 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California San Diego; Scripps Institution of Oceanography	Matson, PG (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	pmatson@gmail.com	Matson, Paul/AAB-9767-2019	Matson, Paul/0000-0003-2105-7308; Martz, Todd/0000-0002-1996-7145	U.S. National Science Foundation (NSF), Antarctic and Organisms and Ecosystems Program [ANT-0944201]; NSF grant OCE (OTIC) [0844394]; University of California; Office of Polar Programs (OPP) [0944201] Funding Source: National Science Foundation	U.S. National Science Foundation (NSF), Antarctic and Organisms and Ecosystems Program(National Science Foundation (NSF)); NSF grant OCE (OTIC)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); University of California(University of California System); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by (1) U.S. National Science Foundation (NSF) award ANT-0944201 to GEH from the Antarctic and Organisms and Ecosystems Program, (2) NSF grant OCE (OTIC) 0844394 to TRM (in support of the SeaFET development), and (3) by funds from the University of California in support of a multi-campus research program, Ocean Acidification: A Training and Research Consortium, (http://oceanacidification.msi.ucsb.edu/) to GEH and TRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann K, 2003, ANTARCT SCI, V15, P3, DOI 10.1017/S0954102003001007; Baehr MM, 2004, LIMNOL OCEANOGR, V49, P330, DOI 10.4319/lo.2004.49.2.0330; BARRY JP, 1988, POLAR BIOL, V8, P367, DOI 10.1007/BF00442028; BARRY JP, 1988, POLAR BIOL, V8, P377, DOI 10.1007/BF00442029; Bates NR, 1998, J GEOPHYS RES-OCEANS, V103, P2883, DOI 10.1029/97JC02473; Bednarsek N, 2012, NAT GEOSCI, V5, P881, DOI 10.1038/NGEO1635; Byrne M, 2013, GLOBAL CHANGE BIOL, V19, P2264, DOI 10.1111/gcb.12190; Cummings V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016069; DAYTON PK, 1986, POLAR BIOL, V6, P207, DOI 10.1007/BF00443397; DAYTON PK, 1969, SCIENCE, V163, P273, DOI 10.1126/science.163.3864.273; Dickson A. G., 2007, PICES SPECIAL PUBLIC, DOI DOI 10.1159/000331784; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Enzor LA, 2013, COMP BIOCHEM PHYS A, V164, P154, DOI 10.1016/j.cbpa.2012.07.016; Fangue NA, 2010, LIMNOL OCEANOGR-METH, V8, P441, DOI 10.4319/lom.2010.8.441; Fransson A, 2011, J GEOPHYS RES, V116; Gleitz M, 1996, MAR ECOL PROG SER, V135, P169, DOI 10.3354/meps135169; Goring DG, 2003, NEW ZEAL J MAR FRESH, V37, P241, DOI 10.1080/00288330.2003.9517162; Hofmann GE, 2005, J EXP MAR BIOL ECOL, V316, P79, DOI 10.1016/j.jembe.2004.10.007; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; JACOBS SS, 1979, SCIENCE, V203, P439, DOI 10.1126/science.203.4379.439; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540, DOI 10.4319/lo.1976.21.4.0540; Jerlov N. G., 1976, MARINE OPTICS; Kawaguchi S, 2013, NAT CLIM CHANGE, V3, DOI 10.1038/NCLIMATE1937; Kelly MW, 2013, GLOBAL CHANGE BIOL, V19, P2536, DOI 10.1111/gcb.12251; Kozlyaninov MV, 1966, APPL ONE DIMENSIONAL; Lee K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027207; LEGENDRE L, 1992, POLAR BIOL, V12, P429; Leonard GH, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC002952; LITTLEPAGE J.L, 1965, ANTARCTIC RESEARCH S, V5, P1, DOI DOI 10.1029/AR005P0001; Mahoney AR, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007060; Martz TR, 2010, LIMNOL OCEANOGR-METH, V8, P172, DOI 10.4319/lom.2010.8.172; Matson PG, 2011, ANTARCT SCI, V23, P607, DOI 10.1017/S0954102011000551; McMinn A, 2007, MAR BIOL, V151, P985, DOI 10.1007/s00227-006-0533-8; McMinn A, 2003, MAR BIOL, V143, P359, DOI 10.1007/s00227-003-1052-5; McMinn A, 2010, POLAR BIOL, V33, P1547, DOI 10.1007/s00300-010-0844-6; McMinn A, 2000, AQUAT MICROB ECOL, V21, P177, DOI 10.3354/ame021177; McMinn A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086984; McMinn A, 2010, MAR BIOL, V157, P1345, DOI 10.1007/s00227-010-1414-8; McNeil B, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044597; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Meredith MP, 2013, CURR OPIN ENV SUST, V5, P306, DOI 10.1016/j.cosust.2013.03.002; MILLER KA, 1991, AM ZOOL, V31, P35; Nielsen ES, 1962, INT REV GES HYDROBIO, V47, P333; PALMISANO AC, 1986, J PLANKTON RES, V8, P891, DOI 10.1093/plankt/8.5.891; PALMISANO AC, 1983, POLAR BIOL, V2, P171, DOI 10.1007/BF00448967; Peck LS, 2010, MAR BIOL, V157, P2051, DOI 10.1007/s00227-010-1473-x; Peck LS, 2005, ANTARCT SCI, V17, P497, DOI 10.1017/S0954102005002920; Raven JA, 2005, CAN J BOT, V83, P879, DOI 10.1139/B05-074; Reddy TE, 2010, CONT SHELF RES, V30, P733, DOI 10.1016/j.csr.2010.01.007; Rivest EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096172; RIVKIN RB, 1989, MAR BIOL, V101, P273, DOI 10.1007/BF00391467; RIVKIN RB, 1991, AM ZOOL, V31, P5; Robbins L.L., 2010, US GEOL SURV OPEN FI, P17; Robinson NJ, 2014, J GEOPHYS RES-OCEANS, V119, P3425, DOI 10.1002/2013JC009399; Robinson NJ, 2010, J GEOPHYS RES, V115; Roden NP, 2013, MAR CHEM, V155, P135, DOI 10.1016/j.marchem.2013.06.006; Ryan KG, 2006, ANTARCT SCI, V18, P583, DOI 10.1017/S0954102006000629; Sanford E, 2011, ANNU REV MAR SCI, V3, P509, DOI 10.1146/annurev-marine-120709-142756; SATOH H, 1988, Journal of the Oceanographical Society of Japan, V44, P287, DOI 10.1007/BF02302571; Schwarz AM, 2005, MAR ECOL PROG SER, V294, P131, DOI 10.3354/meps294131; Schwarz AM, 2003, POLAR BIOL, V26, P789, DOI 10.1007/s00300-003-0556-2; Shadwick EH, 2014, J GEOPHYS RES-OCEANS, V119, P1, DOI 10.1002/2013JC009286; Smethie WM, 2005, DEEP-SEA RES PT I, V52, P959, DOI 10.1016/j.dsr.2004.11.016; Stevens CL, 2009, OCEAN SCI, V5, P435, DOI 10.5194/os-5-435-2009; Trenerry LJ, 2002, POLAR BIOL, V25, P72, DOI 10.1007/s003000100314; van Heuven S., 2009, ORNLCDIAC105B US DEP; Yu PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052448; Yu PC, 2011, J EXP MAR BIOL ECOL, V400, P288, DOI 10.1016/j.jembe.2011.02.016	69	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107239	10.1371/journal.pone.0107239	http://dx.doi.org/10.1371/journal.pone.0107239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25221950	gold, Green Published, Green Submitted			2022-12-25	WOS:000341774800055
J	Schneider, MJ; Cyran, CC; Nikolaou, K; Hirner, H; Reiser, MF; Dietrich, O				Schneider, Moritz Joerg; Cyran, Clemens Christian; Nikolaou, Konstantin; Hirner, Heidrun; Reiser, Maximilian F.; Dietrich, Olaf			Monitoring Early Response to Anti-Angiogenic Therapy: Diffusion-Weighted Magnetic Resonance Imaging and Volume Measurements in Colon Carcinoma Xenografts	PLOS ONE			English	Article							IN-VIVO; WATER DIFFUSION; TUMOR RESPONSE; CANCER; MRI; COEFFICIENT; PERFUSION; PREDICTION; BIOMARKER; CHEMOTHERAPY	Objectives: To evaluate the use of diffusion-weighted MRI (DW-MRI) and volume measurements for early monitoring of antiangiogenic therapy in an experimental tumor model. Materials and Methods: 23 athymic nude rats, bearing human colon carcinoma xenografts (HT-29) were examined before and after 6 days of treatment with regorafenib (n = 12) or placebo (n = 11) in a clinical 3-Tesla MRI. For DW-MRI, a single-shot EPI sequence with 9 b-values (10-800 s/mm(2)) was used. The apparent diffusion coefficient (ADC) was calculated voxelwise and its median value over a region of interest, covering the entire tumor, was defined as the tumor ADC. Tumor volume was determined using T2-weighted images. ADC and volume changes between first and second measurement were evaluated as classifiers by a receiver-operator-characteristic (ROC) analysis individually and combined using Fisher's linear discriminant analysis (FLDA). Results: All ADCs and volumes are stated as median +/- standard deviation. Tumor ADC increased significantly in the therapy group (0.76 +/- 0.09x10(-3) mm(2)/s to 0.90 +/- 0.12x10(-3) mm(2)/s; p<0.001), with significantly higher changes of tumor ADC than in the control group (0.10 +/- 0.11x10(-3) mm(2)/s vs. 0.03 +/- 0.09x10(-3) mm(2)/s; p = 0.027). Tumor volume increased significantly in both groups (therapy: 347.8 +/- 449.1 to 405.3 +/- 823.6 mm(3); p = 0.034; control: 219.7 +/- 79.5 to 443.7 +/- 141.5 mm(3); p<0.001), however, the therapy group showed significantly reduced tumor growth (33.30 +/- 47.30% vs. 96.43 +/- 31.66%; p<0.001). Area under the curve and accuracy of the ADC-based ROC analysis were 0.773 and 78.3%; and for the volume change 0.886 and 82.6%. The FLDA approach yielded an AUC of 0.985 and an accuracy of 95.7%. Conclusions: Regorafenib therapy significantly increased tumor ADC after 6 days of treatment and also significantly reduced tumor growth. However, ROC analyses using each parameter individually revealed a lack of accuracy in discriminating between therapy and control group. The combination of both parameters using FLDA substantially improved diagnostic accuracy, thus highlighting the potential of multi-parameter MRI as an imaging biomarker for non-invasive early tumor therapy monitoring.	[Schneider, Moritz Joerg; Reiser, Maximilian F.; Dietrich, Olaf] Univ Hosp Munich, Inst Clin Radiol, Josef Lissner Lab Biomed Imaging, Munich, Germany; [Cyran, Clemens Christian; Nikolaou, Konstantin; Hirner, Heidrun; Reiser, Maximilian F.] Univ Hosp Munich, Inst Clin Radiol, Expt Radiol Lab, Munich, Germany; [Nikolaou, Konstantin] Univ Tubingen Hosp, Dept Diagnost & Intervent Radiol, Tubingen, Germany	University of Munich; University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schneider, MJ (corresponding author), Univ Hosp Munich, Inst Clin Radiol, Josef Lissner Lab Biomed Imaging, Munich, Germany.	Moritz.Schneider@med.uni-muenchen.de	Dietrich, Olaf/C-4696-2014	Dietrich, Olaf/0000-0001-6182-5039	German Federal Ministry of Education and Research (BMBF); Excellence Cluster M4 [01EX1021X]; Bayer HealthCare	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Excellence Cluster M4; Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals)	This study was supported by the German Federal Ministry of Education and Research (BMBF, www.bmbf.de), Excellence Cluster M4 (01EX1021X) (www.m4.de) and a research grant from Bayer HealthCare (healthcare.bayer.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elkacem L, 2013, MOL CANCER THER, V12, P1322, DOI 10.1158/1535-7163.MCT-12-1162; [Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Bauer WR, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.053412; Biffar A, 2011, INVEST RADIOL, V46, P601, DOI 10.1097/RLI.0b013e31821e637d; Biffar A, 2010, EUR RADIOL, V20, P2679, DOI 10.1007/s00330-010-1833-4; Cui Y, 2008, RADIOLOGY, V248, P894, DOI 10.1148/radiol.2483071407; Cyran CC, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-3; Cyran CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076009; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DeVries AF, 2003, INT J RADIAT ONCOL, V56, P958, DOI 10.1016/S0360-3016(03)00208-6; Diederich S, 2012, CANCER IMAGING, V12, P347, DOI 10.1102/1470-7330.2012.9013; Dzik-Jurasz A, 2002, LANCET, V360, P307, DOI 10.1016/S0140-6736(02)09520-X; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Ganten MK, 2013, CANCER IMAGING, V13, P548, DOI 10.1102/1470-7330.2013.0045; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Halappa VG, 2012, RADIOLOGY, V264, P285, DOI 10.1148/radiol.12112142; Hamstra DA, 2007, J CLIN ONCOL, V25, P4104, DOI 10.1200/JCO.2007.11.9610; Herneth AM, 2003, EUR J RADIOL, V45, P208, DOI 10.1016/S0720-048X(02)00310-8; Huang MQ, 2008, NMR BIOMED, V21, P1021, DOI 10.1002/nbm.1261; Humphries PD, 2007, RADIOLOGY, V245, P848, DOI 10.1148/radiol.2452061535; Juge L, 2012, RADIOLOGY, V264, P436, DOI 10.1148/radiol.12111548; Kim H, 2008, CANCER RES, V68, P8369, DOI 10.1158/0008-5472.CAN-08-1771; Koh DM, 2007, AM J ROENTGENOL, V188, P1001, DOI 10.2214/AJR.06.0601; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Li SP, 2012, J MAGN RESON IMAGING, V35, P745, DOI 10.1002/jmri.22838; Liimatainen T, 2009, NMR BIOMED, V22, P272, DOI 10.1002/nbm.1320; Manenti G, 2008, RADIOL MED, V113, P199, DOI 10.1007/s11547-008-0246-9; Morelli JN, 2010, INVEST RADIOL, V45, P29, DOI 10.1097/RLI.0b013e3181c65c11; Patterson DM, 2008, NAT CLIN PRACT ONCOL, V5, P220, DOI 10.1038/ncponc1073; Pickles MD, 2006, MAGN RESON IMAGING, V24, P843, DOI 10.1016/j.mri.2005.11.005; R Core Team, 2022, R LANG ENV STAT COMP; Ratain MJ, 2004, J CLIN ONCOL, V22, P4442, DOI 10.1200/JCO.2004.07.960; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Roe K, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-65; Slawski M, 2009, CMA SYNTHESIS MICROA; Sohaib A, 2012, CANCER IMAGING, V12, P345, DOI 10.1102/1470-7330.2012.9011; Sourbron S, 2009, MAGN RESON MATER PHY, V22, P539; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Sumi M, 2003, AM J NEURORADIOL, V24, P1627; Theilmann RJ, 2004, NEOPLASIA, V6, P831, DOI 10.1593/neo.03343; Thoeny HC, 2010, J MAGN RESON IMAGING, V32, P2, DOI 10.1002/jmri.22167; Thoeny HC, 2005, NEOPLASIA, V7, P779, DOI 10.1593/neo.04748; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Wybranski C, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-43; Zelhof B, 2009, BJU INT, V103, P883, DOI 10.1111/j.1464-410X.2008.08130.x; Zhai G, 2013, J MAGN RESON IMAGING; Zhang XY, 2011, J MAGN RESON IMAGING, V33, P1171, DOI 10.1002/jmri.22558	49	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e106970	10.1371/journal.pone.0106970	http://dx.doi.org/10.1371/journal.pone.0106970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222284	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774800035
J	Gulko, MK; Dyall-Smith, M; Gonzalez, O; Oesterhelt, D				Gulko, Miriam Kolog; Dyall-Smith, Mike; Gonzalez, Orland; Oesterhelt, Dieter			How Do Haloarchaea Synthesize Aromatic Amino Acids?	PLOS ONE			English	Article							ARCHAEON METHANOCOCCUS-MARIPALUDIS; HALOBACTERIUM-SALINARUM; METHANOCALDOCOCCUS-JANNASCHII; SHIKIMATE PATHWAY; GENE; BIOSYNTHESIS; ALDOLASE; MICROARRAY; EXPRESSION; METABOLISM	Genomic analysis of H. salinarum indicated that the de novo pathway for aromatic amino acid (AroAA) biosynthesis does not follow the classical pathway but begins from non-classical precursors, as is the case for M. jannaschii. The first two steps in the pathway were predicted to be carried out by genes OE1472F and OE1475F, while the 3rd step follows the canonical pathway involving gene OE1477R. The functions of these genes and their products were tested by biochemical and genetic methods. In this study, we provide evidence that supports the role of proteins OE1472F and OE1475F catalyzing consecutive enzymatic reactions leading to the production of 3-dehydroquinate (DHQ), after which AroAA production proceeds via the canonical pathway starting with the formation of DHS (dehydroshikimate), catalyzed by the product of ORF OE1477R. Nutritional requirements and AroAA uptake studies of the mutants gave results that were consistent with the proposed roles of these ORFs in AroAA biosynthesis. DNA microarray data indicated that the 13 genes of the canonical pathway appear to be utilised for AroAA biosynthesis in H. salinarum, as they are differentially expressed when cells are grown in medium lacking AroAA.	[Gulko, Miriam Kolog; Oesterhelt, Dieter] Max Planck Inst Biochem, Dept Membrane Biochem, D-82152 Martinsried, Germany; [Dyall-Smith, Mike] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia; [Gonzalez, Orland] Univ Munich, Inst Informat, Teaching & Res Unit Bioinformat, D-80539 Munich, Germany	Max Planck Society; Charles Sturt University; University of Munich	Gulko, MK (corresponding author), Univ Gottingen, Dept Mol Microbiol & Genet, Inst Microbiol & Genet, D-37073 Gottingen, Germany.	mkologg@gwdg.de			Max-Planck Institute of Biochemistry	Max-Planck Institute of Biochemistry	The Max-Planck Institute of Biochemistry funded the fellowship of Miriam Kolog Gulko as well as all experiments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 2003, BIOSCI BIOTECH BIOCH, V67, P2124, DOI 10.1271/bbb.67.2124; Baliga NS, 2000, MOL MICROBIOL, V36, P1184, DOI 10.1046/j.1365-2958.2000.01916.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Blank CE, 2009, GEOBIOLOGY, V7, P495, DOI 10.1111/j.1472-4669.2009.00219.x; Blank CE, 2009, ASTROBIOLOGY, V9, P193, DOI 10.1089/ast.2008.0248; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Bottomley JR, 1996, BIOCHEM J, V319, P559, DOI 10.1042/bj3190559; CLINE SW, 1987, J BACTERIOL, V169, P1341, DOI 10.1128/jb.169.3.1341-1344.1987; CLINE SW, 1989, CAN J MICROBIOL, V35, P148, DOI 10.1139/m89-022; Facciotti MT, 2007, P NATL ACAD SCI USA, V104, P4630, DOI 10.1073/pnas.0611663104; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; Feng J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041621; Gonzalez O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000332; HASLAM E, 1963, METHOD ENZYMOL, V6, P498, DOI 10.1016/0076-6879(63)06214-5; Holmes ML, 2000, MOL MICROBIOL, V36, P114, DOI 10.1046/j.1365-2958.2000.01832.x; Ikeda M, 2006, APPL MICROBIOL BIOT, V69, P615, DOI 10.1007/s00253-005-0252-y; Koch MK, 2005, MOL MICROBIOL, V55, P1681, DOI 10.1111/j.1365-2958.2005.04516.x; Koide T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.42; LANYI JK, 1977, J SUPRAMOL STR CELL, V6, P169, DOI 10.1002/jss.400060203; MITSUHASHI S, 1954, BIOCHIM BIOPHYS ACTA, V15, P268, DOI 10.1016/0006-3002(54)90069-4; Morar M, 2007, BIOCHEMISTRY-US, V46, P10562, DOI 10.1021/bi700934v; OESTERHELT D, 1983, ANN INST PASTEUR MIC, VB134, P137, DOI 10.1016/S0769-2609(83)80101-X; Paris M, 1998, TETRAHEDRON LETT, V39, P1341, DOI 10.1016/S0040-4039(97)10813-9; Patenge N, 2000, MOL MICROBIOL, V36, P105, DOI 10.1046/j.1365-2958.2000.01831.x; Pittard AJ, 1996, BIOSYNTHESIS AROMATI; Porat I, 2004, J BACTERIOL, V186, P4940, DOI 10.1128/JB.186.15.4940-4950.2004; Porat I, 2006, MOL MICROBIOL, V62, P1117, DOI 10.1111/j.1365-2958.2006.05426.x; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; RAE C, 1992, J BIOL CHEM, V267, P9713; RICHARD JP, 1991, BIOCHEMISTRY-US, V30, P4581, DOI 10.1021/bi00232a031; Roberts SJ, 2003, BIOORG MED CHEM LETT, V13, P265, DOI 10.1016/S0960-894X(02)00923-X; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schwaiger R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-40; SIBLEY JA, 1949, J BIOL CHEM, V177, P859; Siebers B, 2001, J BIOL CHEM, V276, P28710, DOI 10.1074/jbc.M103447200; Soderberg Tim, 2005, Archaea, V1, P347, DOI 10.1155/2005/314760; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Thomson GJ, 1998, BIOCHEM J, V331, P437, DOI 10.1042/bj3310437; Twellmeyer J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001064; White RH, 2004, BIOCHEMISTRY-US, V43, P7618, DOI 10.1021/bi0495127; White RH, 2006, BIOCHEMISTRY-US, V45, P12366, DOI 10.1021/bi061018a; WHITING GC, 1967, BIOCHEM J, V102, P283, DOI 10.1042/bj1020283; Zaigler A, 2003, MOL MICROBIOL, V48, P1089, DOI 10.1046/j.1365-2958.2003.03497.x	44	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107475	10.1371/journal.pone.0107475	http://dx.doi.org/10.1371/journal.pone.0107475			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216252	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774300068
J	Wright, KM; Wu, KL; Babatunde, O; Du, HJ; Massiah, MA				Wright, Katharine M.; Wu, Kuanlin; Babatunde, Omotolani; Du, Haijuan; Massiah, Michael A.			XLOS-Observed Mutations of MID1 Bbox1 Domain Cause Domain Unfolding	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; PP2A REGULATORY SUBUNIT; SYNDROME GENE-PRODUCT; OPITZ G/BBB SYNDROME; UBIQUITIN LIGASE; BINDING PROTEIN; B-BOXES; ALPHA-4; REVEALS; FINGERS	MID1 catalyzes the ubiquitination of the protein alpha4 and the catalytic subunit of protein phosphatase 2A. Mutations within the MID1 Bbox1 domain are associated with X-linked Opitz G syndrome (XLOS). Our functional assays have shown that mutations of Ala130 to Val or Thr, Cys142 to Ser and Cys145 to Thr completely disrupt the polyubiquitination of alpha4. Using NMR spectroscopy, we characterize the effect of these mutations on the tertiary structure of the Bbox1 domain by itself and in tandem with the Bbox2 domain. The mutation of either Cys142 or Cys145, each of which is involved in coordinating one of the two zinc ions, results in the collapse of signal dispersion in the HSQC spectrum of the Bbox1 domain indicating that the mutant protein structure is unfolded. Each mutation caused the coordination of both zinc ions, which are similar to 13 angstrom apart, to be lost. Although Ala130 is not involved in the coordination of a zinc ion, the Ala130Thr mutant Bbox1 domain yields a poorly dispersed HSQC spectrum similar to those of the Cys142Ser and Cys145Thr mutants. Interestingly, neither cysteine mutation affects the structure of the adjacent Bbox2 domain when the two Bbox domains are engineered in their native tandem Bbox1-Bbox2 protein construct. Dynamic light scattering measurements suggest that the mutant Bbox1 domain has an increased propensity to form aggregates compared to the wild type Bbox1 domain. These studies provide insight into the mechanism by which mutations observed in XLOS affect the structure and function of the MID1 Bbox1 domain.	[Wright, Katharine M.; Wu, Kuanlin; Babatunde, Omotolani; Du, Haijuan; Massiah, Michael A.] George Washington Univ, Dept Chem, Washington, DC 20052 USA	George Washington University	Massiah, MA (corresponding author), George Washington Univ, Dept Chem, Washington, DC 20052 USA.	massiah@gwu.edu			National Science Foundation [1052520]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (Award 1052520). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda-Orgilles B, 2008, HUM GENET, V123, P163, DOI 10.1007/s00439-007-0456-6; Bell JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037470; BERG JM, 1990, ANNU REV BIOPHYS BIO, V19, P405; Berkovits HJ, 1999, BIOCHEMISTRY-US, V38, P16826, DOI 10.1021/bi991433l; Borden KLB, 1998, BIOCHEM CELL BIOL, V76, P351, DOI 10.1139/bcb-76-2-3-351; Cox TC, 2000, HUM MOL GENET, V9, P2553, DOI 10.1093/hmg/9.17.2553; Cox TC, 2004, CLIN GENET, V65, P163, DOI 10.1111/j.0009-9163.2004.00225.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Du HJ, 2013, J BIOL CHEM, V288, P21341, DOI 10.1074/jbc.M113.481093; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Ferrentino R, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9480; Garcia A, 2003, BIOCHIMIE, V85, P721, DOI 10.1016/j.biochi.2003.09.004; Goddard T.D., SPARKY 3; GREEN LM, 1989, P NATL ACAD SCI USA, V86, P4047, DOI 10.1073/pnas.86.11.4047; Han XF, 2011, J MOL BIOL, V407, P505, DOI 10.1016/j.jmb.2011.01.048; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Klug A, 2010, Q REV BIOPHYS, V43, P1, DOI 10.1017/S0033583510000089; Kong M, 2007, J BIOL CHEM, V282, P29712, DOI 10.1074/jbc.M703159200; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; LeNoue-Newton M, 2011, J BIOL CHEM, V286, P17665, DOI 10.1074/jbc.M111.222414; Liu EB, 2011, P NATL ACAD SCI USA, V108, P8680, DOI 10.1073/pnas.1100131108; Massiah MA, 2006, J MOL BIOL, V358, P532, DOI 10.1016/j.jmb.2006.02.009; Massiah MA, 2007, J MOL BIOL, V369, P1, DOI 10.1016/j.jmb.2007.03.017; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; McConnell JL, 2010, BIOCHEMISTRY-US, V49, P1713, DOI 10.1021/bi901837h; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Schweiger S, 1999, P NATL ACAD SCI USA, V96, P2794, DOI 10.1073/pnas.96.6.2794; Schweiger S, 2003, BIOESSAYS, V25, P356, DOI 10.1002/bies.10256; Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Short KM, 2006, J BIOL CHEM; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tao H, 2008, BIOCHEMISTRY-US, V47, P2450, DOI 10.1021/bi7018496; Tao H, 2010, BIOTECHNIQUES, V48, P61, DOI 10.2144/000113304; Torok M, 2001, DIFFERENTIATION, V67, P63, DOI 10.1046/j.1432-0436.2001.067003063.x; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Van Hoof C, 2003, BBA-MOL CELL RES, V1640, P97, DOI 10.1016/S0167-4889(03)00029-6; Watkins GR, 2012, J BIOL CHEM, V287, P24207, DOI 10.1074/jbc.M112.368613; WERA S, 1995, BIOCHEM J, V311, P17, DOI 10.1042/bj3110017; Winter J, 2003, HUM GENET, V112, P249, DOI 10.1007/s00439-002-0901-5	45	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107537	10.1371/journal.pone.0107537	http://dx.doi.org/10.1371/journal.pone.0107537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216264	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774300076
J	Davydova, E; Ho, AYY; Malecki, J; Moen, A; Enserink, JM; Jakobsson, ME; Loenarz, C; Falnes, PO				Davydova, Erna; Ho, Angela Y. Y.; Malecki, Jedrzej; Moen, Anders; Enserink, Jorrit M.; Jakobsson, Magnus E.; Loenarz, Christoph; Falnes, Pal O.			Identification and Characterization of a Novel Evolutionarily Conserved Lysine-specific Methyltransferase Targeting Eukaryotic Translation Elongation Factor 2 (eEF2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST RIBOSOMAL-PROTEINS; ADP-RIBOSYLATION; FACTOR 1-ALPHA; HELA-CELLS; METHYLATION; DIPHTHAMIDE; ACCURACY; TRANSLOCATION; BIOSYNTHESIS; INHIBITION	The components of the cellular protein translation machinery, such as ribosomal proteins and translation factors, are subject to numerous post-translational modifications. In particular, this group of proteins is frequently methylated. However, for the majority of these methylations, the responsible methyltransferases (MTases) remain unknown. The human FAM86A (family with sequence similarity 86) protein belongs to a recently identified family of protein MTases, and we here show that FAM86A catalyzes the trimethylation of eukaryotic elongation factor 2 (eEF2) on Lys-525. Moreover, we demonstrate that the Saccharomyces cerevisiae MTase Yjr129c, which displays sequence homology to FAM86A, is a functional FAM86A orthologue, modifying the corresponding residue (Lys-509) in yeast eEF2, both in vitro and in vivo. Finally, Yjr129c-deficient yeast cells displayed phenotypes related to eEF2 function (i.e. increased frameshifting during protein translation and hypersensitivity toward the eEF2-specific drug sordarin). In summary, the present study establishes the function of the previously uncharacterized MTases FAM86A and Yjr129c, demonstrating that these enzymes introduce a functionally important lysine methylation in eEF2. Based on the previous naming of similar enzymes, we have redubbed FAM86A and Yjr129c as eEF2-KMT and Efm3, respectively.	[Davydova, Erna; Ho, Angela Y. Y.; Malecki, Jedrzej; Moen, Anders; Jakobsson, Magnus E.; Falnes, Pal O.] Univ Oslo, Fac Math & Nat Sci, Dept Biosci, N-0316 Oslo, Norway; [Enserink, Jorrit M.] Oslo Univ Hosp, Dept Microbiol, N-0027 Oslo, Norway; [Enserink, Jorrit M.] Univ Oslo, N-0027 Oslo, Norway; [Loenarz, Christoph] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England	University of Oslo; University of Oslo; University of Oslo; University of Oxford	Falnes, PO (corresponding author), Univ Oslo, Fac Math & Nat Sci, Dept Biosci, N-0316 Oslo, Norway.	pal.falnes@ibv.uio.no	Enserink, Jorrit/E-5383-2010; Falnes, Pål Ø./AAA-4581-2020	Enserink, Jorrit/0000-0002-2394-5387; Malecki, Jedrzej/0000-0003-0825-7962; Loenarz, Christoph/0000-0002-8843-2531; Davydova, Erna/0000-0001-7072-4539; Falnes, Pal/0000-0001-8114-6025	University of Oslo; Norwegian Cancer Society; Research Council of Norway; Leverhulme Trust	University of Oslo; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); Leverhulme Trust(Leverhulme Trust)	Research in the laboratory of P.O.F. is supported by the University of Oslo and by grants from the Norwegian Cancer Society and the Research Council of Norway.; Recipient of a Leverhulme Trust Early Career Fellowship.	ALKSNE LE, 1993, P NATL ACAD SCI USA, V90, P9538, DOI 10.1073/pnas.90.20.9538; BARTEL RL, 1984, MOL PHARMACOL, V25, P418; Bernkopf M, 2014, HUM MOL GENET, V23, P4015, DOI 10.1093/hmg/ddu115; CHANG FN, 1978, BIOCHIM BIOPHYS ACTA, V518, P89, DOI 10.1016/0005-2787(78)90118-1; CHANG FN, 1976, ARCH BIOCHEM BIOPHYS, V172, P627, DOI 10.1016/0003-9861(76)90117-X; Chen TS, 2010, J BIOL CHEM, V285, P37281, DOI 10.1074/jbc.M110.157008; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; COPPARD NJ, 1983, FEBS LETT, V164, P330, DOI 10.1016/0014-5793(83)80311-1; Couttas TA, 2012, PROTEOMICS, V12, P960, DOI 10.1002/pmic.201100570; Darai-Ramqvist E, 2008, GENOME RES, V18, P370, DOI 10.1101/gr.7010208; FAUMAN EB, 1999, S ADENOSYLMETHIONINE, P1, DOI DOI 10.1142/9789812813077_0001; Figaro S, 2008, FEBS LETT, V582, P2352, DOI 10.1016/j.febslet.2008.05.045; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; FONZI WA, 1985, MOL CELL BIOL, V5, P1100, DOI 10.1128/MCB.5.5.1100; Gietz RD, 2007, NAT PROTOC, V2, P1, DOI 10.1038/nprot.2007.17; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; HIATT WR, 1982, P NATL ACAD SCI-BIOL, V79, P3433, DOI 10.1073/pnas.79.11.3433; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Jorgensen R, 2003, NAT STRUCT BIOL, V10, P379, DOI 10.1038/nsb923; Jorgensen R, 2002, ACTA CRYSTALLOGR D, V58, P712, DOI 10.1107/S0907444902003001; Justice MC, 1998, J BIOL CHEM, V273, P3148, DOI 10.1074/jbc.273.6.3148; Katz JE, 2003, MOL CELL PROTEOMICS, V2, P525, DOI 10.1074/mcp.M300037-MCP200; Kaul G, 2011, CELL BIOCHEM FUNCT, V29, P227, DOI 10.1002/cbf.1740; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; KRUISWIJK T, 1978, BIOCHEM J, V175, P221, DOI 10.1042/bj1750221; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Lipson RS, 2010, ARCH BIOCHEM BIOPHYS, V500, P137, DOI 10.1016/j.abb.2010.05.023; Liu SH, 2006, MOL CELL BIOL, V26, P3835, DOI 10.1128/MCB.26.10.3835-3841.2006; Loenarz C, 2014, P NATL ACAD SCI USA, V111, P4019, DOI 10.1073/pnas.1311750111; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Nyman T, 2002, J MOL BIOL, V317, P577, DOI 10.1006/jmbi.2002.5436; OPPENHEIMER NJ, 1981, J BIOL CHEM, V256, P8579; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Reiff RE, 2014, HUM MOL GENET, V23, P3456, DOI 10.1093/hmg/ddu054; RYAZANOV AG, 1989, FEBS LETT, V251, P187, DOI 10.1016/0014-5793(89)81452-8; Shastry M, 2001, MICROBIOL-UK, V147, P383, DOI 10.1099/00221287-147-2-383; Sprung R, 2008, J PROTEOME RES, V7, P1001, DOI [10.1021/pr0705338, 10.1021/pr8005155]; Su XY, 2013, CRIT REV BIOCHEM MOL, V48, P515, DOI 10.3109/10409238.2013.831023; Synetos D, 1996, BBA-GENE STRUCT EXPR, V1309, P156, DOI 10.1016/S0167-4781(96)00128-5; Thayer JS, 2002, APPL ORGANOMET CHEM, V16, P677, DOI 10.1002/aoc.375; Uthman S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003334; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Webb KJ, 2010, J BIOL CHEM, V285, P37598, DOI 10.1074/jbc.M110.170787; Webb TR, 2008, J CELL SCI, V121, P3140, DOI 10.1242/jcs.035550; Williamson NA, 1997, EUR J BIOCHEM, V246, P786, DOI 10.1111/j.1432-1033.1997.00786.x; Zhang LL, 2014, BIOCHEM BIOPH RES CO, V451, P229, DOI 10.1016/j.bbrc.2014.07.110; Zhang Y, 2008, BIOCHEM J, V413, P163, DOI 10.1042/BJ20071083	53	35	39	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30499	30510		10.1074/jbc.M114.601658	http://dx.doi.org/10.1074/jbc.M114.601658			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25231979	Green Published, hybrid			2022-12-25	WOS:000344549700029
J	Kaur, D; Angala, SK; Wu, SW; Khoo, KH; Chatterjee, D; Brennan, PJ; Jackson, M; McNeil, MR				Kaur, Devinder; Angala, Shiva K.; Wu, Sz-Wei; Khoo, Kay-Hooi; Chatterjee, Delphi; Brennan, Patrick J.; Jackson, Mary; McNeil, Michael R.			A Single Arabinan Chain Is Attached to the Phosphatidylinositol Mannosyl Core of the Major Immunomodulatory Mycobacterial Cell Envelope Glycoconjugate, Lipoarabinomannan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; STRUCTURAL FEATURES; TUBERCULOSIS; BIOSYNTHESIS; MANNOSYLTRANSFERASE; LIPOMANNAN; ARABINOGALACTAN; IDENTIFICATION; SUBSTITUENT; RESIDUES	Lipoarabinomannan (LAM) is composed of a phosphatidylinositol anchor followed by a mannan followed by an arabinan that may be capped with various motifs including oligosaccharides of mannose. A related polymer, lipomannan (LM), is composed of only the phosphatidylinositol and mannan core. Both the structure and the biosynthesis of LAM have been studied extensively. However, fundamental questions about the branching structure of LM and the number of arabinan chains on the mannan backbone in LAM remain. LM and LAM molecules produced by three different glycosyltransferase mutants of Mycobacterium smegmatis were used here to investigate these questions. Using an MSMEG_4241 mutant that lacks the alpha-(1,6)-mannosyltransferase used late in LM elongation, we showed that the reducing end region of the mannan that is attached to inositol has 5-7 unbranched alpha-6-linked-mannosyl residues followed by two or three alpha-6-linked mannosyl residues branched with single alpha-mannopyranose residues at O-2. After these branched mannosyl residues, the alpha-6-linked mannan chain is terminated with an alpha-mannopyranose at O-2 rather than O-6 of the penultimate residue. Analysis of the number of arabinans attached to the mannan core of LM in two other mutants (Delta embC and Delta MSMEG_4247) demonstrated exactly one arabinosyl substitution of the mannan core suggestive of the arabinosylation of a linear LM precursor with similar to 10-12 mannosyl residues followed by additional mannosylation of the core and arabinosylation of a single arabinosyl "primer." Thus, these studies suggest that only a single arabinan chain attached near the middle of the mannan core is present in mature LAM and allow for an updated working model of the biosynthetic pathway of LAM and LM.	[Kaur, Devinder; Angala, Shiva K.; Chatterjee, Delphi; Brennan, Patrick J.; Jackson, Mary; McNeil, Michael R.] Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Wu, Sz-Wei; Khoo, Kay-Hooi] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan	Colorado State University; Academia Sinica - Taiwan	Jackson, M (corresponding author), Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Mary.Jackson@colostate.edu; mmcneil@colostate.edu	McNeil, Michael/G-3325-2019; Khoo, Kay-Hooi/E-1989-2019; Jackson, Mary/D-5345-2017; Brennan, Patrick J/G-6896-2017	Khoo, Kay-Hooi/0000-0003-2906-406X; Jackson, Mary/0000-0002-9212-0258; 	National Research Program for Genomic Medicine Core Facilities for Proteomics and Glycomics [NSC 99-3112-B-001-025]; Taiwan National Core Facility Program for Biotechnology [NSC 100-2325-B-001-029]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064798] Funding Source: NIH RePORTER	National Research Program for Genomic Medicine Core Facilities for Proteomics and Glycomics; Taiwan National Core Facility Program for Biotechnology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The MALDI-TOF/TOF MS/MS data were acquired at the previous National Research Program for Genomic Medicine Core Facilities for Proteomics and Glycomics (NSC 99-3112-B-001-025) and current Core Facilities for Protein Structural Analysis at Academia Sinica, supported under the Taiwan National Core Facility Program for Biotechnology, NSC 100-2325-B-001-029.	Angala SK, 2014, CRIT REV BIOCHEM MOL, V49, P361, DOI 10.3109/10409238.2014.925420; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6234; CHATTERJEE D, 1991, J BIOL CHEM, V266, P9652; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6228; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; DAFFE M, 1990, J BIOL CHEM, V265, P6734; Gilleron M, 2008, MYCOBACTERIAL CELL ENVELOPE, P75; HUNTER SW, 1990, J BIOL CHEM, V265, P9272; HUNTER SW, 1986, J BIOL CHEM, V261, P2345; Joe M, 2006, J AM CHEM SOC, V128, P5059, DOI 10.1021/ja057373q; Kaur D, 2007, J BIOL CHEM, V282, P27133, DOI 10.1074/jbc.M703389200; Kaur D, 2006, P NATL ACAD SCI USA, V103, P13664, DOI 10.1073/pnas.0603049103; KHOO KH, 1995, GLYCOBIOLOGY, V5, P117, DOI 10.1093/glycob/5.1.117; MCNEIL M, 1983, CARBOHYD RES, V123, P31, DOI 10.1016/0008-6215(83)88378-5; MCNEIL MR, 1994, GLYCOBIOLOGY, V4, P165, DOI 10.1093/glycob/4.2.165; Mishra AK, 2007, MOL MICROBIOL, V65, P1503, DOI 10.1111/j.1365-2958.2007.05884.x; Morita YS, 2006, J BIOL CHEM, V281, P25143, DOI 10.1074/jbc.M604214200; Sena CBC, 2010, J BIOL CHEM, V285, P13326, DOI 10.1074/jbc.M109.077297; Shi LB, 2006, J BIOL CHEM, V281, P19512, DOI 10.1074/jbc.M513846200; Torrelles JB, 2010, TUBERCULOSIS, V90, P84, DOI 10.1016/j.tube.2010.02.003; Treumann A, 2002, J MOL BIOL, V316, P89, DOI 10.1006/jmbi.2001.5317; Turnbull WB, 2004, ANGEW CHEM INT EDIT, V43, P3918, DOI 10.1002/anie.200454119; Yu SY, 2006, GLYCOCONJUGATE J, V23, P355, DOI 10.1007/s10719-006-8492-3; Zhang N, 2003, MOL MICROBIOL, V50, P69, DOI 10.1046/j.1365-2958.2003.03681.x	24	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30249	30256		10.1074/jbc.M114.599415	http://dx.doi.org/10.1074/jbc.M114.599415			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25231986	hybrid, Green Published			2022-12-25	WOS:000344549700009
J	Yamada, K; Kim, CT; Kim, JH; Chung, JH; Lee, HG; Jun, S				Yamada, Kara; Kim, Chong-Tai; Kim, Jong-Hoon; Chung, Jae-Hyun; Lee, Hyeon Gyu; Jun, Soojin			Single Walled Carbon Nanotube-Based Junction Biosensor for Detection of Escherichia coli	PLOS ONE			English	Article							MICROWIRE SENSOR; RAPID DETECTION; IMMUNOSENSOR; ADSORPTION; TOOLS; FOOD	Foodborne pathogen detection using biomolecules and nanomaterials may lead to platforms for rapid and simple electronic biosensing. Integration of single walled carbon nanotubes (SWCNTs) and immobilized antibodies into a disposable bio-nano combinatorial junction sensor was fabricated for detection of Escherichia coli K-12. Gold tungsten wires (50 mm diameter) coated with polyethylenimine (PEI) and SWCNTs were aligned to form a crossbar junction, which was functionalized with streptavidin and biotinylated antibodies to allow for enhanced specificity towards targeted microbes. In this study, changes in electrical current (Delta I) after bioaffinity reactions between bacterial cells (E. coli K-12) and antibodies on the SWCNT surface were monitored to evaluate the sensor's performance. The averaged Delta I increased from 33.13 nA to 290.9 nA with the presence of SWCNTs in a 10(8) CFU/mL concentration of E. coli, thus showing an improvement in sensing magnitude. Electrical current measurements demonstrated a linear relationship (R-2 = 0.973) between the changes in current and concentrations of bacterial suspension in range of 10(2)-10(5) CFU/mL. Current decreased as cell concentrations increased, due to increased bacterial resistance on the bio-nano modified surface. The detection limit of the developed sensor was 10(2) CFU/mL with a detection time of less than 5 min with nanotubes. Therefore, the fabricated disposable junction biosensor with a functionalized SWCNT platform shows potential for high-performance biosensing and application as a detection device for foodborne pathogens.	[Yamada, Kara; Jun, Soojin] Univ Hawaii, Dept Human Nutr Food & Anim Sci, Honolulu, HI 96822 USA; [Kim, Chong-Tai] Korea Food Res Inst, Songnam, South Korea; [Kim, Jong-Hoon; Chung, Jae-Hyun] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA; [Lee, Hyeon Gyu] Hanyang Univ, Dept Food & Nutr, Seoul 133791, South Korea	University of Hawaii System; Korea Food Research Institute (KFRI); University of Washington; University of Washington Seattle; Hanyang University	Jun, S (corresponding author), Univ Hawaii, Dept Human Nutr Food & Anim Sci, Honolulu, HI 96822 USA.	soojin@hawaii.edu	Lee, Hyeon Gyu/AAO-7504-2020; jun, soojin/AAC-5330-2020	Lee, Hyeon Gyu/0000-0002-9141-9469; jun, soojin/0000-0002-0865-4565; Kim, Jong-Hoon/0000-0001-6088-7676	MSIP (Ministry of Science, ICT & Future Planning in Korea); KFRI (Korea Food Research Institute)	MSIP (Ministry of Science, ICT & Future Planning in Korea); KFRI (Korea Food Research Institute)	This study was completed with partial support of the MSIP (Ministry of Science, ICT & Future Planning in Korea) and KFRI (Korea Food Research Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar AD, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2128038; Allen BL, 2007, ADV MATER, V19, P1439, DOI 10.1002/adma.200602043; Arora P, 2011, BIOSENS BIOELECTRON, V28, P1, DOI 10.1016/j.bios.2011.06.002; Artyukhin AB, 2006, NANO LETT, V6, P2080, DOI 10.1021/nl061343j; Besteman K, 2003, NANO LETT, V3, P727, DOI 10.1021/nl034139u; Boussaad S, 2003, CHEM COMMUN, P1502, DOI 10.1039/b302681g; Center for Disease Control and Prevention, 2011, EST FOODB ILLN US; Chen RJ, 2004, J AM CHEM SOC, V126, P1563, DOI 10.1021/ja038702m; Chen RJ, 2001, J AM CHEM SOC, V123, P3838, DOI 10.1021/ja010172b; Forzani ES, 2004, NANO LETT, V4, P1785, DOI 10.1021/nl049080l; Gruner G, 2006, ANAL BIOANAL CHEM, V384, P322, DOI 10.1007/s00216-005-3400-4; Heller I, 2008, NANO LETT, V8, P591, DOI 10.1021/nl072996i; Kang IP, 2006, COMPOS PART B-ENG, V37, P382, DOI 10.1016/j.compositesb.2006.02.011; Katz E, 2004, CHEMPHYSCHEM, V5, P1085, DOI 10.1002/cphc.200400193; Kim JH, 2013, RSC ADV, V3, P4281, DOI 10.1039/c3ra40262b; Kim S, 2011, INNOV FOOD SCI EMERG, V12, P617, DOI 10.1016/j.ifset.2011.06.006; Lu L, 2013, BIOSENS BIOELECTRON, V42, P492, DOI 10.1016/j.bios.2012.10.060; Lu L, 2012, BIOSENS BIOELECTRON, V36, P257, DOI 10.1016/j.bios.2012.04.033; Majumdar T., 2013, FOOD BIOSCI, V4, P38, DOI DOI 10.1016/J.FBI0.2013.08.002; Maruccio G, 2007, SMALL, V3, P1184, DOI 10.1002/smll.200600600; Mello LD, 2002, FOOD CHEM, V77, P237, DOI 10.1016/S0308-8146(02)00104-8; Okuno J, 2007, BIOSENS BIOELECTRON, V22, P2377, DOI 10.1016/j.bios.2006.09.038; Patolsky F, 2006, SCIENCE, V313, P1100, DOI 10.1126/science.1128640; Pei RJ, 2001, BIOSENS BIOELECTRON, V16, P355, DOI 10.1016/S0956-5663(01)00150-6; Rouse JH, 2004, CHEM MATER, V16, P3904, DOI 10.1021/cm049708t; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Scharff RL, 2012, J FOOD PROTECT, V75, P123, DOI 10.4315/0362-028X.JFP-11-058; So HM, 2008, SMALL, V4, P197, DOI 10.1002/smll.200700664; Vashist SK, 2011, BIOTECHNOL ADV, V29, P169, DOI 10.1016/j.biotechadv.2010.10.002; Velusamy V, 2010, BIOTECHNOL ADV, V28, P232, DOI 10.1016/j.biotechadv.2009.12.004; Villamizar RA, 2008, BIOSENS BIOELECTRON, V24, P279, DOI 10.1016/j.bios.2008.03.046; Wang J, 2005, ELECTROANAL, V17, P7, DOI 10.1002/elan.200403113; Zhao GY, 2011, ANAL BIOCHEM, V408, P53, DOI 10.1016/j.ab.2010.08.039; Zhou G, 2002, ANAL BIOCHEM, V408, P53	34	37	37	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e105767	10.1371/journal.pone.0105767	http://dx.doi.org/10.1371/journal.pone.0105767			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233366	gold, Green Published, Green Submitted			2022-12-25	WOS:000342921200006
J	Yan, JH; Gu, GJ; Jost, C; Hammond, M; Pluckthun, A; Landegren, U; Kamali-Moghaddam, M				Yan, Junhong; Gu, Gucci Jijuan; Jost, Christian; Hammond, Maria; Plueckthun, Andreas; Landegren, Ulf; Kamali-Moghaddam, Masood			A Universal Approach to Prepare Reagents for DNA-Assisted Protein Analysis	PLOS ONE			English	Article							PROXIMITY LIGATION; AFFINITY BINDERS; MOLECULES; CANCER; ASSAYS	The quality of DNA-labeled affinity probes is critical in DNA-assisted protein analyses, such as proximity ligation and extension assays, immuno-PCR, and immuno-rolling circle amplification reactions. Efficient, high-performance methods are therefore required for isolation of pure conjugates from reactions where DNA strands have been coupled to antibodies or recombinant affinity reagents. Here we describe a universal, scalable approach for preparing high-quality oligonucleotide-protein conjugates by sequentially removing any unconjugated affinity reagents and remaining free oligonucleotides from conjugation reactions. We applied the approach to generate high-quality probes using either antibodies or recombinant affinity reagents. The purified high-grade probes were used in proximity ligation assays in solution and in situ, demonstrating both augmented assay sensitivity and improved signal-to-noise ratios.	[Yan, Junhong; Gu, Gucci Jijuan; Hammond, Maria; Landegren, Ulf; Kamali-Moghaddam, Masood] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Gu, Gucci Jijuan] Stanford Univ, Dept Genet, Palo Alto, CA 94304 USA; [Jost, Christian; Plueckthun, Andreas] Univ Zurich, Dept Biochem, Zurich, Switzerland	Uppsala University; Stanford University; University of Zurich	Kamali-Moghaddam, M (corresponding author), Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden.	masood.kamali@igp.uu.se	Plückthun, Andreas/C-2746-2009; Landegren, Ulf D/A-8197-2019	Plückthun, Andreas/0000-0003-4191-5306; Yan, Junhong/0000-0002-2332-2315; Jost, Christian/0000-0002-4169-5879	European Community [241481, 294409, 259881]; Swedish Research Council for Medicine; IngaBritt och Arne Lundbergs Research Foundation	European Community(European Commission); Swedish Research Council for Medicine; IngaBritt och Arne Lundbergs Research Foundation	The research leading to these results has received funding from the European Community's 7th Framework Program (FP7/2007-2013) under grant agreements No. 241481 (Affinomics), 294409 (ProteinSeq) and 259881 (IMAGINT) (http://cordis.europa.eu/fp7/home_en.html); the Swedish Research Council for Medicine (http://www.vr.se/inenglish. 4.12fff4451215cbd83e4800015152.html); and IngaBritt och Arne Lundbergs Research Foundation (http://www.lundbergsstiftelsen.se/index_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Conze T, 2009, ANNU REV ANAL CHEM, V2, P215, DOI 10.1146/annurev-anchem-060908-155239; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Fredriksson S, 2007, NAT METHODS, V4, P327, DOI 10.1038/NMETH1020; Gu GJ, 2013, NEUROMOL MED, V15, P458, DOI 10.1007/s12017-013-8232-3; Gu GJ, 2013, NEW BIOTECHNOL, V30, P144, DOI 10.1016/j.nbt.2012.05.005; Gullberg M, 2004, P NATL ACAD SCI USA, V101, P8420, DOI 10.1073/pnas.0400552101; Hansson M, 1999, IMMUNOTECHNOLOGY, V4, P237, DOI 10.1016/S1380-2933(98)00026-8; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Larsson C, 2010, NAT METHODS, V7, P395, DOI [10.1038/NMETH.1448, 10.1038/nmeth.1448]; Lundberg M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr424; Nong RY, 2012, EXPERT REV PROTEOMIC, V9, P21, DOI [10.1586/epr.11.78, 10.1586/EPR.11.78]; SKERRA A, 1988, SCIENCE, V240, P1038, DOI 10.1126/science.3285470; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Steiner D, 2008, J MOL BIOL, V382, P1211, DOI 10.1016/j.jmb.2008.07.085; Thorsen SB, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-253; Yan J, 2013, J BIOTECHNOL, V167, P235, DOI 10.1016/j.jbiotec.2013.06.010; Zahnd C, 2007, J MOL BIOL, V369, P1015, DOI 10.1016/j.jmb.2007.03.028	19	5	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e108061	10.1371/journal.pone.0108061	http://dx.doi.org/10.1371/journal.pone.0108061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233463	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000342921200076
J	Zha, LY; Chen, JD; Sun, SX; Mao, LM; Chu, XW; Deng, H; Cai, JW; Li, XF; Liu, ZQ; Cao, WH				Zha, Longying; Chen, Jiading; Sun, Suxia; Mao, Limei; Chu, Xinwei; Deng, Hong; Cai, Junwei; Li, Xuefeng; Liu, Zhenqi; Cao, Wenhong			Soyasaponins Can Blunt Inflammation by Inhibiting the Reactive Oxygen Species-Mediated Activation of PI3K/Akt/NF-kB Pathway	PLOS ONE			English	Article							FACTOR-KAPPA-B; SOYASAPOGENOL-B; INSULIN; CANCER; SOY; HEALTH; AKT; PROLIFERATION; TRITERPENOIDS; CONSTITUENTS	We and others have recently shown that soyasaponins abundant in soybeans can decrease inflammation by suppressing the nuclear factor kappa B (NF-kB)-mediated inflammation. However, the exact molecular mechanisms by which soyasaponins inhibit the NF-kB pathway have not been established. In this study in macrophages, soyasaponins (A(1), A(2) and I) inhibited the lipopolysaccharide (LPS)-induced release of inflammatory marker prostaglandin E-2 (PGE(2)) to a similar extent as the NF-kB inhibitor (BAY117082). Soyasaponins (A(1), A(2) and I) also suppressed the LPS-induced expression of cyclooxygenase 2 (COX-2), another inflammatory marker, in a dose-dependent manner by inhibiting NF-kB activation. In defining the associated mechanisms, we found that soyasaponins (A(1), A(2) and I) blunted the LPS-induced IKK alpha/beta phosphorylation, IkB phosphorylation and degradation, and NF-kB p65 phosphorylation and nuclear translocation. In studying the upstream targets of soyasaponins on the NF-kB pathway, we found that soyasaponins (A(1), A(2) and I) suppressed the LPS-induced activation of PI3K/Akt similarly as the PI3K inhibitor LY294002, which alone blocked the LPS-induced activation of NF-kB. Additionally, soyasaponins (A(1), A(2) and I) reduced the LPS-induced production of reactive oxygen species (ROS) to the same extent as the anti-oxidant N-acetyl-L-cysteine, which alone inhibited the LPS-induced phosphorylation of Akt, IKK alpha/beta, IkB alpha, and p65, transactivity of NF-kB, PGE2 production, and malondialdehyde production. Finally, our results show that soyasaponins (A(1), A(2) and I) elevated SOD activity and the GSH/GSSG ratio. Together, these results show that soyasaponins (A(1), A(2) and I) can blunt inflammation by inhibiting the ROS-mediated activation of the PI3K/Akt/NF-kB pathway.	[Zha, Longying; Chen, Jiading; Sun, Suxia; Mao, Limei; Chu, Xinwei; Deng, Hong] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Nutr & Food Hyg, Guangzhou, Guangdong, Peoples R China; [Cai, Junwei; Li, Xuefeng; Cao, Wenhong] Hubei Univ Med, Taihe Hosp, Dept Endocrinol, Shiyan, Peoples R China; [Liu, Zhenqi] Univ Virginia Hlth Syst, Dept Med, Charlottesville, VA USA; [Zha, Longying; Cai, Junwei; Cao, Wenhong] Univ N Carolina, Nutr Res Inst Kannapolis, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Cao, Wenhong] Duke Univ, Sch Med, Dept Med Endocrinol & Metab, Durham, NC USA	Southern Medical University - China; Hubei University of Medicine; University of Virginia; University of North Carolina; University of North Carolina Chapel Hill; Duke University	Zha, LY (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Nutr & Food Hyg, Guangzhou, Guangdong, Peoples R China.	lyzha@smu.edu.cn; caow@unc.edu			National Natural Science Foundation of China (NSFC) [81102130]; Medical Scientific Research Foundation of Guangdong Province, China [A2011357]; American Diabetes Association [7-09-BS-27, 1-14-BS-26]; National Institutes of Health [NIH R01DK076039]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076039] Funding Source: NIH RePORTER	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Medical Scientific Research Foundation of Guangdong Province, China; American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by The National Natural Science Foundation of China (NSFC) (Grant No. 81102130 to L.Z.); The Medical Scientific Research Foundation of Guangdong Province, China (Grant No. A2011357 to L.Z.); the American Diabetes Association (7-09-BS-27 and 1-14-BS-26 to W.C.) and the National Institutes of Health (NIH R01DK076039 to W.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Al-Shawwa BA, 2007, J ASTHMA, V44, P469, DOI 10.1080/02770900701423597; Azadbakht L, 2008, DIABETES CARE, V31, P648, DOI 10.2337/dc07-2065; Azadbakht L, 2007, DIABETES CARE, V30, P967, DOI 10.2337/dc06-2126; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Berhow MA, 2000, MUTAT RES-FUND MOL M, V448, P11, DOI 10.1016/S0027-5107(99)00225-0; Bhattacharyya J, 2004, CURR MED CHEM, V11, P359, DOI 10.2174/0929867043456098; Boyapati SM, 2005, BREAST CANCER RES TR, V92, P11, DOI 10.1007/s10549-004-6019-9; Burns JM, 2007, NEUROLOGY, V69, P1094, DOI 10.1212/01.wnl.0000276952.91704.af; Cao Wenhong, 2011, Curr Mol Pharmacol, V4, P154; Cole GM, 2007, EXP GERONTOL, V42, P10, DOI 10.1016/j.exger.2006.08.009; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crowell JA, 2007, MOL CANCER THER, V6, P2139, DOI 10.1158/1535-7163.MCT-07-0120; Hattori Y, 2003, EUR J PHARMACOL, V481, P153, DOI 10.1016/j.ejphar.2003.09.034; Hayashi K, 1997, PLANTA MED, V63, P102, DOI 10.1055/s-2006-957622; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hirai S, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/367838; Isanga J, 2008, FOOD REV INT, V24, P252, DOI 10.1080/87559120801926351; Ishii Y, 2006, BIOL PHARM BULL, V29, P1759, DOI 10.1248/bpb.29.1759; Jun Hye-Seung, 2002, Journal of Medicinal Food, V5, P235; Kang JH, 2005, CANCER LETT, V230, P219, DOI 10.1016/j.canlet.2004.12.041; Kang J, 2010, J AGR FOOD CHEM, V58, P8119, DOI 10.1021/jf100901b; Kaplan MJ, 2009, NAT REV RHEUMATOL, V5, P208, DOI 10.1038/nrrheum.2009.29; Kerwin S. M., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P263, DOI 10.2174/1568011043352993; Kinjo J, 2003, BIOL PHARM BULL, V26, P1357, DOI 10.1248/bpb.26.1357; Kinjo J, 1998, PLANTA MED, V64, P233, DOI 10.1055/s-2006-957416; Lee IA, 2010, J AGR FOOD CHEM, V58, P10929, DOI 10.1021/jf102296y; Lee SO, 2005, EXP BIOL MED, V230, P472; Li QT, 2005, TRENDS IMMUNOL, V26, P318, DOI 10.1016/j.it.2005.04.003; Liu HY, 2009, AM J PHYSIOL-ENDOC M, V297, pE898, DOI 10.1152/ajpendo.00374.2009; Luo J.L KH, 2013, J CLIN INVEST, V15, P2625; MESSINA MJ, 1994, NUTR CANCER, V21, P113, DOI 10.1080/01635589409514310; Messina MJ, 1999, AM J CLIN NUTR, V70, p439S, DOI 10.1093/ajcn/70.3.439s; Murillo MM, 2007, BIOCHEM J, V405, P251, DOI 10.1042/BJ20061846; NAKASHIMA H, 1989, AIDS, V3, P655, DOI 10.1097/00002030-198910000-00007; OAKENFULL D, 1990, EUR J CLIN NUTR, V44, P79; Okazaki Ryo, 2008, Clin Calcium, V18, P638, DOI CliCa0805638643; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Popa C, 2007, J LIPID RES, V48, P751, DOI 10.1194/jlr.R600021-JLR200; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Sterry W, 2007, BRIT J DERMATOL, V157, P649, DOI 10.1111/j.1365-2133.2007.08068.x; Toyomura Kengo, 2002, Asian Pac J Cancer Prev, V3, P125; Venkatesan B, 2010, J MOL CELL CARDIOL, V49, P655, DOI 10.1016/j.yjmcc.2010.05.007; Xiao JX, 2007, EXP TOXICOL PATHOL, V59, P35, DOI 10.1016/j.etp.2007.02.004; Yadav VR, 2010, TOXINS, V2, P2428, DOI 10.3390/toxins2102428; Yoon JH, 2005, YONSEI MED J, V46, P585, DOI 10.3349/ymj.2005.46.5.585; YOSHIKI Y, 1995, BIOSCI BIOTECH BIOCH, V59, P1556, DOI 10.1271/bbb.59.1556; Zha LY, 2011, BIOORG MED CHEM LETT, V21, P2415, DOI 10.1016/j.bmcl.2011.02.071; Zhang W, 2008, J AGR FOOD CHEM, V56, P2603, DOI 10.1021/jf0731550; Zhang W, 2009, MOLECULES, V14, P2959, DOI 10.3390/molecules14082959	52	80	88	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107655	10.1371/journal.pone.0107655	http://dx.doi.org/10.1371/journal.pone.0107655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233217	Green Published, gold, Green Submitted			2022-12-25	WOS:000342921200040
J	Hu, W; Wehrle-Haller, B; Vogel, V				Hu, Wei; Wehrle-Haller, Bernhard; Vogel, Viola			Maturation of Filopodia Shaft Adhesions Is Upregulated by Local Cycles of Lamellipodia Advancements and Retractions	PLOS ONE			English	Article							FOCAL ADHESIONS; ACTIN-FILAMENTS; LEADING-EDGE; NASCENT ADHESIONS; INTEGRIN-BINDING; FORCE GENERATION; VINCULIN BINDING; MIGRATING CELLS; STRESS FIBERS; RHO GTPASES	While cell-substrate adhesions that form between the protruding edge of a spreading cell and flat surfaces have been studied extensively, processes that regulate the maturation of filopodia adhesions are far less characterized. Since little is known about how the kinetics of formation or disassembly of filopodia adhesions is regulated upon integration into the lamellum, a kinetic analysis of the formation and disassembly of filopodia adhesions was conducted at the leading edge of beta 3-integrin-EGFP-expressing rat embryonic fibroblasts spreading on fibronectin-coated glass or on soft polyacrylamide gels. Filopodia beta 3-integrin adhesions matured only if the lamellipodium in their immediate vicinity showed cyclic protrusions and retractions. Filopodia beta 3-integrin shaft adhesions elongated rapidly when they were overrun by the advancing lamellipodium. Subsequently and once the lamellipodium stopped its advancement at the distal end of the filopodia beta 3-integrin adhesion, these beta 3-integrin shaft adhesions started to grow sidewise and colocalize with the newly assembled circumferential actin stress fibers. In contrast, the suppression of the cyclic protrusions and retractions of the lamellipodium by blocking myosin light chain kinase suppressed the growth of filopodia adhesion and resulted in the premature disassembly of filopodia adhesions. The same failure to stabilize those adhesions was found for the advancing lamellipodium that rapidly overran filopodia shaft adhesions without pausing as seen often during fast cell spreading. In turn, plating cells on soft polyacrylamide gels resulted in a reduction of lamellipodia activity, which was partially restored locally by the presence of filopodia adhesions. Thus filopodia adhesions could also mature and be integrated into the lamellum for fibroblasts on soft polyacrylamide substrates.	[Hu, Wei; Vogel, Viola] ETH, Dept Hlth Sci & Technol, Lab Appl Mechanobiol, Zurich, Switzerland; [Wehrle-Haller, Bernhard] Univ Geneva, Univ Med Ctr, Dept Cellular Physiol & Metab, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva	Vogel, V (corresponding author), ETH, Dept Hlth Sci & Technol, Lab Appl Mechanobiol, Zurich, Switzerland.	viola.vogel@hest.ethz.ch	Vogel, Viola/O-8025-2015	Vogel, Viola/0000-0003-2898-7671	ETH Zurich; European Research Council [233157]	ETH Zurich(ETH Zurich); European Research Council(European Research Council (ERC)European Commission)	The authors gratefully acknowledge financial support from the ETH Zurich (http://www.ethz.ch/) and from the European Research Council (http://erc.europa.eu/; ERC-2009-Advanced Grant nr. 233157 to W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuschies J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01658; Alexandrova AY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003234; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; AVNUR Z, 1981, J MOL BIOL, V153, P361, DOI 10.1016/0022-2836(81)90283-7; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; Bornschlogl T, 2013, P NATL ACAD SCI USA, V110, P18928, DOI 10.1073/pnas.1316572110; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Choi CH, 2007, BIOMATERIALS, V28, P1672, DOI 10.1016/j.biomaterials.2006.11.031; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Cluzel C, 2005, J CELL BIOL, V171, P383, DOI 10.1083/jcb.200503017; Cojoc D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001072; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; DEROSIER DJ, 1980, EXP CELL RES, V126, P490, DOI 10.1016/0014-4827(80)90295-5; Dubin-Thaler BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003735; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Gallo G, 2011, ADV NEUROBIOL, V5, P7, DOI 10.1007/978-1-4419-7368-9_2; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Graves CE, 2009, J NEUROSCI METH, V179, P278, DOI 10.1016/j.jneumeth.2009.02.004; Gupton Stephanie L, 2007, Sci STKE, V2007, pre5, DOI 10.1126/stke.4002007re5; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Heckman CA, 2013, CELL SIGNAL, V25, P2298, DOI 10.1016/j.cellsig.2013.07.006; Herbert BS, 2013, NATURE CELL BIOL, V15, P625; Hinz B, 2003, MOL BIOL CELL, V14, P2508, DOI 10.1091/mbc.E02-11-0729; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hytonen VP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040024; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Kress H, 2007, P NATL ACAD SCI USA, V104, P11633, DOI 10.1073/pnas.0702449104; LANG RDA, 1981, J CELL SCI, V49, P383; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Medalia O, 2007, CURR BIOL, V17, P79, DOI 10.1016/j.cub.2006.11.022; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Moller J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02884; Mongiu AK, 2007, J CELL SCI, V120, P1113, DOI 10.1242/jcs.03384; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; Nermut MV, 1995, RAPID FREEZING FREEZ, P151; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Oldenbourg R, 2000, BIOPHYS J, V78, P1176, DOI 10.1016/S0006-3495(00)76675-6; Partridge MA, 2006, MOL BIOL CELL, V17, P4237, DOI 10.1091/mbc.E06-06-0496; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Roca-Cusachs P, 2013, P NATL ACAD SCI USA, V110, pE1361, DOI 10.1073/pnas.1220723110; Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106; Saltel F, 2009, J CELL BIOL, V187, P715, DOI 10.1083/jcb.200908134; Schafer C, 2010, CELL ADHES MIGR, V4, P215, DOI 10.4161/cam.4.2.10745; Schafer C, 2009, EXP CELL RES, V315, P1212, DOI 10.1016/j.yexcr.2008.11.008; Shahapure R, 2010, BIOPHYS J, V98, P979, DOI 10.1016/j.bpj.2009.11.041; Shemesh T, 2009, BIOPHYS J, V97, P1254, DOI 10.1016/j.bpj.2009.05.065; Steketee MB, 2002, J NEUROSCI, V22, P8071; Tse J.R., 2010, CURR PROTOC CELL BIO; Verkhovsky AB, 1999, BIOCHEM SOC SYMP, V65, P207; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; Vignjevic D, 2008, SEMIN CANCER BIOL, V18, P12, DOI 10.1016/j.semcancer.2007.08.001; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yang SY, 2013, J BIOL CHEM, V288, P274, DOI 10.1074/jbc.M112.427971; Yu CH, 2011, P NATL ACAD SCI USA, V108, P20585, DOI 10.1073/pnas.1109485108; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416	73	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107097	10.1371/journal.pone.0107097	http://dx.doi.org/10.1371/journal.pone.0107097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229609	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900024
J	Oh, CD; Lu, Y; Liang, SD; Mori-Akiyama, Y; Chen, D; de Crombrugghe, B; Yasuda, H				Oh, Chun-do; Lu, Yue; Liang, Shoudan; Mori-Akiyama, Yuko; Chen, Di; de Crombrugghe, Benoit; Yasuda, Hideyo			SOX9 Regulates Multiple Genes in Chondrocytes, Including Genes Encoding ECM Proteins, ECM Modification Enzymes, Receptors, and Transporters	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SOX9; MESSENGER-RNA LEVELS; CAMPOMELIC DYSPLASIA; COLLAGEN GENE; SKELETAL MORPHOGENESIS; BETA SUPERFAMILY; ENHANCER ELEMENT; RETINOIC ACID; AGGRECAN GENE; GROWTH-PLATE	The transcription factor SOX9 plays an essential role in determining the fate of several cell types and is a master factor in regulation of chondrocyte development. Our aim was to determine which genes in the genome of chondrocytes are either directly or indirectly controlled by SOX9. We used RNA-Seq to identify genes whose expression levels were affected by SOX9 and used SOX9 ChIP-Seq to identify those genes that harbor SOX9-interaction sites. For RNA-Seq, the RNA expression profile of primary Sox9(flox/flox) mouse chondrocytes infected with Ad-CMV-Cre was compared with that of the same cells infected with a control adenovirus. Analysis of RNA-Seq data indicated that, when the levels of Sox9 mRNA were decreased more than 8-fold by infection with Ad-CMV-Cre, 196 genes showed a decrease in expression of at least 4-fold. These included many cartilage extracellular matrix (ECM) genes and a number of genes for ECM modification enzymes (transferases), membrane receptors, transporters, and others. In ChIP-Seq, 75% of the SOX9-interaction sites had a canonical inverted repeat motif within 100 bp of the top of the peak. SOX9-interaction sites were found in 55% of the genes whose expression was decreased more than 8-fold in SOX9-depleted cells and in somewhat fewer of the genes whose expression was reduced more than 4-fold, suggesting that these are direct targets of SOX9. The combination of RNA-Seq and ChIP-Seq has provided a fuller understanding of the SOX9-controlled genetic program of chondrocytes.	[Oh, Chun-do; de Crombrugghe, Benoit; Yasuda, Hideyo] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Lu, Yue; Liang, Shoudan] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Sci, Houston, TX 77030 USA; [Mori-Akiyama, Yuko] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Chen, Di] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Rush University	Yasuda, H (corresponding author), Mariabiotech Co Ltd, Seoul, South Korea.	h-yasuda@yk9.so-net.ne.jp	Chen, Di/AAJ-3665-2021	Lu, Yue/0000-0002-5479-9095; Oh, Chundo/0000-0002-5419-8011	National Institutes of Health [RO1AR309854]; Arthritis Foundation; National Cancer Institute Cancer Center [CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054465] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a National Institutes of Health grant (RO1AR309854) to BdC, an Arthritis Foundation Postdoctoral Fellowship to C-DO, and the National Cancer Institute Cancer Center Support Grant (CA16672) to MD Anderson Cancer Center (for sequence analysis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Amano K, 2011, MOL BIOL CELL, V22, P1300, DOI 10.1091/mbc.E10-07-0566; Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Bernard P, 2003, HUM MOL GENET, V12, P1755, DOI 10.1093/hmg/ddg182; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bridgewater LC, 2003, NUCLEIC ACIDS RES, V31, P1541, DOI 10.1093/nar/gkg230; Bridgewater LC, 1998, J BIOL CHEM, V273, P14998, DOI 10.1074/jbc.273.24.14998; Camper L, 2001, CELL TISSUE RES, V306, P107, DOI 10.1007/s004410100385; Coustry F, 2010, NUCLEIC ACIDS RES, V38, P6018, DOI 10.1093/nar/gkq417; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Genzer MA, 2007, NUCLEIC ACIDS RES, V35, P1178, DOI 10.1093/nar/gkm014; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hall CR, 2002, AM J MED GENET, V112, P1, DOI 10.1002/ajmg.10635; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hoang B, 1996, J BIOL CHEM, V271, P26131, DOI 10.1074/jbc.271.42.26131; Huang BL, 2010, J BIOL CHEM, V285, P27702, DOI 10.1074/jbc.M110.108498; Huang WD, 2001, P NATL ACAD SCI USA, V98, P160, DOI 10.1073/pnas.011393998; Johnson EB, 2005, HUM MOL GENET, V14, P3523, DOI 10.1093/hmg/ddi381; Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157; Kawaguchi Y, 2013, J CLIN INVEST, V123, P1881, DOI 10.1172/JCI66022; KINGSLEY DM, 1992, CELL, V71, P399, DOI 10.1016/0092-8674(92)90510-J; Kist R, 2002, GENESIS, V32, P121, DOI 10.1002/gene.10050; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Leijten JCH, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4306; Liu SR, 2000, P NATL ACAD SCI USA, V97, P5369, DOI 10.1073/pnas.100113197; Matheu A, 2012, CANCER RES, V72, P1301, DOI 10.1158/0008-5472.CAN-11-3660; MUKHOPADHYAY K, 1995, J BIOL CHEM, V270, P27711, DOI 10.1074/jbc.270.46.27711; Murakami S, 2000, P NATL ACAD SCI USA, V97, P1113, DOI 10.1073/pnas.97.3.1113; Murakami S, 2000, J BIOL CHEM, V275, P3687, DOI 10.1074/jbc.275.5.3687; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakamura Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1242; Oh CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010113; Passeron T, 2007, P NATL ACAD SCI USA, V104, P13984, DOI 10.1073/pnas.0705117104; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Shi ZC, 2013, AM J PHYSIOL-GASTR L, V305, pG74, DOI 10.1152/ajpgi.00086.2013; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Shung CY, 2012, HUM MOL GENET, V21, P4628, DOI 10.1093/hmg/dds305; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Sock E, 2003, HUM MOL GENET, V12, P1439, DOI 10.1093/hmg/ddg158; Takigawa Y, 2010, J CELL SCI, V123, P3780, DOI 10.1242/jcs.071373; Tsuda M, 2003, J BIOL CHEM, V278, P27224, DOI 10.1074/jbc.M303471200; Wakahara T, 2007, DEV BIOL, V303, P527, DOI 10.1016/j.ydbio.2006.11.041; WROBLEWSKI J, 1992, CELL BIOL INT REP, V16, P133, DOI 10.1016/S0309-1651(06)80107-4; Xie WF, 1999, J BONE MINER RES, V14, P757, DOI 10.1359/jbmr.1999.14.5.757; Xu L, 2001, MATRIX BIOL, V20, P147, DOI 10.1016/S0945-053X(00)00138-4; Zalzali H, 2008, ONCOGENE, V27, P7131, DOI 10.1038/onc.2008.331	53	67	68	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107577	10.1371/journal.pone.0107577	http://dx.doi.org/10.1371/journal.pone.0107577			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229425	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900052
J	Zhao, YL; Haney, MJ; Gupta, R; Bohnsack, JP; He, ZJ; Kabanov, AV; Batrakova, EV				Zhao, Yuling; Haney, Matthew J.; Gupta, Richa; Bohnsack, John P.; He, Zhijian; Kabanov, Alexander V.; Batrakova, Elena V.			GDNF-Transfected Macrophages Produce Potent Neuroprotective Effects in Parkinson's Disease Mouse Model	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; FACTOR GENE-TRANSFER; NEUROTROPHIC FACTOR; GROWTH-FACTOR; RAT MODEL; DOPAMINERGIC NEURODEGENERATION; INTRASTRIATAL INJECTION; NEURAL TRANSPLANTATION; FUNCTIONAL RECOVERY; DELIVERY PROTECTS	The pathobiology of Parkinson's disease (PD) is associated with the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) projecting to the striatum. Currently, there are no treatments that can halt or reverse the course of PD; only palliative therapies, such as replacement strategies for missing neurotransmitters, exist. Thus, the successful brain delivery of neurotrophic factors that promote neuronal survival and reverse the disease progression is crucial. We demonstrated earlier systemically administered autologous macrophages can deliver nanoformulated antioxidant, catalase, to the SNpc providing potent anti-inflammatory effects in PD mouse models. Here we evaluated genetically-modified macrophages for active targeted brain delivery of glial cell-line derived neurotropic factor (GDNF). To capitalize on the beneficial properties afforded by alternatively activated macrophages, transfected with GDNF-encoded pDNA cells were further differentiated toward regenerative M2 phenotype. A systemic administration of GDNF-expressing macrophages significantly ameliorated neurodegeneration and neuroinflammation in PD mice. Behavioral studies confirmed neuroprotective effects of the macrophage-based drug delivery system. One of the suggested mechanisms of therapeutic effects is the release of exosomes containing the expressed neurotropic factor followed by the efficient GDNF transfer to target neurons. Such formulations can serve as a new technology based on cell-mediated active delivery of therapeutic proteins that attenuate and reverse progression of PD, and ultimately provide hope for those patients who are already significantly disabled by the disease.	[Zhao, Yuling; Haney, Matthew J.; Gupta, Richa; He, Zhijian; Kabanov, Alexander V.; Batrakova, Elena V.] Univ N Carolina, Ctr Nanotechnol Drug Delivery, Chapel Hill, NC 27599 USA; [Zhao, Yuling; Haney, Matthew J.; Gupta, Richa; Bohnsack, John P.; He, Zhijian; Kabanov, Alexander V.; Batrakova, Elena V.] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC USA; [Kabanov, Alexander V.] Moscow MV Lomonosov State Univ, Fac Chem, Dept Chem Enzymol, Moscow 117234, Russia	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Lomonosov Moscow State University	Batrakova, EV (corresponding author), Univ N Carolina, Ctr Nanotechnol Drug Delivery, Chapel Hill, NC 27599 USA.	batrakov@email.unc.edu	Kabanov, Alexander V/N-3356-2013; Kabanov, Alexander/AAY-5751-2020; He, Zhijian/GPP-3720-2022	Kabanov, Alexander V/0000-0002-3665-946X; Kabanov, Alexander/0000-0002-3665-946X; He, Zhijian/0000-0003-4871-5497	US National Institutes of Health [1R01 NS057748, RR021937, R01 CA116591]; US Department of Defense [W81XWH-09-1-0386, W81XWH11-1-0770]; Russian Ministry of Science and Education [02.740.11.5231, 11.G34.31.0004]; NATIONAL CANCER INSTITUTE [R01CA116591] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057748] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Russian Ministry of Science and Education(Ministry of Education and Science, Russian Federation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the grants of the US National Institutes of Health 1R01 NS057748 (to EVB), RR021937 and R01 CA116591 (to AVK), US Department of Defense Award No. W81XWH-09-1-0386 (to AVK) and W81XWH11-1-0770 (to AVK), and the Russian Ministry of Science and Education No. 02.740.11.5231 and No. 11.G34.31.0004 (to AVK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerud P, 2001, J NEUROSCI, V21, P8108, DOI 10.1523/JNEUROSCI.21-20-08108.2001; Anthony D C, 2001, Prog Brain Res, V132, P507; Anthony DC, 1997, BRAIN, V120, P435, DOI 10.1093/brain/120.3.435; Bachis A, 2005, ANN NY ACAD SCI, V1053, P247, DOI 10.1196/annals.1344.022; Batrakova EV, 2007, BIOCONJUGATE CHEM, V18, P1498, DOI 10.1021/bc700184b; Batrakova EV, 2011, EXPERT OPIN DRUG DEL, V8, P415, DOI 10.1517/17425247.2011.559457; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Biju KC, 2013, NEUROSCI LETT, V535, P24, DOI 10.1016/j.neulet.2012.12.034; Biju KC, 2010, MOL THER, V18, P1536, DOI 10.1038/mt.2010.107; BilangBleuel A, 1997, P NATL ACAD SCI USA, V94, P8818, DOI 10.1073/pnas.94.16.8818; Blamire AM, 2000, J NEUROSCI, V20, P8153; Brinton RD, 1999, INT J FERTIL WOMEN M, V44, P174; Brynskikh AM, 2010, NANOMEDICINE-UK, V5, P379, DOI [10.2217/nnm.10.7, 10.2217/NNM.10.7]; Casper D, 2002, CELL TRANSPLANT, V11, P331; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; Desnick RJ, 2002, NAT REV GENET, V3, P954, DOI 10.1038/nrg963; Dogrukol-Ak D, 2003, PEPTIDES, V24, P437, DOI 10.1016/S0196-9781(03)00059-7; Eketjall S, 1999, EMBO J, V18, P5901, DOI 10.1093/emboj/18.21.5901; Emborg ME, 2009, NEUROBIOL DIS, V36, P303, DOI 10.1016/j.nbd.2009.07.022; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Garcia P, 2010, J NEUROSCI, V30, P7516, DOI 10.1523/JNEUROSCI.4182-09.2010; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Georgievska B, 2004, EUR J NEUROSCI, V20, P3121, DOI 10.1111/j.1460-9568.2004.03770.x; Gozes I, 2001, TRENDS NEUROSCI, V24, P700, DOI 10.1016/S0166-2236(00)01931-7; Grondin R, 2003, J NEUROSCI, V23, P1974; Haney MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061852; Haney MJ, 2012, NANOMEDICINE-UK, V7, P815, DOI [10.2217/NNM.11.156, 10.2217/nnm.11.156]; Haney MJ, 2011, NANOMEDICINE-UK, V6, P1215, DOI [10.2217/nnm.11.32, 10.2217/NNM.11.32]; HUDSON J, 1995, BRAIN RES BULL, V36, P425, DOI 10.1016/0361-9230(94)00224-O; JOHNSTONE RM, 1992, BIOCHEM CELL BIOL, V70, P179, DOI 10.1139/o92-028; Kells AP, 2012, NEUROBIOL DIS, V48, P228, DOI 10.1016/j.nbd.2011.10.004; Keshet GI, 2007, J COMP NEUROL, V504, P690, DOI 10.1002/cne.21483; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kirik D, 2004, NAT NEUROSCI, V7, P105, DOI 10.1038/nn1175; Klyachko NL, 2013, NANOMEDICINE LOND; KOLIATSOS VE, 1991, ANN NEUROL, V30, P831, DOI 10.1002/ana.410300613; Kroll RA, 1998, NEUROSURGERY, V42, P1083, DOI 10.1097/00006123-199805000-00082; Kuby J., 1994, IMMUNOLOGY; Lossinsky AS, 2004, HISTOL HISTOPATHOL, V19, P535, DOI 10.14670/HH-19.535; LOW WC, 1982, NATURE, V300, P260, DOI 10.1038/300260a0; Martinez-Serrano A, 1998, P NATL ACAD SCI USA, V95, P1858, DOI 10.1073/pnas.95.4.1858; MartinezSerrano A, 1996, EUR J NEUROSCI, V8, P727, DOI 10.1111/j.1460-9568.1996.tb01258.x; McLeod M, 2006, EUR J NEUROSCI, V24, P361, DOI 10.1111/j.1460-9568.2006.04919.x; Mogi M, 1999, NEUROSCI LETT, V270, P45, DOI 10.1016/S0304-3940(99)00463-2; Nolte-'t Hoen ENM, 2009, BLOOD, V113, P1977, DOI 10.1182/blood-2008-08-174094; Nutt JG, 2003, NEUROLOGY, V60, P69, DOI 10.1212/WNL.60.1.69; Papathanou M, 2011, EUR J NEUROSCI, V33, P2247, DOI 10.1111/j.1460-9568.2011.07704.x; PAWLOWSKI NA, 1988, J EXP MED, V168, P1865, DOI 10.1084/jem.168.5.1865; PERRY VH, 1995, CURR OPIN NEUROBIOL, V5, P636, DOI 10.1016/0959-4388(95)80069-7; Persidsky Y, 1999, AM J PATHOL, V155, P1599, DOI 10.1016/S0002-9440(10)65476-4; Pizzo DP, 2006, MOL THER, V13, P175, DOI 10.1016/j.ymthe.2005.08.001; Ramaswamy S, 2009, PROG BRAIN RES, V175, P201, DOI 10.1016/S0079-6123(09)17514-3; Rana S, 2012, INT J BIOCHEM CELL B, V44, P1574, DOI 10.1016/j.biocel.2012.06.018; Rozas G, 1997, BRAIN RES PROTOC, V2, P75, DOI 10.1016/S1385-299X(97)00034-2; SAUER H, 1994, NEUROSCIENCE, V59, P401, DOI 10.1016/0306-4522(94)90605-X; SHULTS CW, 1995, NEUROREPORT, V6, P1109, DOI 10.1097/00001756-199505300-00009; Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216; Suschek CV, 2004, CURR MOL MED, V4, P763, DOI 10.2174/1566524043359908; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Urayama A, 2004, P NATL ACAD SCI USA, V101, P12658, DOI 10.1073/pnas.0405042101; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang JY, 2003, VIROLOGY, V305, P66, DOI 10.1006/viro.2002.1690; Wang L, 2002, GENE THER, V9, P381, DOI 10.1038/sj.gt.3301682; Yasuda T, 2010, EXPERT REV NEUROTHER, V10, P915, DOI [10.1586/ern.10.55, 10.1586/ERN.10.55]; Yasuhara T, 2005, BRAIN RES, V1053, P10, DOI 10.1016/j.brainres.2005.05.027; Zhao Y., 2011, J NANOMED NANOTECH S, VS4; Zhao YL, 2011, NANOMEDICINE-UK, V6, P25, DOI [10.2217/nnm.10.129, 10.2217/NNM.10.129]; Zomer Anoek, 2010, Commun Integr Biol, V3, P447, DOI 10.4161/cib.3.5.12339	71	100	105	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e106867	10.1371/journal.pone.0106867	http://dx.doi.org/10.1371/journal.pone.0106867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229627	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900014
J	Cai, L; Han, XY; Qi, Z; Li, Z; Zhang, YM; Wang, PY; Liu, AP				Cai, Li; Han, Xiaoyan; Qi, Zhi; Li, Zhe; Zhang, Yumei; Wang, Peiyu; Liu, Aiping			Prevalence of Overweight and Obesity and Weight Loss Practice among Beijing Adults, 2011	PLOS ONE			English	Article							SELF-REPORTED WEIGHT; BODY-MASS INDEX; PHYSICAL-ACTIVITY; NATIONAL-HEALTH; UNITED-STATES; CHINA HEALTH; US ADULTS; WOMEN; AFFIRMATION; PERCEPTION	Objective: This study aims to determine the up-to-date prevalence of overweight and obesity, the distributions of body weight perception and weight loss practice in Beijing adults. Methods: A cross-sectional study was conducted in 2011. A total of 2563 men and 4088 women aged 18-79 years from the general population were included. Data were obtained from questionnaire and physical examination. Results: The prevalence of overweight (BMI 24-27.9 kg/m(2)) and obesity (BMI >= 28 kg/m(2)) was 42.1% and 20.3% in men and 35.6% and 17.1% in women, respectively. Age was inversely associated with overweight in both sexes, and obesity in women. Education level was negatively associated with overweight and obesity in women but not in men. Only 49.1% men and 58.3% women had a correct perception of their body weight. Underestimation of body weight was more common than overestimation, especially in men, the older people, and those with low education level. The percentage of taking action to lose weight was inversely associated with men and old age, and positively associated with higher education level, higher BMI, and self-perception as "fat" (OR = 3.78 in men, OR = 2.91 in women). Only 26.1% of overweight/obese individuals took action to lose weight. The top two weight loss practices were to reduce the amount of food intake and exercise. Conclusion: Overweight and obesity were highly prevalent with high incorrect body weight perceptions in the general adult population in Beijing. Weight loss practice was poor in overweight and obese individuals. Actions at multiple levels are needed to slow or control this overweight and obesity epidemic.	[Cai, Li; Zhang, Yumei] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Nutr & Food Hyg, Beijing 100871, Peoples R China; [Han, Xiaoyan; Qi, Zhi; Li, Zhe] Chaoyang Dist Ctr Dis Control & Prevent, Beijing, Peoples R China; [Wang, Peiyu; Liu, Aiping] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Social Med & Hlth Educ, Beijing 100871, Peoples R China; [Cai, Li] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China	Peking University; Peking University; Sun Yat Sen University	Liu, AP (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Social Med & Hlth Educ, Beijing 100871, Peoples R China.	apingliu@163.com	Cai, Li/AGZ-9127-2022; han, xiao/HDN-9782-2022	Cai, Li/0000-0002-8579-5986; 				Anderson LA, 2002, PREV MED, V35, P390, DOI 10.1006/pmed.2002.1079; Ball K, 2005, SOC SCI MED, V60, P1987, DOI 10.1016/j.socscimed.2004.08.056; Chang VW, 2003, AM J PREV MED, V24, P332, DOI 10.1016/S0749-3797(03)00020-5; Cheung Patrick C. H., 2007, Hong Kong Medical Journal, V13, P16; Crocker J, 2008, PSYCHOL SCI, V19, P740, DOI 10.1111/j.1467-9280.2008.02150.x; Du S, 2001, Wei Sheng Yan Jiu, V30, P221; Epton T, 2008, HEALTH PSYCHOL, V27, P746, DOI 10.1037/0278-6133.27.6.746; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gao RongTao, 2010, Chinese Journal of Prevention and Control of Chronic Diseases, V18, P454; Jaacks LM, 2013, INT J EPIDEMIOL, V42, P828, DOI 10.1093/ije/dyt052; Khang YH, 2010, J KOREAN MED SCI, V25, P1582, DOI 10.3346/jkms.2010.25.11.1582; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Liu AD, 2011, CHINESE J HLTH ED, V27, P167, DOI 10.16168/j.cnki. issn.1002-9982.2011.03.007; Liu YanJing, 2011, Disease Surveillance, V26, P377; Ma Guan-sheng, 2005, Zhonghua Yufang Yixue Zazhi, V39, P311; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Ng SW, 2009, SOC SCI MED, V68, P1305, DOI 10.1016/j.socscimed.2009.01.035; Nicolaou M, 2008, PUBLIC HEALTH NUTR, V11, P1332, DOI 10.1017/S1368980008002966; Pan WH, 2004, AM J CLIN NUTR, V79, P31; PASQUALI R, 1994, INT J OBESITY, V18, P614; Riley NM, 1998, AM J EPIDEMIOL, V148, P1062, DOI 10.1093/oxfordjournals.aje.a009583; Martin AR, 2008, APPETITE, V51, P266, DOI 10.1016/j.appet.2008.02.021; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; Sherman DK, 2002, CURR DIR PSYCHOL SCI, V11, P119, DOI 10.1111/1467-8721.00182; Sternfeld B, 2005, MED SCI SPORT EXER, V37, P1195, DOI 10.1249/01.mss.0000170083.41186.b1; Strauss RS, 1999, ARCH PEDIAT ADOL MED, V153, P741, DOI 10.1001/archpedi.153.7.741; Tang S, 2013, CHINESE HLTH NUTR, V9; Tsugane S, 2012, J GASTROEN HEPATOL, V27, P121, DOI 10.1111/j.1440-1746.2011.07021.x; Wang Shu-mei, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P1033; Weiss EC, 2006, AM J PREV MED, V31, P18, DOI 10.1016/j.amepre.2006.03.016; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323; Wu Y, 2005, CHINA PREVENTIVE MAG, V5, P316; Wu Y, 2009, CVD PREVENTION CONTR, V1, P19, DOI DOI 10.1016/J.CVDPC.2008.11.003; Yang Gong-huan, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P246; Zhou Beifan, 2002, Obes Rev, V3, P147, DOI 10.1046/j.1467-789X.2002.00068.x	35	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e98744	10.1371/journal.pone.0098744	http://dx.doi.org/10.1371/journal.pone.0098744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS5NP	25225884	Green Submitted, Green Published, gold			2022-12-25	WOS:000344317700001
J	Li, YQ; Wang, Z; Yu, T; Chen, BN; Zhang, JS; Huang, KZ; Huang, Z				Li, Yanqun; Wang, Zi; Yu, Ting; Chen, Bingni; Zhang, Jinshun; Huang, Kunzhao; Huang, Zhong			Increased Expression of IL-37 in Patients with Graves' Disease and Its Contribution to Suppression of Proinflammatory Cytokines Production in Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INTERFERON-GAMMA; FACTOR-ALPHA; SERUM INTERLEUKIN-6; THYROID-FUNCTION; RECEPTOR; MEMBERS; OPHTHALMOPATHY; IDENTIFICATION; POLYMORPHISMS	Background: Intreleukin-37 (IL-37), a member of IL-1 family, is primarily an anti-inflammatory cytokine, which reduces systemic and local inflammation. However, the expression and role of IL-37 in Graves' disease (GD) remains unknown. This study aims to measure the levels of serum and peripheral blood mononuclear cells (PBMCs) IL-37 in patients with Graves' disease and to examine its association with disease activity. Furthermore, we investigate the effect of IL-37 on proinflammatory cytokines involved in the pathogenesis of GD. Methods: The expressions of IL-37, TNF-alpha, IL-6, and IL-17 mRNA in peripheral blood mononuclear cells (PBMCs) of 40 patients with Graves' disease were determined by real-time reverse transcription-polymerase chain reaction (RT-PCR), and the levels of IL-37, TNF-alpha, IL-6, and IL-17 in serum were detected by enzyme-linked immunoassay (ELISA). The correlation of serum IL-37 levels with cytokines and disease activity in Graves' disease patients were investigated. The expressions of cytokines TNF-alpha, IL-6, and IL-17 in PBMCs under recombinant IL-37 stimulation were determined by RT-PCR and ELISA respectively. Results: The levels of IL-37, TNF-alpha, IL-6, and IL-17 in PBMCs and serum were significantly increased in patients with GD compared with healthy controls (HC). Serum IL-37 were closely correlated with TNF-alpha, IL-6, IL-17, thyrotropin (TSH), free thyroxine (FT4), free triiodothyronine (FT3) and thyrotropin receptor antibody (TRAB). GD patients with active disease showed higher IL-37 mRNA and serum protein levels compared with those with inactive disease as well as HC. Moreover, IL-37 suppressed the production of IL-6, IL-17 and TNF-alpha in PBMCs of patients with GD. Conclusions: Increased level of IL-37 in patients with GD are associated with TNF-alpha, IL-6, IL-17 and disease activity, and it plays a protective role against inflammatory effect in GD by inhibiting the production of proinflammatory cytokines. Thus, IL-37 may provide a novel research target for the pathogenesis and therapy of GD.	[Li, Yanqun; Wang, Zi; Yu, Ting; Chen, Bingni; Zhang, Jinshun; Huang, Kunzhao; Huang, Zhong] Shenzhen Univ, Sch Med, Biol Therapy Inst, Shenzhen, Peoples R China; [Li, Yanqun; Wang, Zi; Yu, Ting; Chen, Bingni; Zhang, Jinshun; Huang, Kunzhao; Huang, Zhong] Shenzhen Univ, Sch Med, Dept Pathogen Biol & Immunol, Shenzhen, Peoples R China; [Li, Yanqun; Wang, Zi; Yu, Ting; Chen, Bingni; Zhang, Jinshun; Huang, Kunzhao; Huang, Zhong] Shenzhen City Shenzhen Univ Immunodiagnost Techno, Shenzhen, Peoples R China	Shenzhen University; Shenzhen University	Huang, Z (corresponding author), Shenzhen Univ, Sch Med, Biol Therapy Inst, Shenzhen, Peoples R China.	zhuang809@126.com			National Natural Science Foundation of China [81273305]; Basic Research Program of Science and Technology Plan of Shenzhen [JC201005280578A]; Special Program of Construction National Innovative City of Shenzhen [301201003010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Program of Science and Technology Plan of Shenzhen; Special Program of Construction National Innovative City of Shenzhen	This work was supported by grants from the National Natural Science Foundation of China (No: 81273305), the Basic Research Program of Science and Technology Plan of Shenzhen (No: JC201005280578A), and the Special Program of Construction National Innovative City of Shenzhen (No: 301201003010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Al-Humaidi MA, 2000, SAUDI MED J, V21, P639; Ballak DB, 2013, CYTOKINE, V63, P245, DOI 10.1016/j.cyto.2013.06.015; BARTALENA L, 1993, J ENDOCRINOL INVEST, V16, P213, DOI 10.1007/BF03344951; BARTALENA L, 1994, J CLIN ENDOCR METAB, V78, P423, DOI 10.1210/jc.78.2.423; Bossowski A, 2001, J PEDIATR ENDOCR MET, V14, P741; Bufler P, 2004, BIOCHEM J, V381, P503, DOI 10.1042/BJ20040217; Bulau AM, 2011, THESCIENTIFICWORLDJO, V11, P2480, DOI 10.1100/2011/968479; BUSCEMA M, 1989, J CLIN ENDOCR METAB, V69, P433, DOI 10.1210/jcem-69-2-433; Busfield SJ, 2000, GENOMICS, V66, P213, DOI 10.1006/geno.2000.6184; Cawood TJ, 2006, EUR J ENDOCRINOL, V155, P395, DOI 10.1530/eje.1.02242; CELIK I, 1995, EUR J ENDOCRINOL, V132, P668, DOI 10.1530/eje.0.1320668; Davis PJ, 2008, CURR OPIN ENDOCRINOL, V15, P428, DOI 10.1097/MED.0b013e32830eba0e; Falgarone G, 2013, EUR J ENDOCRINOL, V168, pR13, DOI 10.1530/EJE-12-0539; FRANKLYN JA, 1994, NEW ENGL J MED, V330, P1731; Imaeda H, 2013, CLIN EXP IMMUNOL, V172, P410, DOI 10.1111/cei.12061; Kiziltunc A, 1999, TURK J MED SCI, V29, P25; Kumar S, 2000, J BIOL CHEM, V275, P10308, DOI 10.1074/jbc.275.14.10308; Lakatos P, 1997, J CLIN ENDOCR METAB, V82, P78, DOI 10.1210/jc.82.1.78; Li JR, 2013, CELL IMMUNOL, V281, P85, DOI 10.1016/j.cellimm.2013.02.002; Marshall W.J., 2008, CLIN CHEM, V6th ed; McNamee EN, 2011, P NATL ACAD SCI USA, V108, P16711, DOI 10.1073/pnas.1111982108; Monaco F., 2012, THYROID DIS; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Pan GH, 2001, CYTOKINE, V13, P1, DOI 10.1006/cyto.2000.0799; Papanicolaou D A, 2000, Rev Endocr Metab Disord, V1, P43; Peng Di, 2013, PLOS ONE, V8; Rapoport B, 1998, ENDOCR REV, V19, P673, DOI 10.1210/er.19.6.673; Sakai N, 2012, J GASTROEN HEPATOL, V27, P1609, DOI 10.1111/j.1440-1746.2012.07187.x; Salvi M, 1996, J CLIN ENDOCR METAB, V81, P2976, DOI 10.1210/jc.81.8.2976; Salvi M, 2000, EUR J ENDOCRINOL, V143, P197, DOI 10.1530/eje.0.1430197; SATO K, 1990, J CLIN ENDOCR METAB, V70, P1735, DOI 10.1210/jcem-70-6-1735; Shiau MY, 2007, CLIN BIOCHEM, V40, P213, DOI 10.1016/j.clinbiochem.2006.11.009; Siddiqi A, 1999, J CLIN ENDOCR METAB, V84, P435, DOI 10.1210/jc.84.2.435; Simmonds MJ, 2004, GENES IMMUN, V5, P267, DOI 10.1038/sj.gene.6364066; SMITH BR, 1988, ENDOCR REV, V9, P106, DOI 10.1210/edrv-9-1-106; Smith DE, 2000, J BIOL CHEM, V275, P1169, DOI 10.1074/jbc.275.2.1169; Taylor SL, 2002, GENOMICS, V79, P726, DOI 10.1006/geno.2002.6752; Teng X, 2014, J IMMUNOL, V22; Wan ZY, 2014, INT J CLIN EXP PATHO, V7, P656; WEETMAN AP, 1988, IMMUNOLOGY, V63, P285; Weetman AP, 2000, NEW ENGL J MED, V343, P1236, DOI 10.1056/NEJM200010263431707; Ye L, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-69	43	33	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107183	10.1371/journal.pone.0107183	http://dx.doi.org/10.1371/journal.pone.0107183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226272	Green Published, gold, Green Submitted			2022-12-25	WOS:000344317700035
J	Cesar, C; Shepherd, BE; Jenkins, CA; Ghidinelli, M; Castro, JL; Veloso, VG; Cortes, CP; Padgett, D; Crabtree-Ramirez, B; Gotuzzo, E; Fink, V; Duran, A; Sued, O; McGowan, CC; Cahn, P				Cesar, Carina; Shepherd, Bryan E.; Jenkins, Cathy A.; Ghidinelli, Massimo; Castro, Jose Luis; Veloso, Valdilea Goncalves; Cortes, Claudia P.; Padgett, Denis; Crabtree-Ramirez, Brenda; Gotuzzo, Eduardo; Fink, Valeria; Duran, Adriana; Sued, Omar; McGowan, Catherine C.; Cahn, Pedro		Caribbean Cent & South Amer Networ	Use of Third Line Antiretroviral Therapy in Latin America	PLOS ONE			English	Article							VIROLOGICAL FAILURE; MORTALITY; AFRICA; COHORT; AGE	Background: Access to highly active antiretroviral therapy (HAART) is expanding in Latin America. Many patients require second and third line therapy due to toxicity, tolerability, failure, or a combination of factors. The need for third line HAART, essential for program planning, is not known. Methods: Antiretroviral-naive patients >= 18 years who started first HAART after January 1, 2000 in Caribbean, Central and South America Network (CCASAnet) sites in Argentina, Brazil, Honduras, Mexico, and Peru were included. Clinical trials participants were excluded. Third line HAART was defined as use of darunavir, tipranavir, etravirine, enfuvirtide, maraviroc or raltegravir. Need for third line HAART was defined as virologic failure while on second line HAART. Results: Of 5853 HAART initiators followed for a median of 3.5 years, 310 (5.3%) failed a second line regimen and 44 (0.8%) received a third line regimen. Cumulative incidence of failing a 2nd or starting a 3rd line regimen was 2.7% and 6.0% three and five years after HAART initiation, respectively. Predictors at HAART initiation for failing a second or starting a third line included female sex (hazard ratio [HR] = 1.54, 95% confidence interval [CI] 1.18-2.00, p = 0.001), younger age (HR = 2.76 for 20 vs. 40 years, 95% CI 1.86-4.10, p<0.001), and prior AIDS (HR = 2.17, 95% CI 1.62-2.90, p<0.001). Conclusions: Third line regimens may be needed for at least 6% of patients in Latin America within 5 years of starting HAART, a substantial proportion given the large numbers of patients on HAART in the region. Improved accessibility to third line regimens is warranted.	[Cesar, Carina; Fink, Valeria; Sued, Omar; Cahn, Pedro] Fdn Huesped, Buenos Aires, DF, Argentina; [Shepherd, Bryan E.; Jenkins, Cathy A.; McGowan, Catherine C.] Vanderbilt Univ, Nashville, TN 37235 USA; [Ghidinelli, Massimo; Castro, Jose Luis] Pan Amer Hlth Org, Washington, DC USA; [Veloso, Valdilea Goncalves] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Cortes, Claudia P.] Univ Chile, Santiago, Chile; [Padgett, Denis] Inst Hondureno Seguridad Social, Tegucigalpa, Honduras; [Padgett, Denis] Hosp Escuela Tegucigalpa, Tegucigalpa, Honduras; [Crabtree-Ramirez, Brenda] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Gotuzzo, Eduardo] Inst Med Trop Alexander Von Humboldt, Lima, Peru; [Duran, Adriana] Minist Salud Ciudad Autonoma Buenos Aires, Coordinac Sida, Buenos Aires, DF, Argentina	Vanderbilt University; Pan American Health Organization; Fundacao Oswaldo Cruz; Universidad de Chile; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Peruana Cayetano Heredia	Cesar, C (corresponding author), Fdn Huesped, Buenos Aires, DF, Argentina.	carina.cesar@huesped.org.ar	Cortes, Claudia P/AAF-7326-2020; Sued, Omar/H-3325-2019; Cesar, Carina/H-2831-2019	Cortes, Claudia P/0000-0001-9101-9783; Sued, Omar/0000-0001-5818-770X; Crabtree-Ramirez, Brenda/0000-0002-2587-1123	National Institute of Allergy and Infectious Diseases (NIAID), International Epidemiologic Databases to Evaluate AIDS (IeDEA) [U01 AI069923]; FOGARTY INTERNATIONAL CENTER [D43TW009763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069923] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID), International Epidemiologic Databases to Evaluate AIDS (IeDEA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID) as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA): U01 AI069923. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajose O, 2012, AIDS, V26, P929, DOI 10.1097/QAD.0b013e328351f5b2; Alave J, 2013, REV CHIL INFECTOL, V30, P42, DOI 10.4067/S0716-10182013000100006; [Anonymous], 2013, PAIS AM PODR ADQ INS; [Anonymous], 2013, WHO REPORT PARTNERSH; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Caseiro MM, 2008, BRAZ J INFECT DIS, V12, P162, DOI 10.1590/S1413-86702008000300001; Cesar C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010490; Crabtree-Ramirez B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020272; Fox MP, 2010, JAIDS-J ACQ IMM DEF, V53, P500, DOI 10.1097/QAI.0b013e3181bcdac1; Greenbaum AH, 2008, AIDS, V22, P2331, DOI 10.1097/QAD.0b013e32831883f9; Keiser O, 2010, TROP MED INT HEALTH, V15, P251, DOI 10.1111/j.1365-3156.2009.02445.x; Kumarasamy N, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P71, DOI 10.1177/1545109710382780; McGowan CC, 2007, INT J EPIDEMIOL, V36, P969, DOI 10.1093/ije/dym073; Nagles J, 2007, MED UPB, V26, P109; PAHO/WHO, 2013, ANT TREATM SPOTL PUB; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Pujades-Rodriguez M, 2010, JAMA-J AM MED ASSOC, V304, P303, DOI 10.1001/jama.2010.980; Silverberg MJ, 2007, ARCH INTERN MED, V167, P684, DOI 10.1001/archinte.167.7.684; Siripassorn K, 2010, AIDS RES HUM RETROV, V26, P139, DOI 10.1089/aid.2009.0125; Tuboi SH, 2009, JAIDS-J ACQ IMM DEF, V51, P615, DOI 10.1097/QAI.0b013e3181a44f0a; *UNAIDS WHO, 2003, AIDS EP UPD; Win May Myat, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P57, DOI 10.1177/1545109710387301	22	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e106887	10.1371/journal.pone.0106887	http://dx.doi.org/10.1371/journal.pone.0106887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25221931	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774800031
J	Hustoft, HK; Vehus, T; Brandtzaeg, OK; Krauss, S; Greibrokk, T; Wilson, SR; Lundanes, E				Hustoft, Hanne Kolsrud; Vehus, Tore; Brandtzaeg, Ole Kristian; Krauss, Stefan; Greibrokk, Tyge; Wilson, Steven Ray; Lundanes, Elsa			Open Tubular Lab-On-Column/Mass Spectrometry for Targeted Proteomics of Nanogram Sample Amounts	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; PROTEIN EXPRESSION; TRYPSIN REACTOR; ENZYME REACTOR; ONLINE; DIGESTION; APC; QUANTIFICATION; GENE	A novel open tubular nanoproteomic platform featuring accelerated on-line protein digestion and high-resolution nano liquid chromatography mass spectrometry (LC-MS) has been developed. The platform features very narrow open tubular columns, and is hence particularly suited for limited sample amounts. For enzymatic digestion of proteins, samples are passed through a 20 mu m inner diameter (ID) trypsin + endoproteinase Lys-C immobilized open tubular enzyme reactor (OTER). Resulting peptides are subsequently trapped on a monolithic pre-column and transferred on-line to a 10 mu m ID porous layer open tubular (PLOT) liquid chromatography LC separation column. Wnt/B-catenein signaling pathway (Wnt-pathway) proteins of potentially diagnostic value were digested+detected in targeted-MS/MS mode in small cell samples and tumor tissues within 120 minutes. For example, a potential biomarker Axin1 was identifiable in just 10 ng of sample (protein extract of similar to 1,000 HCT15 colon cancer cells). In comprehensive mode, the current OTER-PLOT set-up could be used to identify approximately 1500 proteins in HCT15 cells using a relatively short digestion+detection cycle (240 minutes), outperforming previously reported on-line digestion/separation systems. The platform is fully automated utilizing common commercial instrumentation and parts, while the reactor and columns are simple to produce and have low carry-over. These initial results point to automated solutions for fast and very sensitive MS based proteomics, especially for samples of limited size.	[Hustoft, Hanne Kolsrud; Vehus, Tore; Brandtzaeg, Ole Kristian; Greibrokk, Tyge; Wilson, Steven Ray; Lundanes, Elsa] Univ Oslo, Dept Chem, Oslo, Norway; [Krauss, Stefan] Oslo Univ Hosp, Canc Stem Cell Innovat Ctr, Unit Cell Signaling, Oslo, Norway	University of Oslo; University of Oslo	Vehus, T (corresponding author), Univ Oslo, Dept Chem, Oslo, Norway.	toreveh@mn.uio.no	wilson, steven/D-6614-2012	wilson, steven/0000-0002-9755-1188; Krauss, Stefan/0000-0001-6992-8091	University of Oslo; SFI-CAST; Norwegian Research Council	University of Oslo; SFI-CAST; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was funded by the University of Oslo, SFI-CAST and the Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele S, 2010, ANALYST, V135, P477, DOI 10.1039/b920789a; Aebersold R, 2013, MOL CELL PROTEOMICS, V12, P2381, DOI 10.1074/mcp.E113.031658; AMANKWA LN, 1992, ANAL CHEM, V64, P1610, DOI 10.1021/ac00038a019; Azkargorta M, 2014, J PROTEOME RES; Chen C, 2014, J PROTEOME RES, V13, P1969, DOI 10.1021/pr4010986; Compton C, 2014, OE, V13, P13; Cooperberg MR, 2013, J CLIN ONCOL, V31, P1428, DOI 10.1200/JCO.2012.46.4396; D'Aguanno S, 2014, J PROTEOME RES, V13, P2120, DOI 10.1021/pr4012574; Fekete S, 2013, ULTRA-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY AND ITS APPLICATIONS, P133; Gallien S, 2012, MOL CELL PROTEOMICS, V11, P1709, DOI 10.1074/mcp.O112.019802; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Henderson BR, 2002, EMBO REP, V3, P834, DOI 10.1093/embo-reports/kvf181; Hu JW, 2012, CHEM J CHINESE U, V33, P268; Huang T, 2006, J SEP SCI, V29, P277, DOI 10.1002/jssc.200500317; Hustoft HK, 2013, SCI REP-UK, V3, DOI 10.1038/srep03511; Jiang H, 2012, J CHROMATOGR A, V1246, P111, DOI 10.1016/j.chroma.2012.03.014; Kim JH, 2013, ANAL CHEM, V85, P8039, DOI 10.1021/ac401477w; Kocher T, 2014, PROTEOMICS; Koomen JM, 2008, MOL CELL PROTEOMICS, V7, P1780, DOI 10.1074/mcp.R800002-MCP200; Lau T, 2013, CANCER RES, V73, P3132, DOI 10.1158/0008-5472.CAN-12-4562; Leung F, 2013, TRANS PROTEOMICS, V1, P74, DOI DOI 10.1016/J.TRPR0T.2013.08.001; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; LICKLIDER L, 1994, ANAL CHEM, V66, P4400, DOI 10.1021/ac00096a003; Luo QZ, 2008, ELECTROPHORESIS, V29, P1604, DOI 10.1002/elps.200700741; Luo Q, 2007, ANAL CHEM, V79, P6174, DOI 10.1021/ac070583w; Lv DW, 2014, J PROTEOME RES; Maak M, 2013, ANN SURG, V257, P1053, DOI 10.1097/SLA.0b013e31827c1180; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Massolini G, 2005, J SEP SCI, V28, P7, DOI 10.1002/jssc.200401941; Mayne J, 2014, ANAL CHEM, V86, P176, DOI 10.1021/ac403551f; MIYAKI M, 1994, CANCER RES, V54, P3011; Musunuri S, 2014, J PROTEOME RES, V13, P2056, DOI 10.1021/pr401202d; Nasir A, 2011, ANTICANCER RES, V31, P2191; Neufeld KL, 2000, EMBO REP, V1, P519; Nilsson T, 2010, NAT METHODS, V7, P681, DOI 10.1038/nmeth0910-681; Nolte H, 2014, J PROTEOME RES, V13, P2162, DOI 10.1021/pr5000335; Nunez O, 2008, J CHROMATOGR A, V1191, P231, DOI 10.1016/j.chroma.2008.02.029; Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]; Pires SD, 2014, J PROTEOME RES, V13, P1860, DOI 10.1021/pr400923g; Poschmann G, 2014, J PROTEOME RES; Promega, 2014, TRYPS LYS C MIX; Rogeberg M, 2013, J SEP SCI, V36, P2838, DOI 10.1002/jssc.201300499; Rogeberg M, 2010, J CHROMATOGR A, V1217, P2782, DOI 10.1016/j.chroma.2010.02.025; Safdar M, 2014, J CHROMATOGR A, V1324, P1, DOI 10.1016/j.chroma.2013.11.045; Schappler J, 2013, ULTRA-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY AND ITS APPLICATIONS, P95; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Serafino A, 2014, ONCOTARGET, V5, P978, DOI 10.18632/oncotarget.1571; Spross J, 2013, ANAL BIOANAL CHEM, V405, P2163, DOI 10.1007/s00216-012-6057-9; Stigter ECA, 2007, ANAL BIOANAL CHEM, V389, P1967, DOI 10.1007/s00216-007-1584-5; Sun LL, 2012, ANAL CHEM, V84, P8715, DOI 10.1021/ac3019608; Svec F, 2004, J SEP SCI, V27, P747, DOI 10.1002/jssc.200401721; Sveen A, 2012, CLIN CANCER RES, V18, P6001, DOI 10.1158/1078-0432.CCR-11-3302; Thakur D, 2011, J CHROMATOGR A, V1218, P8168, DOI 10.1016/j.chroma.2011.09.022; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Wang TT, 2011, ELECTROPHORESIS, V32, P2848, DOI 10.1002/elps.201100030; Xie F, 2011, J BIOL CHEM, V286, P25443, DOI 10.1074/jbc.R110.199703; Yamaguchi H, 2013, PROTEOMICS, V13, P457, DOI 10.1002/pmic.201200272; Yue GH, 2007, ANAL CHEM, V79, P938, DOI 10.1021/ac061411m; Zhao X, 2014, J PROTEOME RES; Zhao XL, 2014, J PROTEOME RES, V13, P2175, DOI 10.1021/pr500040a	61	29	29	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e106881	10.1371/journal.pone.0106881	http://dx.doi.org/10.1371/journal.pone.0106881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222838	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774800030
J	Landi, M; Dimech, M; Arculeo, M; Biondo, G; Martins, R; Carneiro, M; Carvalho, GR; Lo Brutto, S; Costa, FO				Landi, Monica; Dimech, Mark; Arculeo, Marco; Biondo, Girolama; Martins, Rogelia; Carneiro, Miguel; Carvalho, Gary Robert; Lo Brutto, Sabrina; Costa, Filipe O.			DNA Barcoding for Species Assignment: The Case of Mediterranean Marine Fishes	PLOS ONE			English	Article							IDENTIFICATION; PERCIFORMES; ATLANTIC; REVEALS; DIVERSIFICATION; DIVERGENCE; PROSPECTS; INSIGHTS; PISCES	Background: DNA barcoding enhances the prospects for species-level identifications globally using a standardized and authenticated DNA-based approach. Reference libraries comprising validated DNA barcodes (COI) constitute robust datasets for testing query sequences, providing considerable utility to identify marine fish and other organisms. Here we test the feasibility of using DNA barcoding to assign species to tissue samples from fish collected in the central Mediterranean Sea, a major contributor to the European marine ichthyofaunal diversity. Methodology/Principal Findings: A dataset of 1278 DNA barcodes, representing 218 marine fish species, was used to test the utility of DNA barcodes to assign species from query sequences. We tested query sequences against 1) a reference library of ranked DNA barcodes from the neighbouring North East Atlantic, and 2) the public databases BOLD and GenBank. In the first case, a reference library comprising DNA barcodes with reliability grades for 146 fish species was used as diagnostic dataset to screen 486 query DNA sequences from fish specimens collected in the central basin of the Mediterranean Sea. Of all query sequences suitable for comparisons 98% were unambiguously confirmed through complete match with reference DNA barcodes. In the second case, it was possible to assign species to 83% (BOLD-IDS) and 72% (GenBank) of the sequences from the Mediterranean. Relatively high intraspecific genetic distances were found in 7 species (2.2%-18.74%), most of them of high commercial relevance, suggesting possible cryptic species. Conclusion/Significance: We emphasize the discriminatory power of COI barcodes and their application to cases requiring species level resolution starting from query sequences. Results highlight the value of public reference libraries of reliability grade-annotated DNA barcodes, to identify species from different geographical origins. The ability to assign species with high precision from DNA samples of disparate quality and origin has major utility in several fields, from fisheries and conservation programs to control of fish products authenticity.	[Landi, Monica; Costa, Filipe O.] Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal; [Dimech, Mark] MCFS, Ft San Lucjan Marsaxlokk, Malta; [Arculeo, Marco; Biondo, Girolama; Lo Brutto, Sabrina] Univ Palermo, Dipartimento Sci & Tecnol Biol Chim Farmaceut STE, Palermo, Italy; [Martins, Rogelia; Carneiro, Miguel] Inst Portugues Mar & Atmosfera, Modelling & Management Fishery Resources Div DIV, Lisbon, Portugal; [Carvalho, Gary Robert] Bangor Univ, Sch Biol Sci, Mol Ecol & Fisheries Genet Lab, Bangor, Gwynedd, Wales	Universidade do Minho; University of Palermo; Instituto Portugues do Mar e da Atmosfera; Bangor University	Landi, M (corresponding author), Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal.	mlandi@bio.uminho.pt	Lo Brutto, Sabrina/G-4322-2010; Landi, Monica/J-3611-2012; Costa, Filipe/B-5890-2009; Costa, Filipe/M-9623-2019; Costa, Filipe/GSD-2439-2022	Lo Brutto, Sabrina/0000-0002-9964-904X; Landi, Monica/0000-0003-2180-5062; Costa, Filipe/0000-0001-5398-3942; Costa, Filipe/0000-0001-5398-3942; Martins, Rogelia/0000-0002-6273-8372	Fondi di Ateneo ex 60% Universita di Palermo; FEDER through POFCCOMPETE; Fundacaopara a Ciencia e a Tecnologia (FCT) [FCOMP-01-0124-FEDER-010596, PEst-OE/BIA/UI4050/2014]; Fundacaopara a Ciencia e a Tecnologia [SFRH/BPD/45246/2008]	Fondi di Ateneo ex 60% Universita di Palermo; FEDER through POFCCOMPETE; Fundacaopara a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacaopara a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	Research carried out at University of Palermo was supported by "Fondi di Ateneo ex 60% Universita di Palermo". This work was supported by FEDER through POFCCOMPETE and by national funds from "Fundacaopara a Ciencia e a Tecnologia (FCT)" in the scope of the grants, FCOMP-01-0124-FEDER-010596 and PEst-OE/BIA/UI4050/2014. ML's work was supported by the fellowship Ref: SFRH/BPD/45246/2008 from Fundacaopara a Ciencia e a Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Aurelle D, 2003, CR BIOL, V326, P771, DOI 10.1016/j.crvi.2003.08.001; Azzurro E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024885; Barbuto M, 2010, FOOD RES INT, V43, P376, DOI 10.1016/j.foodres.2009.10.009; Bauchot M. L., 1987, GCPINT422EEC FAO, V2, P761; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Cannas R, 2010, MAR BIOL RES, V6, P341, DOI 10.1080/17451000903428496; Cardenas L, 2005, MOL PHYLOGENET EVOL, V35, P496, DOI 10.1016/j.ympev.2005.01.011; Carneiro M, 2014, EUR J TAXON, V73, P1, DOI 10.5852/ejt.2014.73; Cerutti-Pereyra F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036479; COLL M, 2010, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0011842; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Costa F. O., 2012, NATURAL RESOURCES SU, V37-68, DOI [10.1007/978-94-007-1321-5_4, DOI 10.1007/978-94-007-1321-5_4]; Costa FO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035858; Costa FO, 2010, THEOR BIOSCI, V129, P149, DOI 10.1007/s12064-010-0091-y; COSTA FO, 2007, GENOMICS SOC POLICY, V3, P29, DOI DOI 10.1186/1746-5354-3-2-29; FAO, 2003, 435 FAO; FAO, 2003, FAO TECHN GUID RESP, V4; Guillemaud T, 2000, J MAR BIOL ASSOC UK, V80, P929, DOI 10.1017/S0025315400002915; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Handy SM, 2011, J AOAC INT, V94, P201; Hanner R, 2011, MITOCHONDR DNA, V22, P27, DOI 10.3109/19401736.2011.596833; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Iglesias SP, 2010, AQUAT CONSERV, V20, P319, DOI 10.1002/aqc.1083; Imsiridou A, 2011, J FISH BIOL, V78, P373, DOI 10.1111/j.1095-8649.2010.02858.x; Jaafar TNAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049623; Joly S, 2014, MOL ECOL RESOUR, V14, P221, DOI 10.1111/1755-0998.12173; Kazancioglu E, 2009, P ROY SOC B-BIOL SCI, V276, P3439, DOI 10.1098/rspb.2009.0876; Keskin E, 2013, MOL ECOL RESOUR, V13, P788, DOI 10.1111/1755-0998.12120; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knebelsberger T, 2014, MOL ECOL RESOUR, V14, P1060, DOI 10.1111/1755-0998.12238; Kochzius M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012620; Lago FC, 2012, FOOD CONTROL, V24, P38, DOI 10.1016/j.foodcont.2011.08.034; Lo Brutto S, 2011, CHEM ECOL, V27, P107, DOI 10.1080/02757540.2010.547486; Maggio T, 2009, ICES J MAR SCI, V66, P1883, DOI 10.1093/icesjms/fsp160; Martins Rogelia, 2012, Marine Biodiversity Records, V5, pe30, DOI 10.1017/S1755267211000522; McCusker MR, 2013, MOL ECOL RESOUR, V13, P177, DOI 10.1111/1755-0998.12043; Mejri R, 2011, MOL PHYLOGENET EVOL, V58, P395, DOI 10.1016/j.ympev.2010.12.001; Mejri R, 2009, MOL PHYLOGENET EVOL, V53, P596, DOI 10.1016/j.ympev.2009.04.018; Ordines F, 2012, ACTA ICHTHYOL PISCAT, V42, P21, DOI 10.3750/AIP2011.42.1.03; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Plan Bleu, 2009, UNEP MAP PLAN BLEU S; Rasmussen RS, 2008, COMPR REV FOOD SCI F, V7, P280, DOI 10.1111/j.1541-4337.2008.00046.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Steinke D, 2011, MITOCHONDR DNA, V22, P10, DOI 10.3109/19401736.2010.536538; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tortonese E, 1970, FAUNA ITALIA; Tortonese E, 1975, FAUNA ITALIA, VXI; Tortonese E, 1956, FAUNA ITALIA, VII; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, AQUAT BIOL, V3, P71, DOI 10.3354/ab00068; Ward Robert D, 2012, Methods Mol Biol, V858, P423, DOI 10.1007/978-1-61779-591-6_21; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Whitehead P. J. P., 1984, FISHES NE ATLANTIC M; Yamanoue Y, 2007, MOL PHYLOGENET EVOL, V45, P89, DOI 10.1016/j.ympev.2007.03.008; Zemlak TS, 2009, MOL ECOL RESOUR, V9, P237, DOI 10.1111/j.1755-0998.2009.02649.x	59	79	80	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e106135	10.1371/journal.pone.0106135	http://dx.doi.org/10.1371/journal.pone.0106135			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222272	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774800011
J	Nishiyama, MY; Ferreira, SS; Tang, PZ; Becker, S; Portner-Taliana, A; Souza, GM				Nishiyama, Milton Yutaka, Jr.; Ferreira, Savio Siqueira; Tang, Pei-Zhong; Becker, Scott; Poertner-Taliana, Antje; Souza, Glaucia Mendes			Full-Length Enriched cDNA Libraries and ORFeome Analysis of Sugarcane Hybrid and Ancestor Genotypes	PLOS ONE			English	Article							NATURAL ANTISENSE TRANSCRIPTS; EXPRESSED SEQUENCE TAG; GENOME STRUCTURE; GENE-EXPRESSION; MATURING STEM; IDENTIFICATION; ANNOTATION; SACCHARUM; REVEALS; SENSE	Sugarcane is a major crop used for food and bioenergy production. Modern cultivars are hybrids derived from crosses between Saccharum officinarum and Saccharum spontaneum. Hybrid cultivars combine favorable characteristics from ancestral species and contain a genome that is highly polyploid and aneuploid, containing 100-130 chromosomes. These complex genomes represent a huge challenge for molecular studies and for the development of biotechnological tools that can facilitate sugarcane improvement. Here, we describe full-length enriched cDNA libraries for Saccharum officinarum, Saccharum spontaneum, and one hybrid genotype (SP803280) and analyze the set of open reading frames (ORFs) in their genomes (i.e., their ORFeomes). We found 38,195 (19%) sugarcane-specific transcripts that did not match transcripts from other databases. Less than 1.6% of all transcripts were ancestor-specific (i.e., not expressed in SP803280). We also found 78,008 putative new sugarcane transcripts that were absent in the largest sugarcane expressed sequence tag database (SUCEST). Functional annotation showed a high frequency of protein kinases and stress-related proteins. We also detected natural antisense transcript expression, which mapped to 94% of all plant KEGG pathways; however, each genotype showed different pathways enriched in antisense transcripts. Our data appeared to cover 53.2% (17,563 genes) and 46.8% (937 transcription factors) of all sugarcane full-length genes and transcription factors, respectively. This work represents a significant advancement in defining the sugarcane ORFeome and will be useful for protein characterization, single nucleotide polymorphism and splicing variant identification, evolutionary and comparative studies, and sugarcane genome assembly and annotation.	[Nishiyama, Milton Yutaka, Jr.; Ferreira, Savio Siqueira; Souza, Glaucia Mendes] Univ Sao Paulo, Dept Bioquim, Sao Paulo, Brazil; [Tang, Pei-Zhong; Becker, Scott; Poertner-Taliana, Antje] ThermoFisher Sci, Carlsbad, CA USA	Universidade de Sao Paulo	Souza, GM (corresponding author), Univ Sao Paulo, Dept Bioquim, Sao Paulo, Brazil.	glmsouza@iq.usp.br	Nishiyama, Milton Y/H-4002-2013; Souza, Glaucia/E-6780-2012; Nishiyama, Milton/AAE-5736-2021; Ferreira, Savio S/N-3639-2014	Nishiyama, Milton Y/0000-0002-2410-0562; Souza, Glaucia/0000-0001-6903-9913; Nishiyama, Milton/0000-0002-2410-0562; Ferreira, Savio S/0000-0001-9926-9066	CNPq; CAPES; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) under the FAPESP Bioenergy Research Program BIOEN [08/52146-0]; Thermo Fisher Scientific	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) under the FAPESP Bioenergy Research Program BIOEN(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Thermo Fisher Scientific	Dr. SSF was recipient of a CNPq Fellowship, MYNJ is recipient of a CAPES Fellowship. Dr. GMS is the recipient of a CNPq Productivity Fellowship. This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) under the FAPESP Bioenergy Research Program BIOEN (project number 08/52146-0). Co-author Pei-zhong Tang is an employee of Thermo Fisher Scientific. Co-authors Antje Taliana and Scott Backer were employees of Life Technologies (now Thermo Fisher Scientific). Thermo Fisher Scientific provided support in the form of salaries for authors PZ, AT and SB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alexandrov NN, 2006, PLANT MOL BIOL, V60, P69, DOI 10.1007/s11103-005-2564-9; Amorim HV, 2011, APPL MICROBIOL BIOT, V91, P1267, DOI 10.1007/s00253-011-3437-6; Aoki K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-210; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basnayake J, 2012, J EXP BOT, V63, P6023, DOI 10.1093/jxb/ers251; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Berkman PJ, 2014, TROP PLANT BIOL, V7, P71, DOI 10.1007/s12042-014-9139-3; Cardoso-Silva CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088462; Casu R. E., 2010, Genetics, genomics and breeding of sugarcane, P229; Casu RE, 2004, PLANT MOL BIOL, V54, P503, DOI 10.1023/B:PLAN.0000038255.96128.41; Casu RE, 2003, PLANT MOL BIOL, V52, P371, DOI 10.1023/A:1023957214644; Casu RE, 2007, FUNCT INTEGR GENOMIC, V7, P153, DOI 10.1007/s10142-006-0038-z; Charrad M, 2013, PACKAGE NBCLUST; Conley AB, 2012, NUCLEIC ACIDS RES, V40, P1438, DOI 10.1093/nar/gkr1010; Costet L, 2012, THEOR APPL GENET, V125, P825, DOI 10.1007/s00122-012-1875-x; D'Hont A, 2005, CYTOGENET GENOME RES, V109, P27, DOI 10.1159/000082378; D'Hont Angelique, 2008, V1, P483; de Setta N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-540; De Souza AP, 2008, PLANT CELL ENVIRON, V31, P1116, DOI 10.1111/j.1365-3040.2008.01822.x; DHont A, 1996, MOL GEN GENET, V250, P405, DOI [10.1007/BF02174028, 10.1007/s004380050092]; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Ferreira SD, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-210; Garcia AAF, 2013, SCI REP-UK, V3, DOI 10.1038/srep03399; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Henz SR, 2007, PLANT PHYSIOL, V144, P1247, DOI 10.1104/pp.107.100396; Hotta CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071847; Irvine JE, 1999, THEOR APPL GENET, V98, P186, DOI 10.1007/s001220051057; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jannoo N, 2007, PLANT J, V50, P574, DOI 10.1111/j.1365-313X.2007.03082.x; Jia JP, 2006, PLANT J, V48, P710, DOI 10.1111/j.1365-313X.2006.02905.x; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kiyosawa H, 2005, GENOME RES, V15, P463, DOI 10.1101/gr.3155905; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lapidot M, 2006, EMBO REP, V7, P1216, DOI 10.1038/sj.embor.7400857; Lembke CG, 2012, PLANT MOL BIOL, V79, P461, DOI 10.1007/s11103-012-9922-1; Liu SK, 2013, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-595; Ma J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r22; Manners J. M., 2011, Tropical Plant Biology, V4, P9, DOI 10.1007/s12042-011-9066-5; Marconi Thiago G, 2011, BMC Res Notes, V4, P264, DOI 10.1186/1756-0500-4-264; Menossi M, 2008, Int J Plant Genomics, V2008, P458732, DOI 10.1155/2008/458732; Ming R, 2006, PL BRED RE, V27, P15; Mochida K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075265; MOORE PH, 1995, AUST J PLANT PHYSIOL, V22, P661, DOI 10.1071/PP9950661; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2010, GENOME RES, V20, P1740, DOI 10.1101/gr.111021.110; Nishiyama-Jr MY, 2013, GENOMICS SACCHARINAE, P121; Nogueira FTS, 2003, PLANT PHYSIOL, V132, P1811, DOI 10.1104/pp.102.017483; Palhares AC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-51; Papini-Terzi FS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-120; Papini-Terzi FS, 2005, DNA RES, V12, P27, DOI 10.1093/dnares/12.1.27; Pastina MM, 2012, THEOR APPL GENET, V124, P835, DOI 10.1007/s00122-011-1748-8; Paterson AH., 2013, GENOMICS SACCHARINAE, P43, DOI [DOI 10.1007/978-1-4419-5947-8_3, 10.1007/978-1-4419-5947-8_3]; Ralph SG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-57; Rocha FR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-71; Salehi-Ashtiani K, 2009, GENOME RES, V19, P2334, DOI 10.1101/gr.098640.109; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sticklen MB, 2008, NAT REV GENET, V9, P433, DOI 10.1038/nrg2336; Thomas S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094650; Tilgner H, 2014, P NATL ACAD SCI USA, V111, P9869, DOI 10.1073/pnas.1400447111; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Vettore AL, 2003, GENOME RES, V13, P2725, DOI 10.1101/gr.1532103; Vettore AL, 2001, GENET MOL BIOL, V24, P1, DOI 10.1590/S1415-47572001000100002; Wang H, 2014, GENOME RES; Wei XM, 2010, GENOME, V53, P973, DOI 10.1139/G10-050; Xue W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-604; Yilmaz A, 2009, PLANT PHYSIOL, V149, P171, DOI 10.1104/pp.108.128579; Yu X, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-208; Zhang JS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-314; Zhou Xiaofan, 2008, Plant Biology (Rockville), V2008, P70	72	20	23	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107351	10.1371/journal.pone.0107351	http://dx.doi.org/10.1371/journal.pone.0107351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222706	Green Submitted, gold, Green Published			2022-12-25	WOS:000341774800061
J	Xu, C; Zhang, X; Qian, Y; Chen, XX; Liu, R; Zeng, GH; Zhao, H; Fang, WG				Xu, Chuan; Zhang, Xing; Qian, Ying; Chen, Xiaoxuan; Liu, Ran; Zeng, Guohong; Zhao, Hong; Fang, Weiguo			A High-Throughput Gene Disruption Methodology for the Entomopathogenic Fungus Metarhizium robertsii	PLOS ONE			English	Article							FILAMENTOUS FUNGI; ANISOPLIAE; VIRULENCE; PROTEIN; STRAINS	Systematic gene disruption is a direct way to interrogate a fungal genome to functionally characterize the full suite of genes involved in various biological processes. Metarhizium robertsii is extraordinarily versatile, and it is a pathogen of arthropods, a saprophyte and a beneficial colonizer of rhizospheres. Thus, M. robertsii can be used as a representative to simultaneously study several major lifestyles that are not shared by the "model'' fungi Saccharomyces cerevisiae and Neurospora crassa; a systematic genetic analysis of M. robertsii will benefit studies in other fungi. In order to systematically disrupt genes in M. robertsii, we developed a high-throughput gene disruption methodology, which includes two technologies. One is the modified OSCAR-based, high-throughput construction of gene disruption plasmids. This technology involves two donor plasmids (pA-Bar-OSCAR with the herbicide resistance genes Bar and pA-Sur-OSCAR with another herbicide resistance gene Sur) and a recipient binary plasmid pPK2-OSCAR-GFP that was produced by replacing the Bar cassette in pPK2-bar-GFP with a ccdB cassette and recombination recognition sites. Using this technology, a gene disruption plasmid can be constructed in one cloning step in two days. The other is a highly efficient gene disruption technology based on homologous recombination using a Ku70 deletion mutant (Delta MrKu70) as the recipient strain. The deletion of MrKu70, a gene encoding a key component involved in nonhomologous end-joining DNA repair in fungi, dramatically increases the gene disruption efficiency. The frequency of disrupting the conidiation-associated gene Cag8 in Delta MrKu70 was 93% compared to 7% in the wild-type strain. Since Delta MrKu70 is not different from the wild-type strain in development, pathogenicity and tolerance to various abiotic stresses, it can be used as a recipient strain for a systematic gene disruption project to characterize the whole suite of genes involved in the biological processes of M. robertsii.	[Xu, Chuan; Zhang, Xing; Qian, Ying; Chen, Xiaoxuan; Liu, Ran; Zeng, Guohong; Zhao, Hong; Fang, Weiguo] Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Fang, WG (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China.	wfang1@zju.edu.cn	Fang, Weiguo/G-6680-2012	Fang, Weiguo/0000-0002-8431-8256	National Natural Science Foundation of China [31272097]; Zhejiang Provincial Natural Science Foundation of China [LR13C010001]; "1000 Young Talents Program of China''	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); "1000 Young Talents Program of China''	This work was funded by the National Natural Science Foundation of China (31272097) and Zhejiang Provincial Natural Science Foundation of China (LR13C010001) and "1000 Young Talents Program of China'' to W.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidochka MJ, 2001, APPL ENVIRON MICROB, V67, P1335, DOI 10.1128/AEM.67.3.1335-1342.2001; Carvalho NDSP, 2010, APPL MICROBIOL BIOT, V87, P1463, DOI 10.1007/s00253-010-2588-1; Catalano V, 2011, CURR GENET, V57, P13, DOI 10.1007/s00294-010-0322-2; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; Fang WG, 2007, MICROBIOL-SGM, V153, P1017, DOI 10.1099/mic.0.2006/002105-0; Fang WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043069; Fang WG, 2010, PLANT PHYSIOL, V154, P1549, DOI 10.1104/pp.110.163014; Fang WG, 2010, ENVIRON MICROBIOL, V12, P810, DOI 10.1111/j.1462-2920.2009.02127.x; Fang WG, 2009, J INVERTEBR PATHOL, V102, P155, DOI 10.1016/j.jip.2009.07.013; Fang W, 2009, FUNGAL GENET BIOL, V46, P277, DOI 10.1016/j.fgb.2008.12.001; Fang WG, 2004, J INVERTEBR PATHOL, V85, P18, DOI 10.1016/j.jip.2003.12.003; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Hu G, 2002, APPL ENVIRON MICROB, V68, P6383, DOI 10.1128/AEM.68.12.6383-6387.2002; Kito H, 2008, FUNGAL GENET BIOL, V45, P1543, DOI 10.1016/j.fgb.2008.09.005; Krappmann Sven, 2007, Fungal Biology Reviews, V21, P25, DOI 10.1016/j.fbr.2007.02.004; Malik M, 2006, MOL CANCER THER, V5, P1405, DOI 10.1158/1535-7163.MCT-05-0263; Meyer V, 2007, J BIOTECHNOL, V128, P770, DOI 10.1016/j.jbiotec.2006.12.021; Mikuni T, 1982, NIHON SANSHIGAKU ZAS, V51, P325; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; Paz Z, 2011, FUNGAL GENET BIOL, V48, P677, DOI 10.1016/j.fgb.2011.02.003; PRIOR C, 1992, BIOLOGICAL CONTROL OF LOCUSTS AND GRASSHOPPERS, P159; Roberts DW, 2004, ADV APPL MICROBIOL, V54, P1, DOI 10.1016/S0065-2164(04)54001-7; Sambrook J, 2001, MOL CLONING LAB MANU; Snoek ISI, 2009, FUNGAL GENET BIOL, V46, P418, DOI 10.1016/j.fgb.2009.02.008; St Leger RJ, 2009, INSECT PATHOGENS: MOLECULAR APPROACHES AND TECHNIQUES, P365, DOI 10.1079/9781845934781.0365; Wu SC, 2006, APPL ENVIRON MICROB, V72, P986, DOI 10.1128/AEM.72.2.986-993.2006; Zhao H, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004009	27	41	43	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107657	10.1371/journal.pone.0107657	http://dx.doi.org/10.1371/journal.pone.0107657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222118	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774800089
J	Yoo, RE; Choi, SH; Cho, HR; Jeon, BS; Kwon, E; Kim, EG; Park, J; Myeong, WJ; Won, JK; Lee, YS; Kim, JH; Park, SW; Sohn, CH				Yoo, Roh-Eul; Choi, Seung Hong; Cho, Hye Rim; Jeon, Bong-sik; Kwon, Eunbyul; Kim, Eung-gyu; Park, Juyoung; Myeong, Wan-Jae; Won, Jae-Kyung; Lee, Yun-Sang; Kim, Ji-Hoon; Park, Sun-Won; Sohn, Chul-Ho			Magnetic Resonance Imaging Diagnosis of Metastatic Lymph Nodes in a Rabbit Model: Efficacy of PJY10, a New Ultrasmall Superparamagnetic Iron Oxide Agent, with Monodisperse Iron Oxide Core and Multiple-Interaction Ligands	PLOS ONE			English	Article							CELL LUNG-CANCER; POSITRON-EMISSION-TOMOGRAPHY; RECTAL-CANCER; CONTRAST AGENTS; MR LYMPHOGRAPHY; PROSTATE-CANCER; ENHANCED MRI; USPIO; NANOPARTICLES; CRITERIA	Background: Accurate diagnosis of lymph node metastasis is crucial in treatment planning for cancer patients. Despite the use of various parameters, making correct diagnosis of a small metastatic or a hyperplastic benign node is still a challenge. In this study, we evaluated the feasibility of detecting lymph node metastasis using a new ultrasmall superparamagnetic iron oxide particle, PJY10, in a rabbit model. Methods: To make metastatic and benign lymph nodes, either VX2 carcinoma or fecal material suspension was inoculated into thighs of 56 rabbits three weeks or three days before magnetic resonance (MR) imaging, respectively. T2*-weighted 3T MR imaging was performed before and 24 hours after PJY10 injection (5.2 [n = 15], 7.8 [n = 17], and 10.4 [n = 24] mg Fe/kg). MR images were correlated with pathologic results to calculate sensitivity and specificity. Quantitative analysis of the signal intensity (SI) - number of voxels([low]) (the fraction of the number of voxels with the normalized SI on the postcontrast image lower than that on the precontrast image) and mean SI ratio - was also performed for each lymph node. Results: Sensitivities were 100% at all three dosages, whereas specificity increased with increasing dosage (89% at 10.4 mg Fe/kg). The benign nodes had a significantly higher number of voxels([low]) and a lower mean SI ratio than the metastatic nodes at the dosage of 10.4 mg Fe/kg (P<.001). Az values were 0.905 for the number of voxels([low]) and 0.952 for the mean SI ratio. The number of voxels([low]) (P = .019) and the mean SI ratio (P = .034) had significant correlations with the histopathologic area ratio of metastatic foci in the metastatic nodes at 10.4 mg Fe/kg. Conclusions: PJY10 enabled clear demonstration of lymph node metastasis with high sensitivity and specificity at its optimal dosage of 10.4 mg Fe/kg.	[Yoo, Roh-Eul; Choi, Seung Hong; Cho, Hye Rim; Kim, Ji-Hoon; Park, Sun-Won; Sohn, Chul-Ho] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Ctr Nanoparticle Res, Inst Basic Sci, Seoul, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea; [Cho, Hye Rim] Seoul Natl Univ, Coll Med, Dept Radiat Appl Life Sci, Seoul, South Korea; [Jeon, Bong-sik; Kwon, Eunbyul; Kim, Eung-gyu; Park, Juyoung; Myeong, Wan-Jae] Hanwha Chem Corp, Ctr Res & Dev, Taejon, South Korea; [Won, Jae-Kyung] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Lee, Yun-Sang] Seoul Natl Univ, Coll Med, Dept Nucl Med, Seoul 151, South Korea; [Park, Sun-Won] Boramae Med Ctr, Dept Radiol, Seoul, South Korea	Seoul National University (SNU); Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Jeon, BS (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.	verocay@snuh.org	Sohn, ChulHo/AAV-4565-2021; Kim, Ji-hoon/D-5754-2012	Kim, Ji-hoon/0000-0002-6349-6950; Won, Jae-Kyung/0000-0003-1459-8093	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1120300]; Korea Healthcare technology R&D Projects, Ministry for Health, Welfare Family Affairs [A112028]; Research Center Program of IBS (Institute for Basic Science) in Korea; Hanwha Chemicals Corp.	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Healthcare technology R&D Projects, Ministry for Health, Welfare Family Affairs; Research Center Program of IBS (Institute for Basic Science) in Korea; Hanwha Chemicals Corp.	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1120300), the Korea Healthcare technology R&D Projects, Ministry for Health, Welfare & Family Affairs (A112028), and the Research Center Program of IBS (Institute for Basic Science) in Korea. S.H.C. acknowledges financial support by Hanwha Chemicals Corp. The funder (Hanwha Chemical Corp.) provided support in the form of salaries for authors [BSJ, EBK, EGK, JP, WJM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoch G, 2003, RADIOLOGY, V229, P526, DOI 10.1148/radiol.2292021598; Anzai Y, 2003, RADIOLOGY, V228, P777, DOI 10.1148/radiol.2283020872; Bellin MF, 2000, EUR J RADIOL, V34, P257, DOI 10.1016/S0720-048X(00)00204-7; Bellin MF, 2002, ABDOM IMAGING, V28, P155, DOI 10.1007/s00261-001-0182-9; Brown G, 2003, RADIOLOGY, V227, P371, DOI 10.1148/radiol.2272011747; Choi EK, 2009, EUR RADIOL, V19, P2024, DOI 10.1007/s00330-009-1350-5; Choi SH, 2006, RADIOLOGY, V241, P753, DOI 10.1148/radiol.2413051979; Choi SH, 2010, J MAGN RESON IMAGING, V31, P134, DOI 10.1002/jmri.22020; Duan HW, 2007, J AM CHEM SOC, V129, P3333, DOI 10.1021/ja068158s; Dunne AA, 2002, ANTICANCER RES, V22, P3273; Dwamena BA, 1999, RADIOLOGY, V213, P530, DOI 10.1148/radiology.213.2.r99nv46530; Fischbein NJ, 2003, AM J NEURORADIOL, V24, P301; Hamilton AM, 2010, J MAGN RESON IMAGING, V31, P110, DOI 10.1002/jmri.22008; Harisinghani MG, 2006, AM J ROENTGENOL, V186, P144, DOI 10.2214/AJR.04.1287; Harisinghani MG, 2004, RADIOGRAPHICS, V24, P867, DOI 10.1148/rg.243035190; Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749; Hauger O, 2000, RADIOLOGY, V217, P819, DOI 10.1148/radiology.217.3.r00dc04819; Islam T, 2009, CANCER BIOMARK, V5, P61, DOI 10.3233/CBM-2009-0578; Jun YW, 2005, J AM CHEM SOC, V127, P5732, DOI 10.1021/ja0422155; Kim JH, 2004, EUR J RADIOL, V52, P78, DOI 10.1016/j.ejrad.2003.12.005; Kitajima K, 2013, ANN NUCL MED, V27, P581, DOI 10.1007/s12149-013-0731-7; Koh DM, 2004, RADIOLOGY, V231, P91, DOI 10.1148/radiol.2311030142; Lahaye MJ, 2008, RADIOLOGY, V246, P804, DOI 10.1148/radiol.2463070221; Lee N, 2012, CHEM SOC REV, V41, P2575, DOI 10.1039/c1cs15248c; Lind K, 2002, J DRUG TARGET, V10, P221, DOI 10.1080/10611860290022651; Ling D, 2011, ANGEW CHEM INT EDIT, V50, P11360, DOI 10.1002/anie.201101521; Misselwitz B, 2006, EUR J RADIOL, V58, P375, DOI 10.1016/j.ejrad.2005.12.044; Morishige K, 2010, CIRCULATION, V122, P1707, DOI 10.1161/CIRCULATIONAHA.109.891804; Na HB, 2009, ADV MATER, V21, P2133, DOI 10.1002/adma.200802366; Narayanan P, 2009, RADIOGRAPHICS, V29, P1057, DOI 10.1148/rg.294085231; Pieterman RM, 2000, NEW ENGL J MED, V343, P254, DOI 10.1056/NEJM200007273430404; RAO JNK, 1992, BIOMETRICS, V48, P577, DOI 10.2307/2532311; Shen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094876; Simon GH, 2006, EUR RADIOL, V16, P738, DOI 10.1007/s00330-005-0031-2; Torabi M, 2004, J NUCL MED, V45, P1509; Vesselle H, 2002, J THORAC CARDIOV SUR, V124, P511, DOI 10.1067/mtc.2002.123130; WAGNER S, 1994, INVEST RADIOL, V29, P364, DOI 10.1097/00004424-199403000-00021; WEISSLEDER R, 1989, AM J ROENTGENOL, V152, P167, DOI 10.2214/ajr.152.1.167; Wu LC, 2011, EUR J RADIOL, V80, P582, DOI 10.1016/j.ejrad.2009.11.027	39	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107583	10.1371/journal.pone.0107583	http://dx.doi.org/10.1371/journal.pone.0107583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216040	Green Submitted, Green Published, gold			2022-12-25	WOS:000341774300082
J	Libiad, M; Yadav, PK; Vitvitsky, V; Martinov, M; Banerjee, R				Libiad, Marouane; Yadav, Pramod Kumar; Vitvitsky, Victor; Martinov, Michael; Banerjee, Ruma			Organization of the Human Mitochondrial Hydrogen Sulfide Oxidation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOSULFATE; METABOLISM; RAT; CYSTEINE; DIOXYGENASE; TOXICITY; LIVER; H2S; OXIDOREDUCTASE; MECHANISM	Sulfide oxidation is expected to play an important role in cellular switching between low steady-state intracellular hydrogen sulfide levels and the higher concentrations where the physiological effects are elicited. Yet despite its significance, fundamental questions regarding how the sulfide oxidation pathway is wired remain unanswered, and competing proposals exist that diverge at the very first step catalyzed by sulfide quinone oxidoreductase (SQR). We demonstrate that, in addition to sulfite, glutathione functions as a persulfide acceptor for human SQR and that rhodanese preferentially synthesizes rather than utilizes thiosulfate. The kinetic behavior of these enzymes provides compelling evidence for the flow of sulfide via SQR to glutathione persulfide, which is then partitioned to thiosulfate or sulfite. Kinetic simulations at physiologically relevant metabolite concentrations provide additional support for the organizational logic of the sulfide oxidation pathway in which glutathione persulfide is the first intermediate formed.	[Libiad, Marouane; Yadav, Pramod Kumar; Vitvitsky, Victor; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA; [Martinov, Michael] Natl Res Ctr Hematol, Moscow 125167, Russia	University of Michigan System; University of Michigan; Russian Academy of Medical Sciences; National Medical Research Center for Hematology	Banerjee, R (corresponding author), Univ Michigan, 4220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Vitvitsky, Victor/ABA-2967-2021; Yadav, Pramod K./A-6166-2010; Martinov, Michael V./M-5643-2014	Vitvitsky, Victor/0000-0001-6251-6115; Yadav, Pramod K./0000-0003-0026-1684; Martinov, Michael V./0000-0003-4578-9490; Libiad, Marouane/0000-0003-1717-9206	National Institutes of Health [HL58984, GM112455]; American Heart Association Postdoctoral Fellowship [14POST18760003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Postdoctoral Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL58984 and GM112455 (to R.B.). This work was also supported by American Heart Association Postdoctoral Fellowship 14POST18760003 (to P.K.Y.).	BARTHOLOMEW TC, 1980, BIOCHEM PHARMACOL, V29, P2431, DOI 10.1016/0006-2952(80)90346-9; BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; BEYER RE, 1985, MECH AGEING DEV, V32, P267, DOI 10.1016/0047-6374(85)90085-5; Bouillaud F, 2011, ANTIOXID REDOX SIGN, V15, P379, DOI 10.1089/ars.2010.3678; Brito JA, 2009, BIOCHEMISTRY-US, V48, P5613, DOI 10.1021/bi9003827; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; CURTIS CG, 1972, BIOCHEM PHARMACOL, V21, P2313, DOI 10.1016/0006-2952(72)90382-6; Furne J, 2001, BIOCHEM PHARMACOL, V62, P255, DOI 10.1016/S0006-2952(01)00657-8; Goubern M, 2007, FASEB J, V21, P1699, DOI 10.1096/fj.06-7407com; GRIFFITH OW, 1983, J BIOL CHEM, V258, P1591; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Huang J, 1998, CHEM-BIOL INTERACT, V110, P189, DOI 10.1016/S0009-2797(98)00015-5; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; Jackson MR, 2012, BIOCHEMISTRY-US, V51, P6804, DOI 10.1021/bi300778t; JI AJ, 1995, CLIN CHEM, V41, P897; Kabil O, 2014, BBA-PROTEINS PROTEOM, V1844, P1355, DOI 10.1016/j.bbapap.2014.01.002; Kabil O, 2014, ANTIOXID REDOX SIGN, V20, P770, DOI 10.1089/ars.2013.5339; Kabil O, 2012, J BIOL CHEM, V287, P44561, DOI 10.1074/jbc.M112.407411; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; KAJI A, 1959, J BACTERIOL, V77, P630, DOI 10.1128/JB.77.5.630-637.1959; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; Kwon DY, 2013, PLANTA MED, V79, P997, DOI 10.1055/s-0032-1328704; Melideo SL, 2014, BIOCHEMISTRY-US, V53, P4739, DOI 10.1021/bi500650h; Olson KR, 2010, ANTIOXID REDOX SIGN, V12, P1219, DOI 10.1089/ars.2009.2921; Roman HB, 2013, ANTIOXID REDOX SIGN, V19, P1321, DOI 10.1089/ars.2012.5010; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; Stipanuk MH, 2004, AM J PHYSIOL-ENDOC M, V286, pE439, DOI 10.1152/ajpendo.00336.2003; Sugiyama A, 2012, J FOOD SCI, V77, pH268, DOI 10.1111/j.1750-3841.2012.02997.x; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; TOGAWA T, 1992, CHEM PHARM BULL, V40, P3000, DOI 10.1248/cpb.40.3000; UHTEG LC, 1979, ARCH BIOCHEM BIOPHYS, V195, P211, DOI 10.1016/0003-9861(79)90343-6; Vitvitsky V, 2004, AM J PHYSIOL-REG I, V287, pR39, DOI 10.1152/ajpregu.00036.2004; Vitvitsky V, 2013, MECH AGEING DEV, V134, P321, DOI 10.1016/j.mad.2013.05.004	33	151	156	2	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					30901	30910		10.1074/jbc.M114.602664	http://dx.doi.org/10.1074/jbc.M114.602664			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25225291	Green Published, hybrid			2022-12-25	WOS:000344549900003
J	Feld, GK; El-Etr, S; Corzett, MH; Hunter, MS; Belhocine, K; Monack, DM; Frank, M; Segelke, BW; Rasley, A				Feld, Geoffrey K.; El-Etr, Sahar; Corzett, Michele H.; Hunter, Mark S.; Belhocine, Kamila; Monack, Denise M.; Frank, Matthias; Segelke, Brent W.; Rasley, Amy			Structure and Function of REP34 Implicates Carboxypeptidase Activity in Francisella tularensis Host Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-AVIUM; VIRULENCE FACTORS; TULAREMIA; AMEBAS; METALLOCARBOXYPEPTIDASE; ELECTROSTATICS; IDENTIFICATION; INHIBITOR; SURVIVAL; COMPLEX	Francisella tularensis is the etiological agent of tularemia, or rabbit fever. Although F. tularensis is a recognized biothreat agent with broad and expanding geographical range, its mechanism of infection and environmental persistence remain poorly understood. Previously, we identified seven F. tularensis proteins that induce a rapid encystment phenotype (REP) in the free-living amoeba, Acanthamoeba castellanii. Encystment is essential to the pathogen's long term intracellular survival in the amoeba. Here, we characterize the cellular and molecular function of REP34, a REP protein with a mass of 34 kDa. A REP34 knock-out strain of F. tularensis has a reduced ability to both induce encystment in A. castellanii and invade human macrophages. We determined the crystal structure of REP34 to 2.05-angstrom resolution and demonstrate robust carboxypeptidase B-like activity for the enzyme. REP34 is a zinc-containing monomeric protein with close structural homology to the metallocarboxypeptidase family of peptidases. REP34 possesses a novel topology and substrate binding pocket that deviates from the canonical funnelin structure of carboxypeptidases, putatively resulting in a catalytic role for a conserved tyrosine and distinct S1' recognition site. Taken together, these results identify REP34 as an active carboxypeptidase, implicate the enzyme as a potential key F. tularensis effector protein, and may help elucidate a mechanistic understanding of F. tularensis infection of phagocytic cells.	[Feld, Geoffrey K.; El-Etr, Sahar; Corzett, Michele H.; Segelke, Brent W.; Rasley, Amy] Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Phys & Life Sci Directorate, Livermore, CA 94550 USA; [Hunter, Mark S.; Frank, Matthias] Lawrence Livermore Natl Lab, Div Phys, Phys & Life Sci Directorate, Livermore, CA 94550 USA; [Belhocine, Kamila; Monack, Denise M.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Stanford University	Rasley, A (corresponding author), Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, 7000 East Ave,L452, Livermore, CA 94550 USA.	rasley2@llnl.gov	Frank, Matthias/O-9055-2014; Pacific-Southwest, RCE/B-6155-2009	Rasley, Amy/0000-0002-4767-6628; Frank, Matthias/0000-0002-5244-0791; Feld, Geoffrey/0000-0003-0496-1995; Monack, Denise/0000-0003-3804-2209; Segelke, Brent/0000-0003-3358-5028	National Institutes of Health (NIH), NIAID [AI65359]; Lawrence Livermore National Laboratory (LLNL) Laboratory-directed Research and Development (LDRD) [06-ERD-057, 012-ERD-031]; United States Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; United States Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, NIGMS [P41GM103393]; NIH, NCI [Y1-CO-1020]; NIH, NIGMS [Y1-GM-1104, P41 GM103403]; NIH, NCRR [5P41RR015301-10]; DOE [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Lawrence Livermore National Laboratory (LLNL) Laboratory-directed Research and Development (LDRD); United States Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); United States Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NIAID, Grant AI65359 (to A. R.). This research was also supported by Lawrence Livermore National Laboratory (LLNL) Laboratory-directed Research and Development (LDRD) Project 06-ERD-057 (to A. R.) and LDRD Project 012-ERD-031 (to M. F.). Work was performed under the auspices of the United States Department of Energy by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. Use of the Stanford Synchrotron Radiation Laboratory (SSRL), SLAC National Accelerator Laboratory, was supported by the United States Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health, NIGMS (including Grant P41GM103393). GM/CA at the Advanced Photon Source (APS) has been funded in whole or in part with Federal funds from NIH, NCI, Grant Y1-CO-1020 and NIH, NIGMS, Grant Y1-GM-1104. The Northeastern Collaborative Access Team is supported by NIH, NCRR, Grant 5P41RR015301-10 and NIH, NIGMS, Grant P41 GM103403. Use of the APS is supported by the DOE under Contract DE-AC02-06CH11357.	Abd H, 2003, APPL ENVIRON MICROB, V69, P600, DOI 10.1128/AEM.69.1.600-606.2003; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adler M, 2005, BIOCHEMISTRY-US, V44, P9339, DOI 10.1021/bi0501941; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bayes A, 2007, BIOCHEMISTRY-US, V46, P6921, DOI 10.1021/bi700480b; Berdal BP, 1996, FEMS IMMUNOL MED MIC, V13, P191, DOI 10.1111/j.1574-695X.1996.tb00235.x; Brieland J, 1996, INFECT IMMUN, V64, P2449, DOI 10.1128/IAI.64.7.2449-2456.1996; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; Chen YY, 2002, J BIOL CHEM, V277, P23433, DOI 10.1074/jbc.M200811200; Cho JH, 2002, BIOORGAN MED CHEM, V10, P2015, DOI 10.1016/S0968-0896(01)00429-1; Cirillo JD, 1997, INFECT IMMUN, V65, P3759, DOI 10.1128/IAI.65.9.3759-3767.1997; Clemens DL, 2007, ANN NY ACAD SCI, V1105, P160, DOI 10.1196/annals.1409.001; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; El-Etr SH, 2009, APPL ENVIRON MICROB, V75, P7488, DOI 10.1128/AEM.01829-09; Eliasson H, 2007, SCAND J INFECT DIS, V39, P880, DOI 10.1080/00365540701402970; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feldman KA, 2001, NEW ENGL J MED, V345, P1601, DOI 10.1056/NEJMoa011374; Fischetti RF, 2009, J SYNCHROTRON RADIAT, V16, P217, DOI 10.1107/S0909049508040612; FOLK JE, 1960, J BIOL CHEM, V235, P2272; Gurcan S, 2006, JPN J INFECT DIS, V59, P391; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Maier TA, 2007, INFECT IMMUN, V75, P5376, DOI 10.1128/IAI.00238-07; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPherson A Jr, 1976, Methods Biochem Anal, V23, P249, DOI 10.1002/9780470110430.ch4; Miyake M, 2005, INFECT IMMUN, V73, P6272, DOI 10.1128/IAI.73.10.6272-6282.2005; Molmeret M, 2005, APPL ENVIRON MICROB, V71, P20, DOI 10.1128/AEM.71.1.20-28.2005; Mueller RS, 2007, J BACTERIOL, V189, P5348, DOI 10.1128/JB.01867-06; Nigrovic LE, 2008, INFECT DIS CLIN N AM, V22, P489, DOI 10.1016/j.idc.2008.03.004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Oyston PCF, 2008, J MED MICROBIOL, V57, P921, DOI 10.1099/jmm.0.2008/000653-0; Petersen JM, 2009, VET RES, V40, DOI 10.1051/vetres:2008045; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Reddy V, 2003, ACTA CRYSTALLOGR D, V59, P2200, DOI 10.1107/S0907444903020316; Reverter D, 2000, NAT STRUCT BIOL, V7, P322, DOI 10.1038/74092; Salah IB, 2009, CLIN MICROBIOL INFEC, V15, P894, DOI 10.1111/j.1469-0691.2009.03011.x; Segelke B. W., 2001, J CRYST GROWTH, V232, P553; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Steinert M, 1998, APPL ENVIRON MICROB, V64, P2256; STEPANOV VM, 1995, METHOD ENZYMOL, V248, P675; TEPLYAKOV A, 1992, EUR J BIOCHEM, V208, P281, DOI 10.1111/j.1432-1033.1992.tb17184.x; Tung CH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r31; Winiecka-Krusnell J, 2001, RES MICROBIOL, V152, P613, DOI 10.1016/S0923-2508(01)01240-2; Winiecka-Krusnell J, 2009, EXP PARASITOL, V121, P124, DOI 10.1016/j.exppara.2008.09.022; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Zaugg C, 2008, INT J MED MICROBIOL, V298, P669, DOI 10.1016/j.ijmm.2007.11.005; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	53	3	3	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30668	30679		10.1074/jbc.M114.599381	http://dx.doi.org/10.1074/jbc.M114.599381			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25231992	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000344549700043
J	Tai, LM; Koster, KP; Luo, J; Lee, SH; Wang, YT; Collins, NC; Ben Aissa, M; Thatcher, GRJ; LaDu, MJ				Tai, Leon M.; Koster, Kevin P.; Luo, Jia; Lee, Sue H.; Wang, Yue-ting; Collins, Nicole C.; Ben Aissa, Manel; Thatcher, Gregory R. J.; LaDu, Mary Jo			Amyloid-beta Pathology and APOE Genotype Modulate Retinoid X Receptor Agonist Activity in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MOUSE MODEL; MILD COGNITIVE IMPAIRMENT; APOLIPOPROTEIN-E; A-BETA; ALZHEIMERS-DISEASE; BEXAROTENE THERAPY; ABCA1; BRAIN; DEPOSITION; LIVER	Previous data demonstrate that bexarotene (Bex), retinoid X receptor (RXR) agonist, reduces soluble and insoluble amyloid-beta (A beta) in Alzheimer disease (AD)-transgenic mice either by increasing the levels of mouse apolipoprotein E (apoE) or increasing ABCA1/ABCG1-induced apoE lipoprotein association/lipidation. However, although the mechanism of action of RXR agonists remains unclear, a major concern for their use is human (h)-APOE4, the greatest AD genetic risk factor. If APOE4 imparts a toxic gain-of-function, then increasing apoE4 may increase soluble A beta, likely the proximal AD neurotoxin. If the APOE4 loss-of-function is lipidation of apoE4, then induction of ABCA1/ABCG1 may be beneficial. In novel EFAD-Tg mice (overexpressing h-A beta 42 with h-APOE), levels of soluble A beta (A beta 42 and oligomeric A beta) are highest in E4FAD hippocampus (HP) > E3FAD-HP > E4FAD cortex (CX) > E3FAD-CX, whereas levels of lipoprotein-associated/lipidated apoE have the opposite pattern (6 months). In E4FAD-HP, short-term RXR agonist treatment (Bex or LG100268; 5.75-6 months) increased ABCA1, apoE4 lipoprotein-association/lipidation, and apoE4/A beta complex, decreased soluble A beta, and increased PSD95. In addition, hydrogel delivery, which mimics low sustained release, was equally effective as gavage for Bex and LG100268. RXR agonists induced no beneficial effects in the E4FAD-HP in a prevention protocol (5-6 months) and actually increased soluble A beta levels in E3FAD-CX and E4FAD-CX with the short-term protocol, possibly the result of systemic hepatomegaly. Thus, RXR agonists address the loss-of-function associated with APOE4 and exacerbated by A beta pathology, i.e. low levels of apoE4 lipoprotein association/lipidation. Further studies are vital to address whether RXR agonists are an APOE4-specific AD therapeutic and the systemic side effects that limit translational application.	[Tai, Leon M.; Koster, Kevin P.; Collins, Nicole C.; Ben Aissa, Manel; LaDu, Mary Jo] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Luo, Jia; Lee, Sue H.; Thatcher, Gregory R. J.] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA; [Wang, Yue-ting] Univ Illinois, UICtr Drug Discovery UIC, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	LaDu, MJ (corresponding author), Univ Illinois, Dept Anat & Cell Biol, 808 S Wood St,M-C 512, Chicago, IL 60612 USA.	mladu@uic.edu		Lee, Sue/0000-0002-6843-0280; LaDu, Mary Jo/0000-0003-2141-1450	National Institutes of Health from NIA [P01AG030128]; Alzheimer Drug Discovery Foundation; University of Illinois at Chicago Center for Clinical and Translational Science [UL1RR029879]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG030128] Funding Source: NIH RePORTER	National Institutes of Health from NIA; Alzheimer Drug Discovery Foundation; University of Illinois at Chicago Center for Clinical and Translational Science; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant P01AG030128 from NIA (to M. J. L.). This work was also supported by Alzheimer Drug Discovery Foundation grant (to M. J. L. and L. M. T.) and University of Illinois at Chicago Center for Clinical and Translational Science Grant UL1RR029879 (to M. J. L.). In collaboration with Skip Binder, M. J. L. developed the antibody MOAB-2 used to develop the apoE/A beta complex and oA beta ELISAs. MOAB-2 is licensed as a research tool to multiple companies. Also, for research purposes, Biosensis Pty. Ltd. has licensed the rights to ELISA kits with MOAB-2 for detection of oA beta and apoE/A beta complex.	Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Altmann A, 2014, ANN NEUROL, V75, P563, DOI 10.1002/ana.24135; Bachstetter AD, 2014, J NEUROIMMUNE PHARM, V9, P454, DOI 10.1007/s11481-014-9543-3; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; BOEHM MF, 1995, J MED CHEM, V38, P3146, DOI 10.1021/jm00016a018; Boehm-Cagan A, 2014, J NEUROSCI, V34, P7293, DOI 10.1523/JNEUROSCI.5198-13.2014; Bretsky PM, 1999, ALZ DIS ASSOC DIS, V13, P216, DOI 10.1097/00002093-199910000-00007; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; de la Monte SM, 2014, ENDOCRIN METAB CLIN, V43, P245, DOI 10.1016/j.ecl.2013.09.006; der Weij JD, 2009, ENDOCRINOLOGY, V150, P2368, DOI 10.1210/en.2008-1540; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Elliott C, 2013, DIGEST DIS SCI, V58, P2383, DOI 10.1007/s10620-013-2657-2; Erbas O, 2014, SCI WORLD J, DOI 10.1155/2014/946265; Farlow MR, 1998, NEUROLOGY, V50, P669, DOI 10.1212/WNL.50.3.669; Faul MM, 2001, J ORG CHEM, V66, P5772, DOI 10.1021/jo0103064; Fitz NF, 2013, SCIENCE, V340, DOI 10.1126/science.1235809; Fowler SW, 2014, J NEUROSCI, V34, P7871, DOI 10.1523/JNEUROSCI.0572-14.2014; Fryer JD, 2005, J NEUROSCI, V25, P2803, DOI 10.1523/JNEUROSCI.5170-04.2005; Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012; Hirsch-Reinshagen V, 2005, J BIOL CHEM, V280, P43243, DOI 10.1074/jbc.M508781200; Hirsch-Reinshagen V, 2004, J BIOL CHEM, V279, P41197, DOI 10.1074/jbc.M407962200; Hong SY, 2011, J NEUROSCI, V31, P15861, DOI 10.1523/JNEUROSCI.3272-11.2011; Howell SR, 2001, DRUG METAB DISPOS, V29, P990; Hudry E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007000; Jacobs EG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054713; Janakiram NB, 2012, NEOPLASIA, V14, P159, DOI 10.1593/neo.111440; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Jurutka PW, 2013, J MED CHEM, V56, P8432, DOI 10.1021/jm4008517; Karran E, 2014, NEW ENGL J MED, V370, P377, DOI 10.1056/NEJMe1313943; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; Kunzler J, 2014, NEUROSCI LETT, V560, P131, DOI 10.1016/j.neulet.2013.12.032; Kuo YM, 1996, J BIOL CHEM, V271, P4077; LaClair KD, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-18; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Leoni V, 2011, CLIN CHEM LAB MED, V49, P375, DOI 10.1515/CCLM.2011.088; Lewis M, 2003, QJM-INT J MED, V96, P623, DOI 10.1093/qjmed/hcg110; Li J, 2012, J BIOL CHEM, V287, P44593, DOI 10.1074/jbc.M112.420224; Lim WLF, 2014, J GENET GENOMICS, V41, P261, DOI 10.1016/j.jgg.2014.04.003; Liu S, 2002, ENDOCRINOLOGY, V143, P2880, DOI 10.1210/en.143.8.2880; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Ly S, 2013, J BIOL CHEM, V288, P11628, DOI 10.1074/jbc.M112.411900; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mikulca JA, 2014, J CLIN PHARM THER, V39, P25, DOI 10.1111/jcpt.12112; Mohamed A, 2012, J NEUROSCI, V32, P6490, DOI 10.1523/JNEUROSCI.0630-12.2012; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Overk CR, 2012, NEUROBIOL DIS, V45, P479, DOI 10.1016/j.nbd.2011.08.035; Overk CR, 2011, J NEUROSCI METH, V195, P194, DOI 10.1016/j.jneumeth.2010.12.009; Payami H, 1996, AM J HUM GENET, V58, P803; Perez E, 2012, BBA-MOL CELL BIOL L, V1821, P57, DOI 10.1016/j.bbalip.2011.04.003; Price AR, 2013, SCIENCE, V340, DOI 10.1126/science.1234089; Qiu WQ, 2013, J ALZHEIMERS DIS, V37, P421, DOI 10.3233/JAD-130716; Reitz C, 2010, J ALZHEIMERS DIS, V19, P229, DOI 10.3233/JAD-2010-1255; Risner ME, 2006, PHARMACOGENOMICS J, V6, P246, DOI 10.1038/sj.tpj.6500369; Scarisbrick JJ, 2013, BRIT J DERMATOL, V168, P192, DOI 10.1111/bjd.12042; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Sherman SI, 2003, CLIN LYMPHOMA, V3, P249, DOI 10.3816/CLM.2003.n.006; Sonneville R, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-15; Sperling R, 2012, LANCET NEUROL, V11, P241, DOI 10.1016/S1474-4422(12)70015-7; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Sultana R, 2010, J NEUROSCI RES, V88, P469, DOI 10.1002/jnr.22227; Tai LM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-2; Tai Leon M, 2011, Int J Alzheimers Dis, V2011, P810981, DOI 10.4061/2011/810981; Tai LM, 2013, J BIOL CHEM, V288, P5914, DOI 10.1074/jbc.M112.442103; Tesseur I, 2013, SCIENCE, V340, DOI 10.1126/science.1233937; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Torino F, 2013, THYROID, V23, P1345, DOI 10.1089/thy.2013.0241; Vakeva L, 2012, ACTA DERM-VENEREOL, V92, P258, DOI 10.2340/00015555-1359; Veeraraghavalu K, 2013, SCIENCE, V340, DOI 10.1126/science.1235505; Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Wahrle SE, 2005, J BIOL CHEM, V280, P43236, DOI 10.1074/jbc.M508780200; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085; Wang Y, 2006, MOL CANCER THER, V5, P1060, DOI 10.1158/1535-7163.MCT-05-0322; Weissenborn K, 2005, AIDS, V19, pS93, DOI 10.1097/01.aids.0000192076.03443.6d; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; Wu K, 2002, CANCER EPIDEM BIOMAR, V11, P467; Yaffe K, 2000, NEUROLOGY, V54, P1949, DOI 10.1212/WNL.54.10.1949; Youmans KL, 2012, J BIOL CHEM, V287, P41774, DOI 10.1074/jbc.M112.407957; Youmans KL, 2011, J NEUROSCI METH, V196, P51, DOI 10.1016/j.jneumeth.2010.12.025; Yu CJ, 2010, BBA-MOL CELL BIOL L, V1801, P819, DOI 10.1016/j.bbalip.2010.05.001; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104	87	70	70	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30538	30555		10.1074/jbc.M114.600833	http://dx.doi.org/10.1074/jbc.M114.600833			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25217640	Green Published, hybrid			2022-12-25	WOS:000344549700032
J	Wang, CY; Miller, TF				Wang, Connie Y.; Miller, Thomas F., III			Allosteric Response and Substrate Sensitivity in Peptide Binding of the Signal Recognition Particle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-ENERGY CALCULATIONS; FACILITATED PROTEIN TRANSLOCATION; EUKARYOTIC ENDOPLASMIC-RETICULUM; MOLECULAR-DYNAMICS SIMULATION; CRYSTAL-STRUCTURE; SRP RNA; TRANSLATING RIBOSOME; COMPUTER-SIMULATION; STRUCTURAL BASIS; GTPASE DOMAIN	We characterize the conformational dynamics and substrate selectivity of the signal recognition particle (SRP) using a thermodynamic free energy cycle approach and microsecond timescale molecular dynamics simulations. The SRP is a central component of the co-translational protein targeting machinery that binds to the N-terminal signal peptide (SP) of nascent proteins. We determined the shift in relative conformational stability of the SRP upon substrate binding to quantify allosteric coupling between SRP domains. In particular, for dipeptidyl aminopeptidase, an SP that is recognized by the SRP for co-translational targeting, it is found that substrate binding induces substantial changes in the SRP toward configurations associated with targeting of the nascent protein, and it is found that the changes are modestly enhanced by a mutation that increases the hydrophobicity of the SP. However, for alkaline phosphatase, an SP that is recognized for post-translational targeting, substrate binding induces the reverse change in the SRP conformational distribution away from targeting configurations. Microsecond timescale trajectories reveal the intrinsic flexibility of the SRP conformational landscape and provide insight into recent single molecule studies by illustrating that 10-nm lengthscale changes between FRET pairs occur via the rigid-body movement of SRP domains connected by the flexible linker region. In combination, these results provide direct evidence for the hypothesis that substrate-controlled conformational switching in the SRP provides a mechanism for discriminating between different SPs and for connecting substrate binding to downstream steps in the protein targeting pathway.	[Wang, Connie Y.; Miller, Thomas F., III] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91106 USA	California Institute of Technology	Miller, TF (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 East Calif Blvd, Pasadena, CA 91106 USA.	tfm@caltech.edu			Office of Science of the United States Department of Energy [DE-AC02-05CH11231]; Biomedical Technology Research Center for Multiscale Modeling of Biological Systems through National Institutes of Health [P41GM103712-S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103712] Funding Source: NIH RePORTER	Office of Science of the United States Department of Energy(United States Department of Energy (DOE)); Biomedical Technology Research Center for Multiscale Modeling of Biological Systems through National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Computational resources were provided by the National Energy Research Scientific Computing Center, which is supported by the Office of Science of the United States Department of Energy under Contract DE-AC02-05CH11231. Additionally, Anton computer time was provided by the National Resource for Biomedical Supercomputing, the Pittsburgh Supercomputing Center, and the Biomedical Technology Research Center for Multiscale Modeling of Biological Systems through National Institutes of Health Grant P41GM103712-S1. The Anton machine at NRBSC/PSC was generously made available by D. E. Shaw Research. We also thank Shu-ou Shan and David Akopian for helpful discussions.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Ariosa AR, 2013, MOL BIOL CELL, V24, P63, DOI 10.1091/mbc.E12-06-0434; Ataide SF, 2011, SCIENCE, V331, P881, DOI 10.1126/science.1196473; BASH PA, 1987, SCIENCE, V236, P564, DOI 10.1126/science.3576184; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Batson B., 2009, MILL SCAL MOL DYN SI, P1, DOI [10.1145/1654059.1654099, DOI 10.1145/1654059.1654099]; BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BEUTLER TC, 1994, CHEM PHYS LETT, V222, P529, DOI 10.1016/0009-2614(94)00397-1; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Bradshaw N, 2009, SCIENCE, V323, P127, DOI 10.1126/science.1165971; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Essex JW, 1997, J PHYS CHEM B, V101, P9663, DOI 10.1021/jp971990m; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Estrozi LF, 2011, NAT STRUCT MOL BIOL, V18, P88, DOI 10.1038/nsmb.1952; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; FLETCHER R, 1963, COMPUT J, V6, P163, DOI 10.1093/comjnl/6.2.163; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Freymann DM, 1997, NATURE, V385, P361, DOI 10.1038/385361a0; GIERASCH LM, 1989, BIOCHEMISTRY-US, V28, P923, DOI 10.1021/bi00429a001; Hainzl T, 2007, P NATL ACAD SCI USA, V104, P14911, DOI 10.1073/pnas.0702467104; Hainzl T, 2011, NAT STRUCT MOL BIOL, V18, P389, DOI 10.1038/nsmb.1994; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Hatsuzawa K, 1997, J BIOCHEM-TOKYO, V121, P270; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holtkamp W, 2012, NAT STRUCT MOL BIOL, V19, P1332, DOI 10.1038/nsmb.2421; Huber D, 2005, J BACTERIOL, V187, P2983, DOI 10.1128/JB.187.9.2983-2991.2005; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; Jayaram B, 1998, J AM CHEM SOC, V120, P10629, DOI 10.1021/ja981307p; JORGENSEN WL, 1985, J CHEM PHYS, V83, P3050, DOI 10.1063/1.449208; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; KURZCHALIA TV, 1986, NATURE, V320, P634, DOI 10.1038/320634a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin YL, 2014, J CHEM THEORY COMPUT, V10, P2690, DOI 10.1021/ct500195p; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Noriega TR, 2014, J BIOL CHEM, V289, P19294, DOI 10.1074/jbc.M114.563239; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pohlschroder M, 1997, CELL, V91, P563, DOI 10.1016/S0092-8674(00)80443-2; Pohorille A, 2010, J PHYS CHEM B, V114, P10235, DOI 10.1021/jp102971x; PORITZ MA, 1990, SCIENCE, V250, P1111, DOI 10.1126/science.1701272; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; RAO SN, 1987, NATURE, V328, P551, DOI 10.1038/328551a0; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Rosendal KR, 2003, P NATL ACAD SCI USA, V100, P14701, DOI 10.1073/pnas.2436132100; Roux B, 1996, BIOPHYS J, V71, P670, DOI 10.1016/S0006-3495(96)79267-6; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saraogi I, 2014, J CELL BIOL, V205, P693, DOI 10.1083/jcb.201311028; Satpati P, 2011, J PHYS CHEM B, V115, P6749, DOI 10.1021/jp201934p; Schaffitzel C, 2006, NATURE, V444, P503, DOI 10.1038/nature05182; Shan YB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839571; Shaw DE, 2007, CONF PROC INT SYMP C, P1, DOI 10.1145/1273440.1250664; Shen K, 2012, NATURE, V492, P271, DOI 10.1038/nature11726; Shen K, 2011, RNA, V17, P892, DOI 10.1261/rna.2610411; Siu FY, 2007, RNA, V13, P240, DOI 10.1261/rna.135407; Steinbrecher T, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799191; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; VANGUNSTEREN WF, 1990, ANGEW CHEM INT EDIT, V29, P992, DOI 10.1002/anie.199009921; von Loeffelholz O, 2013, NAT STRUCT MOL BIOL, V20, P604, DOI 10.1038/nsmb.2546; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545; Wild K, 2004, MOL MICROBIOL, V53, P357, DOI 10.1111/j.1365-2958.2004.04139.x; Wild K, 2010, ACTA CRYSTALLOGR D, V66, P295, DOI 10.1107/S0907444910000879; Woo HJ, 2005, P NATL ACAD SCI USA, V102, P6825, DOI 10.1073/pnas.0409005102; Zhang B, 2012, CELL REP, V2, P927, DOI 10.1016/j.celrep.2012.08.039; Zhang B, 2012, J AM CHEM SOC, V134, P13700, DOI 10.1021/ja3034526; Zhang X, 2011, P NATL ACAD SCI USA, V108, P6450, DOI 10.1073/pnas.1019051108; Zhang X, 2010, SCIENCE, V328, P757, DOI 10.1126/science.1186743; Zhang X, 2009, P NATL ACAD SCI USA, V106, P1754, DOI 10.1073/pnas.0808573106	82	2	2	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30868	30879		10.1074/jbc.M114.584912	http://dx.doi.org/10.1074/jbc.M114.584912			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25237192	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000344549700060
J	Wu, M; Lu, WY; Santos, RE; Frattini, MG; Kelly, TJ				Wu, Min; Lu, Wenyan; Santos, Ruth E.; Frattini, Mark G.; Kelly, Thomas J.			Geminin Inhibits a Late Step in the Formation of Human Pre-replicative Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIGIN RECOGNITION COMPLEX; EUKARYOTIC DNA-REPLICATION; MINICHROMOSOME MAINTENANCE PROTEINS; LICENSING FACTOR CDT1; HBO1 HISTONE ACETYLASE; XENOPUS EGG EXTRACTS; HELICASE ACTIVITY; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; MCM-PROTEINS	The initial step in initiation of eukaryotic DNA replication involves the assembly of pre-replicative complexes (pre-RCs) at origins of replication during the G(1) phase of the cell cycle. In metazoans initiation is inhibited by the regulatory factor Geminin. We have purified the human pre-RC proteins, studied their interactions in vitro with each other and with origin DNA, and analyzed the effects of HsGeminin on formation of DNA-protein complexes. The formation of an initial complex containing the human origin recognition complex (HsORC), HsCdt1, HsCdc6, and origin DNA is cooperative, involving all possible binary interactions among the components. Maximal association of HsMCM2-7, a component of the replicative helicase, requires HsORC, HsCdc6, HsCdt1, and ATP, and is driven by interactions of HsCdt1 and HsCdc6 with multiple HsMCM2-7 subunits. Formation of stable complexes, resistant to high salt, requires ATP hydrolysis. In the absence of HsMCM proteins, HsGeminin inhibits the association of HsCdt1 with DNA or with HsORC-HsCdc6-DNA complexes. However, HsGeminin does not inhibit recruitment of HsMCM2-7 to DNA to form complexes containing all of the pre-RC proteins. In fact, HsGeminin itself is a component of such complexes, and interacts directly with the HsMcm3 and HsMcm5 subunits of HsMCM2-7, as well as with HsCdt1. Although HsGeminin does not prevent the initial formation of DNA-protein complexes containing the pre-RC proteins, it strongly inhibits the formation of stable preRCs that are resistant to high salt. We suggest that bound HsGeminin prevents transition of the pre-RC to a state that is competent for initiation of DNA replication.	[Wu, Min; Lu, Wenyan; Santos, Ruth E.; Kelly, Thomas J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Frattini, Mark G.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Frattini, MG (corresponding author), Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, 1130 St Nicholas Ave,Rm 216, New York, NY 10032 USA.	mwu4@jhmi.edu; mgf2122@columbia.edu; tkelly@mskcc.org			National Institutes of Health [R01 CA40414]; Mathers Foundation; NATIONAL CANCER INSTITUTE [R01CA040414, P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA40414 and The Mathers Foundation (to T. J. K.).	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bochman ML, 2007, J BIOL CHEM, V282, P33795, DOI 10.1074/jbc.M703824200; Bochman ML, 2010, NUCLEIC ACIDS RES, V38, P6078, DOI 10.1093/nar/gkq422; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; BURKHART R, 1995, EUR J BIOCHEM, V228, P431; Cook JG, 2004, J BIOL CHEM, V279, P9625, DOI 10.1074/jbc.M311933200; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Duncker BP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-214; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Ferenbach A, 2005, NUCLEIC ACIDS RES, V33, P316, DOI 10.1093/nar/gki176; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Gambus A, 2011, J BIOL CHEM, V286, P11855, DOI 10.1074/jbc.M110.199521; GIACCA M, 1994, P NATL ACAD SCI USA, V91, P7119, DOI 10.1073/pnas.91.15.7119; Gillespie PJ, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-15; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; Houchens CR, 2008, J BIOL CHEM, V283, P30216, DOI 10.1074/jbc.M802649200; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Ishimi Y, 1996, J BIOL CHEM, V271, P24115, DOI 10.1074/jbc.271.39.24115; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Kawasaki Y, 2006, GENES CELLS, V11, P745, DOI 10.1111/j.1365-2443.2006.00975.x; KIMURA H, 1995, NUCLEIC ACIDS RES, V23, P2097, DOI 10.1093/nar/23.12.2097; Klemm RD, 2001, P NATL ACAD SCI USA, V98, P8361, DOI 10.1073/pnas.131006898; Kulartz M, 2004, J BIOL CHEM, V279, P41686, DOI 10.1074/jbc.M405798200; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Miotto B, 2008, GENE DEV, V22, P2633, DOI 10.1101/gad.1674108; Miotto B, 2010, MOL CELL, V37, P57, DOI 10.1016/j.molcel.2009.12.012; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; MUSAHL C, 1995, EUR J BIOCHEM, V230, P1096, DOI 10.1111/j.1432-1033.1995.tb20660.x; Neuwald AF, 1999, GENOME RES, V9, P27; Ode KL, 2011, GENES CELLS, V16, P380, DOI 10.1111/j.1365-2443.2011.01501.x; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Rowles A, 1999, J CELL SCI, V112, P2011; Seki T, 2000, P NATL ACAD SCI USA, V97, P14115, DOI 10.1073/pnas.97.26.14115; Sherman DA, 1998, NUCLEIC ACIDS RES, V26, P3955, DOI 10.1093/nar/26.17.3955; Speck C, 2007, J BIOL CHEM, V282, P11705, DOI 10.1074/jbc.M700399200; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Vashee S, 2001, J BIOL CHEM, V276, P26666, DOI 10.1074/jbc.M102493200; Waga S, 2006, J BIOL CHEM, V281, P10926, DOI 10.1074/jbc.M600299200; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wong PG, 2010, CELL CYCLE, V9, P4351, DOI 10.4161/cc.9.21.13596; Yanagi K, 2005, J BIOL CHEM, V280, P19689, DOI 10.1074/jbc.C500070200; Yanagi K, 2002, J BIOL CHEM, V277, P40871, DOI 10.1074/jbc.M206202200; You ZY, 2008, J BIOL CHEM, V283, P24469, DOI 10.1074/jbc.M803212200; You ZY, 1999, MOL CELL BIOL, V19, P8003	55	7	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30810	30821		10.1074/jbc.M114.552935	http://dx.doi.org/10.1074/jbc.M114.552935			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25231993	Green Published, hybrid			2022-12-25	WOS:000344549700055
J	Bezuidenhout, M; Liu, P; Singh, S; Kiely, M; Ryan, KM; Kiely, PA				Bezuidenhout, Michael; Liu, Pai; Singh, Shalini; Kiely, Maeve; Ryan, Kevin M.; Kiely, Patrick A.			Promoting Cell Proliferation Using Water Dispersible Germanium Nanowires	PLOS ONE			English	Article							SILICON NANOWIRES; ADHESION; RACK1; CALCIFICATION; BEHAVIOR; NANOTECHNOLOGY; RATIO	Group IV Nanowires have strong potential for several biomedical applications. However, to date their use remains limited because many are synthesised using heavy metal seeds and functionalised using organic ligands to make the materials water dispersible. This can result in unpredicted toxic side effects for mammalian cells cultured on the wires. Here, we describe an approach to make seedless and ligand free Germanium nanowires water dispersible using glutamic acid, a natural occurring amino acid that alleviates the environmental and health hazards associated with traditional functionalisation materials. We analysed the treated material extensively using Transmission electron microscopy (TEM), High resolution-TEM, and scanning electron microscope (SEM). Using a series of state of the art biochemical and morphological assays, together with a series of complimentary and synergistic cellular and molecular approaches, we show that the water dispersible germanium nanowires are non-toxic and are biocompatible. We monitored the behaviour of the cells growing on the treated germanium nanowires using a real time impedance based platform (xCELLigence) which revealed that the treated germanium nanowires promote cell adhesion and cell proliferation which we believe is as a result of the presence of an etched surface giving rise to a collagen like structure and an oxide layer. Furthermore this study is the first to evaluate the associated effect of Germanium nanowires on mammalian cells. Our studies highlight the potential use of water dispersible Germanium Nanowires in biological platforms that encourage anchorage-dependent cell growth.	[Bezuidenhout, Michael; Kiely, Maeve; Kiely, Patrick A.] Univ Limerick, Dept Life Sci, Limerick, Ireland; [Bezuidenhout, Michael; Liu, Pai; Singh, Shalini; Kiely, Maeve; Ryan, Kevin M.; Kiely, Patrick A.] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland; [Liu, Pai; Singh, Shalini; Ryan, Kevin M.] Univ Limerick, Dept Chem & Environm Sci, Limerick, Ireland; [Kiely, Patrick A.] Univ Limerick, Stokes Inst, Limerick, Ireland	University of Limerick; University of Limerick; University of Limerick; University of Limerick	Kiely, PA (corresponding author), Univ Limerick, Dept Life Sci, Limerick, Ireland.	Patrick.Kiely@ul.ie	Liu, Pai/N-2982-2019; Singh, Shalini/L-2942-2016; Singh, Shalini/AAR-1355-2020; Liu, Pai/AAF-4074-2019; Ryan, Kevin M./ABG-7492-2020; Ryan, kevin M/D-8047-2011	Singh, Shalini/0000-0001-8607-8383; Singh, Shalini/0000-0001-8607-8383; Liu, Pai/0000-0002-7877-153X; Ryan, Kevin M./0000-0003-3670-8505; Ryan, kevin M/0000-0003-3670-8505; Bailey-Whyte, Maeve/0000-0002-4539-1223	Irish Research Council Postgraduate Scholarship Scheme; Mid-Western Cancer Foundation (MWCF); Health Research Board of Ireland (HRB) grant [HRA/2009/188]; Irish Cancer Society [CRS11KIE]; Science Foundation Ireland (SFI) under the Principal Investigator Program [11PI-1148]	Irish Research Council Postgraduate Scholarship Scheme(Irish Research Council for Science, Engineering and Technology); Mid-Western Cancer Foundation (MWCF); Health Research Board of Ireland (HRB) grant; Irish Cancer Society; Science Foundation Ireland (SFI) under the Principal Investigator Program(Science Foundation Ireland)	This work was supported in whole by grants received from the Irish Research Council Postgraduate Scholarship Scheme (MB), the Mid-Western Cancer Foundation (MWCF) and Health Research Board of Ireland (HRB) grant HRA/2009/188 (to PAK), Irish Cancer Society CRS11KIE (MK) and by Science Foundation Ireland (SFI) under the Principal Investigator Program (Contract No. 11PI-1148) and was conducted under the framework of the Irish Government's Programme for Research in Third Level Institutions Cycle 5, National Development Plan 2007-2013 with the assistance of the European Regional Development Fund KMR, PL, SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett CA, 2011, CHEM COMMUNICATIONS, V47; Canham LT, 1996, ADV MATER, V8, P847, DOI 10.1002/adma.19960081019; Chan CK, 2008, NANO LETT, V8, P307, DOI 10.1021/nl0727157; Choi K, 2000, LANGMUIR, V16, P7737, DOI 10.1021/la000413d; Cullen GW, 1962, J ELECTROCHEMICAL SO, V109; Deng ZJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/45/455101; Dowling CM, 2014, BIOSCIENCE REPORTS; Dwane S, 2014, CELL SIGNAL, V26, P9, DOI 10.1016/j.cellsig.2013.08.036; Dwane Susan, 2013, BMC Res Notes, V6, P366, DOI 10.1186/1756-0500-6-366; Geaney H, 2011, CHEM MATER, V23, P4838, DOI 10.1021/cm202276m; Geaney H, 2011, CRYST GROWTH DES, V11, P3266, DOI 10.1021/cg200510y; Hanrath T, 2004, J AM CHEM SOC, V126, P15466, DOI 10.1021/ja0465808; Holmberg VC, 2010, LANGMUIR, V26, P14241, DOI 10.1021/la102124y; Huang JS, 2009, SOL ENERG MAT SOL C, V93, P621, DOI 10.1016/j.solmat.2008.12.016; Ji Z, 2012, ACS NANO, V6, P5366, DOI 10.1021/nn3012114; Jiang K, 2009, ACS APPL MATER INTER, V1, P266, DOI 10.1021/am800219r; Kiely PA, 2002, J BIOL CHEM, V277, P22581, DOI 10.1074/jbc.M201758200; Kiely PA, 2008, J BIOL CHEM, V283, P22952, DOI 10.1074/jbc.M800802200; Kiely PA, 2009, J BIOL CHEM, V284, P20263, DOI 10.1074/jbc.M109.017640; Kim W, 2007, J AM CHEM SOC, V129, P7228, DOI 10.1021/ja071456k; Li B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055563; Liu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035014; Ma YH, 2011, TOXICOL LETT, V207, P258, DOI 10.1016/j.toxlet.2011.09.018; McNeilly JD, 2004, TOXICOL APPL PHARM, V196, P95, DOI 10.1016/j.taap.2003.11.021; Nagesha DK, 2005, ADV MATER, V17, P921, DOI 10.1002/adma.200401362; Park EJ, 2010, TOXICOL IN VITRO, V24, P872, DOI 10.1016/j.tiv.2009.12.001; Pokrovski GS, 1998, GEOCHIM COSMOCHIM AC, V62, P1631, DOI 10.1016/S0016-7037(98)00081-7; Qi SJ, 2007, CHEMBIOCHEM, V8, P1115, DOI 10.1002/cbic.200700119; Qi SJ, 2009, ACS APPL MATER INTER, V1, P30, DOI 10.1021/am800027d; Su YY, 2012, NANO LETT, V12, P1845, DOI 10.1021/nl204203t; Tamerler C, 2009, PHILOS T R SOC A, V367, P1705, DOI 10.1098/rsta.2009.0018; Tay CY, 2014, NANO LETT, V14, P83, DOI 10.1021/nl4032549; Tian BZ, 2012, NAT MATER, V11, P986, DOI [10.1038/NMAT3404, 10.1038/nmat3404]; Tian BZ, 2010, SCIENCE, V329, P830, DOI 10.1126/science.1192033; Willett RL, 2005, P NATL ACAD SCI USA, V102, P7817, DOI 10.1073/pnas.0408565102; Xie Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101062; Yi CQ, 2007, CHEMBIOCHEM, V8, P1225, DOI 10.1002/cbic.200700136; Zhang GJ, 2012, ANAL CHIM ACTA, V749, P1, DOI 10.1016/j.aca.2012.08.035; Zhang HY, 2012, ACS NANO, V6, P4349, DOI 10.1021/nn3010087; Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014	40	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e108006	10.1371/journal.pone.0108006	http://dx.doi.org/10.1371/journal.pone.0108006			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25237816	Green Published, gold			2022-12-25	WOS:000342491600075
J	Arya, P; Kumar, G; Acharya, V; Singh, AK				Arya, Preeti; Kumar, Gulshan; Acharya, Vishal; Singh, Anil K.			Genome-Wide Identification and Expression Analysis of NBS-Encoding Genes in Malus x domestica and Expansion of NBS Genes Family in Rosaceae	PLOS ONE			English	Article							DISEASE RESISTANCE GENES; DOWNY MILDEW RESISTANCE; TIR-NBS; LRR GENES; PHYLOGENIES; PATHOGENS; ALIGNMENT; PROTEINS; ANCIENT; REVEALS	Nucleotide binding site leucine-rich repeats (NBS-LRR) disease resistance proteins play an important role in plant defense against pathogen attack. A number of recent studies have been carried out to identify and characterize NBS-LRR gene families in many important plant species. In this study, we identified NBS-LRR gene family comprising of 1015 NBS-LRRs using highly stringent computational methods. These NBS-LRRs were characterized on the basis of conserved protein motifs, gene duplication events, chromosomal locations, phylogenetic relationships and digital gene expression analysis. Surprisingly, equal distribution of Toll/interleukin-1 receptor (TIR) and coiled coil (CC) (1: 1) was detected in apple while the unequal distribution was reported in majority of all other known plant genome studies. Prediction of gene duplication events intriguingly revealed that not only tandem duplication but also segmental duplication may equally be responsible for the expansion of the apple NBS-LRR gene family. Gene expression profiling using expressed sequence tags database of apple and quantitative real-time PCR (qRT-PCR) revealed the expression of these genes in wide range of tissues and disease conditions, respectively. Taken together, this study will provide a blueprint for future efforts towards improvement of disease resistance in apple.	[Acharya, Vishal] AcSIR, New Delhi, India; Inst Himalayan Bioresource Technol, CSIR, Div Biotechnol, Palampur, Himachal Prades, India	Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT)	Acharya, V (corresponding author), AcSIR, New Delhi, India.	vishal@ihbt.res.in; anil@ihbt.res.in	Singh, Ashok/HGF-2506-2022	ACHARYA, VISHAL/0000-0003-2175-9799; Arya, Preeti/0000-0002-0845-8003	Council of Scientific and Industrial Research (CSIR), New Delhi, India in the form of CSIR network project PlaGen [BSC0107]; CSIR-IHBT [MLP0076]	Council of Scientific and Industrial Research (CSIR), New Delhi, India in the form of CSIR network project PlaGen; CSIR-IHBT	This work was financially supported by Council of Scientific and Industrial Research (CSIR), New Delhi, India in the form of CSIR network project PlaGen (BSC0107) and CSIR-IHBT project MLP0076. Authors are thankful to Department of Biotechnology, Government of India for infrastructural support in the form of Bioinformatics Infrastructure Facility (BIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2010, PLANT BREEDING, V129, P208, DOI 10.1111/j.1439-0523.2009.01672.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ameline-Torregrosa C, 2008, PLANT PHYSIOL, V146, P5, DOI 10.1104/pp.107.104588; [Anonymous], 2012, MAPINSPECT SOFTW; [柏素花 Bai Suhua], 2014, [植物生理学报, Plant Physiology Journal], V50, P178; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Cannon SB, 2002, J MOL EVOL, V54, P548, DOI [10.1007/s00239-001-0057-2, 10.1007/s0023901-0057-2]; Cheng Y, 2012, FEBS J, V279, P2431, DOI 10.1111/j.1742-4658.2012.08621.x; Collier SM, 2011, MOL PLANT MICROBE IN, V24, P918, DOI 10.1094/MPMI-03-11-0050; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Das A, 2012, FUNCT INTEGR GENOMIC, V12, P215, DOI 10.1007/s10142-012-0284-1; Eddy S., 2003, HMMER USERS GUIDE; Ellis M A, 2008, FIRE BLIGHT APPLES P; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Feuillet C, 2003, P NATL ACAD SCI USA, V100, P15253, DOI 10.1073/pnas.2435133100; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Gassmann W, 1999, PLANT J, V20, P265, DOI 10.1046/j.1365-313X.1999.t01-1-00600.x; Gong CY, 2013, INT J MOL SCI, V14, P15330, DOI 10.3390/ijms140815330; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo YL, 2011, PLANT PHYSIOL, V157, P757, DOI 10.1104/pp.111.181990; Gupta SK, 2012, J EXP BOT, V63, P757, DOI 10.1093/jxb/err297; Han JingLan, 2013, African Journal of Biotechnology, V12, P5294; Horvath DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042036; Johnson K.B, 2000, PLANT HLTH INSTRUCTO, DOI [10.1094/PHII-2000-0726-01, DOI 10.1094/PHII-2000-0726-01]; Jupe F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-75; Kang YJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-139; Kohler A, 2008, PLANT MOL BIOL, V66, P619, DOI 10.1007/s11103-008-9293-9; Kumar S, 2012, INDIAN J VIROL, V23, P75, DOI 10.1007/s13337-011-0056-x; Kunkel SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039332; Lee SY, 2005, J PLANT BIOL, V48, P220, DOI 10.1007/BF03030411; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Li CJ, 2013, PHYSIOL MOL PLANT P, V84, P70, DOI 10.1016/j.pmpp.2013.07.006; Li J, 2010, MOL GENET GENOMICS, V283, P427, DOI 10.1007/s00438-010-0527-6; Lozano R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034775; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marine S.C., 2010, PLANT HLTH INSTR, DOI [10.1094/PHI-I-2010-1021-01, DOI 10.1094/PHI-I-2010-1021-01]; Marone D, 2013, INT J MOL SCI, V14, P7302, DOI 10.3390/ijms14047302; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Mohr TJ, 2010, MOL PLANT MICROBE IN, V23, P1303, DOI 10.1094/MPMI-01-10-0022; Mun JH, 2009, MOL GENET GENOMICS, V282, P617, DOI 10.1007/s00438-009-0492-0; Muoki RC, 2012, MOL BIOTECHNOL, V52, P82, DOI 10.1007/s12033-011-9476-5; Nandety RS, 2013, PLANT PHYSIOL, V162, P1459, DOI 10.1104/pp.113.219162; Perazzolli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083844; Porter BW, 2009, MOL GENET GENOMICS, V281, P609, DOI 10.1007/s00438-009-0434-x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tan SL, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/418208; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wan HJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-502; Wan HJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-186; Wang YP, 2012, NUCLEIC ACIDS RES, V40, DOI [10.1093/nar/gkr1293, 10.1093/nar/gkr1132]; Yang SH, 2008, MOL GENET GENOMICS, V280, P187, DOI 10.1007/s00438-008-0355-0; Yang SH, 2006, PLANT MOL BIOL, V62, P181, DOI 10.1007/s11103-006-9012-3; Yue JX, 2012, NEW PHYTOL, V193, P1049, DOI 10.1111/j.1469-8137.2011.04006.x; Zhang XC, 2003, PLANT CELL, V15, P2333, DOI 10.1105/tpc.013474; Zhang XH, 2011, MOL GENET GENOMICS, V285, P79, DOI 10.1007/s00438-010-0587-7; Zhou T, 2004, MOL GENET GENOMICS, V271, P402, DOI 10.1007/s00438-004-0990-z	62	62	67	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107987	10.1371/journal.pone.0107987	http://dx.doi.org/10.1371/journal.pone.0107987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232838	gold, Green Published, Green Submitted			2022-12-25	WOS:000342921200071
J	Fu, QS; Choi, JY; Gordon, AM; Jesunathadas, M; Santello, M				Fu, Qiushi; Choi, Jason Y.; Gordon, Andrew M.; Jesunathadas, Mark; Santello, Marco			Learned Manipulation at Unconstrained Contacts Does Not Transfer across Hands	PLOS ONE			English	Article							UNDERLYING MOTOR COMMANDS; CENTER-OF-MASS; SENSORIMOTOR MEMORY; ANTICIPATORY CONTROL; REACHING MOVEMENTS; REPRESENTATIONS; ADAPTATION; WEIGHT; FORCES; TASK	Recent studies about sensorimotor control of the human hand have focused on how dexterous manipulation is learned and generalized. Here we address this question by testing the extent to which learned manipulation can be transferred when the contralateral hand is used and/or object orientation is reversed. We asked subjects to use a precision grip to lift a grip device with an asymmetrical mass distribution while minimizing object roll during lifting by generating a compensatory torque. Subjects were allowed to grasp anywhere on the object's vertical surfaces, and were therefore able to modulate both digit positions and forces. After every block of eight trials performed in one manipulation context (i.e., using the right hand and at a given object orientation), subjects had to lift the same object in the second context for one trial (transfer trial). Context changes were made by asking subjects to switch the hand used to lift the object and/or rotate the object 180 degrees about a vertical axis. Therefore, three transfer conditions, hand switch (HS), object rotation (OR), and both hand switch and object rotation (HS+OR), were tested and compared with hand matched control groups who did not experience context changes. We found that subjects in all transfer conditions adapted digit positions across multiple transfer trials similar to the learning of control groups, regardless of different changes of contexts. Moreover, subjects in both HS and HS+OR group also adapted digit forces similar to the control group, suggesting independent learning of the left hand. In contrast, the OR group showed significant negative transfer of the compensatory torque due to an inability to adapt digit forces. Our results indicate that internal representations of dexterous manipulation tasks may be primarily built through the hand used for learning and cannot be transferred across hands.	[Fu, Qiushi; Choi, Jason Y.; Jesunathadas, Mark; Santello, Marco] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA; [Gordon, Andrew M.] Columbia Univ, Teachers Coll, Dept Biobehav Sci, New York, NY 10027 USA	Arizona State University; Arizona State University-Tempe; Columbia University; Columbia University Teachers College	Santello, M (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA.	marco.santello@asu.edu	Jesunathadas, Mark/K-5900-2019	Gordon, Andrew/0000-0003-1041-0479	National Science Foundation (NSF) [BCS-1153034, BCS 1152916]; European Commission [248587, FP7-ICT-2009-4-2-1]; Direct For Social, Behav & Economic Scie [1153034] Funding Source: National Science Foundation; Division Of Behavioral and Cognitive Sci [1152916] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was partially supported by a Collaborative Research Grant BCS-1153034 (MS) and BCS 1152916 (AG) from the National Science Foundation (NSF) and the European Commission with the Collaborative Project no. 248587, "THE Hand Embodied" within the FP7-ICT-2009-4-2-1 program "Cognitive Systems and Robotics". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert F, 2009, NEUROSCI LETT, V463, P188, DOI 10.1016/j.neulet.2009.07.080; Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Bursztyn LLCD, 2008, EXP BRAIN RES, V184, P127, DOI 10.1007/s00221-007-1173-z; Craje C, 2011, EXP BRAIN RES, V212, P119, DOI 10.1007/s00221-011-2704-1; Criscimagna-Hemminger SE, 2003, J NEUROPHYSIOL, V89, P168, DOI 10.1152/jn.00622.2002; Davare M, 2011, CURR OPIN NEUROBIOL, V21, P565, DOI 10.1016/j.conb.2011.05.021; DIZIO P, 1995, J NEUROPHYSIOL, V74, P1787, DOI 10.1152/jn.1995.74.4.1787; EDIN BB, 1992, J PHYSIOL-LONDON, V450, P547, DOI 10.1113/jphysiol.1992.sp019142; Flanagan JR, 2009, SENSORIMOTOR CONTROL, P161; Friedman J, 2007, CORTEX, V43, P444, DOI 10.1016/S0010-9452(08)70469-6; Fu QS, 2012, J NEUROSCI, V32, P15086, DOI 10.1523/JNEUROSCI.2468-12.2012; Fu QS, 2011, J NEUROSCI, V31, P13576, DOI 10.1523/JNEUROSCI.1143-11.2011; Fu QS, 2010, J NEUROSCI, V30, P9117, DOI 10.1523/JNEUROSCI.4159-09.2010; Gilster R, 2012, EXP BRAIN RES, V217, P137, DOI 10.1007/s00221-011-2980-9; GORDON AM, 1994, NEUROPSYCHOLOGIA, V32, P555, DOI 10.1016/0028-3932(94)90144-9; GORDON AM, 1993, J NEUROPHYSIOL, V69, P1789, DOI 10.1152/jn.1993.69.6.1789; Grafton ST, 2010, EXP BRAIN RES, V204, P475, DOI 10.1007/s00221-010-2315-2; Howard IS, 2013, J NEUROPHYSIOL, V109, P2632, DOI 10.1152/jn.00773.2012; Ingram JN, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002196; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1992, CURR OPIN NEUROBIOL, V2, P815, DOI 10.1016/0959-4388(92)90139-C; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P59; Lederman SJ, 2003, EXP BRAIN RES, V152, P156, DOI 10.1007/s00221-003-1522-5; Lukos J, 2007, J NEUROSCI, V27, P3894, DOI 10.1523/JNEUROSCI.4693-06.2007; Lukos JR, 2008, J NEUROSCI, V28, P12765, DOI 10.1523/JNEUROSCI.4335-08.2008; Malfait N, 2004, J NEUROSCI, V24, P8084, DOI 10.1523/JNEUROSCI.1742-04.2004; Quaney BM, 2004, EXP BRAIN RES, V155, P145, DOI 10.1007/s00221-003-1711-2; Sainburg RL, 2002, EXP BRAIN RES, V142, P241, DOI 10.1007/s00221-001-0913-8; Salimi I, 2003, EXP BRAIN RES, V150, P9, DOI 10.1007/s00221-003-1394-8; Salimi I, 2000, J NEUROPHYSIOL, V84, P2390, DOI 10.1152/jn.2000.84.5.2390; Zhang W, 2010, J NEUROPHYSIOL, V103, P2953, DOI 10.1152/jn.00140.2010	32	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e108222	10.1371/journal.pone.0108222	http://dx.doi.org/10.1371/journal.pone.0108222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233091	Green Published, gold, Green Submitted			2022-12-25	WOS:000342921200087
J	Gonzalez-Dominguez, E; Armengol, J; Rossi, V				Gonzalez-Dominguez, Elisa; Armengol, Josep; Rossi, Vittorio			Development and Validation of a Weather-Based Model for Predicting Infection of Loquat Fruit by Fusicladium eriobotryae	PLOS ONE			English	Article							LEAF WETNESS DURATION; VENTURIA-INAEQUALIS; PEAR LEAVES; APPLE-SCAB; CLADOSPORIUM-CARPOPHILUM; ENVIRONMENTAL-FACTORS; ASCOSPORE MATURATION; RELATIVE-HUMIDITY; TEMPERATURE; CONIDIA	A mechanistic, dynamic model was developed to predict infection of loquat fruit by conidia of Fusicladium eriobotryae, the causal agent of loquat scab. The model simulates scab infection periods and their severity through the sub-processes of spore dispersal, infection, and latency (i.e., the state variables); change from one state to the following one depends on environmental conditions and on processes described by mathematical equations. Equations were developed using published data on F. eriobotryae mycelium growth, conidial germination, infection, and conidial dispersion pattern. The model was then validated by comparing model output with three independent data sets. The model accurately predicts the occurrence and severity of infection periods as well as the progress of loquat scab incidence on fruit (with concordance correlation coefficients >0.95). Model output agreed with expert assessment of the disease severity in seven loquat-growing seasons. Use of the model for scheduling fungicide applications in loquat orchards may help optimise scab management and reduce fungicide applications.	[Gonzalez-Dominguez, Elisa; Armengol, Josep] Univ Politecn Valencia, Inst Agroforestal Mediterraneo, E-46071 Valencia, Spain; [Rossi, Vittorio] Univ Cattolica Sacro Cuore, Ist Entomol & Patol Vegetale, Piacenza, Italy	Universitat Politecnica de Valencia; Catholic University of the Sacred Heart	Gonzalez-Dominguez, E (corresponding author), Univ Politecn Valencia, Inst Agroforestal Mediterraneo, E-46071 Valencia, Spain.	elgondo2@gmail.com	Rossi, Vittorio/I-7869-2012	Rossi, Vittorio/0000-0003-4090-6117; Armengol, Josep/0000-0003-3815-8578; Gonzalez-Dominguez, Elisa/0000-0001-6598-0204	Cooperativa Agricola de Callosa d'En Sarria (Alicante, Spain); Programa de Apoyo a la Investigacion y Desarrollo de la Universidad Politecnica de Valencia [PAID-00-12]	Cooperativa Agricola de Callosa d'En Sarria (Alicante, Spain); Programa de Apoyo a la Investigacion y Desarrollo de la Universidad Politecnica de Valencia	This work was funded by Cooperativa Agricola de Callosa d'En Sarria (Alicante, Spain). Three months' stay of E. Gonzalez-Dominguez at the Universita Cattolica del Sacro Cuore (Piacenza, Italy) was supported by the Programa de Apoyo a la Investigacion y Desarrollo (PAID-00-12) de la Universidad Politecnica de Valencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavanja MCR, 2004, ANNU REV PUBL HEALTH, V25, P155, DOI 10.1146/annurev.publhealth.25.101802.123020; BECKER CM, 1994, PHYTOPATHOLOGY, V84, P372, DOI 10.1094/Phyto-84-372; Bennett JC, 2013, PEST MANAG SCI, V69, P955, DOI 10.1002/ps.3459; Boller EEF, 1998, IOBC WPRS B, V21, P1; BORIC B, 1985, Zastita Bilja, V36, P295; Brent KJ, 2007, FRAC MONOG, V2; BUCK AL, 1981, J APPL METEOROL, V20, P1527, DOI 10.1175/1520-0450(1981)020<1527:NEFCVP>2.0.CO;2; Caffi T, 2009, J PLANT PATHOL, V91, P535; De Marzo L., 1993, Bulletin OEPP (Organisation Europeenne et Mediterraneenne pour la Protection des Plantes), V23, P389, DOI 10.1111/j.1365-2338.1993.tb01341.x; De Wolf ED, 2007, ANNU REV PHYTOPATHOL, V45, P203, DOI 10.1146/annurev.phyto.44.070505.143329; Eikemo H, 2011, PLANT DIS, V95, P279, DOI 10.1094/PDIS-02-10-0125; Fourie P, 2013, PHYTOPATHOLOGY, V103, P281, DOI 10.1094/PHYTO-07-11-0194; GADOURY DM, 1982, PHYTOPATHOLOGY, V72, P901, DOI 10.1094/Phyto-72-901; GADOURY DM, 1986, PHYTOPATHOLOGY, V76, P112, DOI 10.1094/Phyto-76-112; Gent DH, 2013, ANNU REV PHYTOPATHOL, V51, P267, DOI 10.1146/annurev-phyto-082712-102356; Gent DH, 2011, PHYTOPATHOLOGY, V101, P640, DOI 10.1094/PHYTO-04-10-0124; Ghanbarnia K, 2009, PHYTOPATHOLOGY, V99, P879, DOI 10.1094/PHYTO-99-7-0879; Giosue S, 2010, IOBC WPRS B, V54, P345; Gladieux P, 2010, FUNGAL GENET BIOL, V47, P511, DOI 10.1016/j.fgb.2009.12.007; Gonzalez-Dominguez E, 2013, PLANT DIS, V97, P1331, DOI 10.1094/PDIS-02-13-0131-RE; Gonzalez-Dominguez E, 2013, PHYTOMA, V247, P50; Gonzalez-Dominguez E, 2014, PLANT HEAL IN PRESS; Gonzalez-Dominguez E, 2014, EUR J PLANT PATHOL, V139, P849, DOI 10.1007/s10658-014-0439-0; Gonzalez-Dominguez E, 2014, EUR J PLANT PATHOL, V139, P413, DOI 10.1007/s10658-014-0400-2; GOTTWALD TR, 1982, PHYTOPATHOLOGY, V72, P330; GOTTWALD TR, 1985, PHYTOPATHOLOGY, V75, P190, DOI 10.1094/Phyto-75-190; GVA, 2013, BUTLLETI AVISOS, V13; Hartman JR, 1999, PLANT DIS, V83, P531, DOI 10.1094/PDIS.1999.83.6.531; Holb IJ, 2004, J PHYTOPATHOL, V152, P639, DOI 10.1111/j.1439-0434.2004.00910.x; Holb IJ, 2003, ANN APPL BIOL, V142, P225, DOI 10.1111/j.1744-7348.2003.tb00245.x; Holtslag QA, 2004, CAN J PLANT PATHOL, V26, P304; Hui C, 2006, ECOL MODEL, V192, P317, DOI 10.1016/j.ecolmodel.2005.07.001; Jamar L, 2010, BIOTECHNOL AGRON SOC, V14, P423; JAMES JR, 1982, PHYTOPATHOLOGY, V72, P1073, DOI 10.1094/Phyto-72-1073; KRAUSE RA, 1975, ANNU REV PHYTOPATHOL, V13, P31, DOI 10.1146/annurev.py.13.090175.000335; Lan Z, 2003, PHYTOPATHOLOGY, V93, P1581, DOI 10.1094/PHYTO.2003.93.12.1581; LATHAM AJ, 1982, PHYTOPATHOLOGY, V72, P1339, DOI 10.1094/Phyto-77-1339; LAWRENCE EG, 1982, PHYTOPATHOLOGY, V72, P773, DOI 10.1094/Phyto-72-773; Leffelaar P.A., 1993, SYSTEMS ANAL SIMULAT; Legler SE, 2014, PLANT PATHOL, V63, P911, DOI 10.1111/ppa.12145; Li B, 2003, PLANT PATHOL, V52, P546, DOI 10.1046/j.1365-3059.2003.00887.x; Li BH, 2007, EUR J PLANT PATHOL, V118, P227, DOI 10.1007/s10658-007-9138-4; Li BH, 2005, PLANT PATHOL, V54, P357, DOI 10.1111/j.1365-3059.2005.01207.x; Lops F., 1993, Bulletin OEPP (Organisation Europeenne et Mediterraneenne pour la Protection des Plantes), V23, P385, DOI 10.1111/j.1365-2338.1993.tb01340.x; Luo Y, 2001, PHYTOPATHOLOGY, V91, P1197, DOI 10.1094/PHYTO.2001.91.12.1197; Mac Hardy, 1996, APPLE SCAB BIOL EPID, P545; MACHARDY WE, 1989, PHYTOPATHOLOGY, V79, P304, DOI 10.1094/Phyto-79-304; Mills W, 1954, CORNELL EXT B, V711; Nash J.E., 1970, J HYDROL, V10, P282, DOI [DOI 10.1016/0022-1694(70)90255-6, 10.1016/0022-1694(70)90255-6]; Obanor FO, 2011, PLANT PATHOL, V60, P190, DOI 10.1111/j.1365-3059.2010.02370.x; Obanor FO, 2008, EUR J PLANT PATHOL, V120, P211, DOI 10.1007/s10658-007-9209-6; Payne AF, 2012, PLANT DIS, V96, P1358, DOI 10.1094/PDIS-03-11-0202-RE; PROTA U., 1960, Studi sassaresi, Sez. III, V8, P175; Ptskialadze L, 1968, REV APPL MYCOL, V47, P268; Rossi V., 2007, Bulletin OEPP, V37, P300, DOI 10.1111/j.1365-2338.2007.01125.x; Rossi V, 2003, J PHYTOPATHOL, V151, P50, DOI 10.1046/j.1439-0434.2003.00680.x; Rossi V, 2009, PHYTOPATHOLOGY, V99, P453, DOI 10.1094/PHYTO-99-4-0453; Rossi V, 2005, ITAL J AGROMETEOROL, V13, P7; Rossi V, 2012, PHYTOPATHOL MEDITERR, V51, P457; Rossi V, 2010, PRECISION CROP PROTECTION - THE CHALLENGE AND USE OF HETEROGENEITY, P241, DOI 10.1007/978-90-481-9277-9_15; Roubal C, 2013, PLANT PATHOL, V62, P657, DOI 10.1111/j.1365-3059.2012.02666.x; Salerno M., 1971, Tecnica Agricola Catania, V23, P3; Sanchez-Torres P, 2009, PLANT DIS, V93, P1151, DOI 10.1094/PDIS-93-11-1151; Schut M, 2014, CROP PROT, V56, P98, DOI 10.1016/j.cropro.2013.11.017; Shtienberg D, 2013, ANNU REV PHYTOPATHOL, V51, P1, DOI 10.1146/annurev-phyto-082712-102244; SPOTTS RA, 1994, PHYTOPATHOLOGY, V84, P260, DOI 10.1094/Phyto-84-260; SPOTTS RA, 1991, PLANT DIS, V75, P1204, DOI 10.1094/PD-75-1204; Stensvand A, 1997, PHYTOPATHOLOGY, V87, P1046, DOI 10.1094/PHYTO.1997.87.10.1046; TENG PS, 1981, Z PFLANZENK PFLANZEN, V88, P49; Townsend C, 2008, ESSENTIALS ECOLOGY, P510; Trapman M., 2008, Ecofruit. 13th International Conference on Cultivation Technique and Phytopathological Problems in Organic Fruit-Growing. Proceedings of the conference, Weinsberg, Germany, 18-20 February 2008, P16; UMEMOTO S, 1990, Annals of the Phytopathological Society of Japan, V56, P468, DOI 10.3186/jjphytopath.56.468; Villalta O, 2000, AUSTRALAS PLANT PATH, V29, P255, DOI 10.1071/AP00048; Villalta ON, 2000, AUST J AGR RES, V51, P97, DOI 10.1071/AR99068; Viruega JR, 2013, PLANT DIS, V97, P1549, DOI 10.1094/PDIS-12-12-1206-RE; Viruega JR, 2011, PLANT DIS, V95, P1139, DOI 10.1094/PDIS-02-11-0126; Xu XM, 1995, PLANT PATHOL, V44, P865, DOI 10.1111/j.1365-3059.1995.tb02746.x; ZADOKS J C, 1979, P427	80	7	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107547	10.1371/journal.pone.0107547	http://dx.doi.org/10.1371/journal.pone.0107547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233340	gold, Green Published			2022-12-25	WOS:000342921200034
J	Kilickaya, O; Schmickl, C; Ahmed, A; Pulido, J; Onigkeit, J; Kashani, K; Gajic, O; Herasevich, V; Pickering, B				Kilickaya, Oguz; Schmickl, Christopher; Ahmed, Adil; Pulido, Juan; Onigkeit, James; Kashani, Kianoush; Gajic, Ognjen; Herasevich, Vitaly; Pickering, Brian			Customized Reference Ranges for Laboratory Values Decrease False Positive Alerts in Intensive Care Unit Patients	PLOS ONE			English	Article							INFORMATION OVERLOAD; USER INTERFACES; ALARMS; ICU; THERAPY; RECORD; TESTS	Background: Traditional electronic medical record (EMR) interfaces mark laboratory tests as abnormal based on standard reference ranges derived from healthy, middle-aged adults. This yields many false positive alerts with subsequent alert-fatigue when applied to complex populations like hospitalized, critically ill patients. Novel EMR interfaces using adjusted reference ranges customized for specific patient populations may ameliorate this problem. Objective: To compare accuracy of abnormal laboratory value indicators in a novel vs traditional EMR interface. Methods: Laboratory data from intensive care unit (ICU) patients consecutively admitted during a two-day period were recorded. For each patient, available laboratory results and the problem list were sent to two mutually blinded critical care experts, who marked the values about which they would like to be alerted. All disagreements were resolved by an independent super-reviewer. Based on this gold standard, we calculated and compared the sensitivity, specificity, positive and negative predictive values (PPV, NPV) of customized vs traditional abnormal value indicators. Results: Thirty seven patients with a total of 1341 laboratory results were included. Experts' agreement was fair (kappa = 0.39). Compared to the traditional EMR, custom abnormal laboratory value indicators had similar sensitivity (77% vs 85%, P = 0.22) and NPV (97.1% vs 98.6%, P = 0.06) but higher specificity (79% vs 61%, P<0.001) and PPV (28% vs 11%, P<0.001). Conclusions: Reference ranges for laboratory values customized for an ICU population decrease false positive alerts. Disagreement among clinicians about which laboratory values should be indicated as abnormal limits the development of customized reference ranges.	[Kilickaya, Oguz; Schmickl, Christopher; Ahmed, Adil; Pulido, Juan; Onigkeit, James; Gajic, Ognjen; Herasevich, Vitaly; Pickering, Brian] Mayo Clin, Dept Med, Div Pulm & Crit Care Med, Multidisciplinary Epidemiol & Translat Res Intens, Rochester, MN 55905 USA; [Schmickl, Christopher] Univ Witten Herdecke, Witten, Germany; [Pulido, Juan; Onigkeit, James; Gajic, Ognjen; Herasevich, Vitaly; Pickering, Brian] Mayo Clin, Dept Anesthesiol, Div Crit Care, Rochester, MN USA; [Kashani, Kianoush] Mayo Clin, Dept Med, Div Pulm & Crit Care, Rochester, MN USA; [Kashani, Kianoush] Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN USA	Mayo Clinic; Witten Herdecke University; Mayo Clinic; Mayo Clinic; Mayo Clinic	Pickering, B (corresponding author), Mayo Clin, Dept Med, Div Pulm & Crit Care Med, Multidisciplinary Epidemiol & Translat Res Intens, Rochester, MN 55905 USA.	Pickering.Brian@mayo.edu	Herasevich, Vitaly/V-4000-2019	Herasevich, Vitaly/0000-0002-0214-0651; Schmickl, Christopher/0000-0001-5417-9980	Centers for Medicare and Medicaid Service, Center for Medicare and Medicaid Innovation, a component of the United States Department of Human Health and Services (HHS) [CMS-1C1-12-0001]; CTSA from National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) [UL1 TR000135]	Centers for Medicare and Medicaid Service, Center for Medicare and Medicaid Innovation, a component of the United States Department of Human Health and Services (HHS); CTSA from National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The study was supported (VH, BP, OG) by Funding Opportunity Number CMS-1C1-12-0001 from the Centers for Medicare and Medicaid Service, Center for Medicare and Medicaid Innovation (http://www.cms.gov/), a component of the United States Department of Human Health and Services (HHS). This study was further supported (OK) in part by CTSA Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS, http://www.ncats.nih.gov/), a component of the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this report are solely the responsibility of the authors and do not necessarily represent the official view of HHS or any of its agencies (including NIH).	Ahmed A, 2011, CRIT CARE MED, V39, P1626, DOI 10.1097/CCM.0b013e31821858a0; Brigden ML, 2000, POSTGRAD MED, V107, P145; Carlsson L, 2010, GERONTOLOGY, V56, P259, DOI 10.1159/000251722; CARPENTER PC, 1994, INT J BIOMED COMPUT, V34, P159, DOI 10.1016/0020-7101(94)90019-1; Chambrin MC, 1999, INTENS CARE MED, V25, P1360, DOI 10.1007/s001340051082; Herasevich V, 2010, MAYO CLIN PROC, V85, P247, DOI 10.4065/mcp.2009.0479; Hwang MI, 1999, J INFORM SCI, V25, P213, DOI 10.1177/016555159902500305; LAWLESS ST, 1994, CRIT CARE MED, V22, P981, DOI 10.1097/00003246-199406000-00017; Lundberg G., 1972, MED LAB OBSERV, V4, P47; OCARROLL TM, 1986, ANAESTHESIA, V41, P742, DOI 10.1111/j.1365-2044.1986.tb12844.x; Pickering BW, 2009, AM J RESP CRIT CARE, V179; Pickering BW, 2010, APPL CLIN INFORM, V1, P116, DOI 10.4338/ACI-2009-12-CR-0027; Pickering BW, 2013, CRIT CARE MED, V41, P1502, DOI 10.1097/CCM.0b013e318287f0c0; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; The Joint Commission on Accreditation of Healthcare Organizations, LAB SERV 2014 NAT PA	15	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107930	10.1371/journal.pone.0107930	http://dx.doi.org/10.1371/journal.pone.0107930			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233485	Green Published, Green Submitted, gold			2022-12-25	WOS:000342921200062
J	Lieber, DJ; Catlett, J; Madayiputhiya, N; Nandakumar, R; Lopez, MM; Metcalf, WW; Buan, NR				Lieber, Dillon J.; Catlett, Jennifer; Madayiputhiya, Nandu; Nandakumar, Renu; Lopez, Madeline M.; Metcalf, William W.; Buan, Nicole R.			A Multienzyme Complex Channels Substrates and Electrons through Acetyl-CoA and Methane Biosynthesis Pathways in Methanosarcina	PLOS ONE			English	Article							CARBON-MONOXIDE DEHYDROGENASE; COENZYME-A; DECARBONYLASE/SYNTHASE COMPLEX; HETERODISULFIDE REDUCTASE; ESCHERICHIA-COLI; SUBUNIT-BETA; BINDING-SITE; BARKERI; ACETIVORANS; ACETATE	Multienzyme complexes catalyze important metabolic reactions in many organisms, but little is known about the complexes involved in biological methane production (methanogenesis). A crosslinking-mass spectrometry (XL-MS) strategy was employed to identify proteins associated with coenzyme M-coenzyme B heterodisulfide reductase (Hdr), an essential enzyme in all methane-producing archaea (methanogens). In Methanosarcina acetivorans, Hdr forms a multienzyme complex with acetyl-CoA decarbonylase synthase (ACDS), and F-420-dependent methylene-H4MPT reductase (Mer). ACDS is essential for production of acetyl-CoA during growth on methanol, or for methanogenesis from acetate, whereas Mer is essential for methanogenesis from all substrates. Existence of a Hdr: ACDS: Mer complex is consistent with growth phenotypes of ACDS and Mer mutant strains in which the complex samples the redox status of electron carriers and directs carbon flux to acetyl-CoA or methanogenesis. We propose the Hdr: ACDS: Mer complex comprises a special class of multienzyme redox complex which functions as a "biological router'' that physically links methanogenesis and acetyl-CoA biosynthesis pathways.	[Lieber, Dillon J.; Catlett, Jennifer; Buan, Nicole R.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Lieber, Dillon J.; Catlett, Jennifer; Buan, Nicole R.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE USA; [Madayiputhiya, Nandu; Nandakumar, Renu] Univ Nebraska, Redox Biol Ctr, Metabol Core Facil, Lincoln, NE USA; [Lopez, Madeline M.; Metcalf, William W.] Univ Illinois, Dept Microbiol, Urbana, IL USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Illinois System; University of Illinois Urbana-Champaign	Buan, NR (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA.	nbuan@unl.edu			National Science Foundation [IOS-1449525]; National Institute of General Medical Sciences of the National Institutes of Health [F32 GM078796, P20 RR-17675, P30GM103335]; Pepsi UCARE Fellowship; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-FG02-02ER15296]; Nebraska Tobacco Settlement Biomedical Research Development Funds; Direct For Biological Sciences [1449525] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103335, F32GM078796] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pepsi UCARE Fellowship; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Nebraska Tobacco Settlement Biomedical Research Development Funds; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This material is based upon work supported by the National Science Foundation under Grant No. IOS-1449525 to NRB; by the National Institute of General Medical Sciences of the National Institutes of Health under award numbers F32 GM078796 to NRB, P20 RR-17675, and P30GM103335; a Pepsi UCARE Fellowship to DJL; by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Award Number DE-FG02-02ER15296 to WWM; and by the Nebraska Tobacco Settlement Biomedical Research Development Funds. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation, the National Institutes of Health, the Department of Energy, or Pepsi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapakis CM, 2012, NAT CHEM BIOL, V8, P527, DOI [10.1038/NCHEMBIO.975, 10.1038/nchembio.975]; Aparicio JF, 2000, CHEM BIOL, V7, P895, DOI 10.1016/S1074-5521(00)00038-7; Aufhammer SW, 2005, PROTEIN SCI, V14, P1840, DOI 10.1110/ps.041289805; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Buan N, 2011, METHOD ENZYMOL, V494, P23, DOI 10.1016/B978-0-12-385112-3.00002-0; Buan NR, 2010, MOL MICROBIOL, V75, P843, DOI 10.1111/j.1365-2958.2009.06990.x; de Kok A, 1998, BBA-PROTEIN STRUCT M, V1385, P353, DOI 10.1016/S0167-4838(98)00079-X; Deppenmeier U, 1999, FEBS LETT, V457, P291, DOI 10.1016/S0014-5793(99)01026-1; FISCHER R, 1990, FEBS LETT, V269, P368, DOI 10.1016/0014-5793(90)81195-T; Funk T, 2004, J AM CHEM SOC, V126, P88, DOI 10.1021/ja0366033; Gencic S, 2008, BIOCHEMISTRY-US, V47, P5544, DOI 10.1021/bi7024035; Gong W, 2008, P NATL ACAD SCI USA, V105, P9558, DOI 10.1073/pnas.0800415105; GORST CM, 1991, J BIOL CHEM, V266, P20687; Guss Adam M., 2008, Archaea, V2, P193, DOI 10.1155/2008/534081; HEIDEN S, 1994, EUR J BIOCHEM, V221, P855, DOI 10.1111/j.1432-1033.1994.tb18800.x; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; Korndorfer IP, 2002, PROTEIN SCI, V11, P883, DOI 10.1110/ps.4150102; KRZYCKI JA, 1982, J BACTERIOL, V149, P247, DOI 10.1128/JB.149.1.247-254.1982; KRZYCKI JA, 1985, J BACTERIOL, V163, P1000, DOI 10.1128/JB.163.3.1000-1006.1985; Kung Y, 2012, NATURE, V484, P265, DOI 10.1038/nature10916; Lie TJ, 2012, P NATL ACAD SCI USA, V109, P15473, DOI 10.1073/pnas.1208779109; Matschiavelli N, 2012, J BACTERIOL, V194, P5377, DOI 10.1128/JB.00881-12; Metcalf WW, 1998, APPL ENVIRON MICROB, V64, P768; Metcalf WW, 1997, P NATL ACAD SCI USA, V94, P2626, DOI 10.1073/pnas.94.6.2626; Metcalf WW, 1996, J BACTERIOL, V178, P5797, DOI 10.1128/jb.178.19.5797-5802.1996; Miles EW, 2013, J BIOL CHEM, V288, P10084, DOI 10.1074/jbc.X113.463331; Oelgeschlager E, 2009, MOL MICROBIOL, V72, P1260, DOI 10.1111/j.1365-2958.2009.06723.x; PEER CW, 1994, J BACTERIOL, V176, P6974, DOI 10.1128/JB.176.22.6974-6979.1994; Rother M, 2004, P NATL ACAD SCI USA, V101, P16929, DOI 10.1073/pnas.0407486101; Schlegel K, 2012, FEBS J, V279, P4444, DOI 10.1111/febs.12031; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; TEBROMMELSTROET BWJ, 1991, BIOCHIM BIOPHYS ACTA, V1079, P293, DOI 10.1016/0167-4838(91)90072-8; UETAKE H, 1958, VIROLOGY, V5, P68, DOI 10.1016/0042-6822(58)90006-0; Wang MY, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-165; Welander PV, 2008, J BACTERIOL, V190, P1928, DOI 10.1128/JB.01424-07; Yu LPC, 2009, STRUCTURE, V17, P823, DOI 10.1016/j.str.2009.04.008	37	12	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107563	10.1371/journal.pone.0107563	http://dx.doi.org/10.1371/journal.pone.0107563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232733	Green Published, gold			2022-12-25	WOS:000342921200036
J	Tseng, TS; Park, JY; Zabaleta, J; Moody-Thomas, S; Sothern, MS; Chen, T; Evans, DE; Lin, HY				Tseng, Tung-Sung; Park, Jong Y.; Zabaleta, Jovanny; Moody-Thomas, Sarah; Sothern, Melinda S.; Chen, Ted; Evans, David E.; Lin, Hui-Yi			Role of Nicotine Dependence on the Relationship between Variants in the Nicotinic Receptor Genes and Risk of Lung Adenocarcinoma	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; TELOMERE DNA-CONTENT; FAGERSTROM TEST; SUSCEPTIBILITY LOCUS; CIGARETTE-SMOKING; GENOMIC INSTABILITY; HISTOLOGIC TYPE; SUBUNIT GENES; CANCER TRENDS; ODDS RATIOS	Several variations in the nicotinic receptor genes have been identified to be associated with both lung cancer risk and smoking in the genome-wide association (GWA) studies. However, the relationships among these three factors (genetic variants, nicotine dependence, and lung cancer) remain unclear. In an attempt to elucidate these relationships, we applied mediation analysis to quantify the impact of nicotine dependence on the association between the nicotinic receptor genetic variants and lung adenocarcinoma risk. We evaluated 23 single nucleotide polymorphisms (SNPs) in the five nicotinic receptor related genes (CHRNB3, CHRNA6, and CHRNA5/A3/B4) previously reported to be associated with lung cancer risk and smoking behavior and 14 SNPs in the four 'control' genes (TERT, CLPTM1L, CYP1A1, and TP53), which were not reported in the smoking GWA studies. A total of 661 lung adenocarcinoma cases and 1,347 controls with a smoking history, obtained from the Environment and Genetics in Lung Cancer Etiology case-control study, were included in the study. Results show that nicotine dependence is a mediator of the association between lung adenocarcinoma and gene variations in the regions of CHRNA5/A3/B4 and accounts for approximately 15% of this relationship. The top two CHRNA3 SNPs associated with the risk for lung adenocarcinoma were rs1051730 and rs12914385 (p-value = 1.9x10(-10) and 1.1x10(-10), respectively). Also, these two SNPs had significant indirect effects on lung adenocarcinoma risk through nicotine dependence (p = 0.003 and 0.007). Gene variations rs2736100 and rs2853676 in TERT and rs401681 and rs31489 in CLPTM1L had significant direct associations on lung adenocarcinoma without indirect effects through nicotine dependence. Our findings suggest that nicotine dependence plays an important role between genetic variants in the CHRNA5/A3/B4 region, especially CHRNA3, and lung adenocarcinoma. This may provide valuable information for understanding the pathogenesis of lung adenocarcinoma and for conducting personalized smoking cessation interventions.	[Tseng, Tung-Sung; Moody-Thomas, Sarah; Sothern, Melinda S.] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, New Orleans, LA USA; [Tseng, Tung-Sung; Zabaleta, Jovanny; Moody-Thomas, Sarah; Sothern, Melinda S.] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA USA; [Park, Jong Y.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL 33612 USA; [Zabaleta, Jovanny] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA USA; [Chen, Ted] Tulane Univ, Dept Global Community Hlth & Behav Sci, New Orleans, LA 70118 USA; [Evans, David E.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Hlth Outcomes & Behav, Tampa, FL 33612 USA; [Lin, Hui-Yi] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL 33612 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tulane University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Lin, HY (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL 33612 USA.	hui-Yi.lin@moffitt.org	Tseng, Tung-Sung/AFL-4208-2022	Lin, Hui-Yi/0000-0002-3307-5549; Tseng, Tung-Sung/0000-0001-6266-9891	NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA076292] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; American Cancer Society, 2013, CANC FACTS FIG 2013; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Anic GM, 2013, CANCER EPIDEMIOL, V37, P434, DOI 10.1016/j.canep.2013.02.010; Artandi SE, 2000, NAT MED, V6, P852, DOI 10.1038/78595; Artandi SE, 2000, CURR OPIN GENET DEV, V10, P39, DOI 10.1016/S0959-437X(99)00047-7; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Brennan P, 2011, LANCET ONCOL, V12, P399, DOI 10.1016/S1470-2045(10)70126-1; Buckley TC, 2005, ADDICT BEHAV, V30, P1029, DOI 10.1016/j.addbeh.2004.09.005; Chen LS, 2012, AM J PSYCHIAT, V169, P735, DOI 10.1176/appi.ajp.2012.11101545; Collins Allan C, 2009, Handb Exp Pharmacol, P85, DOI 10.1007/978-3-540-69248-5_4; Dasgupta P, 2006, CELL CYCLE, V5, P2324, DOI 10.4161/cc.5.20.3366; Davison GM, 2007, TRANSFUS APHER SCI, V37, P43, DOI 10.1016/j.transci.2007.04.006; Desmaze C, 2003, CANCER LETT, V194, P173, DOI 10.1016/S0304-3835(02)00704-8; Devesa SS, 2005, INT J CANCER, V117, P294, DOI 10.1002/ijc.21183; Diaz FJ, 2005, AUST NZ J PSYCHIAT, V39, P161, DOI 10.1111/j.1440-1614.2005.01538.x; DiFranza JR, 2013, ISRN ADDICTION; Ditlevsen S, 2005, EPIDEMIOLOGY, V16, P114, DOI 10.1097/01.ede.0000147107.76079.07; Doria-Rose VP, 2010, SCREENING PREVENTION, P53; Fagerstrom K O, 1996, Tob Control, V5, P52, DOI 10.1136/tc.5.1.52; Fidler JA, 2011, ADDICTION, V106, P631, DOI 10.1111/j.1360-0443.2010.03226.x; Fordyce CA, 2005, J UROLOGY, V173, P610, DOI 10.1097/01.ju.0000143195.49685.ce; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gabrielson E, 2006, RESPIROLOGY, V11, P533, DOI 10.1111/j.1440-1843.2006.00909.x; Gallus S, 2004, EUR J PUBLIC HEALTH, V14, P93, DOI 10.1093/eurpub/14.1.93; Gertler R, 2004, J CLIN ONCOL, V22, P1807, DOI 10.1200/JCO.2004.09.160; Granger MP, 2002, CRIT REV ONCOL HEMAT, V41, P29, DOI 10.1016/S1040-8428(01)00188-3; Griffith JK, 1999, BREAST CANCER RES TR, V54, P59, DOI 10.1023/A:1006128228761; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hecht SS, 2008, CHEM RES TOXICOL, V21, P160, DOI 10.1021/tx7002068; Hindorff L., 2014, CATALOG PUBLISHED GE; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Hoft NR, 2009, NEUROPSYCHOPHARMACOL, V34, P698, DOI 10.1038/npp.2008.122; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Le Marchand L, 2008, CANCER RES, V68, P9137, DOI 10.1158/0008-5472.CAN-08-2271; Lee KM, 2008, CANCER EPIDEM BIOMAR, V17, P1120, DOI 10.1158/1055-9965.EPI-07-2786; Lerman C, 2009, NICOTINE DEPENDENCE; Li Ming D, 2006, Curr Psychiatry Rep, V8, P158, DOI 10.1007/s11920-006-0016-0; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Londono-Vallejo JA, 2008, BIOCHIMIE, V90, P73, DOI 10.1016/j.biochi.2007.07.009; MacKinnon DP, 2007, CLIN TRIALS, V4, P499, DOI 10.1177/1740774507083434; MACKINNON DP, 1993, EVALUATION REV, V17, P144, DOI 10.1177/0193841X9301700202; Macqueen DA, 2013, PHARMACOGENOMICS J; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Montgomery E, 2004, AM J PATHOL, V164, P1523, DOI 10.1016/S0002-9440(10)63710-8; Ni ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052598; Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1; Peres J, 2011, J NATL CANCER I, V103, P848, DOI 10.1093/jnci/djr214; Perez-Rios M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-493; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Rodier F, 2005, INT J BIOCHEM CELL B, V37, P977, DOI 10.1016/j.biocel.2004.10.012; Rollison DE, 2011, LEUKEMIA LYMPHOMA, V52, P1528, DOI 10.3109/10428194.2011.568648; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Shay JW, 2001, RADIAT RES, V155, P188, DOI 10.1667/0033-7587(2001)155[0188:TATIFC]2.0.CO;2; Siedlinski M, 2013, HUM GENET, V132, P431, DOI 10.1007/s00439-012-1262-3; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sobel ME., 1982, SOCIOL METHODOL, V13, P290, DOI [DOI 10.2307/270723, 10.2307/270723]; Sobue T, 2002, INT J CANCER, V99, P245, DOI 10.1002/ijc.10308; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sullivan P F, 1999, Nicotine Tob Res, V1 Suppl 2, pS51; Sullivan P.F., 1999, NICOTINE TOB RES S2, V1, pS69; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Thun MJ, 1997, JNCI-J NATL CANCER I, V89, P1580, DOI 10.1093/jnci/89.21.1580; VanderWeele TJ, 2012, AM J EPIDEMIOL, V175, P1013, DOI 10.1093/aje/kwr467; VanderWeele TJ, 2010, AM J EPIDEMIOL, V172, P1339, DOI 10.1093/aje/kwq332; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047705; Wang J, 2011, GENET EPIDEMIOL, V35, P739, DOI 10.1002/gepi.20611; Wang JA, 2011, GENET EPIDEMIOL, V35, P190, DOI 10.1002/gepi.20568; Wang JA, 2010, CANCER-AM CANCER SOC, V116, P3458, DOI 10.1002/cncr.25085; Wang YF, 2010, CARCINOGENESIS, V31, P234, DOI 10.1093/carcin/bgp287; Weiss W, 1997, CHEST, V111, P1414, DOI 10.1378/chest.111.5.1414; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Widmann T, 2008, EXP HEMATOL, V36, P104, DOI 10.1016/j.exphem.2007.08.028; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; XH Ye, 2013, MOL BIOL REP; Xu CH, 2013, TUMOUR BIOL; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250; Yokota J, 2010, ADV CANCER RES, V109, P51, DOI 10.1016/B978-0-12-380890-5.00002-8; Zeiger JS, 2008, HUM MOL GENET, V17, P724, DOI 10.1093/hmg/ddm344	82	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107268	10.1371/journal.pone.0107268	http://dx.doi.org/10.1371/journal.pone.0107268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233467	Green Published, gold, Green Submitted			2022-12-25	WOS:000342921200021
J	Tullos, DD; Finn, DS; Walter, C				Tullos, Desiree D.; Finn, Debra S.; Walter, Cara			Geomorphic and Ecological Disturbance and Recovery from Two Small Dams and Their Removal	PLOS ONE			English	Article							CHANNEL RESPONSE; SPECIES TRAITS; RIVER; COMMUNITIES; VARIABILITY; FEEDBACKS; HABITAT; CONTEXT; SYSTEMS; CREEK	Dams are known to impact river channels and ecosystems, both during their lifetime and in their decommissioning. In this study, we applied a before-after-control-impact design associated with two small dam removals to investigate abiotic and biotic recovery trajectories from both the elimination of the press disturbance associated with the presence of dams and the introduction of a pulse disturbance associated with removal of dams. The two case studies represent different geomorphic and ecological conditions that we expected to represent low and high sensitivities to the pulse disturbance of dam removal: the 4 m tall, gravel-filled Brownsville Dam on the wadeable Calapooia River and the 12.5 m tall, sand and gravel-filled Savage Rapids Dam on the largely non-wadeable Rogue River. We evaluated both geomorphic and ecological responses annually for two years post removal, and asked if functional traits of the macroinvertebrate assemblages provided more persistent signals of ecological disturbance than taxonomically defined assemblages over the period of study. Results indicate that: 1) the presence of the dams constituted a strong ecological press disturbance to the near-downstream reaches on both rivers, despite the fact that both rivers passed unregulated flow and sediment during the high flow season; 2) ecological recovery from this press disturbance occurred within the year following the restoration action of dam removal, whereas signals of geomorphic disturbance from the pulse of released sediment persisted two years post-removal, and 3) the strength of the press disturbance and the rapid ecological recovery were detected regardless of whether recovery was assessed by taxonomic or functional assemblages and for both case studies, in spite of their different geomorphic settings.	[Tullos, Desiree D.; Walter, Cara] Oregon State Univ, Corvallis, OR 97331 USA; [Finn, Debra S.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Tullos, DD (corresponding author), Oregon State Univ, Corvallis, OR 97331 USA.	desiree.tullos@oregonstate.edu		Walter, Cara/0000-0001-5934-5482	Oregon Watershed Enhancement Board [207-091]; National Oceanic and Atmospheric Association (NOAA), National Marine Fisheries Service [NA07NMF4630201]	Oregon Watershed Enhancement Board; National Oceanic and Atmospheric Association (NOAA), National Marine Fisheries Service(National Oceanic Atmospheric Admin (NOAA) - USA)	The authors gratefully acknowledge funding support from the Oregon Watershed Enhancement Board, award number 207-091 and the National Oceanic and Atmospheric Association (NOAA), National Marine Fisheries Service, award number NA07NMF4630201 [DT, CW]. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartley R, 2002, IAHS-AISH P, P35; BENDER EA, 1984, ECOLOGY, V65, P1, DOI 10.2307/1939452; Brierly G.J., 2005, GEOMORPHOLOGY RIVER; Bunte K., 2001, RMRSGTR74 USDA FOR S, DOI DOI 10.2737/RMRS-GTR-74; Bushaw-Newton KL, 2002, J AM WATER RESOUR AS, V38, P1581, DOI 10.1111/j.1752-1688.2002.tb04366.x; Chiu MC, 2013, AQUAT ECOL, V47, P245, DOI 10.1007/s10452-013-9439-y; Church M.A., 1987, SEDIMENT TRANSPORT G, P43; Doledec S, 1999, FRESHWATER BIOL, V42, P737, DOI 10.1046/j.1365-2427.1999.00509.x; Doyle MW, 2005, GEOMORPHOLOGY, V71, P227, DOI 10.1016/j.geomorph.2004.04.011; Doyle MW, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001714; Doyle MW, 2002, J AM WATER RESOUR AS, V38, P1567, DOI 10.1111/j.1752-1688.2002.tb04365.x; East AE, 2014, GEOMORPHOLO IN PRESS; EPA, 2000, ENV MON ASS PROGR SU; EPA, 2001, ENV MON ASS PROGR SU; Faustini JM, 2007, J AM WATER RESOUR AS, V43, P1293, DOI 10.1111/j.1752-1688.2007.00114.x; Feld CK, 2011, ADV ECOL RES; Finn DS, 2005, FRESHWATER BIOL, V50, P243, DOI 10.1111/j.1365-2427.2004.01320.x; Gayraud S, 2003, FRESHWATER BIOL, V48, P2045, DOI 10.1046/j.1365-2427.2003.01139.x; GRAF WL, 1977, AM J SCI, V277, P178, DOI 10.2475/ajs.277.2.178; Jones KL, 2012, 20111280 US GEOL SUR; Karr J.R., 1999, RESTORING LIFE RUNNI, V1; Kaufmann P.R., 1999, EPA620R99003; Kaufmann PR, 2008, GEOMORPHOLOGY, V99, P150, DOI 10.1016/j.geomorph.2007.10.007; Kibler K, 2011, J AM WATER RESOUR AS, V47, P408, DOI 10.1111/j.1752-1688.2011.00523.x; Knighton D., 1998, FLUVIAL FORMS PROCES; LENAT D R, 1988, Journal of the North American Benthological Society, V7, P222, DOI 10.2307/1467422; Lisle TE, 2001, EARTH SURF PROC LAND, V26, P1409, DOI 10.1002/esp.300; Lisle TE, 2008, DEV EARTH S, V11, P443, DOI 10.1016/S0928-2025(07)11136-6; Lytle DA, 2004, TRENDS ECOL EVOL, V190, P1; Madej MA, 2001, WATER RESOUR RES, V37, P2259, DOI 10.1029/2001WR000229; Madej MA, 1996, EARTH SURF PROCESSES, V21, P911, DOI 10.1002/(SICI)1096-9837(199610)21:10<911::AID-ESP621>3.3.CO;2-T; McCowan K, 2007, REGISTER GUARD  0828, pA1; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McCune B., 2006, PC ORD MULTIVARIATE; Montgomery DR, 1999, J AM WATER RESOUR AS, V35, P397, DOI 10.1111/j.1752-1688.1999.tb03598.x; Mossop B, 2006, CAN J FISH AQUAT SCI, V63, P1515, DOI 10.1139/F06-060; NIEMI GJ, 1990, ENVIRON MANAGE, V14, P571, DOI 10.1007/BF02394710; Orr CH, 2008, RIVER RES APPL, V24, P804, DOI 10.1002/rra.1084; Palmer MA, 2005, J APPL ECOL, V42, P208, DOI 10.1111/j.1365-2664.2005.01004.x; Pearson AJ, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009733; Pizzuto J, 2002, BIOSCIENCE, V52, P683, DOI 10.1641/0006-3568(2002)052[0683:EODROR]2.0.CO;2; Poff NL, 2006, J N AM BENTHOL SOC, V25, P730, DOI 10.1899/0887-3593(2006)025[0730:FTNONA]2.0.CO;2; Poff NL, 2002, BIOSCIENCE, V52, P659, DOI 10.1641/0006-3568(2002)052[0659:HDVAWI]2.0.CO;2; POFF NL, 1990, ENVIRON MANAGE, V14, P629, DOI 10.1007/BF02394714; POFF NL, 1992, J N AM BENTHOL SOC, V11, P86, DOI 10.2307/1467885; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; Pollard AI, 2010, FRESHWATER BIOL, V55, P1420, DOI 10.1111/j.1365-2427.2009.02235.x; Pollard AI, 2004, HYDROBIOLOGIA, V513, P51, DOI 10.1023/B:hydr.0000018164.17234.4f; Reinhardt L, 2010, EARTH SURF PROC LAND, V35, P78, DOI 10.1002/esp.1912; Renofalt BM, 2013, RIVER RES APPL, V29, P1082, DOI 10.1002/rra.2592; RESH VH, 1988, J N AM BENTHOL SOC, V7, P433, DOI 10.2307/1467300; Runyon J, 2004, CALAPOOIA RIVER WATE; Sawaske SR, 2012, GEOMORPHOLOGY, V151, P50, DOI 10.1016/j.geomorph.2012.01.013; Service RF, 2011, SCIENCE, V334, P888, DOI 10.1126/science.334.6058.888; Sethi SA, 2004, HYDROBIOLOGIA, V525, P157, DOI 10.1023/B:HYDR.0000038862.63229.56; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Stanley EH, 2003, FRONT ECOL ENVIRON, V1, P15, DOI 10.1890/1540-9295(2003)001[0015:TOTEEO]2.0.CO;2; Stanley EH, 2002, J N AM BENTHOL SOC, V21, P172, DOI 10.2307/1468307; Thomson JR, 2005, J N AM BENTHOL SOC, V24, P192, DOI 10.1899/0887-3593(2005)024<0192:EOROAS>2.0.CO;2; Tullos DD, 2009, J N AM BENTHOL SOC, V28, P80, DOI 10.1899/07-122.1; U.S. Bureau of Reclamation, 2009, 13 US BUR RECL; U.S. Bureau of Reclamation, 2001, SAV RAP DAM SED EV S; Van Looy K, 2014, ECOL INDIC, V37, P10, DOI 10.1016/j.ecolind.2013.10.006; Walter C, 2010, RIVER RES APPL, V26, P1220, DOI 10.1002/rra.1323; Ward J., 1983, DYNAMICS LOTIC ECOSY, P29, DOI 10.2307/2259560; Wheaton JM, 2011, GEOMORPHOLOGY, V126, P265, DOI 10.1016/j.geomorph.2011.01.002; Wolman M. G., 1954, T AM GEOPHYS UNION, V35, P951, DOI DOI 10.1029/TR035I006P00951; WOLMAN MG, 1978, EARTH SURF PROC LAND, V3, P189, DOI 10.1002/esp.3290030207; Zuellig RE, 2002, WEST N AM NATURALIST, V62, P59; Zunka J, 2014, EARTH SURFA IN PRESS	70	42	44	1	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e108091	10.1371/journal.pone.0108091	http://dx.doi.org/10.1371/journal.pone.0108091			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233231	Green Published, gold, Green Submitted			2022-12-25	WOS:000342921200081
J	Beaufort, CM; Helmijr, JCA; Piskorz, AM; Hoogstraat, M; Ruigrok-Ritstier, K; Besselink, N; Murtaza, M; van IJcken, WFJ; Heine, AAJ; Smid, M; Koudijs, MJ; Brenton, JD; Berns, EMJJ; Helleman, J				Beaufort, Corine M.; Helmijr, Jean C. A.; Piskorz, Anna M.; Hoogstraat, Marlous; Ruigrok-Ritstier, Kirsten; Besselink, Nicolle; Murtaza, Muhammed; van IJcken, Wilfred F. J.; Heine, Anouk A. J.; Smid, Marcel; Koudijs, Marco J.; Brenton, James D.; Berns, Els M. J. J.; Helleman, Jozien			Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HYALURONIC ACID-PACLITAXEL; CARCINOMA-CELLS; CYANOMORPHOLINO DOXORUBICIN; TUMOR-MICROENVIRONMENT; GENOMIC ENRICHMENT; DRUG-SENSITIVITY; GENE-EXPRESSION; SIDE POPULATION; BREAST-CANCER	Epithelial ovarian cancer is a highly heterogeneous disease and remains the most lethal gynaecological malignancy in the Western world. Therapeutic approaches need to account for inter-patient and intra-tumoural heterogeneity and detailed characterization of in vitro models representing the different histological and molecular ovarian cancer subtypes is critical to enable reliable preclinical testing. There are approximately 100 publicly available ovarian cancer cell lines but their cellular and molecular characteristics are largely undescribed. We have characterized 39 ovarian cancer cell lines under uniform conditions for growth characteristics, mRNA/microRNA expression, exon sequencing, drug response for clinically-relevant therapeutics and collated all available information on the original clinical features and site of origin. We tested for statistical associations between the cellular and molecular features of the lines and clinical features. Of the 39 ovarian cancer cell lines, 14 were assigned as high-grade serous, four serous-type, one low-grade serous and 20 non-serous type. Three morphological subtypes: Epithelial (n = 21), Round (n = 7) and Spindle (n = 12) were identified that showed distinct biological and molecular characteristics, including overexpression of cell movement and migration-associated genes in the Spindle subtype. Comparison with the original clinical data showed association of the spindle-like tumours with metastasis, advanced stage, suboptimal debulking and poor prognosis. In addition, the expression profiles of Spindle, Round and Epithelial morphologies clustered with the previously described C1-stromal, C5-mesenchymal and C4 ovarian subtype expression profiles respectively. Comprehensive profiling of 39 ovarian cancer cell lines under controlled, uniform conditions demonstrates clinically relevant cellular and genomic characteristics. This data provides a rational basis for selecting models to develop specific treatment approaches for histological and molecular subtypes of ovarian cancer.	[Beaufort, Corine M.; Helmijr, Jean C. A.; Ruigrok-Ritstier, Kirsten; Heine, Anouk A. J.; Smid, Marcel; Berns, Els M. J. J.; Helleman, Jozien] Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands; [van IJcken, Wilfred F. J.] Erasmus MC, Ctr Biom, Rotterdam, Netherlands; [Piskorz, Anna M.; Brenton, James D.] Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Funct Genom Ovarian Canc Lab, Cambridge, England; [Hoogstraat, Marlous; Besselink, Nicolle; Koudijs, Marco J.] Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands; [Hoogstraat, Marlous; Besselink, Nicolle; Koudijs, Marco J.] Univ Med Ctr Utrecht, Ctr Personalized Canc Treatment, Utrecht, Netherlands; [Murtaza, Muhammed] Univ Cambridge, Canc Res UK Cambridge Inst, Mol & Computat Diagnost Lab, Cambridge, England	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Berns, EMJJ (corresponding author), Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands.	p.berns@erasmusmc.nl	van ijcken, willem/N-9805-2018; Hoogstraat, Marlous/ABD-2968-2021; Brenton, James D/B-3174-2008	van ijcken, willem/0000-0002-0421-8301; Brenton, James D/0000-0002-5738-6683; Hoogstraat, Marlous/0000-0002-4916-1177; Smid, Marcel/0000-0003-0605-1901; Murtaza, Muhammed/0000-0001-7557-2861	Center for Personalized Cancer Treatment (UMC Utrecht, Erasmus MC Rotterdam); Center for Personalized Cancer Treatment (Netherlands Cancer Institute Amsterdam); KWF-Alpe [UU 2011-4977]; European Organization for Research and Treatment of Cancer [EORTC STrF 2008-03]; Cancer Research UK [15601] Funding Source: researchfish	Center for Personalized Cancer Treatment (UMC Utrecht, Erasmus MC Rotterdam); Center for Personalized Cancer Treatment (Netherlands Cancer Institute Amsterdam); KWF-Alpe; European Organization for Research and Treatment of Cancer; Cancer Research UK(Cancer Research UK)	This research was supported in part by the Center for Personalized Cancer Treatment (a collaboration between the UMC Utrecht, Erasmus MC Rotterdam and the Netherlands Cancer Institute Amsterdam), the KWF-Alpe (UU 2011-4977) and the European Organization for Research and Treatment of Cancer (grant nr. EORTC STrF 2008-03, JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Anglesio MS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072162, 10.1371/annotation/ffcaf179-872f-470b-8bb6-f06d8ba6d03a]; Auzenne E, 2007, NEOPLASIA, V9, P479, DOI 10.1593/neo.07229; Banerjee S, 2011, EUR J CANCER, V47, pS116, DOI 10.1016/S0959-8049(11)70155-1; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BENARD J, 1985, CANCER RES, V45, P4970; Berns EMJJ, 2012, CANCER RES, V72, P2701, DOI 10.1158/0008-5472.CAN-11-3911; BOOCOCK CA, 1995, JNCI-J NATL CANCER I, V87, P506, DOI 10.1093/jnci/87.7.506; Bookman MA, 2011, EUR J CANCER, V47, pS93, DOI 10.1016/S0959-8049(11)70153-8; BUICK RN, 1985, CANCER RES, V45, P3668; Capes-Davis A, 2012, DATABASE CROSS CONTA, V6.8; Correia AL, 2012, DRUG RESIST UPDATE, V15, P39, DOI 10.1016/j.drup.2012.01.006; De Stefano I, 2011, CANCER CHEMOTH PHARM, V68, P107, DOI 10.1007/s00280-010-1462-2; de Toledo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048344; DelloRusso C, 2007, MOL CANCER RES, V5, P35, DOI 10.1158/1541-7786.MCR-06-0234; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Erkan M, 2012, NAT REV GASTRO HEPAT, V9, P454, DOI 10.1038/nrgastro.2012.115; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; FREEDMAN RS, 1978, CANCER, V42, P2352, DOI 10.1002/1097-0142(197811)42:5<2352::AID-CNCR2820420536>3.0.CO;2-#; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gupta N, 2013, GYNECOL ONCOL, V130, P200, DOI 10.1016/j.ygyno.2013.03.019; HAMILTON TC, 1984, SEMIN ONCOL, V11, P285; HAMILTON TC, 1983, CANCER RES, V43, P5379; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Harakalova M, 2011, NAT PROTOC, V6, P1870, DOI 10.1038/nprot.2011.396; Helleman J, 2006, INT J CANCER, V118, P1963, DOI 10.1002/ijc.21599; Helleman J, 2008, CLIN CANCER RES, V14, P5555, DOI 10.1158/1078-0432.CCR-08-0555; Helleman J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-201; Helleman J, 2010, GYNECOL ONCOL, V117, P170, DOI 10.1016/j.ygyno.2010.01.010; Helleman J, 2010, INT J BIOCHEM CELL B, V42, P25, DOI 10.1016/j.biocel.2009.10.016; HILLS CA, 1989, BRIT J CANCER, V59, P527, DOI 10.1038/bjc.1989.108; Hollestelle A, 2013, BREAST CANCER RES TR, V138, P47, DOI 10.1007/s10549-013-2415-3; Hollestelle A, 2010, BREAST CANCER RES TR, V122, P125, DOI 10.1007/s10549-009-0545-4; Hynes RO, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a004903; Iglewicz B, 1993, DETECT HANDLE OUTLIE, V16; Itamochi H, 2011, GYNECOL ONCOL, V122, P641, DOI 10.1016/j.ygyno.2011.05.003; Jansen MPHM, 2005, J CLIN ONCOL, V23, P732, DOI 10.1200/JCO.2005.05.145; KARLAN BY, 1988, GYNECOL ONCOL, V31, P103, DOI 10.1016/0090-8258(88)90276-4; Kompier LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013821; Korch C, 2012, GYNECOL ONCOL, V127, P241, DOI 10.1016/j.ygyno.2012.06.017; KUPPEN PJK, 1988, CANCER RES, V48, P3355; Kurman RJ, 2008, INT J GYNECOL PATHOL, V27, P151, DOI 10.1097/PGP.0b013e318161e4f5; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; LANGDON SP, 1988, CANCER RES, V48, P6166; Latifi A, 2011, J CELL BIOCHEM, V112, P2850, DOI 10.1002/jcb.23199; LAU DHM, 1990, CANCER RES, V50, P4056; LAU DHM, 1991, CANCER RES, V51, P5181; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lounis H, 1998, ONCOGENE, V17, P2359, DOI 10.1038/sj.onc.1202152; Lurkin I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008802; MACKILLOP WJ, 1983, CANCER RES, V43, P874; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; MARTH C, 1992, INT J CANCER, V50, P64, DOI 10.1002/ijc.2910500114; Meng EH, 2012, CLIN EXP METASTAS, V29, P939, DOI 10.1007/s10585-012-9482-4; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Naba A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014647; Nijman IJ, 2013, J ALLERGY CLIN IMMUN; Nijman IJ, 2010, NAT METHODS, V7, P913, DOI 10.1038/nmeth.1516; Paulsson J, 2014, SEMIN CANC BIOL; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Qi WJ, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-3; Ramirez-Ardila DE, 2013, BREAST CANCER RES TR, V139, P39, DOI 10.1007/s10549-013-2529-7; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saito K, 2012, MOL BIOL CELL, V23, P4739, DOI 10.1091/mbc.E12-04-0310; Schmuck R, 2011, AM J PATHOL, V178, P1792, DOI 10.1016/j.ajpath.2010.12.043; Sheppard KE, 2013, EUR J CANCER, V49, P3936, DOI 10.1016/j.ejca.2013.08.007; Sieuwerts AM, 2009, J NATL CANCER I, V101, P61, DOI 10.1093/jnci/djn419; Steg AD, 2012, CLIN CANCER RES, V18, P869, DOI 10.1158/1078-0432.CCR-11-2188; Tab TH, 2012, MATRISOME PROJECT; Taddei ML, 2011, MOL CANCER RES, V9, P149, DOI 10.1158/1541-7786.MCR-10-0298; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; VANDENBERGBAKKER CAM, 1993, INT J CANCER, V53, P613, DOI 10.1002/ijc.2910530415; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Vega FM, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120076; Verhaak RGW, 2013, J CLIN INVEST, V123, P517, DOI 10.1172/JCI65833; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang Y, 2013, ONCOGENE, V32, P872, DOI 10.1038/onc.2012.104; Wilson AP, 1996, BRIT J CANCER, V74, P722, DOI 10.1038/bjc.1996.428; WILSON AP, 1984, J NATL CANCER I, V72, P513; WOLF CR, 1987, INT J CANCER, V39, P695, DOI 10.1002/ijc.2910390607; Wood SL, 2014, CANCER TREAT REV, V40, P558, DOI 10.1016/j.ctrv.2013.10.001; Young JL, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-6; Zhang XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057692; Zheng HX, 2013, ONCOGENE, V32, P1183, DOI 10.1038/onc.2012.126; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	89	252	258	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e103988	10.1371/journal.pone.0103988	http://dx.doi.org/10.1371/journal.pone.0103988			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25230021	Green Published, Green Submitted, gold			2022-12-25	WOS:000342123900002
J	Burzynska, AZ; Chaddock-Heyman, L; Voss, MW; Wong, CN; Gothe, NP; Olson, EA; Knecht, A; Lewis, A; Monti, JM; Cooke, GE; Wojcicki, TR; Fanning, J; Chung, HD; Awick, E; McAuley, E; Kramer, AF				Burzynska, Agnieszka Zofia; Chaddock-Heyman, Laura; Voss, Michelle W.; Wong, Chelsea N.; Gothe, Neha P.; Olson, Erin A.; Knecht, Anya; Lewis, Andrew; Monti, Jim M.; Cooke, Gillian E.; Wojcicki, Thomas R.; Fanning, Jason; Chung, Hyondo David; Awick, Elisabeth; McAuley, Edward; Kramer, Arthur F.			Physical Activity and Cardiorespiratory Fitness Are Beneficial for White Matter in Low-Fit Older Adults	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; ENERGY-EXPENDITURE; VOXELWISE ANALYSIS; AEROBIC CAPACITY; ELDERLY-PEOPLE; BLOOD-PRESSURE; BED REST; BRAIN; EXERCISE; INTEGRITY	Physical activity (PA) and cardiorespiratory fitness (CRF) are associated with better cognitive function in late life, but the neural correlates for these relationships are unclear. To study these correlates, we examined the association of both PA and CRF with measures of white matter (WM) integrity in 88 healthy low-fit adults (age 60-78). Using accelerometry, we objectively measured sedentary behavior, light PA, and moderate to vigorous PA (MV-PA) over a week. We showed that greater MV-PA was related to lower volume of WM lesions. The association between PA and WM microstructural integrity (measured with diffusion tensor imaging) was region-specific: light PA was related to temporal WM, while sedentary behavior was associated with lower integrity in the parahippocampal WM. Our findings highlight that engaging in PA of various intensity in parallel with avoiding sedentariness are important in maintaining WM health in older age, supporting public health recommendations that emphasize the importance of active lifestyle.	[Burzynska, Agnieszka Zofia; Chaddock-Heyman, Laura; Wong, Chelsea N.; Knecht, Anya; Lewis, Andrew; Monti, Jim M.; Cooke, Gillian E.; McAuley, Edward; Kramer, Arthur F.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Voss, Michelle W.] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [Gothe, Neha P.; Olson, Erin A.; Wojcicki, Thomas R.; Fanning, Jason; Chung, Hyondo David; Awick, Elisabeth; McAuley, Edward] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Iowa; University of Illinois System; University of Illinois Urbana-Champaign	Burzynska, AZ (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.	agaburza@illinois.edu	Kramer, Arthur/AAB-2937-2019; Gothe, Neha/B-2781-2016; Salerno, Elizabeth/N-1317-2019; burzynska, agnieszka/ACX-5166-2022; Wojcicki, Thomas/L-1248-2016	Gothe, Neha/0000-0002-2736-757X; Salerno, Elizabeth/0000-0001-5152-3168; Kramer, Arthur/0000-0001-5870-2724; Wojcicki, Thomas/0000-0001-6320-413X	National Institute on Aging (NIA) [R37-AG025667]; Abbott Nutrition through the Center of Nutrition, Learning and Memory at the University of Illinois; "Changing Viewpoints" grant from the Robert Bosch Foundation; NATIONAL INSTITUTE ON AGING [R37AG025667] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Abbott Nutrition through the Center of Nutrition, Learning and Memory at the University of Illinois; "Changing Viewpoints" grant from the Robert Bosch Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging (NIA) grant (R37-AG025667) and a grant from Abbott Nutrition through the Center of Nutrition, Learning and Memory at the University of Illinois. A.Z.B was supported by the "Changing Viewpoints" grant from the Robert Bosch Foundation (http://www.bosch-stiftung.de/content/language2/html/39607.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, CIRCULATION, DOI DOI 10.1161/CIRCULATIONAHA.107.185649; BALOH RW, 1995, ARCH NEUROL-CHICAGO, V52, P975, DOI 10.1001/archneur.1995.00540340067014; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bennett IJ, 2010, HUM BRAIN MAPP, V31, P378, DOI 10.1002/hbm.20872; Bhadelia RA, 2009, STROKE, V40, P3816, DOI 10.1161/STROKEAHA.109.564765; Bhagat YA, 2004, J MAGN RESON IMAGING, V20, P216, DOI 10.1002/jmri.20102; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Bullitt E, 2009, AM J NEURORADIOL, V30, P1857, DOI 10.3174/ajnr.A1695; Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041; Burzynska AZ, 2013, J NEUROSCI, V 33, P17150, DOI 10.1523/JNEUROSCI.1426-13.2013; Cao LX, 2007, CURR BIOL, V17, P911, DOI 10.1016/j.cub.2007.04.040; Carro E, 2000, J NEUROSCI, V20, P2926; Chiang MC, 2011, NEUROIMAGE, V55, P448, DOI 10.1016/j.neuroimage.2010.12.053; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Craft LL, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-122; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; Demiot C, 2007, AM J PHYSIOL-HEART C, V293, pH3159, DOI 10.1152/ajpheart.00591.2007; Donahoo WT, 2004, CURR OPIN CLIN NUTR, V7, P599, DOI 10.1097/00075197-200411000-00003; Dunstan DW, 2012, DIABETES RES CLIN PR, V97, P368, DOI 10.1016/j.diabres.2012.05.020; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Erickson KI, 2009, HIPPOCAMPUS, V19, P1030, DOI 10.1002/hipo.20547; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gouw AA, 2006, J NEUROL, V253, P1189, DOI 10.1007/s00415-006-0193-5; Greenwood CE, 2005, NEUROBIOL AGING, V26, pS42, DOI 10.1016/j.neurobiolaging.2005.08.017; Hamburg NM, 2007, ARTERIOSCL THROM VAS, V27, P2650, DOI 10.1161/ATVBAHA.107.153288; Hamilton MT, 2004, EXERC SPORT SCI REV, V32, P161; Hart TL, 2011, J PHYS ACT HEALTH, V8, P848, DOI 10.1123/jpah.8.6.848; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013e3180304570; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; HOPPELER H, 1985, J APPL PHYSIOL, V59, P320, DOI 10.1152/jappl.1985.59.2.320; Husson I, 2005, CEREB CORTEX, V15, P250, DOI 10.1093/cercor/bhh127; Johnson NF, 2012, NEUROIMAGE, V59, P1514, DOI 10.1016/j.neuroimage.2011.08.032; Kramer AF, 1999, AGEING FITNESS NEURO; Longstreth WT, 1996, STROKE, V27, P1274, DOI 10.1161/01.STR.27.8.1274; Madden DJ, 2012, BBA-MOL BASIS DIS, V1822, P386, DOI 10.1016/j.bbadis.2011.08.003; Marks BL, 2011, BRIT J SPORT MED, V45, P1208, DOI 10.1136/bjsm.2009.068114; McAuley Edward, 2011, Ment Health Phys Act, V4, P5, DOI 10.1016/j.mhpa.2011.01.001; McDonnell BJ, 2013, AM J HYPERTENS, V26, P334, DOI 10.1093/ajh/hps055; Middleton LE, 2011, ARCH INTERN MED, V171, P1251, DOI 10.1001/archinternmed.2011.277; Mori S.W., 2005, MRI ATLAS HUMAN WHIT; O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; Pantoni L, 2002, CEREBROVASC DIS, V13, P7, DOI 10.1159/000049143; Peter I, 2014, MED SCI SPORT EXER, V46, P302, DOI 10.1249/MSS.0b013e3182a66155; Rasmussen P, 2009, EXP PHYSIOL, V94, P1062, DOI 10.1113/expphysiol.2009.048512; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sachdev PS, 2005, J NEUROL NEUROSUR PS, V76, P362, DOI 10.1136/jnnp.2004.042945; Schmidt R, 2003, LANCET, V361, P2046, DOI 10.1016/S0140-6736(03)13616-1; Schmidt R, 2007, STROKE, V38, P2619, DOI 10.1161/STROKEAHA.107.489112; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; SPINA RJ, 1993, J APPL PHYSIOL, V75, P849, DOI 10.1152/jappl.1993.75.2.849; Srikanth V, 2009, STROKE, V40, P175, DOI 10.1161/STROKEAHA.108.524355; Starr JM, 2003, J NEUROL NEUROSUR PS, V74, P94, DOI 10.1136/jnnp.74.1.94; Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055; Stranahan AM, 2011, J NEUROCHEM, V118, P611, DOI 10.1111/j.1471-4159.2011.07351.x; Szabo AN, 2011, NEUROPSYCHOLOGY, V25, P545, DOI 10.1037/a0022733; Thomas C, 2013, NEUROIMAGE, V73, P225, DOI 10.1016/j.neuroimage.2012.03.069; Tost H, 2013, NEUROPSYCHOPHARMACOL, V38, P525, DOI 10.1038/npp.2012.214; Tremblay MS, 2010, APPL PHYSIOL NUTR ME, V35, P725, DOI 10.1139/H10-079; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tseng BY, 2013, NEUROIMAGE, V82, P510, DOI 10.1016/j.neuroimage.2013.06.011; Ungvari Z, 2010, J GERONTOL A-BIOL, V65, P1028, DOI 10.1093/gerona/glq113; VAITKEVICIUS PV, 1993, CIRCULATION, V88, P1456, DOI 10.1161/01.CIR.88.4.1456; van Dijk EJ, 2004, HYPERTENSION, V44, P625, DOI 10.1161/01.HYP.0000145857.98904.20; Van Impe A, 2012, NEUROBIOL AGING, V33, P1900, DOI 10.1016/j.neurobiolaging.2011.06.013; Vernooij MW, 2008, NEUROIMAGE, V43, P470, DOI 10.1016/j.neuroimage.2008.07.052; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119; Voss MW, 2013, TRENDS COGN SCI, V17, P525, DOI 10.1016/j.tics.2013.08.001; Voss MW, 2013, BRAIN BEHAV IMMUN, V28, P90, DOI 10.1016/j.bbi.2012.10.021; Voss MW, 2010, NEUROPSYCHOLOGIA, V48, P1394, DOI 10.1016/j.neuropsychologia.2010.01.005; Voss MW, 2012, HUM BRAIN MAPP; Voss MW, 2014, MENT HLTH PHYS ACT; Wakefield DB, 2010, J AM GERIATR SOC, V58, P275, DOI 10.1111/j.1532-5415.2009.02699.x; Weinstock-Guttman B, 2007, J NEUROIMMUNOL, V188, P167, DOI 10.1016/j.jneuroim.2007.06.003; Whitman GT, 2001, NEUROLOGY, V57, P990, DOI 10.1212/WNL.57.6.990; Wickelgren I, 1998, SCIENCE, V280, P517, DOI 10.1126/science.280.5363.517; Yanagibori R, 1998, J INTERN MED, V243, P307, DOI 10.1046/j.1365-2796.1998.00303.x; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zheng JJJ, 2012, GERONTOLOGY, V58, P398, DOI 10.1159/000337815; Ziegler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069290; Zoladz JA, 2008, J PHYSIOL PHARMACOL, V59, P119	91	98	99	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107413	10.1371/journal.pone.0107413	http://dx.doi.org/10.1371/journal.pone.0107413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229455	gold, Green Published, Green Submitted			2022-12-25	WOS:000342123900042
J	Ghosh, R; Tiwary, BK; Kumar, A; Chakraborty, R				Ghosh, Runu; Tiwary, Bipransh Kumar; Kumar, Anoop; Chakraborty, Ranadhir			Guava Leaf Extract Inhibits Quorum-Sensing and Chromobacterium violaceum Induced Lysis of Human Hepatoma Cells: Whole Transcriptome Analysis Reveals Differential Gene Expression	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA VIRULENCE; PSIDIUM-GUAJAVA; MEDICINAL-PLANTS; BIOFILM FORMATION; IDENTIFICATION; L.; SYNERGY; SYSTEM; GROWTH; COMMUNICATION	Quorum sensing (QS) is a process mediated via small molecules termed autoinducers (AI) that allow bacteria to respond and adjust according to the cell population density by altering the expression of multitudinous genes. Since QS governs numerous bioprocesses in bacteria, including virulence, its inhibition promises to be an ideal target for the development of novel therapeutics. We found that the aqueous leaf extract of Psidium guajava (GLE) exhibited anti-QS properties as evidenced by inhibition of violacein production in Chromobacterium violaceum and swarming motility of Pseudomonas aeruginosa. The gram-negative bacterium, C. violaceum is a rare pathogen with high mortality rate. In this study, perhaps for the first time, we identified the target genes of GLE in C. violaceum MTCC 2656 by whole transcriptome analysis on Ion Torrent. Our data revealed that GLE significantly down-regulated 816 genes at least three fold, with p value <= 0.01, which comprises 19% of the C. violaceum MTCC 2656 genome. These genes were distributed throughout the genome and were associated with virulence, motility and other cellular processes, many of which have been described as quorum regulated in C. violaceum and other gram negative bacteria. Interestingly, GLE did not affect the growth of the bacteria. However, consistent with the gene expression pattern, GLE treated C. violaceum cells were restrained from causing lysis of human hepatoma cell line, HepG2, indicating a positive relationship between the QS-regulated genes and pathogenicity. Overall, our study proposes GLE as a QS inhibitor (QSI) with the ability to attenuate virulence without affecting growth. To the best of our knowledge, this is the first report which provides with a plausible set of candidate genes regulated by the QS system in the neglected pathogen C. violaceum.	[Ghosh, Runu; Tiwary, Bipransh Kumar; Kumar, Anoop; Chakraborty, Ranadhir] Univ N Bengal, Dept Biotechnol, OMICS Lab, Siliguri, W Bengal, India	University of North Bengal	Ghosh, R (corresponding author), Univ N Bengal, Dept Biotechnol, OMICS Lab, Siliguri, W Bengal, India.	disanru@yahoo.com	Kumar, Anoop/ABB-7336-2020; CHAKRABORTY, RANADHIR/M-4439-2016	Tiwary, Bipransh/0000-0002-9479-8740	Department of Biotechnology, Government of India [BT/Bio-CARe/06/141/2010-11]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study was funded by the Department of Biotechnology, Government of India (BT/Bio-CARe/06/141/2010-11) [Project Investigator-RG; Junior Research Fellow- BKT]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adonizio AL, 2006, J ETHNOPHARMACOL, V105, P427, DOI 10.1016/j.jep.2005.11.025; Al-Hussaini R, 2009, MOLECULES, V14, P3425, DOI 10.3390/molecules14093425; Atkinson S, 1999, MOL MICROBIOL, V33, P1267, DOI 10.1046/j.1365-2958.1999.01578.x; Baca-DeLancey RR, 1999, P NATL ACAD SCI USA, V96, P4610, DOI 10.1073/pnas.96.8.4610; Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; Birdi T, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-33; Brito Cristiana F Alves de, 2004, Genet Mol Res, V3, P148; Castro-Gomes T, 2014, J MICROBIOL, V52, P350, DOI 10.1007/s12275-014-3202-5; Chen HY, 2007, FOOD CHEM, V101, P686, DOI 10.1016/j.foodchem.2006.02.047; Chernin LS, 1998, J BACTERIOL, V180, P4435, DOI 10.1128/JB.180.17.4435-4441.1998; Choo JH, 2006, LETT APPL MICROBIOL, V42, P637, DOI 10.1111/j.1472-765X.2006.01928.x; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Dandekar AA, 2012, SCIENCE, V338, P264, DOI 10.1126/science.1227289; de Almeida DF, 2003, P NATL ACAD SCI USA, V100, P11660, DOI 10.1073/pnas.1832124100; Defoirdt T, 2013, TRENDS MICROBIOL, V21, P619, DOI 10.1016/j.tim.2013.09.006; Defoirdt T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000989; Deguchi Y, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-9; DeLisa MP, 2001, J BACTERIOL, V183, P5239, DOI 10.1128/JB.183.18.5239-5247.2001; Duran N, 2001, CRIT REV MICROBIOL, V27, P201, DOI 10.1080/20014091096747; Fantinatti-Garboggini Fabiana, 2004, Genet Mol Res, V3, P134; Gilbert B, 2003, CURR MED CHEM, V10, P13, DOI 10.2174/0929867033368583; Ginsburg H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S1; Gu XM, 2009, FEBS J, V276, P1450, DOI 10.1111/j.1742-4658.2009.06886.x; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Kalia VC, 2013, BIOTECHNOL ADV, V31, P224, DOI 10.1016/j.biotechadv.2012.10.004; Kalia VC, 2011, CRIT REV MICROBIOL, V37, P121, DOI 10.3109/1040841X.2010.532479; Karthik R, 2012, J INFECT DEV COUNTR, V6, P751, DOI 10.3855/jidc.1866; Kennan RM, 2001, J BACTERIOL, V183, P4451, DOI 10.1128/JB.183.15.4451-4458.2001; KESSLER E, 1995, METHOD ENZYMOL, V248, P740; KOBURGER JA, 1982, APPL ENVIRON MICROB, V44, P1463, DOI 10.1128/AEM.44.6.1463-1465.1982; Koh KH, 2011, J MICROBIOL IMMUNOL, V44, P144, DOI 10.1016/j.jmii.2009.10.001; Lee JH, 2011, CURR MICROBIOL, V62, P1321, DOI 10.1007/s00284-010-9862-4; Liu ZJ, 2013, FEMS MICROBIOL LETT, V341, P37, DOI 10.1111/1574-6968.12086; Martinelli D, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-25; MATSUO T, 1994, PHYTOCHEMISTRY, V36, P1027, DOI 10.1016/S0031-9422(00)90484-9; May CO, 2011, APPL ENVIRON MICROB, V77, P3061; McLean RJC, 2004, J MICROBIOL METH, V58, P351, DOI 10.1016/j.mimet.2004.04.016; Metwally AM, 2010, PHARMACOGN MAG, V6, P212, DOI 10.4103/0973-1296.66939; Miki T, 2010, MOL MICROBIOL, V77, P855, DOI 10.1111/j.1365-2958.2010.07248.x; Miller JH, 1972, DETERMINATION VIABLE, P31; Nicolau, 2012, MED AROMAT PLANTS, V11, P104, DOI DOI 10.4172/2167-0412.1000104; Orsetti A.G., 2013, OA CASE REPORTS, V2, P19, DOI DOI 10.13172/2052-0077-2-2-426; PASSADOR L, 1993, SCIENCE, V260, P1127, DOI 10.1126/science.8493556; Gutierrez RMP, 2008, J ETHNOPHARMACOL, V117, P1, DOI 10.1016/j.jep.2008.01.025; Prabu GR, 2006, J APPL MICROBIOL, V101, P487, DOI 10.1111/j.1365-2672.2006.02912.x; Preston MJ, 1997, INFECT IMMUN, V65, P3086, DOI 10.1128/IAI.65.8.3086-3090.1997; Priya K, 2013, SENSORS-BASEL, V13, P14558, DOI 10.3390/s131114558; Quave CL, 2008, J ETHNOPHARMACOL, V118, P418, DOI 10.1016/j.jep.2008.05.005; Rasmussen TB, 2006, INT J MED MICROBIOL, V296, P149, DOI 10.1016/j.ijmm.2006.02.005; Rasoanaivo P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S4; Razak Fathilah Abdul, 2003, J Oral Sci, V45, P201; Recouvreux DOS, 2008, CURR MICROBIOL, V57, P469, DOI 10.1007/s00284-008-9271-0; Rutherford ST, 2012, COLD SPRING HARB PER, V2; Ryu NH, 2012, J MED FOOD, V15, P231, DOI 10.1089/jmf.2011.1701; Sarkar S, 2008, FEMS MICROBIOL LETT, V282, P160, DOI 10.1111/j.1574-6968.2008.01080.x; Schaefer AL, 1996, P NATL ACAD SCI USA, V93, P9505, DOI 10.1073/pnas.93.18.9505; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2013, ANNU REV MICROBIOL, V67, P43, DOI 10.1146/annurev-micro-092412-155635; Stauff DL, 2011, J BACTERIOL, V193, P3871, DOI 10.1128/JB.05125-11; Swem LR, 2009, MOL CELL, V35, P143, DOI 10.1016/j.molcel.2009.05.029; Teoh A. Y. B., 2006, Hong Kong Medical Journal, V12, P228; Tremblay J, 2007, ENVIRON MICROBIOL, V9, P2622, DOI 10.1111/j.1462-2920.2007.01396.x; Vasavi Halkare Suryanarayana, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P954, DOI 10.1016/S2221-1691(13)60185-9; Wagner H, 2009, PHYTOMEDICINE, V16, P97, DOI 10.1016/j.phymed.2008.12.018; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0; Wood TK, 2009, ENVIRON MICROBIOL, V11, P1, DOI 10.1111/j.1462-2920.2008.01768.x; Yang CH, 2011, J CHIN MED ASSOC, V74, P435, DOI 10.1016/j.jcma.2011.08.013; Yang Q, 2015, ENVIRON MICROBIOL, V17, P960, DOI 10.1111/1462-2920.12420	70	29	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107703	10.1371/journal.pone.0107703	http://dx.doi.org/10.1371/journal.pone.0107703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229331	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900062
J	Shaukat, S; Angez, M; Alam, MM; Sharif, S; Khurshid, A; Malik, F; Rehman, L; Zaidi, SSZ				Shaukat, Shahzad; Angez, Mehar; Alam, Muhammad Masroor; Sharif, Salmaan; Khurshid, Adnan; Malik, Farzana; Rehman, Lubna; Zaidi, Syed Sohail Zahoor			Molecular Characterization and Phylogenetic Relationship of Wild Type 1 Poliovirus Strains Circulating across Pakistan and Afghanistan Bordering Areas during 2010-2012	PLOS ONE			English	Article							EPIDEMIOLOGY; ERADICATION; EMERGENCE; SEQUENCE	Pakistan and Afghanistan share a long uncontrolled border with extensive population movement on both sides. Wild poliovirus transmission has never been interrupted in this block due to war against terrorism, poor public health infrastructure, misconceptions about polio vaccines and inadequate immunization activities. All these issues complicate the eradication operations and reinforce the complexity of wiping out poliomyelitis from this region. This study illustrates the origins and routes of cross-border wild poliovirus type 1 (WPV1) transmission during 2010-2012 between Pakistan and Afghanistan. Sequence analyses were conducted based on complete VP1 capsid protein sequences for WPV1 study strains to determine the origin of poliovirus genetic lineages and their evolutionary relationships. Phylogenetic tree was constructed from VP1 gene sequences applying Maximum Likelihood method using Kimura 2-parameter model in MEGA program v 5.0. A total of 72 (14.3%) out of 502 wild-type 1 polioviruses were found circulating in border areas of both countries during 2010-2012. Molecular phylogenetic analysis classified these strains in to two sub-genotypes with four clusters and 18 lineages. Genetic data confirmed that the most of WPV1 lineages (12; 66.6%) were transmitted from Pakistan to Afghanistan. However, the genetic diversity was significantly reduced during 2012 as most of the lineages were completely eliminated. In conclusion, Pakistan-Afghanistan block has emerged as a single poliovirus reservoir sharing the multiple poliovirus lineages due to uncontrolled movement of people across the borders between two countries. If it is neglected, it can jeopardize the extensive global efforts done so-far to eradicate the poliovirus infection. Our data will be helpful to devise the preventive strategies for effective control of wild poliovirus transmission in this region.	[Shaukat, Shahzad; Angez, Mehar; Alam, Muhammad Masroor; Sharif, Salmaan; Khurshid, Adnan; Malik, Farzana; Rehman, Lubna; Zaidi, Syed Sohail Zahoor] Natl Inst Hlth, Dept Virol, Islamabad, Pakistan		Zaidi, SSZ (corresponding author), Natl Inst Hlth, Dept Virol, Islamabad, Pakistan.	sohailz@live.com	Shaukat, Shahzad/HHZ-1088-2022; Angez, Mehar/J-3792-2015; Zaidi, Syed Sohail Zahoor/F-7432-2015		WHO Global Polio Eradication Initiative	WHO Global Polio Eradication Initiative	The study was conducted with the help of donor organizations including Rotary International, Japan International Cooperation Agency, Bill and Melinda Gates Foundation and UNICEF that support the WHO Global Polio Eradication Initiative activities in Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander Jim, 2011, Morbidity and Mortality Weekly Report, V60, P1523; Angez M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-51; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P501; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P181; BELL EJ, 1980, B WORLD HEALTH ORGAN, V58, P423; CDC, 2010, CDC ASS RISKS GLOB P; Cruz JR, 2012, AM J EPIDEMIOL, V175, P86, DOI 10.1093/aje/kwr426; CSO, 2012, POP AFGH STAT YB 201, P6; GPEI, 2012, DAT MON; GPEI, 2013, 29 GPEI WHO; GPEI, 2013, INF COUNTR; Khan T, 2013, J EPIDEMIOL COMMUN H, V67, P696, DOI 10.1136/jech-2012-202162; Kilpatrick DR, 2009, J CLIN MICROBIOL, V47, P1939, DOI 10.1128/JCM.00702-09; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Majidi N, 2009, RES STUDY CROSS BORD; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Mirza MN, 2010, CROSS BORDER SECURIT; Modlin JF, 2010, NEW ENGL J MED, V362, P2346, DOI 10.1056/NEJMp1005405; Monsutti A, 2006, AFGHAN TRANSNATIONAL; MULDERS MN, 1995, J INFECT DIS, V171, P1399, DOI 10.1093/infdis/171.6.1399; Nathanson N, 2010, AM J EPIDEMIOL, V172, P1213, DOI 10.1093/aje/kwq320; Nishtar S, 2010, B WORLD HEALTH ORGAN, V88, P159, DOI 10.2471/BLT.09.066480; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; Shah M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-457; Siddique Q, 2011, PAKISTANS FUTURE POL; Stigter E, 2004, KANDHAR BUS STAND KA, P1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Webeck Jenna, 2012, Morbidity and Mortality Weekly Report, V61, P790; WHO, 2013, WKLY EPIDEMIOL REC, V62, P928; WHO, 1998, GEN SEQ EP TRACK P 1; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; Wood DJ, 1999, J MED VIROL, V58, P188, DOI 10.1002/(SICI)1096-9071(199906)58:2<188::AID-JMV15>3.3.CO;2-8; World Health Organization, 2004, WHOIVB0410	34	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107697	10.1371/journal.pone.0107697	http://dx.doi.org/10.1371/journal.pone.0107697			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229826	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900059
J	Bethge, N; Honne, H; Andresen, K; Hilden, V; Troen, G; Liestol, K; Holte, H; Delabie, J; Lind, GE; Smeland, EB				Bethge, Nicole; Honne, Hilde; Andresen, Kim; Hilden, Vera; Troen, Gunhild; Liestol, Knut; Holte, Harald; Delabie, Jan; Lind, Guro E.; Smeland, Erlend B.			A Gene Panel, Including LRP12, Is Frequently Hypermethylated in Major Types of B-Cell Lymphoma	PLOS ONE			English	Article							BETA-RECEPTOR-II; PROMOTER HYPERMETHYLATION; DNA METHYLATION; E-CADHERIN; BREAST-CANCER; CPG-ISLANDS; EXPRESSION; RESISTANCE; MALIGNANCIES; DETERMINANT	Epigenetic modifications and DNA methylation in particular, have been recognized as important mechanisms to alter gene expression in malignant cells. Here, we identified candidate genes which were upregulated after an epigenetic treatment of B-cell lymphoma cell lines (Burkitt's lymphoma, BL; Follicular lymphoma, FL; Diffuse large B-cell lymphoma, DLBCL activated B-cell like, ABC; and germinal center like, GCB) and simultaneously expressed at low levels in samples from lymphoma patients. Qualitative methylation analysis of 24 candidate genes in cell lines revealed five methylated genes (BMP7, BMPER, CDH1, DUSP4 and LRP12), which were further subjected to quantitative methylation analysis in clinical samples from 59 lymphoma patients (BL, FL, DLBCL ABC and GCB; and primary mediastinal B-cell lymphoma, PMBL). The genes LRP12 and CDH1 showed the highest methylation frequencies (94% and 92%, respectively). BMPER (58%), DUSP4 (32%) and BMP7 (22%), were also frequently methylated in patient samples. Importantly, all gene promoters were unmethylated in various control samples (CD19+ peripheral blood B cells, peripheral blood mononuclear cells and tonsils) as well as in follicular hyperplasia samples, underscoring a high specificity. The combination of LRP12 and CDH1 methylation could successfully discriminate between the vast majority of the lymphoma and control samples, emphasized by receiver operating characteristic analysis with a c-statistic of 0.999. These two genes represent promising epigenetic markers which may be suitable for monitoring of B-cell lymphoma.	[Bethge, Nicole; Hilden, Vera; Smeland, Erlend B.] Oslo Univ Hosp, Inst Canc Res, Dept Immunol, Oslo, Norway; [Bethge, Nicole; Honne, Hilde; Andresen, Kim; Hilden, Vera; Liestol, Knut; Holte, Harald; Lind, Guro E.; Smeland, Erlend B.] Univ Oslo, Ctr Canc Biomed, Oslo, Norway; [Honne, Hilde; Andresen, Kim; Lind, Guro E.] Oslo Univ Hosp, Inst Canc Res, Dept Canc Prevent, Oslo, Norway; [Troen, Gunhild; Delabie, Jan] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Liestol, Knut] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Holte, Harald] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Oncol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Smeland, EB (corresponding author), Oslo Univ Hosp, Inst Canc Res, Dept Immunol, Oslo, Norway.	ebs@rr-research.no	Holte, Harald/AAO-5647-2020; Smeland, Erlend/AAO-3214-2020	Delabie, Jan/0000-0001-5023-0689	South-Eastern Norway Regional Health Authority [39232, 39535]; Norwegian Cancer Society [33260, PR-2008-0163]; Research Council of Norway through its Centres of Excellence funding scheme [179571]	South-Eastern Norway Regional Health Authority; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway through its Centres of Excellence funding scheme	This work was supported by grants from the South-Eastern Norway Regional Health Authority (ES: no. 39232, funding NB as PhD and GEL: no. 39535), and The Norwegian Cancer Society (ES: no. 33260 and GEL: PR-2008-0163). In addition, this work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 179571. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Amara K, 2008, ANN ONCOL, V19, P1774, DOI 10.1093/annonc/mdn374; Andresen K, 2012, EPIGENETICS-US, V7, P1249, DOI 10.4161/epi.22191; Berx G, 2009, COLD SPRING HARBOR P, DOI [10.1101/cshperspect.a0031291, DOI 10.1101/CSHPERSPECT.A0031291]; Chen G, 2007, BLOOD, V109, P5301, DOI 10.1182/blood-2006-06-032128; Corn PG, 2000, CLIN CANCER RES, V6, P4243; Daibata M, 2007, CLIN CANCER RES, V13, P3528, DOI 10.1158/1078-0432.CCR-06-2766; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; de Carvalho F, 2009, INT J CANCER, V125, P1985, DOI 10.1002/ijc.24431; De S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003137; Esteller M, 2002, J NATL CANCER I, V94, P26; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Garnis C, 2004, ONCOGENE, V23, P2582, DOI 10.1038/sj.onc.1207367; Helbing T, 2010, CARDIOVASC RES, V85, P551, DOI 10.1093/cvr/cvp314; Herman JG, 1997, CANCER RES, V57, P837; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Huang Q, 2007, LEUKEMIA LYMPHOMA, V48, P1988, DOI 10.1080/10428190701573224; Ibanez de Caceres I, 2010, ONCOGENE, V29, P1681, DOI 10.1038/onc.2009.454; Inman GJ, 2011, CURR OPIN GENET DEV, V21, P93, DOI 10.1016/j.gde.2010.12.004; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kelley R, 2009, J CELL BIOL, V184, P597, DOI 10.1083/jcb.200808064; Kron K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004830; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Melki JR, 2000, BLOOD, V95, P3208; Mulero-Navarro S, 2008, CRIT REV ONCOL HEMAT, V68, P1, DOI 10.1016/j.critrevonc.2008.03.001; O'Riain C, 2009, LEUKEMIA, V23, P1858, DOI 10.1038/leu.2009.114; Pinto M, 2003, J PATHOL, V200, P32, DOI 10.1002/path.1327; Sebova K, 2011, CANCER BIOMARK, V10, P13, DOI 10.3233/CBM-2012-0230; Shaffer AL, 2002, NAT REV IMMUNOL, V2, P920, DOI 10.1038/nri953; Shaknovich R, 2010, BLOOD, V116, pE81, DOI 10.1182/blood-2010-05-285320; Shi HD, 2007, CARCINOGENESIS, V28, P60, DOI 10.1093/carcin/bgl092; Shivapurkar N, 2010, CURR MOL MED, V10, P123, DOI 10.2174/156652410790963303; Sudo M, 2004, INT J CANCER, V109, P194, DOI 10.1002/ijc.11701; Syed N, 2011, CANCER RES, V71, P3317, DOI 10.1158/0008-5472.CAN-10-2048; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Uccella S, 2009, J CLIN PATHOL, V62, P715, DOI 10.1136/jcp.2009.064741; Waha A, 2010, CANCER RES, V70, P1689, DOI 10.1158/0008-5472.CAN-09-3218; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Yamashita S, 2006, CANCER SCI, V97, P64, DOI 10.1111/j.1349-7006.2006.00136.x	42	9	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e104249	10.1371/journal.pone.0104249	http://dx.doi.org/10.1371/journal.pone.0104249			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226156	Green Published, gold, Green Submitted			2022-12-25	WOS:000344317700003
J	Ebeling, A; Meyer, ST; Abbas, M; Eisenhauer, N; Hillebrand, H; Lange, M; Scherber, C; Vogel, A; Weigelt, A; Weisser, WW				Ebeling, Anne; Meyer, Sebastian T.; Abbas, Maike; Eisenhauer, Nico; Hillebrand, Helmut; Lange, Markus; Scherber, Christoph; Vogel, Anja; Weigelt, Alexandra; Weisser, Wolfgang W.			Plant Diversity Impacts Decomposition and Herbivory via Changes in Aboveground Arthropods	PLOS ONE			English	Article							BIODIVERSITY LOSS; SPECIES RICHNESS; MULTITROPHIC INTERACTIONS; EXPERIMENTAL GRASSLANDS; LITTER DECOMPOSITION; SUBTROPICAL FORESTS; TEMPORAL STABILITY; INSECT HERBIVORY; FUNCTIONAL-ROLE; TROPHIC GROUPS	Loss of plant diversity influences essential ecosystem processes as aboveground productivity, and can have cascading effects on the arthropod communities in adjacent trophic levels. However, few studies have examined how those changes in arthropod communities can have additional impacts on ecosystem processes caused by them (e. g. pollination, bioturbation, predation, decomposition, herbivory). Therefore, including arthropod effects in predictions of the impact of plant diversity loss on such ecosystem processes is an important but little studied piece of information. In a grassland biodiversity experiment, we addressed this gap by assessing aboveground decomposer and herbivore communities and linking their abundance and diversity to rates of decomposition and herbivory. Path analyses showed that increasing plant diversity led to higher abundance and diversity of decomposing arthropods through higher plant biomass. Higher species richness of decomposers, in turn, enhanced decomposition. Similarly, species-rich plant communities hosted a higher abundance and diversity of herbivores through elevated plant biomass and C:N ratio, leading to higher herbivory rates. Integrating trophic interactions into the study of biodiversity effects is required to understand the multiple pathways by which biodiversity affects ecosystem functioning.	[Ebeling, Anne; Eisenhauer, Nico; Vogel, Anja; Weisser, Wolfgang W.] Univ Jena, Inst Ecol, Jena, Germany; [Meyer, Sebastian T.; Weisser, Wolfgang W.] Tech Univ Munich, Ctr Food & Life Sci Weihenstephan, Dept Ecol & Ecosyst Management, Freising Weihenstephan, Germany; [Abbas, Maike; Hillebrand, Helmut] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, Wilhelmshaven, Germany; [Lange, Markus] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Scherber, Christoph] Univ Gottingen, DNPW, D-37073 Gottingen, Germany; [Weigelt, Alexandra] Univ Leipzig, Dept Systemat Bot & Funct Biodivers, D-04109 Leipzig, Germany	Friedrich Schiller University of Jena; Technical University of Munich; Carl von Ossietzky Universitat Oldenburg; Max Planck Society; University of Gottingen; Leipzig University	Ebeling, A (corresponding author), Univ Jena, Inst Ecol, Jena, Germany.	anne.ebeling@uni-jena.de	Scherber, Christoph/B-6611-2009; Weisser, Wolfgang W/B-9718-2014; Meyer, Sebastian Tobias/AAH-3856-2021; Hillebrand, Helmut/I-1717-2014; Eisenhauer, Nico/I-3191-2019; Eisenhauer, Nico/I-5932-2012	Scherber, Christoph/0000-0001-7924-8911; Weisser, Wolfgang W/0000-0002-2757-8959; Meyer, Sebastian Tobias/0000-0003-0833-1472; Hillebrand, Helmut/0000-0001-7449-1613; Eisenhauer, Nico/0000-0002-0371-6720; Eisenhauer, Nico/0000-0002-0371-6720	Deutsche Forschungsgemeinschaft [FOR 1451]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was funded by the Deutsche Forschungsgemeinschaft (FOR 1451). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058179; ABRAMS PA, 1995, ECOLOGY, V76, P2019, DOI 10.2307/1941677; Allan E, 2011, ECOL LETT, V14, P1246, DOI 10.1111/j.1461-0248.2011.01694.x; ARBUCKLE JL, 1995, AMOS 4 0 USERS GUIDE; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Bardgett RD, 1999, SOIL BIOL BIOCHEM, V31, P317, DOI 10.1016/S0038-0717(98)00121-7; BERNAYS EA, 1993, COMP BIOCHEM PHYS A, V104, P125, DOI 10.1016/0300-9629(93)90019-Z; Berner D, 2005, OIKOS, V111, P525, DOI 10.1111/j.1600-0706.2005.14144.x; Borer ET, 2012, ECOL LETT, V15, P1457, DOI 10.1111/ele.12006; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Coleman D.C., 2004, FUNDAMENTALS SOIL EC; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Ebeling A, 2008, OIKOS, V117, P1808, DOI 10.1111/j.1600-0706.2008.16819.x; Ebeling A, 2013, BASIC APPL ECOL, V14, P246, DOI 10.1016/j.baae.2013.01.006; Eisenhauer N, 2012, BASIC APPL ECOL, V13, P571, DOI 10.1016/j.baae.2012.09.002; Eisenhauer N, 2012, PLANT SOIL, V351, P1, DOI 10.1007/s11104-011-1027-0; Eisenhauer N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016055; Frost PC, 2006, ECOL LETT, V9, P774, DOI 10.1111/j.1461-0248.2006.00919.x; Grace JB., 2015, STRUCTURAL EQUATION; Gruner DS, 2008, ECOL LETT, V11, P740, DOI 10.1111/j.1461-0248.2008.01192.x; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; Hattenschwiler S, 2005, P NATL ACAD SCI USA, V102, P1519, DOI 10.1073/pnas.0404977102; Hector A, 2000, OIKOS, V90, P357, DOI 10.1034/j.1600-0706.2000.900217.x; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; Hillebrand H, 2009, ECOL LETT, V12, P516, DOI 10.1111/j.1461-0248.2009.01304.x; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hooper DU, 2000, BIOSCIENCE, V50, P1049, DOI 10.1641/0006-3568(2000)050[1049:IBAABB]2.0.CO;2; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jonsson M, 2000, OIKOS, V89, P519, DOI 10.1034/j.1600-0706.2000.890311.x; Koricheva J, 2000, OECOLOGIA, V125, P271, DOI 10.1007/s004420000450; Long ZT, 2003, ECOLOGY, V84, P652, DOI 10.1890/0012-9658(2003)084[0652:ETRCHT]2.0.CO;2; Loranger H, 2013, INVERTEBRATE HERBIVO; Loranger J, 2013, ECOLOGY, V94, P1499, DOI 10.1890/12-2063.1; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; MCNAUGHTON SJ, 1989, NATURE, V341, P142, DOI 10.1038/341142a0; Milcu A, 2008, ECOLOGY, V89, P1872, DOI 10.1890/07-1377.1; Mulder CPH, 1999, ECOL LETT, V2, P237; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Reich PB, 2012, SCIENCE, V336, P589, DOI 10.1126/science.1217909; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Rosenkranz S, 2012, SOIL BIOL BIOCHEM, V48, P78, DOI 10.1016/j.soilbio.2012.01.008; Rzanny M, 2013, OIKOS, V122, P967, DOI 10.1111/j.1600-0706.2012.00114.x; Rzanny M, 2012, J ANIM ECOL, V81, P614, DOI 10.1111/j.1365-2656.2012.01951.x; Sabais ACW, 2011, ACTA OECOL, V37, P195, DOI 10.1016/j.actao.2011.02.002; Scherber C, 2006, J ECOL, V94, P922, DOI 10.1111/j.1365-2745.2006.01144.x; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Scherer-Lorenzen M, 2008, FUNCT ECOL, V22, P547, DOI 10.1111/j.1365-2435.2008.01389.x; Schuldt A, 2012, ECOL LETT, V15, P732, DOI 10.1111/j.1461-0248.2012.01792.x; Schuldt A, 2010, J ECOL, V98, P917, DOI 10.1111/j.1365-2745.2010.01659.x; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Srivastava DS, 1998, AM NAT, V152, P510, DOI 10.1086/286187; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; Vogel A, 2013, GLOBAL CHANGE BIOL, V19, P2795, DOI 10.1111/gcb.12225; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1	58	58	60	3	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e106529	10.1371/journal.pone.0106529	http://dx.doi.org/10.1371/journal.pone.0106529			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226237	Green Published, gold, Green Submitted			2022-12-25	WOS:000344317700012
J	Fang, XQ; Liu, XF; Yao, L; Chen, CQ; Lin, JF; Ni, PH; Zheng, XM; Fan, QS				Fang, Xuqian; Liu, Xiangfan; Yao, Ling; Chen, Changqiang; Lin, Jiafei; Ni, Peihua; Zheng, Xinmin; Fan, Qishi			New Insights into FAK Phosphorylation Based on a FAT Domain-Defective Mutation	PLOS ONE			English	Article							FOCAL ADHESION KINASE; TYROSINE PHOSPHORYLATION; STRUCTURAL BASIS; CELL-MIGRATION; CANCER-THERAPY; GROWTH-FACTOR; SRC SH2; V-SRC; LOCALIZATION; PAXILLIN	Mounting evidence suggests that the FAK N-terminal (FERM) domain controls FAK phosphorylation and function; however, little is known regarding the role of the C terminal (FAT) domain in FAK regulation. We identified a patient-derived FAK mutant, in which a 27-amino acid segment was deleted from the C-terminal FAT domain (named FAK-Del33). When FAK-Del33 was overexpressed in specific tumor cell lines, Y397 phosphorylation increased compared with that observed in cells expressing FAK-WT. Here, we attempt to unveil the mechanism of this increased phosphorylation. Using cell biology experiments, we show that FAK-Del33 is incapable of co-localizing with paxillin, and has constitutively high Y397 phosphorylation. With a kinase-dead mutation, it showed phosphorylation of FAK-Del33 has enhanced through autophosphorylation. It was also demonstrated that phosphorylation of FAK-Del33 is not Src dependent or enhanced intermolecular interactions, and that the hyperphosphorylation can be lowered using increasing amounts of transfected FERM domain. This result suggests that Del33 mutation disrupting of FAT's structural integrity and paxillin binding capacity leads to incapable of targeting Focal adhesions, but has gained the capacity for auto-phosphorylation in cis.	[Fang, Xuqian; Chen, Changqiang; Lin, Jiafei; Fan, Qishi] Shanghai Jiao Tong Univ, Sch Med, Ruijin North Hosp, Dept Clin Lab,Ruijin Hosp, Shanghai 200030, Peoples R China; [Liu, Xiangfan; Ni, Peihua] Shanghai Jiao Tong Univ, Sch Med, Fac Med Lab Sci, Shanghai 200030, Peoples R China; [Yao, Ling; Zheng, Xinmin] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Biol, Shanghai 200030, Peoples R China; [Zheng, Xinmin] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Cornell University	Fan, QS (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin North Hosp, Dept Clin Lab,Ruijin Hosp, Shanghai 200030, Peoples R China.	qishifan@126.com		fangxuqian, xuqian/0000-0002-0059-393X	National Natural Science Foundation of China [81071745]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was funded by National Natural Science Foundation of China under the grant 81071745. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbi S, 2002, HISTOL HISTOPATHOL, V17, P1163, DOI 10.14670/HH-17.1163; Arold ST, 2002, STRUCTURE, V10, P319, DOI 10.1016/S0969-2126(02)00717-7; Brami-Cherrier K, 2014, EMBO J, V33, P356, DOI 10.1002/embj.201386399; Brunton VG, 2005, CANCER RES, V65, P1335, DOI 10.1158/0008-5472.CAN-04-1949; CHAN PY, 1994, J BIOL CHEM, V269, P20567; Chen SY, 2006, MOL CELL BIOL, V26, P5155, DOI 10.1128/MCB.02186-05; Cohen LA, 2005, J BIOL CHEM, V280, P8197, DOI 10.1074/jbc.M412021200; Cooley MA, 2000, MOL BIOL CELL, V11, P3247, DOI 10.1091/mbc.11.9.3247; Corsi JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-198; Derkinderen P, 2001, J BIOL CHEM, V276, P38289; Dikic I, 1998, J BIOL CHEM, V273, P14301, DOI 10.1074/jbc.273.23.14301; Dixon RDS, 2004, STRUCTURE, V12, P2161, DOI 10.1016/j.str.2004.09.011; Fang XQ, 2014, BIOCHEM BIOPH RES CO, V443, P363, DOI 10.1016/j.bbrc.2013.11.134; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Gabarra-Niecko V, 2002, BIOCHEM J, V365, P591, DOI 10.1042/BJ20020065; Hauck CR, 2002, EMBO J, V21, P6289, DOI 10.1093/emboj/cdf631; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993; HILDEBRAND JD, 1995, MOL BIOL CELL, V6, P637, DOI 10.1091/mbc.6.6.637; Katz BZ, 2002, BBA-MOL CELL RES, V1592, P141, DOI 10.1016/S0167-4889(02)00308-7; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Lim ST, 2008, CELL CYCLE, V7, P2306, DOI 10.4161/cc.6367; Meng XN, 2009, BRIT J CANCER, V101, P327, DOI 10.1038/sj.bjc.6605154; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Poullet P, 2001, J BIOL CHEM, V276, P37686, DOI 10.1074/jbc.M106175200; Ryu SJ, 2006, APOPTOSIS, V11, P303, DOI 10.1007/s10495-006-3978-9; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; Shen Y, 1999, MOL BIOL CELL, V10, P2507, DOI 10.1091/mbc.10.8.2507; Shi Q, 2003, MOL BIOL CELL, V14, P4306, DOI 10.1091/mbc.E03-01-0046; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Thomas JW, 1999, J BIOL CHEM, V274, P36684, DOI 10.1074/jbc.274.51.36684; Toutant M, 2002, MOL CELL BIOL, V22, P7731, DOI 10.1128/MCB.22.22.7731-7743.2002; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; Xiong WC, 1998, J CELL SCI, V111, P1981	38	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107134	10.1371/journal.pone.0107134	http://dx.doi.org/10.1371/journal.pone.0107134			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226367	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700029
J	Karoopongse, E; Yeung, C; Byon, J; Ramakrishnan, A; Holman, ZJ; Jiang, PYZ; Yu, Q; Deeg, HJ; Marcondes, AM				Karoopongse, Ekapun; Yeung, Cecilia; Byon, John; Ramakrishnan, Aravind; Holman, Zaneta J.; Jiang, Peter Y. Z.; Yu, Qiang; Deeg, H. Joachim; Marcondes, A. Mario			The KDM2B-Let-7b-EZH2 Axis in Myelodysplastic Syndromes as a Target for Combined Epigenetic Therapy	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE EZH2; REGULATES CELL-PROLIFERATION; ACUTE MYELOID-LEUKEMIA; LUNG-CANCER CELLS; INHIBITOR 3-DEAZANEPLANOCIN; GENE-EXPRESSION; DNA METHYLATION; BONE-MARROW; STEM-CELLS; PROGRESSION	Both DNA and histone methylation are dysregulated in the myelodysplastic syndromes (MDS). Based on preliminary data we hypothesized that dysregulated interactions of KDM2B, let-7b and EZH2 signals lead to an aberrant epigenetic landscape. Gene expression in CD34+ cells from MDS marrows was analyzed by NanoString miR array and validated by real-time polymerase chain reaction (PCR). The functions of KDM2B, let-7b and EZH2 were characterized in myeloid cell lines and in primary MDS cells. Let-7b levels were significantly higher, and KDM2B and EZH2 expression was lower in primary CD34+ MDS marrow cells (n = 44) than in healthy controls (n = 21; p<0.013, and p<0.0001, respectively). Overexpression of let-7b reduced EZH2 and KDM2B protein levels, and decreased cells in S-phase while increasing G0/G1 cells (p = 0.0005), accompanied by decreased H3K27me3 and cyclin D1. Silencing of KDM2B increased let-7b expression. Treatment with the cyclopentanyl analog of 3-deazaadenosine, DZNep, combined with the DNA hypomethylating agent 5-azacitidine, decreased levels of EZH2, suppressed methylation of di-and tri-methylated H3K27, and increased p16 expression, associated with cell proliferation. Thus, KDM2B, via let-7b/EZH2, promotes transcriptional repression. DZNep bypassed the inhibitory KDM2B/let-7b/EZH2 axis by preventing H3K27 methylation and reducing cell proliferation. DZNep might be able to enhance the therapeutic effects of DNA hypomethylating agents such as 5-azacitidine, currently considered standard therapy for patients with MDS.	[Karoopongse, Ekapun; Yeung, Cecilia; Ramakrishnan, Aravind; Holman, Zaneta J.; Deeg, H. Joachim; Marcondes, A. Mario] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Yeung, Cecilia] Univ Washington, Dept Anat Pathol, Seattle, WA 98195 USA; [Byon, John] Univ Washington, Dept Hematol, Seattle, WA 98195 USA; [Ramakrishnan, Aravind; Deeg, H. Joachim; Marcondes, A. Mario] Univ Washington, Dept Med, Seattle, WA USA; [Jiang, Peter Y. Z.] Providence Reg Canc Partnership, Med Oncol, Everett, WA USA; [Jiang, Peter Y. Z.] Everett Clin, Everett, WA USA; [Yu, Qiang] Biopolis, A STAR, Genome Inst Singapore, Singapore, Singapore	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Marcondes, AM (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	mmarcond@fhcrc.org		Yu, Qiang/0000-0003-2132-8278	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [1 K08 DK085156-01A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK085156] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES, 1 K08 DK085156-01A1 - Transcriptional Control of Stroma Dependent Apoptosis in MDS. Author who received the funding is AMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Cheng LL, 2012, CLIN CANCER RES, V18, P4201, DOI 10.1158/1078-0432.CCR-12-0036; Crea F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-40; Elias HK, 2014, ONCOGENE, V33, P5139, DOI 10.1038/onc.2013.520; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Fiskus W, 2012, CLIN CANCER RES, V18, P6227, DOI 10.1158/1078-0432.CCR-12-0873; Garcia-Manero Guillermo, 2007, Hematology Am Soc Hematol Educ Program, P405; Garcia-Manero G, 2011, J CLIN ONCOL, V29, P516, DOI 10.1200/JCO.2010.31.0854; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; He J, 2011, BLOOD, V117, P3869, DOI 10.1182/blood-2010-10-312736; Hussein K, 2010, LEUKEMIA RES, V34, P1169, DOI 10.1016/j.leukres.2010.04.012; Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2008-06-163246; Kikuchi J, 2012, LUNG CANCER, V78, P138, DOI 10.1016/j.lungcan.2012.08.003; Kottakis F, 2011, MOL CELL, V43, P285, DOI 10.1016/j.molcel.2011.06.020; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Larsson CA, 2013, MOL CANCER RES, V11, P815, DOI 10.1158/1541-7786.MCR-12-0695; Lee JK, 2013, BIOCHEM BIOPH RES CO, V438, P647, DOI 10.1016/j.bbrc.2013.07.128; Li JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-49; Li X, 2013, HAEMATOLOGICA, V98, P414, DOI 10.3324/haematol.2012.071753; Li XA, 2010, BLOOD, V116, P2304, DOI 10.1182/blood-2009-09-242313; Makishima H, 2012, BLOOD, V119, P3203, DOI 10.1182/blood-2011-12-399774; Marcondes AM, 2010, BLOOD, V115, P1993, DOI 10.1182/blood-2009-08-236992; Nakagawa S, 2014, ONCOL REP, V31, P983, DOI 10.3892/or.2013.2922; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Pellagatti A, 2010, LEUKEMIA, V24, P756, DOI 10.1038/leu.2010.31; Pfau R, 2008, P NATL ACAD SCI USA, V105, P1907, DOI 10.1073/pnas.0711865105; Puppe J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2354; Richter T, 1999, J CLIN PATHOL, V52, P461, DOI 10.1136/jcp.52.6.461; Skriner K, 1997, J CLIN INVEST, V100, P127, DOI 10.1172/JCI119504; Sokol L, 2011, BRIT J HAEMATOL, V153, P24, DOI 10.1111/j.1365-2141.2011.08581.x; TOHYAMA K, 1994, BRIT J HAEMATOL, V87, P235, DOI 10.1111/j.1365-2141.1994.tb04904.x; Tzatsos A, 2011, J BIOL CHEM, V286, P33061, DOI 10.1074/jbc.M111.257667; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Will B, 2012, BLOOD, V120, P2076, DOI 10.1182/blood-2011-12-399683; Yamazaki J, 2013, INT J HEMATOL, V97, P175, DOI 10.1007/s12185-012-1197-4	36	24	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107817	10.1371/journal.pone.0107817	http://dx.doi.org/10.1371/journal.pone.0107817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225797	Green Published, gold, Green Submitted			2022-12-25	WOS:000344317700088
J	Pinna, A; Masala, S; Blasetti, F; Maiore, I; Cossu, D; Paccagnini, D; Mameli, G; Sechi, LA				Pinna, Antonio; Masala, Speranza; Blasetti, Francesco; Maiore, Irene; Cossu, Davide; Paccagnini, Daniela; Mameli, Giuseppe; Sechi, Leonardo A.			Detection of Serum Antibodies Cross-Reacting with Mycobacterium avium Subspecies paratuberculosis and Beta-Cell Antigen Zinc Transporter 8 Homologous Peptides in Patients with High-Risk Proliferative Diabetic Retinopathy	PLOS ONE			English	Article							PREVALENCE; INFECTION; CHILDREN; CXCL10; AGE	Purpose: MAP3865c, a Mycobacterium avium subspecies paratuberculosis (MAP) cell membrane protein, has a relevant sequence homology with zinc transporter 8 (ZnT8), a beta-cell membrane protein involved in Zn++ transportation. Recently, antibodies recognizing MAP3865c epitopes have been shown to cross-react with ZnT8 in type 1 diabetes patients. The purpose of this study was to detect antibodies against MAP3865c peptides in patients with high-risk proliferative diabetic retinopathy and speculate on whether they may somehow be involved in the pathogenesis of this severe retinal disorder. Methods: Blood samples were obtained from 62 type 1 and 80 type 2 diabetes patients with high-risk proliferative diabetic retinopathy and 81 healthy controls. Antibodies against 6 highly immunogenic MAP3865c peptides were detected by indirect ELISA. Results: Type 1 diabetes patients had significantly higher rates of positive antibodies than controls. Conversely, no statistically significant differences were found between type 2 diabetes patients and controls. After categorization of type 1 diabetes patients into two groups, one with positive, the other with negative antibodies, we found that they had similar mean visual acuity (similar to 0.6) and identical rates of vitreous hemorrhage (28.6%). Conversely, Hashimoto's thyroiditis prevalence was 4/13 (30.7%) in the positive antibody group and 1/49 (2%) in the negative antibody group, a statistically significant difference (P = 0.016). Conclusions: This study confirmed that type 1 diabetes patients have significantly higher rates of positive antibodies against MAP/ZnT8 peptides, but failed to find a correlation between the presence of these antibodies and the severity degree of high-risk proliferative diabetic retinopathy. The significantly higher prevalence of Hashimoto's disease among type 1 diabetes patients with positive antibodies might suggest a possible common environmental trigger for these conditions.	[Pinna, Antonio; Blasetti, Francesco; Maiore, Irene] Univ Sassari, Sect Ophthalmol, Dept Surg Microsurg & Med Sci, I-07100 Sassari, Italy; [Masala, Speranza; Cossu, Davide; Paccagnini, Daniela; Mameli, Giuseppe; Sechi, Leonardo A.] Univ Sassari, Dept Biomed Sci, Sect Expt & Clin Microbiol, I-07100 Sassari, Italy; [Pinna, Antonio] Azienda Osped Univ Sassari, Sassari, Italy	University of Sassari; University of Sassari; University of Sassari	Pinna, A (corresponding author), Univ Sassari, Sect Ophthalmol, Dept Surg Microsurg & Med Sci, I-07100 Sassari, Italy.	apinna@uniss.it	Sechi, Leonardo Antonio/Y-3109-2018; Cossu, Davide/AAD-7958-2019; Pinna, Antonio/H-5067-2018	Cossu, Davide/0000-0002-0557-9467; Pinna, Antonio/0000-0003-3052-2662; sechi, leonardo antonio/0000-0003-0566-2049; mameli, giuseppe/0000-0002-0286-5433				Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 1991, OPHTHALMOLOGY, V98, P786; [Anonymous], 1991, OPHTHALMOLOGY, V98, P741; Antonelli A, 2014, CYTOKINE GROWTH F R, V25, P57, DOI 10.1016/j.cytogfr.2014.01.006; Antonelli A, 2014, AUTOIMMUN REV, V13, P272, DOI 10.1016/j.autrev.2013.10.010; Bitti MLM, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/785262; Cossu A, 2013, CYTOKINE, V61, P337, DOI 10.1016/j.cyto.2012.11.008; Cossu D, 2013, FUTURE MICROBIOL, V8, P223, DOI [10.2217/fmb.12.135, 10.2217/FMB.12.135]; D'Amore M, 2010, J MED MICROBIOL, V59, P137, DOI 10.1099/jmm.0.013474-0; DeNiro M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050360; Grahn BH, 2001, J AM COLL NUTR, V20, P106, DOI 10.1080/07315724.2001.10719022; KARCIOGLU ZA, 1982, SURV OPHTHALMOL, V27, P114, DOI 10.1016/0039-6257(82)90195-3; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P520, DOI 10.1001/archopht.1984.01040030398010; La Torre D, 2013, ADV EXP MED BIOL, V771, P194; Masala S, 1014, PLOS ONE, V9; Masala S, 2014, ACTA DIABETOL, V51, P577, DOI 10.1007/s00592-014-0558-2; Masala S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063371; Masala S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026931; Paccagnini D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007109; Pozzato N, 2011, PREV VET MED, V102, P83, DOI 10.1016/j.prevetmed.2011.07.001; Sardu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032487; Scotto M, 2012, DIABETOLOGIA, V55, P2026, DOI 10.1007/s00125-012-2543-z; Sechi LA, 2005, AM J GASTROENTEROL, V100, P1529, DOI 10.1111/j.1572-0241.2005.41415.x; Sisto M, 2010, SCAND J INFECT DIS, V42, P787, DOI 10.3109/00365541003762306; Wills NK, 2008, EXP EYE RES, V87, P80, DOI 10.1016/j.exer.2008.04.013	26	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107802	10.1371/journal.pone.0107802	http://dx.doi.org/10.1371/journal.pone.0107802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226393	Green Published, gold			2022-12-25	WOS:000344317700085
J	Spanne, A; Geborek, P; Bengtsson, F; Jorntell, H				Spanne, Anton; Geborek, Pontus; Bengtsson, Fredrik; Jorntell, Henrik			Simulating Spinal Border Cells and Cerebellar Granule Cells under Locomotion - A Case Study of Spinocerebellar Information Processing	PLOS ONE			English	Article							RETICULOSPINAL NEURONAL-ACTIVITY; NUCLEUS INTERPOSITUS ANTERIOR; FIBER RECEPTIVE-FIELDS; PURKINJE-CELLS; TRACT NEURONS; DEVELOPMENTAL ADAPTATION; FUNCTIONAL-ORGANIZATION; RETROGRADE TRANSPORT; WITHDRAWAL REFLEXES; PARAVERMAL PART	The spinocerebellar systems are essential for the brain in the performance of coordinated movements, but our knowledge about the spinocerebellar interactions is very limited. Recently, several crucial pieces of information have been acquired for the spinal border cell (SBC) component of the ventral spinocerebellar tract (VSCT), as well as the effects of SBC mossy fiber activation in granule cells of the cerebellar cortex. SBCs receive monosynaptic input from the reticulospinal tract (RST), which is an important driving system under locomotion, and disynaptic inhibition from Ib muscle afferents. The patterns of activity of RST neurons and Ib afferents under locomotion are known. The activity of VSCT neurons under fictive locomotion, i.e. without sensory feedback, is also known, but there is little information on how these neurons behave under actual locomotion and for cerebellar granule cells receiving SBC input this is completely unknown. But the available information makes it possible to simulate the interactions between the spinal and cerebellar neuronal circuitries with a relatively large set of biological constraints. Using a model of the various neuronal elements and the network they compose, we simulated the modulation of the SBCs and their target granule cells under locomotion and hence generated testable predictions of their general pattern of modulation under this condition. This particular system offers a unique opportunity to simulate these interactions with a limited number of assumptions, which helps making the model biologically plausible. Similar principles of information processing may be expected to apply to all spinocerebellar systems.	[Spanne, Anton; Geborek, Pontus; Bengtsson, Fredrik; Jorntell, Henrik] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University	Jorntell, H (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	henrik.jorntell@med.lu.se			National Institute of Neurological Disorders and Stroke (NINDS)/National Institutes of Health (NIH) [R01 NS040863]; Hand Embodied (THE) - EU [248587]; Swedish Research Council (VR Medicine); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040863] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Hand Embodied (THE) - EU; Swedish Research Council (VR Medicine)(Swedish Research Council); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants from National Institute of Neurological Disorders and Stroke (NINDS)/National Institutes of Health (NIH) (R01 NS040863), The Hand Embodied (THE) (an Integrated Project funded by the EU under FP7, project no. 248587) and the Swedish Research Council (VR Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON G, 1987, J PHYSIOL-LONDON, V385, P107, DOI 10.1113/jphysiol.1987.sp016487; ARMSTRONG DM, 1984, J PHYSIOL-LONDON, V352, P403, DOI 10.1113/jphysiol.1984.sp015300; ARMSTRONG DM, 1988, J PHYSIOL-LONDON, V400, P405, DOI 10.1113/jphysiol.1988.sp017128; ARSHAVSKY YI, 1972, BRAIN RES, V43, P272, DOI 10.1016/0006-8993(72)90295-8; ARSHAVSKY YI, 1972, BRAIN RES, V43, P276, DOI 10.1016/0006-8993(72)90296-X; ARSHAVSKY YI, 1978, BRAIN RES, V151, P493, DOI 10.1016/0006-8993(78)91082-X; Bengtsson F, 2012, NEURAL NETW; Bengtsson F, 2009, P NATL ACAD SCI USA, V106, P2389, DOI 10.1073/pnas.0808428106; Bosco G, 2006, EXP BRAIN RES, V175, P83, DOI 10.1007/s00221-006-0530-7; BURKE R, 1971, EXP BRAIN RES, V12, P283; Cathala L, 2003, J NEUROSCI, V23, P6074, DOI 10.1523/JNEUROSCI.23-14-06074.2003; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Dean P, 2010, NAT REV NEUROSCI, V11, P30, DOI 10.1038/nrn2756; DREW T, 1986, J NEUROPHYSIOL, V55, P375, DOI 10.1152/jn.1986.55.2.375; Duguid I, 2012, J NEUROSCI, V32, P11132, DOI 10.1523/JNEUROSCI.0460-12.2012; EDGLEY SA, 1988, J PHYSIOL-LONDON, V401, P399, DOI 10.1113/jphysiol.1988.sp017169; EDGLEY SA, 1987, J PHYSIOL-LONDON, V392, P315, DOI 10.1113/jphysiol.1987.sp016782; EKEROT CF, 1995, EXP BRAIN RES, V106, P365; Ekerot CF, 2001, EUR J NEUROSCI, V13, P1303, DOI 10.1046/j.0953-816x.2001.01499.x; Fedirchuk B, 2013, J NEUROPHYSIOL, V109, P375, DOI 10.1152/jn.00649.2012; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; Geborek P, 2013, EUR J NEUROSCI, V37, P380, DOI 10.1111/ejn.12060; Geborek P, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00157; Hammar I, 2011, J PHYSIOL-LONDON, V589, P653, DOI 10.1113/jphysiol.2010.201178; Holmberg H, 1996, J PHYSIOL-LONDON, V495, P399, DOI 10.1113/jphysiol.1996.sp021602; Holmberg H, 1997, J NEUROSCI, V17, P2071; Jankowska E, 2011, J PHYSIOL-LONDON, V589, P5709, DOI 10.1113/jphysiol.2011.213678; Jankowska E, 2011, J PHYSIOL-LONDON, V589, P5727, DOI 10.1113/jphysiol.2011.213694; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; Jorntell H, 1999, J PHYSIOL-LONDON, V514, P551, DOI 10.1111/j.1469-7793.1999.551ae.x; Jorntell H, 2003, J NEUROSCI, V23, P9620; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; Jorntell H, 2010, TRENDS NEUROSCI, V33, P524, DOI 10.1016/j.tins.2010.08.004; LUNDBERG A, 1971, EXP BRAIN RES, V12, P295; Lundqvist M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000803; Maier MA, 1998, J NEUROPHYSIOL, V80, P2495, DOI 10.1152/jn.1998.80.5.2495; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MATSUSHITA M, 1980, J COMP NEUROL, V192, P143, DOI 10.1002/cne.901920110; MATSUSHITA M, 1979, J COMP NEUROL, V184, P81, DOI 10.1002/cne.901840106; Matsuyama K, 2000, J NEUROPHYSIOL, V84, P2257, DOI 10.1152/jn.2000.84.5.2257; Matsuyama K, 2000, J NEUROPHYSIOL, V84, P2237, DOI 10.1152/jn.2000.84.5.2237; OSCARSSON O, 1965, PHYSIOL REV, V45, P495, DOI 10.1152/physrev.1965.45.3.495; Oscarsson O., 1973, HDB SENSORY PHYSL VO, P339; Perlmutter SI, 1998, J NEUROPHYSIOL, V80, P2475, DOI 10.1152/jn.1998.80.5.2475; Prochazka A, 1998, J PHYSIOL-LONDON, V507, P293, DOI 10.1111/j.1469-7793.1998.293bu.x; Prut Y, 1999, NATURE, V401, P590, DOI 10.1038/44145; Raphael G, 2010, J NEUROSCI, V30, P9431, DOI 10.1523/JNEUROSCI.5537-09.2010; Saarinen A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000004; Santello M, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00023; Shrestha SS, 2012, NEUROSCIENCE, V226, P253, DOI 10.1016/j.neuroscience.2012.09.015; Shrestha SS, 2012, J PHYSIOL-LONDON, V590, P1737, DOI 10.1113/jphysiol.2011.226852; Spanne A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00199; Spanne A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002979; Takei T, 2010, J NEUROSCI, V30, P17041, DOI 10.1523/JNEUROSCI.4297-10.2010	55	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107793	10.1371/journal.pone.0107793	http://dx.doi.org/10.1371/journal.pone.0107793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226298	gold, Green Published, Green Submitted			2022-12-25	WOS:000344317700084
J	Maertens, L; Erpicum, C; Detry, B; Blacher, S; Lenoir, B; Carnet, O; Pequeux, C; Cataldo, D; Lecomte, J; Paupert, J; Noel, A				Maertens, Ludovic; Erpicum, Charlotte; Detry, Benoit; Blacher, Silvia; Lenoir, Benedicte; Carnet, Oriane; Pequeux, Christel; Cataldo, Didier; Lecomte, Julie; Paupert, Jenny; Noel, Agnes			Bone Marrow-Derived Mesenchymal Stem Cells Drive Lymphangiogenesis	PLOS ONE			English	Article							STROMAL CELLS; LYMPHATIC REGENERATION; ENDOTHELIAL-CELLS; PROGENITOR CELLS; TUMOR-GROWTH; VEGF-A; PROMOTES; ANGIOGENESIS; CANCER; METASTASIS	It is now well accepted that multipotent Bone-Marrow Mesenchymal Stem Cells (BM-MSC) contribute to cancer progression through several mechanisms including angiogenesis. However, their involvement during the lymphangiogenic process is poorly described. Using BM-MSC isolated from mice of two different backgrounds, we demonstrate a paracrine lymphangiogenic action of BM-MSC both in vivo and in vitro. Co-injection of BM-MSC and tumor cells in mice increased the in vivo tumor growth and intratumoral lymphatic vessel density. In addition, BM-MSC or their conditioned medium stimulated the recruitment of lymphatic vessels in vivo in an ear sponge assay, and ex vivo in the lymphatic ring assay (LRA). In vitro, MSC conditioned medium also increased the proliferation rate and the migration of both primary lymphatic endothelial cells (LEC) and an immortalized lymphatic endothelial cell line. Mechanistically, these pro-lymphangiogenic effects relied on the secretion of Vascular Endothelial Growth Factor (VEGF)-A by BM-MSC that activates VEGF Receptor (VEGFR)-2 pathway on LEC. Indeed, the trapping of VEGF-A in MSC conditioned medium by soluble VEGF Receptors (sVEGFR)-1, -2 or the inhibition of VEGFR-2 activity by a specific inhibitor (ZM 323881) both decreased LEC proliferation, migration and the phosphorylation of their main downstream target ERK1/2. This study provides direct unprecedented evidence for a paracrine lymphangiogenic action of BM-MSC via the production of VEGF-A which acts on LEC VEGFR-2.	[Maertens, Ludovic; Erpicum, Charlotte; Detry, Benoit; Blacher, Silvia; Carnet, Oriane; Pequeux, Christel; Cataldo, Didier; Lecomte, Julie; Paupert, Jenny; Noel, Agnes] Univ Liege, Lab Tumor & Dev Biol, GIGA Canc, Liege, Belgium; [Lenoir, Benedicte] CRP Sante, Lab Cardiovasc Res, Luxembourg, Luxembourg	University of Liege; Luxembourg Institute of Health	Noel, A (corresponding author), Univ Liege, Lab Tumor & Dev Biol, GIGA Canc, Liege, Belgium.	agnes.noel@ulg.ac.be	Cataldo, Didier/GPG-3453-2022	Paupert, Jenny/0000-0001-9550-9296; Noel, Agnes/0000-0002-7670-6179; Cataldo, Didier/0000-0002-3079-7941; Pequeux, Christel/0000-0001-8275-1489	Fonds de la Recherche Scientifique - FNRS (F.R.S.-FNRS, Belgium) [7.4583.12, 7.4531.11, 7.4529.11]; Fondation contre le Cancer (foundation of public interest, Belgium); Fonds speciaux de la Recherche (University of Liege); Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege); Direction Generale Operationnelle de l'Economie, de l'Emploi et de la Recherche from the Service Public de Wallonie (SPW, Belgium); Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium); Plan National Cancer (Service Public Federal); Actions de Recherche Concertees (University of Liege, Belgium); Televie-FNRS grant	Fonds de la Recherche Scientifique - FNRS (F.R.S.-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Fondation contre le Cancer (foundation of public interest, Belgium); Fonds speciaux de la Recherche (University of Liege)(University of Liege); Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege)(University of Liege); Direction Generale Operationnelle de l'Economie, de l'Emploi et de la Recherche from the Service Public de Wallonie (SPW, Belgium); Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium)(Belgian Federal Science Policy Office); Plan National Cancer (Service Public Federal); Actions de Recherche Concertees (University of Liege, Belgium); Televie-FNRS grant	This work was supported by grants from the Fonds de la Recherche Scientifique - FNRS (F.R.S.-FNRS, Belgium) no. 7.4583.12, 7.4531.11 and 7.4529.11. This work was also supported by grants from the Fondation contre le Cancer (foundation of public interest, Belgium), the Fonds speciaux de la Recherche (University of Liege); the Centre Anticancereux pres l'Universite de Liege; the Fonds Leon Fredericq (University of Liege); the Direction Generale Operationnelle de l'Economie, de l'Emploi et de la Recherche from the Service Public de Wallonie (SPW, Belgium); the Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium); the Plan National Cancer (Service Public Federal); The Actions de Recherche Concertees (University of Liege, Belgium). L.M., C.E., O.C. and B.D. each received a Televie-FNRS grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo A, 2012, ONCOGENE, V31, P4499, DOI 10.1038/onc.2011.602; Avraham T, 2010, AM J PATHOL, V177, P3202, DOI 10.2353/ajpath.2010.100594; Barcellos-de-Souza P, 2013, BBA-REV CANCER, V1836, P321, DOI 10.1016/j.bbcan.2013.10.004; Bergfeld SA, 2010, CANCER METAST REV, V29, P249, DOI 10.1007/s10555-010-9222-7; Berndt S, 2009, J CLIN ENDOCR METAB, V94, P4567, DOI 10.1210/jc.2009-0443; Bexell D, 2009, MOL THER, V17, P183, DOI 10.1038/mt.2008.229; Bjorndahl MA, 2005, CANCER RES, V65, P9261, DOI 10.1158/0008-5472.CAN-04-2345; Blacher Silvia, 2001, Angiogenesis, V4, P133, DOI 10.1023/A:1012251229631; Bruyere F, 2008, NAT METHODS, V5, P431, DOI [10.1038/nmeth.1205, 10.1038/NMETH.1205]; Bruyere F, 2010, FASEB J, V24, P8, DOI 10.1096/fj.09-132852; Buttler K, 2013, CELL MOL LIFE SCI; Coffelt SB, 2009, P NATL ACAD SCI USA, V106, P3806, DOI 10.1073/pnas.0900244106; Conrad C, 2009, CIRCULATION, V119, P281, DOI 10.1161/CIRCULATIONAHA.108.793208; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Davani S, 2003, CIRCULATION, V108, P253, DOI 10.1161/01.cir.0000089186.09692.fa; De Boeck A, 2013, GUT, V62, P550, DOI 10.1136/gutjnl-2011-301393; Dellinger MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028947; Detry B, 2013, INVEST OPHTH VIS SCI, V54, P3082, DOI 10.1167/iovs.12-10856; Detry B, 2012, BLOOD, V119, P5048, DOI 10.1182/blood-2011-12-400267; El Hour M, 2010, ONCOGENE, V29, P3025, DOI 10.1038/onc.2010.49; Galdiero MR, 2013, J CELL PHYSIOL, V228, P1404, DOI 10.1002/jcp.24260; Hammer T, 2009, MICROVASC RES, V78, P25, DOI 10.1016/j.mvr.2009.02.007; Hass R, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-26; Hernanda PY, 2013, CARCINOGENESIS, V34, P2330, DOI 10.1093/carcin/bgt210; Hsiao ST, 2013, STEM CELLS DEV, V22, P1614, DOI 10.1089/scd.2012.0602; Hsiao STF, 2012, STEM CELLS DEV, V21, P2189, DOI 10.1089/scd.2011.0674; Huang WH, 2013, ONCOGENE, V32, P4343, DOI 10.1038/onc.2012.458; Jeltsch M, 2014, CIRCULATION, V129, P1962, DOI 10.1161/CIRCULATIONAHA.113.002779; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kidd S, 2008, CYTOTHERAPY, V10, P657, DOI 10.1080/14653240802486517; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kwon YW, 2013, BBA-MOL BASIS DIS, V1832, P2136, DOI 10.1016/j.bbadis.2013.08.002; Lecomte J, 2012, NEOPLASIA, V14, P943, DOI 10.1593/neo.121092; Lecomte J, 2011, CELL MOL LIFE SCI, V68, P677, DOI 10.1007/s00018-010-0476-6; Liersch R, 2007, THROMB HAEMOSTASIS, V98, P304, DOI 10.1160/TH07-04-0238; Lin RZ, 2012, ANGIOGENESIS, V15, P443, DOI 10.1007/s10456-012-9272-2; Liu Y, 2011, J BIOL CHEM, V286, P25007, DOI 10.1074/jbc.M110.213108; Marino D, 2013, J DERMATOL SCI, V71, P184, DOI 10.1016/j.jdermsci.2013.04.024; Masset A, 2011, INT J CANCER, V128, P283, DOI 10.1002/ijc.25326; O'Connell JT, 2011, P NATL ACAD SCI USA, V108, P16002, DOI 10.1073/pnas.1109493108; Paupert J, 2011, MOL ASPECTS MED, V32, P146, DOI 10.1016/j.mam.2011.04.002; Religa P, 2005, BLOOD, V106, P4184, DOI 10.1182/blood-2005-01-0226; Shinagawa K, 2010, INT J CANCER, V127, P2323, DOI 10.1002/ijc.25440; Shiota M, 2007, EXP CELL RES, V313, P1008, DOI 10.1016/j.yexcr.2006.12.017; Sohni A, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/130763; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Takeda K, 2014, ANN PLAST SURG; Thurston G, 2003, CELL TISSUE RES, V314, P61, DOI 10.1007/s00441-003-0749-6; Tsai KS, 2011, GASTROENTEROLOGY, V141, P1046, DOI 10.1053/j.gastro.2011.05.045; Tu B, 2012, CANCER LETT, V325, P80, DOI 10.1016/j.canlet.2012.06.006; Vittet D, 2012, J CELL PHYSIOL, V227, P3593, DOI 10.1002/jcp.24063; Witte M H, 1997, EXS, V79, P65; Yan A, 2011, FUTURE ONCOL, V7, P1457, DOI [10.2217/fon.11.121, 10.2217/FON.11.121]; Zhu W, 2012, CANCER LETT, V315, P28, DOI 10.1016/j.canlet.2011.10.002	55	24	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e106976	10.1371/journal.pone.0106976	http://dx.doi.org/10.1371/journal.pone.0106976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222747	gold, Green Published, Green Submitted			2022-12-25	WOS:000341774800038
J	Preitschopf, A; Li, KZ; Schorghofer, D; Kinslechner, K; Schutz, B; Pham, HTT; Rosner, M; Joo, GJ; Rohrl, C; Weichhart, T; Stangl, H; Lubec, G; Hengstschlager, M; Mikula, M				Preitschopf, Andrea; Li, Kongzhao; Schorghofer, David; Kinslechner, Katharina; Schutz, Birgit; Ha Thi Thanh Pham; Rosner, Margit; Joo, Gabor Jozsef; Rohrl, Clemens; Weichhart, Thomas; Stangl, Herbert; Lubec, Gert; Hengstschlager, Markus; Mikula, Mario			mTORC1 Is Essential for Early Steps during Schwann Cell Differentiation of Amniotic Fluid Stem Cells and Regulates Lipogenic Gene Expression	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; SCIATIC-NERVE; MYELINATION; OLIGODENDROCYTES; ACTIVATION; RAPAMYCIN; DEPENDS; GROWTH	Schwann cell development is hallmarked by the induction of a lipogenic profile. Here we used amniotic fluid stem (AFS) cells and focused on the mechanisms occurring during early steps of differentiation along the Schwann cell lineage. Therefore, we initiated Schwann cell differentiation in AFS cells and monitored as well as modulated the activity of the mechanistic target of rapamycin (mTOR) pathway, the major regulator of anabolic processes. Our results show that mTOR complex 1 (mTORC1) activity is essential for glial marker expression and expression of Sterol Regulatory Element-Binding Protein (SREBP) target genes. Moreover, SREBP target gene activation by statin treatment promoted lipogenic gene expression, induced mTORC1 activation and stimulated Schwann cell differentiation. To investigate mTORC1 downstream signaling we expressed a mutant S6K1, which subsequently induced the expression of the Schwann cell marker S100b, but did not affect lipogenic gene expression. This suggests that S6K1 dependent and independent pathways downstream of mTORC1 drive AFS cells to early Schwann cell differentiation and lipogenic gene expression. In conclusion our results propose that future strategies for peripheral nervous system regeneration will depend on ways to efficiently induce the mTORC1 pathway.	[Preitschopf, Andrea; Li, Kongzhao; Schorghofer, David; Kinslechner, Katharina; Schutz, Birgit; Ha Thi Thanh Pham; Rosner, Margit; Weichhart, Thomas; Hengstschlager, Markus; Mikula, Mario] Med Univ Vienna, Inst Med Genet, Vienna, Austria; [Li, Kongzhao; Lubec, Gert] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Joo, Gabor Jozsef] Semmelweis Univ, Sch Med, Dept Obstet & Gynecol 1, Budapest, Hungary; [Rohrl, Clemens; Stangl, Herbert] Med Univ Vienna, Inst Med Chem, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Semmelweis University; Medical University of Vienna	Mikula, M (corresponding author), Med Univ Vienna, Inst Med Genet, Vienna, Austria.	mario.mikula@meduniwien.ac.at	Weichhart, Thomas/J-3531-2014; Stangl, Herbert/R-9441-2019; Pichler, Katharina/ABF-8252-2020; Stangl, Herbert/AAT-4379-2021	Weichhart, Thomas/0000-0002-4349-0797; Stangl, Herbert/0000-0002-7288-7320; De Luna, Andrea/0000-0003-1937-0186; Rohrl, Clemens/0000-0002-1192-0748; Mikula, Mario/0000-0001-5782-0681; Lubec, Gert/0000-0002-6333-9461; Pichler, Katharina M/0000-0001-9944-9999	Austrian Science Fund, FWF [P25336-B13]; Aktion Osterreich Ungam Project [86ou5]	Austrian Science Fund, FWF(Austrian Science Fund (FWF)); Aktion Osterreich Ungam Project	This work was supported by the Austrian Science Fund, FWF, grant number P25336-B13 (to Mario Mikula) and the Aktion Osterreich Ungam Project 86ou5 (to Mario Mikula and Gabor Jozsef Joo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakan I, 2012, CURR OPIN LIPIDOL, V23, P226, DOI 10.1097/MOL.0b013e328352dd03; BILHEIMER DW, 1983, P NATL ACAD SCI-BIOL, V80, P4124, DOI 10.1073/pnas.80.13.4124; BOYLES JK, 1989, J CLIN INVEST, V83, P1015, DOI 10.1172/JCI113943; Brohlin M, 2009, NEUROSCI RES, V64, P41, DOI 10.1016/j.neures.2009.01.010; Caddick J, 2006, GLIA, V54, P840, DOI 10.1002/glia.20421; Calandra S, 2011, J LIPID RES, V52, P1885, DOI 10.1194/jlr.R017855; Chen WQ, 2009, J PROTEOME RES, V8, P5285, DOI 10.1021/pr900630s; Chrast R, 2011, J LIPID RES, V52, P419, DOI 10.1194/jlr.R009761; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Fu Q, 1998, J NEUROCHEM, V71, P549; Fuchs C, 2012, HUM MOL GENET, V21, P1049, DOI 10.1093/hmg/ddr535; Heller BA, 2014, J CELL BIOL, V204, P1219, DOI 10.1083/jcb.201307057; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Kim J, 2007, CELL PROLIFERAT, V40, P75; King RHM, 2011, NEUROBIOL DIS, V42, P368, DOI 10.1016/j.nbd.2011.01.030; Ladak A, 2011, EXP NEUROL, V228, P242, DOI 10.1016/j.expneurol.2011.01.013; LeBlanc SE, 2005, J NEUROCHEM, V93, P737, DOI 10.1111/j.1471-4159.2005.03056.x; Liang C, 2012, J NEUROSCI, V32, P15169, DOI 10.1523/JNEUROSCI.2466-12.2012; Maier O, 2009, GLIA, V57, P402, DOI 10.1002/glia.20769; Martin I, 2012, STEM CELL REV REP, V8, P1178, DOI 10.1007/s12015-012-9387-2; Murinson BB, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-100; Myckatyn TM, 2002, PLAST RECONSTR SURG, V109, P2405, DOI 10.1097/00006534-200206000-00035; Paintlia AS, 2005, FASEB J, V19, P1407, DOI 10.1096/fj.05-3861com; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Prusa AR, 2004, AM J OBSTET GYNECOL, V191, P309, DOI 10.1016/j.ajog.2003.12.014; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; Schalm SS, 2005, J BIOL CHEM, V280, P11101, DOI 10.1074/jbc.M413995200; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharpe LJ, 2013, J BIOL CHEM, V288, P18707, DOI 10.1074/jbc.R113.479808; Sheean ME, 2014, GENE DEV, V28, P290, DOI 10.1101/gad.230045.113; Sherman DL, 2012, J NEUROSCI, V32, P1817, DOI 10.1523/JNEUROSCI.4814-11.2012; Siegel N, 2010, HUM MOL GENET, V19, P3320, DOI 10.1093/hmg/ddq236; Swoboda A, 2012, HUM MOL GENET, V21, P3387, DOI 10.1093/hmg/dds171; Tian XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042804; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Valli A, 2010, ONCOGENE, V29, P966, DOI 10.1038/onc.2009.405; Verheijen MHG, 2009, P NATL ACAD SCI USA, V106, P21383, DOI 10.1073/pnas.0905633106; Wegner M, 2000, GLIA, V31, P1, DOI 10.1002/(SICI)1098-1136(200007)31:1<1::AID-GLIA10>3.0.CO;2-V; Zhao SF, 2007, DEV DYNAM, V236, P2708, DOI 10.1002/dvdy.21283	40	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107004	10.1371/journal.pone.0107004	http://dx.doi.org/10.1371/journal.pone.0107004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25221943	Green Submitted, gold, Green Published			2022-12-25	WOS:000341774800039
J	Martinez, AC; Hernandez, M; Novella, S; Martinez, MP; Pagan, RM; Hermenegildo, C; Garcia-Sacristan, A; Prieto, D; Benedito, S				Cristina Martinez, Ana; Hernandez, Medardo; Novella, Susana; Pilar Martinez, Maria; Maria Pagan, Rosa; Hermenegildo, Carlos; Garcia-Sacristan, Albino; Prieto, Dolores; Benedito, Sara			Diminished Neurogenic Femoral Artery Vasoconstrictor Response in a Zucker Obese Rat Model: Differential Regulation of NOS and COX Derivatives	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; PENILE ARTERIES; NORADRENERGIC VASOCONSTRICTION; CARDIOVASCULAR-SYSTEM; MESENTERIC-ARTERIES; INSULIN-RESISTANCE; METABOLIC SYNDROME; BLOOD-PRESSURE	Objective: Peripheral arterial disease is one of the macrovascular complications of type 2 diabetes mellitus. This study addresses femoral artery regulation in a prediabetic model of obese Zucker rats (OZR) by examining cross-talk between endothelial and neural factors. Methods and Results: Arterial preparations from lean (LZR) and OZR were subjected to electrical field stimulation (EFS) on basal tone. Nitric oxide synthase (NOS) and cyclooxygenase (COX) isoform expression patterns were determined by immunohistochemical labelling and Western blotting. Results indicate significantly reduced noradrenergic contractions in preparations from OZR compared with those of LZR. Functional inhibition of endothelial NOS (eNOS) indicated a predominant role of this isoform in LZR and its modified activity in OZR. Neural (nNOS) and inducible NOS (iNOS) were activated and their expression was higher in femoral arteries from OZR. Neurotransmission modulated by large-conductance Ca2+-activated (BKCa) or voltage-dependent (K-V) K+ channels did not seem compromised in the obese animals. Endothelial COX-1 and COX-2 were expressed in LZR and an additional adventitial location of COX-2 was also observed in OZR, explaining the higher COX-2 protein levels detected in this group. Prostanoids derived from both isoforms helped maintain vasoconstriction in LZR while in OZR only COX-2 was active. Superoxide anion inhibition reduced contractions in endothelium-intact arteries from OZR. Conclusions: Endothelial dysfunction led to reduced neurogenic vasoconstriction in femoral arteries from OZR. In a setting of obesity, NO-dependent nNOS and iNOS dilation activity could be an alternative mechanism to offset COX-2- and reactive oxygen species-mediated vasoconstriction, along with impaired endothelial NO relaxation.	[Cristina Martinez, Ana; Hernandez, Medardo; Maria Pagan, Rosa; Garcia-Sacristan, Albino; Prieto, Dolores; Benedito, Sara] Univ Complutense Madrid, Fac Farm, Dept Fisiol, Madrid, Spain; [Novella, Susana; Hermenegildo, Carlos] Univ Valencia, Fac Med, Dept Fisiol, Valencia, Spain; [Pilar Martinez, Maria] Univ Complutense Madrid, Fac Vet, Dept Anat & Anat Patol Comparadas, Madrid, Spain	Complutense University of Madrid; University of Valencia; Complutense University of Madrid	Benedito, S (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Fisiol, Madrid, Spain.	sbenedi@ucm.es	Hermenegildo, Carlos/C-5995-2008; Martínez, Ana Cristina/H-9795-2015; Pilar Martinez, P Martinez/E-8591-2016; BENEDITO, SARA/H-9730-2015; Novella, Susana/A-7406-2017; PRIETO, DOLORES/S-8172-2018	Martínez, Ana Cristina/0000-0002-2829-0914; Pilar Martinez, P Martinez/0000-0001-9063-3191; BENEDITO, SARA/0000-0001-9660-2409; Novella, Susana/0000-0001-8303-7252; PRIETO, DOLORES/0000-0001-7049-5991; Hermenegildo, Carlos/0000-0002-4015-2645	Ministerio de Economia y Competitividad (Spain) [SAF2009-10448, SAF 2012-31631]	Ministerio de Economia y Competitividad (Spain)	This study was supported by grant SAF2009-10448 and SAF 2012-31631 from Ministerio de Economia y Competitividad (Spain) (http://www.mineco.gob.es/). Authors who received the funding include DP (lead researcher), ACM and SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfranca A, 2006, CARDIOVASC RES, V70, P446, DOI 10.1016/j.cardiores.2005.12.020; Barton M, 2003, INT J BIOCHEM CELL B, V35, P826, DOI 10.1016/S1357-2725(02)00307-2; Blanco-Rivero J, 2011, BRIT J PHARMACOL, V162, P271, DOI 10.1111/j.1476-5381.2010.01030.x; Chadha PS, 2010, J PHARMACOL EXP THER, V335, P284, DOI 10.1124/jpet.110.167593; Cohen RA, 2010, J CARDIOVASC PHARM, V55, P308, DOI 10.1097/FJC.0b013e3181d89670; Contreras C, 2013, J SEX MED, V10, P2141, DOI 10.1111/jsm.12234; Contreras C, 2010, BRIT J PHARMACOL, V161, P350, DOI 10.1111/j.1476-5381.2010.00825.x; Martinez AC, 2009, J PHARMACOL SCI, V111, P299, DOI 10.1254/jphs.09135FP; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; Erdos B, 2004, AM J PHYSIOL-REG I, V287, pR1456, DOI 10.1152/ajpregu.00279.2004; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; Feletou M, 2011, BRIT J PHARMACOL, V164, P894, DOI 10.1111/j.1476-5381.2011.01276.x; Feletou M, 2010, PFLUG ARCH EUR J PHY, V459, P941, DOI 10.1007/s00424-010-0812-6; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Hernanz R, 2014, CLIN SCI, V126, P111, DOI 10.1042/CS20120651; Hopfner RL, 1999, DIABETOLOGIA, V42, P1383, DOI 10.1007/s001250051308; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Icks A, 2009, EXP CLIN ENDOCR DIAB, V117, P500, DOI 10.1055/s-0029-1225333; Joseph BK, 2013, PHARMACOL RES, V70, P126, DOI 10.1016/j.phrs.2013.01.008; KASISKE BL, 1992, HYPERTENSION, V19, pI110, DOI 10.1161/01.HYP.19.1_Suppl.I110; Linton MF, 2004, CURR OPIN PHARMACOL, V4, P116, DOI 10.1016/j.coph.2003.12.003; Macarthur H, 2011, ACTA PHYSIOL, V203, P37, DOI 10.1111/j.1748-1716.2010.02242.x; Pagan RM, 2012, BIOCHEM PHARMACOL, V83, P882, DOI 10.1016/j.bcp.2011.12.038; Pagan RM, 2009, EUR J PHARMACOL, V616, P166, DOI 10.1016/j.ejphar.2009.06.002; Oltman CL, 2005, AM J PHYSIOL-ENDOC M, V289, pE113, DOI 10.1152/ajpendo.00594.2004; Pannirselvam M, 2005, BRIT J PHARMACOL, V144, P953, DOI 10.1038/sj.bjp.0706121; Sanchez A, 2010, BRIT J PHARMACOL, V159, P604, DOI 10.1111/j.1476-5381.2009.00553.x; Sanchez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036027; Sanchez A, 2010, ATHEROSCLEROSIS, V213, P392, DOI 10.1016/j.atherosclerosis.2010.09.022; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Shi Y, 2008, BRIT J PHARMACOL, V154, P639, DOI 10.1038/bjp.2008.110; Soskic SS, 2011, OPEN CARDIOVASC MED, V5, P153, DOI 10.2174/1874192401105010153; Straznicky NE, 2008, CURR HYPERTENS REP, V10, P440, DOI 10.1007/s11906-008-0083-1; Subramanian R, 2003, EUR J PHARMACOL, V477, P143, DOI 10.1016/j.ejphar.2003.08.003; Tang EHC, 2008, CARDIOVASC RES, V78, P130, DOI 10.1093/cvr/cvm112; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; Tsutsui Masato, 2004, J Atheroscler Thromb, V11, P41; Tsutsui M, 2010, PHARMACOL THERAPEUT, V128, P499, DOI 10.1016/j.pharmthera.2010.08.010; Vanhoutte PM, 2005, BRIT J PHARMACOL, V144, P449, DOI 10.1038/sj.bjp.0706042; Velkoska E, 2005, AM J PHYSIOL-ENDOC M, V288, pE1236, DOI 10.1152/ajpendo.00505.2004; Villalba N, 2009, AM J PHYSIOL-HEART C, V297, pH696, DOI 10.1152/ajpheart.01308.2008; Weil BR, 2011, AM J PHYSIOL-HEART C, V301, pH689, DOI 10.1152/ajpheart.00206.2011; Wise H, 2002, NEUROSIGNALS, V11, P20, DOI 10.1159/000057318; Wu SQ, 2000, CARDIOVASC RES, V45, P994, DOI 10.1016/S0008-6363(99)00417-4; Zacharia J, 2004, BRIT J PHARMACOL, V141, P915, DOI 10.1038/sj.bjp.0705690	45	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106372	10.1371/journal.pone.0106372	http://dx.doi.org/10.1371/journal.pone.0106372			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216050	Green Submitted, Green Published, gold			2022-12-25	WOS:000341774300010
J	Dominguez, LJ; Martinez-Gonzalez, MA; Basterra-Gortari, FJ; Gea, A; Barbagallo, M; Bes-Rastrollo, M				Dominguez, Ligia J.; Martinez-Gonzalez, Miguel A.; Javier Basterra-Gortari, Francisco; Gea, Alfredo; Barbagallo, Mario; Bes-Rastrollo, Maira			Fast Food Consumption and Gestational Diabetes Incidence in the SUN Project	PLOS ONE			English	Article							WEIGHT-GAIN; SEGUIMIENTO-UNIVERSIDAD; MEDITERRANEAN DIET; FREQUENCY QUESTIONNAIRE; LIFE-STYLE; RISK; MELLITUS; POPULATION; ADHERENCE; PATTERNS	Background: Gestational diabetes prevalence is increasing, mostly because obesity among women of reproductive age is continuously escalating. We aimed to investigate the incidence of gestational diabetes according to the consumption of fast food in a cohort of university graduates. Methods: The prospective dynamic "Seguimiento Universidad de Navarra" (SUN) cohort included data of 3,048 women initially free of diabetes or previous gestational diabetes who reported at least one pregnancy between December 1999 and March 2011. Fast food consumption was assessed through a validated 136-item semi-quantitative food frequency questionnaire. Fast food was defined as the consumption of hamburgers, sausages, and pizza. Three categories of fast food were established: low (0-3 servings/month), intermediate (>3 servings/month and <= 2 servings/week) and high (>2 servings/week). Non-conditional logistic regression models were used to adjust for potential confounders. Results: We identified 159 incident cases of gestational diabetes during follow-up. After adjusting for age, baseline body mass index, total energy intake, smoking, physical activity, family history of diabetes, cardiovascular disease/hypertension at baseline, parity, adherence to Mediterranean dietary pattern, alcohol intake, fiber intake, and sugar-sweetened soft drinks consumption, fast food consumption was significantly associated with a higher risk of incident gestational diabetes, with multivariate adjusted OR of 1.31 (95% conficence interval [CI]: 0.81-2.13) and 1.86 (95% CI: 1.13-3.06) for the intermediate and high categories, respectively, versus the lowest category of baseline fast food consumption (p for linear trend: 0.007). Conclusion: Our results suggest that pre-pregnancy higher consumption of fast food is an independent risk factor for gestational diabetes.	[Dominguez, Ligia J.; Barbagallo, Mario] Univ Palermo, Dept Internal Med & Specialties, Geriatr Unit, Palermo, Sicily, Italy; [Martinez-Gonzalez, Miguel A.; Javier Basterra-Gortari, Francisco; Gea, Alfredo; Bes-Rastrollo, Maira] Univ Navarra, Dept Prevent Med & Publ Hlth, Navarra, Spain; [Martinez-Gonzalez, Miguel A.; Javier Basterra-Gortari, Francisco; Gea, Alfredo; Bes-Rastrollo, Maira] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Madrid, Spain; [Javier Basterra-Gortari, Francisco] Hosp Reina Sofia, Dept Internal Med Endocrinol, Navarra, Spain	University of Palermo; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Dominguez, LJ (corresponding author), Univ Palermo, Dept Internal Med & Specialties, Geriatr Unit, Palermo, Sicily, Italy.	ligia.dominguez@unipa.it; mbes@unav.es	Bes-Rastrollo, Maira/A-1329-2009; BARBAGALLO, MARIO/K-4794-2017; Martinez-Gonzalez, Miguel A./AAE-7669-2019	Bes-Rastrollo, Maira/0000-0002-9139-4206; BARBAGALLO, MARIO/0000-0002-1349-6530; dominguez, ligia j/0000-0003-1466-8610; Gea, Alfredo/0000-0002-2229-4690	Spanish Ministry of Health Government [PI10/02658, PI10/02293, RD06/0045, G03/140, PI13/00615]; Navarra Regional Government [45/2011]; University of Navarra; FPU fellowship from the Spanish Government	Spanish Ministry of Health Government; Navarra Regional Government; University of Navarra; FPU fellowship from the Spanish Government(Spanish Government)	The SUN Study has received funding from the Spanish Ministry of Health Government (current grants PI10/02658, PI10/02293, RD06/0045, G03/140 and PI13/00615), the Navarra Regional Government (45/2011) and the University of Navarra. AG is supported by a FPU fellowship from the Spanish Government. Funding sources had no role in the design, collection, analysis, and interpretation of the data; in the writing, and in the decision to submit the paper for publication.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Albrecht SS, 2010, DIABETES CARE, V33, P768, DOI 10.2337/dc09-1801; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; American Diabetes Association, 2004, DIABETES CARE S1, V27, pS88, DOI [10.2337/diacare.27.2007.S88, DOI 10.2337/DIACARE.27.2007.S88]; Bao W, 2013, DIABETES CARE, V36, P2001, DOI 10.2337/dc12-2018; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Bes-Rastrollo M, 2006, AM J CLIN NUTR, V83, P362; Bes-Rastrollo M., 2005, REV ESP OBES, V3, P352; Bes-Rastrollo M, 2010, PUBLIC HEALTH NUTR, V13, P1356, DOI 10.1017/S1368980009992783; Bowers K, 2012, AM J CLIN NUTR, V95, P446, DOI 10.3945/ajcn.111.026294; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Buckley BS, 2012, DIABETIC MED, V29, P844, DOI 10.1111/j.1464-5491.2011.03541.x; Cuadrado C., 2013, TABLAS COMPOSICION A, V16th; Dabelea D, 2005, DIABETES CARE, V28, P579, DOI 10.2337/diacare.28.3.579; de la Fuente-Arrillaga C, 2010, PUBLIC HEALTH NUTR, V13, P1364, DOI 10.1017/S1368980009993065; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; GREENLAND S, 1980, INT J EPIDEMIOL, V9, P361, DOI 10.1093/ije/9.4.361; HARRIS M, 1979, DIABETES, V28, P1039; Horvath K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1395; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Lawrence JM, 2008, DIABETES CARE, V31, P899, DOI 10.2337/dc07-2345; Lopez S, 2011, AM J CLIN NUTR, V93, P494, DOI 10.3945/ajcn.110.003251; Martinez-Gonzalez MA, 2008, BMJ-BRIT MED J, V336, P1348, DOI 10.1136/bmj.39561.501007.BE; Martinez-Gonzalez MA, 2005, PUBLIC HEALTH NUTR, V8, P920, DOI 10.1079/PHN2005745; Martinez-Gonzalez MA, 2002, NUTR NEUROSCI, V5, P65, DOI 10.1080/10284150290007047; MARTINMORENO JM, 1993, INT J EPIDEMIOL, V22, P512, DOI 10.1093/ije/22.3.512; Mataix Verdu J., 2009, TABLA COMPOSICION AL, V5th; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; NICE, 2008, CLIN GUID; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Odegaard AO, 2012, CIRCULATION, V126, P182, DOI 10.1161/CIRCULATIONAHA.111.084004; Pan A, 2012, CIRCULATION, V126, P163, DOI 10.1161/CIRCULATIONAHA.112.115923; Park S, 2013, EUR J CLIN NUTR, V67, P196, DOI 10.1038/ejcn.2012.207; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Segui-Gomez M, 2006, INT J EPIDEMIOL, V35, P1417, DOI 10.1093/ije/dyl223; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Tobias DK, 2012, AM J CLIN NUTR, V96, P289, DOI 10.3945/ajcn.111.028266; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Uusitalo U, 2009, PUBLIC HEALTH NUTR, V12, P2392, DOI 10.1017/S136898000900528X; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P496, DOI 10.1097/EDE.0b013e3181a82f12; Willett W., 2012, NUTR EPIDEMIOLOGY; Zhang C, 2006, DIABETOLOGIA, V49, P2604, DOI 10.1007/s00125-006-0422-1; Zhang CL, 2006, DIABETES CARE, V29, P2223, DOI 10.2337/dc06-0266; Zhang CL, 2011, AM J CLIN NUTR, V94, p1975S, DOI 10.3945/ajcn.110.001032	45	22	22	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106627	10.1371/journal.pone.0106627	http://dx.doi.org/10.1371/journal.pone.0106627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215961	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774300018
J	Mansson, C; Arosio, P; Hussein, R; Kampinga, HH; Hashem, RM; Boelens, WC; Dobson, CM; Knowles, TPJ; Linse, S; Emanuelsson, C				Mansson, Cecilia; Arosio, Paolo; Hussein, Rasha; Kampinga, Harm H.; Hashem, Reem M.; Boelens, Wilbert C.; Dobson, Christopher M.; Knowles, Tuomas P. J.; Linse, Sara; Emanuelsson, Cecilia			Interaction of the Molecular Chaperone DNAJB6 with Growing Arnyloid-beta 42 (A beta 42) Aggregates Leads to Sub-stoichiometric Inhibition of Amyloid Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; PROTEIN AGGREGATION; ALZHEIMERS-DISEASE; POLYGLUTAMINE PEPTIDES; NUCLEATION MECHANISM; COMMON MECHANISM; OLIGOMERS; KINETICS; TOXICITY; BINDING	The human molecular chaperone protein DNAJB6 was recently found to inhibit the formation of amyloid fibrils from polyglutamine peptides associated with neurodegenerative disorders such as Huntington disease. We show in the present study that DNAJB6 also inhibits amyloid formation by an even more aggregation-prone peptide (the amyloid-beta peptide, A beta 42, implicated in Alzheimer disease) in a highly efficient manner. By monitoring fibril formation using Thioflavin T fluorescence and far-UV CD spectroscopy, we have found that the aggregation of A beta 42 is retarded by DNAJB6 in a concentration-dependent manner, extending to very low sub -stoichiometric molar ratios of chaperone to peptide. Quantitative kinetic analysis and immunochemistry studies suggest that the high inhibitory efficiency is due to the interactions of the chaperone with aggregated forms of A beta 42 rather than the monomeric form of the peptide. This interaction prevents the growth of such species to longer fibrils and inhibits the formation of new amyloid fibrils through both primary and secondary nucleation. A low dissociation rate of DNAJB6 from A beta 42 aggregates leads to its incorporation into growing fibrils and hence to its gradual depletion from solution with time. When DNAJB6 is eventually depleted, fibril proliferation takes place, but the inhibitory activity can be prolonged by introducing DNAJB6 at regular intervals during the aggregation reaction. These results reveal the highly efficacious mode of action of this molecular chaperone against protein aggregation, and demonstrate that the role of molecular chaperones can involve interactions with multiple aggregated species leading to the inhibition of both principal nucleation pathways through which aggregates are able to form.	[Mansson, Cecilia; Linse, Sara; Emanuelsson, Cecilia] Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, S-22100 Lund, Sweden; [Arosio, Paolo; Dobson, Christopher M.; Knowles, Tuomas P. J.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Hussein, Rasha; Kampinga, Harm H.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands; [Hussein, Rasha; Hashem, Reem M.] Beni Suef Univ, Fac Pharm, Dept Biochem, Bani Suwayf 62511, Egypt; [Boelens, Wilbert C.] Radboud Univ Nijmegen, Dept Biomol Chem, NL-6500 HB Nijmegen, Netherlands	Lund University; University of Cambridge; University of Groningen; Egyptian Knowledge Bank (EKB); Beni Suef University; Radboud University Nijmegen	Emanuelsson, C (corresponding author), Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, POB 124, S-22100 Lund, Sweden.	cecilia.emanuelsson@biochemistry.lu.se	Knowles, Tuomas/C-6663-2009; Boelens, Wilbert/D-8877-2012	Knowles, Tuomas/0000-0002-7879-0140; Hashem, Reem/0000-0003-3011-8109; Kampinga, Harm/0000-0002-8966-8466	LU Research School for Pharmaceutical Science; Magnus Berg walls Stiftelse; Egyptian Ministry of Higher Education; Nanometer Structure Consortium for IR system; Swedish Research Council; Linneus Centre Organizing Molecular Matter for CD spectrometer, plate readers; Alzheimer Foundation Sweden; Swiss National Science Foundation; Frances and Augustus Newman Foundation; BBSRC; European Commission; Welcome Trust; Marie Curie fellowship scheme for career development; Senter Novem [IOP-IGE07004]	LU Research School for Pharmaceutical Science; Magnus Berg walls Stiftelse; Egyptian Ministry of Higher Education(Science and Technology Development Fund (STDF)); Nanometer Structure Consortium for IR system; Swedish Research Council(Swedish Research CouncilEuropean Commission); Linneus Centre Organizing Molecular Matter for CD spectrometer, plate readers; Alzheimer Foundation Sweden; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Frances and Augustus Newman Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Welcome Trust(Wellcome Trust); Marie Curie fellowship scheme for career development; Senter Novem	This work was supported by the LU Research School for Pharmaceutical Science (to C. M.), Magnus Berg walls Stiftelse (to C. E.), the Egyptian Ministry of Higher Education (to R. H.), the Nanometer Structure Consortium for IR system (to S. L.), the Swedish Research Council (to S. L.), and its Linneus Centre Organizing Molecular Matter for CD spectrometer, plate readers (to S. L.), the Alzheimer Foundation Sweden (to S. L.), the Swiss National Science Foundation (to P. A.), the Frances and Augustus Newman Foundation (to T. P. J. K.), the BBSRC (to T. P. J. K.), the European Commission (to S. L., T. P. J. K.), the Welcome Trust (to C. M. D.), the Marie Curie fellowship scheme for career development (to P. A.), and the Senter Novem, IOP-IGE07004 (to H. H. K.).	Arosio P, 2014, TRENDS PHARMACOL SCI, V35, P127, DOI 10.1016/j.tips.2013.12.005; Assarsson A, 2014, ACS CHEM NEUROSCI, V5, P266, DOI 10.1021/cn400124r; BLENNOW A, 1995, BBA-PROTEIN STRUCT M, V1252, P69, DOI 10.1016/0167-4838(95)00111-7; Boelens WC, 2001, BBA-PROTEIN STRUCT M, V1544, P311, DOI 10.1016/S0167-4838(00)00243-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; COHEN AS, 1959, NATURE, V183, P1202, DOI 10.1038/1831202a0; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608916; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608917; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4; Ellis RJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0398; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Fandrich M, 2011, TRENDS BIOCHEM SCI, V36, P338, DOI 10.1016/j.tibs.2011.02.002; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; FERRONE FA, 1985, J MOL BIOL, V183, P611, DOI 10.1016/0022-2836(85)90175-5; Gillis J, 2013, J BIOL CHEM, V288, P17225, DOI 10.1074/jbc.M112.421685; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Hard T, 2012, J MOL BIOL, V421, P441, DOI 10.1016/j.jmb.2011.12.062; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v; Hermansson E, 2014, DIS MODEL MECH, V7, P659, DOI 10.1242/dmm.014787; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; KAMPINGA HH, 1993, J CELL SCI, V104, P11; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Ladiwala ARA, 2012, J BIOL CHEM, V287, P24765, DOI 10.1074/jbc.M111.329763; Lorenzen N, 2012, BIOPHYS J, V102, P2167, DOI 10.1016/j.bpj.2012.03.047; Mannini B, 2012, P NATL ACAD SCI USA, V109, P12479, DOI 10.1073/pnas.1117799109; Mansson C, 2014, CELL STRESS CHAPERON, V19, P227, DOI 10.1007/s12192-013-0448-5; Meisl G, 2014, P NATL ACAD SCI USA, V111, P9384, DOI 10.1073/pnas.1401564111; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Narayan P, 2012, BIOCHEMISTRY-US, V51, P9270, DOI 10.1021/bi301277k; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Selkoe J. D., 2011, COLD SPRING HARBOR P, V3; Shammas SL, 2011, BIOPHYS J, V101, P1681, DOI 10.1016/j.bpj.2011.07.056; Sorensen BK, 2002, ANAL BIOCHEM, V304, P33, DOI 10.1006/abio.2001.5604; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2012, PROG MOL BIOL TRANSL, V107, P101, DOI 10.1016/B978-0-12-385883-2.00012-6; Walsh DM, 2009, FEBS J, V276, P1266, DOI 10.1111/j.1742-4658.2008.06862.x; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030; Willander H, 2012, J BIOL CHEM, V287, P31608, DOI 10.1074/jbc.M112.393157; Yoo BC, 2001, BIOCHEM BIOPH RES CO, V280, P249, DOI 10.1006/bbrc.2000.4109	54	111	112	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31066	31076		10.1074/jbc.M114.595124	http://dx.doi.org/10.1074/jbc.M114.595124			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25217638	Green Published, hybrid			2022-12-25	WOS:000344549900016
J	Schmidt, ML; Donninger, H; Clark, GJ				Schmidt, M. Lee; Donninger, Howard; Clark, Geoffrey J.			Ras Regulates SCF beta-TrCP Protein Activity and Specificity via Its Effector Protein NORE1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-SUPPRESSOR RASSF1A; HIPPO-YAP PATHWAY; UBIQUITIN LIGASE; DEPENDENT DEGRADATION; ORGAN SIZE; H-RAS; CATENIN; CANCER; WNT	Ras is the most frequently activated oncogene found in human cancer, but its mechanisms of action remain only partially understood. Ras activates multiple signaling pathways to promote transformation. However, Ras can also exhibit a potent ability to induce growth arrest and death. NORE1A (RASSF5) is a direct Ras effector that acts as a tumor suppressor by promoting apoptosis and cell cycle arrest. Expression of NORE1A is frequently lost in human tumors, and its mechanism of action remains unclear. Here we show that NORE1A forms a direct, Ras-regulated complex with beta-TrCP, the substrate recognition component of the SCF beta-TrCP ubiquitin ligase complex. This interaction allows Ras to stimulate the ubiquitin ligase activity of SCF beta-TrCP toward its target beta-catenin, resulting in degradation of beta-catenin by the 26 S proteasome. However, the action of Ras/NORE1A/beta-TrCP is substrate-specific because I kappa B, another substrate of SCF beta-TrCP, is not sensitive to NORE1A-promoted degradation. We identify a completely new signaling mechanism for Ras that allows for the specific regulation of SCF beta-TrCP targets. We show that the NORM levels in a cell may dictate the effects of Ras on the Wnt/beta-catenin pathway. Moreover, because NORE1A expression is frequently impaired in tumors, we provide an explanation for the observation that beta-TrCP can act as a tumor suppressor or an oncogene in different cell systems.	[Schmidt, M. Lee] Univ Louisville, Mol Targets Grp, James Graham Brown Canc Ctr, Dept Biochem & Mol Biol, Louisville, KY 40202 USA; [Donninger, Howard] Univ Louisville, Mol Targets Grp, James Graham Brown Canc Ctr, Dept Med, Louisville, KY 40202 USA; [Clark, Geoffrey J.] Univ Louisville, Mol Targets Grp, James Graham Brown Canc Ctr, Dept Pharmacol & Toxicol, Louisville, KY 40202 USA	University of Louisville; University of Louisville; University of Louisville	Clark, GJ (corresponding author), Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, 505 S Hancock St,CTR 417, Louisville, KY 40202 USA.	gjclar01@louisville.edu	Donninger, Howard/I-9874-2019	Donninger, Howard/0000-0002-8589-1660	National Institutes of Health [R01 CA133171-01A2]; NATIONAL CANCER INSTITUTE [R01CA133171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA133171-01A2 (to G. J. C.).	Aoyama Y, 2004, ONCOGENE, V23, P3426, DOI 10.1038/sj.onc.1207486; Baeuerle PA, 1998, CELL, V95, P729, DOI 10.1016/S0092-8674(00)81694-3; Biechele T.L., 2009, COLD SPRING HARBOR P; BOS JL, 1989, CANCER RES, V49, P4682; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Chen JD, 2003, CANCER CELL, V4, P405, DOI 10.1016/S1535-6108(03)00269-1; CLARK GJ, 1995, METHOD ENZYMOL, V255, P395; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Espada J, 1999, J CELL BIOL, V146, P967, DOI 10.1083/jcb.146.5.967; Estrabaud E, 2007, CANCER RES, V67, P1054, DOI 10.1158/0008-5472.CAN-06-2530; Fiordalisi JJ, 2001, METHOD ENZYMOL, V332, P3; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; Horst D, 2012, CANCER RES, V72, P1547, DOI 10.1158/0008-5472.CAN-11-3222; Huntzicker EG, 2006, GENE DEV, V20, P276, DOI 10.1101/gad.1380906; Jang JW, 2006, MOL CELL BIOL, V26, P8109, DOI 10.1128/MCB.00404-06; Jeong WJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002242; Kanemori Y, 2005, P NATL ACAD SCI USA, V102, P6279, DOI 10.1073/pnas.0501873102; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Kim D, 2007, ONCOGENE, V26, P4571, DOI 10.1038/sj.onc.1210230; Kim SE, 2009, J CELL SCI, V122, P842, DOI 10.1242/jcs.040493; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Konsavage WM, 2013, ACTA BIOCH BIOPH SIN, V45, P71, DOI 10.1093/abbs/gms084; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Orian A, 2000, EMBO J, V19, P2580, DOI 10.1093/emboj/19.11.2580; Ortiz-Vega S, 2002, ONCOGENE, V21, P1381, DOI 10.1038/sj.onc.1205192; Pacheco-Pinedo EC, 2011, ONCOTARGET, V2, P569; Pan Y, 2007, J BIOL CHEM, V282, P10846, DOI 10.1074/jbc.M608599200; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Reuter CWM, 2000, BLOOD, V96, P1655, DOI 10.1182/blood.V96.5.1655.h8001655_1655_1669; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Saifo MS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-310; Schmidt L. C. G., 2011, ATLAS GENET CYTOGENE; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Shinmura K, 2011, LUNG CANCER, V71, P19, DOI 10.1016/j.lungcan.2010.04.006; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vos MD, 2003, J BIOL CHEM, V278, P21938, DOI 10.1074/jbc.M211019200; Vos MD, 2003, J BIOL CHEM, V278, P28045, DOI 10.1074/jbc.M300554200; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Xu M. X., 2013, INT J ONCOL; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	54	17	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31102	31110		10.1074/jbc.M114.594283	http://dx.doi.org/10.1074/jbc.M114.594283			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25217643	hybrid, Green Published			2022-12-25	WOS:000344549900019
J	Heuch, I; Heuch, I; Hagen, K; Zwart, JA				Heuch, Ingrid; Heuch, Ivar; Hagen, Knut; Zwart, John-Anker			Do Abnormal Serum Lipid Levels Increase the Risk of Chronic Low Back Pain? The Nord-Trondelag Health Study	PLOS ONE			English	Article							LUMBAR INTERVERTEBRAL DISKS; BODY-MASS INDEX; FOLLOW-UP; BLOOD-PRESSURE; MUSCULOSKELETAL DISORDERS; SOCIOECONOMIC-STATUS; PHYSICAL-ACTIVITY; PRIMARY-CARE; ATHEROSCLEROSIS; POPULATION	Background: Cross-sectional studies suggest associations between abnormal lipid levels and prevalence of low back pain (LBP), but it is not known if there is any causal relationship. Objective: The objective was to determine, in a population-based prospective cohort study, whether there is any relation between levels of total cholesterol, high density lipoprotein (HDL) cholesterol and triglycerides and the probability of experiencing subsequent chronic (LBP), both among individuals with and without LBP at baseline. Methods: Information was collected in the community-based HUNT 2 (1995-1997) and HUNT 3 (2006-2008) surveys of an entire Norwegian county. Participants were 10,151 women and 8731 men aged 30-69 years, not affected by chronic LBP at baseline, and 3902 women and 2666 men with LBP at baseline. Eleven years later the participants indicated whether they currently suffered from chronic LBP. Results: Among women without LBP at baseline, HDL cholesterol levels were inversely associated and triglyceride levels positively associated with the risk of chronic LBP at end of follow-up in analyses adjusted for age only. Adjustment for the baseline factors education, work status, physical activity, smoking, blood pressure and in particular BMI largely removed these associations (RR: 0.96, 95% CI: 0.85-1.07 per mmol/l of HDL cholesterol; RR: 1.16, 95% CI: 0.94-1.42 per unit of lg(triglycerides)). Total cholesterol levels showed no associations. In women with LBP at baseline and men without LBP at baseline weaker relationships were observed. In men with LBP at baseline, an inverse association with HDL cholesterol remained after complete adjustment (RR: 0.83, 95% CI: 0.72-0.95 per mmol/l). Conclusion: Crude associations between lipid levels and risk of subsequent LBP in individuals without current LBP are mainly caused by confounding with body mass. However, an association with low HDL levels may still remain in men who are already affected and possibly experience a higher pain intensity.	[Heuch, Ingrid; Zwart, John-Anker] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Heuch, Ingrid; Zwart, John-Anker] Oslo Univ Hosp, FORMI, Oslo, Norway; [Heuch, Ivar] Univ Bergen, Dept Math, N-5007 Bergen, Norway; [Hagen, Knut] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Hagen, Knut] St Olavs Hosp, Norwegian Natl Headache Ctr, Dept Neurol, Trondheim, Norway; [Zwart, John-Anker] Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; University of Oslo; University of Bergen; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Oslo	Heuch, I (corresponding author), Oslo Univ Hosp, Dept Neurol, Oslo, Norway.	ingrid.heuch@ous-hf.no	Heuch, Ivar/A-4510-2008	Heuch, Ivar/0000-0003-3386-9688	Olav Raagholt and Gerd Meidel Raagholt's Legacy; Legacy of Trygve Gythfeldt and Wife	Olav Raagholt and Gerd Meidel Raagholt's Legacy; Legacy of Trygve Gythfeldt and Wife	This study was supported in part by grants from Olav Raagholt and Gerd Meidel Raagholt's Legacy and the Legacy of Trygve Gythfeldt and Wife. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorck-van Dijken C, 2008, J REHABIL MED, V40, P864, DOI 10.2340/16501977-0273; Boggild H, 2006, SCAND J WORK ENV HEA, V32, P20, DOI 10.5271/sjweh.972; BONAA KH, 1991, CIRCULATION, V83, P1305, DOI 10.1161/01.CIR.83.4.1305; CRAIG WY, 1989, BMJ-BRIT MED J, V298, P784, DOI 10.1136/bmj.298.6676.784; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; Dionne CE, 2001, J EPIDEMIOL COMMUN H, V55, P455, DOI 10.1136/jech.55.7.455; Espahbodi S, 2013, SPINE, V38, pE230, DOI 10.1097/BRS.0b013e31827ecd6e; Goodson NJ, 2013, PAIN, V154, P1595, DOI 10.1016/j.pain.2013.04.043; Ha IH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093671; Hangai M, 2008, SPINE J, V8, P732, DOI 10.1016/j.spinee.2007.07.392; Hayden JA, 2010, BEST PRACT RES CL RH, V24, P167, DOI 10.1016/j.berh.2009.12.005; Hemingway H, 1999, J EPIDEMIOL COMMUN H, V53, P197, DOI 10.1136/jech.53.4.197; Heuch I, 2014, EUR J PAIN, V18, P590, DOI 10.1002/j.1532-2149.2013.00398.x; Heuch I, 2013, SPINE, V38, P133, DOI 10.1097/BRS.0b013e3182647af2; Heuch I, 2010, EPIDEMIOLOGY, V21, P837, DOI 10.1097/EDE.0b013e3181f20808; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Hong JH, 2013, SPINE, V38, P75, DOI 10.1097/BRS.0b013e318276450f; Jhawar Balraj S, 2006, Spine J, V6, P684, DOI 10.1016/j.spinee.2006.04.016; Kang MG, 2005, PREV MED, V40, P583, DOI 10.1016/j.ypmed.2004.07.018; Kauppila LI, 2009, EUR J VASC ENDOVASC, V37, P661, DOI 10.1016/j.ejvs.2009.02.006; Kauppila LI, 1997, SPINE, V22, P1642, DOI 10.1097/00007632-199707150-00023; Kauppila LI, 2004, SPINE, V29, P2147, DOI 10.1097/01.brs.0000141168.77393.b8; KAUPPILA LI, 1995, LANCET, V346, P888, DOI 10.1016/S0140-6736(95)92714-X; Kauppila LI, 1997, ANN RHEUM DIS, V56, P591, DOI 10.1136/ard.56.10.591; KAUPPILA LI, 1993, J SPINAL DISORD, V6, P124; Keogh E, 2006, J MENS HLTH GEND, V3, P236, DOI DOI 10.1016/J.JMHG.2006.03.006; Kostova V, 2001, J NEUROL SCI, V192, P17, DOI 10.1016/S0022-510X(01)00585-8; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Kurunlahti M, 1999, SPINE, V24, P2080, DOI 10.1097/00007632-199910150-00003; Kurunlahti M, 2001, RADIOLOGY, V221, P779, DOI 10.1148/radiol.2213010134; Langhammer A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-143; Leboeuf-Yde C, 1999, SPINE, V24, P1463, DOI 10.1097/00007632-199907150-00012; Leino-Arjas P, 2006, SPINE, V31, P1032, DOI 10.1097/01.brs.0000214889.31505.08; Leino-Arjas P, 2006, SCAND J WORK ENV HEA, V32, P12, DOI 10.5271/sjweh.971; Leino-Arjas P, 2008, ATHEROSCLEROSIS, V197, P43, DOI 10.1016/j.atherosclerosis.2007.07.035; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Makovey J, 2009, BONE, V44, P208, DOI 10.1016/j.bone.2008.09.020; Merskey H., 1994, CLASSIFICATION CHRON, V2nd ed; Monda KL, 2009, J LIPID RES, V50, P1685, DOI 10.1194/jlr.P900029-JLR200; OSTI OL, 1994, CLIN J PAIN, V10, P331, DOI 10.1097/00002508-199412000-00015; Pereira SMP, 2013, EUR HEART J, V34, P1215, DOI 10.1093/eurheartj/ehs333; Shi S, 2011, MED HYPOTHESES, V76, P125, DOI 10.1016/j.mehy.2010.08.050; Suri P, 2012, SPINE J, V12, P315, DOI 10.1016/j.spinee.2012.03.033; SVENSSON HO, 1983, SPINE, V8, P277, DOI 10.1097/00007632-198304000-00008; Tokuda O, 2007, J MAGN RESON IMAGING, V25, P185, DOI 10.1002/jmri.20785; Tsai SP, 2011, J OCCUP ENVIRON MED, V53, P434, DOI 10.1097/JOM.0b013e3182128b12; Turgut Ahmet Tuncay, 2008, Pathophysiology, V15, P31, DOI 10.1016/j.pathophys.2007.12.001; Uesugi K, 2013, SPINE, V38, pE540, DOI 10.1097/BRS.0b013e31828a2517; van Diepen JA, 2013, ATHEROSCLEROSIS, V228, P306, DOI 10.1016/j.atherosclerosis.2013.02.028; Von Korff M, 2008, PAIN, V138, P267, DOI 10.1016/j.pain.2007.12.010; VonKorff M, 1996, SPINE, V21, P2833, DOI 10.1097/00007632-199612150-00004; Wamala SP, 1997, J EPIDEMIOL COMMUN H, V51, P400, DOI 10.1136/jech.51.4.400; WELIN L, 1978, SCAND J RHEUMATOL, V7, P7	54	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e108227	10.1371/journal.pone.0108227	http://dx.doi.org/10.1371/journal.pone.0108227			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233233	Green Published, gold, Green Submitted			2022-12-25	WOS:000342921200088
J	Kirimoto, H; Tamaki, H; Suzuki, M; Matsumoto, T; Sugawara, K; Kojima, S; Onishi, H				Kirimoto, Hikari; Tamaki, Hiroyuki; Suzuki, Makoto; Matsumoto, Takuya; Sugawara, Kazuhiro; Kojima, Syo; Onishi, Hideaki			Sensorimotor Modulation Differs with Load Type during Constant Finger Force or Position	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; SOMATOSENSORY-EVOKED-POTENTIALS; CORTICAL SILENT PERIOD; SUBMAXIMAL FATIGUING CONTRACTIONS; MAINTAINING ARM POSITION; TASK-DEPENDENT CHANGES; SOLEUS H-REFLEXES; MOTOR CORTEX; BICEPS-BRACHII; VOLUNTARY MOVEMENT	During submaximal isometric contraction, there are two different load types: production of a constant force against a rigid restraint (force task), and maintenance of position against a constant load (position task). Previous studies reported that the time to task failure during a fatigue task was twice as long in the force task compared with the position task. Sensory feedback processing may contribute to these differences. The purpose of the current study was to determine the influence of load types during static muscle contraction tasks on the gating effect, i. e., attenuation of somatosensory-evoked potentials (SEPs) and the cortical silent period (cSP). Ten healthy subjects contracted their right first dorsal interosseus muscle by abducting their index finger for 90 s, to produce a constant force against a rigid restraint that was 20% of the maximum voluntary contraction (force task), or to maintain a constant position with 10 degrees abduction of the metacarpophalangeal joint against the same load (position task). Somatosensory evoked potentials (SEPs) were recorded from C3' by stimulating either the right ulnar or median nerve at the wrist while maintaining contraction. The cortical silent period (cSP) was also elicited by transcranial magnetic stimulation. Reduction of the amplitude of the P45 component of SEPs was significantly larger during the position task than during the force task and under control rest conditions when the ulnar nerve, but not the median nerve, was stimulated. The position task had a significantly shorter cSP duration than the force task. These results suggest the need for more proprioceptive information during the position task than the force task. The shorter duration of the cSP during the position task may be attributable to larger amplitude of heteronymous short latency reflexes. Sensorimotor modulations may differ with load type during constant finger force or position tasks.	[Kirimoto, Hikari; Tamaki, Hiroyuki; Matsumoto, Takuya; Sugawara, Kazuhiro; Onishi, Hideaki] Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Japan; [Suzuki, Makoto] Kitasato Univ, Sch Allied Hlth Sci, Sagamihara, Kanagawa, Japan; [Matsumoto, Takuya; Kojima, Syo] Niigata Univ Hlth & Welf, Grad Sch Hlth & Welf, Niigata, Japan; [Kojima, Syo] Tokyo Bay Rehabil Hosp, Chiba, Japan	Niigata University; Kitasato University; Niigata University	Kirimoto, H (corresponding author), Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Japan.	kirimoto@nuhw.ac.jp	Kirimoto, Hikari/O-6495-2016	Kirimoto, Hikari/0000-0003-3768-5907	Japan Society for the Promotion of Science (JSPS) [08042773]; Niigata University of Health and Welfare (NUHW)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Niigata University of Health and Welfare (NUHW)	This work was supported by a Grant-in-Aid for Scientific Research (C) No. 08042773 from the Japan Society for the Promotion of Science (JSPS) (http://www.jsps.go.jp/english/e-grants/index.html) and a Research Grant from Niigata University of Health and Welfare (NUHW) (http://www.nuhw.ac.jp/e/). HK received both grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAZAWA K, 1983, J NEUROPHYSIOL, V49, P16, DOI 10.1152/jn.1983.49.1.16; ANGEL RW, 1984, NEUROLOGY, V34, P123, DOI 10.1212/WNL.34.1.123; BARKER AT, 1985, LANCET, V1, P1106; Baudry S, 2011, J NEUROPHYSIOL, V106, P265, DOI 10.1152/jn.00954.2010; Baudry S, 2009, EXP BRAIN RES, V199, P83, DOI 10.1007/s00221-009-1951-x; Baudry S, 2009, J NEUROPHYSIOL, V102, P1725, DOI 10.1152/jn.00382.2009; Baudry S, 2009, CLIN NEUROPHYSIOL, V120, P210, DOI 10.1016/j.clinph.2008.10.013; Binder C, 2009, MUSCLE NERVE, V39, P776, DOI 10.1002/mus.21240; BUCHANAN TS, 1995, NEUROSCI LETT, V194, P61, DOI 10.1016/0304-3940(95)11727-E; Capaday C, 1997, J NEUROSCI METH, V74, P201, DOI 10.1016/S0165-0270(97)02250-4; Classen J, 2000, EXP BRAIN RES, V130, P48, DOI 10.1007/s002210050005; COHEN LG, 1987, BRAIN, V110, P451, DOI 10.1093/brain/110.2.451; DAVEY NJ, 1994, J PHYSIOL-LONDON, V477, P223, DOI 10.1113/jphysiol.1994.sp020186; Di Lazzaro V, 2008, J PHYSIOL-LONDON, V586, P4481, DOI 10.1113/jphysiol.2008.159558; Di Lazzaro V, 2002, EXP BRAIN RES, V147, P108, DOI 10.1007/s00221-002-1223-5; Di Lazzaro V, 2004, CLIN NEUROPHYSIOL, V115, P255, DOI 10.1016/j.clinph.2003.10.009; DOEMGES F, 1992, J PHYSIOL-LONDON, V447, P575, DOI 10.1113/jphysiol.1992.sp019019; DUCHATEAU J, 1993, J PHYSIOL-LONDON, V471, P787, DOI 10.1113/jphysiol.1993.sp019928; Enoka RM, 2011, J ELECTROMYOGR KINES, V21, P208, DOI 10.1016/j.jelekin.2010.10.006; Espiritu MG, 2003, MUSCLE NERVE, V27, P720, DOI 10.1002/mus.10388; EVARTS EV, 1977, NEUROSCI LETT, V5, P267, DOI 10.1016/0304-3940(77)90077-5; FISHER MA, 1992, MUSCLE NERVE, V15, P1223, DOI 10.1002/mus.880151102; FUHR P, 1991, ELECTROEN CLIN NEURO, V81, P257, DOI 10.1016/0168-5597(91)90011-L; HALLETT M, 1995, ADV NEUROL, V67, P107; Hunter SK, 2008, J APPL PHYSIOL, V105, P463, DOI 10.1152/japplphysiol.90398.2008; Hunter SK, 2003, J APPL PHYSIOL, V94, P2439, DOI 10.1152/japplphysiol.01038.2002; Hunter SK, 2002, J NEUROPHYSIOL, V88, P3087, DOI 10.1152/jn.00232.2002; INGHILLERI M, 1993, J PHYSIOL-LONDON, V466, P521; Inui K, 2004, CEREB CORTEX, V14, P851, DOI 10.1093/cercor/bhh043; Kasai T, 1999, MUSCLE NERVE, V22, P1419, DOI 10.1002/(SICI)1097-4598(199910)22:10<1419::AID-MUS12>3.0.CO;2-K; Kimiskidis VK, 2005, EXP BRAIN RES, V163, P21, DOI 10.1007/s00221-004-2134-4; Klass M, 2008, J NEUROPHYSIOL, V99, P1096, DOI 10.1152/jn.01252.2007; Kojima S, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-43; Kouchtir-Devanne N, 2012, J NEUROPHYSIOL, V107, P1522, DOI 10.1152/jn.00786.2011; Legon W, 2008, NEUROREPORT, V19, P87, DOI 10.1097/WNR.0b013e3282f36f5f; MAIER MA, 1995, EXP BRAIN RES, V103, P108, DOI 10.1007/BF00241969; Maluf KS, 2007, CLIN NEUROPHYSIOL, V118, P2063, DOI 10.1016/j.clinph.2007.06.009; Maluf KS, 2005, EXP BRAIN RES, V167, P165, DOI 10.1007/s00221-005-0017-y; MAUGUIERE F, 1983, BRAIN, V106, P271, DOI 10.1093/brain/106.2.271; Mesrati F, 2004, NEUROPHYSIOL CLIN, V34, P217, DOI 10.1016/j.neucli.2004.09.005; MIZUNO Y, 1971, J NEUROPHYSIOL, V34, P1010, DOI 10.1152/jn.1971.34.6.1010; Mottram CJ, 2006, J NEUROPHYSIOL, V95, P1185, DOI 10.1152/jn.00807.2005; Ni Z, 2006, EUR J NEUROSCI, V23, P3399, DOI 10.1111/j.1460-9568.2006.04852.x; Ogata K, 2009, CLIN NEUROPHYSIOL, V120, P1143, DOI 10.1016/j.clinph.2009.01.020; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orth M, 2004, CLIN NEUROPHYSIOL, V115, P1076, DOI 10.1016/j.clinph.2003.12.025; PAPAKOSTOPOULOS D, 1975, NATURE, V258, P321, DOI 10.1038/258321a0; ROICK H, 1993, EXP BRAIN RES, V94, P489, DOI 10.1007/BF00230207; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rothwell J C, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P97; Rudroff T, 2005, MUSCLE NERVE, V31, P78, DOI 10.1002/mus.20241; Rudroff T, 2007, J APPL PHYSIOL, V102, P1000, DOI 10.1152/japplphysiol.00564.2006; Rudroff T, 2007, MUSCLE NERVE, V35, P657, DOI 10.1002/mus.20752; Rudroff T, 2010, EXP BRAIN RES, V203, P307, DOI 10.1007/s00221-010-2233-3; RUSHTON DN, 1981, BRAIN, V104, P465, DOI 10.1093/brain/104.3.465; Sakamoto M, 2004, BRAIN RES, V1029, P272, DOI 10.1016/j.brainres.2004.09.054; Sato D, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-13; Sekino M, 2004, IEEE T MAGN, V40, P2167, DOI 10.1109/TMAG.2004.828982; Sekino M, 2002, J APPL PHYS, V91, P8730, DOI 10.1063/1.1454987; Shimazu H, 1999, NEUROREPORT, V10, P2457, DOI 10.1097/00001756-199908200-00004; Sowman PF, 2008, CLIN NEUROPHYSIOL, V119, P1119, DOI 10.1016/j.clinph.2007.12.019; Staines WR, 1997, EXP BRAIN RES, V115, P156, DOI 10.1007/PL00005676; Tamaki H, 2011, J PHYSIOL SCI, V61, P411, DOI 10.1007/s12576-011-0157-8; TAPIA MC, 1987, ELECTROEN CLIN NEURO, V68, P226, DOI 10.1016/0168-5597(87)90031-1; TAX AAM, 1989, EXP BRAIN RES, V76, P55, DOI 10.1007/BF00253623; Touge T, 1997, EVOKED POTENTIAL, V104, P108, DOI 10.1016/S0168-5597(97)96136-0; Walters A ZU, 2011, CORTICAL SILENT PERI; Wu T, 2005, J PHYSIOL-LONDON, V562, P605, DOI 10.1113/jphysiol.2004.076042	68	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e108058	10.1371/journal.pone.0108058	http://dx.doi.org/10.1371/journal.pone.0108058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233353	gold, Green Published, Green Submitted			2022-12-25	WOS:000342921200075
J	Kotti, M; Duffell, LD; Faisal, AA; McGregor, AH				Kotti, Margarita; Duffell, Lynsey D.; Faisal, Aldo A.; McGregor, Alison H.			The Complexity of Human Walking: A Knee Osteoarthritis Study	PLOS ONE			English	Article							AUTOMATIC CLASSIFICATION; PATTERNS; FEATURES; TIME	This study proposes a framework for deconstructing complex walking patterns to create a simple principal component space before checking whether the projection to this space is suitable for identifying changes from the normality. We focus on knee osteoarthritis, the most common knee joint disease and the second leading cause of disability. Knee osteoarthritis affects over 250 million people worldwide. The motivation for projecting the highly dimensional movements to a lower dimensional and simpler space is our belief that motor behaviour can be understood by identifying a simplicity via projection to a low principal component space, which may reflect upon the underlying mechanism. To study this, we recruited 180 subjects, 47 of which reported that they had knee osteoarthritis. They were asked to walk several times along a walkway equipped with two force plates that capture their ground reaction forces along 3 axes, namely vertical, anterior-posterior, and medio-lateral, at 1000 Hz. Data when the subject does not clearly strike the force plate were excluded, leaving 1-3 gait cycles per subject. To examine the complexity of human walking, we applied dimensionality reduction via Probabilistic Principal Component Analysis. The first principal component explains 34% of the variance in the data, whereas over 80% of the variance is explained by 8 principal components or more. This proves the complexity of the underlying structure of the ground reaction forces. To examine if our musculoskeletal system generates movements that are distinguishable between normal and pathological subjects in a low dimensional principal component space, we applied a Bayes classifier. For the tested cross-validated, subject-independent experimental protocol, the classification accuracy equals 82.62%. Also, a novel complexity measure is proposed, which can be used as an objective index to facilitate clinical decision making. This measure proves that knee osteoarthritis subjects exhibit more variability in the two-dimensional principal component space.	[Kotti, Margarita; Duffell, Lynsey D.; McGregor, Alison H.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, Biodynam Lab,Div Surg, London, England; [Kotti, Margarita; Faisal, Aldo A.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, Brain Behav Lab, London, England; [Faisal, Aldo A.] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England; [Faisal, Aldo A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London	Kotti, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, Biodynam Lab,Div Surg, London, England.	m.kotti@imperial.ac.uk	Faisal, Aldo/A-2367-2009	Faisal, Aldo/0000-0003-0813-7207; Duffell, Lynsey/0000-0002-8137-6071	Medical Engineering Solutions in Osteoarthritis Centre of Excellence - Wellcome Trust; EPSRC; Human Frontiers in Science program grant [RGP0022/2012]	Medical Engineering Solutions in Osteoarthritis Centre of Excellence - Wellcome Trust; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Human Frontiers in Science program grant	MK, LD, and AM acknowledge support from the Medical Engineering Solutions in Osteoarthritis Centre of Excellence funded by the Wellcome Trust and the EPSRC. AF acknowledges support from his Human Frontiers in Science program grant (grant number RGP0022/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaqtash M, 2011, IEEE ENG MED BIO, P453, DOI 10.1109/IEMBS.2011.6090063; [Anonymous], 1997, WORLD HLTH REPORT 50; Bayes T., 1764, PHILOS T ROY SOC LON, V53, P370, DOI [10.1098/rstl.1763.0053, DOI 10.1098/RSTL.1763.0053]; Beynon MJ, 2006, IEEE T SYST MAN CY A, V36, P173, DOI 10.1109/TSMCA.2006.859098; Bishop C.M., 2006, PATTERN RECOGNITION; Bullens PHJ, 2001, J ARTHROPLASTY, V16, P740, DOI 10.1054/arth.2001.23922; Carr AJ, 2012, LANCET, V379, P1331, DOI 10.1016/S0140-6736(11)60752-6; Chen A, 2012, ARTHRITIS, DOI 10.1155/2012/698709; Ching Yee Yong, 2013, Applied Mechanics and Materials, V284-287, P3126, DOI 10.4028/www.scientific.net/AMM.284-287.3126; Deluzio KJ, 2007, GAIT POSTURE, V25, P86, DOI 10.1016/j.gaitpost.2006.01.007; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; Duda R.O., 2006, PATTERN CLASSIFICATI; Duffell LD, 2013, GAIT POSTURE, V38, P745, DOI 10.1016/j.gaitpost.2013.03.015; Faisal A. A., 2012, COMPUTATIONAL SYSTEM, P227, DOI [10.1007/978-94-007-3858-4-8, DOI 10.1007/978-94-007-3858-4-8]; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Faisal AA, 2009, J NEUROPHYSIOL, V101, P1901, DOI 10.1152/jn.90974.2008; Faisal AA, 2002, IEEE IJCNN, P1661, DOI 10.1109/IJCNN.2002.1007767; Faisal AA, 2008, P COMP SYST NEUR COS; Faisal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013718; Haber D, 2014, IEEE INT C BOD SENS, P625; Howard IS, 2009, J NEUROPHYSIOL, V102, P1902, DOI 10.1152/jn.00013.2009; Huber C, 2013, J BIOMECH, V46, P1262, DOI 10.1016/j.jbiomech.2013.02.017; Ilg W, 2007, BRAIN, V130, P786, DOI 10.1093/brain/awl376; Karg M, 2009, 3 INT C AFF COMP INT, DOI [10.1109/ACII.2009.5349438, DOI 10.1109/ACII.2009.5349438]; Kutch JJ, 2011, J BIOMECH, V44, P1264, DOI 10.1016/j.jbiomech.2011.02.014; Linden M, 2012, INDEPENDENT NEWSPAPE; Lynn SK, 2007, KNEE, V14, P22, DOI 10.1016/j.knee.2006.09.002; Mezghani N, 2008, IEEE T BIO-MED ENG, V55, P1230, DOI 10.1109/TBME.2007.905388; Moustakidis SP, 2010, MED ENG PHYS, V32, P1145, DOI 10.1016/j.medengphy.2010.08.006; NABNEY I, 2002, ADV PATTERN RECOGNIT; Ormoneit D, 2005, IMAGE VISION COMPUT, V23, P1264, DOI 10.1016/j.imavis.2005.09.004; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Thomik A, 2012, BERNST COMP NEUR C 2, DOI [10.3389/conf.fncom.2012.55.00256, DOI 10.3389/CONF.FNCOM.2012.55.00256]; THOMIK AAC, 2013, 6 INT IEEE EMBS C NE, P625, DOI DOI 10.1109/NER.2013.6696012; Tipping ME, 1999, J R STAT SOC B, V61, P611, DOI 10.1111/1467-9868.00196; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Williams DP, 2013, BONE JOINT J, V95B, P38, DOI 10.1302/0301-620X.95B1.28061; Wilson JLA, 2011, OSTEOARTHR CARTILAGE, V19, P186, DOI 10.1016/j.joca.2010.10.020	38	12	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107325	10.1371/journal.pone.0107325	http://dx.doi.org/10.1371/journal.pone.0107325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232949	Green Submitted, Green Published, gold			2022-12-25	WOS:000342921200024
J	Xie, D; Seremwe, M; Edwards, JG; Podolsky, R; Bollag, WB				Xie, Ding; Seremwe, Mutsa; Edwards, John G.; Podolsky, Robert; Bollag, Wendy B.			Distinct Effects of Different Phosphatidylglycerol Species on Mouse Keratinocyte Proliferation	PLOS ONE			English	Article							PROTEIN-KINASE; INFLAMMATION; ACTIVATION; CELLS; PHOSPHORYLATION; APOPTOSIS; BINDING; LIPIDS	We have previously shown that liposomes composed of egg-derived phosphatidylglycerol (PG), with a mixed fatty acid composition (comprising mainly palmitate and oleate), inhibit the proliferation and promote the differentiation of rapidly dividing keratinocytes, and stimulate the growth of slowly proliferating epidermal cells. To determine the species of PG most effective at modulating keratinocyte proliferation, primary mouse keratinocytes were treated with different PG species, and proliferation was measured. PG species containing polyunsaturated fatty acids were effective at inhibiting rapidly proliferating keratinocytes, whereas PG species with monounsaturated fatty acids were effective at promoting proliferation in slowly dividing cells. Thus, palmitoyl-arachidonyl-PG (16:0/20:4), palmitoyl-linoleoyl-PG (16:0/18:2), dilinoleoyl-PG (18:2/18:2) and soy PG (a PG mixture with a large percentage of polyunsaturated fatty acids) were particularly effective at inhibiting proliferation in rapidly dividing keratinocytes. Conversely, palmitoyl-oleoyl-PG (16:0/18:1) and dioleoyl-PG (18:1/18:1) were especially effective proproliferative PG species. This result represents the first demonstration of opposite effects of different species of a single class of phospholipid and suggests that these different PG species may signal to diverse effector enzymes to differentially affect keratinocyte proliferation and normalize keratinocyte proliferation. Thus, different PG species may be useful for treating skin diseases characterized by excessive or insufficient proliferation.	[Bollag, Wendy B.] Charlie Norwood VA Med Ctr, Augusta, GA 30904 USA; [Xie, Ding; Seremwe, Mutsa; Bollag, Wendy B.] Georgia Regents Univ, Med Coll Georgia, Dept Physiol, Augusta, GA USA; [Edwards, John G.] Apeliotus Technol Inc, Atlanta, GA USA; [Podolsky, Robert] Georgia Regents Univ, Med Coll Georgia, Dept Med, Ctr Biotechnol & Genom Med, Augusta, GA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; Augusta University; University System of Georgia; Augusta University	Bollag, WB (corresponding author), Charlie Norwood VA Med Ctr, Augusta, GA 30904 USA.	WB@gru.edu	Podolsky, Robert/GRY-0740-2022; Edwards, Jeff/P-9759-2016; Seremwe, Mutsa P/Q-9783-2018	Edwards, Jeff/0000-0001-7298-1889; Bollag, Wendy/0000-0003-3146-162X	NIH [AR45212, AR55022]; Georgia Research Alliance; VA Research Career Scientist Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR045212, R01AR045212, R41AR055022] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; VA Research Career Scientist Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH grants #AR45212 and AR55022 and an award from the Georgia Research Alliance. WBB is supported by a VA Research Career Scientist Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this article do not represent the views of the Department of Veterans Affairs or the United States Government.	Bao H, 2013, J BIOL CHEM, V288, P23666, DOI 10.1074/jbc.M113.489567; Bollag WB, 2005, J PHARMACOL EXP THER, V312, P1223, DOI 10.1124/jpet.104.075622; BOLLAG WB, 1993, J INVEST DERMATOL, V100, P240, DOI 10.1111/1523-1747.ep12468992; Bollag WB, 2007, J INVEST DERMATOL, V127, P2823, DOI 10.1038/sj.jid.5700921; Chiba H, 2006, RESPIROLOGY, V11, pS2, DOI 10.1111/j.1440-1843.2006.00797.x; Gokmen-Polar Y, 1998, J BIOL CHEM, V273, P20261, DOI 10.1074/jbc.273.32.20261; Goldsmith L.A., 1991, PHYSL BIOCH MOL BIOL, V2nd; Griner RD, 1999, J BIOL CHEM, V274, P4663, DOI 10.1074/jbc.274.8.4663; Kandasamy P, 2011, J BIOL CHEM, V286, P7841, DOI 10.1074/jbc.M110.170241; KLEMM DJ, 1988, EXP HEMATOL, V16, P855; KLEMM DJ, 1988, ARCH BIOCHEM BIOPHYS, V265, P506, DOI 10.1016/0003-9861(88)90155-5; Kruse O, 2000, J BIOL CHEM, V275, P6509, DOI 10.1074/jbc.275.9.6509; Kuronuma K, 2009, J BIOL CHEM, V284, P25488, DOI 10.1074/jbc.M109.040832; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Langley R, 2005, PSORIASIS EVERYTHING; Marty NJ, 2013, BIOCHEMISTRY-US, V52, P5585, DOI 10.1021/bi400432f; McCarthy CG, 2014, AM J PHYSIOL-HEART C, V306, pH184, DOI 10.1152/ajpheart.00328.2013; Modlin RL, 2012, J INVEST DERMATOL, V132, P882, DOI 10.1038/jid.2011.373; MURRAY NR, 1994, J BIOL CHEM, V269, P21385; Murray NR, 1998, J BIOL CHEM, V273, P11514, DOI 10.1074/jbc.273.19.11514; Numata M, 2012, AM J RESP CELL MOL, V46, P479, DOI 10.1165/rcmb.2011-0194OC; Numata M, 2010, P NATL ACAD SCI USA, V107, P320, DOI 10.1073/pnas.0909361107; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; Potting C, 2013, CELL METAB, V18, P287, DOI 10.1016/j.cmet.2013.07.008; Qin HX, 2011, ARCH BIOCHEM BIOPHYS, V508, P138, DOI 10.1016/j.abb.2011.01.014; Shaban H, 2002, EXP EYE RES, V75, P99, DOI 10.1006/exer.2001.1192; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Stanwell C, 1996, J INVEST DERMATOL, V106, P482, DOI 10.1111/1523-1747.ep12343690; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; Terashi H, 2000, J DERMATOL SCI, V24, P14, DOI 10.1016/S0923-1811(00)00077-3; YUSPA SH, 1982, CANCER RES, V42, P2344; Zheng XJ, 2003, BBA-MOL CELL RES, V1643, P25, DOI 10.1016/j.bbamcr.2003.08.006; Zheng XJ, 2003, J INVEST DERMATOL, V121, P1487, DOI 10.1111/j.1523-1747.2003.12614.x	34	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107119	10.1371/journal.pone.0107119	http://dx.doi.org/10.1371/journal.pone.0107119			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233484	gold, Green Submitted, Green Published			2022-12-25	WOS:000342921200014
J	Miller, BS; Leaper, R; Calderan, S; Gedamke, J				Miller, Brian S.; Leaper, Russell; Calderan, Susannah; Gedamke, Jason			Red Shift, Blue Shift: Investigating Doppler Shifts, Blubber Thickness, and Migration as Explanations of Seasonal Variation in the Tonality of Antarctic Blue Whale Song	PLOS ONE			English	Article							SOUTHERN-HEMISPHERE; SOUND PRODUCTION; BALEEN WHALES; SPERM-WHALES; FREQUENCY; PACIFIC; SEA; VOCALIZATIONS; MOVEMENTS; DISCOVERY	The song of Antarctic blue whales (Balaenoptera musculus intermedia) comprises repeated, stereotyped, low-frequency calls. Measurements of these calls from recordings spanning many years have revealed a long-term linear decline as well as an intra-annual pattern in tonal frequency. While a number of hypotheses for this long-term decline have been investigated, including changes in population structure, changes in the physical environment, and changes in the behaviour of the whales, there have been relatively few attempts to explain the intra-annual pattern. An additional hypothesis that has not yet been investigated is that differences in the observed frequency from each call are due to the Doppler effect. The assumptions and implications of the Doppler effect on whale song are investigated using 1) vessel-based acoustic recordings of Antarctic blue whales with simultaneous observation of whale movement and 2) long-term acoustic recordings from both the subtropics and Antarctic. Results from vessel-based recordings of Antarctic blue whales indicate that variation in peak-frequency between calls produced by an individual whale was greater than would be expected by the movement of the whale alone. Furthermore, analysis of intra-annual frequency shift at Antarctic recording stations indicates that the Doppler effect is unlikely to fully explain the observations of intra-annual pattern in the frequency of Antarctic blue whale song. However, data do show cyclical changes in frequency in conjunction with season, thus suggesting that there might be a relationship among tonal frequency, body condition, and migration to and from Antarctic feeding grounds.	[Miller, Brian S.; Calderan, Susannah] Australian Antarctic Div, Australian Marine Mammal Ctr, Kingston, Tas, Australia; [Leaper, Russell] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Gedamke, Jason] NOAA, Ocean Acoust Program, Fisheries Off Sci & Technol, Silver Spring, MD USA	Australian Antarctic Division; University of Aberdeen; National Oceanic Atmospheric Admin (NOAA) - USA	Miller, BS (corresponding author), Australian Antarctic Div, Australian Marine Mammal Ctr, Kingston, Tas, Australia.	brian.miller@aad.gov.au		Miller, Brian/0000-0001-7615-3044	International Whale and Marine Mammal Conservation Initiative of the Australian Government via Southern Ocean Research Partnership of the International Whaling Commission; Australian Antarctic Division	International Whale and Marine Mammal Conservation Initiative of the Australian Government via Southern Ocean Research Partnership of the International Whaling Commission; Australian Antarctic Division	Deployment of long-term recorders was supported by the Australian Antarctic Division. This work was supported by the International Whale and Marine Mammal Conservation Initiative of the Australian Government via Southern Ocean Research Partnership of the International Whaling Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam O, 2013, APPL ACOUST, V74, P1182, DOI 10.1016/j.apacoust.2013.04.007; Andrews-Goff V, 2013, REPORT SC 65A SH03; Aroyan JL, 2000, SPR HDB AUD, V12, P409; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Ballot B., 1845, ANN PHYS CHEM, V11, P321; Branch TA, 2007, MAMMAL REV, V37, P116, DOI 10.1111/j.1365-2907.2007.00106.x; de la Mare WK, 2014, CAN J FISH AQUAT SCI, V71, P106, DOI 10.1139/cjfas-2013-0016; Double MC, 2013, SC65ASH21 INT WHAL C; Gavrilov AN, 2012, J ACOUST SOC AM, V131, P4476, DOI 10.1121/1.4707425; Gavrilov AN, 2011, J ACOUST SOC AM, V130, P3651, DOI 10.1121/1.3651817; Gedamke J, 2007, SC59SH5; Gillespie D., 2008, P I ACOUSTICS, V30, P54; Gordon JC, 1990, REP INT WHAL COMMN, V40, P581; Greene CR, 2004, J ACOUST SOC AM, V116, P799, DOI 10.1121/1.1765191; Growcott A, 2011, J ACOUST SOC AM, V130, P568, DOI 10.1121/1.3578455; Jaquet N, 2006, MAR MAMMAL SCI, V22, P862, DOI 10.1111/j.1748-7692.2006.00060.x; Ketten Darlene R., 1997, Bioacoustics, V8, P103; Leaper Russell, 2001, Journal of Cetacean Research and Management, V3, P131; Mackintosh N. A., 1929, Discovery Reports Cambridge, V1, P257; Mackintosh NA., 1966, WHALES DOLPHINS PORP, P125; Maranda B. H., 2001, CALIBRATION FACTORS; McDonald Mark A., 2009, Endangered Species Research, V9, P13, DOI 10.3354/esr00217; Miller BS, 2014, J ACOUST SOC AM, V135, P1616, DOI 10.1121/1.4863647; Miller BS, 2014, SUBMITT SCI COMM B, P14; Miller BS, 2014, SUBMITT SCI COMM B, P8; Miller BS, 2013, SC65ASH1 SCI COMM IN, P1; Miller CA, 2011, MAR ECOL PROG SER, V438, P267, DOI 10.3354/meps09174; Moore M. J., 2001, Journal of Cetacean Research and Management Special Issue, P301; Nosal EM, 2007, J ACOUST SOC AM, V122, P1969, DOI 10.1121/1.2775423; Nousek-McGregor AE, 2014, PHYSIOL BIOCHEM ZOOL, V87, P160, DOI 10.1086/671811; Oleson EM, 2007, MAR ECOL PROG SER, V330, P269, DOI 10.3354/meps330269; Rankin Shannon, 2005, Journal of Cetacean Research and Management, V7, P13; Reidenberg JS, 2007, ANAT REC, V290, P745, DOI 10.1002/ar.20544; Samaran F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071561; Samaran F, 2010, APPL ACOUST, V71, P1099, DOI 10.1016/j.apacoust.2010.05.014; Samaran Flore, 2010, Endangered Species Research, V12, P157, DOI 10.3354/esr00302; Sears R, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P120; Sirovic A, 2004, DEEP-SEA RES PT II, V51, P2327, DOI 10.1016/j.dsr2.2004.08.005; Sirovic A, 2009, MAR MAMMAL SCI, V25, P125, DOI 10.1111/j.1748-7692.2008.00239.x; Stafford KM, 2004, DEEP-SEA RES PT I, V51, P1337, DOI 10.1016/j.dsr.2004.05.007; Sullivan EJ, 2006, J ACOUST SOC AM, V120, pEL49, DOI 10.1121/1.2266024; Thode AM, 2000, J ACOUST SOC AM, V107, P1286, DOI 10.1121/1.428417; THOMPSON RKR, 1975, J ACOUST SOC AM, V57, P943, DOI 10.1121/1.380513; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Valtierra RD, 2013, J ACOUST SOC AM, V134, P2571, DOI 10.1121/1.4816582; Wiggins S, 2003, MAR TECHNOL SOC J, V37, P13, DOI 10.4031/002533203787537375	46	12	14	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107740	10.1371/journal.pone.0107740	http://dx.doi.org/10.1371/journal.pone.0107740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229644	gold, Green Published, Green Submitted			2022-12-25	WOS:000342123900068
J	Spornraft, M; Kirchner, B; Haase, B; Benes, V; Pfaffl, MW; Riedmaier, I				Spornraft, Melanie; Kirchner, Benedikt; Haase, Bettina; Benes, Vladimir; Pfaffl, Michael W.; Riedmaier, Irmgard			Optimization of Extraction of Circulating RNAs from Plasma - Enabling Small RNA Sequencing	PLOS ONE			English	Article							SENSITIVE BIOMARKERS; MICRORNAS; EXPRESSION; PIWI	There are several protocols and kits for the extraction of circulating RNAs from plasma with a following quantification of specific genes via RT-qPCR. Due to the marginal amount of cell-free RNA in plasma samples, the total RNA yield is insufficient to perform Next-Generation Sequencing (NGS), the state-of-the-art technology in massive parallel sequencing that enables a comprehensive characterization of the whole transcriptome. Screening the transcriptome for biomarker signatures accelerates progress in biomarker profiling for molecular diagnostics, early disease detection or food safety. Therefore, the aim was to optimize a method that enables the extraction of sufficient amounts of total RNA from bovine plasma to generate good-quality small RNA Sequencing (small RNA-Seq) data. An increased volume of plasma (9 ml) was processed using the Qiagen miRNeasy Serum/Plasma Kit in combination with the QIAvac24 Plus system, a vacuum manifold that enables handling of high volumes during RNA isolation. 35 ng of total RNA were passed on to cDNA library preparation followed by small RNA high-throughput sequencing analysis on the Illumina HiSeq2000 platform. Raw sequencing reads were processed by a data analysis pipeline using different free software solutions. Seq-data was trimmed, quality checked, gradually selected for miRNAs/piRNAs and aligned to small RNA reference annotation indexes. Mapping to human reference indexes resulted in 4.8 +/- 2.8% of mature miRNAs and 1.4 +/- 0.8% of piRNAs and of 5.0 +/- 2.9% of mature miRNAs for bos taurus.	[Spornraft, Melanie; Kirchner, Benedikt; Pfaffl, Michael W.; Riedmaier, Irmgard] Tech Univ Munich, Physiol Weihenstephan, Freising Weihenstephan, Germany; [Spornraft, Melanie; Kirchner, Benedikt; Pfaffl, Michael W.; Riedmaier, Irmgard] Tech Univ Munich, ZIEL Res Ctr Nutr & Food Sci, Freising Weihenstephan, Germany; [Haase, Bettina; Benes, Vladimir] European Mol Biol Lab, Genom Core Facil, D-69012 Heidelberg, Germany	Technical University of Munich; Technical University of Munich; European Molecular Biology Laboratory (EMBL)	Spornraft, M (corresponding author), Tech Univ Munich, Physiol Weihenstephan, Freising Weihenstephan, Germany.	melanie.spornraft@wzw.tum.de	Pfaffl, Michael/G-6622-2013	Pfaffl, Michael/0000-0002-3192-1019; Haase, Bettina/0000-0002-9811-473X; Kirchner, Benedikt/0000-0003-3878-0148	Chair of Physiology, TUM; German Research Foundation (DFG); Technische Universitat Munchen	Chair of Physiology, TUM; German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen	The project was funded by internal budget of the Chair of Physiology, TUM. This work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniewski C, 2014, METHODS MOL BIOL, V1173, P135, DOI 10.1007/978-1-4939-0931-5_12; Bailly-Chouriberry L, 2010, DRUG TEST ANAL, V2, P339, DOI 10.1002/dta.146; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Illumina Inc, 2011, QUAL SCOR NEXT GEN S; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Jin XF, 2013, CELL MOL NEUROBIOL, V33, P601, DOI 10.1007/s10571-013-9940-9; Kong Y, 2011, GENOMICS, V98, P152, DOI 10.1016/j.ygeno.2011.05.009; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li CW, 2012, CLIN BIOCHEM, V45, P727, DOI 10.1016/j.clinbiochem.2012.04.013; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Mei YP, 2013, CANCER LETT, V336, P46, DOI 10.1016/j.canlet.2013.04.008; Mitchell CJ, 2009, J CLIN ENDOCR METAB, V94, P4703, DOI 10.1210/jc.2009-1038; Morillon A, 2013, METHODS, V63, P1, DOI 10.1016/j.ymeth.2013.08.030; Ortega FJ, 2014, DIABETES CARE, V37, P1375, DOI 10.2337/dc13-1847; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Riedmaier I, 2013, METHODS, V59, P3, DOI 10.1016/j.ymeth.2012.08.012; Riedmaier I, 2012, DRUG TEST ANAL, V4, P70, DOI 10.1002/dta.1386; Rosenkranz D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-5; Selth LA, 2012, ENDOCR-RELAT CANCER, V19, pR99, DOI 10.1530/ERC-12-0010; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Tang DF, 2013, EUR J CANCER PREV, V22, P540, DOI 10.1097/CEJ.0b013e32835f3be9; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110; Xu JH, 2012, J MOL MED, V90, P865, DOI 10.1007/s00109-011-0840-5; Yan Z, 2011, NUCLEIC ACIDS RES, V39, P6596, DOI 10.1093/nar/gkr298; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	37	41	41	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107259	10.1371/journal.pone.0107259	http://dx.doi.org/10.1371/journal.pone.0107259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229651	Green Published, Green Submitted, gold			2022-12-25	WOS:000342123900036
J	Tahamtani, FM; Hansen, TB; Orritt, R; Nicol, C; Moe, RO; Janczak, AM				Tahamtani, Fernanda M.; Hansen, Tone Beate; Orritt, Rachel; Nicol, Christine; Moe, Randi O.; Janczak, Andrew M.			Does Rearing Laying Hens in Aviaries Adversely Affect Long-Term Welfare following Transfer to Furnished Cages?	PLOS ONE			English	Article							FEATHER PECKING; DOMESTIC-FOWL; LEARNED HELPLESSNESS; RECEPTOR ANTAGONIST; LIGHT-INTENSITY; BEHAVIOR; CANNIBALISM; QUALITY; ACCESS; FLOOR	This study tests the hypothesis that hens that are reared in aviaries but produce in furnished cages experience poorer welfare in production than hens reared in caged systems. This hypothesis is based on the suggestion that the spatial restriction associated with the transfer from aviaries to cages results in frustration or stress for the aviary reared birds. To assess the difference in welfare between aviary and cage reared hens in production, non-beak trimmed white leghorn birds from both rearing backgrounds were filmed at a commercial farm that used furnished cage housing. The videos were taken at 19 and 21 weeks of age, following the birds' transition to the production environment at 16 weeks. Videos were analysed in terms of the performance of aversion-related behaviour in undisturbed birds, comfort behaviour in undisturbed birds, and alert behaviour directed to a novel object in the home cage. A decrease in the performance of the former behaviour and increase in the performance of the latter two behaviours indicates improved welfare. The results showed that aviary reared birds performed more alert behaviour near to the object than did cage reared birds at 19 but not at 21 weeks of age (P = 0.03). Blood glucose concentrations did not differ between the treatments (P > 0.10). There was a significant difference in mortality between treatments (P = 0.000), with more death in aviary reared birds (5.52%) compared to cage birds (2.48%). The higher mortality of aviary-reared birds indicates a negative effect of aviary rearing on bird welfare, whereas the higher duration of alert behavior suggests a positive effect of aviary rearing.	[Tahamtani, Fernanda M.; Orritt, Rachel; Moe, Randi O.; Janczak, Andrew M.] NMBU, Dept Prod Anim Clin Sci, Anim Welf Res Grp, Oslo, Norway; [Hansen, Tone Beate] Norwegian Meat & Poultry Res Ctr, Oslo, Norway; [Orritt, Rachel] Lincoln Univ, Sch Psychol, Lincoln, England; [Nicol, Christine] Univ Bristol, Div Anim Hlth & Husb, Bristol, Avon, England	Norwegian University of Life Sciences; University of Lincoln; University of Bristol	Janczak, AM (corresponding author), NMBU, Dept Prod Anim Clin Sci, Anim Welf Res Grp, Oslo, Norway.	andrew.janczak@nmbu.no	Tahamtani, Fernanda/J-6339-2019; Moe, Randi O/D-3396-2013; Janczak, Andrew M/B-4113-2013; Nicol, Christine J/B-4841-2011	Tahamtani, Fernanda/0000-0002-4439-9733; Moe, Randi O/0000-0003-2519-1707; Janczak, Andrew M/0000-0002-1141-8272; Nicol, Christine J/0000-0001-6734-2177; Orritt, Rachel/0000-0001-8396-7679	Foundation for Research Levy on Agricultural Products (FFL); Agricultural Agreement Research Fund (JA); UFAW Student Scholarship; Animalia (Norwegian Meat and Poultry Research Centre); Biotechnology and Biological Sciences Research Council [BB/K00042X/1] Funding Source: researchfish; BBSRC [BB/K00042X/1] Funding Source: UKRI	Foundation for Research Levy on Agricultural Products (FFL); Agricultural Agreement Research Fund (JA); UFAW Student Scholarship; Animalia (Norwegian Meat and Poultry Research Centre); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Foundation for Research Levy on Agricultural Products (FFL), the Agricultural Agreement Research Fund (JA), a UFAW Student Scholarship, and Animalia (Norwegian Meat and Poultry Research Centre). The author TBH is employed by Animalia, and contributed as described under author contributions. Animalia finances and performs applied agricultural research in collaboration with the private and public sectors. Animalia's sole interest in the present study was to support publication of the unbiased results in order to provide advice to poultry rearers. The financial contribution by Animalia does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Albentosa MJ, 2004, ANIM WELFARE, V13, P419; Altman D.G., 1991, PRACTICAL STATISTIC; ANDERSON KE, 1994, POULTRY SCI, V73, P1233, DOI 10.3382/ps.0731233; Roll VFB, 2009, CIENC RURAL, V39, P1527, DOI 10.1590/S0103-84782009000500034; de Haas EN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090577; de Jong IC, 2007, APPL ANIM BEHAV SCI, V104, P24, DOI 10.1016/j.applanim.2006.04.027; DUNCAN IJH, 1972, ANIM BEHAV, V20, P68, DOI 10.1016/S0003-3472(72)80174-X; European Comission, 1999, OFF J EUR UNION, P53; Ferguson DM, 2008, MEAT SCI, V80, P12, DOI 10.1016/j.meatsci.2008.05.004; Gilani AM, 2013, APPL ANIM BEHAV SCI, V148, P54, DOI 10.1016/j.applanim.2013.07.014; Haskell M, 2000, BEHAVIOUR, V137, P531, DOI 10.1163/156853900502196; Janczak AM, 2009, ACTA AGR SCAND A-AN, V59, P80, DOI 10.1080/09064700903023348; Johnsen PF, 1998, APPL ANIM BEHAV SCI, V60, P25, DOI 10.1016/S0168-1591(98)00149-X; Kjaer JB, 2004, APPL ANIM BEHAV SCI, V86, P77, DOI 10.1016/j.applanim.2003.11.009; Kjaer JB, 2002, APPL ANIM BEHAV SCI, V76, P21, DOI 10.1016/S0168-1591(01)00209-X; Lewis PD, 1999, WORLD POULTRY SCI J, V55, P241, DOI 10.1079/WPS19990018; Moe RO, 2013, APPL ANIM BEHAV SCI, V148, P46, DOI 10.1016/j.applanim.2013.08.001; Moe RO, 2011, PHYSIOL BEHAV, V102, P400, DOI 10.1016/j.physbeh.2010.12.008; Moe RO, 2009, APPL ANIM BEHAV SCI, V121, P171, DOI 10.1016/j.applanim.2009.10.002; Moe RO, 2009, APPL ANIMAL BE UNPUB; MORRIS TR, 1994, WORLD POULTRY SCI J, V50, P283; Nicol CJ, 2011, ANIM WELFARE, V20, P133; Nicol CJ, 2009, ANIM BEHAV, V78, P413, DOI 10.1016/j.anbehav.2009.05.016; NICOL CJ, 1987, BRIT POULTRY SCI, V28, P327, DOI 10.1080/00071668708416965; NICOL CJ, 1989, APPL ANIM BEHAV SCI, V22, P75, DOI 10.1016/0168-1591(89)90081-6; Onbasilar EE, 2005, LIVEST PROD SCI, V95, P255, DOI 10.1016/j.livprodsci.2005.01.006; Patzke N, 2009, J CHEM NEUROANAT, V37, P141, DOI 10.1016/j.jchemneu.2008.12.005; Petracci M, 2010, WORLD POULTRY SCI J, V66, P17, DOI 10.1017/S0043933910000024; Richter SH, 2013, BEHAV BRAIN RES, V252, P287, DOI 10.1016/j.bbr.2013.06.021; Rodenburg TB, 2005, APPL ANIM BEHAV SCI, V91, P85, DOI 10.1016/j.applanim.2004.08.023; Salomons AR, 2009, SCAND J LAB ANIM SCI, V36, P37; SAVORY CJ, 1995, WORLD POULTRY SCI J, V51, P215, DOI 10.1079/WPS19950016; Sherwin CM, 2010, BRIT POULTRY SCI, V51, P488, DOI 10.1080/00071668.2010.502518; SIMON J, 1984, DIABETES METAB, V10, P211; TAUSON R, 1980, SWED J AGR RES, V10, P35; Taylor PE, 2001, APPL ANIM BEHAV SCI, V71, P319, DOI 10.1016/S0168-1591(00)00182-9; van Hierden YM, 2005, PHYSIOL BEHAV, V84, P471, DOI 10.1016/j.physbeh.2005.01.015; Vollmayr B, 2013, CELL TISSUE RES, V354, P171, DOI 10.1007/s00441-013-1654-2; Walstra I, 2010, ANIMAL, V4, P1688, DOI 10.1017/S175173111000073X; Wichman A, 2009, ANIM WELFARE, V18, P149; Zimmerman PH, 2011, ANIM BEHAV, V81, P569, DOI 10.1016/j.anbehav.2010.11.028; Zimmerman PH, 2003, ANIM WELFARE, V12, P315	42	13	13	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107357	10.1371/journal.pone.0107357	http://dx.doi.org/10.1371/journal.pone.0107357			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229879	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000342123900038
J	Chen, L; Lu, J; Huang, T; Yin, J; Wei, L; Cai, YD				Chen, Lei; Lu, Jing; Huang, Tao; Yin, Jun; Wei, Lai; Cai, Yu-Dong			Finding Candidate Drugs for Hepatitis C Based on Chemical-Chemical and Chemical-Protein Interactions	PLOS ONE			English	Article							ANTIVIRAL TREATMENT; VIRUS-INFECTION; PREDICTION; THERAPY; REPLICATION; COMBINATION; INTERFERON; CELGOSIVIR; DRUGBANK; MACHINE	Hepatitis C virus (HCV) is an infectious virus that can cause serious illnesses. Only a few drugs have been reported to effectively treat hepatitis C. To have greater diversity in drug choice and better treatment options, it is necessary to develop more drugs to treat the infection. However, it is time-consuming and expensive to discover candidate drugs using experimental methods, and computational methods may complement experimental approaches as a preliminary filtering process. This type of approach was proposed by using known chemical-chemical interactions to extract interactive compounds with three known drug compounds of HCV, and the probabilities of these drug compounds being able to treat hepatitis C were calculated using chemical-protein interactions between the interactive compounds and HCV target genes. Moreover, the randomization test and expectation-maximization (EM) algorithm were both employed to exclude false discoveries. Analysis of the selected compounds, including acyclovir and ganciclovir, indicated that some of these compounds had potential to treat the HCV. Hopefully, this proposed method could provide new insights into the discovery of candidate drugs for the treatment of HCV and other diseases.	[Chen, Lei; Yin, Jun; Wei, Lai] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Lu, Jing] Yantai Univ, Sch Pharm, Dept Med Chem, Yantai, Shandong, Peoples R China; [Huang, Tao] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China	Shanghai Maritime University; Yantai University; Icahn School of Medicine at Mount Sinai; Shanghai University	Cai, YD (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	cai_yud@126.com	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510101, 2011CB510102]; National Natural Science Foundation of China [61202021, 31170952, 31371335, 61373028, 11371008, 61203240]; Innovation Program of the Shanghai Municipal Education Commission [12YZ120, 12ZZ087, 14YZ102]; Shanghai Educational Development Foundation [12CG55]; Shanghai Municipal Natural Science Foundation [13ZR1455600]; Science AMP; Technology Program of the Shanghai Maritime University [20120105, 20120109]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of the Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Shanghai Educational Development Foundation; Shanghai Municipal Natural Science Foundation; Science AMP; Technology Program of the Shanghai Maritime University	This study was supported by the National Basic Research Program of China (2011CB510101, 2011CB510102), the National Natural Science Foundation of China (61202021, 31170952, 31371335, 61373028, 11371008, 61203240), the Innovation Program of the Shanghai Municipal Education Commission (12YZ120, 12ZZ087, 14YZ102), the Shanghai Educational Development Foundation (12CG55), the Shanghai Municipal Natural Science Foundation (13ZR1455600) and the Science & Technology Program of the Shanghai Maritime University (No. 20120105, No. 20120109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader T, 2008, AM J GASTROENTEROL, V103, P1383, DOI 10.1111/j.1572-0241.2008.01876.x; Chander G, 2002, HEPATOLOGY, V36, pS135, DOI 10.1053/jhep.2002.37146; Chen L, 2014, MOL BIOSYST, V10, P868, DOI 10.1039/c3mb70490d; Chen L, 2014, BBA-PROTEINS PROTEOM, V1844, P207, DOI 10.1016/j.bbapap.2013.05.021; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; de Bruijne J, 2009, VOX SANG, V97, P1, DOI 10.1111/j.1423-0410.2009.01187.x; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Himmelsbach K, 2009, GUT, V58, P1644, DOI 10.1136/gut.2009.182212; Himmelsbach K, 2013, EUR J CELL BIOL, V92, P12, DOI 10.1016/j.ejcb.2012.09.001; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034460; Ikeda M, 2006, HEPATOLOGY, V44, P117, DOI 10.1002/hep.21232; Jiang M, 2013, MOL BIOSYST, V9, P2720, DOI 10.1039/c3mb70089e; Johnson M. A., 1990, CONCEPTS APPL MOL SI; Kaita K, 2007, J HEPATOL, V46, pS56, DOI 10.1016/S0168-8278(07)61725-5; Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033393; Lu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087791; Lu J, 2011, J COMPUT AID MOL DES, V25, P885, DOI 10.1007/s10822-011-9472-7; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; McCartney Erin M, 2011, Hepatology, V54, P1472, DOI 10.1002/hep.24586; Speck-Planche A, 2012, CURR TOP MED CHEM, V12, P802, DOI 10.2174/156802612800166783; Ueda Y, 2011, BIOCHEM BIOPH RES CO, V409, P663, DOI 10.1016/j.bbrc.2011.05.061; VENTO S, 1991, AIDS, V5, P776, DOI 10.1097/00002030-199106000-00024; Wang M, 2014, SAR QSAR ENVIRON RES, V25, P1, DOI 10.1080/1062936X.2013.820790; Wang Y, 2012, J CHEM INF MODEL, V52, P1994, DOI 10.1021/ci300266p; Weidlich IE, 2013, BIOORGAN MED CHEM, V21, P3127, DOI 10.1016/j.bmc.2013.03.032; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Witten I. H., 2005, DATA MINING PRACTICA; Yoshida E, 2006, GASTROENTEROLOGY, V130, pA784; Zheng MY, 2006, BIOINFORMATICS, V22, P2099, DOI 10.1093/bioinformatics/btl352; Zhu Y, 2013, WORLD J GASTROENTERO, V19, P8963, DOI 10.3748/wjg.v19.i47.8963	34	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107767	10.1371/journal.pone.0107767	http://dx.doi.org/10.1371/journal.pone.0107767			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225900	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700081
J	Leger, D; Beck, F; Richard, JB; Sauvet, F; Faraut, B				Leger, Damien; Beck, Francois; Richard, Jean-Baptiste; Sauvet, Fabien; Faraut, Brice			The Risks of Sleeping "Too Much". Survey of a National Representative Sample of 24671 Adults (INPES Health Barometer)	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; LONG-SLEEP; DURATION; OBESITY; METAANALYSIS; ASSOCIATION; DEPRIVATION; PARAMETERS	Background: A significant U-shaped association between sleep duration and several morbidity (obesity, diabetes or cardiovascular disease) and mortality risks has been regularly reported. However, although the physiological pathways and risks associated with "too short sleep" (<5 hours/day) have been well demonstrated, little is known about "too much sleeping". Purpose: To explore socio-demographic characteristics and comorbidities of "long sleepers" (over 10 hours/day) from a nationally representative sample of adults. Methods: A cross-sectional nationally representative sample of 24,671 subjects from 15 to 85-year-old. An estimated total sleep time (TST) on non-leisure days was calculated based on a specifically designed sleep log which allows to distinguish "long sleepers" from "short sleepers" (, 5 hours/day). Insomnia was assessed according to the International classification of sleep disorders (ICSD-2). Results: The average TST was 7 hours and 13 minutes (+/- 17 minutes). Six hundred and twelve subjects were "long sleepers" (2.7%) and 1969 "short sleepers" (7.5%). Compared to the whole group, "long sleepers" were more often female, younger (15-25 year-old) or older (above 65 year-old), with no academic degree, mostly clerks and blue collar workers. "Long sleepers" were significantly more likely to have psychiatric diseases and a greater body mass index (BMI). However, long sleep was not significantly associated with the presence of any other chronic medical disease assessed. Conversely, short sleep duration was significantly associated with almost all the other chronic diseases assessed. Conclusions: In the general population, sleeping too much was associated with psychiatric diseases and higher BMI, but not with other chronic medical diseases.	[Leger, Damien; Faraut, Brice] Univ Paris 05, Sorbonne Paris Cite, Hotel Dieu, APHP,Ctr Sommeil & Vigilance, Paris, France; [Leger, Damien; Beck, Francois; Richard, Jean-Baptiste; Sauvet, Fabien; Faraut, Brice] Univ Paris 05, Sorbonne Paris Cite, VIFASOM, Equipe Accueil Vigilance Fatigue & Sommeil, Paris, France; [Beck, Francois; Richard, Jean-Baptiste] Univ Paris 05, Equipe Cesames, Ctr Rech Med,Direct Affaires Sci INPES, CNRS,UMR 8211,Inserm,U988,EHESS,Cermes 3, St Denis, France; [Sauvet, Fabien] IRBA, Bretigny Sur Orge, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Leger, D (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Hotel Dieu, APHP,Ctr Sommeil & Vigilance, Paris, France.	damien.leger@htd.aphp.fr		Richard, Jean-Baptiste/0000-0002-4193-9159; Beck, Francois/0000-0002-4880-1638	INPES (Institut National de Prevention et d'education pour la Sante) (French national Institute of prevention and health education)	INPES (Institut National de Prevention et d'education pour la Sante) (French national Institute of prevention and health education)	In France, this study was supported by INPES (Institut National de Prevention et d'education pour la Sante) (French national Institute of prevention and health education). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann K, 2012, SLEEP, V35, P933, DOI 10.5665/sleep.1954; American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS, V3rd; American Psychiatric Association, 2013, DSM5 AM PSYCH ASS, V5th; Beck F, 2011, PRATIQUES METHODES S, P310; Beck F, 2007, BAROMETRE SANTE, P608; Bin YS, 2013, AM J EPIDEMIOL, V177, P826, DOI 10.1093/aje/kws308; Bin YS, 2012, SLEEP MED REV, V16, P223, DOI 10.1016/j.smrv.2011.07.003; Buxton OM, 2010, SOC SCI MED, V71, P1027, DOI 10.1016/j.socscimed.2010.05.041; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Chao CY, 2011, METABOLISM, V60, P799, DOI 10.1016/j.metabol.2010.07.031; Cohen-Mansfield J, 2012, SLEEP, V35, P1003, DOI 10.5665/sleep.1970; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dolgin E, 2013, NATURE, V497, pS6, DOI 10.1038/497S6a; Duggan KA, 2014, HLTH PSYCHOL; Edinger JD, 2004, SLEEP, V27, P1567, DOI 10.1093/sleep/27.8.1567; Faraut B, 2012, J HYPERTENS, V30, P1354, DOI 10.1097/HJH.0b013e32835465e5; Faraut B, 2012, SLEEP MED REV, V16, P137, DOI 10.1016/j.smrv.2011.05.001; Gallicchio L, 2009, J SLEEP RES, V18, P148, DOI 10.1111/j.1365-2869.2008.00732.x; Grandner MA, 2010, SLEEP MED REV, V14, P191, DOI 10.1016/j.smrv.2009.07.006; Gumenyuk V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059007; Guo XF, 2013, SLEEP MED, V14, P324, DOI 10.1016/j.sleep.2012.12.001; Horne J, 2011, BIOL PSYCHOL, V87, P1, DOI 10.1016/j.biopsycho.2010.10.004; Ikehara S, 2009, SLEEP, V32, P295, DOI 10.1093/sleep/32.3.295; Institut National de Statistiques et des etudes economiques (INSEE), 2010, DEM FRANC 2010; Knutson KL, 2010, BEST PRACT RES CL EN, V24, P731, DOI 10.1016/j.beem.2010.07.001; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Kronholm E, 2011, SLEEP MED, V12, P215, DOI 10.1016/j.sleep.2010.07.021; Kurina LM, 2013, ANN EPIDEMIOL, V23, P361, DOI 10.1016/j.annepidem.2013.03.015; Leger D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045204; Legleye S, 2010, J AFFECT DISORDERS, V123, P108, DOI 10.1016/j.jad.2009.10.016; Leplege A, 1998, J CLIN EPIDEMIOL, V51, P1013, DOI 10.1016/S0895-4356(98)00093-6; Luyster FS, 2012, SLEEP, V35, P727, DOI 10.5665/sleep.1846; Maia Q, 2013, ACCIDENT ANAL PREV, V59, P618, DOI 10.1016/j.aap.2013.07.028; Markwald RR, 2013, P NATL ACAD SCI USA, V110, P5695, DOI 10.1073/pnas.1216951110; Morgenthaler TI, 2007, SLEEP, V30, P1445, DOI 10.1093/sleep/30.11.1445; Nagai M, 2013, SLEEP MED, V14, P206, DOI 10.1016/j.sleep.2012.09.024; National Institutes of Health: National Cancer Institute, NIH PUBLICATION; National Sleep Foundation, MUCH SLEEP DO WE REA; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Patel SR, 2012, SLEEP, V35, P641, DOI 10.5665/sleep.1822; Ramos AR, 2013, AM J CARDIOL, V112, P599, DOI 10.1016/j.amjcard.2013.04.029; Ramos AR, 2013, J CLIN SLEEP MED, V9, P669, DOI 10.5664/jcsm.2834; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Siegel JM, 2009, NAT REV NEUROSCI, V10, P747, DOI 10.1038/nrn2697; Stenholm S, 2011, SLEEP, V34, P1583, DOI 10.5665/sleep.1402; Stranges S, 2008, AM J EPIDEMIOL, V168, P1353, DOI 10.1093/aje/kwn337; Theorell-Haglow J, 2012, SLEEP MED, V13, P1079, DOI 10.1016/j.sleep.2012.06.013; World Health Organisation World Regional Office for Europe, WHO TECHN M SLEEP HL	50	29	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e106950	10.1371/journal.pone.0106950	http://dx.doi.org/10.1371/journal.pone.0106950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226585	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700023
J	Agne, MC; Shaw, DC; Woolley, TJ; Queijeiro-Bolanos, ME				Agne, Michelle C.; Shaw, David C.; Woolley, Travis J.; Queijeiro-Bolanos, Monica E.			Effects of Dwarf Mistletoe on Stand Structure of Lodgepole Pine Forests 21-28 Years Post-Mountain Pine Beetle Epidemic in Central Oregon	PLOS ONE			English	Article							CANOPY STRUCTURE; COMPOUNDED PERTURBATIONS; PHYSIOLOGICAL-ASPECTS; BRITISH-COLUMBIA; TREE MORTALITY; BARK BEETLES; DYNAMICS; COLORADO; FIRE; OUTBREAKS	Lodgepole pine (Pinus contorta) forests are widely distributed throughout North America and are subject to mountain pine beetle (Dendroctonus ponderosae) epidemics, which have caused mortality over millions of hectares of mature trees in recent decades. Mountain pine beetle is known to influence stand structure, and has the ability to impact many forest processes. Dwarf mistletoe (Arceuthobium americanum) also influences stand structure and occurs frequently in post-mountain pine beetle epidemic lodgepole pine forests. Few studies have incorporated both disturbances simultaneously although they co-occur frequently on the landscape. The aim of this study is to investigate the stand structure of lodgepole pine forests 21-28 years after a mountain pine beetle epidemic with varying levels of dwarf mistletoe infection in the Deschutes National Forest in central Oregon. We compared stand density, stand basal area, canopy volume, proportion of the stand in dominant/codominant, intermediate, and suppressed cohorts, average height and average diameter of each cohort, across the range of dwarf mistletoe ratings to address differences in stand structure. We found strong evidence of a decrease in canopy volume, suppressed cohort height, and dominant/codominant cohort diameter with increasing stand-level dwarf mistletoe rating. There was strong evidence that as dwarf mistletoe rating increases, proportion of the stand in the dominant/codominant cohort decreases while proportion of the stand in the suppressed cohort increases. Structural differences associated with variable dwarf mistletoe severity create heterogeneity in this forest type and may have a significant influence on stand productivity and the resistance and resilience of these stands to future biotic and abiotic disturbances. Our findings show that it is imperative to incorporate dwarf mistletoe when studying stand productivity and ecosystem recovery processes in lodgepole pine forests because of its potential to influence stand structure.	[Agne, Michelle C.; Shaw, David C.; Woolley, Travis J.] Oregon State Univ, Dept Forest Engn Resources & Management, Corvallis, OR 97331 USA; [Queijeiro-Bolanos, Monica E.] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Ecol & Recursos Nat, Mexico City 04510, DF, Mexico	Oregon State University; Universidad Nacional Autonoma de Mexico	Agne, MC (corresponding author), Oregon State Univ, Dept Forest Engn Resources & Management, Corvallis, OR 97331 USA.	Michelle.Agne@oregonstate.edu	Shaw, David/A-1191-2018	Shaw, David/0000-0002-3898-782X	College of Forestry at Oregon State University; The Western Wildland Environmental Threat Assessment Center; Joint Fire Science project [09-1-06-17]	College of Forestry at Oregon State University; The Western Wildland Environmental Threat Assessment Center; Joint Fire Science project	The Richard Strachan Fellowship granted through the College of Forestry at Oregon State University provided financial support for this project. The Western Wildland Environmental Threat Assessment Center provided additional funds for data collection. The authors also benefited from the Joint Fire Science project # 09-1-06-17. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMAN GD, 1972, J ECON ENTOMOL, V65, P138, DOI 10.1093/jee/65.1.138; Amman GD., 1977, ROLE ARTHROPODS FORE, P3; AMMAN GD, 1978, THEORY PRACTICE MOUN, P39; Astrup R, 2008, FOREST ECOL MANAG, V256, P1743, DOI 10.1016/j.foreco.2008.07.025; Axelson JN, 2010, FOREST CHRON, V86, P87, DOI 10.5558/tfc86087-1; Axelson JN, 2009, FOREST ECOL MANAG, V257, P1874, DOI 10.1016/j.foreco.2009.01.047; Baranyay JA, 1970, DEP FISHERIES FOREST, V1285; Bright BC, 2012, ENVIRON RES LETT, V7, P6; Browne WJ, 2005, J ROY STAT SOC A STA, V168, P599, DOI 10.1111/j.1467-985X.2004.00365.x; Buma B, 2012, FOREST ECOL MANAG, V266, P25, DOI 10.1016/j.foreco.2011.10.040; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Coder K. D., 2000, EXTENSION PUBLICATIO; Cole D.M, 1973, USDA FOREST SERVICE; Collins BJ, 2011, FOREST ECOL MANAG, V261, P2168, DOI 10.1016/j.foreco.2011.03.016; D'Amato AW, 2011, FOREST ECOL MANAG, V262, P2070, DOI 10.1016/j.foreco.2011.09.003; Diskin M, 2011, CAN J FOREST RES, V41, P782, DOI [10.1139/X10-247, 10.1139/x10-247]; Environmental Systems Research Institute (ESRI), 2007, ARCGIS 9 3; Franklin JF, 1973, PNWGTR008 USDA PAC N; GEISZLER DR, 1980, OECOLOGIA, V46, P239, DOI 10.1007/BF00540132; Godfree RC, 2003, CAN J FOREST RES, V33, P997, DOI 10.1139/X03-024; Godfree RC, 2003, PLANT ECOL, V165, P69, DOI 10.1023/A:1021598712920; Godfree RC, 2002, CAN J FOREST RES, V32, P1360, DOI [10.1139/x02-058, 10.1139/X02-058]; Hansen EM, 2014, FOREST SCI, V60, P476, DOI 10.5849/forsci.13-039; Hawksworth F. G., 1977, RM48 USDA FOR SERV R; HAWKSWORTH FG, 1983, ENVIRON ENTOMOL, V12, P1447, DOI 10.1093/ee/12.5.1447; Hawksworth FG, 1996, USDA FOREST SERVICE, V709; HAWKSWORTH FRANK G., 1964, JOUR FOREST, V62, P27; Hicke JA, 2012, FOREST ECOL MANAG, V271, P81, DOI 10.1016/j.foreco.2012.02.005; HULL RJ, 1964, PLANT PHYSIOL, V39, P996, DOI 10.1104/pp.39.6.996; HULL RJ, 1964, PLANT PHYSIOL, V39, P1008, DOI 10.1104/pp.39.6.1008; JOHNSON DW, 1981, PLANT DIS, V65, P437, DOI 10.1094/PD-65-437; Kayes LJ, 2012, FOREST ECOL MANAG, V263, P57, DOI 10.1016/j.foreco.2011.09.035; Klutsch JG, 2014, FOREST ECOL MANAG, V315, P63, DOI 10.1016/j.foreco.2013.12.024; Klutsch JG, 2011, WEST J APPL FOR, V26, P101, DOI 10.1093/wjaf/26.3.101; Klutsch JG, 2009, FOREST ECOL MANAG, V258, P641, DOI 10.1016/j.foreco.2009.04.034; Koch AJ, 2011, BIODIVERS CONSERV, V20, P3555, DOI 10.1007/s10531-011-0148-3; Kulakowski D, 2013, FOREST ECOL MANAG, V289, P544, DOI 10.1016/j.foreco.2012.10.020; Lotan J.E., 1990, SILVICS N AM, V654, P302, DOI DOI 10.2307/j.ctt1ffjhpb.19; Mainwaring DB, 2004, CAN J FOREST RES, V34, P2217, DOI 10.1139/X04-108; Mathiasen RL, 2008, PLANT DIS, V92, P988, DOI 10.1094/PDIS-92-7-0988; McGregor MD, 1978, THEORY PRACTICE MOUN, P129; Mikkelson KM, 2013, BIOGEOCHEMISTRY, V115, P1, DOI 10.1007/s10533-013-9875-8; Mitchell Russel G., 1998, Western Journal of Applied Forestry, V13, P23; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Parmeter J.R., 1978, P S DWARF MISTL CONT, P16; Pelz KA, 2012, FOREST ECOL MANAG, V280, P93, DOI 10.1016/j.foreco.2012.05.032; R Development Core Team, 2009, R FDN STAT COMP; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; RAMSEY F, 2013, STAT SLEUTH COURSE M; Roe AL, 1970, INT71 USDA FOR SERV; Seidl R, 2011, ECOL MODEL, V222, P903, DOI 10.1016/j.ecolmodel.2010.09.040; Shaw David, 2000, Western Journal of Applied Forestry, V15, P8; Shaw DC, 2004, AUST J BOT, V52, P481, DOI 10.1071/BT03074; Shore TL, 1982, SURVEY DWARF MISTLET; Sibold JS, 2007, ECOL APPL, V17, P1638, DOI 10.1890/06-0907.1; Simard M, 2012, GLOBAL ECOL BIOGEOGR, V21, P556, DOI 10.1111/j.1466-8238.2011.00710.x; Simard M, 2011, ECOL MONOGR, V81, P3, DOI 10.1890/10-1176.1; Simpson M., 2007, R6NRECOLTP032007 USD; Smith GD, 2011, AGR FOREST ENTOMOL, V13, P37, DOI 10.1111/j.1461-9563.2010.00499.x; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Stevens R.E., 1984, BIOL DWARF MISTLETOE, P94; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; USDA Forest Service [USFS], 2012, FOR INS DIS AER SURV; Van Pelt R, 2004, FOREST SCI, V50, P326; Varhola A, 2010, CAN J FOREST RES, V40, P812, DOI 10.1139/X10-008; Volland LA, 1988, R6ECOL1041985 USDA F; WANNER JL, 1989, CAN J FOREST RES, V19, P736, DOI 10.1139/x89-113; Wanner JL, 1986, THESIS PORTLAND STAT; Weir JR, 1916, USDA B, V306; Western Regional Climate Center, 2013, MONTHL PREC MIN MAX; Winder RS, 2006, CAN J PLANT PATHOL, V28, pS221, DOI 10.1080/07060660609507378	72	13	13	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107532	10.1371/journal.pone.0107532	http://dx.doi.org/10.1371/journal.pone.0107532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25221963	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774800079
J	Manas, NHA; Pachelles, S; Mahadi, NM; Illias, RM				Manas, Nor Hasmaliana Abdul; Pachelles, Samson; Mahadi, Nor Muhammad; Illias, Rosli Md.			The Characterisation of an Alkali-Stable Maltogenic Amylase from Bacillus lehensis G1 and Improved Malto-Oligosaccharide Production by Hydrolysis Suppression	PLOS ONE			English	Article							ALPHA-AMYLASE; BRANCHED OLIGOSACCHARIDES; TRANSGLYCOSYLATION ACTIVITY; MOLECULAR CHARACTERIZATION; GALACTO-OLIGOSACCHARIDES; PYROCOCCUS-FURIOSUS; BETA-GALACTOSIDASE; ORGANIC-SOLVENTS; CYCLOMALTODEXTRINASE; PURIFICATION	A maltogenic amylase (MAG1) from alkaliphilic Bacillus lehensis G1 was cloned, expressed in Escherichia coli, purified and characterised for its hydrolysis and transglycosylation properties. The enzyme exhibited high stability at pH values from 7.0 to 10.0. The hydrolysis of beta-cyclodextrin (beta-CD) produced malto-oligosaccharides of various lengths. In addition to hydrolysis, MAG1 also demonstrated transglycosylation activity for the synthesis of longer malto-oligosaccharides. The thermodynamic equilibrium of the multiple reactions was shifted towards synthesis when the reaction conditions were optimised and the water activity was suppressed, which resulted in a yield of 38% transglycosylation products consisting of malto-oligosaccharides of various lengths. Thin layer chromatography and high-performance liquid chromatography analyses revealed the presence of malto-oligosaccharides with a higher degree of polymerisation than maltoheptaose, which has never been reported for other maltogenic amylases. The addition of organic solvents into the reaction further suppressed the water activity. The increase in the transglycosylation-to-hydrolysis ratio from 1.29 to 2.15 and the increased specificity toward maltopentaose production demonstrated the enhanced synthetic property of the enzyme. The high transglycosylation activity of maltogenic amylase offers a great advantage for synthesising malto-oligosaccharides and rare carbohydrates.	[Manas, Nor Hasmaliana Abdul; Pachelles, Samson; Illias, Rosli Md.] Univ Teknol Malaysia, Fac Chem Engn, Dept Bioproc Engn, Skudai, Johor, Malaysia; [Mahadi, Nor Muhammad] Malaysia Genome Inst, Comparat Genom & Genet Res Ctr, Kajang, Selangor, Malaysia	Universiti Teknologi Malaysia	Illias, RM (corresponding author), Univ Teknol Malaysia, Fac Chem Engn, Dept Bioproc Engn, Skudai, Johor, Malaysia.	r-rosli@utm.my	Manas, Nor Hasmaliana Abdul/I-8737-2019	ABDUL MANAS, NOR HASMALIANA/0000-0001-6758-9057	Malaysia Genome Institute, Ministry of Science, Technology and Innovation Malaysia under the Project of Structural Genomics of the Extremophilic microbes Leucosporidium antarcticum and Bacillus lehensis G1 [10-03-MGI-MB006]	Malaysia Genome Institute, Ministry of Science, Technology and Innovation Malaysia under the Project of Structural Genomics of the Extremophilic microbes Leucosporidium antarcticum and Bacillus lehensis G1	The research was supported by Malaysia Genome Institute, Ministry of Science, Technology and Innovation Malaysia under the Project of Structural Genomics of the Extremophilic microbes Leucosporidium antarcticum and Bacillus lehensis G1 (No. 10-03-MGI-MB006, http://www.genomemalaysia.gov.my/v3/). RMI and NMM received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Auh JH, 2006, J AGR FOOD CHEM, V54, P2314, DOI 10.1021/jf051887r; Ben Mabrouk S, 2013, J IND MICROBIOL BIOT, V40, P947, DOI 10.1007/s10295-013-1300-8; Benson SW, 1976, THERMOCHEM KINET; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bucke C, 1996, J CHEM TECHNOL BIOT, V67, P217, DOI 10.1002/(SICI)1097-4660(199611)67:3<217::AID-JCTB558>3.0.CO;2-8; Cha HJ, 1998, EUR J BIOCHEM, V253, P251, DOI 10.1046/j.1432-1327.1998.2530251.x; Chakraborty S, 2011, J MOL CATAL B-ENZYM, V68, P52, DOI 10.1016/j.molcatb.2010.09.009; Cheong KA, 2005, BIOCATAL BIOTRANSFOR, V23, P79, DOI 10.1080/10242420500090094; Cho, 2007, J MICROBIOL BIOTECHN, V17, P1521; Cho HY, 2000, BBA-PROTEIN STRUCT M, V1478, P333, DOI 10.1016/S0167-4838(00)00037-6; Cruz-Guerrero AE, 2006, BIOTECHNOL BIOENG, V93, P1123, DOI 10.1002/bit.20824; Doukyu N, 2003, BIOSCI BIOTECH BIOCH, V67, P334, DOI 10.1271/bbb.67.334; Doukyu N, 2007, EXTREMOPHILES, V11, P781, DOI 10.1007/s00792-007-0096-8; Fernandez-Arrojo L, 2007, PROCESS BIOCHEM, V42, P1530, DOI 10.1016/j.procbio.2007.08.007; Gosling A, 2010, FOOD CHEM, V121, P307, DOI 10.1016/j.foodchem.2009.12.063; Hansson T, 2001, BIOTECHNOL BIOENG, V73, P203, DOI 10.1002/bit.1052; Hinz SWA, 2006, BIOTECHNOL BIOENG, V93, P122, DOI 10.1002/bit.20713; Jakubovics NS, 2002, MICROBIOL-SGM, V148, P3255, DOI 10.1099/00221287-148-10-3255; Kamasaka H, 2002, APPL ENVIRON MICROB, V68, P1658, DOI 10.1128/AEM.68.4.1658-1664.2002; Karmakar M, 2011, J MICROB BIOTEC FOOD, V1, P91; KIM IC, 1994, BIOSCI BIOTECH BIOCH, V58, P416, DOI 10.1271/bbb.58.416; Kim JS, 1999, J BIOL CHEM, V274, P26279, DOI 10.1074/jbc.274.37.26279; Kim TJ, 1999, APPL ENVIRON MICROB, V65, P1644; Kolcuoglu Y, 2010, PROCESS BIOCHEM, V45, P821, DOI 10.1016/j.procbio.2010.02.001; Kumar S, 2012, BIORESOURCE TECHNOL, V116, P247, DOI 10.1016/j.biortech.2011.11.109; Kuriki T, 1996, J BIOL CHEM, V271, P17321, DOI 10.1074/jbc.271.29.17321; Kwon KS, 1999, J FOOD SCI, V64, P258, DOI 10.1111/j.1365-2621.1999.tb15878.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee HS, 2002, J AGR FOOD CHEM, V50, P2812, DOI 10.1021/jf011529y; Lee HS, 2002, J BIOL CHEM, V277, P21891, DOI 10.1074/jbc.M201623200; LEE SJ, 1995, STARCH-STARKE, V47, P127, DOI 10.1002/star.19950470403; Li D, 2010, NEW BIOTECHNOL, V27, P300, DOI 10.1016/j.nbt.2010.04.001; Li XL, 2010, APPL MICROBIOL BIOT, V85, P1821, DOI 10.1007/s00253-009-2190-6; Liu B, 2006, ENZYME MICROB TECH, V39, P805, DOI 10.1016/j.enzmictec.2006.01.003; Mabrouk SB, 2008, MOL BIOTECHNOL, V38, P211, DOI 10.1007/s12033-007-9017-4; Mahoney RR, 1998, FOOD CHEM, V63, P147, DOI 10.1016/S0308-8146(98)00020-X; Maugard T, 2003, BIOTECHNOL LETT, V25, P623, DOI 10.1023/A:1023060030558; Mehta D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073612; Mehta D, 2013, J MOL CATAL B-ENZYM, V85-86, P229, DOI 10.1016/j.molcatb.2012.08.017; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Oku T, 2002, PURE APPL CHEM, V74, P1253, DOI 10.1351/pac200274071253; Park KH, 1998, CARBOHYD RES, V313, P235; Park KH, 2000, BBA-PROTEIN STRUCT M, V1478, P165, DOI 10.1016/S0167-4838(00)00041-8; PODKOVYROV SM, 1992, J BACTERIOL, V174, P5400, DOI 10.1128/JB.174.16.5400-5405.1992; Prakash B, 2009, PROCESS BIOCHEM, V44, P210, DOI 10.1016/j.procbio.2008.10.013; Quig D, 1998, Altern Med Rev, V3, P262; Roberfroid M, 2000, CRIT REV FOOD SCI, V40, P461, DOI 10.1080/10408690091189239; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Satoh E, 1997, APPL ENVIRON MICROB, V63, P4941, DOI 10.1128/AEM.63.12.4941-4944.1997; Scigelova M, 1999, J MOL CATAL B-ENZYM, V6, P483, DOI 10.1016/S1381-1177(99)00012-0; Tang K, 2006, FEMS MICROBIOL LETT, V260, P91, DOI 10.1111/j.1574-6968.2006.00308.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Voragen AGJ, 1998, TRENDS FOOD SCI TECH, V9, P328, DOI 10.1016/S0924-2244(98)00059-4; Wu YF, 2013, FOOD CHEM, V138, P1588, DOI 10.1016/j.foodchem.2012.11.052; Yang CH, 2004, ENZYME MICROB TECH, V35, P254, DOI 10.1016/j.enzmictec.2004.05.004; Yang SJ, 2006, CARBOHYD RES, V341, P420, DOI 10.1016/j.carres.2005.11.031	57	25	26	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e106481	10.1371/journal.pone.0106481	http://dx.doi.org/10.1371/journal.pone.0106481			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25221964	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774800015
J	Nandlal, V; Moodley, D; Grobler, A; Bagratee, J; Maharaj, NR; Richardson, P				Nandlal, Vikesh; Moodley, Dhayendre; Grobler, Anneke; Bagratee, Jayanthilall; Maharaj, Niren R.; Richardson, Paul			Anaemia in Pregnancy Is Associated with Advanced HIV Disease	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; OUTCOMES; PREVENTION; PREVALENCE; TERM	Background: Anaemia is a common clinical finding in HIV infected women and has been associated with advanced disease. The use of antiretroviral drugs such as Zidovudine (ZDV) either for prevention of mother to child transmission (MTCT) of HIV or used in combination with other antiretrovirals have been implicated in the development or increased severity of anaemia. We report the prevalence, type, severity and incidence of anaemia in a cohort of HIV infected women who initiated antiretroviral prophylaxis or treatment during pregnancy. Methods and Materials: This is a retrospective cohort data analysis of 408 HIV infected pregnant women who participated in a breastfeeding intervention study (HPTN 046 Study, ClinicalTrials.gov NCT 00074412) in South Africa. Women initiated zidovudine prophylaxis for PMTCT or triple antiretroviral treatment in pregnancy according to the standard of care. Laboratory and clinical data in pregnancy, <72 hours and 2 weeks postdelivery were extracted from the main database and analysed. Results: The mean Hb concentration was 10.6 g/dL at baseline and 262/408 (64.2%) women were diagnosed with anaemia (Hb<11 g/dL) in pregnancy, 48/146 (32.9%) subsequently developed anaemia intrapartum or postpartum and 89/310 (28.7%) of all cases of anaemia remained unresolved by 2 weeks postdelivery. In a univariate analysis, CD4 count and gravidity were significant risk factors for anaemia in pregnancy, RR 1.41; 1.23-1.61 (p<0.001) and 1.10; 1.01-1.18 (p = 0.02) respectively. After adjusting for antiretroviral regimen, age and gravidity in a multivariable analysis, only the CD4 count remains a significant risk factor for anaemia in pregnancy and postdelivery. Conclusion: In conclusion, anaemia was most common among women in the advanced stage of HIV infection (CD4<200 cells/mm(3)). There was no evidence of an association between ZDV or triple ARVs and anaemia.	[Nandlal, Vikesh; Moodley, Dhayendre; Bagratee, Jayanthilall; Maharaj, Niren R.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Obstet & Gynaecol, Durban, South Africa; [Richardson, Paul] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Moodley, Dhayendre; Grobler, Anneke] Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa	University of Kwazulu Natal; Johns Hopkins University	Moodley, D (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Obstet & Gynaecol, Durban, South Africa.	moodleyd1@ukzn.ac.za	Moodley, Dhayendre/U-6802-2019	Grobler, Anneke/0000-0002-7809-7688	International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) group [5U01AI069469]; US National Institute of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069469, UM1AI069469] Funding Source: NIH RePORTER	International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) group; US National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	No funding was obtained for the sub study. The HPTN 046 study was funded by the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) group 5U01AI069469) which receives funding from the US National Institute of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MICR DEF IR DEF AN; Belperio PS, 2004, AM J MED, V116, P27, DOI 10.1016/j.amjmed.2003.12.010; Bunders MJ, 2005, ACTA PAEDIATR, V94, P1571, DOI 10.1080/08035250510042951; Coovadia HM, 2012, LANCET, V379, P221, DOI 10.1016/S0140-6736(11)61653-X; Dryden-Peterson S, 2011, JAIDS-J ACQ IMM DEF, V56, P428, DOI 10.1097/QAI.0b013e31820bd2b6; Feiterna-Sperling C, 2007, JAIDS-J ACQ IMM DEF, V45, P43, DOI 10.1097/QAI.0b013e318042d5e3; Gangopadhyay R, 2011, INT J GYNECOL OBSTET, V115, pS11, DOI 10.1016/S0020-7292(11)60005-2; Haider BA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3443; Johnson-Wimbley Terri D, 2011, Therap Adv Gastroenterol, V4, P177, DOI 10.1177/1756283X11398736; Le Chenadec J, 2003, AIDS, V17, P2053, DOI 10.1097/00002030-200309260-00006; Levine AM, 2001, J ACQ IMMUN DEF SYND, V26, P28, DOI 10.1097/00126334-200101010-00004; Lewis DK, 2005, T ROY SOC TROP MED H, V99, P561, DOI 10.1016/j.trstmh.2005.01.002; Lundgren JD, 2003, CLIN INFECT DIS, V37, pS297, DOI 10.1086/376909; Marazzi MC, 2011, AIDS, V25, P1611, DOI 10.1097/QAD.0b013e3283493ed0; Marchant T, 2004, TROP MED INT HEALTH, V9, P262, DOI 10.1046/j.1365-3156.2003.01178.x; Massawe SN, 1999, ACTA OBSTET GYN SCAN, V78, P573, DOI 10.1034/j.1600-0412.1999.780703.x; Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010; Moyle Graeme, 2002, AIDS Reviews, V4, P13; National Department of Health, 2008, POL GUID IMPL PMTCT; National Department of Health South Africa, 2012, 5 NDOH STAT OFF; Sartorius BKD, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-522; SCHIEVE LA, 1994, AM J PUBLIC HEALTH, V84, P405, DOI 10.2105/AJPH.84.3.405; Spiga MG, 1999, ANTIVIR RES, V44, P167, DOI 10.1016/S0166-3542(99)00065-0; Srasuebkul P, 2009, CLIN INFECT DIS, V48, P940, DOI 10.1086/597354; Villamor E, 2004, J NUTR, V134, P1424, DOI 10.1093/jn/134.6.1424; WHO, 2001, IRON DEFICIENCY ANAE; World Health Organisation, 2011, WHONMHNHDMNM111; Ziske J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055633	28	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e106103	10.1371/journal.pone.0106103	http://dx.doi.org/10.1371/journal.pone.0106103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222119	Green Published, gold			2022-12-25	WOS:000341774800010
J	Narita, TB; Chen, ZH; Schaap, P; Saito, T				Narita, Takaaki B.; Chen, Zhi-hui; Schaap, Pauline; Saito, Tamao			The Hybrid Type Polyketide Synthase SteelyA Is Required for cAMP Signalling in Early Dictyostelium Development	PLOS ONE			English	Article							DIFFERENTIATION-INDUCING FACTOR; DEPENDENT PROTEIN-KINASE; ADENYLYL-CYCLASE-G; TERMINAL DIFFERENTIATION; CELL-DIFFERENTIATION; CYTOSOLIC REGULATOR; MEDIATED ACTIVATION; EXTRACELLULAR CAMP; FACTOR-I; DISCOIDEUM	Background: In our previous study we found that the expression of stlA showed peaks both in the early and last stages of development and that a product of SteelyA, 4-methyl-5-pentylbenzene-1,3-diol (MPBD), controlled Dictyostelium spore maturation during the latter. In this study we focused on the role of SteelyA in early stage development. Principal Findings: Our stlA null mutant showed aggregation delay and abnormally small aggregation territories. Chemotaxis analysis revealed defective cAMP chemotaxis in the stlA null mutant. cAMP chemotaxis was restored by MPBD addition during early stage development. Assay for cAMP relay response revealed that the stlA null mutant had lower cAMP accumulation during aggregation, suggesting lower ACA activity than the wild type strain. Exogenous cAMP pulses rescued the aggregation defect of the stlA null strain in the absence of MPBD. Expression analysis of cAMP signalling genes revealed lower expression levels in the stlA null mutant during aggregation. Conclusion: Our data indicate a regulatory function by SteelyA on cAMP signalling during aggregation and show that SteelyA is indispensable for full activation of ACA.	[Narita, Takaaki B.] Sophia Univ, Grad Sch Sci & Technol, Tokyo 102, Japan; [Narita, Takaaki B.] Res Fellow Japan Soc Promot Sci DC2, Tokyo, Japan; [Chen, Zhi-hui; Schaap, Pauline] Univ Dundee, Coll Life Sci, Dundee, Scotland; [Saito, Tamao] Sophia Univ, Dept Mat & Life Sci, Tokyo 102, Japan	Sophia University; Japan Society for the Promotion of Science; University of Dundee; Sophia University	Saito, T (corresponding author), Sophia Univ, Dept Mat & Life Sci, Tokyo 102, Japan.	tasaito@sophia.ac.jp	Schaap, Pauline/M-5355-2019	Schaap, Pauline/0000-0003-4500-2555	JSPS KAKENHI [24510306]; Biotechnology and Biological Sciences Research Council [BB/K000799/1, BB/G020426/1] Funding Source: researchfish; Wellcome Trust [100293/Z/12/Z] Funding Source: researchfish; BBSRC [BB/G020426/1, BB/K000799/1] Funding Source: UKRI	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by JSPS KAKENHI Grant Number 24510306 to TS. TBN is a research fellow of Japan Society for the Promotion of Science (DC2). This work was supported by Grant-in-Aid for JSPS Fellows to TBN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Curto E, 2007, DEVELOPMENT, V134, P959, DOI 10.1242/dev.02775; Anjard C, 2011, EUKARYOT CELL, V10, P956, DOI 10.1128/EC.05053-11; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Austin MB, 2006, NAT CHEM BIOL, V2, P494, DOI 10.1038/nchembio811; Cai HQ, 2010, J CELL BIOL, V190, P233, DOI 10.1083/jcb.201001129; Charest PG, 2010, DEV CELL, V18, P737, DOI 10.1016/j.devcel.2010.03.017; Chen MY, 1997, GENE DEV, V11, P3218, DOI 10.1101/gad.11.23.3218; Chen ZH, 2010, J BIOL CHEM, V285, P41724, DOI 10.1074/jbc.M110.156380; DINAUER MC, 1980, J CELL BIOL, V86, P537, DOI 10.1083/jcb.86.2.537; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; FAURE M, 1990, MOL CELL BIOL, V10, P1921, DOI 10.1128/MCB.10.5.1921; Garciandia A, 2013, DEV BIOL, V381, P411, DOI 10.1016/j.ydbio.2013.06.013; Ghosh R, 2008, J BIOL CHEM, V283, P11348, DOI 10.1074/jbc.M709588200; GILMAN AG, 1972, ADV CYCL NUCL RES<D>, V2, P9; HARWOOD AJ, 1992, CELL, V69, P615, DOI 10.1016/0092-8674(92)90225-2; HOPPER NA, 1993, EMBO J, V12, P2459, DOI 10.1002/j.1460-2075.1993.tb05900.x; HOPPER NA, 1993, DEVELOPMENT, V119, P147; Kamimura Y, 2008, CURR BIOL, V18, P1034, DOI 10.1016/j.cub.2008.06.068; Kay RR, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001503; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; KONIJN TM, 1967, P NATL ACAD SCI USA, V58, P1152, DOI 10.1073/pnas.58.3.1152; KUMAGAI A, 1991, J BIOL CHEM, V266, P1220; Kuwayama H, 2000, DEV GROWTH DIFFER, V42, P531; Kuwayama H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006658; Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342; LILLY PJ, 1994, J BIOL CHEM, V269, P14123; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MA PCC, 1990, MOL CELL BIOL, V10, P3297, DOI 10.1128/MCB.10.7.3297; Mahadeo DC, 2006, CURR TOP DEV BIOL, V73, P115, DOI 10.1016/S0070-2153(05)73004-0; Narita TB, 2011, FEMS MICROBIOL LETT, V319, P82, DOI 10.1111/j.1574-6968.2011.02273.x; NOEGEL A, 1986, EMBO J, V5, P1473, DOI 10.1002/j.1460-2075.1986.tb04384.x; Nunez-Corcuera B, 2008, DEV BIOL, V321, P331, DOI 10.1016/j.ydbio.2008.06.027; PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5; Raisley B, 2004, DEV BIOL, V265, P433, DOI 10.1016/j.ydbio.2003.09.035; Roisin-Bouffay C, 2000, MOL CELL, V6, P953, DOI 10.1016/S1097-2765(05)00082-1; Rot G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-265; Saito T, 2008, DEV BIOL, V317, P444, DOI 10.1016/j.ydbio.2008.02.036; Sato YG, 2013, BIOSCI BIOTECH BIOCH, V77, P2008, DOI 10.1271/bbb.130294; Shaulsky G, 1996, P NATL ACAD SCI USA, V93, P15260, DOI 10.1073/pnas.93.26.15260; Shen B, 2003, CURR OPIN CHEM BIOL, V7, P285, DOI 10.1016/S1367-5931(03)00020-6; Soderbom F, 1999, DEVELOPMENT, V126, P5463; Stepanovic V, 2005, EUKARYOT CELL, V4, P775, DOI 10.1128/EC.4.4.775-786.2005; Tang YT, 2008, EUKARYOT CELL, V7, P1758, DOI 10.1128/EC.00210-08; vanEs S, 1996, J BIOL CHEM, V271, P23623, DOI 10.1074/jbc.271.39.23623; VANHAASTERT PJM, 1984, J GEN MICROBIOL, V130, P2559; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; Zucko J, 2007, BIOINFORMATICS, V23, P2543, DOI 10.1093/bioinformatics/btm381	47	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e106634	10.1371/journal.pone.0106634	http://dx.doi.org/10.1371/journal.pone.0106634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222736	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774800021
J	Donninger, H; Clark, JA; Monaghan, MK; Schmidt, ML; Vos, M; Clark, GJ				Donninger, Howard; Clark, Jennifer A.; Monaghan, Megan K.; Schmidt, M. Lee; Vos, Michele; Clark, Geoffrey J.			Cell Cycle Restriction Is More Important Than Apoptosis Induction for RASSF1A Protein Tumor Suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSOCIATION DOMAIN FAMILY-1; EPIGENETIC INACTIVATION; BINDING-PROTEIN; MST2 PATHWAY; K-RAS; MICROTUBULES; EFFECTOR; KINASE; METHYLATION; STABILIZES	The Ras association domain family protein 1A (RASSF1A) is arguably one of the most frequently inactivated tumor suppressors in human cancer. RASSF1A modulates apoptosis via the Hippo and Bax pathways but also modulates the cell cycle. In part, cell cycle regulation appears to be dependent upon the ability of RASSF1A to complex with microtubules and regulate their dynamics. Which property of RASSF1A, apoptosis induction or microtubule regulation, is responsible for its tumor suppressor function is not known. We have identified a short conserved motif that is essential for the binding of RASSF family proteins with microtubule-associated proteins. By making a single point mutation in the motif, we were able to generate a RASSF1A variant that retains wild-type apoptotic properties but completely loses the ability to bind microtubule-associated proteins and complex with microtubules. Comparison of this mutant to wild-type RASSF1A showed that, despite retaining its proapoptotic properties, the mutant was completely unable to induce cell cycle arrest or suppress the tumorigenic phenotype. Therefore, it appears that the cell cycle/microtubule effects of RASSF1A are key to its tumor suppressor function rather than its apoptotic effects.	[Donninger, Howard; Clark, Jennifer A.; Monaghan, Megan K.] Univ Louisville, Dept Med, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40202 USA; [Schmidt, M. Lee] Univ Louisville, Dept Biochem & Mol Biol, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40202 USA; [Clark, Geoffrey J.] Univ Louisville, Dept Pharmacol & Toxicol, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40202 USA; [Vos, Michele] NCI, Cell & Canc Biol Branch, NIH, Rockville, MD 20850 USA	University of Louisville; University of Louisville; University of Louisville; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Clark, GJ (corresponding author), Univ Louisville, Dept Pharmacol & Toxicol, James Graham Brown Canc Ctr, Mol Targets Program, 505 S Hancock St, Louisville, KY 40202 USA.	gjclar01@louisville.edu	Donninger, Howard/I-9874-2019	Donninger, Howard/0000-0002-8589-1660	National Institutes of Health [1P20 RR18733, R01 CA133171-01A2]; NATIONAL CANCER INSTITUTE [R01CA133171] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants 1P20 RR18733 and R01 CA133171-01A2 (to G.J.C.).	Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; Arnette C, 2014, MOL BIOL CELL, V25, P800, DOI 10.1091/mbc.E13-07-0374; Avruch J, 2006, METHOD ENZYMOL, V407, P290, DOI 10.1016/S0076-6879(05)07025-4; Baksh S, 2005, MOL CELL, V18, P637, DOI 10.1016/j.molcel.2005.05.010; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Casar B, 2009, MOL CELL BIOL, V29, P1338, DOI 10.1128/MCB.01359-08; Chen Z, 2000, J BIOL CHEM, V275, P41251, DOI 10.1074/jbc.M006687200; Chien CL, 2005, EXP CELL RES, V308, P446, DOI 10.1016/j.yexcr.2005.05.007; Clark Jennifer, 2012, Mol Biol Int, V2012, P705948, DOI 10.1155/2012/705948; Cooper WN, 2009, ONCOGENE, V28, P2988, DOI 10.1038/onc.2009.152; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; Dallol A, 2004, CANCER RES, V64, P4112, DOI 10.1158/0008-5472.CAN-04-0267; Dallol A, 2007, CANCER RES, V67, P492, DOI 10.1158/0008-5472.CAN-06-3604; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Dammann R, 2005, HISTOL HISTOPATHOL, V20, P645, DOI 10.14670/HH-20.645; Demir O, 2009, MOL CELL NEUROSCI, V40, P111, DOI 10.1016/j.mcn.2008.10.004; Donninger H, 2008, BIOL CHEM, V389, P57, DOI 10.1515/BC.2008.010; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Donninger H, 2011, FRONT ONCOL, V1, DOI 10.3389/fonc.2011.00054; Donninger H, 2011, J BIOL CHEM, V286, P18483, DOI 10.1074/jbc.M110.214874; El-Kalla M, 2010, ONCOGENE, V29, P5729, DOI 10.1038/onc.2010.316; Fiordalisi JJ, 2001, METHOD ENZYMOL, V332, P3; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; Liu LY, 2005, BIOCHEM BIOPH RES CO, V332, P670, DOI 10.1016/j.bbrc.2005.05.006; Liu LY, 2005, CANCER RES, V65, P1830, DOI 10.1158/0008-5472.CAN-04-3896; Malumbres M, 1998, FRONT BIOSCI-LANDMRK, V3, P887; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Matallanas D, 2011, MOL CELL, V44, P893, DOI 10.1016/j.molcel.2011.10.016; Moshnikova Anna, 2008, BMC Res Notes, V1, P13, DOI 10.1186/1756-0500-1-13; Ortiz-Vega S, 2002, ONCOGENE, V21, P1381, DOI 10.1038/sj.onc.1205192; Rong R, 2007, ONCOGENE, V26, P7700, DOI 10.1038/sj.onc.1210575; Rong R, 2004, ONCOGENE, V23, P8216, DOI 10.1038/sj.onc.1207901; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; Thaler S, 2009, CANCER RES, V69, P1748, DOI 10.1158/0008-5472.CAN-08-1377; Thissen JA, 1997, J BIOL CHEM, V272, P30362, DOI 10.1074/jbc.272.48.30362; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vos MD, 2006, J BIOL CHEM, V281, P4557, DOI 10.1074/jbc.M512128200; Vos MD, 2004, CANCER RES, V64, P4244, DOI 10.1158/0008-5472.CAN-04-0339; Vos MD, 2000, J BIOL CHEM, V275, P35669, DOI 10.1074/jbc.C000463200	41	32	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31287	31295		10.1074/jbc.M114.609537	http://dx.doi.org/10.1074/jbc.M114.609537			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25225292	Green Published, hybrid			2022-12-25	WOS:000344549900033
J	Lambert, HP; Zenger, M; Azarias, G; Chatton, JY; Magistretti, PJ; Lengacher, S				Lambert, Helene Perreten; Zenger, Manuel; Azarias, Guillaume; Chatton, Jean-Yves; Magistretti, Pierre J.; Lengacher, Sylvain			Control of Mitochondrial pH by Uncoupling Protein 4 in Astrocytes Promotes Neuronal Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; SKELETAL-MUSCLE; SPECTROPHOTOMETRIC DETERMINATION; CORTICAL ASTROCYTES; ENERGY-METABOLISM; EXPRESSION; BRAIN; UCP4; GENE; TEMPERATURE	Brain activity is energetically costly and requires a steady and highly regulated flow of energy equivalents between neural cells. It is believed that a substantial share of cerebral glucose, the major source of energy of the brain, will preferentially be metabolized in astrocytes via aerobic glycolysis. The aim of this study was to evaluate whether uncoupling proteins (UCPs), located in the inner membrane of mitochondria, play a role in setting up the metabolic response pattern of astrocytes. UCPs are believed to mediate the transmembrane transfer of protons, resulting in the uncoupling of oxidative phosphorylation from ATP production. UCPs are therefore potentially important regulators of energy fluxes. The main UCP isoforms expressed in the brain are UCP2, UCP4, and UCP5. We examined in particular the role of UCP4 in neuron-astrocyte metabolic coupling and measured a range of functional metabolic parameters including mitochondrial electrical potential and pH, reactive oxygen species production, NAD/NADH ratio, ATP/ADP ratio, CO2 and lactate production, and oxygen consumption rate. In brief, we found that UCP4 regulates the intramitochondrial pH of astrocytes, which acidifies as a consequence of glutamate uptake, with the main consequence of reducing efficiency of mitochondrial ATP production. The diminished ATP production is effectively compensated by enhancement of glycolysis. This nonoxidative production of energy is not associated with deleterious H2O2 production. We show that astrocytes expressing more UCP4 produced more lactate, which is used as an energy source by neurons, and had the ability to enhance neuronal survival.	[Lambert, Helene Perreten; Zenger, Manuel; Magistretti, Pierre J.; Lengacher, Sylvain] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Magistretti, Pierre J.] King Abdullah Univ Sci & Technol, Thuwal 239556900, Saudi Arabia; [Azarias, Guillaume; Chatton, Jean-Yves] Univ Lausanne, Dept Fundamental Neurosci, CH-1005 Lausanne, Switzerland; [Magistretti, Pierre J.; Lengacher, Sylvain] Ctr Psychiat Neurosci, CH-7008 Prilly, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; King Abdullah University of Science & Technology; University of Lausanne	Lengacher, S (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Brain & Mind Inst, CH-1015 Lausanne, Switzerland.	Sylvain.Lengacher@epfl.ch	Lengacher, Sylvain/C-2591-2009	Lengacher, Sylvain/0000-0003-2190-9654; Chatton, Jean-Yves/0000-0002-8911-0315; Magistretti, Pierre Julius/0000-0002-6678-320X	Swiss National Science Foundation [108336, 31003A-135720]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grants 108336 (to P. J. M.) and 31003A-135720 (to J. Y. C.).	Alan L, 2009, J BIOENERG BIOMEMBR, V41, P71, DOI 10.1007/s10863-009-9201-2; Allaman I, 2004, J NEUROCHEM, V88, P900, DOI 10.1046/j.1471-4159.2003.02235.x; Allaman I, 2010, J NEUROSCI, V30, P3326, DOI 10.1523/JNEUROSCI.5098-09.2010; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Azarias G, 2011, J NEUROSCI, V31, P3550, DOI 10.1523/JNEUROSCI.4378-10.2011; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bittar PG, 1996, J CEREBR BLOOD F MET, V16, P1079, DOI 10.1097/00004647-199611000-00001; Boss O, 1998, LANCET, V351, P1933, DOI 10.1016/S0140-6736(05)78617-7; Boss O, 1998, J BIOL CHEM, V273, P5, DOI 10.1074/jbc.273.1.5; BOUILLAUD F, 1988, BIOCHEM BIOPH RES CO, V157, P783, DOI 10.1016/S0006-291X(88)80318-8; Chan SL, 2006, J BIOL CHEM, V281, P37391, DOI 10.1074/jbc.M605552200; Chatton JY, 2000, EUR J NEUROSCI, V12, P3843, DOI 10.1046/j.1460-9568.2000.00269.x; de la Monte SM, 2006, J ALZHEIMERS DIS, V9, P167; Demaurex N, 2009, J PHYSIOL SCI, V59, P348; Haskew-Layton RE, 2010, P NATL ACAD SCI USA, V107, P17385, DOI 10.1073/pnas.1003996107; Horvath TL, 1999, J NEUROSCI, V19, P10417; Huang PS, 2011, NEUROSCIENCE, V196, P189, DOI 10.1016/j.neuroscience.2011.09.007; Jezek P, 2004, PHYSIOL RES, V53, pS199; Kim-Han JS, 2001, J NEUROCHEM, V79, P658, DOI 10.1046/j.1471-4159.2001.00604.x; KOZAK LP, 1988, J BIOL CHEM, V263, P12274; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Lengacher S, 2004, J CEREBR BLOOD F MET, V24, P780, DOI 10.1097/01.WCB.0000122743.72175.52; Liu D, 2006, NEUROMOL MED, V8, P389, DOI 10.1385/NMM:8:3:389; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nicholls D G, 1978, Experientia Suppl, V32, P89; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Pellerin L, 2004, SCIENCE, V305, P50, DOI 10.1126/science.1100428; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pichiule P, 2003, ADV EXP MED BIOL, V540, P103; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Ricquier D, 2006, CR BIOL, V329, P578, DOI 10.1016/j.crvi.2005.10.010; ROSENBERG JC, 1966, CLIN CHEM, V12, P299; Sanchis D, 1998, J BIOL CHEM, V273, P34611, DOI 10.1074/jbc.273.51.34611; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Smorodchenko A, 2009, BBA-BIOMEMBRANES, V1788, P2309, DOI 10.1016/j.bbamem.2009.07.018; SORG O, 1992, J NEUROSCI, V12, P4923; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Szolnoki Z, 2009, NEUROMOL MED, V11, P101, DOI 10.1007/s12017-009-8071-4; Wu ZF, 2009, ANTIOXID REDOX SIGN, V11, P1805, DOI [10.1089/ars.2009.2427, 10.1089/ARS.2009.2427]; Yu XX, 2000, FASEB J, V14, P1611, DOI 10.1096/fj.14.11.1611; ZEREZ CR, 1987, ANAL BIOCHEM, V164, P367, DOI 10.1016/0003-2697(87)90506-9; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	46	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31014	31028		10.1074/jbc.M114.570879	http://dx.doi.org/10.1074/jbc.M114.570879			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25237189	hybrid, Green Published			2022-12-25	WOS:000344549900012
J	Song, LN; Bachert, C; Schjoldager, KT; Clausen, H; Linstedt, AD				Song, Lina; Bachert, Collin; Schjoldager, Katrine T.; Clausen, Henrik; Linstedt, Adam D.			Development of Isoform-specific Sensors of Polypeptide GalNAc-transferase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-GLYCOSYLATION; LECTIN DOMAINS; UDP-GALNAC; CANCER; GLYCOSYLTRANSFERASES; EXPRESSION; FAMILY; CELLS	Humans express up to 20 isoforms of GalNAc-transferase ( herein T1-T20) that localize to the Golgi apparatus and initiate O-glycosylation. Regulation of this enzyme family affects a vast array of proteins transiting the secretory pathway and diseases arise upon misregulation of specific isoforms. Surprisingly, molecular probes to monitor GalNAc-transferase activity are lacking and there exist no effective global or isoform-specific inhibitors. Here we describe the development of T2- and T3-isoform specific fluorescence sensors that traffic in the secretory pathway. Each sensor yielded little signal when glycosylated but was strongly activated in the absence of its glycosylation. Specificity of each sensor was assessed in HEK cells with either the T2 or T3 enzymes deleted. Although the sensors are based on specific substrates of the T2 and T3 enzymes, elements in or near the enzyme recognition sequence influenced their activity and required modification, which we carried out based on previous in vitro work. Significantly, the modified T2 and T3 sensors were activated only in cells lacking their corresponding isozymes. Thus, we have developed T2- and T3-specific sensors that will be valuable in both the study of GalNAc-transferase regulation and in high-throughput screening for potential therapeutic regulators of specific GalNAc-transferases.	[Song, Lina; Bachert, Collin; Linstedt, Adam D.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Schjoldager, Katrine T.; Clausen, Henrik] Univ Copenhagen, Dept Cellular Med, DK-2200 Copenhagen, Denmark; [Schjoldager, Katrine T.; Clausen, Henrik] Univ Copenhagen, Dept Mol Med, DK-2200 Copenhagen, Denmark; [Schjoldager, Katrine T.; Clausen, Henrik] Univ Copenhagen, Sch Dent, Copenhagen Ctr Glyc, DK-2200 Copenhagen, Denmark	Carnegie Mellon University; University of Copenhagen; University of Copenhagen; University of Copenhagen	Linstedt, AD (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	linstedt@cmu.edu	clausen, henrik/AAD-8016-2021	Clausen, Henrik/0000-0002-0915-5055	National Institutes of Health [GM095549, GM056779]; Novo Nordisk Foundation; Danish National Research Foundation [DNRF107]; Danish Medical Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095549, R01GM056779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM095549 and GM056779 (to A. D. L.), the Novo Nordisk Foundation and Danish National Research Foundation Grant DNRF107 (to H. C.), and the Danish Medical Research Council (to K. T. S.).	Bachert C, 2013, TRAFFIC, V14, P47, DOI 10.1111/tra.12019; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Boskovski MT, 2013, NATURE, V504, P456, DOI 10.1038/nature12723; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Brooks SA, 2007, ACTA HISTOCHEM, V109, P273, DOI 10.1016/j.acthis.2007.02.009; Chefetz I, 2009, BBA-MOL BASIS DIS, V1792, P847, DOI 10.1016/j.bbadis.2008.10.008; Contessa JN, 2010, CLIN CANCER RES, V16, P3205, DOI 10.1158/1078-0432.CCR-09-3331; Fritz TA, 2006, J BIOL CHEM, V281, P8613, DOI 10.1074/jbc.M513590200; Gao Y, 2013, ONCOL LETT, V5, P113, DOI 10.3892/ol.2012.980; Gerken TA, 2013, J BIOL CHEM, V288, P19900, DOI 10.1074/jbc.M113.477877; Gerken TA, 2011, J BIOL CHEM, V286, P14493, DOI 10.1074/jbc.M111.218701; Gill DJ, 2013, P NATL ACAD SCI USA, V110, pE3152, DOI 10.1073/pnas.1305269110; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Kitada S, 2013, BRIT J CANCER, V109, P472, DOI 10.1038/bjc.2013.331; Kohsaki T, 2000, J GASTROENTEROL, V35, P840, DOI 10.1007/s005350070021; Losfeld ME, 2012, FASEB J, V26, P4210, DOI 10.1096/fj.12-211656; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Peng RQ, 2012, J BIOL CHEM, V287, P14301, DOI 10.1074/jbc.M111.337642; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schjoldager KTBG, 2012, P NATL ACAD SCI USA, V109, P9893, DOI 10.1073/pnas.1203563109; Schjoldager KTBG, 2011, J BIOL CHEM, V286, P40122, DOI 10.1074/jbc.M111.287912; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/NMETH.1731, 10.1038/nmeth.1731]; Tagliabracci VS, 2014, P NATL ACAD SCI USA, V111, P5520, DOI 10.1073/pnas.1402218111; van der Post S, 2013, J BIOL CHEM, V288, P14636, DOI 10.1074/jbc.M113.459479; Wandall HH, 2007, GLYCOBIOLOGY, V17, P374, DOI 10.1093/glycob/cwl082; Yoshimura Y, 2012, GLYCOBIOLOGY, V22, P429, DOI 10.1093/glycob/cwr159	34	12	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30556	30566		10.1074/jbc.M114.599563	http://dx.doi.org/10.1074/jbc.M114.599563			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25225288	Green Published, hybrid			2022-12-25	WOS:000344549700033
J	Alvarez-Uria, G; Pakam, R; Naik, PK; Midde, M				Alvarez-Uria, Gerardo; Pakam, Raghavakalyan; Naik, Praveen Kumar; Midde, Manoranjan			Induction with Lopinavir-Based Treatment Followed by Switch to Nevirapine-Based Regimen versus Non-Nucleoside Reverse Transcriptase Inhibitors-Based Treatment for First Line Antiretroviral Therapy in HIV Infected Children Three Years and Older	PLOS ONE			English	Article							PROTEASE-INHIBITOR; VIRAL LOAD; OPEN-LABEL; FAILURE; LOPINAVIR/RITONAVIR; OUTCOMES; RISK	Background: The World Health Organization recommends non-nucleoside reverse transcriptase inhibitors (NNRTIs)-based antiretroviral therapy (ART) for children three years and older. In younger children, starting ART with lopinavir boosted with ritonavir (LPVr) results in lower risk of virological failure, but data in children three years and older are scarce, and long-term ART with LPVr is problematic in resource-poor settings. Methodology: Retrospective cohort of children three years and older who started triple ART including LPVr or a NNRTI between 2007 and 2013 in a rural setting in India. Children who started LPVr were switched to nevirapine-based ART after virological suppression. We analysed two outcomes, virological suppression (HIV-RNA < 400 copies/ml) within one year of ART using logistic regression, and time to virological failure (HIV-RNA > 1000 copies/ml) after virological suppression using Cox proportional hazard regression. A sensitivity analysis was performed using inverse probability of treatment weighting (IPTW) based of propensity score methods. Findings: Of 325 children having a viral load during the first year of ART, 74/83 (89.2%) in the LPVr group achieved virological suppression versus 185/242 (76.5%) in the NNRTI group. In a multivariable analysis, the use of LPVr-based ART was associated with higher probability of virological suppression (adjusted odds ratio 3.19, 95% confidence interval [CI] 1.11-9.13). After IPTW, the estimated risk difference was 12.2% (95% CI, 2.9-21.5). In a multivariable analysis including 292 children who had virological suppression and available viral loads after one year of ART, children switched from LPVr to nevirapine did not have significant higher risk of virological failure (adjusted hazard ratio 1.18, 95% CI 0.36-3.81). Conclusions: In a cohort of HIV infected children three years and older in a resource-limited setting, an LPVr induction-nevirapine maintenance strategy resulted in more initial virological suppression and similar incidence of virological failure after initial virological suppression than NNRTI-based regimens.	[Alvarez-Uria, Gerardo; Pakam, Raghavakalyan; Naik, Praveen Kumar; Midde, Manoranjan] Rural Dev Trust Hosp, Dept Infect Dis, Bathalapalli, AP, India		Alvarez-Uria, G (corresponding author), Rural Dev Trust Hosp, Dept Infect Dis, Bathalapalli, AP, India.	gerardouria@gmail.com	Alvarez-Uria, Gerardo/G-6030-2012	Alvarez-Uria, Gerardo/0000-0003-1847-9614				Alvarez-Uria G, 2012, INFECT DIS REP, V4, pe19, DOI [10.4081/idr.2012.e19, DOI 10.4081/IDR.2012.E19]; Alvarez-Uria G., 2012, INTERDISCIP PERSPECT, V2012, P293795; Alvarez-Uria G, 2012, J PUBLIC HEALTH RES, V1, P79, DOI 10.4081/jphr.2012.e14; Alvarez-Uria Gerardo, 2012, ISRN Pediatr, V2012, P763591, DOI 10.5402/2012/763591; Alvarez-Uria G, 2012, TROP MED INT HEALTH, V17, P1152, DOI 10.1111/j.1365-3156.2012.02982.x; Arpadi S, 2013, ARCH DIS CHILD, V98, P258, DOI 10.1136/archdischild-2012-302633; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; Babiker A, 2011, LANCET INFECT DIS, V11, P273, DOI 10.1016/S1473-3099(10)70313-3; Boyd K, 2010, AIDS, V24, P1213, DOI 10.1097/QAD.0b013e3283389f41; Dlamini JN, 2011, JAIDS-J ACQ IMM DEF, V58, P304, DOI 10.1097/QAI.0b013e3182278c29; Dunn DT, 2006, AIDS, V20, P1289, DOI 10.1097/01.aids.0000232237.20792.68; Estripeaut D, 2013, PEDIATR INFECT DIS J, V32, pE466, DOI 10.1097/INF.0b013e3182a09276; Gang I. N., 2002, CASTE ETHNICITY POVE; Hill J., 2004, REDUCING BIAS TREATM; Jaspan HB, 2008, PEDIATR INFECT DIS J, V27, P993, DOI 10.1097/INF.0b013e31817acf7b; Kamya MR, 2007, JAIDS-J ACQ IMM DEF, V46, P187, DOI 10.1097/QAI.0b013e31814278c0; Kuhn L, 2012, LANCET INFECT DIS, V12, P521, DOI 10.1016/S1473-3099(12)70051-8; Lockman S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001236; McCaffrey DF, 2013, STAT MED, V32, P3388, DOI 10.1002/sim.5753; National AIDS Control Organisation, 2006, GUID HIV CAR TREATM; Office of The Registrar General & Census Commissioner India, 2011, CENS IND; Palumbo P, 2010, NEW ENGL J MED, V363, P1510, DOI 10.1056/NEJMoa1000931; Ramos JT, 2009, HIV MED, V10, P536, DOI 10.1111/j.1468-1293.2009.00728.x; Ridgeway G, 2013, TOOLKIT WEIGHTING AN; Royston P, 2009, STATA J, V9, P466, DOI 10.1177/1536867X0900900308; Saez-Llorens X, 2003, PEDIATR INFECT DIS J, V22, P216, DOI 10.1097/00006454-200303000-00003; Sigaloff KCE, 2011, LANCET INFECT DIS, V11, P769, DOI 10.1016/S1473-3099(11)70141-4; UNITAID, HIV AIDS DIAGN TECHN; Violari A, 2012, NEW ENGL J MED, V366, P2380, DOI 10.1056/NEJMoa1113249; Welch S, 2009, HIV MED, V10, P591, DOI 10.1111/j.1468-1293.2009.00759.x; World Health Organisation, 2021, CONSOLIDATED GUIDELI; World Health Organization, 2010, ANT THER HIV INF INF	32	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e108063	10.1371/journal.pone.0108063	http://dx.doi.org/10.1371/journal.pone.0108063			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232730	Green Submitted, Green Published, gold			2022-12-25	WOS:000342921200077
J	Go, N; Bidot, C; Belloc, C; Touzeau, S				Go, Natacha; Bidot, Caroline; Belloc, Catherine; Touzeau, Suzanne			Integrative Model of the Immune Response to a Pulmonary Macrophage Infection: What Determines the Infection Duration?	PLOS ONE			English	Article							RESPIRATORY-SYNDROME-VIRUS; MYCOBACTERIUM-TUBERCULOSIS; DENDRITIC CELLS; T-CELL; PIGS; PRRSV; LUNGS; KINETICS; SWINE; REPLICATION	The immune mechanisms which determine the infection duration induced by pathogens targeting pulmonary macrophages are poorly known. To explore the impact of such pathogens, it is indispensable to integrate the various immune mechanisms and to take into account the variability in pathogen virulence and host susceptibility. In this context, mathematical models complement experimentation and are powerful tools to represent and explore the complex mechanisms involved in the infection and immune dynamics. We developed an original mathematical model in which we detailed the interactions between the macrophages and the pathogen, the orientation of the adaptive response and the cytokine regulations. We applied our model to the Porcine Respiratory and Reproductive Syndrome virus (PRRSv), a major concern for the swine industry. We extracted value ranges for the model parameters from modelling and experimental studies on respiratory pathogens. We identified the most influential parameters through a sensitivity analysis. We defined a parameter set, the reference scenario, resulting in a realistic and representative immune response to PRRSv infection. We then defined scenarios corresponding to graduated levels of strain virulence and host susceptibility around the reference scenario. We observed that high levels of antiviral cytokines and a dominant cellular response were associated with either short, the usual assumption, or long infection durations, depending on the immune mechanisms involved. To identify these mechanisms, we need to combine the levels of antiviral cytokines, including IFN gamma, and IL10. The latter is a good indicator of the infected macrophage level, both combined provide the adaptive response orientation. Available PRRSv vaccines lack efficiency. By integrating the main interactions between the complex immune mechanisms, this modelling framework could be used to help designing more efficient vaccination strategies.	[Go, Natacha; Bidot, Caroline] INRA, MIA UR341, Jouy En Josas, France; [Go, Natacha; Belloc, Catherine] LUNAM Univ, Oniris, INRA, UMR BioEpAR 1300, Nantes, France; [Touzeau, Suzanne] Univ Nice Sophia Antipolis, CNRS, ISA UMR1355, Sophia Antipolis, France; [Touzeau, Suzanne] Inria, BIOCORE, Sophia Antipolis, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Inria	Go, N (corresponding author), INRA, MIA UR341, Jouy En Josas, France.	Natacha.Go@jouy.inra.fr		Go, Natacha/0000-0003-4674-3726; Touzeau, Suzanne/0000-0001-5255-8960; Bidot, Caroline/0000-0002-8000-9165	ABIES (AgroParisTech) INRA; French Research Agency (ANR) [ANR-10-BINF-07]	ABIES (AgroParisTech) INRA; French Research Agency (ANR)(French National Research Agency (ANR))	Financial support for this research was provided by ABIES (AgroParisTech) INRA, and the French Research Agency (ANR), program Investments for the future, project ANR-10-BINF-07 (MIHMES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Ali T, 2007, VIRAL IMMUNOL, V20, P105, DOI 10.1089/vim.2006.0078; Ait-Ali T, 2011, IMMUNOGENETICS, V63, P437, DOI 10.1007/s00251-011-0518-8; Albina E, 1998, VET IMMUNOL IMMUNOP, V61, P49, DOI 10.1016/S0165-2427(97)00134-7; Beauchemin C, 2011, BMC PUBLIC HLTH, V11; Beyer J, 2000, J VET MED B, V47, P9, DOI 10.1046/j.1439-0450.2000.00305.x; Borghetti P, 2005, PRRS FATTI VS SPECUL, P27; Bosch AATM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003057; Braciale TJ, 2012, NAT REV IMMUNOL, V12, P295, DOI 10.1038/nri3166; Choi C, 2002, RES VET SCI, V72, P45, DOI 10.1053/rvsc.2001.0519; Coquerelle C, 2010, IMMUNOL REV, V234, P317, DOI 10.1111/j.0105-2896.2009.00887.x; Costers S, 2006, J GEN VIROL, V87, P2341, DOI 10.1099/vir.0.81808-0; Darwich L, 2011, VET MICROBIOL, V150, P49, DOI 10.1016/j.vetmic.2011.01.008; Darwich L, 2010, VIRUS RES, V154, P123, DOI 10.1016/j.virusres.2010.07.017; DeFranco AL, 2009, IMMUNITE REPONSE IMM; Diaz I, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-30; Dobrovolny HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057088; Doeschl-Wilson AB, 2009, J ANIM SCI, V87, P1638, DOI 10.2527/jas.2008-1447; Duan F, 2012, J IMMUNOL METHODS, V382, P224, DOI 10.1016/j.jim.2012.06.005; Duan X, 1997, VET MICROBIOL, V56, P9, DOI 10.1016/S0378-1135(96)01347-8; Flores-Mendoza L, 2008, CLIN VACCINE IMMUNOL, V15, P720, DOI 10.1128/CVI.00224-07; Gammack D, 2005, MULTISCALE MODEL SIM, V3, P312, DOI 10.1137/040603127; Gammack D, 2004, J MATH BIOL, V48, P218, DOI 10.1007/s00285-003-0232-8; Gaudreault N, 2009, ARCH VIROL, V154, P133, DOI 10.1007/s00705-008-0271-y; Gimeno M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-9; Gomez-Laguna J, 2013, VET J, V195, P148, DOI 10.1016/j.tvjl.2012.11.012; Gomez-Laguna J, 2012, VET MICROBIOL, V158, P187, DOI 10.1016/j.vetmic.2012.02.003; Heffernan JM, 2011, MATH POPUL STUD, V18, P47, DOI 10.1080/08898480.2011.564559; Johnson W, 2004, VET IMMUNOL IMMUNOP, V102, P233, DOI 10.1016/j.vetimm.2004.09.010; Karniychuk UU, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-30; Kidd Parris, 2003, Altern Med Rev, V8, P223; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; Knosp CA, 2012, IMMUNOLOGY, V135, P101, DOI 10.1111/j.1365-2567.2011.03520.x; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; Labarque G, 2003, VET RES, V34, P249, DOI 10.1051/vetres:2003001; Labarque GG, 2000, J GEN VIROL, V81, P1327, DOI 10.1099/0022-1317-81-5-1327; Lamboni M, 2011, RELIAB ENG SYST SAFE, V96, P450, DOI 10.1016/j.ress.2010.12.002; LeRoith T, 2012, INFLAMMATION CHRONIC, P121, DOI [10.5772/28502, DOI 10.5772/28502]; Lunney JK, 2010, VIRUS RES, V154, P161, DOI 10.1016/j.virusres.2010.08.004; Marino S, 2004, J THEOR BIOL, V227, P463, DOI 10.1016/j.jtbi.2003.11.023; Marino S, 2011, WIRES SYST BIOL MED, V3, P479, DOI 10.1002/wsbm.131; Marino S, 2010, J THEOR BIOL, V265, P586, DOI 10.1016/j.jtbi.2010.05.012; Mateu E, 2008, VET J, V177, P345, DOI 10.1016/j.tvjl.2007.05.022; Mogler M, 2012, THESIS IOWA STATE U; Molina RM, 2008, VET IMMUNOL IMMUNOP, V126, P283, DOI 10.1016/j.vetimm.2008.08.002; Murtaugh MP, 2011, VACCINE, V29, P8192, DOI 10.1016/j.vaccine.2011.09.013; Murtaugh MP, 2002, VIRAL IMMUNOL, V15, P533, DOI 10.1089/088282402320914485; Murtaugh MP, 2004, P ANN M AM ASS SWIN, P359; Murtaugh MP, 2005, PRRS FATTI VS SPECUL, P73; Nauwynck HJ, 2012, TRANSBOUND EMERG DIS, V59, P50, DOI 10.1111/j.1865-1682.2011.01292.x; Park JY, 2008, J MICROBIOL BIOTECHN, V18, P1709; Petry DB, 2007, J ANIM SCI, V85, P2075, DOI 10.2527/jas.2006-721; Petry DB, 2005, J ANIM SCI, V83, P1494; Reiner G, 2010, J ANIM BREED GENET, V127, P100, DOI 10.1111/j.1439-0388.2009.00818.x; Roth AJ, 2009, DIS SWINE, P15; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Saltelli A., 2000, SENSITIVITY ANAL; Silva-Campa E, 2009, VIROLOGY, V387, P373, DOI 10.1016/j.virol.2009.02.033; Smith AM, 2011, WIRES SYST BIOL MED, V3, P429, DOI 10.1002/wsbm.129; Thanawongnuwech R, 2010, VIRUS RES, V154, P133, DOI 10.1016/j.virusres.2010.09.003; Tosi MF, 2005, J ALLERGY CLIN IMMUN, V116, P241, DOI 10.1016/j.jaci.2005.05.036; Van Reeth K, 2002, VET IMMUNOL IMMUNOP, V87, P161, DOI 10.1016/S0165-2427(02)00047-8; Vidal SM, 2011, CURR OPIN VIROL, V1, P497, DOI 10.1016/j.coviro.2011.10.017; Weesendorp E, 2013, VET MICROBIOL, V163, P1, DOI 10.1016/j.vetmic.2012.09.013; Wesley RD, 2006, CAN J VET RES, V70, P176; Wigginton JE, 2001, J IMMUNOL, V166, P1951, DOI 10.4049/jimmunol.166.3.1951; Wongyanin P, 2010, VET IMMUNOL IMMUNOP, V133, P170, DOI 10.1016/j.vetimm.2009.07.012; Xiao ZG, 2004, J VIROL, V78, P5923, DOI 10.1128/JVI.78.11.5923-5933.2004; Yates A, 2000, J THEOR BIOL, V206, P539, DOI 10.1006/jtbi.2000.2147; Zimmerman J., 2006, DIS SWINE, P387	69	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107818	10.1371/journal.pone.0107818	http://dx.doi.org/10.1371/journal.pone.0107818			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233096	Green Published, gold, Green Submitted			2022-12-25	WOS:000342921200052
J	Yang, Y; Swennenhuis, JF; Rho, HS; Le Gac, S; Terstappen, LWMM				Yang, Yoonsun; Swennenhuis, Joost F.; Rho, Hoon Suk; Le Gac, Severine; Terstappen, Leon W. M. M.			Parallel Single Cancer Cell Whole Genome Amplification Using Button-Valve Assisted Mixing in Nanoliter Chambers	PLOS ONE			English	Article							EVOLUTION; RECOVERY; DEVICE	The heterogeneity of tumor cells and their alteration during the course of the disease urges the need for real time characterization of individual tumor cells to improve the assessment of treatment options. New generations of therapies are frequently associated with specific genetic alterations driving the need to determine the genetic makeup of tumor cells. Here, we present a microfluidic device for parallel single cell whole genome amplification (pscWGA) to obtain enough copies of a single cell genome to probe for the presence of treatment targets and the frequency of its occurrence among the tumor cells. Individual cells were first captured and loaded into eight parallel amplification units. Next, cells were lysed on a chip and their DNA amplified through successive introduction of dedicated reagents while mixing actively with the help of integrated button-valves. The reaction chamber volume for scWGA 23.85 nl, and starting from 6-7 pg DNA contained in a single cell, around 8 ng of DNA was obtained after WGA, representing over 1000-fold amplification. The amplified products from individual breast cancer cells were collected from the device to either directly investigate the amplification of specific genes by qPCR or for re-amplification of the DNA to obtain sufficient material for whole genome sequencing. Our pscWGA device provides sufficient DNA from individual cells for their genetic characterization, and will undoubtedly allow for automated sample preparation for single cancer cell genomic characterization.	[Yang, Yoonsun; Swennenhuis, Joost F.; Terstappen, Leon W. M. M.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Med Cell BioPhys Grp, NL-7500 AE Enschede, Netherlands; [Rho, Hoon Suk] Univ Twente, MESA Inst Nanotechnol, Mesoscale Chem Syst Grp, NL-7500 AE Enschede, Netherlands; [Le Gac, Severine] Univ Twente, MESA Inst Nanotechnol, BIOS Lab, Chip Grp, NL-7500 AE Enschede, Netherlands	University of Twente; University of Twente; University of Twente	Terstappen, LWMM (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, Med Cell BioPhys Grp, POB 217, NL-7500 AE Enschede, Netherlands.	l.w.m.m.terstappen@utwente.nl	terstappen, leon/O-4923-2018; Rho, Hoon Suk/AAK-5398-2021; Le Gac, Séverine/B-7806-2013; Rho, Hoon Suk/G-2276-2018	terstappen, leon/0000-0001-5944-3787; Le Gac, Séverine/0000-0002-4546-6184; Rho, Hoon Suk/0000-0002-5345-3965	NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands	NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands	This study is funded by NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands and 130 partners. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bontoux N, 2008, LAB CHIP, V8, P443, DOI 10.1039/b716543a; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Fabbri F, 2013, CANCER LETT, V335, P225, DOI 10.1016/j.canlet.2013.02.015; Fiegler H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1030; Fuchs AB, 2006, LAB CHIP, V6, P121, DOI 10.1039/b505884h; Geigl JB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp526; Gellrich S, 1997, J INVEST DERMATOL, V109, P541, DOI 10.1111/1523-1747.ep12336753; Handyside AH, 2004, MOL HUM REPROD, V10, P767, DOI 10.1093/molehr/gah101; Hanna W, 2007, BREAST J, V13, P122, DOI 10.1111/j.1524-4741.2007.00396.x; Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Jiang ZW, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni089; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Lecault V, 2012, CURR OPIN CHEM BIOL, V16, P381, DOI 10.1016/j.cbpa.2012.03.022; Marcy Y, 2007, PLOS GENET, V3, P1702, DOI 10.1371/journal.pgen.0030155; Maryanski JL, 1996, IMMUNITY, V4, P47, DOI 10.1016/S1074-7613(00)80297-6; Meng SD, 2004, P NATL ACAD SCI USA, V101, P9393, DOI 10.1073/pnas.0402993101; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Pan XH, 2008, P NATL ACAD SCI USA, V105, P15499, DOI 10.1073/pnas.0808028105; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584; Spits C, 2006, HUM MUTAT, V27, P496, DOI 10.1002/humu.20324; Spits C, 2006, NAT PROTOC, V1, P1965, DOI 10.1038/nprot.2006.326; Stoecklein NH, 2008, CANCER CELL, V13, P441, DOI 10.1016/j.ccr.2008.04.005; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; van den Brink FTG, 2011, ELECTROPHORESIS, V32, P3094, DOI 10.1002/elps.201100413; White AK, 2011, P NATL ACAD SCI USA, V108, P13999, DOI 10.1073/pnas.1019446108; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Xu Y, 2009, ANAL CHEM, V81, P7436, DOI 10.1021/ac9012072	32	22	22	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107958	10.1371/journal.pone.0107958	http://dx.doi.org/10.1371/journal.pone.0107958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233459	Green Submitted, Green Published, gold			2022-12-25	WOS:000342921200069
J	Koromilas, ND; Lainioti, GC; Gialeli, C; Barbouri, D; Kouravelou, KB; Karamanos, NK; Voyiatzis, GA; Kallitsis, JK				Koromilas, Nikos D.; Lainioti, Georgia Ch.; Gialeli, Chrisostomi; Barbouri, Despoina; Kouravelou, Katerina B.; Karamanos, Nikos K.; Voyiatzis, George A.; Kallitsis, Joannis K.			Preparation and Toxicological Assessment of Functionalized Carbon Nanotube-Polymer Hybrids	PLOS ONE			English	Article							IN-VITRO TOXICITY; ANTIMICROBIAL POLYMERS; CYTOTOXICITY; CHEMISTRY; CELLS; NANOCOMPOSITES; NANOPARTICLES; NANOMATERIALS; DEPENDENCE; VIABILITY	Novel Carbon Nanotube-Polymer Hybrids were synthesized as potential materials for the development of membranes for water treatment applications in the field of Membrane Bioreactors (MBRs). Due to the toxicological concerns regarding the use of nanomaterials in water treatment as well as the rising demand for safe drinking water to protect public health, we studied the functionalization of MWCNTs and Thin-MWCNTs as to control their properties and increase their ability of embedment into porous anisotropic polymeric membranes. Following the growth of the hydrophilic monomer on the surface of the properly functionalized CNTs, that act as initiator for the controlled radical polymerization (ATRP) of sodium styrene sulfonate (SSNa), the antimicrobial quaternized phosphonium and ammonium salts were attached on CNTs-g-PSSN alpha through non-covalent bonding. In another approach the covalent attachment of quaternized ammonium polymeric moieties of acrylic acid-vinyl benzyl chloride copolymers with N, N-dimethylhexadecylamine (P(AA12-co-VBCHAM)) on functionalized CNTs has also been attempted. Finally, the toxicological assessment in terms of cell viability and cell morphological changes revealed that surface characteristics play a major role in the biological response of functionalized CNTs.	[Koromilas, Nikos D.; Lainioti, Georgia Ch.; Gialeli, Chrisostomi; Barbouri, Despoina; Karamanos, Nikos K.; Kallitsis, Joannis K.] Univ Patras, Dept Chem, Patras, Greece; [Koromilas, Nikos D.; Lainioti, Georgia Ch.; Gialeli, Chrisostomi; Barbouri, Despoina; Karamanos, Nikos K.; Voyiatzis, George A.; Kallitsis, Joannis K.] Fdn Res & Technol Hellas FORTH, Inst Chem Engn Sci ICE HT, Rion, Greece; [Kouravelou, Katerina B.] Nanothinx SA, Rion, Greece	University of Patras; Foundation for Research & Technology - Hellas (FORTH); Institute of Chemical Engineering Sciences (ICE-HT)	Karamanos, NK (corresponding author), Univ Patras, Dept Chem, Patras, Greece.	n.k.karamanos@upatras.gr; j.kallitsis@upatras.gr	Lainioti, Georgia/AAH-6825-2021; Karamanos, Nikos/A-3616-2008; Voyiatzis, George A/G-9039-2012; Kallitsis, Joannis/K-1043-2015	Karamanos, Nikos/0000-0003-3618-0288; 	European Union's Seventh Framework Programme (FP7); BioNexGen-Development of the next generation bioreactor system [246039]	European Union's Seventh Framework Programme (FP7); BioNexGen-Development of the next generation bioreactor system	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013). Research Funding Project: BioNexGen-Development of the next generation bioreactor system (Grant agreement: 246039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee S, 2005, ADV MATER, V17, P17, DOI 10.1002/adma.200401340; Carmona-Ribeiro AM, 2013, INT J MOL SCI, V14, P9906, DOI 10.3390/ijms14059906; Chang JS, 2007, ENVIRON SCI TECHNOL, V41, P2064, DOI 10.1021/es062347t; Cheng C, 2009, J PHYS CONF SER, V151, DOI 10.1088/1742-6596/151/1/012030; Cui HF, 2010, CHEM RES TOXICOL, V23, P1131, DOI 10.1021/tx100050h; Davoren M, 2007, TOXICOL IN VITRO, V21, P438, DOI 10.1016/j.tiv.2006.10.007; De Volder MFL, 2013, SCIENCE, V339, P535, DOI 10.1126/science.1222453; Dhawan A, 2010, ANAL BIOANAL CHEM, V398, P589, DOI 10.1007/s00216-010-3996-x; Du J, 2013, ENVIRON TOXICOL PHAR, V36, P451, DOI 10.1016/j.etap.2013.05.007; Fubini B, 2010, NANOTOXICOLOGY, V4, P347, DOI 10.3109/17435390.2010.509519; Gao C, 2005, MACROMOLECULES, V38, P8634, DOI 10.1021/ma050823e; Gialeli C, 2013, INVEST NEW DRUG, V31, P516, DOI 10.1007/s10637-012-9875-x; Gioni V, 2008, MOL CANCER RES, V6, P706, DOI 10.1158/1541-7786.MCR-07-0355; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hudson JL, 2004, J AM CHEM SOC, V126, P11158, DOI 10.1021/ja0467061; Johnston HJ, 2010, NANOTOXICOLOGY, V4, P207, DOI 10.3109/17435390903569639; Kenawy ER, 2007, BIOMACROMOLECULES, V8, P1359, DOI 10.1021/bm061150q; Kong H, 2004, J AM CHEM SOC, V126, P412, DOI 10.1021/ja0380493; Kong H, 2004, MACROMOLECULES, V37, P4022, DOI 10.1021/ma049694c; Koromilas ND, 2014, P 3 INT S CONTR LIV; Koromilas ND, 2014, EUR POLYM J, V54, P39, DOI 10.1016/j.eurpolymj.2014.02.009; Kourkouli SN, 2013, MACROMOLECULES, V46, P2590, DOI 10.1021/ma3025464; Lin Y, 2003, MACROMOLECULES, V36, P7199, DOI 10.1021/ma0348876; Liu Y, 2013, ACCOUNTS CHEM RES, V46, P702, DOI 10.1021/ar300028m; Liu Z, 2009, NAT PROTOC, V4, P1372, DOI 10.1038/nprot.2009.146; Magoulas GE, 2011, EUR J MED CHEM, V46, P721, DOI 10.1016/j.ejmech.2010.12.008; Meng L, 2013, TOXICOLOGY, V313, P49, DOI 10.1016/j.tox.2012.11.011; Moniruzzaman M, 2006, MACROMOLECULES, V39, P5194, DOI 10.1021/ma060733p; Monteiro-Riviere NA, 2006, CARBON, V44, P1070, DOI 10.1016/j.carbon.2005.11.004; Monteiro-Riviere NA, 2005, NANOMED-NANOTECHNOL, V1, P293, DOI 10.1016/j.nano.2005.10.007; Moore VC, 2003, NANO LETT, V3, P1379, DOI 10.1021/nl034524j; Papadopoulou A, 2011, INT J ONCOL, V39, P989, DOI 10.3892/ijo.2011.1132; Poncharal P, 1999, SCIENCE, V283, P1513, DOI 10.1126/science.283.5407.1513; Prato M, 2008, ACCOUNTS CHEM RES, V41, P60, DOI 10.1021/ar700089b; Pulskamp K, 2007, TOXICOL LETT, V168, P58, DOI 10.1016/j.toxlet.2006.11.001; Qin SH, 2004, MACROMOLECULES, V37, P9963, DOI 10.1021/ma048692p; Qin SH, 2004, J AM CHEM SOC, V126, P170, DOI 10.1021/ja037937v; Sayes CM, 2006, TOXICOL LETT, V161, P135, DOI 10.1016/j.toxlet.2005.08.011; Simeonova PP, 2009, NANOMEDICINE-UK, V4, P373, DOI 10.2217/NNM.09.25; Svitkina T, 2009, METHODS MOL BIOL, V586, P187, DOI 10.1007/978-1-60761-376-3_10; Tabet L, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-3; Tasis D, 2006, CHEM REV, V106, P1105, DOI 10.1021/cr050569o; Usrey ML, 2005, J AM CHEM SOC, V127, P16129, DOI 10.1021/ja0537530; Vardharajula S, 2012, INT J NANOMED, V7, P5361, DOI 10.2147/IJN.S35832; Wang CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033772; Wang H, 2004, NANO LETT, V4, P1789, DOI 10.1021/nl048969z; Wang X, 2009, J NANOSCI NANOTECHNO, V9, P3025, DOI 10.1166/jnn.2009.025; Wang ZM, 2007, CARBON, V45, P285, DOI 10.1016/j.carbon.2006.09.025; Wick P, 2007, TOXICOL LETT, V168, P121, DOI 10.1016/j.toxlet.2006.08.019; Worle-Knirsch JM, 2006, NANO LETT, V6, P1261, DOI 10.1021/nl060177c; Xu HK, 2010, J MEMBRANE SCI, V354, P206, DOI 10.1016/j.memsci.2010.02.028; Yao ZL, 2003, J AM CHEM SOC, V125, P16015, DOI 10.1021/ja037564y; Ye SF, 2009, BIOCHEM BIOPH RES CO, V379, P643, DOI 10.1016/j.bbrc.2008.12.137; Zarogoulidis P, 2012, THER DELIV, V3, P1021, DOI 10.4155/tde.12.77; Zhang LW, 2007, INT J TOXICOL, V26, P103, DOI 10.1080/10915810701225133; Zhu J, 2003, NANO LETT, V3, P1107, DOI 10.1021/nl0342489	56	18	19	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107029	10.1371/journal.pone.0107029	http://dx.doi.org/10.1371/journal.pone.0107029			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229474	Green Published, Green Submitted, gold			2022-12-25	WOS:000342123900021
J	Nervo, B; Tocco, C; Caprio, E; Palestrini, C; Rolando, A				Nervo, Beatrice; Tocco, Claudia; Caprio, Enrico; Palestrini, Claudia; Rolando, Antonio			The Effects of Body Mass on Dung Removal Efficiency in Dung Beetles	PLOS ONE			English	Article							ECOSYSTEM FUNCTION; BIODIVERSITY LOSS; DIVERSITY; SCARABAEIDAE; COLEOPTERA; FOREST; FRAGMENTATION; CONSEQUENCES; CONSERVATION; RICHNESS	Understanding of the role of body mass in structural-functional relationships is pressing, particularly because species losses often occur non-randomly with respect to body size. Our study examined the effects of dung beetle body mass on dung removal at two levels. First, we used the lab experiment to evaluate the efficiency of eight dung beetle species belonging to two functional groups (tunnelers, dwellers) on dung removal. Second, the same species employed in the lab were used in field mesocosms to examine the effects of the two functional groups on dung removal maintaining realistic differences in the total body mass between tunneler and dweller assemblages. Furthermore, the experimental assemblages contained one and four species within each functional group, so the effect of body mass heterogeneity was examined. We used a statistical approach (offset method) which took into account a priori constraints due to the study design allowing us to analyse the effect of larger species in mesocosm style experiments. Body size played a crucial role in dung removal: large beetles were more efficient than small ones and the percentage of removed dung increased with higher body mass heterogeneity. Tunnelers were more efficient than dwellers over both short and long time periods (one month and one year). Significant effects of dwellers were found only after one year. Moreover, our study showed that not including the body mass as an offset in the model resulted in sometimes different results, as the offset expresses dung removal independently of the body mass. This approach confirmed that body size is likely a pivotal factor controlling dung removal efficiency at multiple levels, from single species to overall dung beetle assemblages. Even though other specific traits should be examined, this study has begun to address the consequences of losing individuals with specific traits that are especially sensitive to perturbations.	[Nervo, Beatrice; Tocco, Claudia; Caprio, Enrico; Palestrini, Claudia; Rolando, Antonio] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy	University of Turin	Nervo, B (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy.	beatrice.nervo@unito.it	; Caprio, Enrico/G-1310-2011	ROLANDO, Antonio/0000-0002-3432-1780; Caprio, Enrico/0000-0002-5997-5959				Amezquita S, 2010, ENVIRON ENTOMOL, V39, P328, DOI 10.1603/EN09182; Andresen E, 2002, ECOL ENTOMOL, V27, P257, DOI 10.1046/j.1365-2311.2002.00408.x; Andresen E, 2003, ECOGRAPHY, V26, P87, DOI 10.1034/j.1600-0587.2003.03362.x; Barbero E, 1999, J INSECT CONSERV, V3, P75, DOI 10.1023/A:1009609826831; Beynon SA, 2012, J APPL ECOL, V49, P1365, DOI 10.1111/j.1365-2664.2012.02210.x; Caprio E, 2011, BIOL CONSERV, V144, P2958, DOI 10.1016/j.biocon.2011.08.021; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Carpaneto GM, 2007, DIVERS DISTRIB, V13, P903, DOI 10.1111/j.1472-4642.2007.00397.x; De Rosario-Martinez H, 2013, PHIA POSTHOC INTERAC; Diaz S, 2003, TRENDS ECOL EVOL, V18, P140, DOI 10.1016/S0169-5347(03)00007-7; Dortel E, 2013, J INSECT CONSERV, V17, P1059, DOI 10.1007/s10841-013-9590-8; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Falcucci A, 2007, LANDSCAPE ECOL, V22, P617, DOI 10.1007/s10980-006-9056-4; Holter P, 2002, ECOL ENTOMOL, V27, P169, DOI 10.1046/j.1365-2311.2002.00399.x; Hotter P., 1977, Oikos, V28, P130, DOI 10.2307/3543332; Huston M A, 2000, Science, V289, P1255; Kaartinen R, 2013, ECOLOGY, V94, P2645, DOI 10.1890/12-1165.1; KLEMPERER HG, 1980, ECOL ENTOMOL, V5, P143, DOI 10.1111/j.1365-2311.1980.tb01135.x; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Lobo Jorge Miguel, 2001, Diversity and Distributions, V7, P257, DOI 10.1046/j.1366-9516.2001.00122.x; Miranda C. H. B., 2000, Pasturas Tropicales, V22, P14; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2013, J ANIM ECOL, V82, P717, DOI 10.1111/1365-2656.12099; O'Hea NM, 2010, OIKOS, V119, P1081, DOI 10.1111/j.1600-0706.2009.18116.x; Penttila A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071454; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Raffaelli D, 2004, SCIENCE, V306, P1141, DOI 10.1126/science.1106365; REICHLE D, 1968, ECOLOGY, V49, P538, DOI 10.2307/1934119; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Rolando A, 2007, J APPL ECOL, V44, P210, DOI 10.1111/j.1365-2664.2006.01253.x; Rosenlew H, 2008, OIKOS, V117, P1659, DOI 10.1111/j.1600-0706.2008.16904.x; SG Shi, 2010, DIRECT ANAL PREADJUS, P1; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Srivastava DS, 2002, OIKOS, V98, P351, DOI 10.1034/j.1600-0706.2002.980216.x; Tocco C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083344; Tocco C, 2013, J INSECT CONSERV, V17, P207, DOI 10.1007/s10841-012-9498-8; Wardle DA, 2004, FRONT ECOL ENVIRON, V2, P145, DOI 10.1890/1540-9295(2004)002[0145:HCILHM]2.0.CO;2; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; [No title captured]; [No title captured]; [No title captured]	45	77	79	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107699	10.1371/journal.pone.0107699	http://dx.doi.org/10.1371/journal.pone.0107699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229237	gold, Green Published, Green Submitted			2022-12-25	WOS:000342123900061
J	Elamin, E; Masclee, A; Troost, F; Pieters, HJ; Keszthelyi, D; Aleksa, K; Dekker, J; Jonkers, D				Elamin, Elhaseen; Masclee, Ad; Troost, Freddy; Pieters, Harm-Jan; Keszthelyi, Daniel; Aleksa, Katarina; Dekker, Jan; Jonkers, Daisy			Ethanol Impairs Intestinal Barrier Function in Humans through Mitogen Activated Protein Kinase Signaling: A Combined In Vivo and In Vitro Approach	PLOS ONE			English	Article							ALCOHOLIC LIVER-DISEASE; CACO-2 CELL MONOLAYER; PARACELLULAR PERMEABILITY; ACTIN CYTOSKELETON; ALDEHYDE DEHYDROGENASES; EPITHELIAL BARRIER; TIGHT; DISRUPTION; CONSUMPTION; METABOLISM	Background: Ethanol-induced gut barrier disruption is associated with several gastrointestinal and liver disorders. Aim: Since human data on effects of moderate ethanol consumption on intestinal barrier integrity and involved mechanisms are limited, the objectives of this study were to investigate effects of a single moderate ethanol dose on small and large intestinal permeability and to explore the role of mitogen activated protein kinase (MAPK) pathway as a primary signaling mechanism. Methods: Intestinal permeability was assessed in 12 healthy volunteers after intraduodenal administration of either placebo or 20 g ethanol in a randomised cross-over trial. Localization of the tight junction (TJ) and gene expression, phosphorylation of the MAPK isoforms p38, ERK and JNK as indicative of activation were analyzed in duodenal biopsies. The role of MAPK was further examined in vitro using Caco-2 monolayers. Results: Ethanol increased small and large intestinal permeability, paralleled by redistribution of ZO-1 and occludin, downregulation of ZO-1 and up-regulation of myosin light chain kinase (MLCK) mRNA expression, and increased MAPK isoforms phosphorylation. In Caco-2 monolayers, ethanol increased permeability, induced redistribution of the junctional proteins and F-actin, and MAPK and MLCK activation, as indicated by phosphorylation of MAPK isoforms and myosin light chain (MLC), respectively, which could be reversed by pretreatment with either MAPK inhibitors or the anti-oxidant L-cysteine. Conclusions: Administration of moderate ethanol dosage can increase both small and colon permeability. Furthermore, the data indicate a pivotal role for MAPK and its crosstalk with MLCK in ethanol-induced intestinal barrier disruption.	[Elamin, Elhaseen; Masclee, Ad; Troost, Freddy; Keszthelyi, Daniel; Dekker, Jan; Jonkers, Daisy] TIFN, Wageningen, Netherlands; [Elamin, Elhaseen; Masclee, Ad; Troost, Freddy; Pieters, Harm-Jan; Keszthelyi, Daniel; Jonkers, Daisy] Maastricht Univ, Med Ctr, Dept Internal Med, Div Gastroenterol Hepatol, Maastricht, Netherlands; [Aleksa, Katarina] Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada; [Dekker, Jan] Wageningen Univ, Dept Anim Sci, NL-6700 AP Wageningen, Netherlands	Top Institute Food & Nutrition; Maastricht University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Wageningen University & Research	Masclee, A (corresponding author), TIFN, Wageningen, Netherlands.	a.masclee@mumc.nl	Keszthelyi, Daniel/ABD-9496-2021; Troost, Freddy/B-2782-2015; Keszthelyi, Daniel/H-7746-2019	Keszthelyi, Daniel/0000-0001-9856-9980	Top Institute Food and Nutrition	Top Institute Food and Nutrition	This study is supported by the Top Institute Food and Nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aepfelbacher M, 2005, CURR TOP MICROBIOL, V291, P167; Bhoopathi P, 2011, CELL SIGNAL, V23, P1978, DOI 10.1016/j.cellsig.2011.07.008; BODE C, 1987, J HEPATOL, V4, P8, DOI 10.1016/S0168-8278(87)80003-X; BODE JC, 1984, HEPATO-GASTROENTEROL, V31, P30; Cunningham KE, 2012, ANN NY ACAD SCI, V1258, P34, DOI 10.1111/j.1749-6632.2012.06526.x; Diczfalusy MA, 2001, J LIPID RES, V42, P1025; Dufour MC, 1999, ALCOHOL RES HEALTH, V23, P5; Eckardt MJ, 1998, ALCOHOL CLIN EXP RES, V22, P998, DOI 10.1111/j.1530-0277.1998.tb03695.x; Elamin EE, 2013, NUTR REV, V2; Elamin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058561; Elamin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035008; Elamin EE, 2013, NUTR REV, V71, P483, DOI 10.1111/nure.12027; Ferrier L, 2006, AM J PATHOL, V168, P1148, DOI 10.2353/ajpath.2006.050617; Fisher OZ, 2008, J DRUG DELIV SCI TEC, V18, P47, DOI 10.1016/S1773-2247(08)50006-2; Forsyth CB, 2011, ALCOHOL CLIN EXP RES; Guo X, 2003, AM J PHYSIOL-CELL PH, V285, pC1174, DOI 10.1152/ajpcell.00015.2003; Hutson JR, 2011, ALCOHOL, V45, P193, DOI 10.1016/j.alcohol.2010.07.005; Karczewski J, 2010, AM J PHYSIOL-GASTR L, V298, pG851, DOI 10.1152/ajpgi.00327.2009; KESHAVARZIAN A, 1994, AM J GASTROENTEROL, V89, P2205; Keszthelyi D, 2012, AM J CLIN NUTR, V95, P603, DOI 10.3945/ajcn.111.028589; Koivisto T, 1996, ALCOHOL CLIN EXP RES, V20, P551, DOI 10.1111/j.1530-0277.1996.tb01091.x; Leve F, 2008, J PHARMACOL EXP THER, V327, P777, DOI 10.1124/jpet.108.140798; Ma TY, 1999, AM J PHYSIOL-GASTR L, V276, pG965, DOI 10.1152/ajpgi.1999.276.4.G965; Mandrekar P, 1999, INT IMMUNOL, V11, P1781, DOI 10.1093/intimm/11.11.1781; Mann RE, 2003, ALCOHOL RES HEALTH, V27, P209; MILLAN MS, 1980, DIGEST DIS SCI, V25, P513, DOI 10.1007/BF01315213; Nosova T, 1996, ALCOHOL ALCOHOLISM, V31, P555; Nosova T, 1998, ALCOHOL ALCOHOLISM, V33, P273; Rao R. K., 2008, V447, P171, DOI 10.1007/978-1-59745-242-7_13; Rao RK, 2004, AM J PHYSIOL-GASTR L, V286, pG881, DOI 10.1152/ajpgi.00006.2004; ROBINSON GM, 1981, DIGEST DIS SCI, V26, P971, DOI 10.1007/BF01314757; Salaspuro M, 1996, ANN MED, V28, P195, DOI 10.3109/07853899609033120; Samak G, 2011, J BIOL CHEM, V286, P30232, DOI 10.1074/jbc.M111.240358; Sawada T, 2007, HEPATO-GASTROENTEROL, V54, P2306; Seitz Helmut K, 2007, Novartis Found Symp, V285, P110; SEITZ HK, 1993, GUT, V34, P1433, DOI 10.1136/gut.34.10.1433; Seitz HK, 2007, NOVART FDN SYMP, V285, P119; Seitz HK, 2007, NOVART FDN SYMP, V285, P119; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Sheth P, 2004, ALCOHOL CLIN EXP RES, V28, P797, DOI 10.1097/01.ALC.0000125358.92335.90; SHIBAYAMA Y, 1991, EXP MOL PATHOL, V55, P196, DOI 10.1016/0014-4800(91)90053-Z; SQUIER CA, 1986, J ORAL PATHOL MED, V15, P276, DOI 10.1111/j.1600-0714.1986.tb00623.x; Stermer E, 2002, ISR MED ASSOC J, V4, P200; Swanson GR, 2011, DIGESTION, V84, P238, DOI 10.1159/000329403; Szabo G, 2010, WORLD J GASTROENTERO, V16, P1321, DOI 10.3748/wjg.v16.i11.1321; Tabata T, 2002, J GASTROENTEROL, V37, P726, DOI 10.1007/s005350200118; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; Troost FJ, 2003, EUR J CLIN NUTR, V57, P1579, DOI 10.1038/sj.ejcn.1601727; U. S. Department of Agriculture and U. S. Department of Health and Human Services, 2010, DIET GUID AM, P30; Usatyuk PV, 2004, J BIOL CHEM, V279, P11789, DOI 10.1074/jbc.M311184200; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Weathermon R, 1999, ALCOHOL RES HEALTH, V23, P40; Wu H, 2006, TOXICOL APPL PHARM, V216, P238, DOI 10.1016/j.taap.2006.05.003; Zhou YN, 2005, PEDIATR RES, V58, P1192, DOI 10.1203/01.pdr.0000185133.65966.4e	55	55	57	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107421	10.1371/journal.pone.0107421	http://dx.doi.org/10.1371/journal.pone.0107421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226407	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700053
J	Hsu, JT; Chen, YJ; Ho, JT; Huang, HL; Wang, SP; Cheng, FC; Wu, J; Tsai, MT				Hsu, Jui-Ting; Chen, Ying-Ju; Ho, Jung-Ting; Huang, Heng-Li; Wang, Shun-Ping; Cheng, Fu-Chou; Wu, Jay; Tsai, Ming-Tzu			A Comparison of Micro-CT and Dental CT in Assessing Cortical Bone Morphology and Trabecular Bone Microarchitecture	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; STRENGTH; DENSITY; VALUES; BODY	Objective: The objective of this study was to evaluate the relationship between the trabecular bone microarchitecture and cortical bone morphology by using micro-computed tomography (micro-CT) and dental cone-beam computed tomography (dental CT). Materials and Methods: Sixteen femurs and eight fifth lumbar vertebrae were collected from eight male Sprague Dawley rats. Four trabecular bone microarchitecture parameters related to the fifth lumbar vertebral body (percent bone volume [BV/TV], trabecular thickness [TbTh], trabecular separation [TbSp], and trabecular number [TbN]) were calculated using micro-CT. In addition, the volumetric cancellous bone grayscale value (vCanGrayscale) of the fifth lumbar vertebral body was measured using dental CT. Furthermore, four cortical bone morphology parameters of the femoral diaphysis (total crosssectional area [TtAr], cortical area [CtAr], cortical bone area fraction [CtAr/TtAr], and cortical thickness [CtTh]) were calculated using both micro-CT and dental CT. Pearson analysis was conducted to calculate the correlation coefficients (r) of the microCT and dental CT measurements. Paired-sample t tests were used to compare the differences between the measurements of the four cortical bone morphology parameters obtained using micro-CT and dental CT. Results: High correlations between the vCanGrayscale measured using dental CT and the trabecular bone microarchitecture parameters (BV/TV [r = 0.84] and TbTh [r = 0.84]) measured using micro-CT were observed. The absolute value of the four cortical bone morphology parameters may be different between the dental CT and micro-CT approaches. However, high correlations (r ranged from 0.71 to 0.90) among these four cortical bone morphology parameters measured using the two approaches were obtained. Conclusion: We observed high correlations between the vCanGrayscale measured using dental CT and the trabecular bone microarchitecture parameters (BV/TV and TbTh) measured using micro-CT, in addition to high correlations between the cortical bone morphology measured using micro-CT and dental CT. Further experiments are necessary to validate the use of dental CT on human bone.	[Hsu, Jui-Ting; Ho, Jung-Ting; Huang, Heng-Li] China Med Univ, Sch Dent, Coll Med, Taichung, Taiwan; [Chen, Ying-Ju; Cheng, Fu-Chou] Taichung Vet Gen Hosp, Dept Med Res, Stem Cell Med Res Ctr, Taichung, Taiwan; [Wang, Shun-Ping] Taichung Vet Gen Hosp, Dept Orthopaed, Taichung, Taiwan; [Wu, Jay] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Tsai, Ming-Tzu] Hungkuang Univ, Dept Biomed Engn, Taichung, Taiwan	China Medical University Taiwan; Taichung Veterans General Hospital; Taichung Veterans General Hospital; China Medical University Taiwan; Hungkuang University	Tsai, MT (corresponding author), Hungkuang Univ, Dept Biomed Engn, Taichung, Taiwan.	anniemtt@gmail.com	Hsu, Jui-Ting/I-8224-2012; Tsai, Ming-Tzu/GSM-9284-2022		China Medical University, Taiwan [CMU102-S-23]; National Science Council, Taiwan [NSC 102-2221-E-039-011]	China Medical University, Taiwan(China Medical University); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by China Medical University, Taiwan (Grant number: CMU102-S-23) and the National Science Council, Taiwan (Grant number: NSC 102-2221-E-039-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisan V, 2013, CLIN IMPLANT DENT R, V15, P893, DOI 10.1111/j.1708-8208.2011.00436.x; Bagi CM, 2011, COMPARATIVE MED, V61, P76; Benavides E, 2012, IMPLANT DENT, V21, P78, DOI 10.1097/ID.0b013e31824885b5; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Dawood A, 2012, DENTOMAXILLOFAC RAD, V41, P70, DOI 10.1259/dmfr/16421849; Fanning Brendan, 2011, J Ir Dent Assoc, V57, P256; Genant HK, 2008, RHEUMATOLOGY, V47, P9, DOI 10.1093/rheumatology/ken180; Genant HK, 1996, J BONE MINER RES, V11, P707; Gonzalez-Garcia R, 2013, CLIN ORAL IMPLAN RES, V24, P871, DOI 10.1111/j.1600-0501.2011.02390.x; Hasan I, 2014, ANN ANAT, VS0940-9602; Hashimoto Koji, 2006, J Oral Sci, V48, P27, DOI 10.2334/josnusd.48.27; Heep H, 2008, INT J BIOL SCI, V4, P169; Hsu JT, 2013, J BIOMECH, V46, P2611, DOI 10.1016/j.jbiomech.2013.08.004; Hsu JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050008; Ito M, 2002, BONE, V31, P351, DOI 10.1016/S8756-3282(02)00830-X; Jiang SD, 2006, OSTEOPOROSIS INT, V17, P1552, DOI 10.1007/s00198-006-0165-3; Jiang Y., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P45; Katsumata A, 2007, ORAL SURG ORAL MED O, V104, P829, DOI 10.1016/j.tripleo.2006.12.005; LAYTON MW, 1988, ARTHRITIS RHEUM-US, V31, P1400, DOI 10.1002/art.1780311109; Leppanen OV, 2008, J BIOMECH, V41, P1623, DOI 10.1016/j.jbiomech.2008.03.017; Lima I, 2008, MICRON, V39, P617, DOI 10.1016/j.micron.2007.04.001; Link TM, 2012, RADIOLOGY, V263, P3, DOI 10.1148/radiol.12110462; Ma L, 2010, BONE, V47, P5, DOI 10.1016/j.bone.2010.03.016; Medeiros DM, 2004, J NUTR, V134, P3061, DOI 10.1093/jn/134.11.3061; Moisio K. C., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P240; Monje A, 2014, CLIN ORAL IMPLAN RES, V25, P723, DOI 10.1111/clr.12133; Nackaerts O, 2011, CLIN ORAL IMPLAN RES, V22, P873, DOI 10.1111/j.1600-0501.2010.02076.x; Nomura Y, 2013, CLIN ORAL IMPLAN RES, V24, P543, DOI 10.1111/j.1600-0501.2012.02420.x; Nomura Y, 2010, CLIN ORAL IMPLAN RES, V21, P558, DOI 10.1111/j.1600-0501.2009.01896.x; Parsa A, 2015, CLIN ORAL IMPLAN RES, V26, pE1, DOI 10.1111/clr.12315; Sibilia V, 2013, ENDOCRINE, V44, P790, DOI 10.1007/s12020-013-9962-6; Siu WS, 2003, J BONE MINER METAB, V21, P316, DOI 10.1007/s00774-003-0427-5; Yao W, 2005, OSTEOPOROSIS INT, V16, P1939, DOI 10.1007/s00198-005-1969-2; Zioupos P, 2008, J BIOMECH, V41, P1961, DOI 10.1016/j.jbiomech.2008.03.025	34	30	31	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107545	10.1371/journal.pone.0107545	http://dx.doi.org/10.1371/journal.pone.0107545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226587	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700063
J	Lin, XC; Wang, M; Zuo, YJ; Li, MG; Lin, XF; Zhu, SP; Zheng, YX; Yu, MB; Lamoureux, EL				Lin, Xianchai; Wang, Mei; Zuo, Yajing; Li, Mingge; Lin, Xiaofeng; Zhu, Siping; Zheng, Yongxin; Yu, Minbin; Lamoureux, Ecosse L.			Health Literacy, Computer Skills and Quality of Patient-Physician Communication in Chinese Patients with Cataract	PLOS ONE			English	Article							OUTCOMES; INFORMATION	Purpose: The aim of the study was to assess levels of health literacy and computer skills in Chinese patients with cataract, and their impact on the doctor-patient relationship. Methods: We undertook a cross-sectional study of cataract patients scheduled for cataract extraction procedures in Guangdong Province, China. Generic health literacy was assessed using 3 established screening questions. Adequate computer skills was determined if patients had used a computer and routinely used search engines on the Internet. Socio-demographic measures (e. g., age, sex, education) were obtained from a standardized interview. Participants who indicated that they could not understand what their doctors mean were considered to have had poor patient-physician communications. Results: Of the 211 participants, 92 (43.6%) had inadequate health literacy and 204 (96.7%) inadequate computer skills. In multivariate analysis, females were more likely to have inadequate health literacy (odds ratio = 2.5, 95% confidence intervals [CI]: 1.3 to 4.7). People with inadequately health literacy were more likely to have a poor patient-physician communication (odds ratio = 3.5, 95% CIs: 1.3 to 9.0). Similar associations were found for inadequate computer skills. Conclusion: Chinese elderly patients with cataract have inadequate health literacy and very limited computer skills, which place them at high risk of misunderstanding and mismanaging their ocular conditions. Patient education information other than online materials may improve the eye care and outcomes of these patients.	[Lin, Xianchai; Zuo, Yajing; Li, Mingge; Zhu, Siping; Zheng, Yongxin; Yu, Minbin] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Mei] Sun Yat Sen Univ, Dept Ophthalmol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Xiaofeng] Shantou Cent Hosp, Shantou, Peoples R China; [Lamoureux, Ecosse L.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Lamoureux, Ecosse L.] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Lamoureux, Ecosse L.] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia	Sun Yat Sen University; Sun Yat Sen University; National University of Singapore; Singapore National Eye Center; National University of Singapore; Centre for Eye Research Australia; University of Melbourne	Yu, MB (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	max-yu@tom.com	Lamoureux, Ecosse/Z-5482-2019		National Natural Science Foundation of China [81200685]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Dr. Lin Xianchai is funded by National Natural Science Foundation of China 81200685. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Ophthalmology, 2011, CAT AD EYE; Chew LD, 2004, FAM MED, V36, P588; Davis T C, 1993, Fam Med, V25, P391; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; Edmunds MR, 2013, JAMA OPHTHALMOL, V131, P1610, DOI 10.1001/jamaophthalmol.2013.5521; Eichler K, 2009, INT J PUBLIC HEALTH, V54, P313, DOI 10.1007/s00038-009-0058-2; Institute of Medicine, 2004, PRESCR END CONF; Kaestle CF, 2001, ADULT LITERACY ED AM; Lee PP, 1999, ARCH OPHTHALMOL-CHIC, V117, P100; Lundberg George D, 2008, Medscape J Med, V10, P255; Muir KW, 2006, AM J OPHTHALMOL, V142, P223, DOI 10.1016/j.ajo.2006.03.018; Muir KW, 2009, ARCH OPHTHALMOL-CHIC, V127, P698, DOI 10.1001/archophthalmol.2009.59; Muir KW, 2008, BR J OPHTHALMOL; Parker R.M., 1999, PATIENT FAMILY ED MA, P63; PARKER RM, 1995, J GEN INTERN MED, V10, P537, DOI 10.1007/BF02640361; Peterson PN, 2011, JAMA-J AM MED ASSOC, V305, P1695, DOI 10.1001/jama.2011.512; Powers BJ, 2010, JAMA-J AM MED ASSOC, V304, P76, DOI 10.1001/jama.2010.896; Schillinger D, 2002, JAMA-J AM MED ASSOC, V288, P475, DOI 10.1001/jama.288.4.475; Swanson MW, 2012, OPTOMETRY VISION SCI, V89, pE23, DOI 10.1097/OPX.0b013e31826a3d85; von Wagner C, 2009, HEALTH EDUC BEHAV, V36, P860, DOI 10.1177/1090198108322819; Williams Mark V., 1995, JAMA (Journal of the American Medical Association), V274, P1677, DOI 10.1001/jama.274.21.1677; Zheng YF, 2011, OPHTHALMOLOGY, V118, P1798, DOI 10.1016/j.ophtha.2011.02.014	22	18	18	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107615	10.1371/journal.pone.0107615	http://dx.doi.org/10.1371/journal.pone.0107615			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226299	gold, Green Published			2022-12-25	WOS:000344317700068
J	Martin, L; Coronel, J; Faulx, D; Valdez, M; Metzler, M; Crudder, C; Castillo, E; Caviedes, L; Grandjean, L; Rodriguez, M; Friedland, JS; Gilman, RH; Moore, DAJ				Martin, Laura; Coronel, Jorge; Faulx, Dunia; Valdez, Melissa; Metzler, Mutsumi; Crudder, Chris; Castillo, Edith; Caviedes, Luz; Grandjean, Louis; Rodriguez, Mitzi; Friedland, Jon S.; Gilman, Robert H.; Moore, David A. J.			A Field Evaluation of the Hardy TB MODS Kit (TM) for the Rapid Phenotypic Diagnosis of Tuberculosis and Multi-Drug Resistant Tuberculosis	PLOS ONE			English	Article							DRUG-SUSCEPTIBILITY ASSAY; MYCOBACTERIUM-TUBERCULOSIS; MICROSCOPIC-OBSERVATION; CULTURE; SPUTUM; BROTH	Background: Even though the WHO-endorsed, non-commercial MODS assay offers rapid, reliable TB liquid culture and phenotypic drug susceptibility testing (DST) at lower cost than any other diagnostic, uptake has been patchy. In part this reflects misperceptions about in-house assay quality assurance, but user convenience of one-stop procurement is also important. A commercial MODS kit was developed by Hardy Diagnostics (Santa Maria, CA, USA) with PATH (Seattle, WA, USA) to facilitate procurement, simplify procedures through readymade media, and enhance safety with a sealing silicone plate lid. Here we report the results from a large-scale field evaluation of the MODS kit in a government service laboratory. Methods & Findings: 2446 sputum samples were cultured in parallel in Lowenstein-Jensen (LJ), conventional MODS and in the MODS kit. MODS kit DST was compared with conventional MODS (direct) DST and proportion method (indirect) DST. 778 samples (31.8%) were Mycobacterium tuberculosis culture-positive. Compared to conventional MODS the sensitivity, specificity, positive, and negative predictive values (95% confidence intervals) of the MODS Kit were 99.3% (98.3-99.8%), 98.3% (97.5-98.8%), 95.8% (94.0-97.1%), and 99.7% (99.3-99.9%). Median (interquartile ranges) time to culture-positivity (and rifampicin and isoniazid DST) was 10 (9-13) days for conventional MODS and 8.5 (7-11) for MODS Kit (p<0.01). Direct rifampicin and isoniazid DST in MODS kit was almost universally concordant with conventional MODS (97.9% agreement, 665/679 evaluable samples) and reference indirect DST (97.9% agreement, 687/702 evaluable samples). Conclusions: MODS kit delivers performance indistinguishable from conventional MODS and offers a convenient, affordable alternative with enhanced safety from the sealing silicone lid. The availability in the marketplace of this platform, which conforms to European standards (CE-marked), readily repurposed for second-line DST in the near future, provides a fresh opportunity for improving equity of access to TB diagnosis and first and second-line DST in settings where the need is greatest.	[Martin, Laura; Coronel, Jorge; Caviedes, Luz; Grandjean, Louis; Gilman, Robert H.; Moore, David A. J.] Univ Peruana Cayetano Heredia, Lab Invest Enfermedades Infecciosas, Lima, Peru; [Martin, Laura; Grandjean, Louis; Friedland, Jon S.] Univ London Imperial Coll Sci Technol & Med, Wellcome Ctr Clin Trop Med, London, England; [Faulx, Dunia; Valdez, Melissa; Metzler, Mutsumi; Crudder, Chris] PATH, Seattle, WA USA; [Castillo, Edith; Rodriguez, Mitzi] Direcc Reg Salud Callao, Lab Salud Publ, Lima, Peru; [Gilman, Robert H.; Moore, David A. J.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Moore, David A. J.] London Sch Hyg & Trop Med, TB Ctr, London WC1, England; [Moore, David A. J.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England	Universidad Peruana Cayetano Heredia; Imperial College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Martin, L (corresponding author), Univ Peruana Cayetano Heredia, Lab Invest Enfermedades Infecciosas, Lima, Peru.	martin.lauraj@gmail.com		Coronel, Jorge/0000-0002-4580-6716; Friedland, Jonathan S/0000-0001-7789-9649; Grandjean, Louis/0000-0002-1457-8327	Wellcome Trust Fellowship [078067/Z/05/Z]; PATH; MRC [MR/K007467/1] Funding Source: UKRI; Medical Research Council [MR/K007467/1] Funding Source: researchfish	Wellcome Trust Fellowship(Wellcome Trust); PATH; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DM was supported by a Wellcome Trust Fellowship No. 078067/Z/05/Z (http://www.wellcome.ac.uk). PATH provided funding for materials & lab study personnel and were involved in discussions regarding the study designs. They reviewed & contributed to the manuscript but did not have editorial control over the final version (http://www.path.org). Hardy Diagnostics, the manufacturers of the MODS Kit, did not fund the study and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caviedes L, 2000, J CLIN MICROBIOL, V38, P1203, DOI 10.1128/JCM.38.3.1203-1208.2000; Coronel J, 2014, CLIN MICROBIOL INFEC, V20, P536, DOI 10.1111/1469-0691.12401; Fitzwater SP, 2012, EUR RESP J; Grandjean L, 2008, J CLIN MICROBIOL, V46, P2339, DOI 10.1128/JCM.02476-07; Kent PT, 1985, 86216547 CDC; Limaye Kashmira, 2010, Indian J Tuberc, V57, P207; Mauch V, 2010, HEALTH POLICY, V96, P118, DOI 10.1016/j.healthpol.2010.01.003; Minion J, 2010, LANCET INFECT DIS, V10, P688, DOI 10.1016/S1473-3099(10)70165-1; Miotto P, 2006, J CLIN MICROBIOL, V44, P2485, DOI 10.1128/JCM.00083-06; Moore DAJ, 2004, J CLIN MICROBIOL, V42, P4432, DOI 10.1128/JCM.42.10.4432-4437.2004; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Moore DAJ, 2006, DIAGN MICR INFEC DIS, V56, P35, DOI 10.1016/j.diagmicrobio.2006.03.009; Shah NS, 2011, AM J RESP CRIT CARE, V183, P1427, DOI 10.1164/rccm.201009-1449OC; Shiferaw G, 2007, J CLIN MICROBIOL, V45, P1093, DOI 10.1128/JCM.01949-06; Solari Lely, 2011, Rev. perú. med. exp. salud publica, V28, P426; Trollip AP, 2014, INT J TUBERC LUNG D, V18, P227, DOI 10.5588/ijtld.13.0229; World Health Organization, TUB LAB BIOS MAN; World Health Organization, 1998, WHO PUBL, VMSA/MDN/98.2, P55; World Health Organization, GLOB TUB REP 2013	19	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107258	10.1371/journal.pone.0107258	http://dx.doi.org/10.1371/journal.pone.0107258			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225802	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000344317700040
J	Cambridge, G; Moura, RA; Santos, T; Khawaja, AA; Polido-Pereira, J; Canhao, H; Leandro, MJ; Fonseca, JE				Cambridge, Geraldine; Moura, Rita A.; Santos, Tania; Khawaja, Akif A.; Polido-Pereira, Joaquim; Canhao, Helena; Leandro, Maria J.; Fonseca, Joao E.			Expression of the Inherently Autoreactive Idiotope 9G4 on Autoantibodies to Citrullinated Peptides and on Rheumatoid Factors in Patients with Early and Established Rheumatoid Arthritis	PLOS ONE			English	Article							B-CELL SUBPOPULATIONS; V(H)4-21 GENE; ANTIBODIES; IGM; USAGE; MATURATION; REFLECTS; SEGMENT	Background: The pre-symptomatic stage of Rheumatoid arthritis (RA) is associated with pro-inflammatory cytokines and autoantibodies. High levels and epitope spread by Rheumatoid factors (RhF) and autoantibodies to citrullinated proteins signify progression towards disease expression. In established RA, the persistence of high autoantibody levels reflects production by both long-lived plasma cells and short-lived plasmablasts. Neither the relative contributions to pathogenesis by autoantibodies from either source, nor the factors responsible for deciding the fate of autoantigen specific 'parent' B-cells, is understood. Phenotypic markers identifying subsets of autoreactive B-cells are therefore of interest in understanding the origin and perpetuation of the autoimmune response in RA. One such phenotypic marker is the rat monoclonal antibody, 9G4, which recognises an idiotope on immunoglobuins derived from the inherently autoreactive VH-gene, VH4-34. We therefore investigated whether the 9G4 idiotope was expressed on autoantibodies in patients with RA. Methodology/Principal Findings: Sera from 19 patients with established RA and those with <1year history of untreated polyarthritis either resolving into RA (n = 42) or non-RA diagnosis (n = 31) were included. Autoantibodies to cyclic citrullinated peptides (CCP), RhF and co-expression of the 9G4 idiotope were measured by ELISA. 9G4 recognised a population of anti-CCP antibodies in the majority of sera from patients with established disease and also in samples from patients with early disaese. 9G4+RhF levels were generally lower and not associated with positivity for, or levels of 9G4+CCP. Conclusions/Significance: The persistence of 9G4+ immunoglobulins, of any isotype, in serum is rare. We describe here the novel finding of 9G4 expression on anti-CCP antibodies in patients from the earliest symptoms of RA through to established disease. Our results suggest that 9G4 expression on anti-CCP autoantibodies was not due to polyclonal expansion of VH4-34-encoded immunoglobulins. These studies may therefore provide a new focus for investigation into the evolution of the autoimmune response in RA patients.	[Cambridge, Geraldine; Moura, Rita A.; Khawaja, Akif A.; Leandro, Maria J.] UCL, Ctr Rheumatol, London, England; [Moura, Rita A.; Santos, Tania; Polido-Pereira, Joaquim; Canhao, Helena; Fonseca, Joao E.] Univ Lisbon, Fac Med, Inst Mol Med, Rheumatol Res Unit, P-1699 Lisbon, Portugal; [Khawaja, Akif A.] UCL, Ctr Inflammat & Tissue Repair, London, England; [Polido-Pereira, Joaquim; Canhao, Helena; Fonseca, Joao E.] Hosp Santa Maria, Ctr Hosp Lisboa Norte, EPE, Dept Rheumatol, Lisbon, Portugal	University of London; University College London; Universidade de Lisboa; University of London; University College London; Universidade de Lisboa; Hospital Santa Maria	Cambridge, G (corresponding author), UCL, Ctr Rheumatol, London, England.	g.cambridge@ucl.ac.uk	Moura, Rita A./AAI-5024-2020; Cambridge, G/N-3776-2015; Polido-Pereira, Joaquim/AAV-7464-2020; Canhao, Helena/C-9611-2018	Cambridge, G/0000-0002-6022-6322; Canhao, Helena/0000-0003-1894-4870; Moura, Rita A./0000-0002-9685-6924; Polido Pereira, Joaquim/0000-0002-7188-8516; Khawaja, Akif/0000-0003-3267-0482; dos Santos, Tania/0000-0002-4650-0153	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BPD/81936/2011]; Erasmus Programme; Rosetrees Trust [M123-F1] Funding Source: researchfish	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Erasmus Programme; Rosetrees Trust(Rosetrees Trust)	RAM was supported with a fellowship from Fundacao para a Ciencia e a Tecnologia (FCT, SFRH/BPD/81936/2011). TS was supported with a grant from Erasmus Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohnhorst JO, 2001, J IMMUNOL, V167, P3610, DOI 10.4049/jimmunol.167.7.3610; Cambridge G, 2003, ARTHRITIS RHEUM-US, V48, P2146, DOI 10.1002/art.11181; Cambridge G, 2013, J AUTOIMMUN; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; Cappione AJ, 2004, J IMMUNOL, V172, P4298, DOI 10.4049/jimmunol.172.7.4298; Chapman C, 1995, ANN NY ACAD SCI, V764, P195; Chapman CJ, 1996, CLIN EXP IMMUNOL, V105, P360, DOI 10.1046/j.1365-2249.1996.d01-769.x; Dorner T, 2001, ARTHRITIS RHEUM-US, V44, P2715, DOI 10.1002/1529-0131(200112)44:12<2715::AID-ART458>3.0.CO;2-L; Eda S, 2004, J BIOL CHEM, V279, P5967, DOI 10.1074/jbc.M310805200; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; ISENBERG D, 1993, BRIT J RHEUMATOL, V32, P876; Jansen ALMA, 2002, J RHEUMATOL, V29, P2074; Kobie JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035356; KRAJ P, 1995, J IMMUNOL, V154, P6406; Lakos G, 2008, CLIN EXP RHEUMATOL, V26, P253; Locke IC, 1999, CLIN EXP IMMUNOL, V115, P369, DOI 10.1046/j.1365-2249.1999.00809.x; Lundberg K, 2008, ARTHRITIS RHEUM-US, V58, P3009, DOI 10.1002/art.23936; Milner ECB, 2005, SPRINGER SEMIN IMMUN, V26, P433, DOI 10.1007/s00281-004-0188-9; Mockridge CI, 2004, AUTOIMMUNITY, V37, P9, DOI 10.1080/08916930310001624656; Moura RA, 2012, ANN RHEUMATIC DIS, V71; Moura RA, 2013, J RHEUMATOL, V40, P1293, DOI 10.3899/jrheum.121110; Moura RA, 2013, ANN RHEUM DIS, V72, pA34, DOI 10.1136/annrheumdis-2013-203219.13; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; PASCAL V, 1994, SCAND J IMMUNOL, V40, P125; PASCUAL V, 1992, J IMMUNOL, V149, P2337; POTTER KN, 1994, SCAND J IMMUNOL, V40, P43, DOI 10.1111/j.1365-3083.1994.tb03431.x; Pugh-Bernard AE, 2001, J CLIN INVEST, V108, P1061, DOI 10.1172/JCI12462; Rahman A, 1998, SEMIN ARTHRITIS RHEU, V28, P141, DOI 10.1016/S0049-0172(98)80031-0; RANDEN I, 1992, J IMMUNOL, V148, P3296; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; ROUDIER J, 1990, J IMMUNOL, V144, P1526; Samuels J, 2005, J EXP MED, V201, P1659, DOI 10.1084/jem.20042321; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Sokolove J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035296; Suwannalai P, 2012, ARTHRITIS RHEUM-US, V64, P1323, DOI 10.1002/art.33489; van de Stadt LA, 2011, ARTHRITIS RHEUM-US, V63, P3226, DOI 10.1002/art.30537; van der Woude D, 2010, ANN RHEUM DIS, V69, P1110, DOI 10.1136/ard.2009.116384; van Vollenhoven RF, 1999, J RHEUMATOL, V26, P1727; Villeneuve E, 2010, REV BRAS REUMATOL, V50, P484; WEIBLEN BJ, 1990, J IMMUNOL METHODS, V126, P199, DOI 10.1016/0022-1759(90)90151-K; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Young KA, 2013, ARTHRITIS RHEUM-US, V65, P1995, DOI 10.1002/art.38022	43	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107513	10.1371/journal.pone.0107513	http://dx.doi.org/10.1371/journal.pone.0107513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222933	gold, Green Published			2022-12-25	WOS:000341774800078
J	Yang, J; Zheng, M; Chen, SQ; Ou, S; Zhang, J; Wang, N; Cao, YY; Wang, J				Yang, Juan; Zheng, Min; Chen, Shuqun; Ou, Shu; Zhang, Jie; Wang, Ni; Cao, Yingying; Wang, Jian			Knowledge of Thrombolytic Therapy for Acute Ischemic Stroke among Community Residents in Western Urban China	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; AMERICAN-HEART-ASSOCIATION; RISK-FACTORS; MICHIGAN ADULTS; WARNING SIGNS; SYMPTOMS; DELAY; RECOGNITION; POPULATION; EDUCATION	Background and Purpose: Thrombolytic therapy rate for acute ischemic stroke remains low, and improving public awareness of thrombolytic therapy may be helpful to reduce delay and increase chances of thrombolytic therapy. Our purpose was to survey the level of knowledge about thrombolytic therapy for acute ischemic stroke among community residents in Yuzhong district, Chongqing, China. Methods: In 2011, a population-based face-to-face interview survey was conducted in Yuzhong district, Chongqing. A total of 1500 potential participants aged >= 18 years old were selected using a multi-stage sampling method. Results: A total of 1101 participants completed the survey. Only 23.3% (95% CI = 20.8 to 25.8) were aware of thrombolytic therapy for acute ischemic stroke, of whom 59.9% (95% CI = 53.9 to 65.9) knew the time window. Awareness of thrombolytic therapy was higher among young people, those with higher levels of education and household income, those with health insurance, and those who knew all 5 stroke warning signs, while awareness of the time window was higher among those aged 75 years or older. Multivariate logistic regression analysis showed that awareness of thrombolytic therapy was independently associated with age, education level, health insurance and knowledge of stroke warning signs (P<0.05). Conclusions: In this population-based survey the community residents have poor awareness of thrombolytic therapy for acute ischemic stroke.	[Yang, Juan; Wang, Jian] Second Peoples Hosp Chengdu, Dept Neurol, Chengdu, Peoples R China; [Zheng, Min] Chongqing Med Univ, Basic Med Coll, Chongqing, Peoples R China; [Chen, Shuqun] Chongqing Med Univ, Dept Prevent Med, Chongqing, Peoples R China; [Ou, Shu; Zhang, Jie; Wang, Ni; Cao, Yingying] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Wang, J (corresponding author), Second Peoples Hosp Chengdu, Dept Neurol, Chengdu, Peoples R China.	jian.wx@163.com						ALBERTS MJ, 1992, STROKE, V23, P352, DOI 10.1161/01.STR.23.3.352; Anderson BE, 2009, STROKE, V40, P2564, DOI 10.1161/STROKEAHA.108.545988; [Anonymous], WARN SIGNS; Barr J, 2006, NEUROEPIDEMIOLOGY, V26, P168, DOI 10.1159/000091659; BARSAN WG, 1994, STROKE, V25, P2132, DOI 10.1161/01.STR.25.11.2132; Becker KJ, 2001, CEREBROVASC DIS, V11, P34, DOI 10.1159/000047609; Billings-Gagliardi S, 2005, STROKE, V36, P1035, DOI 10.1161/01.STR.0000162716.82295.ac; California Acute Stroke Pilot Registry (CASPR) Investigators, 2005, NEUROLOGY, V64, P654; Chen SY, 2013, NEUROL RES, V35, P522, DOI 10.1179/1743132813Y.0000000203; Chen Z., 2008, 3 NATL SURVEY CAUSE, V1, P14; Deng YZ, 2006, NEUROLOGY, V66, P306, DOI 10.1212/01.wnl.0000196478.77152.fc; Ellis C, 2009, AM J MED SCI, V337, P5, DOI 10.1097/MAJ.0b013e318176abd1; Ferris A, 2005, CIRCULATION, V111, P1321, DOI 10.1161/01.CIR.0000157745.46344.A1; Fussman C, 2010, STROKE, V41, P1501, DOI 10.1161/STROKEAHA.110.578195; Jin HQ, 2012, STROKE, V43, P362, DOI 10.1161/STROKEAHA.111.623512; Jurkowski Janine M, 2008, Prev Chronic Dis, V5, pA41; Kleindorfer D, 2009, STROKE, V40, P2502, DOI 10.1161/STROKEAHA.109.551861; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Morgenstern LB, 2003, ARCH INTERN MED, V163, P2198, DOI 10.1001/archinte.163.18.2198; Morgenstern LB, 2002, STROKE, V33, P160, DOI 10.1161/hs0102.101990; Morgenstern LB, 2001, STROKE, V32, P1360, DOI 10.1161/01.STR.32.6.1360; Moser DK, 2007, J CARDIOVASC NURS, V22, P326, DOI 10.1097/01.JCN.0000278963.28619.4a; Reeves MJ, 2008, CEREBROVASC DIS, V25, P385, DOI 10.1159/000121338; Ritter MA, 2007, NEUROL RES, V29, P476, DOI 10.1179/016164107X163202; Rudd AG, 2011, J NEUROL NEUROSUR PS, V82, P14, DOI 10.1136/jnnp.2009.203174; Schroeder EB, 2000, STROKE, V31, P2591, DOI 10.1161/01.STR.31.11.2591; Sun HX, 2011, NEUROL RES, V33, P536, DOI 10.1179/016164111X13007856084368; Wang YL, 2009, CHINESE J STROKE, V4, P23, DOI DOI 10.3969/J.ISSN.1673-5765.2009.01.005; Williams LS, 1997, STROKE, V28, P912, DOI 10.1161/01.STR.28.5.912; Wojner AW, 2003, AM J CRIT CARE, V12, P411, DOI 10.4037/ajcc2003.12.5.411; Yang J, 2014, J STROKE CEREBROVASC, V23, P1216, DOI 10.1016/j.jstrokecerebrovasdis.2013.10.019; Yang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073578; Yoon SS, 2001, STROKE, V32, P1926, DOI 10.1161/01.STR.32.8.1926	35	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107892	10.1371/journal.pone.0107892	http://dx.doi.org/10.1371/journal.pone.0107892			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222126	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774800098
J	Taylor, AJ; McClure, CD; Shipkowski, KA; Thompson, EA; Hussain, S; Garantziotis, S; Parsons, GN; Bonner, JC				Taylor, Alexia J.; McClure, Christina D.; Shipkowski, Kelly A.; Thompson, Elizabeth A.; Hussain, Salik; Garantziotis, Stavros; Parsons, Gregory N.; Bonner, James C.			Atomic Layer Deposition Coating of Carbon Nanotubes with Aluminum Oxide Alters Pro-Fibrogenic Cytokine Expression by Human Mononuclear Phagocytes In Vitro and Reduces Lung Fibrosis in Mice In Vivo	PLOS ONE			English	Article							CERIUM DIOXIDE NANOPARTICLES; INFLAMMATORY RESPONSES; MURINE MODEL; OSTEOPONTIN; INHALATION; TOXICITY; EXPOSURE; RATS; NANOMATERIALS; FIBROBLASTS	Background: Multi-walled carbon nanotubes (MWCNTs) pose a possible human health risk for lung disease as a result of inhalation exposure. Mice exposed to MWCNTs develop pulmonary fibrosis. Lung macrophages engulf MWCNTs and produce pro-fibrogenic cytokines including interleukin (IL)-1 beta, IL-6, tumor necrosis factor (TNF)-alpha, and osteopontin (OPN). Atomic layer deposition (ALD) is a novel process used to enhance functional properties of MWCNTs, yet the consequence of ALD-modified MWCNTs on macrophage biology and fibrosis is unknown. Methods: The purpose of this study was to determine whether ALD coating with aluminum oxide (Al2O3) would alter the fibrogenic response to MWCNTs and whether cytokine expression in human macrophage/monocytes exposed to MWCNTs in vitro would predict the severity of lung fibrosis in mice. Uncoated (U)-MWCNTs or ALD-coated (A)-MWCNTs were incubated with THP-1 macrophages or human peripheral blood mononuclear cells (PBMC) and cell supernatants assayed for cytokines by ELISA. C57BL6 mice were exposed to a single dose of A- or U-MWCNTs by oropharyngeal aspiration (4 mg/kg) followed by evaluation of histopathology, lung inflammatory cell counts, and cytokine levels at day 1 and 28 post-exposure. Results: ALD coating of MWCNTs with Al2O3 enhanced IL-1 beta secretion by THP-1 and PBMC in vitro, yet reduced protein levels of IL-6, TNF-alpha, and OPN production by THP-1 cells. Moreover, Al2O3 nanoparticles, but not carbon black NPs, increased IL-1 beta but decreased OPN and IL-6 in THP-1 and PBMC. Mice exposed to U-MWCNT had increased levels of all four cytokines assayed and developed pulmonary fibrosis by 28 days, whereas ALD-coating significantly reduced fibrosis and cytokine levels at the mRNA or protein level. Conclusion: These findings indicate that ALD thin film coating of MWCNTs with Al2O3 reduces fibrosis in mice and that in vitro phagocyte expression of IL-6, TNF-alpha, and OPN, but not IL-1 beta, predict MWCNT-induced fibrosis in the lungs of mice in vivo.	[Taylor, Alexia J.; Shipkowski, Kelly A.; Thompson, Elizabeth A.; Bonner, James C.] N Carolina State Univ, Dept Biol Sci, Environm & Mol Toxicol Program, Raleigh, NC 27695 USA; [McClure, Christina D.; Parsons, Gregory N.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA; [Hussain, Salik; Garantziotis, Stavros] NIEHS, Clin Res Unit, Res Triangle Pk, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Bonner, JC (corresponding author), N Carolina State Univ, Dept Biol Sci, Environm & Mol Toxicol Program, Raleigh, NC 27695 USA.	james_bonner@ncsu.edu	Hussain, Salik/AAG-1017-2020; Hussain, Salik/O-1687-2016; Parsons, Gregory N/O-9762-2014; Garantziotis, Stavros/A-6903-2009	Parsons, Gregory N/0000-0002-0048-5859; Garantziotis, Stavros/0000-0003-4007-375X	U.S. Public Health Service Grants; National Institute of Environmental Health Sciences (NIEHS) [R01ES020897, NIEHS RC2-ES018772]; Intramural Research Program of the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020897, RC2ES018772, ZIAES102605] Funding Source: NIH RePORTER	U.S. Public Health Service Grants(United States Department of Health & Human ServicesUnited States Public Health Service); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural Research Program of the NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by U.S. Public Health Service Grants, National Institute of Environmental Health Sciences (NIEHS) R01ES020897 and NIEHS RC2-ES018772 (awarded to JCB), and in part by the Intramural Research Program of the NIEHS (SH, SG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcakova-Dodd A, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-22; Artlett CM, 2013, J PATHOL, V229, P157, DOI 10.1002/path.4116; Bonner JC, 2007, TOXICOL PATHOL, V35, P148, DOI 10.1080/01926230601060009; Bonner JC, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-15; Bonner JC, 2009, HYPERTENSION, V53, P751, DOI 10.1161/HYPERTENSIONAHA.108.122846; Braydich-Stolle LK, 2010, ACS NANO, V4, P3661, DOI 10.1021/nn9016789; Buzea C, 2007, BIOINTERPHASES, V2, pMR17, DOI 10.1116/1.2815690; Cesta MF, 2010, AM J RESP CELL MOL, V43, P142, DOI 10.1165/rcmb.2009-0113OC; Devine CK, 2011, LANGMUIR, V27, P14497, DOI 10.1021/la202677u; Donaldson K, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-5; George SM, 2010, CHEM REV, V110, P111, DOI 10.1021/cr900056b; Girtsman TA, 2014, NANOTOXICOLOGY, V8, P17, DOI 10.3109/17435390.2012.744110; Hamilton RF, 2012, INHAL TOXICOL, V24, P995, DOI 10.3109/08958378.2012.745633; Huizar I, 2011, AM J RESP CELL MOL, V45, P858, DOI 10.1165/rcmb.2010-0401OC; Hull MJ, 2002, HUM PATHOL, V33, P819, DOI 10.1053/hupa.2002.125382; Hussain S, 2012, ACS NANO, V6, P5820, DOI 10.1021/nn302235u; Hussain S, 2012, INT J NANOMED, V7, P1387, DOI 10.2147/IJN.S29429; Hyde GK, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025001; Katwa P, 2012, SMALL, V8, P2904, DOI 10.1002/smll.201200873; Laverny G, 2013, TOXICOL LETT, V217, P91, DOI 10.1016/j.toxlet.2012.12.008; Lee HJ, 2011, NAT NANOTECHNOL, V6, P120, DOI 10.1038/nnano.2010.281; Li HY, 2011, NAT NANOTECHNOL, V6, P645, DOI [10.1038/nnano.2011.153, 10.1038/NNANO.2011.153]; Ma-Hock L, 2009, TOXICOL SCI, V112, P468, DOI 10.1093/toxsci/kfp146; Mangum JB, 2004, EXP LUNG RES, V30, P585, DOI 10.1080/01902140490476346; Marichy C, 2012, ADV MATER, V24, P1017, DOI 10.1002/adma.201104129; Mercer RR, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-21; Muller J, 2005, TOXICOL APPL PHARM, V207, P221, DOI 10.1016/j.taap.2005.01.008; Murphy FA, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-8; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; O'Regan A, 2003, CYTOKINE GROWTH F R, V14, P479, DOI 10.1016/S1359-6101(03)00055-8; Palomaki J, 2011, ACS NANO, V5, P6861, DOI 10.1021/nn200595c; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Park EJ, 2009, TOXICOLOGY, V259, P113, DOI 10.1016/j.tox.2009.02.009; Parsons GN, 2011, MRS BULL, V36, P865, DOI 10.1557/mrs.2011.238; Pass HI, 2005, NEW ENGL J MED, V353, P1564, DOI 10.1056/NEJMoa051185; Pauluhn J, 2010, TOXICOL SCI, V113, P226, DOI 10.1093/toxsci/kfp247; Peng Q, 2007, NANO LETT, V7, P719, DOI 10.1021/nl062948i; Peng Q, 2009, CHEM MATER, V21, P820, DOI 10.1021/cm8020403; Prato M, 2008, ACCOUNTS CHEM RES, V41, P60, DOI 10.1021/ar700089b; Ryman-Rasmussen JP, 2009, NAT NANOTECHNOL, V4, P747, DOI [10.1038/nnano.2009.305, 10.1038/NNANO.2009.305]; Ryman-Rasmussen JP, 2009, AM J RESP CELL MOL, V40, P349, DOI 10.1165/rcmb.2008-0276OC; Sabo-Attwood T, 2011, AM J PATHOL, V178, P1975, DOI 10.1016/j.ajpath.2011.01.048; Singh S, 2008, INT J NANOTECHNOL, V5, P900, DOI 10.1504/IJNT.2008.019826; Sullivan DE, 2005, AM J RESP CELL MOL, V32, P342, DOI 10.1165/rcmb.2004-0288OC; Tsukui T, 2013, AM J PATHOL, V183, P758, DOI 10.1016/j.ajpath.2013.06.005; Wang X, 2011, ACS NANO, V5, P9772, DOI 10.1021/nn2033055; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xia T, 2013, ENVIRON HEALTH PERSP, V121, P683, DOI 10.1289/ehp.1306561	48	36	36	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106870	10.1371/journal.pone.0106870	http://dx.doi.org/10.1371/journal.pone.0106870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216247	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774300028
J	Zhu, J; Yu, AX; Qi, BW; Li, ZH; Hu, X				Zhu, Jin; Yu, Aixi; Qi, Baiwen; Li, Zonghuan; Hu, Xiang			Effects of Negative Pressure Wound Therapy on Mesenchymal Stem Cells Proliferation and Osteogenic Differentiation in a Fibrin Matrix	PLOS ONE			English	Article							VACUUM-ASSISTED CLOSURE; SUBATMOSPHERIC PRESSURE; HYDROSTATIC-PRESSURE; MECHANICAL STRAIN; BONE REGENERATION; STRETCH PROMOTES; VIABILITY; PATHWAYS	Vacuum-assisted closure (VAC) negative pressure wound therapy (NPWT) has been proven to be an effective therapeutic method for the treatment of recalcitrant wounds. However, its role in bone healing remains to be unclear. Here, we investigated the effects of NPWT on rat periosteum-derived mesenchymal stem cells (P-MSCs) proliferation and osteoblastic differentiation in a 3D fibrin matrix. P-MSCs underwent primary culture for three passages before being used to construct cell clots. The fibrin clots were incubated with NPWT under continuous suction at -125 mmHg in a subatmospheric perfusion bioreactor. Clots exposed to atmospheric pressure served as the static control. Compared to the control group, cell proliferation significantly increased in NPWT group after incubation for 3 days. There was no statistical difference in apoptosis rate between two groups. The ALP activity and mineralization of P-MSCs all increased under continuous suction. The expressions of collagen type 1 and transcription factor Cbfa-1 were higher at the 1-, 3-, and 7-day timepoints and the expressions of osteocalcin and integrin beta 5 were higher at the 3-, and 7-day timepoints in the NPWT group. These results indicate that a short time treatment with NPWT, applied with continuous suction at 2125 mmHg, can enhance cellular proliferation of P-MSCs and induce the differentiation toward an osteogenic phenotype. The mechanotransduction molecule integrin beta 5 was found to be highly expressed after NPWT treatment, which indicates that NPWT may play a positive role in fracture healing through enhance bone formation and decrease bone resorption.	[Zhu, Jin; Yu, Aixi; Qi, Baiwen; Li, Zonghuan; Hu, Xiang] Wuhan Univ, Zhongnan Hosp, Dept Microorthoped, Wuhan 430072, Peoples R China	Wuhan University	Yu, AX (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Microorthoped, Wuhan 430072, Peoples R China.	yuaixi666@hotmail.com			National Natural Science Foundation of China [81171713]; Hubei Provience's Outstanding Medical Academic Leader Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Provience's Outstanding Medical Academic Leader Program	This study was supported by the National Natural Science Foundation of China (no. 81171713) and the Hubei Provience's Outstanding Medical Academic Leader Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argenta LC, 1997, ANN PLAS SURG, V38, P563, DOI 10.1097/00000637-199706000-00002; Armstrong DG, 2005, LANCET, V366, P1704, DOI 10.1016/S0140-6736(05)67695-7; Babiak I, 2012, INT WOUND J; Banwell Paul E, 2004, Int Wound J, V1, P95, DOI 10.1111/j.1742-4801.2004.00031.x; Bee TK, 2008, J TRAUMA, V65, P337, DOI 10.1097/TA.0b013e31817fa451; Coudert AE, 2014, LAB INVEST, V94, P275, DOI 10.1038/labinvest.2013.140; Deng K, 2013, MOL MED REP, V8, P468, DOI 10.3892/mmr.2013.1536; DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070; Fleck Tatjana, 2006, Int Wound J, V3, P273, DOI 10.1111/j.1742-481X.2006.00273.x; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Huang CY, 2012, TISSUE ENG PT A, V18, P2106, DOI [10.1089/ten.TEA.2012.0064, 10.1089/ten.tea.2012.0064]; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; Kang MN, 2012, CONNECT TISSUE RES, V53, P149, DOI 10.3109/03008207.2011.619284; Koike M, 2005, J BONE MINER METAB, V23, P219, DOI 10.1007/s00774-004-0587-y; Lane NE, 2005, J BONE MINER RES, V20, P58, DOI 10.1359/JBMR.041017; Liu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090494; Lu F, 2011, ANN PLAS SURG, V66, P296, DOI 10.1097/SAP.0b013e3181ea1e9b; McNulty AK, 2007, WOUND REPAIR REGEN, V15, P838, DOI 10.1111/j.1524-475X.2007.00287.x; Morykwas MJ, 1997, ANN PLAS SURG, V38, P553, DOI 10.1097/00000637-199706000-00001; Morykwas MJ, 2001, ANN PLAS SURG, V47, P547, DOI 10.1097/00000637-200111000-00013; Orgill DP, 2011, PLAST RECONSTR SURG, V127, p105S, DOI 10.1097/PRS.0b013e318200a427; Puetzer J, 2013, TISSUE ENG PT A, V19, P299, DOI [10.1089/ten.tea.2012.0015, 10.1089/ten.TEA.2012.0015]; Rosales-Rocabado JM, 2014, J ORAL MAXIL SURG, V72, DOI 10.1016/j.joms.2013.12.001; Scherer SS, 2008, PLAST RECONSTR SURG, V122, P786, DOI 10.1097/PRS.0b013e31818237ac; Song GB, 2007, COLLOID SURFACE B, V58, P271, DOI 10.1016/j.colsurfb.2007.04.001; Suzuki T, 2014, J ORTHOP SURG-HONG K, V22, P30, DOI 10.1177/230949901402200109; Swain Larry D, 2013, Bonekey Rep, V2, P299, DOI 10.1038/bonekey.2013.33; Takeuchi Naohide, 2011, Fukuoka Acta Medica, V102, P293; Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076; Wang X, 2013, INT ORTHOP, V37, P2491, DOI 10.1007/s00264-013-2059-2; Weed T, 2004, ANN PLAS SURG, V52, P276, DOI 10.1097/01.sap.0000111861.75927.4d; Wilkes RP, 2007, TISSUE ENG, V13, P3003, DOI 10.1089/ten.2007.0036; Wu YQ, 2012, CONNECT TISSUE RES, V53, P451, DOI 10.3109/03008207.2012.702815; Yamazaki S, 2011, J ARTIF ORGANS, V14, P310, DOI 10.1007/s10047-011-0580-x; Yang Z, 2014, MOL MED REP, V9, P1331, DOI 10.3892/mmr.2014.1968; Zhang P, 2012, INT J MOL MED, V29, P1083, DOI 10.3892/ijmm.2012.934; Zhang YG, 2010, CONNECT TISSUE RES, V51, P14, DOI 10.3109/03008200902855891	37	12	13	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107339	10.1371/journal.pone.0107339	http://dx.doi.org/10.1371/journal.pone.0107339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216182	gold, Green Submitted, Green Published			2022-12-25	WOS:000341774300059
J	Billeter, AT; Hellmann, J; Roberts, H; Druen, D; Gardner, SA; Sarojini, H; Galandiuk, S; Chien, SF; Bhatnagar, A; Spite, M; Polk, HC				Billeter, Adrian T.; Hellmann, Jason; Roberts, Henry; Druen, Devin; Gardner, Sarah A.; Sarojini, Harshini; Galandiuk, Susan; Chien, Sufan; Bhatnagar, Aruni; Spite, Matthew; Polk, Hiram C., Jr.			MicroRNA-155 potentiates the inflammatory response in hypothermia by suppressing IL-10 production	FASEB JOURNAL			English	Article						sepsis; peritonitis; cold exposure	RANDOMIZED CLINICAL-TRIAL; TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; THERAPEUTIC HYPOTHERMIA; INTRAOPERATIVE HYPOTHERMIA; PERIOPERATIVE HYPOTHERMIA; DENDRITIC CELLS; WOUND-INFECTION; IN-VIVO; MIR-155	Therapeutic hypothermia is commonly used to improve neurological outcomes in patients after cardiac arrest. However, therapeutic hypothermia increases sepsis risk and unintentional hypothermia in surgical patients increases infectious complications. Nonetheless, the molecular mechanisms by which hypothermia dysregulates innate immunity are incompletely understood. We found that exposure of human monocytes to cold (32 degrees C) potentiated LPS-induced production of TNF and IL-6, while blunting IL-10 production. This dysregulation was associated with increased expression of microRNA-155 (miR-155), which potentiates Toll-like receptor (TLR) signaling by negatively regulating Ship1 and Socs1. Indeed, Ship1 and Socs1 were suppressed at 32 degrees C and miR-155 antagomirs increased Ship1 and Socs1 and reversed the alterations in cytokine production in cold-exposed monocytes. In contrast, miR-155 mimics phenocopied the effects of cold exposure, reducing Ship1 and Socs1 and altering TNF and IL-10 production. In a murine model of LPS-induced peritonitis, cold exposure potentiated hypothermia and decreased survival (10 vs. 50%; P < 0.05), effects that were associated with increased miR-155, suppression of Ship1 and Socs1, and alterations in TNF and IL-10. Importantly, miR-155-deficiency reduced hypothermia and improved survival (78 vs. 32%, P < 0.05), which was associated with increased Ship1, Socs1, and IL-10. These results establish a causal role of miR-155 in the dysregulation of the inflammatory response to hypothermia.	[Billeter, Adrian T.; Roberts, Henry; Druen, Devin; Gardner, Sarah A.; Sarojini, Harshini; Galandiuk, Susan; Chien, Sufan; Polk, Hiram C., Jr.] Univ Louisville, Sch Med, Dept Surg, Price Inst Surg Res, Louisville, KY 40292 USA; [Hellmann, Jason; Bhatnagar, Aruni; Spite, Matthew] Univ Louisville, Sch Med, Diabet & Obes Ctr, Inst Mol Cardiol, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Billeter, AT (corresponding author), Univ Louisville, Sch Med, Dept Surg, Price Inst Surg Res, Louisville, KY 40292 USA.	adrianbilleter@bluewin.ch; mspite@partners.org	Billeter, Adrian/O-2185-2019; Sarojini, Harshini/AAD-4870-2019; Hellmann, Jason/B-9360-2012	Sarojini, Harshini/0000-0002-3103-9712; Billeter, Adrian/0000-0001-8724-4793	Price Trust Fund; Joint Royal College of Surgeons of Edinburgh (RCSEd)/James and Emmeline Ferguson Research Fellowship Trust; U. S. National Institutes of Health [HL-106173, GM-103492, HL-116186]; Joint RCSEd/James and Emmeline Ferguson Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106173, F32HL116186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103492] Funding Source: NIH RePORTER	Price Trust Fund; Joint Royal College of Surgeons of Edinburgh (RCSEd)/James and Emmeline Ferguson Research Fellowship Trust; U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joint RCSEd/James and Emmeline Ferguson Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Donald E. Fry for insight, advice, and productive discussions and Dr. James McCracken for help with the FACS analysis of the peritoneal exudate cells. This work was funded by the Price Trust Fund, by the Joint Royal College of Surgeons of Edinburgh (RCSEd)/James and Emmeline Ferguson Research Fellowship Trust and by U. S. National Institutes of Health grants HL-106173 (to M. S.) and GM-103492 (to M. S. and A. B.). A. T. B. holds the Joint RCSEd/James and Emmeline Ferguson Research Fellowship and currently works at the Department of Surgery at the University of Heidelberg (Heidelberg, Germany). J.H. is the recipient of a National Research Service Award from the U. S. National Institutes of Health (grant HL-116186). The funding sources had no role in the production of the manuscript.	Ahmad FU, 2014, WORLD NEUROSURG, V82, P207, DOI 10.1016/j.wneu.2013.01.008; Ajuebor MN, 1999, J IMMUNOL, V162, P1685; AKRIOTIS V, 1985, J LEUKOCYTE BIOL, V37, P51, DOI 10.1002/jlb.37.1.51; Ariel A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00004; Arons MM, 1999, CRIT CARE MED, V27, P699, DOI 10.1097/00003246-199904000-00020; Arrich J, 2012, COCHRANE DB SYST REV, V4, P9; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Beilman GJ, 2009, ANN SURG, V249, P845, DOI 10.1097/SLA.0b013e3181a41f6f; Billeter AT, 2014, SURGERY, V156, P1245, DOI 10.1016/j.surg.2014.04.024; Billeter AT, 2012, SURGERY, V151, P1, DOI 10.1016/j.surg.2011.08.006; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Brock M, 2014, EUR HEART J, V35, P3203, DOI 10.1093/eurheartj/ehs060; Bukur M, 2012, J SURG RES, V175, P24, DOI 10.1016/j.jss.2011.07.003; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Clark N, 2007, FASEB J, V21, P3747, DOI 10.1096/fj.06-7460com; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; Fairchild KD, 2005, AM J PHYSIOL-CELL PH, V289, pC1114, DOI 10.1152/ajpcell.00152.2005; Fairchild KD, 2004, AM J PHYSIOL-CELL PH, V287, pC422, DOI 10.1152/ajpcell.00507.2003; Fairchild KD, 2000, J INTERF CYTOK RES, V20, P1049, DOI 10.1089/107999000750053708; Fernandes ES, 2012, J IMMUNOL, V188, P5741, DOI 10.4049/jimmunol.1102147; Flores-Maldonado A, 2001, ARCH MED RES, V32, P227, DOI 10.1016/S0188-4409(01)00272-7; Frank SM, 1997, JAMA-J AM MED ASSOC, V277, P1127, DOI 10.1001/jama.277.14.1127; Fries M, 2009, J CRIT CARE, V24, P453, DOI 10.1016/j.jcrc.2008.10.012; Geurts M, 2014, CRIT CARE MED, V42, P231, DOI 10.1097/CCM.0b013e3182a276e8; Goldszmid RS, 2012, IMMUNITY, V36, P1047, DOI 10.1016/j.immuni.2012.03.026; Hammarfjord O, 2010, J LEUKOCYTE BIOL, V88, P747, DOI 10.1189/jlb.0310155; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Inaba K, 2012, J TRAUMA ACUTE CARE, V73, P1478, DOI 10.1097/TA.0b013e3182781db3; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jiang SY, 2013, CRIT CARE, V17, DOI 10.1186/cc12559; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; Li RC, 2013, CIRC RES, V112, P601, DOI 10.1161/CIRCRESAHA.112.300806; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsui T, 2014, NEUROCRIT CARE, V20, P301, DOI 10.1007/s12028-013-9911-5; McCoy CE, 2010, J BIOL CHEM, V285, P20492, DOI 10.1074/jbc.M110.102111; Meybohm P, 2010, CRIT CARE, V14, DOI 10.1186/cc8879; Monk CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013669; Mourvillier B, 2013, JAMA-J AM MED ASSOC, V310, P2174, DOI 10.1001/jama.2013.280506; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Perbet S, 2011, AM J RESP CRIT CARE, V184, P1048, DOI 10.1164/rccm.201102-0331OC; Pu J, 2012, BIOCHEM BIOPH RES CO, V428, P210, DOI 10.1016/j.bbrc.2012.09.126; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Seamon MJ, 2012, ANN SURG, V255, P789, DOI 10.1097/SLA.0b013e31824b7e35; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Tian DH, 2013, ANN CARDIOTHORAC SUR, V2, P148, DOI 10.3978/j.issn.2225-319X.2013.03.13; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Trotta R, 2012, BLOOD, V119, P3478, DOI 10.1182/blood-2011-12-398099; Truettner JS, 2013, BRAIN RES, V1533, P122, DOI 10.1016/j.brainres.2013.08.011; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; van Der Poll Tom, 1997, Clin Microbiol Infect, V3, P605, DOI 10.1111/j.1469-0691.1997.tb00465.x; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Wenisch C, 1996, ANESTH ANALG, V82, P810, DOI 10.1097/00000539-199604000-00023; Xiao HY, 2005, CRIT CARE MED, V33, P161, DOI 10.1097/01.CCM.0000151049.19253.54; Zhu QY, 2010, J IMMUNOL, V185, P7435, DOI 10.4049/jimmunol.1000798	60	40	46	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2014	28	12					5322	5336		10.1096/fj.14-258335	http://dx.doi.org/10.1096/fj.14-258335			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AU9EN	25231976	Green Published			2022-12-25	WOS:000345894500026
J	Zhong, DL; Blount, P				Zhong, Dalian; Blount, Paul			Electrostatics at the membrane define MscL channel mechanosensitivity and kinetics	FASEB JOURNAL			English	Article						protein-lipid interactions; liposome reconstitution; mechanosensation; mechanosensory	PROTEIN-PROTEIN INTERACTIONS; LARGE-CONDUCTANCE MSCL; ESCHERICHIA-COLI; LIPID-INTERFACE; MYCOBACTERIUM-TUBERCULOSIS; GATING MECHANISM; ION-CHANNEL; PRESSURE; DYNAMICS; DOMAINS	The bacterial mechanosensitive channel of large conductance (MscL) serves as a biological emergency release valve, preventing the occurrence of cell lysis caused by acute osmotic stress. Its tractable nature allows it to serve as a paradigm for how a protein can directly sense membrane tension. Although much is known of the importance of the hydrophobicity of specific residues in channel gating, it has remained unclear whether electrostatics at the membrane plays any role. We studied MscL chimeras derived from functionally distinct orthologues: Escherichia coli and Staphylococcus aureus. Dissection of one set led to an observation that changing the charge of a single residue, K101, of E. coli (Ec)-MscL, effects a channel phenotype: when mutated to a negative residue, the channel is less mechanosensitive and has longer open dwell times. Assuming electrostatic interactions, we determined whether they are due to protein-protein or protein-lipid interactions by performing site-directed mutagenesis elsewhere in the protein and reconstituting channels into defined lipids, with and without negative head groups. We found that although both interactions appear to play some role, the primary determinant of the channel phenotype seems to be protein-lipid electrostatics. The data suggest a model for the role of electrostatic interactions in the dynamics of MscL gating.	[Zhong, Dalian] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Ctr Translat Neurodegenerat & Regenerat Therapy, Shanghai 200092, Peoples R China; [Zhong, Dalian; Blount, Paul] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	Tongji University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Blount, P (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	paul.blount@utsouthwestern.edu			Welch Foundation [I-1420]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP100146]; U.S. National Institutes of Health [GM061028]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061028] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); Cancer Prevention and Research Institute of Texas (CPRIT); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Drs. Irene Iscla, Limin Yang, and Hannah Malcolm, as well as Robin Wray and Christina Eaton, for useful discussions and critical reading of the manuscript. The study was funded by grant I-1420 of the Welch Foundation, grant RP100146 from the Cancer Prevention and Research Institute of Texas (CPRIT; http://www.cprit.state.tx.us/), and grant GM061028 from the U.S. National Institutes of Health. The authors declare no conflicts of interest.	Blount P, 1999, Methods Enzymol, V294, P458; BLOUNT P, 1993, REGUL PEPTIDES, V46, P447, DOI 10.1016/0167-0115(93)90115-O; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Blount P, 1996, EMBO J, V15, P4798, DOI 10.1002/j.1460-2075.1996.tb00860.x; Booth IR, 2012, J BACTERIOL, V194, P4802, DOI 10.1128/JB.00576-12; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Innis MA, 1990, PCR PROTOCOLS GUIDE; Iscla I, 2012, CHANNELS, V6, P255, DOI 10.4161/chan.20756; Iscla I, 2012, BIOPHYS J, V103, P169, DOI 10.1016/j.bpj.2012.06.021; Iscla I, 2011, FASEB J, V25, P694, DOI 10.1096/fj.10-170878; Kloda A, 2006, BIOPHYS J, V90, P1992, DOI 10.1529/biophysj.105.075481; Levin G, 2004, BIOPHYS J, V86, P2862, DOI 10.1016/S0006-3495(04)74338-6; Li YZ, 2009, FASEB J, V23, P2197, DOI 10.1096/fj.09-129296; Liu ZF, 2009, NATURE, V461, P120, DOI 10.1038/nature08277; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; Maurer JA, 2003, J BIOL CHEM, V278, P21076, DOI 10.1074/jbc.M302892200; Moe P, 2005, BIOCHEMISTRY-US, V44, P12239, DOI 10.1021/bi0509649; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Perozo E, 2001, J GEN PHYSIOL, V118, P193, DOI 10.1085/jgp.118.2.193; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Poolman B, 2004, BBA-BIOMEMBRANES, V1666, P88, DOI 10.1016/j.bbamem.2004.06.013; Powl AM, 2005, BIOCHEM SOC T, V33, P905, DOI 10.1042/BST0330905; Powl AM, 2005, BIOCHEMISTRY-US, V44, P5873, DOI 10.1021/bi047439e; Powl AM, 2008, BIOCHEMISTRY-US, V47, P4317, DOI 10.1021/bi702409t; Romantsov T, 2009, BBA-BIOMEMBRANES, V1788, P2092, DOI 10.1016/j.bbamem.2009.06.010; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; van der Heide T, 2001, EMBO J, V20, P7022, DOI 10.1093/emboj/20.24.7022; Yang LM, 2013, CELL REP, V3, P520, DOI 10.1016/j.celrep.2013.01.018; Zhong DL, 2014, BIOPHYS J, V106, P375, DOI 10.1016/j.bpj.2013.12.006; Zhong DL, 2013, BIOCHEMISTRY-US, V52, P5415, DOI 10.1021/bi400790j	31	5	5	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2014	28	12					5234	5241		10.1096/fj.14-259309	http://dx.doi.org/10.1096/fj.14-259309			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AU9EN	25223610	Green Published			2022-12-25	WOS:000345894500018
J	Chen, PW; Luo, RB; Jian, XY; Randazzo, PA				Chen, Pei-Wen; Luo, Ruibai; Jian, Xiaoying; Randazzo, Paul A.			The Arf6 GTPase-activating Proteins ARAP2 and ACAP1 Define Distinct Endosomal Compartments That Regulate Integrin alpha 5 beta 1 Traffic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; RECEPTOR TRAFFICKING; ACTIN CYTOSKELETON; SORTING SIGNALS; COPI VESICLES; ADHESION; MEMBRANE; CLATHRIN; PHOSPHORYLATION; ENDOCYTOSIS	Arf6 and the Arf6 GTPase-activating protein (GAP) ACAP1 are established regulators of integrin traffic important to cell adhesion and migration. However, the function of Arf6 with ACAP1 cannot explain the range of Arf6 effects on integrin-based structures. We propose that Arf6 has different functions determined, in part, by the associated Arf GAP. We tested this idea by comparing the Arf6 GAPs ARAP2 and ACAP1. We found that ARAP2 and ACAP1 had opposing effects on apparent integrin beta 1 internalization. ARAP2 knockdown slowed, whereas ACAP1 knockdown accelerated, integrin beta 1 internalization. Integrin beta 1 association with adaptor protein containing a pleckstrin homology (PH) domain, phosphotyrosine-binding (PTB) domain, and leucine zipper motif (APPL)-positive endosomes and EEA1-positive endosomes was affected by ARAP2 knockdown and depended on ARAP2 GAP activity. ARAP2 formed a complex with APPL1 and colocalized with Arf6 and APPL in a compartment distinct from the Arf6/ACAP1 tubular recycling endosome. In addition, although ACAP1 and ARAP2 each colocalized with Arf6, they did not colocalize with each other and had opposing effects on focal adhesions (FAs). ARAP2 overexpression promoted large FAs, but ACAP1 overexpression reduced FAs. Taken together, the data support a model in which Arf6 has at least two sites of opposing action defined by distinct Arf6 GAPs.	[Chen, Pei-Wen; Luo, Ruibai; Jian, Xiaoying; Randazzo, Paul A.] NCI, Cellular & Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Randazzo, PA (corresponding author), NCI, Cellular & Mol Biol Lab, Bldg 37,Rm 2012, Bethesda, MD 20892 USA.	randazzp@mail.nih.gov	Chen, Pei-Wen/B-7142-2015		NCI, National Institutes of Health [BC 007365]; NATIONAL CANCER INSTITUTE [ZIABC007365] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the intramural program of the NCI, National Institutes of Health (Project BC 007365).	Arjonen A, 2012, TRAFFIC, V13, P610, DOI 10.1111/j.1600-0854.2012.01327.x; Bai M, 2012, J BIOL CHEM, V287, P28675, DOI 10.1074/jbc.M112.378810; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Broussard JA, 2012, MOL BIOL CELL, V23, P1486, DOI 10.1091/mbc.E11-02-0124; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Campa F, 2009, J BIOL CHEM, V284, P28069, DOI 10.1074/jbc.M109.028266; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Chaineau M, 2013, TRAFFIC, V14, P1109, DOI 10.1111/tra.12096; Chen PW, 2013, J BIOL CHEM, V288, P5849, DOI 10.1074/jbc.M112.415778; Chen PW, 2010, CELL ADHES MIGR, V4, P527, DOI 10.4161/cam.4.4.12399; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dai J, 2004, DEV CELL, V7, P771, DOI 10.1016/j.devcel.2004.10.002; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Dozynkiewicz MA, 2012, DEV CELL, V22, P131, DOI 10.1016/j.devcel.2011.11.008; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; Goldberg J, 2000, CELL, V100, P671, DOI 10.1016/S0092-8674(00)80703-5; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Ha VL, 2008, ADV CANCER RES, V101, P1, DOI 10.1016/S0065-230X(08)00401-6; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Jackson TR, 2000, J CELL BIOL, V151, P627, DOI 10.1083/jcb.151.3.627; Jacquemet G, 2013, CURR OPIN CELL BIOL, V25, P627, DOI 10.1016/j.ceb.2013.05.008; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935; Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017; Li J, 2005, DEV CELL, V9, P663, DOI 10.1016/j.devcel.2005.09.012; Luo RB, 2007, BIOCHEM J, V402, P439, DOI 10.1042/BJ20061217; Maldonado-Baez Lymarie, 2013, Bioarchitecture, V3, P141, DOI 10.4161/bioa.26638; Maldonado-Baez L, 2013, EXP CELL RES, V319, P2759, DOI 10.1016/j.yexcr.2013.08.008; Maldonado-Baez L, 2013, J CELL BIOL, V201, P233, DOI 10.1083/jcb.201208172; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Moravec R, 2012, J BIOL CHEM, V287, P31138, DOI 10.1074/jbc.M112.383117; Morgan MR, 2013, DEV CELL, V24, P472, DOI 10.1016/j.devcel.2013.01.027; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Raaijmakers JH, 2007, CELL SIGNAL, V19, P1249, DOI 10.1016/j.cellsig.2006.12.015; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Sakurai A, 2011, J BIOL CHEM, V286, P34335, DOI 10.1074/jbc.M111.259499; Sakurai A, 2010, MOL CELL BIOL, V30, P3086, DOI 10.1128/MCB.01652-09; Schuldt A, 2012, NAT REV MOL CELL BIO, V13, P1, DOI 10.1038/nrm3258; Shiba Y, 2013, CURR BIOL, V23, P1945, DOI 10.1016/j.cub.2013.07.087; Teckchandani A, 2009, J CELL BIOL, V186, P98, DOI 10.1083/jcb.200812160; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Valdembri D, 2009, PLOS BIOL, V7, P115, DOI 10.1371/journal.pbio.1000025; Yoon HY, 2006, J CELL SCI, V119, P4650, DOI 10.1242/jcs.03237	47	32	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30237	30248		10.1074/jbc.M114.596155	http://dx.doi.org/10.1074/jbc.M114.596155			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25225293	Green Published, hybrid			2022-12-25	WOS:000344549700008
J	Tsoka-Gwegweni, JM; Okafor, U				Tsoka-Gwegweni, Joyce M.; Okafor, Uchenna			Asymptomatic Malaria in Refugees Living in a Non-Endemic South African City	PLOS ONE			English	Article							PRE-DEPARTURE	Background: Asymptomatic malaria infection in refugees is both a threat to the lives of the individuals and the public in the host country. Although South Africa has been experiencing an unprecedented influx of refugees since 1994, data on malaria infection among refugees is lacking. Such information is critical since South Africa is among the countries that have planned to eliminate malaria. The objective of this study was to determine prevalence of asymptomatic malaria infection among a refugee population living in a city of KwaZulu-Natal province, South Africa. Methods and Findings: A survey was conducted on adult refugee participants who attended a faith-based facility offering social services in a city of KwaZulu-Natal province, South Africa. The participants were screened for the presence of malaria using rapid diagnostic tests and microscopy. Demographic data for the participants were obtained using a closed ended questionnaire. Data was obtained for 303 participants consisting of 51.5% females and 47.5% males, ranging from 19 to 64 years old. More than 95% of them originated from sub-Saharan African countries. Two hundred and ninety participants provided a blood sample for screening of malaria. Of these, 3.8% tested positive for rapid diagnostic test and 5.9% for microscopy. The majority of malaria infections were due to Plasmodium falciparum. Conclusions: The study confirms the presence of asymptomatic malaria infections among a refugee population residing in a city of KwaZulu-Natal province that is not endemic for malaria. The results have important implications for both public health and malaria control in South Africa, particularly since the country has decided to eliminate malaria by 2018. To achieve this goal, South Africa needs to expand research, surveillance and elimination activities to include non-endemic areas, particularly with high refugee populations. We further recommend use of powerful diagnostic tests such as PCR for these interventions.	[Tsoka-Gwegweni, Joyce M.; Okafor, Uchenna] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa	University of Kwazulu Natal	Tsoka-Gwegweni, JM (corresponding author), Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa.	tsokagwegweni@ukzn.ac.za			University of KwaZulu-Natal; College of Health Sciences; FOGARTY INTERNATIONAL CENTER [R24TW008863] Funding Source: NIH RePORTER	University of KwaZulu-Natal; College of Health Sciences; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by the University of KwaZulu-Natal Staff Competitive Grant; College of Health Sciences Strategic Funds; College of Health Sciences Mastes Scholarships. All sources of funding are based at the University of KwaZulu-Natal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Jamie, 2011, Confl Health, V5, P17, DOI 10.1186/1752-1505-5-17; Apalata T, 2007, REFUGEE PERCEPTION T; Dal-Bianco MP, 2007, AM J TROP MED HYG, V77, P939, DOI 10.4269/ajtmh.2007.77.939; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Kaplan C., 2011, MIGRATION VULNERABIL; KZN Department of Economic Development & Tourism, 2013, KWAZULU NAT TOUR MAS; KZN Top Business, 2013, DURB TOUR WARM PLAC; Maharaj R, 2013, SAMJ S AFR MED J, V103, P779, DOI [10.7196/samj.7441, 10.7196/SAMJ.7441]; Maharaj R, 2012, MALARIA J, V11, DOI [10.1186/1475-2875-11-320, 10.1186/1475-2875-11-423]; Matisz CE, 2011, AM J TROP MED HYG, V84, P161, DOI 10.4269/ajtmh.2011.10-0494; Medecins Sans Frontieres, 2011, NOWH ELS GO SURV MIG; Medecins Sans Frontieres, 2010, LIV VULN MIGR S AFR; Monge-Maillo B, 2011, EXPERT REV ANTI-INFE, V9, P521, DOI [10.1586/eri.11.37, 10.1586/ERI.11.37]; Monge-Maillo B, 2009, EMERG INFECT DIS, V15, P1745, DOI 10.3201/eid1511.090718; Moonasar D, 2013, SAMJ S AFR MED J, V103, P801, DOI [10.7196/SAMJ.7445, 10.7196/samj.7445, 10.7196/samj.7533]; Moonasar D, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-294; Ndao M, 2004, J CLIN MICROBIOL, V42, P2694, DOI 10.1128/JCM.42.6.2694-2700.2004; Paxton G, 2013, IMMIGRANT HLTH CLIN; Shandukani B, 2011, PROGR MALARIA ELIMIN; South Africa National Department of Health, 2012, MAL EL STRAT S AFR 2; Statistics South Africa, 2011, CENS 2011; Stauffer WM, 2008, AM J TROP MED HYG, V79, P141, DOI 10.4269/ajtmh.2008.79.141; Stauffer WM, 2006, PEDIAT INFECT DIS J, V25; UNHCR, 2013, UNHCR GLOB APP 2013; *US DEP STAT, 2006, PROP REF ADM GUID FI; US Department of Health and Human Services, 2012, OV REF HLTH GUID MAL; US Department of Health and Human Services, 2012, DOM REF HLTH GUID MA; Wickramage K, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-276; World Health Organization, 2007, MAL EL FIELD MAN LOW; Young MK, 2010, COMMUN DIS INTELL, V34, P37	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107693	10.1371/journal.pone.0107693	http://dx.doi.org/10.1371/journal.pone.0107693			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25237812	Green Submitted, Green Published, gold			2022-12-25	WOS:000342491600043
J	Meraviglia, V; Azzimato, V; Piacentini, L; Chiesa, M; Kesharwani, RK; Frati, C; Capogrossi, MC; Gaetano, C; Pompilio, G; Colombo, GI; Rossini, A				Meraviglia, Viviana; Azzimato, Valerio; Piacentini, Luca; Chiesa, Mattia; Kesharwani, Rupesh K.; Frati, Caterina; Capogrossi, Maurizio C.; Gaetano, Carlo; Pompilio, Giulio; Colombo, Gualtiero I.; Rossini, Alessandra			Syngeneic Cardiac and Bone Marrow Stromal Cells Display Tissue-Specific microRNA Signatures and microRNA Subsets Restricted to Diverse Differentiation Processes	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; TRANSCRIPTIONAL REGULATION; IN-VITRO; EXPRESSION; ROLES; MOUSE; MIRNA; FIBROBLASTS; REVEALS	MicroRNAs are key modulators at molecular level in different biological processes, including determination of cell fate and differentiation. Herein, microRNA expression profiling experiments were performed on syngeneic cardiac (CStC) and bone marrow (BMStC) mesenchymal stromal cells cultured in standard growth medium and then in vitro exposed to adipogenic, osteogenic, cardiomyogenic and endothelial differentiation media. Analysis identified a tissue-specific microRNA signature composed of 16 microRNAs that univocally discriminated cell type of origin and that were completely unaffected by in vitro differentiation media: 4 microRNAs were over-expressed in cardiac stromal cells, and 12 were overexpressed or present only in bone marrow stromal cells. Further, results revealed microRNA subsets specifically modulated by each differentiation medium, irrespective of the cell type of origin, and a subset of 7 microRNAs that were down-regulated by all media with respect to growth medium. Finally, we identified 16 microRNAs that were differentially modulated by the media when comparing the two tissues of origin. The existence of a tissue-specific microRNA signature surviving to any differentiation stimuli, strongly support the role if microRNAs determining cell identity related to tissue origin. Moreover, we identified microRNA subsets modulated by different culture conditions in a tissue-specific manner, pointing out their importance during differentiation processes.	[Meraviglia, Viviana; Azzimato, Valerio; Pompilio, Giulio] Ctr Cardiol Monzino IRCCS, Lab Vasc Biol & Regenerat Med, Milan, Italy; [Meraviglia, Viviana] Med Univ Lubeck, Affiliated Inst, European Acad Bozen Bolzano EURAC, Ctr Biomed, Bolzano, Italy; [Azzimato, Valerio] Univ Milan, Dept Pharmacol Chemotherapy & Med Toxicol, Milan, Italy; [Piacentini, Luca; Chiesa, Mattia; Kesharwani, Rupesh K.; Colombo, Gualtiero I.] Ctr Cardiol Monzino IRCCS, Lab Immunol & Funct Genom, Milan, Italy; [Chiesa, Mattia; Kesharwani, Rupesh K.] Univ Pavia, Dept Elect Comp & Biomed Engn, I-27100 Pavia, Italy; [Frati, Caterina] Univ Parma, Dipartimento Med Interna & Sci Biomed, CISTAC, I-43100 Parma, Italy; [Capogrossi, Maurizio C.] Ist Dermopat Immacolata IRCCS, Lab Vasc Pathol, Rome, Italy; [Gaetano, Carlo] Goethe Univ Frankfurt, Dept Cardiol, Div Cardiovasc Epigenet, D-60054 Frankfurt, Germany; [Pompilio, Giulio; Rossini, Alessandra] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy	IRCCS Centro Cardiologico Monzino; European Academy of Bozen-Bolzano; University of Milan; IRCCS Centro Cardiologico Monzino; University of Pavia; University of Parma; IRCCS Istituto Dermopatico dell'Immacolata (IDI); Goethe University Frankfurt; University of Milan	Colombo, GI (corresponding author), Ctr Cardiol Monzino IRCCS, Lab Immunol & Funct Genom, Milan, Italy.	gualtiero.colombo@ccfm.it; alessandra.rossini@unimi.it	Azzimato, Valerio/AAX-2711-2021; Pompilio, Giulio/J-6701-2014; Gaetano, Carlo/P-9997-2019; Meraviglia, Viviana/J-4823-2016; Colombo, Gualtiero/B-4737-2010; Piacentini, Luca/K-8908-2016	Azzimato, Valerio/0000-0003-4141-961X; Pompilio, Giulio/0000-0003-2581-5735; Gaetano, Carlo/0000-0002-5238-1832; Frati, Caterina/0000-0002-3343-6471; Meraviglia, Viviana/0000-0002-9571-0309; Colombo, Gualtiero/0000-0002-7348-1939; Rossini, Alessandra/0000-0002-0440-1130; Kesharwani, Rupesh/0000-0002-4678-5419; Piacentini, Luca/0000-0003-1022-4481	Italian Ministry of Health [RC 2008]; Italian Ministry of Education, University and Research [FIRB-MIUR RBFR087JMZ_001]	Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	The present study was supported by Italian Ministry of Health (RC 2008) to MCC, and by Italian Ministry of Education, University and Research (FIRB-MIUR RBFR087JMZ_001 to AR and VA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokye-Danso F, 2012, J CELL SCI, V125, P4179, DOI 10.1242/jcs.095968; Baglio SR, 2013, GENE, V527, P321, DOI 10.1016/j.gene.2013.06.021; Bang C, 2012, MICROCIRCULATION, V19, P208, DOI 10.1111/j.1549-8719.2011.00153.x; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Benhamed M, 2012, NAT CELL BIOL, V14, P266, DOI 10.1038/ncb2443; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Cao L, 2012, INT J MOL MED, V30, P1095, DOI 10.3892/ijmm.2012.1092; Chen CY, 2011, J CELL MOL MED, V15, P14, DOI 10.1111/j.1582-4934.2010.01219.x; Chen C, 2014, J MOL ENDOCRINOL, V52, P311, DOI 10.1530/JME-14-0013; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chinchilla A, 2011, CARDIOVASC RES, V89, P98, DOI 10.1093/cvr/cvq264; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Dmitriev P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-265; Ewing P, 2003, J IMMUNOL METHODS, V283, P307, DOI 10.1016/j.jim.2003.08.004; Foley NH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-83; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hazarika S, 2013, CIRCULATION, V127, P1818, DOI 10.1161/CIRCULATIONAHA.112.000860; Heinrich EM, 2012, CIRC RES, V110, P1014, DOI 10.1161/CIRCRESAHA.111.243394; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; John E, 2012, NUCLEIC ACIDS RES, V40, P4446, DOI 10.1093/nar/gks025; Juan LR, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S1-S7; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Ko JY, 2013, BONE, V57, P468, DOI 10.1016/j.bone.2013.09.019; Krishnakumar R, 2013, CURR OPIN GENET DEV, V23, P548, DOI 10.1016/j.gde.2013.06.005; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lamouille S, 2013, CURR OPIN CELL BIOL, V25, P200, DOI 10.1016/j.ceb.2013.01.008; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Liu J, 2011, J CELL MOL MED, V15, P1474, DOI 10.1111/j.1582-4934.2010.01104.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Malizia AP, 2011, WIRES SYST BIOL MED, V3, P183, DOI 10.1002/wsbm.111; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Meraviglia V, 2012, DIFFERENTIATION, V83, P260, DOI 10.1016/j.diff.2012.02.006; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Nam YJ, 2013, NAT MED, V19, P413, DOI 10.1038/nm.3147; Pedrioli DML, 2010, MOL CELL BIOL, V30, P3620, DOI 10.1128/MCB.00185-10; Phinney DG, 2013, CYTOTHERAPY, V15, P140, DOI 10.1016/j.jcyt.2012.11.005; Potus F, 2014, PULM CIRC, V4, P175, DOI 10.1086/675980; Rossini A, 2008, J MOL CELL CARDIOL, V44, P683, DOI 10.1016/j.yjmcc.2008.01.009; Rossini A, 2011, CARDIOVASC RES, V89, P650, DOI 10.1093/cvr/cvq290; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakurai K, 2011, CANCER RES, V71, P1680, DOI 10.1158/0008-5472.CAN-10-2345; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Sharma S, 2012, EMBO MOL MED, V4, P617, DOI 10.1002/emmm.201200234; Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Vecellio M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051694; Wang Y, 2011, BIOMATERIALS, V32, P9207, DOI 10.1016/j.biomaterials.2011.08.058; Wystub K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003793; Xiang XX, 2011, ACTA BIOCH BIOPH SIN, V43, P501, DOI 10.1093/abbs/gmr041; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Younger ST, 2011, MOL BIOSYST, V7, P2383, DOI 10.1039/c1mb05090g; Zaragosi LE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r64; Zhang ZJ, 2012, J CELL BIOCHEM, V113, P888, DOI 10.1002/jcb.23418	62	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107269	10.1371/journal.pone.0107269	http://dx.doi.org/10.1371/journal.pone.0107269			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232725	Green Submitted, gold, Green Published			2022-12-25	WOS:000342921200022
J	Nakayama, K; Inoue, T; Sekiya, S; Terada, N; Miyazaki, Y; Goto, T; Kajihara, S; Kawabata, SI; Iwamoto, S; Ikawa, K; Oosaga, J; Tsuji, H; Tanaka, K; Ogawa, O				Nakayama, Kenji; Inoue, Takahiro; Sekiya, Sadanori; Terada, Naoki; Miyazaki, Yu; Goto, Takayuki; Kajihara, Shigeki; Kawabata, Shin-Ichiro; Iwamoto, Shinichi; Ikawa, Kuniko; Oosaga, Junko; Tsuji, Hiroaki; Tanaka, Koichi; Ogawa, Osamu			The C-Terminal Fragment of Prostate-Specific Antigen, a 2331 Da Peptide, as a New Urinary Pathognomonic Biomarker Candidate for Diagnosing Prostate Cancer	PLOS ONE			English	Article							MASS-SPECTROMETRY; LASER-DESORPTION; SCREENING-TESTS; SYSTEMS BIOLOGY; SERUM; MORTALITY; OVERDIAGNOSIS; PROTEOMICS; DEGRADOMICS; IONIZATION	Background and Objectives: Prostate cancer (PCa) is one of the most common cancers and leading cause of cancer-related deaths in men. Mass screening has been carried out since the 1990s using prostate-specific antigen (PSA) levels in the serum as a PCa biomarker. However, although PSA is an excellent organ-specific marker, it is not a cancer-specific marker. Therefore, the aim of this study was to discover new biomarkers for the diagnosis of PCa. Materials and Methods: We focused on urine samples voided following prostate massage (digital rectal examination [DRE]) and conducted a peptidomic analysis of these samples using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/MSn). Urinary biomaterials were concentrated and desalted using CM-Sepharose prior to the following analyses being performed by MALDI-TOF/MSn: 1) differential analyses of mass spectra; 2) determination of amino acid sequences; and 3) quantitative analyses using a stable isotope-labeled internal standard. Results: Multivariate analysis of the MALDI-TOF/MS mass spectra of urinary extracts revealed a 2331 Da peptide in urine samples following DRE. This peptide was identified as a C-terminal PSA fragment composed of 19 amino acid residues. Moreover, quantitative analysis of the relationship between isotope-labeled synthetic and intact peptides using MALDI-TOF/MS revealed that this peptide may be a new pathognomonic biomarker candidate that can differentiate PCa patients from non-cancer subjects. Conclusion: The results of the present study indicate that the 2331 Da peptide fragment of PSA may become a new pathognomonic biomarker for the diagnosis of PCa. A further large-scale investigation is currently underway to assess the possibility of using this peptide in the early detection of PCa.	[Nakayama, Kenji; Inoue, Takahiro; Terada, Naoki; Miyazaki, Yu; Goto, Takayuki; Ogawa, Osamu] Kyoto Univ, Grad Sch Med, Dept Urol, Sakyo Ku, Kyoto, Japan; [Sekiya, Sadanori; Kajihara, Shigeki; Kawabata, Shin-Ichiro; Iwamoto, Shinichi; Tanaka, Koichi] Shimadzu Co Ltd, Koichi Tanaka Lab Adv Sci & Technol, Nakagyou Ku, Kyoto, Japan; [Ikawa, Kuniko; Oosaga, Junko; Tsuji, Hiroaki] Kyoto Univ Hosp, Dept Clin Lab, Sakyo Ku, Kyoto 606, Japan	Kyoto University; Shimadzu Corporation; Kyoto University	Nakayama, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Urol, Sakyo Ku, Kyoto, Japan.	knakayam@kuhp.kyoto-u.ac.jp	Sekiya, Sadanori/AAT-9089-2021; Terada, Naoki/ABD-2387-2020	Miyazaki, Yu/0000-0003-0949-4812	Japan Society for the Promotion of Science through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"; Council for Science and Technology Policy	Japan Society for the Promotion of Science through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy(Council for Science and Technology Policy (CSTP))	This research was granted by the Japan Society for the Promotion of Science through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)", initiated by the Council for Science and Technology Policy. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Shimadzu Corporation provided support in the form of salaries for authors, Sadanori Sekiya, Shigeki Kajihara, Shin-Ichiro Kawabata, Shinichi Iwamoto and Koichi Tanaka, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	Andrade L, 2003, J VLSI SIG PROC SYST, V35, P229, DOI 10.1023/B:VLSI.0000003022.86639.1f; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Barry MJ, 2001, NEW ENGL J MED, V344, P1373, DOI 10.1056/NEJM200105033441806; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Catalona WJ, 2010, J NATL COMPR CANC NE, V8, P265, DOI 10.6004/jnccn.2010.0017; CATALONA WJ, 1991, NEW ENGL J MED, V324, P1156, DOI 10.1056/NEJM199104253241702; Cauwe B, 2009, INTEGR BIOL-UK, V1, P404, DOI 10.1039/b904701h; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Coombes KR, 2005, PROTEOMICS, V5, P4107, DOI 10.1002/pmic.200401261; Cornu JN, 2013, PROSTATE, V73, P242, DOI 10.1002/pros.22563; Dimitriadis E, 2013, ANTICANCER RES, V33, P191; Doucet A, 2008, MOL ASPECTS MED, V29, P339, DOI 10.1016/j.mam.2008.04.003; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Drake RR, 2009, J PROTEOMICS, V72, P907, DOI 10.1016/j.jprot.2009.01.007; Elgamal AAA, 2000, SEMIN SURG ONCOL, V18, P10, DOI 10.1002/(SICI)1098-2388(200001/02)18:1<10::AID-SSU3>3.3.CO;2-M; Etzioni R, 2002, J NATL CANCER I, V94, P981; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Hamilton RJ, 2009, JNCI-J NATL CANCER I, V101, P611, DOI 10.1093/jnci/djp043; Ilic D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004720.pub3; Ito K, 2009, INT J UROL, V16, P458, DOI 10.1111/j.1442-2042.2009.02293.x; Jeffries N, 2005, BIOINFORMATICS, V21, P3066, DOI 10.1093/bioinformatics/bti482; Kettaneh-Wold N, 2006, MULTI MEGAVARIATE 2; Kirby RS, 2009, BJU INT, V103, P441, DOI 10.1111/j.1464-410X.2008.08280.x; Laurent-Matha V, 2012, FASEB J, V26, P5172, DOI 10.1096/fj.12-205229; Levi F, 2004, INT J CANCER, V110, P155, DOI 10.1002/ijc.20097; Lin K, 2008, ANN INTERN MED, V149, P192, DOI 10.7326/0003-4819-149-3-200808050-00009; Loeb S, 2010, NAT REV UROL, V7, P184, DOI 10.1038/nrurol.2010.41; Marugame T, 2005, JPN J CLIN ONCOL, V35, P690, DOI 10.1093/jjco/hyi185; Mistry K, 2003, J AM BOARD FAM PRACT, V16, P95, DOI 10.3122/jabfm.16.2.95; OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V270, P860, DOI 10.1001/jama.270.7.860; Overall CM, 2006, CANCER METAST REV, V25, P69, DOI 10.1007/s10555-006-7890-0; Pashayan N, 2006, BRIT J CANCER, V95, P401, DOI 10.1038/sj.bjc.6603246; Ramirez ML, 2008, PROSTATE CANCER P D, V11, P216, DOI 10.1038/pcan.2008.2; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Rogers CG, 2004, J UROLOGY, V172, P1501, DOI 10.1097/01.ju.0000137659.53129.14; Roobol MJ, 2007, PROSTATE, V67, P439, DOI 10.1002/pros.20545; Schiffer E, 2007, WORLD J UROL, V25, P557, DOI 10.1007/s00345-007-0203-6; Shibata A, 1998, J NATL CANCER I, V90, P1230, DOI 10.1093/jnci/90.16.1230; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sogawa K, 2011, CLIN CHIM ACTA, V412, P1094, DOI 10.1016/j.cca.2011.02.029; Somasundaram K, 2009, EXPERT REV MOL DIAGN, V9, P695, DOI 10.1586/ERM.09.52; St John Jason, 2012, J Cancer Sci Ther, V4, P94; Stephan C, 2007, EUR J CANCER, V43, P1918, DOI 10.1016/j.ejca.2007.06.006; Tanase CP, 2010, ADV CLIN CHEM, V51, P145, DOI 10.1016/S0065-2423(10)51006-0; Thompson Ian M, 2008, J Natl Cancer Inst, V100, P1487, DOI 10.1093/jnci/djn368; Tyan YC, 2013, CLIN CHIM ACTA, V420, P99, DOI 10.1016/j.cca.2012.10.014; Whelan LC, 2008, J CELL MOL MED, V12, P1535, DOI 10.1111/j.1582-4934.2008.00250.x; Xu DM, 2008, MOL CELL PROTEOMICS, V7, P2215, DOI 10.1074/mcp.M800095-MCP200	48	8	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107234	10.1371/journal.pone.0107234	http://dx.doi.org/10.1371/journal.pone.0107234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233230	gold, Green Published, Green Submitted			2022-12-25	WOS:000342921200019
J	Sabir, JSM; Yu, MJ; Ashworth, MP; Baeshen, NA; Baeshen, MN; Bahieldin, A; Theriot, EC; Jansen, RK				Sabir, Jamal S. M.; Yu, Mengjie; Ashworth, Matt P.; Baeshen, Nabih A.; Baeshen, Mohammad N.; Bahieldin, Ahmed; Theriot, Edward C.; Jansen, Robert K.			Conserved Gene Order and Expanded Inverted Repeats Characterize Plastid Genomes of Thalassiosirales	PLOS ONE			English	Article							CHLOROPLAST GENOMES; DIATOM; MARINE; EVOLUTION; PSEUDONANA; SEQUENCE; REVEALS; WATERS; VELVET; SIZE	Diatoms are mostly photosynthetic eukaryotes within the heterokont lineage. Variable plastid genome sizes and extensive genome rearrangements have been observed across the diatom phylogeny, but little is known about plastid genome evolution within order-or family-level clades. The Thalassiosirales is one of the more comprehensively studied orders in terms of both genetics and morphology. Seven complete diatom plastid genomes are reported here including four Thalassiosirales: Thalassiosira weissflogii, Roundia cardiophora, Cyclotella sp. WC03_2, Cyclotella sp. L04_2, and three additional non-Thalassiosirales species Chaetoceros simplex, Cerataulina daemon, and Rhizosolenia imbricata. The sizes of the seven genomes vary from 116,459 to 129,498 bp, and their genomes are compact and lack introns. The larger size of the plastid genomes of Thalassiosirales compared to other diatoms is due primarily to expansion of the inverted repeat. Gene content within Thalassiosirales is more conserved compared to other diatom lineages. Gene order within Thalassiosirales is highly conserved except for the extensive genome rearrangement in Thalassiosira oceanica. Cyclotella nana, Thalassiosira weissflogii and Roundia cardiophora share an identical gene order, which is inferred to be the ancestral order for the Thalassiosirales, differing from that of the other two Cyclotella species by a single inversion. The genes ilvB and ilvH are missing in all six diatom plastid genomes except for Cerataulina daemon, suggesting an independent gain of these genes in this species. The acpP1 gene is missing in all Thalassiosirales, suggesting that its loss may be a synapomorphy for the order and this gene may have been functionally transferred to the nucleus. Three genes involved in photosynthesis, psaE, psaI, psaM, are missing in Rhizosolenia imbricata, which represents the first documented instance of the loss of photosynthetic genes in diatom plastid genomes.	[Sabir, Jamal S. M.; Baeshen, Nabih A.; Baeshen, Mohammad N.; Bahieldin, Ahmed; Jansen, Robert K.] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Jeddah, Saudi Arabia; [Yu, Mengjie; Ashworth, Matt P.; Theriot, Edward C.; Jansen, Robert K.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	King Abdulaziz University; University of Texas System; University of Texas Austin	Yu, MJ (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	annaymj_2010@utexas.edu	Baeshen, Mohammed Nabih/I-4398-2012; bahieldin, ahmed/I-9186-2012; Sabir, Jamal S M/C-8102-2014	Baeshen, Mohammed Nabih/0000-0002-0235-5222; Bahieldin, Ahmed/0000-0002-6496-7881	King Abdulaziz University (KAU)	King Abdulaziz University (KAU)	The authors gratefully acknowledge the financial support from King Abdulaziz University (KAU) Vice President for Educational Affairs Prof. Dr. Abdulrahman O. Alyoubi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverson AJ, 2007, MOL PHYLOGENET EVOL, V45, P193, DOI 10.1016/j.ympev.2007.03.024; Alverson AJ, 2007, LIMNOL OCEANOGR, V52, P1420, DOI 10.4319/lo.2007.52.4.1420; Alverson AJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-125; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Ashworth J, 2013, P NATL ACAD SCI USA, V110, P7518, DOI 10.1073/pnas.1300962110; BALDAUF SL, 1990, NATURE, V344, P262, DOI 10.1038/344262a0; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Brembu T, 2013, MAR GENOM, V21; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Eugene, 2010, DIATOMS APPL ENV EAR, P8; Evans KM, 2004, J PHYCOL, V40, P911, DOI 10.1111/j.1529-8817.2004.04027.x; Galachyants YP, 2012, INT J BIOL, V4, P27, DOI DOI 10.5539/IJB.V4N1P27; Gockel G, 2000, PROTIST, V151, P347, DOI 10.1078/S1434-4610(04)70033-4; Goulding SE, 1996, MOL GEN GENET, V252, P195, DOI 10.1007/BF02173220; Green BR, 2011, PLANT J, V66, P34, DOI 10.1111/j.1365-313X.2011.04541.x; Gruber A, 2007, PLANT MOL BIOL, V64, P519, DOI 10.1007/s11103-007-9171-x; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Huesgen PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074483; Interlandi SJ, 1998, WATER SCI TECHNOL, V38, P139, DOI 10.1016/S0273-1223(98)00743-4; Janouskovec J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059001; Jansen R. K., 2012, GENOMICS CHLOROPLAST, P103, DOI [10.1007/978-94-007-2920-9, DOI 10.1007/978-94-007-2920-9_5]; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kowallik KV, 1995, PLANT MOL BIOL REP, V13, P336, DOI 10.1007/BF02669188; Lohse M, 2013, NUCLEIC ACIDS RES, V41, P22; Lommer M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-718; Madhu NV, 2013, INDIAN J GEO-MAR SCI, V42, P453; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Nakov T, 2014, LIMNOL OCEANOGR, V59, P79, DOI 10.4319/lo.2014.59.1.0079; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Oudot-Le Secq MP, 2007, MOL GENET GENOMICS, V277, P427, DOI 10.1007/s00438-006-0199-4; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; ROUND FE, 1984, PROC R SOC SER B-BIO, V221, P169, DOI 10.1098/rspb.1984.0029; Ruck EC, 2014, GENOME BIOL EVOL, V6, P644, DOI 10.1093/gbe/evu039; Rumpho ME, 2008, P NATL ACAD SCI USA, V105, P17867, DOI 10.1073/pnas.0804968105; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tanaka T, 2011, PHOTOSYNTH RES, V109, P223, DOI 10.1007/s11120-011-9622-8; Tesler G, 2002, BIOINFORMATICS, V18, P492, DOI 10.1093/bioinformatics/18.3.492; Theriot EC, 2011, DIATOM WORLD, P600; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; VILLAREAL TA, 1990, MAR ECOL-P S Z N I, V11, P117, DOI 10.1111/j.1439-0485.1990.tb00233.x; Vivarest CP, 2002, CURR OPIN MICROBIOL, V5, P499, DOI 10.1016/S1369-5274(02)00356-9; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008407	47	26	26	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107854	10.1371/journal.pone.0107854	http://dx.doi.org/10.1371/journal.pone.0107854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233465	Green Submitted, Green Published, gold			2022-12-25	WOS:000342921200055
J	Moore, DR; Edmondson-Jones, M; Dawes, P; Fortnum, H; McCormack, A; Pierzycki, RH; Munro, KJ				Moore, David R.; Edmondson-Jones, Mark; Dawes, Piers; Fortnum, Heather; McCormack, Abby; Pierzycki, Robert H.; Munro, Kevin J.			Relation between Speech-in-Noise Threshold, Hearing Loss and Cognition from 40-69 Years of Age	PLOS ONE			English	Article							RECEPTION THRESHOLD; INDIVIDUAL-DIFFERENCES; SCREENING-TEST; IMPAIRMENT; POPULATION; EPIDEMIOLOGY; PREVALENCE; VALIDATION; ACCURACY; ADULTS	Background: Healthy hearing depends on sensitive ears and adequate brain processing. Essential aspects of both hearing and cognition decline with advancing age, but it is largely unknown how one influences the other. The current standard measure of hearing, the pure-tone audiogram is not very cognitively demanding and does not predict well the most important yet challenging use of hearing, listening to speech in noisy environments. We analysed data from UK Biobank that asked 40-69 year olds about their hearing, and assessed their ability on tests of speech-in-noise hearing and cognition. Methods and Findings: About half a million volunteers were recruited through NHS registers. Respondents completed 'whole-body' testing in purpose-designed, community-based test centres across the UK. Objective hearing (spoken digit recognition in noise) and cognitive (reasoning, memory, processing speed) data were analysed using logistic and multiple regression methods. Speech hearing in noise declined exponentially with age for both sexes from about 50 years, differing from previous audiogram data that showed a more linear decline from <40 years for men, and consistently less hearing loss for women. The decline in speech-in-noise hearing was especially dramatic among those with lower cognitive scores. Decreasing cognitive ability and increasing age were both independently associated with decreasing ability to hear speech-in-noise (0.70 and 0.89 dB, respectively) among the population studied. Men subjectively reported up to 60% higher rates of difficulty hearing than women. Workplace noise history associated with difficulty in both subjective hearing and objective speech hearing in noise. Leisure noise history was associated with subjective, but not with objective difficulty hearing. Conclusions: Older people have declining cognitive processing ability associated with reduced ability to hear speech in noise, measured by recognition of recorded spoken digits. Subjective reports of hearing difficulty generally show a higher prevalence than objective measures, suggesting that current objective methods could be extended further.	[Moore, David R.; Edmondson-Jones, Mark; Fortnum, Heather; McCormack, Abby; Pierzycki, Robert H.] NIHR Nottingham Hearing Biomed Res Unit, Nottingham, England; [Moore, David R.; McCormack, Abby] Inst Hearing Res, MRC, Nottingham, England; [Moore, David R.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Moore, David R.] Univ Cincinnati, Coll Med, Dept Otolaryngol, Cincinnati, OH USA; [Edmondson-Jones, Mark; Fortnum, Heather; McCormack, Abby; Pierzycki, Robert H.] Univ Nottingham, Sch Med, Otol & Hearing Grp, Div Clin Neurosci, Nottingham, England; [Dawes, Piers; Munro, Kevin J.] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Munro, Kevin J.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Nottingham; University of Manchester; University of Manchester	Moore, DR (corresponding author), NIHR Nottingham Hearing Biomed Res Unit, Nottingham, England.	david.moore2@cchmc.org	munro, kevin j/A-2899-2015; Pierzycki, Robert H./D-4750-2016	munro, kevin j/0000-0001-6543-9098; Pierzycki, Robert H./0000-0003-4471-0699; Hunter, Abby/0000-0002-6533-6918; Dawes, Piers/0000-0003-3180-9884	Intramural Programme of the Medical Research Council [U135097130]; Cincinnati Children's Hospital; National Institute for Health Research; National Institute for Health Research (NIHR); Medical Research Council [MC_U135097130, MC_qA137853] Funding Source: researchfish; MRC [MC_U135097130] Funding Source: UKRI	Intramural Programme of the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cincinnati Children's Hospital; National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DRM was supported by the Intramural Programme of the Medical Research Council [Grant U135097130] and by Cincinnati Children's Hospital. The Nottingham Hearing Biomedical Research Unit is funded by the National Institute for Health Research. This paper presents independent research funded in part by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. This research was facilitated by the NIHR Manchester Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd M, 2008, INT J AUDIOL, V47, pS53, DOI 10.1080/14992020802301142; Allen N, 2012, HEALTH POLICY TECHN, V1, P123, DOI 10.1016/j.hlpt.2012.07.003; [Anonymous], 1988, J Acoust Soc Am, V83, P859; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; BERGMAN M, 1971, AUDIOLOGY, V10, P164; Bronkhorst AW, 2000, ACUSTICA, V86, P117; Brungart DS, 2014, J ACOUST SO IN PRESS; Chia EM, 2007, EAR HEARING, V28, P187, DOI 10.1097/AUD.0b013e31803126b6; CLARK K, 1991, AM J EPIDEMIOL, V134, P704, DOI 10.1093/oxfordjournals.aje.a116147; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Davis A, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11420; Davis AC, 1995, HEARING IN ADULTS; Dawes P, HEARING LOS IN PRESS; Dawes P, 2014, OPHTHAL PHYSL OPT, V34, P479, DOI 10.1111/opo.12138; Dawes P, 2014, JARO-J ASSOC RES OTO, V15, P663, DOI 10.1007/s10162-014-0461-0; Dawes P, 2014, EAR HEARING, V35, pE44, DOI 10.1097/AUD.0000000000000010; Dobreva MS, 2011, J NEUROPHYSIOL, V105, P2471, DOI 10.1152/jn.00951.2010; Dubno JR, 2013, JARO-J ASSOC RES OTO, V14, P687, DOI 10.1007/s10162-013-0396-x; Gershon R, 2012, NIH TOOLBOX NORMING; Gordon-Salant S, 2009, AGING AUDITORY SYSTE; Hoffman HJ, 2010, EAR HEARING, V31, P725, DOI 10.1097/AUD.0b013e3181e9770e; Houtgast T, 2008, INT J AUDIOL, V47, P287, DOI 10.1080/14992020802127109; Humes LE, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00055; Humes LE, 2013, ATTEN PERCEPT PSYCHO, V75, P508, DOI 10.3758/s13414-012-0406-9; Jansen S, 2013, EAR HEARING, V34, P773, DOI 10.1097/AUD.0b013e318297920b; JOHNSON EW, 1970, LARYNGOSCOPE, V80, P49, DOI 10.1288/00005537-197001000-00005; Killion MC, 2004, J ACOUST SOC AM, V116, P2395, DOI 10.1121/1.1784440; Leensen MCJ, 2011, INT J AUDIOL, V50, P835, DOI 10.3109/14992027.2011.595017; Makary CA, 2011, JARO-J ASSOC RES OTO, V12, P711, DOI 10.1007/s10162-011-0283-2; McCormack A, 2014, J PSYCHOSOM RES, V76, P56, DOI 10.1016/j.jpsychores.2013.08.018; Moore DR, 2010, PEDIATRICS, V126, pE382, DOI 10.1542/peds.2009-2826; Moore DR, 2012, J HEAR SCI, V2, P58; Neisser U., 1967, COGNITIVE PSYCHOL; Nondahl DM, 1998, AUDIOLOGY, V37, P295; PICHORAFULLER MK, 1995, J ACOUST SOC AM, V97, P593, DOI 10.1121/1.412282; PLOMP R, 1979, J ACOUST SOC AM, V66, P1333, DOI 10.1121/1.383554; PLOMP R, 1986, J SPEECH HEAR RES, V29, P146, DOI 10.1044/jshr.2902.146; RABBITT P, 1993, Q J EXP PSYCHOL-A, V46, P385, DOI 10.1080/14640749308401055; Ronnberg J, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00031; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; ROSENHALL U, 1987, SCAND AUDIOL, V16, P211, DOI 10.3109/01050398709074943; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Sergeyenko Y, 2013, J NEUROSCI, V33, P13686, DOI 10.1523/JNEUROSCI.1783-13.2013; Sindhusake D, 2001, INT J EPIDEMIOL, V30, P1371, DOI 10.1093/ije/30.6.1371; Smits C, 2005, EAR HEARING, V26, P89, DOI 10.1097/00003446-200502000-00008; Smits C, 2004, INT J AUDIOL, V43, P15, DOI 10.1080/14992020400050004; Smits C, 2013, J ACOUST SOC AM, V133, P1693, DOI 10.1121/1.4789933; Sorqvist P, 2012, J COGNITIVE NEUROSCI, V24, P2147; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; Vermiglio AJ, 2012, J AM ACAD AUDIOL, V23, P779, DOI 10.3766/jaaa.23.10.4; Vlaming MSMG, 2014, EAR HEAR, V35; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wilson DH, 1999, INT J EPIDEMIOL, V28, P247, DOI 10.1093/ije/28.2.247; Zhan WH, 2010, AM J EPIDEMIOL, V171, P260, DOI 10.1093/aje/kwp370; ZWISLOCKI J, 1958, J ACOUST SOC AM, V30, P254, DOI 10.1121/1.1909559	55	123	127	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107720	10.1371/journal.pone.0107720	http://dx.doi.org/10.1371/journal.pone.0107720			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229622	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900067
J	Sobczynski, DJ; Charoenphol, P; Heslinga, MJ; Onyskiw, PJ; Namdee, K; Thompson, AJ; Eniola-Adefeso, O				Sobczynski, Daniel J.; Charoenphol, Phapanin; Heslinga, Michael J.; Onyskiw, Peter J.; Namdee, Katawut; Thompson, Alex J.; Eniola-Adefeso, Omolola			Plasma Protein Corona Modulates the Vascular Wall Interaction of Drug Carriers in a Material and Donor Specific Manner	PLOS ONE			English	Article							PEG CHAIN-LENGTH; HUMAN BLOOD-FLOW; TARGETING THERAPEUTICS; MARGINATION PROPENSITY; CANCER-CELLS; NANOPARTICLES; PARTICLES; DELIVERY; SURFACE; NANOMATERIALS	The nanoscale plasma protein interaction with intravenously injected particulate carrier systems is known to modulate their organ distribution and clearance from the bloodstream. However, the role of this plasma protein interaction in prescribing the adhesion of carriers to the vascular wall remains relatively unknown. Here, we show that the adhesion of vascular-targeted poly(lactide-co-glycolic-acid) (PLGA) spheres to endothelial cells is significantly inhibited in human blood flow, with up to 90% reduction in adhesion observed relative to adhesion in simple buffer flow, depending on the particle size and the magnitude and pattern of blood flow. This reduced PLGA adhesion in blood flow is linked to the adsorption of certain high molecular weight plasma proteins on PLGA and is donor specific, where large reductions in particle adhesion in blood flow (> 80% relative to buffer) is seen with similar to 60% of unique donor bloods while others exhibit moderate to no reductions. The depletion of high molecular weight immunoglobulins from plasma is shown to successfully restore PLGA vascular wall adhesion. The observed plasma protein effect on PLGA is likely due to material characteristics since the effect is not replicated with polystyrene or silica spheres. These particles effectively adhere to the endothelium at a higher level in blood over buffer flow. Overall, understanding how distinct plasma proteins modulate the vascular wall interaction of vascular-targeted carriers of different material characteristics would allow for the design of highly functional delivery vehicles for the treatment of many serious human diseases.	[Sobczynski, Daniel J.; Charoenphol, Phapanin; Heslinga, Michael J.; Onyskiw, Peter J.; Thompson, Alex J.; Eniola-Adefeso, Omolola] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Namdee, Katawut; Eniola-Adefeso, Omolola] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Eniola-Adefeso, O (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	lolaa@umich.edu		Thompson, Alex/0000-0002-2670-4626; Namdee, Katawut/0000-0003-3763-9388; Charoenphol, Phapanin/0000-0003-1328-9344	National Institutes of Health (NIH) Cellular Biotechnology Training grant at the University of Michigan; NIH [R01 (HL115138)]; STFC [ST/J001465/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008353] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Cellular Biotechnology Training grant at the University of Michigan; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) Cellular Biotechnology Training grant at the University of Michigan to D.J.S. and a NIH R01 (HL115138) grant to O.E.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2004, FASEB J, V18, P152, DOI 10.1096/fj.03-0346fje; Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Boutry S, 2006, CONTRAST MEDIA MOL I, V1, P15, DOI 10.1002/cmmi.87; Burns AR, 1997, J IMMUNOL, V159, P2893; Caracciolo G, 2013, ACS APPL MATER INTER, V5, P13171, DOI 10.1021/am404171h; Charoenphol P, 2012, J BIOMECH, V45, P2822, DOI 10.1016/j.jbiomech.2012.08.035; Charoenphol P, 2011, ATHEROSCLEROSIS, V217, P364, DOI 10.1016/j.atherosclerosis.2011.04.016; Charoenphol P, 2010, BIOMATERIALS, V31, P1392, DOI 10.1016/j.biomaterials.2009.11.007; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Decuzzi P, 2005, ANN BIOMED ENG, V33, P179, DOI 10.1007/s10439-005-8976-5; Deng ZJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/45/455101; Eniola AO, 2005, BIOMATERIALS, V26, P7136, DOI 10.1016/j.biomaterials.2005.05.005; Eniola AO, 2005, BIOMATERIALS, V26, P661, DOI 10.1016/j.biomaterials.2004.03.003; Fillafer C, 2009, LAB CHIP, V9, P2782, DOI 10.1039/b906006e; Fleischer CC, 2013, BIOMATER SCI-UK, V1, P975, DOI 10.1039/c3bm60121h; Galimard A, 2012, SMALL, V8, P2036, DOI 10.1002/smll.201102356; Gref R, 2000, COLLOID SURFACE B, V18, P301, DOI 10.1016/S0927-7765(99)00156-3; Hajitou A, 2006, TRENDS CARDIOVAS MED, V16, P80, DOI 10.1016/j.tcm.2006.01.003; Heslinga MJ, 2009, J CONTROL RELEASE, V138, P235, DOI 10.1016/j.jconrel.2009.05.020; Huang RB, 2013, BIOTECHNOL BIOENG, V110, P999, DOI 10.1002/bit.24746; Huang RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031874; Kittler S, 2010, J MATER CHEM, V20, P512, DOI 10.1039/b914875b; Kona S, 2012, INT J PHARMACEUT, V423, P516, DOI 10.1016/j.ijpharm.2011.11.043; Kuo SC, 1997, BIOPHYS J, V73, P517, DOI 10.1016/S0006-3495(97)78090-1; Lee SY, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/49/495101; Lee SY, 2009, J BIOMECH, V42, P1885, DOI 10.1016/j.jbiomech.2009.05.012; Lee TR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02079; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Medina SH, 2013, ADV HEALTHC MATER, V2, P1337, DOI 10.1002/adhm.201200406; Mirshafiee V, 2013, CHEM COMMUN, V49, P2557, DOI 10.1039/c3cc37307j; Mortimer GM, 2014, ACS NANO, V8, P3357, DOI 10.1021/nn405830g; Muro S, 2006, J PHARMACOL EXP THER, V317, P1161, DOI 10.1124/jpet.105.098970; Namdee K, 2013, LANGMUIR, V29, P2530, DOI 10.1021/la304746p; Onyskiw PJ, 2013, LANGMUIR, V29, P11127, DOI 10.1021/la402182j; Pozzi D, 2014, NANOSCALE, V6, P2782, DOI 10.1039/c3nr05559k; Safi M, 2011, BIOMATERIALS, V32, P9353, DOI 10.1016/j.biomaterials.2011.08.048; Sah H, 2013, INT J NANOMED, V8, P747, DOI 10.2147/IJN.S40579; Salvati A, 2013, NAT NANOTECHNOL, V8, P137, DOI [10.1038/nnano.2012.237, 10.1038/NNANO.2012.237]; Schwendeman SP, 2014, J CONTROL RELEASE; Sempf K, 2013, EUR J PHARM BIOPHARM, V85, P53, DOI 10.1016/j.ejpb.2012.11.030; Tenzer S, 2011, ACS NANO, V5, P7155, DOI 10.1021/nn201950e; Thompson AJ, 2013, BIOMATERIALS, V34, P5863, DOI 10.1016/j.biomaterials.2013.04.011; Unger RE, 2002, MICROVASC RES, V64, P384, DOI 10.1006/mvre.2002.2434; Van Langendonckt A, 2008, MOL HUM REPROD, V14, P259, DOI 10.1093/molehr/gan019; Walkey CD, 2012, CHEM SOC REV, V41, P2780, DOI 10.1039/c1cs15233e; WATTS PJ, 1990, CRIT REV THER DRUG, V7, P235; Xu H, 2013, J CARDIOVASC TRANSL, V6, P570, DOI 10.1007/s12265-013-9460-5; Yan Y, 2013, ACS NANO, V7, P10960, DOI 10.1021/nn404481f; Yovita H, 2004, Acta Med Indones, V36, P197; Zhang Wandong, 2002, Current Drug Targets - Inflammation and Allergy, V1, P151, DOI 10.2174/1568010023344689	50	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107408	10.1371/journal.pone.0107408	http://dx.doi.org/10.1371/journal.pone.0107408			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229244	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900039
J	Gao, HJ; Wu, XR; Simon, L; Fossett, N				Gao, Hongjuan; Wu, Xiaorong; Simon, LaTonya; Fossett, Nancy			Antioxidants Maintain E-Cadherin Levels to Limit Drosophila Prohemocyte Differentiation	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; TO-MESENCHYMAL TRANSITION; POLYCOMB GROUP PROTEINS; SELF-RENEWAL; OXIDATIVE STRESS; LYMPH-GLAND; HYDROGEN-PEROXIDE; NADPH OXIDASE; DUAL ROLE; EXPRESSION	Mitochondrial reactive oxygen species (ROS) regulate a variety of biological processes by networking with signal transduction pathways to maintain homeostasis and support adaptation to stress. In this capacity, ROS have been shown to promote the differentiation of progenitor cells, including mammalian embryonic and hematopoietic stem cells and Drosophila hematopoietic progenitors (prohemocytes). However, many questions remain about how ROS alter the regulatory machinery to promote progenitor differentiation. Here, we provide evidence for the hypothesis that ROS reduce E-cadherin levels to promote Drosophila prohemocyte differentiation. Specifically, we show that knockdown of the antioxidants, Superoxide dismutatase 2 and Catalase reduce E-cadherin protein levels prior to the loss of Odd-skipped-expressing prohemocytes. Additionally, over-expression of E-cadherin limits prohemocyte differentiation resulting from paraquat-induced oxidative stress. Furthermore, two established targets of ROS, Enhancer of Polycomb and FOS, control the level of E-cadherin protein expression. Finally, we show that knockdown of either Superoxide dismutatase 2 or Catalase leads to an increase in the E-cadherin repressor, Serpent. As a result, antioxidants and targets of ROS can control E-cadherin protein levels, and over-expression of E-cadherin can ameliorate the prohemocyte response to oxidative stress. Collectively, these data strongly suggest that ROS promote differentiation by reducing E-cadherin levels. In mammalian systems, ROS promote embryonic stem cell differentiation, whereas E-cadherin blocks differentiation. However, it is not known if elevated ROS reduce E-cadherin to promote embryonic stem cell differentiation. Thus, our findings may have identified an important mechanism by which ROS promote stem/progenitor cell differentiation.	[Gao, Hongjuan; Wu, Xiaorong; Fossett, Nancy] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Gao, Hongjuan; Wu, Xiaorong; Fossett, Nancy] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Simon, LaTonya] Univ Maryland Baltimore Cty, Dept Chem & Biochem Engn, Baltimore, MD 21228 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore County	Fossett, N (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA.	nfossett@som.umaryland.edu			National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK 07229]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072229] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, NIDDK 07229 (NF), www.niddk.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afouda BA, 2008, DEVELOPMENT, V135, P3185, DOI 10.1242/dev.026443; Agaisse Herve, 2004, Immunol Rev, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Barnett P, 2011, BIOCHEM BIOPH RES CO, V404, P34, DOI 10.1016/j.bbrc.2010.11.044; Baud O, 2004, J NEUROSCI, V24, P1531, DOI 10.1523/JNEUROSCI.3989-03.2004; Benmimoun B, 2012, DEVELOPMENT, V139, P1713, DOI 10.1242/dev.080259; Bohrer LR, 2010, ENDOCRINOLOGY, V151, P5136, DOI 10.1210/en.2010-0436; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Budovskaya YV, 2008, CELL, V134, P291, DOI 10.1016/j.cell.2008.05.044; Cadenas S, 2010, CARDIOVASC RES, V88, P219, DOI 10.1093/cvr/cvq256; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456; Cocheme HM, 2009, METHOD ENZYMOL, V456, P395, DOI 10.1016/S0076-6879(08)04422-4; DeGennaro M, 2011, DEV CELL, V20, P233, DOI 10.1016/j.devcel.2010.12.007; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Fossett N, 2003, P NATL ACAD SCI USA, V100, P11451, DOI 10.1073/pnas.1635050100; Fossett N, 2001, DIFFERENTIATION, V69, P83, DOI 10.1046/j.1432-0436.2001.690202.x; Fossett N, 2001, TRENDS CARDIOVAS MED, V11, P185, DOI 10.1016/S1050-1738(01)00092-5; Fossett N, 2001, P NATL ACAD SCI USA, V98, P7342, DOI 10.1073/pnas.131215798; Fossett N, 2013, BBA-GEN SUBJECTS, V1830, P2375, DOI 10.1016/j.bbagen.2012.06.005; Frandsen Joel L., 2008, Proceedings of the National Academy of Sciences of the United States of America, V105, P14952, DOI 10.1073/pnas.0808208105; Frelin C, 2013, NAT IMMUNOL, V14, P1037, DOI 10.1038/ni.2692; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Fukawa T, 2012, EXP CELL RES, V318, P1926, DOI 10.1016/j.yexcr.2012.05.023; Gao H, 2011, J GENETICS DEV; Gao HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074684; Gao HJ, 2009, MOL CELL BIOL, V29, P6086, DOI 10.1128/MCB.00244-09; Ghaffari S, 2008, ANTIOXID REDOX SIGN, V10, P1923, DOI 10.1089/ars.2008.2142; Goitre L, 2012, J SIGNAL TRANSDUCT, V2012, DOI DOI 10.1155/2012/807682; Gorowiec MR, 2012, FREE RADICAL BIO MED, V52, P1024, DOI 10.1016/j.freeradbiomed.2011.12.020; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Harris TJC, 2012, INT REV CEL MOL BIO, V293, P45, DOI 10.1016/B978-0-12-394304-0.00007-5; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Herranz H, 2001, DEVELOPMENT, V128, P4837; Hole PS, 2011, BLOOD, V117, P5816, DOI 10.1182/blood-2011-01-326025; Holz A, 2003, DEVELOPMENT, V130, P4955, DOI 10.1242/dev.00702; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Ji AR, 2010, EXP MOL MED, V42, P175, DOI 10.3858/emm.2010.42.3.018; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Kalyanaraman B, 2013, REDOX BIOL, V1, P244, DOI 10.1016/j.redox.2013.01.014; Kane NM, 2011, PHARMACOL THERAPEUT, V129, P29, DOI 10.1016/j.pharmthera.2010.10.004; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kim YM, 2014, CELL SIGNAL, V26, P784, DOI 10.1016/j.cellsig.2013.12.005; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Kurucz E, 2007, ACTA BIOL HUNG, V58, P95, DOI 10.1556/ABiol.58.2007.Suppl.8; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lee N, 2005, NATURE, V438, P234, DOI 10.1038/nature04120; Li L, 2010, STEM CELLS, V28, P247, DOI 10.1002/stem.289; Lim SO, 2008, GASTROENTEROLOGY, V135, P2128, DOI 10.1053/j.gastro.2008.07.027; Lyle AN, 2014, J BIOL CHEM, V289, P275, DOI 10.1074/jbc.M113.489641; Mandal L, 2004, NAT GENET, V36, P1019, DOI 10.1038/ng1404; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Manoli I, 2007, TRENDS ENDOCRIN MET, V18, P190, DOI 10.1016/j.tem.2007.04.004; Martinez-Agosto JA, 2007, GENE DEV, V21, P3044, DOI 10.1101/gad.1602607; Mejlvang J, 2007, EXP CELL RES, V313, P380, DOI 10.1016/j.yexcr.2006.10.017; Milton VJ, 2011, P NATL ACAD SCI USA, V108, P17521, DOI 10.1073/pnas.1014511108; Minakhina S, 2010, DEVELOPMENT, V137, P27, DOI 10.1242/dev.043943; Mohamet L, 2011, J ONCOL, V2011, DOI 10.1155/2011/352616; Mondal BC, 2011, CELL, V147, P1589, DOI 10.1016/j.cell.2011.11.041; Morceau F, 2004, ANN NY ACAD SCI, V1030, P537, DOI 10.1196/annals.1329.064; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; Muratoglu S, 2007, DEV BIOL, V311, P636, DOI 10.1016/j.ydbio.2007.08.015; Muratoglu S, 2006, DEV BIOL, V296, P561, DOI 10.1016/j.ydbio.2006.04.455; Murray TVA, 2013, J BIOL CHEM, V288, P15745, DOI 10.1074/jbc.M112.439844; Nakano M, 2005, GENES CELLS, V10, P47, DOI 10.1111/j.1365-2443.2005.00814.x; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Parmar H, 2005, BREAST, V14, P256, DOI 10.1016/j.breast.2005.02.004; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Redmer T, 2011, EMBO REP, V12, P720, DOI 10.1038/embor.2011.88; Rehorn KP, 1996, DEVELOPMENT, V122, P4023; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Sardina JL, 2012, CRIT REV ONCOL HEMAT, V81, P257, DOI 10.1016/j.critrevonc.2011.03.005; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shim J, 2012, NAT CELL BIOL, V14, P394, DOI 10.1038/ncb2453; Shimizu R, 2004, BLOOD, V103, P2560, DOI 10.1182/blood-2003-07-2514; Sinenko SA, 2012, EMBO REP, V13, P83, DOI 10.1038/embor.2011.223; Sinenko SA, 2009, DEV CELL, V16, P756, DOI 10.1016/j.devcel.2009.03.003; Small C, 2014, GENETICS, V197, P471, DOI 10.1534/genetics.113.159210; Soncin F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021463; Soncin F, 2009, STEM CELLS, V27, P2069, DOI 10.1002/stem.134; Sorrentino RP, 2005, SEMIN CELL DEV BIOL, V16, P107, DOI 10.1016/j.semcdb.2004.10.005; Sorrentino RP, 2002, DEV BIOL, V243, P65, DOI 10.1006/dbio.2001.0542; Spencer H, 2011, METHODS MOL BIOL, V690, P81, DOI 10.1007/978-1-60761-962-8_5; Taneyhill LA, 2008, CELL ADHES MIGR, V2, P223, DOI 10.4161/cam.2.4.6835; Tokusumi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006429; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P2517, DOI [10.1089/ars.2009.2582, 10.1089/ARS.2009.2582]; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Varum S, 2009, STEM CELL RES, V3, P142, DOI 10.1016/j.scr.2009.07.002; Waltzer L, 2002, EMBO J, V21, P5477, DOI 10.1093/emboj/cdf545; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Ward EJ, 2000, DEVELOPMENT, V127, P4959; Wei JY, 2013, CELL SIGNAL, V25, P2788, DOI 10.1016/j.cellsig.2013.09.009; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005; Xu X, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003108; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Yoshida T, 2013, NAT IMMUNOL, V14, P1032, DOI 10.1038/ni.2715; Zhang LA, 2010, FEBS LETT, V584, P4646, DOI 10.1016/j.febslet.2010.10.038; Zhou ST, 2012, CANCER LETT, V318, P14, DOI 10.1016/j.canlet.2011.10.038	108	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107768	10.1371/journal.pone.0107768	http://dx.doi.org/10.1371/journal.pone.0107768			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226030	gold, Green Published, Green Submitted			2022-12-25	WOS:000344317700082
J	Ma, C; Wu, GY; Wang, ZL; Wang, PH; Wu, LM; Zhu, GX; Zhao, HQ				Ma, Chuan; Wu, Gaoyi; Wang, Zhaoling; Wang, Peihuan; Wu, Longmei; Zhu, Guoxiong; Zhao, Huaqiang			Effects of Chronic Sleep Deprivation on the Extracellular Signal-Regulated Kinase Pathway in the Temporomandibular Joint of Rats	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MATRIX-METALLOPROTEINASE (MMP)-1; MULTIPLE PLATFORM METHOD; PARADOXICAL SLEEP; INTERNAL DERANGEMENT; GENE-EXPRESSION; SYNOVIAL-FLUID; PAIN PATIENTS; FACIAL-PAIN; DISORDER	Objectives: To examine the possible involvement and regulatory mechanisms of extracellular signal-regulated kinase (ERK) pathway in the temporomandibular joint (TMJ) of rats subjected to chronic sleep deprivation (CSD). Methods: Rats were subjected to CSD using the modified multiple platform method (MMPM). The serum levels of corticosterone (CORT) and adrenocorticotropic hormone (ACTH) were tested and histomorphology and ultrastructure of the TMJ were observed. The ERK and phospho-ERK (p-ERK) expression levels were detected by Western blot analysis, and the MMP-1, MMP-3, and MMP-13 expression levels were detected by real-time quantitative polymerase chain reaction (PCR) and Western blotting. Results: The elevated serum CORT and ACTH levels confirmed that the rats were under CSD stress. Hematoxylin and eosin (HE) staining and scanning electron microscopy (SEM) showed pathological alterations in the TMJ following CSD; furthermore, the p-ERK was activated and the mRNA and protein expression levels of MMP-1, MMP-3, and MMP-13 were upregulated after CSD. In the rats administered with the selective ERK inhibitor U0126, decreased tissue destruction was observed. Phospho-ERK activation was visibly blocked and the MMP-1, MMP-3, and MMP-13 mRNA and protein levels were lower than the corresponding levels in the CSD without U0126 group. Conclusion: These findings indicate that CSD activates the ERK pathway and upregulates the MMP-1, MMP-3, and MMP-13 mRNA and protein levels in the TMJ of rats. Thus, CSD induces ERK pathway activation and causes pathological alterations in the TMJ. ERK may be associated with TMJ destruction by promoting the expression of MMPs.	[Ma, Chuan; Wu, Gaoyi; Wang, Zhaoling; Wang, Peihuan; Zhu, Guoxiong] Jinan Mil Gen Hosp, Dept Stomatol, Jinan City, Shandong Provin, Peoples R China; [Ma, Chuan; Zhao, Huaqiang] Shandong Univ, Coll Stomatol, Jinan City, Shandong, Peoples R China; [Ma, Chuan; Zhao, Huaqiang] Shandong Prov Key Lab Oral Biomed, Jinan City, Shandong Provin, Peoples R China; [Wu, Longmei] He Bei Med Univ, Shijiazhuang, Hebei Province, Peoples R China	Shandong University	Zhao, HQ (corresponding author), Shandong Univ, Coll Stomatol, Jinan City, Shandong, Peoples R China.	huaqiang_zh@163.com	wu, gaoyi/E-2154-2015					Andersen ML, 2005, J SLEEP RES, V14, P83, DOI 10.1111/j.1365-2869.2004.00428.x; Auerbach SM, 2001, J ORAL MAXIL SURG, V59, P628, DOI 10.1053/joms.2001.23371; Brauchle M, 2000, EXP CELL RES, V258, P135, DOI 10.1006/excr.2000.4913; Buenaver LF, 2012, PAIN, V153, P1159, DOI 10.1016/j.pain.2012.01.023; Chen J, 2009, OSTEOARTHR CARTILAGE, V17, P354, DOI 10.1016/j.joca.2008.05.021; Chen J, 2013, BR J ORAL MAXILLOFAC; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Dhillon AS, 2002, ARCH BIOCHEM BIOPHYS, V404, P3, DOI 10.1016/S0003-9861(02)00244-8; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Firestein GS, 1999, ARTHRITIS RHEUM-US, V42, P609, DOI 10.1002/1529-0131(199904)42:4<609::AID-ANR3>3.0.CO;2-I; Ge XP, 2009, ARTHRITIS RHEUM-US, V60, P2714, DOI 10.1002/art.24779; HARNESS DM, 1990, CLIN J PAIN, V6, P4, DOI 10.1097/00002508-199003000-00003; Kubota E, 1998, J ORAL MAXIL SURG, V56, P192, DOI 10.1016/S0278-2391(98)90868-0; Lai WC, 2003, J IMMUNOL, V170, P6244, DOI 10.4049/jimmunol.170.12.6244; Landesberg R, 1999, ARCH ORAL BIOL, V44, P41, DOI 10.1016/S0003-9969(98)00091-0; LeResche L, 1997, PAIN, V69, P153, DOI 10.1016/S0304-3959(96)03230-7; LeResche L, 2007, PAIN, V129, P269, DOI 10.1016/j.pain.2006.10.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machado RB, 2006, BRAIN RES BULL, V70, P213, DOI 10.1016/j.brainresbull.2006.04.001; Mengshol JA, 2001, NUCLEIC ACIDS RES, V29, P4361, DOI 10.1093/nar/29.21.4361; Ohno S, 2005, J DENT RES, V84, P1005, DOI 10.1177/154405910508401107; Park CH, 2004, J INVEST DERMATOL, V123, P1012, DOI 10.1111/j.0022-202X.2004.23487.x; Pelletier JP, 2003, ARTHRITIS RHEUM-US, V48, P1582, DOI 10.1002/art.11014; Reunanen N, 2002, J BIOL CHEM, V277, P32360, DOI 10.1074/jbc.M204296200; Riley JL, 2001, CRANIO, V19, P106, DOI 10.1080/08869634.2001.11746159; Rollman G B, 2000, Curr Rev Pain, V4, P71; Rosales VP, 2002, EUR J ORTHODONT, V24, P107, DOI 10.1093/ejo/24.1.107; Schett G, 2000, ARTHRITIS RHEUM, V43, P2501, DOI 10.1002/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K; Shim YJ, 2011, J LEUKOCYTE BIOL, V90, P761, DOI 10.1189/jlb.0311110; Singh A, 2008, METHOD FIND EXP CLIN, V30, P681, DOI [10.1358/mf.2008.30.9.1323493, 10.1358/mf.2008.30.9.1186076]; Slade GD, 2007, J DENT RES, V86, P1120, DOI 10.1177/154405910708601119; Smith MT, 2009, SLEEP, V32, P779, DOI 10.1093/sleep/32.6.779; Srinivas R, 2001, ORAL SURG ORAL MED O, V91, P517, DOI 10.1067/moe.2001.115136; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Suchecki D, 2000, BRAIN RES, V875, P14, DOI 10.1016/S0006-8993(00)02531-2; Suchecki D, 2000, PHYSIOL BEHAV, V68, P309, DOI 10.1016/S0031-9384(99)00181-X; Tolwinski NS, 1999, J BIOL CHEM, V274, P6168, DOI 10.1074/jbc.274.10.6168; Wang YL, 2008, BRIT J ORAL MAX SURG, V46, P192, DOI 10.1016/j.bjoms.2007.10.007; Wattanachai T, 2009, ANGLE ORTHOD, V79, P652, DOI 10.2319/080808-417.1; Wu GY, 2011, ORAL SURG ORAL MED O, V112, pE106, DOI 10.1016/j.tripleo.2011.06.005; Wu Gaoyi, J ORAL MAXI IN PRESS; Yatani H, 2002, J OROFAC PAIN, V16, P221	42	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107544	10.1371/journal.pone.0107544	http://dx.doi.org/10.1371/journal.pone.0107544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226519	Green Submitted, Green Published, gold			2022-12-25	WOS:000344317700062
J	Mickiene, A; Pakalniene, J; Nordgren, J; Carlsson, B; Hagbom, M; Svensson, L; Lindquist, L				Mickiene, Aukse; Pakalniene, Jolita; Nordgren, Johan; Carlsson, Beatrice; Hagbom, Marie; Svensson, Lennart; Lindquist, Lars			Polymorphisms in Chemokine Receptor 5 and Toll-Like Receptor 3 Genes Are Risk Factors for Clinical Tick-Borne Encephalitis in the Lithuanian Population	PLOS ONE			English	Article							NILE-VIRUS-INFECTION; SINGLE NUCLEOTIDE POLYMORPHISM; TICKBORNE ENCEPHALITIS; HUMAN PREDISPOSITION; IMMUNE-RESPONSES; DISEASE; ASSOCIATION; DEFICIENCY; REGION; BRAIN	Background: Tick-borne encephalitis virus (TBEV) infections can be asymptomatic or cause moderate to severe injuries of the nervous system. We previously reported that a nonfunctional chemokine receptor 5 (CCR5) and a functional Toll-like receptor 3 (TLR3) predispose adults to clinical tick-borne encephalitis (TBE). This study expands our previous findings and further examines polymorphisms in CCR5 and TLR3 genes in different age and disease severity groups. Methods: 117 children and 129 adults, stratified into mild, moderate and severe forms of TBE, and 103 adults with severe TBE were analyzed. 135 healthy individuals and 79 patients with aseptic meningoencephalitis served as controls. CCR5 delta 32 and rs3775291 TLR3 genotypes were established by pyrosequencing, and their frequencies were analyzed using recessive genetic, genotype and allelic models. Findings: The prevalence of CCR5 Delta 32 homozygotes was higher in children (2.5%), in adults with severe TBE (1.9%), and in the combined cohort of TBE patients (2.3%) than in controls (0%) (p<0.05). The nonfunctional homozygous TLR3 genotype was less prevalent among the combined TBE cohort (11.5%) than among controls (19.9%) (p = 0.025), but did not differ between children TBE and controls. The genotype and allele prevalence of CCR5 and TLR3 did not differ in children nor adult TBE cohorts stratified by disease severity. However, in the severe adult TBE cohort, homozygous functional TLR3 genotype and wt allele were less prevalent compared to the adult cohort with the whole disease severity spectrum (44.4% vs 59.8% p = 0.022 and 65.2% vs 76.4% p = 0.009; respectively). Conclusions: Independently of age, nonfunctional CCR5D32 mutation is a significant risk factor for development of clinical TBE, but not for disease severity. The polymorphism of TLR3 gene predisposes to clinical TBE in adults only and may be associated with disease severity. Further studies are needed to clarify the role of these polymorphisms in susceptibility to TBEV infection.	[Mickiene, Aukse; Pakalniene, Jolita] Lithuanian Univ Hlth Sci, Dept Infect Dis, Kaunas, Lithuania; [Mickiene, Aukse; Lindquist, Lars] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, Infect Dis Unit, Stockholm, Sweden; [Nordgren, Johan; Carlsson, Beatrice; Hagbom, Marie; Svensson, Lennart] Linkoping Univ, Fac Med, Div Mol Virol, Linkoping, Sweden; [Svensson, Lennart] Linkoping Univ Hosp, Dept Clin Microbiol, S-58185 Linkoping, Sweden	Lithuanian University of Health Sciences; Karolinska Institutet; Karolinska University Hospital; Linkoping University; Linkoping University	Mickiene, A (corresponding author), Lithuanian Univ Hlth Sci, Dept Infect Dis, Kaunas, Lithuania.	aukse.mickiene@lsmuni.lt	svensson, lennart/K-6163-2019	Pakalniene, Jolita/0000-0002-3252-3901; Hagbom, Marie/0000-0002-9770-4623	Research Council of Lithuania [MIP-11174]; Swedish Research Council [3485]	Research Council of Lithuania(Research Council of Lithuania (LMTLT)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	AM and JP received the research grant from Research Council of Lithuania (grant number MIP-11174) URL: http://www.lmt.lt/en/about.html. LS received grant from Swedish Research Council (grant No: 3485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnez M, 2009, EXPERT REV ANTI-INFE, V7, P1251, DOI 10.1586/ERI.09.99; Barkhash AV, 2013, ANTIVIR RES, V99, P136, DOI 10.1016/j.antiviral.2013.05.008; Barkhash AV, 2012, ANTIVIR RES, V93, P64, DOI 10.1016/j.antiviral.2011.10.017; Barkhash AV, 2010, J INFECT DIS, V202, P1813, DOI 10.1086/657418; Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08; Dhiman N, 2008, VACCINE, V26, P1731, DOI 10.1016/j.vaccine.2008.01.017; Gelpi E, 2005, J NEUROPATH EXP NEUR, V64, P506, DOI 10.1093/jnen/64.6.506; Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Gorbea C, 2010, J BIOL CHEM, V285, P23206, DOI 10.1074/jbc.M109.047464; Gunther G, 1997, J NEUROL, V244, P230, DOI 10.1007/s004150050077; Hayasaka D., 2011, FLAVIVIRUS ENCEPHALI, P157; Hayasaka D, 2009, VIROLOGY, V390, P139, DOI 10.1016/j.virol.2009.04.026; HOFMANN H, 1983, ZBL BAKT-INT J MED M, V255, P448; Kindberg E, 2008, J INFECT DIS, V197, P266, DOI 10.1086/524709; Kindberg E, 2011, J INFECT DIS, V203, P523, DOI 10.1093/infdis/jiq082; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Monique L, 2006, J MOL NEUROSCI, V29, P185, DOI 10.1385/JMN/29:03:185; Lee SO, 2013, TRANSPL INFECT DIS, V15, P111, DOI 10.1111/tid.12033; Lim JK, 2008, J INFECT DIS, V197, P262, DOI 10.1086/524691; Lim JK, 2010, J INFECT DIS, V201, P178, DOI 10.1086/649426; Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4; Lindquist L, 2008, ACTA PAEDIATR, V97, P532, DOI 10.1111/j.1651-2227.2008.00761.x; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Luat Le Xuan, 2014, Trop Med Health, V42, P15, DOI 10.2149/tmh.2013-27; Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0; Mickiene A, 2002, CLIN INFECT DIS, V35, P650, DOI 10.1086/342059; Mickiene A, 2005, PROGRESS IN ENCEPHALITIS RESEARCH, P1; O'Dwyer DN, 2013, AM J RESP CRIT CARE, V188, P1442, DOI 10.1164/rccm.201304-0760OC; Palus M, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-77; Robertson SJ, 2009, IMMUNOL RES, V43, P172, DOI 10.1007/s12026-008-8065-6; Ruzek D, 2009, VIROLOGY, V384, P1, DOI 10.1016/j.virol.2008.11.023; Suss J, 2011, TICKS TICK-BORNE DIS, V2, P2, DOI 10.1016/j.ttbdis.2010.10.007; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Wong MM, 2003, SEMIN IMMUNOL, V15, P5, DOI 10.1016/S1044-5323(02)00123-9	36	47	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e106798	10.1371/journal.pone.0106798	http://dx.doi.org/10.1371/journal.pone.0106798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226020	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700018
J	Paina, C; Byrne, SL; Domnisoru, C; Asp, T				Paina, Cristiana; Byrne, Stephen L.; Domnisoru, Cristian; Asp, Torben			Vernalization Mediated Changes in the Lolium perenne Transcriptome	PLOS ONE			English	Article							FLOWERING-LOCUS-T; CLOCK-ASSOCIATED GENES; QUANTITATIVE RT-PCR; RNA-SEQ DATA; CIRCADIAN CLOCK; LOW-TEMPERATURE; FREEZING TOLERANCE; ARABIDOPSIS-THALIANA; COLD-ACCLIMATION; STRESS TOLERANCE	Vernalization is a key requirement for the induction of flowering in perennial ryegrass (Lolium perenne L.). The transcriptome of two genotypes with contrasting vernalization requirement was studied during primary (vernalization and short day conditions) and secondary induction (higher temperature and long day conditions) using an RNA-Seq approach. This revealed transcripts with expression profiles indicative of a role in floral induction, both in the promotion and repression of flowering. We observed similarities and specific differences between the two genotypes related to cold response, carbohydrate metabolism, and photoperiod regulation. Components of the photoperiod pathway showed regulation during vernalization, pointing to possible interactions between elements of the photoperiod and vernalization pathways. The results provide a global picture of the processes ongoing during the transition from vegetative to reproductive phase of perennial ryegrass genotypes with and without a vernalization requirement.	[Paina, Cristiana; Byrne, Stephen L.; Asp, Torben] Aarhus Univ, Dept Mol Biol & Genet, Slagelse, Denmark; [Domnisoru, Cristian] k4C Consulting, Eden Prairie, MN USA	Aarhus University	Asp, T (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Slagelse, Denmark.	Torben.Asp@agrsci.dk	Byrne, Stephen/L-3572-2019	Byrne, Stephen/0000-0002-1179-2272; Paina, Cristiana/0000-0001-7124-1280	Ministry of Food, Agriculture and Fisheries of Denmark [703, 3304-FVFP-09-B-002]	Ministry of Food, Agriculture and Fisheries of Denmark	This study was supported by the Ministry of Food, Agriculture and Fisheries of Denmark 703 (grant number 3304-FVFP-09-B-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamlid TS, 2000, ANN BOT-LONDON, V86, P1087, DOI 10.1006/anbo.2000.1275; Amasino RM, 2010, PLANT PHYSIOL, V154, P516, DOI 10.1104/pp.110.161653; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen JR, 2006, PLANT MOL BIOL, V60, P481, DOI 10.1007/s11103-005-4815-1; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Aroca R, 2005, PLANT PHYSIOL, V137, P341, DOI 10.1104/pp.104.051045; Asp T, 2011, MOL GENET GENOMICS, V286, P433, DOI 10.1007/s00438-011-0654-8; Bergonzi S, 2013, SCIENCE, V340, P1094, DOI 10.1126/science.1234116; Bond DM, 2011, PLANT CELL ENVIRON, V34, P1737, DOI 10.1111/j.1365-3040.2011.02370.x; Byrne S, 2011, EUCARPIA 29 FODD CRO, P23; Campoli C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-97; Cao SQ, 2005, PLANT CELL REP, V24, P683, DOI 10.1007/s00299-005-0061-x; Charron JBF, 2002, PLANT PHYSIOL, V129, P363, DOI 10.1104/pp.001776; Chen A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003134; Ciannamea S, 2006, PLANT CELL PHYSIOL, V47, P481, DOI 10.1093/pcp/pcj015; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Coneva V, 2012, J EXP BOT, V63, P5079, DOI 10.1093/jxb/ers158; Corbesier L, 1998, PLANTA, V206, P131, DOI 10.1007/s004250050383; CRESPI MD, 1991, PLANT PHYSIOL, V96, P887, DOI 10.1104/pp.96.3.887; Dalchau N, 2011, P NATL ACAD SCI USA, V108, P5104, DOI 10.1073/pnas.1015452108; Dhillon T, 2010, PLANT PHYSIOL, V153, P1846, DOI 10.1104/pp.110.159079; Dong MA, 2011, P NATL ACAD SCI USA, V108, P7241, DOI 10.1073/pnas.1103741108; Dubcovsky J, 2006, PLANT MOL BIOL, V60, P469, DOI 10.1007/s11103-005-4814-2; Edwards J, 2010, PLANT J, V63, P651, DOI 10.1111/j.1365-313X.2010.04269.x; EIMERT K, 1995, PLANT CELL, V7, P1703, DOI 10.1105/tpc.7.10.1703; Farrell JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103567; Feugier FG, 2013, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00305; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Fujiwara S, 2008, PLANT CELL, V20, P2960, DOI 10.1105/tpc.108.061531; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Greenup AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017900; HEIDE OM, 1994, NEW PHYTOL, V128, P347, DOI 10.1111/j.1469-8137.1994.tb04019.x; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Hisano H, 2008, NEW PHYTOL, V178, P766, DOI 10.1111/j.1469-8137.2008.02409.x; Huijser P, 2011, DEVELOPMENT, V138, P4117, DOI 10.1242/dev.063511; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Iordachescu M, 2008, J INTEGR PLANT BIOL, V50, P1223, DOI 10.1111/j.1744-7909.2008.00736.x; Jensen LB, 2005, THEOR APPL GENET, V110, P527, DOI 10.1007/s00122-004-1865-8; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Keunen E, 2013, PLANT CELL ENV; Kim WY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2357; King RW, 2012, RUSS J PLANT PHYSL+, V59, P479, DOI 10.1134/S1021443712040061; King RW, 2008, J EXP BOT, V59, P3811, DOI 10.1093/jxb/ern231; Kobayashi F, 2005, J EXP BOT, V56, P887, DOI 10.1093/jxb/eri081; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li CX, 2011, PLANT J, V67, P763, DOI 10.1111/j.1365-313X.2011.04630.x; Limin AE, 2006, PLANTA, V224, P360, DOI 10.1007/s00425-006-0219-y; Livingston DP, 2009, CELL MOL LIFE SCI, V66, P2007, DOI 10.1007/s00018-009-0002-x; Lu CG, 2002, PLANT PHYSIOL, V130, P1335, DOI 10.1104/pp.008979; Lunn J, 2006, COMP BIOCHEM PHYS A, V143, pS156; Maleux K, 2007, J PLANT BIOL, V50, P671, DOI 10.1007/BF03030612; Martin RC, 2008, CROP SCI, V48, P1881, DOI 10.2135/cropsci2007.10.0597; Mendez-Vigo B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003289; Nagaraj VJ, 2004, NEW PHYTOL, V161, P735, DOI 10.1111/j.1469-8137.2004.00995.x; Nakamichi N, 2007, PLANT CELL PHYSIOL, V48, pS187; Nakamichi N, 2007, PLANT CELL PHYSIOL, V48, P822, DOI 10.1093/pcp/pcm056; Nakamichi N, 2010, PLANT CELL, V22, P594, DOI 10.1105/tpc.109.072892; Nakamichi N, 2009, PLANT CELL PHYSIOL, V50, P447, DOI 10.1093/pcp/pcp004; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Niwa Y, 2007, PLANT CELL PHYSIOL, V48, P925, DOI 10.1093/pcp/pcm067; Park HJ, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24820; Pearce S, 2013, PLANT PHYSIOL, V163, P1433, DOI 10.1104/pp.113.225854; Pennycooke JC, 2003, PLANT PHYSIOL, V133, P901, DOI 10.1104/pp.103.024554; Porri A, 2012, DEVELOPMENT, V139, P2198, DOI 10.1242/dev.077164; Purvis ON, 1937, ANN BOT-LONDON, V1, P569, DOI 10.1093/oxfordjournals.aob.a083490; Ream TS, 2014, PLANT PHYSIOL, V164, P694, DOI 10.1104/pp.113.232678; Rekarte-Cowie I, 2008, J EXP BOT, V59, P4205, DOI 10.1093/jxb/ern262; Roldan M, 1999, PLANT J, V20, P581, DOI 10.1046/j.1365-313X.1999.00632.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Salome PA, 2005, PLANT CELL, V17, P791, DOI 10.1105/tpc.104.029504; Sandve SR, 2011, PLANT SCI, V180, P69, DOI 10.1016/j.plantsci.2010.07.011; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Sawa M, 2011, P NATL ACAD SCI USA, V108, P11698, DOI 10.1073/pnas.1106771108; Silverstone AL, 2007, PLANT PHYSIOL, V143, P987, DOI 10.1104/pp.106.091025; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Studer B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-140; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Team RDC, 2010, R LANG ENV STAT COMP; Tremblay K, 2005, PLANT CELL PHYSIOL, V46, P884, DOI 10.1093/pcp/pci093; Trevaskis B, 2006, PLANT PHYSIOL, V140, P1397, DOI 10.1104/pp.105.073486; Trevaskis B, 2007, TRENDS PLANT SCI, V12, P352, DOI 10.1016/j.tplants.2007.06.010; Tseng TS, 2004, PLANT CELL, V16, P1550, DOI 10.1105/tpc.019224; Tunc-Ozdemir M, 2009, PLANT PHYSIOL, V151, P421, DOI 10.1104/pp.109.140046; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Wahl V, 2013, SCIENCE, V339, P704, DOI 10.1126/science.1230406; Wanner LA, 1999, PLANT PHYSIOL, V120, P391, DOI 10.1104/pp.120.2.391; Wei JZ, 2001, J PLANT PHYSIOL, V158, P635, DOI 10.1078/0176-1617-00308; Winfield MO, 2010, PLANT BIOTECHNOL J, V8, P749, DOI 10.1111/j.1467-7652.2010.00536.x; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Zhang CZ, 2010, PLANTA, V232, P155, DOI 10.1007/s00425-010-1163-4; Zhang CZ, 2009, J PLANT PHYSIOL, V166, P1436, DOI 10.1016/j.jplph.2009.03.001; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	98	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107365	10.1371/journal.pone.0107365	http://dx.doi.org/10.1371/journal.pone.0107365			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225807	Green Submitted, Green Published, gold			2022-12-25	WOS:000344317700048
J	Franceschetti, T; Dole, NS; Kessler, CB; Lee, SK; Delany, AM				Franceschetti, Tiziana; Dole, Neha S.; Kessler, Catherine B.; Lee, Sun-Kyeong; Delany, Anne M.			Pathway Analysis of MicroRNA Expression Profile during Murine Osteoclastogenesis	PLOS ONE			English	Article							REGULATES OSTEOCLASTOGENESIS; DENDRITIC CELLS; BONE-RESORPTION; TNF-ALPHA; DIFFERENTIATION; MIRNA; MIR-29; IDENTIFICATION; CONTRIBUTES; INTEGRATION	To design novel therapeutics against bone loss, understanding the molecular mechanisms regulating osteoclastogenesis is critical. Osteoclast formation and function are tightly regulated by transcriptional, post-transcriptional and post-translational mechanisms. This stringent regulation is crucial to prevent excessive or insufficient bone resorption and to maintain bone homeostasis. microRNAs (miRNAs) are key post-transcriptional regulators that repress expression of target mRNAs controlling osteoclast proliferation, differentiation, and apoptosis. Disruption of miRNA-mediated regulation alters osteoclast formation and bone resorption. Prior studies profiled miRNA expression in murine osteoclast precursors treated with RANKL for 24 hours. However, a more complete miRNA signature, encompassing early, mid and late stages of osteoclastogenesis, is wanting. An Agilent microarray platform was used to analyze expression of mature miRNAs in an enriched population of murine bone marrow osteoclast precursors (depleted of B220(+) and CD3(+) cells) undergoing 1, 3, or 5 days of RANKL-driven differentiation. Expression of 93 miRNAs, changed by >2 fold during early, mid, and late stages of osteoclastogenesis, were identified and sorted into 7 clusters. We validated the function and expression of miR-365, miR451, and miR-99b, which were found in distinct clusters. Inhibition of miR-365 increased osteoclast number but decreased osteoclast size, while miR-99b inhibition decreased both osteoclast number and size. In contrast, overexpression of miR-451 had no effect. Computational analyses predicted mTOR, PI3 kinase/AKT, cell-matrix interactions, actin cytoskeleton organization, focal adhesion, and axon guidance pathways to be top targets of several miRNA clusters. This suggests that many miRNA clusters differentially expressed during osteoclastogenesis converge on some key functional pathways. Overall, our study is unique in that we identified miRNAs differentially expressed during early, mid, and late osteoclastogenesis in a population of primary mouse bone marrow cells enriched for osteoclast progenitors. This novel data set contributes to our understanding of the molecular mechanisms regulating the complex process of osteoclast differentiation.	[Franceschetti, Tiziana; Dole, Neha S.; Kessler, Catherine B.; Delany, Anne M.] Univ Connecticut, Ctr Hlth, Ctr Mol Med, Farmington, CT 06030 USA; [Lee, Sun-Kyeong] Univ Connecticut, Ctr Hlth, Ctr Aging, Farmington, CT USA	University of Connecticut; University of Connecticut	Delany, AM (corresponding author), Univ Connecticut, Ctr Hlth, Ctr Mol Med, Farmington, CT 06030 USA.	adelany@uchc.edu		Franceschetti, Tiziana/0000-0002-8839-0247; Dole, Neha/0000-0003-4675-2649	National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health [AR044877, AR055143]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044877, R29AR044877, R01AR055143, R56AR044877] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This project was supported by Grant Number AR044877 (to AMD) and AR055143 (to SKL) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIAMS or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Axtell MJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-221; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; Bidzhekov K, 2012, THROMB HAEMOSTASIS, V107, P619, DOI 10.1160/TH11-09-0607; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bruzzaniti A, 2006, REV ENDOCR METAB DIS, V7, P123, DOI 10.1007/s11154-006-9009-x; Chen C, 2014, J BONE MINER RES, V29, P338, DOI 10.1002/jbmr.2032; Cheng P, 2013, J BONE MINER RES, V28, P1180, DOI 10.1002/jbmr.1845; Dobson KR, 1999, CALCIFIED TISSUE INT, V65, P411, DOI 10.1007/s002239900723; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Franceschetti T, 2013, J BIOL CHEM, V288, P33347, DOI 10.1074/jbc.M113.484568; Gerrits A, 2012, BLOOD, V119, P377, DOI 10.1182/blood-2011-01-331686; Glantschnig H, 2003, CELL DEATH DIFFER, V10, P1165, DOI 10.1038/sj.cdd.4401285; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Guo SL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3544; Hamada S, 2014, CELL SIGNAL, V26, P179, DOI 10.1016/j.cellsig.2013.11.003; Jacome-Galarza CE, 2013, J BONE MINER RES, V28, P1203, DOI 10.1002/jbmr.1822; Jacquin C, 2006, J BONE MINER RES, V21, P67, DOI 10.1359/JBMR.051007; Jin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064434; Kagiya T, 2012, J PERIODONTAL RES, V18, P12017; Kanazawa K, 2005, J BONE MINER RES, V20, P840, DOI 10.1359/JBMR.041225; Kapinas K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3325; Lee Y, 2013, BONE, V56, P383, DOI 10.1016/j.bone.2013.07.007; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Mann M, 2010, P NATL ACAD SCI USA, V107, P15804, DOI 10.1073/pnas.0915022107; Mizoguchi F, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4282; Mizoguchi F, 2010, J CELL BIOCHEM, V109, P866, DOI 10.1002/jcb.22228; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Nakamura I, 2007, J BONE MINER METAB, V25, P337, DOI 10.1007/s00774-007-0773-9; Nakasa T, 2011, ARTHRITIS RHEUM-US, V63, P1582, DOI 10.1002/art.30321; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; Ory S, 2008, EUR J CELL BIOL, V87, P469, DOI 10.1016/j.ejcb.2008.03.002; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Patrick DM, 2010, GENE DEV, V24, P1614, DOI 10.1101/gad.1942810; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Sims N, 2010, IBMS BONEKEY, V7, P304, DOI DOI 10.1138/20100463; Singh Y, 2013, J BIOL CHEM, V288, P5056, DOI 10.1074/jbc.C112.439778; Smith SS, 2013, ENDOCRINOLOGY, V154, P253, DOI 10.1210/en.2012-1476; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; Sugatani T, 2011, BLOOD, V117, P3648, DOI 10.1182/blood-2010-10-311415; Sugatani T, 2009, J BIOL CHEM, V284, P4667, DOI 10.1074/jbc.M805777200; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Tanic M, 2012, BREAST CANCER RES TR, V134, P41, DOI 10.1007/s10549-011-1905-4; Teitelbaum SL, 2011, ANN NY ACAD SCI, V1240, P14, DOI 10.1111/j.1749-6632.2011.06283.x; Torres A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-369; Tumaneng K, 2012, NAT CELL BIOL, V14, P1322, DOI 10.1038/ncb2615; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wei F, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-81; Xu Z, 2011, J BIOL CHEM, V286, P21401, DOI 10.1074/jbc.M110.198630	51	28	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107262	10.1371/journal.pone.0107262	http://dx.doi.org/10.1371/journal.pone.0107262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222202	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774800058
J	Palacio, S; Aitkenhead, M; Escudero, A; Montserrat-Marti, G; Maestro, M; Robertson, AHJ				Palacio, Sara; Aitkenhead, Matt; Escudero, Adrian; Montserrat-Marti, Gabriel; Maestro, Melchor; Jean Robertson, A. H.			Gypsophile Chemistry Unveiled: Fourier Transform Infrared (FTIR) Spectroscopy Provides New Insight into Plant Adaptations to Gypsum Soils	PLOS ONE			English	Article							COMMUNITY PATTERNS; NITROGEN; IDENTIFICATION; PREDICTION; TRANSPORT; ECOLOGY	Gypsum soils are among the most restrictive and widespread substrates for plant life. Plants living on gypsum are classified as gypsophiles (exclusive to gypsum) and gypsovags (non-exclusive to gypsum). The former have been separated into wide and narrow gypsophiles, each with a putative different ecological strategy. Mechanisms displayed by gypsum plants to compete and survive on gypsum are still not fully understood. The aim of this study was to compare the main chemical groups in the leaves of plants with different specificity to gypsum soils and to explore the ability of Fourier transform infrared (FTIR) spectra analyzed with neural network (NN) modelling to discriminate groups of gypsum plants. Leaf samples of 14 species with different specificity to gypsum soils were analysed with FTIR spectroscopy coupled to neural network (NN) modelling. Spectral data were further related to the N, C, S, P, K, Na, Ca, Mg and ash concentrations of samples. The FTIR spectra of the three groups analyzed showed distinct features that enabled their discrimination through NN models. Wide gypsophiles stood out for the strong presence of inorganic compounds in their leaves, particularly gypsum and, in some species, also calcium oxalate crystals. The spectra of gypsovags had less inorganic chemical species, while those of narrow gypsum endemisms had low inorganics but shared with wide gypsophiles the presence of oxalate. Gypsum and calcium oxalate crystals seem to be widespread amongst gypsum specialist plants, possibly as a way to tolerate excess Ca and sulphate. However, other mechanisms such as the accumulation of sulphates in organic molecules are also compatible with plant specialization to gypsum. While gypsovags seem to be stress tolerant plants that tightly regulate the uptake of S and Ca, the ability of narrow gypsum endemisms to accumulate excess Ca as oxalate may indicate their incipient specialization to gypsum.	[Palacio, Sara] IPE CSIC, Jaca, Huesca, Spain; [Aitkenhead, Matt; Jean Robertson, A. H.] James Hutton Inst, Aberdeen, Scotland; [Escudero, Adrian] Univ Rey Juan Carlos, ESCET, Biodivers & Conservat Grp, Madrid, Spain; [Montserrat-Marti, Gabriel; Maestro, Melchor] IPE CSIC, Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); James Hutton Institute; Universidad Rey Juan Carlos; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE)	Palacio, S (corresponding author), IPE CSIC, Jaca, Huesca, Spain.	s.palacio@ipe.csic.es	Escudero, Adrián/H-5046-2015; Aitkenhead, Matt/AAP-5334-2021; Palacio, Sara/B-3907-2011	Escudero, Adrián/0000-0002-1427-5465; Aitkenhead, Matt/0000-0002-1572-4015; Palacio, Sara/0000-0002-8362-6820	Juan de la Cierva contract (Ministerio de Ciencia e Innovacion, Spain); Ministerio de Economia y Competitividad, Spain [CGL2011-26654]; Organismo Autonomo de Parques Nacionales, Ministerio de Agricultura, Alimentacion y Medio Ambiente, Spain [ARBALMONT/786-2012]	Juan de la Cierva contract (Ministerio de Ciencia e Innovacion, Spain); Ministerio de Economia y Competitividad, Spain; Organismo Autonomo de Parques Nacionales, Ministerio de Agricultura, Alimentacion y Medio Ambiente, Spain	SP was funded by a Juan de la Cierva contract (Ministerio de Ciencia e Innovacion, Spain) and projects [CGL2011-26654] (Ministerio de Economia y Competitividad, Spain) and [ARBALMONT/786-2012] (Organismo Autonomo de Parques Nacionales, Ministerio de Agricultura, Alimentacion y Medio Ambiente, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitkenhead MJ, 2013, GEODERMA, V200, P99, DOI 10.1016/j.geoderma.2013.02.013; Aitkenhead MJ, 2003, ECOL MODEL, V162, P87, DOI 10.1016/S0304-3800(02)00401-5; Allen SE, 1989, CHEM ANAL ECOLOGICAL; Alvarado JJ, 2000, J PLANT PHYSIOL, V156, P612, DOI 10.1016/S0176-1617(00)80220-5; Artz RRE, 2008, SOIL BIOL BIOCHEM, V40, P515, DOI 10.1016/j.soilbio.2007.09.019; Becker, 1961, ANALISIS VALORACION; Berthomieu C, 2009, PHOTOSYNTH RES, V101, P157, DOI 10.1007/s11120-009-9439-x; Borer CH, 2012, J ARID ENVIRON, V85, P128, DOI 10.1016/j.jaridenv.2012.06.004; BOUKHRIS M, 1975, REV ECOL BIOL SOL, V12, P329; Boukhris M., 1970, ACTA OECOL, V5, P345; BRAUN-BLANQUET J., 1957, AN ESTAC EXPTL AULA DEI, V5, P1; Delgado-Baquerizo M, 2011, PEDOSPHERE, V21, P309, DOI 10.1016/S1002-0160(11)60131-8; Denaeyer-De Smet S., 1970, B SOC ROY BOT BELG, V103, P273; DEVESA JA, 2004, ESPECIES VEGETALES P; Dharmaraj S, 2011, SPECTROSC-BIOMED APP, V26, P69, DOI 10.1155/2011/980109; Duvigneaud P., 1968, B SOC ROY BOT BELG, V101, P279; Duvigneaud P, 1966, B SOC ROY BOT BELG, V99, P263; Dziuba B, 2011, ACTA SCI POLON-TECHN, V10, P275; Escudero A, 2015, BIOL REV, V90, P1, DOI 10.1111/brv.12092; Eswaran H., 1991, SPECIAL PUBLICATION, V26, P89, DOI DOI 10.2136/SSSASPECPUB26.C6; Euring D, 2012, TREES-STRUCT FUNCT, V26, P1933, DOI 10.1007/s00468-012-0761-0; FAO, 1990, MAN GYPS SOILS; Farmer V. C., 1974, INFRARED SPECTRA MIN; GANKIN R, 1964, ECOLOGY, V45, P792, DOI 10.2307/1934926; Grigore MN, 2011, SCI ANN AI CUZA U IA, V57, P31; Guerrero-Campo J, 1999, J ARID ENVIRON, V41, P411, DOI 10.1006/jare.1999.0493; Guerrero-Campo J, 1999, J ARID ENVIRON, V41, P401, DOI 10.1006/jare.1999.0492; He HH, 2014, TRENDS PLANT SCI, V19, P166, DOI 10.1016/j.tplants.2013.11.002; He HH, 2012, ANN BOT-LONDON, V109, P887, DOI 10.1093/aob/mcs004; HERSCHBACH C, 1994, J EXP BOT, V45, P1069, DOI 10.1093/jxb/45.8.1069; Hong QH, 2011, CHINESE J CHEM, V29, P1024, DOI 10.1002/cjoc.201190174; ITO K, 1956, CAN J CHEM, V34, P170, DOI 10.1139/v56-021; Jones F, 2012, CRYSTENGCOMM, V14, P8374, DOI 10.1039/c2ce25918d; Jones R, 2012, ENVIRON EXP BOT, V81, P72, DOI 10.1016/j.envexpbot.2012.02.006; Mason Herbert L., 1946, MADROnO, V8, P209; McNair JB, 1932, AM J BOT, V19, P255, DOI 10.2307/2436337; McNear DH, 2010, PHYTOCHEMISTRY, V71, P188, DOI 10.1016/j.phytochem.2009.10.023; Merlo M.E., 1998, INVESTIGACI N GESTI, V3, P103; MEYER SE, 1986, ECOLOGY, V67, P1303, DOI 10.2307/1938686; MEYER SE, 1989, J ARID ENVIRON, V16, P147, DOI 10.1016/S0140-1963(18)31021-8; MEYER SE, 1992, J VEG SCI, V3, P429, DOI 10.2307/3235799; Mota J.F., 2011, DIVERSIDAD VEGETAL Y; Mota JF, 2003, PHYTOCOENOLOGIA, V33, P13, DOI 10.1127/0340-269X/2003/0033-0013; Mouazen AM, 2010, GEODERMA, V158, P23, DOI 10.1016/j.geoderma.2010.03.001; Nakata PA, 2003, PLANT SCI, V164, P901, DOI 10.1016/S0168-9452(03)00120-1; Palacio S, 2007, ANN BOT-LONDON, V99, P333, DOI 10.1093/aob/mcl263; PARSONS RF, 1976, AM MIDL NAT, V96, P1, DOI 10.2307/2424564; Pitre FE, 2010, TREE PHYSIOL, V30, P1273, DOI 10.1093/treephys/tpq073; RAVEN PH, 1964, EVOLUTION, V18, P336, DOI 10.2307/2406409; Romao RL, 2005, PLANT ECOL, V181, P127, DOI 10.1007/s11258-005-5321-x; Ruiz JM, 2003, INT J PHYTOREMEDIAT, V5, P203, DOI 10.1080/713779220; Salmeron-Sanchez E, 2014, PLANT SOIL, V374, P233, DOI 10.1007/s11104-013-1857-z; Smidt E, 2011, FOURIER TRANSFORMS - NEW ANALYTICAL APPROACHES AND FTIR STRATEGIES, P405; Tcherkez G, 2013, NEW PHYTOL, V200, P44, DOI 10.1111/nph.12314; Verheye WH, 1997, SOIL USE MANAGE, V13, P97, DOI 10.1111/j.1475-2743.1997.tb00565.x; Wei ZL, 2009, PAK J BOT, V41, P1743; Wilson M.J., 1994, CLAY MINERALOGY SPEC; [薛生国 Xue Shengguo], 2011, [生态学报, Acta Ecologica Sinica], V31, P6143	58	49	51	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107285	10.1371/journal.pone.0107285	http://dx.doi.org/10.1371/journal.pone.0107285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222564	Green Published, gold			2022-12-25	WOS:000341774800060
J	Shi, Y; Wang, JY; Wang, HM; Hu, YH; Chen, XM; Yang, ZM				Shi, Yang; Wang, Jingyu; Wang, Huaimin; Hu, Yanhui; Chen, Xuemei; Yang, Zhimou			Glutathione-Triggered Formation of a Fmoc-Protected Short Peptide-Based Supramolecular Hydrogel	PLOS ONE			English	Article							MOLECULAR HYDROGELS; DELIVERY SYSTEM; SELF; NANOFIBERS; PH; NANOSTRUCTURES; INHIBITION; MATRICES; GELATION; RELEASE	A biocompatible method of glutathione (GSH) catalyzed disulfide bond reduction was used to form Fmoc-short peptide-based supramolecular hydrogels. The hydrogels could form in both buffer solution and cell culture medium containing 10% of Fetal Bovine Serum (FBS) within minutes. The hydrogel was characterized by rheology, transmission electron microscopy, and fluorescence emission spectra. Their potential in three dimensional (3D) cell culture was evaluated and the results indicated that the gel with a low concentration of the peptide (0.1 wt%) was suitable for 3D cell culture of 3T3 cells. This study provides an alternative candidate of supramolecular hydrogel for 3D cell culture and cell delivery.	[Shi, Yang; Wang, Jingyu; Wang, Huaimin; Yang, Zhimou] Nankai Univ, Coll Life Sci, Key Lab Bioact Mat, State Key Lab Med Chem Biol,Minist Educ, Tianjin 300071, Peoples R China; [Shi, Yang; Wang, Jingyu; Wang, Huaimin; Yang, Zhimou] Nankai Univ, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 300071, Peoples R China; [Hu, Yanhui; Chen, Xuemei] Hubei Inst Technol, Sch Chem & Mat Engn, Huangshi, Hubei, Peoples R China	Nankai University; Nankai University	Yang, ZM (corresponding author), Nankai Univ, Coll Life Sci, Key Lab Bioact Mat, State Key Lab Med Chem Biol,Minist Educ, Tianjin 300071, Peoples R China.	yangzm@nankai.edu.cn	wang, huaimin/G-8722-2011; Yang, Zhimou/F-1798-2010; Wang, Huaimin/O-3260-2019	wang, huaimin/0000-0002-8796-0367; Yang, Zhimou/0000-0003-2967-6920; Wang, Huaimin/0000-0002-8796-0367	National Natural Science Foundation of China [51373079, 51173060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (51373079 and 51173060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behanna HA, 2005, J AM CHEM SOC, V127, P1193, DOI 10.1021/ja044863u; Beniash E, 2005, ACTA BIOMATER, V1, P387, DOI 10.1016/j.actbio.2005.04.002; Boekhoven J, 2013, NAT CHEM, V5, P433, DOI 10.1038/nchem.1617; Bowerman CJ, 2010, J AM CHEM SOC, V132, P9526, DOI 10.1021/ja1025535; Bremmer SC, 2012, CHEM COMMUN, V48, P5482, DOI 10.1039/c2cc31537h; Cai YB, 2014, ANAL CHEM, V86, P2193, DOI 10.1021/ac4038653; Cao H, 2013, ANGEW CHEM INT EDIT, V52, P4122, DOI 10.1002/anie.201300444; Channon KJ, 2008, J AM CHEM SOC, V130, P5487, DOI 10.1021/ja710310c; Collier JH, 2004, ADV MATER, V16, P907, DOI 10.1002/adma.200306379; Collier JH, 2003, BIOCONJUGATE CHEM, V14, P748, DOI 10.1021/bc034017t; Collier JH, 2010, CHEM SOC REV, V39, P3413, DOI 10.1039/b914337h; Debnath S, 2013, J AM CHEM SOC, V135, P16789, DOI 10.1021/ja4086353; Du X, 2013, RSC ADV, V3, P18259, DOI 10.1039/c3ra43457e; Duan PF, 2011, CHEM-EUR J, V17, P6389, DOI 10.1002/chem.201003049; Fu YT, 2013, LANGMUIR, V29, P6013, DOI 10.1021/la400910g; Gao Y, 2010, CHEM SOC REV, V39, P3425, DOI 10.1039/b919450a; Gelain F, 2010, J CONTROL RELEASE, V145, P231, DOI 10.1016/j.jconrel.2010.04.026; He MT, 2013, J AM CHEM SOC, V135, P18718, DOI 10.1021/ja409000b; Hirst AR, 2008, ANGEW CHEM INT EDIT, V47, P8002, DOI 10.1002/anie.200800022; Ikeda M, 2011, J AM CHEM SOC, V133, P1670, DOI 10.1021/ja109692z; Jayawarna V, 2006, ADV MATER, V18, P611, DOI 10.1002/adma.200501522; Jung JP, 2009, BIOMATERIALS, V30, P2400, DOI 10.1016/j.biomaterials.2009.01.033; Kuang Y, 2013, ANGEW CHEM INT EDIT, V52, P6944, DOI 10.1002/anie.201302658; Kuang Y, 2011, CHEM COMMUN, V47, P12625, DOI 10.1039/c1cc15577f; Kumar DK, 2014, CHEM SOC REV, V43, P2080, DOI 10.1039/c3cs60224a; Li XM, 2010, J AM CHEM SOC, V132, P17707, DOI 10.1021/ja109269v; Lin R, 2013, CHEM COMMUN, V49, P4968, DOI 10.1039/c3cc41896k; Lv LN, 2013, COLLOID SURFACE B, V108, P352, DOI 10.1016/j.colsurfb.2013.03.013; Mahler A, 2006, ADV MATER, V18, P1365, DOI 10.1002/adma.200501765; Marini DM, 2002, NANO LETT, V2, P295, DOI 10.1021/nl015697g; Miao XM, 2013, ANGEW CHEM INT EDIT, V52, P7781, DOI 10.1002/anie.201303199; Minkenberg CB, 2012, CHEM COMMUN, V48, P9837, DOI 10.1039/c2cc34863b; Piepenbrock MOM, 2010, CHEM REV, V110, P1960, DOI 10.1021/cr9003067; Qiu ZJ, 2009, CHEM COMMUN, P3342, DOI 10.1039/b822840j; Ren CH, 2011, CHEM COMMUN, V47, P1619, DOI 10.1039/c0cc04135a; Rudra JS, 2012, ACS NANO, V6, P1557, DOI 10.1021/nn204530r; Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107; Smith AM, 2008, ADV MATER, V20, P37, DOI 10.1002/adma.200701221; Steed JW, 2010, CHEM SOC REV, V39, P3686, DOI 10.1039/b926219a; Sun ZF, 2013, J AM CHEM SOC, V135, P13379, DOI 10.1021/ja403345p; Toledano S, 2006, J AM CHEM SOC, V128, P1070, DOI 10.1021/ja056549l; Wang HM, 2012, MATER TODAY, V15, P500, DOI 10.1016/S1369-7021(12)70219-5; Wang HM, 2012, NANOSCALE, V4, P5259, DOI 10.1039/c2nr31149f; Wang HM, 2012, SOFT MATTER, V8, P2344, DOI 10.1039/c2sm06923g; Wang TY, 2010, LANGMUIR, V26, P18694, DOI 10.1021/la103435t; Wang ZH, 2011, CHEM COMMUN, V47, P8901, DOI 10.1039/c1cc11564b; Xu XD, 2012, MACROMOL RAPID COMM, V33, P426, DOI 10.1002/marc.201100689; Xu XD, 2010, ACS APPL MATER INTER, V2, P2663, DOI 10.1021/am100484c; Yang YG, 2007, J AM CHEM SOC, V129, P581, DOI 10.1021/ja064240b; Yang Z, 2008, ACCOUNTS CHEM RES, V41, P315, DOI 10.1021/ar7001914; Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102; Zhang X, 2012, ANGEW CHEM, V124, P4464, DOI DOI 10.1002/ANGE.201108612; Zhang Y, 2013, J AM CHEM SOC, V135, P5008, DOI 10.1021/ja402490j; Zhao Y, 2008, BIOMACROMOLECULES, V9, P1511, DOI 10.1021/bm701143g; Zheng C, 2012, J AM CHEM SOC, V134, P5026, DOI 10.1021/ja210846d	55	17	17	0	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e106968	10.1371/journal.pone.0106968	http://dx.doi.org/10.1371/journal.pone.0106968			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222132	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774800034
J	Zou, YH; Lee, J; Nambiar, SM; Hu, M; Rui, WJ; Bao, Q; Chan, JY; Dai, GL				Zou, Yuhong; Lee, Joonyong; Nambiar, Shashank Manohar; Hu, Min; Rui, Wenjuan; Bao, Qi; Chan, Jefferson Y.; Dai, Guoli			Nrf2 Is Involved in Maintaining Hepatocyte Identity during Liver Regeneration	PLOS ONE			English	Article							INTESTINAL TREFOIL FACTOR; BETA-CELL DEDIFFERENTIATION; HEPATIC PROGENITOR CELLS; PARTIAL-HEPATECTOMY; PROTEIN-KINASE; KNOCKOUT MICE; IN-VIVO; IDENTIFICATION; PROLIFERATION; CANCER	Nrf2, a central regulator of the cellular defense against oxidative stress and inflammation, participates in modulating hepatocyte proliferation during liver regeneration. It is not clear, however, whether Nrf2 regulates hepatocyte growth, an important cellular mechanism to regain the lost liver mass after partial hepatectomy (PH). To determine this, various analyses were performed in wild-type and Nrf2-null mice following PH. We found that, at 60 h post-PH, the vast majority of hepatocytes lacking Nrf2 reduced their sizes, activated hepatic progenitor markers (CD133, TWEAK receptor, and trefoil factor family 3), depleted HNF4 alpha protein, and downregulated the expression of a group of genes critical for their functions. Thus, the identity of hepatocytes deficient in Nrf2 was transiently but massively impaired in response to liver mass loss. This event was associated with the coupling of protein depletion of hepatic HNF4 alpha, a master regulator of hepatocyte differentiation, and concomitant inactivation of hepatic Akt1 and p70S6K, critical hepatocyte growth signaling molecules. We conclude that Nrf2 participates in maintaining newly regenerated hepatocytes in a fully differentiated state by ensuring proper regulation of HNF4 alpha, Akt1, and p70S6K during liver regeneration.	[Zou, Yuhong; Lee, Joonyong; Nambiar, Shashank Manohar; Hu, Min; Rui, Wenjuan; Bao, Qi; Dai, Guoli] Indiana Univ Purdue Univ, Ctr Regenerat Biol & Med, Dept Biol, Indianapolis, IN 46202 USA; [Chan, Jefferson Y.] Univ Calif Irvine, Sch Med, Irvine, CA 92717 USA	Indiana University System; Indiana University-Purdue University Indianapolis; University of California System; University of California Irvine	Dai, GL (corresponding author), Indiana Univ Purdue Univ, Ctr Regenerat Biol & Med, Dept Biol, Indianapolis, IN 46202 USA.	gdai@iupui.edu		Nambiar, Shashank/0000-0002-2925-5627	National Institute of Diabetes and Digestive and Kidney Diseases [7RO1DK07596]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075968] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (7RO1DK07596). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya MJ, 2014, HEPATOLOGY, V59, P274, DOI 10.1002/hep.26609; Beyer TA, 2008, EMBO J, V27, P212, DOI 10.1038/sj.emboj.7601950; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Buitrago-Molina LE, 2013, HEPATOLOGY, V58, P1143, DOI 10.1002/hep.26412; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen YX, 2012, HEPATOLOGY, V55, P563, DOI 10.1002/hep.24712; Dai GL, 2008, HEPATOLOGY, V47, P1277, DOI 10.1002/hep.22129; Dayoub R, 2013, MOL MED, V19, P237, DOI 10.2119/molmed.2013.00027; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; Grosse-Gehling P, 2013, J PATHOL, V229, P355, DOI 10.1002/path.4086; Haga S, 2005, J HEPATOL, V43, P799, DOI 10.1016/j.jhep.2005.03.027; Haga S, 2009, HEPATOLOGY, V49, P204, DOI 10.1002/hep.22583; Hayes JD, 2014, TRENDS BIOCH SCI; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031; Iida K, 2004, CANCER RES, V64, P6424, DOI 10.1158/0008-5472.CAN-04-1906; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; JIRTLE RL, 1991, J BIOL CHEM, V266, P22444; Kanai M, 1998, P NATL ACAD SCI USA, V95, P178, DOI 10.1073/pnas.95.1.178; Karaca G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083987; Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028; Klochendler A, 2012, DEV CELL, V23, P681, DOI 10.1016/j.devcel.2012.08.009; Kohler U.A., 2013, HEPATOLOGY; Landsman L, 2011, P NATL ACAD SCI USA, V108, P17010, DOI 10.1073/pnas.1105404108; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Minamishima YA, 2002, CANCER RES, V62, P995; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Mitsuishi Y, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00200; Miyaoka Y, 2012, CURR BIOL, V22, P1166, DOI 10.1016/j.cub.2012.05.016; Perry JK, 2008, TRENDS ENDOCRIN MET, V19, P74, DOI 10.1016/j.tem.2007.10.003; PODOLSKY DK, 1993, J BIOL CHEM, V268, P6694; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Shirasaki K, 2014, HEPATOLOGY; STARZL TE, 1976, METABOLISM, V25, P1429, DOI 10.1016/S0026-0495(76)80158-8; SUEMORI S, 1991, P NATL ACAD SCI USA, V88, P11017, DOI 10.1073/pnas.88.24.11017; Suzuki A, 2008, HEPATOLOGY, V48, P1964, DOI 10.1002/hep.22558; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tirnitz-Parker JEE, 2010, HEPATOLOGY, V52, P291, DOI 10.1002/hep.23663; Wakabayashi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000762; White P, 2005, J BIOL CHEM, V280, P3715, DOI 10.1074/jbc.M410844200; Xu CJ, 2006, CANCER RES, V66, P8293, DOI 10.1158/0008-5472.CAN-06-0300; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Yovchev MI, 2008, HEPATOLOGY, V47, P636, DOI 10.1002/hep.22047	47	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107423	10.1371/journal.pone.0107423	http://dx.doi.org/10.1371/journal.pone.0107423			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222179	Green Published, gold			2022-12-25	WOS:000341774800066
J	Bartumeus, F; Raposo, EP; Viswanathan, GM; da Luz, MGE				Bartumeus, Frederic; Raposo, Ernesto P.; Viswanathan, Gandhimohan M.; da Luz, Marcos G. E.			Stochastic Optimal Foraging: Tuning Intensive and Extensive Dynamics in Random Searches	PLOS ONE			English	Article							LEVY WALKS EVOLVE; MOVEMENT; STRATEGIES; ANIMALS; PATCHES; SUCCESS; MODELS	Recent theoretical developments had laid down the proper mathematical means to understand how the structural complexity of search patterns may improve foraging efficiency. Under information-deprived scenarios and specific landscape configurations, Levy walks and flights are known to lead to high search efficiencies. Based on a one-dimensional comparative analysis we show a mechanism by which, at random, a searcher can optimize the encounter with close and distant targets. The mechanism consists of combining an optimal diffusivity (optimally enhanced diffusion) with a minimal diffusion constant. In such a way the search dynamics adequately balances the tension between finding close and distant targets, while, at the same time, shifts the optimal balance towards relatively larger close-to-distant target encounter ratios. We find that introducing a multiscale set of reorientations ensures both a thorough local space exploration without oversampling and a fast spreading dynamics at the large scale. Levy reorientation patterns account for these properties but other reorientation strategies providing similar statistical signatures can mimic or achieve comparable efficiencies. Hence, the present work unveils general mechanisms underlying efficient random search, beyond the Levy model. Our results suggest that animals could tune key statistical movement properties (e.g. enhanced diffusivity, minimal diffusion constant) to cope with the very general problem of balancing out intensive and extensive random searching. We believe that theoretical developments to mechanistically understand stochastic search strategies, such as the one here proposed, are crucial to develop an empirically verifiable and comprehensive animal foraging theory.	[Bartumeus, Frederic] CEAB CSIC, ICREA Movement Ecol Lab, Blanes, Spain; [Bartumeus, Frederic] CREAF, Barcelona, Spain; [Raposo, Ernesto P.] Univ Fed Pernambuco, Dept Fis, Lab Fis Teor & Computac, BR-50739 Recife, PE, Brazil; [Viswanathan, Gandhimohan M.] Univ Fed Rio Grande do Norte, Dept Fis Teor & Expt, BR-59072970 Natal, RN, Brazil; [da Luz, Marcos G. E.] Univ Fed Parana, Dept Fis, BR-80060000 Curitiba, PR, Brazil	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); ICREA; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); University of Barcelona; Universidade Federal de Pernambuco; Universidade Federal do Rio Grande do Norte; Universidade Federal do Parana	Bartumeus, F (corresponding author), CEAB CSIC, ICREA Movement Ecol Lab, Blanes, Spain.	fbartu@ceab.csic.es	Raposo, Ernesto P./ABA-7215-2020; Raposo, Ernesto P/N-2786-2017; Viswanathan, Gandhimohan M/J-8558-2012; da luz, marcos g e gomes eleuterio/H-7835-2012; Viswanathan, Gandhimohan/AAF-3937-2020; Bartumeus, Frederic/D-1911-2010	Raposo, Ernesto P./0000-0002-4178-8266; Raposo, Ernesto P/0000-0002-3595-4352; Viswanathan, Gandhimohan M/0000-0002-2301-5593; da luz, marcos g e gomes eleuterio/0000-0003-3865-2621; Bartumeus, Frederic/0000-0001-6908-3797	Spanish Government and Ministry of Science [BFU-2010-22337]; Human Frontier Science Program [RGY0084-2011]; CNPq (Brazilian agency); CAPES (Brazilian agency); FACEPE (Brazilian agency); ICREA Funding Source: Custom	Spanish Government and Ministry of Science; Human Frontier Science Program(Human Frontier Science Program); CNPq (Brazilian agency)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Brazilian agency)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FACEPE (Brazilian agency); ICREA(ICREA)	The authors thank for financial support the Spanish Government and Ministry of Science (BFU-2010-22337), the Human Frontier Science Program (RGY0084-2011), and CNPq, CAPES, and FACEPE (Brazilian agencies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DJ, 1983, THEOR POPUL BIOL, V24, P145, DOI 10.1016/0040-5809(83)90038-2; Bartumeus F, 2008, EUR PHYS J-SPEC TOP, V157, P157, DOI 10.1140/epjst/e2008-00638-6; Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bartumeus F, 2009, OIKOS, V118, P488, DOI 10.1111/j.1600-0706.2009.17313.x; Bartumeus F, 2013, LECT NOTES MATH, V2071, P3, DOI 10.1007/978-3-642-35497-7_1; Bartumeus F, 2008, P NATL ACAD SCI USA, V105, P19072, DOI 10.1073/pnas.0801926105; Bell W. J., 1991, CHAPMAN HALL ANIMAL; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Benichou O, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.020102; Benichou O, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.81; Berg, 2018, RANDOM WALKS BIOL; Buldyrev SV, 2001, PHYSICA A, V302, P148, DOI 10.1016/S0378-4371(01)00461-7; Buldyrev SV, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.041108; Campos D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.028102; CUTHILL IC, 1994, BEHAV ECOL, V5, P81, DOI 10.1093/beheco/5.1.81; da Luz MGE, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8121/42/43/430301; de Jager M, 2012, SCIENCE, V335, DOI 10.1126/science.1215903; de Jager M, 2011, SCIENCE, V332, P1551, DOI 10.1126/science.1201187; Dees ND, 2008, J THEOR BIOL, V252, P69, DOI 10.1016/j.jtbi.2008.01.026; Dees ND, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/4/044001; Dusenbery D.B., 1992, SENSORY ECOLOGY ORGA; Green R.F., 1987, P273; Hein AM, 2012, P NATL ACAD SCI USA, V109, P12070, DOI 10.1073/pnas.1202686109; HOFFMANN G, 1983, BEHAV ECOL SOCIOBIOL, V13, P81, DOI 10.1007/BF00293798; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; James A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051128; James A, 2011, J R SOC INTERFACE, V8, P1233, DOI 10.1098/rsif.2011.0200; Jansen VAA, 2012, SCIENCE, V335, DOI 10.1126/science.1215747; KACELNIK A, 1992, ANIM BEHAV, V43, P313, DOI 10.1016/S0003-3472(05)80226-X; Kamil A.C., 1981, GARLAND SERIES ETHOL; Kamil A. C., 1987, FORAGING BEHAV; KAUFFMAN S, 1987, J THEOR BIOL, V128, P11, DOI 10.1016/S0022-5193(87)80029-2; Kawai R, 2012, P ROY SOC A-MATH PHY, V468, P1428, DOI 10.1098/rspa.2011.0665; Krebs JR, 1993, INTRO BEHAV ECOLOGY; Levin SA, 1998, ECOSYSTEMS, V1, P431, DOI 10.1007/s100219900037; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; Lomholt MA, 2008, P NATL ACAD SCI USA, V105, P11055, DOI 10.1073/pnas.0803117105; Mendez V, 2014, SPRINGER SER SYNERG, P177, DOI 10.1007/978-3-642-39010-4_6; MONTROLL EW, 1965, J MATH PHYS, V6, P167, DOI 10.1063/1.1704269; OKUBO A, 2001, DIFFUSION ECOLOGICAL; Plank MJ, 2008, J R SOC INTERFACE, V5, P1077, DOI 10.1098/rsif.2008.0006; Raposo EP, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002233; Raposo EP, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.240601; Redner S, 2001, GUIDE 1 PASSAGE PROC; Reynolds AM, 2009, J THEOR BIOL, V260, P98, DOI 10.1016/j.jtbi.2009.05.033; Reynolds AM, 2007, ECOLOGY, V88, P1955, DOI 10.1890/06-1916.1; Reynolds A, 2008, ECOLOGY, V89, P2347, DOI 10.1890/07-1688.1; Reynolds AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000354; Reynolds AM, 2010, J R SOC INTERFACE, V7, P1753, DOI 10.1098/rsif.2010.0292; Santos MC, 2004, EUROPHYS LETT, V67, P734, DOI 10.1209/epl/i2004-10114-9; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Schoener T.W., 1987, P5; Shlesinger M., 1995, LEVY FLIGHTS RELATED, Ved, DOI [10.1007/3-540-59222-9, DOI 10.1007/3-540-59222-9]; Shlesinger M. F., 1985, GROWTH FORM, P279, DOI DOI 10.1103/PHYSREVLETT.108.230602; SHLESINGER MF, 1985, PHYS REV LETT, V54, P2551, DOI 10.1103/PhysRevLett.54.2551; Stephens David W., 2007, P31; Viswanathan G. M., 2011, PHYS FORAGING; Viswanathan GM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.011111; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Zollner PA, 1999, ANIM BEHAV, V58, P489, DOI 10.1006/anbe.1999.1186; Zollner PA, 1997, OIKOS, V80, P51, DOI 10.2307/3546515	62	48	48	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106373	10.1371/journal.pone.0106373	http://dx.doi.org/10.1371/journal.pone.0106373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216191	Green Published, gold			2022-12-25	WOS:000341774300011
J	Deiner, S; Chu, I; Mahanian, M; Lin, HM; Hecht, AC; Silverstein, JH				Deiner, Stacie; Chu, Isaac; Mahanian, Michelle; Lin, Hung-Mo; Hecht, Andrew C.; Silverstein, Jeffrey H.			Prone Position Is Associated with Mild Cerebral Oxygen Desaturation in Elderly Surgical Patients	PLOS ONE			English	Article							SURGERY; DEXMEDETOMIDINE; SATURATION; PRESSURE; FLOW	Purpose: A variety of hemodynamic and respiratory alterations accompany patients in the prone position; however the effect of the prone position on intraoperative cerebral saturation has not been studied. We sought to examine whether the incidence of cerebral oxygen desaturation in elderly patients (>= 68 years of age) undergoing spine surgery in the prone position was more common than patients undergoing major surgery in the supine position. Methods: We performed a retrospective cohort study of 205 patients; 63 patients underwent surgery in the prone position and 142 in the supine position. Patients were evaluated for cerebral desaturation with bilateral cerebral oximetry. The primary predictor was position, secondary were: length of the surgery, incidence and duration of cerebral desaturation episodes at several thresholds, average time of Bispectral index below threshold of 45 in minutes, average electroencephalogram suppression ratio >0, amount of blood transfused, and the incidence of hypotension and hypertension. Results: Elderly spine surgery patients in the prone position were more than twice as likely to experience mild cerebral desaturation as patients in the supine position. Patients in the prone position had longer surgeries; however cerebral desaturation in the prone position was significantly more common even when adjusted for surgery time and the occurrence of intraoperative hypotension. Conclusion: Cerebral desaturation is related to the prone position in elderly surgery patients. Future studies are necessary to determine whether this translates to a higher incidence of postoperative cognitive dysfunction and delirium.	[Deiner, Stacie; Chu, Isaac; Mahanian, Michelle; Silverstein, Jeffrey H.] Icahn Sch Med Mt Sinai, Dept Anesthesiol, New York, NY 10029 USA; [Silverstein, Jeffrey H.] Icahn Sch Med Mt Sinai, Dept Surg, New York, NY 10029 USA; [Deiner, Stacie] Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA; [Deiner, Stacie; Silverstein, Jeffrey H.] Icahn Sch Med Mt Sinai, Dept Geriatr & Palliat Care, New York, NY 10029 USA; [Lin, Hung-Mo] Icahn Sch Med Mt Sinai, Dept Hlth Evidence & Policy, New York, NY 10029 USA; [Hecht, Andrew C.] Icahn Sch Med Mt Sinai, Dept Orthoped Surg, New York, NY 10029 USA; [Mahanian, Michelle] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Deiner, Stacie; Silverstein, Jeffrey H.] Outcomes Res Consortium, Cleveland, OH USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Deiner, S (corresponding author), Icahn Sch Med Mt Sinai, Dept Anesthesiol, New York, NY 10029 USA.	stacie.deiner@mssm.edu			National Institute of Health [R01 AG029656, R03 AG040624, P50 AG005138]; American Geriatrics Society; Foundation of Anesthesia Education and Research; NATIONAL INSTITUTE ON AGING [R01AG029656, R03AG040624, P50AG005138] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Geriatrics Society; Foundation of Anesthesia Education and Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by: R01 AG029656 (JHS) and R03 AG040624(SD), and P50 AG005138 (SD) from National Institute of Health, American Geriatrics Society (SD) and the Foundation of Anesthesia Education and Research (SD). Product support was obtained from CASMED and Covidien. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037410; Casati A, 2005, ANESTH ANALG, V101, P740, DOI 10.1213/01.ane.0000166974.96219.cd; de Tournay-Jette E, 2011, J CARDIOTHOR VASC AN, V25, P95, DOI 10.1053/j.jvca.2010.03.019; Dharmavaram S, 2006, SPINE, V31, P1388, DOI 10.1097/01.brs.0000218485.96713.44; Edgcombe H, 2008, BRIT J ANAESTH, V100, P165, DOI 10.1093/bja/aem380; Fischer GW, 2008, SEMIN CARDIOTHORAC V, V12, P60, DOI 10.1177/1089253208316443; Ganjoo P, 1998, ANESTHESIOLOGY, V88, P429, DOI 10.1097/00000542-199802000-00022; Grille P, 2005, NEUROCIRUGIA, V16, P411; Heringlake M, 2011, ANESTHESIOLOGY, V114, P58, DOI 10.1097/ALN.0b013e3181fef34e; Hojlund J, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/647258; Kazan R, 2009, BRIT J ANAESTH, V103, P811, DOI 10.1093/bja/aep309; Lawrence CJ, 1996, ANESTH ANALG, V83, P1160, DOI 10.1097/00000539-199612000-00005; Nekludov M, 2006, ACTA ANAESTH SCAND, V50, P932, DOI 10.1111/j.1399-6576.2006.01099.x; Rasmussen JH, 2007, EUR J APPL PHYSIOL, V101, P369, DOI 10.1007/s00421-007-0513-9; Rasmussen P, 2007, J CEREBR BLOOD F MET, V27, P1082, DOI 10.1038/sj.jcbfm.9600416; Reinprecht A, 2003, CRIT CARE MED, V31, P1831, DOI 10.1097/01.CCM.0000063453.93855.0A	16	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106387	10.1371/journal.pone.0106387	http://dx.doi.org/10.1371/journal.pone.0106387			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216265	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774300012
J	Li, QX; Yan, CY; Xu, HS; Wang, Z; Long, JF; Li, WQ; Wu, JP; Yin, P; Yan, N				Li, Quanxiu; Yan, Chuangye; Xu, Huisha; Wang, Zheng; Long, Jiafu; Li, Wenqi; Wu, Jianping; Yin, Ping; Yan, Nieng			Examination of the Dimerization States of the Single-stranded RNA Recognition Protein Pentatricopeptide Repeat 10 (PPR10)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODULAR RECOGNITION; RESTORES FERTILITY; STRUCTURAL BASIS; SIGNAL PEPTIDES; BINDING; IDENTIFICATION; STABILIZES; PREDICTION; MECHANISM; INSIGHTS	Pentatricopeptide repeat (PPR) proteins, particularly abundant in plastids and mitochrondria of angiosperms, include a large number of sequence-specific RNA binding proteins that are involved in diverse aspects of organelle RNA metabolisms. PPR proteins contain multiple tandom repeats, and each repeat can specifically recognize a RNA base through residues 2, 5, and 35 in a modular fashion. The crystal structure of PPR10 from maize chloroplast exhibits dimeric existence both in the absence and presence of the 18-nucleotide psaJ RNA element. However, previous biochemical analysis suggested a monomeric shift of PPR10 upon RNA binding. In this report, we show that the amino-terminal segments of PPR10 determine the dimerization state of PPR10. A single amino acid alteration of cysteine to serine within repeat 10 of PPR10 further drives dimerization of PPR10. The biochemical elucidation of the determinants for PPR10 dimerization may provide an important foundation to understand the working mechanisms of PPR proteins underlying their diverse physiological functions.	[Li, Quanxiu; Li, Wenqi; Yan, Nieng] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Li, Quanxiu; Yan, Chuangye; Li, Wenqi; Wu, Jianping; Yan, Nieng] Tsinghua Univ, Sch Life Sci, Ctr Struct Biol, Beijing 100084, Peoples R China; [Li, Quanxiu; Yan, Chuangye; Li, Wenqi; Wu, Jianping; Yan, Nieng] Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Yan, Chuangye; Wu, Jianping] Tsinghua Univ, Minist Educ, Key Lab Prot Sci, Beijing 100084, Peoples R China; [Xu, Huisha; Wang, Zheng; Long, Jiafu] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Xu, Huisha; Wang, Zheng; Long, Jiafu] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Yin, Ping] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China; [Yin, Ping] Huazhong Agr Univ, Natl Ctr Plant Gene Res, Wuhan 430070, Peoples R China; [Yin, Ping] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Nankai University; Nankai University; Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University	Yin, P (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Peoples R China.	yinping@mail.hzau.edu.cn; nyan@tsinghua.edu.cn	Long, Jiafu/B-7420-2012; Yan, Chuangye/AAJ-5832-2021	Long, Jiafu/0000-0002-6625-0147; Yan, Chuangye/0000-0001-9338-8048	Ministry of Science and Technology Grant [2011CB910501]; National Natural Science Foundation of China [91017011, 31070644, 31200567]; Fundamental Research Funds for the Central Universities [2662014PY026]; Howard Hughes Medical Institute	Ministry of Science and Technology Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by Ministry of Science and Technology Grant 2011CB910501 (to N. Y.) and Projects 91017011 (to N. Y.), 31070644 (to N. Y.), and 31200567 (to P. Y.) of the National Natural Science Foundation of China and Project 2662014PY026 (to P. Y.) of the Fundamental Research Funds for the Central Universities.; Supported in part by an international early career scientist grant from the Howard Hughes Medical Institute. To whom correspondence may be addressed: School of Life Sciences and School of Medicine, Tsinghua University, Beijing 100084, China. E-mail: nyan@tsinghua.edu.cn.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban T, 2013, J BIOL CHEM, V288, P31540, DOI 10.1074/jbc.M113.496828; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Beick S, 2008, MOL CELL BIOL, V28, P5337, DOI 10.1128/MCB.00563-08; Bentolila S, 2002, P NATL ACAD SCI USA, V99, P10887, DOI 10.1073/pnas.102301599; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cushing DA, 2005, PLANTA, V221, P424, DOI 10.1007/s00425-004-1452-x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Desloire S, 2003, EMBO REP, V4, P588, DOI 10.1038/sj.embor.embor848; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2541; Filipovska A, 2012, MOL BIOSYST, V8, P699, DOI 10.1039/c2mb05392f; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Hu J, 2012, PLANT CELL, V24, P109, DOI 10.1105/tpc.111.093211; Kang CB, 2013, SCI REP-UK, V3, DOI 10.1038/srep02985; Ke JY, 2013, NAT STRUCT MOL BIOL, V20, P1377, DOI 10.1038/nsmb.2710; Khrouchtchova A, 2012, RNA, V18, P1197, DOI 10.1261/rna.032623.112; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Main ERG, 2003, STRUCTURE, V11, P497, DOI 10.1016/S0969-2126(03)00076-5; Meierhoff K, 2003, PLANT CELL, V15, P1480, DOI 10.1105/tpc.010397; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Nakamura T, 2003, EUR J BIOCHEM, V270, P4070, DOI 10.1046/j.1432-1033.2003.03796.x; Nakamura T, 2012, PLANT CELL PHYSIOL, V53, P1171, DOI 10.1093/pcp/pcs069; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park HC, 2011, MOL CELLS, V32, P143, DOI 10.1007/s10059-011-2297-3; Pfalz J, 2009, EMBO J, V28, P2042, DOI 10.1038/emboj.2009.121; Prikryl J, 2011, P NATL ACAD SCI USA, V108, P415, DOI 10.1073/pnas.1012076108; Saha D, 2007, PLANT PHYSIOL BIOCH, V45, P521, DOI 10.1016/j.plaphy.2007.03.026; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schmitz-Linneweber C, 2006, PLANT CELL, V18, P2650, DOI 10.1105/tpc.106.046110; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Thebault P, 2012, BIOCHEM J, V448, P321, DOI 10.1042/BJ20121448; Wang ZH, 2006, PLANT CELL, V18, P676, DOI 10.1105/tpc.105.038240; Williams-Carrier R, 2008, RNA, V14, P1930, DOI 10.1261/rna.1077708; Yagi Y, 2014, PLANT J, V78, P772, DOI 10.1111/tpj.12377; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651	43	15	17	1	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31503	31512		10.1074/jbc.M114.575472	http://dx.doi.org/10.1074/jbc.M114.575472			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25231995	Green Published, hybrid			2022-12-25	WOS:000344549900052
J	Kwan, HY; Fu, XQ; Liu, B; Chao, XJ; Chan, CL; Cao, HH; Su, T; Tse, AKW; Fong, WF; Yu, ZL				Kwan, Hiu Yee; Fu, Xiuqiong; Liu, Bin; Chao, Xiaojuan; Chan, Chi Leung; Cao, Huihui; Su, Tao; Tse, Anfernee Kai Wing; Fong, Wang Fun; Yu, Zhi-Ling			Subcutaneous Adipocytes Promote Melanoma Cell Growth by Activating the Akt Signaling Pathway ROLE OF PALMITIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COA-CARBOXYLASE-ALPHA; CANCER-CELLS; FATTY-ACIDS; MALIGNANT-MELANOMA; SYNTHASE; OBESITY; METABOLISM; PROLIFERATION; IDENTIFICATION; INHIBITION	Tumorigenesis involves constant communication between tumor cells and neighboring normal cells such as adipocytes. The canonical function of adipocytes is to store triglyceride and release fatty acids for other tissues. This study was aimed to find out if adipocytes promoted melanoma cell growth and to investigate the underlying mechanism. Here we isolated adipocytes from inguinal adipose tissue in mice and co-cultured with melanoma cells. We found that the co-cultured melanoma had higher lipid accumulation compared with mono-cultured melanoma. In addition, fluorescently labeled fatty acid BODIPY (R) FLC16 signal was detected in melanoma co-cultured with the adipocytes that had been loaded with the fluorescent dye, suggesting that the adipocytes provide fatty acids to melanoma cells. Compared with mono-cultured melanoma, co-cultured melanoma cells had a higher proliferation and phospho-Akt (Ser-473 and Thr-450) expression. Overexpression of Akt mutants in melanoma cells reduced the co-culture-enhanced proliferation. A lipidomic study showed that the co-cultured melanoma had an elevated palmitic acid level. Interestingly, we found that palmitic acid stimulated melanoma cell proliferation, changed the cell cycle distribution, and increased phospho-Akt (Ser-473 and Thr-450) and PI3K but not phospho-PTEN (phosphophosphatase and tensin homolog) expressions. More importantly, the palmitic acid-stimulated proliferation was further enhanced in the Akt-overexpressed melanoma cells and was reduced by LY294002 or knockdown of endogenous Akt or overexpression of Akt mutants. We also found that palmitic acid-pretreated B16F10 cells were grown to a significantly larger tumor in mice compared with control cells. Taken together, we suggest that adipocytes may serve as an exogenous source of palmitic acid that promotes melanoma cell growth by activating Akt.	[Tse, Anfernee Kai Wing; Fong, Wang Fun; Yu, Zhi-Ling] Hong Kong Baptist Univ, Sch Chinese Med, Ctr Canc & Inflammat Res, Kowloon Tong, Hong Kong, Peoples R China; [Liu, Bin] Guangzhou Med Univ, Guangzhou Inst Cardiovasc Dis, Guangzhou Key Lab Cardiovasc Dis, Guangzhou, Guangdong, Peoples R China; [Liu, Bin] Guangzhou Med Univ, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China	Hong Kong Baptist University; Guangzhou Medical University; Guangzhou Medical University	Kwan, HY (corresponding author), Hong Kong Baptist Univ, Sch Chinese Med, 7 Baptist Univ Rd, Kowloon Tong, Hong Kong, Peoples R China.	hykwan@hkbu.edu.hk; zlyu@hkbu.edu.hk		Yu, Zhiling/0000-0002-2979-9608; Tse, Kai Wing/0000-0002-0046-9808; Liu, Bin/0000-0003-2184-4723; KWAN, Hiu Yee/0000-0002-6088-7323; Fu, Xiu-Qiong/0000-0002-1458-9720	Research Grant Council of SAR of Hong Kong under GRF [HKBU262512, HKBU260613]; Hong Kong Baptist University [FRG2/13-14/016, FRG1/13-14/062, FRG2/12-13/039, FRG2/13-14/030]; Shenzhen STIC Grant [JCYJ20120829154222473]	Research Grant Council of SAR of Hong Kong under GRF; Hong Kong Baptist University; Shenzhen STIC Grant	This work was supported in part by the Research Grant Council of SAR of Hong Kong under GRF (HKBU262512) and Hong Kong Baptist University Grants FRG2/13-14/016 and FRG1/13-14/062 and by Shenzhen STIC Grant JCYJ20120829154222473 (to Z.-L. Y.). This work was also supported by Research Grant Council of SAR of Hong Kong under GRF (HKBU260613) and Hong Kong Baptist University Grant FRG2/12-13/039 and FRG2/13-14/030 (to H. Y. K.).	Abaffy T, 2013, METABOLOMICS, V9, P998, DOI 10.1007/s11306-013-0523-z; Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Ahmadian M, 2007, FUTURE LIPIDOL, V2, P229, DOI 10.2217/17460875.2.2.229; Amemori Sadahiro, 2007, Am J Physiol Gastrointest Liver Physiol, V292, pG923; Bai JN, 1997, BIOCHEMISTRY-US, V36, P8840, DOI 10.1021/bi970145r; Brandon EL, 2009, CANCER BIOL THER, V8, P1871, DOI 10.4161/cbt.8.19.9650; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Charriere G, 2003, J BIOL CHEM, V278, P9850, DOI 10.1074/jbc.M210811200; D'Esposito V, 2012, DIABETOLOGIA, V55, P2811, DOI 10.1007/s00125-012-2629-7; Dennis LK, 2008, ANN EPIDEMIOL, V18, P214, DOI 10.1016/j.annepidem.2007.09.003; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Ellerhorst JA, 2010, ONCOL REP, V23, P901, DOI 10.3892/or_00000713; Furuta E, 2010, BBA-REV CANCER, V1805, P141, DOI 10.1016/j.bbcan.2010.01.005; Furuya Y, 1997, ANTICANCER RES, V17, P4589; Gazi E, 2007, J LIPID RES, V48, P1846, DOI 10.1194/jlr.M700131-JLR200; Hardy S, 2005, J BIOL CHEM, V280, P13285, DOI 10.1074/jbc.M410922200; Harvey AE, 2011, ANN NY ACAD SCI, V1229, P45, DOI 10.1111/j.1749-6632.2011.06096.x; Jung JI, 2015, INT J CANCER, V136, P258, DOI 10.1002/ijc.28983; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; Kushiro K, 2012, CANCER MICROENVIRON, V5, P73, DOI 10.1007/s12307-011-0087-2; Kushiro K, 2011, CLIN EXP METASTAS, V28, P877, DOI 10.1007/s10585-011-9418-4; Kwan HY, 2013, J PROTEOME RES, V12, P1387, DOI 10.1021/pr3010327; Louie SM, 2013, BBA-MOL CELL BIOL L, V1831, P1566, DOI 10.1016/j.bbalip.2013.07.008; Madhunapantula Subbarao V, 2011, Enzyme Res, V2011, P327923, DOI 10.4061/2011/327923; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Nieman KM, 2013, BBA-MOL CELL BIOL L, V1831, P1533, DOI 10.1016/j.bbalip.2013.02.010; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Peng G, 2011, ENDOCRINOLOGY, V152, P2206, DOI 10.1210/en.2010-1369; Pizer ES, 1996, CANCER RES, V56, P745; Prados J, 2010, EXP DERMATOL, V19, P363, DOI 10.1111/j.1600-0625.2009.00914.x; Proebstle TM, 1996, EUR J CANCER, V32A, P1664, DOI 10.1016/0959-8049(95)00534-X; Pu J, 2011, J LIPID RES, V52, P1319, DOI 10.1194/jlr.M011254; Ralph SJ, 2010, MOL ASPECTS MED, V31, P29, DOI 10.1016/j.mam.2009.12.006; Roberts DL, 2010, ANNU REV MED, V61, P301, DOI 10.1146/annurev.med.080708.082713; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Seguin F, 2012, BRIT J CANCER, V107, P977, DOI 10.1038/bjc.2012.355; Sergentanis TN, 2013, EUR J CANCER, V49, P642, DOI 10.1016/j.ejca.2012.08.028; Vinciguerra M, 2008, GASTROENTEROLOGY, V134, P268, DOI 10.1053/j.gastro.2007.10.010; Wang X, 2011, FREE RADICAL BIO MED, V51, P539, DOI 10.1016/j.freeradbiomed.2011.04.019; Wang XL, 2006, DIABETES, V55, P2301, DOI 10.2337/db05-1574; Wang Z, 2014, J NEUROSCI RES, V92, P574, DOI 10.1002/jnr.23342; Wangari-Talbot Janet, 2013, Frontiers in Genetics, V3, P330, DOI 10.3389/fgene.2012.00330; Yajima I, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/354191	49	50	51	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30525	30537		10.1074/jbc.M114.593210	http://dx.doi.org/10.1074/jbc.M114.593210			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25228694	hybrid, Green Published			2022-12-25	WOS:000344549700031
J	Parvin, AA; Pranap, AR; Shalini, U; Devendran, A; Baker, JE; Dhanasekaran, A				Parvin, Asiya A.; Pranap, Raj A.; Shalini, U.; Devendran, Ajay; Baker, John E.; Dhanasekaran, Anuradha			Erythropoietin Protects Cardiomyocytes from Cell Death during Hypoxia/Reperfusion Injury through Activation of Survival Signaling Pathways	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; SPECIES-INDUCED APOPTOSIS; OXIDATIVE STRESS; RENAL INJURY; MITOCHONDRIAL; NECROSIS; ISCHEMIA/REPERFUSION; DEGENERATION; MYOCARDIUM; MECHANISMS	Hypoxia/Reoxygenation (H/R) cardiac injury is of great importance in understanding Myocardial Infarctions, which affect a major part of the working population causing debilitating side effects and often-premature mortality. H/R injury primarily consists of apoptotic and necrotic death of cardiomyocytes due to a compromise in the integrity of the mitochondrial membrane. Major factors associated in the deregulation of the membrane include fluctuating reactive oxygen species (ROS), deregulation of mitochondrial permeability transport pore (MPTP), uncontrolled calcium (Ca2+) fluxes, and abnormal caspase-3 activity. Erythropoietin (EPO) is strongly inferred to be cardioprotective and acts by inhibiting the above-mentioned processes. Surprisingly, the underlying mechanism of EPO's action and H/R injury is yet to be fully investigated and elucidated. This study examined whether EPO maintains Ca2+ homeostasis and the mitochondrial membrane potential (Delta Psi(m)) in cardiomyocytes when subjected to H/R injury and further explored the underlying mechanisms involved. H9C2 cells were exposed to different concentrations of EPO post-H/R, and 20 U/ml EPO was found to significantly increase cell viability by inhibiting the intracellular production of ROS and caspase-3 activity. The protective effect of EPO was abolished when H/R-induced H9C2 cells were treated with Wortmannin, an inhibitor of Akt, suggesting the mechanism of action through the activation Akt, a major survival pathway.	[Parvin, Asiya A.; Pranap, Raj A.; Shalini, U.; Devendran, Ajay; Dhanasekaran, Anuradha] Anna Univ, Ctr Biotechnol, Chennai 600025, Tamil Nadu, India; [Baker, John E.] Med Coll Wisconsin, Dept Surg, Div Cardiothorac Surg, Milwaukee, WI 53226 USA	Anna University; Anna University Chennai; Medical College of Wisconsin	Dhanasekaran, A (corresponding author), Anna Univ, Ctr Biotechnol, Chennai 600025, Tamil Nadu, India.		Baker, John/V-8897-2019; Dhanasekaran, Anuradha/AFH-8265-2022; Dhanasekaran, Anuradha/AAF-3160-2022	Baker, John/0000-0001-7899-3266; Dhanasekaran, Anuradha/0000-0002-0195-9681; Arun, Raj Pranap/0000-0001-5746-4728	UGC-Maulana Azad fellowship; University Grants Commission, New Delhi, India	UGC-Maulana Azad fellowship; University Grants Commission, New Delhi, India(University Grants Commission, India)	Asiya Parvin acknowledges the financial support through the UGC-Maulana Azad fellowship sponsored by the University Grants Commission, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahman M, 2004, SHOCK, V22, P63, DOI 10.1097/01.shk.00001276869.21260.9d; Braun JS, 1999, NAT MED, V5, P298, DOI 10.1038/6514; Brines M, 2006, KIDNEY INT, V70, P246, DOI 10.1038/sj.ki.5001546; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Cai ZQ, 2004, CIRCULATION, V109, P2050, DOI 10.1161/01.CIR.0000127954.98131.23; Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100; CasciolaRosen L, 1996, J EXP MED, V183, P1957, DOI 10.1084/jem.183.5.1957; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Chen ZY, 2001, AM J PHYSIOL-HEART C, V280, pH2313, DOI 10.1152/ajpheart.2001.280.5.H2313; Cho KS, 1999, INVEST OPHTH VIS SCI, V40, P911; Chong ZZ, 2002, CIRCULATION, V106, P2973, DOI 10.1161/01.CIR.0000039103.58920.1F; Chung YM, 2008, J BIOL CHEM, V283, P33763, DOI 10.1074/jbc.M805334200; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Cuzzocrea S, 2005, ARTHRITIS RHEUM, V52, P940, DOI 10.1002/art.20875; Dhanasekaran A, 2008, AM J PHYSIOL-HEART C, V294, pH724, DOI 10.1152/ajpheart.00979.2007; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; He Y, 2008, INVEST OPHTH VIS SCI, V49, P1447, DOI 10.1167/iovs.07-1361; Higuchi M, 1998, ONCOGENE, V17, P2753, DOI 10.1038/sj.onc.1202211; Johnson DW, 2006, KIDNEY INT, V69, P1806, DOI 10.1038/sj.ki.5000356; Joshi DC, 2011, JOVE-J VIS EXP, DOI 10.3791/2704; Kao R, 2007, CRIT CARE, V11, DOI 10.1186/cc5920; Koshimura K, 1999, J NEUROCHEM, V72, P2565, DOI 10.1046/j.1471-4159.1999.0722565.x; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Le Bras M., 2005, REACTIVE OXYGEN SPEC; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Lingadurai S, 2011, INDIAN J PHARMACOL, V43, P143, DOI 10.4103/0253-7613.77348; Liu YY, 2010, AM J PHYSIOL-RENAL, V298, pF1033, DOI 10.1152/ajprenal.00518.2009; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Mudalagiri NR, 2008, BRIT J PHARMACOL, V153, P50, DOI 10.1038/sj.bjp.0707461; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Naganska E, 2010, FOLIA NEUROPATHOL, V48, P35; O'Malley YQ, 2003, AM J PHYSIOL-LUNG C, V284, pL420, DOI 10.1152/ajplung.00316.2002; Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200; Patel NSA, 2004, KIDNEY INT, V66, P983, DOI 10.1111/j.1523-1755.2004.00847.x; Pitrak DL, 1996, J CLIN INVEST, V98, P2714, DOI 10.1172/JCI119096; Rossert J, 2005, NEPHROL DIAL TRANSPL, V20, P1025, DOI 10.1093/ndt/gfh800; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Schmeding M, 2009, TRANSPL INT, V22, P738, DOI 10.1111/j.1432-2277.2009.00861.x; Sepodes B, 2006, TRANSPL INT, V19, P919, DOI 10.1111/j.1432-2277.2006.00366.x; Shang YC, 2012, AGING-US, V4, P187, DOI 10.18632/aging.100440; Sharples EJ, 2005, NAT CLIN PRACT NEPHR, V1, P87, DOI 10.1038/ncpneph0042; Sharples EJ, 2004, J AM SOC NEPHROL, V15, P2115, DOI 10.1097/01.ASN.0000135059.67385.5D; Skarka L, 2002, PHYSIOL RES, V51, P425; Taniguchi N, 2010, CIRC J, V74, P2365, DOI 10.1253/circj.CJ-10-0267; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Tramontano AF, 2003, BIOCHEM BIOPH RES CO, V308, P990, DOI 10.1016/S0006-291X(03)01503-1; Vesey DA, 2004, NEPHROL DIAL TRANSPL, V19, P348, DOI 10.1093/ndt/gfg547; Wang G, 2008, FREE RADICAL RES, V42, P435, DOI 10.1080/10715760802074462; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	51	25	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107453	10.1371/journal.pone.0107453	http://dx.doi.org/10.1371/journal.pone.0107453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25237819	Green Published, gold, Green Submitted			2022-12-25	WOS:000342491600027
J	Eapen, V; Dadds, M; Barnett, B; Kohlhoff, J; Khan, F; Radom, N; Silove, DM				Eapen, Valsamma; Dadds, Mark; Barnett, Bryanne; Kohlhoff, Jane; Khan, Feroza; Radom, Naomi; Silove, Derrick M.			Separation Anxiety, Attachment and Inter-Personal Representations: Disentangling the Role of Oxytocin in the Perinatal Period	PLOS ONE			English	Article							POSTNATAL DEPRESSION SCALE; PLASMA OXYTOCIN; MATERNAL-BEHAVIOR; AFFILIATIVE BEHAVIOR; STRESS RESPONSES; BLOOD-PRESSURE; INFANT; VASOPRESSIN; PREGNANCY; CORTISOL	In this paper, we aimed to assess cross-sectionally and longitudinally associations between disturbances in maternal early attachment experiences, symptoms of separation anxiety and depression and oxytocin plasma levels. We examined a mediational model that tested the hypothesis that anxious attachment style arising from the mothers' early bonding experiences with her own parents was associated with high levels of separation anxiety which, via its impact on depression, was associated with reduced levels of oxytocin in the postnatal period. Data is reported on a structured sample of 127 women recruited during pregnancy from a general hospital antenatal clinic and an initial follow up cohort of 57 women who were re-assessed at 3-months post-partum. We found an association between lower oxytocin level in the post partum period and symptoms of separation anxiety and depression during pregnancy, as well as maternal negative interpersonal representations, upbringing attributes and anxious attachment style. Further meditational analysis revealed that the unique association between anxious attachment and depression is mediated by separation anxiety and that depressed mood mediated the relationship between separation anxiety and oxytocin. In conjunction with evidence from the literature suggesting that lower oxytocin level is associated with bonding difficulties, our findings have significant implications for understanding the biological processes underpinning adverse attachment experiences, negative affect state, and mother-to- infant bonding difficulties.	[Eapen, Valsamma; Barnett, Bryanne; Khan, Feroza; Radom, Naomi; Silove, Derrick M.] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Eapen, Valsamma; Khan, Feroza; Radom, Naomi] South West Sydney Local Hlth Dist, Acad Unit Child Psychiat, Liverpool, Merseyside, England; [Dadds, Mark] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Barnett, Bryanne; Kohlhoff, Jane] Karitane, Villawood, NSW, Australia; [Silove, Derrick M.] South West Sydney Local Hlth Dist, Psychiat Res & Teaching Unit, Ctr Populat Mental Hlth Res, Liverpool, Merseyside, England	University of New South Wales Sydney; University of New South Wales Sydney	Eapen, V (corresponding author), Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia.	v.eapen@unsw.edu.au	Eapen, Valsamma N/N-9608-2017	Eapen, Valsamma N/0000-0001-6296-8306; Dadds, Mark/0000-0002-2900-1715; Kohlhoff, Jane/0000-0001-6202-6685	Australian Research Council (ARC) [LP110100334]; ARC; Partners Organizations Karitane; South Western Sydney Local Health District	Australian Research Council (ARC)(Australian Research Council); ARC(Australian Research Council); Partners Organizations Karitane; South Western Sydney Local Health District	This study was funded by an Australian Research Council (ARC) Linkage grant (LP110100334), ARC website: www.arc.gov.au, with financial and in-kind contributions from Partners Organizations Karitane, and South Western Sydney Local Health District. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carter CS, 1998, PSYCHONEUROENDOCRINO, V23, P779; Champagne F, 2001, P NATL ACAD SCI USA, V98, P12736, DOI 10.1073/pnas.221224598; Champagne FA, 2008, FRONT NEUROENDOCRIN, V29, P386, DOI 10.1016/j.yfrne.2008.03.003; CHARD T, 1970, J ENDOCRINOL, V48, P223, DOI 10.1677/joe.0.0480223; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; DAWOOD MY, 1978, OBSTET GYNECOL, V51, P138; Eapen V, 2012, J PERINAT MED, DOI 10.1515/jpm-2012-0111; Eapen V, 2013, J PERINAT MED, V41, P159, DOI 10.1515/jpm-2012-0111; Eapen V, 2012, INT J WOMENS HEALTH, V4, P251, DOI 10.2147/IJWH.S30981; Ebner NC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00487; Feeney J., 1994, ATTACHMENT ADULTS CL; Feldman R, 1999, J CHILD PSYCHOL PSYC, V40, P929, DOI 10.1017/S0021963099004308; Feldman R, 2003, DEV PSYCHOBIOL, V43, P109, DOI 10.1002/dev.10126; Feldman R, 2007, PSYCHOL SCI, V18, P965, DOI 10.1111/j.1467-9280.2007.02010.x; Feldman R, 2010, HORM BEHAV, V58, P669, DOI 10.1016/j.yhbeh.2010.06.005; Francis DD, 2000, J NEUROENDOCRINOL, V12, P1145, DOI 10.1046/j.1365-2826.2000.00599.x; Galbally M, 2011, HARVARD REV PSYCHIAT, V19, P1, DOI 10.3109/10673229.2011.549771; Gordon I, 2008, PSYCHOPHYSIOLOGY, V45, P349, DOI 10.1111/j.1469-8986.2008.00649.x; Gordon I, 2010, BIOL PSYCHIAT, V68, P377, DOI 10.1016/j.biopsych.2010.02.005; Grant KA, 2008, J AFFECT DISORDERS, V108, P101, DOI 10.1016/j.jad.2007.10.002; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Grewen KM, 2005, PSYCHOSOM MED, V67, P531, DOI 10.1097/01.psy.0000170341.88395.47; Heinrichs M, 2003, BIOL PSYCHIAT, V54, P1389, DOI 10.1016/S0006-3223(03)00465-7; Hienrichs M, 2007, CURR OPIN PSYCHIATR, V20, P158, DOI 10.1097/YCO.0b013e3280146a13; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; Leuine A, 2007, PEPTIDES, V28, P1162, DOI 10.1016/j.peptides.2007.04.016; Light KC, 2005, BIOL PSYCHOL, V69, P5, DOI 10.1016/j.biopsycho.2004.11.002; Lim MM, 2006, HORM BEHAV, V50, P506, DOI 10.1016/j.yhbeh.2006.06.028; Manicavasagar V, 2003, COMPR PSYCHIAT, V44, P146, DOI 10.1053/comp.2003.50024; Manicavasagar V, 2009, AUST NZ J PSYCHIAT, V43, P167, DOI 10.1080/00048670802607139; Matthiesen AS, 2001, BIRTH-ISS PERINAT C, V28, P13, DOI 10.1046/j.1523-536x.2001.00013.x; McErlean R, 2012, PERINATAL DEPRESSION, P39; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; MURRAY L, 1990, BRIT J PSYCHIAT, V157, P288, DOI 10.1192/bjp.157.2.288; Murray L, 2010, J AFFECT DISORDERS, V122, P218, DOI 10.1016/j.jad.2009.06.034; Neumann ID, 2013, PSYCHONEUROENDOCRINO, V38, P1985, DOI 10.1016/j.psyneuen.2013.03.003; Parent CI, 2008, DEV PSYCHOBIOL, V50, P767, DOI 10.1002/dev.20342; Pariante CM, 2003, J NEUROENDOCRINOL, V15, P811; Parker G, 1997, PSYCHOL MED, V27, P1193, DOI 10.1017/S003329179700545X; Pedersen CA, 2006, GENES BRAIN BEHAV, V5, P274, DOI 10.1111/j.1601-183X.2005.00162.x; Pedersen CA, 2002, STRESS, V5, P259, DOI 10.1080/1025389021000037586; ROBINSON AG, 1975, J CLIN INVEST, V55, P360, DOI 10.1172/JCI107939; Ross HE, 2009, NEUROSCIENCE, V162, P892, DOI 10.1016/j.neuroscience.2009.05.055; Ross HE, 2009, J NEUROSCI, V29, P1312, DOI 10.1523/JNEUROSCI.5039-08.2009; Russell JA, 2003, FRONT NEUROENDOCRIN, V24, P27, DOI 10.1016/S0091-3022(02)00104-8; Scantamburlo G, 2007, PSYCHONEUROENDOCRINO, V32, P407, DOI 10.1016/j.psyneuen.2007.01.009; Skrundz M, 2011, NEUROPSYCHOPHARMACOL, V36, P1886, DOI 10.1038/npp.2011.74; SOFRONIEW MV, 1983, PROG BRAIN RES, V60, P101; Spielberger CD, 1983, BIB, V2010, P180; STOCK S, 1989, ACTA OBSTET GYN SCAN, V68, P75, DOI 10.3109/00016348909087694; Strathearn L, 2012, HORM BEHAV, V61, P429, DOI 10.1016/j.yhbeh.2012.01.014; Taylor A, 2005, ARCH WOMEN MENT HLTH, V8, P45, DOI 10.1007/s00737-005-0074-z; Taylor SE, 2006, PSYCHOSOM MED, V68, P238, DOI 10.1097/01.psy.0000203242.95990.74; Tops M, 2007, PSYCHOPHYSIOLOGY, V44, P444, DOI 10.1111/j.1469-8986.2007.00510.x; Uvnas-Moberg K, 1998, PSYCHONEUROENDOCRINO, V23, P819, DOI 10.1016/S0306-4530(98)00056-0; vanderPost JAM, 1997, J ENDOCRINOL, V152, P345, DOI 10.1677/joe.0.1520345; Wang ZX, 2000, J NEUROENDOCRINOL, V12, P111, DOI 10.1046/j.1365-2826.2000.00435.x; Weisman O, 2013, PSYCHONEUROENDOCRINO, V38, P694, DOI 10.1016/j.psyneuen.2012.08.011; Wotjak CT, 1998, NEUROSCIENCE, V85, P1209, DOI 10.1016/S0306-4522(97)00683-0	60	61	62	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107745	10.1371/journal.pone.0107745	http://dx.doi.org/10.1371/journal.pone.0107745			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP5MS	25229827	gold, Green Published, Green Submitted			2022-12-25	WOS:000342123900070
J	Dabral, N; Martha-Moreno-Lafont; Sriranganathan, N; Vemulapalli, R				Dabral, Neha; Martha-Moreno-Lafont; Sriranganathan, Nammalwar; Vemulapalli, Ramesh			Oral Immunization of Mice with Gamma-Irradiated Brucella neotomae Induces Protection against Intraperitoneal and Intranasal Challenge with Virulent B. abortus 2308	PLOS ONE			English	Article							BALB/C MICE; HUMORAL IMMUNITY; T-CELLS; MELITENSIS; VACCINES; LIPOPOLYSACCHARIDE; INFECTION; RESPONSES; RB51; EXTRACTION	Brucella spp. are Gram-negative, facultative intracellular coccobacilli that cause one of the most frequently encountered zoonosis worldwide. Humans naturally acquire infection through consumption of contaminated dairy and meat products and through direct exposure to aborted animal tissues and fluids. No vaccine against brucellosis is available for use in humans. In this study, we tested the ability of orally inoculated gamma-irradiated B. neotomae and B. abortus RB51 in a prime-boost immunization approach to induce antigen-specific humoral and cell mediated immunity and protection against challenge with virulent B. abortus 2308. Heterologous prime-boost vaccination with B. abortus RB51 and B. neotomae and homologous prime-boost vaccination of mice with B. neotomae led to the production of serum and mucosal antibodies specific to the smooth LPS. The elicited serum antibodies included the isotypes of IgM, IgG1, IgG2a, IgG2b and IgG3. All oral vaccination regimens induced antigen-specific CD4(+) and CD8(+) T cells capable of secreting IFN-gamma and TNF-alpha. Upon intraperitoneal challenge, mice vaccinated with B. neotomae showed the highest level of resistance against virulent B. abortus 2308 colonization in spleen and liver. Experiments with different doses of B. neotomae showed that all tested doses of 10(9), 10(10) and 10(11) CFU-equivalent conferred significant protection against the intra-peritoneal challenge. However, a dose of 10(11) CFU-equivalent of B. neotomae was required for affording protection against intranasal challenge as shown by the reduced bacterial colonization in spleens and lungs. Taken together, these results demonstrate the feasibility of using gamma-irradiated B. neotomae as an effective and safe oral vaccine to induce protection against respiratory and systemic infections with virulent Brucella.	[Dabral, Neha; Martha-Moreno-Lafont; Vemulapalli, Ramesh] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Martha-Moreno-Lafont] Inst Politecn Nacl, Dept Inmunol, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico; [Sriranganathan, Nammalwar] Virginia Tech, Dept Biomed Sci & Pathobiol, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Instituto Politecnico Nacional - Mexico; Virginia Polytechnic Institute & State University	Vemulapalli, R (corresponding author), Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.	rvemulap@purdue.edu		Vemulapalli, Ramesh/0000-0002-2473-2906; Moreno-Lafont, Martha C/0000-0003-2896-5819	Public Health Service grant from the National Institute of Allergy and Infectious Diseases [AI065667-01A2]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065667] Funding Source: NIH RePORTER	Public Health Service grant from the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by Public Health Service grant AI065667-01A2 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAYA LN, 1990, INFECT IMMUN, V58, P254, DOI 10.1128/IAI.58.1.254-256.1990; ARAYA LN, 1989, J IMMUNOL, V143, P3330; BLASCO JM, 1993, LANCET, V342, P805, DOI 10.1016/0140-6736(93)91571-3; Clapp B, 2011, INFECT IMMUN, V79, P4165, DOI 10.1128/IAI.05080-11; Cloeckaert A, 1996, FEMS MICROBIOL LETT, V145, P1, DOI 10.1016/0378-1097(96)00373-4; Dietrich G, 2003, VACCINE, V21, P678, DOI 10.1016/S0264-410X(02)00579-0; Ferreira Pedro, 2008, Rev Port Cardiol, V27, P1309; Ficht TA, 2009, VACCINE, V27, pD40, DOI 10.1016/j.vaccine.2009.08.058; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Gonzalez D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002760; Izadjoo MJ, 2004, INFECT IMMUN, V72, P4031, DOI 10.1128/IAI.72.7.4031-4039.2004; Kahl-McDonagh MM, 2006, INFECT IMMUN, V74, P4048, DOI 10.1128/IAI.01787-05; MONTARAZ JA, 1986, INFECT IMMUN, V53, P245, DOI 10.1128/IAI.53.2.245-251.1986; MORRISON DC, 1975, J BIOL CHEM, V250, P2911; Moustafa D, 2011, VACCINE, V29, P784, DOI 10.1016/j.vaccine.2010.11.018; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Murphy EA, 2001, IMMUNOLOGY, V103, P511, DOI 10.1046/j.1365-2567.2001.01258.x; Pasquali P, 2003, INFECT IMMUN, V71, P2326, DOI 10.1128/IAI.71.5.2326-2330.2003; Perkins SD, 2010, FEMS MICROBIOL REV, V34, P379, DOI 10.1111/j.1574-6976.2010.00211.x; PHILLIPS M, 1989, AM J VET RES, V50, P311; Sanakkayala N, 2005, CLIN DIAGN LAB IMMUN, V12, P1429, DOI 10.1128/CDLI.12.12.1429-1436.2005; SCHURIG GG, 1991, VET MICROBIOL, V28, P171, DOI 10.1016/0378-1135(91)90091-S; Vemulapalli R, 1998, INFECT IMMUN, V66, P5684, DOI 10.1128/IAI.66.12.5684-5691.1998; Vitry MA, 2014, J IMMUNOL, V192, P3740, DOI 10.4049/jimmunol.1302561; YOUNG EJ, 1995, CLIN INFECT DIS, V21, P283, DOI 10.1093/clinids/21.2.283; Zhan YF, 1996, INFECT IMMUN, V64, P2782, DOI 10.1128/IAI.64.7.2782-2786.1996	26	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107180	10.1371/journal.pone.0107180	http://dx.doi.org/10.1371/journal.pone.0107180			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225910	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700033
J	Kanteti, R; Dhanasingh, I; Kawada, I; Lennon, FE; Arif, Q; Bueno, R; Hasina, R; Husain, AN; Vigneswaran, W; Seiwert, T; Kindler, HL; Salgia, R				Kanteti, Rajani; Dhanasingh, Immanuel; Kawada, Ichiro; Lennon, Frances E.; Arif, Qudsia; Bueno, Raphael; Hasina, Rifat; Husain, Aliya N.; Vigneswaran, Wickii; Seiwert, Tanguy; Kindler, Hedy L.; Salgia, Ravi			MET and PI3K/mTOR as a Potential Combinatorial Therapeutic Target in Malignant Pleural Mesothelioma	PLOS ONE			English	Article							CELL LUNG-CANCER; PI3-KINASE/MTOR INHIBITOR NVP-BEZ235; C-MET; ARQ 197; CYTOTOXIC ACTIVITY; ANTITUMOR-ACTIVITY; MAMMALIAN TARGET; PHASE-III; GROWTH; MUTATIONS	Malignant pleural mesothelioma (MPM) is an aggressive disease with a poor prognosis. Studies have shown that both MET and its key downstream intracellular signaling partners, PI3K and mTOR, are overexpressed in MPM. Here we determined the combinatorial therapeutic efficacy of a new generation small molecule inhibitor of MET, ARQ 197, and dual PI3K/mTOR inhibitors NVP-BEZ235 and GDC-0980 in mesothelioma cell and mouse xenograft models. Cell viability results show that mesothelioma cell lines were sensitive to ARQ 197, NVP-BEZ235 and GDC-0980 inhibitors. The combined use of ARQ 197 with either NVP-BEZ235 or GDC-0980, was synergistic (CI<1). Significant delay in wound healing was observed with ARQ 197 (p<0.001) with no added advantage of combining it with either NVP-BEZ235 or GDC-0980. ARQ 197 alone mainly induced apoptosis (20 +/- 2.36%) that was preceded by suppression of MAPK activity, while all the three suppressed cell cycle progression. Both GDC-0980 and NVP-BEZ235 strongly inhibited activities of PI3K and mTOR as evidenced from the phosphorylation status of AKT and S6 kinase. The above observation was further substantiated by the finding that a majority of the MPM archival samples tested revealed highly active AKT. While the single use of ARQ 197 and GDC-0980 inhibited significantly the growth of MPM xenografts (p<0.05, p<0.001 respectively) in mice, the combination of the above two drugs was highly synergistic (p<0.001). Our results suggest that the combined use of ARQ 197/NVP-BEZ235 and ARQ 197/GDC-0980 is far more effective than the use of the drugs singly in suppressing MPM tumor growth and motility and therefore merit further translational studies.	[Kanteti, Rajani; Dhanasingh, Immanuel; Kawada, Ichiro; Lennon, Frances E.; Hasina, Rifat; Seiwert, Tanguy; Kindler, Hedy L.; Salgia, Ravi] Univ Chicago, Dept Hematol Oncol, Chicago, IL 60637 USA; [Arif, Qudsia; Husain, Aliya N.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Bueno, Raphael] Harvard Univ, Sch Med, Dept Surg, Brigham & Womens Hosp, Boston, MA 02115 USA; [Vigneswaran, Wickii] Univ Chicago, Dept Surg, Chicago, IL 60637 USA	University of Chicago; University of Chicago; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Chicago	Salgia, R (corresponding author), Univ Chicago, Dept Hematol Oncol, Chicago, IL 60637 USA.	rsalgia@medicine.bsd.uchicago.edu		Dhanasingh, Immanuel/0000-0001-6044-869X	Department of Defense grant [528300-5400]; NATIONAL CANCER INSTITUTE [R01CA120528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	Department of Defense grant(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study is funded by Department of Defense grant to Ravi Salgia, grant no. 528300-5400. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Basilico C, 2013, CLIN CANCER RES, V19, P2381, DOI 10.1158/1078-0432.CCR-12-3459; Baumann P, 2009, EXP CELL RES, V315, P485, DOI 10.1016/j.yexcr.2008.11.007; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; Bi Y, 2013, HUM CELL; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Britton M, 2002, SEMIN ONCOL, V29, P18, DOI 10.1053/sonc.2002.30237; Campbell NP, 2011, SEMIN RESP CRIT CARE, V32, P102, DOI 10.1055/s-0031-1272874; Cao P, 2009, BRIT J CANCER, V100, P1267, DOI 10.1038/sj.bjc.6604995; Cedres S, 2012, LUNG CANCER, V77, P192, DOI 10.1016/j.lungcan.2012.02.022; Chen TH, 2011, ONCOGENE, V30, P153, DOI 10.1038/onc.2010.398; Cho DC, 2010, CLIN CANCER RES, V16, P3628, DOI 10.1158/1078-0432.CCR-09-3022; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; DAZZI H, 1990, BRIT J CANCER, V61, P924, DOI 10.1038/bjc.1990.207; de Melo M, 2006, J HISTOCHEM CYTOCHEM, V54, P855, DOI 10.1369/jhc.5A6807.2006; DeLuca A, 1997, NAT MED, V3, P913, DOI 10.1038/nm0897-913; Destro A, 2006, LUNG CANCER, V51, P207, DOI 10.1016/j.lungcan.2005.10.016; Dogan AU, 2006, CANCER RES, V66, P5063, DOI 10.1158/0008-5472.CAN-05-4642; Eathiraj S, 2011, J BIOL CHEM, V286, P20666, DOI 10.1074/jbc.M110.213801; Fei SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069104; Gandin Valentina, 2013, Genes Cancer, V4, P369, DOI 10.1177/1947601913486348; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Herrera VA, 2011, ANTICANCER RES, V31, P849; Hoang CD, 2004, CANCER RES, V64, P7479, DOI 10.1158/0008-5472.CAN-04-1898; Hoda MA, 2011, J THORAC ONCOL, V6, P852, DOI 10.1097/JTO.0b013e31820e1a25; Humbert M, 2013, BIOCHEM BIOPH RES CO, V431, P264, DOI 10.1016/j.bbrc.2012.12.120; Jagadeeswaran R, 2006, CANCER RES, V66, P352, DOI 10.1158/0008-5472.CAN-04-4567; Jagadeeswaran R, 2008, CANCER RES, V68, P132, DOI 10.1158/0008-5472.CAN-07-1998; Kanteti R, 2009, LAB INVEST, V89, P301, DOI 10.1038/labinvest.2008.168; Katayama R, 2013, CANCER RES, V73, P3087, DOI 10.1158/0008-5472.CAN-12-3256; Kawaguchi K, 2009, CARCINOGENESIS, V30, P1097, DOI 10.1093/carcin/bgp097; Liu R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-269; Liu TJ, 2009, MOL CANCER THER, V8, P2204, DOI 10.1158/1535-7163.MCT-09-0160; Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650; Ma PC, 2003, CANCER RES, V63, P6272; Markman B, 2012, ANN ONCOL, V23, P2399, DOI 10.1093/annonc/mds011; Miller TW, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3039; Miyoshi S, 2012, INT J ONCOL, V41, P449, DOI 10.3892/ijo.2012.1462; Munshi N, 2010, MOL CANCER THER, V9, P1544, DOI 10.1158/1535-7163.MCT-09-1173; Pass HI, 1999, CHEST, V116, p455S, DOI 10.1378/chest.116.suppl_3.455S; Roper J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025132; Saleh SN, 2009, J PHYSIOL-LONDON, V587, P5361, DOI 10.1113/jphysiol.2009.180331; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Sharma Neelesh, 2011, Ther Adv Med Oncol, V3, pS37, DOI 10.1177/1758834011423403; Tsiouris A, 2007, NAT CLIN PRACT ONCOL, V4, P344, DOI 10.1038/ncponc0839; Tward JD, 2006, CANCER-AM CANCER SOC, V107, P108, DOI 10.1002/cncr.21971; van Meerbeeck JP, 2005, J CLIN ONCOL, V23, P6881, DOI 10.1200/JCO.20005.14.589; Varghese S, 2011, CANCER-AM CANCER SOC, V117, P361, DOI 10.1002/cncr.25555; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Wallin JJ, 2011, MOL CANCER THER, V10, P2426, DOI 10.1158/1535-7163.MCT-11-0446; Willems L, 2012, CURR ONCOL REP, V14, P129, DOI 10.1007/s11912-012-0227-y; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu CX, 2011, CANCER BIOL THER, V12, P549, DOI 10.4161/cbt.12.6.16397; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643	54	47	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e105919	10.1371/journal.pone.0105919	http://dx.doi.org/10.1371/journal.pone.0105919			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25221930	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774800007
J	Laddha, NC; Dwivedi, M; Mansuri, MS; Singh, M; Patel, HH; Agarwal, N; Shah, AM; Begum, R				Laddha, Naresh C.; Dwivedi, Mitesh; Mansuri, Mohmmad Shoab; Singh, Mala; Patel, Hetanshi H.; Agarwal, Nishtha; Shah, Anish M.; Begum, Rasheedunnisa			Association of Neuropeptide Y (NPY), Interleukin-1B (IL1B) Genetic Variants and Correlation of IL1B Transcript Levels with Vitiligo Susceptibility	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SUPEROXIDE-DISMUTASE; GENERALIZED VITILIGO; OXIDATIVE STRESS; L-TYROSINE; T-CELLS; POLYMORPHISM; PROGRESSION; SECRETION; HORMONE	Background: Vitiligo is a depigmenting disorder resulting from loss of functional melanocytes in the skin. NPY plays an important role in induction of immune response by acting on a variety of immune cells. NPY synthesis and release is governed by IL1B. Moreover, genetic variability in IL1B is reported to be associated with elevated NPY levels. Objectives: Aim of the present study was to explore NPY promoter 2399T/C (rs16147) and exon2 +1128T/C (rs16139) polymorphisms as well as IL1B promoter 2511C/T (rs16944) polymorphism and to correlate IL1B transcript levels with vitiligo. Methods: PCR-RFLP method was used to genotype NPY -399T/C SNP in 454 patients and 1226 controls; +1128T/C SNP in 575 patients and 1279 controls and IL1B -511C/T SNP in 448 patients and 785 controls from Gujarat. IL1B transcript levels in blood were also assessed in 105 controls and 95 patients using real-time PCR. Results: Genotype and allele frequencies for NPY -399T/C, +1128T/C and IL1B -511C/T SNPs differed significantly (p<0.0001, p<0.0001; p = 0.0161, p = 0.0035 and p<0.0001, p<0.0001) between patients and controls. 'TC' haplotype containing minor alleles of NPY polymorphisms was significantly higher in patients and increased the risk of vitiligo by 2.3 fold (p<0.0001). Transcript levels of IL1B were significantly higher, in patients compared to controls (p = 0.0029), in patients with active than stable vitiligo (p = 0.015), also in female patients than male patients (p = 0.026). Genotype-phenotype correlation showed moderate association of IL1B -511C/T polymorphism with higher IL1B transcript levels. Trend analysis revealed significant difference between patients and controls for IL1B transcript levels with respect to different genotypes. Conclusion: Our results suggest that NPY -399T/C, +1128T/C and IL1B -511C/T polymorphisms are associated with vitiligo and IL1B -511C/T SNP influences its transcript levels leading to increased risk for vitiligo in Gujarat population. Upregulation of IL1B transcript in patients advocates its possible role in autoimmune pathogenesis of vitiligo.	[Laddha, Naresh C.; Dwivedi, Mitesh; Mansuri, Mohmmad Shoab; Singh, Mala; Patel, Hetanshi H.; Agarwal, Nishtha; Shah, Anish M.; Begum, Rasheedunnisa] Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Biochem, Vadodara, Gujarat, India	Maharaja Sayajirao University Baroda	Begum, R (corresponding author), Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Biochem, Vadodara, Gujarat, India.	rasheedunnisab@yahoo.co.in	Begum, Rasheedunnisa/AAF-2981-2020; agarwal, nishtha/GOK-0188-2022; Dwivedi, Mitesh/Q-1276-2019	Dwivedi, Mitesh/0000-0001-8497-0765; BEGUM, RASHEEDUNNISA/0000-0003-3446-0980	ICMR, New Delhi, India [BMS/Adhoc/122/11-2012]; GSBTM, Gandhinagar, Gujarat, India [GSBTM/MD/PROJECTS/SSA/453/2010-2011]; DBT, New Delhi, India [BT/PR9024/MED/12/332/2007]	ICMR, New Delhi, India(Indian Council of Medical Research (ICMR)); GSBTM, Gandhinagar, Gujarat, India; DBT, New Delhi, India(Department of Biotechnology (DBT) India)	This work was supported by grants to RB (BMS/Adhoc/122/11-2012) ICMR, New Delhi, India; (GSBTM/MD/PROJECTS/SSA/453/2010-2011), GSBTM, Gandhinagar, Gujarat, India and (BT/PR9024/MED/12/332/2007) DBT, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Ali D, 2004, MOL ENDOCRINOL, V18, P1721, DOI 10.1210/me.2003-0129; ALABADIE MSK, 1994, BRIT J DERMATOL, V131, P160; Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bedoui S, 2004, TRENDS IMMUNOL, V25, P508, DOI 10.1016/j.it.2004.08.005; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; BENDTZEN K, 1988, IMMUNOL LETT, V19, P183, DOI 10.1016/0165-2478(88)90141-1; Birlea SA, 2013, J INVEST DERMATOL, V133, P1369, DOI 10.1038/jid.2012.501; Cavadas C, 2001, J CLIN ENDOCR METAB, V86, P5956, DOI 10.1210/jc.86.12.5956; Cavadas C, 2006, P NATL ACAD SCI USA, V103, P10497, DOI 10.1073/pnas.0600913103; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Cox ME, 1997, J NEUROCHEM, V69, P1119; DeSanctis JB, 1997, IMMUNOLOGY, V90, P526, DOI 10.1046/j.1365-2567.1997.00174.x; Dinarello CA, 2010, CURR OPIN ENDOCRINOL, V17, P314, DOI 10.1097/MED.0b013e32833bf6dc; Dwivedi M, 2013, BRIT J DERMATOL, V169, P1114, DOI 10.1111/bjd.12467; Dwivedi M, 2013, J INTERF CYTOK RES, V33, P646, DOI 10.1089/jir.2012.0171; Dwivedi M, 2013, J DERMATOL SCI, V71, P195, DOI 10.1016/j.jdermsci.2013.04.026; Dwivedi M, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12105; Dwivedi M, 2011, PIGM CELL MELANOMA R, V24, P737, DOI 10.1111/j.1755-148X.2011.00892.x; Glassman SJ, 2011, CLIN SCI, V120, P99, DOI 10.1042/CS20090603; Hazneci E, 2005, INT J DERMATOL, V44, P636, DOI 10.1111/j.1365-4632.2004.02027.x; Hernanz A, 1996, J NEUROIMMUNOL, V71, P25, DOI 10.1016/S0165-5728(96)00118-X; Hoogduijn MJ, 2002, BIOCHEM BIOPH RES CO, V296, P698, DOI 10.1016/S0006-291X(02)00932-4; Hulkkonen J, 2000, EUR CYTOKINE NETW, V11, P251; Hwang IR, 2002, GASTROENTEROLOGY, V123, P1793, DOI 10.1053/gast.2002.37043; Imran M, 2012, BRIT J DERMATOL, V167, P314, DOI 10.1111/j.1365-2133.2012.11000.x; IYENGAR B, 1989, ACTA ANAT, V136, P139; Joana RS, 2009, J NEUROCHEM, V109, P911; Johnsen AK, 2008, ARTHRITIS RHEUM-US, V58, P1947, DOI 10.1002/art.23592; Kallio J, 2001, FASEB J, V15, P1242, DOI 10.1096/fj.00-0436fje; Kemp EH, 2002, J CLIN INVEST, V109, P923, DOI 10.1172/JCI200214643; Kobayashi H, 2003, HYPERTENS RES, V26, pS71, DOI 10.1291/hypres.26.S71; Laddha NC, 2014, EXP DERMATOL, V23, P352, DOI 10.1111/exd.12372; Laddha NC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081736; Laddha NC, 2013, FREE RADICAL BIO MED, V65, P1110, DOI 10.1016/j.freeradbiomed.2013.08.189; Laddha NC, 2013, EXP DERMATOL, V22, P245, DOI 10.1111/exd.12103; Laddha NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052298; Liu PY, 1996, ARCH DERMATOL RES, V288, P670, DOI 10.1007/s004030050122; Ma J, 2007, EUR J ENDOCRINOL, V157, P641, DOI 10.1530/EJE-07-0354; Mahe Y, 1992, ENCY IMMUNOLOGY, pP897; MALISZEWSKI CR, 1990, J IMMUNOL, V144, P3028; MCLANE J, 1987, BIOCHEM BIOPH RES CO, V145, P719, DOI 10.1016/0006-291X(87)91024-2; MORITA K, 1987, J NEUROCHEM, V48, P243, DOI 10.1111/j.1471-4159.1987.tb13154.x; MORRONE A, 1992, PIGM CELL RES, V5, P65, DOI 10.1111/j.1600-0749.1992.tb00003.x; Nussdorfer GG, 1998, PEPTIDES, V19, P1443, DOI 10.1016/S0196-9781(98)00102-8; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Prod'homme T, 2006, TRENDS IMMUNOL, V27, P164, DOI 10.1016/J.IT.2006.02.003; ROZENGURT E, 1995, CANCER SURV, V24, P81; Schallreuter KU, 2011, PIGM CELL MELANOMA R, V24, P51, DOI 10.1111/j.1755-148X.2010.00794.x; Schwanstecher M, 2011, HDB EXPT PHARM; Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7; Shajil E. M., 2006, Indian Journal of Dermatology, V51, P100; Shajil E. M., 2006, Indian Journal of Experimental Biology, V44, P526; Shajil EM, 2006, INDIAN J DERMATOL, V51, P289; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Silver DL, 2006, FROM MELANOCYTES TO MELANOMA: THE PROGRESSION TO MALIGNANCY, P3, DOI 10.1007/978-1-59259-994-3_1; Simon JD, 2009, PIGM CELL MELANOMA R, V22, P563, DOI 10.1111/j.1755-148X.2009.00610.x; Singh A, 2012, J INVEST DERMATOL, V132, P124, DOI 10.1038/jid.2011.240; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; SLOMINSKI A, 1989, BIOSCIENCE REP, V9, P579, DOI 10.1007/BF01119801; Slominski A, 2000, PHYSIOL REV, V80, P979, DOI 10.1152/physrev.2000.80.3.979; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Sommer WH, 2010, HUM MUTAT, V31, pE1594, DOI 10.1002/humu.21299; Tsang AHK, 2009, BBA-MOL BASIS DIS, V1792, P643, DOI 10.1016/j.bbadis.2008.12.006; Tu CX, 2001, J DERMATOL SCI, V27, P178, DOI 10.1016/S0923-1811(01)00134-7; VISNER GA, 1992, BIOCHEM BIOPH RES CO, V188, P453; Wheway J, 2005, J EXP MED, V202, P1527, DOI 10.1084/jem.20051971; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Zhou ZF, 2008, NATURE, V452, P997, DOI 10.1038/nature06858	72	44	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107020	10.1371/journal.pone.0107020	http://dx.doi.org/10.1371/journal.pone.0107020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25221996	Green Submitted, gold, Green Published			2022-12-25	WOS:000341774800040
J	Makila-Mabe, BG; Kikandau, KJ; Sombo, TM; Okitundu, DL; Mwanza, JC; Boivin, MJ; Ngoyi, MD; Muyembe, JJT; Banea, JP; Boss, GR; Tshala-Katumbay, D				Makila-Mabe, Bumoko G.; Kikandau, Kambale J.; Sombo, Therese M.; Okitundu, Daniel L.; Mwanza, Jean-Claude; Boivin, Michael J.; Ngoyi, Mumba D.; Muyembe, Jean-Jacques T.; Banea, Jean-Pierre; Boss, Gerard R.; Tshala-Katumbay, Desire			Serum 8,12-iso-iPF2 alpha-VI Isoprostane Marker of Oxidative Damage and Cognition Deficits in Children with Konzo	PLOS ONE			English	Article							DISEASE; CASSAVA; STRESS; PLASMA; F-2-ISOPROSTANES; THIOCYANATE; PERFORMANCE; BIOMARKERS; CYANOGENS; PRODUCTS	We sought to determine whether motor and cognitive deficits associated with cassava (food) cyanogenic poisoning were associated with high concentrations of F2-isoprostanes, well-established indicators of oxidative damage. Concentrations of serum F2-isoprostanes were quantified by LC-MS/MS and anchored to measures of motor proficiency and cognitive performance, which were respectively assessed through BOT-2 (Bruininks/Oseretsky Test, 2nd Edition) and KABC-II (Kaufman Assessment Battery for Children, 2nd edition) testing of 40 Congolese children (21 with konzo and 19 presumably healthy controls, overall mean age (SD): 9.3 (3.2) years). Exposure to cyanide was ascertained by concentrations of its main metabolite thiocyanate (SCN) in plasma and urine. Overall, SCN concentrations ranged from 91 to 325 and 172 to 1032 mu mol/l in plasma and urine, respectively. Serum isoprostanes ranged from 0.1 to 0.8 (Isoprostane-III), 0.8 to 8.3 (total Isoprostane-III), 0.1 to 1.5 (Isoprostane-VI), 2.0 to 9.0 (total Isoprostane-VI), or 0.2 to 1.3 ng/ml (8,12-iso-iPF2 alpha-VI isoprostane). Children with konzo poorly performed at the BOT-2 and KABC-II testing relative to presumably healthy children (p<0.01). Within regression models adjusting for age, gender, motor proficiency, and other biochemical variables, 8,12-iso-iPF2 alpha-VI isoprostane was significantly associated with the overall cognitive performance (beta = -32.36 (95% CI: -51.59 to -13.03; P<0.001). This model explained over 85% of variation of the KABC-II score in children with konzo, but was not significant in explaining the motor proficiency impairment. These findings suggest that cognitive deficits and, possibly, brain injury associated with cassava poisoning is mediated in part by oxidative damage in children with konzo. 8,12-iso-iPF2 alpha-VI isoprostane appears to be a good marker of the neuropathogenic mechanisms of konzo and may be used to monitor the impact of interventional trials to prevent the neurotoxic effects of cassava cyanogenic poisoning.	[Makila-Mabe, Bumoko G.; Sombo, Therese M.; Okitundu, Daniel L.; Tshala-Katumbay, Desire] Univ Kinshasa, Dept Neurol, Kinshasa, DEM REP CONGO; [Kikandau, Kambale J.] Univ Kinshasa, Dept Biomed Sci, Kinshasa, DEM REP CONGO; [Mwanza, Jean-Claude] Univ N Carolina, Dept Ophthalmol, Chapel Hill, NC USA; [Boivin, Michael J.] Michigan State Univ, Dept Psychiat & Neurol Ophthalmol, E Lansing, MI USA; [Ngoyi, Mumba D.; Muyembe, Jean-Jacques T.] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO; [Ngoyi, Mumba D.; Muyembe, Jean-Jacques T.] Inst Natl Rech Biomed, Dept Parasitol, Kinshasa, DEM REP CONGO; [Banea, Jean-Pierre] Sch Publ Hlth, Dept Nutr, Kinshasa, DEM REP CONGO; [Banea, Jean-Pierre] Natl Nutr Program, Kinshasa, DEM REP CONGO; [Boss, Gerard R.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Tshala-Katumbay, Desire] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Tshala-Katumbay, Desire] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA	Universite de Kinshasa; Universite de Kinshasa; University of North Carolina; University of North Carolina Chapel Hill; Michigan State University; Universite de Kinshasa; Institute Nacional de Recherche Biomedical; University of California System; University of California San Diego; Oregon Health & Science University; Oregon Health & Science University	Tshala-Katumbay, D (corresponding author), Univ Kinshasa, Dept Neurol, Kinshasa, DEM REP CONGO.	tshalad@ohsu.edu	Mwanza, Jean-Claude/L-4235-2017	Boss, Gerry/0000-0002-9758-8714	Fogarty International Center; National Institute of Environmental Health and Science (National Institutes of Health, Bethesda, MD) [R01ES019841]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058030] Funding Source: NIH RePORTER	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Environmental Health and Science (National Institutes of Health, Bethesda, MD); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by a grant from the Fogarty International Center and the National Institute of Environmental Health and Science R01ES019841 (National Institutes of Health, Bethesda, MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamolekun B, 2011, METAB BRAIN DIS, V26, P79, DOI 10.1007/s11011-011-9237-y; Banea JP, 2014, FOOD NUTR BULL, V35, P28, DOI 10.1177/156482651403500104; Banea-Mayambu JP, 1997, TROP MED INT HEALTH, V2, P1143, DOI 10.1046/j.1365-3156.1997.d01-215.x; Barden AE, 2014, ANAL BIOCHEM, V449, P129, DOI 10.1016/j.ab.2013.12.030; Boivin MJ, 2013, PEDIATRICS, V131, pE1231, DOI 10.1542/peds.2012-3011; Bowler RG, 1944, BIOCHEM J, V38, P385, DOI 10.1042/bj0380385; Bumoko GM, 2014, METAB BRAIN DIS, V29, P359, DOI 10.1007/s11011-014-9492-9; Chabwine JN, 2011, FOOD CHEM TOXICOL, V49, P644, DOI 10.1016/j.fct.2010.07.050; Ciglenecki I, 2011, FOOD CHEM TOXICOL, V49, P579, DOI 10.1016/j.fct.2010.05.081; Cliff J, 2011, FOOD CHEM TOXICOL, V49, P631, DOI 10.1016/j.fct.2010.06.056; Cliff J, 1997, TROP MED INT HEALTH, V2, P1068, DOI 10.1046/j.1365-3156.1997.d01-178.x; Haque MR, 1999, CLIN CHEM, V45, P1459; HOWLETT WP, 1990, BRAIN, V113, P223, DOI 10.1093/brain/113.1.223; Kadiiska MB, 2013, FREE RADICAL BIO MED, V61, P408, DOI 10.1016/j.freeradbiomed.2013.04.023; Kassa RM, 2011, FOOD CHEM TOXICOL, V49, P571, DOI 10.1016/j.fct.2010.05.080; Kimani S, 2014, METAB BRAIN DIS, V29, P105, DOI 10.1007/s11011-013-9459-2; Kunapuli P, 1998, J BIOL CHEM, V273, P22442, DOI 10.1074/jbc.273.35.22442; Li HW, 1999, P NATL ACAD SCI USA, V96, P13381, DOI 10.1073/pnas.96.23.13381; Milatovic D, 2011, METHODS MOL BIOL, V758, P195, DOI 10.1007/978-1-61779-170-3_13; Mlingi NLV, 2011, FOOD CHEM TOXICOL, V49, P673, DOI 10.1016/j.fct.2010.09.017; Morrow JD, 1999, DRUG METAB REV, V31, P117, DOI 10.1081/DMR-100101910; Morrow JD, 1996, BIOCHEM PHARMACOL, V51, P1, DOI 10.1016/0006-2952(95)02072-1; Nunn PB, 2011, FOOD CHEM TOXICOL, V49, P662, DOI 10.1016/j.fct.2010.08.037; Nzwalo H, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001051; Ogawa F, 2006, RHEUMATOLOGY, V45, P815, DOI 10.1093/rheumatology/kel012; Osuntokun B O, 1981, World Rev Nutr Diet, V36, P141; Polidori MC, 2004, J CARD FAIL, V10, P334, DOI 10.1016/j.cardfail.2003.11.004; Rokach J, 1997, PROSTAG OTH LIPID M, V54, P853, DOI 10.1016/S0090-6980(97)00184-6; Tshala-Katumbay D, 2013, NEUROLOGY, V80, P949, DOI 10.1212/WNL.0b013e3182840b81; TYLLESKAR T, 1992, LANCET, V339, P208, DOI 10.1016/0140-6736(92)90006-O; Watters JL, 2009, BIOMARKERS, V14, P587, DOI 10.3109/13547500903183954; World Health Organization, 1996, WKLY EPIDEMIOL REC, V71, P225; Yan WY, 2007, J LIPID RES, V48, P1607, DOI 10.1194/jlr.M700097-JLR200; Zhao Z, 2001, CLIN CHEM, V47, P1306	34	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107191	10.1371/journal.pone.0107191	http://dx.doi.org/10.1371/journal.pone.0107191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222616	gold, Green Published, Green Submitted			2022-12-25	WOS:000341774800045
J	Shen, MC; Zhao, XM; Siegal, GP; Desmond, R; Hardy, RW				Shen, Ming-Che; Zhao, Xiangmin; Siegal, Gene P.; Desmond, Renee; Hardy, Robert W.			Dietary Stearic Acid Leads to a Reduction of Visceral Adipose Tissue in Athymic Nude Mice	PLOS ONE			English	Article							BODY-MASS INDEX; BREAST-CANCER; FATTY-ACIDS; HUMAN PREADIPOCYTES; INDUCE APOPTOSIS; PALMITIC ACID; MORTALITY; OBESITY; WOMEN; SURVIVAL	Stearic acid (C18:0) is a long chain dietary saturated fatty acid that has been shown to reduce metastatic tumor burden. Based on preliminary observations and the growing evidence that visceral fat is related to metastasis and decreased survival, we hypothesized that dietary stearic acid may reduce visceral fat. Athymic nude mice, which are used in models of human breast cancer metastasis, were fed a stearic acid, linoleic acid (safflower oil), or oleic acid (corn oil) enriched diet or a low fat diet ad libitum. Total body weight did not differ significantly between dietary groups over the course of the experiment. However visceral fat was reduced by similar to 70% in the stearic acid fed group compared to other diets. In contrast total body fat was only slightly reduced in the stearic acid diet fed mice when measured by dual-energy x-ray absorptiometry and quantitative magnetic resonance. Lean body mass was increased in the stearic acid fed group compared to all other groups by dual-energy x-ray absorptiometry. Dietary stearic acid significantly reduced serum glucose compared to all other diets and increased monocyte chemotactic protein-1 (MCP-1) compared to the low fat control. The low fat control diet had increased serum leptin compared to all other diets. To investigate possible mechanisms whereby stearic acid reduced visceral fat we used 3T3L1 fibroblasts/preadipocytes. Stearic acid had no direct effects on the process of differentiation or on the viability of mature adipocytes. However, unlike oleic acid and linoleic acid, stearic acid caused increased apoptosis (programmed cell death) and cytotoxicity in preadipocytes. The apoptosis was, at least in part, due to increased caspase-3 activity and was associated with decreased cellular inhibitor of apoptosis protein-2 (cIAP2) and increased Bax gene expression. In conclusion, dietary stearic acid leads to dramatically reduced visceral fat likely by causing the apoptosis of preadipocytes.	[Shen, Ming-Che; Zhao, Xiangmin; Siegal, Gene P.; Hardy, Robert W.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Siegal, Gene P.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Siegal, Gene P.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Siegal, Gene P.; Desmond, Renee; Hardy, Robert W.] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Hardy, RW (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	HARDY@PATH.UAB.EDU			UAB Diabetes Research and Training Center; UAB Center for Metabolic Bone Disease; UAB SPORE in Breast Cancer [5P50CA089019]; Small Animal Phenotyping Core of the UAB Nutrition Obesity Research Center [P30DK56336]; Diabetes Research and Training Center [P60DK079626]; NATIONAL CANCER INSTITUTE [P50CA089019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079626, P30DK056336, P30DK079626] Funding Source: NIH RePORTER	UAB Diabetes Research and Training Center; UAB Center for Metabolic Bone Disease; UAB SPORE in Breast Cancer; Small Animal Phenotyping Core of the UAB Nutrition Obesity Research Center; Diabetes Research and Training Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support for these studies came from the UAB Diabetes Research and Training Center as well as the UAB Center for Metabolic Bone Disease and the UAB SPORE in Breast Cancer (5P50CA089019) and by the Small Animal Phenotyping Core of the UAB Nutrition Obesity Research Center (P30DK56336) and Diabetes Research and Training Center (P60DK079626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmanov AA, 2001, PHYSIOL BEHAV, V72, P603, DOI 10.1016/S0031-9384(01)00412-7; Balentine CJ, 2010, J GASTROINTEST SURG, V14, P1832, DOI 10.1007/s11605-010-1297-5; Barnett JB, 2003, NUTR REV, V61, P73, DOI [10.1031/nr.2003.febr.73-76, 10.1301/nr.2003.febr.73-76]; Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343; Berclaz G, 2004, ANN ONCOL, V15, P875, DOI 10.1093/annonc/mdh222; BONANOME A, 1988, NEW ENGL J MED, V318, P1244, DOI 10.1056/NEJM198805123181905; BUCKMAN DK, 1990, J NUTR, V120, P148, DOI 10.1093/jn/120.2.148; Cai Z, 2009, NEOPLASIA, V11, P228, DOI 10.1593/neo.81282; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cirillo D, 2008, J CELL BIOCHEM, V105, P956, DOI 10.1002/jcb.21911; Cleveland RJ, 2007, CANCER EPIDEM BIOMAR, V16, P1803, DOI 10.1158/1055-9965.EPI-06-0889; Daling JR, 2001, CANCER, V92, P720, DOI 10.1002/1097-0142(20010815)92:4<720::AID-CNCR1375>3.0.CO;2-T; Darding M, 2011, CELL DEATH DIFFER, V18, P1376, DOI 10.1038/cdd.2011.10; Dehqanzada ZA, 2006, CLIN CANCER RES, V12, P478, DOI 10.1158/1078-0432.CCR-05-1425; Evans LM, 2009, NUTR CANCER, V61, P746, DOI 10.1080/01635580902825597; Evans LM, 2009, CLIN EXP METASTAS, V26, P415, DOI 10.1007/s10585-009-9239-x; Guiu B, 2010, GUT, V59, P341, DOI 10.1136/gut.2009.188946; Guo W, 2007, AM J PHYSIOL-ENDOC M, V293, pE576, DOI 10.1152/ajpendo.00523.2006; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Hunter JE, 2010, AM J CLIN NUTR, V91, P46, DOI 10.3945/ajcn.2009.27661; Kelly FD, 2001, EUR J CLIN NUTR, V55, P88, DOI 10.1038/sj.ejcn.1601122; Ladoire S, 2011, ONCOLOGIST, V16, P71, DOI 10.1634/theoncologist.2010-0227; Li CY, 2011, CARCINOGENESIS, V32, P1251, DOI 10.1093/carcin/bgr092; Louheranta AM, 1998, METABOLISM, V47, P529, DOI 10.1016/S0026-0495(98)90235-9; Lu ZH, 2003, BIOCHEM BIOPH RES CO, V303, P1002, DOI 10.1016/S0006-291X(03)00449-2; Morimoto LM, 2002, CANCER CAUSE CONTROL, V13, P741, DOI 10.1023/A:1020239211145; Mu YM, 2001, ENDOCRINOLOGY, V142, P3590, DOI 10.1210/en.142.8.3590; Niesler CU, 2001, INT J OBESITY, V25, P1027, DOI 10.1038/sj.ijo.0801649; Niesler CU, 1998, DIABETES, V47, P1365, DOI 10.2337/diabetes.47.8.1365; Pai T, 1996, LIPIDS, V31, P159, DOI 10.1007/BF02522615; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Reeves KW, 2007, CANCER EPIDEM BIOMAR, V16, P1468, DOI 10.1158/1055-9965.EPI-07-0051; Sampath H, 2007, J BIOL CHEM, V282, P2483, DOI 10.1074/jbc.M610158200; Simard JR, 2005, P NATL ACAD SCI USA, V102, P17958, DOI 10.1073/pnas.0506440102; SPECTOR AA, 1969, ANAL BIOCHEM, V32, P297, DOI 10.1016/0003-2697(69)90089-X; Wang D, 2008, BIOTECH HISTOCHEM, V83, P179, DOI 10.1080/10520290802451085; WIRTH A, 1979, EUR J APPL PHYSIOL, V41, P51, DOI 10.1007/BF00424468; ZOCK PL, 1993, EUR J CLIN NUTR, V47, P437	38	13	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e104083	10.1371/journal.pone.0104083	http://dx.doi.org/10.1371/journal.pone.0104083			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222131	gold, Green Published, Green Submitted			2022-12-25	WOS:000341774800002
J	Brazhe, AR; Marsh, DJ; Holstein-Rathlou, NH; Sosnovtseva, O				Brazhe, Alexey R.; Marsh, Donald J.; Holstein-Rathlou, Niels-Henrik; Sosnovtseva, Olga			Synchronized Renal Blood Flow Dynamics Mapped with Wavelet Analysis of Laser Speckle Flowmetry Data	PLOS ONE			English	Article							PHASE SYNCHRONIZATION; DOPPLER FLOWMETRY; VASCULAR NETWORK; RATS; MICROCIRCULATION; OSCILLATIONS; PRESSURE; TISSUE; CORTEX; MODEL	Full-field laser speckle microscopy provides real-time imaging of superficial blood flow rate. Here we apply continuous wavelet transform to time series of speckle-estimated blood flow from each pixel of the images to map synchronous patterns in instantaneous frequency and phase on the surface of rat kidneys. The regulatory mechanism in the renal microcirculation generates oscillations in arterial blood flow at several characteristic frequencies. Our approach to laser speckle image processing allows detection of frequency and phase entrainments, visualization of their patterns, and estimation of the extent of synchronization in renal cortex dynamics.	[Brazhe, Alexey R.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Biophys, Moscow, Russia; [Marsh, Donald J.] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Holstein-Rathlou, Niels-Henrik; Sosnovtseva, Olga] Univ Copenhagen, Panum Inst, Dept Biomed Sci, DK-2200 Copenhagen, Denmark	Lomonosov Moscow State University; Brown University; University of Copenhagen	Brazhe, AR (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Dept Biophys, Moscow, Russia.	brazhe@biophys.msu.ru	Brazhe, Alexey/G-9635-2016; Sosnovtseva, Olga/H-5115-2016	Brazhe, Alexey/0000-0002-1495-4652; Sosnovtseva, Olga/0000-0001-7334-9869; Holstein-Rathlou, Niels-Henrik/0000-0003-1683-3464				AFRAIMOVICH VS, 1994, INT J BIFURCAT CHAOS, V4, P631, DOI 10.1142/S0218127494000459; Balanov A, 2009, SPRINGER SER SYNERG, P1; Brazhe A, 2013, NEUROIMAGE, V68, P192, DOI 10.1016/j.neuroimage.2012.11.024; Briers J D, 1996, J Biomed Opt, V1, P174, DOI 10.1117/12.231359; Calamante F, 1999, J CEREBR BLOOD F MET, V19, P701, DOI 10.1097/00004647-199907000-00001; Chapman CL, 2002, J MATH BIOL, V45, P57, DOI 10.1007/s002850200141; Cheng HY, 2004, PHYS MED BIOL, V49, P1347, DOI 10.1088/0031-9155/49/7/020; DIRNAGL U, 1989, J CEREBR BLOOD F MET, V9, P589, DOI 10.1038/jcbfm.1989.84; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195, DOI 10.1097/00004647-200103000-00002; FERCHER AF, 1981, OPT COMMUN, V37, P326, DOI 10.1016/0030-4018(81)90428-4; Gu ZY, 2012, IEEE T IMAGE PROCESS, V21, P674, DOI 10.1109/TIP.2011.2166969; Holstein-Rathlou NH, 2011, AM J PHYSIOL-RENAL, V300, pF319, DOI 10.1152/ajprenal.00417.2010; HOLSTEINRATHLOU NH, 1987, PFLUG ARCH EUR J PHY, V408, P438, DOI 10.1007/BF00585066; HOLSTEINRATHLOU NH, 1989, AM J PHYSIOL, V256, pF1007, DOI 10.1152/ajprenal.1989.256.6.F1007; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jesse S, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/8/085714; Jones E., 2001, SCIPY OPEN SOURCE SC; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Marsh DJ, 2013, AM J PHYSIOL-RENAL, V304, pF88, DOI 10.1152/ajprenal.00237.2012; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Pavlov AN, 2006, BRIEF BIOINFORM, V7, P375, DOI 10.1093/bib/bbl041; Pikovsky A., 2003, SYNCHRONIZATION UNIV; Postnov DD, 2012, B MATH BIOL, V74, P2820, DOI 10.1007/s11538-012-9781-6; Richards LM, 2013, BIOMED OPT EXPRESS, V4, P2269, DOI 10.1364/BOE.4.002269; Rosenblum M., 2001, HDB BIOL PHYS, V4, P279; RUTH B, 1994, MED ENG PHYS, V16, P105, DOI 10.1016/1350-4533(94)90023-X; Scully CG, 2013, AM J PHYSIOL-REG I, V304, pR929, DOI 10.1152/ajpregu.00002.2013; Senarathna Janaka, 2013, IEEE Rev Biomed Eng, V6, P99, DOI 10.1109/RBME.2013.2243140; Sosnovtseva OV, 2007, AM J PHYSIOL-RENAL, V293, pF1545, DOI 10.1152/ajprenal.00054.2007; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Yaoeda K, 2000, AM J OPHTHALMOL, V129, P734, DOI 10.1016/S0002-9394(00)00382-2; YIP KP, 1992, AM J PHYSIOL, V262, pF980, DOI 10.1152/ajprenal.1992.262.6.F980; Zimnyakov DA, 2002, APPL OPTICS, V41, P5989, DOI 10.1364/AO.41.005989	34	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e105879	10.1371/journal.pone.0105879	http://dx.doi.org/10.1371/journal.pone.0105879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216274	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774300004
J	Gondo, A; Shinotsuka, T; Morita, A; Abe, Y; Yasui, M; Nuriya, M				Gondo, Asako; Shinotsuka, Takanori; Morita, Ayaka; Abe, Yoichiro; Yasui, Masato; Nuriya, Mutsuo			Sustained Down-regulation of beta-Dystroglycan and Associated Dysfunctions of Astrocytic Endfeet in Epileptic Cerebral Cortex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; LIPID RAFTS; BRAIN; AQUAPORIN-4; MEMBRANE; MODEL; WATER; COMPLEX; SYSTEM; MICRODOMAINS	Epilepsy is characterized by the abnormal activation of neurons in the cerebral cortex, but the molecular and cellular mechanisms contributing to the development of recurrent seizures are largely unknown. Recently, the critical involvement of astrocytes in the pathophysiology of epilepsy has been proposed. However, the nature of plastic modulations of astrocytic proteins in the epileptic cortex remains poorly understood. In this study, we utilized the zero magnesium in vitro model of epilepsy and examined the potential molecular changes of cortical astrocytes, focusing specifically on endfeet, where specialized biochemical compartments exist. We find that the continuous epileptic activation of neurons for 1 h decreases the expression level of beta-dystroglycan (beta DG) in acute cortical brain slices prepared from mice. This change is completely abolished by the pharmacological blockade of NMDA-type glutamate receptors as well as by matrix metalloproteinase inhibitors. Consistent with the highly specialized localization of beta DG at astrocytic endfeet, where it plays a pivotal role in anchoring endfeet-enriched proteins in astrocytes, the down-regulation of beta DG is accompanied by a decrease in the expression of AQP4 but not laminin. Importantly, this down-regulation of beta DG persists for at least 1 h, even after the apparent recovery of neuronal activation. Finally, we show that the down-regulation of beta DG is associated with the dysfunction of the endfeet at the blood-brain interface as a diffusion barrier. These results suggest that the sustained down-regulation of beta DG leads to dysfunctions of astrocytic endfeet in the epileptic cerebral cortex and may contribute to the pathogenesis of epilepsy.	[Gondo, Asako; Shinotsuka, Takanori; Morita, Ayaka; Abe, Yoichiro; Yasui, Masato; Nuriya, Mutsuo] Keio Univ, Sch Med, Dept Pharmacol, Tokyo 1608582, Japan; [Gondo, Asako] Tokyo Med Univ, Dept Nephrol & Dialysis, Tokyo 1600023, Japan; [Morita, Ayaka] Yokohama Natl Univ, Coll Engn, Yokohama, Kanagawa 2408501, Japan; [Nuriya, Mutsuo] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan	Keio University; Tokyo Medical University; Yokohama National University; Yokohama National University	Nuriya, M (corresponding author), Keio Univ, Sch Med, Dept Pharmacol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	mnuriya@z2.keio.jp	Abe, Yoichiro/AAN-8801-2020; Nuriya, Mutsuo/J-5928-2013; Abe, Yoichiro/J-5576-2013	Abe, Yoichiro/0000-0001-6163-8794; Nuriya, Mutsuo/0000-0002-5689-8222; Abe, Yoichiro/0000-0001-6163-8794	Grants-in-Aid for Scientific Research [14J07414] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Alvestad S, 2013, EPILEPSY RES, V105, P30, DOI 10.1016/j.eplepsyres.2013.01.006; Ambrosini E, 2008, MOL CELL NEUROSCI, V37, P480, DOI 10.1016/j.mcn.2007.11.003; ARAM JA, 1988, J NEUROSCI METH, V23, P211, DOI 10.1016/0165-0270(88)90005-2; Badea T, 2001, J NEUROBIOL, V48, P215, DOI 10.1002/neu.1052; Beaumont TL, 2012, J NEUROSCI, V32, P14389, DOI 10.1523/JNEUROSCI.3408-12.2012; Crunelli V, 2013, J PHYSIOL-LONDON, V591, P775, DOI 10.1113/jphysiol.2012.243378; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; DREIER JP, 1990, NEUROSCI LETT, V119, P68, DOI 10.1016/0304-3940(90)90757-Z; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Eid T, 2005, P NATL ACAD SCI USA, V102, P1193, DOI 10.1073/pnas.0409308102; Fort PE, 2008, GLIA, V56, P597, DOI 10.1002/glia.20633; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; Gomez-Gonzalo M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000352; Hibino H, 2007, EUR J NEUROSCI, V26, P2539, DOI 10.1111/j.1460-9568.2007.05876.x; Iliff JJ, 2013, STROKE, V44, pS93, DOI 10.1161/STROKEAHA.112.678698; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Lee DJ, 2012, EXP NEUROL, V235, P246, DOI 10.1016/j.expneurol.2012.02.002; Li YJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-80; Mathiisen TM, 2010, GLIA, V58, P1094, DOI 10.1002/glia.20990; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; Noel G, 2009, J BIOL CHEM, V284, P19694, DOI 10.1074/jbc.M109.010090; Noell S, 2011, EUR J NEUROSCI, V33, P2179, DOI 10.1111/j.1460-9568.2011.07688.x; Nuriya M, 2013, CEREB CORTEX, V23, P2118, DOI 10.1093/cercor/bhs198; Nuriya M, 2013, J NEUROSCI, V33, P3692, DOI 10.1523/JNEUROSCI.3050-12.2013; Pisani A, 2004, EPILEPSIA, V45, P719, DOI 10.1111/j.0013-9580.2004.02204.x; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Shinotsuka T, 2014, BIOCHEM BIOPH RES CO, V444, P171, DOI 10.1016/j.bbrc.2014.01.035; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; VILAGI I, 1991, EPILEPSY RES, V8, P102, DOI 10.1016/0920-1211(91)90077-S; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yoshioka M, 2005, J CHILD NEUROL, V20, P385, DOI 10.1177/08830738050200041901; Yuste R, 2010, DENDRITIC SPINES	36	20	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30279	30288		10.1074/jbc.M114.588384	http://dx.doi.org/10.1074/jbc.M114.588384			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25228692	hybrid, Green Published			2022-12-25	WOS:000344549700012
J	Karst, JC; Enguene, VYN; Cannella, SE; Subrini, O; Hessel, A; Debard, S; Ladant, D; Chenal, A				Karst, Johanna C.; Enguene, V. Yvette Ntsogo; Cannella, Sara E.; Subrini, Orso; Hessel, Audrey; Debard, Sylvain; Ladant, Daniel; Chenal, Alexandre			Calcium, Acylation, and Molecular Confinement Favor Folding of Bordetella pertussis Adenylate Cyclase CyaA Toxin into a Monomeric and Cytotoxic Form	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; TARGET-CELLS; HEMOLYTIC ACTIVITIES; MEMBRANE TRANSLOCATION; CATALYTIC DOMAIN; RTX PROTEINS; CALMODULIN; PURIFICATION; SECRETION; BINDING	The adenylate cyclase (CyaA) toxin, a multidomain protein of 1706 amino acids, is one of the major virulence factors produced by Bordetella pertussis, the causative agent of whooping cough. CyaA is able to invade eukaryotic target cells in which it produces high levels of cAMP, thus altering the cellular physiology. Although CyaA has been extensively studied by various cellular and molecular approaches, the structural and functional states of the toxin remain poorly characterized. Indeed, CyaA is a large protein and exhibits a pronounced hydrophobic character, making it prone to aggregation into multimeric forms. As a result, CyaA has usually been extracted and stored in denaturing conditions. Here, we define the experimental conditions allowing CyaA folding into a monomeric and functional species. We found that CyaA forms mainly multimers when refolded by dialysis, dilution, or buffer exchange. However, a significant fraction of monomeric, folded protein could be obtained by exploiting molecular confinement on size exclusion chromatography. Folding of CyaA into a monomeric form was found to be critically dependent upon the presence of calcium and post-translational acylation of the protein. We further show that the monomeric preparation displayed hemolytic and cytotoxic activities suggesting that the monomer is the genuine, physiologically active form of the toxin. We hypothesize that the structural role of the post-translational acylation in CyaA folding may apply to other RTX toxins.	[Karst, Johanna C.; Enguene, V. Yvette Ntsogo; Cannella, Sara E.; Subrini, Orso; Hessel, Audrey; Debard, Sylvain; Ladant, Daniel; Chenal, Alexandre] Inst Pasteur, CNRS UMR 3528, Unite Biochim Interact Macromol, Dept Biol Struct & Chim, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ladant, D (corresponding author), Inst Pasteur, CNRS URA 3528, Unite Biochim Interact Macromol, 28 Rue Dr Roux, F-75724 Paris 15, France.	daniel.ladant@pasteur.fr; alexandre.chenal@pasteur.fr	Chenal, Alexandre/C-2240-2009	Chenal, Alexandre/0000-0002-4959-1003; LADANT, Daniel/0000-0003-1955-548X; NTSOGO, YVETTE/0000-0003-0096-3192	Agence Nationale de la Recherche, program Jeunes Chercheurs [ANR-09-JCJC-0012]; Institut Pasteur Projet Transversal de Recherche PTR [374]; Jacob class of Pasteur-Paris University International Ph.D. Program from Institut Pasteur; CNRS (UMR 3528, Biologie Structurale et Agents Infectieux)	Agence Nationale de la Recherche, program Jeunes Chercheurs(French National Research Agency (ANR)); Institut Pasteur Projet Transversal de Recherche PTR; Jacob class of Pasteur-Paris University International Ph.D. Program from Institut Pasteur; CNRS (UMR 3528, Biologie Structurale et Agents Infectieux)	This work was supported by the Agence Nationale de la Recherche, program Jeunes Chercheurs (Grant ANR-09-JCJC-0012), the Institut Pasteur Projet Transversal de Recherche PTR#374, the Jacob class of Pasteur-Paris University International Ph.D. Program from Institut Pasteur, and CNRS (UMR 3528, Biologie Structurale et Agents Infectieux).	BARRY EM, 1991, J BACTERIOL, V173, P720, DOI 10.1128/jb.173.2.720-726.1991; Basler M, 2007, J BIOL CHEM, V282, P12419, DOI 10.1074/jbc.M611226200; Bauche C, 2006, J BIOL CHEM, V281, P16914, DOI 10.1074/jbc.M601594200; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; BELLALOU J, 1990, INFECT IMMUN, V58, P3242, DOI 10.1128/IAI.58.10.3242-3247.1990; BENZ R, 1994, J BIOL CHEM, V269, P27231; Bumba L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000901; Carbonetti NH, 2010, FUTURE MICROBIOL, V5, P455, DOI 10.2217/FMB.09.133; Chenal A, 2010, BIOPHYS J, V99, P3744, DOI 10.1016/j.bpj.2010.10.016; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; Cheung GYC, 2009, MICROB PATHOGENESIS, V46, P36, DOI 10.1016/j.micpath.2008.10.005; Dadaglio G, 2003, INT IMMUNOL, V15, P1423, DOI 10.1093/intimm/dxg144; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Eby JC, 2010, J BIOL CHEM, V285, P10662, DOI 10.1074/jbc.M109.089219; Fiser R, 2007, J BIOL CHEM, V282, P2808, DOI 10.1074/jbc.M609979200; GENTILE F, 1990, J BIOL CHEM, V265, P10686; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; GLASER P, 1988, MOL MICROBIOL, V2, P19, DOI 10.1111/j.1365-2958.1988.tb00003.x; GORDON VM, 1989, J BIOL CHEM, V264, P14792; Gray MC, 2004, MOL MICROBIOL, V53, P1709, DOI 10.1111/j.1365-2958.2004.04227.x; Guermonprez P, 1999, J IMMUNOL, V162, P1910; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; HACKETT M, 1994, SCIENCE, V266, P433, DOI 10.1126/science.7939682; Herlax V, 2007, BIOCHEMISTRY-US, V46, P5177, DOI 10.1021/bi0618013; Heveker N, 1997, EUR J BIOCHEM, V243, P643, DOI 10.1111/j.1432-1033.1997.00643.x; Hewlett EL, 2006, MOL MICROBIOL, V59, P447, DOI 10.1111/j.1365-2958.2005.04958.x; HEWLETT EL, 1976, P NATL ACAD SCI USA, V73, P1926, DOI 10.1073/pnas.73.6.1926; HEWLETT EL, 1991, J BIOL CHEM, V266, P17503; HEWLETT EL, 1989, J BIOL CHEM, V264, P19379; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; Karimova G, 1998, P NATL ACAD SCI USA, V95, P12532, DOI 10.1073/pnas.95.21.12532; Karst Johanna C, 2012, Methods Mol Biol, V896, P163, DOI 10.1007/978-1-4614-3704-8_10; Karst JC, 2012, J BIOL CHEM, V287, P9200, DOI 10.1074/jbc.M111.316166; Karst JC, 2010, BIOCHEMISTRY-US, V49, P318, DOI 10.1021/bi9016389; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; LADANT D, 1986, J BIOL CHEM, V261, P6264; Lieutaud P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S25; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Masin J, 2005, BIOCHEMISTRY-US, V44, P12759, DOI 10.1021/bi050459b; MASURE HR, 1990, BIOCHEMISTRY-US, V29, P140, DOI 10.1021/bi00453a017; Meier R, 2007, J BIOL CHEM, V282, P31477, DOI 10.1074/jbc.M704942200; Paccani SR, 2011, J EXP MED, V208, P1317, DOI 10.1084/jem.20101558; Preville X, 2005, CANCER RES, V65, P641; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; ROGEL A, 1989, EMBO J, V8, P2755, DOI 10.1002/j.1460-2075.1989.tb08417.x; ROGEL A, 1992, J BIOL CHEM, V267, P22599; ROSE T, 1995, J BIOL CHEM, V270, P26370, DOI 10.1074/jbc.270.44.26370; SAKAMOTO H, 1992, J BIOL CHEM, V267, P13598; Saron MF, 1997, P NATL ACAD SCI USA, V94, P3314, DOI 10.1073/pnas.94.7.3314; Satchell KJF, 2011, ANNU REV MICROBIOL, V65, P71, DOI 10.1146/annurev-micro-090110-102943; SEBO P, 1991, GENE, V104, P19, DOI 10.1016/0378-1119(91)90459-O; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Sotomayor Perez AC, 2010, J MOL BIOL, V397, P534, DOI 10.1016/j.jmb.2010.01.031; Sotomayor-Perez Ana Cristina, 2012, Methods Mol Biol, V896, P331, DOI 10.1007/978-1-4614-3704-8_22; Sotomayor-Perez AC, 2011, J BIOL CHEM, V286, P16997, DOI 10.1074/jbc.M110.210393; Sotomayor-Perez AC, 2013, J AM CHEM SOC, V135, P11929, DOI 10.1021/ja404790f; Subrini O, 2013, J BIOL CHEM, V288, P32585, DOI 10.1074/jbc.M113.508838; Szilvay GR, 2009, BIOCHEMISTRY-US, V48, P11273, DOI 10.1021/bi901447j; Uribe KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067648; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Veneziano R, 2013, P NATL ACAD SCI USA, V110, P20473, DOI 10.1073/pnas.1312975110; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; Vojtova-Vodolanova J, 2009, FASEB J, V23, P2831, DOI 10.1096/fj.09-131250; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85; WELCH RA, 1991, MOL MICROBIOL, V5, P521, DOI 10.1111/j.1365-2958.1991.tb00723.x; Westrop GD, 1996, GENE, V180, P91, DOI 10.1016/S0378-1119(96)00412-X	70	39	40	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30702	30716		10.1074/jbc.M114.580852	http://dx.doi.org/10.1074/jbc.M114.580852			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25231985	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000344549700046
J	Cybulska, J; Brzyska, A; Zdunek, A; Wolinski, K				Cybulska, Justyna; Brzyska, Agnieszka; Zdunek, Artur; Wolinski, Krzysztof			Simulation of Force Spectroscopy Experiments on Galacturonic Acid Oligomers	PLOS ONE			English	Article							ENFORCED STRUCTURAL-CHANGES; CELL-WALL; PECTINS; MICROSCOPY; AFM; NANOSTRUCTURE; CONFORMATIONS; TEXTURE; MODEL	Pectins, forming a matrix for cellulose and hemicellulose, determine the mechanics of plant cell walls. They undergo salient structural changes during their development. In the presence of divalent cations, usually calcium, pectins can form gel-like structures. Because of their importance they have been the subject of many force spectroscopy experiments, which have examined the conformational changes and molecular tensions due to external forces. The most abundant unit present in the pectin backbone is polygalacturonic acid. Unfortunately, experimental force spectroscopy on polygalacturonic acid molecules is still not a trivial task. The mechanism of the single-molecule response to external forces can be inferred by theoretical methods. Therefore, in this work we simulated such force spectroscopy experiments using the Enforced Geometry Optimization (EGO) method. We examined the oligomeric (up to hexamer) structures of alpha-D-galacturonic acid exposed to external stretching forces. The EGO simulation of the force spectroscopy appropriately reproduced the experimental course of the enforced conformational transition: chair -> inverted chair via the twisted boat conformation(s) in the pyranose ring of alpha-D-galacturonic acid. Additionally, our theoretical approach also allowed to determine the minimum oligomer size adequate for the description of nano-mechanical properties of (poly)-alpha-D-galacturonic acid.	[Cybulska, Justyna; Zdunek, Artur] Polish Acad Sci, Inst Agrophys, PL-20236 Lublin, Poland; [Brzyska, Agnieszka] Polish Acad Sci, Jerzy Haber Inst Catalysis & Surface Chem, Krakow, Poland; [Wolinski, Krzysztof] Marie Curie Sklodowska Univ, Dept Chem, Lublin, Poland	Polish Academy of Sciences; Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences; Polish Academy of Sciences; Jerzy Haber Institute of Catalysis & Surface Chemistry; Maria Curie-Sklodowska University	Cybulska, J (corresponding author), Polish Acad Sci, Inst Agrophys, PL-20236 Lublin, Poland.	j.cybulska@ipan.lublin.pl	Brzyska, Agnieszka/AAW-3777-2021	Brzyska, Agnieszka/0000-0003-3088-3425; Cybulska, Justyna/0000-0003-3323-4535; Zdunek, Artur/0000-0001-9395-1486	Polish National Budget for Science [IP2011 007871]	Polish National Budget for Science	This work was funded by The Polish National Budget for Science 2012 2014 (Project No. IP2011 007871). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachrach SM, 2007, COMPUTATIONAL ORGANI, P21; Baker J, 2011, J COMPUT CHEM, V32, P43, DOI 10.1002/jcc.21597; Berces A, 2001, TETRAHEDRON, V57, P477, DOI 10.1016/S0040-4020(00)01019-X; Cohen AJ, 2012, CHEM REV, V112, P289, DOI 10.1021/cr200107z; Cosgrove DJ, 1997, ANNU REV CELL DEV BI, V13, P171, DOI 10.1146/annurev.cellbio.13.1.171; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; Cybulska J, 2010, INT AGROPHYS, V24, P107; Cybulska J, 2013, CARBOHYD POLYM, V92, P128, DOI 10.1016/j.carbpol.2012.08.103; Cybulska J, 2010, J FOOD ENG, V96, P287, DOI 10.1016/j.jfoodeng.2009.08.001; DINOLA A, 1994, BIOPOLYMERS, V34, P457, DOI 10.1002/bip.360340403; Fisher TE, 2000, NAT STRUCT BIOL, V7, P719; Hill AD, 2007, J CHEM INF MODEL, V47, P1031, DOI 10.1021/ci600492e; Kirby AR, 2008, CARBOHYD POLYM, V71, P640, DOI 10.1016/j.carbpol.2007.07.014; Kirby AR, 2006, FOOD BIOPHYS, V1, P163, DOI 10.1007/s11483-006-9013-4; Liu H, 2009, FOOD RES INT, V42, P1131, DOI 10.1016/j.foodres.2009.05.014; Lopes da Silva J. A., 2006, P353; Marszalek PE, 1999, P NATL ACAD SCI USA, V96, P7894, DOI 10.1073/pnas.96.14.7894; Marszalek PE, 1998, NATURE, V396, P661, DOI 10.1038/25322; Morris VJ, 2011, FOOD HYDROCOLLOID, V25, P230, DOI 10.1016/j.foodhyd.2009.11.015; Neelov I, 2007, MACROMOL SYMP, V252, P140, DOI 10.1002/masy.200750614; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; RUGGIERO JR, 1995, INT J BIOL MACROMOL, V17, P205, DOI 10.1016/0141-8130(95)92687-L; Sila DN, 2008, TRENDS FOOD SCI TECH, V19, P309, DOI 10.1016/j.tifs.2007.12.007; Thimm JC, 2000, PLANTA, V212, P25, DOI 10.1007/s004250000359; WALKINSHAW MD, 1981, J MOL BIOL, V153, P1055, DOI 10.1016/0022-2836(81)90467-8; Williams MAK, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021927; Williams MAK, 2008, FOOD HYDROCOLLOID, V22, P18, DOI 10.1016/j.foodhyd.2007.01.020; Wolinski K, 2010, MOL PHYS, V108, P1845, DOI 10.1080/00268976.2010.492795; Wolinski K, 2009, MOL PHYS, V107, P2403, DOI 10.1080/00268970903321348; Yang HS, 2009, POSTHARVEST BIOL TEC, V51, P391, DOI 10.1016/j.postharvbio.2008.08.009; Yang HS, 2005, EUR FOOD RES TECHNOL, V220, P587, DOI 10.1007/s00217-004-1102-3	31	14	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107896	10.1371/journal.pone.0107896	http://dx.doi.org/10.1371/journal.pone.0107896			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229407	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900085
J	Gleditsch, JM; Carlo, TA				Gleditsch, Jason M.; Carlo, Tomas A.			Living with Aliens: Effects of Invasive Shrub Honeysuckles on Avian Nesting	PLOS ONE			English	Article							HABITAT SELECTION; SITE SELECTION; PREDATION; PLANTS; PENNSYLVANIA; POPULATION; LANDSCAPE; ABUNDANCE; LONICERA; DENSITY	Invasive species have come to the forefront of conservation biology as a major threat to native biodiversity. Habitats dominated by shrub honeysuckles (Lonicera spp.) in the United States have been characterized as "ecological traps'' by ecologists. Here we tested this hypothesis by investigating the effects of shrub honeysuckles on the nesting ecology of native birds in seven study sites in central Pennsylvania, USA. We examined how the abundance of shrub honeysuckles influenced the selection of nesting substrates and habitat for a community of common songbirds, and the parental-care behavior and nestling development of gray catbirds (Dumetella carolinensis). We found that birds had a strong bias towards nesting in honeysuckle shrubs, but not necessarily for nesting in honeysuckle-dominated habitats. Nest predation rates were affected by the density of nests in a habitat, but not by the overall abundance of honeysuckles in such habitats. Honeysuckle abundance in the habitat did show significant effects on some parental-care behavioral parameters: catbirds had higher nest visitation rates and shorter visit lengths in areas of high honeysuckle density. On average, Gray catbirds fed fruit 12%+/- 0.31 s.e. of their nestling-feeding bouts, mostly fruits of shrub honeysuckles. Nestlings in sites with high honeysuckle density also showed higher mass: tarsus ratios, suggesting a good (possibly better) physiological condition of catbird nestlings at the time of fledging. Our study shows that honeysuckle-dominated habitats could have equivocal effects on nesting parameters of common species of native birds. We advise more caution in the widespread denomination of novel plant communities with high densities of honeysuckle as "cological traps'' as effects can be null or positive on native birds in certain localities.	[Gleditsch, Jason M.; Carlo, Tomas A.] Penn State Univ, Dept Biol & Intercoll Grad Degree Ecol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gleditsch, JM (corresponding author), Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA.	gledits2@illinois.edu		Gleditsch, Jason/0000-0003-0911-3127; Carlo, Tomas/0000-0002-2092-0053	Pennsylvania State University Department of Biology; Huck Institute of the Life Sciences	Pennsylvania State University Department of Biology; Huck Institute of the Life Sciences	All funding that supported this work came from the Pennsylvania State University Department of Biology (http://www.bio.psu.edu) and the Huck Institute of the Life Sciences (http://www.huck.psu.edu/). TAC obtained funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslan CE, 2010, ECOL APPL, V20, P1005, DOI 10.1890/08-2128.1; Borgmann KL, 2004, ECOL APPL, V14, P1757, DOI 10.1890/03-5129; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gleditsch JM, 2011, DIVERS DISTRIB, V17, P244, DOI 10.1111/j.1472-4642.2010.00733.x; Heckscher CM, 2004, AM MIDL NAT, V151, P326, DOI 10.1674/0003-0031(2004)151[0326:VNSIAM]2.0.CO;2; INGOLD JL, 1983, OHIO J SCI, V83, P256; Kristan WB, 2003, OIKOS, V103, P457; Labocha MK, 2012, J ORNITHOL, V153, P1, DOI 10.1007/s10336-011-0706-1; Langlois LA, 2010, AUK, V127, P850, DOI 10.1525/auk.2010.10068; Lichstein JW, 2002, ECOL APPL, V12, P836; Lugo AE, 2012, ANIM CONSERV, V15, P233, DOI 10.1111/j.1469-1795.2012.00523.x; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; MARTIN TE, 1988, CONDOR, V90, P51, DOI 10.2307/1368432; Martin TE, 2001, ECOLOGY, V82, P175, DOI 10.2307/2680095; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; Remes V, 2003, CONSERV BIOL, V17, P1127, DOI 10.1046/j.1523-1739.2003.01611.x; Rodewald AD, 2005, P OH INV PLANT RES C, V196, P43; Rodewald AD, 2010, BIOL INVASIONS, V12, P33, DOI 10.1007/s10530-009-9426-3; Schlossberg S, 2010, ANIM CONSERV, V13, P286, DOI 10.1111/j.1469-1795.2009.00338.x; Schmidt KA, 1999, CONSERV BIOL, V13, P1502, DOI 10.1046/j.1523-1739.1999.99050.x; Smith RJ, 2008, CONDOR, V110, P682, DOI 10.1525/cond.2008.8588; Smith SB, 2013, NORTHEAST NAT, V20, P171, DOI 10.1656/045.020.0114; Sogge MK, 2008, RESTOR ECOL, V16, P146, DOI 10.1111/j.1526-100X.2008.00357.x; Tallamy DW, 2010, BIOL INVASIONS, V12, P2285, DOI 10.1007/s10530-009-9639-5; Tallamy DW, 2004, CONSERV BIOL, V18, P1689, DOI 10.1111/j.1523-1739.2004.00512.x; THOMPSON JN, 1979, EVOLUTION, V33, P973, DOI 10.1111/j.1558-5646.1979.tb04751.x; Watling JI, 2010, LANDSCAPE ECOL, V25, P69, DOI 10.1007/s10980-009-9416-y	28	17	19	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107120	10.1371/journal.pone.0107120	http://dx.doi.org/10.1371/journal.pone.0107120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229633	gold, Green Published			2022-12-25	WOS:000342123900025
J	Kwon, DN; Chang, BS; Kim, JH				Kwon, Deug-Nam; Chang, Byung-Soo; Kim, Jin-Hoi			Gene Expression and Pathway Analysis of Effects of the CMAH Deactivation on Mouse Lung, Kidney and Heart	PLOS ONE			English	Article							N-GLYCOLYLNEURAMINIC ACID; ACETYLNEURAMINIC ACID; ONTOLOGY; ANTIGENS; LIPASE	Background: N-glycolylneuraminic acid (Neu5Gc) is generated by hydroxylation of CMP-Neu5Ac to CMP-Neu5Gc, catalyzed by CMP-Neu5Ac hydroxylase (CMAH). However, humans lack this common mammalian cell surface molecule, Neu5Gc, due to inactivation of the CMAH gene during evolution. CMAH is one of several human-specific genes whose function has been lost by disruption or deletion of the coding frame. It has been suggested that CMAH inactivation has resulted in biochemical or physiological characteristics that have resulted in human-specific diseases. Methodology/Principal Findings: To identify differential gene expression profiles associated with the loss of Neu5Gc expression, we performed microarray analysis using Illumina MouseRef-8 v2 Expression BeadChip, using the main tissues (lung, kidney, and heart) from control mice and CMP-Neu5Ac hydroxylase (Cmah) gene knock-out mice, respectively. Out of a total of 25,697 genes, 204, 162, and 147 genes were found to be significantly modulated in the lung, kidney, and heart tissues of the Cmah null mouse, respectively. In this study, we examined the gene expression profiles, using three commercial pathway analysis software packages: Ingenuity Pathways Analysis, Kyoto Encyclopedia of Genes and Genomes analysis, and Pathway Studio. The gene ontology analysis revealed that the top 6 biological processes of these genes included protein metabolism and modification, signal transduction, lipid, fatty acid, and steroid metabolism, nucleoside, nucleotide and nucleic acid metabolism, immunity and defense, and carbohydrate metabolism. Gene interaction network analysis showed a common network that was common to the different tissues of the Cmah null mouse. However, the expression of most sialytransferase mRNAs of Hanganutziu-Deicher antigen, sialy-Tn antigen, Forssman antigen, and Tn antigen was significantly down-regulated in the liver tissue of Cmah null mice. Conclusions/Significance: Mice bearing a human-like deletion of the Cmah gene serve as an important model for the study of abnormal pathogenesis and/or metabolism caused by the evolutionary loss of Neu5Gc synthesis in humans.	[Kwon, Deug-Nam; Kim, Jin-Hoi] Konkuk Univ, Dept Anim Biotechnol, Seoul, South Korea; [Chang, Byung-Soo] Hanseo Univ, Dept Cosmetol, Seosan, Chungnam, South Korea	Konkuk University; Hanseo University	Kim, JH (corresponding author), Konkuk Univ, Dept Anim Biotechnol, Seoul, South Korea.	jhkim541@konkuk.ac.kr		kim, jin-hoi/0000-0003-1232-5307	next generation of Biogreen 21 from the Rural Development Administration (RDA), Republic of Korea [PJ009625]	next generation of Biogreen 21 from the Rural Development Administration (RDA), Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by the next generation of Biogreen 21 (PJ009625) from the Rural Development Administration (RDA), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BUSCHER HP, 1977, EUR J BIOCHEM, V77, P297, DOI 10.1111/j.1432-1033.1977.tb11668.x; Cao HN, 2003, J HUM GENET, V48, P443, DOI 10.1007/s10038-003-0051-1; Chandrasekharan K, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000692; Chen G, 2005, NAT MED, V11, P1295, DOI 10.1038/nm1330; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Ekser B, 2009, TRANSPL IMMUNOL, V21, P87, DOI 10.1016/j.trim.2008.10.005; Ezzelarab M, 2005, IMMUNOL CELL BIOL, V83, P396, DOI 10.1111/j.1440-1711.2005.01344.x; Griesemer A, 2014, IMMUNOL REV, V258, P241, DOI 10.1111/imr.12152; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hayakawa T, 2001, P NATL ACAD SCI USA, V98, P11399, DOI 10.1073/pnas.191268198; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; Jimenez-Marin Angeles, 2009, BMC Proc, V3 Suppl 4, pS6, DOI 10.1186/1753-6561-3-S4-S6; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kavaler S, 2011, FASEB J, V25, P1887, DOI 10.1096/fj.10-175281; Kwon DN, 2013, SCI REP-UK, V3, DOI 10.1038/srep01981; Miwa Y, 2004, XENOTRANSPLANTATION, V11, P247, DOI 10.1111/j.1399-3089.2004.00126.x; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Reboul E, 2006, BBA-MOL CELL BIOL L, V1761, P4, DOI 10.1016/j.bbalip.2005.12.013; SANDRIN MS, 1994, IMMUNOL REV, V141, P169, DOI 10.1111/j.1600-065X.1994.tb00877.x; SCHAUER R, 1971, H-S Z PHYSIOL CHEM, V352, P1282, DOI 10.1515/bchm2.1971.352.2.1282; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Varki NM, 2011, ANNU REV PATHOL-MECH, V6, P365, DOI 10.1146/annurev-pathol-011110-130315; Zhang G, 2013, CLIN CANCER RES, V19, P4983, DOI 10.1158/1078-0432.CCR-13-0209	28	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107559	10.1371/journal.pone.0107559	http://dx.doi.org/10.1371/journal.pone.0107559			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229777	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900048
J	Baldrighi, E; Lavaleye, M; Aliani, S; Conversi, A; Manini, E				Baldrighi, Elisa; Lavaleye, Marc; Aliani, Stefano; Conversi, Alessandra; Manini, Elena			Large Spatial Scale Variability in Bathyal Macrobenthos Abundance, Biomass, alpha- and beta-Diversity along the Mediterranean Continental Margin	PLOS ONE			English	Article							DEEP-SEA MACROBENTHOS; COMMUNITY STRUCTURE; SPECIES-DIVERSITY; ORGANIC-MATTER; NEMATODE BIODIVERSITY; BENTHIC DIVERSITY; STANDING STOCK; CARBON FLUX; SLOPE; PATTERNS	The large-scale deep-sea biodiversity distribution of the benthic fauna was explored in the Mediterranean Sea, which can be seen as a miniature model of the oceans of the world. Within the framework of the BIOFUN project ("Biodiversity and Ecosystem Functioning in Contrasting Southern European Deep-sea Environments: from viruses to megafauna"), we investigated the large spatial scale variability (over >1,000 km) of the bathyal macrofauna communities that inhabit the Mediterranean basin, and their relationships with the environmental variables. The macrofauna abundance, biomass, community structure and functional diversity were analysed and the alpha-diversity and beta-diversity were estimated across six selected slope areas at different longitudes and along three main depths. The macrobenthic standing stock and alpha-diversity were lower in the deep-sea sediments of the eastern Mediterranean basin, compared to the western and central basins. The macrofaunal standing stock and diversity decreased significantly from the upper bathyal to the lower bathyal slope stations. The major changes in the community composition of the higher taxa and in the trophic (functional) structure occurred at different longitudes, rather than at increasing water depth. For the beta-diversity, very high dissimilarities emerged at all levels: (i) between basins; (ii) between slopes within the same basin; and (iii) between stations at different depths; this therefore demonstrates the high macrofaunal diversity of the Mediterranean basins at large spatial scales. Overall, the food sources (i. e., quantity and quality) that characterised the west, central and eastern Mediterranean basins, as well as sediment grain size, appear to influence the macrobenthic standing stock and the biodiversity along the different slope areas.	[Baldrighi, Elisa; Manini, Elena] Natl Res Council ISMAR CNR, Inst Marine Sci, Ancona, Italy; [Lavaleye, Marc] Royal Netherlands Inst Sea Res NIOZ, Dept Marine Ecol, Texel, Netherlands; [Aliani, Stefano; Conversi, Alessandra] Natl Res Council ISMAR CNR, Inst Marine Sci, La Spezia, Italy; [Conversi, Alessandra] Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); University of Plymouth	Manini, E (corresponding author), Natl Res Council ISMAR CNR, Inst Marine Sci, Ancona, Italy.	e.manini@ismar.cnr.it	Manini, Elena/C-2032-2015; Aliani, Stefano/B-5854-2012; Baldrighi, Elisa/AAP-1826-2020; Conversi, Alessandra/G-3899-2011; CNR, Ismar/P-1247-2014	Manini, Elena/0000-0002-8990-2929; Aliani, Stefano/0000-0002-2555-4398; Conversi, Alessandra/0000-0002-8566-8282; CNR, Ismar/0000-0001-5351-1486	ESF-EuroDEEP project BIOFUN [CTM2007-28739-E]; BALMAS (IPA ADRIATIC project) [1oSTR/0005]	ESF-EuroDEEP project BIOFUN; BALMAS (IPA ADRIATIC project)	This study is part of ESF-EuroDEEP project BIOFUN (CTM2007-28739-E) and for final version by BALMAS (IPA ADRIATIC project; 1<SUP>o</SUP>STR/0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arvanitidis C, 2002, MAR ECOL PROG SER, V244, P139, DOI 10.3354/meps244139; Basso D, 2004, SCI MAR, V68, P53, DOI 10.3989/scimar.2004.68s353; Beaugrand G, 2013, GLOBAL ECOL BIOGEOGR, V22, P440, DOI 10.1111/geb.12009; Boetius A, 1996, DEEP-SEA RES PT I, V43, P1439, DOI 10.1016/S0967-0637(96)00053-2; BOUCHET P, 1992, DEEP-SEA RES, V39, P169, DOI 10.1016/0198-0149(92)90103-Z; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; Carpine C., 1970, MEM I OC ANOGR MONAC, V2, P146; Cartes J. E., 2004, MEDITERRANEAN DEEP S, P9; CARTES JE, 1993, CRUSTACEANA, V64, P155; Cartes JE, 2009, J SEA RES, V61, P244, DOI 10.1016/j.seares.2009.01.005; Chardy P, 1973, RAPPORT COMMISSION I, V22, P107; Chardy P, 1974, VIE MILIEU, V24, P409; Clarke K.R, 2006, PRIMER V6 USER MANUA; COLL M, 2010, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0011842; Company JB, 2004, SCI MAR, V68, P73, DOI 10.3989/scimar.2004.68s373; Corbera J, 2001, ISRAEL J ZOOL, V47, P135, DOI 10.1560/V50U-X6QE-K76X-9D97; Corliss BH, 2009, DEEP-SEA RES PT I, V56, P835, DOI 10.1016/j.dsr.2008.12.009; Cosson N, 1997, DEEP-SEA RES PT I, V44, P247, DOI 10.1016/S0967-0637(96)00110-0; D'Ortenzio F, 2009, BIOGEOSCIENCES, V6, P139, DOI 10.5194/bg-6-139-2009; Danovaro R, 2009, MAR ECOL PROG SER, V396, P197, DOI 10.3354/meps08269; Danovaro R., 2010, METHODS STUDY DEEP S; Danovaro R, 2008, ECOGRAPHY, V31, P231, DOI 10.1111/j.0906-7590.2008.5484.x; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; DEBOVEE F, 1990, CONT SHELF RES, V10, P1123, DOI 10.1016/0278-4343(90)90077-Y; DEJONGE VN, 1980, MAR ECOL PROG SER, V2, P345, DOI 10.3354/meps002345; Dinet A., 1985, PEUPLEMENTS PROFONDS, P121; Ellingsen KE, 2002, J ANIM ECOL, V71, P373, DOI 10.1046/j.1365-2656.2002.00606.x; ETTER RJ, 1992, NATURE, V360, P576, DOI 10.1038/360576a0; FABIANO M, 1995, CONT SHELF RES, V15, P1453, DOI 10.1016/0278-4343(94)00088-5; Fauchald K., 1979, Oceanography and Marine Biology an Annual Review, V17, P193; Flach E, 1999, J MAR BIOL ASSOC UK, V79, P233, DOI 10.1017/S0025315498000265; Flach E, 1998, PROG OCEANOGR, V42, P209, DOI 10.1016/S0079-6611(98)00035-4; Fredj G, 1985, DEEP MEDITERRANEAN B, P109; Fry J. C., 1990, METHODS AQUATIC BACT, P27; Gage J. D., 1991, DEEP SEA BIOL NATURA; Gage JD, 2003, ECOSY WORLD, V28, P313; Gage JD, 2000, HYDROBIOLOGIA, V440, P261, DOI 10.1023/A:1004143816391; Galeron J, 2009, DEEP-SEA RES PT II, V56, P2299, DOI 10.1016/j.dsr2.2009.04.011; Galeron J, 2000, MAR ECOL PROG SER, V197, P121, DOI 10.3354/meps197121; Galil BS, 2004, SCI MAR, V68, P63, DOI 10.3989/scimar.2004.68s363; Gambi C., 2010, ADV OCEANOGR LIMNOL, V1, P167, DOI [10.4081/aiol.2010.5299, DOI 10.4081/AIOL.2010.5299]; GERINO M, 1995, CONT SHELF RES, V15, P1483, DOI 10.1016/0278-4343(94)00082-X; Giovannelli D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072996; Gooday AJ, 2001, DEEP-SEA RES PT I, V48, P1709, DOI 10.1016/S0967-0637(00)00098-4; GRAY JS, 1994, MAR ECOL PROG SER, V112, P205, DOI 10.3354/meps112205; Gray JS, 2000, J EXP MAR BIOL ECOL, V250, P23, DOI 10.1016/S0022-0981(00)00178-7; Gutu Modest, 2002, Travaux du Museum National d'Histoire Naturelle "Grigore Antipa", V44, P19; Gutu Modest, 2001, Travaux du Museum National d'Histoire Naturelle "Grigore Antipa", V43, P59; Hasemann C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029152; Hughes DJ, 2004, PROG OCEANOGR, V63, P29, DOI 10.1016/j.pocean.2004.09.002; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Johnson NA, 2007, DEEP-SEA RES PT I, V54, P1350, DOI 10.1016/j.dsr.2007.04.011; Karakassis I, 1997, MAR ECOL PROG SER, V160, P185, DOI 10.3354/meps160185; Kroncke I, 2003, MAR ECOL-P S Z N I, V24, P193, DOI 10.1046/j.0173-9565.2003.00825.x; Kroncke I, 2000, MAR ECOL PROG SER, V199, P31, DOI 10.3354/meps199031; Laubier L., 1973, Vie et Milieu (A), V23(2), P243; Leduc D, 2012, MAR ECOL PROG SER, V454, P37, DOI 10.3354/meps09690; Leduc D, 2012, DEEP-SEA RES PT I, V63, P164, DOI 10.1016/j.dsr.2011.10.009; Lee J.J., 1980, BIOCH PHYSL PROTOZOA, V3, P43; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Levin LA, 1998, DEEP-SEA RES PT II, V45, P129, DOI 10.1016/S0967-0645(97)00085-4; Levin LA, 2012, ANNU REV MAR SCI, V4, P79, DOI 10.1146/annurev-marine-120709-142714; Levin LA, 2010, MAR ECOL-EVOL PERSP, V31, P1, DOI 10.1111/j.1439-0485.2009.00358.x; Lipps J.H., 1983, Topics in Geobiology, V3, P331; Luna GM, 2002, APPL ENVIRON MICROB, V68, P3509, DOI 10.1128/AEM.68.7.3509-3513.2002; Lutz M, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2000GB001383; Mamouridis V, 2011, DEEP-SEA RES PT I, V58, P323, DOI 10.1016/j.dsr.2011.01.005; Manini E, 2006, FEMS MICROBIOL ECOL, V55, P416, DOI 10.1111/j.1574-6941.2005.00042.x; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Muhlenhardt-Siegel U, 2009, ZOOTAXA, P413, DOI 10.11646/zootaxa.2096.1.25; Narayanaswamy BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058909; Narayanaswamy BE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014295; Norman AN, 1889, CRUSTACEA ISOPODA LI; Pape E, 2013, BIOGEOSCIENCES, V10, P3127, DOI 10.5194/bg-10-3127-2013; Pape E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059954; Pavithran S, 2009, J EARTH SYST SCI, V118, P689, DOI 10.1007/s12040-009-0051-4; Pavithran S, 2009, MAR BIOL RES, V5, P391, DOI 10.1080/17451000802441285; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Pusceddu A, 2010, DEEP-SEA RES PT I, V57, P441, DOI 10.1016/j.dsr.2009.11.008; Pusceddu A, 2009, MAR ECOL PROG SER, V375, P41, DOI 10.3354/meps07735; Ramirez-Llodra E, 2010, BIOGEOSCIENCES, V7, P2851, DOI 10.5194/bg-7-2851-2010; Rex MA, 2005, AM NAT, V165, P163, DOI 10.1086/427226; REX MA, 1981, ANNU REV ECOL SYST, V12, P331, DOI 10.1146/annurev.es.12.110181.001555; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Reyss D, 1974, CRUSTACEANA, V27, P275; Reyss D, 1972, CUMACES CRUSTACEA S3, P362; ROMEROWETZEL MB, 1987, MAR BIOL, V96, P87, DOI 10.1007/BF00394841; Rosso A, 2010, DEEP-SEA RES PT II, V57, P360, DOI 10.1016/j.dsr2.2009.08.024; Rowe GT, 1983, SEA, P97; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Santinelli C, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004151; Sarda F, 2004, SCI MAR, V68, P7, DOI 10.3989/scimar.2004.68s37; Sars GO, 1882, ACCOUNT CRUSTACEA NO; Serpetti N, 2012, BIOGEOSCIENCES, V9, P16907; Shannon CE., 1949, MATH THEORY COMMUNIC; Sharma J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014491; Sharma Jyotsna, 2011, Marine Biodiversity, V41, P455, DOI 10.1007/s12526-010-0060-1; Snelgrove PVR, 2002, OCEANOGR MAR BIOL, V40, P311; Sorbe JC, 2002, CRUSTACEANA, V75, P957, DOI 10.1163/15685400260569607; Stora G, 1999, DEEP-SEA RES PT I, V46, P1339, DOI 10.1016/S0967-0637(99)00012-6; SUESS E, 1980, NATURE, V288, P260, DOI 10.1038/288260a0; TAHEY TM, 1994, MAR ECOL PROG SER, V104, P119, DOI 10.3354/meps104119; Tecchio S, 2011, MAR ECOL PROG SER, V439, P181, DOI 10.3354/meps09333; Tecchio S, 2011, SCI MAR, V75, P341, DOI 10.3989/scimar.2011.75n2341; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tselepides A, 2000, PROG OCEANOGR, V46, P401, DOI 10.1016/S0079-6611(00)00027-6; Tselepides A, 2004, DEEP-SEA RES PT I, V51, P833; Tselepides A, 1992, S AEGEAN E MEDITERRA; Tyler PA, 2003, ECOSY WORLD, V28, P261; Vamvakas C.-N. E ., 1970, Tethys, V2, P89; Vanreusel A, 2010, MAR ECOL-EVOL PERSP, V31, P6, DOI 10.1111/j.1439-0485.2009.00352.x; WAGELE JW, 1980, ZOOL SCR, V9, P53, DOI 10.1111/j.1463-6409.1980.tb00650.x; Wei CL, 2010, MAR ECOL PROG SER, V399, P1, DOI 10.3354/meps08388; Witte U, 2000, DEEP-SEA RES PT II, V47, P2979, DOI 10.1016/S0967-0645(00)00055-2; Zajac RN, 2008, J EXP MAR BIOL ECOL, V366, P198, DOI 10.1016/j.jembe.2008.07.025	119	25	25	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107261	10.1371/journal.pone.0107261	http://dx.doi.org/10.1371/journal.pone.0107261			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225909	gold, Green Published			2022-12-25	WOS:000344317700041
J	Mamidi, S; Lee, RK; Goos, JR; McClean, PE				Mamidi, Sujan; Lee, Rian K.; Goos, Jay R.; McClean, Phillip E.			Genome-Wide Association Studies Identifies Seven Major Regions Responsible for Iron Deficiency Chlorosis in Soybean (Glycine max)	PLOS ONE			English	Article							FERRIC-CHELATE REDUCTASE; POPULATION-STRUCTURE; LINKAGE DISEQUILIBRIUM; MICROARRAY ANALYSIS; METAL TRANSPORTER; MIXED-MODEL; ARABIDOPSIS; GENES; TOLERANCE; EXPRESSION	Iron deficiency chlorosis (IDC) is a yield limiting problem in soybean (Glycine max (L.) Merr) production regions with calcareous soils. Genome-wide association study (GWAS) was performed using a high density SNP map to discover significant markers, QTL and candidate genes associated with IDC trait variation. A stepwise regression model included eight markers after considering LD between markers, and identified seven major effect QTL on seven chromosomes. Twelve candidate genes known to be associated with iron metabolism mapped near these QTL supporting the polygenic nature of IDC. A non-synonymous substitution with the highest significance in a major QTL region suggests soybean orthologs of FRE1 on Gm03 is a major gene responsible for trait variation. NAS3, a gene that encodes the enzyme nicotianamine synthase which synthesizes the iron chelator nicotianamine also maps to the same QTL region. Disease resistant genes also map to the major QTL, supporting the hypothesis that pathogens compete with the plant for Fe and increase iron deficiency. The markers and the allelic combinations identified here can be further used for marker assisted selection.	[Mamidi, Sujan; Lee, Rian K.; McClean, Phillip E.] N Dakota State Univ, Genom & Bioinformat Program, Fargo, ND 58105 USA; [Mamidi, Sujan; Lee, Rian K.; McClean, Phillip E.] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA; [Goos, Jay R.] N Dakota State Univ, Dept Soil Sci, Fargo, ND 58105 USA	North Dakota State University Fargo; North Dakota State University Fargo; North Dakota State University Fargo	McClean, PE (corresponding author), N Dakota State Univ, Genom & Bioinformat Program, Fargo, ND 58105 USA.	Phillip.Mcclean@ndsu.edu	mamidi, sujan/P-7009-2018	mamidi, sujan/0000-0002-3837-6121	North Central Soybean Research Program	North Central Soybean Research Program	This work is supported by North Central Soybean Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsterfjord M, 2004, PLANT CELL PHYSIOL, V45, P1202, DOI 10.1093/pcp/pch136; Arrivault S, 2006, PLANT J, V46, P861, DOI 10.1111/j.1365-313X.2006.02746.x; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Bai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072126; Barker A.V., 2010, HDB PLANT NUTR; Bloom AJ, 2002, J PLANT GROWTH REGUL, V21, P416, DOI 10.1007/s00344-003-0009-8; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Briat JF, 2007, CURR OPIN PLANT BIOL, V10, P276, DOI 10.1016/j.pbi.2007.04.003; Caicedo AL, 2004, P NATL ACAD SCI USA, V101, P15670, DOI 10.1073/pnas.0406232101; Chen SY, 2007, PLANT SOIL, V299, P131, DOI 10.1007/s11104-007-9370-x; Chen WW, 2010, PLANT PHYSIOL, V154, P810, DOI 10.1104/pp.110.161109; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Colangelo EP, 2004, PLANT CELL, V16, P3400, DOI 10.1105/tpc.104.024315; Connolly EL, 2003, PLANT PHYSIOL, V133, P1102, DOI 10.1104/pp.103.025122; Connolly EL, 2002, PLANT CELL, V14, P1347, DOI 10.1105/tpc.001263; Conte SS, 2011, MOL PLANT, V4, P464, DOI 10.1093/mp/ssr015; Curie C, 2003, ANNU REV PLANT BIOL, V54, P183, DOI 10.1146/annurev.arplant.54.031902.135018; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Deschamps S, 2010, MOL BREEDING, V25, P553, DOI 10.1007/s11032-009-9357-9; DIERS BW, 1992, J PLANT NUTR, V15, P2127, DOI 10.1080/01904169209364462; Durrett TP, 2006, PLANT J, V47, P467, DOI 10.1111/j.1365-313X.2006.02803.x; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fones H, 2012, FEMS MICROBIOL LETT, V327, P1, DOI 10.1111/j.1574-6968.2011.02449.x; Franzen DW, 2000, J PLANT NUTR, V23, P67, DOI 10.1080/01904160009381998; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Grillo MA, 2013, NEW PHYTOL, V197, P1321, DOI 10.1111/nph.12109; Gu RL, 2013, PLANT CELL PHYSIOL, V54, P1515, DOI 10.1093/pcp/pct099; Gurung S, 2011, THEOR APPL GENET, V123, P1029, DOI 10.1007/s00122-011-1645-1; Iqbal MJ, 2012, THEOR APPL GENET, V125, P517, DOI 10.1007/s00122-012-1850-6; Ishimaru Y, 2007, P NATL ACAD SCI USA, V104, P7373, DOI 10.1073/pnas.0610555104; Jiang ZF, 2010, EUPHYTICA, V175, P227, DOI 10.1007/s10681-010-0172-5; Kang YJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-139; Kim SA, 2007, FEBS LETT, V581, P2273, DOI 10.1016/j.febslet.2007.04.043; King KE, 2013, J PLANT NUTR, V36, P2132, DOI 10.1080/01904167.2013.766804; Kobayashi T, 2012, ANNU REV PLANT BIOL, V63, P131, DOI 10.1146/annurev-arplant-042811-105522; Lee S, 2009, P NATL ACAD SCI USA, V106, P22014, DOI 10.1073/pnas.0910950106; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JL, 2009, J NONPARAMETR STAT, V21, P649, DOI 10.1080/10485250902770035; Lin HX, 2003, BREEDING SCI, V53, P51, DOI 10.1270/jsbbs.53.51; Lin S, 1997, MOL BREEDING, V3, P219, DOI 10.1023/A:1009637320805; Lin SF, 2000, J PLANT NUTR, V23, P1929, DOI 10.1080/01904160009382154; Lin SF, 1998, CROP SCI, V38, P254, DOI 10.2135/cropsci1998.0011183X003800010043x; Long Q, 2013, NAT GENET, V45, P884, DOI 10.1038/ng.2678; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; Mamidi S, 2011, PLANT GENOME-US, V4, P154, DOI 10.3835/plantgenome2011.04.0011; Mandel JR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003378; Mangin B, 2012, HEREDITY, V108, P285, DOI 10.1038/hdy.2011.73; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; MARSCHNER H, 1986, J PLANT NUTR, V9, P695, DOI 10.1080/01904168609363475; Masuda H, 2009, RICE, V2, P155, DOI 10.1007/s12284-009-9031-1; Meyer KB, 2013, AM J HUM GENET, V93, P1046, DOI 10.1016/j.ajhg.2013.10.026; MILLER GW, 1984, J PLANT NUTR, V7, P1, DOI 10.1080/01904168409363172; Morel M, 2009, PLANT PHYSIOL, V149, P894, DOI 10.1104/pp.108.130294; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; O'Rourke JA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-476; Oki H, 2004, SOIL SCI PLANT NUTR, V50, P1159, DOI 10.1080/00380768.2004.10408589; Patel JS, 2013, CROP SCI, V53, P842, DOI 10.2135/cropsci2012.01.0036; Peiffer GA, 2012, PLANT PHYSIOL, V158, P1745, DOI 10.1104/pp.111.189860; Pich A, 2001, PLANTA, V213, P967, DOI 10.1007/s004250100573; Pineau C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003120; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pyhajarvi T, 2007, GENETICS, V177, P1713, DOI 10.1534/genetics.107.077099; Rakitsch B, 2013, BIOINFORMATICS, V29, P206, DOI 10.1093/bioinformatics/bts669; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Samuelsen AI, 1998, PLANT PHYSIOL, V118, P51, DOI 10.1104/pp.118.1.51; Schaaf G, 2006, J BIOL CHEM, V281, P25532, DOI 10.1074/jbc.M601062200; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schmidt W, 1999, NEW PHYTOL, V141, P1, DOI 10.1046/j.1469-8137.1999.00331.x; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Seo PJ, 2012, BIOCHEM J, V442, P551, DOI 10.1042/BJ20111311; Severin AJ, 2010, PLANT PHYSIOL, V154, P3, DOI 10.1104/pp.110.158949; Shang JL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-475; Stacey MG, 2006, PLANTA, V223, P291, DOI 10.1007/s00425-005-0087-x; Stec AO, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00104; Stram DO, 2004, GENET EPIDEMIOL, V27, P365, DOI 10.1002/gepi.20028; Tarantino D, 2010, J PLANT PHYSIOL, V167, P1598, DOI 10.1016/j.jplph.2010.06.020; Taylor AR, 1998, PLANT CELL ENVIRON, V21, P1255, DOI 10.1046/j.1365-3040.1998.00357.x; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; von Wiren N, 1999, PLANT PHYSIOL, V119, P1107, DOI 10.1104/pp.119.3.1107; Wang J, 2008, THEOR APPL GENET, V116, P777, DOI 10.1007/s00122-008-0710-x; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Wang YH, 2001, PLANT PHYSIOL, V127, P345, DOI 10.1104/pp.127.1.345; Woeste KE, 2000, PLANT CELL, V12, P443, DOI 10.1105/tpc.12.3.443; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang NY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009991; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zheng LQ, 2009, PLANT PHYSIOL, V151, P262, DOI 10.1104/pp.109.141051; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zou C, 2001, PLANT SOIL, V235, P143, DOI 10.1023/A:1011902320662	94	71	77	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107469	10.1371/journal.pone.0107469	http://dx.doi.org/10.1371/journal.pone.0107469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225893	Green Published, gold, Green Submitted			2022-12-25	WOS:000344317700057
J	Tawa, GJ; AbdulHameed, MDM; Yu, XP; Kumar, K; Ippolito, DL; Lewis, JA; Stallings, JD; Wallqvist, A				Tawa, Gregory J.; AbdulHameed, Mohamed Diwan M.; Yu, Xueping; Kumar, Kamal; Ippolito, Danielle L.; Lewis, John A.; Stallings, Jonathan D.; Wallqvist, Anders			Characterization of Chemically Induced Liver Injuries Using Gene Co-Expression Modules	PLOS ONE			English	Article							DRUG DISCOVERY; UNDERSTAND MECHANISMS; TOXICITY; TOXICOGENOMICS; INTEGRATION; EXPRESSION; INHIBITOR; FIBROSIS; DATABASE; CLASSIFICATION	Liver injuries due to ingestion or exposure to chemicals and industrial toxicants pose a serious health risk that may be hard to assess due to a lack of non-invasive diagnostic tests. Mapping chemical injuries to organ-specific damage and clinical outcomes via biomarkers or biomarker panels will provide the foundation for highly specific and robust diagnostic tests. Here, we have used DrugMatrix, a toxicogenomics database containing organ-specific gene expression data matched to dose-dependent chemical exposures and adverse clinical pathology assessments in Sprague Dawley rats, to identify groups of co-expressed genes (modules) specific to injury endpoints in the liver. We identified 78 such gene co-expression modules associated with 25 diverse injury endpoints categorized from clinical pathology, organ weight changes, and histopathology. Using gene expression data associated with an injury condition, we showed that these modules exhibited different patterns of activation characteristic of each injury. We further showed that specific module genes mapped to 1) known biochemical pathways associated with liver injuries and 2) clinically used diagnostic tests for liver fibrosis. As such, the gene modules have characteristics of both generalized and specific toxic response pathways. Using these results, we proposed three gene signature sets characteristic of liver fibrosis, steatosis, and general liver injury based on genes from the co-expression modules. Out of all 92 identified genes, 18 (20%) genes have well-documented relationships with liver disease, whereas the rest are novel and have not previously been associated with liver disease. In conclusion, identifying gene co-expression modules associated with chemically induced liver injuries aids in generating testable hypotheses and has the potential to identify putative biomarkers of adverse health effects.	[Tawa, Gregory J.; AbdulHameed, Mohamed Diwan M.; Yu, Xueping; Kumar, Kamal; Wallqvist, Anders] US Army Med Res & Mat Command, Dept Def High Performance Comp Software Applicat, Telemed & Adv Technol Res Ctr, Ft Detrick, MD 21702 USA; [Ippolito, Danielle L.; Lewis, John A.; Stallings, Jonathan D.] US Army Ctr Environm Hlth Res, Ft Detrick, MD USA	United States Department of Defense; United States Army	Tawa, GJ (corresponding author), US Army Med Res & Mat Command, Dept Def High Performance Comp Software Applicat, Telemed & Adv Technol Res Ctr, Ft Detrick, MD 21702 USA.	gtawa@bhsai.org; awallqvist@bhsai.org	AbdulHameed, Mohamed Diwan M/O-3088-2015; Stallings, Jonathan D/H-7779-2013; wallqvist, anders/W-2584-2019	AbdulHameed, Mohamed Diwan M/0000-0003-1483-4084; Stallings, Jonathan D/0000-0002-6430-5888; wallqvist, anders/0000-0002-9775-7469; Kumar, Kamal/0000-0002-9470-6682	Military Operational Medicine Research Program; U.S. Army's Network Science Initiative, U.S. Army Medical Research and Materiel Command, Ft. Detrick, MD	Military Operational Medicine Research Program(United States Department of DefenseUnited States ArmyUnited States Army Medical Research & Development Command (USAMRDC)); U.S. Army's Network Science Initiative, U.S. Army Medical Research and Materiel Command, Ft. Detrick, MD	The authors were supported by the Military Operational Medicine Research Program and the U.S. Army's Network Science Initiative, U.S. Army Medical Research and Materiel Command (mrmc.amedd.army.mil), Ft. Detrick, MD. This research was supported in part by an appointment to the Postgraduate Research Participation Program at the U.S. Army Center for Environmental Health Research (usacehr.amedd.army.mil) administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and USAMRMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JPF, 2013, ANNU REV PHARMACOL, V53, P451, DOI 10.1146/annurev-pharmtox-011112-140248; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Beghe B, 2013, AM J RESP CRIT CARE, V188, P271, DOI 10.1164/rccm.201301-0021PP; Bergmann S, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031902; Blomme EAG, 2009, TOXICOL LETT, V186, P22, DOI 10.1016/j.toxlet.2008.09.017; Boone L, 2005, VET CLIN PATH, V34, P182, DOI 10.1111/j.1939-165X.2005.tb00041.x; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Buttgereit F, 2005, SCAND J RHEUMATOL, V34, P14, DOI 10.1080/03009740510017706; Carlson MC, 2002, RAT2302 DB AFFYMETRI; Chen YJ, 2005, NUCLEIC ACIDS RES, V33, pD169; Csardi G, 2010, BIOINFORMATICS, V26, P1376, DOI 10.1093/bioinformatics/btq130; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; Deeter DP, 1993, TXB MILITARY MED 3; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Gant TW, 2009, CURR OPIN DRUG DISC, V12, P72; Ganter B, 2005, J BIOTECHNOL, V119, P219, DOI 10.1016/j.jbiotec.2005.03.022; Ganter B, 2006, PHARMACOGENOMICS, V7, P1025, DOI 10.2217/14622416.7.7.1025; Gentleman R, 2013, GENEFILTER METHODS F; Gresham V, 2009, ADV DRUG DELIVER REV, V61, P369, DOI 10.1016/j.addr.2008.12.002; Gressier L, 2009, ANN DERMATOL VENER, V136, P50, DOI 10.1016/j.annder.2008.07.063; GRIMBERT S, 1994, DIGEST DIS SCI, V39, P2032, DOI 10.1007/BF02088142; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Judson R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-241; Jump DB, 2005, J NUTR, V135, P2503, DOI 10.1093/jn/135.11.2503; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Koricanac G, 2012, EUR J PHARMACOL, V694, P127, DOI 10.1016/j.ejphar.2012.08.007; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Larson JL, 1996, PHARMACOL TOXICOL, V78, P44, DOI 10.1111/j.1600-0773.1996.tb00178.x; Laulederkind SJF, 2013, BRIEF BIOINFORM, V14, P520, DOI 10.1093/bib/bbt007; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; Moreno M, 2010, HEPATOLOGY, V51, P974, DOI 10.1002/hep.23421; Nakazato K, 2010, J GASTROEN HEPATOL, V25, P1692, DOI 10.1111/j.1440-1746.2009.06187.x; Natsoulis G, 2005, GENOME RES, V15, P724, DOI 10.1101/gr.2807605; Natsoulis G, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.9; Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021; Panagiotou G, 2012, SAR QSAR ENVIRON RES, V23, P221, DOI 10.1080/1062936X.2012.657237; Parkes Julie, 2012, Comp Hepatol, V11, P5, DOI 10.1186/1476-5926-11-5; Peraza MA, 2006, TOXICOL SCI, V90, P269, DOI 10.1093/toxsci/kfj062; Rinaldo A, 2005, GENET EPIDEMIOL, V28, P193, DOI 10.1002/gepi.20056; ROBERTSON DG, 1993, FUND APPL TOXICOL, V20, P446, DOI 10.1006/faat.1993.1055; Rossi E, 2003, CLIN CHEM, V49, P450, DOI 10.1373/49.3.450; Rossi Enrico, 2007, Clin Biochem Rev, V28, P3; Sarnes E, 2011, CLIN THER, V33, P1413, DOI 10.1016/j.clinthera.2011.09.009; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Seki K, 1983, Gastroenterol Jpn, V18, P197; Smalley JL, 2010, TOXICOLOGY, V268, P143, DOI 10.1016/j.tox.2009.09.014; Spicker JS, 2008, TOXICOL SCI, V102, P444, DOI 10.1093/toxsci/kfn001; Teixeira MM, 1997, TRENDS PHARMACOL SCI, V18, P164, DOI 10.1016/S0165-6147(97)90613-1; Thatishetty AV, 2013, CLIN LIVER DIS, V17, P671, DOI 10.1016/j.cld.2013.07.010; Uehara T, 2010, MOL NUTR FOOD RES, V54, P218, DOI 10.1002/mnfr.200900169; Yang X, 2012, CURRENT BIOMARKER FI, V2, P12; Yu XP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-79; Zhang LM, 2011, J PROTEOME RES, V10, P614, DOI 10.1021/pr100792q	57	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107230	10.1371/journal.pone.0107230	http://dx.doi.org/10.1371/journal.pone.0107230			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226513	Green Submitted, Green Published, gold			2022-12-25	WOS:000344317700037
J	Tella, JL; Hiraldo, F				Tella, Jose L.; Hiraldo, Fernando			Illegal and Legal Parrot Trade Shows a Long-Term, Cross-Cultural Preference for the Most Attractive Species Increasing Their Risk of Extinction	PLOS ONE			English	Article							WILD-BIRD TRADE; CONSERVATION; ABUNDANCE; IMPACTS; NEST	Illegal trade constitutes a major threat for a variety of wildlife. A criminology framework has been recently applied to parrot poaching in Mexico, suggesting an opportunistic crime in which the most abundant and accessible species, and not the rare or highly priced species, were poached more often. We analyzed this information, together with additional long-term data (1981-2005) on both the legal and illegal trade of the 22 Mexican parrot species (n = 31,019 individuals), using multivariate statistics and hypothesis-testing approaches. Our results showed a selective capture of parrot species attending to their attractiveness. Parrot species widely differed in attractiveness to people (as reflected by their combined measures of body size, coloration, and ability to imitate human speech), and their attractiveness strongly correlated with their prices both in the Mexican and US markets. The most attractive and valuable species (amazons and macaws) were disproportionally caught attending to the number of years they were legally trapped. Similar patterns were found for parrots poached for the domestic Mexican market, for those smuggled to the USA, and for those legally exported before or after 1992, when the USA ban led parrot exports to be mostly directed to European countries. Finally, the long-term cross-cultural preference for the most attractive species has led them to be among the most threatened species today. Since current parrot poaching mostly responds to local demand, socio-ecological work is needed to reverse the long-standing pet-keeping tradition that may decimate the most desired species in Neotropical countries.	[Tella, Jose L.; Hiraldo, Fernando] Estn Biol Donana CSIC, Dept Conservat Biol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Tella, JL (corresponding author), Estn Biol Donana CSIC, Dept Conservat Biol, Seville, Spain.	tella@ebd.csic.es	Tella, José L/I-3707-2015; Hiraldo, Fernando/AAA-8314-2019	Tella, José L/0000-0002-3038-7424; 	Fundacion Biodiversidad	Fundacion Biodiversidad(European Commission)	This work was conducted within the framework of a project on conflicts between parrots and people funded by Fundacion Biodiversidad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beissinger S.R., 2001, CONSERVATION EXPLOIT, P182; BEISSINGER SR, 1991, AUK, V108, P982; BEISSINGER SR, 1992, BIOSCIENCE, V42, P164, DOI 10.2307/1311821; Butchart SHM, 2008, BIRD CONSERV INT, V18, pS245, DOI 10.1017/S095927090800035X; Cantu J. C. G., 2007, ILLEGAL PARROT TRADE; Carrete M, 2008, FRONT ECOL ENVIRON, V6, P207, DOI 10.1890/070075; Casagrande DG, 1997, CONDOR, V99, P445, DOI 10.2307/1369951; Marin-Togo MC, 2012, BIODIVERS CONSERV, V21, P451, DOI 10.1007/s10531-011-0193-y; Cooney R, 2006, ORYX, V40, P18, DOI 10.1017/S0030605306000056; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; de Grahl W, 1990, PAPAGEIEN; Donald P. F., 2010, FACING EXTINCTION; Frynta D, 2011, HUM ECOL, V39, P829, DOI 10.1007/s10745-011-9447-2; Frynta D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012568; Gastanaga M, 2011, BIRD CONSERV INT, V21, P76, DOI 10.1017/S0959270910000249; Gibbs C, 2010, BRIT J CRIMINOL, V50, P124, DOI 10.1093/bjc/azp045; Gilardi JD, 2006, ORYX, V40, P24, DOI 10.1017/S0030605306000160; Gonzalez JA, 2003, BIOL CONSERV, V114, P437, DOI 10.1016/S0006-3207(03)00071-5; Gore ML, 2011, CONSERV BIOL, V25, P659, DOI 10.1111/j.1523-1739.2011.01701.x; Grilli Pablo G, 2012, Hornero, V27, P63; Hall RJ, 2008, CONSERV LETT, V1, P75, DOI 10.1111/j.1755-263X.2008.00013.x; Herrera M, 2007, BIRD CONSERV INT, V17, P295, DOI 10.1017/S0959270907000858; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Briceno-Linares JM, 2011, BIOL CONSERV, V144, P1188, DOI 10.1016/j.biocon.2010.12.010; Marsden SJ, 2003, IBIS, V145, P45, DOI 10.1046/j.1474-919X.2003.00107.x; Munn CA, 2006, MANUAL OF PARROT BEHAVIOR, P27, DOI 10.1002/9780470344651.ch3; Pain DJ, 2006, ANIM CONSERV, V9, P322, DOI 10.1111/j.1469-1795.2006.00040.x; Pinho J. B., 2000, ARARAJUBA, V8, P51; Pires S, 2012, J RES CRIME DELINQ, V49, P122, DOI 10.1177/0022427810397950; Pires SF, 2012, GLOB CRIME, V13, P176, DOI 10.1080/17440572.2012.700180; Pires SF, 2011, BRIT J CRIMINOL, V51, P314, DOI 10.1093/bjc/azq074; Pires S, 2011, EUR J CRIM POLICY RE, V17, P101, DOI 10.1007/s10610-011-9141-3; Rivalan P, 2007, NATURE, V447, P529, DOI 10.1038/447529a; SERMARNAT, 2010, NOM059SERMANAT; Sollund R, 2011, CRIME LAW SOCIAL CH, V55, P437, DOI 10.1007/s10611-011-9296-3; Tella JL, 2013, BIOL CONSERV, V167, P425, DOI 10.1016/j.biocon.2013.08.035; Tella JL, 2011, ARDEOLA, V58, P399, DOI 10.13157/arla.58.2.2011.399; Wright TF, 2001, CONSERV BIOL, V15, P710, DOI 10.1046/j.1523-1739.2001.015003710.x	38	74	74	0	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107546	10.1371/journal.pone.0107546	http://dx.doi.org/10.1371/journal.pone.0107546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS5NP	25225808	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700064
J	Wang, AX; Tao, J; Guo, XH; Liu, XM; Luo, YX; Liu, XR; Huang, Z; Chen, SH; Zhao, XQ; Jonas, JB; Wu, SL				Wang, Anxin; Tao, Jie; Guo, Xiuhua; Liu, Xuemei; Luo, Yanxia; Liu, Xiurong; Huang, Zhe; Chen, Shuohua; Zhao, Xingquan; Jonas, Jost B.; Wu, Shouling			The Product of Resting Heart Rate Times Blood Pressure Is Associated with High Brachial-Ankle Pulse Wave Velocity	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INCREASED ARTERIAL STIFFNESS; METABOLIC SYNDROME; CARDIOVASCULAR RISK; AORTIC STIFFNESS; HYPERTENSIVE PATIENTS; CIGARETTE-SMOKING; ATHEROSCLEROSIS; DISTENSIBILITY; POPULATIONS	Objective: To investigate potential associations between resting heart rate, blood pressure and the product of both, and the brachial-ankle pulse wave velocity (baPWV) as a maker of arterial stiffness. Methods: The community-based "Asymptomatic Polyvascular Abnormalities in Community (APAC) Study'' examined asymptomatic polyvascular abnormalities in a general Chinese population and included participants with an age of 40+ years without history of stroke and coronary heart disease. Arterial stiffness was defined as baPWV >= 1400 cm/s. We measured and calculated the product of resting heart rate and systolic blood pressure (RHR-SBP) and the product of resting heart rate and mean arterial pressure (RHR-MAP). Results: The study included 5153 participants with a mean age of 55.1 +/- 11.8 years. Mean baPWV was 158 +/- 6400 cm/s. Significant (P<0.0001) linear relationships were found between higher baPWV and higher resting heart rate or higher arterial blood pressure, with the highest baPWV observed in individuals from the highest quartiles of resting heart rate and blood pressure. After adjusting for confounding parameters such as age, sex, educational level, body mass index, fasting blood concentrations of glucose, blood lipids and high-sensitive C-reactive protein, smoking status and alcohol consumption, prevalence of arterial stiffness increased significantly (P<0.0001) with increasing RHR-SBP quartile (Odds Ratio (OR): 2.72; 95% Confidence interval (CI): 1.46,5.08) and increasing RHR-MAP (OR: 2.10; 95% CI: 1.18,3.72). Similar results were obtained in multivariate linear regression analyses with baPWV as continuous variable. Conclusions: Higher baPWV as a marker of arterial stiffness was associated with a higher product of RHR-SBP and RHR-MAP in multivariate analysis. In addition to other vascular risk factors, higher resting heart rate in combination with higher blood pressure are risk factors for arterial stiffness.	[Wang, Anxin; Zhao, Xingquan] Beijing Tiantan Hosp, Capital Med Univ, Dept Neurol, Beijing, Peoples R China; [Wang, Anxin; Guo, Xiuhua; Luo, Yanxia] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China; [Wang, Anxin; Guo, Xiuhua; Luo, Yanxia] Capital Med Univ, Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Tao, Jie; Liu, Xuemei; Liu, Xiurong; Huang, Zhe; Chen, Shuohua; Wu, Shouling] Hebei United Univ, Kailuan Hosp, Tangshan, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany	Capital Medical University; Capital Medical University; Capital Medical University; North China University of Science & Technology; Ruprecht Karls University Heidelberg	Zhao, XQ (corresponding author), Beijing Tiantan Hosp, Capital Med Univ, Dept Neurol, Beijing, Peoples R China.	zxq@vip.163.com; drwusl@163.com	Wang, Anxin/AAD-4073-2021		National Natural Science Foundation of China [81202279]; advanced health care professional development project of Beijing Municipal Health Bureau [2009-3-32]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); advanced health care professional development project of Beijing Municipal Health Bureau	This research was supported by a grant from the National Natural Science Foundation of China (Grant No. 81202279), and by a grant from advanced health care professional development project of Beijing Municipal Health Bureau (Grant No. 2009-3-32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASMAR R, 1995, HYPERTENSION, V26, P485, DOI 10.1161/01.HYP.26.3.485; Asmar R, 2001, AM J HYPERTENS, V14, P91, DOI 10.1016/S0895-7061(00)01232-2; AVOLIO AP, 1985, CIRCULATION, V71, P202, DOI 10.1161/01.CIR.71.2.202; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Blacher J, 1999, HYPERTENSION, V33, P1111, DOI 10.1161/01.HYP.33.5.1111; Custodis F, 2013, J CARDIOL, V62, P183, DOI 10.1016/j.jjcc.2013.02.018; Gordon SM, 2013, DIABETES, V62, P2958, DOI 10.2337/db12-1753; Greenwald SE, 2007, J PATHOL, V211, P157, DOI 10.1002/path.2101; Kangas P, 2013, METABOLISM, V62, P1114, DOI 10.1016/j.metabol.2013.02.009; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Lehmann ED, 1999, LANCET, V354, P528, DOI 10.1016/S0140-6736(99)00179-8; LEVENSON J, 1987, ARTERIOSCLEROSIS, V7, P572, DOI 10.1161/01.ATV.7.6.572; Mattace-Raso FUS, 2004, ATHEROSCLEROSIS, V176, P111, DOI 10.1016/j.atherosclerosis.2004.04.014; McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037; OROURKE MF, 1976, AUST NZ J MED, V6, P40, DOI 10.1111/j.1445-5994.1976.tb03322.x; Palatini P, 2010, J HYPERTENS, V28, P653, DOI 10.1097/HJH.0b013e3283389e3d; Park BJ, 2010, ARCH CARDIOVASC DIS, V103, P246, DOI 10.1016/j.acvd.2010.03.004; Rhee MY, 2007, AM J HYPERTENS, V20, P637, DOI 10.1016/j.amjhyper.2006.12.017; Scuteri A, 2014, ATHEROSCLEROSIS, V233, P654, DOI 10.1016/j.atherosclerosis.2014.01.041; Sipila K, 2007, METABOLISM, V56, P320, DOI 10.1016/j.metabol.2006.10.008; Suzuki E, 2001, DIABETES CARE, V24, P2107, DOI 10.2337/diacare.24.12.2107; Tomiyama H, 2005, HYPERTENSION, V45, P997, DOI 10.1161/01.HYP.0000165018.63523.8a; van Popele NM, 2001, STROKE, V32, P454, DOI 10.1161/01.STR.32.2.454; Wang AX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061665; Weng CY, 2013, AM J MED SCI, V346, P289, DOI 10.1097/MAJ.0b013e3182732e97; Whelton SP, 2013, HYPERTENSION, V62, P477, DOI 10.1161/HYPERTENSIONAHA.113.01605; Woodard GA, 2011, MENOPAUSE, V18, P1291, DOI 10.1097/gme.0b013e31821f81c2; Yamashina A, 2003, HYPERTENS RES, V26, P615, DOI 10.1291/hypres.26.615; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Yasmin, 2004, ARTERIOSCL THROM VAS, V24, P969, DOI 10.1161/01.ATV.zhq0504.0173; Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084685	31	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107852	10.1371/journal.pone.0107852	http://dx.doi.org/10.1371/journal.pone.0107852			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225895	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700089
J	Wee, CY; Zhao, ZM; Yap, PT; Wu, GR; Shi, F; Price, T; Du, YS; Xu, JR; Zhou, Y; Shen, D				Wee, Chong-Yaw; Zhao, Zhimin; Yap, Pew-Thian; Wu, Guorong; Shi, Feng; Price, True; Du, Yasong; Xu, Jianrong; Zhou, Yan; Shen, Dinggang			Disrupted Brain Functional Network in Internet Addiction Disorder: A Resting-State Functional Magnetic Resonance Imaging Study	PLOS ONE			English	Article							PROPOSED DIAGNOSTIC-CRITERIA; GRAPH-THEORETICAL ANALYSIS; GENDER-RELATED DIFFERENCES; ANTERIOR THALAMIC NUCLEI; MEDIAL PREFRONTAL CORTEX; DEFAULT-MODE; MEDIODORSAL THALAMUS; EEG ALPHA; CONNECTIVITY; HIPPOCAMPUS	Internet addiction disorder (IAD) is increasingly recognized as a mental health disorder, particularly among adolescents. The pathogenesis associated with IAD, however, remains unclear. In this study, we aim to explore the encephalic functional characteristics of IAD adolescents at rest using functional magnetic resonance imaging data. We adopted a graph-theoretic approach to investigate possible disruptions of functional connectivity in terms of network properties including small-worldness, efficiency, and nodal centrality on 17 adolescents with IAD and 16 socio-demographically matched healthy controls. False discovery rate-corrected parametric tests were performed to evaluate the statistical significance of group-level network topological differences. In addition, a correlation analysis was performed to assess the relationships between functional connectivity and clinical measures in the IAD group. Our results demonstrate that there is significant disruption in the functional connectome of IAD patients, particularly between regions located in the frontal, occipital, and parietal lobes. The affected connections are long-range and inter-hemispheric connections. Although significant alterations are observed for regional nodal metrics, there is no difference in global network topology between IAD and healthy groups. In addition, correlation analysis demonstrates that the observed regional abnormalities are correlated with the IAD severity and behavioral clinical assessments. Our findings, which are relatively consistent between anatomically and functionally defined atlases, suggest that IAD causes disruptions of functional connectivity and, importantly, that such disruptions might link to behavioral impairments.	[Wee, Chong-Yaw; Yap, Pew-Thian; Wu, Guorong; Shi, Feng; Price, True; Shen, Dinggang] Univ N Carolina, Image Display Enhancement & Anal IDEA Lab, BRIC, Chapel Hill, NC USA; [Wee, Chong-Yaw; Yap, Pew-Thian; Wu, Guorong; Shi, Feng; Price, True; Shen, Dinggang] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA; [Zhao, Zhimin; Du, Yasong] Shanghai Jiao Tong Univ, Dept Child & Adolescent Psychiat, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China; [Xu, Jianrong; Zhou, Yan] Shanghai Jiao Tong Univ, Sch Med, Jiao Tong Univ, Dept Radiol,Renji Hosp, Shanghai 200030, Peoples R China; [Shen, Dinggang] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Korea University	Zhou, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Jiao Tong Univ, Dept Radiol,Renji Hosp, Shanghai 200030, Peoples R China.	clare1475@hotmail.com; dgshen@med.unc.edu	Shen, Dinggang/ABF-6812-2020	Shen, Dinggang/0000-0002-7934-5698	National Institutes of Health (NIH) [EB006733, EB008374, EB009634, AG041721, CA140413]; National Natural Science Foundation of China [81171325]; National Key Technology RD Program [2007BAI17B03]; NATIONAL CANCER INSTITUTE [R01CA140413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008374, R01EB009634, R01EB006733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041721] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health (NIH) grants EB006733, EB008374, EB009634, AG041721, and CA140413, as well as the National Natural Science Foundation of China (81171325) and the National Key Technology R&D Program 2007BAI17B03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Alavi SS, 2011, J RES MED SCI, V16, P793; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI 10.1176/appi.books.9780890425596; Anderson JS, 2011, CEREB CORTEX, V21, P1134, DOI 10.1093/cercor/bhq190; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Beard KW, 2005, CYBERPSYCHOL BEHAV, V8, P7, DOI 10.1089/cpb.2005.8.7; Beard KW, 2001, CYBERPSYCHOL BEHAV, V4, P377, DOI 10.1089/109493101300210286; Bernardi S, 2009, COMPR PSYCHIAT, V50, P510, DOI 10.1016/j.comppsych.2008.11.011; Block JJ, 2008, AM J PSYCHIAT, V165, P306, DOI 10.1176/appi.ajp.2007.07101556; Block JJ, 2007, CNS SPECTRUMS, V12, P14, DOI 10.1017/S1092852900020459; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cao FL, 2007, EUR PSYCHIAT, V22, P466, DOI 10.1016/j.eurpsy.2007.05.004; Caplan SE, 2002, COMPUT HUM BEHAV, V18, P553, DOI 10.1016/S0747-5632(02)00004-3; Corbit LH, 2003, EUR J NEUROSCI, V18, P1286, DOI 10.1046/j.1460-9568.2003.02833.x; Ding WN, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059902, 10.1371/journal.pone.0061533]; Ding XY, 2013, NEUROSCI LETT, V548, P110, DOI 10.1016/j.neulet.2013.05.029; Doidge N., 2007, BRAIN CHANGES ITSELF; Dong GH, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-41; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Egger O, 1996, TECHNICAL REPORT; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Ernst M, 2006, PSYCHOL MED, V36, P299, DOI 10.1017/S0033291705005891; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fingelkurts AA, 2007, NEUROSCI RES, V58, P40, DOI 10.1016/j.neures.2007.01.011; Fingelkurts AA, 2006, PSYCHOPHARMACOLOGY, V188, P42, DOI 10.1007/s00213-006-0474-4; Fitzpatrick JJ, 2008, ARCH PSYCHIAT NURS, V22, P59, DOI 10.1016/j.apnu.2007.12.001; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Fujiwara J, 2009, J NEUROPHYSIOL, V101, P3284, DOI 10.1152/jn.90909.2008; Garavan H, 2006, BRAIN RES, V1105, P130, DOI 10.1016/j.brainres.2006.03.029; Goldstein RZ, 2007, NEUROSCIENCE, V144, P1153, DOI 10.1016/j.neuroscience.2006.11.024; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grusser SM, 2004, PSYCHOPHARMACOLOGY, V175, P296, DOI 10.1007/s00213-004-1828-4; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hong SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057831; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Kelly C, 2011, BIOL PSYCHIAT, V69, P684, DOI 10.1016/j.biopsych.2010.11.022; Ko CH, 2012, EUR PSYCHIAT, V27, P1, DOI 10.1016/j.eurpsy.2010.04.011; Ko CH, 2005, J NERV MENT DIS, V193, P728, DOI 10.1097/01.nmd.0000185891.13719.54; Ko CH, 2009, J PSYCHIATR RES, V43, P739, DOI 10.1016/j.jpsychires.2008.09.012; Kolb B, 2003, CURR DIR PSYCHOL SCI, V12, P1, DOI 10.1111/1467-8721.01210; Kolb B, 1998, ANNU REV PSYCHOL, V49, P43, DOI 10.1146/annurev.psych.49.1.43; Kolb Bryan, 2011, J Can Acad Child Adolesc Psychiatry, V20, P265; Koschutzki D, 2005, LECT NOTES COMPUT SC, V3418, P16; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Liang M, 2006, NEUROREPORT, V17, P209, DOI 10.1097/01.wnr.0000198434.06518.b8; Lin FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030253; Liu J., 2010, PROC 16 ACM SIGKDD I, P323; Ma N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016560; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Matochik JA, 2003, NEUROIMAGE, V19, P1095, DOI 10.1016/S1053-8119(03)00244-1; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Miedl SF, 2010, PSYCHIAT RES-NEUROIM, V181, P165, DOI 10.1016/j.pscychresns.2009.11.008; Ng BD, 2005, CYBERPSYCHOL BEHAV, V8, P110, DOI 10.1089/cpb.2005.8.110; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Petrie H, 1998, BRIT PSYCH SOC LOND; Pine D S, 2001, CNS Spectr, V6, P27; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RAY JP, 1993, J COMP NEUROL, V337, P1, DOI 10.1002/cne.903370102; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Saper CB, 2002, ANNU REV NEUROSCI, V25, P433, DOI 10.1146/annurev.neuro.25.032502.111311; Shapira NA, 2003, DEPRESS ANXIETY, V17, P207, DOI 10.1002/da.10094; Shaw C. A., 2001, THEORY NEUROPLASTICI; Shaw M, 2008, CNS DRUGS, V22, P353, DOI 10.2165/00023210-200822050-00001; Silveri MM, 2004, ANN NY ACAD SCI, V1021, P363, DOI 10.1196/annals.1308.046; Smit DJA, 2008, HUM BRAIN MAPP, V29, P1368, DOI 10.1002/hbm.20468; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stam CJ, 2010, INT J PSYCHOPHYSIOL, V77, P186, DOI 10.1016/j.ijpsycho.2010.06.024; Stein T, 2000, AM J NEURORADIOL, V21, P1397; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Tao R, 2010, ADDICTION, V105, P556, DOI 10.1111/j.1360-0443.2009.02828.x; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tononi G, 1998, TRENDS COGN SCI, V2, P474, DOI 10.1016/S1364-6613(98)01259-5; Tschernegg M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00625; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2011, J NEUROSCI, V31, P18578, DOI 10.1523/JNEUROSCI.4465-11.2011; Uddin LQ, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00021; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Warburton EC, 2001, J NEUROSCI, V21, P7323, DOI 10.1523/JNEUROSCI.21-18-07323.2001; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Wilson TW, 2007, BIOL PSYCHIAT, V62, P192, DOI 10.1016/j.biopsych.2006.07.002; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yoo HJ, 2004, PSYCHIAT CLIN NEUROS, V58, P487, DOI 10.1111/j.1440-1819.2004.01290.x; Young K.S., 1998, CAUGHT NET RECOGNIZE; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; Young K S., 1999, INNOVATIONS CLIN PRA, P19; Yu CX, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00014; Yuan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078708; Yuan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053055; Yuan K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020708; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhou Y, 2011, EUR J RADIOL, V79, P92, DOI 10.1016/j.ejrad.2009.10.025; Zhu WL, 2012, NEUROBIOL AGING, V33, P899, DOI 10.1016/j.neurobiolaging.2010.06.022; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269; 黄希庭, 2001, [心理学报, Acta Psychologica Sinica], V33, P338	111	48	49	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107306	10.1371/journal.pone.0107306	http://dx.doi.org/10.1371/journal.pone.0107306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226035	gold, Green Submitted, Green Published			2022-12-25	WOS:000344317700042
J	Zhou, JF; Qian, CY; Zhao, MY; Yu, XY; Kang, Y; Ma, XC; Ai, YH; Xu, Y; Liu, DX; An, YZ; Wu, DW; Sun, RH; Li, SS; Hu, ZJ; Cao, XY; Zhou, FC; Jiang, L; Lin, JD; Mao, EQ; Qin, TH; He, ZY; Zhou, LH; Du, B				Zhou, Jianfang; Qian, Chuanyun; Zhao, Mingyan; Yu, Xiangyou; Kang, Yan; Ma, Xiaochun; Ai, Yuhang; Xu, Yuan; Liu, Dexin; An, Youzhong; Wu, Dawei; Sun, Renhua; Li, Shusheng; Hu, Zhenjie; Cao, Xiangyuan; Zhou, Fachun; Jiang, Li; Lin, Jiandong; Mao, Enqiang; Qin, Tiehe; He, Zhenyang; Zhou, Lihua; Du, Bin		CCCCTG	Epidemiology and Outcome of Severe Sepsis and Septic Shock in Intensive Care Units in Mainland China	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; CONSENSUS CONFERENCE; RISK-FACTORS; OF-LIFE; MULTICENTER; DEFINITIONS; MORTALITY; FAILURE; ENGLAND; COHORT	Introduction: Information about sepsis in mainland China remains scarce and incomplete. The purpose of this study was to describe the epidemiology and outcome of severe sepsis and septic shock in mixed ICU in mainland China, as well as the independent predictors of mortality. Methods: We performed a 2-month prospective, observational cohort study in 22 closed multi-disciplinary intensive care units (ICUs). All admissions into those ICUs during the study period were screened and patients with severe sepsis or septic shock were included. Results: A total of 484 patients, 37.3 per 100 ICU admissions were diagnosed with severe sepsis (n = 365) or septic shock (n = 119) according to clinical criteria and included into this study. The most frequent sites of infection were the lung and abdomen. The overall ICU and hospital mortality rates were 28.7% (n = 139) and 33.5% (n = 162), respectively. In multivariate analyses, APACHE II score (odds ratio[OR], 1.068; 95% confidential interval[CI], 1.027-1.109), presence of ARDS (OR, 2.676; 95% CI, 1.691-4.235), bloodstream infection (OR, 2.520; 95% CI, 1.142-5.564) and comorbidity of cancer (OR, 2.246; 95% CI, 1.141-4.420) were significantly associated with mortality. Conclusions: Our results indicated that severe sepsis and septic shock were common complications in ICU patients and with high mortality in China, and can be of help to know more about severe sepsis and septic shock in China and to improve characterization and risk stratification in these patients.	[Zhou, Jianfang; Du, Bin] Peking Union Med Coll Hosp, Peking Union Med Coll, Med ICU, Beijing 100021, Peoples R China; [Zhou, Jianfang; Du, Bin] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Qian, Chuanyun] Kunming Med Univ, Affiliated Hosp 1, Dept Emergency Med, Kunming, Peoples R China; [Qian, Chuanyun] Kunming Med Univ, Affiliated Hosp 1, Med ICU, Kunming, Peoples R China; [Zhao, Mingyan] Harbin Med Univ, Dept Crit Care Med, Affiliated Hosp 1, Harbin, Peoples R China; [Yu, Xiangyou] Xinjiang Med Univ, Affiliated Hosp 1, Dept Crit Care Med, Urumqi, Peoples R China; [Kang, Yan] Sichuan Univ, Dept Crit Care Med, West China Hosp, Chengdu 610064, Peoples R China; [Ma, Xiaochun] China Med Univ, Affiliated Hosp 1, Dept Crit Care Med, Shenyang, Peoples R China; [Ai, Yuhang] Cent South Univ, Xiangya Hosp, Dept Crit Care Med, Changsha, Hunan, Peoples R China; [Xu, Yuan] Capital Med Univ, Beijing Tongren Hosp, Dept Crit Care Med, Beijing, Peoples R China; [Liu, Dexin] Jilin Univ, Dept Crit Care Med, Hosp 2, Changchun 130023, Peoples R China; [An, Youzhong] Peking Univ, Peoples Hosp, Dept Crit Care Med, Beijing 100871, Peoples R China; [Wu, Dawei] Shandong Univ, Qilu Hosp, Dept Crit Care Med, Jinan 250100, Peoples R China; [Sun, Renhua] Zhejiang Prov Peoples Hosp, Dept Crit Care Med, Hangzhou, Zhejiang, Peoples R China; [Li, Shusheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Crit Care Med, Wuhan 430074, Peoples R China; [Hu, Zhenjie] Hebei Med Univ, Dept Crit Care Med, Hosp 4, Shijiazhuang, Peoples R China; [Cao, Xiangyuan] Ningxia Med Univ, Gen Hosp, Dept Crit Care Med, Yinchuan, Peoples R China; [Zhou, Fachun] Chongqing Med Univ, Affiliated Hosp 1, Dept Emergency & Intens Care Med, Chongqing, Peoples R China; [Jiang, Li] Capital Med Univ, Fuxing Hosp, Dept Crit Care Med, Beijing, Peoples R China; [Lin, Jiandong] Fujian Med Univ, Affiliated Hosp 1, Dept Crit Care Med, Fuzhou, Peoples R China; [Mao, Enqiang] Shanghai Jiao Tong Univ, Ruijin Hosp, Emergency ICU, Shanghai 200030, Peoples R China; [Qin, Tiehe] Guangdong Gen Hosp, Dept Crit Care Med, Guangzhou, Guangdong, Peoples R China; [He, Zhenyang] Hainan Prov Peoples Hosp, Dept Crit Care Med, Haikou, Peoples R China; [Zhou, Lihua] Inner Mongolia Med Univ, Affiliated Hosp, Dept Crit Care Med, Hohhot, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Kunming Medical University; Kunming Medical University; Harbin Medical University; Xinjiang Medical University; Sichuan University; China Medical University; Central South University; Capital Medical University; Jilin University; Peking University; Shandong University; Zhejiang Provincial People's Hospital; Huazhong University of Science & Technology; Hebei Medical University; Ningxia Medical University; Chongqing Medical University; Capital Medical University; Fujian Medical University; Shanghai Jiao Tong University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Inner Mongolia Medical University	Du, B (corresponding author), Peking Union Med Coll Hosp, Peking Union Med Coll, Med ICU, Beijing 100021, Peoples R China.	dubin98@gmail.com	; Du, Bin/K-4283-2013	Zhou, Fachun/0000-0003-0693-6494; Du, Bin/0000-0001-6237-2895	Capital Clinical Application Research grant from the Science and Technology Commission of Beijing [Z131107002213112]	Capital Clinical Application Research grant from the Science and Technology Commission of Beijing	This research was supported in part, by the Capital Clinical Application Research grant (Number: Z131107002213112) from the Science and Technology Commission of Beijing, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrie C, 2005, J CRIT CARE, V20, P46, DOI 10.1016/j.jcrc.2004.10.005; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; Austin S, 2014, INTENS CARE MED, V40, P342, DOI 10.1007/s00134-013-3174-7; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; Cheng BL, 2007, CRIT CARE MED, V35, P2538, DOI 10.1097/01.CCM.0000284492.30800.00; de Montmollin E, 2013, SHOCK, V39, P250, DOI 10.1097/SHK.0b013e3182866d32; Du B, 2013, CRIT CARE MED, V41, P84, DOI 10.1097/CCM.0b013e31826a4082; Du B, 2010, CRIT CARE, V14, DOI 10.1186/cc8222; Finfer S, 2004, INTENS CARE MED, V30, P589, DOI 10.1007/s00134-004-2157-0; Glickman SW, 2010, ACAD EMERG MED, V17, P383, DOI 10.1111/j.1553-2712.2010.00664.x; Harrison DA, 2006, CRIT CARE, V10, DOI 10.1186/cc4854; Heyland DK, 2000, CRIT CARE MED, V28, P3599, DOI 10.1097/00003246-200011000-00006; Khwannimit B, 2009, EPIDEMIOL INFECT, V137, P1333, DOI 10.1017/S0950268809002027; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Li LB, 2013, CRIT CARE, V17, DOI 10.1186/cc13140; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mikkelsen ME, 2013, SHOCK; Padkin A, 2003, CRIT CARE MED, V31, P2332, DOI 10.1097/01.CCM.0000085141.75513.2B; PERL TM, 1995, JAMA-J AM MED ASSOC, V274, P338, DOI 10.1001/jama.274.4.338; Phua J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3245; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Rodriguez F, 2011, CRIT CARE MED, V39, P1675, DOI 10.1097/CCM.0b013e318218a35e; Sakr Y, 2013, MINERVA ANESTESIOL, V79, P993; Silva E, 2004, CRIT CARE, V8, pR251, DOI 10.1186/cc2892; Song YH, 2012, SHOCK, V38, P249, DOI 10.1097/SHK.0b013e3182613e33; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Zahar JR, 2011, CRIT CARE MED, V39, P1886, DOI 10.1097/CCM.0b013e31821b827c	34	85	132	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107181	10.1371/journal.pone.0107181	http://dx.doi.org/10.1371/journal.pone.0107181			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226033	Green Published, gold, Green Submitted			2022-12-25	WOS:000344317700034
J	Abu Choudhury, M; Lott, WB; Aaskov, J				Abu Choudhury, Md; Lott, William B.; Aaskov, John			Distribution of Fitness in Populations of Dengue Viruses	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; NUCLEOTIDE-SEQUENCE; GENETIC DIVERSITY; GLOBAL SPREAD; FATAL DENGUE; TYPE-3 VIRUS; LIVER; RNA; SEROTYPE-3; HEPATITIS	Genetically diverse RNA viruses like dengue viruses (DENVs) segregate into multiple, genetically distinct, lineages that temporally arise and disappear on a regular basis. Lineage turnover may occur through multiple processes such as, stochastic or due to variations in fitness. To determine the variation of fitness, we measured the distribution of fitness within DENV populations and correlated it with lineage extinction and replacement. The fitness of most members within a population proved lower than the aggregate fitness of populations from which they were drawn, but lineage replacement events were not associated with changes in the distribution of fitness. These data provide insights into variations in fitness of DENV populations, extending our understanding of the complexity between members of individual populations.	[Abu Choudhury, Md; Lott, William B.; Aaskov, John] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Lott, William B.] Queensland Univ Technol, Fac Sci & Engn, Sch Chem Phys & Mech Engn, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Abu Choudhury, M (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	nahidqut13@gmail.com	Lott, William B/J-1062-2012; Choudhury/T-2659-2019	Lott, William B/0000-0001-7118-7560; Choudhury, Nahid/0000-0002-6527-4876	National Health and Medical Research Council of Australia [497203]; Cook Estate; QUT Postgraduate Research Scholarships, Queensland University of Technology	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cook Estate; QUT Postgraduate Research Scholarships, Queensland University of Technology	The work was supported by National Health and Medical Research Council of Australia, under grant 497203, Cook Estate and QUT Postgraduate Research Scholarships, Queensland University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaskov J, 2006, SCIENCE, V311, P236, DOI 10.1126/science.1115030; Aaskov J, 2007, J GEN VIROL, V88, P3334, DOI 10.1099/vir.0.83122-0; Anderson JR, 2006, AM J TROP MED HYG, V75, P886, DOI 10.4269/ajtmh.2006.75.886; Armstrong PM, 2003, AM J TROP MED HYG, V68, P539, DOI 10.4269/ajtmh.2003.68.539; Bennett SN, 2003, MOL BIOL EVOL, V20, P1650, DOI 10.1093/molbev/msg182; BHAMARAP.N, 1967, ANN TROP MED PARASIT, V61, P500, DOI 10.1080/00034983.1967.11686519; BHAMARAPRAVATI N, 1989, REV INFECT DIS, V11, pS826; BRINTON MA, 1982, VIROLOGY, V116, P84, DOI 10.1016/0042-6822(82)90405-6; BURKE T, 1968, T ROY SOC TROP MED H, V62, P682, DOI 10.1016/0035-9203(68)90120-X; CATTANEO R, 1988, CELL, V55, P255, DOI 10.1016/0092-8674(88)90048-7; Chao DY, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-72; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; Couvelard A, 1999, HUM PATHOL, V30, P1106, DOI 10.1016/S0046-8177(99)90230-7; Craig S, 2003, J VIROL, V77, P4463, DOI 10.1128/JVI.77.7.4463-4467.2003; Diamond MS, 2000, J VIROL, V74, P7814, DOI 10.1128/JVI.74.17.7814-7823.2000; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; DUARTE EA, 1994, J VIROL, V68, P4295, DOI 10.1128/JVI.68.7.4295-4301.1994; Duong V, 2011, INFECT GENET EVOL J, P1; Garcia-Arriaza J, 2007, VIRUS RES, V129, P123, DOI 10.1016/j.virusres.2007.07.001; GRUENBERG A, 1988, J GEN VIROL, V69, P1391, DOI 10.1099/0022-1317-69-6-1391; GUBLER DJ, 1981, AM J TROP MED HYG, V30, P1094, DOI 10.4269/ajtmh.1981.30.1094; GUBLER DJ, 1978, AM J TROP MED HYG, V27, P581, DOI 10.4269/ajtmh.1978.27.581; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Hanley Kathryn A., 2008, BMC Ecology, V8, P1, DOI 10.1186/1472-6785-8-1; Harrington LC, 2001, J MED ENTOMOL, V38, P537, DOI 10.1603/0022-2585-38.4.537; HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830; Holmes EC, 2000, TRENDS MICROBIOL, V8, P74, DOI 10.1016/S0966-842X(99)01669-8; Houng HSH, 2001, J VIROL METHODS, V95, P19, DOI 10.1016/S0166-0934(01)00280-4; Hsieh SC, 2011, VIROLOGY, V410, P170, DOI 10.1016/j.virol.2010.11.006; Huerre MR, 2001, VIRCHOWS ARCH, V438, P107; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Lambrechts L, 2012, J VIROL, V86, P1853, DOI 10.1128/JVI.06458-11; Li DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019447; Lin SR, 2011, J VIROL, V85, P5159, DOI 10.1128/JVI.02099-10; Messer WB, 2003, EMERG INFECT DIS, V9, P800; Mohan B, 2000, J TROP PEDIATRICS, V46, P40, DOI 10.1093/tropej/46.1.40; Nguyen TL, 1997, RES VIROLOGY, V148, P273, DOI 10.1016/S0923-2516(97)88364-1; Noppornpanth S, 2007, J VIROL, V81, P12496, DOI 10.1128/JVI.01059-07; Ooi EE, 2009, FUTURE VIROL, V4, P571, DOI 10.2217/FVL.09.55; OSATOMI K, 1990, VIROLOGY, V176, P643, DOI 10.1016/0042-6822(90)90037-R; Pacini L, 2009, J VIROL, V83, P9079, DOI 10.1128/JVI.00308-09; Parameswaran P, 2012, J VIROL, V86, P8546, DOI 10.1128/JVI.00736-12; Ramos C, 1998, J NEUROVIROL, V4, P465, DOI 10.3109/13550289809114548; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; ROEHRIG JT, 1982, VIROLOGY, V118, P269, DOI 10.1016/0042-6822(82)90346-4; Rosen L, 1999, AM J TROP MED HYG, V61, P720, DOI 10.4269/ajtmh.1999.61.720; ROSEN L, 1989, RES VIROLOGY, V140, P351, DOI 10.1016/S0923-2516(89)80115-3; Steel A, 2010, VIROLOGY, V405, P505, DOI 10.1016/j.virol.2010.05.033; TAYLOR WP, 1975, J GEN VIROL, V28, P59, DOI 10.1099/0022-1317-28-1-59; Thai KTD, 2012, J VIROL, V86, P835, DOI 10.1128/JVI.05985-11; Thu HM, 2005, VIROLOGY, V336, P163, DOI 10.1016/j.virol.2005.03.018; Thu HM, 2004, EMERG INFECT DIS, V10, P593, DOI 10.3201/eid1004.030216; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Vu TTH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000757; Wahala WMPB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000821; Wahid S. Fadilah S. Abdul, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P259; Wang WK, 2002, VIROLOGY, V303, P181, DOI 10.1006/viro.2002.1635; Wang WK, 2002, J VIROL, V76, P4662, DOI 10.1128/JVI.76.9.4662-4665.2002; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002; Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7; Wittke V, 2002, VIROLOGY, V301, P148, DOI 10.1006/viro.2002.1549; World Health Organization, 2012, DENG SEV DENG; Worobey M, 1999, P NATL ACAD SCI USA, V96, P7352, DOI 10.1073/pnas.96.13.7352; Zhang CL, 2006, J GEN VIROL, V87, P873, DOI 10.1099/vir.0.81486-0; Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005; [No title captured]	68	4	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107264	10.1371/journal.pone.0107264	http://dx.doi.org/10.1371/journal.pone.0107264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222471	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774800059
J	Jawallapersand, P; Mashele, SS; Kovacic, L; Stojan, J; Komel, R; Pakala, SB; Krasevec, N; Syed, K				Jawallapersand, Poojah; Mashele, Samson Sitheni; Kovacic, Lidija; Stojan, Jure; Komel, Radovan; Pakala, Suresh Babu; Krasevec, Nada; Syed, Khajamohiddin			Cytochrome P450 Monooxygenase CYP53 Family in Fungi: Comparative Structural and Evolutionary Analysis and Its Role as a Common Alternative Anti-Fungal Drug Target	PLOS ONE			English	Article							SUBSTRATE RECOGNITION SITES; COMPARATIVE GENOMICS; ACID-DERIVATIVES; PROTEIN-SEQUENCE; BENZOIC-ACID; AMINO-ACID; LIGNIN; CHRYSOSPORIUM; POTENTIALS; RESISTANCE	Cytochrome P450 monooxygenases (CYPs/P450s) are heme-thiolate proteins whose role as a drug target against pathogenic microbes has been explored because of their stereo- and regio-specific oxidation activity. We aimed to assess the CYP53 family's role as a common alternative drug target against animal (including human) and plant pathogenic fungi and its role in fungal-mediated wood degradation. Genome-wide analysis of fungal species revealed the presence of CYP53 members in ascomycetes and basidiomycetes. Basidiomycetes had a higher number of CYP53 members in their genomes than ascomycetes. Only two CYP53 subfamilies were found in ascomycetes and six subfamilies in basidiomycetes, suggesting that during the divergence of phyla ascomycetes lost CYP53 P450s. According to phylogenetic and gene-structure analysis, enrichment of CYP53 P450s in basidiomycetes occurred due to the extensive duplication of CYP53 P450s in their genomes. Numerous amino acids (103) were found to be conserved in the ascomycetes CYP53 P450s, against only seven in basidiomycetes CYP53 P450s. 3D-modelling and active-site cavity mapping data revealed that the ascomycetes CYP53 P450s have a highly conserved protein structure whereby 78% amino acids in the active-site cavity were found to be conserved. Because of this rigid nature of ascomycetes CYP53 P450s' active site cavity, any inhibitor directed against this P450 family can serve as a common anti-fungal drug target, particularly toward pathogenic ascomycetes. The dynamic nature of basidiomycetes CYP53 P450s at a gene and protein level indicates that these P450s are destined to acquire novel functions. Functional analysis of CYP53 P450s strongly supported our hypothesis that the ascomycetes CYP53 P450s ability is limited for detoxification of toxic molecules, whereas basidiomycetes CYP53 P450s play an additional role, i.e. involvement in degradation of wood and its derived components. This study is the first report on genome-wide comparative structural (gene and protein structure-level) and evolutionary analysis of a fungal P450 family.	[Jawallapersand, Poojah; Mashele, Samson Sitheni; Syed, Khajamohiddin] Cent Univ Technol, Fac Hlth & Environm Sci, Dept Hlth Sci, Bloemfontein, Free State, South Africa; [Kovacic, Lidija] Univ Coll Dublin, Sch Med & Med Sci, Conway Inst, Dublin 4, Ireland; [Kovacic, Lidija] Jozef Stefan Inst, Dept Mol Biomed Sci, Ljubljana 1000, Slovenia; [Stojan, Jure] Univ Ljubljana, Fac Med, Inst Biochem, SI-1000 Ljubljana, Slovenia; [Komel, Radovan; Krasevec, Nada] Natl Inst Chem, SI-1000 Ljubljana, Slovenia; [Pakala, Suresh Babu] Sri Krishnadevaraya Univ, Dept Biochem, Anantapur 515003, Andhra Pradesh, India	Central University of Technology; University College Dublin; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; National Institute of Chemistry - Slovenia; Sri Krishnadevaraya University	Krasevec, N (corresponding author), Natl Inst Chem, Hajdrihova 19, SI-1000 Ljubljana, Slovenia.	nada.krasevec@ki.si; khajamohiddinsyed@gmail.com	Mashele, Samson Sitheni/AAC-4015-2020; Syed, Khajamohiddin/L-8774-2013	Mashele, Samson Sitheni/0000-0002-6339-4807; Syed, Khajamohiddin/0000-0002-1497-3570; Pakala, Suresh Babu/0000-0002-5679-4837	Central University of Technology (CUT), Bloemfontein, Free State, University Research and Innovation fund; National Research Foundation (NRF), South Africa; Slovenian Research Agency Program [P1-0104]; Masters in Technology research fellowship	Central University of Technology (CUT), Bloemfontein, Free State, University Research and Innovation fund; National Research Foundation (NRF), South Africa(National Research Foundation - South Africa); Slovenian Research Agency Program(Slovenian Research Agency - Slovenia); Masters in Technology research fellowship	, KS, PJ, and SSM thank the Central University of Technology (CUT), Bloemfontein, Free State for a grant from the University Research and Innovation fund (to KS and SSM) and Masters in Technology research fellowship (to PJ). SSM also thanks the National Research Foundation (NRF), South Africa for the research grant. NK and RK thank the Slovenian Research Agency Program P1-0104. SBP thanks the University Grants Commission (UGC), New Delhi, India for selecting for the UGC-Faculty Recharge Programme. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amborabe BE, 2002, PLANT PHYSIOL BIOCH, V40, P1051, DOI 10.1016/S0981-9428(02)01470-5; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Brul S, 1999, INT J FOOD MICROBIOL, V50, P1, DOI 10.1016/S0168-1605(99)00072-0; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Cresnar B, 2011, BBA-PROTEINS PROTEOM, V1814, P29, DOI 10.1016/j.bbapap.2010.06.020; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; DURHAM DR, 1984, J BACTERIOL, V160, P771, DOI 10.1128/JB.160.2.771-777.1984; Faber BW, 2001, ARCH BIOCHEM BIOPHYS, V394, P245, DOI 10.1006/abbi.2001.2534; Fernandez-Fueyo E, 2012, P NATL ACAD SCI USA, V109, P5458, DOI 10.1073/pnas.1119912109; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Fraser JA, 2002, FUNGAL GENET BIOL, V35, P135, DOI 10.1006/fgbi.2001.1307; Fujii T, 1997, MOL GEN GENET, V256, P115, DOI 10.1007/s004380050552; GOTOH O, 1992, J BIOL CHEM, V267, P83; Grigoriev I. V., 2011, Mycology - An International Journal on Fungal Biology, V2, P192; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Haupert LJ, 2012, FUEL, V95, P634, DOI 10.1016/j.fuel.2011.12.015; Hlavica P, 2013, BBA-PROTEINS PROTEOM, V1834, P205, DOI 10.1016/j.bbapap.2012.09.012; Hof H, 2001, ANTIMICROB AGENTS CH, V45, P2987, DOI 10.1128/AAC.45.11.2987-2990.2001; Hunt CG, 2013, ENVIRON MICROBIOL, V15, P956, DOI 10.1111/1462-2920.12039; Ide M, 2012, ARCH MICROBIOL, V194, P243, DOI 10.1007/s00203-011-0753-2; JENSEN KA, 1994, APPL ENVIRON MICROB, V60, P709, DOI 10.1128/AEM.60.2.709-714.1994; Kelly SL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0476; Korosec B, 2014, J APPL MICROBIOL, V116, P955, DOI 10.1111/jam.12417; Lah L, 2008, FUNGAL GENET BIOL, V45, P446, DOI 10.1016/j.fgb.2007.10.004; Lapadatescu C, 2000, APPL ENVIRON MICROB, V66, P1517, DOI 10.1128/AEM.66.4.1517-1522.2000; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lepesheva GI, 2004, MOL CELL ENDOCRINOL, V215, P165, DOI 10.1016/j.mce.2003.11.016; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martinez AT, 2005, INT MICROBIOL, V8, P195; Moktali V, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-525; Monk BC, 2014, P NATL ACAD SCI USA, V111, P3865, DOI 10.1073/pnas.1324245111; Nei M., 2000, MOL EVOLUTION PHYLOG; Nelson DR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0430; Nelson David R., 2009, Human Genomics, V4, P59; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; Podobnik B, 2008, J MED CHEM, V51, P3480, DOI 10.1021/jm800030e; Podust LM, 2001, J INORG BIOCHEM, V87, P227, DOI 10.1016/S0162-0134(01)00388-9; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sangamwar AT, 2008, INDIAN J PHARM SCI, V70, P423, DOI 10.4103/0250-474X.44588; Sanglard D, 2002, CURR OPIN MICROBIOL, V5, P379, DOI 10.1016/S1369-5274(02)00344-2; Suzuki H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-444; Syed K, 2014, GENES GENOM, V36, P321, DOI 10.1007/s13258-013-0170-9; Syed K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095616; Syed K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086683; Syed K, 2013, MYCOLOGIA, V105, P1445, DOI 10.3852/13-002; Syed K, 2013, APPL ENVIRON MICROB, V79, P2692, DOI 10.1128/AEM.03767-12; Syed K, 2012, CRIT REV MICROBIOL, V38, P339, DOI 10.3109/1040841X.2012.682050; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; ten Have R, 1998, FEBS LETT, V430, P390, DOI 10.1016/S0014-5793(98)00682-6; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; WRIGHT JD, 1993, WORLD J MICROB BIOT, V9, P9, DOI 10.1007/BF00656508; Yoshida Y, 1988, Curr Top Med Mycol, V2, P388; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002; ZUCKERKANDL EMILE, 1965, P97	58	43	45	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107209	10.1371/journal.pone.0107209	http://dx.doi.org/10.1371/journal.pone.0107209			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222113	Green Submitted, Green Published, gold			2022-12-25	WOS:000341774800049
J	Hendrayani, SF; Al-Khalaf, HH; Aboussekhra, A				Hendrayani, Siti-Fauziah; Al-Khalaf, Huda H.; Aboussekhra, Abdelilah			The Cytokine IL-6 Reactivates Breast Stromal Fibroblasts through Transcription Factor STAT3-dependent Up-regulation of the RNA-binding Protein AUF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-ASSOCIATED FIBROBLASTS; MESSENGER-RNA; TRANSFORMING GROWTH-FACTOR-BETA-1; TUMOR-SUPPRESSOR; GROWTH-FACTOR; FACTOR SNAIL; STAT3; INTERLEUKIN-6; CARCINOMA; EXPRESSION	The development and spread of mammary carcinomas require synergetic interplay between tumor cells and their microenvironment through paracrine secretions, which are still not well defined. We have shown here that interleukin-6 (IL-6), either recombinant or secreted from highly invasive breast cancer cells, down-regulates the tumor suppressor proteins p16(INK4A), p21(WAF1), and p53 and activates breast stromal fibroblasts in a paracrine manner. The formation of myofibroblasts requires p16(INK4A) down-regulation and the activation of the JAK2/STAT3 pathway. Indeed, the transcription factor STAT3 positively controls the expression of the three major myofibroblast markers, SDF-1, alpha-smooth muscle actin (alpha-SMA), and TGF-beta 1, and mediates IL-6-related down-regulation of p16(INK4A), p21(WAF1), and p53 as well as the activation of stromal fibroblasts. Importantly, these effects were mediated through STAT3-dependent up-regulation of the mRNA-binding protein AUF1, whose promoter contains three canonical STAT3 binding sites. AUF1 binds the SDF-1, alpha-SMA, TGF-beta 1, and IL-6 mRNAs and reduces their turnover. Consequently, specific AUF1 down-regulation inhibits IL-6-dependent activation of breast stromal fibroblasts, whereas AUF1 ectopic expression of p37(AUF1) activated these cells and enhanced their paracrine induction of epithelial-to-mesenchymal transition in breast cancer cells, which shows a non-cell-autonomous oncogenic function of AUF1. Together, these results demonstrate a major role of IL-6 in activating breast stromal fibroblasts through STAT3-dependent AUF1 induction.	[Hendrayani, Siti-Fauziah; Al-Khalaf, Huda H.; Aboussekhra, Abdelilah] King Faisal Specialist Hosp & Res Ctr, Dept Mol Oncol, Riyadh 11211, Saudi Arabia; [Al-Khalaf, Huda H.] King Abdulaziz City Sci & Technol, Joint Ctr Genom Res, Riyadh 11211, Saudi Arabia	King Faisal Specialist Hospital & Research Center	Aboussekhra, A (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Mol Oncol, MBC 03,POB 3354, Riyadh 11211, Saudi Arabia.	aboussekhra@kfshrc.edu.sa	Alkhalaf, Huda/Z-5701-2019		King Abdulaziz City for Science and Technology under National Comprehensive Plan for Science and Technology [11-BIO1435-20]	King Abdulaziz City for Science and Technology under National Comprehensive Plan for Science and Technology	This work was performed under Research Advisory Council Proposal 2120034 and was supported in part by a King Abdulaziz City for Science and Technology Grant 11-BIO1435-20, under National Comprehensive Plan for Science and Technology.	Abdelmohsen K, 2012, NUCLEIC ACIDS RES, V40, P11531, DOI 10.1093/nar/gks930; Aboussekhra A, 2011, INT J DEV BIOL, V55, P841, DOI 10.1387/ijdb.113362aa; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Al-Ansari MM, 2013, ONCOGENE, V32, P2356, DOI 10.1038/onc.2012.270; Al-Khalaf HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021111; Al-Mohanna MA, 2007, NUCLEIC ACIDS RES, V35, P223, DOI 10.1093/nar/gkl1075; Albini A, 2008, CANCER METAST REV, V27, P75, DOI 10.1007/s10555-007-9111-x; Allen M, 2011, J PATHOL, V223, P162, DOI 10.1002/path.2803; Bar J, 2009, ONCOGENE, V28, P933, DOI 10.1038/onc.2008.445; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chang Q, 2013, NEOPLASIA, V15, P848, DOI 10.1593/neo.13706; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Dethlefsen C, 2013, BREAST CANCER RES TR, V138, P657, DOI 10.1007/s10549-013-2488-z; Dolled-Filhart M, 2003, CLIN CANCER RES, V9, P594; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Gouble A, 2002, CANCER RES, V62, P1489; Groner B, 2008, SEMIN CELL DEV BIOL, V19, P341, DOI 10.1016/j.semcdb.2008.06.005; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hawsawi NM, 2008, CANCER RES, V68, P2717, DOI 10.1158/0008-5472.CAN-08-0192; Jablonka S, 2001, HUM MOL GENET, V10, P497, DOI 10.1093/hmg/10.5.497; Kiaris H, 2005, CANCER RES, V65, P1627, DOI 10.1158/0008-5472.CAN-04-3791; Knupfer H, 2007, BREAST CANCER RES TR, V102, P129, DOI 10.1007/s10549-006-9328-3; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lieblein JC, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-302; Moskovits N, 2006, CANCER RES, V66, P10671, DOI 10.1158/0008-5472.CAN-06-2323; Niu GL, 2005, MOL CELL BIOL, V25, P7432, DOI 10.1128/MCB.25.17.7432-7440.2005; Paschoud S, 2006, MOL CELL BIOL, V26, P8228, DOI 10.1128/MCB.01155-06; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; RONNOVJESSEN L, 1995, J CLIN INVEST, V95, P859, DOI 10.1172/JCI117736; RONNOVJESSEN L, 1993, LAB INVEST, V68, P696; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sasser AK, 2007, FASEB J, V21, P3763, DOI 10.1096/fj.07-8832com; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Sriuranpong V, 2003, CANCER RES, V63, P2948; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; TAMM I, 1989, J EXP MED, V170, P1649, DOI 10.1084/jem.170.5.1649; Trimis G, 2008, HUM MOL GENET, V17, P3596, DOI 10.1093/hmg/ddn252; Trojanowicz B, 2009, ENDOCR-RELAT CANCER, V16, P857, DOI 10.1677/ERC-08-0234; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; Wang WG, 2005, EMBO REP, V6, P158, DOI 10.1038/sj.embor.7400346; Xu J, 2013, CANCER LETT, V335, P380, DOI 10.1016/j.canlet.2013.02.054; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zucconi BE, 2011, FRONT BIOSCI-LANDMRK, V16, P2307, DOI 10.2741/3855	50	50	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					30962	30976		10.1074/jbc.M114.594044	http://dx.doi.org/10.1074/jbc.M114.594044			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25231991	Green Published, hybrid			2022-12-25	WOS:000344549900008
J	Jasinski-Bergner, S; Stehle, F; Gonschorek, E; Kalich, J; Schulz, K; Huettelmaier, S; Braun, J; Seliger, B				Jasinski-Bergner, Simon; Stehle, Franziska; Gonschorek, Evamaria; Kalich, Jana; Schulz, Kristin; Huettelmaier, Stefan; Braun, Juliane; Seliger, Barbara			Identification of 14-3-3 beta Gene as a Novel miR-152 Target Using a Proteome-based Approach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-CELL PROLIFERATION; RT-PCR; HLA-C; MICRORNA; EXPRESSION; PROTEINS; CANCER; SUPPRESSOR; QUANTIFICATION; 14-3-3-SIGMA	Recent studies demonstrated that miR-152 overexpression down-regulates the nonclassical human leukocyte antigen (HLA) class I molecule HLA-G in human tumors thereby contributing to their immune surveillance. Using two-dimensional gel electrophoresis followed by MALDI-TOF mass spectrometry, the protein expression profile of HLA-G(+), miR-152(low) cells, and their miR-152-overexpressing (miR(high)) counterparts was compared leading to the identification of 24 differentially expressed proteins. These were categorized according to their function and localization demonstrating for most of them an important role in the initiation and progression of tumors. The novel miR-152 target 14-3-3 protein beta/alpha/YWHAB (14-3-3 beta) is down-regulated upon miR-152 overexpression, although its overexpression was often found in tumors of distinct origin. The miR-152-mediated reduction of the 14-3-3 beta expression was accompanied by an up-regulation of BAX protein expression resulting in a pro-apoptotic phenotype. In contrast, the reconstitution of 14-3-3 beta expression in miR-152(high) cells increased the expression of the anti-apoptotic BCL2 gene, enhances the proliferative activity in the presence of the cytostatic drug paclitaxel, and causes resistance to apoptosis induced by this drug. By correlating clinical microarray data with the patients' outcome, a link between 1.4-3-3 beta and HLA-G expression was found, which could be associated with poor prognosis and overall survival of patients with tumors. Because miR-152 controls both the expression of 14-3-3 beta and HLA-G, it exerts a dual role in tumor cells by both altering the immunogenicity and the tumorigenicity.	[Jasinski-Bergner, Simon; Stehle, Franziska; Gonschorek, Evamaria; Kalich, Jana; Schulz, Kristin; Seliger, Barbara] Univ Halle Wittenberg, Inst Med Immunol, D-06112 Halle, Germany; [Huettelmaier, Stefan; Braun, Juliane] Univ Halle Wittenberg, Inst Mol Med, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Seliger, B (corresponding author), Univ Halle Wittenberg, Inst Med Immunol, Magdeburger Str 2, D-06112 Halle, Germany.	barbara.seliger@uk-halle.de	Hüttelmaier, Stefan/AAQ-1203-2021	Seliger, Barbara/0000-0002-5544-4958; Braun, Juliane/0000-0002-2491-5788	Deutsche Forschungsgemeinschaft [GRK 1591]; Mildred Scheel Cancer Research Foundation; Else Kroener Fresenius Foundation; intramural Roux program of the Martin Luther University Halle-Wittenberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Mildred Scheel Cancer Research Foundation; Else Kroener Fresenius Foundation; intramural Roux program of the Martin Luther University Halle-Wittenberg	This work was supported by Deutsche Forschungsgemeinschaft Grant GRK 1591, the Mildred Scheel Cancer Research Foundation, the Else Kroener Fresenius Foundation, and the intramural Roux program of the Martin Luther University Halle-Wittenberg.	Almeida CR, 2006, J IMMUNOL, V177, P6904, DOI 10.4049/jimmunol.177.10.6904; Almeida CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024927; Amiot L, 2011, CELL MOL LIFE SCI, V68, P417, DOI 10.1007/s00018-010-0583-4; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Bonelli P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/361020; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Braun J, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku127; Bukur J, 2003, CANCER RES, V63, P4107; Bukur J, 2012, SEMIN CANCER BIOL, V22, P350, DOI 10.1016/j.semcancer.2012.03.003; Bukur J, 2010, J BIOL CHEM, V285, P30419, DOI 10.1074/jbc.M109.094284; Cai MY, 2009, CLIN CANCER RES, V15, P4686, DOI 10.1158/1078-0432.CCR-09-0463; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Diao S, 2010, PROTEOMICS, V10, P3723, DOI 10.1002/pmic.201000050; Dunker K, 2008, TISSUE ANTIGENS, V72, P137, DOI 10.1111/j.1399-0039.2008.01090.x; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Freeman AK, 2011, SEMIN CELL DEV BIOL, V22, P681, DOI 10.1016/j.semcdb.2011.08.009; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Haraguchi T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp040; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Herrmann F, 2003, IMMUNOGENETICS, V55, P379, DOI 10.1007/s00251-003-0597-2; Kohn M, 2010, RNA, V16, P1420, DOI 10.1261/rna.2152710; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lichtenfels R, 2001, ELECTROPHORESIS, V22, P1801, DOI 10.1002/1522-2683(200105)22:9<1801::AID-ELPS1801>3.0.CO;2-I; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Liu TA, 2011, AM J PATHOL, V179, P2698, DOI 10.1016/j.ajpath.2011.08.010; Manaster I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033395; Minamida S, 2011, ANAL BIOANAL CHEM, V401, P245, DOI 10.1007/s00216-011-5057-5; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Neal CL, 2010, EXPERT OPIN THER TAR, V14, P1343, DOI 10.1517/14728222.2010.531011; Nishimura Y, 2013, BRIT J CANCER, V108, P1324, DOI 10.1038/bjc.2013.65; Nomura M, 2003, J BIOL CHEM, V278, P2058, DOI 10.1074/jbc.M207880200; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Pavan L, 2003, CARCINOGENESIS, V24, P1325, DOI 10.1093/carcin/bgg074; Sanfiorenzo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054596; Seliger B, 2007, CLIN CANCER RES, V13, P27, DOI 10.1158/1078-0432.CCR-06-0824; Song YX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-1; Stehle F, 2013, J BIOL CHEM, V288, P16334, DOI 10.1074/jbc.M112.437962; Takihara Y, 2000, CARCINOGENESIS, V21, P2073, DOI 10.1093/carcin/21.11.2073; Tsuruta T, 2011, CANCER RES, V71, P6450, DOI 10.1158/0008-5472.CAN-11-0364; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Xiang Y, 2014, ONCOGENE, V33, P378, DOI 10.1038/onc.2012.575; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhao J, 2011, SEMIN CELL DEV BIOL, V22, P705, DOI 10.1016/j.semcdb.2011.09.012; Zhu C, 2013, PROSTATE, V73, P1082, DOI 10.1002/pros.22656; Zhu XM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.002	53	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31121	31135		10.1074/jbc.M114.556290	http://dx.doi.org/10.1074/jbc.M114.556290			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25228695	Green Published, hybrid			2022-12-25	WOS:000344549900021
J	Brandt, U; Schurmann, M; Steinbuchel, A				Brandt, Ulrike; Schuermann, Marc; Steinbuechel, Alexander			Mercaptosuccinate Dioxygenase, a Cysteine Dioxygenase Homologue, from Variovorax paradoxus Strain B4 Is the Key Enzyme of Mercaptosuccinate Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUANTUM DOTS; PURIFICATION; IDENTIFICATION; INTERMEDIATE; ACTIVATION; CATABOLISM; EXPRESSION; MECHANISM; DPN7(T); PLANTS	The versatile thiol mercaptosuccinate has a wide range of applications, e.g. in quantum dot research or in bioimaging. Its metabolism is investigated in Variovorax paradoxus strain B4, which can utilize this compound as the sole source of carbon and sulfur. Proteomic studies of strain B4 resulted in the identification of a putative mercaptosuccinate dioxygenase, a cysteine dioxygenase homologue, possibly representing the key enzyme in the degradation of mercaptosuccinate. Therefore, the putative mercaptosuccinate dioxygenase was heterologously expressed, purified, and characterized in this study. The results clearly demonstrated that the enzyme utilizes mercaptosuccinate with concomitant consumption of oxygen. Thus, the enzyme is designated as mercaptosuccinate dioxygenase. Succinate and sulfite were verified as the final reaction products. The enzyme showed an apparent K-m of 0.4 mM, and a specific activity (V-max) of 20.0 mu mol min(-1) mg(-1) corresponding to a k(cat) of 7.7 s(-1). Furthermore, the enzyme was highly specific for mercaptosuccinate, no activity was observed with cysteine, dithiothreitol, 2-mercaptoethanol, and 3-mercaptopropionate. These structurally related thiols did not have an inhibitory effect either. Fe(II) could clearly be identified as metal cofactor of the mercaptosuccinate dioxygenase with a content of 0.6 mol of Fe(II)/mol of enzyme. The recently proposed hypothesis for the degradation pathway of mercaptosuccinate based on proteome analyses could be strengthened in the present study. (i) Mercaptosuccinate is first converted to sulfinosuccinate by this mercaptosuccinate dioxygenase; (ii) sulfinosuccinate is spontaneously desulfinated to succinate and sulfite; and (iii) whereas succinate enters the central metabolism, sulfite is detoxified by the previously identified putative molybdopterin oxidoreductase.	[Brandt, Ulrike; Schuermann, Marc; Steinbuechel, Alexander] Univ Munster, Inst Mol Microbiol & Biotechnol, D-48149 Munster, Germany; [Steinbuechel, Alexander] King Abdulaziz Univ, Fac Biol, Jeddah 21413, Saudi Arabia	University of Munster; King Abdulaziz University	Steinbuchel, A (corresponding author), Univ Munster, Inst Mol Microbiol & Biotechnol, D-48149 Munster, Germany.	steinbu@uni-muenster.de						Bach LG, 2013, J COLLOID INTERF SCI, V394, P132, DOI 10.1016/j.jcis.2012.11.068; Belimov AA, 2009, NEW PHYTOL, V181, P413, DOI 10.1111/j.1469-8137.2008.02657.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt U, 2014, APPL MICROBIOL BIOT, V98, P6039, DOI 10.1007/s00253-014-5811-7; Britton HTS, 1931, J CHEM SOC, P1456, DOI 10.1039/jr9310001456; Bruland N, 2009, J BIOL CHEM, V284, P660, DOI 10.1074/jbc.M806762200; Carbajal-Rodriguez I, 2011, J BACTERIOL, V193, P527, DOI 10.1128/JB.00793-10; Chai SC, 2005, J BIOL CHEM, V280, P9865, DOI 10.1074/jbc.M413733200; CHENEY GE, 1959, J PHYS CHEM-US, V63, P2055, DOI 10.1021/j150582a018; Dominy JE, 2006, J BACTERIOL, V188, P5561, DOI 10.1128/JB.00291-06; Driggers CM, 2013, J MOL BIOL, V425, P3121, DOI 10.1016/j.jmb.2013.05.028; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Filby G., 1974, U.S. Patent, Patent No. [US3950404A, 3950404]; Fu T, 2010, J NANOSCI NANOTECHNO, V10, P1741, DOI 10.1166/jnn.2010.2049; Ghaderi S, 2012, J NANOSCI NANOTECHNO, V12, P4928, DOI 10.1166/jnn.2012.4907; Levin EJ, 2007, STRUCTURE, V15, P1040, DOI 10.1016/j.str.2007.06.019; McCoy JG, 2006, P NATL ACAD SCI USA, V103, P3084, DOI 10.1073/pnas.0509262103; Mubbeler JH, 2006, INT J SYST EVOL MICR, V56, P1305, DOI 10.1099/ijs.0.64126-0; Pawelec M, 2004, DALTON T, P292, DOI 10.1039/b311053b; Pierce BS, 2007, BIOCHEMISTRY-US, V46, P8569, DOI 10.1021/bi700662d; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Rizvi Sarwat B, 2012, Int J Nanomedicine, V7, P3915, DOI 10.2147/IJN.S28577; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Satola B, 2013, APPL MICROBIOL BIOT, V97, P541, DOI 10.1007/s00253-012-4585-z; Schurmann M, 2013, J BACTERIOL, V195, P1538, DOI 10.1128/JB.02105-12; Schurmann M, 2011, J BACTERIOL, V193, P3078, DOI 10.1128/JB.00049-11; Simmons CR, 2008, BIOCHEMISTRY-US, V47, P11390, DOI 10.1021/bi801546n; Simmons CR, 2006, J BIOL CHEM, V281, P18723, DOI 10.1074/jbc.M601555200; Simmons CR, 2006, PROTEIN EXPRES PURIF, V47, P74, DOI 10.1016/j.pep.2005.10.025; SMITH GF, 1952, ANALYST, V77, P418, DOI 10.1039/an9527700418; SORBO B, 1987, METHOD ENZYMOL, V143, P3; Souness RJ, 2013, BIOCHEMISTRY-US, V52, P7606, DOI 10.1021/bi400661a; Stein SE, 1999, J AM SOC MASS SPECTR, V10, P770, DOI 10.1016/S1044-0305(99)00047-1; Stipanuk MH, 2009, AMINO ACIDS, V37, P55, DOI 10.1007/s00726-008-0202-y; Stipanuk MH, 2011, AMINO ACIDS, V41, P91, DOI 10.1007/s00726-010-0518-2; Tchesnokov EP, 2012, BIOCHEMISTRY-US, V51, P257, DOI 10.1021/bi201597w; YAMAGUCHI K, 1978, J BIOCHEM-TOKYO, V83, P479, DOI 10.1093/oxfordjournals.jbchem.a131935; Ye S, 2007, J BIOL CHEM, V282, P3391, DOI 10.1074/jbc.M609337200	40	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30800	30809		10.1074/jbc.M114.579730	http://dx.doi.org/10.1074/jbc.M114.579730			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25228698	Green Published, hybrid			2022-12-25	WOS:000344549700054
J	Chen, SH; Zhao, Y; Zhang, Y; Zhang, DH				Chen, Shaohua; Zhao, Yang; Zhang, Yu; Zhang, Daohai			Fucoidan Induces Cancer Cell Apoptosis by Modulating the Endoplasmic Reticulum Stress Cascades	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; BREAST-CANCER; ANTICANCER ACTIVITY; OXIDATIVE STRESS; DOWN-REGULATION; IN-VITRO; ACTIVATION; METASTASIS; TRANSLOCON; TRANSITION	Background: Cancer metastasis is the main cause leading to disease recurrence and high mortality in cancer patients. Therefore, inhibiting metastasis process or killing metastatic cancer cells by inducing apoptosis is of clinical importance in improving cancer patient survival. Previous studies revealed that fucoidan, a fucose-rich polysaccharide isolated from marine brown alga, is a promising natural product with significant anti-cancer activity. However, little is known about the role of endoplasmic reticulum (ER) stress in fucoidan-induced cell apoptosis. Principal Findings: We reported that fucoidan treatment inhibits cell growth and induces apoptosis in cancer cells. Fucoidan treatments resulted in down-regulation of the glucose regulated protein 78 (GRP78) in the metastatic MDA-MB-231 breast cancer cells, and of the ER protein 29 (ERp29) in the metastatic HCT116 colon cancer cells. However, fucoidan treatment promoted ER Ca2+-dependent calmodulin-dependent kinase II (CaMKII) phosphorylation, Bcl-associated X protein (Bax) and caspase 12 expression in MDA-MB-231 cells, but not in HCT116 cells. In both types of cancer cells, fucoidan activated the phosphorylation of eukaryotic initiation factor 2 alpha (p-eIF2 alpha)\CCAAT/enhancer binding protein homologous protein (CHOP) pro-apoptotic cascade and inhibited the phosphorylation of inositol-requiring kinase 1 (p-IRE-1)\X-box binding proteins 1 splicing (XBP-1s) pro-survival cascade. Furthermore, CHOP knockdown prevented DNA damage and cell death induced by fucoidan. Conclusion/Significance: Fucoidan exerts its anti-tumor function by modulating ER stress cascades. Contribution of ER stress to the fucoidan-induced cell apoptosis augments our understanding of the molecular mechanisms underlying its antitumour activity and provides evidence for the therapeutic application of fucoidan in cancer.	[Chen, Shaohua] Zhejiang Univ, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Yang] Univ Sydney, Centenary Inst Canc Med & Cell Biol, Sydney, NSW 2006, Australia; [Zhang, Yu] Zhejiang Hosp, Dept Oncol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Daohai] Australia Natl Univ, ANU Med Sch, Canberra Hosp, Caner Res Grp, Canberra, ACT, Australia	Zhejiang University; University of Sydney; Centenary Institute; Australian National University; Canberra Hospital	Zhang, Y (corresponding author), Zhejiang Hosp, Dept Oncol, Hangzhou, Zhejiang, Peoples R China.	zjhoszy@126.com			National Natural Science Foundation of China [81370524]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81370524). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; Bambang IF, 2013, ONCOGENE, V32, P1240, DOI 10.1038/onc.2012.149; Baryshev M, 2006, BIOCHEM BIOPH RES CO, V340, P617, DOI 10.1016/j.bbrc.2005.12.052; Bilan MI, 2002, CARBOHYD RES, V337, P719, DOI 10.1016/S0008-6215(02)00053-8; Boo HJ, 2013, MAR DRUGS, V11, P2982, DOI 10.3390/md11082982; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Durig J, 1997, THROMB RES, V85, P479, DOI 10.1016/S0049-3848(97)00037-6; Gideon TP, 2008, J MED FOOD, V11, P638, DOI 10.1089/jmf.2007.0127; Hammadi M, 2013, FASEB J, V27, P1600, DOI 10.1096/fj.12-218875; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haze K, 2001, BIOCHEM J, V355, P19, DOI 10.1042/0264-6021:3550019; Hsu HY, 2013, CARCINOGENESIS, V34, P874, DOI 10.1093/carcin/bgs396; Huser CAA, 2007, ARTHRITIS RHEUM-US, V56, P2322, DOI 10.1002/art.22717; Ishizu K, 2007, BIOL PHARM BULL, V30, P1779, DOI 10.1248/bpb.30.1779; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee H, 2013, PLOS ONE, V7; Li B, 2008, MOLECULES, V13, P1671, DOI 10.3390/molecules13081671; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Nagamine T, 2009, NUTR CANCER, V61, P340, DOI 10.1080/01635580802567133; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Park HS, 2013, MAR DRUGS, V11, P2347, DOI 10.3390/md11072347; Park HS, 2011, J FOOD SCI, V76, pT77, DOI 10.1111/j.1750-3841.2011.02099.x; Thinh PD, 2013, MAR DRUGS, V11, P1456, DOI 10.3390/md11051456; Prokofjeva MM, 2013, MAR DRUGS, V11, P3000, DOI 10.3390/md11083000; Qi L, 2012, MED ONCOL, V29, P721, DOI 10.1007/s12032-011-9929-5; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schewe DM, 2009, CANCER RES, V69, P1545, DOI 10.1158/0008-5472.CAN-08-3858; Senthilkumar K, 2013, INT J BIOL MACROMOL, V60, P366, DOI 10.1016/j.ijbiomac.2013.06.030; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Teske BF, 2011, METHOD ENZYMOL, V490, P333, DOI 10.1016/B978-0-12-385114-7.00019-2; Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857; Wu CT, 2011, FREE RADICAL BIO MED, V51, P671, DOI 10.1016/j.freeradbiomed.2011.04.038; Xue ML, 2013, NUTR CANCER, V65, P460, DOI 10.1080/01635581.2013.757628; Xue ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043483; Zhang DH, 2010, EXP CELL RES, V316, P3522, DOI 10.1016/j.yexcr.2010.08.014; Zhang LH, 2010, J CELL BIOCHEM, V110, P1299, DOI 10.1002/jcb.22679; Zhang ZY, 2013, MAR DRUGS, V11, P81, DOI 10.3390/md11010081; Zhang ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027441	44	48	50	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e108157	10.1371/journal.pone.0108157	http://dx.doi.org/10.1371/journal.pone.0108157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232957	Green Published, Green Submitted, gold			2022-12-25	WOS:000342921200086
J	Xu, XM; Mao, W; Chen, Q; Zhuang, Q; Wang, LH; Dai, J; Wang, HB; Huang, ZQ				Xu, Xiaoming; Mao, Wei; Chen, Qian; Zhuang, Qin; Wang, Lihui; Dai, Jin; Wang, Haibing; Huang, Zhaoquan			Endostar, a Modified Recombinant Human Endostatin, Suppresses Angiogenesis through Inhibition of Wnt/beta-Catenin Signaling Pathway	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BETA-CATENIN; ANTIANGIOGENIC THERAPY; VEGF EXPRESSION; CYCLIN D1; WNT; CELLS; NEOVASCULARIZATION; ACTIVATION; TARGET	Endostar, a novel modified recombinant human endostatin, is now widely studied for the treatment of diseases that are characterized or caused by pathological angiogenesis. However, its molecular mechanism remains unclear. In this study, we investigated the effects of Endostar on the Wnt/beta-catenin signaling pathway, which has emerged as an important aspect of angiogenesis. We showed that Endostar significantly inhibited the proliferation, migration, invasion, and capillary-like tube formation of human umbilical vascular endothelial cells in a dose-dependent manner. Using a luciferase reporter assay, we also demonstrated that Endostar suppressed b-catenin-dependent T cell factor transcriptional activity in increasing doses. Moreover, we found that Endostar treatment also restricted the stabilized mutant beta-catenin-mediated increase in transcriptional activity, suggesting that Endostar exerts its inhibitory influence on Wnt/beta-catenin signaling by targeting beta-catenin or its downstream molecules. Western blot and immunofluorescence results revealed that Endostar significantly decreased nuclear and total beta-catenin levels. Finally, we discovered that Endostar down-regulated cyclin D1 and VEGF, two proteins that are known as the downstream targets of Wnt/b-catenin signaling and that also play important roles in angiogenesis. Our findings suggested that Endostar inhibits angiogenesis and that the downregulation of the Wnt/beta-catenin signaling pathway may be involved in the inhibition of angiogenesis by Endostar. These results support the use of Endostar in further clinical applications.	[Xu, Xiaoming; Mao, Wei; Dai, Jin; Wang, Haibing; Huang, Zhaoquan] Zhejiang Prov Hosp Tradit Chinese Med, Dept Cardiol, Hangzhou, Zhejiang, Peoples R China; [Chen, Qian; Zhuang, Qin; Wang, Lihui] Zhejiang Chinese Med Univ, Coll Clin Med 1, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University	Mao, W (corresponding author), Zhejiang Prov Hosp Tradit Chinese Med, Dept Cardiol, Hangzhou, Zhejiang, Peoples R China.	maoweilw@163.com			National Natural Science Foundation of China [81170270]; Zhejiang Medical Health Science and Technology Program [2010KYA153]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Medical Health Science and Technology Program	This work was funded by the National Natural Science Foundation of China (81170270) and Zhejiang Medical Health Science and Technology Program (2010KYA153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Cabebe Elwyn, 2007, Curr Treat Options Oncol, V8, P15, DOI 10.1007/s11864-007-0022-4; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Corada M, 2010, DEV CELL, V18, P938, DOI 10.1016/j.devcel.2010.05.006; Cowan CE, 2010, CIRC RES, V107, P959, DOI 10.1161/CIRCRESAHA.110.219592; Crawford TN, 2009, CURR DIABETES REV, V5, P8, DOI 10.2174/157339909787314149; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; Doyle B, 2007, J AM COLL CARDIOL, V49, P2073, DOI 10.1016/j.jacc.2007.01.089; Du QA, 2006, CANCER RES, V66, P7024, DOI 10.1158/0008-5472.CAN-05-4110; Duh EJ, 2004, AM J OPHTHALMOL, V137, P668, DOI 10.1016/j.ajo.2003.11.015; Easwaran V, 2003, CANCER RES, V63, P3145; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Goodwin AM, 2006, DEV DYNAM, V235, P3110, DOI 10.1002/dvdy.20939; Hu W, 2012, INFLAMM RES, V61, P827, DOI 10.1007/s00011-012-0477-z; Jia HP, 2006, NAT BIOTECHNOL, V24, P117, DOI 10.1038/nbt0206-117; Jin FY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047161; Lai SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038103; Li XQ, 2011, CANCER LETT, V301, P212, DOI 10.1016/j.canlet.2010.12.004; Li ZP, 2006, MOL CELL BIOL, V26, P4240, DOI 10.1128/MCB.02124-05; Ling Y, 2007, BIOCHEM BIOPH RES CO, V361, P79, DOI 10.1016/j.bbrc.2007.06.155; Ling Y, 2009, ANTICANCER RES, V29, P411; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao W, 2010, J ZHEJIANG UNIV-SC B, V11, P599, DOI 10.1631/jzus.B1001011; Masckauchan T. Nestor H., 2005, Angiogenesis, V8, P43, DOI 10.1007/s10456-005-5612-9; Moreno PR, 2006, CIRCULATION, V113, P2245, DOI 10.1161/CIRCULATIONAHA.105.578955; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Moulton KS, 1999, CIRCULATION, V99, P1726, DOI 10.1161/01.CIR.99.13.1726; Mundhenke C, 2001, CLIN CANCER RES, V7, P3366; Otrock ZK, 2007, BLOOD CELL MOL DIS, V39, P212, DOI 10.1016/j.bcmd.2007.04.001; Patan S, 2004, CANC TREAT, V117, P3; Planutiene M, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-28; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Simo R, 2008, DIABETOLOGIA, V51, P1574, DOI 10.1007/s00125-008-0989-9; Skurk C, 2005, CIRC RES, V96, P308, DOI 10.1161/01.RES.0000156273.30274.f7; Wang Q, 2010, ONCOGENE, V29, P128, DOI 10.1038/onc.2009.302; Xu WJ, 2011, CHINESE MED J-PEKING, V124, P2883, DOI 10.3760/cma.j.issn.0366-6999.2011.18.016; Yu DD, 2013, ACTA BIOCH BIOPH SIN, V45, P742, DOI 10.1093/abbs/gmt070; Zerlin M, 2008, ANGIOGENESIS, V11, P63, DOI 10.1007/s10456-008-9095-3; Zhang B, 2010, P NATL ACAD SCI USA, V107, P6900, DOI 10.1073/pnas.0906764107; Zhang L, 2012, MOL BIOL REP, V39, P89, DOI 10.1007/s11033-011-0713-6; Zhang XB, 2001, CANCER RES, V61, P6050	44	33	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107463	10.1371/journal.pone.0107463	http://dx.doi.org/10.1371/journal.pone.0107463			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232946	Green Submitted, gold, Green Published			2022-12-25	WOS:000342921200031
J	Herrera, VL; Decano, JL; Giordano, N; Moran, AM; Ruiz-Opazo, N				Herrera, Victoria L.; Decano, Julius L.; Giordano, Nicholas; Moran, Ann Marie; Ruiz-Opazo, Nelson			Aortic and Carotid Arterial Stiffness and Epigenetic Regulator Gene Expression Changes Precede Blood Pressure Rise in Stroke-Prone Dahl Salt-Sensitive Hypertensive Rats	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; INDEPENDENT PREDICTOR; CARDIOVASCULAR MORTALITY; VASCULAR STIFFNESS; DIETARY-SODIUM; ALL-CAUSE; MICE; PREVALENCE; DISEASE; ATHEROSCLEROSIS	Multiple clinical studies show that arterial stiffness, measured as pulse wave velocity (PWV), precedes hypertension and is an independent predictor of hypertension end organ diseases including stroke, cardiovascular disease and chronic kidney disease. Risk factor studies for arterial stiffness implicate age, hypertension and sodium. However, causal mechanisms linking risk factor to arterial stiffness remain to be elucidated. Here, we studied the causal relationship of arterial stiffness and hypertension in the Na-induced, stroke-prone Dahl salt-sensitive (S) hypertensive rat model, and analyzed putative molecular mechanisms. Stroke-prone and non-stroke-prone male and female rats were studied at 3- and 6-weeks of age for arterial stiffness (PWV, strain), blood pressure, vessel wall histology, and gene expression changes. Studies showed that increased left carotid and aortic arterial stiffness preceded hypertension, pulse pressure widening, and structural wall changes at the 6-week time-point. Instead, differential gene induction was detected implicating molecular-functional changes in extracellular matrix (ECM) structural constituents, modifiers, cell adhesion, and matricellular proteins, as well as in endothelial function, apoptosis balance, and epigenetic regulators. Immunostaining testing histone modifiers Ep300, HDAC3, and PRMT5 levels confirmed carotid artery-upregulation in all three layers: endothelial, smooth muscle and adventitial cells. Our study recapitulates observations in humans that given salt-sensitivity, increased Na-intake induced arterial stiffness before hypertension, increased pulse pressure, and structural vessel wall changes. Differential gene expression changes associated with arterial stiffness suggest a molecular mechanism linking sodium to full-vessel wall response affecting gene-networks involved in vascular ECM structure-function, apoptosis balance, and epigenetic regulation.	[Herrera, Victoria L.; Decano, Julius L.; Giordano, Nicholas; Moran, Ann Marie; Ruiz-Opazo, Nelson] Boston Univ, Sch Med, Dept Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA	Boston University	Ruiz-Opazo, N (corresponding author), Boston Univ, Sch Med, Dept Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA.	nruizo@bu.edu			National Heart, Lung, and Blood Institute [RO1 HL105286]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105286] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Heart, Lung, and Blood Institute Grant RO1 HL105286, awarded to NRO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlGhatrif M, 2013, HYPERTENSION, V62, P934, DOI 10.1161/HYPERTENSIONAHA.113.01445; AVOLIO AP, 1986, ARTERIOSCLEROSIS, V6, P166, DOI 10.1161/01.ATV.6.2.166; AVOLIO AP, 1985, CIRCULATION, V71, P202, DOI 10.1161/01.CIR.71.2.202; Ben-Shlomo Y, 2014, J AM COLL CARDIOL, V63, P636, DOI 10.1016/j.jacc.2013.09.063; BENETOS A, 1992, J HYPERTENS, V10, P355, DOI 10.1097/00004872-199204000-00006; Bezie Y, 1998, ARTERIOSCL THROM VAS, V18, P1027, DOI 10.1161/01.ATV.18.7.1027; Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031; Bussemaker E, 2010, AM J KIDNEY DIS, V55, P1111, DOI 10.1053/j.ajkd.2009.12.022; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Calvet D, 2014, INT J STROKE, V9, P291, DOI 10.1111/ijs.12015; Cecelja M, 2009, HYPERTENSION, V54, P1328, DOI 10.1161/HYPERTENSIONAHA.109.137653; Celik T, 2006, BLOOD PRESS MONIT, V11, P251, DOI 10.1097/01.mbp.0000209084.55364.3a; CHRISTENSEN KL, 1991, HYPERTENSION, V18, P722, DOI 10.1161/01.HYP.18.6.722; Decano JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055222; Decano JL, 2011, MOL IMAGING BIOL, V13, P1096, DOI 10.1007/s11307-010-0444-4; Decano JL, 2009, CIRCULATION, V119, P1501, DOI 10.1161/CIRCULATIONAHA.108.833327; Dernellis J, 2005, HYPERTENSION, V45, P426, DOI 10.1161/01.HYP.0000157818.58878.93; Dudenbostel T, 2012, CARDIOL REV, V20, P259, DOI 10.1097/CRD.0b013e31825d0a44; Durier S, 2003, CIRCULATION, V108, P1845, DOI 10.1161/01.CIR.0000091407.86925.7A; Fels J, 2010, PFLUG ARCH EUR J PHY, V460, P915, DOI 10.1007/s00424-010-0871-8; Fujiwara N, 2000, CIRCULATION, V101, P856, DOI 10.1161/01.CIR.101.8.856; Ge DL, 2007, AM J HYPERTENS, V20, P1065, DOI 10.1016/j.amjhyper.2007.05.013; Gepner AD, 2014, STROKE, V45, P48, DOI 10.1161/STROKEAHA.113.002649; Gutierrez-Misis A, 2011, J HYPERTENS, V29, P1863, DOI 10.1097/HJH.0b013e32834ab497; Hartley CJ, 1997, AM J PHYSIOL-HEART C, V273, pH494, DOI 10.1152/ajpheart.1997.273.1.H494; Hartley CJ, 2008, ULTRASOUND MED BIOL, V34, P892, DOI 10.1016/j.ultrasmedbio.2007.11.019; Herrera VLM, 2006, PHYSIOL GENOMICS, V26, P172, DOI 10.1152/physiolgenomics.00285.2005; Herrera VLM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043160; Herrera VLM, 2005, PHYSIOL GENOMICS, V23, P257, DOI 10.1152/physiolgenomics.00144.2005; Kaess BM, 2012, JAMA-J AM MED ASSOC, V308, P875, DOI 10.1001/2012.jama.10503; Karras A, 2012, HYPERTENSION, V60, P1451, DOI 10.1161/HYPERTENSIONAHA.112.197210; Lacolley P, 2009, CARDIOVASC RES, V81, P637, DOI 10.1093/cvr/cvn353; Laurent S, 2003, STROKE, V34, P1203, DOI 10.1161/01.STR.0000065428.03209.64; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Laurent S, 2007, J NEPHROL, V20, pS45; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Levy D, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S3; Li J, 2009, J NUTR, V139, P447, DOI 10.3945/jn.108.097451; Mercier N, 2007, AM J HYPERTENS, V20, P319, DOI 10.1016/j.amjhyper.2006.09.002; Mimran A, 2008, NEPHROL DIAL TRANSPL, V23, P2138, DOI 10.1093/ndt/gfn160; Mitchell GF, 2005, CIRCULATION, V112, P194, DOI 10.1161/CIRCULATIONAHA.104.530675; Mukherjee D, 2012, JAMA-J AM MED ASSOC, V308, P919, DOI 10.1001/2012.jama.10931; Oberleithner H, 2011, PFLUG ARCH EUR J PHY, V462, P519, DOI 10.1007/s00424-011-0999-1; Oberleithner H, 2011, BLOOD PURIFICAT, V31, P82, DOI 10.1159/000321842; Oberleithner H, 2010, KIDNEY INT, V77, P490, DOI 10.1038/ki.2009.490; Ochi N, 2009, HYPERTENS RES, V32, P255, DOI 10.1038/hr.2009.13; Reddy AK, 2009, IEEE ENG MED BIO, P1104, DOI 10.1109/IEMBS.2009.5334387; Safar ME, 2006, HDB HYPERTENSION, V23, P3; Safar ME, 2012, CURR HYPERTENS REP, V14, P339, DOI 10.1007/s11906-012-0272-9; Safar ME, 2009, HYPERTENSION, V54, P203, DOI 10.1161/HYPERTENSIONAHA.109.129585; Simon G, 1998, HYPERTENSION, V32, P654, DOI 10.1161/01.HYP.32.4.654; Williams R, 2007, ULTRASOUND MED BIOL, V33, P1368, DOI 10.1016/j.ultrasmedbio.2007.03.012; ZEMEL MB, 1988, AM J CARDIOL, V61, pH7, DOI 10.1016/0002-9149(88)91098-3; Zhang XM, 2006, J ACOUST SOC AM, V119, P1238, DOI 10.1121/1.2159294	54	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107888	10.1371/journal.pone.0107888	http://dx.doi.org/10.1371/journal.pone.0107888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229245	Green Published, Green Submitted, gold			2022-12-25	WOS:000342123900083
J	Lim, ML; Ooi, BNS; Jungebluth, P; Sjoqvist, S; Hultman, I; Lemon, G; Gustafsson, Y; Asmundsson, J; Baiguera, S; Douagi, I; Gilevich, I; Popova, A; Haag, JC; Rodriguez, AB; Lim, J; Lieden, A; Nordenskjold, M; Alici, E; Baker, D; Unger, C; Luedde, T; Vassiliev, I; Inzunza, J; Ahrlund-Richter, L; Macchiarini, P				Lim, Mei Ling; Ooi, Brandon Nick Sern; Jungebluth, Philipp; Sjoqvist, Sebastian; Hultman, Isabell; Lemon, Greg; Gustafsson, Ylva; Asmundsson, Jurate; Baiguera, Silvia; Douagi, Iyadh; Gilevich, Irina; Popova, Alina; Haag, Johannes Cornelius; Rodriguez, Antonio Beltran; Lim, Jianri; Lieden, Agne; Nordenskjold, Magnus; Alici, Evren; Baker, Duncan; Unger, Christian; Luedde, Tom; Vassiliev, Ivan; Inzunza, Jose; Ahrlund-Richter, Lars; Macchiarini, Paolo			Characterization of Stem-Like Cells in Mucoepidermoid Tracheal Paediatric Tumor	PLOS ONE			English	Article							MESENCHYMAL STEM; CANCER; CARCINOMA; IDENTIFICATION; SALIVARY; GLANDS	Stem cells contribute to regeneration of tissues and organs. Cells with stem cell-like properties have been identified in tumors from a variety of origins, but to our knowledge there are yet no reports on tumor-related stem cells in the human upper respiratory tract. In the present study, we show that a tracheal mucoepidermoid tumor biopsy obtained from a 6 year-old patient contained a subpopulation of cells with morphology, clonogenicity and surface markers that overlapped with bone marrow mesenchymal stromal cells (BM-MSCs). These cells, designated as MEi (mesenchymal stem cell-like mucoepidermoid tumor) cells, could be differentiated towards mesenchymal lineages both with and without induction, and formed spheroids in vitro. The MEi cells shared several multipotent characteristics with BM-MSCs. However, they displayed differences to BM-MSCs in growth kinectics and gene expression profiles relating to cancer pathways and tube development. Despite this, the MEi cells did not possess in vivo tumor-initiating capacity, as proven by the absence of growth in situ after localized injection in immunocompromised mice. Our results provide an initial characterization of benign tracheal cancer-derived niche cells. We believe that this report could be of importance to further understand tracheal cancer initiation and progression as well as therapeutic development.	[Lim, Mei Ling; Jungebluth, Philipp; Sjoqvist, Sebastian; Lemon, Greg; Gustafsson, Ylva; Baiguera, Silvia; Haag, Johannes Cornelius; Rodriguez, Antonio Beltran; Lim, Jianri; Ahrlund-Richter, Lars] Karolinska Inst, Adv Ctr Translat Regenerat Med, Dept Clin Sci Intervent & Technol, Div Ear Nose Throat, Stockholm, Sweden; [Ooi, Brandon Nick Sern] Republ Polytech, Sch Appl Sci, Singapore, Singapore; [Hultman, Isabell; Ahrlund-Richter, Lars] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Asmundsson, Jurate] Karolinska Univ Hosp, Dept Pathol & Oncol, Stockholm, Sweden; [Douagi, Iyadh; Alici, Evren] Karolinska Inst, Dept Med, Ctr Hematol & Regenerat Med, Stockholm, Sweden; [Gilevich, Irina; Popova, Alina] Kuban State Med Univ, Int Sci Res Clin & Educ Ctr Regenerat Med, Krasnodar, Russia; [Lieden, Agne; Nordenskjold, Magnus] Karolinska Univ Hosp, Dept Clin Genet, Stockholm, Sweden; [Lieden, Agne; Nordenskjold, Magnus] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Lieden, Agne; Nordenskjold, Magnus] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Baker, Duncan; Unger, Christian] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Luedde, Tom] Univ Hosp RWTH Aachen, Dept Med 3, Aachen, Germany; [Vassiliev, Ivan] Univ Adelaide, Robinson Inst, Ctr Stem Cell Res, Adelaide, SA, Australia; [Inzunza, Jose] Karolinska Inst, Karolinska Univ Hosp, Dept Biosci & Nutr, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Kuban State Medical University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; University of Sheffield; RWTH Aachen University; RWTH Aachen University Hospital; Robinson Research Institute; University of Adelaide; Karolinska Institutet; Karolinska University Hospital	Macchiarini, P (corresponding author), Karolinska Inst, Adv Ctr Translat Regenerat Med, Dept Clin Sci Intervent & Technol, Div Ear Nose Throat, Stockholm, Sweden.	paolo.macchiarini@ki.se	Alici, Evren/A-4696-2010; Lim, Mei Ling/N-8596-2014; Luedde, Tom/AAE-9135-2022; Gilevich, Irina/R-4566-2016; Baiguera, Silvia/AAC-4738-2022; Sjöqvist, Sebastian/AAM-6958-2021	Luedde, Tom/0000-0002-6288-8821; Baiguera, Silvia/0000-0002-6669-7061; Alici, Evren/0000-0001-5307-6648; Nordenskjold, Magnus/0000-0002-4974-425X; Unger, Christian/0000-0002-4216-3575; Ambrosiani, Ylva/0000-0003-0393-0038; Haag, Johannes C./0000-0003-0405-4885; Inzunza, Jose/0000-0003-0876-6767	ALF medicine (Stockholm County Council) [20110639]; European Project FP7-NMP-SMALL-5 [280584]; Russian Ministry of Education and Science [11.G34.31.0065]	ALF medicine (Stockholm County Council); European Project FP7-NMP-SMALL-5; Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation)	This study was supported through ALF medicine (Stockholm County Council) application number 20110639 and the European Project FP7-NMP-2011-SMALL-5 Grant agreement number 280584. Megagrant of the Russian Ministry of Education and Science (Agreement No. 11.G34.31.0065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNEREN G, 1982, HEREDITAS, V96, P255, DOI 10.1111/j.1601-5223.1982.tb00855.x; AUCLAIR PL, 1992, CANCER, V69, P2021, DOI 10.1002/1097-0142(19920415)69:8<2021::AID-CNCR2820690803>3.0.CO;2-7; Azvolinsky A, 2012, J NATL CANCER I, V104, P893, DOI 10.1093/jnci/djs292; Bailey JM, 2014, GASTROENTEROLOGY, V146, P245, DOI 10.1053/j.gastro.2013.09.050; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Brandwein MS, 2001, AM J SURG PATHOL, V25, P835, DOI 10.1097/00000478-200107000-00001; Cedervall J, 2009, CANCER RES, V69, P3746, DOI 10.1158/0008-5472.CAN-08-3746; de Sousa EMF, 2011, CLIN CANCER RES, V17, P647, DOI 10.1158/1078-0432.CCR-10-1204; Dieter SM, 2011, CELL STEM CELL, V9, P357, DOI 10.1016/j.stem.2011.08.010; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Gaissert HA, 2006, ANN THORAC SURG, V82, P268, DOI 10.1016/j.athoracsur.2006.01.065; Gaissert Henning A, 2006, Cancer Control, V13, P286; Guzman-Ramirez N, 2009, PROSTATE, V69, P1683, DOI 10.1002/pros.21018; Holland JD, 2013, CURR OPIN CELL BIOL, V25, P254, DOI 10.1016/j.ceb.2013.01.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jung YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2766; Kratz JR, 2010, ANN THORAC SURG, V89, pS2090, DOI 10.1016/j.athoracsur.2010.03.038; Lawson DA, 2005, COLD SH Q B, V70, P187, DOI 10.1101/sqb.2005.70.003; Lee CJ, 2008, J CLIN ONCOL, V26, P2806, DOI 10.1200/JCO.2008.16.6702; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li H, 2009, METHODS MOL BIOL, V568, P85, DOI 10.1007/978-1-59745-280-9_7; Lim ML, 2013, STEM CELL TRANSL MED, V2, P975, DOI 10.5966/sctm.2013-0077; Liu XF, 2013, SCI REP-UK, V3, DOI 10.1038/srep02473; Lu Y, 2010, PLOS ONE, V5; Macchiarini P, 2006, LANCET ONCOL, V7, P83, DOI 10.1016/S1470-2045(05)70541-6; Merchant AA, 2010, CLIN CANCER RES, V16, P3130, DOI 10.1158/1078-0432.CCR-09-2846; O'Neill ID, 2009, ORAL ONCOL, V45, P2, DOI 10.1016/j.oraloncology.2008.03.012; Pannuti A, 2010, CLIN CANCER RES, V16, P3141, DOI 10.1158/1078-0432.CCR-09-2823; Papiashvilli M, 2012, INTERACT CARDIOV TH, V15, P311, DOI 10.1093/icvts/ivs199; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Qian H, 2012, J BIOL CHEM, V287, P25795, DOI 10.1074/jbc.M112.339622; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Romao Rodrigo Luiz Pinto, 2009, J Pediatr Surg, V44, pe1, DOI 10.1016/j.jpedsurg.2009.07.045; Sanchez-Mora N, 2007, HISTOL HISTOPATHOL, V22, P9, DOI 10.14670/HH-22.9; Serraj M, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-229; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Song LL, 2007, EXPERT OPIN BIOL TH, V7, P431, DOI 10.1517/14712598.7.4.431; Song Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017687; Tirado Y, 2007, GENE CHROMOSOME CANC, V46, P708, DOI 10.1002/gcc.20458; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang PH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052088, 10.1371/journal.pone.0057020]; Williams SCP, 2013, P NATL ACAD SCI USA, V110, P4861, DOI 10.1073/pnas.1304186110; Xu M, 2009, ENDOCRINOLOGY, V150, P2064, DOI 10.1210/en.2008-1265	43	2	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107712	10.1371/journal.pone.0107712	http://dx.doi.org/10.1371/journal.pone.0107712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229469	Green Published, Green Accepted, gold			2022-12-25	WOS:000342123900064
J	Merino-Ramos, T; Blazquez, AB; Escribano-Romero, E; Canas-Arranz, R; Sobrino, F; Saiz, JC; Martin-Acebes, MA				Merino-Ramos, Teresa; Blazquez, Ana-Belen; Escribano-Romero, Estela; Canas-Arranz, Rodrigo; Sobrino, Francisco; Saiz, Juan-Carlos; Martin-Acebes, Miguel A.			Protection of a Single Dose West Nile Virus Recombinant Subviral Particle Vaccine against Lineage 1 or 2 Strains and Analysis of the Cross-Reactivity with Usutu Virus	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS-VIRUS; TICK-BORNE ENCEPHALITIS; CENTRAL-EUROPE; NEUTRALIZING ANTIBODY; INFECTION; FLAVIVIRUSES; MICE; CHALLENGE; PROTEIN; GLYCOSYLATION	West Nile virus (WNV) is a neurovirulent mosquito-borne flavivirus. High WNV virulence was mainly associated with lineage 1 strains, but recent outbreaks have unveiled circulation of highly virulent lineage 2 strains. Co-expression of flavivirus prM and E glycoproteins drives the assembly of recombinant subviral particles (RSPs) that share antigenic features with virions. Mouse immunization with lineage 1 WNV RSPs induced a potent humoral response against WNV with production of neutralizing antibodies. A single inoculation of RSPs formulated with Al(OH)(3) as adjuvant protected mice against a lethal challenge with WNV strains from lineage 1 or 2. The cross-reactivity of the response elicited by these RSPs was analyzed against the related flavivirus Usutu virus (USUV), which shares multiple ecological and antigenic features with WNV. Immunization with WNV-RSPs increased specific, although low, antibody titers found upon subsequent USUV infection.	[Merino-Ramos, Teresa; Blazquez, Ana-Belen; Escribano-Romero, Estela; Saiz, Juan-Carlos] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotecnol, Madrid, Spain; [Canas-Arranz, Rodrigo; Sobrino, Francisco; Martin-Acebes, Miguel A.] CSIC UAM, Ctr Biol Mol Severo Ochoa, Dept Virol & Microbiol, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Sobrino, F (corresponding author), CSIC UAM, Ctr Biol Mol Severo Ochoa, Dept Virol & Microbiol, Madrid, Spain.	fsobrino@cbm.csic.es; jcsaiz@inia.es	Martin-Acebes, Miguel A./L-2258-2014; Escribano-Romero, Estela/H-1495-2015; Blazquez, Ana/G-9791-2015	Martin-Acebes, Miguel A./0000-0001-6015-3613; Escribano-Romero, Estela/0000-0002-5036-7607; Blazquez, Ana/0000-0002-0847-0977; Saiz, Juan-Carlos/0000-0001-8269-5544; Sobrino, Francisco/0000-0003-4968-8291	Fundacion Ramon Areces; Spanish Research Council (CSIC); INIA;  [BIO2011-24351];  [RTA2013-0036];  [ERTA2013-00013-C04-00]	Fundacion Ramon Areces; Spanish Research Council (CSIC); INIA(Instituto de Investigacion Agropecuaria (INIA)); ; ; 	This work was supported by grant BIO2011-24351 and an institutional grant from Fundacion Ramon Areces to F.S., grant RTA2013-0036 to J.-C.S. and by grant ERTA2013-00013-C04-00. M.A.M.-A. is a recipient of a "Junta de Ampliacion de Estudios (JAE)'' post-doctoral fellowship from the Spanish Research Council (CSIC). T.M.-R. is a recipient of a "Formacion de Personal Investigador (FPI)'' pre-doctoral fellowship from INIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLERING L, 2012, EURO SURVEILL, V17; Allison SL, 2003, J VIROL, V77, P11357, DOI 10.1128/JVI.77.21.11357-11366.2003; Bakonyi T, 2006, EMERG INFECT DIS, V12, P618; Bakonyi T, 2004, VIROLOGY, V328, P301, DOI 10.1016/j.virol.2004.08.005; Bakonyi T, 2013, VET MICROBIOL, V165, P61, DOI 10.1016/j.vetmic.2013.03.005; Barbic L, 2013, VECTOR-BORNE ZOONOT, V13, P772, DOI 10.1089/vbz.2012.1236; Beasley DWC, 2011, IMMUNOTHERAPY-UK, V3, P269, DOI 10.2217/IMT.10.93; Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005; Blazquez AB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002509; Brandler S, 2013, VIRUSES-BASEL, V5, P2384, DOI 10.3390/v5102384; Cavrini F, 2009, EURO SURVEILL, V14; Chang GJJ, 2000, J VIROL, V74, P4244, DOI 10.1128/JVI.74.9.4244-4252.2000; Cordoba L, 2007, J GEN VIROL, V88, P476, DOI 10.1099/vir.0.82439-0; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; DeBiasi RL, 2006, NAT CLIN PRACT NEURO, V2, P264, DOI 10.1038/ncpneuro0176; DEMADRID AT, 1974, J GEN VIROL, V23, P91, DOI 10.1099/0022-1317-23-1-91; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Escribano-Romero E, 2013, VACCINE, V31, P4523, DOI 10.1016/j.vaccine.2013.07.071; Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4; Gaibani P, 2010, J CLIN MICROBIOL, V48, P3338, DOI 10.1128/JCM.02501-09; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005; Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024; Heinz FX, 1995, VACCINE, V13, P1636, DOI 10.1016/0264-410X(95)00133-L; Hunt AR, 2001, J VIROL METHODS, V97, P133, DOI 10.1016/S0166-0934(01)00346-9; Ishikawa T, 2014, VACCINE; Iyer AV, 2013, INT J ENV RES PUB HE, V10, P4200, DOI 10.3390/ijerph10094200; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Konishi E, 1999, J VIROL, V73, P5527, DOI 10.1128/JVI.73.7.5527-5534.1999; Kroeger MA, 2002, ARCH VIROL, V147, P1155, DOI 10.1007/s00705-002-0809-3; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Lim SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074575; Lobigs M, 2012, EXPERT REV VACCINES, V11, P177, DOI [10.1586/ERV.11.180, 10.1586/erv.11.180]; Lobigs M, 2009, J VIROL, V83, P2436, DOI 10.1128/JVI.02273-08; Lupulovic D, 2011, VECTOR-BORNE ZOONOT, V11, P1303, DOI 10.1089/vbz.2010.0249; Mackenzie JS, 2009, ZOONOSES PUBLIC HLTH, V56, P338, DOI 10.1111/j.1863-2378.2008.01208.x; Magnusson SE, 2014, VACCINE, V32, P800, DOI 10.1016/j.vaccine.2013.12.030; Martin-Acebes Miguel A, 2012, World J Virol, V1, P51, DOI 10.5501/wjv.v1.i2.51; Martin-Acebes MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069479; Martin-Acebes MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024970; Martin-Acebes MA, 2011, J GEN VIROL, V92, P831, DOI 10.1099/vir.0.027185-0; Martin-Acebes MA, 2010, J VIROL, V84, P2902, DOI 10.1128/JVI.02311-09; Mehlhop E, 2008, CURR TOP MICROBIOL, V317, P125; Minke JM, 2011, VACCINE, V29, P4608, DOI 10.1016/j.vaccine.2011.04.058; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Nikolay B, 2011, VECTOR-BORNE ZOONOT, V11, P1417, DOI 10.1089/vbz.2011.0631; Ohtaki N, 2010, VACCINE, V28, P6588, DOI 10.1016/j.vaccine.2010.07.055; Papa A, 2011, EMERG INFECT DIS, V17, P920, DOI 10.3201/eid1705.101759; Pecorari M, 2009, EURO SURVEILL, V14; Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042; Petrovic T, 2013, EURO SURVEILL, V18, P20622; Petrovsky N, 2013, J VIROL, V87, P10324, DOI 10.1128/JVI.00480-13; Pierro A, 2013, CLIN MICROBIOL INFEC, V19, pE451, DOI 10.1111/1469-0691.12241; Popovic N, 2013, EUROSURVEILLANCE, V18, P18, DOI 10.2807/1560-7917.ES2013.18.43.20613; Savini G, 2011, VET MICROBIOL, V151, P264, DOI 10.1016/j.vetmic.2011.03.036; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schijns VEJC, 2011, EXPERT REV VACCINES, V10, P539, DOI [10.1586/erv.11.21, 10.1586/ERV.11.21]; Tang F, 2008, AM J TROP MED HYG, V78, P999, DOI 10.4269/ajtmh.2008.78.999; Vazquez A, 2011, EUROSURVEILLANCE, V16, P22; Venter M, 2013, VACCINE, V31, P3856, DOI 10.1016/j.vaccine.2013.06.059; Venter M, 2010, VECTOR-BORNE ZOONOT, V10, P659, DOI 10.1089/vbz.2009.0230; Vilibic-Cavlek T, 2014, INFECTION; Wang PG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008325; Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094; Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025; Whiteman MC, 2011, VACCINE, V29, P9702, DOI 10.1016/j.vaccine.2011.09.036; Yamshchikov G, 2004, VIROLOGY, V330, P304, DOI 10.1016/j.virol.2004.09.014	69	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e108056	10.1371/journal.pone.0108056	http://dx.doi.org/10.1371/journal.pone.0108056			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229345	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900095
J	Zabel, F; Putzenlechner, B; Mauser, W				Zabel, Florian; Putzenlechner, Birgitta; Mauser, Wolfram			Global Agricultural Land Resources - A High Resolution Suitability Evaluation and Its Perspectives until 2100 under Climate Change Conditions	PLOS ONE			English	Article							FOOD SECURITY; MODEL; SOIL; CONSEQUENCES; DEMAND	Changing natural conditions determine the land's suitability for agriculture. The growing demand for food, feed, fiber and bioenergy increases pressure on land and causes trade-offs between different uses of land and ecosystem services. Accordingly, an inventory is required on the changing potentially suitable areas for agriculture under changing climate conditions. We applied a fuzzy logic approach to compute global agricultural suitability to grow the 16 most important food and energy crops according to the climatic, soil and topographic conditions at a spatial resolution of 30 arc seconds. We present our results for current climate conditions (1981-2010), considering today's irrigated areas and separately investigate the suitability of densely forested as well as protected areas, in order to investigate their potentials for agriculture. The impact of climate change under SRES A1B conditions, as simulated by the global climate model ECHAM5, on agricultural suitability is shown by comparing the time-period 2071-2100 with 1981-2010. Our results show that climate change will expand suitable cropland by additionally 5.6 million km(2), particularly in the Northern high latitudes (mainly in Canada, China and Russia). Most sensitive regions with decreasing suitability are found in the Global South, mainly in tropical regions, where also the suitability for multiple cropping decreases.	[Zabel, Florian; Putzenlechner, Birgitta; Mauser, Wolfram] Univ Munich, Dept Geog, Munich, Germany	University of Munich	Zabel, F (corresponding author), Univ Munich, Dept Geog, Munich, Germany.	f.zabel@lmu.de	Putzenlechner, Birgitta/AAE-2987-2019; Zabel, Florian/O-8909-2015	Putzenlechner, Birgitta/0000-0002-5663-581X; Zabel, Florian/0000-0002-2923-4412	German Ministry of Education and Research (BMBF) program [FKZ 01LL0901E]	German Ministry of Education and Research (BMBF) program(Federal Ministry of Education & Research (BMBF))	This research was carried out within the framework of the GLUES (Global Assessment of Land Use Dynamics, Greenhouse Gas Emissions and Ecosystem Services) Project, which has been supported by the German Ministry of Education and Research (BMBF) program on sustainable land management (FKZ 01LL0901E). (http://modul-a.nachhaltiges-landmanagement.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed TRN, 2000, AGR SYST, V63, P75, DOI 10.1016/S0308-521X(99)00036-0; Alexandratos N., 2012, WORLD AGR 2030 2050; [Anonymous], 2012, SCIENCE, DOI DOI 10.1126/science.1215904; Avellan T, 2012, SOIL USE MANAGE, V28, P249, DOI 10.1111/j.1475-2743.2012.00400.x; Avellan T, 2013, ENVIRON POLLUT, V2, P11; Avellan T, 2012, REMOTE SENS LETT, V3, P631, DOI 10.1080/01431161.2012.659353; Baja S, 2002, ENVIRON MANAGE, V29, P647, DOI 10.1007/s00267-001-0053-8; Bengtsson L, 2009, J CLIMATE, V22, P2276, DOI 10.1175/2008JCLI2678.1; Bontemps S., 2009, GLOBCOVER 2009 PRODU; Braimoh AK, 2004, ENVIRON MANAGE, V33, P226, DOI 10.1007/s00267-003-0171-6; Bruinsma J., 2011, LOOKING AHEAD WORLD; BURROUGH PA, 1992, J SOIL SCI, V43, P193, DOI 10.1111/j.1365-2389.1992.tb00129.x; BURROUGH PA, 1989, J SOIL SCI, V40, P477, DOI 10.1111/j.1365-2389.1989.tb01290.x; Cassidy ES, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034015; Erb K.-H., 2009, 116 I SOC EC; [FAO IIASA ISRIC ISSCAS JRC], 2012, HARM WORLD SOIL DAT; FAOSTAT, 2014, FAOSTAT LAND USE MOD; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gregory PJ, 2011, J EXPT BOT; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IIASA and FAO, 2012, GLOB AGR ZON GAEZ V3, P196; IUCN, 2008, GUIDELINES APPL PROT; Jungclaus JH, 2006, J CLIMATE, V19, P3952, DOI 10.1175/JCLI3827.1; Kalogirou S., 2002, Computers, Environment and Urban Systems, V26, P89, DOI 10.1016/S0198-9715(01)00031-X; Kastner T, 2012, P NATL ACAD SCI USA, V109, P6868, DOI 10.1073/pnas.1117054109; Kurtener D, 2008, LECT NOTES COMPUT SC, V5072, P475, DOI 10.1007/978-3-540-69839-5_35; Lane A, 2007, J SAT AGR RES, V4, P12; Marker T.R., 2013, ENVIRON EARTH SCI, P1; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; Pretty J, 2010, INT J AGR SUSTAIN, V8, P219, DOI 10.3763/ijas.2010.0534; Ramankutty N, 2002, GLOBAL ECOL BIOGEOGR, V11, P377, DOI 10.1046/j.1466-822x.2002.00294.x; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Schmitz C, 2014, AGR ECON-BLACKWELL, V45, P69, DOI 10.1111/agec.12090; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Siebert S., 2013, GLOBAL MAP IRRIGATIO; Spiertz JHJ, 2009, NJAS-WAGEN J LIFE SC, V56, P281, DOI 10.1016/S1573-5214(09)80001-8; Sys CO, 1993, AGR PUBLICATIONS GAD; Teka K, 2012, MOMONA ETHIOP J SCI, V4, P64; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; UNCCD, 2014, DES INV FRONTL; Vaclavik T, 2013, GLOBAL ENVIRON CHANG, V23, P1637, DOI 10.1016/j.gloenvcha.2013.09.004; VanRanst E, 1996, GEODERMA, V70, P1, DOI 10.1016/0016-7061(95)00061-5; Vermeulen S, 2012, CURR OPIN ENV SUST, V4, P128, DOI 10.1016/j.cosust.2011.12.004; Wiberg D., 2011, SCARCITY ABUNDANCE L	48	179	185	3	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107522	10.1371/journal.pone.0107522	http://dx.doi.org/10.1371/journal.pone.0107522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229634	Green Submitted, Green Published, gold			2022-12-25	WOS:000342123900046
J	Dysart, MM; Galvis, BR; Russell, AG; Barker, TH				Dysart, Marilyn M.; Galvis, Boris R.; Russell, Armistead G.; Barker, Thomas H.			Environmental Particulate (PM2.5) Augments Stiffness-Induced Alveolar Epithelial Cell Mechanoactivation of Transforming Growth Factor Beta	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; LATENT TGF-BETA; MESENCHYMAL TRANSITION; EXTRACELLULAR-MATRIX; LYSYL OXIDASE; FOCAL ADHESIONS; IN-VIVO; LUNG; ACTIVATION; FIBRONECTIN	Dysfunctional pulmonary homeostasis and repair, including diseases such as pulmonary fibrosis (PF), chronic obstructive pulmonary disease (COPD), and tumorigenesis have been increasing over the past decade, a fact that heavily implicates environmental influences. Several investigations have suggested that in response to increased transforming growth factor beta (TGF beta) signaling, the alveolar type II (ATII) epithelial cell undergoes phenotypic changes that may contribute to the complex pathobiology of PF. We have previously demonstrated that increased tissue stiffness associated with PF is a potent extracellular matrix (ECM) signal for epithelial cell activation of TGF beta. The work reported here explores the relationship between tissue stiffness and exposure to environmental stimuli in the activation of TGF beta. We hypothesized that exposure of ATII cells to fine particulate matter (PM2.5) will result in enhanced cell contractility, TGF beta activation, and subsequent changes to ATII cell phenotype. ATII cells were cultured on increasingly stiff substrates with or without addition of PM2.5. Exposure to PM2.5 resulted in increased activation of TGF beta, increased cell contractility, and elongation of ATII cells. Most notably, on 8 kPa substrates, a stiffness greater than normal but less than established fibrotic lung, addition of PM2.5 resulted in increased cortical cell stiffness, enhanced actin staining and cell elongation; a result not seen in the absence of PM2.5. Our work suggests that PM2.5 exposure additionally enhances the existing interaction between ECM stiffness and TGF beta that has been previously reported. Furthermore, we show that this additional enhancement is likely a consequence of intracellular reactive oxygen species (ROS) leading to increased TGF beta signaling events. These results highlight the importance of both the micromechanical and biochemical environment in lung disease initiation and suggest that individuals in early stages of lung remodeling during fibrosis may be more susceptible than healthy individuals when exposed to environmental injury adjuvants.	[Dysart, Marilyn M.; Barker, Thomas H.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Dysart, Marilyn M.; Barker, Thomas H.] Emory Univ, Atlanta, GA 30322 USA; [Galvis, Boris R.; Russell, Armistead G.] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA; [Barker, Thomas H.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; Emory University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Barker, TH (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	thomas.barker@bme.gatech.edu		Galvis, Boris/0000-0003-3659-427X	Health Effects Institute New Investigator Award; National Science Foundation Graduate Research Fellowship Program	Health Effects Institute New Investigator Award; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	This work was supported by Health Effects Institute New Investigator Award (www.healtheffects.org) and National Science Foundation Graduate Research Fellowship Program (http://www.nsfgrfp.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Arnoux V, 2008, MOL BIOL CELL, V19, P4738, DOI 10.1091/mbc.E07-10-1078; BarcellosHoff MH, 1996, MOL ENDOCRINOL, V10, P1077, DOI 10.1210/me.10.9.1077; Becker S, 1996, TOXICOL APPL PHARM, V141, P637, DOI 10.1006/taap.1996.0330; Behr J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-101; Bocchino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014003; Bonner JC, 2007, TOXICOL PATHOL, V35, P148, DOI 10.1080/01926230601060009; Booth AJ, 2012, AM J RESP CRIT CARE, V186, P866, DOI 10.1164/rccm.201204-0754OC; Brown AC, 2013, J PATHOL, V229, P25, DOI 10.1002/path.4114; Brown AC, 2011, TISSUE ENG PT A, V17, P139, DOI 10.1089/ten.TEA.2010.0199; Butler AJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002234; Camara J, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-2; Carson AE, 2009, REGEN MED, V4, P593, DOI 10.2217/RME.09.30; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Day BJ, 2005, CHEST, V127, P12, DOI 10.1378/chest.127.1.12; Day BJ, 2008, ANTIOXID REDOX SIGN, V10, P355, DOI 10.1089/ars.2007.1916; Degryse AL, 2011, AM J PHYSL LUNG CELL; Diaz-Sanchez D, 2000, CLIN IMMUNOL, V97, P140, DOI 10.1006/clim.2000.4921; Dreher KL, 1997, J TOXICOL ENV HEALTH, V50, P285, DOI 10.1080/009841097160492; El-Haibi CP, 2012, P NATL ACAD SCI USA, V109, P17460, DOI 10.1073/pnas.1206653109; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Felton VM, 2009, AM J PHYSIOL-LUNG C, V297, pL805, DOI 10.1152/ajplung.00009.2009; Fogelgren B, 2005, J BIOL CHEM, V280, P24690, DOI 10.1074/jbc.M412979200; Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004; Gharaee-Kermani M, 2009, CURR MED CHEM, V16, P1400, DOI 10.2174/092986709787846497; Giacomini MM, 2012, EXP CELL RES, V318, P716, DOI 10.1016/j.yexcr.2012.01.020; Hinz Boris, 2009, Curr Rheumatol Rep, V11, P120; Huang XW, 2012, AM J RESP CELL MOL, V47, P340, DOI 10.1165/rcmb.2012-0050OC; Jenkins RG, 2006, J CLIN INVEST, V116, P1606, DOI 10.1172/JCI27183; Jobling ME, 2006, RADIAT RES, V166, P839, DOI 10.1667/RR0695.1; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Katsouyanni K, 2001, EPIDEMIOLOGY, V12, P521, DOI 10.1097/00001648-200109000-00011; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Lee K, 2012, MOL BIOL CELL, V23, P4097, DOI 10.1091/mbc.E12-02-0166; Leight JL, 2012, MOL BIOL CELL, V23, P781, DOI 10.1091/mbc.E11-06-0537; Li J, 2008, MOL CELL BIOCHEM, V309, P41, DOI 10.1007/s11010-007-9641-0; Li WD, 2011, INT J ENV RES PUB HE, V8, P161, DOI 10.3390/ijerph8010161; Maher TM, 2007, EUR RESPIR J, V30, P835, DOI 10.1183/09031936.00069307; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Marinkovic A, 2013, AM J RESP CELL MOL, V48, P422, DOI 10.1165/rcmb.2012-0335OC; Markowski MC, 2012, J BIOMED MATER RES A, V100A, P2119, DOI 10.1002/jbm.a.34068; Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047; Meltzer EB, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-8; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Ostro B, 2006, ENVIRON HEALTH PERSP, V114, P29, DOI 10.1289/ehp.8335; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1998, BIOL BULL, V194, P348, DOI 10.2307/1543109; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Selman Moises, 2006, Proc Am Thorac Soc, V3, P364, DOI 10.1513/pats.200601-003TK; Sheppard D, 2003, PHYSIOL REV, V83, P673, DOI 10.1152/physrev.00033.2002; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; Taipale J, 1998, ADV CANCER RES, V75, P87, DOI 10.1016/S0065-230X(08)60740-X; Thevenot PT, 2013, AM J RESP CELL MOL, V48, P188, DOI 10.1165/rcmb.2012-0052OC; Tse J.R., 2010, CURR PROTOC CELL BIO, V10, pUnit, DOI [DOI 10.1002/0471143030.CB1016S47, 10.1002/0471143030.cb1016s47]; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Wu Z, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-1; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xu Guo-ping, 2007, Zhonghua Yi Xue Za Zhi, V87, P1918; Yidirim Z, 2005, PULM PHARMACOL THER, V18, P367, DOI 10.1016/j.pupt.2005.02.001; Yu Q, 2000, GENE DEV, V14, P163; Yue JB, 2001, PHARMACOL THERAPEUT, V91, P1, DOI 10.1016/S0163-7258(01)00143-7; Zanobetti A, 2000, ENVIRON HEALTH PERSP, V108, P1071, DOI 10.2307/3434961; Zhou GF, 2009, AM J PHYSIOL-LUNG C, V297, pL1120, DOI 10.1152/ajplung.00007.2009; Zou W, 2012, AM J PHYSL LUNG CELL	78	34	34	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e106821	10.1371/journal.pone.0106821	http://dx.doi.org/10.1371/journal.pone.0106821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226160	gold, Green Published, Green Submitted			2022-12-25	WOS:000344317700019
J	Moller, AP; Samia, DSM; Weston, MA; Guay, PJ; Blumstein, DT				Moller, Anders Pape; Samia, Diogo S. M.; Weston, Mike A.; Guay, Patrick-Jean; Blumstein, Daniel T.			American Exceptionalism: Population Trends and Flight Initiation Distances in Birds from Three Continents	PLOS ONE			English	Article							HISTORY TRAITS; FARMLAND BIRDS; LIFE-HISTORY; SAMPLE-SIZE; DISTURBANCE; PREDICT; PATTERNS; DECLINES	Background: All organisms may be affected by humans' increasing impact on Earth, but there are many potential drivers of population trends and the relative importance of each remains largely unknown. The causes of spatial patterns in population trends and their relationship with animal responses to human proximity are even less known. Methodology/Principal Finding: We investigated the relationship between population trends of 193 species of bird in North America, Australia and Europe and flight initiation distance (FID); the distance at which birds take flight when approached by a human. While there is an expected negative relationship between population trend and FID in Australia and Europe, we found the inverse relationship for North American birds; thus FID cannot be used as a universal predictor of vulnerability of birds. However, the analysis of the joint explanatory ability of multiple drivers (farmland breeding habitat, pole-most breeding latitude, migratory habit, FID) effects on population status replicated previously reported strong effects of farmland breeding habitat (an effect apparently driven mostly by European birds), as well as strong effects of FID, body size, migratory habit and continent. Farmland birds are generally declining. Conclusions/Significance: Flight initiation distance is related to population trends in a way that differs among continents opening new research possibilities concerning the causes of geographic differences in patterns of anti-predator behavior.	[Moller, Anders Pape] Univ Paris 11, Ctr Natl Rech Sci, Unite Mixte Rech 8079, Lab Ecol Systemat & Evolut, Orsay, France; [Samia, Diogo S. M.] Univ Fed Goias, Lab Theoret Ecol & Synth, Goiania, Go, Brazil; [Weston, Mike A.] Deakin Univ, Fac Sci Engn & Built Environm, Sch Life & Environm Sci, Ctr Integrat Ecol, Melbourne, Vic, Australia; [Guay, Patrick-Jean] Victoria Univ, Coll Engn & Sci, Melbourne, Vic 8001, Australia; [Guay, Patrick-Jean] Victoria Univ, Inst Sustainabil & Innovat, Melbourne, Vic 8001, Australia; [Blumstein, Daniel T.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Universidade Federal de Goias; Deakin University; Victoria University; Victoria University; University of California System; University of California Los Angeles	Moller, AP (corresponding author), Univ Paris 11, Ctr Natl Rech Sci, Unite Mixte Rech 8079, Lab Ecol Systemat & Evolut, Orsay, France.	anders.moller@u-psud.fr	Moller, Anders/O-6665-2016	Moller, Anders/0000-0003-3739-4675; Blumstein, Daniel/0000-0001-5793-9244; Weston, Michael/0000-0002-8717-0410	CAPES; NSF	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NSF(National Science Foundation (NSF))	Thanks to Andrew Silcocks at BirdLife Australia and Geoff Barrett at the Western Australian Department of Environment and Conservation for useful discussions regarding the Australian Atlas data and change analysis. D. S. M. S. is grateful for support from CAPES. Daniel T. Blumstein is currently supported by the NSF.	BAILLIE SR, 1992, IBIS, V134, P120; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Barrett G.W., 2003, NEW ATLAS AUSTR BIRD; Bennett P. M., 2002, OX ECOL EV; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Chamberlain DE, 2000, J APPL ECOL, V37, P771, DOI 10.1046/j.1365-2664.2000.00548.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cramp S, 1977, BIRDS W PALEARCTIC; Cuervo JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077654; Diaz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064634; Dunn AM, 2008, EMU, V108, P42, DOI 10.1071/MU07034; Ehrlich PR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2845; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fuller RJ, 1995, CONSERV BIOL, V9, P1425, DOI 10.1046/j.1523-1739.1995.09061425.x; Garamszegi LZ, 2010, BIOL REV, V85, P797, DOI 10.1111/j.1469-185X.2010.00126.x; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Guay PJ, 2013, WILDLIFE RES, V40, P289, DOI 10.1071/WR13013; Guay PJ, 2013, AUSTRAL ECOL, V38, P516, DOI 10.1111/j.1442-9993.2012.02441.x; Higgins P.J., 1996, HDB AUSTR NZ ANTARCT; HJORT C, 1978, OIKOS, V30, P387, DOI 10.2307/3543487; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jiguet F, 2007, GLOBAL CHANGE BIOL, V13, P1672, DOI 10.1111/j.1365-2486.2007.01386.x; Jr Cooper WE, 2015, ESCAPING PREDATORS I; Julliard R, 2004, GLOBAL CHANGE BIOL, V10, P148, DOI 10.1111/j.1365-2486.2003.00723.x; Moller AP, 2008, BEHAV ECOL, V19, P1095, DOI 10.1093/beheco/arn103; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pizzey G., 2012, FIELD GUIDE BIRDS AU, V9th edition; Pocock MJO, 2011, P ROY SOC B-BIOL SCI, V278, P1532, DOI 10.1098/rspb.2010.1971; POOLE A, 1993, BIRDS N AM; Reif J, 2013, ACTA ORNITHOL, V48, P1, DOI 10.3161/000164513X669955; Reif J, 2011, BIOL CONSERV, V144, P2524, DOI 10.1016/j.biocon.2011.07.009; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Sarkar D., 2011, LINEAR NONLINEAR MIX; Shultz S, 2005, P ROY SOC B-BIOL SCI, V272, P2305, DOI 10.1098/rspb.2005.3250; Simpson K, 1996, PRINCETON FIELD GUID; Small A., 1974, BIRDS CALIFORNIA; Thaxter CB, 2010, BIOL CONSERV, V143, P2006, DOI 10.1016/j.biocon.2010.05.004; Weston MA, 2012, EMU, V112, P269, DOI 10.1071/MU12026; Weston MA, 2005, BIRD CONSERV INT, V15, P193; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8; Garamszegi LZ, 2011, SYST BIOL, V60, P876, DOI 10.1093/sysbio/syr060	46	31	32	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107883	10.1371/journal.pone.0107883	http://dx.doi.org/10.1371/journal.pone.0107883			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226165	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000344317700091
J	Otupiri, E; Wobil, P; Nguah, SB; Hindin, MJ				Otupiri, Easmon; Wobil, Priscilla; Nguah, Samuel Blay; Hindin, Michelle J.			Anthropometric Measurements: Options for Identifying Low Birth Weight Newborns in Kumasi, Ghana	PLOS ONE			English	Article							CHEST CIRCUMFERENCE; NEONATAL DEATHS; CHILD-MORTALITY; NATIONAL CAUSES; FOOT LENGTH; COMMUNITY; COUNTRIES; SURVIVAL; BABIES; CARE	Background: In Ghana, 32% of deliveries take place outside a health facility, and birth weight is not measured. Low birth weight (LBW) newborns who are at increased risk of death and disability, are not identified; 13%-14% of newborns in Ghana are LBW. We aimed at determining whether alternative anthropometrics could be used to identify LBW newborns when weighing scales are not available to measure birth weight. Methods: We studied 973 mother and newborn pairs at the Komfo Anokye Teaching and the Suntreso Government hospitals between November 2011 and October 2012. We used standard techniques to record anthropometric measurements of newborns within 24 hours of birth; low birth weight was defined as birth weight <2.5kg. Pearson's correlation coefficient and the area under the curve were used to determine the best predictors of low birth weight. The sensitivity, specificity and predictive values were reported with 95% confidence intervals at generated cut-off values. Results: One-fifth (21.7%) of newborns weighed less than 2.5 kg. Among LBW newborns, the following measurements had the highest correlations with birth weight: chest circumference (r = 0.69), mid-upper arm circumference (r = 0.68) and calf circumference (r = 0.66); the areas under the curves of these three measurements demonstrated the highest accuracy in determining LBW newborns. Chest, mid-upper arm and calf circumferences at cut-off values of <= 29.8 cm, <= 9.4 cm and <= 9.5 cm respectively, had the best combination of maximum sensitivity, specificity and predictive values for identifying newborns with LBW. Conclusions: Anthropometric measurements, such as the chest circumference, mid-upper arm circumference and calf circumference, offer an opportunity for the identification of and subsequent support for LBW newborns in settings in Ghana, where birth weights are not measured by standardized weighing scales.	[Otupiri, Easmon] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Wobil, Priscilla; Nguah, Samuel Blay] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Hindin, Michelle J.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Otupiri, E (corresponding author), Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana.	easmono@yahoo.com	Nguah, Samuel/AAQ-9725-2020	Hindin, Michelle/0000-0001-9941-7639	Kwame Nkrumah University of Science and Technology	Kwame Nkrumah University of Science and Technology	The Kwame Nkrumah University of Science and Technology sources for funding graduate studies supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, Bull World Health Organ, V71, P157; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Darmstadt GL, 2007, J PERINATOL, V27, P602, DOI 10.1038/sj.jp.7211797; Das Jagadish C, 2005, Bangladesh Med Res Counc Bull, V31, P1; Das S, 2011, J TROPICAL PEDIAT, P1; Dhar B, 2002, J HEALTH POPUL NUTR, V20, P36; Elshibly EM, 2008, AM J PERINAT, V25, P135, DOI 10.1055/s-2008-1040342; Ezeaka V C, 2003, Niger Postgrad Med J, V10, P168; Ghosh M, 2011, J TROP PEDIATRICS, V57, P464, DOI 10.1093/tropej/fmr004; Goto E, 2011, J EPIDEMIOL, V21, P354, DOI 10.2188/jea.JE20100182; Goto E, 2011, INDIAN J PEDIATR, V78, P311, DOI 10.1007/s12098-010-0288-6; Graft-Johnson J, 2006, CONTINUUM CARE MATER; GSS, 2012, 2011 GHAN MULT IND C; GSS/GHS/ICF-MACRO, 2009, 2008 GHAN DEM HLTH S; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; ICF Macro, 2008, MILL DEV GOALS NEW L; Lawn JE, 2009, BJOG-INT J OBSTET GY, V116, P49, DOI 10.1111/j.1471-0528.2009.02328.x; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Marchant T, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-624; Mullany LC, 2007, EUR J CLIN NUTR, V61, P40, DOI 10.1038/sj.ejcn.1602504; Nguah SB, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-99; Nur M., 2001, PAEDIATR INDONES, V41, P288; Olusanya BO, 2010, J CHILD HEALTH CARE, V14, P386, DOI 10.1177/1367493510380080; POJDA J., 2000, 18 INT CTR DIARRH DI; Rustagi N, 2012, ASIA-PAC J PUBLIC HE, V24, P343, DOI 10.1177/1010539510384717; Sajjadian N, 2011, HEALTH, V3, P752; Sreeramareddy CT, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-16; Taksande A, 2007, J TROP PEDIATRICS, V53, P420, DOI 10.1093/tropej/fmm052; Wall SN, 2010, SEMIN PERINATOL, V34, P395, DOI 10.1053/j.semperi.2010.09.009; World Health Organization, 2012, WORLD HLTH STAT	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e106712	10.1371/journal.pone.0106712	http://dx.doi.org/10.1371/journal.pone.0106712			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226505	gold, Green Published, Green Submitted			2022-12-25	WOS:000344317700014
J	Reis-Cunha, JL; Mendes, TAD; Lourdes, RD; Ribeiro, DRD; Machado-de-Avila, RA; Tavares, MD; Lemos, DS; Camara, ACJ; Olortegui, CC; de Lana, M; Galvao, LMD; Fujiwara, RT; Bartholomeu, DC				Reis-Cunha, Joao Luis; de Oliveira Mendes, Tiago Antonio; Lourdes, Rodrigo de Almeida; dos Santos Ribeiro, Daihana Rodrigues; Machado-de-Avila, Ricardo Andrez; Tavares, Maykon de Oliveira; Lemos, Denise Silveira; Jacome Camara, Antonia Claudia; Olortegui, Carlos Chavez; de Lana, Marta; da Cunha Galvao, Lucia Maria; Fujiwara, Ricardo Toshio; Bartholomeu, Daniella Castanheira			Genome-Wide Screening and Identification of New Trypanosoma cruzi Antigens with Potential Application for Chronic Chagas Disease Diagnosis	PLOS ONE			English	Article							CROSS-REACTIVITY; LATIN-AMERICA; EPIDEMIOLOGY; RECOMBINANT; INFECTION; LINEAGES; SEQUENCE; SERODIAGNOSIS; RANGELI; TESTS	The protozoan Trypanosoma cruzi is the etiologic agent of Chagas disease, an infection that afflicts approximately 8 million people in Latin America. Diagnosis of chronic Chagas disease is currently based on serological tests because this condition is usually characterized by high anti-T. cruzi IgG titers and low parasitemia. The antigens used in these assays may have low specificity due to cross reactivity with antigens from related parasite infections, such as leishmaniasis, and low sensitivity caused by the high polymorphism among T. cruzi strains. Therefore, the identification of new T. cruzi-specific antigens that are conserved among the various parasite discrete typing units (DTUs) is still required. In the present study, we have explored the hybrid nature of the T. cruzi CL Brener strain using a broad genome screening approach to select new T. cruzi antigens that are conserved among the different parasite DTUs and that are absent in other trypanosomatid species. Peptide arrays containing the conserved antigens with the highest epitope prediction scores were synthesized, and the reactivity of the peptides were tested by immunoblot using sera from C57BL/6 mice chronically infected with T. cruzi strains from the TcI, TcII or TcVI DTU. The two T. cruzi proteins that contained the most promising peptides were expressed as recombinant proteins and tested in ELISA experiments with sera from chagasic patients with distinct clinical manifestations: those infected with T. cruzi from different DTUs and those with cutaneous or visceral leishmaniasis. These proteins, named rTc_11623.20 and rTc_N_10421.310, exhibited 94.83 and 89.66% sensitivity, 98.2 and 94.6% specificity, respectively, and a pool of these 2 proteins exhibited 96.55% sensitivity and 98.18% specificity. This work led to the identification of two new antigens with great potential application in the diagnosis of chronic Chagas disease.	[Reis-Cunha, Joao Luis; de Oliveira Mendes, Tiago Antonio; Lourdes, Rodrigo de Almeida; dos Santos Ribeiro, Daihana Rodrigues; Lemos, Denise Silveira; Fujiwara, Ricardo Toshio; Bartholomeu, Daniella Castanheira] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Machado-de-Avila, Ricardo Andrez; Olortegui, Carlos Chavez; de Lana, Marta] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Tavares, Maykon de Oliveira] Univ Fed Ouro Preto, Escola Farm, Dept Anal Clin, Ouro Preto, Brazil; [Jacome Camara, Antonia Claudia; da Cunha Galvao, Lucia Maria] Univ Fed Rio Grande do Norte, Programa Posgrad Ciencias Saude, BR-59072970 Natal, RN, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Ouro Preto; Universidade Federal do Rio Grande do Norte	Bartholomeu, DC (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.	daniella@icb.ufmg.br	da Cunha Galvão, Lúcia Maria/A-1512-2014; Tavares, Maykon/Q-4801-2019; Fujiwara, Ricardo Toshio/J-7579-2012; de Ávila, Ricardo Andrez Machado/J-8224-2015; Bartholomeu, Daniella C./J-4714-2015; Reis-Cunha, João/AAX-6470-2020; Mendes, Tiago/AAG-1709-2021; Chavez Olortegui, Carlos Delfin/F-9227-2019	Fujiwara, Ricardo Toshio/0000-0002-4713-575X; de Ávila, Ricardo Andrez Machado/0000-0002-1303-0490; Bartholomeu, Daniella C./0000-0003-0974-7357; Reis-Cunha, João/0000-0003-1034-0992; Mendes, Tiago/0000-0002-5569-4893; Camara, Antonia Claudia/0000-0001-7337-9320; Tavares de Oliveira, Maykon/0000-0002-7652-3225; Galvao, Lucia/0000-0002-6207-4502; Lana, Marta/0000-0002-1565-4707; Chavez Olortegui, Carlos Delfin/0000-0001-9390-7207; Silveira Lemos, Denise/0000-0003-0955-458X	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CNPq; CAPES	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). CCO, ML, RTF and DCB are CNPq research fellows. JLRC and DRSR received scholarships from CNPq and TAOM, RAL and DSL received scholarships from CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barona-Vilar C, 2012, EPIDEMIOL INFECT, V140, P1896, DOI 10.1017/S0950268811002482; Benjamin RJ, 2012, TRANSFUSION, V52, P1913, DOI 10.1111/j.1537-2995.2011.03554.x; Bern C, 2008, REV SOC BRAS MED TRO, V41, P315; Bern C, 2011, CLIN MICROBIOL REV, V24, P655, DOI 10.1128/CMR.00005-11; Bogliolo AR, 1996, ACTA TROP, V61, P31, DOI 10.1016/0001-706X(95)00138-5; Brasil PEAA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-337; Brisse S, 2000, MOL BIOCHEM PARASIT, V111, P95, DOI 10.1016/S0166-6851(00)00302-9; Burgos JM, 2007, INT J PARASITOL, V37, P1319, DOI 10.1016/j.ijpara.2007.04.015; Caballero ZC, 2007, CLIN VACCINE IMMUNOL, V14, P1045, DOI 10.1128/CVI.00127-07; Camara ACJ, 2010, ACTA TROP, V115, P205, DOI 10.1016/j.actatropica.2010.03.003; CAMARGO MARIO E., 1966, REV INST MED TROP SAO PAULO, V8, P227; Cerqueira GC, 2008, MOL BIOCHEM PARASIT, V157, P65, DOI 10.1016/j.molbiopara.2007.10.002; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Coura JR, 2012, REV SOC BRAS MED TRO, V45, P286, DOI 10.1590/S0037-86822012000300002; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P31, DOI 10.1590/S0074-02762009000900006; da Silveira JF, 2001, TRENDS PARASITOL, V17, P286, DOI 10.1016/S1471-4922(01)01897-9; de Freitas JM, 2006, PLOS PATHOG, V2, P226, DOI 10.1371/journal.ppat.0020024; De Marchi CR, 2011, CLIN VACCINE IMMUNOL, V18, P1850, DOI 10.1128/CVI.05289-11; de Moraes MH, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-20; Mendes TAD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002524; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; Dutra WO, 2005, TRENDS PARASITOL, V21, P581, DOI 10.1016/j.pt.2005.09.007; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Ferrer E, 2013, ENFERM INFEC MICR CL, V31, P277, DOI 10.1016/j.eimc.2012.09.007; Franzen O, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-531; Franzen O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000984; Gomes YM, 2009, MEM I OSWALDO CRUZ, V104, P115, DOI 10.1590/S0074-02762009000900017; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300; Junqueira C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001560; Kessler DA, 2013, TRANSFUSION, V53, P1083, DOI 10.1111/j.1537-2995.2012.03856.x; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Marchini FK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025381; Martins-Melo FR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001508; Miles MA, 2009, PARASITOLOGY, V136, P1509, DOI 10.1017/S0031182009990977; Morales L, 2002, EXP PARASITOL, V102, P72, DOI 10.1016/S0014-4894(03)00027-4; PERALTA JM, 1994, J CLIN MICROBIOL, V32, P971, DOI 10.1128/JCM.32.4.971-974.1994; Perez-Molina JA, 2012, CURR INFECT DIS REP, V14, P263, DOI 10.1007/s11908-012-0259-3; Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2; Saez-Alquezar A, 2000, J CLIN MICROBIOL, V38, P851; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Souto RP, 1996, MOL BIOCHEM PARASIT, V83, P141, DOI 10.1016/S0166-6851(96)02755-7; Teixeira ARL, 2006, MEM I OSWALDO CRUZ, V101, P463, DOI 10.1590/S0074-02762006000500001; Umezawa ES, 1996, J CLIN MICROBIOL, V34, P2143, DOI 10.1128/JCM.34.9.2143-2147.1996; Vargas N, 2004, MOL BIOCHEM PARASIT, V138, P131, DOI 10.1016/j.molbiopara.2004.08.005; Vega Benedetti AF, 2013, TROP MED INT HLTH; Verani JR, 2009, AM J TROP MED HYG, V80, P410; Vexenat Ana De Cassia, 1996, Revista do Instituto de Medicina Tropical de Sao Paulo, V38, P177, DOI 10.1590/S0036-46651996000300003; Westenberger SJ, 2005, GENETICS, V171, P527, DOI 10.1534/genetics.104.038745; WHO, 2014, CHAG DIS AM TRYP NEG; World Health Organization, 2012, WHO TECHNICAL REPORT, V975; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	52	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e106304	10.1371/journal.pone.0106304	http://dx.doi.org/10.1371/journal.pone.0106304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225853	gold, Green Submitted, Green Published			2022-12-25	WOS:000344317700009
J	Scarponi, C; Butturini, E; Sestito, R; Madonna, S; Cavani, A; Mariotto, S; Albanesi, C				Scarponi, Claudia; Butturini, Elena; Sestito, Rosanna; Madonna, Stefania; Cavani, Andrea; Mariotto, Sofia; Albanesi, Cristina			Inhibition of Inflammatory and Proliferative Responses of Human Keratinocytes Exposed to the Sesquiterpene Lactones Dehydrocostuslactone and Costunolide	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NF-KAPPA-B; S-GLUTATHIONYLATION; CANCER CELLS; EPIDERMAL-KERATINOCYTES; OXIDATIVE STRESS; TRANSCRIPTION 3; SKIN DISEASES; PSORIASIS; APOPTOSIS	The imbalance of the intracellular redox state and, in particular, of the glutathione (GSH)/GSH disulfide couple homeostasis, is involved in the pathogenesis of a number of diseases. In many skin diseases, including psoriasis, oxidative stress plays an important role, as demonstrated by the observation that treatments leading to increase of the local levels of oxidant species ameliorate the disease. Recently, dehydrocostuslactone (DCE) and costunolide (CS), two terpenes naturally occurring in many plants, have been found to exert various anti-inflammatory and pro-apoptotic effects on different human cell types. These compounds decrease the level of the intracellular GSH by direct interaction with it, and, therefore, can alter cellular redox state. DCE and CS can trigger S-glutathionylation of various substrates, including the transcription factor STAT3 and JAK1/2 proteins. In the present study, we investigated on the potential role of DCE and CS in regulating inflammatory and proliferative responses of human keratinocytes to cytokines. We demonstrated that DCE and CS decreased intracellular GSH levels in human keratinocytes, as well as inhibited STAT3 and STAT1 phosphorylation and activation triggered by IL-22 or IFN-gamma, respectively. Consequently, DCE and CS decreased the IL-22- and IFN-gamma-induced expression of inflammatory and regulatory genes in keratinocytes, including CCL2, CXCL10, ICAM-1 and SOCS3. DCE and CS also inhibited proliferation and cell-cycle progression-related gene expression, as well as they promoted cell cycle arrest and apoptosis. In parallel, DCE and CS activated the anti-inflammatory EGFR and ERK1/2 molecules in keratinocytes, and, thus, wound healing in an in vitro injury model. In light of our findings, we can hypothesize that the employment of DCE and CS in psoriasis could efficiently counteract the pro-inflammatory effects of IFN-gamma and IL-22 on keratinocytes, revert the apoptosis-resistant phenotype, as well as inhibit hyperproliferation in the psoriatic epidermis.	[Scarponi, Claudia; Sestito, Rosanna; Madonna, Stefania; Cavani, Andrea; Albanesi, Cristina] IDI IRCCS, Expt Immunol Lab, Rome, Italy; [Butturini, Elena; Mariotto, Sofia] Univ Verona, Dept Life & Reprod Sci, I-37100 Verona, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); University of Verona	Albanesi, C (corresponding author), IDI IRCCS, Expt Immunol Lab, Rome, Italy.	c.albanesi@idi.it	Sestito, Rosanna/K-2361-2018; Albanesi, Cristina/K-4699-2016; mariotto, sofia/AAH-5473-2019; Madonna, stefania/AAC-3381-2022	Sestito, Rosanna/0000-0001-5460-2777; Albanesi, Cristina/0000-0002-7537-6833; Butturini, Elena/0000-0001-6612-8945	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	The study was financially supported by the Italian Ministry of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi C, 2010, CURR DRUG METAB, V11, P210, DOI 10.2174/138920010791196328; Albanesi C, 2001, J LEUKOCYTE BIOL, V70, P617; Albanesi C, 2007, CLIN DERMATOL, V25, P581, DOI 10.1016/j.clindermatol.2007.08.013; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Butturini E, 2014, EUR J PHARMACOL, V730, P107, DOI 10.1016/j.ejphar.2014.02.031; Butturini E, 2013, FREE RADICAL BIO MED, V65, P1322, DOI 10.1016/j.freeradbiomed.2013.09.015; Butturini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020174; Choi JH, 2002, JPN J CANCER RES, V93, P1327, DOI 10.1111/j.1349-7006.2002.tb01241.x; Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; Elango T, 2013, CLIN EXP MED; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Fitsialos G, 2007, J BIOL CHEM, V282, P15090, DOI 10.1074/jbc.M606094200; Grundmann-Kollmann M, 2004, J AM ACAD DERMATOL, V50, P734, DOI 10.1016/S0190-9622(03)00792-8; Hancock JT, 2009, MOL BIOTECHNOL, V43, P162, DOI 10.1007/s12033-009-9189-1; Hsu YL, 2009, J PHARMACOL EXP THER, V329, P808, DOI 10.1124/jpet.108.148395; Hung JY, 2010, LUNG CANCER, V68, P355, DOI 10.1016/j.lungcan.2009.07.017; Jin MR, 2000, ARCH PHARM RES, V23, P54, DOI 10.1007/BF02976467; Kirkham BW, 2014, IMMUNOLOGY, V141, P133, DOI 10.1111/imm.12142; Klotz LO, 2001, CURR PROBL DERMATOL, V29, P95; Kuo PL, 2009, MOL CANCER THER, V8, P1328, DOI 10.1158/1535-7163.MCT-08-0914; Kurdi M, 2012, INT J BIOCHEM CELL B, V44, P2106, DOI 10.1016/j.biocel.2012.08.016; Lew W, 2004, TRENDS IMMUNOL, V25, P295, DOI 10.1016/j.it.2004.03.006; Liu CY, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-56; Liu YC, 2008, VASC PHARMACOL, V48, P54, DOI 10.1016/j.vph.2007.11.006; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Madonna S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.69; Madonna S, 2008, FASEB J, V22, P3287, DOI 10.1096/fj.08-106831; McGill A, 2005, FASEB J, V19, P1012, DOI 10.1096/fj.04-2664fje; Mrowietz U, 2005, TRENDS MOL MED, V11, P43, DOI 10.1016/j.molmed.2004.11.003; Oh GS, 2004, IMMUNOPHARM IMMUNOT, V26, P163, DOI 10.1081/IPH-120037712; Pastore S, 2005, J IMMUNOL, V174, P5047, DOI 10.4049/jimmunol.174.8.5047; Pastore S, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/861949; Peus D, 2004, EXP DERMATOL, V13, P78, DOI 10.1111/j.0906-6705.2004.00119.x; Sestito R, 2011, FASEB J, V25, P916, DOI 10.1096/fj.10-172288; Shah AA, 2013, EUR J DERMATOL, V23, P5, DOI 10.1684/ejd.2012.1884; Tohyama M, 2009, EUR J IMMUNOL, V39, P2779, DOI 10.1002/eji.200939473; Torres L, 2009, FREE RADICAL BIO MED, V46, P1534, DOI 10.1016/j.freeradbiomed.2009.03.005; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Zeigler ME, 1999, J CELL PHYSIOL, V180, P271	39	37	42	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107904	10.1371/journal.pone.0107904	http://dx.doi.org/10.1371/journal.pone.0107904			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226283	Green Submitted, Green Published, gold			2022-12-25	WOS:000344317700092
J	Chang, CL; Cai, JJ; Huang, SY; Cheng, PJ; Chueh, HY; Hsu, SYT				Chang, Chia Lin; Cai, James J.; Huang, Shang Yu; Cheng, Po Jen; Chueh, Ho Yen; Hsu, Sheau Yu Teddy			Adaptive Human CDKAL1 Variants Underlie Hormonal Response Variations at the Enteroinsular Axis	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; GENOME-WIDE ASSOCIATION; BETA-CELL FUNCTION; POSITIVE SELECTION; TYPE-2; POPULATION; RISK; GENE; POLYMORPHISMS; EVOLUTION	Recent analyses have identified positively selected loci that explain differences in immune responses, body forms, and adaptations to extreme climates, but variants that describe adaptations in energy-balance regulation remain underexplored. To identify variants that confer adaptations in energy-balance regulation, we explored the evolutionary history and functional associations of candidate variants in 207 genes. We screened single nucleotide polymorphisms in genes that had been associated with energy-balance regulation for unusual genetic patterns in human populations, followed by studying associations among selected variants and serum levels of GIP, insulin, and C-peptide in pregnant women after an oral glucose tolerance test. Our analysis indicated that 5' variants in CDKAL1, CYB5R4, GAD2, and PPARG are marked with statistically significant signals of gene-environment interactions. Importantly, studies of serum hormone levels showed that variants in CDKAL1 are associated with glucose-induced GIP and insulin responses (p<0.05). On the other hand, a GAD2 variant exhibited a significant association with glucose-induced C-peptide response. In addition, simulation analysis indicated that a type 2 diabetes risk variant in CDKAL1 (rs7754840) was selected in East Asians similar to 6,900 years ago. Taken together, these data indicated that variants in CDKAL1 and GAD2 were targets of prior environmental selection. Because the selection of the CDKAL1 variant overlapped with the selection of a cluster of GIP variants in the same population similar to 11,800 to 2,000 years ago, we speculate that these regulatory genes at the human enteroinsular axis could be highly responsive to environmental selection in recent human history.	[Chang, Chia Lin; Huang, Shang Yu; Cheng, Po Jen; Chueh, Ho Yen] Chang Gung Univ, Chang Gung Mem Hosp Linkou, Med Ctr, Dept Obstet & Gynecol, Taoyuan, Taiwan; [Cai, James J.] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA; [Hsu, Sheau Yu Teddy] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Reprod Biol & Stem Cell Res Program, Stanford, CA USA	Chang Gung Memorial Hospital; Chang Gung University; Texas A&M University System; Texas A&M University College Station; Stanford University	Chang, CL (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp Linkou, Med Ctr, Dept Obstet & Gynecol, Taoyuan, Taiwan.	amego@cgmh.org.tw	Cai, James/C-4928-2008	Cai, James/0000-0002-8081-6725	National Science Council (NSC) [102-2314-B-182A-086]; Chang Gung Memorial Hospital [CMRPG391151-3]; National Institute of Health [DK70652]; Avon Foundation [02-2009-054]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070652] Funding Source: NIH RePORTER	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Avon Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from National Science Council (NSC 102-2314-B-182A-086, CLC); Chang Gung Memorial Hospital (CMRPG391151-3, CLC); National Institute of Health (DK70652, SYTH); and Avon Foundation (02-2009-054, SYTH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amigo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-428; Bannai M, 1998, BRAIN RES, V784, P305, DOI 10.1016/S0006-8993(97)01349-8; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boesgaard TW, 2007, DIABETIC MED, V24, P702, DOI 10.1111/j.1464-5491.2007.02110.x; Bonaventura MM, 2012, EUR J PHARMACOL, V677, P188, DOI 10.1016/j.ejphar.2011.12.013; Boutin P, 2003, PLOS BIOL, V1, P361, DOI 10.1371/journal.pbio.0000068; Braun M, 2010, DIABETES, V59, P1694, DOI 10.2337/db09-0797; Cai JJ, 2008, J HERED, V99, P438, DOI 10.1093/jhered/esm127; Chang CL, 2011, DIABETES, V60, P726, DOI 10.2337/db10-1331; Chang CL, 2011, GENOME RES, V21, P21, DOI 10.1101/gr.110593.110; Chen KC, 2012, ANN SAUDI MED, V32, P121, DOI 10.5144/0256-4947.2012.121; Chen R, 2012, PLOS GENET, V8, P100, DOI 10.1371/journal.pgen.1002621; Chistiakov DA, 2011, ACTA DIABETOL, V48, P227, DOI 10.1007/s00592-011-0299-4; Cho YM, 2009, DIABETOLOGIA, V52, P253, DOI 10.1007/s00125-008-1196-4; Crisci JL, 2011, GENOME BIOL EVOL, V3, P791, DOI 10.1093/gbe/evr075; Dehwah MAS, 2010, GENET MOL RES, V9, P1109, DOI 10.4238/vol9-2gmr802; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gjesing AP, 2012, DIABETOLOGIA, V55, P1338, DOI 10.1007/s00125-012-2484-6; Goossens GH, 2009, INT J OBESITY, V33, P669, DOI 10.1038/ijo.2009.59; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hancock AM, 2010, P NATL ACAD SCI USA, V107, P8924, DOI 10.1073/pnas.0914625107; Hansen L, 2006, J CLIN ENDOCR METAB, V91, P3446, DOI 10.1210/jc.2006-0590; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; KIMURA M, 1973, GENETICS, V75, P199; Kirchhoff K, 2008, DIABETOLOGIA, V51, P597, DOI 10.1007/s00125-008-0926-y; Kjos SL, 1999, NEW ENGL J MED, V341, P1749, DOI 10.1056/NEJM199912023412307; Kwak SH, 2012, DIABETES, V61, P531, DOI 10.2337/db11-1034; Lauenborg J, 2009, J CLIN ENDOCR METAB, V94, P145, DOI 10.1210/jc.2008-1336; Leslie M, 2010, SCIENCE, V329, P263, DOI 10.1126/science.329.5989.263; Luca F, 2010, ANNU REV NUTR, V30, P291, DOI 10.1146/annurev-nutr-080508-141048; McIntosh CHS, 2009, VITAM HORM, V80, P409, DOI 10.1016/S0083-6729(08)00615-8; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Miyaki K, 2010, AM J EPIDEMIOL, V172, P985, DOI 10.1093/aje/kwq281; Moffett RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078560; Nei M, 2010, ANNU REV GENOM HUM G, V11, P265, DOI 10.1146/annurev-genom-082908-150129; Ohara-Imaizumi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015553; Pascoe L, 2007, DIABETES, V56, P3101, DOI 10.2337/db07-0634; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Reich DE, 1998, ESTIMATING AGE MUTAT, P129; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Ruff JS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3245; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Simonson TS, 2010, SCIENCE         0513; Stancakova A, 2008, J CLIN ENDOCR METAB, V93, P1924, DOI 10.1210/jc.2007-2218; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Taneera J, 2012, DIABETOLOGIA, V55, P1985, DOI 10.1007/s00125-012-2548-7; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026953; Wei FY, 2011, ENDOCR J, V58, P819, DOI 10.1507/endocrj.EJ11-0099; Wei FY, 2011, J CLIN INVEST, V121, P3598, DOI 10.1172/JCI58056; Witchel SF, 2009, FERTIL STERIL, V91, P1869, DOI 10.1016/j.fertnstert.2008.01.085; Xie JX, 2004, P NATL ACAD SCI USA, V101, P10750, DOI 10.1073/pnas.0404044101; Xie P, 2013, CLIN CHEM, V59, P1604, DOI 10.1373/clinchem.2013.210401	58	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e105410	10.1371/journal.pone.0105410	http://dx.doi.org/10.1371/journal.pone.0105410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222615	Green Submitted, Green Published, gold			2022-12-25	WOS:000341774800005
J	Dokubo, EK; Shiraishi, RW; Young, PW; Neal, JJ; Aberle-Grasse, J; Honwana, N; Mbofana, F				Dokubo, E. Kainne; Shiraishi, Ray W.; Young, Peter W.; Neal, Joyce J.; Aberle-Grasse, John; Honwana, Nely; Mbofana, Francisco			Awareness of HIV Status, Prevention Knowledge and Condom Use among People Living with HIV in Mozambique	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; DISCORDANT COUPLES; TESTING SERVICES; SOUTH-AFRICA; INFECTION; CARE; UGANDA; RISK; TRANSMISSION	Objective: To determine factors associated with HIV status unawareness and assess HIV prevention knowledge and condom use among people living with HIV/AIDS (PLHIV) in Mozambique. Design: Cross-sectional household-based nationally representative AIDS Indicator Survey. Methods: Analyses focused on HIV-infected adults and were weighted for the complex sampling design. We identified PLHIV who had never been tested for HIV or received their test results prior to this survey. Logistic regression was used to assess factors associated with HIV status unawareness. Results: Of persons with positive HIV test results (N = 1182), 61% (95% confidence interval [CI] 57-65%) were unaware of their serostatus. Men had twice the odds of being unaware of their serostatus compared with women [adjusted odds ratio (aOR) 2.05, CI 1.40-2.98]. PLHIV in the poorest wealth quintile were most likely to be unaware of their serostatus (aOR 3.15, CI 1.09-9.12) compared to those in the middle wealth quintile. Most PLHIV (83%, CI 79-87%) reported not using a condom during their last sexual intercourse, and PLHIV who reported not using a condom during their last sexual intercourse were more likely to be unaware of their serostatus (aOR 2.32, CI 1.57-3.43) than those who used a condom. Conclusions: Knowledge of HIV-positive status is associated with more frequent condom use in Mozambique. However, most HIV-infected persons are unaware of their serostatus, with men and persons in the poorest wealth quintile being more likely to be unaware. These findings support calls for expanded HIV testing, especially among groups less likely to be aware of their HIV status and key populations at higher risk for infection.	[Dokubo, E. Kainne; Shiraishi, Ray W.; Neal, Joyce J.; Aberle-Grasse, John] US Ctr Dis Control & Prevent CDC, Div Global HIV AIDS, Atlanta, GA 30333 USA; [Young, Peter W.; Honwana, Nely] Ctr Dis Control & Prevent CDC, Div Global HIV AIDS, Maputo, Mozambique; [Mbofana, Francisco] Minist Hlth, Maputo, Mozambique	Centers for Disease Control & Prevention - USA	Dokubo, EK (corresponding author), US Ctr Dis Control & Prevent CDC, Div Global HIV AIDS, Atlanta, GA 30333 USA.	kdokubo@cdc.gov		Shiraishi, Ray/0000-0001-7640-0666; Dokubo, Emily Kainne/0000-0002-1499-0151	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC)	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC)	This project was conducted under a grant or cooperative award mechanism from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC). CDC employees were involved in data analysis, decision to publish, and preparation of the manuscript.	Agha S, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-20; ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; Anand A, 2009, AIDS, V23, P1565, DOI 10.1097/QAD.0b013e32832cb10c; Arthur G, 2007, SEX TRANSM INFECT, V83, P541, DOI 10.1136/sti.2007.026732; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; Bwambale FM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-263; Cherutich P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036797; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Ferrand RA, 2010, CLIN INFECT DIS, V51, P844, DOI 10.1086/656361; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Heeringa SG, 2017, APPL SURVEY DATA ANA, VSecond, DOI DOI 10.1201/9781315153278; Hull MW, 2012, CURR OPIN HIV AIDS, V7, P579, DOI 10.1097/COH.0b013e3283590617; Instituto Nacional de Saude,, 2010, INQ NAC PREV RISC CO; Kidder DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057215; Langa J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094838; Leta TH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-438; Macro International, 2007, AIDS IND SURV HIV TE; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; McNairy ML, 2012, AIDS, V26, P1735, DOI 10.1097/QAD.0b013e328355d67b; Mhlongo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062637; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; Mishra V, 2007, AIDS, V21, pS17, DOI 10.1097/01.aids.0000300532.51860.2a; Msisha WM, 2008, INT J EPIDEMIOL, V37, P1297, DOI 10.1093/ije/dyn186; Musheke M, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-220, 10.1186/1472-6963-13-97]; Office of the Global AIDS Coordinator, 2012, PEPFAR BLUEPR CREAT; Peltzer K, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-174; Rosenberg NE, 2013, JAIDS-J ACQ IMM DEF, V62, P226, DOI 10.1097/QAI.0b013e31827971ca; Rutstein SO, 2004, DHS COMP REPORTS, V6; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; UNAIDS, 2011, POL DECL HIV AIDS IN; UNAIDS, 2010, GLOB REP UNAIDS REP; Were WA, 2006, JAIDS-J ACQ IMM DEF, V43, P91, DOI 10.1097/01.qai.0000225021.81384.28; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wringe A, 2008, TROP MED INT HEALTH, V13, P319, DOI 10.1111/j.1365-3156.2008.02005.x; Younge SN, 2008, ADOLESCENCE, V43, P927	36	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e106760	10.1371/journal.pone.0106760	http://dx.doi.org/10.1371/journal.pone.0106760			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222010	Green Published, gold			2022-12-25	WOS:000341774800025
J	Ebrahim, F; Shankaranarayanan, JS; Kanwar, JR; Gurudevan, S; Krishnan, UM; Kanwar, RK				Ebrahim, Fawzi; Shankaranarayanan, Jayanth Suryanarayanan; Kanwar, Jagat R.; Gurudevan, Sneha; Krishnan, Uma Maheswari; Kanwar, Rupinder K.			Identification of Unprecedented Anticancer Properties of High Molecular Weight Biomacromolecular Complex Containing Bovine Lactoferrin (HMW-bLf)	PLOS ONE			English	Article							STIMULATE OLIGOMERIZATION; THERMAL-DENATURATION; IRON; BINDING; DNA; COLOSTRUM; CALCIUM; OLIGOSACCHARIDES; NANOCARRIERS; APOPTOSIS	With the successful clinical trials, multifunctional glycoprotein bovine lactoferrin is gaining attention as a safe nutraceutical and biologic drug targeting cancer, chronic-inflammatory, viral and microbial diseases. Interestingly, recent findings that human lactoferrin oligomerizes under simulated physiological conditions signify the possible role of oligomerization in the multifunctional activities of lactoferrin molecule during infections and in disease targeting signaling pathways. Here we report the purification and physicochemical characterization of high molecular weight biomacromolecular complex containing bovine lactoferrin (>= 250 kDa), from bovine colostrum, a naturally enriched source of lactoferrin. It showed structural similarities to native monomeric iron free (Apo) lactoferrin (similar to 78-80 kDa), retained anti-bovine lactoferrin antibody specific binding and displayed potential receptor binding properties when tested for cellular internalization. It further displayed higher thermal stability and better resistance to gut enzyme digestion than native bLf monomer. High molecular weight bovine lactoferrin was functionally bioactive and inhibited significantly the cell proliferation (p<0.01) of human breast and colon carcinoma derived cells. It induced significantly higher cancer cell death (apoptosis) and cytotoxicity in a dose-dependent manner in cancer cells than the normal intestinal cells. Upon cellular internalization, it led to the up-regulation of caspase-3 expression and degradation of actin. In order to identify the cutting edge future potential of this bio-macromolecule in medicine over the monomer, its in-depth structural and functional properties need to be investigated further.	[Ebrahim, Fawzi; Shankaranarayanan, Jayanth Suryanarayanan; Kanwar, Jagat R.; Gurudevan, Sneha; Kanwar, Rupinder K.] Deakin Univ, Fac Hlth, Sch Med, Nanomed Lab Immunol & Mol Biomed Res, Geelong, Vic 3217, Australia; [Krishnan, Uma Maheswari] SASTRA Univ, Ctr Nanotechnol & Adv Biomat CeNTAB, Sch Chem & Biotechnol, Thanjavur, India	Deakin University; Shanmugha Arts, Science, Technology & Research Academy (SASTRA)	Kanwar, RK (corresponding author), Deakin Univ, Fac Hlth, Sch Med, Nanomed Lab Immunol & Mol Biomed Res, Geelong, Vic 3217, Australia.	rupinder.kanwar@deakin.edu.au	Narayanan, Jayanth Surya Narayanan Shankara/U-8652-2019	Shankara Narayanan, Jayanth Surya Narayanan/0000-0002-8772-8680	Australia-India Strategic Research Fund (AISRF) [BF 030016]; Deakin University; Ministry of Higher Education of Libya; BTRC	Australia-India Strategic Research Fund (AISRF)(Australian GovernmentDepartment of Industry, Innovation and Science); Deakin University; Ministry of Higher Education of Libya; BTRC	The work was funded by Australia-India Strategic Research Fund (AISRF, BF 030016). The financial support for Postgraduate Fellowships from Deakin University and Ministry of Higher Education of Libya and BTRC is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni CV, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2811; Baker EN, 2005, CELL MOL LIFE SCI, V62, P2531, DOI 10.1007/s00018-005-5368-9; Baker HM, 2004, BIOMETALS, V17, P209, DOI 10.1023/B:BIOM.0000027694.40260.70; BENNETT RM, 1981, BIOCHEM BIOPH RES CO, V101, P88, DOI 10.1016/S0006-291X(81)80014-9; Brisson G, 2007, INT DAIRY J, V17, P617, DOI 10.1016/j.idairyj.2006.09.002; CASTELLI.FJ, 1970, J BIOL CHEM, V245, P4269; Conesa C, 2007, J AGR FOOD CHEM, V55, P4848, DOI 10.1021/jf063335u; DEPT. OF HEALTH E AND WELFARE PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION *ORA/ORO/DEIO/IB*, 1985, INSP TECHN GUID BACT; Duarte DC, 2011, J DAIRY SCI, V94, P66, DOI 10.3168/jds.2010-3629; FLEET JC, 1995, NUTR REV, V53, P226, DOI 10.1111/j.1753-4887.1995.tb01556.x; Fujie Y, 2005, JPN J CLIN ONCOL, V35, P453, DOI 10.1093/jjco/hyi130; Gibbons Jessica A, 2011, Front Biosci (Schol Ed), V3, P1080; GUTTERIDGE JMC, 1981, BIOCHEM J, V199, P259, DOI 10.1042/bj1990259; HARMON RJ, 1976, INFECT IMMUN, V13, P533, DOI 10.1128/IAI.13.2.533-542.1976; Iigo M, 1999, CLIN EXP METASTAS, V17, P35; Jiang R, 2011, FASEB J, V25, P340346; Kanwar JR, 2008, IMMUNOL CELL BIOL, V86, P277, DOI 10.1038/sj.icb.7100163; Kanwar JR, 2015, NANOMEDICINE-UK, V10, P35, DOI 10.2217/nnm.14.132; Kanwar JR, 2012, NANOMEDICINE-UK, V7, P1521, DOI [10.2217/NNM.12.29, 10.2217/nnm.12.29]; Kanwar JR, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-7; Kanwar RK, 2013, PROTEIN PEPTIDE LETT, V20, P450; Kanyshkova TG, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1, DOI 10.1023/A:1002817226110; KLIMES J, 1986, ACTA VET BRNO, V55, P23, DOI 10.2754/avb198655010023; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kussendrager K, 1994, EFFECTS HEAT TREATME; Loennerdal B, 2011, J PEDIATR GASTR NUTR, V53, P606, DOI 10.1097/MPG.0b013e318230a419; Mantel C, 1994, PHYS CHARACTERISTICS, P121; Nevinskii AG, 2009, J MOL RECOGNIT, V22, P330, DOI 10.1002/jmr.952; Persson BA, 2010, BIOPHYS CHEM, V151, P187, DOI 10.1016/j.bpc.2010.06.005; Roseanu A, 2010, BIOMETALS, V23, P485, DOI 10.1007/s10534-010-9312-6; RUEGG M, 1977, J DAIRY RES, V44, P509, DOI 10.1017/S002202990002046X; RULIS AM, 2001, AGENCY RESPONSE LETT; Samarasinghe RM, 2014, BIOMATERIALS, V35, P7522, DOI 10.1016/j.biomaterials.2014.04.109; SANCHEZ L, 1988, BIOL CHEM H-S, V369, P1005, DOI 10.1515/bchm3.1988.369.2.1005; SCHANBACHER F L, 1971, Federation Proceedings, V30, P532; Sitaram MP, 1997, BIOCHEM J, V323, P815, DOI 10.1042/bj3230815; Smith SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026908; Soboleva SE, 2009, MOL BIOL+, V43, P142, DOI 10.1134/S0026893309010191; Stelwagen K, 2009, J ANIM SCI, V87, P3, DOI 10.2527/jas.2008-1377; Tomita M, 2009, BIOCHIMIE, V91, P52, DOI 10.1016/j.biochi.2008.05.021; Troost FJ, 2001, J NUTR, V131, P2101, DOI 10.1093/jn/131.8.2101; Tsuda H, 2010, BIOMETALS, V23, P399, DOI 10.1007/s10534-010-9331-3; VANBERKEL PHC, 1995, BIOCHEM J, V312, P107, DOI 10.1042/bj3120107; Wang H, 1998, J DAIRY SCI, V81, P1896, DOI 10.3168/jds.S0022-0302(98)75761-3; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Xavier PL, 2010, NANOSCALE, V2, P2769, DOI 10.1039/c0nr00377h	46	16	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e106568	10.1371/journal.pone.0106568	http://dx.doi.org/10.1371/journal.pone.0106568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222273	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774800018
J	Peterson, AC; McKenzie, VJ				Peterson, Anna C.; McKenzie, Valerie J.			Investigating Differences across Host Species and Scales to Explain the Distribution of the Amphibian Pathogen Batrachochytrium dendrobatidis	PLOS ONE			English	Article							NORTH-AMERICAN BULLFROG; INFECTIOUS-DISEASE; BOREAL TOADS; CHYTRIDIOMYCOSIS; ECOLOGY; DECLINE; COMMUNITIES; POPULATIONS; UNDERSTAND; MOUNTAINS	Many pathogens infect more than one host species, and clarifying how these different hosts contribute to pathogen dynamics can facilitate the management of pathogens and can lend insight into the functioning of pathogens in ecosystems. In this study, we investigated a suite of native and non-native amphibian hosts of the pathogen Batrachochytrium dendrobatidis (Bd) across multiple scales to identify potential mechanisms that may drive infection patterns in the Colorado study system. Specifically, we aimed to determine if: 1) amphibian populations vary in Bd infection across the landscape, 2) amphibian community composition predicts infection (e.g., does the presence or abundance of any particular species influence infection in others?), 3) amphibian species vary in their ability to produce infectious zoospores in a laboratory infection, 4) heterogeneity in host ability observed in the laboratory scales to predict patterns of Bd prevalence in the landscape. We found that non-native North American bullfrogs (Lithobates catesbeianus) are widespread and have the highest prevalence of Bd infection relative to the other native species in the landscape. Additionally, infection in some native species appears to be related to the density of sympatric L. catesbeianus populations. At the smaller host scale, we found that L. catesbeianus produces more of the infective zoospore stage relative to some native species, but that this zoospore output does not scale to predict infection in sympatric wild populations of native species. Rather, landscape level infection relates most strongly to density of hosts at a wetland as well as abiotic factors. While non-native L. catesbeianus have high levels of Bd infection in the Colorado Front Range system, we also identified Bd infection in a number of native amphibian populations allopatric with L. catesbeianus, suggesting that multiple host species are important contributors to the dynamics of the Bd pathogen in this landscape.	[Peterson, Anna C.; McKenzie, Valerie J.] Univ Colorado, Boulder, CO 80309 USA; [Peterson, Anna C.] Tulane Univ, New Orleans, LA 70118 USA	University of Colorado System; University of Colorado Boulder; Tulane University	Peterson, AC (corresponding author), Univ Colorado, Boulder, CO 80309 USA.	apeter1@tulane.edu			Boulder County Parks and Open Space; University of Colorado Department of Ecology and Evolutionary Biology; University of Colorado Graduate School Beverly Sears Graduate Student Award; Society of Wetland Scientists; National Fish and Wildlife Foundation Wildlife Links Program; NSF [DEB: 1146284]	Boulder County Parks and Open Space; University of Colorado Department of Ecology and Evolutionary Biology; University of Colorado Graduate School Beverly Sears Graduate Student Award; Society of Wetland Scientists; National Fish and Wildlife Foundation Wildlife Links Program; NSF(National Science Foundation (NSF))	This work was funded through support from: Boulder County Parks and Open Space, the University of Colorado Department of Ecology and Evolutionary Biology, the University of Colorado Graduate School Beverly Sears Graduate Student Award, the Society of Wetland Scientists, the National Fish and Wildlife Foundation Wildlife Links Program, and NSF grant (DEB: 1146284) to VJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2010, ECOL APPL, V20, P289, DOI 10.1890/08-2319.1; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CAREY C, 1993, CONSERV BIOL, V7, P355, DOI 10.1046/j.1523-1739.1993.07020355.x; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; Casper GS, 2000, AMPHIBIAN DECLINES C, P540; Cronin JP, 2010, ECOL LETT, V13, P1221, DOI 10.1111/j.1461-0248.2010.01513.x; Daszak P, 2004, HERPETOL J, V14, P201; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; DOBSON AP, 1986, TRENDS ECOL EVOL, V1, P11, DOI 10.1016/0169-5347(86)90060-1; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher Matthew C., 2007, Fungal Biology Reviews, V21, P2, DOI 10.1016/j.fbr.2007.02.002; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268; Hammerson GA, 1999, AMPHIBIANS REPTILES, P139; Hudson PJ, 2002, ECOLOGY WILDLIFE DIS, P1; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Johnson LR, 2011, J THEOR BIOL, V277, P90, DOI 10.1016/j.jtbi.2011.02.010; Johnson PTJ, 2013, J APPL ECOL, V50, P34, DOI 10.1111/1365-2664.12022; Johnson PTJ, 2011, CONSERV BIOL, V25, P556, DOI 10.1111/j.1523-1739.2010.01645.x; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Malmstrom CM, 2005, OECOLOGIA, V145, P153, DOI 10.1007/s00442-005-0099-z; MCCLANAH.L, 1969, COMP BIOCHEM PHYSIOL, V28, P381, DOI 10.1016/0010-406X(69)91351-6; McKenzie VJ, 2012, ISME J, V6, P588, DOI 10.1038/ismej.2011.129; Muths E, 2003, BIOL CONSERV, V110, P357, DOI 10.1016/S0006-3207(02)00239-2; Muths E, 2008, BIOL CONSERV, V141, P1484, DOI 10.1016/j.biocon.2008.03.011; Ostfeld R. S. et al., 2008, INFECT DIS ECOLOGY E; Padgett-Flohr Gretchen E., 2005, Herpetological Review, V36, P50; Peterson AC, 2013, BIOL INVASIONS; R Core Team, 2022, R LANG ENV STAT COMP; R_odder D., 2013, N W J ZOOL, V9; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Rosenblum EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006494; Schloegel LM, 2010, ANIM CONSERV, V13, P53, DOI 10.1111/j.1469-1795.2009.00307.x; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Schloegel LM, 2009, BIOL CONSERV, V142, P1420, DOI 10.1016/j.biocon.2009.02.007; Schmeller DS, 2014, CURR BIOL, V24, P176, DOI 10.1016/j.cub.2013.11.032; Searle CL, 2011, P NATL ACAD SCI USA, V108, P16322, DOI 10.1073/pnas.1108490108; Shaw DJ, 1995, PARASITOLOGY, V111, pS111, DOI 10.1017/S0031182000075855; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; SPIGHT TM, 1968, PHYSIOL ZOOL, V41, P195, DOI 10.1086/physzool.41.2.30155450; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Wiener JD., 2008, WATER RESOUR IMPACT, V10, P18; Zuur Alain F., 2009, P1	56	13	13	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107441	10.1371/journal.pone.0107441	http://dx.doi.org/10.1371/journal.pone.0107441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222375	Green Submitted, Green Published, gold			2022-12-25	WOS:000341774800067
J	Silveira, AL; Faheina-Martins, GV; Maia, RC; Araujo, DAM				Silveira, Aletheia L.; Faheina-Martins, Glaucia V.; Maia, Raquel C.; Araujo, Demetrius A. M.			Compound A398, a Novel Podophyllotoxin Analogue: Cytotoxicity and Induction of Apoptosis in Human Leukemia Cells	PLOS ONE			English	Article							NATURAL-PRODUCTS; TARGETING MITOCHONDRIA; DNA FRAGMENTATION; OXIDATIVE STRESS; CANCER; DEATH; ANTICANCER; PATHWAYS; CASPASES; KINASE	Despite advances in oncology research, cancer is one of the leading causes of death worldwide. Thus, there is a demand for the development of more selective and effective antitumor agents. This study showed that A398, a novel podophyllotoxin analogue, was cytotoxic to the HT-29, MCF-7, MOLT-4 and HL-60 tumor cell lines, being less active in human peripheral blood mononuclear cells and normal cell lines FGH and IEC-6. Tests using the HepG2 lineage indicated that its metabolites do not contribute to its cytotoxicity. In the HL-60 cells, A398 induced apoptosis in a time and concentration-dependent manner, promoting mitochondrial depolarization, inhibition of Bcl-2, phosphatidylserine exposure, activation of caspases -8, -9 and -3, and DNA fragmentation. The production of reactive oxygen species does not seem to be a crucial event for the apoptotic process. Pretreatment with specific inhibitors of kinases ERK1/2, JNK and p38 resulted in an increased percentage of death induced by A398. These results indicate that the compound induced apoptosis through activation of intrinsic and extrinsic death pathways with the mechanism involving the inhibition of the MAPKs and Bcl-2. Taken together, our findings suggest that A398 has an anticancer potential, proving itself to be a candidate for preclinical studies.	[Silveira, Aletheia L.; Faheina-Martins, Glaucia V.; Araujo, Demetrius A. M.] Univ Fed Paraiba, Dept Biotecnol, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Faheina-Martins, Glaucia V.] Univ Fed Paraiba, Dept Biol Mol, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Maia, Raquel C.] Inst Nacl Canc INCA, Lab Hematooncol Celular & Mol, Rio De Janeiro, RJ, Brazil	Universidade Federal da Paraiba; Universidade Federal da Paraiba; National Cancer Institute (Inca)	Araujo, DAM (corresponding author), Univ Fed Paraiba, Dept Biotecnol, BR-58059900 Joao Pessoa, Paraiba, Brazil.	demetrius@cbiotec.ufpb.br	Veríssimo Faheina Martins, Glaucia/GLS-1344-2022; Araujo, Demetrius/N-8441-2014; maia, raquel c/L-4869-2015; Araujo, Demetrius/AIE-4581-2022	Veríssimo Faheina Martins, Glaucia/0000-0002-0160-9788; maia, raquel c/0000-0003-0225-471X; Araujo, Demetrius/0000-0001-7320-7203	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for their financial support in the form of grants and fellowship awards. DAMA, ALS, GVFM, and RCM are CNPq fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrushkina NI, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1436, DOI 10.1134/S0006297912130032; Alenzi FQ, 2010, ASIAN PAC J CANCER P, V11, P271; Bagnyukova T, 2010, CANCER BIOL THER, V10, P843, DOI 10.4161/cbt.10.9.13738; Baguley BC, 2011, FRONT BIOSCI-LANDMRK, V16, P1759, DOI 10.2741/3819; Bai LC, 2014, ANNU REV MED, V65, P139, DOI 10.1146/annurev-med-010713-141310; Bailly C, 2009, BIOCHEM PHARMACOL, V77, P1447, DOI 10.1016/j.bcp.2008.12.013; Bergholz J, 2012, CANCER MICROENVIRON, V5, P311, DOI 10.1007/s12307-012-0116-9; Borutaite V, 2010, ENVIRON MOL MUTAGEN, V51, P406, DOI 10.1002/em.20564; Burton GJ, 2011, BEST PRACT RES CL OB, V25, P287, DOI 10.1016/j.bpobgyn.2010.10.016; Chung E, 2011, IMMUNOL RES, V49, P248, DOI 10.1007/s12026-010-8187-5; Ciavarella S, 2010, BIODRUGS, V24, P77, DOI 10.2165/11530830-000000000-00000; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Feng YD, 2009, ARCH PATHOL LAB MED, V133, P1850, DOI 10.1043/1543-2165-133.11.1850; Fiandalo M. V., 2012, Experimental Oncology, V34, P165; Fogg Vanessa C, 2011, Chin J Cancer, V30, P526, DOI 10.5732/cjc.011.10018; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Golubovskaya VM, 2013, SURG ONCOL CLIN N AM, V22, P747, DOI 10.1016/j.soc.2013.06.003; Gordaliza M, 2007, CLIN TRANSL ONCOL, V9, P767, DOI 10.1007/s12094-007-0138-9; Guguen-Guillouzo C, 2010, METHODS MOL BIOL, V640, P1, DOI 10.1007/978-1-60761-688-7_1; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Hensley P, 2013, BIOL CHEM, V394, P831, DOI 10.1515/hsz-2013-0128; Karikas GA, 2010, J BUON, V15, P627; Kitazumi I, 2011, FEBS J, V278, P427, DOI 10.1111/j.1742-4658.2010.07975.x; Kumar A, 2011, CURR MED CHEM, V18, P3853, DOI 10.2174/092986711803414331; Kwak CS, 2009, J MED FOOD, V12, P508, DOI 10.1089/jmf.2008.1103; Leibowitz Brian, 2010, Cancer Biol Ther, V9, P417, DOI 10.4161/cbt.9.6.11392; Liu JJ, 2011, CANCER LETT, V300, P105, DOI 10.1016/j.canlet.2010.10.001; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mates JM, 2012, ARCH TOXICOL, V86, P1649, DOI 10.1007/s00204-012-0906-3; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Micheau O, 2013, BRIT J PHARMACOL, V169, P1723, DOI 10.1111/bph.12238; Mishra BB, 2011, EUR J MED CHEM, V46, P4769, DOI 10.1016/j.ejmech.2011.07.057; Moffitt KL, 2010, J PHARM PHARMACOL, V62, P547, DOI 10.1211/jpp.62.05.0001; Montecucco A, 2007, CANCER LETT, V252, P9, DOI 10.1016/j.canlet.2006.11.005; Nowsheen S., 2012, Experimental Oncology, V34, P243; Ocker M, 2012, EUR SURG RES, V48, P111, DOI 10.1159/000336875; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Parsons MJ, 2010, ESSAYS BIOCHEM, V47, P99, DOI [10.1042/BSE0470099, 10.1042/bse0470099]; Plati J, 2011, INTEGR BIOL-UK, V3, P279, DOI 10.1039/c0ib00144a; Portt L, 2011, BBA-MOL CELL RES, V1813, P238, DOI 10.1016/j.bbamcr.2010.10.010; Roy MJ, 2014, BRIT J PHARMACOL, V171, P1973, DOI 10.1111/bph.12431; Sahi Jasminder, 2010, Curr Drug Discov Technol, V7, P188; Sang CY, 2013, EUR J MED CHEM, V70, P59, DOI 10.1016/j.ejmech.2013.09.053; Santarpia L, 2012, EXPERT OPIN THER TAR, V16, P103, DOI 10.1517/14728222.2011.645805; Shang H, 2012, ARCH PHARM, V345, P43, DOI 10.1002/ardp.201100094; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Takeda K, 2011, ANTIOXID REDOX SIGN, V15, P719, DOI 10.1089/ars.2010.3392; Torres F, 2008, APOPTOSIS, V13, P716, DOI 10.1007/s10495-008-0202-0; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wenner CE, 2012, J CELL PHYSIOL, V227, P450, DOI 10.1002/jcp.22788; Widlak P, 2009, CELL MOL LIFE SCI, V66, P263, DOI 10.1007/s00018-008-8472-9; Wyllie AH, 2010, MOL NEUROBIOL, V42, P4, DOI 10.1007/s12035-010-8125-5; Yoshida K, 2010, CANCER SCI, V101, P831, DOI 10.1111/j.1349-7006.2010.01488.x; You YJ, 2005, CURR PHARM DESIGN, V11, P1695, DOI 10.2174/1381612053764724	58	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107404	10.1371/journal.pone.0107404	http://dx.doi.org/10.1371/journal.pone.0107404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25221997	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774800064
J	Negrin, KA; Flach, RJR; DiStefano, MT; Matevossian, A; Friedline, RH; Jung, D; Kim, JK; Czech, MP				Negrin, Kimberly A.; Flach, Rachel J. Roth; DiStefano, Marina T.; Matevossian, Anouch; Friedline, Randall H.; Jung, DaeYoung; Kim, Jason K.; Czech, Michael P.			IL-1 Signaling in Obesity-Induced Hepatic Lipogenesis and Steatosis	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; ACETYL-COA CARBOXYLASE-1; DE-NOVO LIPOGENESIS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; FATTY LIVER; PROTECTS MICE; CELLS; INFLAMMATION; MACROPHAGES	Non-alcoholic fatty liver disease is prevalent in human obesity and type 2 diabetes, and is characterized by increases in both hepatic triglyceride accumulation (denoted as steatosis) and expression of pro-inflammatory cytokines such as IL-1 beta. We report here that the development of hepatic steatosis requires IL-1 signaling, which upregulates Fatty acid synthase to promote hepatic lipogenesis. Using clodronate liposomes to selectively deplete liver Kupffer cells in ob/ob mice, we observed remarkable amelioration of obesity-induced hepatic steatosis and reductions in liver weight, triglyceride content and lipogenic enzyme expressions. Similar results were obtained with diet-induced obese mice, although visceral adipose tissue macrophage depletion also occurred in response to clodronate liposomes in this model. There were no differences in the food intake, whole body metabolic parameters, serum beta-hydroxybutyrate levels or lipid profiles due to clodronate-treatment, but hepatic cytokine gene expressions including IL-1 beta were decreased. Conversely, treatment of primary mouse hepatocytes with IL-1 beta significantly increased triglyceride accumulation and Fatty acid synthase expression. Furthermore, the administration of IL-1 receptor antagonist to obese mice markedly reduced obesity-induced steatosis and hepatic lipogenic gene expression. Collectively, our findings suggest that IL-1 beta signaling upregulates hepatic lipogenesis in obesity, and is essential for the induction of pathogenic hepatic steatosis in obese mice.	[Negrin, Kimberly A.; Flach, Rachel J. Roth; DiStefano, Marina T.; Matevossian, Anouch; Friedline, Randall H.; Jung, DaeYoung; Kim, Jason K.; Czech, Michael P.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA; [Friedline, Randall H.; Jung, DaeYoung; Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA.	Michael.Czech@umassmed.edu		Kim, Jason/0000-0002-7185-042X	National Institutes of Health [DK085753, AI046629, DK325220]; International Research Alliance at Novo Nordisk Foundation Center for Metabolic Research; Juvenile Diabetes Research Foundation [17-2009-546]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI046629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085753, U24DK093000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Research Alliance at Novo Nordisk Foundation Center for Metabolic Research; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by grants to M.P.C. from the National Institutes of Health (DK085753, AI046629), a grant from the International Research Alliance at Novo Nordisk Foundation Center for Metabolic Research, a grant from the Juvenile Diabetes Research Foundation (17-2009-546), and by Core Facilities in the University of Massachusetts Diabetes and Endocrinology Research Center also funded by the National Institutes of Health (DK325220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Aouadi M, 2013, P NATL ACAD SCI USA, V110, P8278, DOI 10.1073/pnas.1300492110; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Bu L, 2013, AAPS J, V15, P1001, DOI 10.1208/s12248-013-9501-7; Clementi AH, 2009, BBA-MOL BASIS DIS, V1792, P1062, DOI 10.1016/j.bbadis.2009.08.007; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; Dinarello CA, 2009, NEW ENGL J MED, V360, P2467, DOI 10.1056/NEJMe0811014; Dixon LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056100; Donath MY, 2010, TRENDS ENDOCRIN MET, V21, P261, DOI 10.1016/j.tem.2009.12.010; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; FEINGOLD KR, 1989, ENDOCRINOLOGY, V125, P267, DOI 10.1210/endo-125-1-267; Feng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024358; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gabay C, 2001, EUR J IMMUNOL, V31, P490, DOI 10.1002/1521-4141(200102)31:2<490::AID-IMMU490>3.0.CO;2-H; GRUNFELD C, 1990, ENDOCRINOLOGY, V127, P46, DOI 10.1210/endo-127-1-46; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Harada N, 2007, MOL CELL BIOL, V27, P1881, DOI 10.1128/MCB.01122-06; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ikarashi M, 2013, J LEUKOCYTE BIOL, V94, P1325, DOI 10.1189/jlb.0313144; Isoda K, 2005, J BIOL CHEM, V280, P7002, DOI 10.1074/jbc.M412220200; Juge-Aubry CE, 2003, DIABETES, V52, P1104, DOI 10.2337/diabetes.52.5.1104; Kamari Y, 2007, ATHEROSCLEROSIS, V195, P31, DOI 10.1016/j.atherosclerosis.2006.11.026; Kamari Y, 2011, J HEPATOL, V55, P1086, DOI 10.1016/j.jhep.2011.01.048; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Lamacchia C, 2010, J IMMUNOL, V185, P2516, DOI 10.4049/jimmunol.1000872; Lanthier N, 2011, FASEB J, V25, P4301, DOI 10.1096/fj.11-189472; Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Leroux A, 2012, J HEPATOL, V57, P141, DOI 10.1016/j.jhep.2012.02.028; Li SZ, 2009, CIRC RES, V105, P1072, DOI 10.1161/CIRCRESAHA.109.199570; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; McGillicuddy FC, 2011, DIABETES, V60, P1688, DOI 10.2337/db10-1278; Meier CA, 2002, CYTOKINE, V18, P320, DOI 10.1006/cyto.2002.1945; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Moschen AR, 2011, MOL MED, V17, P840, DOI 10.2119/molmed.2010.00108; Nov O, 2010, ENDOCRINOLOGY, V151, P4247, DOI 10.1210/en.2010-0340; Osborn O, 2008, CYTOKINE, V44, P141, DOI 10.1016/j.cyto.2008.07.004; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Promrat K, 2004, HEPATOLOGY, V39, P188, DOI 10.1002/hep.20012; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Szabo G, 2012, J HEPATOL, V57, P642, DOI 10.1016/j.jhep.2012.03.035; Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Young JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029688; Zeyda M, 2009, GERONTOLOGY, V55, P379, DOI 10.1159/000212758	61	91	95	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107265	10.1371/journal.pone.0107265	http://dx.doi.org/10.1371/journal.pone.0107265			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216251	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774300052
J	Sadinski, W; Roth, M; Hayes, T; Jones, P; Gallant, A				Sadinski, Walt; Roth, Mark; Hayes, Tyrone; Jones, Perry; Gallant, Alisa			Indicators of the Statuses of Amphibian Populations and Their Potential for Exposure to Atrazine in Four Midwestern US Conservation Areas	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; FROGS RANA-PIPIENS; DETECTION PROBABILITIES; TREMATODE INFECTION; HABITAT LOSS; FRAGMENTATION; ABUNDANCE; DECLINES; TRENDS; RATES	Extensive corn production in the midwestern United States has physically eliminated or fragmented vast areas of historical amphibian habitat. Midwestern corn farmers also apply large quantities of fertilizers and herbicides, which can cause direct and indirect effects on amphibians. Limited field research regarding the statuses of midwestern amphibian populations near areas of corn production has left resource managers, conservation planners, and other stakeholders needing more information to improve conservation strategies and management plans. We repeatedly sampled amphibians in wetlands in four conservation areas along a gradient of proximity to corn production in Illinois, Iowa, Minnesota, and Wisconsin from 2002 to 2005 and estimated site occupancy. We measured frequencies of gross physical deformities in recent metamorphs and triazine concentrations in the water at breeding sites. We also measured trematode infection rates in kidneys of recently metamorphosed Lithobates pipiens collected from nine wetlands in 2003 and 2004. We detected all possible amphibian species in each study area. The amount of nearby row crops was limited in importance as a covariate for estimating site occupancy. We observed deformities in <5% of metamorphs sampled and proportions were not associated with triazine concentrations. Trematode infections were high in metamorphs from all sites we sampled, but not associated with site triazine concentrations, except perhaps for a subset of sites sampled in both years. We detected triazines more often and in higher concentrations in breeding wetlands closer to corn production. Triazine concentrations increased in floodplain wetlands as water levels rose after rainfall and were similar among lotic and lentic sites. Overall, our results suggest amphibian populations were not faring differently among these four conservation areas, regardless of their proximity to corn production, and that the ecological dynamics of atrazine exposure were complex.	[Sadinski, Walt; Roth, Mark] US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI 54603 USA; [Hayes, Tyrone] Univ Calif Berkeley, Lab Integrat Studies Amphibian Biol Mol Toxicol, Energy & Resources Grp, Museum Vertebrate Zool,Grp Endocrinol, Berkeley, CA 94720 USA; [Hayes, Tyrone] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Jones, Perry] US Geol Survey, Minnesota Water Sci Ctr, Mounds View, MN USA; [Gallant, Alisa] US Geol Survey, Earth Resources Observat & Sci Ctr, Sioux Falls, SD USA	United States Department of the Interior; United States Geological Survey; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Sadinski, W (corresponding author), US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI 54603 USA.	wsadinski@usgs.gov		Roth, Mark/0000-0001-5095-1865	U.S. Geological Survey's Amphibian Research and Monitoring Initiative and Geographic Analysis and Monitoring Program; U.S. National Park Service's Great Lakes Inventory and Monitoring Program; Park Water Company; Mitchell Kapor Foundation; David Foundation; Cornell-Douglas Foundation, Global Wallace Fund; Class of '43 Endowed Chair and Biology Fellows Program at the University of California, Berkeley; Howard Hughes Medical Institute	U.S. Geological Survey's Amphibian Research and Monitoring Initiative and Geographic Analysis and Monitoring Program; U.S. National Park Service's Great Lakes Inventory and Monitoring Program; Park Water Company; Mitchell Kapor Foundation; David Foundation; Cornell-Douglas Foundation, Global Wallace Fund; Class of '43 Endowed Chair and Biology Fellows Program at the University of California, Berkeley; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	U.S. Geological Survey's Amphibian Research and Monitoring Initiative and Geographic Analysis and Monitoring Program; U.S. National Park Service's Great Lakes Inventory and Monitoring Program; Park Water Company; Mitchell Kapor Foundation; David Foundation; Cornell-Douglas Foundation, Global Wallace Fund; Class of '43 Endowed Chair and Biology Fellows Program at the University of California, Berkeley; Howard Hughes Medical Institute. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RB, 2008, ENVIRON SCI TECHNOL, V42, P822, DOI 10.1021/es0716103; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; *ARMI, 2014, US GEOL SURV AMPH RE; Bailey LL, 2004, ECOL APPL, V14, P692, DOI 10.1890/03-5012; Bishop CA, 1999, ENVIRON MONIT ASSESS, V57, P21, DOI 10.1023/A:1005988611661; Blann KL, 2009, CRIT REV ENV SCI TEC, V39, P909, DOI 10.1080/10643380801977966; Blaustein AR, 2003, FRONT ECOL ENVIRON, V1, P87, DOI 10.1890/1540-9295(2003)001[0087:TCODA]2.0.CO;2; Bonin Joel, 1997, Herpetological Conservation, V1, P141; Brander SM, 2007, J HERPETOL, V41, P52, DOI 10.1670/0022-1511(2007)41[52:EOTSOA]2.0.CO;2; Byer JD, 2011, CHEMOSPHERE, V82, P1155, DOI 10.1016/j.chemosphere.2010.12.054; Conant R., 1991, FIELD GUIDE REPTILES; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; *EPA, 2008, US ENV PROT AG ATR F; *EPA, 1999, US ENV PROT AG LEV 3; FARGIONE J, 2008, SCI EXP         0207, DOI DOI 10.1126/SCIENCE.1152747; FROG I, 2014, IOW FROG TOAD SURV 1; FROG I, 2014, IOW FROG TOAD CALL S; FROG M, 2014, MICH FROG TOAD SURV; FROG M, 2014, 2009 SURV RES; Gallant AL, 2007, COPEIA, P967, DOI 10.1643/0045-8511(2007)7[967:GROHLA]2.0.CO;2; Gallant AL, 2011, J SOIL WATER CONSERV, V66, p67A, DOI 10.2489/jswc.66.3.67A; Gibson LA, 2011, DIVERS DISTRIB, V17, P613, DOI 10.1111/j.1472-4642.2011.00766.x; Giddings J.M., 2005, ATRAZINE N AM SURFAC; Hayes T, 2003, ENVIRON HEALTH PERSP, V111, P568, DOI 10.1289/ehp.5932; Hayes TB, 2010, J EXP BIOL, V213, P921, DOI 10.1242/jeb.040865; Hayes TB, 2004, BIOSCIENCE, V54, P1138, DOI 10.1641/0006-3568(2004)054[1138:TINDTD]2.0.CO;2; Hayes TB, 2011, EMERG TOP ECOTOXICOL, V3, P301, DOI 10.1007/978-0-387-89432-4_10; Hayes TB, 2011, J STEROID BIOCHEM, V127, P64, DOI 10.1016/j.jsbmb.2011.03.015; Hecnar Stephen J., 1997, Herpetological Conservation, V1, P1; Hines J. E, 2006, PRESENCE SOFTWARE ES; Johnson PTJ, 2007, P NATL ACAD SCI USA, V104, P15781, DOI 10.1073/pnas.0707763104; Johnson PTJ, 1999, SCIENCE, V284, P802, DOI 10.1126/science.284.5415.802; Kalkhoff SJ, 2003, J ENVIRON QUAL, V32, P1025, DOI 10.2134/jeq2003.1025; Kiesecker JM, 2002, P NATL ACAD SCI USA, V99, P9900, DOI 10.1073/pnas.152098899; Knutson MG, 1999, CONSERV BIOL, V13, P1437, DOI 10.1046/j.1523-1739.1999.98445.x; Knutson MG, 2004, ECOL APPL, V14, P669, DOI 10.1890/02-5305; Lannoo M, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P1; LEE EA, 2002, US GEOLOGICAL SURVEY; MacKenzie D. I., 2004, Animal Biodiversity and Conservation, V27, P461; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2387, DOI 10.2307/3071800; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MacKenzie DI., 2006, OCCUPANCY ESTIMATION; Mann RM, 2009, ENVIRON POLLUT, V157, P2903, DOI 10.1016/j.envpol.2009.05.015; McDaniel TV, 2008, AQUAT TOXICOL, V88, P230, DOI 10.1016/j.aquatox.2008.05.002; Mehaffey M, 2012, ECOL APPL, V22, P8, DOI 10.1890/10-1573.1; Meteyer CU, 2000, TERATOLOGY, V62, P151, DOI 10.1002/1096-9926(200009)62:3<151::AID-TERA3>3.0.CO;2-2; Murphy MB, 2006, AQUAT TOXICOL, V76, P230, DOI 10.1016/j.aquatox.2005.09.010; Muths E., 2006, 20065224 US GEOL SUR; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; Pellet J, 2005, BIOL CONSERV, V123, P27, DOI 10.1016/j.biocon.2004.10.005; Relyea RA, 2009, OECOLOGIA, V159, P363, DOI [10.1007/s00442-008-1141-8, 10.1007/s00442-008-1213-9]; Rohr JR, 2008, NATURE, V455, P1235, DOI 10.1038/nature07281; Rohr JR, 2010, ENVIRON HEALTH PERSP, V118, P20, DOI 10.1289/ehp.0901164; RORABAUGH JC, 2005, AMPHIBIAN DECLINES C, P00570; Royle JA, 2004, CONSERV BIOL, V18, P1378, DOI 10.1111/j.1523-1739.2004.00147.x; Schmidt BR, 2003, CR BIOL, V326, pS119, DOI 10.1016/S1631-0691(03)00048-9; Smith LL, 2006, AM MIDL NAT, V155, P149, DOI 10.1674/0003-0031(2006)155[0149:DPASOE]2.0.CO;2; Solomon KR, 2008, CRIT REV TOXICOL, V38, P721, DOI [10.1080/10408440802116496, 10.1080/10408440802116496 ]; Solomon KR, 1996, ENVIRON TOXICOL CHEM, V15, P31, DOI [10.1002/etc.5620150105, 10.1897/1551-5028(1996)015&lt;0031:ERAOAI&gt;2.3.CO;2]; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; *US NAT PARK SERVI, 2014, GREAT LAK NETW; *USFWS, 2012, US FISH WILDL SERV R; *USGS, 2009, NATIONAL FIELD MANUA, pCHA1; Vie J-C, 2009, WILDLIFE CHANGING WO; WESTCOTT PC, 2007, FDS07D01 USDA; Wiener JG, 2010, HYDROBIOLOGIA, V640, P49, DOI 10.1007/s10750-009-0064-7	67	1	1	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107018	10.1371/journal.pone.0107018	http://dx.doi.org/10.1371/journal.pone.0107018			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216249	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774300036
J	Qu, H; Tu, YZ; Guan, JL; Xiao, GZ; Wu, CY				Qu, Hong; Tu, Yizeng; Guan, Jun-Lin; Xiao, Guozhi; Wu, Chuanyue			Kindlin-2 Tyrosine Phosphorylation and Interaction with Src Serve as a Regulatable Switch in the Integrin Outside-in Signaling Circuit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; CELL-MATRIX ADHESION; EXTRACELLULAR-MATRIX; ADAPTER PROTEIN; GROWTH-FACTOR; PAXILLIN; TRANSDUCTION; CYTOSKELETON; ACTIVATION; BINDING	Integrin-mediated cell-extracellular matrix (ECM) adhesion is critical for control of intracellular signaling; however, the mechanisms underlying this "outside-in" signaling are incompletely understood. Here we show that depletion of kindlin-2 impairs integrin outside-in signaling. Kindlin-2 is tyrosine-phosphorylated upon cell-ECM adhesion. Furthermore, kindlin-2 binds Src in a cell-ECM adhesion-regulatable fashion. At the molecular level, the kindlin-2 . Src interaction is mediated by the kindlin-2 F0 and the Src SH2 and SH3 domains center dot Src activation increases kindlin-2 tyrosine phosphorylation and the kindlin-2 . Src interaction. Conversely, inhibition of Src reduces kindlin-2 tyrosine phosphorylation and diminishes the kindlin-2 center dot Src interaction. Finally, disruption of the kindlin-2 center dot Src interaction, unlike depletion of kindlin-2, impairs neither cell-ECM adhesion nor cell-ECM adhesion-induced focal adhesion kinase Tyr-397 phosphorylation. However, it markedly inhibits cell-ECM adhesion-induced paxillin tyrosine phosphorylation, cell migration, and proliferation. These results suggest that kindlin-2 tyrosine phosphorylation and interaction with Src serve as a regulatable switch downstream of focal adhesion kinase in the integrin outside-in signaling circuit, relaying signals from cell-ECM adhesion to paxillin that control cell migration and proliferation.	[Qu, Hong; Tu, Yizeng; Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [Guan, Jun-Lin] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45267 USA; [Xiao, Guozhi] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; University of Cincinnati; Rush University	Wu, CY (corresponding author), Univ Pittsburgh, Dept Pathol, 707B Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	carywu@pitt.edu			National Institutes of Health [GM65188]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM65188 (to C. W.).	BELLIS SL, 1995, J BIOL CHEM, V270, P17437, DOI 10.1074/jbc.270.29.17437; BIBBINS KB, 1993, MOL CELL BIOL, V13, P7278, DOI 10.1128/MCB.13.12.7278; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Cai XM, 2008, MOL CELL BIOL, V28, P201, DOI 10.1128/MCB.01324-07; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; GUAN JL, 1991, CELL REGUL, V2, P951, DOI 10.1091/mbc.2.11.951; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; Hall JE, 2011, INT REV CEL MOL BIO, V288, P185, DOI 10.1016/B978-0-12-386041-5.00005-4; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Katz E, 2007, INT J BIOCHEM CELL B, V39, P715, DOI 10.1016/j.biocel.2006.11.004; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kohno M, 1999, J AM SOC NEPHROL, V10, P2495; KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392; LaFlamme SE, 1997, MATRIX BIOL, V16, P153, DOI 10.1016/S0945-053X(97)90003-2; LaFlamme SE, 1996, SEMIN CANCER BIOL, V7, P111, DOI 10.1006/scbi.1996.0016; Lai-Cheong JE, 2010, INT J BIOCHEM CELL B, V42, P595, DOI 10.1016/j.biocel.2009.10.015; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Plow EF, 2009, CURR OPIN HEMATOL, V16, P323, DOI 10.1097/MOH.0b013e32832ea389; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; Richardson A, 1996, NATURE, V380, P538, DOI 10.1038/380538a0; Rosado JA, 2004, J BIOL CHEM, V279, P1665, DOI 10.1074/jbc.M307963200; Schaller MD, 2000, J CELL BIOL, V150, pF9, DOI 10.1083/jcb.150.1.F9; Schaller MD, 1997, J BIOL CHEM, V272, P25319, DOI 10.1074/jbc.272.40.25319; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Schaller MD, 1999, MOL BIOL CELL, V10, P3489, DOI 10.1091/mbc.10.10.3489; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Schwartz MA, 1997, J CELL BIOL, V139, P575, DOI 10.1083/jcb.139.3.575; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; THOMAS SM, 1995, NATURE, V376, P267, DOI 10.1038/376267a0; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; TURNER CE, 1991, J CELL BIOL, V115, P201, DOI 10.1083/jcb.115.1.201; TWAMLEYSTEIN GM, 1993, P NATL ACAD SCI USA, V90, P7696, DOI 10.1073/pnas.90.16.7696; Wu CY, 2005, J CELL SCI, V118, P659, DOI 10.1242/jcs.01639; Ye F, 2014, FRONT MED-PRC, V8, P6, DOI 10.1007/s11684-014-0317-3; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001	54	24	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31001	31013		10.1074/jbc.M114.580811	http://dx.doi.org/10.1074/jbc.M114.580811			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25237194	Green Published, hybrid			2022-12-25	WOS:000344549900011
J	Khazaei, MR; Girouard, MP; Alchini, R; Tone, SO; Shimada, T; Bechstedt, S; Cowan, M; Guillet, D; Wiseman, PW; Brouhard, G; Cloutier, JF; Fournier, AE				Khazaei, Mohamad R.; Girouard, Marie-Pier; Alchini, Ricardo; Tone, Stephan Ong; Shimada, Tadayuki; Bechstedt, Susanne; Cowan, Mitra; Guillet, Dominique; Wiseman, Paul W.; Brouhard, Gary; Cloutier, Jean Francois; Fournier, Alyson E.			Collapsin Response Mediator Protein 4 Regulates Growth Cone Dynamics through the Actin and Microtubule Cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Axon; Cell Biology; Cytoskeleton; Microfilaments; Microtubule; Neurodevelopment; Neuroscience; CRMP; Growth Cone	AXON OUTGROWTH INHIBITION; F-ACTIN; NEURITE OUTGROWTH; SHORT-STOP; HIPPOCAMPAL-NEURONS; BINDING PROTEIN; MOTOR-NEURONS; GUIDANCE CUE; PHOSPHORYLATION; CRMP-2	Background: Intricate regulation of the growth cone cytoskeleton controls growth cone dynamics. Results: Loss of CRMP4 disrupts growth cone cytoskeletal dynamics, growth cone expansion, and axon growth. Conclusion: CRMP4 regulates both the actin and microtubule growth cone cytoskeleton. Significance: CRMP4 plays a critical role in regulating cytoskeletal dynamics underlying growth cone properties. Coordinated control of the growth cone cytoskeleton underlies axon extension and guidance. Members of the collapsin response mediator protein (CRMP) family of cytosolic phosphoproteins regulate the microtubule and actin cytoskeleton, but their roles in regulating growth cone dynamics remain largely unexplored. Here, we examine how CRMP4 regulates the growth cone cytoskeleton. Hippocampal neurons from CRMP4-/- mice exhibited a selective decrease in axon extension and reduced growth cone area, whereas overexpression of CRMP4 enhanced the formation and length of growth cone filopodia. Biochemically, CRMP4 can impact both microtubule assembly and F-actin bundling in vitro. Through a structure function analysis of CRMP4, we found that the effects of CRMP4 on axon growth and growth cone morphology were dependent on microtubule assembly, whereas filopodial extension relied on actin bundling. Intriguingly, anterograde movement of EB3 comets, which track microtubule protrusion, slowed significantly in neurons derived from CRMP4-/- mice, and rescue of microtubule dynamics required CRMP4 activity toward both the actin and microtubule cytoskeleton. Together, this study identified a dual role for CRMP4 in regulating the actin and microtubule growth cone cytoskeleton.	[Khazaei, Mohamad R.; Girouard, Marie-Pier; Alchini, Ricardo; Tone, Stephan Ong; Cloutier, Jean Francois; Fournier, Alyson E.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Shimada, Tadayuki] Tokyo Metropolitan Inst Med Sci, Neural Plast Project, Setagaya Ku, Tokyo 1568506, Japan; [Bechstedt, Susanne; Brouhard, Gary] McGill Univ, Dept Biol, Montreal, PQ H3G 0B1, Canada; [Guillet, Dominique; Wiseman, Paul W.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Wiseman, Paul W.] McGill Univ, Dept Chem, Montreal, PQ H3A 2K6, Canada; [Cowan, Mitra] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ H2X 0A9, Canada	McGill University; Tokyo Metropolitan Institute of Medical Science; McGill University; McGill University; McGill University; Universite de Montreal	Fournier, AE (corresponding author), McGill Univ, Montreal Neurol Inst, BT-109,3801 Rue Univ, Montreal, PQ H3A 2B4, Canada.	alyson.fournier@mcgill.ca	Brouhard, Gary/AAZ-7789-2021		Canadian Institutes of Health Research; McGill Program in Neuroengineering; Canada Research Chair	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McGill Program in Neuroengineering; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by grants from the Canadian Institutes of Health Research and the McGill Program in Neuroengineering and by a Canada Research Chair (to A. E. F.).	Alabed YZ, 2007, J NEUROSCI, V27, P1702, DOI 10.1523/JNEUROSCI.5055-06.2007; Alabed YZ, 2010, J NEUROSCI, V30, P5635, DOI 10.1523/JNEUROSCI.6154-09.2010; Alves-Silva J, 2012, J NEUROSCI, V32, P9143, DOI 10.1523/JNEUROSCI.0416-12.2012; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; Aylsworth A, 2009, EXP CELL RES, V315, P2856, DOI 10.1016/j.yexcr.2009.06.014; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brot S, 2010, J NEUROSCI, V30, P10639, DOI 10.1523/JNEUROSCI.0059-10.2010; Buck KB, 2002, J NEUROSCI, V22, P9358; Chae YC, 2009, CELL SIGNAL, V21, P1818, DOI 10.1016/j.cellsig.2009.07.017; Challacombe JF, 1996, J CELL SCI, V109, P2031; Challacombe JF, 1997, J NEUROSCI, V17, P3085; Cohan CS, 2001, CELL MOTIL CYTOSKEL, V48, P109, DOI 10.1002/1097-0169(200102)48:2<109::AID-CM1002>3.0.CO;2-G; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; EDWARDS RA, 1995, CELL MOTIL CYTOSKEL, V32, P1, DOI 10.1002/cm.970320102; Fournier AE, 2000, METHOD ENZYMOL, V325, P473; Fu XQ, 2013, J NEUROSCI, V33, P709, DOI 10.1523/JNEUROSCI.4603-12.2013; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Geraldo S, 2008, NAT CELL BIOL, V10, P1181, DOI 10.1038/ncb1778; Gordon-Weeks PR, 2014, J NEUROCHEM, V129, P206, DOI 10.1111/jnc.12502; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; Hebert B, 2005, BIOPHYS J, V88, P3601, DOI 10.1529/biophysj.104.054874; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Heo K, 2006, CELL SIGNAL, V18, P2182, DOI 10.1016/j.cellsig.2006.05.006; Higurashi M, 2012, DEV NEUROBIOL, V72, P1528, DOI 10.1002/dneu.22017; Hur EM, 2012, TRENDS NEUROSCI, V35, P164, DOI 10.1016/j.tins.2011.11.002; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Lee S, 2000, J NEUROSCI, V20, P1096, DOI 10.1523/JNEUROSCI.20-03-01096.2000; Lee S, 2002, DEVELOPMENT, V129, P1195; Lee S, 2007, DEVELOPMENT, V134, P1767, DOI 10.1242/dev.02842; Lin PC, 2011, J BIOL CHEM, V286, P41466, DOI 10.1074/jbc.M111.283580; Maniar TA, 2012, NAT NEUROSCI, V15, P48, DOI 10.1038/nn.2970; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; MORIMURA R, 2013, J PEDIATR ONCOL NURS, V30, P911, DOI DOI 10.1002/DNEU.22117; Nagai J, 2012, NEUROSCI LETT, V519, P56, DOI 10.1016/j.neulet.2012.05.020; Niisato E, 2012, DEV NEUROBIOL, V72, P1447, DOI 10.1002/dneu.22007; Paul C. A., 2008, CSH PROTOC, V2008; Prokop A, 1998, J CELL BIOL, V143, P1283, DOI 10.1083/jcb.143.5.1283; Quach TT, 2000, GENE, V242, P175, DOI 10.1016/S0378-1119(99)00528-4; Quach TT, 2004, MOL CELL NEUROSCI, V25, P433, DOI 10.1016/j.mcn.2003.11.006; Quinn CC, 2003, J NEUROSCI, V23, P2815; Rembutsu M, 2008, BIOCHEMISTRY-US, V47, P2153, DOI 10.1021/bi702030w; Rosslenbroich V, 2005, EXP CELL RES, V310, P434, DOI 10.1016/j.yexcr.2005.08.005; Sanchez-Soriano N, 2009, J CELL SCI, V122, P2534, DOI 10.1242/jcs.046268; Stepanova T, 2003, J NEUROSCI, V23, P2655; Tanaka H, 2012, DEV BIOL, V370, P223, DOI 10.1016/j.ydbio.2012.07.032; Tone SO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014345; Vitriol EA, 2012, NEURON, V73, P1068, DOI 10.1016/j.neuron.2012.03.005; Wang LH, 1996, J NEUROSCI, V16, P6197; Wang LH, 1997, J NEUROCHEM, V69, P2261; Williamson T, 1996, P NATL ACAD SCI USA, V93, P15221, DOI 10.1073/pnas.93.26.15221; Yang SY, 2013, J BIOL CHEM, V288, P274, DOI 10.1074/jbc.M112.427971; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yuasa-Kawada J, 2003, EUR J NEUROSCI, V17, P2329, DOI 10.1046/j.1460-9568.2003.02664.x	56	43	45	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					30133	30143		10.1074/jbc.M114.570440	http://dx.doi.org/10.1074/jbc.M114.570440			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25225289	Green Published, hybrid			2022-12-25	WOS:000344370800052
J	Akcali, A; Bostanci, N; Ozcaka, O; Ozturk-Ceyhan, B; Gumus, P; Buduneli, N; Belibasakis, GN				Akcali, Aliye; Bostanci, Nagihan; Ozcaka, Ozgun; Ozturk-Ceyhan, Banu; Gumus, Pinar; Buduneli, Nurcan; Belibasakis, Georgios N.			Association between Polycystic Ovary Syndrome, Oral Microbiota and Systemic Antibody Responses	PLOS ONE			English	Article							PERIODONTAL-DISEASE; HOST-RESPONSE; BACTERIA; SEX; PERIODONTOPATHOGENS; GINGIVITIS; PATHOGENS; PREGNANCY; DYNAMICS; HORMONES	Polycystic ovary syndrome (PCOS) is a hormonal disorder of women that not only is the leading cause of infertility but also shows a reciprocal link with oral health. This study aimed to investigate the hypothesis that the levels of putative periodontal pathogens in saliva and their antibody response in serum are elevated in PCOS, compared to systemic health. A total of 125 women were included in four groups; 45 women with PCOS and healthy periodontium, 35 women with PCOS and gingivitis, 25 systemically and periodontally healthy women, 20 systemically healthy women with gingivitis. Salivary levels of seven putative periodontal pathogens were analyzed by quantitative real-time polymerase chain reaction and serum antibody levels were analyzed by ELISA. In women with PCOS, salivary Porphyromonas gingivalis, Fusobacterium nucleatum, Streptococcus oralis and Tannerella forsythia levels were higher than matched systemically healthy women, particularly in the case of gingivitis. Aggregatibacter actinomycetemcomitans and Treponema denticola levels were similar among study groups. The presence of PCOS also enhanced P. gingivalis, Prevotella intermedia and S. oralis serum antibody levels, when gingivitis was also present. Gingival inflammation correlated positively with levels of the studied taxa in saliva, particularly in PCOS. The presence of P. gingivalis and F. nucleatum in saliva also exhibited a strong positive correlation with the corresponding serum antibody levels. In conclusion, as an underlying systemic endocrine condition, PCOS may quantitatively affect the composition of oral microbiota and the raised systemic response to selective members of this microbial community, exerting a confounding role in resultant gingival inflammation and periodontal health. The most consistent effect appeared to be exerted on P. gingivalis.	[Akcali, Aliye; Bostanci, Nagihan; Belibasakis, Georgios N.] Univ Zurich, Inst Oral Biol, Ctr Dent Med, Zurich, Switzerland; [Akcali, Aliye; Ozcaka, Ozgun; Gumus, Pinar; Buduneli, Nurcan] Ege Univ, Sch Dent, Dept Periodontol, Izmir, Turkey; [Ozturk-Ceyhan, Banu] Aydin Govt Hosp, Sch Med, Dept Endocrinol, Aydin, Turkey	University of Zurich; Ege University; Aydin State Hospital	Belibasakis, GN (corresponding author), Univ Zurich, Inst Oral Biol, Ctr Dent Med, Zurich, Switzerland.	george.belibasakis@zzm.uzh.ch	Belibasakis, Georgios/AAL-3159-2020; AKCALI, Aliye/ABF-4819-2020; Bostanci, Nagihan/ABD-5524-2020	Belibasakis, Georgios/0000-0002-8164-0653; Bostanci, Nagihan/0000-0002-6742-3556	Continental European Division of the International Association of Dental Research; Institute of Oral Biology, Center of Dental Medicine, University of Zurich	Continental European Division of the International Association of Dental Research; Institute of Oral Biology, Center of Dental Medicine, University of Zurich	This study was supported by a Visiting Research Fellowship (AA) of the Continental European Division of the International Association of Dental Research, and the Institute of Oral Biology, Center of Dental Medicine, University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens LA, 2009, J PERIODONTOL, V80, P72, DOI [10.1902/jop.2009.080012, 10.1902/jop.2009.080012 ]; Albandar JM, 2001, J PERIODONTOL, V72, P1463, DOI 10.1902/jop.2001.72.11.1463; Ammann TW, 2013, J PERIODONTAL RES, V48, P517, DOI 10.1111/jre.12034; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Awartani F, 2010, J CONT DENT PRACT, V11, P1, DOI DOI 10.5005/jcdp-11-3-1; Belibasakis GN, 2014, J PERIODONTOL, V85, P204, DOI 10.1902/jop.2013.130144; BIMSTEIN E, 1991, Pediatric Dentistry, V13, P267; Craig RG, 2002, J PERIODONTAL RES, V37, P132, DOI 10.1034/j.1600-0765.2002.00031.x; Dokras A, 2013, STEROIDS, V78, P773, DOI 10.1016/j.steroids.2013.04.009; Dursun E, 2011, FERTIL STERIL, V95, P320, DOI 10.1016/j.fertnstert.2010.07.1052; Dye BA, 2009, J PERIODONTOL, V80, P634, DOI 10.1902/jop.2009.080474; Ebejer K, 2013, GYNECOL ENDOCRINOL, V29, P536, DOI 10.3109/09513590.2012.760195; Ebersole JL, 2008, J PERIODONTOL, V79, P637, DOI [10.1902/jop.2008.070455, 10.1902/jop.2008.070455 ]; EBERSOLE JL, 1987, J PERIODONTAL RES, V22, P184, DOI 10.1111/j.1600-0765.1987.tb01563.x; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; GMUR R, 1986, INFECT IMMUN, V52, P768; Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x; HAFFAJEE AD, 1984, J CLIN PERIODONTOL, V11, P600, DOI 10.1111/j.1600-051X.1984.tb00913.x; Hsu MI, 2013, STEROIDS, V78, P761, DOI 10.1016/j.steroids.2013.04.005; Hwang AM, 2014, J PERIODONTOL, V85, P592, DOI 10.1902/jop.2013.130172; JENSEN J, 1981, J PERIODONTOL, V52, P599, DOI 10.1902/jop.1981.52.10.599; KINANE DF, 1993, ORAL MICROBIOL IMMUN, V8, P65, DOI 10.1111/j.1399-302X.1993.tb00546.x; Kinney JS, 2011, J DENT RES, V90, P752, DOI 10.1177/0022034511399908; KORNMAN KS, 1980, J PERIODONTAL RES, V15, P111, DOI 10.1111/j.1600-0765.1980.tb00265.x; Kumar PS, 2013, PERIODONTOL 2000, V61, P103, DOI 10.1111/j.1600-0757.2011.00398.x; Lebbe M, 2013, MOL HUM REPROD, V19, P828, DOI 10.1093/molehr/gat065; Lim SS, 2013, OBES REV, V14, P95, DOI 10.1111/j.1467-789X.2012.01053.x; Loe H, 1967, J Periodontol, V38; Mariotti A, 2013, PERIODONTOL 2000, V61, P69, DOI 10.1111/j.1600-0757.2011.00424.x; Moutsopoulos NM, 2006, ANN NY ACAD SCI, V1088, P251, DOI 10.1196/annals.1366.032; Muramatsu Yasuko, 1994, Bulletin of Tokyo Dental College, V35, P139; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Ozcaka O, 2013, J PERIODONTOL, V84, P1827, DOI 10.1902/jop.2013.120483; Ozcaka O, 2012, J PERIODONTOL, V83, P1529, DOI 10.1902/jop.2012.110588; Papapanou PN, 2004, J CLIN PERIODONTOL, V31, P985, DOI 10.1111/j.1600-051X.2004.00599.x; Pussinen PJ, 2011, J CLIN PERIODONTOL, V38, P405, DOI 10.1111/j.1600-051X.2011.01703.x; RABERDURLACHER JE, 1994, J CLIN PERIODONTOL, V21, P549, DOI 10.1111/j.1600-051X.1994.tb01172.x; Ramseier CA, 2009, J PERIODONTOL, V80, P436, DOI [10.1902/jop.2009.080480, 10.1902/jop.2009.080480 ]; Stein IF, 1935, AM J OBSTET GYNECOL, V29, P181, DOI 10.1016/S0002-9378(15)30642-6; SUZUKI JB, 1984, J PERIODONTAL RES, V19, P599, DOI 10.1111/j.1600-0765.1984.tb01323.x; Tanner ACR, 2000, J CLIN PERIODONTOL, V27, P473, DOI 10.1034/j.1600-051x.2000.027007473.x; Ueno M, 2012, INT HEART J, V53, P209, DOI 10.1536/ihj.53.209; Vlachojannis C, 2010, J CLIN PERIODONTOL, V37, P685, DOI 10.1111/j.1600-051X.2010.01592.x; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]	44	35	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e108074	10.1371/journal.pone.0108074	http://dx.doi.org/10.1371/journal.pone.0108074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232962	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000342921200079
J	Farzadi, A; Solati-Hashjin, M; Asadi-Eydivand, M; Abu Osman, NA				Farzadi, Arghavan; Solati-Hashjin, Mehran; Asadi-Eydivand, Mitra; Abu Osman, Noor Azuan			Effect of Layer Thickness and Printing Orientation on Mechanical Properties and Dimensional Accuracy of 3D Printed Porous Samples for Bone Tissue Engineering	PLOS ONE			English	Article							SOLID FREEFORM FABRICATION; CALCIUM-PHOSPHATE; 3-DIMENSIONAL SCAFFOLDS; HYDROXYAPATITE; PRINTABILITY; REGENERATION; SUBSTITUTES; CERAMICS; PURPOSES; POWDERS	Powder-based inkjet 3D printing method is one of the most attractive solid free form techniques. It involves a sequential layering process through which 3D porous scaffolds can be directly produced from computer-generated models. 3D printed products' quality are controlled by the optimal build parameters. In this study, Calcium Sulfate based powders were used for porous scaffolds fabrication. The printed scaffolds of 0.8 mm pore size, with different layer thickness and printing orientation, were subjected to the depowdering step. The effects of four layer thicknesses and printing orientations, (parallel to X, Y and Z), on the physical and mechanical properties of printed scaffolds were investigated. It was observed that the compressive strength, toughness and Young's modulus of samples with 0.1125 and 0.125 mm layer thickness were more than others. Furthermore, the results of SEM and mu CT analyses showed that samples with 0.1125 mm layer thickness printed in X direction have more dimensional accuracy and significantly close to CAD software based designs with predefined pore size, porosity and pore interconnectivity.	[Farzadi, Arghavan; Solati-Hashjin, Mehran; Asadi-Eydivand, Mitra; Abu Osman, Noor Azuan] Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur, Malaysia; [Solati-Hashjin, Mehran] Amirkabir Univ Technol, Biomat Ctr Excellence, Tehran, Iran	Universiti Malaya; Amirkabir University of Technology	Farzadi, A (corresponding author), Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur, Malaysia.	arghavan@um.edu.my	Asadi-Eydivand, Mitra/H-4092-2019; ABU OSMAN, NOOR AZUAN/B-9265-2010; Solati-Hashjin, Mehran/X-8822-2019	Asadi-Eydivand, Mitra/0000-0002-7809-7880; ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421; Solati-Hashjin, Mehran/0000-0002-1187-1237	High Impact Research UM/MOHE/HIR Project [D000010-16001]	High Impact Research UM/MOHE/HIR Project	This study was supported by High Impact Research UM/MOHE/HIR Project no. D000010-16001. AAO received this funding for completing this project. www.hir.um.edu.my. The funder had no role in study design, and preparation of the manuscript.	Bergmann C, 2010, J EUR CERAM SOC, V30, P2563, DOI 10.1016/j.jeurceramsoc.2010.04.037; Bibb R, 2011, MED ENG PHYS, V33, P590, DOI 10.1016/j.medengphy.2010.12.015; Billiet T, 2012, BIOMATERIALS, V33, P6020, DOI 10.1016/j.biomaterials.2012.04.050; Bose S, 2013, MATER TODAY, V16, P496, DOI 10.1016/j.mattod.2013.11.017; Butscher A, 2013, ACTA BIOMATER, V9, P9149, DOI 10.1016/j.actbio.2013.07.019; Butscher A, 2013, ACTA BIOMATER, V9, P5369, DOI 10.1016/j.actbio.2012.10.009; Butscher A, 2011, ACTA BIOMATER, V7, P907, DOI 10.1016/j.actbio.2010.09.039; Butscher A, 2012, ACTA BIOMATER, V8, P373, DOI 10.1016/j.actbio.2011.08.027; Castilho M, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/1/015006; Castilho M, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035012; Chua CK, 2012, INNOVATIVE DEVELOPMENTS ON VIRTUAL AND PHYSICAL PROTOTYPING, P13, DOI 10.1201/b11341-4; Chumnanklang R, 2007, MAT SCI ENG C-BIO S, V27, P914, DOI 10.1016/j.msec.2006.11.004; Declercq HA, 2013, ACTA BIOMATER, V9, P7699, DOI 10.1016/j.actbio.2013.05.003; Dimitrov D, 2006, RAPID PROTOTYPING J, V12, P42, DOI 10.1108/13552540610637264; Gbureck U, 2007, ADV FUNCT MATER, V17, P3940, DOI 10.1002/adfm.200700019; Inzana JA, 2014, BIOMATERIALS, V35, P4026, DOI 10.1016/j.biomaterials.2014.01.064; Jones JR, 2003, CURR OPIN SOLID ST M, V7, P301, DOI 10.1016/j.cossms.2003.09.012; Kumar S, 2010, MATER DESIGN, V31, P850, DOI 10.1016/j.matdes.2009.07.045; Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9; Leukers B, 2005, J MATER SCI-MATER M, V16, P1121, DOI 10.1007/s10856-005-4716-5; Liu C, 2007, CHEM ENG RES DES, V85, P1051, DOI 10.1205/cherd06196; Liu W, 2013, J NANOMATERIALS; Lu K, 2008, POWDER TECHNOL, V187, P11, DOI 10.1016/j.powtec.2007.12.017; Peltola SM, 2008, ANN MED, V40, P268, DOI 10.1080/07853890701881788; Seitz H, 2005, J BIOMED MATER RES B, V74B, P782, DOI 10.1002/jbm.b.30291; Serra T, 2013, ACTA BIOMATER, V9, P5521, DOI 10.1016/j.actbio.2012.10.041; Shanjani Y, 2011, ACTA BIOMATER, V7, P1788, DOI 10.1016/j.actbio.2010.12.017; Shanjani Y, 2010, J BIOMED MATER RES B, V93B, P510, DOI 10.1002/jbm.b.31610; Suwanprateeb J, 2012, RAPID PROTOTYPING J, V18, P490, DOI 10.1108/13552541211272036; Suwanprateeb J, 2010, MAT SCI ENG C-MATER, V30, P610, DOI 10.1016/j.msec.2010.02.014; Tian X., 2011, NET SHAPING CERAMIC; Utela B., 2008, J MANUF PROCESS, V10, P96, DOI [DOI 10.1016/J.JMAPRO.2009.03.002, 10.1016/j.jmapro.2009.03.002]; Vaezi M, 2011, INT J ADV MANUF TECH, V53, P275, DOI 10.1007/s00170-010-2821-1; Vorndran E, 2008, ADV ENG MATER, V10, pB67, DOI 10.1002/adem.200800179; Will J, 2013, CHARACTERIZATION OF BIOMATERIALS, P299, DOI 10.1016/B978-0-12-415800-9.00008-5; Withell A., 2011, INNOVATIVE DEV VIRTU, P313; Wu CT, 2012, J MATER CHEM, V22, P12288, DOI 10.1039/c2jm30566f; Yan X, 1996, COMPUT AIDED DESIGN, V28, P307, DOI 10.1016/0010-4485(95)00035-6; Yoo J, 1993, SOLID FREE FABR S, V11; Zhou Z, 2012, ISRN BIOMATERIALS, V2013, P1; Zhou ZX, 2014, MAT SCI ENG C-MATER, V38, P1, DOI 10.1016/j.msec.2014.01.027	41	157	166	4	149	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e108252	10.1371/journal.pone.0108252	http://dx.doi.org/10.1371/journal.pone.0108252			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233468	Green Submitted, gold, Green Published			2022-12-25	WOS:000342921200090
J	Ferro, VG; Lemes, P; Melo, AS; Loyola, R				Ferro, Viviane G.; Lemes, Priscila; Melo, Adriano S.; Loyola, Rafael			The Reduced Effectiveness of Protected Areas under Climate Change Threatens Atlantic Forest Tiger Moths	PLOS ONE			English	Article							CLIMATICALLY SUITABLE AREAS; SPATIAL CONSERVATION PRIORITIES; SPECIES DISTRIBUTION; BIODIVERSITY CONSERVATION; RANGE SHIFTS; LEPIDOPTERA; ARCTIIDAE; RESERVES; STRATEGIES; HERBIVORY	Climate change leads to species' range shifts, which may end up reducing the effectiveness of protected areas. These deleterious changes in biodiversity may become amplified if they include functionally important species, such as herbivores or pollinators. We evaluated how effective protected areas in the Brazilian Atlantic Forest are in maintaining the diversity of tiger moths (Arctiinae) under climate change. Specifically, we assessed whether protected areas will gain or lose species under climate change and mapped their locations in the Atlantic Forest, in order to assess potential spatial patterns of protected areas that will gain or lose species richness. Comparisons were completed using modeled species occurrence data based on the current and projected climate in 2080. We also built a null model for random allocation of protected areas to identify where reductions in species richness will be more severe than expected. We employed several modern techniques for modeling species' distributions and summarized results using ensembles of models. Our models indicate areas of high species richness in the central and southern regions of the Atlantic Forest both for now and the future. However, we estimate that in 2080 these regions should become climatically unsuitable, decreasing the species' distribution area. Around 4% of species were predicted to become extinct, some of them being endemic to the biome. Estimates of species turnover from current to future climate tended to be high, but these findings are dependent on modeling methods. Our most important results show that only a few protected areas in the southern region of the biome would gain species. Protected areas in semideciduous forests in the western region of the biome would lose more species than expected by the null model employed. Hence, current protected areas are worse off, than just randomly selected areas, at protecting species in the future.	[Ferro, Viviane G.; Melo, Adriano S.; Loyola, Rafael] Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil; [Lemes, Priscila] Univ Fed Goias, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Loyola, R (corresponding author), Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil.	rdiasloyola@gmail.com	Melo, Adriano Sanches/D-6859-2013; Ferro, Viviane G/E-2556-2013; Loyola, Rafael/A-4425-2008; Loyola, Rafael/S-3978-2019	Loyola, Rafael/0000-0001-5323-2735; Loyola, Rafael/0000-0001-5323-2735; Melo, Adriano Sanches/0000-0002-4695-2854	CNPq [563332/2010-7, 304703/2011-7, 307479/2011-0]; CAPES-FCT Program; Brazilian Research Network on Global Climate Change (Rede CLIMA); Conservation International Brazil; Site 13 (Parque Nacional das Emas) of the Brazilian Long Term Ecological Research Network (CNPq) [558187/2009-9]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-FCT Program; Brazilian Research Network on Global Climate Change (Rede CLIMA); Conservation International Brazil; Site 13 (Parque Nacional das Emas) of the Brazilian Long Term Ecological Research Network (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	VGF work is funded by CNPq (grant #563332/2010-7). PL received a PhD studentship from CNPq. RDL and ASM received productivity fellowships granted by CNPq (grants #304703/2011-7 and #307479/2011-0, respectively). RDL work is funded by CAPES-FCT Program, by the Brazilian Research Network on Global Climate Change (Rede CLIMA), and Conservation International Brazil. This study benefited from resources provided by Site 13 (Parque Nacional das Emas) of the Brazilian Long Term Ecological Research Network (CNPq, grant #558187/2009-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Betzholtz PE, 2002, J INSECT CONSERV, V6, P57, DOI 10.1023/A:1015794522642; Bouchard M, 2006, ECOLOGY, V87, P2319, DOI 10.1890/0012-9658(2006)87[2319:FDASSB]2.0.CO;2; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; CARPENTER G, 1993, BIODIVERS CONSERV, V2, P667, DOI 10.1007/BF00051966; Chapman SK, 2003, ECOLOGY, V84, P2867, DOI 10.1890/02-0046; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Conrad KF, 2002, BIOL CONSERV, V106, P329, DOI 10.1016/S0006-3207(01)00258-0; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Diniz JAF, 2010, INSECT CONSERV DIVER, V3, P213, DOI 10.1111/j.1752-4598.2010.00090.x; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Duarte M, 2012, INSETOS BRASIL DIVER, P625; Faleiro FV, 2013, BIOL CONSERV, V158, P248, DOI 10.1016/j.biocon.2012.09.020; Diniz JAF, 2010, REV BRAS ENTOMOL, V54, P339, DOI 10.1590/S0085-56262010000300001; FERRO V. G., 2010, CERRADO CONHECIMENTO, P255; Ferro VG, 2007, REV BRAS ZOOL, V24, P635, DOI 10.1590/S0101-81752007000300015; Ferro VG, 2011, J INSECT CONSERV, V15, P643, DOI 10.1007/s10841-010-9363-6; Ferro VG, 2012, ZOOLOGIA-CURITIBA, V29, P7, DOI 10.1590/S1984-46702012000100002; Franklin J, 2009, MAPPING SPECIES DIST; Garcia RA, 2012, GLOBAL CHANGE BIOL, V18, P1253, DOI 10.1111/j.1365-2486.2011.02605.x; Griffith B, 2009, ENVIRON MANAGE, V44, P1043, DOI 10.1007/s00267-009-9323-7; Grimaldi David, 2005, pi; Gutierrez AP, 2006, ACTA OECOL, V30, P353, DOI 10.1016/j.actao.2006.06.003; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hannah L, 2010, CONSERV BIOL, V24, P70, DOI 10.1111/j.1523-1739.2009.01405.x; HEPPNER J B, 1991, Tropical Lepidoptera, V2, P1; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hodar JA, 2004, BIODIVERS CONSERV, V13, P493, DOI 10.1023/B:BIOC.0000009495.95589.a7; IUCN UNEP, 2010, WORLD DAT PROT AR WD, P1; Klorvuttimontara S, 2011, BIOL CONSERV, V144, P2534, DOI 10.1016/j.biocon.2011.07.012; Kocsis M, 2011, APPL ECOL ENV RES, V9, P43, DOI 10.15666/aeer/0901_043072; Lemes P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054323; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Logan JA, 2003, FRONT ECOL ENVIRON, V1, P130, DOI 10.2307/3867985; Loucks C, 2008, J BIOGEOGR, V35, P1337, DOI 10.1111/j.1365-2699.2008.01899.x; Loyola Rafael D., 2012, Alytes (Paris), V29, P61; Loyola RD, 2013, BIODIVERS CONSERV, V22, P483, DOI 10.1007/s10531-012-0424-x; Loyola RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046257; Loyola RD, 2009, BIODIVERS CONSERV, V18, P2017, DOI 10.1007/s10531-008-9570-6; Manel S, 1999, J APPL ECOL, V36, P734, DOI 10.1046/j.1365-2664.1999.00440.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; MARQUIS RJ, 1984, SCIENCE, V226, P537, DOI 10.1126/science.226.4674.537; Mawdsley J, 2011, WIRES CLIM CHANGE, V2, P498, DOI 10.1002/wcc.127; Mawdsley JR, 2009, CONSERV BIOL, V23, P1080, DOI 10.1111/j.1523-1739.2009.01264.x; Moilanen A, 2009, SPATIAL CONSERVATION; Monzon J, 2011, BIOSCIENCE, V61, P752, DOI 10.1525/bio.2011.61.10.5; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nori J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025718; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson R. G., 2007, SPECIES DISTRIBUTION, P1; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Pellmyr O, 2003, ANN MO BOT GARD, V90, P35, DOI 10.2307/3298524; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2012, NAT CONSERVACAO, V10, P102, DOI 10.4322/natcon.2012.019; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Rangel TF, 2012, NAT CONSERVACAO, V10, P119, DOI 10.4322/natcon.2012.030; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Singer RB, 2007, FUNCTIONAL ECOSYSTEM, V1, P10; Speight M.R., 2008, ECOLOGY INSECTS CONC, V2nd ed.; STOCKWELL DRB, 1992, MATH COMPUT SIMULAT, V33, P385, DOI 10.1016/0378-4754(92)90126-2; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; WAGNER D. L., 2008, TIGER MOTHS WOOLLY B, P31; Wasserthal LT, 1997, BOT ACTA, V110, P343, DOI 10.1111/j.1438-8677.1997.tb00650.x; Weller SJ, 1999, BIOL J LINN SOC, V68, P557, DOI 10.1111/j.1095-8312.1999.tb01188.x; Wiens JA, 2011, BIOL CONSERV, V144, P2119, DOI 10.1016/j.biocon.2011.05.002; Williams P, 2005, CONSERV BIOL, V19, P1063, DOI 10.1111/j.1523-1739.2005.00080.x; Yamanaka T, 2001, ENVIRON ENTOMOL, V30, P1150, DOI 10.1603/0046-225X-30.6.1150; Zahiri R, 2012, SYST ENTOMOL, V37, P102, DOI 10.1111/j.1365-3113.2011.00607.x; Zanuncio JC, 1998, FOREST ECOL MANAG, V108, P85, DOI 10.1016/S0378-1127(98)00215-1	80	52	53	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107792	10.1371/journal.pone.0107792	http://dx.doi.org/10.1371/journal.pone.0107792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229422	Green Submitted, Green Published, gold			2022-12-25	WOS:000342123900074
J	Guarnieri, S; Morabito, C; Belia, S; Barberi, L; Musaro, A; Fano-Illic, G; Mariggio, MA				Guarnieri, Simone; Morabito, Caterina; Belia, Silvia; Barberi, Laura; Musaro, Antonio; Fano-Illic, Giorgio; Mariggio, Maria A.			New Insights into the Relationship between mIGF-1-Induced Hypertrophy and Ca2+ Handling in Differentiated Satellite Cells	PLOS ONE			English	Article							SKELETAL-MUSCLE; GROWTH-FACTOR; EXTRACELLULAR GUANOSINE; IGF-1; REGENERATION; CALCINEURIN; EXPRESSION; FATIGUE; ACTIVATION; CURRENTS	Muscle regeneration involves the activation of satellite cells, is regulated at the genetic and epigenetic levels, and is strongly influenced by gene activation and environmental conditions. The aim of this study was to determine whether the overexpression of mIGF-1 can modify functional features of satellite cells during the differentiation process, particularly in relation to modifications of intracellular Ca2+ handling. Satellite cells were isolated from wild-type and MLC/mIGF-1 transgenic mice. The cells were differentiated in vitro, and morphological analyses, intracellular Ca2+ measurements, and ionic current recordings were performed. mIGF-1 overexpression accelerates satellite cell differentiation and promotes myotube hypertrophy. In addition, mIGF-1 overexpression-induced potentiation of myogenesis triggers both quantitative and qualitative changes to the control of intracellular Ca2+ handling. In particular, the differentiated MLC/mIGF-1 transgenic myotubes have reduced velocity and amplitude of intracellular Ca2+ increases after stimulation with caffeine, KCl and acetylcholine. This appears to be due, at least in part, to changes in the physico-chemical state of the sarcolemma (increased membrane lipid oxidation, increased output currents) and to increased expression of dihydropyridine voltage-operated Ca2+ channels. Interestingly, extracellular ATP and GTP evoke intracellular Ca2+ mobilization to greater extents in the MLC/mIGF-1 transgenic satellite cells, compared to the wild-type cells. These data suggest that these MLC/mIGF-1 transgenic satellite cells are more sensitive to trophic stimuli, which can potentiate the effects of mIGF-1 on the myogenic programme.	[Guarnieri, Simone; Morabito, Caterina; Fano-Illic, Giorgio; Mariggio, Maria A.] Univ G dAnnunzio, StemTeCh Grp CeSI, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Guarnieri, Simone; Morabito, Caterina; Barberi, Laura; Musaro, Antonio; Fano-Illic, Giorgio; Mariggio, Maria A.] Interuniv Inst Myol, San Donato Milanese, Italy; [Belia, Silvia] Univ Perugia, Dept Cellular & Environm Biol, I-06100 Perugia, Italy; [Barberi, Laura; Musaro, Antonio] Univ Roma La Sapienza, DAHFMO Unit Histol & Med Embryol, Inst Pasteur Cenci Bolognetti, I-00185 Rome, Italy; [Musaro, Antonio] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy	G d'Annunzio University of Chieti-Pescara; University of Perugia; Fondazione Cenci Bolognetti; Sapienza University Rome; Istituto Italiano di Tecnologia - IIT	Mariggio, MA (corresponding author), Univ G dAnnunzio, StemTeCh Grp CeSI, Dept Neurosci Imaging & Clin Sci, Chieti, Italy.	mariggio@unich.it	Musaro, Antonio/P-2953-2019; Fanò-Illic, Giorgio/AAU-5731-2021; Musarò, Antonio/K-9598-2016; Guarnieri, Simone/AAA-5921-2020; Mariggiò, Maria Addolorata/T-9047-2017	Musaro, Antonio/0000-0002-2944-9739; Musarò, Antonio/0000-0002-2944-9739; Mariggiò, Maria Addolorata/0000-0001-5306-7143; Guarnieri, Simone/0000-0002-2916-2965; Fano Illic, Giorgio/0000-0002-8753-5707; Mariggio, Maria Addolorata/0000-0002-3508-8706; Morabito, Caterina/0000-0002-5144-2584	Ministero della Ricerca Scientifica (PRIN) [2007ABK385]; 'G. d'Annunzio' University of Chieti-Pescara; French Muscular Dystrophy Association (AFM); Telethon	Ministero della Ricerca Scientifica (PRIN)(Ministry of Education, Universities and Research (MIUR)); 'G. d'Annunzio' University of Chieti-Pescara; French Muscular Dystrophy Association (AFM)(Association Francaise contre les Myopathies); Telethon(Fondazione Telethon)	This study was supported by research funds from the Ministero della Ricerca Scientifica (PRIN 2007ABK385) to GFI and AM, from 'G. d'Annunzio' University of Chieti-Pescara to GFI and MAM, and from the French Muscular Dystrophy Association (AFM) and Telethon to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GR, 2002, J APPL PHYSIOL, V93, P1159, DOI 10.1152/japplphysiol.01264.2001; Belia S, 2009, FREE RADICAL RES, V43, P138, DOI 10.1080/10715760802629588; Bernheim L, 2002, NEWS PHYSIOL SCI, V17, P22; Borno A, 2012, PURINERG SIGNAL, V8, P255, DOI 10.1007/s11302-011-9279-y; Burnstock G, 2013, PURINERG SIGNAL, V9, P541, DOI 10.1007/s11302-013-9381-4; Carosio S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01420; Chin ER, 2005, J APPL PHYSIOL, V99, P414, DOI 10.1152/japplphysiol.00015.2005; Clark KD, 1997, J MEMBRANE BIOL, V157, P159, DOI 10.1007/s002329900225; Colombini B, 2009, J MUSCLE RES CELL M, V30, P199, DOI 10.1007/s10974-009-9187-8; Del Prete Z, 2008, ANN BIOMED ENG, V36, P1281, DOI 10.1007/s10439-008-9496-x; Di Capite J, 2009, CURR BIOL, V19, P853, DOI 10.1016/j.cub.2009.03.063; EDWALL D, 1989, ENDOCRINOLOGY, V124, P820, DOI 10.1210/endo-124-2-820; Fulle S, 2000, FREE RADICAL BIO MED, V29, P1252, DOI 10.1016/S0891-5849(00)00419-6; Fulle S, 2003, NEUROMUSCULAR DISORD, V13, P479, DOI 10.1016/S0960-8966(03)00042-7; Guarnieri S, 2004, NEUROSCIENCE, V128, P697, DOI 10.1016/j.neuroscience.2004.06.073; Guarnieri S, 2009, INT J DEV NEUROSCI, V27, P135, DOI 10.1016/j.ijdevneu.2008.11.007; Guarnieri S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053267; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hemmings SJ, 2001, CELL BIOCHEM FUNCT, V19, P133, DOI 10.1002/cbf.909; Hudson MB, 2013, INT J BIOCHEM CELL B, V45, P2173, DOI 10.1016/j.biocel.2013.06.029; Li TY, 2012, MOL CELL BIOL, V32, P3009, DOI 10.1128/MCB.06599-11; Lorenzon P, 2004, EXP GERONTOL, V39, P1545, DOI 10.1016/j.exger.2004.07.008; MANCINELLI L, 1983, CAN J PHYSIOL PHARM, V61, P590, DOI 10.1139/y83-090; Mancinelli R, 2012, PURINERG SIGNAL, V8, P207, DOI 10.1007/s11302-011-9266-3; Mariggio MA, 2010, HIGH ALT MED BIOL, V11, P333, DOI 10.1089/ham.2009.1097; Markworth JF, 2013, AM J PHYSIOL-CELL PH, V304, pC56, DOI 10.1152/ajpcell.00038.2012; Musaro A, 1999, MOL CELL BIOL, V19, P3115; Musaro A, 2004, P NATL ACAD SCI USA, V101, P1206, DOI 10.1073/pnas.0303792101; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Musaro A, 2010, METHODS MOL BIOL, V633, P101, DOI 10.1007/978-1-59745-019-5_8; Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690com; Philippou A, 2007, IN VIVO, V21, P45; Pietrangelo T, 2002, J MUSCLE RES CELL M, V23, P107, DOI 10.1023/A:1020288117082; Pietrangelo T, 2006, Purinergic Signal, V2, P633, DOI 10.1007/s11302-006-9021-3; Pietrangelo T, 2006, J PHYSIOL-LONDON, V572, P721, DOI 10.1113/jphysiol.2005.102194; Riquelme MA, 2013, NEUROPHARMACOLOGY; Ryten M, 2002, J CELL BIOL, V158, P345, DOI 10.1083/jcb.200202025; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; Scicchitano BM, 2009, AGING-US, V1, P451, DOI 10.18632/aging.100050; Semsarian C, 1999, NATURE, V400, P576, DOI 10.1038/23054; Tu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050157; Uhlen P, 2010, BIOCHEM BIOPH RES CO, V396, P28, DOI 10.1016/j.bbrc.2010.02.117; Wang ZM, 2002, BIOPHYS J, V82, P1338, DOI 10.1016/S0006-3495(02)75489-1; Zheng Z, 2004, J MEMBRANE BIOL, V197, P101, DOI 10.1007/s00232-003-0645-8	45	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107753	10.1371/journal.pone.0107753	http://dx.doi.org/10.1371/journal.pone.0107753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229238	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900072
J	Snyder, JM; Treuting, PM; Nagy, L; Yam, C; Yi, J; Brasfield, A; Nguyen, LPA; Hajjar, AM				Snyder, Jessica M.; Treuting, Piper M.; Nagy, Lee; Yam, Cathy; Yi, Jaehun; Brasfield, Alicia; Nguyen, Lisa Phuong Anh; Hajjar, Adeline M.			Humanized TLR7/8 Expression Drives Proliferative Multisystemic Histiocytosis in C57BL/6 Mice	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TOLL-LIKE RECEPTORS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; AUTOANTIBODY PRODUCTION; B-CELLS; MULTIPLE-SCLEROSIS; REGULATORY ROLES; DENDRITIC CELLS; ADAPTER MYD88; MURINE MODEL	A humanized TLR7/TLR8 transgenic mouse line was engineered for studies using TLR7/8 ligands as vaccine adjuvants. The mice developed a spontaneous immune-mediated phenotype prior to six months of age characterized by runting, lethargy, blepharitis, and corneal ulceration. Histological examination revealed a marked, multisystemic histiocytic infiltrate that effaced normal architecture. The histological changes were distinct from those previously reported in mouse models of systemic lupus erythematosus. When the mice were crossed with MyD88(-/-) mice, which prevented toll-like receptor signaling, the inflammatory phenotype resolved. Illness may be caused by constitutive activation of human TLR7 or TLR8 in the bacterial artificial chromosome positive mice as increased TLR7 and TLR8 expression or activation has previously been implicated in autoimmune disease.	[Snyder, Jessica M.; Treuting, Piper M.; Nagy, Lee; Yam, Cathy; Yi, Jaehun; Brasfield, Alicia; Nguyen, Lisa Phuong Anh; Hajjar, Adeline M.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Snyder, Jessica M.; Treuting, Piper M.] Univ Washington, Comparat Pathol Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hajjar, AM (corresponding author), Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA.	hajjar@uw.edu	Treuting, Piper M./AAB-2721-2019	Treuting, Piper M./0000-0002-1812-1519; Hajjar, Adeline/0000-0002-4838-8070	National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272200900036C]; National Center for Research Resources (NCRR) [R25 OD 010450-01A1]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R25OD010450] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID) under contract HHSN272200900036C (to Corixa Corporation d/b/a GlaxoSmithKline Vaccines) - AMH. A small portion of PMT's time was supported by grant R25 OD 010450-01A1 by the National Center for Research Resources (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akkina R, 2013, VIROLOGY, V435, P14, DOI 10.1016/j.virol.2012.10.007; Been RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097280; Buechler MB, 2013, J IMMUNOL, V190, P886, DOI 10.4049/jimmunol.1202739; Butchi NB, 2011, AM J PATHOL, V179, P783, DOI 10.1016/j.ajpath.2011.04.011; Cervantes JL, 2012, CELL MOL IMMUNOL, V9, P434, DOI 10.1038/cmi.2012.38; CHAN CC, 1995, J IMMUNOL, V154, P4830; Christensen SR, 2007, SEMIN IMMUNOL, V19, P11, DOI 10.1016/j.smim.2006.12.005; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Crookston KP, 2013, INT J RHEUM DIS, V16, P72, DOI 10.1111/1756-185x.12026; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Demaria O, 2010, J CLIN INVEST, V120, P3651, DOI 10.1172/JCI42081; FRITH CH, 1993, TOXICOL PATHOL, V21, P206, DOI 10.1177/019262339302100213; Giltiay NV, 2013, J EXP MED, V210, P2773, DOI 10.1084/jem.20122798; Guiducci C, 2013, J EXP MED, V210, P2903, DOI 10.1084/jem.20131044; Hajjar AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002963; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Jiang ZL, 2014, IMMUNOL LETT, V160, P17, DOI 10.1016/j.imlet.2014.03.006; Komatsuda A, 2008, CLIN EXP IMMUNOL, V152, P482, DOI 10.1111/j.1365-2249.2008.03646.x; Krieg AM, 2007, IMMUNITY, V27, P695, DOI 10.1016/j.immuni.2007.11.001; Lamagna C, 2013, P NATL ACAD SCI USA, V110, pE3311, DOI 10.1073/pnas.1300617110; Lang JL, 2013, J IMMUNOL, V190, P2090, DOI 10.4049/jimmunol.1202810; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Lim WH, 2007, BLOOD, V109, P1043, DOI 10.1182/blood-2005-12-024802; Mannava S, 2008, CELL CYCLE, V7, P2392, DOI 10.4161/cc.6390; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Marta M, 2008, EUR J IMMUNOL, V38, P565, DOI 10.1002/eji.200737187; Mashima R, 2010, LAB INVEST, V90, P1357, DOI 10.1038/labinvest.2010.121; Miranda-Hernandez S, 2011, J IMMUNOL, V187, P791, DOI 10.4049/jimmunol.1001992; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Nickerson KM, 2010, J IMMUNOL, V184, P1840, DOI 10.4049/jimmunol.0902592; Percy DH, 2007, PATHOLOGY LAB RODENT; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Richez C, 2011, JOINT BONE SPINE, V78, P124, DOI 10.1016/j.jbspin.2010.09.005; Rottman JB, 2010, VET PATHOL, V47, P664, DOI 10.1177/0300985810370005; Sadanaga A, 2007, ARTHRITIS RHEUM-US, V56, P1618, DOI 10.1002/art.22571; Santiago-Raber ML, 2008, J IMMUNOL, V181, P1556, DOI 10.4049/jimmunol.181.2.1556; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Teichmann LL, 2013, IMMUNITY, V38, P528, DOI 10.1016/j.immuni.2012.11.017; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; von Bernuth H, 2012, EUR J IMMUNOL, V42, P3126, DOI 10.1002/eji.201242683; Walsh ER, 2012, P NATL ACAD SCI USA, V109, P16276, DOI 10.1073/pnas.1209372109; Ward JM, 2014, VET PATHOL, V51, P88, DOI 10.1177/0300985813503571; Ward JM, 2004, TOXICOL PATHOL, V32, P710, DOI 10.1080/01926230490885706; WARD JM, 1993, VET PATHOL, V30, P560, DOI 10.1177/030098589303000610; Wexler AG, 2013, J NEUROIMMUNOL, V255, P60, DOI 10.1016/j.jneuroim.2012.11.004; WOFSY D, 1984, J EXP MED, V159, P629, DOI 10.1084/jem.159.2.629; Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034	51	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107257	10.1371/journal.pone.0107257	http://dx.doi.org/10.1371/journal.pone.0107257			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229618	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900035
J	Starling, MJ; Branson, N; Cody, D; Starling, TR; McGreevy, PD				Starling, Melissa J.; Branson, Nicholas; Cody, Denis; Starling, Timothy R.; McGreevy, Paul D.			Canine Sense and Sensibility: Tipping Points and Response Latency Variability as an Optimism Index in a Canine Judgement Bias Assessment	PLOS ONE			English	Article							COGNITIVE BIAS; STARLINGS; DOGS; INDICATORS; EMOTIONS; EXPOSURE; BEHAVIOR; ANIMALS; EXHIBIT; ANXIETY	Recent advances in animal welfare science used judgement bias, a type of cognitive bias, as a means to objectively measure an animal's affective state. It is postulated that animals showing heightened expectation of positive outcomes may be categorised optimistic, while those showing heightened expectations of negative outcomes may be considered pessimistic. This study pioneers the use of a portable, automated apparatus to train and test the judgement bias of dogs. Dogs were trained in a discrimination task in which they learned to touch a target after a tone associated with a lactose-free milk reward and abstain from touching the target after a tone associated with water. Their judgement bias was then probed by presenting tones between those learned in the discrimination task and measuring their latency to respond by touching the target. A Cox's Proportional Hazards model was used to analyse censored response latency data. Dog and Cue both had a highly significant effect on latency and risk of touching a target. This indicates that judgement bias both exists in dogs and differs between dogs. Test number also had a significant effect, indicating that dogs were less likely to touch the target over successive tests. Detailed examination of the response latencies revealed tipping points where average latency increased by 100% or more, giving an indication of where dogs began to treat ambiguous cues as predicting more negative outcomes than positive ones. Variability scores were calculated to provide an index of optimism using average latency and standard deviation at cues after the tipping point. The use of a mathematical approach to assessing judgement bias data in animal studies offers a more detailed interpretation than traditional statistical analyses. This study provides proof of concept for the use of an automated apparatus for measuring cognitive bias in dogs.	[Starling, Melissa J.; McGreevy, Paul D.] Univ Sydney, Fac Vet Sci, Camperdown, NSW, Australia; [Branson, Nicholas] Deakin Univ, Deakin Res, Burwood, Vic, Australia; [Cody, Denis] Indice Ecotech Pty Ltd, Camberwell, Vic, Australia; [Starling, Timothy R.] Wikimedia Fdn Inc, San Francisco, CA USA	University of Sydney; Deakin University; Wikimedia Foundation	Starling, MJ (corresponding author), Univ Sydney, Fac Vet Sci, Camperdown, NSW, Australia.	mjstarling@fastmail.com.au		McGreevy, Paul/0000-0001-7220-8378	Black Dog Wear; Positive Puppies	Black Dog Wear; Positive Puppies	This study had no official funding. Financial contributions were made by Black Dog Wear and Positive Puppies. Neither had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aust U, 2008, ANIM COGN, V11, P587, DOI 10.1007/s10071-008-0149-0; Bateson M, 2007, ANIM WELFARE, V16, P33; Bateson M, 2011, CURR BIOL, V21, P1070, DOI 10.1016/j.cub.2011.05.017; BENNETT MJ, 1966, J NUTR, V88, P163, DOI 10.1093/jn/88.1.163; Bethell EJ, 2012, ANIM WELFARE, V21, P185, DOI 10.7120/09627286.21.2.185; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Brilot BO, 2010, ANIM COGN, V13, P721, DOI 10.1007/s10071-010-0323-z; Brilot BO, 2009, APPL ANIM BEHAV SCI, V118, P182, DOI 10.1016/j.applanim.2009.02.015; Brydges NM, 2011, ANIM BEHAV, V81, P169, DOI 10.1016/j.anbehav.2010.09.030; Burman O, 2011, APPL ANIM BEHAV SCI, V132, P160, DOI 10.1016/j.applanim.2011.04.001; Burman OHP, 2008, BIOL LETTERS, V4, P330, DOI 10.1098/rsbl.2008.0113; Burman OHP, 2008, ANIM BEHAV, V76, P801, DOI 10.1016/j.anbehav.2008.02.014; Burman OHP, 2009, PHYSIOL BEHAV, V98, P345, DOI 10.1016/j.physbeh.2009.06.012; DAVIS M, 1982, J NEUROSCI, V2, P791; Destrez A, 2012, APPL ANIM BEHAV SCI, V139, P233, DOI 10.1016/j.applanim.2012.04.006; Douglas C, 2012, APPL ANIM BEHAV SCI, V139, P65, DOI 10.1016/j.applanim.2012.02.018; Doyle RE, 2011, PHYSIOL BEHAV, V102, P503, DOI 10.1016/j.physbeh.2011.01.001; Doyle RE, 2010, BEHAV PROCESS, V83, P349, DOI 10.1016/j.beproc.2010.01.019; Doyle RE, 2010, APPL ANIM BEHAV SCI, V122, P28, DOI 10.1016/j.applanim.2009.11.003; Dupjan S, 2013, J VET BEHAV, V8, P485, DOI 10.1016/j.jveb.2013.05.007; Duncan IJH, 2006, APPL ANIM BEHAV SCI, V100, P11, DOI 10.1016/j.applanim.2006.04.011; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; HINDE RA, 1985, ANIM BEHAV, V33, P985, DOI 10.1016/S0003-3472(85)80032-4; Korte SM, 2007, PHYSIOL BEHAV, V92, P422, DOI 10.1016/j.physbeh.2006.10.018; Lindstrom L., 2010, 189 SWED U AGR SCI D; Matheson SM, 2008, APPL ANIM BEHAV SCI, V109, P374, DOI 10.1016/j.applanim.2007.03.007; Mendl M, 2010, CURR BIOL, V20, pR839, DOI 10.1016/j.cub.2010.08.030; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Pomerantz O, 2012, ANIM COGN, V15, P689, DOI 10.1007/s10071-012-0497-7; Salmeto AL, 2011, BRAIN RES, V1373, P124, DOI 10.1016/j.brainres.2010.12.007; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.55.1.5; Tami G, 2011, ANIM WELFARE, V20, P185; Titulaer M, 2013, APPL ANIM BEHAV SCI, V147, P149, DOI 10.1016/j.applanim.2013.05.001; Villa AEP, 1998, BIOSYSTEMS, V48, P269, DOI 10.1016/S0303-2647(98)00074-4; Zajonc RB, 2001, CURR DIR PSYCHOL SCI, V10, P224, DOI 10.1111/1467-8721.00154	36	18	18	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107794	10.1371/journal.pone.0107794	http://dx.doi.org/10.1371/journal.pone.0107794			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229458	Green Submitted, Green Published, gold			2022-12-25	WOS:000342123900075
J	Brun, C; Demeaux, A; Guaddachi, F; Jean-Louis, F; Oddos, T; Bagot, M; Bensussan, A; Jauliac, S; Michel, L				Brun, Cecilia; Demeaux, Agathe; Guaddachi, Frederic; Jean-Louis, Francette; Oddos, Thierry; Bagot, Martine; Bensussan, Armand; Jauliac, Sebastien; Michel, Laurence			T-Plastin Expression Downstream to the Calcineurin/NFAT Pathway Is Involved in Keratinocyte Migration	PLOS ONE			English	Article							CELLS; DIFFERENTIATION; LIGAND	Cutaneous wound healing requires keratinocyte proliferation, migration and differentiation to restore the barrier function of the skin. The calcineurin/nuclear factor of activated-T-cell (NFAT) signaling pathway has been recently shown to be involved in keratinocyte growth, differentiation and migration. It is induced by an increased intracellular calcium rate and its inhibition results in decreased capacities of keratinocytes to migrate. Nevertheless, the link between calcineurin activation and keratinocyte migration remains unknown. Recently, Orai1, a pore subunit of a store-operated calcium channel that favors calcium influx, was shown to play a critical role to control proliferation and migration of basal keratinocytes. Of interest, the actin-bundling T-plastin is crucial in cell motility through cross-linking to actin filament and its synthesis was shown to be induced by calcium influx and regulated by the calcineurin/NFAT pathway in tumor Sezary cells. We investigated herein the role of the calcineurin/NFAT pathway-dependent T-plastin in keratinocyte migration, by quantifying T-plastin expression in keratinocytes and by analyzing their migration under calcineurin inhibition or knockdown of NFAT2 or T-plastin. We did confirm the role of the calcineurin/NFAT pathway in keratinocyte migration as shown by their decreased capacities to migrate after FK506 treatment or siNFAT2 transfection in both scratching and Boyden assays. The expression of NFAT2 and T-plastin in keratinocytes was decreased under FK506 treatment, suggesting that T-plastin plays a role in keratinocyte migration downstream to the calcineurin/NFAT pathway. Accordingly, siRNA knockdown of T-plastin expression also decreased their migration capacities. Actin lamellipodia formation as well as FAK and beta 6-integrin expression were also significantly decreased after treatment with FK506 or siRNA, reinforcing that NFAT2-dependent T-plastin expression plays a role in keratinocyte migration. These results indicate that T-plastin might be considered as a major actor in the mechanisms underlying calcineurin/NFAT-dependent keratinocyte migration and may explain wound-healing defects observed in patients under calcineurin inhibitor long-term treatment.	[Brun, Cecilia; Demeaux, Agathe; Guaddachi, Frederic; Jean-Louis, Francette; Bagot, Martine; Bensussan, Armand; Jauliac, Sebastien; Michel, Laurence] Hop St Louis, INSERM, U976, Ctr Rech Peau, Paris, France; [Brun, Cecilia; Demeaux, Agathe; Guaddachi, Frederic; Jean-Louis, Francette; Bagot, Martine; Bensussan, Armand; Jauliac, Sebastien; Michel, Laurence] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Brun, Cecilia; Oddos, Thierry] Johnson & Johnson Sante Beaute France, Ctr Rech, Val De Reuil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Johnson & Johnson	Michel, L (corresponding author), Hop St Louis, INSERM, U976, Ctr Rech Peau, Paris, France.	laurence.michel@inserm.fr	Jauliac, Sebastien/B-7847-2010; Bensussan, Armand/E-5434-2017; Michel, Laurence/E-8605-2017	Jauliac, Sebastien/0000-0002-1712-3416; Bensussan, Armand/0000-0002-0409-2497; BRUN, Cecilia/0000-0002-8421-1870	Johnson & Johnson Sante Beaute France	Johnson & Johnson Sante Beaute France	This work was supported by a grant from Johnson & Johnson Sante Beaute France. The funder provided support in the form of salaries for authors CB and TO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Begue E, 2012, BLOOD, V120, P143, DOI 10.1182/blood-2011-09-379156; Berthou C, 1997, J IMMUNOL, V159, P5293; Castello M, 2013, INDIAN J MED RES, V137, P1188; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; Giganti A, 2005, J CELL SCI, V118, P1255, DOI 10.1242/jcs.01698; Huang XZ, 1998, J CELL SCI, V111, P2189; Jans R, 2013, J INVEST DERMATOL, V133, P793, DOI 10.1038/jid.2012.370; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; LIN CS, 1993, J BIOL CHEM, V268, P2781; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; Moloney FJ, 2005, BRIT J DERMATOL, V153, P574, DOI 10.1111/j.1365-2133.2005.06699.x; NEUFAHRT A, 1976, ARCH DERMATOL RES, V256, P255, DOI 10.1007/BF00572490; O'Connor RS, 2007, J CELL SCI, V120, P149, DOI 10.1242/jcs.03307; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Vandenberghe M, 2013, P NATL ACAD SCI USA, V110, pE4839, DOI 10.1073/pnas.1310394110	15	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e104700	10.1371/journal.pone.0104700	http://dx.doi.org/10.1371/journal.pone.0104700			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226517	Green Published, gold, Green Submitted			2022-12-25	WOS:000344317700006
J	Nittka, S; Krueger, MA; Shively, JE; Boll, H; Brockmann, MA; Doyon, F; Pichler, BJ; Neumaier, M				Nittka, Stefanie; Krueger, Marcel A.; Shively, John E.; Boll, Hanne; Brockmann, Marc A.; Doyon, Fabian; Pichler, Bernd J.; Neumaier, Michael			Radioimmunoimaging of Liver Metastases with PET Using a Cu-64-Labeled CEA Antibody in Transgenic Mice	PLOS ONE			English	Article							HUMAN CARCINOEMBRYONIC-ANTIGEN; COMPLEXATION; XENOGRAFTS; EXPRESSION; CHELATORS; TUMORS; CU-64; MODEL	Purpose: Colorectal cancer is one of the most common forms of cancer, and the development of novel tools for detection and efficient treatment of metastases is needed. One promising approach is the use of radiolabeled antibodies for positron emission tomography (PET) imaging and radioimmunotherapy. Since carcinoembryonic antigen (CEA) is an important target in colorectal cancer, the CEA-specific M5A antibody has been extensively studied in subcutaneous xenograft models; however, the M5A antibody has not yet been tested in advanced models of liver metastases. The aim of this study was to investigate the Cu-64-DOTA-labeled M5A antibody using PET in mice bearing CEA-positive liver metastases. Procedures: Mice were injected intrasplenically with CEA-positive C15A.3 or CEA-negative MC38 cells and underwent micro-computed tomography (micro-CT) to monitor the development of liver metastases. After metastases were detected, PET/MRI scans were performed with Cu-64-DOTA-labeled M5A antibodies. H&E staining, immunohistology, and autoradiography were performed to confirm the micro-CT and PET/MRI findings. Results: PET/MRI showed that M5A uptake was highest in CEA-positive metastases. The %ID/cm(3) (16.5%+/- 66.3%) was significantly increased compared to healthy liver tissue (8.6%+/- 60.9%) and to CEA-negative metastases (5.5%+/- 60.6%). The tumor-to-liver ratio of C15A.3 metastases and healthy liver tissue was 1.9 +/- 0.7. Autoradiography and immunostaining confirmed the micro-CT and PET/MRI findings. Conclusion: We show here that the Cu-64-DOTA-labeled M5A antibody imaged by PET can detect CEA positive liver metastases and is therefore a potential tool for staging cancer, stratifying the patients or radioimmunotherapy.	[Nittka, Stefanie; Neumaier, Michael] Heidelberg Univ, Med Fac Mannheim, Inst Clin Chem, Mannheim, Germany; [Boll, Hanne; Brockmann, Marc A.] Heidelberg Univ, Med Fac Mannheim, Dept Neuroradiol, Mannheim, Germany; [Brockmann, Marc A.] Univ Hosp Rhein Westfaehl Tech Univ Aachen, Dept Diagnost & Intervent Neuroradiol, Aachen, Germany; [Doyon, Fabian] Heidelberg Univ, Med Fac Mannheim, Dept Surg, Mannheim, Germany; [Krueger, Marcel A.; Pichler, Bernd J.] Univ Tubingen, Werner Siemens Imaging Ctr, Dept Preclin Imaging & Radiopharm, Tubingen, Germany; [Shively, John E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA 91010 USA	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; RWTH Aachen University; RWTH Aachen University Hospital; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Siemens AG; City of Hope; Beckman Research Institute of City of Hope	Krueger, MA (corresponding author), Univ Tubingen, Werner Siemens Imaging Ctr, Dept Preclin Imaging & Radiopharm, Tubingen, Germany.	Marcel.Krueger@med.uni-tuebingen.de	Pichler, Bernd J/B-4483-2012	Krueger, Marcel Andre/0000-0002-7979-4549				Anderson CJ, 2008, Q J NUCL MED MOL IM, V52, P185; Anderson CJ, 2009, CANCER BIOTHER RADIO, V24, P379, DOI 10.1089/cbr.2009.0674; Blumenthal RD, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-2; Boll H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025692; Boll H, 2010, J COMPUT ASSIST TOMO, V34, P783, DOI 10.1097/RCT.0b013e3181e1050a; Brand MI, 1996, J SURG RES, V63, P425, DOI 10.1006/jsre.1996.0287; Bryan JN, 2011, CANCER BIOL THER, V11, P1001, DOI 10.4161/cbt.11.12.15528; Chakravarty R, 2014, THERANOSTICS, V4, P386, DOI 10.7150/thno.8006; Clarke P, 1998, CANCER RES, V58, P1469; CORBETT TH, 1975, CANCER RES, V35, P2434; Du XH, 2012, ONCOL REP, V28, P1743, DOI 10.3892/or.2012.2013; EADESPERNER AM, 1994, CANCER RES, V54, P4169; Elsasser-Beile U, 2009, J NUCL MED, V50, P606, DOI 10.2967/jnumed.108.058487; Ferdani R, 2012, DALTON T, V41, P1938, DOI 10.1039/c1dt11743b; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; FUJIMORI K, 1989, CANCER RES, V49, P5656; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; HAND PH, 1993, CANCER IMMUNOL IMMUN, V36, P65, DOI 10.1007/BF01754404; Heine M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036258; Hu SZ, 1996, CANCER RES, V56, P3055; Jain RK, 2012, COLD SPRING HARB PRO, V2012; Li L, 2006, BIOCONJUGATE CHEM, V17, P68, DOI 10.1021/bc0502614; Li L, 2008, BIOCONJUGATE CHEM, V19, P89, DOI 10.1021/bc700161p; Lin YC, 2006, J PHYS CHEM A, V110, P4244, DOI 10.1021/jp056789n; McCarthy DW, 1997, NUCL MED BIOL, V24, P35, DOI 10.1016/S0969-8051(96)00157-6; Pancione M, 2010, HUM PATHOL, V41, P867, DOI 10.1016/j.humpath.2009.09.019; Salavatifar M, 2011, HYBRIDOMA, V30, P229, DOI 10.1089/hyb.2011.0009; Szalai G, 2000, INT J CANCER, V85, P751, DOI 10.1002/(SICI)1097-0215(20000315)85:6<751::AID-IJC2>3.0.CO;2-8; Vavere AL, 2012, J NUCL MED, V53, P1772, DOI 10.2967/jnumed.112.104208; Wadas TJ, 2007, CURR PHARM DESIGN, V13, P3, DOI 10.2174/138161207779313768; Wilkinson RW, 2002, J NUCL MED, V43, P1368; Wong JYC, 1997, J NUCL MED, V38, P1951; Wu AM, 2000, P NATL ACAD SCI USA, V97, P8495, DOI 10.1073/pnas.150228297; Yazaki PJ, 2013, PROTEIN ENG DES SEL, V26, P187, DOI 10.1093/protein/gzs096; Yazaki PJ, 2004, PROTEIN ENG DES SEL, V17, P481, DOI 10.1093/protein/gzh056; Zeng DX, 2014, CHEM COMMUN, V50, P43, DOI 10.1039/c3cc45928d; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028005	37	12	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e106921	10.1371/journal.pone.0106921	http://dx.doi.org/10.1371/journal.pone.0106921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226518	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700022
J	Weidert, E; Pohler, SE; Gomez, EW; Dong, C				Weidert, Eric; Pohler, Steven E.; Gomez, Esther W.; Dong, Cheng			Actinomyosin Contraction, Phosphorylation of VE-Cadherin, and Actin Remodeling Enable Melanoma-Induced Endothelial Cell-Cell Junction Disassembly	PLOS ONE			English	Article							LIGHT-CHAIN PHOSPHORYLATION; BREAST-CANCER CELLS; P38 MAP KINASE; TRANSENDOTHELIAL MIGRATION; BARRIER FUNCTION; TYROSINE PHOSPHORYLATION; VASCULAR-PERMEABILITY; ADHERENS JUNCTIONS; IN-VIVO; INTERLEUKIN-8	During melanoma cell extravasation through the vascular endothelium, melanoma cells interact with endothelial cells through secretion of cytokines and by adhesion between proteins displayed on opposing cell surfaces. How these tumor cell associated signals together regulate the dynamics of intracellular signaling pathways within endothelial cells leading to endothelial cell-cell junction disruption is not well understood. Here, we used a combination of experimental and computational approaches to examine the individual and combined effects of activation of the vascular cell adhesion molecule (VCAM)-1, interleukin (IL)-8, and IL-1 beta signaling pathways on the integrity of vascular junctions. Our simulations predict a multifaceted interplay of signaling resulting from individual activation of VCAM-1, IL-8 and IL-1 beta pathways that is neither synergistic nor additive compared to all inputs turned on simultaneously. Furthermore, we show that the levels of phosphorylated proteins associated with actinomyosin contractility and junction disassembly peak prior to those related to actin remodeling. The results of this work provide insight into the dynamics of tumor-mediated endothelial junction disassembly and suggest that targeting proteins downstream of several interaction pathways may be the most effective therapeutic approach to reduce melanoma extravasation.	[Weidert, Eric; Gomez, Esther W.; Dong, Cheng] Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA; [Pohler, Steven E.; Gomez, Esther W.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gomez, EW (corresponding author), Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA.	ewgomez@engr.psu.edu; cxd23@psu.edu	Pohler, Steve/H-5161-2017	Pohler, Steve/0000-0002-1548-391X; Gomez, Esther/0000-0003-2082-013X	National Institutes of Health [CA-125707]; National Science Foundation [CBET-0729091]; Pennsylvania State University; NATIONAL CANCER INSTITUTE [R01CA125707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Pennsylvania State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (CA-125707) and National Science Foundation (CBET-0729091) to C.D. and by start-up funds from the Pennsylvania State University to E.W.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam AP, 2010, J BIOL CHEM, V285, P7045, DOI 10.1074/jbc.M109.079277; Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Bar-Eli M, 1999, PATHOBIOLOGY, V67, P12, DOI 10.1159/000028045; Bitar KN, 2002, AM J PHYSIOL-GASTR L, V282, pG894, DOI 10.1152/ajpgi.00141.2001; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Browne A, 2013, CYTOKINE, V64, P413, DOI 10.1016/j.cyto.2013.05.006; Chang E, 2011, BLOOD, V117, P2527, DOI 10.1182/blood-2010-08-302281; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Ferro T, 2000, AM J PHYSIOL-LUNG C, V278, pL1107, DOI 10.1152/ajplung.2000.278.6.L1107; Freund A, 2003, ONCOGENE, V22, P256, DOI 10.1038/sj.onc.1206113; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; GAROFALO A, 1995, CANCER RES, V55, P414; GOECKELER ZM, 1995, J CELL BIOL, V130, P613, DOI 10.1083/jcb.130.3.613; Guay J, 1997, J CELL SCI, V110, P357; Haidari M, 2012, J BIOL CHEM, V287, P32981, DOI 10.1074/jbc.M112.395905; Haidari M, 2011, CARDIOVASC RES, V92, P456, DOI 10.1093/cvr/cvr240; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; Hendriks BS, 2008, BIOTECHNOL PROGR, V24, P96, DOI 10.1021/bp070084g; Hoch RC, 1996, J LAB CLIN MED, V128, P134, DOI 10.1016/S0022-2143(96)90005-0; Inoue K, 2000, CANCER RES, V60, P2290; Khanna P, 2011, CELL MOL BIOENG, V4, P656, DOI 10.1007/s12195-011-0201-z; Khanna P, 2010, AM J PHYSIOL-CELL PH, V298, pC1140, DOI 10.1152/ajpcell.00242.2009; Kim SJ, 2001, NEOPLASIA, V3, P33, DOI 10.1038/sj.neo.7900124; Klemke M, 2007, J CELL PHYSIOL, V212, P368, DOI 10.1002/jcp.21029; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Liang S, 2008, AM J PHYSIOL-CELL PH, V295, pC701, DOI 10.1152/ajpcell.00245.2008; Lin Y, 2004, INT J CANCER, V109, P507, DOI 10.1002/ijc.11724; MATTILA P, 1992, INT J CANCER, V52, P918, DOI 10.1002/ijc.2910520615; Mierke CT, 2008, BIOPHYS J, V94, P2832, DOI 10.1529/biophysj.107.113613; Mierke CT, 2011, J BIOL CHEM, V286, P40025, DOI 10.1074/jbc.M111.256172; Mine S, 2002, ATHEROSCLEROSIS, V160, P281, DOI 10.1016/S0021-9150(01)00582-2; Nicolson GL, 1989, CURR OPIN CELL BIOL, V1, P1009, DOI 10.1016/0955-0674(89)90073-2; Peng HH, 2005, FRONT BIOSCI-LANDMRK, V10, P1597, DOI 10.2741/1643; Peng HH, 2009, CELL MOL BIOENG, V2, P375, DOI 10.1007/s12195-009-0067-5; Sandig M, 1997, CELL MOTIL CYTOSKEL, V38, P351, DOI 10.1002/(SICI)1097-0169(1997)38:4<351::AID-CM5>3.3.CO;2-Z; Sandoval R, 2001, J PHYSIOL-LONDON, V533, P433, DOI 10.1111/j.1469-7793.2001.0433a.x; Scalici JM, 2014, GYNECOL ONCOL, V132, P455, DOI 10.1016/j.ygyno.2013.12.031; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Shen Q, 2009, CELL HEALTH CYTOSKEL, V1, P43; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Siflinger-Birnboim A, 2003, AM J PHYSIOL-LUNG C, V284, pL435, DOI 10.1152/ajplung.00106.2002; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Stockton RA, 2004, J BIOL CHEM, V279, P46621, DOI 10.1074/jbc.M408877200; Stroeken PJM, 1998, CANCER RES, V58, P1569; Stroka KM, 2014, AM J PHYSIOL-CELL PH, V306, pC98, DOI 10.1152/ajpcell.00289.2013; Sun HR, 2006, MICROCIRCULATION, V13, P237, DOI 10.1080/10739680600556944; Tinsley JH, 1999, J BIOL CHEM, V274, P24930, DOI 10.1074/jbc.274.35.24930; TOMITA Y, 1995, INT J CANCER, V60, P753, DOI 10.1002/ijc.2910600604; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Vestweber D, 2009, TRENDS CELL BIOL, V19, P8, DOI 10.1016/j.tcb.2008.10.001; Wang Y, 2012, CYTOKINE, V59, P145, DOI 10.1016/j.cyto.2012.04.013; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Wittchen ES, 2009, FRONT BIOSCI-LANDMRK, V14, P2522, DOI 10.2741/3395; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Yano S, 2003, CANCER SCI, V94, P244, DOI 10.1111/j.1349-7006.2003.tb01428.x	57	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e108092	10.1371/journal.pone.0108092	http://dx.doi.org/10.1371/journal.pone.0108092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225982	Green Submitted, Green Published, gold			2022-12-25	WOS:000344317700098
J	Pasma, JH; Bijlsma, AY; Klip, JM; Stijntjes, M; Blauw, GJ; Muller, M; Meskers, CGM; Maier, AB				Pasma, Jantsje H.; Bijlsma, Astrid Y.; Klip, Janneke M.; Stijntjes, Marjon; Blauw, Gerard Jan; Muller, Majon; Meskers, Carel G. M.; Maier, Andrea B.			Blood Pressure Associates with Standing Balance in Elderly Outpatients	PLOS ONE			English	Article							WHITE-MATTER LESIONS; ORTHOSTATIC HYPOTENSION; OLDER-PEOPLE; CARDIOVASCULAR-DISEASE; CONSENSUS STATEMENT; RISK-FACTORS; FALLS; HYPERTENSION; MORTALITY; ADULTS	Objectives: Assessment of the association of blood pressure measurements in supine and standing position after a postural change, as a proxy for blood pressure regulation, with standing balance in a clinically relevant cohort of elderly, is of special interest as blood pressure may be important to identify patients at risk of having impaired standing balance in routine geriatric assessment. Materials and Methods: In a cross-sectional cohort study, 197 community-dwelling elderly referred to a geriatric outpatient clinic of a middle-sized teaching hospital were included. Blood pressure was measured intermittently (n = 197) and continuously (subsample, n = 58) before and after a controlled postural change from supine to standing position. The ability to maintain standing balance was assessed during ten seconds of side-by-side, semi-tandem and tandem stance, with both eyes open and eyes closed. Self-reported impaired standing balance and history of falls were recorded by questionnaires. Logistic regression analyses were used to examine the association between blood pressure and 1) the ability to maintain standing balance; 2) self-reported impaired standing balance; and 3) history of falls, adjusted for age and sex. Results: Blood pressure decrease after postural change, measured continuously, was associated with reduced ability to maintain standing balance in semi-tandem stance with eyes closed and with increased self-reported impaired standing balance and falls. Presence of orthostatic hypotension was associated with reduced ability to maintain standing balance in semi-tandem stance with eyes closed for both intermittent and continuous measurements and with increased self-reported impaired standing balance for continuous measurements. Conclusion: Continuous blood pressure measurements are of additional value to identify patients at risk of having impaired standing balance and may therefore be useful in routine geriatric care.	[Pasma, Jantsje H.] Leiden Univ, Med Ctr, Dept Rehabil Med, Leiden, Netherlands; [Bijlsma, Astrid Y.; Klip, Janneke M.; Stijntjes, Marjon; Blauw, Gerard Jan; Muller, Majon] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Bijlsma, Astrid Y.; Stijntjes, Marjon; Maier, Andrea B.] Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Sect Gerontol & Geriatr, Amsterdam, Netherlands; [Blauw, Gerard Jan] Bronovo Hosp, Dept Geriatr, The Hague, Netherlands; [Meskers, Carel G. M.] Vrije Univ Amsterdam, Med Ctr, Dept Rehabil Med, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Haaglanden Medical Center; Bronovo Hospital; Vrije Universiteit Amsterdam	Maier, AB (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Sect Gerontol & Geriatr, Amsterdam, Netherlands.	a.maier@vumc.nl	Blauw, Gerard/AAW-7904-2021; Maier, Andrea B./Q-5548-2019; Maier, Andrea/W-7060-2019; Blauw, Gerard/GWD-1079-2022	Maier, Andrea/0000-0001-7206-1724; Meskers, Carel/0000-0002-5056-5611; Pasma, Jantsje/0000-0002-8769-1021; Muller, Majon/0000-0002-7127-6413	Dutch Technology Foundation STW, Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs; MYOAGE [HEALTH-2007-2.4.5-10]; Netherlands Consortium for Healthy Aging (NCHA) [050-060-810]	Dutch Technology Foundation STW, Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs; MYOAGE; Netherlands Consortium for Healthy Aging (NCHA)	This study was supported by the Dutch Technology Foundation STW, which is part of the Netherlands Organisation for Scientific Research (NWO) and which is partly funded by the Ministry of Economic Affairs. Furthermore, this study was supported by the seventh framework program MYOAGE (HEALTH-2007-2.4.5-10) and 050-060-810 Netherlands Consortium for Healthy Aging (NCHA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate M, 2009, ARCH GERONTOL GERIAT, V49, P113, DOI 10.1016/j.archger.2008.05.008; BALOH RW, 1995, ARCH NEUROL-CHICAGO, V52, P970, DOI 10.1001/archneur.1995.00540340062013; Benvenuto LJ, 2011, AM J HYPERTENS, V24, P135, DOI 10.1038/ajh.2010.146; Cooke J, 2013, AGE AGEING, V42, P709, DOI 10.1093/ageing/aft112; Dart AM, 2006, HYPERTENSION, V47, P785, DOI 10.1161/01.HYP.0000209340.33592.50; Duschek S, 2013, PSYCHOPHYSIOLOGY, V50, P1183, DOI 10.1111/psyp.12136; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gangavati A, 2011, J AM GERIATR SOC, V59, P383, DOI 10.1111/j.1532-5415.2011.03317.x; Gibbons CH, 2006, NEUROLOGY, V67, P28, DOI 10.1212/01.wnl.0000223828.28215.0b; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hajjar I, 2011, CIRCULATION, V123, P858, DOI 10.1161/CIRCULATIONAHA.110.978114; Hausdorff JM, 2003, AM J CARDIOL, V91, P643, DOI 10.1016/S0002-9149(02)03332-5; Heitterachi E, 2002, AGE AGEING, V31, P181, DOI 10.1093/ageing/31.3.181; HORAK FB, 1989, NEUROBIOL AGING, V10, P727, DOI 10.1016/0197-4580(89)90010-9; Imholz BPM, 1998, CARDIOVASC RES, V38, P605, DOI 10.1016/S0008-6363(98)00067-4; James MA, 1999, AGE AGEING, V28, P522, DOI 10.1093/ageing/28.6.522; Lagro J, 2012, J HYPERTENS, V30, P1195, DOI 10.1097/HJH.0b013e328352b9fd; Lipsitz LA, 2000, STROKE, V31, P1897, DOI 10.1161/01.STR.31.8.1897; LIPSITZ LA, 1989, NEW ENGL J MED, V321, P952; LIU BA, 1995, J AM GERIATR SOC, V43, P1141, DOI 10.1111/j.1532-5415.1995.tb07016.x; Low PA, 2008, CLIN AUTON RES, V18, P8, DOI 10.1007/s10286-007-1001-3; Lucas SJE, 2010, HYPERTENSION, V55, P698, DOI 10.1161/HYPERTENSIONAHA.109.146290; MANCIA G, 1983, CIRC RES, V53, P96, DOI 10.1161/01.RES.53.1.96; Masley SC, 2006, J HUM HYPERTENS, V20, P392, DOI 10.1038/sj.jhh.1002002; Matinolli M, 2009, MOVEMENT DISORD, V24, P745, DOI 10.1002/mds.22457; Maurer Mathew S, 2004, J Am Med Dir Assoc, V5, P233, DOI 10.1097/01.JAM.0000129837.51514.93; Mehagnoul-Schipper DJ, 2000, STROKE, V31, P1615, DOI 10.1161/01.STR.31.7.1615; Muir SW, 2010, J CLIN EPIDEMIOL, V63, P389, DOI 10.1016/j.jclinepi.2009.06.010; Novak V, 1998, STROKE, V29, P104, DOI 10.1161/01.STR.29.1.104; Novak V, 2009, MAGN RESON IMAGING, V27, P752, DOI 10.1016/j.mri.2009.01.010; Odden MC, 2012, ARCH INTERN MED, V172, P1162, DOI 10.1001/archinternmed.2012.2555; OVERSTALL PW, 1977, BRIT MED J, V1, P261, DOI 10.1136/bmj.1.6056.261; Pantoni L, 1997, STROKE, V28, P652, DOI 10.1161/01.STR.28.3.652; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Rickards CA, 2007, AVIAT SPACE ENVIR MD, V78, P653; Rockwood MRH, 2012, ARCH GERONTOL GERIAT, V54, pE255, DOI 10.1016/j.archger.2011.12.009; Romero-Ortuno R, 2011, J AM GERIATR SOC, V59, P655, DOI 10.1111/j.1532-5415.2011.03352.x; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Schatz IJ, 1996, NEUROLOGY, V46, P1470, DOI 10.1212/wnl.46.5.1470; Starr JM, 2003, J NEUROL NEUROSUR PS, V74, P94, DOI 10.1136/jnnp.74.1.94; STRANDGAARD S, 1995, NETH J MED, V47, P180, DOI 10.1016/0300-2977(95)00065-U; Tell GS, 1998, ARCH NEUROL-CHICAGO, V55, P73, DOI 10.1001/archneur.55.1.73; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; van der Velde N, 2007, BLOOD PRESS MONIT, V12, P167, DOI 10.1097/MBP.0b013e3280b083bd; van Hateren KJJ, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X656838; Vernooij MW, 2008, J CEREBR BLOOD F MET, V28, P412, DOI 10.1038/sj.jcbfm.9600526; Verwoert GC, 2008, J AM GERIATR SOC, V56, P1816, DOI 10.1111/j.1532-5415.2008.01946.x; Whitman GT, 2001, NEUROLOGY, V57, P990, DOI 10.1212/WNL.57.6.990; Wieling W, 2007, CLIN SCI, V112, P157, DOI 10.1042/CS20060091; Wieling W, 2009, J HYPERTENS, V27, P935, DOI 10.1097/HJH.0b013e32832b1145; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	52	23	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e106808	10.1371/journal.pone.0106808	http://dx.doi.org/10.1371/journal.pone.0106808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222275	Green Submitted, gold, Green Published			2022-12-25	WOS:000341774800027
J	Wang, BB; Zhang, Z; Hu, Q; Sommerfeld, M; Lu, YH; Han, DX				Wang, Baobei; Zhang, Zhen; Hu, Qiang; Sommerfeld, Milton; Lu, Yinghua; Han, Danxiang			Cellular Capacities for High-Light Acclimation and Changing Lipid Profiles across Life Cycle Stages of the Green Alga Haematococcus pluvialis	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; CHLAMYDOMONAS-REINHARDTII; ELECTROSPRAY-IONIZATION; GALACTOLIPID SYNTHESIS; ASTAXANTHIN PRODUCTION; NITROGEN STARVATION; HARVESTING COMPLEX; OXIDATIVE STRESS; ENERGY-BALANCE; WILD-TYPE	The unicellular microalga Haematococcus pluvialis has emerged as a promising biomass feedstock for the ketocarotenoid astaxanthin and neutral lipid triacylglycerol. Motile flagellates, resting palmella cells, and cysts are the major life cycle stages of H. pluvialis. Fast-growing motile cells are usually used to induce astaxanthin and triacylglycerol biosynthesis under stress conditions (high light or nutrient starvation); however, productivity of biomass and bioproducts are compromised due to the susceptibility of motile cells to stress. This study revealed that the Photosystem II (PSII) reaction center D1 protein, the manganese-stabilizing protein PsbO, and several major membrane glycerolipids (particularly for chloroplast membrane lipids monogalactosyldiacylglycerol and phosphatidylglycerol), decreased dramatically in motile cells under high light (HL). In contrast, palmella cells, which are transformed from motile cells after an extended period of time under favorable growth conditions, have developed multiple protective mechanisms-including reduction in chloroplast membrane lipids content, downplay of linear photosynthetic electron transport, and activating nonphotochemical quenching mechanisms-while accumulating triacylglycerol. Consequently, the membrane lipids and PSII proteins (D1 and PsbO) remained relatively stable in palmella cells subjected to HL. Introducing palmella instead of motile cells to stress conditions may greatly increase astaxanthin and lipid production in H. pluvialis culture.	[Wang, Baobei; Lu, Yinghua] Xiamen Univ, Dept Chem & Biochem Engn, Xiamen, Fujian, Peoples R China; [Wang, Baobei; Zhang, Zhen; Sommerfeld, Milton; Han, Danxiang] Arizona State Univ, Dept Human Syst & Environm, Mesa, AZ USA; [Zhang, Zhen] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China; [Hu, Qiang] Chinese Acad Sci, Ctr Microalgal Biotechnol & Biofuels, Inst Hydrobiol, Wuhan, Hubei, Peoples R China	Xiamen University; Arizona State University; East China University of Science & Technology; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Lu, YH (corresponding author), Xiamen Univ, Dept Chem & Biochem Engn, Xiamen, Fujian, Peoples R China.	ylu@xmu.edu.cn; Danxiang.han@asu.edu		Zhang, Zhen/0000-0001-8057-7624	Natural Science Foundation of China [31071488]; National Marine Commonweal Research Program, National Bureau of Oceanography of China [201205020-2]; China Scholarship Council (CSC)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Marine Commonweal Research Program, National Bureau of Oceanography of China; China Scholarship Council (CSC)(China Scholarship Council)	This work was funded by the Natural Science Foundation of China (No. 31071488), National Marine Commonweal Research Program, National Bureau of Oceanography of China (No. 201205020-2), and China Scholarship Council (CSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflalo C, 2007, BIOTECHNOL BIOENG, V98, P300, DOI 10.1002/bit.21391; ALLEN JF, 1992, BIOCHIM BIOPHYS ACTA, V1098, P275, DOI 10.1016/S0005-2728(09)91014-3; Allorent G, 2013, PLANT CELL, V25, P545, DOI 10.1105/tpc.112.108274; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; BENNING C, 1993, P NATL ACAD SCI USA, V90, P1561, DOI 10.1073/pnas.90.4.1561; Boussiba S, 2000, PHYSIOL PLANTARUM, V108, P111, DOI 10.1034/j.1399-3054.2000.108002111x./; Damiani MC, 2010, BIORESOURCE TECHNOL, V101, P3801, DOI 10.1016/j.biortech.2009.12.136; Chumpolkulwong N, 1997, BIOTECHNOL LETT, V19, P443, DOI 10.1023/A:1018392010218; Delosme R, 1996, BBA-BIOENERGETICS, V1273, P150, DOI 10.1016/0005-2728(95)00143-3; Dubertret G, 2002, PLANT PHYSIOL BIOCH, V40, P829, DOI 10.1016/S0981-9428(02)01442-0; EILERS PHC, 1988, ECOL MODEL, V42, P199, DOI 10.1016/0304-3800(88)90057-9; El Maanni A, 1998, PLANT PHYSIOL BIOCH, V36, P609, DOI 10.1016/S0981-9428(98)80009-0; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; GRUNG M, 1992, J APPL PHYCOL, V4, P165, DOI 10.1007/BF02442465; Gu WH, 2013, PLOS ONE, V8, P1; Guerin M, 2003, TRENDS BIOTECHNOL, V21, P210, DOI 10.1016/S0167-7799(03)00078-7; Han DX, 2013, ALGAE-SEOUL, V28, P131, DOI 10.4490/algae.2013.28.2.131; Han DX, 2012, J PHYCOL, V48, P693, DOI 10.1111/j.1529-8817.2012.01147.x; Han XL, 2001, ANAL BIOCHEM, V295, P88, DOI 10.1006/abio.2001.5178; Harker M, 1996, J FERMENT BIOENG, V82, P113, DOI 10.1016/0922-338X(96)85031-8; Hata N, 2001, J APPL PHYCOL, V13, P395, DOI 10.1023/A:1011921329568; Holzl G, 2005, PLANT CELL PHYSIOL, V46, P1766, DOI 10.1093/pcp/pci189; Hsu FF, 2009, J CHROMATOGR B, V877, P2673, DOI 10.1016/j.jchromb.2009.02.033; Huang W, 2012, PLANTA, V235, P819, DOI 10.1007/s00425-011-1544-3; Huntley M. E., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P573, DOI 10.1007/s11027-006-7304-1; Jakob T, 2007, J EXP BOT, V58, P2101, DOI 10.1093/jxb/erm084; Jones MR, 2007, PROG LIPID RES, V46, P56, DOI 10.1016/j.plipres.2006.06.001; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Khozin-Goldberg I, 2005, BBA-MOL CELL BIOL L, V1738, P63, DOI 10.1016/j.bbalip.2005.09.005; Kobayashi K, 2007, P NATL ACAD SCI USA, V104, P17216, DOI 10.1073/pnas.0704680104; KOBAYASHI M, 1991, J FERMENT BIOENG, V71, P335, DOI 10.1016/0922-338X(91)90346-I; KOBAYASHI M, 1993, APPL ENVIRON MICROB, V59, P867, DOI 10.1128/AEM.59.3.867-873.1993; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Langner U, 2009, PLANT CELL ENVIRON, V32, P250, DOI 10.1111/j.1365-3040.2008.01917.x; Lemoine Y, 2010, PHOTOSYNTH RES, V106, P155, DOI 10.1007/s11120-010-9583-3; Li Y, 2008, J PLANT PHYSIOL, V165, P1783, DOI 10.1016/j.jplph.2007.12.007; Li YT, 2010, J APPL PHYCOL, V22, P253, DOI 10.1007/s10811-009-9453-6; Liu BS, 2013, BIORESOURCE TECHNOL, V146, P310, DOI 10.1016/j.biortech.2013.07.088; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Lorenz RT, 2000, TRENDS BIOTECHNOL, V18, P160, DOI 10.1016/S0167-7799(00)01433-5; Merzlyak MN, 2007, J PHYCOL, V43, P833, DOI 10.1111/j.1529-8817.2007.00375.x; Miao FP, 2006, ANAL BIOCHEM, V352, P176, DOI 10.1016/j.ab.2006.03.006; Mizusawa N, 2007, PHOTOSYNTH RES, V91, P175; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; Nevo R, 2009, ADV PHOTOSYNTH RESP, V30, P295; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; RAO P, 1989, ANAL BIOCHEM, V181, P18, DOI 10.1016/0003-2697(89)90387-4; Reifarth F, 1997, BIOCHEMISTRY-US, V36, P11769, DOI 10.1021/bi9709654; ROESSLER PG, 1990, J PHYCOL, V26, P393, DOI 10.1111/j.0022-3646.1990.00393.x; Sakurai I, 2003, PLANT PHYSIOL, V133, P1376, DOI 10.1104/pp.103.026955; Sato N, 2004, J PLANT RES, V117, P495, DOI 10.1007/s10265-004-0183-1; Shimojima M, 2011, PROG LIPID RES, V50, P258, DOI 10.1016/j.plipres.2011.03.001; Shimojima M, 2011, PROG LIPID RES, V50, P234, DOI 10.1016/j.plipres.2011.02.003; Solovchenko AE, 2012, RUSS J PLANT PHYSL+, V59, P167, DOI 10.1134/S1021443712020161; Steffen R, 2005, BIOCHEMISTRY-US, V44, P3134, DOI 10.1021/bi048465f; Taylor NG, 1999, PLANT CELL, V11, P769, DOI 10.1105/tpc.11.5.769; Thompson GA, 1996, BBA-LIPID LIPID MET, V1302, P17, DOI 10.1016/0005-2760(96)00045-8; Wada H, 2007, PHOTOSYNTH RES, V92, P205, DOI 10.1007/s11120-007-9203-z; Wang JF, 2013, J APPL PHYCOL, V25, P253, DOI 10.1007/s10811-012-9859-4; Welti R, 2003, ANAL BIOCHEM, V314, P149, DOI 10.1016/S0003-2697(02)00623-1; Yoon K, 2012, PLANT CELL, V24, P3708, DOI 10.1105/tpc.112.100701; Yu B, 2003, PLANT J, V36, P762, DOI 10.1046/j.1365-313X.2003.01918.x; Zhekisheva M, 2005, J PHYCOL, V41, P819, DOI 10.1111/j.0022-3646.2005.05015.x	66	30	34	3	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e106679	10.1371/journal.pone.0106679	http://dx.doi.org/10.1371/journal.pone.0106679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25221928	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774800023
J	Zhang, N; Zhou, Y; Huang, T; Zhang, YC; Li, BQ; Chen, L; Cai, YD				Zhang, Ning; Zhou, You; Huang, Tao; Zhang, Yu-Chao; Li, Bi-Qing; Chen, Lei; Cai, Yu-Dong			Discriminating between Lysine Sumoylation and Lysine Acetylation Using mRMR Feature Selection and Analysis	PLOS ONE			English	Article							SECONDARY STRUCTURE; INTRINSIC DISORDER; MODIFICATION SITES; PREDICTION; SUMO; METHYLATION; INSIGHTS; CLASSIFICATION; IDENTIFICATION; ACCESSIBILITY	Post-translational modifications (PTMs) are crucial steps in protein synthesis and are important factors contributing to protein diversity. PTMs play important roles in the regulation of gene expression, protein stability and metabolism. Lysine residues in protein sequences have been found to be targeted for both types of PTMs: sumoylations and acetylations; however, each PTM has a different cellular role. As experimental approaches are often laborious and time consuming, it is challenging to distinguish the two types of PTMs on lysine residues using computational methods. In this study, we developed a method to discriminate between sumoylated lysine residues and acetylated residues. The method incorporated several features: PSSM conservation scores, amino acid factors, secondary structures, solvent accessibilities and disorder scores. By using the mRMR (Maximum Relevance Minimum Redundancy) method and the IFS (Incremental Feature Selection) method, an optimal feature set was selected from all of the incorporated features, with which the classifier achieved 92.14% accuracy with an MCC value of 0.7322. Analysis of the optimal feature set revealed some differences between acetylation and sumoylation. The results from our study also supported the previous finding that there exist different consensus motifs for the two types of PTMs. The results could suggest possible dominant factors governing the acetylation and sumoylation of lysine residues, shedding some light on the modification dynamics and molecular mechanisms of the two types of PTMs, and provide guidelines for experimental validations.	[Zhang, Ning] Tianjin Univ, Tianjin Key Lab Biomed Engn Measurement, Dept Biomed Engn, Tianjin 300072, Peoples R China; [Zhou, You; Zhang, Yu-Chao] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Zhou, You; Cai, Yu-Dong] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Huang, Tao] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Li, Bi-Qing] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China	Tianjin University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Icahn School of Medicine at Mount Sinai; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Maritime University; Shanghai University	Cai, YD (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	cai_yud@126.com	Zhou, You/GMW-4434-2022; Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; cai, yudong/0000-0001-5664-7979; Zhang, Ning/0000-0002-1559-111X	National Basic Research Program of China [2011CB510101, 2011CB510102]; National Natural Science Foundation of China [31371335, 81171342, 81201148]; Tianjin Research Program of Application Foundation and Advanced Technology [14JCQNJC09500]; National Research Foundation for the Doctoral Program of Higher Education of China [20130032120070, 20120032120073]; Seed Foundation of Tianjin University [60302064, 60302069]; Innovation Program of Shanghai Municipal Education Commission [12ZZ087]; First-class Discipline of Universities in Shanghai	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Research Program of Application Foundation and Advanced Technology; National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Seed Foundation of Tianjin University; Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); First-class Discipline of Universities in Shanghai	This study was supported by the National Basic Research Program of China (2011CB510101, 2011CB510102), National Natural Science Foundation of China (31371335, 81171342, 81201148), Tianjin Research Program of Application Foundation and Advanced Technology (14JCQNJC09500), the National Research Foundation for the Doctoral Program of Higher Education of China (20130032120070, 20120032120073), the Seed Foundation of Tianjin University (60302064, 60302069), Innovation Program of Shanghai Municipal Education Commission (12ZZ087) and the grant of "The First-class Discipline of Universities in Shanghai''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anekonda TS, 2006, J NEUROCHEM, V96, P305, DOI 10.1111/j.1471-4159.2005.03492.x; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cai YD, 2008, BIOCHEM BIOPH RES CO, V372, P862, DOI 10.1016/j.bbrc.2008.05.143; Cai YD, 2011, J BIOMOL STRUCT DYN, V28, P797, DOI 10.1080/07391102.2011.10508607; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cubenas-Potts C, 2013, DEV CELL, V24, P1, DOI 10.1016/j.devcel.2012.11.020; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Gnad F, 2010, BIOINFORMATICS, V26, P1666, DOI 10.1093/bioinformatics/btq260; Grant PA, 2001, GENOME BIOL, V2; Guharoy M, 2007, BIOINFORMATICS, V23, P1909, DOI 10.1093/bioinformatics/btm274; Hardison Matthew Thomas, 2012, Front Biosci (Elite Ed), V4, P2402; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Hou T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089575; Huang GH, 2013, MOL BIOSYST, V9, P2729, DOI 10.1039/c3mb70195f; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jiang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065756; Johnson DS, 2008, GENOME RES, V18, P393, DOI 10.1101/gr.7080508; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; KINI RM, 1995, BIOCHEM BIOPH RES CO, V212, P1115, DOI 10.1006/bbrc.1995.2084; Lee TY, 2010, J COMPUT CHEM, V31, P2759, DOI 10.1002/jcc.21569; Li A, 2006, BIOCHEM BIOPH RES CO, V350, P818, DOI 10.1016/j.bbrc.2006.08.199; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045854; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039308; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033393; Li BQ, 2012, J PROTEOMICS, V75, P1654, DOI 10.1016/j.jprot.2011.12.003; Li SL, 2009, PROTEIN PEPTIDE LETT, V16, P977, DOI 10.2174/092986609788923338; Liu BH, 2007, BIOCHEM BIOPH RES CO, V358, P136, DOI 10.1016/j.bbrc.2007.04.097; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Lu ZK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028228; Marmorstein R, 2001, CELL MOL LIFE SCI, V58, P693, DOI 10.1007/PL00000893; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Matunis MJ, 2006, DEV CELL, V11, P596, DOI 10.1016/j.devcel.2006.10.011; Noivirt-Brik O, 2009, PROTEINS, V77, P210, DOI 10.1002/prot.22586; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; Pang CNI, 2007, J PROTEOME RES, V6, P1833, DOI 10.1021/pr060674u; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Petersen B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015079; Picard N, 2012, MOL CELL BIOL, V32, P2709, DOI 10.1128/MCB.06624-11; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Rogers J, 2006, LECT NOTES COMPUT SC, V3940, P173; Rytinki MM, 2008, J BIOL CHEM, V283, P11586, DOI 10.1074/jbc.M709359200; Sasaki K, 2012, GENE, V491, P13, DOI 10.1016/j.gene.2011.09.022; Shaw BF, 2008, PROTEIN SCI, V17, P1446, DOI 10.1110/ps.035154.108; Shi SP, 2012, J THEOR BIOL, V310, P223, DOI 10.1016/j.jtbi.2012.06.030; Shi SP, 2012, MOL BIOSYST, V8, P1520, DOI 10.1039/c2mb05502c; Smith BC, 2009, BBA-GENE REGUL MECH, V1789, P45, DOI 10.1016/j.bbagrm.2008.06.005; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Suo SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049108; Talavera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021053; Teng SL, 2012, AMINO ACIDS, V43, P447, DOI 10.1007/s00726-011-1100-2; Trouillas P, 2011, INT J QUANTUM CHEM, V111, P1143, DOI 10.1002/qua.22556; Van Beekum Olivier, 2007, Subcell Biochem, V41, P233; Vihinen M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S4-S2; WITTEN IH, 2005, DATA MINING PRACTICA; Xiong Y, 2012, J CELL BIOL, V198, P155, DOI 10.1083/jcb.201202056; Xu Y, 2010, J THEOR BIOL, V264, P130, DOI 10.1016/j.jtbi.2010.01.013; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2004, BIOESSAYS, V26, P1076, DOI 10.1002/bies.20104; Zhang N, 2012, MOL BIOSYST, V8, P2946, DOI 10.1039/c2mb25185j	71	10	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107464	10.1371/journal.pone.0107464	http://dx.doi.org/10.1371/journal.pone.0107464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222670	gold, Green Published, Green Submitted			2022-12-25	WOS:000341774800069
J	Chung, H; Lee, YS; Mayoral, R; Oh, DY; Siu, JT; Webster, NJ; Sears, DD; Olefsky, JM; Ellies, LG				Chung, H.; Lee, Y. S.; Mayoral, R.; Oh, D. Y.; Siu, J. T.; Webster, N. J.; Sears, D. D.; Olefsky, J. M.; Ellies, L. G.			Omega-3 fatty acids reduce obesity-induced tumor progression independent of GPR120 in a mouse model of postmenopausal breast cancer	ONCOGENE			English	Article							POLYUNSATURATED FATTY-ACIDS; INSULIN-RESISTANCE; INFLAMMATION; RISK; RECEPTOR; METABOLISM; PREVENTION; OMEGA-6; FISH	Obesity and inflammation are both risk factors for a variety of cancers, including breast cancer in postmenopausal women. Intake of omega-3 polyunsaturated fatty acids (omega-3 PUFAs) decreases the risk of breast cancer, and also reduces obesity-associated inflammation and insulin resistance, but whether the two effects are related is currently unknown. We tested this hypothesis in a postmenopausal breast cancer model using ovariectomized, immune-competent female mice orthotopically injected with Py230 mammary tumor cells. Obesity, whether triggered genetically or by high-fat diet (HFD) feeding, increased inflammation in the mammary fat pad and promoted mammary tumorigenesis. The presence of tumor cells in the mammary fat pad further enhanced the local inflammatory milieu. Tumor necrosis factor-alpha (TNF-alpha) was the most highly upregulated cytokine in the obese mammary fat pad, and we observed that TNF-alpha dose-dependently stimulated Py230 cell growth in vitro. An omega-3 PUFA-enriched HFD (referred to as fish oil diet, FOD) reduced inflammation in the obese mammary fat pad in the absence of tumor cells and inhibited Py230 tumor growth in vivo. Although some anti-inflammatory effects of omega-3 PUFAs were previously shown to be mediated by the G-protein-coupled receptor 120 (GPR120), the FOD reduced Py230 tumor burden in GPR120-deficient mice to a similar degree as observed in wild-type mice, indicating that the effect of FOD to reduce tumor growth does not require GPR120 in the host mouse. Instead, in vitro studies demonstrated that omega-3 PUFAs act directly on tumor cells to activate c-Jun N-terminal kinase, inhibit proliferation and induce apoptosis. Our results show that obesity promotes mammary tumor progression in this model of postmenopausal breast cancer and that omega-3 PUFAs, independent of GPR120, inhibit mammary tumor progression in obese mice.	[Chung, H.; Lee, Y. S.; Mayoral, R.; Oh, D. Y.; Webster, N. J.; Sears, D. D.; Olefsky, J. M.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Mayoral, R.] Biomed Network Ctr Study Hepat & Digest Dis CIBER, Madrid, Spain; [Siu, J. T.; Ellies, L. G.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Webster, N. J.; Sears, D. D.; Olefsky, J. M.; Ellies, L. G.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Webster, N. J.] San Diego VA Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Ellies, LG (corresponding author), Univ Calif San Diego, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	lellies@ucsd.edu	Sears, Dorothy D/AHE-5524-2022; Mayoral Monibas, Rafael/B-3563-2013; Lee, Yun Sok/ABC-9195-2021; Lee, Yun Sok/B-3265-2015; Webster, Nick/AAI-8410-2021	Sears, Dorothy D/0000-0002-9260-3540; Mayoral Monibas, Rafael/0000-0002-6645-7172; Lee, Yun Sok/0000-0001-7967-4734; Lee, Yun Sok/0000-0001-7967-4734; 	National Institutes of Health [U54 CA155435, P30 CA23100, P30 DK063491, K22 CA118182]; Department of Defense [BC102147]; Doris Howell Foundation Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023100, U54CA155435, K22CA118182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R01DK101395, P01DK074868] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Doris Howell Foundation Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	We thank Dr Robert Cardiff for reviewing histologic sections of tumors and Hang Ha and Jonathan Hasselmann for assistance with animal maintenance. We thank the UCSD Histology Core lab for technical assistance with processing the tumor samples. The study was funded in part by the National Institutes of Health grants U54 CA155435, P30 CA23100, P30 DK063491 (JMO), K22 CA118182 (LGE), the Department of Defense grant BC102147 (JMO) and a Doris Howell Foundation Scholarship (JTS).	Biswas T, 2014, CANCER LETT, V346, P129, DOI 10.1016/j.canlet.2013.12.018; Calviello G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/743171; Cui LF, 2008, HISTOPATHOLOGY, V53, P381, DOI 10.1111/j.1365-2559.2008.03128.x; de Lorgeril M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-50; Fares H, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-013-0389-6; Golabek T, 2014, UROL INT, V92, P7, DOI 10.1159/000351325; Handgraaf S, 2013, DIABETES, V62, P4098, DOI 10.2337/db13-0282; Healy LA, 2010, CLIN ONCOL-UK, V22, P281, DOI 10.1016/j.clon.2010.02.001; Iyengar NM, 2013, CURR BREAST CANCER R, V5, P247, DOI 10.1007/s12609-013-0112-1; Jing KP, 2013, ANTI-CANCER AGENT ME, V13, P1162, DOI 10.2174/18715206113139990319; Kang KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010296; Khaw KT, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4518; Kolodecik T, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00415; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Ligibel Jennifer A, 2013, Am Soc Clin Oncol Educ Book, P52, DOI 10.1200/EdBook_AM.2013.33.52; Maccio A, 2011, THESCIENTIFICWORLDJO, V11, P2020, DOI 10.1100/2011/806787; MacLennan MB, 2013, J NUTR BIOCHEM, V24, P388, DOI 10.1016/j.jnutbio.2012.08.002; Manni A, 2014, INT J CANCER, V134, P1549, DOI 10.1002/ijc.28490; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Parada B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/368178; Patterson RE, 2013, J ACAD NUTR DIET, V113, P288, DOI 10.1016/j.jand.2012.08.015; Ramos-Nino Maria E, 2013, ISRN Oncol, V2013, P697521, DOI 10.1155/2013/697521; Rose DP, 2009, EXPERT REV ANTICANC, V9, P1091, DOI 10.1586/ERA.09.71; Sczaniecka AK, 2012, NUTR CANCER, V64, P1131, DOI 10.1080/01635581.2012.718033; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; SheenChen SM, 1997, BREAST CANCER RES TR, V43, P211, DOI 10.1023/A:1005736712307; Signori C, 2011, CANCER RES, V71, P6091, DOI 10.1158/0008-5472.CAN-11-0977; Simopoulos AP, 2010, EXP BIOL MED, V235, P785, DOI 10.1258/ebm.2010.009298; Simpson ER, 2013, MOL ENDOCRINOL, V27, P715, DOI 10.1210/me.2013-1011; Subbaramaiah K, 2011, CANCER PREV RES, V4, P329, DOI 10.1158/1940-6207.CAPR-10-0381; Sundaram Sneha, 2013, J Carcinog, V12, P19, DOI 10.4103/1477-3163.119606; van Kruijsdijk RCM, 2009, CANCER EPIDEM BIOMAR, V18, P2569, DOI 10.1158/1055-9965.EPI-09-0372; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; Wu Q, 2013, ONCOGENE, V32, P5541, DOI 10.1038/onc.2013.264; Xue ML, 2014, J NUTR BIOCHEM, V25, P104, DOI 10.1016/j.jnutbio.2013.09.008; Zheng JS, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3706	37	46	48	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	27					3504	3513		10.1038/onc.2014.283	http://dx.doi.org/10.1038/onc.2014.283			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM1IQ	25220417	Green Submitted, Green Accepted			2022-12-25	WOS:000357434900003
J	Neznansky, A; Blus-Kadosh, I; Yerushalmi, G; Banin, E; Opatowsky, Y				Neznansky, Avi; Blus-Kadosh, Inna; Yerushalmi, Gal; Banin, Ehud; Opatowsky, Yarden			The Pseudomonas aeruginosa phosphate transport protein PstS plays a phosphate-independent role in biofilm formation	FASEB JOURNAL			English	Article						substrate binding protein; swarming; N ' loop	DI-GMP LEVELS; BINDING PROTEIN; LIGAND-BINDING; GENE; IDENTIFICATION; REPLACEMENT; SPECIFICITY; EXPRESSION; STARVATION; RECEPTOR	Pseudomonas aeruginosa (PA) is a primary cause of nosocomial infections. A key element in PA pathogenicity is its ability to form biofilms that withstand eradication by antibiotics and the immune system. Biofilm formation is controlled by phosphate signaling and here we provide evidence that PstS, a subunit of the PA Pst phosphate transporter, has a surprising role in this process. Using X-ray crystallography, we characterized the unique underpinnings of PstS phosphate binding and identified an unusual 15-residue N' loop extension. Structure-based experiments showed that PstS-mediated phosphate uptake and biofilm formation are in fact two distinct functions. Specifically, a point mutation that abrogated phosphate binding did not eliminate biofilm formation; conversely, truncation of the N' loop diminished the ability of PA to form biofilms but had no effect on phosphate binding and uptake. This places PstS at a junction that separately controls phosphate sensing and uptake and the ultrastructure organization of bacteria.	[Neznansky, Avi; Blus-Kadosh, Inna; Yerushalmi, Gal; Banin, Ehud; Opatowsky, Yarden] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-5290002 Ramat Gan, Israel; [Blus-Kadosh, Inna; Yerushalmi, Gal; Banin, Ehud] Bar Ilan Univ, Adv Mat & Nanotechnol Inst, IL-5290002 Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Opatowsky, Y (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-5290002 Ramat Gan, Israel.	ehud.banin@biu.ac.il; yarden.opatowsky@biu.ac.il			Marie Curie International Reintegration grant [PIRG06-GA-2009-256222]; Israel Science Foundation [182/10, 1124/12]; German-Israeli Foundation [2265/2010]; National Institute for Psychobiology [223-11-12]	Marie Curie International Reintegration grant(European Commission); Israel Science Foundation(Israel Science Foundation); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); National Institute for Psychobiology	The authors thank Yoav Pass for help in P<SUP>32</SUP> binding experiments; the beamline scientists of beamlines BM14, ID14, ID23, and ID29 of the European Synchrotron Radiation Facility (Grenoble, France), and the staff of Berliner Elektronenspeicherring-Gesellschaft fur Synchrotronstrahlung (BESSY) II beamline BL14.1 (Belin, Germany). This work was partially supported by funds from a Marie Curie International Reintegration grant (PIRG06-GA-2009-256222, to Y.O.), the Israel Science Foundation (grants 182/10, to Y.O., and 1124/12, to E.B.), the German-Israeli Foundation (grant 2265/2010, to Y.O.), and the National Institute for Psychobiology (grant 223-11-12, to Y.O.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; Bains M., APPL ENV MICROBIOL, V78, P6762; Bastonero S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005357; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Blus-Kadosh I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074444; Borlee BR, 2010, MOL MICROBIOL, V75, P827, DOI 10.1111/j.1365-2958.2009.06991.x; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Diaz M, 2005, MICROBIOL-SGM, V151, P2583, DOI 10.1099/mic.0.27983-0; Duque E., ENV MICROBIOL, V15, P36; ESPITIA C, 1989, CLIN EXP IMMUNOL, V77, P378; Esteban A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-201; Fischer RJ, 2006, J BACTERIOL, V188, P5469, DOI 10.1128/JB.00491-06; Garnett JA, 2012, CURR PROTEIN PEPT SC, V13, P739; GERDES RG, 1977, J BACTERIOL, V131, P512, DOI 10.1128/JB.131.2.512-518.1977; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; HOU CI, 1966, J BACTERIOL, V92, P851, DOI 10.1128/JB.92.4.851-855.1966; Joosten R. P. J. K., 2012, ACTA CRYSTALLOGR D, V68, P13; Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lewenza S, 2005, GENOME RES, V15, P583, DOI 10.1101/gr.3513905; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Madhusudhan KT, 2003, J BASIC MICROB, V43, P36, DOI 10.1002/jobm.200390002; Monds RD, 2001, MOL MICROBIOL, V42, P415, DOI 10.1046/j.1365-2958.2001.02641.x; Monds RD, 2007, MOL MICROBIOL, V63, P656, DOI 10.1111/j.1365-2958.2006.05539.x; Mudrak B, 2012, INFECT IMMUN, V80, P1794, DOI 10.1128/IAI.06277-11; Mueller Lukas N., 2006, BMC Ecology, V6, P1, DOI 10.1186/1472-6785-6-1; Neznansky A, 2014, ACTA CRYSTALLOGR F, V70, P906, DOI 10.1107/S2053230X14010279; Nielsen MW, 2011, JOVE-J VIS EXP, DOI 10.3791/2383; Nikata T, 1996, MOL GEN GENET, V250, P692, DOI 10.1007/s004380050122; O'May GA, 2009, MICROBIOL-SGM, V155, P1523, DOI 10.1099/mic.0.026500-0; Paas Y, 1998, TRENDS NEUROSCI, V21, P117, DOI 10.1016/S0166-2236(97)01184-3; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Rybtke MT, 2012, APPL ENVIRON MICROB, V78, P5060, DOI 10.1128/AEM.00414-12; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; SCHWEIZER HP, 1991, GENE, V97, P109, DOI 10.1016/0378-1119(91)90016-5; Shah M, 2014, FEMS MICROBIOL LETT, V352, P54, DOI 10.1111/1574-6968.12368; van Veen HW, 1997, ANTON LEEUW INT J G, V72, P299, DOI 10.1023/A:1000530927928; Vyas NK, 2003, STRUCTURE, V11, P765, DOI 10.1016/S0969-2126(03)00109-6; WANG ZM, 1994, J BIOL CHEM, V269, P25091; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; YOUNG DB, 1991, RES MICROBIOL, V142, P55, DOI 10.1016/0923-2508(91)90097-T; Zaborina O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040043	44	15	18	1	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2014	28	12					5223	5233		10.1096/fj.14-258293	http://dx.doi.org/10.1096/fj.14-258293			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AU9EN	25223609				2022-12-25	WOS:000345894500017
J	Krishnan, S; Liu, F; Abrol, R; Hodges, J; Goddard, WA; Prasadarao, NV				Krishnan, Subramanian; Liu, Fan; Abrol, Ravinder; Hodges, Jacqueline; Goddard, William A., III; Prasadarao, Nemani V.			The Interaction of N-Glycans in Fc gamma Receptor I alpha-Chain with Escherichia coli K1 Outer Membrane Protein A for Entry into Macrophages EXPERIMENTAL AND COMPUTATIONAL ANALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORCE-FIELD; TRANSMEMBRANE DOMAIN; PATHOGENS; DYNAMICS	Neonatal meningitis, caused by Escherichia coli K1, is a serious central nervous system disease. We have established that macrophages serve as permissive niches for E. coli K1 to multiply in the host and for attaining a threshold level of bacterial load, which is a prerequisite for the onset of the disease. Here, we demonstrate experimentally that three N-glycans in Fc gamma RIa interact with OmpA of E. coli K1 for binding to and entering the macrophages. Adoptive transfer of Fc gamma RIa(-/-) bone marrow-derived macrophages transfected with Fc gamma RIa into Fc gamma RIa(-/-) newborn mice renders them susceptible to E. coli K1-induced meningitis. In contrast, mice that received bone marrow-derived macrophages transfected with Fc gamma RIa in which N-glycosylation sites 1, 4, and 5 are mutated to alanines exhibit resistance to E. coli K1 infection. Our molecular dynamics and simulation studies predict that N-glycan 5 exhibits strong binding at the barrel site of OmpA formed by loops 3 and 4, whereas N-glycans 1 and 4 interact with loops 1, 3, and 4 of OmpA at tip regions. Molecular modeling data also suggest no role for the IgG binding site in the invasion process. In agreement, experimental mutations in IgG binding site had no effect on the E. coli K1 entry into macrophages in vitro or on the onset of meningitis in newborn mice. Together, this integration of experimental and computational studies reveals how the N-glycans in Fc gamma RIa interact with the OmpA of E. coli K1 for inducing the disease pathogenesis.	[Krishnan, Subramanian; Hodges, Jacqueline; Prasadarao, Nemani V.] Univ So Calif, Childrens Hosp Los Angeles, Div Infect Dis, Los Angeles, CA 90027 USA; [Krishnan, Subramanian; Hodges, Jacqueline; Prasadarao, Nemani V.] Univ So Calif, Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA; [Prasadarao, Nemani V.] Univ So Calif, Childrens Hosp Los Angeles, Dept Surg, Los Angeles, CA 90027 USA; [Liu, Fan; Abrol, Ravinder; Goddard, William A., III] CALTECH, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA; [Abrol, Ravinder] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA	Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California; California Institute of Technology; Cedars Sinai Medical Center	Goddard, WA (corresponding author), CALTECH, Mat & Proc Simulat Ctr, Mail Code 139-74, Pasadena, CA 91125 USA.	wag@wag.caltech.edu; pnemani@chla.usc.edu	Krishnan, Subramanian/K-5032-2019; Abrol, Ravinder/R-3458-2019; Hodges, Jacqueline/GMW-4043-2022	Abrol, Ravinder/0000-0001-7333-6793; Krishnan, Subramanian/0000-0001-5780-7452	National Institutes of Health [N5731 15, A140567]; Defense University Research Instruments Program; National Science Foundation Caltech Science and Engineering of Materials; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI040567, R01AI040567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense University Research Instruments Program; National Science Foundation Caltech Science and Engineering of Materials; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants N5731 15 and A140567 (to N. V. P. and W. A. G.). This work was also supported by Defense University Research Instruments Program and National Science Foundation Caltech Science and Engineering of Materials.	Arora A, 2001, NAT STRUCT BIOL, V8, P334, DOI 10.1038/86214; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Datta D, 2003, PROTEINS, V50, P213, DOI 10.1002/prot.10257; Drayman N, 2013, CELL HOST MICROBE, V14, P63, DOI 10.1016/j.chom.2013.05.005; Drevets DA, 2004, CLIN MICROBIOL REV, V17, P323, DOI 10.1128/CMR.17.2.323-347.2004; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P1092; Hornef MW, 2002, NAT IMMUNOL, V3, P1033, DOI 10.1038/ni1102-1033; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krishnan S, 2014, MICROBES INFECT, V16, P540, DOI 10.1016/j.micinf.2014.06.002; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Lu JH, 2011, J BIOL CHEM, V286, P40608, DOI 10.1074/jbc.M111.257550; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; Mehlert A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002618; Mittal R, 2011, J BIOL CHEM, V286, P2183, DOI 10.1074/jbc.M110.178236; Pascal TA, 2010, J BIOL CHEM, V285, P37753, DOI 10.1074/jbc.M110.122804; Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983; Pautsch A, 2000, J MOL BIOL, V298, P273, DOI 10.1006/jmbi.2000.3671; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; Shanmuganathan MV, 2014, MICROBES INFECT, V16, P134, DOI 10.1016/j.micinf.2013.10.013; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; WEISER JN, 1991, INFECT IMMUN, V59, P2252, DOI 10.1128/IAI.59.7.2252-2258.1991	32	11	11	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					30937	30949		10.1074/jbc.M114.599407	http://dx.doi.org/10.1074/jbc.M114.599407			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25231998	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000344549900006
J	Lee, HS; Oh, SJ; Lee, KH; Lee, YS; Ko, E; Kim, KE; Kim, HC; Kim, S; Song, PH; Kim, YI; Kim, C; Han, S				Lee, Hyo Seon; Oh, Seung Ja; Lee, Kwang-Hoon; Lee, Yoon-Sook; Ko, Eun; Kim, Kyung Eun; Kim, Hyung-chan; Kim, Seokkyun; Song, Paul H.; Kim, Yong-In; Kim, Chungho; Han, Sangyeul			Gln-362 of Angiopoietin-2 Mediates Migration of Tumor and Endothelial Cells through Association with alpha 5 beta 1 Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEASE-2; TIE2 RECEPTOR; ANGIOGENESIS; CANCER; PATHWAY; INVASION; ALPHA-V-BETA-3; VASCULATURE; METASTASIS; EXPRESSION	Angiopoietin-2 (Ang-2) not only regulates angiogenesis by binding to its well known receptor Tie2 on endothelial cells but also controls sprouting of Tie2-negative angiogenic endothelial cells and invasion of Tie2-negative non-endothelial cells by binding to integrins. However, the molecular mechanism of the Ang-2/ integrin association has been unclear. In this study, we found that the Gln-362 residue of Ang-2 was essential for binding to alpha 5 beta 1 integrin. A Q362E Ang-2 mutant, which still bound to Tie2, failed to associate with alpha 5 beta 1 integrin and was unable to activate the integrin downstream signaling of focal adhesion kinase. In addition, unlike wild-type Ang-2, the Q362E Ang-2 mutant was defective in mediating invasion of Tie2-negative glioma or Tie2-positive endothelial cells. Furthermore, the tailpiece domain of the alpha 5 subunit in alpha 5 beta 1 integrin was critical for binding to Ang-2. Taken together, these results provide a novel insight into the mechanism of integrin regulation by Ang-2, which contributes to tumor invasion and endothelial cell migration in a Tie2-independent manner.	[Lee, Hyo Seon; Oh, Seung Ja; Lee, Kwang-Hoon; Lee, Yoon-Sook; Ko, Eun; Kim, Kyung Eun; Kim, Hyung-chan; Kim, Seokkyun; Song, Paul H.; Kim, Chungho; Han, Sangyeul] Samsung Elect Co Ltd, Samsung Adv Inst Technol, Bio Therapeut Lab, Suwon 443803, Gyeonggi Do, South Korea; [Kim, Yong-In] Samsung Elect Co Ltd, Samsung Adv Inst Technol, Well Aging Ctr, Suwon 443803, South Korea; [Kim, Chungho] Korea Univ, Sch Life Sci & Biotechnol, Seoul 736707, South Korea	Samsung; Samsung Electronics; Samsung; Samsung Electronics; Korea University	Kim, C (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea.	chungho@korea.ac.kr; sangyeul.han@samsung.com	Oh, Seung Ja/ABC-6168-2021	Oh, Seung Ja/0000-0002-4572-0656				Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Barton WA, 2005, STRUCTURE, V13, P825, DOI 10.1016/j.str.2005.03.009; Barton WA, 2006, NAT STRUCT MOL BIOL, V13, P524, DOI 10.1038/nsmb1101; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Cascone I, 2005, J CELL BIOL, V170, P993, DOI 10.1083/jcb.200507082; Cascone T, 2012, J CLIN ONCOL, V30, P441, DOI 10.1200/JCO.2011.38.7621; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Daly C, 2013, CANCER RES, V73, P108, DOI 10.1158/0008-5472.CAN-12-2064; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Eklund L, 2013, EXP CELL RES, V319, P1271, DOI 10.1016/j.yexcr.2013.03.011; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Gerald D, 2013, CANCER RES, V73, P1649, DOI 10.1158/0008-5472.CAN-12-4697; Hu B, 2006, CANCER RES, V66, P775, DOI 10.1158/0008-5472.CAN-05-1149; Hu B, 2003, P NATL ACAD SCI USA, V100, P8904, DOI 10.1073/pnas.1533394100; Imanishi Y, 2011, J BIOL CHEM, V286, P29249, DOI 10.1074/jbc.M111.235689; Imanishi Y, 2007, CANCER RES, V67, P4254, DOI 10.1158/0008-5472.CAN-06-4100; Kim HZ, 2009, BBA-MOL CELL RES, V1793, P772, DOI 10.1016/j.bbamcr.2009.01.018; Leow CC, 2012, INT J ONCOL, V40, P1321, DOI 10.3892/ijo.2012.1366; Lewis CE, 2011, CANCER CELL, V19, P431, DOI 10.1016/j.ccr.2011.03.016; Nishiuchi R, 2005, P NATL ACAD SCI USA, V102, P1939, DOI 10.1073/pnas.0409493102; Schulz P, 2011, FASEB J, V25, P3325, DOI 10.1096/fj.11-182287; Sfiligoi C, 2003, INT J CANCER, V103, P466, DOI 10.1002/ijc.10851; Thomas M, 2010, J BIOL CHEM, V285, P23842, DOI 10.1074/jbc.M109.097543; Thurston G., 2011, United States Patent, Patent No. [US2011/0027286A1, 20110027286]; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Zhu JQ, 2013, J CELL BIOL, V201, P1053, DOI 10.1083/jcb.201212037	27	24	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31330	31340		10.1074/jbc.M114.572594	http://dx.doi.org/10.1074/jbc.M114.572594			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25237190	Green Published, hybrid			2022-12-25	WOS:000344549900037
J	Miyazaki-Anzai, S; Masuda, M; Levi, M; Keenan, AL; Miyazaki, M				Miyazaki-Anzai, Shinobu; Masuda, Masashi; Levi, Moshe; Keenan, Audrey L.; Miyazaki, Makoto			Dual Activation of the Bile Acid Nuclear Receptor FXR and G-Protein-Coupled Receptor TGR5 Protects Mice against Atherosclerosis	PLOS ONE			English	Article							FARNESOID X RECEPTOR; IDENTIFICATION; MECHANISMS; LIGANDS; CAMP	Bile acid signaling is a critical regulator of glucose and energy metabolism, mainly through the nuclear receptor FXR and the G protein-coupled receptor TGR. The purpose of the present study was to investigate whether dual activation of FXR and TGR5 plays a significant role in the prevention of atherosclerosis progression. To evaluate the effects of bile acid signaling in atherogenesis, ApoE(-/-) mice and LDLR-/- mice were treated with an FXR/TGR5 dual agonist (INT-767). INT-767 treatment drastically reduced serum cholesterol levels. INT-767 treatment significantly reduced atherosclerotic plaque formation in both ApoE(-/-) and LDLR-/- mice. INT-767 decreased the expression of pro-inflammatory cytokines and chemokines in the aortas of ApoE(-/-) mice through the inactivation of NF-kappa B. In addition, J774 macrophages treated with INT-767 had significantly lower levels of active NF-kappa B, resulting in cytokine production in response to LPS through a PKA dependent mechanism. This study demonstrates that concurrent activation of FXR and TGR5 attenuates atherosclerosis by reducing both circulating lipids and inflammation.	[Miyazaki-Anzai, Shinobu; Masuda, Masashi; Levi, Moshe; Keenan, Audrey L.; Miyazaki, Makoto] Univ Colorado Denver, Div Renal Dis & Hypertens, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Miyazaki, M (corresponding author), Univ Colorado Denver, Div Renal Dis & Hypertens, Aurora, CO 80045 USA.	Makoto.Miyazaki@ucdenver.edu		Masuda, Masashi/0000-0003-3762-2770	National Health of Institute [DK096030-01, HL117062-01]; American Heart Association [13POST13820008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096030, R01DK098336] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001954] Funding Source: NIH RePORTER	National Health of Institute; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	National Health of Institute (DK096030-01 and HL117062-01) to Makoto Miyazaki American Heart Association (13POST13820008) to Masashi Masuda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando M, 2006, J PHARMACEUT BIOMED, V40, P1179, DOI 10.1016/j.jpba.2005.09.013; Ceryak S, 2000, ATHEROSCLEROSIS, V153, P59, DOI 10.1016/S0021-9150(00)00396-8; Chin KV, 2002, ANN NY ACAD SCI, V968, P49, DOI 10.1111/j.1749-6632.2002.tb04326.x; Hambruch E, 2012, J PHARMACOL EXP THER, V343, P556, DOI 10.1124/jpet.112.196519; Hartman HB, 2009, J LIPID RES, V50, P1090, DOI 10.1194/jlr.M800619-JLR200; Ichikawa R, 2012, IMMUNOLOGY; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2008, BIOCHEM BIOPH RES CO, V372, P78, DOI 10.1016/j.bbrc.2008.04.171; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; Li TT, 2011, MOL ENDOCRINOL, V25, P1066, DOI 10.1210/me.2010-0460; Lim RS, 2010, J LIPID RES, V51, P1729, DOI 10.1194/jlr.M003616; Liu XQ, 2010, ARTERIOSCL THROM VAS, V30, P31, DOI 10.1161/ATVBAHA.109.195636; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; McMahan RH, 2013, J BIOL CHEM, V288, P11761, DOI 10.1074/jbc.M112.446575; Mencarelli A, 2009, AM J PHYSIOL-HEART C, V296, pH272, DOI 10.1152/ajpheart.01075.2008; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Miyazaki-Anzai S, 2010, CIRC RES, V106, P1807, DOI 10.1161/CIRCRESAHA.109.212969; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Pellicciari R, 2009, J MED CHEM, V52, P7958, DOI 10.1021/jm901390p; Pols TWH, 2011, CELL METAB, V14, P747, DOI 10.1016/j.cmet.2011.11.006; Raskovalova T, 2007, INHIBITION CYTOKINE; Rizzo G, 2010, MOL PHARMACOL, V78, P617, DOI 10.1124/mol.110.064501; Sehayek E, 2001, J LIPID RES, V42, P1250; Slatis K, 2010, J LIPID RES, V51, P3289, DOI 10.1194/jlr.M009308; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Torgersen KM, 2002, CELL SIGNAL, V14, P1, DOI 10.1016/S0898-6568(01)00214-5; Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Zhang YQ, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.083899	32	73	78	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e108270	10.1371/journal.pone.0108270	http://dx.doi.org/10.1371/journal.pone.0108270			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25237811	Green Published, Green Submitted, gold			2022-12-25	WOS:000342491600091
J	Shi, CG; Sun, G; Zhang, HX; Xiao, BX; Ze, B; Zhang, NN; Wu, N				Shi, Changguang; Sun, Geng; Zhang, Hongxuan; Xiao, Bingxue; Ze, Bai; Zhang, Nannan; Wu, Ning			Effects of Warming on Chlorophyll Degradation and Carbohydrate Accumulation of Alpine Herbaceous Species during Plant Senescence on the Tibetan Plateau	PLOS ONE			English	Article							CLIMATE-CHANGE; NUTRIENT RESORPTION; FLOWERING PHENOLOGY; RESPONSES; NITROGEN; GROWTH; LEAF; TEMPERATURE; STORAGE; CARBON	Plant senescence is a critical life history process accompanied by chlorophyll degradation and has large implications for nutrient resorption and carbohydrate storage. Although photoperiod governs much of seasonal leaf senescence in many plant species, temperature has also been shown to modulate this process. Therefore, we hypothesized that climate warming would significantly impact the length of the plant growing season and ultimate productivity. To test this assumption, we measured the effects of simulated autumn climate warming paradigms on four native herbaceous species that represent distinct life forms of alpine meadow plants on the Tibetan Plateau. Conditions were simulated in open-top chambers (OTCs) and the effects on the degradation of chlorophyll, nitrogen (N) concentration in leaves and culms, total non-structural carbohydrate (TNC) in roots, growth and phenology were assessed during one year following treatment. The results showed that climate warming in autumn changed the senescence process only for perennials by slowing chlorophyll degradation at the beginning of senescence and accelerating it in the following phases. Warming also increased root TNC storage as a result of higher N concentrations retained in leaves; however, this effect was species dependent and did not alter the growing and flowering phenology in the following seasons. Our results indicated that autumn warming increases carbohydrate accumulation, not only by enhancing activities of photosynthetic enzymes (a mechanism proposed in previous studies), but also by affecting chlorophyll degradation and preferential allocation of resources to different plant compartments. The different responses to warming can be explained by inherently different growth and phenology patterns observed among the studied species. The results implied that warming leads to changes in the competitive balance among life forms, an effect that can subsequently shift vegetation distribution and species composition in communities.	[Shi, Changguang; Sun, Geng; Zhang, Nannan; Wu, Ning] Chinese Acad Sci, Chengdu Inst Biol, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu, Peoples R China; [Shi, Changguang; Sun, Geng; Zhang, Nannan; Wu, Ning] Chinese Acad Sci, Chengdu Inst Biol, Ecol Restorat Biodivers Conservat Key Lab Sichuan, Chengdu, Peoples R China; [Shi, Changguang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Hongxuan; Xiao, Bingxue; Ze, Bai] Sichuan Acad Grassland Sci, Ctr Ecol Studies, Chengdu, Peoples R China; [Wu, Ning] Int Ctr Integrated Mt Dev ICIMOD, Ecosyst Serv, Kathmandu, Nepal	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sun, G (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu, Peoples R China.	sungeng@cib.ac.cn; wuning@cib.ac.cn			Natural Science Foundation of China [31000233, 31350110328, 31100360, 31200378]; Chinese Academy of Sciences [2012Y1SB0009, 2013FFSA0001]; Sichuan Science & Technology Bureau [2012HH0009]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Sichuan Science & Technology Bureau	This research was funded by the Natural Science Foundation of China (31000233, 31350110328, 31100360, and 31200378), the Chinese Academy of Sciences (2012Y1SB0009 and 2013FFSA0001), and Sichuan Science & Technology Bureau (2012HH0009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2007, OECOLOGIA, V151, P132, DOI 10.1007/s00442-006-0575-0; Aerts R, 1996, J ECOL, V84, P597, DOI 10.2307/2261481; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Bertin RI, 2008, J TORREY BOT SOC, V135, P126, DOI 10.3159/07-RP-035R.1; Busch F, 2007, PLANT PHYSIOL, V143, P1242, DOI 10.1104/pp.106.092312; Canham CD, 1999, OECOLOGIA, V121, P1, DOI 10.1007/s004420050900; Chu CJ, 2008, ECOL LETT, V11, P1189, DOI 10.1111/j.1461-0248.2008.01228.x; Chuine I, 2001, ECOL LETT, V4, P500, DOI 10.1046/j.1461-0248.2001.00261.x; Chuine I, 2000, GLOBAL CHANGE BIOL, V6, P943, DOI 10.1046/j.1365-2486.2000.00368.x; DAVISON IR, 1991, J PHYCOL, V27, P2, DOI 10.1111/j.0022-3646.1991.00002.x; Dunne JA, 2003, ECOL MONOGR, V73, P69, DOI 10.1890/0012-9615(2003)073[0069:SMFPRT]2.0.CO;2; Estrella N, 2006, CLIM RES, V32, P253, DOI 10.3354/cr032253; Gough CM, 2010, FORESTS, V1, P65, DOI 10.3390/f1010065; Gu LH, 2003, SCIENCE, V299, P2035, DOI 10.1126/science.1078366; HEILMEIER H, 1986, OECOLOGIA, V70, P466, DOI 10.1007/BF00379513; HO LC, 1977, NEW PHYTOL, V78, P65, DOI 10.1111/j.1469-8137.1977.tb01543.x; Hoeppner SS, 2012, GLOBAL CHANGE BIOL, V18, P1754, DOI 10.1111/j.1365-2486.2011.02626.x; Hollister RD, 2000, GLOBAL CHANGE BIOL, V6, P835, DOI 10.1046/j.1365-2486.2000.00363.x; Hovenden MJ, 2008, NEW PHYTOL, V178, P815, DOI 10.1111/j.1469-8137.2008.02419.x; Hudson JMG, 2011, GLOBAL CHANGE BIOL, V17, P1013, DOI 10.1111/j.1365-2486.2010.02294.x; Inouye DW, 2008, ECOLOGY, V89, P353, DOI 10.1890/06-2128.1; IPCC, 2007, CONTRIBUTION WORKING; Keskitalo J, 2005, PLANT PHYSIOL, V139, P1635, DOI 10.1104/pp.105.066845; Killingbeck KT, 1996, ECOLOGY, V77, P1716, DOI 10.2307/2265777; Kleijn D, 2005, NEW PHYTOL, V166, P565, DOI 10.1111/j.1469-8137.2005.01321.x; Kobe RK, 1997, OIKOS, V80, P226, DOI 10.2307/3546590; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; KRAMER K, 1995, CLIMATE RES, V5, P119, DOI 10.3354/cr005119; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; Landhausser SM, 2012, TREES-STRUCT FUNCT, V26, P653, DOI 10.1007/s00468-011-0633-z; Landhausser SM, 2003, TREES-STRUCT FUNCT, V17, P471, DOI 10.1007/s00468-003-0263-1; Lin DL, 2010, NEW PHYTOL, V188, P187, DOI 10.1111/j.1469-8137.2010.03347.x; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Lu XT, 2012, J ECOL, V100, P144, DOI 10.1111/j.1365-2745.2011.01881.x; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; McPherson K, 1998, OECOLOGIA, V117, P460, DOI 10.1007/s004420050681; Menzel A, 2003, TASK VEG SC, V39, P319; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Methy M, 1997, CAN J FOREST RES, V27, P31, DOI 10.1139/cjfr-27-1-31; Michelsen A, 1996, OECOLOGIA, V105, P1, DOI 10.1007/BF00328785; Mooney HA, 1992, CARBOHYDRATE WATER N, P134; Morin X, 2010, NEW PHYTOL, V186, P900, DOI 10.1111/j.1469-8137.2010.03252.x; Morrison J. L., 2006, PLANT GROWTH CLIMATE; Nooden LD, 1997, PHYSIOL PLANTARUM, V101, P746, DOI 10.1111/j.1399-3054.1997.tb01059.x; Norby RJ, 2000, PLANT SOIL, V224, P15, DOI 10.1023/A:1004629231766; Olano JM, 2006, NEW PHYTOL, V170, P99, DOI 10.1111/j.1469-8137.2005.01634.x; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Richardson SJ, 2002, J ECOL, V90, P544, DOI 10.1046/j.1365-2745.2002.00681.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; RYAN DF, 1982, BIOSCIENCE, V32, P29, DOI 10.2307/1308751; Silva LCR, 2013, GLOBAL ECOL BIOGEOGR, V22, P83, DOI 10.1111/j.1466-8238.2012.00783.x; Uddling J, 2007, PHOTOSYNTH RES, V91, P37, DOI 10.1007/s11120-006-9077-5; van Wijk MT, 2004, GLOBAL CHANGE BIOL, V10, P105, DOI 10.1111/j.1365-2486.2003.00719.x; vanDerHeyden F, 1996, FUNCT ECOL, V10, P647, DOI 10.2307/2390175; Vitasse Y, 2009, OECOLOGIA, V161, P187, DOI 10.1007/s00442-009-1363-4; Wang XW, 2008, RUSS J PLANT PHYSL+, V55, P54, DOI 10.1134/S1021443708010068; Wolkovich EM, 2012, NATURE, V485, P494, DOI 10.1038/nature11014; Wyka T, 1999, OECOLOGIA, V120, P198, DOI 10.1007/s004420050849; Zhu XH, 2013, J CLIMATE, V26, P10125, DOI 10.1175/JCLI-D-13-00187.1	63	45	51	10	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107874	10.1371/journal.pone.0107874	http://dx.doi.org/10.1371/journal.pone.0107874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232872	Green Published, gold, Green Submitted			2022-12-25	WOS:000342921200057
J	Higashi, T; Mai, Y; Noya, Y; Horinouchi, T; Terada, K; Hoshi, A; Nepal, P; Harada, T; Horiguchi, M; Hatate, C; Kuge, Y; Miwa, S				Higashi, Tsunehito; Mai, Yosuke; Noya, Yoichi; Horinouchi, Takahiro; Terada, Koji; Hoshi, Akimasa; Nepal, Prabha; Harada, Takuya; Horiguchi, Mika; Hatate, Chizuru; Kuge, Yuji; Miwa, Soichi			A Simple and Rapid Method for Standard Preparation of Gas Phase Extract of Cigarette Smoke	PLOS ONE			English	Article							TOBACCO-SMOKE; OXIDATIVE STRESS; NICOTINE; LUNG; TAR; CARCINOGENESIS; EMISSIONS; EXPOSURE; OXIDANTS; DISEASE	Cigarette smoke consists of tar and gas phase: the latter is toxicologically important because it can pass through lung alveolar epithelium to enter the circulation. Here we attempt to establish a standard method for preparation of gas phase extract of cigarette smoke (CSE). CSE was prepared by continuously sucking cigarette smoke through a Cambridge filter to remove tar, followed by bubbling it into phosphate-buffered saline (PBS). An increase in dry weight of the filter was defined as tar weight. Characteristically, concentrations of CSEs were represented as virtual tar concentrations, assuming that tar on the filter was dissolved in PBS. CSEs prepared from smaller numbers of cigarettes (original tar concentrations <= 15 mg/ml) showed similar concentration-response curves for cytotoxicity versus virtual tar concentrations, but with CSEs from larger numbers (tar >= 20 mg/ml), the curves were shifted rightward. Accordingly, the cytotoxic activity was detected in PBS of the second reservoir downstream of the first one with larger numbers of cigarettes. CSEs prepared from various cigarette brands showed comparable concentration-response curves for cytotoxicity. Two types of CSEs prepared by continuous and puff smoking protocols were similar regarding concentration-response curves for cytotoxicity, pharmacology of their cytotoxicity, and concentrations of cytotoxic compounds. These data show that concentrations of CSEs expressed by virtual tar concentrations can be a reference value to normalize their cytotoxicity, irrespective of numbers of combusted cigarettes, cigarette brands and smoking protocols, if original tar concentrations are <= 15 mg/ml.	[Higashi, Tsunehito; Mai, Yosuke; Horinouchi, Takahiro; Terada, Koji; Hoshi, Akimasa; Nepal, Prabha; Harada, Takuya; Horiguchi, Mika; Hatate, Chizuru; Miwa, Soichi] Hokkaido Univ, Grad Sch Med, Dept Cellular Pharmacol, Sapporo, Hokkaido, Japan; [Noya, Yoichi; Kuge, Yuji] Hokkaido Univ, Cent Inst Isotope Sci, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Miwa, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Cellular Pharmacol, Sapporo, Hokkaido, Japan.	smiwa@med.hokudai.ac.jp	洋輔, 眞井/GVS-5202-2022		Japan Society for the Promotion of Science [24390059, 25460326, 25670123]; SRFJ; Akiyama Life Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); SRFJ; Akiyama Life Science Foundation	This work was supported by Grant-in-Aids for Scientific Research (B) 24390059 (SM), Scientific Research (C) 25460326 (KT) and Challenging Exploratory Research 25670123 (SM) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html), by a grant from the SRFJ (SM), and by a grant from the Akiyama Life Science Foundation (THi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Asano H, 2012, J PHARMACOL SCI, V118, P275, DOI 10.1254/jphs.11166FP; BURNS DM, 1991, CLIN CHEST MED, V12, P631; Canales L, 2012, TOXICOLOGY, V300, P1, DOI 10.1016/j.tox.2012.04.016; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Connolly GN, 2000, TOB CONTROL, V9, P283, DOI 10.1136/tc.9.3.283; Csiszar A, 2009, FRONT BIOSCI-LANDMRK, V14, P3128, DOI 10.2741/3440; D'Agostini F, 2008, INT J CANCER, V123, P2497, DOI 10.1002/ijc.23836; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Erhardt L, 2009, ATHEROSCLEROSIS, V205, P23, DOI 10.1016/j.atherosclerosis.2009.01.007; FREI B, 1991, BIOCHEM J, V277, P133, DOI 10.1042/bj2770133; Hammond D, 2007, TOB CONTROL, V16, P8, DOI 10.1136/tc.2005.015297; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hecht SS, 2009, NAT REV CANCER, V9, P476, DOI 10.1038/nrc2674; Jaimes EA, 2004, ARTERIOSCL THROM VAS, V24, P1031, DOI 10.1161/01.ATV.0000127083.88549.58; Kozlowski LT, 2002, TOB CONTROL, V11, pI40, DOI 10.1136/tc.11.suppl_1.i40; Kunitomo M, 2009, J PHARMACOL SCI, V110, P354, DOI 10.1254/jphs.09100FP; Lambert C, 2005, J ALLERGY CLIN IMMUN, V116, P916, DOI 10.1016/j.jaci.2005.05.046; Le Houezec J, 2011, DRUG ALCOHOL REV, V30, P119, DOI 10.1111/j.1465-3362.2010.00264.x; Mai Y, 2012, J PHARMACOL SCI, V120, P310, DOI 10.1254/jphs.12219SC; Noya Y, 2013, TOXICOLOGY, V314, P1, DOI [10.1016/j.cox.2013.08.015, 10.1016/j.tox.2013.08.015]; Nussbaumer-Ochsner Y, 2011, CHEST, V139, P165, DOI 10.1378/chest.10-1252; Orosz Z, 2007, AM J PHYSIOL-HEART C, V292, pH130, DOI 10.1152/ajpheart.00599.2006; PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x; Purkis SW, 2011, REGUL TOXICOL PHARM, V59, P293, DOI 10.1016/j.yrtph.2010.11.002; Purkis SW, 2010, REGUL TOXICOL PHARM, V58, P501, DOI 10.1016/j.yrtph.2010.08.022; Rabinoff M, 2007, AM J PUBLIC HEALTH, V97, P1981, DOI 10.2105/AJPH.2005.078014; Steenland K, 1996, CIRCULATION, V94, P622, DOI 10.1161/01.CIR.94.4.622; Stephens WE, 2007, TOB CONTROL, V16, P170, DOI 10.1136/tc.2006.017491; Su YC, 1998, AM J RESP CELL MOL, V19, P819, DOI 10.1165/ajrcmb.19.5.3091; Takano S, 1997, Fukushima J Med Sci, V43, P1; Tamimi A, 2012, RESP MED, V106, P319, DOI 10.1016/j.rmed.2011.11.003; Tauler J, 2009, CURR OPIN PHARMACOL, V9, P384, DOI 10.1016/j.coph.2009.06.004; Valavanidis A, 2009, INT J ENV RES PUB HE, V6, P445, DOI 10.3390/ijerph6020445; Yamaguchi Y, 2002, FEBS LETT, V512, P218, DOI 10.1016/S0014-5793(02)02263-9; Yamaguchi Y, 2007, J PHARMACOL SCI, V103, P275, DOI 10.1254/jphs.FP0061055; Yu HM, 2012, J APPL TOXICOL, V32, P282, DOI 10.1002/jat.1679	37	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107856	10.1371/journal.pone.0107856	http://dx.doi.org/10.1371/journal.pone.0107856			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229830	Green Published, gold			2022-12-25	WOS:000342123900081
J	Chisti, MJ; Graham, SM; Duke, T; Ahmed, T; Faruque, AG; Ashraf, H; Bardhan, PK; Shahid, AMSB; Shahunja, KM; Salam, MA				Chisti, Mohammod Jobayer; Graham, Stephen M.; Duke, Trevor; Ahmed, Tahmeed; Faruque, Abu Syed Golam; Ashraf, Hasan; Bardhan, Pradip Kumar; Shahid, Abu S. M. S. B.; Shahunja, K. M.; Salam, Mohammed Abdus			Post-Discharge Mortality in Children with Severe Malnutrition and Pneumonia in Bangladesh	PLOS ONE			English	Article							MALNOURISHED CHILDREN; RISK-FACTORS; FOLLOW-UP; DIARRHEA; TRIAL; REHABILITATION; MANAGEMENT; DISCHARGE; DISEASE; MALAWI	Background: Post-discharge mortality among children with severe illness in resource-limited settings is under-recognized and there are limited data. We evaluated post-discharge mortality in a recently reported cohort of children with severe malnutrition and pneumonia, and identified characteristics associated with an increased risk of death. Methods: Young children (< 5 years of age) with severe malnutrition (WHO criteria) and radiographic pneumonia on admission to Dhaka Hospital of icddr, b over a 15-month period were managed according to standard protocols. Those discharged were followed-up and survival status at 12 weeks post-discharge was determined. Verbal autopsy was requested from families of those that died. Results: Of 405 children hospitalized with severe malnutrition and pneumonia, 369 (median age, 10 months) were discharged alive with a follow-up plan. Of these, 32 (8.7%) died in the community within 3 months of discharge: median 22 (IQR 9-35) days from discharge to death. Most deaths were reportedly associated with acute onset of new respiratory or gastrointestinal symptoms. Those that died following discharge were significantly younger (median 6 [IQR 3,12] months) and more severely malnourished, on admission and on discharge, than those that survived. Bivariate analysis found that severe wasting on admission (OR 3.64, 95% CI 1.66-7.97) and age,12 months (OR 2.54, 95% CI 1.1-8.8) were significantly associated with post-discharge death. Of those that died in the community, none had attended a scheduled follow-up and care-seeking from a traditional healer was more common (p, 0.001) compared to those who survived. Conclusion and Significance: Post-discharge mortality was common in Bangladeshi children following inpatient care for severe malnutrition and pneumonia. The underlying contributing factors require a better understanding to inform the potential of interventions that could improve survival.	[Chisti, Mohammod Jobayer; Ahmed, Tahmeed; Faruque, Abu Syed Golam; Ashraf, Hasan; Bardhan, Pradip Kumar; Shahid, Abu S. M. S. B.; Shahunja, K. M.; Salam, Mohammed Abdus] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Chisti, Mohammod Jobayer; Graham, Stephen M.; Duke, Trevor] Univ Melbourne, Dept Paediat, Ctr Int Child Hlth, Melbourne, Vic, Australia; [Chisti, Mohammod Jobayer; Graham, Stephen M.; Duke, Trevor] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Graham, Stephen M.] Int Union TB & Lung Dis, Paris, France	International Centre for Diarrhoeal Disease Research (ICDDR); University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Graham, SM (corresponding author), Univ Melbourne, Dept Paediat, Ctr Int Child Hlth, Melbourne, Vic, Australia.	steve.graham@rch.org.au	Chisti, Mohammod J/A-7216-2018; Shahunja, K M/AAR-6229-2020	Shahunja, K M/0000-0002-9345-206X; Graham, Stephen/0000-0003-3525-2294	Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B) [Gr-00233]	Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B)	This research study was funded by the Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B; grant no Gr-00233) and its donors, which provide unrestricted support to ICDDR, B for its operations and research. Current donors providing unrestricted support include: Australian Agency for International Development, Government of the People's Republic of Bangladesh, Canadian International Development Agency, Swedish International Development Cooperation Agency, and the Department for International Development, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Ashraf H, 2012, J TROP PEDIATRICS, V58, P253, DOI 10.1093/tropej/fmr083; Bejon P, 2008, AM J CLIN NUTR, V88, P1626, DOI 10.3945/ajcn.2008.26510; Brewster DR, 1997, EUR J CLIN NUTR, V51, P139, DOI 10.1038/sj.ejcn.1600367; Chang AB, 2008, PEDIATR PULM, V43, P519, DOI 10.1002/ppul.20821; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; Chisti MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093776; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; Ciliberto MA, 2005, AM J CLIN NUTR, V81, P864, DOI 10.1093/ajcn/81.4.864; D'Souza RM, 2003, J BIOSOC SCI, V35, P131, DOI 10.1017/S0021932003001317; HENNART P, 1987, J TROP PEDIATRICS, V33, P10, DOI 10.1093/tropej/33.1.10; Islam MA, 1996, J TROP PEDIATRICS, V42, P342, DOI 10.1093/tropej/42.6.342; Kerac M, 2009, LANCET, V374, P136, DOI 10.1016/S0140-6736(09)60884-9; Marais BJ, 2010, AM J RESP CRIT CARE, V181, P195, DOI 10.1164/ajrccm.181.2.195a; Mercer A, 2006, HEALTH POLICY PLANN, V21, P432, DOI 10.1093/heapol/czl024; Qureshi JS, 2014, TROP MED INT HLTH; Reneman L, 1997, J TROP PEDIATRICS, V43, P293, DOI 10.1093/tropej/43.5.293; Roy SK, 2011, J HEALTH POPUL NUTR, V29, P229, DOI 10.3329/jhpn.v29i3.7870; ROY SK, 1983, BRIT MED J, V287, P1097, DOI 10.1136/bmj.287.6399.1097; Veirum JE, 2007, ACTA PAEDIATR, V96, P1832, DOI 10.1111/j.1651-2227.2007.00562.x; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Waterlow J C, 1971, Adv Protein Chem, V25, P117, DOI 10.1016/S0065-3233(08)60280-6; Wiens MO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066698; World Health Organization, 2006, GUID COTR PROH HIV R; World Health Organization, 2007, 2007 WHO VERB AUT IN, P20; World Health Organization, 2013, POCK BOOK HOSP CAR C; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6	28	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107663	10.1371/journal.pone.0107663	http://dx.doi.org/10.1371/journal.pone.0107663			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225798	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700072
J	Egana-Gorrono, L; Escriba, T; Boulanger, N; Guardo, AC; Leon, A; Bargallo, ME; Garcia, F; Gatell, JM; Plana, M; Arnedo, M				Egana-Gorrono, Lander; Escriba, Tuixent; Boulanger, Nicolas; Crespo Guardo, Alberto; Leon, Agathe; Enric Bargallo, Manel; Garcia, Felipe; Maria Gatell, Jose; Plana, Montserrat; Arnedo, Mireia		AIDS Spanish Network	Differential MicroRNA Expression Profile between Stimulated PBMCs from HIV-1 Infected Elite Controllers and Viremic Progressors	PLOS ONE			English	Article							HIV-INFECTED INDIVIDUALS; T-CELL RESPONSES; CLASS-I; DISEASE PROGRESSION; VIRUS-REPLICATION; MESSENGER-RNA; HOST ICAM-1; VIRAL LOAD; MIR-155; CD4(+)	Background: The emerging relationship between microRNAs (miRNA) and viral-control is a topic of interest in the field of HIV. Host-genome might play an important role in the control of viremia. The aim of this study was to assess the specific miRNA profile that could contribute to the control of HIV replication in Elite Controllers Results: After adequate normalization, expression profile of 286 human miRNAs (hsa-miR) was evaluated in phytohaemagglutinin-stimulated PBMCs from 29 individuals classified in 4 groups: 8 elite controllers (EC; viral load < 50 cp/ml without treatment), 8 viremic progressors (VP; VL>5000 cp/ml without treatment), 8 patients under antiretroviral treatment (ART; VL<200 cp/ml) and 5 uninfected individuals (HIV-) through TaqMan Array Human microRNA Cards v3.0. A differential expression pattern consisting of 23 miRNAs became significantly different when comparing EC and VP. Profiling analysis segregated the population in two different blocks: while EC and HIV-clustered together in the same block (EC/HIV-_block 1), VP and ART individuals clustered together in a second block (VP/ART_block 2). Two inversely expressed miRNA patterns were determined within those two blocks: a set of 4 miRNAs (hsa-miR-221, -27a, -27b and -29b) was up-expressed in EC/HIV-_block and down-expressed in VP/ART_block while 19 miRNAs were down-expressed in block 1 and up-expressed in block 2. Differential miRNAs were successfully validated through individual RT-qPCR assays. Conclusions: Profile in EC resembled HIV- and differentially clusters with VP and ART. Therefore, differential clustering does not rely on undetectable viremia.	[Egana-Gorrono, Lander; Escriba, Tuixent; Boulanger, Nicolas; Arnedo, Mireia] Hosp Clin Barcelona, IDIBAPS, Catalan Project Dev HIV Vaccine HIVACAT, Grp Genom & Pharmacogen,AIDS Res Grp, Barcelona, Spain; [Crespo Guardo, Alberto; Enric Bargallo, Manel; Plana, Montserrat] Hosp Clin Barcelona, IDIBAPS, Catalan Project Dev HIV Vaccine HIVACAT, AIDS Res Grp, Barcelona, Spain; [Leon, Agathe; Garcia, Felipe; Maria Gatell, Jose] Univ Barcelona, Hosp Clin Barcelona, Dept Infect Dis, Barcelona, Spain; [Boulanger, Nicolas] Sci Pk Barcelona, Ctr Nacl Anal Genom, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona	Arnedo, M (corresponding author), Hosp Clin Barcelona, IDIBAPS, Catalan Project Dev HIV Vaccine HIVACAT, Grp Genom & Pharmacogen,AIDS Res Grp, Barcelona, Spain.	marnedo@clinic.ub.es	Leon, Agathe/K-9851-2015; Casado, Concepcion/F-3060-2016; Genebat, Miguel/F-3072-2015; Lopez-Galindez, Cecilio/A-3603-2008; Plana, Montserrat/AAA-5124-2020; Pernas, Maria/E-3998-2018; Gatell, Jose M/ABC-3607-2020; , Felipe/F-4242-2014	Leon, Agathe/0000-0002-1198-5090; Casado, Concepcion/0000-0003-3412-2877; Lopez-Galindez, Cecilio/0000-0002-2324-9584; Pernas, Maria/0000-0003-2966-0160; , Felipe/0000-0001-7658-5832; Egana Gorrono, Lander/0000-0002-0378-7844; Escriba, Tuixent/0000-0001-9467-7802; Benito, Jose/0000-0002-7172-049X; Rallon, Norma/0000-0002-4643-247X	HIVACAT (HIV Vaccine Research and Development Programme in Catalonia); Fundacion para la Investigacion y la Prevencion del Sida en Espana [FIPSE 09]; Fondo Europeo para el Desarrollo Regional (FEDER); Fondo de Investigacion Sanitaria FIS [FIS PI070291, PI12/00969]; Red de Investigacion en Sida (RIS); Instituto de Salud Carlos III [ISCIII-RETIC RD06/0006/0000]; Spanish Health of the ISCIII (Instituto de SaludCarlos III); Health Department of the Catalan Government (Generalitat de Catalunya); ISCIII [FI10/00174]	HIVACAT (HIV Vaccine Research and Development Programme in Catalonia); Fundacion para la Investigacion y la Prevencion del Sida en Espana; Fondo Europeo para el Desarrollo Regional (FEDER)(European Commission); Fondo de Investigacion Sanitaria FIS(Instituto de Salud Carlos III); Red de Investigacion en Sida (RIS); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Health of the ISCIII (Instituto de SaludCarlos III); Health Department of the Catalan Government (Generalitat de Catalunya)(Generalitat de Catalunya); ISCIII(Instituto de Salud Carlos III)	This work was partially supported by HIVACAT (HIV Vaccine Research and Development Programme in Catalonia), Fundacion para la Investigacion y la Prevencion del Sida en Espana (FIPSE 09), Fondo Europeo para el Desarrollo Regional (FEDER), Fondo de Investigacion Sanitaria FIS, FIS PI070291, PI12/00969, Red de Investigacion en Sida (RIS), Instituto de Salud Carlos III (ISCIII-RETIC RD06/0006/0000). M. Arnedo and M. Plana are researchers from the Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS) and are supported by the Spanish Health of the ISCIII (Instituto de SaludCarlos III) and the Health Department of the Catalan Government (Generalitat de Catalunya). L. Egana-Gorrono is a recipient of a pre-doctoral grant from the ISCIII (FI10/00174). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia JK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-117; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bi YJ, 2009, J CELL PHYSIOL, V218, P467, DOI 10.1002/jcp.21639; Bignami F, 2012, BLOOD, V119, P6259, DOI 10.1182/blood-2011-09-379503; Bounou S, 2004, FASEB J, V18, P1294, DOI 10.1096/fj.04-1755fje; Brennan CA, 2012, J VIROL, V86, P10505, DOI 10.1128/JVI.00102-12; Chiang K, 2012, J VIROL, V86, P3244, DOI 10.1128/JVI.05065-11; Chun TW, 2003, P NATL ACAD SCI USA, V100, P1908, DOI 10.1073/pnas.0437640100; D'haene Barbara, 2012, Methods Mol Biol, V822, P261, DOI 10.1007/978-1-61779-427-8_18; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Dudda JC, 2013, IMMUNITY, V38, P742, DOI 10.1016/j.immuni.2012.12.006; Duskova K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-250; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Grabar S, 2009, AIDS, V23, P1163, DOI 10.1097/QAD.0b013e32832b44c8; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Graf EH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001300; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183; Houzet L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-118; Hu GK, 2010, AM J PHYSIOL-GASTR L, V298, pG542, DOI 10.1152/ajpgi.00490.2009; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Lassen KG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000377; Leonard JA, 2011, J VIROL, V85, P6867, DOI 10.1128/JVI.00229-11; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; Paquette JS, 1998, J VIROL, V72, P9329, DOI 10.1128/JVI.72.11.9329-9336.1998; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Rizzuto CD, 1997, J VIROL, V71, P4847, DOI 10.1128/JVI.71.6.4847-4851.1997; Rodriguez-Garcia M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009436; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Rotger M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000781; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Schaefer MR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000131; Schulte LN, 2013, NUCLEIC ACIDS RES, V41, P542, DOI 10.1093/nar/gks1030; Seddiki N, 2014, IMMUNOLOGY, V142, P32, DOI 10.1111/imm.12227; Seddiki N, 2012, BLOOD, V119, P6396, DOI 10.1182/blood-2012-02-412874; Sun GH, 2012, NUCLEIC ACIDS RES, V40, P2181, DOI 10.1093/nar/gkr961; Swaminathan G, 2014, J MOL BIOL, V426, P1178, DOI 10.1016/j.jmb.2013.12.017; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Vigneault F, 2011, J VIROL, V85, P3015, DOI 10.1128/JVI.01846-10; Witwer KW, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-5; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhang CZ, 2010, INT J ONCOL, V36, P1503, DOI 10.3892/ijo_00000637; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837	57	41	41	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e106360	10.1371/journal.pone.0106360	http://dx.doi.org/10.1371/journal.pone.0106360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225963	Green Published, gold, Green Submitted			2022-12-25	WOS:000344317700010
J	Flores, O; Herault, B; Delcamp, M; Garnier, E; Gourlet-Fleury, S				Flores, Olivier; Herault, Bruno; Delcamp, Matthieu; Garnier, Eric; Gourlet-Fleury, Sylvie			Functional Traits Help Predict Post-Disturbance Demography of Tropical Trees	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; HAWAIIAN METROSIDEROS-POLYMORPHA; MIXED DIPTEROCARP FOREST; WOOD DENSITY; ECONOMICS SPECTRUM; TERRESTRIAL PLANTS; LEAF MORPHOLOGY; MAXIMUM HEIGHT; GAS-EXCHANGE; LOW-RAINFALL	How tropical tree species respond to disturbance is a central issue of forest ecology, conservation and resource management. We define a hierarchical model to investigate how functional traits measured in control plots relate to the population change rate and to demographic rates for recruitment and mortality after disturbance by logging operations. Population change and demographic rates were quantified on a 12-year period after disturbance and related to seven functional traits measured in control plots. The model was calibrated using a Bayesian Network approach on 53 species surveyed in permanent forest plots (37.5 ha) at Paracou in French Guiana. The network analysis allowed us to highlight both direct and indirect relationships among predictive variables. Overall, 89% of interspecific variability in the population change rate after disturbance were explained by the two demographic rates, the recruitment rate being the most explicative variable. Three direct drivers explained 45% of the variability in recruitment rates, including leaf phosphorus concentration, with a positive effect, and seed size and wood density with negative effects. Mortality rates were explained by interspecific variability in maximum diameter only (25%). Wood density, leaf nitrogen concentration, maximum diameter and seed size were not explained by variables in the analysis and thus appear as independent drivers of post-disturbance demography. Relationships between functional traits and demographic parameters were consistent with results found in undisturbed forests. Functional traits measured in control conditions can thus help predict the fate of tropical tree species after disturbance. Indirect relationships also suggest how different processes interact to mediate species demographic response.	[Flores, Olivier] Cirad Univ La Reunion, UMR PVBMT, St Pierre, France; [Herault, Bruno] Cirad, UMR Ecol Forets Guyane, Kourou, France; [Delcamp, Matthieu; Gourlet-Fleury, Sylvie] Cirad, UR B&SEF Biens & Serv Ecosyst Forestiers Trop, Montpellier, France; [Garnier, Eric] CNRS, UMR 5175, Ctr Ecol Fonct & Evolut, Montpellier, France	CIRAD; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CIRAD; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Flores, O (corresponding author), Cirad Univ La Reunion, UMR PVBMT, 7 Chemin IRAT, St Pierre, France.	olivier.flores@cirad.fr	Garnier, Eric/D-1650-2012; Hérault, Bruno/B-2765-2011	Garnier, Eric/0000-0002-9392-5154; Hérault, Bruno/0000-0002-6950-7286; Flores, Olivier/0000-0002-1416-0449	Ministere de l'Enseignement Superieur et de la Recherche	Ministere de l'Enseignement Superieur et de la Recherche	The work was part of a PhD funded by a scholarship from "Ministere de l'Enseignement Superieur et de la Recherche". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anten NPR, 2010, AM NAT, V175, P250, DOI 10.1086/649581; Aubry-Kientz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063678; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Baraloto C, 2005, J ECOL, V93, P1156, DOI 10.1111/j.1365-2745.2005.01041.x; Baraloto C, 2012, J APPL ECOL, V49, P861, DOI 10.1111/j.1365-2664.2012.02164.x; Baraloto C, 2010, FUNCT ECOL, V24, P208, DOI 10.1111/j.1365-2435.2009.01600.x; Bonal D, 2000, OECOLOGIA, V124, P454, DOI 10.1007/PL00008871; Bottcher SG, 2003, J STAT SOFTW, V8, P1; Carreno-Rocabado G, 2012, J ECOL, V100, P1453, DOI 10.1111/j.1365-2745.2012.02015.x; Cernusak LA, 2013, NEW PHYTOL, V200, P950, DOI 10.1111/nph.12423; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Cochran WG., 1963, SAMPLING TECHNIQUES; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Delcamp M, 2008, J VEG SCI, V19, P209, DOI 10.3170/2008-8-18360; DONOVAN LA, 1994, OECOLOGIA, V100, P347, DOI 10.1007/BF00316964; Falster D, 2005, J ECOL, V18, P337; Falster DS, 2005, OIKOS, V111, P57, DOI 10.1111/j.0030-1299.2005.13383.x; Farquhar GD, 1989, ANN REV PLANT PHYSL; Geritz SA, 1995, AM NAT, P685; Gourlet-Fleury S., 2004, ECOLOGY MANAGEMENT N; Gourlet-Fleury S, 2011, J ECOL, V99, P981, DOI 10.1111/j.1365-2745.2011.01829.x; Grime J. P., 2001, PLANT STRATEGIES VEG; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Herault B, 2007, PERSPECT PLANT ECOL, V9, P71, DOI 10.1016/j.ppees.2007.08.001; Herault B, 2011, J ECOL, V99, P1431, DOI 10.1111/j.1365-2745.2011.01883.x; Herault B, 2010, J APPL ECOL, V47, P821, DOI 10.1111/j.1365-2664.2010.01826.x; Hultine KR, 2000, OECOLOGIA, V123, P32, DOI 10.1007/s004420050986; Kammesheidt L, 2001, J APPL ECOL, V38, P756, DOI 10.1046/j.1365-2664.2001.00629.x; King DA, 2006, J ECOL, V94, P670, DOI 10.1111/j.1365-2745.2006.01112.x; King DA, 2006, FOREST ECOL MANAG, V223, P152, DOI 10.1016/j.foreco.2005.10.066; King DA, 2006, J TROP ECOL, V22, P11, DOI 10.1017/S0266467405002774; Koch GW, 2004, NATURE, V428, P851, DOI 10.1038/nature02417; Kohyama T, 2003, J ECOL, V91, P797, DOI 10.1046/j.1365-2745.2003.00810.x; Kraft NJB, 2010, NEW PHYTOL, V188, P1124, DOI 10.1111/j.1469-8137.2010.03444.x; Lamont BB, 2002, FUNCT ECOL, V16, P403, DOI 10.1046/j.1365-2435.2002.00631.x; Lasky JR, 2014, ECOLOGY LETT; LEISHMAN MR, 2000, EVOLUTIONARY ECOLOGY, P00031; Markesteijn L, 2011, PLANT CELL ENVIRON, V34, P137, DOI 10.1111/j.1365-3040.2010.02231.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; MEINZER FC, 1992, OECOLOGIA, V91, P305, DOI 10.1007/BF00317617; Mercado LM, 2011, PHILOS T R SOC B, V366, P3316, DOI 10.1098/rstb.2011.0045; Moles AT, 2006, OIKOS, V113, P91, DOI 10.1111/j.0030-1299.2006.14194.x; Nascimento HEM, 2005, J VEG SCI, V16, P625, DOI 10.1111/j.1654-1103.2005.tb02405.x; Niinemets U, 2003, ACTA OECOL, V24, P209, DOI 10.1016/S1146-609X(03)00094-8; Pearl J, 1998, 980002 URL CIT; PENUELAS J, 2013, NATURE COMMUNICATION, V4; POORTER H, 1994, FUNCTIONAL PLANT BIO, V21, P507; Poorter L, 2008, ECOLOGY, V89, P1908, DOI 10.1890/07-0207.1; Poorter L, 2006, ECOLOGY, V87, P1289, DOI 10.1890/0012-9658(2006)87[1289:AOMTST]2.0.CO;2; R Development Core Team, 2009, R FDN STAT COMP; RAAIMAKERS D, 1995, OECOLOGIA, V102, P120, DOI 10.1007/BF00333319; Reich P. B., 2003, International Journal of Plant Sciences, V164, pS143, DOI 10.1086/374368; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Ruger N, 2008, ECOSYSTEMS, V11, P868, DOI 10.1007/s10021-008-9166-8; Ruger N, 2012, ECOLOGY, V93, P2626, DOI 10.1890/12-0622.1; Russo SE, 2008, J ECOL, V96, P192, DOI 10.1111/j.1365-2745.2007.01330.x; Ryan MG, 1997, BIOSCIENCE, V47, P235, DOI 10.2307/1313077; Santiago LS, 2004, OECOLOGIA, V140, P543, DOI 10.1007/s00442-004-1624-1; Schulze ED, 1998, AUST J PLANT PHYSIOL, V25, P413, DOI 10.1071/PP97113; Sheil D, 2003, TRENDS ECOL EVOL, V18, P18, DOI 10.1016/S0169-5347(02)00005-8; Shipley B, 2000, ECOSCIENCE, V7, P183, DOI 10.1080/11956860.2000.11682587; Shipley B, 2009, ECOLOGY, V90, P363, DOI 10.1890/08-1034.1; Sist P, 2002, FOREST ECOL MANAG, V165, P85, DOI 10.1016/S0378-1127(01)00649-1; Sparks JP, 1997, OECOLOGIA, V109, P362, DOI 10.1007/s004420050094; Stahl C, 2013, OECOLOGIA, V173, P1191, DOI 10.1007/s00442-013-2724-6; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; VITOUSEK PM, 1990, OECOLOGIA, V84, P362, DOI 10.1007/BF00329760; Wagner F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034074; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2001, FUNCT ECOL, V15, P423, DOI 10.1046/j.0269-8463.2001.00542.x; Wright S Joseph, 2010, Ecology, V91, P3664, DOI 10.1890/09-2335.1	76	15	16	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e105022	10.1371/journal.pone.0105022	http://dx.doi.org/10.1371/journal.pone.0105022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226586	Green Published, gold			2022-12-25	WOS:000344317700007
J	Hagenbucher, S; Wackers, FL; Romeis, J				Hagenbucher, Steffen; Waeckers, Felix L.; Romeis, Joerg			Aphid Honeydew Quality as a Food Source for Parasitoids Is Maintained in Bt Cotton	PLOS ONE			English	Article							VIRESCENS F LEPIDOPTERA; WITHIN-PLANT VARIATION; TERPENOID ALDEHYDES; MULTIPLE CROPS; GOSSYPOL; SURVIVAL; PYRROLIZIDINE; HYMENOPTERA; SUPPRESSION; COMPETITION	Bt-transgenic cotton has proven to be highly efficient in controlling key lepidopteran pests. One concern with the deployment of Bt cotton varieties is the potential proliferation of non-target pests. We previously showed that Bt cotton contained lower concentrations of insecticidal terpenoids as a result of reduced caterpillar damage, which benefited the aphid Aphis gossypii. It is thus important that non-target herbivores are under biological control in Bt cotton fields. The induction or lack of induction of terpenoids could also influence the quality of aphid honeydew, an important food source for beneficial insects. We therefore screened A. gossypii honeydew for cotton terpenoids, that are induced by caterpillars but not the aphids. We then tested the influence of induced insect-resistance of cotton on honeydew nutritional quality for the aphid parasitoid Lysiphlebus testaceipes and the whitefly parasitoid Eretmocerus eremicus. We detected the cotton terpenoids gossypol and hemigossypolone in A. gossypii honeydew. Although a feeding assay demonstrated that gossypol reduced the longevity of both parasitoid species in a non-linear, dose-dependent manner, the honeydew was capable of sustaining parasitoid longevity and reproduction. The level of caterpillar damage to Bt and non-Bt cotton had no impact on the quality of honeydew for the parasitoids. These results indicate that the nutritional quality of honeydew is maintained in Bt cotton and is not influenced by induced insect resistance.	[Hagenbucher, Steffen; Romeis, Joerg] Agroscope, ISS, Zurich, Switzerland; [Waeckers, Felix L.] Univ Lancaster, Ctr Sustainable Agr, Lancaster, England	Swiss Federal Research Station Agroscope; Lancaster University	Romeis, J (corresponding author), Agroscope, ISS, Zurich, Switzerland.	joerg.romeis@agroscope.admin.ch			Swiss National Science Foundation (SNF) [31003A-120477]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	This project was supported by the Swiss National Science Foundation (SNF grant no. 31003A-120477). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney MR, 2008, J ECON ENTOMOL, V101, P23, DOI 10.1603/0022-0493(2008)101[23:RAFOCA]2.0.CO;2; Adamczyk JJ, 2001, J ECON ENTOMOL, V94, P1589, DOI 10.1603/0022-0493-94.6.1589; Anderson P, 2005, OECOLOGIA, V144, P427, DOI 10.1007/s00442-005-0095-3; Bezemer TM, 2004, J CHEM ECOL, V30, P53, DOI 10.1023/B:JOEC.0000013182.50662.2a; BOTTGER GT, 1964, J ECON ENTOMOL, V57, P283, DOI 10.1093/jee/57.2.283; BOUCHARD Y, 1984, CAN J ZOOL, V62, P1513, DOI 10.1139/z84-220; BUDENBERG WJ, 1990, ENTOMOL EXP APPL, V55, P139, DOI 10.1007/BF00352575; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Colfer RG, 2001, OECOLOGIA, V126, P292, DOI 10.1007/s004420000510; da Silva RJ, 2008, REV BRAS ENTOMOL, V52, P124, DOI 10.1590/S0085-56262008000100021; DREYER DL, 1985, J CHEM ECOL, V11, P1045, DOI 10.1007/BF01020674; Dulaurent AM, 2011, J APPL ENTOMOL, V135, P184, DOI 10.1111/j.1439-0418.2010.01547.x; Evangelista WS, 2011, REV BRAS ENTOMOL, V55, P267, DOI 10.1590/S0085-56262011005000003; GUNASENA GH, 1989, ENVIRON ENTOMOL, V18, P886, DOI 10.1093/ee/18.5.886; Hagenbucher S, 2013, CRIT REV PLANT SCI, V32, P458, DOI 10.1080/07352689.2013.809293; Hagenbucher S, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0795; Hagenbucher S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0042; Hogervorst PAM, 2007, FUNCT ECOL, V21, P936, DOI 10.1111/j.1365-2435.2007.01297.x; Hogervorst PAM, 2007, ENTOMOL EXP APPL, V122, P223, DOI 10.1111/j.1570-7458.2006.00505.x; Hogervorst PAM, 2009, AGR FOREST ENTOMOL, V11, P161, DOI 10.1111/j.1461-9563.2008.00412.x; JERVIS MA, 1986, BIOL REV, V61, P395, DOI 10.1111/j.1469-185X.1986.tb00660.x; Kaplan I, 2007, ECOL LETT, V10, P977, DOI 10.1111/j.1461-0248.2007.01093.x; Kazana E, 2007, P ROY SOC B-BIOL SCI, V274, P2271, DOI 10.1098/rspb.2007.0237; Lee JC, 2004, ENTOMOL EXP APPL, V111, P189, DOI 10.1111/j.0013-8703.2004.00165.x; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Malcolm S.B., 1990, Chemoecology, V1, P12, DOI 10.1007/BF01240581; Mandour NS, 2007, J APPL ENTOMOL, V131, P645, DOI 10.1111/j.1439-0418.2007.01165.x; McAuslane HJ, 1997, J CHEM ECOL, V23, P2861, DOI 10.1023/A:1022575313325; Merritt SZ, 1996, J CHEM ECOL, V22, P1133, DOI 10.1007/BF02027950; Naranjo SE, 2011, J AGR FOOD CHEM, V59, P5842, DOI 10.1021/jf102939c; Olson DM, 2008, J CHEM ECOL, V34, P1341, DOI 10.1007/s10886-008-9532-1; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; ROJAS MG, 1992, ENVIRON ENTOMOL, V21, P518, DOI 10.1093/ee/21.3.518; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J, 2008, INTEGRATION OF INSEC; Sivasupramaniam S, 2008, J ECON ENTOMOL, V101, P546, DOI 10.1603/0022-0493(2008)101[546:TACOCE]2.0.CO;2; Soler Roxina, 2004, Proceedings of the Section Experimental and Applied Entomology of the Netherlands Entomological Society (N.E.V.), V15, P111; STIPANOVIC RD, 1988, J AGR FOOD CHEM, V36, P509, DOI 10.1021/jf00081a026; Sun YC, 2011, INSECT SCI, V18, P451, DOI 10.1111/j.1744-7917.2010.01328.x; Tena A, 2013, BIOL CONTROL, V67, P117, DOI 10.1016/j.biocontrol.2013.07.018; Tena A, 2013, ECOL ENTOMOL, V38, P278, DOI 10.1111/een.12018; VRIELING K, 1991, OECOLOGIA, V86, P177, DOI 10.1007/BF00317529; Wackers FL, 2008, BIOL CONTROL, V45, P176, DOI 10.1016/j.biocontrol.2008.01.007; Wackers FL, 2000, OIKOS, V90, P197, DOI 10.1034/j.1600-0706.2000.900124.x; Wackers FL, 2005, PLANT-PROVIDED FOOD FOR CARNIVOROUS INSECTS: PROTECTIVE MUTUALISM AND ITS APPLICATIONS, P17, DOI 10.1017/CBO9780511542220.003; Wackers FL, 2001, J INSECT PHYSIOL, V47, P1077, DOI 10.1016/S0022-1910(01)00088-9; Whitehouse MEA, 2007, AUST J AGR RES, V58, P383, DOI 10.1071/AR06100_CO; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Zeilinger AR, 2011, ENTOMOL EXP APPL, V141, P59, DOI 10.1111/j.1570-7458.2011.01165.x	50	12	13	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107806	10.1371/journal.pone.0107806	http://dx.doi.org/10.1371/journal.pone.0107806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226521	Green Submitted, Green Published, gold			2022-12-25	WOS:000344317700086
J	Li, X; Yang, YQ; Sun, XD; Lin, HM; Chen, JH; Ren, J; Hu, XY; Yang, YP				Li, Xiong; Yang, Yunqiang; Sun, Xudong; Lin, Huaming; Chen, Jinhui; Ren, Jian; Hu, Xiangyang; Yang, Yongping			Comparative Physiological and Proteomic Analyses of Poplar (Populus yunnanensis) Plantlets Exposed to High Temperature and Drought	PLOS ONE			English	Article							CARBAMIDE CYTOKININ 4-PU-30; SEXUAL DIFFERENCES; STRESS RESPONSES; PHOTOSYNTHETIC ACTIVITY; HYDROGEN-PEROXIDE; NITRIC-OXIDE; PROTEIN; WHEAT; PROLINE; LEAF	Plantlets of Populus yunnanensis Dode were examined in a greenhouse for 48 h to analyze their physiological and proteomic responses to sustained heat, drought, and combined heat and drought. Compared with the application of a single stress, simultaneous treatment with both stresses damaged the plantlets more heavily. The plantlets experienced two apparent response stages under sustained heat and drought. During the first stage, malondialdehyde and reactive oxygen species (ROS) contents were induced by heat, but many protective substances, including antioxidant enzymes, proline, abscisic acid (ABA), dehydrin, and small heat shock proteins (sHSPs), were also stimulated. The plants thus actively defended themselves against stress and exhibited few pathological morphological features, most likely because a new cellular homeostasis was established through the collaborative operation of physiological and proteomic responses. During the second stage, ROS homeostasis was overwhelmed by substantial ROS production and a sharp decline in antioxidant enzyme activities, while the synthesis of some protective elements, such as proline and ABA, was suppressed. As a result, photosynthetic levels in P. yunnanensis decreased sharply and buds began to die, despite continued accumulation of sHSPs and dehydrin. This study supplies important information about the effects of extreme abiotic environments on woody plants.	[Li, Xiong; Yang, Yunqiang; Sun, Xudong; Lin, Huaming; Hu, Xiangyang; Yang, Yongping] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Biodivers & Biogeog East Asia, Kunming, Peoples R China; [Li, Xiong; Yang, Yunqiang; Sun, Xudong; Lin, Huaming; Hu, Xiangyang; Yang, Yongping] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Plant Germplasm & Genom Ctr, Kunming, Peoples R China; [Li, Xiong; Yang, Yunqiang; Lin, Huaming] Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Jinhui] Nanjing Forestry Univ, Key Lab Forest Genet & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Ren, Jian] Yunnan Agr Univ, Dept Grassland Sci, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nanjing Forestry University; Yunnan Agricultural University	Yang, YP (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Biodivers & Biogeog East Asia, Kunming, Peoples R China.	yangyp@mail.kib.ac.cn	Hu, Xiangyang/AAQ-3313-2021; Sun, Xudong/HHN-3905-2022		Major State Basic Research Development Program [2010CB951700]; Young Academic and Technical Leader Raising Foundation of Yunnan Province [2012HB041]; National Science Foundation of China [31170256, 31260167]	Major State Basic Research Development Program(National Basic Research Program of China); Young Academic and Technical Leader Raising Foundation of Yunnan Province; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This article was supported by Major State Basic Research Development Program (2010CB951700), the Young Academic and Technical Leader Raising Foundation of Yunnan Province (2012HB041) and the National Science Foundation of China (31170256; 31260167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able AJ, 2003, PROTOPLASMA, V221, P137, DOI 10.1007/s00709-002-0064-1; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Bai XG, 2011, J PROTEOME RES, V10, P4349, DOI 10.1021/pr200333f; Bansal S, 2013, TREE PHYSIOL, V33, P451, DOI 10.1093/treephys/tpt019; Barbosa H, 2009, ANAL BIOCHEM, V395, P108, DOI 10.1016/j.ab.2009.07.045; Barua D, 2006, AM J BOT, V93, P102, DOI 10.3732/ajb.93.1.102; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Boyko A, 2008, ENVIRON MOL MUTAGEN, V49, P61, DOI 10.1002/em.20347; Centritto M, 2011, TREE PHYSIOL, V31, P275, DOI 10.1093/treephys/tpq112; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chen LH, 2011, J EXP BOT, V62, P5037, DOI 10.1093/jxb/err203; Chen LH, 2010, PLANT CELL ENVIRON, V33, P1767, DOI 10.1111/j.1365-3040.2010.02182.x; Chinnusamy V, 2009, SCI CHINA SER C, V52, P331, DOI 10.1007/s11427-009-0052-1; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; DAMERVAL C, 1986, ELECTROPHORESIS, V7, P52, DOI 10.1002/elps.1150070108; Duan BL, 2008, PHYSIOL PLANTARUM, V134, P257, DOI 10.1111/j.1399-3054.2008.01128.x; Duan BL, 2013, FOREST ECOL MANAG, V296, P33, DOI 10.1016/j.foreco.2013.01.032; Duan BL, 2005, PHYSIOL PLANTARUM, V124, P476, DOI 10.1111/j.1399-3054.2005.00535.x; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Grigorova B, 2012, J PLANT INTERACT, V7, P204, DOI 10.1080/17429145.2011.654134; Guilioni L, 2003, FUNCT PLANT BIOL, V30, P1151, DOI 10.1071/FP03105; Hurkman WJ, 1998, PHYSIOL PLANTARUM, V103, P80, DOI 10.1034/j.1399-3054.1998.1030110.x; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Ji J, 2006, PLANT BIOLOGY, V8, P597, DOI 10.1055/s-2006-924175; Jiang H, 2013, CHEMOSPHERE, V91, P1213, DOI 10.1016/j.chemosphere.2013.01.041; Jiang H, 2012, J EXP BOT, V63, P3709, DOI 10.1093/jxb/ers064; Jiang MY, 2001, PLANT CELL PHYSIOL, V42, P1265, DOI 10.1093/pcp/pce162; Kim MD, 2010, PHYSIOL PLANTARUM, V140, P153, DOI 10.1111/j.1399-3054.2010.01392.x; Kosova K, 2011, PLANT SCI, V180, P46, DOI 10.1016/j.plantsci.2010.07.003; Kuznetsov VV, 1997, PHYSIOL PLANTARUM, V100, P320, DOI 10.1034/j.1399-3054.1997.1000214.x; LAEMMLI UK, 1970, J MOL BIOL, V47, P69, DOI 10.1016/0022-2836(70)90402-X; Li L, 2013, PHYSIOL PLANTARUM, V147, P477, DOI 10.1111/j.1399-3054.2012.01676.x; Li X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0099857, 10.1371/journal.pone.0098410]; Machado S, 2001, PLANT SOIL, V233, P179, DOI 10.1023/A:1010346601643; Mihailova G, 2011, PHOTOSYNTH RES, V108, P5, DOI 10.1007/s11120-011-9644-2; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Peng SM, 2012, TREE PHYSIOL, V32, P1541, DOI 10.1093/treephys/tps110; Pradhan GP, 2012, FUNCT PLANT BIOL, V39, P190, DOI 10.1071/FP11245; Rivero RM, 2007, P NATL ACAD SCI USA, V104, P19631, DOI 10.1073/pnas.0709453104; Shah NH, 2003, PLANT SOIL, V257, P219, DOI 10.1023/A:1026237816578; Stoyanova D, 1999, PHOTOSYNTHETICA, V37, P621, DOI 10.1023/A:1007183811186; Vassileva V, 2011, J PLANT RES, V124, P147, DOI 10.1007/s10265-010-0340-7; Verlinden M, 2013, PLANT ECOL, V214, P243, DOI 10.1007/s11258-012-0163-9; Wan XY, 2008, MOL CELL PROTEOMICS, V7, P1469, DOI 10.1074/mcp.M700488-MCP200; Wolkovich EM, 2012, NATURE, V485, P494, DOI 10.1038/nature11014; WU MT, 1983, PLANT PHYSIOL, V72, P817, DOI 10.1104/pp.72.3.817; Xue TL, 2000, AGR FOOD SCI FINLAND, V9, P177, DOI 10.23986/afsci.5659; Yang F, 2010, PHYSIOL PLANTARUM, V139, P388, DOI 10.1111/j.1399-3054.2010.01375.x; Yang LM, 2013, J PROTEOME RES, V12, P1316, DOI 10.1021/pr300971n; Yang YQ, 2012, J PROTEOME RES, V11, P3605, DOI 10.1021/pr300027a; Yordanov I, 1999, PHOTOSYNTHETICA, V37, P447, DOI 10.1023/A:1007163928253	51	46	48	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107605	10.1371/journal.pone.0107605	http://dx.doi.org/10.1371/journal.pone.0107605			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225913	Green Submitted, gold, Green Published			2022-12-25	WOS:000344317700065
J	Mailloux, RJ; Florian, M; Chen, QX; Yan, J; Petrov, I; Coughlan, MC; Laziyan, M; Caldwell, D; Lalande, M; Patry, D; Gagnon, C; Sarafin, K; Truong, J; Chan, HM; Ratnayake, N; Li, NQ; Willmore, WG; Jin, XL				Mailloux, Ryan J.; Florian, Maria; Chen, Qixuan; Yan, Jin; Petrov, Ivan; Coughlan, Melanie C.; Laziyan, Mahemuti; Caldwell, Don; Lalande, Michelle; Patry, Dominique; Gagnon, Claude; Sarafin, Kurtis; Truong, Jocelyn; Chan, Hing Man; Ratnayake, Nimal; Li, Nanqin; Willmore, William G.; Jin, Xiaolei			Exposure to a Northern Contaminant Mixture (NCM) Alters Hepatic Energy and Lipid Metabolism Exacerbating Hepatic Steatosis in Obese JCR Rats	PLOS ONE			English	Article							FATTY LIVER-DISEASE; POLYCHLORINATED-BIPHENYLS; NONALCOHOLIC STEATOHEPATITIS; COENZYME Q(10); COMPLEX I; CHOLESTEROL; SECRETION; BIOSYNTHESIS; MITOCHONDRIA; MUSCLE	Non-alcoholic fatty liver disease (NAFLD), defined by the American Liver Society as the buildup of extra fat in liver cells that is not caused by alcohol, is the most common liver disease in North America. Obesity and type 2 diabetes are viewed as the major causes of NAFLD. Environmental contaminants have also been implicated in the development of NAFLD. Northern populations are exposed to a myriad of persistent organic pollutants including polychlorinated biphenyls, organochlorine pesticides, flame retardants, and toxic metals, while also affected by higher rates of obesity and alcohol abuse compared to the rest of Canada. In this study, we examined the impact of a mixture of 22 contaminants detected in Inuit blood on the development and progression of NAFLD in obese JCR rats with or without co-exposure to 10% ethanol. Hepatosteatosis was found in obese rat liver, which was worsened by exposure to 10% ethanol. NCM treatment increased the number of macrovesicular lipid droplets, total lipid contents, portion of mono- and polyunsaturated fatty acids in the liver. This was complemented by an increase in hepatic total cholesterol and cholesterol ester levels which was associated with changes in the expression of genes and proteins involved in lipid metabolism and transport. In addition, NCM treatment increased cytochrome P450 2E1 protein expression and decreased ubiquinone pool, and mitochondrial ATP synthase subunit ATP5A and Complex IV activity. Despite the changes in mitochondrial physiology, hepatic ATP levels were maintained high in NCM-treated versus control rats. This was due to a decrease in ATP utilization and an increase in creatine kinase activity. Collectively, our results suggest that NCM treatment decreases hepatic cholesterol export, possibly also increases cholesterol uptake from circulation, and promotes lipid accumulation and alters ATP homeostasis which exacerbates the existing hepatic steatosis in genetically obese JCR rats with or without co-exposure to ethanol.	[Mailloux, Ryan J.; Florian, Maria; Chen, Qixuan; Yan, Jin; Petrov, Ivan; Coughlan, Melanie C.; Laziyan, Mahemuti; Jin, Xiaolei] Hlth Canada, Food Directorate, Bur Chem Safety, Toxicol Res Div, Ottawa, ON K1A 0L2, Canada; [Caldwell, Don; Lalande, Michelle; Patry, Dominique] Hlth Canada, Food Directorate, Bur Chem Safety, Sci Support Div, Ottawa, ON K1A 0L2, Canada; [Gagnon, Claude; Sarafin, Kurtis; Ratnayake, Nimal] Hlth Canada, Food Directorate, Bur Chem Safety, Nutr Res Div, Ottawa, ON K1A 0L2, Canada; [Li, Nanqin] Hlth Canada, Hazard Identificat Div, Healthy Environm & Consumer Safety Branch, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada; [Mailloux, Ryan J.; Florian, Maria; Laziyan, Mahemuti; Willmore, William G.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Mailloux, Ryan J.; Florian, Maria; Laziyan, Mahemuti; Willmore, William G.] Carleton Univ, Dept Chem, Ottawa, ON K1S 5B6, Canada; [Truong, Jocelyn; Chan, Hing Man] Univ Ottawa, Dept Biol, Ottawa, ON, Canada	Health Canada; Health Canada; Health Canada; Health Canada; Carleton University; Carleton University; University of Ottawa	Jin, XL (corresponding author), Hlth Canada, Food Directorate, Bur Chem Safety, Toxicol Res Div, Ottawa, ON K1A 0L2, Canada.	dawn.jin@hc-sc.gc.ca		Chan, Laurie/0000-0003-4351-7483; Mailloux, Ryan/0000-0003-3986-9830	Health Canada; Northern Contaminants Program, Government of Canada; Natural Sciences and Engineering Research Council of Canada	Health Canada; Northern Contaminants Program, Government of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a research grant (to XJ) from Health Canada and the Northern Contaminants Program as part of a Government of Canada initiative to address potential health risks that may be associated with human exposure to elevated levels of contaminants in the traditional diets of northern Aboriginal peoples, and a discovery grant (to WGW) from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, preparation of the manuscript or the decision to publish.	Adams LA, 2005, CAN MED ASSOC J, V172, P899, DOI 10.1503/cmaj.045232; Astiz M, 2009, ECOTOX ENVIRON SAFE, V72, P2025, DOI 10.1016/j.ecoenv.2009.05.001; Barrientos A., 2009, CURR PROTOC HUM GENE, V19, P13, DOI DOI 10.1002/0471142905.HG1903S63; Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226; BELL FP, 1978, LIPIDS, V13, P673, DOI 10.1007/BF02533744; Braune BM, 2005, SCI TOTAL ENVIRON, V351, P4, DOI 10.1016/j.scitotenv.2004.10.034; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Cave M, 2010, ENVIRON HEALTH PERSP, V118, P1735, DOI 10.1289/ehp.1002720; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Davis CW, 2010, FREE RADICAL BIO MED, V48, P306, DOI 10.1016/j.freeradbiomed.2009.11.001; DeBose-Boyd RA, 2008, CELL RES, V18, P609, DOI 10.1038/cr.2008.61; Dewailly E., 2006, SYNOPSIS RES CONDUCT, P44; Elam MB, 2001, J LIPID RES, V42, P2039; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Grattagliano I, 2012, CLIN BIOCHEM, V45, P610, DOI 10.1016/j.clinbiochem.2012.03.024; HORIO F, 1989, J NUTR, V119, P409, DOI 10.1093/jn/119.3.409; Hyder O, 2013, J GASTROINTEST SURG, V17, P1265, DOI 10.1007/s11605-013-2210-9; Ikeda K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3147; JENKE HS, 1985, BIOCHIM BIOPHYS ACTA, V837, P85, DOI 10.1016/0005-2760(85)90088-8; KLING D, 1982, ENVIRON RES, V27, P10, DOI 10.1016/0013-9351(82)90052-4; KLING D, 1978, J ENVIRON PATHOL TOX, V1, P813; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lind PM, 2004, TOXICOL LETT, V150, P293, DOI 10.1016/j.toxlet.2004.02.008; Longato L, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-14; Mailloux RJ, 2013, TRENDS BIOCHEM SCI, V38, P592, DOI 10.1016/j.tibs.2013.09.001; Mailloux RJ, 2013, J BIOL CHEM, V288, P8365, DOI 10.1074/jbc.M112.442905; Mailloux RJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.393538; Mailloux RJ, 2012, TRENDS ENDOCRIN MET, V23, P451, DOI 10.1016/j.tem.2012.04.004; Mailloux RJ, 2011, EXP CELL RES, V317, P2231, DOI 10.1016/j.yexcr.2011.07.009; Maranzana E, 2013, ANTIOXID REDOX SIGN, V19, P1469, DOI 10.1089/ars.2012.4845; Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102; Mollica MP, 2009, J HEPATOL, V51, P363, DOI 10.1016/j.jhep.2009.03.023; Moriya T, 2009, J OCCUP HEALTH, V51, P391, DOI 10.1539/joh.K9001; Mudipalli A, 2007, INDIAN J MED RES, V126, P518; OGATA M, 1991, TOXICOL LETT, V56, P327, DOI 10.1016/0378-4274(91)90161-X; Pessayre D, 2007, J GASTROEN HEPATOL, V22, pS20, DOI 10.1111/j.1440-1746.2006.04640.x; Pitceathly RDS, 2013, JAMA NEUROL, V70, P1556, DOI 10.1001/jamaneurol.2013.3242; Quinzii CM, 2007, NEUROCHEM RES, V32, P723, DOI 10.1007/s11064-006-9190-z; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Reimer RA, 2008, OBESITY, V16, P40, DOI 10.1038/oby.2007.16; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; Russell DW, 1999, CELL, V97, P539, DOI 10.1016/S0092-8674(00)80763-1; Shen KL, 2011, J HAZARD MATER, V185, P24, DOI 10.1016/j.jhazmat.2010.08.061; Tang PH, 2001, CLIN CHEM, V47, P256; VANCE JE, 1990, J LIPID RES, V31, P1491; Wahlang B, 2013, J NUTR BIOCHEM, V24, P1587, DOI 10.1016/j.jnutbio.2013.01.009; Wahlang B, 2013, TOXICOL PATHOL, V41, P343, DOI 10.1177/0192623312468517; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001; Williams SL, 2004, J BIOL CHEM, V279, P7462, DOI 10.1074/jbc.M309232200; Yao ZM, 2013, CURR OPIN LIPIDOL, V24, P160, DOI 10.1097/MOL.0b013e32835aebe7	51	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e106832	10.1371/journal.pone.0106832	http://dx.doi.org/10.1371/journal.pone.0106832			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222487	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774800028
J	Neau, DB; Bender, G; Boeglin, WE; Bartlett, SG; Brash, AR; Newcomer, ME				Neau, David B.; Bender, Gunes; Boeglin, William E.; Bartlett, Sue G.; Brash, Alan R.; Newcomer, Marcia E.			Crystal Structure of a Lipoxygenase in Complex with Substrate THE ARACHIDONIC ACID-BINDING SITE OF 8R-LIPOXYGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arachidonic Acid (AA) (ARA); Eicosanoid Biosynthesis; Lipid Signaling; Lipoxygenase Pathway; Protein Structure; X-ray Crystallography	ACTIVE-SITE; ARACHIDONIC-ACID; FATTY-ACIDS; INHIBITION; OXYGENATION; SPECIFICITY; MODEL; STEREOSPECIFICITY; 8R-LIPOXYGENASE; DETERMINANTS	Background: Lipoxygenases (LOX) catalyze the oxygenation of polyunsaturated fatty acids but generate distinct products from a common substrate. Results: We report the first structure of a LOX-substrate complex. Conclusion: The structure provides a context for understanding product specificity in enzymes that metabolize arachidonic acid. Significance: With roles in the production of potent lipid mediators, LOX are targets for drug design. Lipoxygenases (LOX) play critical roles in mammalian biology in the generation of potent lipid mediators of the inflammatory response; consequently, they are targets for the development of isoform-specific inhibitors. The regio- and stereo-specificity of the oxygenation of polyunsaturated fatty acids by the enzymes is understood in terms of the chemistry, but structural observation of the enzyme-substrate interactions is lacking. Although several LOX crystal structures are available, heretofore the rapid oxygenation of bound substrate has precluded capture of the enzyme-substrate complex, leaving a gap between chemical and structural insights. In this report, we describe the 2.0 angstrom resolution structure of 8R-LOX in complex with arachidonic acid obtained under anaerobic conditions. Subtle rearrangements, primarily in the side chains of three amino acids, allow binding of arachidonic acid in a catalytically competent conformation. Accompanying experimental work supports a model in which both substrate tethering and cavity depth contribute to positioning the appropriate carbon at the catalytic machinery.	[Bender, Gunes; Bartlett, Sue G.; Newcomer, Marcia E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Neau, David B.] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, Northeastern Collaborat Access Team, Argonne, IL 60439 USA; [Boeglin, William E.; Brash, Alan R.] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA	Louisiana State University System; Louisiana State University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Vanderbilt University	Newcomer, ME (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	newcomer@lsu.edu			Nation Institute of General Medical Sciences from the National Institutes of Health [P41 GM103403]; U. S. Department of Energy [DE-AC02-06CH11357]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, P01GM015431, P50GM015431] Funding Source: NIH RePORTER	Nation Institute of General Medical Sciences from the National Institutes of Health; U. S. Department of Energy(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work includes research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by a grant from the Nation Institute of General Medical Sciences (P41 GM103403) from the National Institutes of Health. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U. S. Department of Energy Office of Science by Argonne National Laboratory, was supported by the U. S. Department of Energy under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreou A, 2009, PHYTOCHEMISTRY, V70, P1504, DOI 10.1016/j.phytochem.2009.05.008; Berry H, 1997, FEBS LETT, V408, P324, DOI 10.1016/S0014-5793(97)00453-5; Borngraber S, 1999, J BIOL CHEM, V274, P37345, DOI 10.1074/jbc.274.52.37345; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; BOYINGTON JC, 1993, SCIENCE, V260, P1482, DOI 10.1126/science.8502991; Brash AR, 2012, LIPIDS, V47, P101, DOI 10.1007/s11745-011-3612-7; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Chen C, 2014, APPL ENVIRON MICROB, V80, P3992, DOI 10.1128/AEM.00215-14; Choi J, 2008, PROTEINS, V70, P1023, DOI 10.1002/prot.21590; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; Dewal MB, 2013, BIOCHEMISTRY-US, V52, P6559, DOI 10.1021/bi400444y; Eek P, 2012, J BIOL CHEM, V287, P22377, DOI 10.1074/jbc.M112.343285; EGMOND MR, 1972, BIOCHEM BIOPH RES CO, V48, P1055, DOI 10.1016/0006-291X(72)90815-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Garreta A, 2013, FASEB J, V27, P4811, DOI 10.1096/fj.13-235952; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; HAMBERG M, 1967, J BIOL CHEM, V242, P5329; Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Klinman JP, 2007, ACCOUNTS CHEM RES, V40, P325, DOI 10.1021/ar6000507; Knapp MJ, 2001, J AM CHEM SOC, V123, P2931, DOI 10.1021/ja003855k; Kobe MJ, 2014, J BIOL CHEM, V289, P8562, DOI 10.1074/jbc.M113.543777; KUHL PW, 1994, BIOCHEM J, V298, P171, DOI 10.1042/bj2980171; KUHN H, 1990, J BIOL CHEM, V265, P16300; LiCata VJ, 1997, BIOPHYS CHEM, V64, P225, DOI 10.1016/S0301-4622(96)02204-1; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Marangoni A. G., 2003, ENZYME KINETICS MODE, P184; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; Neau DB, 2007, ACTA CRYSTALLOGR F, V63, P972, DOI 10.1107/S1744309107050993; Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m; Oldham ML, 2005, J BIOL CHEM, V280, P39545, DOI 10.1074/jbc.M506675200; Peng S, 2003, J AM CHEM SOC, V125, P8988, DOI 10.1021/ja035977t; Schneider C, 2000, ANAL BIOCHEM, V287, P186, DOI 10.1006/abio.2000.4847; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Szegletes T, 1999, BIOCHEMISTRY-US, V38, P122, DOI 10.1021/bi9813577; Willemoes M, 2003, ARCH BIOCHEM BIOPHYS, V413, P17, DOI 10.1016/S0003-9861(03)00085-7; Xu S, 2012, STRUCTURE, V20, P1490, DOI 10.1016/j.str.2012.06.003; YAMAMOTO S, 1992, BIOCHIM BIOPHYS ACTA, V1128, P117, DOI 10.1016/0005-2760(92)90297-9; Ziegler J, 2009, J BIOL CHEM, V284, P26758, DOI 10.1074/jbc.M109.030957	44	46	47	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31905	31913		10.1074/jbc.M114.599662	http://dx.doi.org/10.1074/jbc.M114.599662			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25231982	Green Published, hybrid			2022-12-25	WOS:000345314700021
J	Shahpasandzadeh, H; Popova, B; Kleinknecht, A; Fraser, PE; Outeiro, TF; Braus, GH				Shahpasandzadeh, Hedieh; Popova, Blagovesta; Kleinknecht, Alexandra; Fraser, Paul E.; Outeiro, Tiago F.; Braus, Gerhard H.			Interplay between Sumoylation and Phosphorylation for Protection against alpha-Synuclein Inclusions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODIFIER SUMO MODIFICATION; LEWY BODIES; RAT MODEL; IN-VIVO; PROTEIN; UBIQUITIN; YEAST; AGGREGATION; TOXICITY; DEGRADATION	Parkinson disease is associated with the progressive loss of dopaminergic neurons from the substantia nigra. The pathological hallmark of the disease is the accumulation of intracytoplasmic inclusions known as Lewy bodies that consist mainly of post-translationally modified forms of alpha-synuclein. Whereas phosphorylation is one of the major modifications of alpha-synuclein in Lewy bodies, sumoylation has recently been described. The interplay between alpha-synuclein phosphorylation and sumoylation is poorly understood. Here, we examined the interplay between these modifications as well as their impact on cell growth and inclusion formation in yeast. We found that alpha-synuclein is sumoylated in vivo at the same sites in yeast as in human cells. Impaired sumoylation resulted in reduced yeast growth combined with an increased number of cells with inclusions, suggesting that this modification plays a protective role. In addition, inhibition of sumoylation prevented autophagy-mediated aggregate clearance. A defect in alpha-synuclein sumoylation could be suppressed by serine 129 phosphorylation by the human G protein-coupled receptor kinase 5 (GRK5) in yeast. Phosphorylation reduced foci formation, alleviated yeast growth inhibition, and partially rescued autophagic alpha-synuclein degradation along with the promotion of proteasomal degradation, resulting in aggregate clearance in the absence of a small ubiquitin-like modifier. These findings suggest a complex interplay between sumoylation and phosphorylation in alpha-synuclein aggregate clearance, which may open new horizons for the development of therapeutic strategies for Parkinson disease.	[Shahpasandzadeh, Hedieh; Popova, Blagovesta; Kleinknecht, Alexandra; Braus, Gerhard H.] Univ Gottingen, Inst Microbiol & Genet, Dept Mol Microbiol & genet, D-37077 Gottingen, Germany; [Shahpasandzadeh, Hedieh; Popova, Blagovesta; Kleinknecht, Alexandra; Outeiro, Tiago F.; Braus, Gerhard H.] Ctr Nanoscale Microscopy & Mol Physiol Brain, D-37073 Gottingen, Germany; [Fraser, Paul E.] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5T 2S8, Canada; [Fraser, Paul E.] Univ Toronto, Dept Med Biophys, Toronto, ON M5T 2S8, Canada; [Outeiro, Tiago F.] Univ Med Ctr Gottingen, Dept Neurodegenerat & Restorat Res, D-37073 Gottingen, Germany	University of Gottingen; University of Toronto; University of Toronto; University of Gottingen	Braus, GH (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Dept Mol Microbiol & genet, D-37077 Gottingen, Germany.	gbraus@gwdg.de	Outeiro, Tiago/M-8106-2019; Outeiro, Tiago F/C-1067-2008; Outeiro, Tiago/L-7351-2019; Braus, Gerhard/ABC-6293-2021; Braus, Gerhard H/G-3999-2012	Outeiro, Tiago F/0000-0003-1679-1727; Outeiro, Tiago/0000-0003-1679-1727; Braus, Gerhard/0000-0002-3117-5626; Braus, Gerhard H/0000-0002-3117-5626; Popova, Blagovesta/0000-0001-6323-374X	Deutsche Forschungsgemeinschaft Research Center Nanoscale Microscopy and Molecular Physiology of the Brain; Cluster of Excellence	Deutsche Forschungsgemeinschaft Research Center Nanoscale Microscopy and Molecular Physiology of the Brain; Cluster of Excellence	This work was supported by the Cluster of Excellence and Deutsche Forschungsgemeinschaft Research Center Nanoscale Microscopy and Molecular Physiology of the Brain.	Abramoff M. D., 2004, J BIOPHOTONICS INT, V11, P36; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; [Anonymous], 1991, Methods Enzymol, V194, P1; Arawaka S, 2006, J NEUROSCI, V26, P9227, DOI 10.1523/JNEUROSCI.0341-06.2006; Basso E, 2013, MOL NEUROBIOL, V48, P854, DOI 10.1007/s12035-013-8473-z; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Bergeron M, 2014, NEUROSCIENCE, V256, P72, DOI 10.1016/j.neuroscience.2013.09.061; Biggins S, 2001, GENETICS, V159, P453; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; da Silveira SA, 2009, HUM MOL GENET, V18, P872, DOI 10.1093/hmg/ddn417; Dadke S, 2007, NAT CELL BIOL, V9, P80, DOI 10.1038/ncb1522; Dieckhoff P, 2004, MOL MICROBIOL, V51, P1375, DOI 10.1046/j.1365-2958.2003.03910.x; Dorval V, 2006, J BIOL CHEM, V281, P9919, DOI 10.1074/jbc.M510127200; Droescher M, 2011, J BIOL CHEM, V286, P18731, DOI 10.1074/jbc.M111.235978; DUBIEL W, 1992, J BIOL CHEM, V267, P22699; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Eckermann K, 2013, NEUROMOL MED, V15, P737, DOI 10.1007/s12017-013-8259-5; Ellis CE, 2001, J BIOL CHEM, V276, P3879, DOI 10.1074/jbc.M010316200; Forno LS, 1996, ADV NEUROL, V69, P217; Franssens V, 2010, CELL DEATH DIFFER, V17, P746, DOI 10.1038/cdd.2009.203; Freichel C, 2007, NEUROBIOL AGING, V28, P1421, DOI 10.1016/j.neurobiolaging.2006.06.013; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Galvin JE, 2001, ARCH NEUROL-CHICAGO, V58, P186, DOI 10.1001/archneur.58.2.186; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hodara R, 2004, J BIOL CHEM, V279, P47746, DOI 10.1074/jbc.M408906200; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Inglis KJ, 2009, J BIOL CHEM, V284, P2598, DOI 10.1074/jbc.C800206200; Janer A, 2010, HUM MOL GENET, V19, P181, DOI 10.1093/hmg/ddp478; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Jones EW, 2002, METHOD ENZYMOL, V351, P127; Kametaka S, 1996, GENE, V178, P139, DOI 10.1016/0378-1119(96)00354-X; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Krumova P, 2013, CELL MOL LIFE SCI, V70, P2123, DOI 10.1007/s00018-012-1158-3; Krumova P, 2011, J CELL BIOL, V194, P49, DOI 10.1083/jcb.201010117; KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; McFarland NR, 2009, J NEUROPATH EXP NEUR, V68, P515, DOI 10.1097/NEN.0b013e3181a24b53; Mukherjee S, 2009, J BIOL CHEM, V284, P21296, DOI 10.1074/jbc.M109.011494; Mullen JR, 2010, MOL CELL BIOL, V30, P3737, DOI 10.1128/MCB.01649-09; Nonaka T, 2005, BIOCHEMISTRY-US, V44, P361, DOI 10.1021/bi0485528; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Oueslati A, 2013, P NATL ACAD SCI USA, V110, pE3945, DOI 10.1073/pnas.1309991110; Oueslati A, 2010, PROG BRAIN RES, V183, P115, DOI 10.1016/S0079-6123(10)83007-9; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Petroi D, 2012, J BIOL CHEM, V287, P27567, DOI 10.1074/jbc.M112.361865; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Reynolds MR, 2007, BIOCHEMISTRY-US, V46, P7325, DOI 10.1021/bi700430y; Rott R, 2008, J BIOL CHEM, V283, P3316, DOI 10.1074/jbc.M704809200; Rott R, 2011, P NATL ACAD SCI USA, V108, P18666, DOI 10.1073/pnas.1105725108; Sakamoto M, 2009, BIOCHEM BIOPH RES CO, V384, P378, DOI 10.1016/j.bbrc.2009.04.130; Salvi M, 2012, BIOCHEM BIOPH RES CO, V418, P156, DOI 10.1016/j.bbrc.2011.12.152; Sancenon V, 2012, HUM MOL GENET, V21, P2432, DOI 10.1093/hmg/dds058; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; SIKORSKI RS, 1989, GENETICS, V122, P19; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Soustelle C, 2004, MOL CELL BIOL, V24, P5130, DOI 10.1128/MCB.24.12.5130-5143.2004; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Wang SX, 2012, P NATL ACAD SCI USA, V109, P16119, DOI 10.1073/pnas.1206286109; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; Waxman EA, 2011, J NEUROSCI RES, V89, P231, DOI 10.1002/jnr.22537; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Yao Q, 2011, J BIOL CHEM, V286, P27342, DOI 10.1074/jbc.M111.220848; Zabrocki P, 2005, FEBS J, V272, P1386, DOI 10.1111/j.1742-4658.2005.04571.x; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	82	58	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31224	31240		10.1074/jbc.M114.559237	http://dx.doi.org/10.1074/jbc.M114.559237			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25231978	hybrid, Green Published			2022-12-25	WOS:000344549900028
J	Hayashi, Y; Nemoto-Sasaki, Y; Tanikawa, T; Oka, S; Tsuchiya, K; Zama, K; Mitsutake, S; Sugiura, T; Yamashita, A				Hayashi, Yasuhiro; Nemoto-Sasaki, Yoko; Tanikawa, Takashi; Oka, Saori; Tsuchiya, Kiyoto; Zama, Kouta; Mitsutake, Susumu; Sugiura, Takayuki; Yamashita, Atsushi			Sphingomyelin Synthase 2, but Not Sphingomyelin Synthase 1, Is Involved in HIV-1 Envelope-mediated Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CHEMOKINE RECEPTORS; TYROSINE KINASE; CELL-LINE; ENTRY; CCR5; CD4; INFECTION; DOMAINS; BINDS	Membrane fusion between the viral envelope and plasma membranes of target cells has previously been correlated with HIV-1 infection. Lipids in the plasma membrane, including sphingomyelin, may be crucially involved in HIV-1 infection; however, the role of lipid-metabolic enzymes in membrane fusion remains unclear. In this study, we examined the roles of sphingomyelin synthase (SMS) in HIV-1 Env-mediated membrane fusion using a cell-cell fusion assay with HIV-1 mimetics and their target cells. We employed reconstituted cells as target cells that stably express Sms1 or Sms2 in Sms-deficient cells. Fusion susceptibility was similar to 5-fold higher in Sms2-expressing cells (not in Sms1-expressing cells) than in Sms-deficient cells. The enhancement of fusion susceptibility observed in Sms2-expressing cells was reversed and reduced by Sms2 knockdown. We also found that catalytically nonactive Sms2 promoted membrane fusion susceptibility. Moreover, SMS2 co-localized and was constitutively associated with the HIV receptor co-receptor complex in the plasma membrane. In addition, HIV-1 Env treatment resulted in a transient increase in nonreceptor tyrosine kinase (Pyk2) phosphorylation in Sms2-expressing and catalytically nonactive Sms2-expressing cells. We observed that F-actin polymerization in the region of membrane fusion was more prominent in Sms2-expressing cells than Sms-deficient cells. Taken together, our research provides insight into a novel function of SMS2 which is the regulation of HIV-1 Env-mediated membrane fusion via actin rearrangement.	[Hayashi, Yasuhiro; Nemoto-Sasaki, Yoko; Tanikawa, Takashi; Oka, Saori; Sugiura, Takayuki; Yamashita, Atsushi] Teikyo Univ, Fac Pharma Sci, Itabashi Ku, Tokyo 1738605, Japan; [Tsuchiya, Kiyoto] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Shinjuku Ku, Tokyo 1628655, Japan; [Zama, Kouta] Hokkaido Univ, Fac Adv Life Sci, Dept Biomembrane & Biofunct Chem, Sapporo, Hokkaido 0010021, Japan; [Mitsutake, Susumu] Saga Univ, Fac Agr, Dept Appl Biochem & Food Sci, Saga 8408502, Japan	Teikyo University; National Center for Global Health & Medicine - Japan; Hokkaido University; Saga University	Yamashita, A (corresponding author), Teikyo Univ, Fac Pharma Sci, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	ayamashi@pharm.teikyo-u.ac.jp	Tsuchiya, Kiyoto/L-8650-2013; Mitsutake, Susumu/A-4082-2012	Tsuchiya, Kiyoto/0000-0002-8233-6653; Yamashita, Atsushi/0000-0002-2544-2134	Japan Society for the Promotion of Science [25860055, 24590095]; Ministry of Education, Culture, Sports, and Technology; Grants-in-Aid for Scientific Research [25860055] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Young Scientists (B) 25860055 (to Y. H.) and for Scientific Research (C) 24590095 (to A. Y.) from the Japan Society for the Promotion of Science and in part by Ministry of Education, Culture, Sports, and Technology-supported program for the Strategic Research Foundation at Private Universities.	Abe M, 2012, MOL CELL BIOL, V32, P1396, DOI 10.1128/MCB.06113-11; Anand AR, 2009, BLOOD, V114, P3588, DOI 10.1182/blood-2009-02-206342; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Asano S, 2012, MOL CELL BIOL, V32, P3242, DOI 10.1128/MCB.00121-12; Astier A, 1997, J BIOL CHEM, V272, P228; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Barrero-Villar M, 2009, J CELL SCI, V122, P103, DOI 10.1242/jcs.035873; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Chen YG, 1997, J CELL BIOL, V138, P495, DOI 10.1083/jcb.138.3.495; Chiantia S, 2006, BIOPHYS J, V90, P4500, DOI 10.1529/biophysj.106.081026; de Curtis I, 2012, J CELL SCI, V125, P4435, DOI 10.1242/jcs.108266; Finnegan CM, 2007, J VIROL, V81, P5294, DOI 10.1128/JVI.02553-06; Finnegan CM, 2004, P NATL ACAD SCI USA, V101, P15452, DOI 10.1073/pnas.0402874101; FLORKIEWICZ RZ, 1984, SCIENCE, V225, P721, DOI 10.1126/science.6087454; Fuortes M, 1999, J CLIN INVEST, V104, P327, DOI 10.1172/JCI6018; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Godlee C, 2013, J CELL BIOL, V203, P717, DOI 10.1083/jcb.201307100; Ha KD, 2012, BBA-MOL CELL BIOL L, V1821, P1078, DOI 10.1016/j.bbalip.2012.04.004; Hug P, 2000, J VIROL, V74, P6377, DOI 10.1128/JVI.74.14.6377-6385.2000; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Iyengar S, 1998, J VIROL, V72, P5251, DOI 10.1128/JVI.72.6.5251-5255.1998; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jenkinson S, 2003, J BIOMOL SCREEN, V8, P463, DOI 10.1177/1087057103255747; Ji CH, 2006, J BIOMOL SCREEN, V11, P65, DOI 10.1177/1087057105282959; Jimenez-Baranda S, 2007, NAT CELL BIOL, V9, P838, DOI 10.1038/ncb1610; Keogh RJ, 2002, BIOCHEM BIOPH RES CO, V290, P1470, DOI 10.1006/bbrc.2002.6350; Koot M, 1996, J INFECT DIS, V173, P349, DOI 10.1093/infdis/173.2.349; Lee C, 2003, J LEUKOCYTE BIOL, V74, P676, DOI 10.1189/jlb.0503206; Li ZQ, 2012, ARTERIOSCL THROM VAS, V32, P1577, DOI 10.1161/ATVBAHA.112.251538; Liu Y, 2004, J VIROL, V78, P4120, DOI 10.1128/JVI.78.8.4120-4133.2004; Liu Y., 2009, SCI SIGNAL, V2, P1; Lord C., 2013, COLD SPRING HARBOR P, V5, P1; Maeda K, 2008, J MOL BIOL, V381, P956, DOI 10.1016/j.jmb.2008.06.041; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Roberts PC, 1999, J VIROL, V73, P10447, DOI 10.1128/JVI.73.12.10447-10457.1999; Rucker J, 1997, METHOD ENZYMOL, V288, P118; Shimizu T, 2004, CURR MICROBIOL, V48, P182, DOI 10.1007/s00284-003-4101-x; Speck RF, 1997, J VIROL, V71, P7136, DOI 10.1128/JVI.71.9.7136-7139.1997; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; Tsuchiya K., 2013, SCI REP, V3, P1, DOI DOI 10.1038/SREP01173; Vieira CR, 2010, CHEM BIOL, V17, P766, DOI 10.1016/j.chembiol.2010.05.023; Xiao XD, 1999, P NATL ACAD SCI USA, V96, P7496, DOI 10.1073/pnas.96.13.7496; Yamashita A, 2014, PROG LIPID RES, V53, P18, DOI 10.1016/j.plipres.2013.10.001; Yang XZ, 2001, J VIROL, V75, P1165, DOI 10.1128/JVI.75.3.1165-1171.2001; Yano M, 2011, J BIOL CHEM, V286, P3992, DOI 10.1074/jbc.M110.179176; Yeang C, 2008, BBA-MOL CELL BIOL L, V1781, P610, DOI 10.1016/j.bbalip.2008.07.002; Zama K, 2012, CHEM PHYS LIPIDS, V165, P760, DOI 10.1016/j.chemphyslip.2012.09.003	48	22	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30842	30856		10.1074/jbc.M114.574285	http://dx.doi.org/10.1074/jbc.M114.574285			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25231990	Green Published, hybrid			2022-12-25	WOS:000344549700058
J	Nakanishi-Matsui, M; Sekiya, M; Yano, S; Futai, M				Nakanishi-Matsui, Mayumi; Sekiya, Mizuki; Yano, Shio; Futai, Masamitsu			Inhibition of F-1-ATPase Rotational Catalysis by the Carboxyl-terminal Domain of the epsilon Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI ATP SYNTHASE; ESCHERICHIA-COLI; F-1 SECTOR; GAMMA-SUBUNIT; MECHANISM; COMPLEX; BINDING; FOF1	Escherichia coli ATP synthase (F0F1) couples catalysis and proton transport through subunit rotation. The epsilon subunit, an endogenous inhibitor, lowers F-1-ATPase activity by decreasing the rotation speed and extending the duration of the inhibited state (Sekiya, M., Hosokawa, H., Nakanishi-Matsui, M., Al-Shawi, M. K., Nakamoto, R. K., and Futai, M. (2010) Single molecule behavior of inhibited and active states of Escherichia coli ATP synthase F-1 rotation. J. Biol. Chem. 285, 42058-42067). In this study, we constructed a series of epsilon subunits truncated successively from the carboxyl-terminal domain (helix 1/loop 2/helix 2) and examined their effects on rotational catalysis (ATPase activity, average rotation rate, and duration of inhibited state). As expected, the epsilon subunit lacking helix 2 caused about 1/2-fold reduced inhibition, and that without loop 2/helix 2 or helix 1/loop 2/helix 2 showed a further reduced effect. Substitution of epsilon Ser(108) in loop 2 and epsilon Tyr(114) in helix 2, which possibly interact with the beta and gamma subunits, respectively, decreased the inhibitory effect. These results suggest that the carboxyl-terminal domain of the epsilon subunit plays a pivotal role in the inhibition of F-1 rotation through interaction with other subunits.	[Nakanishi-Matsui, Mayumi; Sekiya, Mizuki; Yano, Shio; Futai, Masamitsu] Iwate Med Univ, Fac Pharmaceut Sci, Dept Biochem, Yahaba, Iwate 0283694, Japan	Iwate Medical University	Nakanishi-Matsui, M (corresponding author), Iwate Med Univ, Fac Pharmaceut Sci, Dept Biochem, Nishitokuta 2-1-1, Yahaba, Iwate 0283694, Japan.	nakanim@iwate-med.ac.jp			Japan Society for the Promotion of Science KAKENHI [24590086]; Terumo Life Science Foundation; Japan Foundation for Applied Enzymology; Hayashi Memorial Foundation for Female Natural Scientists	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Terumo Life Science Foundation(Terumo Life Science Foundation); Japan Foundation for Applied Enzymology; Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists)	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant 24590086, the Terumo Life Science Foundation, and the Japan Foundation for Applied Enzymology. This work was also supported by a grant from the Hayashi Memorial Foundation for Female Natural Scientists (to M. N.-M.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; AlShawi MK, 1997, J BIOL CHEM, V272, P2300; Andrews SH, 2001, BIOCHEMISTRY-US, V40, P10664, DOI 10.1021/bi0155697; Bilyard T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0023; Borsch M, 2013, BIOCHEM SOC T, V41, P1219, DOI 10.1042/BST20130101; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulygin VV, 2004, J BIOL CHEM, V279, P35616, DOI 10.1074/jbc.M405012200; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Cipriano DJ, 2002, J BIOL CHEM, V277, P16782, DOI 10.1074/jbc.M201349200; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; Futai M., 2004, HDB ATPASES BIOCH CE, P237; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; Kashiwagi S, 2008, BIOCHEM BIOPH RES CO, V365, P227, DOI 10.1016/j.bbrc.2007.10.157; Kato-Yamada Y, 1999, J BIOL CHEM, V274, P33991, DOI 10.1074/jbc.274.48.33991; KUKI M, 1988, J BIOL CHEM, V263, P17437; Nakanishi-Matsui M, 2006, J BIOL CHEM, V281, P4126, DOI 10.1074/jbc.M510090200; Nakanishi-Matsui M, 2007, J BIOL CHEM, V282, P20698, DOI 10.1074/jbc.M700551200; Nakanishi-Matsui M, 2013, IUBMB LIFE, V65, P247, DOI 10.1002/iub.1134; Nakanishi-Matsui M, 2010, BBA-BIOENERGETICS, V1797, P1343, DOI 10.1016/j.bbabio.2010.02.014; Nakanishi-Matsui M, 2010, BIOCHEM BIOPH RES CO, V395, P173, DOI 10.1016/j.bbrc.2010.03.127; Oka H, 2014, BIOCHEM BIOPH RES CO, V446, P889, DOI 10.1016/j.bbrc.2014.03.021; Omote H, 1999, P NATL ACAD SCI USA, V96, P7780, DOI 10.1073/pnas.96.14.7780; Peskova YB, 2000, BIOCHEMISTRY-US, V39, P11830, DOI 10.1021/bi0013694; Schulenberg B, 1999, J BIOL CHEM, V274, P28351, DOI 10.1074/jbc.274.40.28351; Sekiya M, 2012, J BIOL CHEM, V287, P22771, DOI 10.1074/jbc.M112.374868; Sekiya M, 2010, J BIOL CHEM, V285, P42058, DOI 10.1074/jbc.M110.176701; Sekiya M, 2009, J BIOL CHEM, V284, P22401, DOI 10.1074/jbc.M109.009019; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Uhlin U, 1997, STRUCTURE, V5, P1219, DOI 10.1016/S0969-2126(97)00272-4; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; Weber J, 1999, J BIOL CHEM, V274, P19124, DOI 10.1074/jbc.274.27.19124; WILKENS S, 1995, NAT STRUCT BIOL, V2, P961, DOI 10.1038/nsb1195-961; Wilkens S, 1998, J BIOL CHEM, V273, P26645, DOI 10.1074/jbc.273.41.26645; Xiong H, 1998, BIOCHEMISTRY-US, V37, P16423, DOI 10.1021/bi981522i	36	12	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30822	30831		10.1074/jbc.M114.578872	http://dx.doi.org/10.1074/jbc.M114.578872			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25228697	Green Published, hybrid			2022-12-25	WOS:000344549700056
J	Cristobal-Azkarate, J; Dunn, JC; Day, JMW; Amabile-Cuevas, CF				Cristobal-Azkarate, Jurgi; Dunn, Jacob C.; Day, Jennifer M. W.; Amabile-Cuevas, Carlos F.			Resistance to Antibiotics of Clinical Relevance in the Fecal Microbiota of Mexican Wildlife	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; BACTERIA; PREVALENCE; PATTERNS; GENES; INTEGRONS; ABUNDANCE; CLASS-1	There are a growing number of reports of antibiotic resistance (ATBR) in bacteria living in wildlife. This is a cause for concern as ATBR in wildlife represents a potential public health threat. However, little is known about the factors that might determine the presence, abundance and dispersion of ATBR bacteria in wildlife. Here, we used culture and molecular methods to assess ATBR in bacteria in fecal samples from howler monkeys (Alouatta palliata), spider monkeys (Ateles geoffroyi), tapirs (Tapirus bairdii) and felids (jaguars, Panthera onca; pumas, Puma concolor; jaguarundis, Puma yagouaroundi; and ocelots, Leopardus pardalis) living freely in two regions of the Mexican state of Veracruz under different degrees of human influence. Overall, our study shows that ATBR is commonplace in bacteria isolated from wildlife in southeast Mexico. Most of the resistances were towards old and naturally occurring antibiotics, but we also observed resistances of potential clinical significance. We found that proximity to humans positively affected the presence of ATBR and that ATBR was higher in terrestrial than arboreal species. We also found evidence suggesting different terrestrial and aerial routes for the transmission of ATBR between humans and wildlife. The prevalence and potential ATBR transfer mechanisms between humans and wildlife observed in this study highlight the need for further studies to identify the factors that might determine ATBR presence, abundance and distribution.	[Cristobal-Azkarate, Jurgi; Dunn, Jacob C.] Univ Cambridge, Div Biol Anthropol, Cambridge, England; [Day, Jennifer M. W.] Univ Washington, Dept Biol, Ctr Conservat Biol, Seattle, WA 98195 USA; [Amabile-Cuevas, Carlos F.] Fdn Lusara, Mexico City, DF, Mexico	University of Cambridge; University of Washington; University of Washington Seattle	Amabile-Cuevas, CF (corresponding author), Fdn Lusara, Mexico City, DF, Mexico.	carlos.amabile@lusara.org	Amábile-Cuevas, Carlos/HDO-1753-2022	Amábile-Cuevas, Carlos/0000-0001-6806-544X; Cristobal-Azkarate, Jurgi/0000-0002-2799-8638; Dunn, Jacob/0000-0003-3487-6513	National Council of Science of Technology (CONACYT) in Mexico; Veracruz State Government [108990]; Isaac Newton Trust; Cambridge Humanities Research Grant Scheme	National Council of Science of Technology (CONACYT) in Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Veracruz State Government; Isaac Newton Trust; Cambridge Humanities Research Grant Scheme	The authors acknowledge the National Council of Science of Technology (CONACYT) in Mexico and the Veracruz State Government for providing partial financial support to JCA (Grant Number 108990). JCD was supported by grants from the Isaac Newton Trust and The Cambridge Humanities Research Grant Scheme. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsa J.A., 2002, INT MICROBIOL, V5, P155, DOI [10.1007/s10123-002-0082-z, DOI 10.1007/S10123-002-0082-Z]; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Amabile-Cuevas CF, 2010, J APPL MICROBIOL, V108, P158, DOI 10.1111/j.1365-2672.2009.04401.x; Amabile-Cuevas CF, 2013, MICROB DRUG RESIST, V19, P73, DOI 10.1089/mdr.2012.0115; Ball MC, 2007, CONSERV GENET, V8, P577, DOI 10.1007/s10592-006-9193-y; Bildstein KL, 2004, ORNITOL NEOTROP, V15, P83; Bonnedahl J, 2014, EMERG INFECT DIS, V20, P897, DOI 10.3201/eid2005.130325; Chaves OM, 2010, REV CHIL HIST NAT, V83, P435, DOI 10.4067/S0716-078X2010000300010; Cole D, 2005, EMERG INFECT DIS, V11, P935; Costa D, 2006, J ANTIMICROB CHEMOTH, V58, P1311, DOI 10.1093/jac/dkl415; Cristobal-Azkarate J, 2005, AM J PRIMATOL, V67, P209, DOI 10.1002/ajp.20178; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; di Fiore A, 2007, PRIMATES PERSPECTIVE; Diaz-Mejia JJ, 2008, MICROBIOL-SGM, V154, P94, DOI 10.1099/mic.0.2007/008649-0; Garrec H, 2011, J CLIN MICROBIOL, V49, P1048, DOI 10.1128/JCM.02130-10; Gilliver MA, 1999, NATURE, V401, P233, DOI 10.1038/45724; Goldberg TL, 2007, BIOL CONSERV, V135, P511, DOI 10.1016/j.biocon.2006.10.048; Guenther S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00246; Guevara Sada S., 2004, TUXTLAS PAISAJE SIER; Haag T, 2009, GENETICA, V136, P505, DOI 10.1007/s10709-008-9347-6; Hardwick SA, 2008, FEMS MICROBIOL LETT, V278, P207, DOI 10.1111/j.1574-6968.2007.00992.x; INEGI, 2010, CENS POBL VIV 2010; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Literak I, 2010, APPL ENVIRON MICROB, V76, P8126, DOI 10.1128/AEM.01446-10; Martinez JL, 2009, ENVIRON POLLUT, V157, P2893, DOI 10.1016/j.envpol.2009.05.051; Mandujano Salvador, 2004, Neotropical Primates, V12, P126, DOI 10.1896/1413-4705.12.3.126; Michalski F, 2011, MOL ECOL RESOUR, V11, P862, DOI 10.1111/j.1755-0998.2011.03031.x; Over U, 2001, CLIN MICROBIOL INFEC, V7, P470, DOI 10.1046/j.1198-743x.2001.00284.x; Rempel R., 1999, PATCH ANAL 2 2; Roe MT, 2003, EMERG INFECT DIS, V9, P822, DOI 10.3201/eid0907.020529; ROLLAND RM, 1985, APPL ENVIRON MICROB, V49, P791, DOI 10.1128/AEM.49.4.791-794.1985; Rose JM, 2009, FEMS MICROBIOL ECOL, V67, P421, DOI 10.1111/j.1574-6941.2009.00648.x; Rwego IB, 2008, CONSERV BIOL, V22, P1600, DOI 10.1111/j.1523-1739.2008.01018.x; Santamaria J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00252; Schaefer AM, 2009, ECOHEALTH, V6, P33, DOI 10.1007/s10393-009-0221-5; Seiler C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00399; Sjolund M, 2008, EMERG INFECT DIS, V14, P70, DOI 10.3201/eid1401.070704; Skurnik D, 2006, J ANTIMICROB CHEMOTH, V57, P1215, DOI 10.1093/jac/dkl122; Souza V, 1999, APPL ENVIRON MICROB, V65, P3373; Stedt Johan, 2014, Infection Ecology & Epidemiology, V4, P21565, DOI 10.3402/iee.v4.21565; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thaller MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008989; Velasco T, 1997, NUEVE ESTUDIOS ESPAC, P133; Vynne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028939; Vynne C, 2011, CONSERV BIOL, V25, P154, DOI 10.1111/j.1523-1739.2010.01581.x; Walson JL, 2001, J INFECT DIS, V184, P1163, DOI 10.1086/323647; Wasser SK, 2011, FRONT ECOL ENVIRON, V9, P546, DOI 10.1890/100071; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020	49	22	23	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107719	10.1371/journal.pone.0107719	http://dx.doi.org/10.1371/journal.pone.0107719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233089	gold, Green Published			2022-12-25	WOS:000342921200046
J	de Boer, JF; Dikkers, A; Jurdzinski, A; von Felden, J; Gaestel, M; Bavendiek, U; Tietge, UJF				de Boer, Jan Freark; Dikkers, Arne; Jurdzinski, Angelika; von Felden, Johann; Gaestel, Matthias; Bavendiek, Udo; Tietge, Uwe J. F.			Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 Deficiency Reduces Insulin Sensitivity in High-Fat Diet-Fed Mice	PLOS ONE			English	Article							NF-KAPPA-B; ADIPOSE-TISSUE; MACROPHAGE POLARIZATION; DIABETES-MELLITUS; RESISTANCE; INFLAMMATION; OBESITY; INFILTRATION; OVEREXPRESSION; DISEASES	Adipose tissue inflammation is considered an important contributor to insulin resistance. Mitogen-activated protein kinase-activated protein kinase 2 (MK2) is a major downstream target of p38 MAPK and enhances inflammatory processes. In line with the role of MK2 as contributor to inflammation, MK2(-/-) mice are protected against inflammation in different disease models. Therefore, MK2 is considered an attractive therapeutic target for the treatment of chronic inflammatory diseases. This study tested the impact of MK2-deficiency on high-fat diet (HFD)-induced adipose tissue inflammation and insulin resistance. After feeding MK2(-/-) and WT control mice a HFD (60% energy from fat) for 24 weeks, body weight was not different between groups. Also, liver weight and the amount of abdominal fat remained unchanged. However, in MK2(-/-) mice plasma cholesterol levels were significantly increased. Surprisingly, macrophage infiltration in adipose tissue was not altered. However, adipose tissue macrophages were more skewed to the inflammatory M1 phenotype in MK2(-/-) mice. This differerence in macrophage polarization did however not translate in significantly altered expression levels of Mcp-1, Tnf alpha and Il6. Glucose and insulin tolerance tests demonstrated that MK2(-/-) mice had a significantly reduced glucose tolerance and increased insulin resistance. Noteworthy, the expression of the insulin-responsive glucose transporter type 4 (GLUT4) in adipose tissue of MK2(-/-) mice was reduced by 55% (p < 0.05) and 33% (p < 0.05) on the mRNA and protein level, respectively, compared to WT mice. In conclusion, HFD-fed MK2(-/-) display decreased glucose tolerance and increased insulin resistance compared to WT controls. Decreased adipose tissue expression of GLUT4 might contribute to this phenotype. The data obtained in this study indicate that clinical use of MK2 inhibitors has to be evaluated with caution, taking potential metabolic adverse effects into account.	[de Boer, Jan Freark; Dikkers, Arne; Jurdzinski, Angelika; Tietge, Uwe J. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, Groningen, Netherlands; [von Felden, Johann; Bavendiek, Udo] Hannover Med Sch, Clin Cardiol & Angiol, Hannover, Germany; [Gaestel, Matthias] Hannover Med Sch, Inst Biochem, Hannover, Germany	University of Groningen; Hannover Medical School; Hannover Medical School	Tietge, UJF (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, Groningen, Netherlands.	u_tietge@yahoo.com	Gaestel, Matthias/A-6560-2013	Gaestel, Matthias/0000-0002-4944-4652	Groningen Expert Center for Kids with Obesity (GECKO); Netherlands Organization for Scientific Research (VIDI Grant) [917-56-358]; Deutsche Forschungsgemeinschaft [SFB 566 B12]	Groningen Expert Center for Kids with Obesity (GECKO); Netherlands Organization for Scientific Research (VIDI Grant); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by the Groningen Expert Center for Kids with Obesity (GECKO, to U.J.F.T.), by a grant from the Netherlands Organization for Scientific Research (VIDI Grant 917-56-358, to UJFT) and the Deutsche Forschungsgemeinschaft (SFB 566 B12 to M.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Anderson EK, 2010, CURR OPIN LIPIDOL, V21, P172, DOI 10.1097/MOL.0b013e3283393867; Apovian CM, 2008, ARTERIOSCL THROM VAS, V28, P1654, DOI 10.1161/ATVBAHA.108.170316; Bouloumie A, 2005, CURR OPIN CLIN NUTR, V8, P347, DOI 10.1097/01.mco.0000172571.41149.52; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Carvalho E, 2005, AM J PHYSIOL-ENDOC M, V289, pE551, DOI 10.1152/ajpendo.00116.2005; Carvalho Eugenia, 2001, FASEB Journal, V15, P1101; Clement SL, 2011, MOL CELL BIOL, V31, P256, DOI 10.1128/MCB.00717-10; Gaestel M, 2007, CURR MED CHEM, V14, P2214, DOI 10.2174/092986707781696636; Gehart H, 2010, EMBO REP, V11, P834, DOI 10.1038/embor.2010.160; Goldfine AB, 2008, CTS-CLIN TRANSL SCI, V1, P36, DOI 10.1111/j.1752-8062.2008.00026.x; Gorska MM, 2007, J EXP MED, V204, P1637, DOI 10.1084/jem.20062621; Hammaker D, 2010, ANN RHEUM DIS, V69, P77, DOI 10.1136/ard.2009.119479; Hegen M, 2006, J IMMUNOL, V177, P1913, DOI 10.4049/jimmunol.177.3.1913; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Jagavelu K, 2007, CIRC RES, V101, P1104, DOI 10.1161/CIRCRESAHA.107.156075; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Liu Zhenqi, 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P38; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Nijstad N, 2009, J BIOL CHEM, V284, P6093, DOI 10.1074/jbc.M807683200; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Tiedje C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002977; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	36	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e106300	10.1371/journal.pone.0106300	http://dx.doi.org/10.1371/journal.pone.0106300			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233471	Green Published, Green Submitted, gold			2022-12-25	WOS:000342921200007
J	Liu, XQ; Mao, Y; Wang, B; Lu, XT; Bai, WW; Sun, YY; Liu, Y; Liu, HM; Zhang, L; Zhao, YX; Zhang, Y				Liu, Xiao Qiong; Mao, Yang; Wang, Bo; Lu, Xiao Ting; Bai, Wen Wu; Sun, Yuan Yuan; Liu, Yan; Liu, Hong Mei; Zhang, Lei; Zhao, Yu Xia; Zhang, Yun			Specific Matrix Metalloproteinases Play Different Roles in Intraplaque Angiogenesis and Plaque Instability in Rabbits	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; ATHEROSCLEROTIC PLAQUE; TUMOR ANGIOGENESIS; DEFICIENT MICE; CELL SURFACE; MATRIX-METALLOPROTEINASE-9; VULNERABILITY; EXPRESSION; INVASION; RELEASE	Background: Ectopic angiogenesis within the intima and media is considered to be a hallmark of advanced vulnerable atherosclerotic lesions. Some studies have shown that specific matrix metalloproteinases (MMPs) might play different roles in angiogenesis. Therefore, we investigated the predominant effects of specific MMPs in intraplaque angiogenesis and plaque instability in a rabbit model of atherosclerosis. Methods and Results: New Zealand rabbits underwent balloon injury of the abdominal artery and ingestion of a high-cholesterol (1%) diet to establish an atherosclerotic animal model. At weeks 4, 6, 8, 10, and 12 after balloon injury, five rabbits were euthanized and the abdominal aorta was harvested. Blood lipid analysis, intravascular ultrasound imaging, pathologic and immunohistochemical expression studies, and western blotting were performed. From weeks 4 to 12, the expression of MMP-1, -2, -3, and -9 and vascular endothelial growth factor A (VEGF-A) increased with atherosclerotic plaque development in the abdominal aorta, while the expression of MMP-14 substantially decreased. The vulnerability index (VI) gradually increased over time. Intraplaque neovessels appeared at week 8. The microvessel density (MVD) was greater at week 12 than at week 8. The VI, MVD, and VEGF-A level were positively correlated with the MMP-1, -2,-3, and -9 levels within plaques. Negative correlations were noted between the MMP-14 level and the VI, MVD, and VEGF-A level. Conclusion: Upregulation of MMP-1, -2, -3, and -9 and downregulation of MMP-14 may contribute to intraplaque angiogenesis and plaque instability at the advanced stage of atherosclerosis in rabbits.	[Liu, Xiao Qiong; Mao, Yang; Lu, Xiao Ting; Bai, Wen Wu; Sun, Yuan Yuan; Liu, Yan; Zhang, Lei; Zhang, Yun] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China; [Liu, Xiao Qiong; Wang, Bo; Bai, Wen Wu; Sun, Yuan Yuan; Zhao, Yu Xia] Shandong Univ, Qilu Hosp, Dept Tradit Chinese Med, Jinan 250100, Shandong, Peoples R China; [Liu, Hong Mei] Jinan Stomatol Hosp, Dept Endodont, Jinan, Shandong, Peoples R China	Shandong University; Shandong University	Zhang, L (corresponding author), Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China.	leilybao@163.com; yxzhao@sdu.edu.cn			National 973 Basic Research Program of China [2012CB518603]; National Natural Science Foundation of China [81270351, 60971023, 81100103, 81302939]; Natural Science Foundation of Shandong Province [ZR2011HQ020]; Ministry of Education of China [20130131110045]	National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Ministry of Education of China(Ministry of Education, China)	This study was supported by the National 973 Basic Research Program of China (No. 2012CB518603), grants from National Natural Science Foundation of China (No. 81270351, 60971023, 81100103, 81302939), Natural Science Foundation of Shandong Province (ZR2011HQ020), and Doctoral Fund of Ministry of Education of China (20130131110045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATTEGAY EJ, 1995, J MOL MED, V73, P333; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Chang JH, 2005, FEBS LETT, V579, P3601, DOI 10.1016/j.febslet.2005.05.043; Chen WQ, 2007, AM J PHYSIOL-HEART C, V293, pH2836, DOI 10.1152/ajpheart.00472.2007; Chetty C, 2010, INT J CANCER, V127, P1081, DOI 10.1002/ijc.25134; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Dong B, 2008, ARTERIOSCL THROM VAS, V28, P1270, DOI 10.1161/ATVBAHA.108.164715; Foley C, 2013, ONCOGENE; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Imai K, 1997, BIOCHEM J, V322, P809, DOI 10.1042/bj3220809; Kaitu'u-Lino TJ, 2012, AM J PATHOL, V180, P888, DOI 10.1016/j.ajpath.2011.11.014; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kargiotis O, 2008, ONCOGENE, V27, P4830, DOI 10.1038/onc.2008.122; Kolodgie FD, 2004, HEART, V90, P1385, DOI 10.1136/hrt.2004.041798; Levi E, 1996, P NATL ACAD SCI USA, V93, P7069, DOI 10.1073/pnas.93.14.7069; Lin HL, 2010, BRIT J PHARMACOL, V160, P1484, DOI 10.1111/j.1476-5381.2010.00799.x; Lin HL, 2007, J MOL CELL CARDIOL, V43, P272, DOI 10.1016/j.yjmcc.2007.05.023; Luttun A, 2004, CIRCULATION, V109, P1408, DOI 10.1161/01.CIR.0000121728.14930.DE; Mazor R, 2013, J BIOL CHEM, V288, P598, DOI 10.1074/jbc.M112.417451; Michel JB, 2011, EUR HEART J, V32, P1977, DOI 10.1093/eurheartj/ehr054; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Mira E, 2004, J CELL SCI, V117, P1847, DOI 10.1242/jcs.01035; Mofidi R, 2001, BRIT J SURG, V88, P945, DOI 10.1046/j.0007-1323.2001.01823.x; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Nguyen M, 2001, INT J BIOCHEM CELL B, V33, P960, DOI 10.1016/S1357-2725(01)00007-3; OGATA Y, 1992, J BIOL CHEM, V267, P3581; Pozzi A, 2002, ONCOGENE, V21, P272, DOI 10.1038/sj.onc.1205045; Silence J, 2001, ARTERIOSCL THROM VAS, V21, P1440, DOI 10.1161/hq0901.097004; Sluijter JPG, 2006, CARDIOVASC RES, V69, P595, DOI 10.1016/j.cardiores.2005.11.026; Sluijter JPG, 2006, STROKE, V37, P235, DOI 10.1161/01.STR.0000196986.50059.e0; Sluimer JC, 2008, J AM COLL CARDIOL, V51, P1258, DOI 10.1016/j.jacc.2007.12.025; Torzewski M, 1998, ARTERIOSCL THROM VAS, V18, P369, DOI 10.1161/01.ATV.18.3.369; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Yu Q, 2000, GENE DEV, V14, P163; Zhang L, 2010, ATHEROSCLEROSIS, V211, P146, DOI 10.1016/j.atherosclerosis.2010.01.023; Zhang L, 2009, J CELL MOL MED, V13, P2713, DOI 10.1111/j.1582-4934.2008.00538.x	42	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107851	10.1371/journal.pone.0107851	http://dx.doi.org/10.1371/journal.pone.0107851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233229	Green Published, gold, Green Submitted			2022-12-25	WOS:000342921200053
J	Nonnekes, J; Arrogi, A; Munneke, MAM; van Asseldonk, EHF; Nijhuis, LBO; Geurts, AC; Weerdesteyn, V				Nonnekes, Jorik; Arrogi, Anass; Munneke, Moniek A. M.; van Asseldonk, Edwin H. F.; Nijhuis, Lars B. Oude; Geurts, Alexander C.; Weerdesteyn, Vivian			Subcortical Structures in Humans Can Be Facilitated by Transcranial Direct Current Stimulation	PLOS ONE			English	Article							POPULATION-DYNAMICS; SPATIAL HETEROGENEITY; HABITAT QUALITY; EFFECT SIZE; DISPERSAL; AUTOCORRELATION; VARIABILITY; PERSISTENCE; MODELS; FRAGMENTATION	Transcranial direct current stimulation (tDCS) is a noninvasive brain stimulation technique that alters cortical excitability. Interestingly, in recent animal studies facilitatory effects of tDCS have also been observed on subcortical structures. Here, we sought to provide evidence for the potential of tDCS to facilitate subcortical structures in humans as well. Subjects received anodal-tDCS and sham-tDCS on two separate testing days in a counterbalanced order. After stimulation, we assessed the effect of tDCS on two responses that arise from subcortical structures; (1) wrist and ankle responses to an imperative stimulus combined with a startling acoustic stimulus (SAS), and (2) automatic postural responses to external balance perturbations with and without a concurrent SAS. During all tasks, response onsets were significantly faster following anodal-tDCS compared to sham-tDCS, both in trials with and without a SAS. The effect of tDCS was similar for the dominant and non-dominant leg. The SAS accelerated the onsets of ankle and wrist movements and the responses to backward, but not forward perturbations. The faster onsets of SAS-induced wrist and ankle movements and automatic postural responses following stimulation provide strong evidence that, in humans, subcortical structures - in particular the reticular formation can be facilitated by tDCS. This effect may be explained by two mechanisms that are not mutually exclusive. First, subcortical facilitation may have resulted from enhanced cortico-reticular drive. Second, the applied current may have directly stimulated the reticular formation. Strengthening reticulospinal output by tDCS may be of interest to neurorehabilitation, as there is evidence for reticulospinal compensation after corticospinal lesions.	[Nonnekes, Jorik; Arrogi, Anass; Geurts, Alexander C.; Weerdesteyn, Vivian] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Rehabil, NL-6525 ED Nijmegen, Netherlands; [Munneke, Moniek A. M.; Nijhuis, Lars B. Oude] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol Clin Neurophysiol, NL-6525 ED Nijmegen, Netherlands; [van Asseldonk, Edwin H. F.] Univ Twente, MIRA, Dept Biomech Engn, NL-7500 AE Enschede, Netherlands; [Geurts, Alexander C.; Weerdesteyn, Vivian] Sint Maartensklin Res Dev & Educ, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University of Twente; Sint Maartens Clinic	Nonnekes, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Rehabil, NL-6525 ED Nijmegen, Netherlands.	jorik.nonnekes@radboudumc.nl	Munneke, Moniek/D-4723-2009; Geurts, Alexander/H-8032-2014; Nonnekes, Jorik/P-6648-2015; Weerdesteyn, Vivian/A-9599-2014	Munneke, Moniek/0000-0002-5542-8034; Geurts, Alexander/0000-0001-7478-1119; Weerdesteyn, Vivian/0000-0003-4327-7600; Nonnekes, Jorik/0000-0003-2434-1427; van Asseldonk, Edwin/0000-0003-1534-2348	Radboud University Nijmegen Medical Centre Research Grant; Netherlands Organization for Scientific Research Veni Research Grants [916.10.106, 916.10.143]	Radboud University Nijmegen Medical Centre Research Grant; Netherlands Organization for Scientific Research Veni Research Grants	This research was funded by a Radboud University Nijmegen Medical Centre Research Grant to Jorik Nonnekes, and Netherlands Organization for Scientific Research Veni Research Grants to Vivian Weerdesteyn (916.10.106) and Edwin van Asseldonk (916.10.143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armsworth PR, 2009, THEOR ECOL-NETH, V2, P105, DOI 10.1007/s12080-008-0032-2; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Boeye J, 2014, LANDSCAPE ECOL, V29, P593, DOI 10.1007/s10980-014-0010-6; Bolker BM, 2003, THEOR POPUL BIOL, V64, P255, DOI 10.1016/S0040-5809(03)00090-X; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Brachet S, 1999, J THEOR BIOL, V198, P479, DOI 10.1006/jtbi.1999.0926; Burgess MD, 2011, J ANIM ECOL, V80, P688, DOI 10.1111/j.1365-2656.2011.01816.x; Chipperfield JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017040; Clarke RT, 1997, P ROY SOC B-BIOL SCI, V264, P347, DOI 10.1098/rspb.1997.0050; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; DHONDT AA, 1992, J ANIM ECOL, V61, P643, DOI 10.2307/5619; DUTILLEUL P, 1993, OIKOS, V66, P152, DOI 10.2307/3545210; Fahrig L, 1998, ECOL MODEL, V105, P273, DOI 10.1016/S0304-3800(97)00163-4; Fleishman E, 2002, CONSERV BIOL, V16, P706, DOI 10.1046/j.1523-1739.2002.00539.x; Getz WM, 2008, P NATL ACAD SCI USA, V105, P19066, DOI 10.1073/pnas.0801732105; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Gonzalez A, 2002, P NATL ACAD SCI USA, V99, P14872, DOI 10.1073/pnas.232589299; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; HAEFNER JW, 1991, ECOL MODEL, V56, P221, DOI 10.1016/0304-3800(91)90201-B; Harrison S, 1999, ECOGRAPHY, V22, P225, DOI 10.1111/j.1600-0587.1999.tb00496.x; HASSELL MP, 1975, J ANIM ECOL, V44, P283, DOI 10.2307/3863; Hiebeler D, 2004, THEOR POPUL BIOL, V66, P205, DOI 10.1016/j.tpb.2004.06.004; Humphries NE, 2013, METHODS ECOL EVOL, V4, P930, DOI 10.1111/2041-210X.12096; Itakura J, 2010, BIOSYSTEMS, V99, P70, DOI 10.1016/j.biosystems.2009.09.001; Jacobson B, 2010, LANDSCAPE ECOL, V25, P495, DOI 10.1007/s10980-009-9442-9; Jager HI, 2001, ECOL MODEL, V144, P61, DOI 10.1016/S0304-3800(01)00362-3; Jonsen ID, 1997, LANDSCAPE ECOL, V12, P185, DOI 10.1023/A:1007961006232; Kendall BE, 1998, THEOR POPUL BIOL, V54, P11, DOI 10.1006/tpbi.1998.1365; Kolasa J, 2003, P ROY SOC B-BIOL SCI, V270, pS198, DOI 10.1098/rsbl.2003.0059; Lawrence M. A., 2011, EZ EASY ANAL VISUALI; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Lou Y, 2006, J DIFFER EQUATIONS, V223, P400, DOI 10.1016/j.jde.2005.05.010; Lovett GM, 2005, Ecosystem Function in Heterogeneous Landscapes, P1, DOI 10.1007/0-387-24091-8_1; Mortelliti A, 2010, OECOLOGIA, V163, P535, DOI 10.1007/s00442-010-1623-3; Nevoux M, 2010, P ROYAL SOC B, V278, P2173; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Parrott L, 2000, COMPLEXITY INT, V7; Pearson SM, 2011, SOURCES SINKS SUSTAI; Petchey OL, 1997, P ROY SOC B-BIOL SCI, V264, P1841, DOI 10.1098/rspb.1997.0254; Pigliucci M, 2001, ENV HETEROGENEITY TE; Pike N, 2004, P ROY SOC B-BIOL SCI, V271, P2143, DOI 10.1098/rspb.2004.2834; Pinto SM, 2010, AM NAT, V175, P675, DOI 10.1086/652467; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; PULLIAM HR, 1992, ECOL APPL, V2, P165, DOI 10.2307/1941773; R Core Team, 2021, R LANG ENV STAT COMP; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Rodenhouse NL, 1997, ECOLOGY, V78, P2025, DOI 10.2307/2265942; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; Schiegg K, 2003, TRENDS ECOL EVOL, V18, P212, DOI 10.1016/S0169-5347(03)00074-0; Schooley RL, 2007, ECOSYSTEMS, V10, P846, DOI 10.1007/s10021-007-9062-7; Skelsey P, 2013, THEOR ECOL-NETH, V6, P203, DOI 10.1007/s12080-012-0171-3; Snyder RE, 2003, ECOL LETT, V6, P301, DOI 10.1046/j.1461-0248.2003.00434.x; Stoddard ST, 2010, ECOL MODEL, V221, P2409, DOI 10.1016/j.ecolmodel.2010.06.024; White JW, 2014, OIKOS, V123, P385, DOI 10.1111/j.1600-0706.2013.01073.x; Wiegand T, 1999, AM NAT, V154, P605, DOI 10.1086/303272; WIENS JA, 1993, OIKOS, V66, P369, DOI 10.2307/3544931; With KA, 1999, CONSERV BIOL, V13, P314, DOI 10.1046/j.1523-1739.1999.013002314.x; Wu J., 2007, KEY TOPICS LANDSCAPE; Wu JG, 2002, LANDSCAPE ECOL, V17, P355, DOI 10.1023/A:1020561630963; Ye XP, 2013, ECOL RES, V28, P949, DOI 10.1007/s11284-013-1077-2; Zajac T, 2008, J AVIAN BIOL, V39, P206, DOI 10.1111/j.0908-8857.2008.04183.x	63	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107731	10.1371/journal.pone.0107731	http://dx.doi.org/10.1371/journal.pone.0107731			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233458	Green Published, gold, Green Submitted			2022-12-25	WOS:000342921200049
J	Cash, BA; Rodo, X; Emch, M; Yunus, M; Faruque, ASG; Pascual, M				Cash, Benjamin A.; Rodo, Xavier; Emch, Michael; Yunus, Md.; Faruque, Abu S. G.; Pascual, Mercedes			Cholera and Shigellosis: Different Epidemiology but Similar Responses to Climate Variability	PLOS ONE			English	Article							INFECTIOUS-DISEASE; GLOBAL CLIMATE; BANGLADESH; DYNAMICS; PREDICTABILITY; PACIFIC; BURDEN; ENSO; RISK	Background: Comparative studies of the associations between different infectious diseases and climate variability, such as the El Nino-Southern Oscillation, are lacking. Diarrheal illnesses, particularly cholera and shigellosis, provide an important opportunity to apply a comparative approach. Cholera and shigellosis have significant global mortality and morbidity burden, pronounced differences in transmission pathways and pathogen ecologies, and there is an established climate link with cholera. In particular, the specific ecology of Vibrio cholerae is often invoked to explain the sensitivity of that disease to climate. Methods and Findings: The extensive surveillance data of the International Center for Diarrheal Disease Research, Bangladesh are used here to revisit the known associations between cholera and climate, and to address their similarity to previously unexplored patterns for shigellosis. Monthly case data for both the city of Dhaka and a rural area known as Matlab are analyzed with respect to their association with El Nino and flooding. Linear correlations are examined between flooding and cumulative cases, as well as for flooding and El Nino. Rank-correlation maps are also computed between disease cases in the post-monsoon epidemic season and sea surface temperatures in the Pacific. Similar climate associations are found for both diseases and both locations. Increased cases follow increased monsoon flooding and increased sea surface temperatures in the preceding winter corresponding to an El Nino event. Conclusions: The similarity in association patterns suggests a systemic breakdown in population health with changing environmental conditions, in which climate variability acts primarily through increasing the exposure risk of the human population. We discuss these results in the context of the on-going debate on the relative importance of the environmental reservoir vs. secondary transmission, as well as the implications for the use of El Nino as an early indicator of flooding and enteric disease risk.	[Cash, Benjamin A.] Ctr Ocean Land Atmosphere Studies, Fairfax, VA 22030 USA; [Rodo, Xavier] Inst Catala Ciencies Clima IC3, Barcelona, Catalunya, Spain; [Rodo, Xavier] Inst Catalana Recerca & Estudis Avancats, Barcelona, Catalunya, Spain; [Emch, Michael] Univ N Carolina, Chapel Hill, NC USA; [Yunus, Md.; Faruque, Abu S. G.] Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh; [Pascual, Mercedes] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Pascual, Mercedes] Howard Hughes Med Inst, Chevy Chase, MD USA	Center for Ocean Land Atmosphere Studies; Institut Catala de Ciencies del Clima (IC3); University of Barcelona; ICREA; University of North Carolina; University of North Carolina Chapel Hill; International Centre for Diarrhoeal Disease Research (ICDDR); University of Michigan System; University of Michigan; Howard Hughes Medical Institute	Cash, BA (corresponding author), Ctr Ocean Land Atmosphere Studies, Fairfax, VA 22030 USA.	bcash@gmu.edu	Rodó, Xavier/F-7663-2017	Rodó, Xavier/0000-0003-4843-6180; Yunus, Mohammed/0000-0003-1116-4978; Cash, Benjamin/0000-0003-2295-3112	United States National Oceanic and Atmospheric Administration grant [F020704]; Australian International Development Agency; government of the People's Republic of Bangladesh; Canadian International Development Agency; Swedish International Development Cooperative Agency; Department for International Development, United Kingdom; ICREA Funding Source: Custom	United States National Oceanic and Atmospheric Administration grant; Australian International Development Agency; government of the People's Republic of Bangladesh; Canadian International Development Agency; Swedish International Development Cooperative Agency; Department for International Development, United Kingdom; ICREA(ICREA)	This work was funded by the United States National Oceanic and Atmospheric Administration grant # F020704. The authors further acknowledge the support of core donors that provide unrestricted support to the International Centre for Diarrheal Disease Research, Bangladesh (icddr, b) for its operations and research. Current donors providing unrestricted support include the Australian International Development Agency, the government of the People's Republic of Bangladesh, the Canadian International Development Agency, the Swedish International Development Cooperative Agency, and the Department for International Development, United Kingdom. The authors gratefully acknowledge these donors for their support and commitment to icddr, b's research efforts. M. Pascual is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanda AS, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009914; Akanda AS, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039312; Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Bertuzzo E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050723; Cash BA, 2013, NAT CLIM CHANGE, V3, P502, DOI [10.1038/nclimate1834, 10.1038/NCLIMATE1834]; Cash BA, 2008, J CLIMATE, V21, P4647, DOI 10.1175/2007JCLI2001.1; Cash BA, 2010, J CLIMATE, V23, P2817, DOI 10.1175/2009JCLI2512.1; Chowdhury MR, 2007, HYDROL PROCESS, V21, P335, DOI 10.1002/hyp.6236; Codeco CT, 2006, PLOS MED, V3, P16, DOI 10.1371/journal.pmed.0030042; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Cook G. C., 1996, P54; Emch M, 2008, HEALTH PLACE, V14, P96, DOI 10.1016/j.healthplace.2007.05.004; Ghil M, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000092; Hossain Md S, 2009, ANN FLOOD REPORT 200; Koelle K, 2005, P ROY SOC B-BIOL SCI, V272, P971, DOI 10.1098/rspb.2004.3043; Koelle K, 2004, AM NAT, V163, P901, DOI 10.1086/420798; Koelle K, 2005, NATURE, V436, P696, DOI 10.1038/nature03820; Kohn G. C., 1995, ENCY PLAGUE PESTILEN; Kosaka Y, 2013, P NATL ACAD SCI USA, V110, P7574, DOI 10.1073/pnas.1215582110; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Kraft CH, 1968, NONPARAMETRIC INTRO; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; Marsland AL, 2002, PHYSIOL BEHAV, V77, P711, DOI 10.1016/S0031-9384(02)00923-X; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Pascual M, 2002, MICROBES INFECT, V4, P237, DOI 10.1016/S1286-4579(01)01533-7; RAHAMAN MM, 1975, J INFECT DIS, V131, P700, DOI 10.1093/infdis/132.1.15; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Reiner RC, 2012, P NATL ACAD SCI USA, V109, P2033, DOI 10.1073/pnas.1108438109; Rinaldo A, 2012, P NATL ACAD SCI USA, V109, P6602, DOI 10.1073/pnas.1203333109; Rodo X, 2002, P NATL ACAD SCI USA, V99, P12901, DOI 10.1073/pnas.182203999; Schwartz BS, 2006, AM J TROP MED HYG, V74, P1067, DOI 10.4269/ajtmh.2006.74.1067	31	21	23	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107223	10.1371/journal.pone.0107223	http://dx.doi.org/10.1371/journal.pone.0107223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229494	Green Submitted, Green Published, gold			2022-12-25	WOS:000342123900033
J	Kuittinen, P; Sipola, P; Leinonen, V; Saari, T; Sinikallio, S; Savolainen, S; Kroger, H; Turunen, V; Airaksinen, O; Aalto, T				Kuittinen, Pekka; Sipola, Petri; Leinonen, Ville; Saari, Tapani; Sinikallio, Sanna; Savolainen, Sakari; Kroger, Heikki; Turunen, Veli; Airaksinen, Olavi; Aalto, Timo			Preoperative MRI Findings Predict Two-Year Postoperative Clinical Outcome in Lumbar Spinal Stenosis	PLOS ONE			English	Article							SURGERY; DEPRESSION; MANAGEMENT; SYMPTOMS; SCALES; PAIN	Purpose: To study the predictive value of preoperative magnetic resonance imaging (MRI) findings for the two-year postoperative clinical outcome in lumbar spinal stenosis (LSS). Methods: 84 patients (mean age 63 +/- 11 years, male 43%) with symptoms severe enough to indicate LSS surgery were included in this prospective observational single-center study. Preoperative MRI of the lumbar spine was performed with a 1.5-T unit. The imaging protocol conformed to the requirements of the American College of Radiology for the performance of MRI of the adult spine. Visual and quantitative assessment of MRI was performed by one experienced neuroradiologist. At the two-year postoperative follow-up, functional ability was assessed with the Oswestry Disability Index (ODI 0-100%) and treadmill test (0-1000 m), pain symptoms with the overall Visual Analogue Scale (VAS 0-100 mm), and specific low back pain (LBP) and specific leg pain (LP) separately with a numeric rating scale from 0-10 (NRS-11). Satisfaction with the surgical outcome was also assessed. Results: Preoperative severe central stenosis predicted postoperatively lower LP, LBP, and VAS when compared in patients with moderate central stenosis (p < 0.05). Moreover, severe stenosis predicted higher postoperative satisfaction (p = 0.029). Preoperative scoliosis predicted an impaired outcome in the ODI (p = 0.031) and lowered the walking distance in the treadmill test (p = 0.001). The preoperative finding of only one stenotic level in visual assessment predicted less postoperative LBP when compared with patients having 2 or more stenotic levels (p = 0.026). No significant differences were detected between quantitative measurements and the patient outcome. Conclusions: Routine preoperative lumbar spine MRI can predict the patient outcome in a two-year follow up in patients with LSS surgery. Severe central stenosis and one-level central stenosis are predictors of good outcome. Preoperative finding of scoliosis may indicate worse functional ability.	[Kuittinen, Pekka; Leinonen, Ville; Savolainen, Sakari] Kuopio Univ Hosp, Dept Neurosurg, SF-70210 Kuopio, Finland; [Kuittinen, Pekka] Univ Eastern Finland, Inst Clin Med, SF-70210 Kuopio, Finland; [Sipola, Petri; Saari, Tapani] Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland; [Sipola, Petri] Univ Eastern Finland, Inst Clin Med, Radiol Unit, Kuopio, Finland; [Leinonen, Ville] Univ Eastern Finland, Inst Clin Med, Neurosurg Unit, Kuopio, Finland; [Sinikallio, Sanna] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Kroger, Heikki; Turunen, Veli] Kuopio Univ Hosp, Dept Orthopaed & Traumatol, SF-70210 Kuopio, Finland; [Kroger, Heikki] Univ Eastern Finland, Bone & Cartilage Res Unit, Kuopio, Finland; [Airaksinen, Olavi] Kuopio Univ Hosp, Dept Phys & Rehabil Med, SF-70210 Kuopio, Finland; [Aalto, Timo] Hlth Ctr Ikioma OY, Mikkeli, Finland	Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Kuittinen, P (corresponding author), Kuopio Univ Hosp, Dept Neurosurg, SF-70210 Kuopio, Finland.	pekkaku@student.uef.fi			Kuopio University Hospital [596013]	Kuopio University Hospital	This study was supported by the Kuopio University Hospital (grant number 596013 - URL:http://www.psshp.fi/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto T, 2012, SCAND J SURG, V101, P255, DOI 10.1177/145749691210100406; Amundsen T, 2000, SPINE, V25, P1424, DOI 10.1097/00007632-200006010-00016; Atlas SJ, 2005, SPINE, V30, P936, DOI 10.1097/01.brs.0000158953.57966.c0; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Breivik EK, 2000, CLIN J PAIN, V16, P22, DOI 10.1097/00002508-200003000-00005; Deyo RA, 2010, JAMA-J AM MED ASSOC, V303, P1259, DOI 10.1001/jama.2010.338; Fairbank J C, 1980, Physiotherapy, V66, P271; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Frazier DD, 1997, SPINE, V22, P2025, DOI 10.1097/00007632-199709010-00017; Geisser ME, 2007, CLIN J PAIN, V23, P780, DOI 10.1097/AJP.0b013e31815349bf; Haig AJ, 2007, J BONE JOINT SURG AM, V89A, P358, DOI 10.2106/JBJS.E.00704; Hiwatashi A, 2004, AM J NEURORADIOL, V25, P170; Jonsson B, 1997, SPINE, V22, P2932, DOI 10.1097/00007632-199712150-00016; Kanno H, 2012, SPINE, V37, P207, DOI 10.1097/BRS.0b013e3182134e73; Kanno H, 2012, SPINE, V37, pE985, DOI 10.1097/BRS.0b013e31821038f2; KATZ JN, 1995, ARTHRITIS RHEUM, V38, P1236, DOI 10.1002/art.1780380910; Kuittinen P, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-83; Lurie JD, 2003, SPINE, V28, P616, DOI 10.1097/00007632-200303150-00018; Mannion AF, 2006, EUR SPINE J, V15, pS93, DOI 10.1007/s00586-005-1045-9; North American Spine Society (NASS), 2011, DIAGN TREATM DEG LUM; Ogikubo O, 2007, SPINE, V32, P1423, DOI 10.1097/BRS.0b013e318060a5f5; Pekkanen L, 2011, SPINE, V36, P332, DOI 10.1097/BRS.0b013e3181cdd702; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; Sigmundsson FG, 2012, ACTA ORTHOP, V83, P536, DOI 10.3109/17453674.2012.733915; Sinikallio S, 2006, DISABIL REHABIL, V28, P415, DOI 10.1080/09638280500192462; Sinikallio S, 2007, EUR SPINE J, V16, P905, DOI 10.1007/s00586-007-0349-3; Sinikallio S, 2011, SPINE, V36, P677, DOI 10.1097/BRS.0b013e3181dcaf4a; Sinikallio S, 2009, SPINE, V34, P2573, DOI 10.1097/BRS.0b013e3181b317bd; Sipola P, 2011, ACTA RADIOL, V52, P1024, DOI 10.1258/ar.2011.110083; Sirvanci M, 2008, EUR SPINE J, V17, P679, DOI 10.1007/s00586-008-0646-5; SPENGLER DM, 1987, J BONE JOINT SURG AM, V69A, P305, DOI 10.2106/00004623-198769020-00027; Wunschmann BW, 2003, ORTHOPADE, V32, P865, DOI 10.1007/s00132-003-0532-0; Yukawa Y, 2002, J BONE JOINT SURG AM, V84A, P1954, DOI 10.2106/00004623-200211000-00008	33	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e106404	10.1371/journal.pone.0106404	http://dx.doi.org/10.1371/journal.pone.0106404			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229343	gold, Green Published, Green Submitted			2022-12-25	WOS:000342123900007
J	Mitra, A; Misquitta, R; Nagaraja, V				Mitra, Anirban; Misquitta, Rachel; Nagaraja, Valakunja			Mycobacterium tuberculosis Rho Is an NTPase with Distinct Kinetic Properties and a Novel RNA-Binding Subdomain	PLOS ONE			English	Article							TERMINATION FACTOR-RHO; DEPENDENT TRANSCRIPTION TERMINATION; STRUCTURAL BASIS; SIGMA-FACTORS; PROTEIN-RHO; PROMOTER; RECOGNITION; POLYMERASE; MECHANISM; SMEGMATIS	Two mechanisms - factor independent and dependent termination - ensure the completion of RNA synthesis in eubacteria. Factor-dependent mechanism relies on the Rho protein to terminate transcription by interacting with RNA polymerase. Although well studied in Escherichia coli, the properties of the Rho homologs from most bacteria are not known. The rho gene is unusually large in genus Mycobacterium and other members of actinobacteria, having,150 additional residues towards the amino terminal end. We describe the distinct properties of Rho from Mycobacterium tuberculosis. It is an NTPase with a preference for purine nucleoside triphosphates with kinetic properties different from E. coli homolog and an ability to use various RNA substrates. The N-terminal subdomain of MtbRho can bind to RNA by itself, and appears to contribute to the interaction of the termination factor with RNAs. Furthermore, the interaction with RNA induces changes in conformation and oligomerization of MtbRho.	[Mitra, Anirban; Misquitta, Rachel; Nagaraja, Valakunja] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Nagaraja, Valakunja] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Nagaraja, V (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	vraj@mcbl.iisc.ernet.in			Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	Support from J.C. Bose Fellowship from Department of Science and Technology, Government of India to VN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHYA S, 1978, ANNU REV BIOCHEM, V47, P967, DOI 10.1146/annurev.bi.47.070178.004535; Agarwal N, 2003, FEMS MICROBIOL LETT, V225, P75, DOI 10.1016/S0378-1097(03)00483-X; Agarwal N, 2006, NUCLEIC ACIDS RES, V34, P4245, DOI 10.1093/nar/gkl521; Arnvig KB, 2005, MICROBIOL-SGM, V151, P467, DOI 10.1099/mic.0.27597-0; Bagchi G, 2005, MICROBIOL-SGM, V151, P4045, DOI 10.1099/mic.0.28333-0; Banerjee S, 2006, J MICROBIOL, V44, P11; Bogden CE, 1999, MOL CELL, V3, P487, DOI 10.1016/S1097-2765(00)80476-1; Boudvillain M, 2011, TRANSCRIPTION, V1, P70; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; CHEN CYA, 1986, CELL, V46, P1023, DOI 10.1016/0092-8674(86)90701-4; CHEN CYA, 1987, J BIOL CHEM, V262, P11292; Chen X, 2004, J BIOL CHEM, V279, P16301, DOI 10.1074/jbc.M313640200; China A, 2010, MICROBIOL-SGM, V156, P1942, DOI 10.1099/mic.0.038620-0; China A, 2010, PROTEIN EXPRES PURIF, V69, P235, DOI 10.1016/j.pep.2009.09.022; Chowdhury RP, 2007, J BACTERIOL, V189, P8973, DOI 10.1128/JB.01222-07; Ciampi MS, 2006, MICROBIOL-SGM, V152, P2515, DOI 10.1099/mic.0.28982-0; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Czyz A, 2014, MBIO, V5, DOI 10.1128/mBio.00931-14; D'Heygere F, 2013, MICROBIOL-SGM, V159, P1423, DOI 10.1099/mic.0.067462-0; Epshtein V, 2010, NATURE, V463, P245, DOI 10.1038/nature08669; FINGER LR, 1982, J MOL BIOL, V156, P203, DOI 10.1016/0022-2836(82)90467-3; GALLUPPI GR, 1980, J MOL BIOL, V138, P513, DOI 10.1016/S0022-2836(80)80016-7; GEISELMANN J, 1992, BIOCHEMISTRY-US, V31, P111, DOI 10.1021/bi00116a017; Guerin M, 1998, NUCLEIC ACIDS RES, V26, P4895, DOI 10.1093/nar/26.21.4895; HARSHEY RM, 1977, J BACTERIOL, V129, P616, DOI 10.1128/JB.129.2.616-622.1977; HART CM, 1994, J MOL BIOL, V237, P255, DOI 10.1006/jmbi.1994.1229; HART CM, 1991, J BIOL CHEM, V266, P24140; HIRIYANNA KT, 1986, ARCH MICROBIOL, V144, P105, DOI 10.1007/BF00414718; Ingham CJ, 1996, J BIOL CHEM, V271, P21803, DOI 10.1074/jbc.271.36.21803; Janscak P, 1996, J MOL BIOL, V257, P977, DOI 10.1006/jmbi.1996.0217; JOSAITIS CA, 1995, P NATL ACAD SCI USA, V92, P1117, DOI 10.1073/pnas.92.4.1117; Kalarickal NC, 2010, J MOL BIOL, V395, P966, DOI 10.1016/j.jmb.2009.12.022; Kalyani BS, 2011, J MOL BIOL, V413, P548, DOI 10.1016/j.jmb.2011.08.053; LOWERY C, 1977, J BIOL CHEM, V252, P1381; Martinez A, 1996, J MOL BIOL, V257, P895, DOI 10.1006/jmbi.1996.0210; Mathew R, 2005, J BACTERIOL, V187, P6565, DOI 10.1128/JB.187.18.6565-6570.2005; Mitra A, 2008, TUBERCULOSIS, V88, P566, DOI 10.1016/j.tube.2008.06.004; Mitra A, 2011, NUCLEIC ACIDS RES, V39, pD129, DOI 10.1093/nar/gkq971; Nowatzke WL, 1997, J BIOL CHEM, V272, P2207; Nowatzke WL, 1996, J BIOL CHEM, V271, P742, DOI 10.1074/jbc.271.2.742; OPPERMAN T, 1994, J BACTERIOL, V176, P5033, DOI 10.1128/jb.176.16.5033-5043.1994; Pashley CA, 2006, MICROBIOL-SGM, V152, P2727, DOI 10.1099/mic.0.28942-0; Peters JM, 2012, GENE DEV, V26, P2621, DOI 10.1101/gad.196741.112; Peters JM, 2011, J MOL BIOL, V412, P793, DOI 10.1016/j.jmb.2011.03.036; Peters JM, 2009, P NATL ACAD SCI USA, V106, P15406, DOI 10.1073/pnas.0903846106; Prabha S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019131; Richardson JP, 1996, J BIOL CHEM, V271, P1251, DOI 10.1074/jbc.271.3.1251; ROBERTS JW, 1988, CELL, V52, P5, DOI 10.1016/0092-8674(88)90523-5; Rodrigue S, 2006, FEMS MICROBIOL REV, V30, P926, DOI 10.1111/j.1574-6976.2006.00040.x; Santangelo TJ, 2011, NAT REV MICROBIOL, V9, P319, DOI 10.1038/nrmicro2560; Schuessler DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034471; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; STEINMETZ EJ, 1994, P NATL ACAD SCI USA, V91, P1401, DOI 10.1073/pnas.91.4.1401; Tare P, 2013, MOL MICROBIOL, V90, P569, DOI 10.1111/mmi.12384; Tare P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043900; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Unniraman S, 1999, GENES CELLS, V4, P697, DOI 10.1046/j.1365-2443.1999.00296.x; Unniraman S, 2002, J BACTERIOL, V184, P5449, DOI 10.1128/JB.184.19.5449-5456.2002; VONHIPPEL PH, 1991, P NATL ACAD SCI USA, V88, P2307, DOI 10.1073/pnas.88.6.2307; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298	61	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107474	10.1371/journal.pone.0107474	http://dx.doi.org/10.1371/journal.pone.0107474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229539	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900044
J	Ray, BR; Johnson, MW; Cammarata, K; Smee, DL				Ray, Brandon R.; Johnson, Matthew W.; Cammarata, Kirk; Smee, Delbert L.			Changes in Seagrass Species Composition in Northwestern Gulf of Mexico Estuaries: Effects on Associated Seagrass Fauna	PLOS ONE			English	Article							LAGUNA MADRE; NUTRIENT ENRICHMENT; HALODULE-WRIGHTII; MEADOWS; GROWTH; COMMUNITIES; PATTERNS; BIOMASS; FISHES; PRODUCTIVITY	The objective of this study was to measure the communities associated with different seagrass species to predict how shifts in seagrass species composition may affect associated fauna. In the northwestern Gulf of Mexico, coverage of the historically dominant shoal grass (Halodule wrightii) is decreasing, while coverage of manatee grass (Syringodium filiforme) and turtle grass (Thalassia testudinum) is increasing. We conducted a survey of fishes, crabs, and shrimp in monospecific beds of shoal, manatee, and turtle grass habitats of South Texas, USA to assess how changes in sea grass species composition would affect associated fauna. We measured seagrass parameters including shoot density, above ground biomass, epiphyte type, and epiphyte abundance to investigate relationships between faunal abundance and these seagrass parameters. We observed significant differences in communities among three seagrass species, even though these organisms are highly motile and could easily travel among the different seagrasses. Results showed species specific relationships among several different characteristics of the seagrass community and individual species abundance. More work is needed to discern the drivers of the complex relationships between individual seagrass species and their associated fauna.	[Ray, Brandon R.; Johnson, Matthew W.; Cammarata, Kirk; Smee, Delbert L.] Texas A&M Univ Corpus Christi, Dept Life Sci, Corpus Christi, TX 78412 USA	Texas A&M University System; Texas A&M University Corpus Christi	Smee, DL (corresponding author), Texas A&M Univ Corpus Christi, Dept Life Sci, Corpus Christi, TX 78412 USA.	lee.smee@tamucc.edu	Johnson, Matthew/AAA-3299-2020; Cammarata, Kirk/ABH-8740-2020		NSF-MRI [0821215]; Texas Sea Grant; Texas Research Development Grant; Harvey Weil Sportsman Conservation Award; TAMU-CC faculty enhancement grant; Ruth A Campbell Professorship in Marine Biology	NSF-MRI(National Science Foundation (NSF)NSF - Office of the Director (OD)); Texas Sea Grant; Texas Research Development Grant; Harvey Weil Sportsman Conservation Award; TAMU-CC faculty enhancement grant; Ruth A Campbell Professorship in Marine Biology	Funding for this work was provided by NSF-MRI grant 0821215, Texas Sea Grant, the Texas Research Development Grant, the Harvey Weil Sportsman Conservation Award, a TAMU-CC faculty enhancement grant, and the Ruth A Campbell Professorship in Marine Biology to D.L. Smee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; BELL JD, 1986, OECOLOGIA, V68, P205, DOI 10.1007/BF00384788; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Contreras C, 2011, WOTS201102; CORNELIUS SE, 1977, J WILDLIFE MANAGE, V41, P374, DOI 10.2307/3800506; CZERNY AB, 1995, ESTUARIES, V18, P418, DOI 10.2307/1352324; DUARTE CM, 1995, OPHELIA, V41, P87, DOI 10.1080/00785236.1995.10422039; Duarte CM, 2002, ENVIRON CONSERV, V29, P192, DOI 10.1017/S0376892902000127; EDGAR GJ, 1992, J EXP MAR BIOL ECOL, V157, P225, DOI 10.1016/0022-0981(92)90164-6; Edwald JJ, 1969, B MAR SCI, V19, P510; FONSECA MS, 1986, MAR ECOL PROG SER, V29, P15, DOI 10.3354/meps029015; Hamilton BM, 2012, MAR ECOL PROG SER, V456, P43, DOI 10.3354/meps09647; Heck KL, 2006, MAR ECOL PROG SER, V326, P145; HECK KL, 1987, J EXP MAR BIOL ECOL, V107, P87, DOI 10.1016/0022-0981(87)90188-2; Heck KL, 2003, MAR ECOL PROG SER, V253, P123, DOI 10.3354/meps253123; Heck KL, 2000, LIMNOL OCEANOGR, V45, P1041, DOI 10.4319/lo.2000.45.5.1041; Hyndes GA, 2003, MAR BIOL, V142, P1195, DOI 10.1007/s00227-003-1010-2; Johnson MW, 2006, MAR ECOL PROG SER, V306, P233, DOI 10.3354/meps306233; Kirk R. E., 1982, EXPT DESIGN; Koch MS, 2007, AQUAT BOT, V86, P14, DOI 10.1016/j.aquabot.2006.08.003; Lefebvre A, 2010, CONT SHELF RES, V30, P1783, DOI 10.1016/j.csr.2010.08.006; MacArthur LD, 2001, ESTUAR COAST SHELF S, V52, P79, DOI 10.1006/ecss.2000.0728; MAIN KL, 1987, ECOLOGY, V68, P170, DOI 10.2307/1938817; MCMILLAN C, 1984, AQUAT BOT, V19, P369, DOI 10.1016/0304-3770(84)90049-4; Micheli F, 1999, CONSERV BIOL, V13, P869, DOI 10.1046/j.1523-1739.1999.98233.x; Micheli F, 2008, ECOL MONOGR, V78, P225, DOI 10.1890/06-1605.1; MORGAN MD, 1984, LIMNOL OCEANOGR, V29, P1066, DOI 10.4319/lo.1984.29.5.1066; MORIARTY DJW, 1990, MAR ECOL PROG SER, V61, P145, DOI 10.3354/meps061145; Nanez-James SE, 2009, ESTUAR COAST, V31, P1143; Onuf CP, 1996, B MAR SCI, V58, P404; ORTH RJ, 1984, ESTUARIES, V7, P339, DOI 10.2307/1351618; Pulich WJ, 1997, CCBNEP20; QUAMMEN ML, 1993, ESTUARIES, V16, P302, DOI 10.2307/1352503; Reese MM, 2008, ESTUAR COAST, V31, P1143, DOI 10.1007/s12237-008-9096-x; ROBERTSON AI, 1979, OECOLOGIA, V38, P193, DOI 10.1007/BF00346563; Robillard MMR, 2010, J SHELLFISH RES, V29, P291, DOI 10.2983/035.029.0203; Rooker JR, 1998, ESTUARIES, V21, P318, DOI 10.2307/1352478; Short FT, 1999, AQUAT BOT, V63, P169, DOI 10.1016/S0304-3770(98)00117-X; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Spitzer PM, 2000, J EXP MAR BIOL ECOL, V244, P67, DOI 10.1016/S0022-0981(99)00130-6; STONER AW, 1983, FISH B-NOAA, V81, P837; Stunz GW, 2002, ESTUARIES, V25, P76, DOI 10.1007/BF02696051; Stunz GW, 2002, MAR ECOL PROG SER, V238, P227, DOI 10.3354/meps238227; Tolan JM, 1997, ESTUARIES, V20, P450, DOI 10.2307/1352357; Tunnell J. W., 2002, LAGUNA MADRE TEXAS T; WIGINTON JR, 1979, AQUAT BOT, V6, P171, DOI 10.1016/0304-3770(79)90060-3; Williams SL, 2001, MARINE COMMUNITY ECOLOGY, P317; WILSON CA, 1982, J EXP MAR BIOL ECOL, V62, P251, DOI 10.1016/0022-0981(82)90205-2; Wilson CJ, 2010, J EXP MAR BIOL ECOL, V395, P128, DOI 10.1016/j.jembe.2010.08.025; ZIEMAN J C, 1975, Aquatic Botany, V1, P107, DOI 10.1016/0304-3770(75)90016-9	50	15	16	3	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107751	10.1371/journal.pone.0107751	http://dx.doi.org/10.1371/journal.pone.0107751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229897	Green Published, Green Submitted, gold			2022-12-25	WOS:000342123900071
J	Fujimoto, M; Moyerbrailean, GA; Noman, S; Gizicki, JP; Ram, ML; Green, PA; Ram, JL				Fujimoto, Masanori; Moyerbrailean, Gregory A.; Noman, Sifat; Gizicki, Jason P.; Ram, Michal L.; Green, Phyllis A.; Ram, Jeffrey L.			Application of Ion Torrent Sequencing to the Assessment of the Effect of Alkali Ballast Water Treatment on Microbial Community Diversity	PLOS ONE			English	Article							SP NOV.; EMENDED DESCRIPTION; GEN. NOV.; GENERATION; MICROORGANISMS; CYANOBACTERIA; SEDIMENT; INVASION; RIVER; SHIPS	The impact of NaOH as a ballast water treatment (BWT) on microbial community diversity was assessed using the 16S rRNA gene based Ion Torrent sequencing with its new 400 base chemistry. Ballast water samples from a Great Lakes ship were collected from the intake and discharge of both control and NaOH (pH 12) treated tanks and were analyzed in duplicates. One set of duplicates was treated with the membrane-impermeable DNA cross-linking reagent propidium mono-azide (PMA) prior to PCR amplification to differentiate between live and dead microorganisms. Ion Torrent sequencing generated nearly 580,000 reads for 31 bar-coded samples and revealed alterations of the microbial community structure in ballast water that had been treated with NaOH. Rarefaction analysis of the Ion Torrent sequencing data showed that BWT using NaOH significantly decreased microbial community diversity relative to control discharge (p<0.001). UniFrac distance based principal coordinate analysis (PCoA) plots and UPGMA tree analysis revealed that NaOH-treated ballast water microbial communities differed from both intake communities and control discharge communities. After NaOH treatment, bacteria from the genus Alishewanella became dominant in the NaOH-treated samples, accounting for <0.5% of the total reads in intake samples but more than 50% of the reads in the treated discharge samples. The only apparent difference in microbial community structure between PMA-processed and non-PMA samples occurred in intake water samples, which exhibited a significantly higher amount of PMA-sensitive cyanobacteria/chloroplast 16S rRNA than their corresponding non-PMA total DNA samples. The community assembly obtained using Ion Torrent sequencing was comparable to that obtained from a subset of samples that were also subjected to 454 pyrosequencing. This study showed the efficacy of alkali ballast water treatment in reducing ballast water microbial diversity and demonstrated the application of new Ion Torrent sequencing techniques to microbial community studies.	[Fujimoto, Masanori; Moyerbrailean, Gregory A.; Noman, Sifat; Gizicki, Jason P.; Ram, Michal L.; Ram, Jeffrey L.] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Moyerbrailean, Gregory A.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Green, Phyllis A.] Isle Royale Natl Pk, Natl Pk Serv, Houghton, MI USA	Wayne State University; Wayne State University; United States Department of the Interior	Fujimoto, M (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA.	mfujimot@med.wayne.edu			Environmental Protection Agency [GL00E00444-0]	Environmental Protection Agency(United States Environmental Protection Agency)	This project was funded by the Environmental Protection Agency under grant GL00E00444-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Beadling C, 2013, J MOL DIAGN, V15, P171, DOI 10.1016/j.jmoldx.2012.09.003; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Borg I, 2010, MODERN MULTIDIMENSIO; Butron A, 2011, MAR POLLUT BULL, V62, P747, DOI 10.1016/j.marpolbul.2011.01.008; Cai L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053649; Cangelosi A, 2013, GSISBFTR1, V1, P1; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caraco NF, 1997, ECOLOGY, V78, P588, DOI 10.1890/0012-9658(1997)078[0588:ZMIIAL]2.0.CO;2; Chang MW, 2013, J VIROL METHODS, V189, P232, DOI 10.1016/j.jviromet.2013.01.019; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Doblin MA, 2007, HARMFUL ALGAE, V6, P519, DOI 10.1016/j.hal.2006.05.007; Drake LA, 2005, BIOL INVASIONS, V7, P969, DOI 10.1007/s10530-004-3001-8; Drake LA, 2007, MAR POLLUT BULL, V55, P333, DOI 10.1016/j.marpolbul.2006.11.007; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elliott Aaron M, 2012, J Biomol Tech, V23, P24, DOI 10.7171/jbt.12-2301-003; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Fonseca VG, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks002; Fujimoto M, 2013, MICROB ECOL, V66, P500, DOI 10.1007/s00248-013-0256-6; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HOLLAND RE, 1993, J GREAT LAKES RES, V19, P617, DOI 10.1016/S0380-1330(93)71245-9; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Jain R, 2014, GEOMICROBIOL J, V31, P82, DOI 10.1080/01490451.2013.811317; Junemann S, 2013, NAT BIOTECHNOL, V31, P294, DOI 10.1038/nbt.2522; Junemann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041606; Jung J, 2012, J BACTERIOL, V194, P2097, DOI 10.1128/JB.00153-12; Kim MS, 2010, INT J SYST EVOL MICR, V60, P2199, DOI 10.1099/ijs.0.011684-0; Kim MS, 2009, INT J SYST EVOL MICR, V59, P2313, DOI 10.1099/ijs.0.007260-0; Kolekar YM, 2013, CURR MICROBIOL, V67, P454, DOI 10.1007/s00284-013-0385-7; Landini P, 2009, RES MICROBIOL, V160, P259, DOI 10.1016/j.resmic.2009.03.001; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Ma YH, 2004, EXTREMOPHILES, V8, P193, DOI 10.1007/s00792-004-0377-4; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MCCARTHY SA, 1994, APPL ENVIRON MICROB, V60, P2597, DOI 10.1128/AEM.60.7.2597-2601.1994; Merriman B, 2012, ELECTROPHORESIS, V33, P3397, DOI 10.1002/elps.201200424; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; National Research Council, 2011, ASS REL PROP PRESS I, p[vi, 144]; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Palleroni N.J., 2010, TOPLEY WILSONS MICRO; R Development Core Team, 2009, R LAUNG ENV STAT COM; Roh SW, 2009, INT J SYST EVOL MICR, V59, P421, DOI 10.1099/ijs.0.65643-0; Ruiz GM, 2000, NATURE, V408, P49, DOI 10.1038/35040695; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Starliper CE, 2013, J ADV RES, V4, P345, DOI 10.1016/j.jare.2012.06.003; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; USCG, 2012, STAND LIV ORG SHIPS, P17254; Vogel BF, 2000, INT J SYST EVOL MICR, V50, P1133, DOI 10.1099/00207713-50-3-1133; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whiteley AS, 2012, J MICROBIOL METH, V91, P80, DOI 10.1016/j.mimet.2012.07.008; Yergeau E, 2012, APPL ENVIRON MICROB, V78, P7626, DOI 10.1128/AEM.02036-12	65	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107534	10.1371/journal.pone.0107534	http://dx.doi.org/10.1371/journal.pone.0107534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222021	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774800080
J	Smutova, V; Albohy, A; Pan, XF; Korchagina, E; Miyagi, T; Bovin, N; Cairo, CW; Pshezhetsky, AV				Smutova, Victoria; Albohy, Amgad; Pan, Xuefang; Korchagina, Elena; Miyagi, Taeko; Bovin, Nicolai; Cairo, Christopher W.; Pshezhetsky, Alexey V.			Structural Basis for Substrate Specificity of Mammalian Neuraminidases	PLOS ONE			English	Article							SERUM SIALIC-ACID; CYTOSOLIC SIALIDASE; LYSOSOMAL SIALIDASE; ALPHA(1)-ACID GLYCOPROTEIN; CLINICAL-SIGNIFICANCE; MOLECULAR-CLONING; MUCOLIPIDOSIS-I; EXPRESSION; MEMBRANE; NEU4	The removal of sialic acid (Sia) residues from glycoconjugates in vertebrates is mediated by a family of neuraminidases (sialidases) consisting of Neu1, Neu2, Neu3 and Neu4 enzymes. The enzymes play distinct physiological roles, but their ability to discriminate between the types of linkages connecting Sia and adjacent residues and between the identity and arrangement of the underlying sugars has never been systematically studied. Here we analyzed the specificity of neuraminidases by studying the kinetics of hydrolysis of BODIPY-labeled substrates containing common mammalian sialylated oligosaccharides: 3'Sia-LacNAc, 3'SiaLac, SiaLe(x), SiaLe(a), SiaLe(c), 6'SiaLac, and 6'SiaLacNAc. We found significant differences in substrate specificity of the enzymes towards the substrates containing alpha 2,6-linked Sia, which were readily cleaved by Neu3 and Neu1 but not by Neu4 and Neu2. The presence of a branching 2-Fuc inhibited Neu2 and Neu4, but had almost no effect on Neu1 or Neu3. The nature of the sugar residue at the reducing end, either glucose (Glc) or N-acetyl-D-glucosamine (GlcNAc) had only a minor effect on all neuraminidases, whereas core structure (1,3 or 1,4 bond between D-galactose (Gal) and GlcNAc) was found to be important for Neu4 strongly preferring beta 3 (core 1) to beta 4 (core 2) isomer. Neu3 and Neu4 were in general more active than Neu1 and Neu2, likely due to their preference for hydrophobic substrates. Neu2 and Neu3 were examined by molecular dynamics to identify favorable substrate orientations in the binding sites and interpret the differences in their specificities. Finally, using knockout mouse models, we confirmed that the substrate specificities observed in vitro were recapitulated in enzymes found in mouse brain tissues. Our data for the first time provide evidence for the characteristic substrate preferences of neuraminidases and their ability to discriminate between distinct sialoside targets.	[Smutova, Victoria; Pan, Xuefang; Pshezhetsky, Alexey V.] Univ Montreal, St Justine Univ Hosp, Res Ctr, Div Med Genet, Montreal, PQ, Canada; [Albohy, Amgad; Cairo, Christopher W.] Univ Alberta, Dept Chem, Alberta Glyc Ctr, Edmonton, AB, Canada; [Korchagina, Elena; Bovin, Nicolai] Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Miyagi, Taeko] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Sendai, Miyagi, Japan	Universite de Montreal; University of Alberta; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Tohoku Medical & Pharmaceutical University	Pshezhetsky, AV (corresponding author), Univ Montreal, St Justine Univ Hosp, Res Ctr, Div Med Genet, Montreal, PQ, Canada.	alexei.pchejetski@umontreal.ca	Albohy, Amgad/AAK-5421-2021; Cairo, Christopher W/B-5355-2009; Bovin, Nicolai/P-2948-2017	Albohy, Amgad/0000-0003-3021-8767; Cairo, Christopher W/0000-0003-3363-8708; Bovin, Nicolai/0000-0001-8669-4477; A, Pshezhetsky/0000-0002-6612-1062	Canadian Diabetes Association; Natural Sciences and Engineering Research Council of Canada; Presidium of the Russian Academy of Science	Canadian Diabetes Association; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Presidium of the Russian Academy of Science(Russian Academy of Sciences)	This work was partially supported by the research grants from Canadian Diabetes Association (www.diabetes.ca) to AVP, Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca) to CWC, and Presidium of the Russian Academy of Science (https://www.ras.ru) to NB and EK (grant "Molecular and Cell Biology''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albohy A, 2011, BIOORGAN MED CHEM, V19, P2817, DOI 10.1016/j.bmc.2011.03.039; Albohy A, 2010, GLYCOBIOLOGY, V20, P1127, DOI 10.1093/glycob/cwq077; Allende ML, 2002, CURR OPIN STRUC BIOL, V12, P587, DOI 10.1016/S0959-440X(02)00376-7; Babal P, 2006, ACTA HISTOCHEM, V108, P133, DOI 10.1016/j.acthis.2006.03.003; Basoglu M, 2003, J SURG ONCOL, V83, P180, DOI 10.1002/jso.10257; Berbec H, 1999, EUR J GYNAECOL ONCOL, V20, P389; Bigi A, 2010, GLYCOBIOLOGY, V20, P148, DOI 10.1093/glycob/cwp156; Bonten E, 1996, GENE DEV, V10, P3156, DOI 10.1101/gad.10.24.3156; Brooks SA, 1999, INVAS METAST, V18, P115; Byrne B, 2007, DRUG DISCOV TODAY, V12, P319, DOI 10.1016/j.drudis.2007.02.010; Chavas LMG, 2005, J BIOL CHEM, V280, P469, DOI 10.1074/jbc.M411506200; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; Comelli EM, 2003, GENE, V321, P155, DOI 10.1016/j.gene.2003.08.005; DAZZO A, 1995, METABOLIC MOL BASES, P2835; DORLAND L, 1978, EUR J BIOCHEM, V87, P323, DOI 10.1111/j.1432-1033.1978.tb12381.x; Dridi L, 2013, DIABETES, V62, P2338, DOI 10.2337/db12-1825; Durand S, 2010, J BIOL CHEM, V285, P31233, DOI 10.1074/jbc.M110.141150; Fanzani A, 2003, FEBS LETT, V547, P183, DOI 10.1016/S0014-5793(03)00709-9; Feijoo-Carnero C, 2004, INT J BIOL MARKER, V19, P38, DOI 10.1177/172460080401900105; Giacopuzzi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044193; Hasegawa T, 2007, FEBS LETT, V581, P406, DOI 10.1016/j.febslet.2006.12.046; Herve F, 1998, J CHROMATOGR B, V715, P111, DOI 10.1016/S0378-4347(98)00085-1; Iijima S, 2000, ELECTROPHORESIS, V21, P753, DOI 10.1002/(SICI)1522-2683(20000301)21:4<753::AID-ELPS753>3.0.CO;2-Y; JONES CJP, 1993, J REPROD FERTIL, V99, P635; Kelm S, 1997, INT REV CYTOL, V175, P137, DOI 10.1016/S0074-7696(08)62127-0; Khedri Z, 2012, CHEM COMMUN, V48, P3357, DOI 10.1039/c2cc17393j; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Koda T, 2009, BIOCHEM BIOPH RES CO, V387, P729, DOI 10.1016/j.bbrc.2009.07.100; Koseki K, 2012, BIOCHEM BIOPH RES CO, V428, P142, DOI 10.1016/j.bbrc.2012.10.028; Kotani K, 2001, BIOCHEM BIOPH RES CO, V286, P250, DOI 10.1006/bbrc.2001.5374; Lehmann F, 2006, CELL MOL LIFE SCI, V63, P1331, DOI 10.1007/s00018-005-5589-y; Lukong KE, 2001, J BIOL CHEM, V276, P46172, DOI 10.1074/jbc.M104547200; MICHALSKI JC, 1977, FEBS LETT, V79, P101, DOI 10.1016/0014-5793(77)80359-1; MIYAGI T, 1985, J BIOL CHEM, V260, P6710; MIYAGI T, 1993, J BIOL CHEM, V268, P26435; Mochalova L, 2007, ARCH VIROL, V152, P2047, DOI 10.1007/s00705-007-1024-z; Monti E, 2000, BIOCHEM J, V349, P343, DOI 10.1042/0264-6021:3490343; Monti E, 2004, GENOMICS, V83, P445, DOI 10.1016/j.ygeno.2003.08.019; Monti E, 1999, GENOMICS, V57, P137, DOI 10.1006/geno.1999.5749; OKAMURAOHO Y, 1994, BBA-MOL BASIS DIS, V1225, P244, DOI 10.1016/0925-4439(94)90002-7; Pazynina G, 2002, TETRAHEDRON LETT, V43, P8011, DOI 10.1016/S0040-4039(02)01983-4; Pshezhetsky AV, 2011, GLYCOCONJUGATE J, V28, P441, DOI 10.1007/s10719-011-9350-5; Pshezhetsky AV, 1996, J BIOL CHEM, V271, P28359, DOI 10.1074/jbc.271.45.28359; Pshezhetsky AV, 1997, NAT GENET, V15, P316, DOI 10.1038/ng0397-316; Pshezhetsky AV, 2001, PROG NUCLEIC ACID RE, V69, P81, DOI 10.1016/S0079-6603(01)69045-7; Rajpura KB, 2005, J ORAL PATHOL MED, V34, P263; Romppanen J, 2002, ANTICANCER RES, V22, P415; Sandbhor MS, 2011, BIOCHEMISTRY-US, V50, P6753, DOI 10.1021/bi200449j; Sato K, 1996, BIOCHEM BIOPH RES CO, V221, P826, DOI 10.1006/bbrc.1996.0681; Seyrantepe V, 2004, J BIOL CHEM, V279, P37021, DOI 10.1074/jbc.M404531200; Seyrantepe V, 2008, HUM MOL GENET, V17, P1556, DOI 10.1093/hmg/ddn043; Seyrantepe V, 2008, CIRCULATION, V117, P1973, DOI 10.1161/CIRCULATIONAHA.107.733212; Shiozaki K, 2011, J BIOL CHEM, V286, P21052, DOI 10.1074/jbc.M111.231191; STRECKER G, 1977, EUR J BIOCHEM, V75, P391, DOI 10.1111/j.1432-1033.1977.tb11540.x; Takashima S, 2008, BIOSCI BIOTECH BIOCH, V72, P1155, DOI 10.1271/bbb.80025; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Tringali C, 2004, J BIOL CHEM, V279, P3169, DOI 10.1074/jbc.M308381200; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; Tuzikov AB, 2000, J CARBOHYD CHEM, V19, P1191, DOI 10.1080/07328300008544143; Uslu C, 2003, ANN CLIN LAB SCI, V33, P156; VANPELT J, 1988, BIOCHIM BIOPHYS ACTA, V965, P36, DOI 10.1016/0304-4165(88)90148-1; VARGHESE JN, 1992, PROTEINS, V14, P327, DOI 10.1002/prot.340140302; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Vinogradova MV, 1998, BIOCHEM J, V330, P641; Wada T, 1999, BIOCHEM BIOPH RES CO, V261, P21, DOI 10.1006/bbrc.1999.0973; Wang Y, 2002, J BIOL CHEM, V277, P26252, DOI 10.1074/jbc.M110515200; Wang Y, 2001, EUR J BIOCHEM, V268, P2201, DOI 10.1046/j.1432-1327.2001.02069.x; Yamaguchi K, 2005, BIOCHEM J, V390, P85, DOI 10.1042/BJ20050017; Yamaguchi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041132; YOSHINO H, 1990, J NEUROL SCI, V97, P53, DOI 10.1016/0022-510X(90)90098-8; Zanchetti G, 2007, BIOCHEM J, V408, P211, DOI 10.1042/BJ20070503; Zhang Y, 2013, J MED CHEM, V56, P2948, DOI 10.1021/jm301892f	72	70	70	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e106320	10.1371/journal.pone.0106320	http://dx.doi.org/10.1371/journal.pone.0106320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222608	Green Submitted, gold, Green Published			2022-12-25	WOS:000341774800013
J	Bon, J; Kahloon, R; Zhang, YZ; Xue, JM; Fuhrman, CR; Tan, JN; Burger, M; Kass, DJ; Csizmadia, E; Otterbein, L; Chandra, D; Bhargava, A; Pilewski, JM; Roodman, GD; Sciurba, FC; Duncan, SR				Bon, Jessica; Kahloon, Rehan; Zhang, Yingze; Xue, Jianmin; Fuhrman, Carl R.; Tan, Jiangning; Burger, Mathew; Kass, Daniel J.; Csizmadia, Eva; Otterbein, Leo; Chandra, Divay; Bhargava, Arpit; Pilewski, Joseph M.; Roodman, G. David; Sciurba, Frank C.; Duncan, Steven R.			Autoreactivity to Glucose Regulated Protein 78 Links Emphysema and Osteoporosis in Smokers	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RADIOGRAPHIC EMPHYSEMA; UNFOLDED PROTEIN; RITUXIMAB; COPD; AUTOIMMUNITY; ASSOCIATION; ANTIBODIES; LUNG	Rationale: Emphysema and osteoporosis are epidemiologically associated diseases of cigarette smokers. The causal mechanism(s) linking these illnesses is unknown. We hypothesized autoimmune responses may be involved in both disorders. Objectives: To discover an antigen-specific autoimmune response associated with both emphysema and osteoporosis among smokers. Methods: Replicate nonbiased discovery assays indicated that autoimmunity to glucose regulated protein 78 (GRP78), an endoplasmic reticulum chaperone and cell surface signaling receptor, is present in many smokers. Subject assessments included spirometry, chest CT scans, dual x-ray absorptiometry, and immunoblots for anti-GRP78 IgG. Anti-GRP78 autoantibodies were isolated from patient plasma by affinity chromatography, leukocyte functions assessed by flow cytometry, and soluble metabolites and mediators measured by immunoassays. Measurements and Main Results: Circulating anti-GRP78 IgG autoantibodies were detected in plasma specimens from 86 (32%) of the 265 smoking subjects. Anti-GRP78 autoantibodies were singularly prevalent among subjects with radiographic emphysema (OR 3.1, 95%CI 1.7-5.7, p = 0.003). Anti-GRP78 autoantibodies were also associated with osteoporosis (OR 4.7, 95%CI 1.7-13.3, p = 0.002), and increased circulating bone metabolites (p = 0.006). Among emphysematous subjects, GRP78 protein was an autoantigen of CD4 T-cells, stimulating lymphocyte proliferation (p = 0.0002) and IFN-gamma production (p = 0.03). Patient-derived anti-GRP78 autoantibodies had avidities for osteoclasts and macrophages, and increased macrophage NFkB phosphorylation (p = 0.005) and productions of IL-8, CCL-2, and MMP9 (p = 0.005, 0.007, 0.03, respectively). Conclusions: Humoral and cellular GRP78 autoimmune responses in smokers have numerous biologically-relevant pro-inflammatory and other deleterious actions, and are associated with emphysema and osteoporosis. These findings may have relevance for the pathogenesis of smoking-associated diseases, and development of biomarker immunoassays and/or novel treatments for these disorders.	[Bon, Jessica; Kahloon, Rehan; Zhang, Yingze; Xue, Jianmin; Tan, Jiangning; Burger, Mathew; Kass, Daniel J.; Chandra, Divay; Bhargava, Arpit; Pilewski, Joseph M.; Sciurba, Frank C.; Duncan, Steven R.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; [Fuhrman, Carl R.] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Csizmadia, Eva; Otterbein, Leo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA; [Roodman, G. David] Indiana Sch Med, Dept Med, Indianapolis, IN USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Indiana University System; Indiana University Bloomington	Zhang, YZ (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA.	duncsr@upmc.edu	Sciurba, Frank/AAZ-9339-2021; Bon, Jessica/AAK-6714-2021; Pilewski, Joseph/AAF-5149-2021	sciurba, frank/0000-0001-7468-2225; Zhang, YIngze/0000-0001-8042-6105	U.S. NIH [HL084948, HL107172, AR57308, HL007563]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084948, T32HL007563, P50HL107172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by U.S. NIH grants HL084948, HL107172, AR57308, and HL007563. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr RG, 2012, COPD, V9, P151, DOI 10.3109/15412555.2012.654923; Bon J, 2011, AM J RESP CRIT CARE, V183, P885, DOI 10.1164/rccm.201004-0666OC; Borie R, 2009, EUR RESPIR J, V33, P1503, DOI 10.1183/09031936.00160908; Brandsma CA, 2011, EUR RESPIR J, V37, P1289, DOI 10.1183/09031936.00116710; Chan CP, 2006, J VIROL, V80, P9279, DOI 10.1128/JVI.00659-06; Chandra D, 2012, CHEST, V142, P655, DOI 10.1378/chest.11-1456; Duncan SR, 2012, NATURE, V489, pS15, DOI 10.1038/489S15a; ERICKSON SB, 1979, MAYO CLIN PROC, V54, P714; Feghali-Bostwick CA, 2008, AM J RESP CRIT CARE, V177, P156, DOI 10.1164/rccm.200701-014OC; Feghali-Bostwick CA, 2007, J IMMUNOL, V179, P2592, DOI 10.4049/jimmunol.179.4.2592; Franks AL, 2012, ANTICANCER RES, V32, P1119; Fu SM, 2011, J AUTOIMMUN, V37, P104, DOI 10.1016/j.jaut.2011.05.004; Furie R, 2011, ARTHRITIS RHEUM-US, V63, P3918, DOI 10.1002/art.30613; Gosselink JV, 2010, AM J RESP CRIT CARE, V181, P1329, DOI 10.1164/rccm.200812-1902OC; Greene CM, 2010, AM J RESP CRIT CARE, V181, P31, DOI 10.1164/rccm.200904-0545OC; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Kahloon RA, 2013, AM J RESP CRIT CARE, V187, P768, DOI 10.1164/rccm.201203-0506OC; Keir GJ, 2012, EUR RESPIR J, V40, P641, DOI 10.1183/09031936.00163911; Kelsen SG, 2008, AM J RESP CELL MOL, V38, P541, DOI 10.1165/rcmb.2007-0221OC; Kim Victor, 2008, Proc Am Thorac Soc, V5, P478, DOI 10.1513/pats.200802-014ET; Kirkham PA, 2011, AM J RESP CRIT CARE, V184, P796, DOI 10.1164/rccm.201010-1605OC; Kurzius-Spencer M, 2001, AM J RESP CRIT CARE, V164, P1261, DOI 10.1164/ajrccm.164.7.2010051; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Lu MC, 2010, ARTHRITIS RHEUM-US, V62, P1213, DOI 10.1002/art.27386; Mannino DM, 2002, CHEST, V121, p121S, DOI 10.1378/chest.121.5_suppl.121S; Monaco Claudia, 2004, Current Drug Targets - Inflammation and Allergy, V3, P35, DOI 10.2174/1568010043483881; Pordeus V, 2008, CLIN REV ALLERG IMMU, V34, P283, DOI 10.1007/s12016-007-8048-8; Purcell AW, 2003, CLIN EXP IMMUNOL, V132, P193, DOI 10.1046/j.1365-2249.2003.02153.x; Retamales I, 2001, AM J RESP CRIT CARE, V164, P469, DOI 10.1164/ajrccm.164.3.2007149; Rinaldi M, 2012, THORAX, V67, P694, DOI 10.1136/thoraxjnl-2011-200690; Sem M, 2009, RHEUMATOLOGY, V48, P968, DOI 10.1093/rheumatology/kep157; Shields AM, 2011, CLIN EXP IMMUNOL, V165, P292, DOI 10.1111/j.1365-2249.2011.04433.x; Sin Don D, 2005, Proc Am Thorac Soc, V2, P8, DOI 10.1513/pats.200404-032MS; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905; Sundaram K, 2007, EXP CELL RES, V313, P168, DOI 10.1016/j.yexcr.2006.10.001; van Kempen LCL, 2002, CANCER CELL, V2, P251, DOI 10.1016/S1535-6108(02)00157-5; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Washko GR, 2008, COPD, V5, P177, DOI 10.1080/15412550802093025; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P738, DOI 10.1164/rccm.200803-435OC	40	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e105066	10.1371/journal.pone.0105066	http://dx.doi.org/10.1371/journal.pone.0105066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216103	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000341774300002
J	Diaz-Real, J; Serrano, D; Perez-Tris, J; Fernandez-Gonzalez, S; Bermejo, A; Calleja, JA; De la Puente, J; De Palacio, D; Martinez, JL; Moreno-Opo, R; Ponce, C; Frias, O; Tella, JL; Moller, AP; Figuerola, J; Pap, PL; Kovacs, I; Vagasi, CI; Melendez, L; Blanco, G; Aguilera, E; Senar, JC; Galvan, I; Atienzar, F; Barba, E; Canto, JL; Cortes, V; Monros, JS; Piculo, R; Vogeli, M; Borras, A; Navarro, C; Mestre, A; Jovani, R				Diaz-Real, Javier; Serrano, David; Perez-Tris, Javier; Fernandez-Gonzalez, Sofia; Bermejo, Ana; Calleja, Juan A.; De la Puente, Javier; De Palacio, Diana; Martinez, Jose L.; Moreno-Opo, Ruben; Ponce, Carlos; Frias, Oscar; Tella, Jose L.; Moller, Anders P.; Figuerola, Jordi; Pap, Peter L.; Kovacs, Istvan; Vagasi, Csongor I.; Melendez, Leandro; Blanco, Guillermo; Aguilera, Eduardo; Carlos Senar, Juan; Galvan, Ismael; Atienzar, Francisco; Barba, Emilio; Canto, Jose L.; Cortes, Veronica; Monros, Juan S.; Piculo, Ruben; Voegeli, Matthias; Borras, Antoni; Navarro, Carlos; Mestre, Alexandre; Jovani, Roger			Repeatability of Feather Mite Prevalence and Intensity in Passerine Birds	PLOS ONE			English	Article							UROPYGIAL GLAND SIZE; BLOOD PARASITES; GEOGRAPHICAL VARIATION; SPECIES CHARACTER; HOST; ABUNDANCE; BODY; TITS; DETERMINANTS; POPULATIONS	Understanding why host species differ so much in symbiont loads and how this depends on ecological host and symbiont traits is a major issue in the ecology of symbiosis. A first step in this inquiry is to know whether observed differences among host species are species-specific traits or more related with host-symbiont environmental conditions. Here we analysed the repeatability (R) of the intensity and the prevalence of feather mites to partition within-and among-host species variance components. We compiled the largest dataset so far available: 119 Paleartic passerine bird species, 75,944 individual birds, ca. 1.8 million mites, seven countries, 23 study years. Several analyses and approaches were made to estimate R and adjusted repeatability (R-adj) after controlling for potential confounding factors (breeding period, weather, habitat, spatial autocorrelation and researcher identity). The prevalence of feather mites was moderately repeatable (R = 0.26-0.53; R-adj = 0.32-0.57); smaller values were found for intensity (R = 0.19-0.30; R-adj = 0.18-0.30). These moderate repeatabilities show that prevalence and intensity of feather mites differ among species, but also that the high variation within species leads to considerable overlap among bird species. Differences in the prevalence and intensity of feather mites within bird species were small among habitats, suggesting that local factors are playing a secondary role. However, effects of local climatic conditions were partially observed for intensity.	[Diaz-Real, Javier; Serrano, David; Tella, Jose L.; Figuerola, Jordi; Aguilera, Eduardo; Galvan, Ismael; Jovani, Roger] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Diaz-Real, Javier] Univ Vigo, Dept Ecol & Biol Anim, Vigo 36310, Pontevedra, Spain; [Perez-Tris, Javier; Fernandez-Gonzalez, Sofia] Univ Complutense Madrid, Dept Zool & Anthropol Fis, Madrid, Spain; [Perez-Tris, Javier; Bermejo, Ana; Calleja, Juan A.; De la Puente, Javier; De Palacio, Diana; Martinez, Jose L.; Moreno-Opo, Ruben; Ponce, Carlos] Univ Autonoma Madrid, Unidad Zool, Grp Ornitol SEO Monticola, Madrid, Spain; [Calleja, Juan A.] Univ Autonoma Barcelona, Dept Biol Anim Vegetal & Ecol, E-08193 Barcelona, Spain; [Ponce, Carlos; Frias, Oscar; Blanco, Guillermo] CSIC, Museo Nacl Ciencias Nat, Dept Evolutionary Ecol, Madrid, Spain; [Moller, Anders P.] Univ Paris 11, CNRS, Lab Ecol Systmat & Evolut, UMR 8079, Orsay, France; [Pap, Peter L.; Vagasi, Csongor I.] Univ Babes Bolyai, Hungarian Dept Biol & Ecol, Evolutionary Ecol Grp, R-3400 Cluj Napoca, Romania; [Pap, Peter L.] Univ Debrecen, Dept Evolutionary Zool & Human Biol, MTA DE Lendulet Behav Ecol Res Grp, H-4012 Debrecen, Hungary; [Kovacs, Istvan] Milvus Grp Bird & Nat Protect Assoc, Targu Mures, Romania; [Melendez, Leandro] Univ Oviedo, CSIC, Inst Cantabrico Biodiversidad, Unidad Mixta Invest Biodiversidad, Oviedo, Spain; [Carlos Senar, Juan; Borras, Antoni] CSIC, Museo Ciencias Nat Barcelona, Unidad Asoc Ecol Evolut & Comportamiento, Barcelona, Spain; [Atienzar, Francisco; Barba, Emilio; Cortes, Veronica; Monros, Juan S.; Piculo, Ruben] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Ecol, Paterna, Spain; [Canto, Jose L.] Parque Nat Carrascal Font Roja, Alcoy, Spain; [Voegeli, Matthias] Fed Off Environm FOEN, Species Ecosyst Landscape Div, Bern, Switzerland; [Mestre, Alexandre] Univ Valencia, Dept Microbiol & Ecol, E-46100 Burjassot, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidade de Vigo; Complutense University of Madrid; Autonomous University of Madrid; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Babes Bolyai University from Cluj; University of Debrecen; Consejo Superior de Investigaciones Cientificas (CSIC); University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); Museu de Ciencies Naturals de Barcelona; University of Valencia; University of Valencia	Jovani, R (corresponding author), CSIC, Estn Biol Donana, E-41080 Seville, Spain.	jovani@ebd.csic.es	Jovani, Roger/C-7080-2013; Vágási, Csongor I./AAU-4548-2020; Blanco, Guillermo/L-3170-2014; Mestre, Alexandre/A-6712-2015; Barba, Emilio/I-5130-2015; Senar, Joan Carles/V-2371-2018; Calleja Alarcón, Juan Antonio/M-1639-2014; Galvan, Ismael/H-8602-2015; Alarcón, Juan Antonio Calleja/T-2297-2019; Vögeli, Matthias/M-4269-2019; Monros, Juan S/L-9750-2014; Moller, Anders/O-6665-2016; Figuerola, Jordi/B-7917-2008; Pérez-Tris, Javier/D-4087-2012; Serrano, David/B-5352-2013; Monros, Juan/AAA-3726-2020; Tella, José L/I-3707-2015; Vögeli, Matthias/G-1815-2010	Jovani, Roger/0000-0002-8693-9742; Vágási, Csongor I./0000-0002-8736-2391; Blanco, Guillermo/0000-0001-5742-4929; Mestre, Alexandre/0000-0003-1764-2248; Barba, Emilio/0000-0003-2882-9788; Senar, Joan Carles/0000-0001-9955-3892; Calleja Alarcón, Juan Antonio/0000-0002-6586-0939; Galvan, Ismael/0000-0002-6523-8592; Alarcón, Juan Antonio Calleja/0000-0002-6586-0939; Vögeli, Matthias/0000-0002-3408-0972; Monros, Juan S/0000-0002-0952-2089; Moller, Anders/0000-0003-3739-4675; Figuerola, Jordi/0000-0002-4664-9011; Pérez-Tris, Javier/0000-0001-5535-3100; Serrano, David/0000-0001-6205-386X; Monros, Juan/0000-0002-0952-2089; Tella, José L/0000-0002-3038-7424; Vögeli, Matthias/0000-0002-3408-0972; Aguilera, Eduardo/0000-0001-7357-4062	Spanish Ministerio de Economia y Competitividad (Ramon y Cajal research) [RYC-2009-03967, CGL2012-38262, CGL2010-15734/BOS, CGL2009-11445, CGL2011-24466]; Babes-Bolyai Univeristy [GTC 34062/2013]; Junta de Andalucia [RNM1274, RNM4014, RNM-7038]; Romanian Ministry of Education and Research [PN II. RU TE 291/2010]; San Martin de la Vega town hall; SEO/BirdLife (Las Minas Ringing Station, Madrid, Spain)	Spanish Ministerio de Economia y Competitividad (Ramon y Cajal research); Babes-Bolyai Univeristy; Junta de Andalucia(Junta de Andalucia); Romanian Ministry of Education and Research(Ministry of Education and Research - Romania); San Martin de la Vega town hall; SEO/BirdLife (Las Minas Ringing Station, Madrid, Spain)	Funding was provided by the Spanish Ministerio de Economia y Competitividad (Ramon y Cajal research contract RYC-2009-03967 to RJ, CGL2012-38262 research project to JCS, CGL2010-15734/BOS to JPT, CGL2009-11445 to JF, CGL2011-24466 to RJ), Babes-Bolyai Univeristy (post-doc grant GTC 34062/2013 to CIV), Junta de Andalucia (Excellence Projects RNM1274 and RNM4014 to MV, DS and JLT, RNM-7038 to JF), Romanian Ministry of Education and Research (research grant PN II. RU TE 291/2010 to PLP and CIV) and San Martin de la Vega town hall and SEO/BirdLife (Las Minas Ringing Station, Madrid, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arneberg P, 1997, OIKOS, V80, P289, DOI 10.2307/3546597; Behnke J, 1999, J ZOOL, V248, P337, DOI 10.1111/j.1469-7998.1999.tb01033.x; Blanco G, 1999, ANN ZOOL FENN, V36, P83; Blanco G, 1997, J AVIAN BIOL, V28, P197, DOI 10.2307/3676970; Blanco G, 2001, ECOGRAPHY, V24, P113, DOI 10.1034/j.1600-0587.2001.240201.x; Blanco G, 2001, J AVIAN BIOL, V32, P271, DOI 10.1111/j.0908-8857.2001.320310.x; Bridge ES, 2003, INT J ACAROL, V29, P389, DOI 10.1080/01647950308684356; Cramp S., 1977, HDB BIRDS EUROPE MID; Dabert J, 1999, EXP APPL ACAROL, V23, P437, DOI 10.1023/A:1006180705101; Dowling DK, 2001, J AVIAN BIOL, V32, P364, DOI 10.1111/j.0908-8857.2001.320412.x; Dubinin V. B., 1951, Fauna USSR Moscow, V6, P1; Fernandez-Gonzalez S, 2013, OIKOS, V122, P1227, DOI 10.1111/j.1600-0706.2012.00241.x; Figuerola J, 2003, ANIM BEHAV, V65, P551, DOI 10.1006/anbe.2003.2072; Figuerola J, 2000, J AVIAN BIOL, V31, P489, DOI 10.1034/j.1600-048X.2000.310408.x; Galvan I, 2008, J EVOLUTION BIOL, V21, P133, DOI 10.1111/j.1420-9101.2007.01459.x; Galvan I, 2006, IBIS, V148, P687, DOI 10.1111/j.1474-919X.2006.00576.x; Galvan I, 2012, J AVIAN BIOL, V43, P273, DOI 10.1111/j.1600-048X.2012.05686.x; Gaud J, 1996, ANN SCI ZOOLOGIQUES, V277, P3; Harper DGC, 1999, ANIM BEHAV, V58, P553, DOI 10.1006/anbe.1999.1154; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Jovani R, 2004, J AVIAN BIOL, V35, P16, DOI 10.1111/j.0908-8857.2004.03213.x; Jovani R, 2000, ECOSCIENCE, V7, P428, DOI 10.1080/11956860.2000.11682613; Korallo-Vinarskaya NP, 2009, EVOL ECOL, V23, P329, DOI 10.1007/s10682-007-9229-x; Krasnov BR, 2007, OECOLOGIA, V154, P185, DOI 10.1007/s00442-007-0824-x; Krasnov BR, 2006, OECOLOGIA, V150, P132, DOI 10.1007/s00442-006-0498-9; Krasnov BR, 2004, J ANIM ECOL, V73, P1121, DOI 10.1111/j.0021-8790.2004.00883.x; Lafferty KD, 2006, P NATL ACAD SCI USA, V103, P11211, DOI 10.1073/pnas.0604755103; Legendre P., 1998, NUMERICAL ECOLOGY, V24; MCCLURE HE, 1989, J FIELD ORNITHOL, V60, P431; Moller AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082886; Moller AP, 2010, OECOLOGIA, V163, P303, DOI 10.1007/s00442-009-1548-x; Moller AP, 1991, ECOLOGY BEHAV EVOLUT, P328; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Oconnor Barry M., 1994, P136; Pap PL, 2010, J AVIAN BIOL, V41, P653, DOI 10.1111/j.1600-048X.2010.05146.x; Pap PL, 2005, CAN J ZOOL, V83, P1059, DOI [10.1139/Z05-100, 10.1139/z05-100]; Poulin R, 2003, MAR ECOL PROG SER, V254, P187, DOI 10.3354/meps254187; Poulin R, 2006, INT J PARASITOL, V36, P877, DOI 10.1016/j.ijpara.2006.02.021; Proctor HC, 2003, ANNU REV ENTOMOL, V48, P185, DOI 10.1146/annurev.ento.48.091801.112725; R Development Core Team, 2012, R LANG ENV STAT COMP; Rozsa L, 1997, CAN J ZOOL, V75, P1535, DOI 10.1139/z97-778; Scheuerlein A, 2004, P ROY SOC B-BIOL SCI, V271, P1363, DOI 10.1098/rspb.2004.2726; Schielzeth H, 2011, RPTR REPEATABILITY G; SENAR JC, 1994, ARDEA, V82, P157; Sol D, 2000, ECOGRAPHY, V23, P307, DOI 10.1034/j.1600-0587.2000.d01-1639.x; Soler JJ, 2012, J EVOLUTION BIOL, V25, P1779, DOI 10.1111/j.1420-9101.2012.02561.x; Szollosi E, 2011, J EVOLUTION BIOL, V24, P2014, DOI 10.1111/j.1420-9101.2011.02339.x; Thieltges DW, 2009, MAR BIOL, V156, P983, DOI 10.1007/s00227-009-1142-0; Tripet F, 2002, J ANIM ECOL, V71, P735, DOI 10.1046/j.1365-2656.2002.00639.x; Wiles PR, 2000, CAN J ZOOL, V78, P1397, DOI 10.1139/cjz-78-8-1397; Garamszegi LZ, 2012, BEHAV ECOL SOCIOBIOL, V66, P107, DOI 10.1007/s00265-011-1259-2	51	16	18	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107341	10.1371/journal.pone.0107341	http://dx.doi.org/10.1371/journal.pone.0107341			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216248	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000341774300060
J	Laouami, S; Clair, G; Armengaud, J; Duport, C				Laouami, Sabrina; Clair, Geremy; Armengaud, Jean; Duport, Catherine			Proteomic Evidences for Rex Regulation of Metabolism in Toxin-Producing Bacillus cereus ATCC 14579	PLOS ONE			English	Article							ENTEROTOXIN GENE-EXPRESSION; STAPHYLOCOCCUS-AUREUS; PROTEIN SECRETION; FAMILY REPRESSOR; OXIDATIVE STRESS; REDOX; VIRULENCE; SUBTILIS; SYSTEM; GROWTH	The facultative anaerobe, Bacillus cereus, causes diarrheal diseases in humans. Its ability to deal with oxygen availability is recognized to be critical for pathogenesis. The B. cereus genome comprises a gene encoding a protein with high similarities to the redox regulator, Rex, which is a central regulator of anaerobic metabolism in Bacillus subtilis and other Gram-positive bacteria. Here, we showed that B. cereus rex is monocistronic and down-regulated in the absence of oxygen. The protein encoded by rex is an authentic Rex transcriptional factor since its DNA binding activity depends on the NADH/NAD(+) ratio. Rex deletion compromised the ability of B. cereus to cope with external oxidative stress under anaerobiosis while increasing B. cereus resistance against such stress under aerobiosis. The deletion of rex affects anaerobic fermentative and aerobic respiratory metabolism of B. cereus by decreasing and increasing, respectively, the carbon flux through the NADH-recycling lactate pathway. We compared both the cellular proteome and exoproteome of the wild-type and Delta rex cells using a high throughput shotgun label-free quantitation approach and identified proteins that are under control of Rex-mediated regulation. Proteomics data have been deposited to the ProteomeXchange with identifier PXD000886. The data suggest that Rex regulates both the cross-talk between metabolic pathways that produce NADH and NADPH and toxinogenesis, especially in oxic conditions.	[Laouami, Sabrina; Clair, Geremy; Duport, Catherine] Avignon Univ, INRA, SQPOV, UMR408, Avignon, France; [Laouami, Sabrina; Clair, Geremy; Duport, Catherine] INRA, SQPOV, UMR408, Avignon, France; [Clair, Geremy; Armengaud, Jean] CEA Marcoule, DSV iBEB SBTN LBSP, Lab Biochim Syst Perturbes, Bagnols Sur Ceze, France	Avignon Universite; INRAE; INRAE; CEA	Duport, C (corresponding author), Avignon Univ, INRA, SQPOV, UMR408, Avignon, France.	catherine.duport@univ-avignon.fr	Clair, Geremy/L-3791-2018	Clair, Geremy/0000-0003-0478-8520; ARMENGAUD, Jean/0000-0003-1589-445X	university of Avignon; Institut National de la Recherche Agronomique; Commissariat a l'Energie atomique; French Region of Provence-Alpes-Cotes d'Azur	university of Avignon; Institut National de la Recherche Agronomique; Commissariat a l'Energie atomique(French Atomic Energy Commission); French Region of Provence-Alpes-Cotes d'Azur	This work was supported by the university of Avignon, the Institut National de la Recherche Agronomique, the Commissariat a l'Energie atomique and the French Region of Provence-Alpes-Cotes d'Azur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo F, 2011, MOL MICROBIOL, V80, P1530, DOI 10.1111/j.1365-2958.2011.07665.x; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Bitoun JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044766; Bitoun JP, 2011, FEMS MICROBIOL LETT, V320, P110, DOI 10.1111/j.1574-6968.2011.02293.x; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Brekasis D, 2003, EMBO J, V22, P4856, DOI 10.1093/emboj/cdg453; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Carvalho PC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-316; Ceuppens S, 2013, FEMS MICROBIOL ECOL, V84, P433, DOI 10.1111/1574-6941.12110; Clair G, 2013, J PROTEOMICS, V94, P527, DOI 10.1016/j.jprot.2013.10.024; Clair G, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013102; Clair G, 2010, MOL CELL PROTEOMICS, V9, P1486, DOI 10.1074/mcp.M000027-MCP201; Copley SD, 2012, BIOESSAYS, V34, P578, DOI 10.1002/bies.201100191; Duport C, 2006, J BACTERIOL, V188, P6640, DOI 10.1128/JB.00702-06; Esbelin J, 2008, J BACTERIOL, V190, P4242, DOI 10.1128/JB.00336-08; Esbelin J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-125; Esbelin J, 2009, J BACTERIOL, V191, P4419, DOI 10.1128/JB.00321-09; Ezraty B, 2005, BBA-PROTEINS PROTEOM, V1703, P221, DOI 10.1016/j.bbapap.2004.08.017; Fagerlund A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-304; Frenzel E, 2012, MOL MICROBIOL, V85, P67, DOI 10.1111/j.1365-2958.2012.08090.x; Garrigues C, 2001, METAB ENG, V3, P211, DOI 10.1006/mben.2001.0182; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Goosens V.J., 2013, BIOCH BIOPHYS ACTA; Gyan S, 2006, J BACTERIOL, V188, P7062, DOI 10.1128/JB.00601-06; Henderson B, 2013, CURR TOP MICROBIOL, V358, P155, DOI 10.1007/82_2011_188; Holley TA, 2013, PROTEINS, V81, P176, DOI 10.1002/prot.24197; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Jakesevic M, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-8; Jiang LH, 2009, J MOL BIOL, V386, P1357, DOI 10.1016/j.jmb.2008.10.079; Laouami S, 2011, J BACTERIOL, V193, P1757, DOI 10.1128/JB.00024-11; Larsson JT, 2005, MICROBIOL-SGM, V151, P3323, DOI 10.1099/mic.0.28124-0; Mailloux RJ, 2011, ANTON LEEUW INT J G, V99, P433, DOI 10.1007/s10482-010-9538-x; Marteyn B, 2011, CELL MICROBIOL, V13, P171, DOI 10.1111/j.1462-5822.2010.01549.x; Marteyn B, 2010, NATURE, V465, P355, DOI 10.1038/nature08970; Meneses N, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-51; Mols M, 2011, ENVIRON MICROBIOL, V13, P1387, DOI 10.1111/j.1462-2920.2011.02433.x; Moran-Barrio J, 2009, ANTIMICROB AGENTS CH, V53, P2908, DOI 10.1128/AAC.01637-08; Moriarty-Craige SE, 2004, ANNU REV NUTR, V24, P481, DOI 10.1146/annurev.nutr.24.012003.132208; MURPHY E, 1985, MOL GEN GENET, V200, P33, DOI 10.1007/BF00383309; Newberry KJ, 2004, J BIOL CHEM, V279, P20356, DOI 10.1074/jbc.M400960200; Pagels M, 2010, MOL MICROBIOL, V76, P1142, DOI 10.1111/j.1365-2958.2010.07105.x; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Ramarao N, 2013, TOXINS, V5, P1119, DOI 10.3390/toxins5061119; Ravcheev DA, 2012, J BACTERIOL, V194, P1145, DOI 10.1128/JB.06412-11; Rivera J, 2010, P NATL ACAD SCI USA, V107, P19002, DOI 10.1073/pnas.1008843107; Roberts IN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045713; Rosenfeld E, 2005, CAN J MICROBIOL, V51, P149, DOI [10.1139/w04-132, 10.1139/W04-132]; Schau M, 2004, J BACTERIOL, V186, P4585, DOI 10.1128/JB.186.14.4585-4595.2004; Schneewind O, 2013, BIOCH BIOPHYS ACTA; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Senesi S, 2010, TOXINS, V2, P1690, DOI 10.3390/toxins2071690; Senesi S, 2010, RES MICROBIOL, V161, P743, DOI 10.1016/j.resmic.2010.10.007; Sickmier EA, 2005, STRUCTURE, V13, P43, DOI 10.1016/j.str.2004.10.012; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; SPIRA WM, 1975, CAN J MICROBIOL, V21, P1236, DOI 10.1139/m75-185; Sprynski N, 2012, FEBS OPEN BIO, V2, P71, DOI 10.1016/j.fob.2012.03.003; ten Bokum AMC, 2008, TRENDS MICROBIOL, V16, P436, DOI 10.1016/j.tim.2008.06.003; Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004; Vesic D, 2013, J BACTERIOL, V195, P1815, DOI 10.1128/JB.02135-12; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang E, 2008, MOL MICROBIOL, V69, P466, DOI 10.1111/j.1365-2958.2008.06295.x; Wang E, 2011, J MOL BIOL, V408, P670, DOI 10.1016/j.jmb.2011.02.050; Wang QZ, 2010, APPL ENVIRON MICROB, V76, P2107, DOI 10.1128/AEM.02545-09; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; Wichgers Schreur PJ, 2011, PLOS ONE, V6; Yang CK, 2011, J BACTERIOL, V193, P5607, DOI 10.1128/JB.05897-11; Yuan JJ, 2010, CELL MOL LIFE SCI, V67, P179, DOI 10.1007/s00018-009-0160-x; Zigha A, 2007, J BACTERIOL, V189, P2813, DOI 10.1128/JB.01701-06	70	13	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107354	10.1371/journal.pone.0107354	http://dx.doi.org/10.1371/journal.pone.0107354			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216269	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774300061
J	Marfil, V; Blazquez, M; Serrano, F; Castell, JV; Bort, R				Marfil, V.; Blazquez, M.; Serrano, F.; Castell, J. V.; Bort, R.			Growth-promoting and tumourigenic activity of c-Myc is suppressed by Hhex	ONCOGENE			English	Article							HEX HOMEOBOX GENE; RICH HOMEODOMAIN PROTEIN; MESSENGER-RNA TRANSPORT; CELL-CYCLE; TUMOR-CELLS; EXPRESSION; PROLIFERATION; TRANSCRIPTION; APOPTOSIS; SIZE	c-Myc transcription factor is a key protein involved in cellular growth, proliferation and metabolism. c-Myc is one of the most frequently activated oncogenes, highlighting the need to identify intracellular molecules that interact directly with c-Myc to suppress its function. Here we show that Hhex is able to interact with the basic region/helix-loop-helix/leucine zipper of c-Myc. Knockdown of Hhex increases proliferation rate in hepatocellular carcinoma cells, whereas Hhex expression cell-autonomously reduces cell proliferation rate in multiple cell lines by increasing G1 phase length through a c-Myc-dependent mechanism. Global transcriptomic analysis shows that Hhex counter-regulates multiple c-Myc targets involved in cell proliferation and metabolism. Concomitantly, Hhex expression leads to reduced cell size, lower levels of cellular RNA, downregulation of metabolism-related genes, decreased sensitivity to methotrexate and severe reduction in the ability to form tumours in nude mouse xenografts, all indicative of decreased c-Myc activity. Our data suggest that Hhex is a novel regulator of c-Myc function that limits c-Myc activity in transformed cells.	[Marfil, V.; Blazquez, M.; Serrano, F.; Castell, J. V.; Bort, R.] CIBERehd, Unidad Hepatol Expt, Inst Invest Sanitaria La Fe, Valencia 46026, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Bort, R (corresponding author), CIBERehd, Unidad Hepatol Expt, Inst Invest Sanitaria La Fe, Avda Fernando Abril Martorell 106,Torre A Despach, Valencia 46026, Spain.	bort_ber@gva.es	Bort, Roque/Y-5466-2019; Castell, Jose V/I-9529-2016	Bort, Roque/0000-0002-7285-0536; Castell, Jose V/0000-0003-1179-6430	Ministerio de Ciencia e Innovacion [SAF2010-15376, SAF2011-29718]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	We thank Dr Di Crocce for providing c-Myc truncated plasmids and Dr Ken Zaret for providing total RNA from Hhex-deficient E9.5 mouse embryos. We also thank Dr Laia Tolosa for assistance with Olympus ScanR screening station, Juan Jose Lozano for microarray analysis, Cristina Corchero for assistance in qRT-PCR and Ana Flores and M<SUP>a</SUP> Jesus Segui (Cell Culture and Cell Sorting facility at the SCSIE from Universidad de Valencia) for assistance in flow cytometry and cell sorting. VM and FS were recipients of pre-doctoral fellowships from the Ministerio de Ciencia e Innovacion. This work was supported by the Ministerio de Ciencia e Innovacion (grant number SAF2010-15376 and SAF2011-29718).	Baena E, 2005, P NATL ACAD SCI USA, V102, P7286, DOI 10.1073/pnas.0409260102; Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Bazarov AV, 2001, CANCER RES, V61, P1178; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Brickman JM, 2000, DEVELOPMENT, V127, P2303; Buschbeck M, 2007, ONCOGENE, V26, P3415, DOI 10.1038/sj.onc.1210128; Bush A, 1998, GENE DEV, V12, P3797, DOI 10.1101/gad.12.24.3797; Cai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053388; Canelles M, 1997, ONCOGENE, V14, P1315, DOI 10.1038/sj.onc.1200948; D'Elia AV, 2002, J CLIN ENDOCR METAB, V87, P1376, DOI 10.1210/jc.87.3.1376; Desjobert C, 2009, BIOCHEM J, V417, P121, DOI 10.1042/BJ20080872; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eekels JJM, 2012, GENE THER, V19, P1058, DOI 10.1038/gt.2011.191; Foley AC, 2005, GENE DEV, V19, P387, DOI 10.1101/gad.1279405; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; GAUBATZ S, 1995, EMBO J, V14, P1508, DOI 10.1002/j.1460-2075.1995.tb07137.x; GERDES J, 1984, J IMMUNOL, V133, P1710; Guiral M, 2001, J BIOL CHEM, V276, P2961, DOI 10.1074/jbc.M004948200; Guo Y, 2003, BLOOD, V102, P2428, DOI 10.1182/blood-2003-02-0634; Hammoudeh DI, 2009, J AM CHEM SOC, V131, P7390, DOI 10.1021/ja900616b; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; HARVEY M, 1993, ONCOGENE, V8, P2457; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Jimenez RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009084; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Mannava S, 2008, CELL CYCLE, V7, P2392, DOI 10.4161/cc.6390; Marfil V, 2010, J BIOL CHEM, V285, P5726, DOI 10.1074/jbc.M109.046649; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Minami T, 2004, J BIOL CHEM, V279, P20626, DOI 10.1074/jbc.M308730200; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Morrish F, 2009, ONCOGENE, V28, P2485, DOI 10.1038/onc.2009.112; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Newman CS, 1997, MECH DEVELOP, V66, P83, DOI 10.1016/S0925-4773(97)00092-0; Ni M, 2013, GENE DEV, V27, P734, DOI 10.1101/gad.209569.112; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5793, DOI 10.1128/MCB.22.16.5793-5800.2002; Noy P, 2010, MOL CELL BIOL, V30, P2120, DOI 10.1128/MCB.01511-09; Obinata A, 2002, DEV GROWTH DIFFER, V44, P281; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Paz H, 2010, BLOOD, V116, P1254, DOI 10.1182/blood-2009-11-254383; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Perna D, 2012, ONCOGENE, V31, P1695, DOI 10.1038/onc.2011.359; PROUTY SM, 1993, ONCOGENE, V8, P899; Puppin C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-192; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Seol Dongrim, 2011, BMC Res Notes, V4, P162, DOI 10.1186/1756-0500-4-162; Serrano F, 2013, STEM CELLS, V31, P71, DOI 10.1002/stem.1272; SHICHIRI M, 1993, CELL GROWTH DIFFER, V4, P93; Shiio Y, 2002, EMBO J, V21, P5088, DOI 10.1093/emboj/cdf525; Sims RJ, 2003, BIOTECHNIQUES, V34, P938, DOI 10.2144/03345bm07; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Swingler TE, 2004, J BIOL CHEM, V279, P34938, DOI 10.1074/jbc.M404488200; Topisirovic I, 2003, MOL CELL BIOL, V23, P8992, DOI 10.1128/MCB.23.24.8992-9002.2003; Topisirovic I, 2003, EMBO J, V22, P689, DOI 10.1093/emboj/cdg069; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; Wang H, 2008, ONCOGENE, V27, P1905, DOI 10.1038/sj.onc.1210823; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xu CR, 2011, SCIENCE, V332, P963, DOI 10.1126/science.1202845; Zanet J, 2005, J CELL SCI, V118, P1693, DOI 10.1242/jcs.02298; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	67	18	18	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 4	2015	34	23					3011	3022		10.1038/onc.2014.240	http://dx.doi.org/10.1038/onc.2014.240			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK3EX	25220416				2022-12-25	WOS:000356100500007
J	Basu, S; Sladecek, S; Pemble, H; Wittmann, T; Slotman, JA; van Cappellen, W; Brenner, HR; Galjart, N				Basu, Sreya; Sladecek, Stefan; Pemble, Hayley; Wittmann, Torsten; Slotman, Johan A.; van Cappellen, Wiggert; Brenner, Hans-Rudolf; Galjart, Niels			Acetylcholine Receptor (AChR) Clustering Is Regulated Both by Glycogen Synthase Kinase 3 beta (GSK3 beta)-dependent Phosphorylation and the Level of CLIP-associated Protein 2 (CLASP2) Mediating the Capture of Microtubule Plus-ends	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROMUSCULAR-JUNCTION; INNERVATED MUSCLE; CELL CORTEX; AGRIN; EB1; DYNAMICS; ACTIN; EXPRESSION; GSK3-BETA; APPARATUS	The postsynaptic apparatus of the neuromuscular junction (NMJ) traps and anchors acetylcholine receptors (AChRs) at high density at the synapse. We have previously shown that microtubule (MT) capture by CLASP2, a MT plus-end-tracking protein (+TIP), increases the size and receptor density of AChR clusters at the NMJ through the delivery of AChRs and that this is regulated by a pathway involving neuronal agrin and several postsynaptic kinases, including GSK3. Phosphorylation by GSK3 has been shown to cause CLASP2 dissociation from MT ends, and nine potential phosphorylation sites for GSK3 have been mapped on CLASP2. How CLASP2 phosphorylation regulates MT capture at the NMJ and how this controls the size of AChR clusters are not yet understood. To examine this, we used myotubes cultured on agrin patches that induce AChR clustering in a two-dimensional manner. We show that expression of a CLASP2 mutant, in which the nine GSK3 target serines are mutated to alanine (CLASP2-9XS/9XA) and are resistant to GSK3 beta-dependent phosphorylation, promotes MT capture at clusters and increases AChR cluster size, compared with myotubes that express similar levels of wild type CLASP2 or that are noninfected. Conversely, myotubes expressing a phosphomimetic form of CLASP2 (CLASP2-8XS/D) show enrichment of immobile mutant CLASP2 in clusters, but MT capture and AChR cluster size are reduced. Taken together, our data suggest that both GSK3 beta-dependent phosphorylation and the level of CLASP2 play a role in the maintenance of AChR cluster size through the regulated capture and release of MT plus-ends.	[Basu, Sreya; Sladecek, Stefan; Brenner, Hans-Rudolf] Univ Basel, Inst Physiol, Dept Biomed, CH-4056 Basel, Switzerland; [Basu, Sreya; Galjart, Niels] Erasmus MC, Dept Cell Biol, NL-3015 GE Rotterdam, Netherlands; [Pemble, Hayley; Wittmann, Torsten] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Slotman, Johan A.; van Cappellen, Wiggert] Erasmus MC, Opt Imaging Ctr, NL-3015 GE Rotterdam, Netherlands	University of Basel; Erasmus University Rotterdam; Erasmus MC; University of California System; University of California San Francisco; Erasmus University Rotterdam; Erasmus MC	Brenner, HR (corresponding author), Inst Physiol, Dept Biomed, Klingelbergstr 50, CH-4056 Basel, Switzerland.	Hans-Rudolf.Brenner@unibas.ch; n.galjart@erasmusmc.nl	Galjart, Niels/D-1146-2010; Wittmann, Torsten/F-9833-2013	Galjart, Niels/0000-0003-1964-3607; Wittmann, Torsten/0000-0001-9134-691X; Slotman, Johan A./0000-0001-9705-9620	Swiss National Science Foundation; Swiss Foundation for Research on Muscle Diseases; Netherlands Organization for Scientific Research CW [70059011]; ZonMW Grant [91208002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079139] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Foundation for Research on Muscle Diseases; Netherlands Organization for Scientific Research CW; ZonMW Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Swiss National Science Foundation, The Swiss Foundation for Research on Muscle Diseases, the Netherlands Organization for Scientific Research CW Grant 70059011, and ZonMW Grant 91208002 (to N. G.).	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Al-Bassam J, 2011, TRENDS CELL BIOL, V21, P604, DOI 10.1016/j.tcb.2011.06.007; Blanco-Bose WE, 2001, EXP CELL RES, V265, P212, DOI 10.1006/excr.2001.5191; Chen YW, 2014, J NEUROSCI, V34, P2413, DOI 10.1523/JNEUROSCI.3226-13.2014; Cohen I, 1997, MOL CELL NEUROSCI, V9, P237, DOI 10.1006/mcne.1997.0623; Dai ZS, 2000, J CELL BIOL, V150, P1321, DOI 10.1083/jcb.150.6.1321; Drabek K, 2006, CURR BIOL, V16, P2259, DOI 10.1016/j.cub.2006.09.065; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Geng L, 2008, CHEM-BIOL INTERACT, V175, P108, DOI 10.1016/j.cbi.2008.04.017; HALL ZW, 1981, J CELL BIOL, V90, P789, DOI 10.1083/jcb.90.3.789; Jones G, 1997, P NATL ACAD SCI USA, V94, P2654, DOI 10.1073/pnas.94.6.2654; Jones G, 1996, P NATL ACAD SCI USA, V93, P5985, DOI 10.1073/pnas.93.12.5985; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kishi M, 2005, J CELL BIOL, V169, P355, DOI 10.1083/jcb.200411012; Kumar P, 2012, J BIOL CHEM, V287, P17050, DOI 10.1074/jbc.M111.316661; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Lin S, 2008, J NEUROSCI, V28, P3333, DOI 10.1523/JNEUROSCI.5590-07.2008; Maurer SP, 2014, CURR BIOL, V24, P372, DOI 10.1016/j.cub.2013.12.042; McMahan Uel J., 1992, Current Opinion in Cell Biology, V4, P869, DOI 10.1016/0955-0674(92)90113-Q; Meier T, 1997, J NEUROSCI, V17, P6534; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Patel K, 2012, CYTOSKELETON, V69, P155, DOI 10.1002/cm.21005; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt N, 2012, J CELL BIOL, V198, P421, DOI 10.1083/jcb.201111130; Schmidt N, 2011, J CELL BIOL, V195, P1171, DOI 10.1083/jcb.201107083; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Sugiyama JE, 1997, J CELL BIOL, V139, P181, DOI 10.1083/jcb.139.1.181; Watanabe T, 2009, J CELL SCI, V122, P2969, DOI 10.1242/jcs.046649; Wittmann T, 2005, J CELL BIOL, V169, P929, DOI 10.1083/jcb.200412114; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006	33	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30857	30867		10.1074/jbc.M114.589457	http://dx.doi.org/10.1074/jbc.M114.589457			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25231989	hybrid, Green Published			2022-12-25	WOS:000344549700059
J	Fristedt, R; Williams-Carrier, R; Merchant, SS; Barkan, A				Fristedt, Rikard; Williams-Carrier, Rosalind; Merchant, Sabeeha S.; Barkan, Alice			A Thylakoid Membrane Protein Harboring a DnaJ-type Zinc Finger Domain Is Required for Photosystem I Accumulation in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA CHLOROPLASTS; ALGA CHLAMYDOMONAS-REINHARDTII; CYTOCHROME B(6)F COMPLEX; BIOGENESIS FACTOR CYO1; PSI-G SUBUNIT; DISULFIDE-ISOMERASE; MOLECULAR CHAPERONE; MAIZE; BINDING; GENE	Photosystem I ( PSI) is a large pigment-protein complex and one of the two photosystems that drive electron transfer in oxygenic photosynthesis. We identified a nuclear gene required specifically for the accumulation of PSI in a forward genetic analysis of chloroplast biogenesis in maize. This gene, designated psa2, belongs to the "GreenCut" gene set, a group of genes found in green algae and plants but not in non-photosynthetic organisms. Disruption of the psa2 ortholog in Arabidopsis likewise resulted in the specific loss of PSI proteins. PSA2 harbors a conserved domain found in DnaJ chaperones where it has been shown to form a zinc finger and to have protein-disulfide isomerase activity. Accordingly, PSA2 exhibited protein-disulfide reductase activity in vitro. PSA2 localized to the thylakoid lumen and was found in a similar to 250-kDa complex harboring the peripheral PSI protein PsaG but lacking several core PSI subunits. PSA2 mRNA is coexpressed with mRNAs encoding various proteins involved in the biogenesis of the photosynthetic apparatus with peak expression preceding that of genes encoding structural components. PSA2 protein abundance was not decreased in the absence of PSI but was reduced in the absence of the PSI assembly factor Ycf3. These findings suggest that a complex harboring PSA2 and PsaG mediates thiol transactions in the thylakoid lumen that are important for the assembly of PSI.	[Fristedt, Rikard; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Fristedt, Rikard; Merchant, Sabeeha S.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Barkan, Alice] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Oregon	Barkan, A (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	abarkan@uoregon.edu			United States Department of Energy [DE-FC02-02ER63421]; National Science Foundation [IOS-0922560]; WennerGren Foundation; Direct For Biological Sciences [0922560] Funding Source: National Science Foundation	United States Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); WennerGren Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by United States Department of Energy Cooperative Agreement DE-FC02-02ER63421 (to David Eisenberg at UCLA), National Science Foundation Grant IOS-0922560 (to A. B.), and a postdoctoral fellowship from the WennerGren Foundation (to R. F.).	Albus CA, 2010, PLANT CELL, V22, P2838, DOI 10.1105/tpc.110.073908; Amann K, 2004, PLANT CELL, V16, P3084, DOI 10.1105/tpc.104.024935; Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; Amunts A, 2010, J BIOL CHEM, V285, P3478, DOI 10.1074/jbc.M109.072645; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Banecki B, 1996, J BIOL CHEM, V271, P14840, DOI 10.1074/jbc.271.25.14840; BARKAN A, 1994, EMBO J, V13, P3170, DOI 10.1002/j.1460-2075.1994.tb06616.x; Boudreau E, 1997, EMBO J, V16, P6095, DOI 10.1093/emboj/16.20.6095; Brutnell TP, 1999, PLANT CELL, V11, P849, DOI 10.1105/tpc.11.5.849; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Cai WH, 2010, PLANT PHYSIOL, V154, P109, DOI 10.1104/pp.110.159558; Celedon JM, 2013, BBA-MOL CELL RES, V1833, P341, DOI 10.1016/j.bbamcr.2012.06.028; Chi W, 2012, PHILOS T R SOC B, V367, P3420, DOI 10.1098/rstb.2012.0065; Dall'Osto L, 2013, PLANT CELL, V25, P591, DOI 10.1105/tpc.112.108621; DECROUYCHANEL A, 1995, J BIOL CHEM, V270, P22669, DOI 10.1074/jbc.270.39.22669; Feiz L., 2014, PLANT J IN PRESS; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; Fristedt R, 2014, PLANT PHYSIOL, V164, P201, DOI 10.1104/pp.113.228338; Fristedt R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024565; Fristedt R, 2009, PLANT CELL, V21, P3950, DOI 10.1105/tpc.109.069435; Fromme P, 2003, FEBS LETT, V555, P40, DOI 10.1016/S0014-5793(03)01124-4; Grossman AR, 2010, PHOTOSYNTH RES, V106, P3, DOI 10.1007/s11120-010-9555-7; Jarvi S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00434; Jarvi S, 2011, BIOCHEM J, V439, P207, DOI 10.1042/BJ20102155; Jensen PE, 2002, J BIOL CHEM, V277, P2798, DOI 10.1074/jbc.M110448200; Joliot P, 2005, P NATL ACAD SCI USA, V102, P4913, DOI 10.1073/pnas.0501268102; Kargul J, 2003, J BIOL CHEM, V278, P16135, DOI 10.1074/jbc.M300262200; Karpowicz SJ, 2011, J BIOL CHEM, V286, P21427, DOI 10.1074/jbc.M111.233734; Krech K, 2012, PLANT PHYSIOL, V159, P579, DOI 10.1104/pp.112.196642; Lezhneva L, 2004, PLANT J, V37, P174, DOI 10.1046/j.1365-313X.2003.01952.x; Lezhneva L, 2008, J BIOL CHEM, V283, P24608, DOI 10.1074/jbc.M803869200; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Liu J, 2012, PLANT CELL, V24, P4992, DOI 10.1105/tpc.112.106542; Lu Y, 2011, PLANT CELL, V23, P1861, DOI 10.1105/tpc.111.085456; LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114; Maple J, 2004, CURR BIOL, V14, P776, DOI 10.1016/j.cub.2004.04.031; Meurer J, 1998, EMBO J, V17, P5286, DOI 10.1093/emboj/17.18.5286; Muranaka A, 2012, J PLANT PHYSIOL, V169, P1212, DOI 10.1016/j.jplph.2012.04.001; Naver H, 2001, PLANT CELL, V13, P2731, DOI 10.1105/tpc.010253; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Ozawa S, 2010, J BIOL CHEM, V285, P20072, DOI 10.1074/jbc.M109.098954; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Plucken H, 2002, FEBS LETT, V532, P85, DOI 10.1016/S0014-5793(02)03634-7; Roose JL, 2014, J BIOL CHEM, V289, P23776, DOI 10.1074/jbc.M114.589085; Rosgaard L, 2005, FEBS J, V272, P4002, DOI 10.1111/j.1742-4658.2005.04824.x; Ruf S, 1997, J CELL BIOL, V139, P95, DOI 10.1083/jcb.139.1.95; Schottler MA, 2011, J PLANT PHYSIOL, V168, P1452, DOI 10.1016/j.jplph.2010.12.009; Schwenkert S, 2010, BIOCHEM J, V425, P207, DOI 10.1042/BJ20091290; SELMANREIMER S, 1981, BIOCHEMISTRY-US, V20, P5476, DOI 10.1021/bi00522a020; Shimada H, 2007, PLANT CELL, V19, P3157, DOI 10.1105/tpc.107.051714; Stern DB, 2004, TRENDS PLANT SCI, V9, P293, DOI 10.1016/j.tplants.2004.04.001; Stockel J, 2006, PLANT PHYSIOL, V141, P870, DOI 10.1104/pp.106.078147; Szabo A, 1996, EMBO J, V15, P408, DOI 10.1002/j.1460-2075.1996.tb00371.x; Tanz SK, 2012, PLANT J, V69, P743, DOI 10.1111/j.1365-313X.2011.04833.x; Tomizioli M, 2014, MOL CELL PROTEOMICS, V13, P2147, DOI 10.1074/mcp.M114.040923; Varotto C, 2002, PLANT PHYSIOL, V129, P616, DOI 10.1104/pp.002089; Voelker R, 1995, MOL GEN GENET, V249, P507, DOI 10.1007/BF00290576; VOELKER R, 1995, EMBO J, V14, P3905, DOI 10.1002/j.1460-2075.1995.tb00062.x; Watkins KP, 2011, PLANT CELL, V23, P1082, DOI 10.1105/tpc.111.084335; Williams-Carrier R, 2010, PLANT J, V63, P167, DOI 10.1111/j.1365-313X.2010.04231.x; Yabe T, 2004, PLANT CELL, V16, P993, DOI 10.1105/tpc.020511; Zoschke R, 2013, PLANT CELL, V25, P2265, DOI 10.1105/tpc.113.111567; Zygadlo A, 2006, J BIOL CHEM, V281, P10548, DOI 10.1074/jbc.M512687200; Zygadlo A, 2005, BBA-BIOENERGETICS, V1708, P154, DOI 10.1016/j.bbabio.2005.02.003	65	41	44	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30657	30667		10.1074/jbc.M114.587758	http://dx.doi.org/10.1074/jbc.M114.587758			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25228689	hybrid, Green Published			2022-12-25	WOS:000344549700042
J	Lees, H; Swann, J; Poucher, SM; Nicholson, JK; Holmes, E; Wilson, ID; Marchesi, JR				Lees, Hannah; Swann, Jonathan; Poucher, Simon M.; Nicholson, Jeremy K.; Holmes, Elaine; Wilson, Ian D.; Marchesi, Julian R.			Age and Microenvironment Outweigh Genetic Influence on the Zucker Rat Microbiome	PLOS ONE			English	Article							HUMAN INTESTINAL MICROBIOTA; GUT MICROBIOTA; ENERGY-BALANCE; OBESE; DIET; MICE; ASSOCIATIONS; RELEVANT; CAPACITY; TIME	Animal models are invaluable tools which allow us to investigate the microbiome-host dialogue. However, experimental design introduces biases in the data that we collect, also potentially leading to biased conclusions. With obesity at pandemic levels animal models of this disease have been developed; we investigated the role of experimental design on one such rodent model. We used 454 pyrosequencing to profile the faecal bacteria of obese (n = 6) and lean (homozygous n = 6; heterozygous n = 6) Zucker rats over a 10 week period, maintained in mixed-genotype cages, to further understand the relationships between the composition of the intestinal bacteria and age, obesity progression, genetic background and cage environment. Phylogenetic and taxon-based univariate and multivariate analyses (non-metric multidimensional scaling, principal component analysis) showed that age was the most significant source of variation in the composition of the faecal microbiota. Second to this, cage environment was found to clearly impact the composition of the faecal microbiota, with samples from animals from within the same cage showing high community structure concordance, but large differences seen between cages. Importantly, the genetically induced obese phenotype was not found to impact the faecal bacterial profiles. These findings demonstrate that the age and local environmental cage variables were driving the composition of the faecal bacteria and were more deterministically important than the host genotype. These findings have major implications for understanding the significance of functional metagenomic data in experimental studies and beg the question; what is being measured in animal experiments in which different strains are housed separately, nature or nurture?	[Lees, Hannah; Nicholson, Jeremy K.; Holmes, Elaine; Wilson, Ian D.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, Sect Computat & Syst Med, London, England; [Swann, Jonathan] Univ Reading, Sch Chem Food & Pharm, Dept Food & Nutr Sci, Reading, Berks, England; [Poucher, Simon M.] AstraZeneca, Cardiovasc & Gastrointestinal Disorders Innovat M, Alderley Pk, Cheshire, England; [Marchesi, Julian R.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Marchesi, Julian R.] Univ London Imperial Coll Sci Technol & Med, Ctr Digest & Gut Hlth, London, England	Imperial College London; University of Reading; AstraZeneca; Cardiff University; Imperial College London	Marchesi, JR (corresponding author), Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales.	MarchesiJR@cardiff.ac.uk	Marchesi, Julian/AAC-9021-2020; Marchesi, Julian/D-3731-2009; Nicholson, Jeremy K/B-3395-2012; Holmes, Elaine/ABE-6606-2020; Wilson, Ian David/ABG-4451-2021; Holmes, Elaine/A-2189-2015; Wilson, Ian/Z-3019-2019	Marchesi, Julian/0000-0002-7994-5239; Nicholson, Jeremy K/0000-0002-8123-8349; Holmes, Elaine/0000-0002-0556-8389; Wilson, Ian/0000-0002-8558-7394; Swann, Jonathan/0000-0002-6485-4529	AstraZeneca	AstraZeneca(AstraZeneca)	The authors have read the journal's policy and have the following conflicts: SMP and IDW were employees of AstraZeneca, the funder of this study, at the time of this study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alexander AD, 2006, MAMM GENOME, V17, P1093, DOI 10.1007/s00335-006-0063-1; AlonsoGalicia M, 1996, HYPERTENSION, V28, P1047, DOI 10.1161/01.HYP.28.6.1047; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; BARNES RH, 1957, J NUTR, V63, P489; BARRY WS, 1969, METABOLIS, V18, P833, DOI 10.1016/0026-0495(69)90058-4; BECKER EE, 1977, PHYSIOL BEHAV, V18, P685, DOI 10.1016/0031-9384(77)90067-1; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Campbell JH, 2012, ISME J, V6, P2033, DOI 10.1038/ismej.2012.54; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Chen HM, 2013, AM J CLIN NUTR, V97, P1044, DOI 10.3945/ajcn.112.046607; Claus SP, 2011, MBIO, V2, DOI 10.1128/mBio.00271-10; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dimitriu PA, 2013, ENV MICROBIOL REP, V5, P200, DOI 10.1111/j.1758-2229.2012.00393.x; Duca FA, 2014, DIABETES, V63, P1624, DOI 10.2337/db13-1526; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Geurts L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00149; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; HARRIS RBS, 1988, J NUTR, V118, P503, DOI 10.1093/jn/118.4.503; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hopkins MJ, 2002, DIGEST LIVER DIS, V34, pS12, DOI 10.1016/S1590-8658(02)80157-8; Hufeldt MR, 2010, COMPARATIVE MED, V60, P336; JENKINS TC, 1978, J NUTR, V108, P124, DOI 10.1093/jn/108.1.124; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li JV, 2011, GUT, V60, P1214, DOI 10.1136/gut.2010.234708; Lindborg KA, 2011, CARDIORENAL MED, V1, P31, DOI 10.1159/000322826; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Makivuokko H, 2010, BRIT J NUTR, V103, P227, DOI 10.1017/S0007114509991553; Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Maukonen J, 2012, FEMS MICROBIOL ECOL, V79, P697, DOI 10.1111/j.1574-6941.2011.01257.x; McCafferty J, 2013, ISME J, V7, P2116, DOI 10.1038/ismej.2013.106; McKnite AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039191; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Nelson TA, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01637.x; O'Toole PW, 2010, INT DAIRY J, V20, P281, DOI 10.1016/j.idairyj.2009.11.010; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Swann JR, 2011, J PROTEOME RES, V10, P3590, DOI 10.1021/pr200243t; Team RDC, 2019, R LANG ENV STAT COMP; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Turroni F, 2009, ISME J, V3, P745, DOI 10.1038/ismej.2009.19; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; VASSELLI JR, 1980, PHYSIOL BEHAV, V25, P565, DOI 10.1016/0031-9384(80)90123-7; Waldram A, 2009, J PROTEOME RES, V8, P2361, DOI 10.1021/pr8009885; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wold S., 1993, 3D QSAR DRUG DESIGN; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112; Zhu QC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090849; ZUCKER TF, 1962, P SOC EXP BIOL MED, V110, P165, DOI 10.3181/00379727-110-27455	60	31	33	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e100916	10.1371/journal.pone.0100916	http://dx.doi.org/10.1371/journal.pone.0100916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232735	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000342921200001
J	Modica, L; Iotti, G; D'Avola, A; Blasi, F				Modica, Livia; Iotti, Giorgio; D'Avola, Annalisa; Blasi, Francesco			Prep1 (pKnox1) Regulates Mouse Embryonic HSC Cycling and Self-Renewal Affecting the Stat1-Sca1 IFN-Dependent Pathway	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; DEFINITIVE HEMATOPOIESIS; PROGENITOR CELLS; FETAL; PURIFICATION; MAINTENANCE; RECEPTOR; LIVER; PBX1; QUIESCENCE	A hypomorphic Prep1 mutation results in embryonic lethality at late gestation with a pleiotropic embryonic phenotype that includes defects in all hematopoietic lineages. Reduced functionality of the hematopoietic stem cells (HSCs) compartment might be responsible for the hematopoietic phenotype observed at mid-gestation. In this paper we demonstrate that Prep1 regulates the number of HSCs in fetal livers (FLs), their clonogenic potential and their ability to de novo generate the hematopoietic system in ablated hosts. Furthermore, we show that Prep1 controls the self-renewal ability of the FL HSC compartment as demonstrated by serial transplantation experiments. The premature exhaustion of Prep1 mutant HSCs correlates with the reduced quiescent stem cell pool thus suggesting that Prep1 regulates the self-renewal ability by controlling the quiescence/proliferation balance. Finally, we show that in FL HSCs Prep1 absence induces the interferon signaling pathway leading to premature cycling and exhaustion of fetal HSCs.	[Modica, Livia; Iotti, Giorgio; D'Avola, Annalisa; Blasi, Francesco] IFOM, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology	Blasi, F (corresponding author), IFOM, Milan, Italy.	francesco.blasi@ifom.eu		Blasi, Francesco/0000-0001-9406-1784	AIRC (Associazione Italiana Ricerche sul Cancro) [8929, 12829]	AIRC (Associazione Italiana Ricerche sul Cancro)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the AIRC (Associazione Italiana Ricerche sul Cancro) (http://www.airc.it), grants 8929 and 12829. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Ariki R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087646; Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; Brzostek-Racine S, 2011, J IMMUNOL, V187, P5336, DOI 10.4049/jimmunol.1100040; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Deflorian G, 2004, DEVELOPMENT, V131, P613, DOI 10.1242/dev.00948; Di Rosa P, 2007, DEV BIOL, V311, P324, DOI 10.1016/j.ydbio.2007.08.031; DiMartino JF, 2001, BLOOD, V98, P618, DOI 10.1182/blood.V98.3.618; Dingli D, 2010, WIRES SYST BIOL MED, V2, P235, DOI 10.1002/wsbm.56; Ema H, 2000, BLOOD, V95, P2284, DOI 10.1182/blood.V95.7.2284.007k14_2284_2288; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Fernandez-Diaz LC, 2010, DEVELOPMENT, V137, P3393, DOI 10.1242/dev.050567; Ferretti E, 2000, DEVELOPMENT, V127, P155; Ferretti E, 2006, MOL CELL BIOL, V26, P5650, DOI 10.1128/MCB.00313-06; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Ficara F, 2013, J CELL SCI, V126, P3181, DOI 10.1242/jcs.125435; Gereige LM, 2009, NAT GENET, V41, P1164, DOI 10.1038/ng1109-1164; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Hsu HC, 2000, BLOOD, V96, P3757, DOI 10.1182/blood.V96.12.3757.h8003757_3757_3762; Iotti G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048353; Iotti G, 2011, P NATL ACAD SCI USA, V108, pE314, DOI 10.1073/pnas.1105216108; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Leong KG, 2008, DIFFERENTIATION, V76, P699, DOI 10.1111/j.1432-0436.2008.00288.x; Longobardi E, 2014, DEV DYNAM, V243, P59, DOI 10.1002/dvdy.24016; Longobardi E, 2010, MOL ONCOL, V4, P126, DOI 10.1016/j.molonc.2010.01.001; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21; Nygren JM, 2006, J IMMUNOL, V177, P201, DOI 10.4049/jimmunol.177.1.201; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Penkov D, 2005, MOL CELL BIOL, V25, P10768, DOI 10.1128/MCB.25.24.10768-10781.2005; Penkov D, 2013, CELL REP, V3, P1321, DOI 10.1016/j.celrep.2013.03.029; Petrenko O, 1999, IMMUNITY, V10, P691, DOI 10.1016/S1074-7613(00)80068-0; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sinclair A, 1996, BLOOD, V87, P2750, DOI 10.1182/blood.V87.7.2750.bloodjournal8772750; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Ting SB, 2012, BLOOD, V119, P2510, DOI 10.1182/blood-2011-11-393272; TSAI S, 1994, GENE DEV, V8, P2831, DOI 10.1101/gad.8.23.2831; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	52	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107916	10.1371/journal.pone.0107916	http://dx.doi.org/10.1371/journal.pone.0107916			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233378	Green Published, Green Submitted, gold			2022-12-25	WOS:000342921200061
J	Wrede, KH; Johst, S; Dammann, P; Ozkan, N; Monninghoff, C; Kraemer, M; Maderwald, S; Ladd, ME; Sure, U; Umutlu, L; Schlamann, M				Wrede, Karsten H.; Johst, Soeren; Dammann, Philipp; Oezkan, Neriman; Moenninghoff, Christoph; Kraemer, Markus; Maderwald, Stefan; Ladd, Mark E.; Sure, Ulrich; Umutlu, Lale; Schlamann, Marc			Improved Cerebral Time-of-Flight Magnetic Resonance Angiography at 7 Tesla - Feasibility Study and Preliminary Results Using Optimized Venous Saturation Pulses	PLOS ONE			English	Article							DIGITAL-SUBTRACTION-ANGIOGRAPHY; MR-ANGIOGRAPHY; INTRACRANIAL ANEURYSMS; LENTICULOSTRIATE ARTERIES; INITIAL-EXPERIENCE; FOLLOW-UP; CONTRAST; BRAIN; 1.5T; PRESATURATION	Purpose: Conventional saturation pulses cannot be used for 7 Tesla ultra-high-resolution time-of-flight magnetic resonance angiography (TOF MRA) due to specific absorption rate (SAR) limitations. We overcome these limitations by utilizing low flip angle, variable rate selective excitation (VERSE) algorithm saturation pulses. Material and Methods: Twenty-five neurosurgical patients (male n = 8, female n = 17; average age 49.64 years; range 26-70 years) with different intracranial vascular pathologies were enrolled in this trial. All patients were examined with a 7 Tesla (Magnetom 7 T, Siemens) whole body scanner system utilizing a dedicated 32-channel head coil. For venous saturation pulses a 35 degrees flip angle was applied. Two neuroradiologists evaluated the delineation of arterial vessels in the Circle of Willis, delineation of vascular pathologies, presence of artifacts, vessel-tissue contrast and overall image quality of TOF MRA scans in consensus on a five-point scale. Normalized signal intensities in the confluence of venous sinuses, M1 segment of left middle cerebral artery and adjacent gray matter were measured and vessel-tissue contrasts were calculated. Results: Ratings for the majority of patients ranged between good and excellent for most of the evaluated features. Venous saturation was sufficient for all cases with minor artifacts in arteriovenous malformations and arteriovenous fistulas. Quantitative signal intensity measurements showed high vessel-tissue contrast for confluence of venous sinuses, M1 segment of left middle cerebral artery and adjacent gray matter. Conclusion: The use of novel low flip angle VERSE algorithm pulses for saturation of venous vessels can overcome SAR limitations in 7 Tesla ultra-high-resolution TOF MRA. Our protocol is suitable for clinical application with excellent image quality for delineation of various intracranial vascular pathologies.	[Wrede, Karsten H.; Johst, Soeren; Dammann, Philipp; Maderwald, Stefan; Ladd, Mark E.; Umutlu, Lale] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Wrede, Karsten H.; Dammann, Philipp; Oezkan, Neriman; Sure, Ulrich] Univ Hosp Essen, Dept Neurosurg, Essen, Germany; [Johst, Soeren; Moenninghoff, Christoph; Maderwald, Stefan; Ladd, Mark E.; Umutlu, Lale; Schlamann, Marc] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Kraemer, Markus] Alfried Krupp von Bohlen & Halbach Hosp, Dept Neurol, Essen, Germany; [Ladd, Mark E.] German Canc Res Ctr, Div Med Phys Radiol E020, Heidelberg, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ)	Wrede, KH (corresponding author), Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany.	karsten.wrede@uk-essen.de	Kraemer, Markus/O-7790-2017; Maderwald, Stefan/B-4241-2011; Wrede, Karsten/AAZ-2154-2020	Kraemer, Markus/0000-0002-5667-3621; Wrede, Karsten/0000-0001-7076-3503; Ladd, Mark/0000-0002-4128-9440	IFORES grant from the University Duisburg-Essen	IFORES grant from the University Duisburg-Essen	An IFORES grant to KHW from the University Duisburg-Essen supported the research [http://www.uni-due.de/med/forschung/forschungsfoerderung/ifores.shtml]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brugieres P, 1998, NEURORADIOLOGY, V40, P96, DOI 10.1007/s002340050547; BRUGIERES P, 1993, J NEURORADIOLOGY, V20, P239; Cho ZH, 2008, STROKE, V39, P1604, DOI 10.1161/STROKEAHA.107.508002; Chung TS, 1999, AM J NEURORADIOL, V20, P229; COGNARD C, 1995, RADIOLOGY, V194, P671, DOI 10.1148/radiology.194.3.7862961; Conijn MMA, 2009, EUR RADIOL, V19, P2986, DOI 10.1007/s00330-009-1485-4; CONOLLY S, 1988, J MAGN RESON, V78, P440, DOI 10.1016/0022-2364(88)90131-X; FELMLEE JP, 1987, RADIOLOGY, V164, P559, DOI 10.1148/radiology.164.2.3602402; Fujii Yukihiko, 2010, No Shinkei Geka, V38, P107; Gaa J, 2004, ACTA RADIOL, V45, P327, DOI 10.1080/02841850410004229; Gibbs GF, 2005, J MAGN RESON IMAGING, V21, P97, DOI 10.1002/jmri.20247; Hendrikse J, 2008, CEREBROVASC DIS, V26, P624, DOI 10.1159/000166838; Heverhagen JT, 2008, INVEST RADIOL, V43, P568, DOI 10.1097/RLI.0b013e31817e9b2c; Johst S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086274; Johst S, 2012, INVEST RADIOL, V47, P445, DOI 10.1097/RLI.0b013e31824ef21f; Kang CK, 2008, MAGN RESON MED, V60, P330, DOI 10.1002/mrm.21472; Kang CK, 2009, MAGN RESON MED, V61, P136, DOI 10.1002/mrm.21786; KELLER PJ, 1989, RADIOLOGY, V173, P527, DOI 10.1148/radiology.173.2.2798885; King KF, 2004, HDB MRI PULSE SEQUEN, P148; Kollia K, 2009, AM J NEURORADIOL, V30, P699, DOI 10.3174/ajnr.A1434; Kraff O, 2013, MED PHYS, V40, DOI 10.1118/1.4795347; Ladd Mark E, 2007, Top Magn Reson Imaging, V18, P139, DOI 10.1097/RMR.0b013e3180f612b3; Loizou C., 2012, J BIOMEDICAL GRAPHIC, V3; Majoie CBLM, 2005, AM J NEURORADIOL, V26, P1349; Martin-Vaquero P, 2011, AM J VET RES, V72, P350, DOI 10.2460/ajvr.72.3.350; Monninghoff C, 2009, ROFO-FORTSCHR RONTG, V181, P16, DOI 10.1055/s-2008-1027863; Noureddine Y, 2013, ISMRM 21 ANN M EXH 2, P4416; Noureddine Y, 2012, P INT SOC MAG RESON, V20, P2767; Nowinski WL, 2013, J NEUROIMAGING, V23, P86, DOI 10.1111/j.1552-6569.2011.00597.x; Papke K, 2006, EUR RADIOL, V16, P2051, DOI 10.1007/s00330-005-0092-2; Schar M, 2004, MAGN RESON MED, V51, P799, DOI 10.1002/mrm.20024; Schmitter S, 2012, MAGN RESON MED, V68, P188, DOI 10.1002/mrm.23226; SPETZLER RF, 1986, J NEUROSURG, V65, P476, DOI 10.3171/jns.1986.65.4.0476; TKACH JA, 1993, JMRI-J MAGN RESON IM, V3, P811, DOI 10.1002/jmri.1880030603; von Morze C, 2007, J MAGN RESON IMAGING, V26, P900, DOI 10.1002/jmri.21097; Willinek WA, 2003, RADIOLOGY, V229, P913, DOI 10.1148/radiol.2293020782; Wrede KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084562; Zwanenburg JJM, 2008, J MAGN RESON IMAGING, V28, P1519, DOI 10.1002/jmri.21591	38	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e106697	10.1371/journal.pone.0106697	http://dx.doi.org/10.1371/journal.pone.0106697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232868	Green Published, gold, Green Submitted			2022-12-25	WOS:000342921200009
J	Hong, H; Jung, J; Park, W				Hong, Hyerim; Jung, Jaejoon; Park, Woojun			Plasmid-Encoded Tetracycline Efflux Pump Protein Alters Bacterial Stress Responses and Ecological Fitness of Acinetobacter oleivorans	PLOS ONE			English	Article							WATER TREATMENT PLANTS; SP STRAIN DR1; ANTIBIOTIC-RESISTANCE PLASMIDS; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; PASTEURELLA-MULTOCIDA; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; BIOLOGICAL COST	Acquisition of the extracellular tetracycline (TC) resistance plasmid pAST2 affected host gene expression and phenotype in the oil-degrading soil bacterium, Acinetobacter oleivorans DR1. Whole-transcriptome profiling of DR1 cells harboring pAST2 revealed that all the plasmid genes were highly expressed under TC conditions, and the expression levels of many host chromosomal genes were modulated by the presence of pAST2. The host energy burden imposed by replication of pAST2 led to (i) lowered ATP concentrations, (ii) downregulated expression of many genes involved in cellular growth, and (iii) reduced growth rate. Interestingly, some phenotypes were restored by deleting the plasmid-encoded efflux pump gene tetH, suggesting that the membrane integrity changes resulting from the incorporation of efflux pump proteins also resulted in altered host response under the tested conditions. Alteration of membrane integrity by tetH deletion was shown by measuring permeability of fluorescent probe and membrane hydrophobicity. The presence of the plasmid conferred peroxide and superoxide resistance to cells, but only peroxide resistance was diminished by tetH gene deletion, suggesting that the plasmid-encoded membrane-bound efflux pump protein provided peroxide resistance. The downregulation of fimbriae-related genes presumably led to reduced swimming motility, but this phenotype was recovered by tetH gene deletion. Our data suggest that not only the plasmid replication burden, but also its encoded efflux pump protein altered host chromosomal gene expression and phenotype, which also alters the ecological fitness of the host in the environment.	[Hong, Hyerim; Jung, Jaejoon; Park, Woojun] Korea Univ, Dept Environm Sci & Ecol Engn, Seoul, South Korea	Korea University	Park, W (corresponding author), Korea Univ, Dept Environm Sci & Ecol Engn, Seoul, South Korea.	wpark@korea.ac.kr		Hong, Hye-Rim/0000-0002-8339-3190	Mid-career Researcher Program through an NRF grant - Ministry of Science, ICT & Future Planning (MSIP) [2014R1A2A2A05007010]	Mid-career Researcher Program through an NRF grant - Ministry of Science, ICT & Future Planning (MSIP)	This work was supported by the Mid-career Researcher Program through an NRF grant (2014R1A2A2A05007010) funded by the Ministry of Science, ICT & Future Planning (MSIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi F, 2013, SCI TOTAL ENVIRON, V444, P508, DOI 10.1016/j.scitotenv.2012.11.077; Andersson DI, 2006, CURR OPIN MICROBIOL, V9, P461, DOI 10.1016/j.mib.2006.07.002; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P1152, DOI 10.1073/pnas.96.3.1152; Bergstrom CT, 2000, GENETICS, V155, P1505; Blanco M, 2007, J ANTIMICROB CHEMOTH, V60, P864, DOI 10.1093/jac/dkm293; BOUMA JE, 1988, NATURE, V335, P351, DOI 10.1038/335351a0; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Cohen BE, 2014, ANTIMICROB AGENTS CH, V58, P640, DOI 10.1128/AAC.02095-13; Dahlberg C, 2003, GENETICS, V165, P1641; Davis MA, 2005, APPL ENVIRON MICROB, V71, P6816, DOI 10.1128/AEM.71.11.6816-6822.2005; DEPAOLA A, 1995, MOL CELL PROBE, V9, P311, DOI 10.1016/S0890-8508(95)91572-9; Deris JB, 2013, SCIENCE, V342, P1068, DOI 10.1126/science.1237435; Enne VI, 2001, LANCET, V357, P1325, DOI 10.1016/S0140-6736(00)04519-0; Glenn LM, 2013, MICROB DRUG RESIST, V19, P175, DOI 10.1089/mdr.2012.0177; HANSEN LM, 1993, ANTIMICROB AGENTS CH, V37, P2699, DOI 10.1128/AAC.37.12.2699; Hong H, 2014, MICROB ECOL, V67, P369, DOI 10.1007/s00248-013-0343-8; Jechalke S, 2013, FEMS MICROBIOL LETT, V348, P127, DOI 10.1111/1574-6968.12284; Jechalke S, 2013, APPL ENVIRON MICROB, V79, P1704, DOI 10.1128/AEM.03172-12; Jung J, 2011, APPL ENVIRON MICROB, V77, P7418, DOI 10.1128/AEM.05231-11; Jung J, 2010, J BACTERIOL, V192, P4794, DOI 10.1128/JB.00722-10; Kang YS, 2010, J APPL MICROBIOL, V109, P1650, DOI 10.1111/j.1365-2672.2010.04793.x; Kang YS, 2007, MICROBIOL-SGM, V153, P3246, DOI 10.1099/mic.0.2007/008896-0; Kang YS, 2011, J MICROBIOL, V49, P29, DOI 10.1007/s12275-011-0315-y; Kang YS, 2010, ENVIRON MICROBIOL, V12, P1304, DOI 10.1111/j.1462-2920.2010.02175.x; Kehrenberg C, 2001, J ANTIMICROB CHEMOTH, V48, P631, DOI 10.1093/jac/48.5.631; Korzeniewska E, 2013, J ENVIRON MANAGE, V128, P904, DOI 10.1016/j.jenvman.2013.06.051; Lamers RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060666; Lancashire JF, 2005, ANTIMICROB AGENTS CH, V49, P1927, DOI 10.1128/AAC.49.5.1927-1931.2005; LEE SW, 1985, GENE, V39, P173, DOI 10.1016/0378-1119(85)90311-7; Lenski R E, 1998, Int Microbiol, V1, P265; LOH B, 1984, ANTIMICROB AGENTS CH, V26, P546, DOI 10.1128/AAC.26.4.546; Maeng JH, 1996, J BACTERIOL, V178, P3695, DOI 10.1128/jb.178.13.3695-3700.1996; Manara A, 2012, J PROTEOME RES, V11, P4169, DOI 10.1021/pr300281f; MCDERMOTT PJ, 1993, LETT APPL MICROBIOL, V17, P139, DOI 10.1111/j.1472-765X.1993.tb01443.x; Miao XS, 2004, ENVIRON SCI TECHNOL, V38, P3533, DOI 10.1021/es030653q; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moura A, 2012, FEMS MICROBIOL LETT, V330, P157, DOI 10.1111/j.1574-6968.2012.02544.x; Moura A, 2010, RES MICROBIOL, V161, P58, DOI 10.1016/j.resmic.2009.11.004; NGUYEN TNM, 1989, MOL BIOL EVOL, V6, P213; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Park J, 2011, CURR MICROBIOL, V62, P249, DOI 10.1007/s00284-010-9698-y; Paytubi S, 2014, ENVIRON MICROBIOL, V16, P950, DOI 10.1111/1462-2920.12244; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Pitondo-Silva A, 2014, SCI TOTAL ENVIRON, V473, P155, DOI 10.1016/j.scitotenv.2013.12.021; Poole K, 2007, ANN MED, V39, P162, DOI 10.1080/07853890701195262; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Ratajczak A, 1998, APPL ENVIRON MICROB, V64, P1175; Schluter A, 2008, J BIOTECHNOL, V136, P65, DOI 10.1016/j.jbiotec.2008.03.017; Schluter A, 2007, FEMS MICROBIOL REV, V31, P449, DOI 10.1111/j.1574-6976.2007.00074.x; STEWART FM, 1977, GENETICS, V87, P209; Subbiah M, 2011, APPL ENVIRON MICROB, V77, P4486, DOI 10.1128/AEM.02788-10; Sundqvist M, 2010, J ANTIMICROB CHEMOTH, V65, P350, DOI 10.1093/jac/dkp387; Szczepanowski R, 2004, MICROBIOL-SGM, V150, P3613, DOI 10.1099/mic.0.27317-0; Szczepanowski R, 2008, J BIOTECHNOL, V136, P54, DOI 10.1016/j.jbiotec.2008.03.020; Throne-Holst M, 2006, APPL MICROBIOL BIOT, V72, P353, DOI 10.1007/s00253-005-0262-9; Valenzuela MS, 1996, BIOCHEM BIOPH RES CO, V219, P876, DOI 10.1006/bbrc.1996.0339; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076079; Ward A, 2001, J MOL MICROB BIOTECH, V3, P193; Ward H, 2009, J EVOLUTION BIOL, V22, P997, DOI 10.1111/j.1420-9101.2009.01712.x; Wibberg D, 2013, PLASMID, V69, P127, DOI 10.1016/j.plasmid.2012.11.001; Wu N, 2010, ENVIRON SCI TECHNOL, V44, P6933, DOI 10.1021/es1007802; Yi H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr617; Zhang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026041	66	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107716	10.1371/journal.pone.0107716	http://dx.doi.org/10.1371/journal.pone.0107716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229538	gold, Green Submitted, Green Published			2022-12-25	WOS:000342123900065
J	Yilmaz-Ozcan, S; Sade, A; Kucukkaraduman, B; Kaygusuz, Y; Senses, KM; Banerjee, S; Gure, AO				Yilmaz-Ozcan, Sinem; Sade, Asli; Kucukkaraduman, Baris; Kaygusuz, Yasemin; Senses, Kerem Mert; Banerjee, Sreeparna; Gure, Ali Osmay			Epigenetic Mechanisms Underlying the Dynamic Expression of Cancer-Testis Genes, PAGE2, -2B and SPANX-B, during Mesenchymal-to-Epithelial Transition	PLOS ONE			English	Article							DNA METHYLATION; IN-VITRO; CANCER/TESTIS ANTIGENS; MYELOMA CELLS; CACO-2; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; DIFFERENTIATION; DEMETHYLATION; FAMILY	Cancer-testis (CT) genes are expressed in various cancers but not in normal tissues other than in cells of the germline. Although DNA demethylation of promoter-proximal CpGs of CT genes is linked to their expression in cancer, the mechanisms leading to demethylation are unknown. To elucidate such mechanisms we chose to study the Caco-2 colorectal cancer cell line during the course of its spontaneous differentiation in vitro, as we found CT genes, in particular PAGE2, -2B and SPANX-B, to be up-regulated during this process. Differentiation of these cells resulted in a mesenchymal-to-epithelial transition (MET) as evidenced by the gain of epithelial markers CDX2, Claudin-4 and E-cadherin, and a concomitant loss of mesenchymal markers Vimentin, Fibronectin-1 and Transgelin. PAGE2 and SPAN-X up-regulation was accompanied by an increase in Ten-eleven translocation-2 (TET2) expression and cytosine 5-hydroxymethylation as well as the disassociation of heterochromatin protein 1 and the polycomb repressive complex 2 protein EZH2 from promoter-proximal regions of these genes. Reversal of differentiation resulted in down-regulation of PAGE2, -2B and SPANX-B, and induction of epithelial-to-mesenchymal transition (EMT) markers, demonstrating the dynamic nature of CT gene regulation in this model.	[Yilmaz-Ozcan, Sinem; Kucukkaraduman, Baris; Kaygusuz, Yasemin; Senses, Kerem Mert; Gure, Ali Osmay] Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey; [Sade, Asli; Banerjee, Sreeparna] Middle E Tech Univ, Dept Biol Sci, TR-06531 Ankara, Turkey	Ihsan Dogramaci Bilkent University; Middle East Technical University	Gure, AO (corresponding author), Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey.	agure@bilkent.edu.tr	SENSES, KEREM MERT/AAB-1658-2020; Sade, Asli/B-7141-2016; Banerjee, Sreeparna/AAZ-6742-2020	SENSES, KEREM MERT/0000-0003-3480-2311; Sade, Asli/0000-0002-8412-6473; Banerjee, Sreeparna/0000-0003-4596-6768; Gure, Ali Osmay/0000-0002-4064-8608; Senses, Kerem Mert/0000-0003-4396-1170	Scientific and Technological Research Council of Turkey (TUBITAK) [112S023]; Turkish Academy of Sciences; TUBITAK-BIDEP fellowships	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Turkish Academy of Sciences(Turkish Academy of Sciences); TUBITAK-BIDEP fellowships(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by grant nr. 112S023 from The Scientific and Technological Research Council of Turkey (TUBITAK) to AOG, a Young Investigator Award from The Turkish Academy of Sciences to SB, and by TUBITAK-BIDEP fellowships to SYO and BK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argast GM, 2011, CLIN EXP METASTAS, V28, P593, DOI 10.1007/s10585-011-9394-8; Astarci E, 2012, FEBS J, V279, P2966, DOI 10.1111/j.1742-4658.2012.08677.x; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Cannuyer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058743; Chen YT, 2011, HUM REPROD, V26, P3232, DOI 10.1093/humrep/der330; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Fleet JC, 2003, PHYSIOL GENOMICS, V13, P57, DOI 10.1152/physiolgenomics.00152.2002; Fratta E, 2011, MOL ONCOL, V5, P164, DOI 10.1016/j.molonc.2011.02.001; Gjerstorff MF, 2008, HUM REPROD, V23, P2194, DOI 10.1093/humrep/den262; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Gure AO, 2005, CLIN CANCER RES, V11, P8055, DOI 10.1158/1078-0432.CCR-05-1203; Hahn MA, 2013, CELL REP, V3, P291, DOI 10.1016/j.celrep.2013.01.011; Halbleib JM, 2007, MOL BIOL CELL, V18, P4261, DOI 10.1091/mbc.E07-04-0308; Hoek KS, 2007, PIGM CELL RES, V20, P466, DOI 10.1111/j.1600-0749.2007.00412.x; Hofmann O, 2008, P NATL ACAD SCI USA, V105, P20422, DOI 10.1073/pnas.0810777105; Isbilen M, 2014, TURKIYE KLIN J HEMAT, V7, P1; Isbilen M, 2013, CURR SIGNAL TRANSD T, V8, P268; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Jiang YQ, 2013, BBA-REV CANCER, V1835, P155, DOI 10.1016/j.bbcan.2012.12.003; Jungbluth AA, 2000, BRIT J CANCER, V83, P493, DOI 10.1054/bjoc.2000.1291; Jungbluth AA, 2002, INT J CANCER, V99, P839, DOI 10.1002/ijc.10416; Jungbluth AA, 2000, INT J CANCER, V85, P460, DOI 10.1002/(SICI)1097-0215(20000215)85:4<460::AID-IJC3>3.0.CO;2-N; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Loenarz C, 2009, CHEM BIOL, V16, P580, DOI 10.1016/j.chembiol.2009.06.002; Loriot A, 2009, STEM CELLS, V27, P822, DOI 10.1002/stem.8; Mashino K, 2001, BRIT J CANCER, V85, P713, DOI 10.1054/bjoc.2001.1974; PINTO M, 1983, BIOL CELL, V47, P323; Saaf AM, 2007, MOL BIOL CELL, V18, P4245, DOI 10.1091/mbc.E07-04-0309; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Simon-Assman P, 2007, CELL BIOL TOXICOL, V23, P241, DOI 10.1007/s10565-006-0175-0; Solary E, 2014, LEUKEMIA, V28, P485, DOI 10.1038/leu.2013.337; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Sun F, 2009, MOL CANCER THER, V8, P3191, DOI 10.1158/1535-7163.MCT-09-0479; Tsukada Y, 2012, J BIOCHEM, V151, P229, DOI 10.1093/jb/mvs003; Wang Y, 2014, CELL REP, V6, P278, DOI 10.1016/j.celrep.2013.12.031; Wang ZQ, 2006, BLOOD, V108, p628A, DOI 10.1182/blood.V108.11.2216.2216; Wang ZQ, 2006, INT J CANCER, V118, P1436, DOI 10.1002/ijc.21499; Wen L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r49; Woloszynska-Read A, 2008, CLIN CANCER RES, V14, P3283, DOI 10.1158/1078-0432.CCR-07-5279; Yao DB, 2011, MOL CANCER RES, V9, P1608, DOI 10.1158/1541-7786.MCR-10-0568	42	11	11	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107905	10.1371/journal.pone.0107905	http://dx.doi.org/10.1371/journal.pone.0107905			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229454	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900086
J	Basu, R; Lai, LT; Meng, ZY; Wu, J; Shao, FW; Zhang, LF				Basu, Reelina; Lai, Lan-Tian; Meng, Zhenyu; Wu, Jun; Shao, Fangwei; Zhang, Li-Feng			Using Amino-Labeled Nucleotide Probes for Simultaneous Single Molecule RNA-DNA FISH	PLOS ONE			English	Article							LONG NONCODING RNAS; MESSENGER-RNA; ACID	Using amino-labeled oligonucleotide probes, we established a simple, robust and low-noise method for simultaneous detection of RNA and DNA by fluorescence in situ hybridization, a highly useful tool to study the large pool of long non-coding RNAs being identified in the current research. With probes either chemically or biologically synthesized, we demonstrate that the method can be applied to study a wide range of RNA and DNA targets at the single-cell and single-molecule level in cellular contexts.	[Basu, Reelina; Lai, Lan-Tian] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Meng, Zhenyu; Wu, Jun; Shao, Fangwei; Zhang, Li-Feng] Nanyang Technol Univ, Div Chem & Biol Chem, Sch Phys & Math Sci, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Shao, FW (corresponding author), Nanyang Technol Univ, Div Chem & Biol Chem, Sch Phys & Math Sci, Singapore 639798, Singapore.	fwshao@ntu.edu.sg; zhanglf@ntu.edu.sg	Shao, Fangwei/B-7026-2011; Zhang, Li-Feng/A-2209-2011	Shao, Fangwei/0000-0003-2007-3920; Zhang, Li-Feng/0000-0003-0917-0017; Basu, Reelina/0000-0001-6589-2618	Singapore National Research Foundation [M4061058]; Nanyang Assistant Professor Fellowship [M4080531]; Ministry of Education [M4020163]	Singapore National Research Foundation(National Research Foundation, Singapore); Nanyang Assistant Professor Fellowship; Ministry of Education	L-FZ is supported by the Singapore National Research Foundation under its Cooperative Basic Research Grant administered by the Singapore Ministry of Health's National Medical Research Council (M4061058). FS is supported by Nanyang Assistant Professor Fellowship (M4080531) and Ministry of Education Tier 2 Research Grant (M4020163). The authors would also like to acknowledge the Nanyang Technological University College of Science Collaborative Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Batish M, 2012, P NATL ACAD SCI USA, V109, P4645, DOI 10.1073/pnas.1111226109; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Lai LT, 2013, EXP CELL RES, V319, P46, DOI 10.1016/j.yexcr.2012.11.009; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2010, METHOD ENZYMOL, V472, P365, DOI 10.1016/S0076-6879(10)72004-8; Ray A, 2000, FASEB J, V14, P1041, DOI 10.1096/fasebj.14.9.1041; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; TELSER J, 1989, J AM CHEM SOC, V111, P6966, DOI 10.1021/ja00200a011; Vargas DY, 2005, P NATL ACAD SCI USA, V102, P17008, DOI 10.1073/pnas.0505580102; WILLIS MC, 1993, SCIENCE, V262, P1255, DOI 10.1126/science.7694369; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Wynes MW, 2014, CLIN CANCER RES, V20, P3299, DOI 10.1158/1078-0432.CCR-13-3060; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036; Zhang LF, 2009, GENETICS, V182, P685, DOI 10.1534/genetics.109.103093	18	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107425	10.1371/journal.pone.0107425	http://dx.doi.org/10.1371/journal.pone.0107425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226542	Green Published, gold			2022-12-25	WOS:000344317700054
J	Hsu, NW; Tsao, HM; Chen, HC; Chou, P				Hsu, Nai-Wei; Tsao, Hsuan-Ming; Chen, Hsi-Chung; Chou, Pesus			Anxiety and Depression Mediate the Health-Related Quality of Life Differently in Patients with Cardiovascular Disease and Stroke-Preliminary Report of the Yilan Study: A Population-Based Community Health Survey	PLOS ONE			English	Article							HOSPITAL ANXIETY; MENTAL-DISORDERS; MORTALITY; ASSOCIATIONS; PROJECTIONS; PREDICTORS; FREQUENCY; OUTCOMES; PROFILE; BURDEN	Background: Cardiovascular disease and stroke have emerged as substantial and growing health challenges to populations around the world. Besides for the survival and medical prognosis, how to improve the health-related quality of life (HRQoL) might also become one of the goals of treatment programs. There are multiple factors that influence HRQol, including comorbidity, mental function and lifestyle. However, substantial research and investigation have still not clarified these underlying pathways, which merit further attention. The purpose of this study was to determine how psychological factors affect the link between cardiovascular disease and stroke with HRQoL. Methods and Result: A total of 1,285 elder subjects at least 65 years of age (47.2% male) were enrolled. The mental function and HRQol of each patient was then measured using the Hospital Anxiety and Depression Scale and Short Form-12. After multiple regression analysis, anxiety, depression, cardiovascular disease, stroke, education level and age were shown to be associated with both mental component score (MCS) and physical component score (PCS). In the mediation analysis using the SPSS macro provided by Preacher and Hayes, cardiovascular disease and stroke affected HRQoL via anxiety and depression, respectively. Conclusions: These results suggest that cardiovascular disease and stroke have negative impacts on patient MCS and PCS through different underlying pathways. Cardiovascular disease influences the HRQoL both directly and indirectly with the mediation of anxiety, and stroke influences the HRQoL by way of depression. These findings support the proposition that different combinations of both physical and psychological support are necessary to best manage these diseases.	[Hsu, Nai-Wei; Tsao, Hsuan-Ming] Natl Yang Ming Univ Hosp, Div Cardiol, Dept Internal Med, Yilan, Taiwan; [Hsu, Nai-Wei; Tsao, Hsuan-Ming] Natl Yang Ming Univ, Dept Med, Sch Med, Taipei 112, Taiwan; [Chen, Hsi-Chung] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Chen, Hsi-Chung] Natl Taiwan Univ Hosp, Ctr Sleep Disorders, Taipei, Taiwan; [Hsu, Nai-Wei; Chou, Pesus] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Hsu, Nai-Wei; Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chou, P (corresponding author), Natl Yang Ming Univ Hosp, Div Cardiol, Dept Internal Med, Yilan, Taiwan.	pschou@ym.edu.tw	Chen, Hsi-Chung/E-9949-2017	Chen, Hsi-Chung/0000-0003-3191-0093	Research Foundation of Cardiovascular Medicine in Taiwan [100-02-023]	Research Foundation of Cardiovascular Medicine in Taiwan	This study was funded by the Research Foundation of Cardiovascular Medicine (100-02-023) in Taiwan and HMT and NWH received the funding. However, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanasiev S, 2013, AM J GERIAT PSYCHIAT, V21, P832, DOI 10.1016/j.jagp.2013.04.012; Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; Ayerbe L, 2013, AGE AGEING; Ayerbe L, 2013, BRIT J PSYCHIAT, V202, P14, DOI 10.1192/bjp.bp.111.107664; Benyamini Y, 2013, ANN BEHAV MED, V46, P310, DOI 10.1007/s12160-013-9509-3; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bullinger M, 1998, J CLIN EPIDEMIOL, V51, P913, DOI 10.1016/S0895-4356(98)00082-1; Burton CAC, 2013, INT J STROKE, V8, P545, DOI 10.1111/j.1747-4949.2012.00906.x; Creed F, 2002, PSYCHOSOMATICS, V43, P302, DOI 10.1176/appi.psy.43.4.302; D'Aniello GE, 2014, J NEUROL SCI, V338, P191, DOI 10.1016/j.jns.2014.01.005; De Smedt D, 2013, INT J CARDIOL, V168, P898, DOI 10.1016/j.ijcard.2012.10.053; Feng C, 2014, SCI WORLD J, DOI 10.1155/2014/521349; Goodwin RD, 2008, J PSYCHIATR RES, V43, P239, DOI 10.1016/j.jpsychires.2008.05.006; Grool AM, 2012, J INTERN MED, V272, P277, DOI 10.1111/j.1365-2796.2012.02521.x; Hackett ML, 2014, LANCET NEUROL, V13, P525, DOI [10.1016/s1474-4422(14)70016-X, 10.1016/S1474-4422(14)70016-X]; Hackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4; Halvorsrud L, 2010, RES THEOR NURS PRACT, V24, P241, DOI 10.1891/1541-6577.24.4.241; Hare DL, 2013, EUR HEART J; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hellmann-Regen J, 2013, EUR ARCH PSY CLIN N, V263, pS123, DOI 10.1007/s00406-013-0448-6; Hopman WM, 2009, CHRONIC DIS CAN, V29, P108; Huang CY, 2010, J CLIN NURS, V19, P2752, DOI 10.1111/j.1365-2702.2010.03327.x; Knutson KM, 2013, NEUROPSYCHOLOGIA, V51, P686, DOI 10.1016/j.neuropsychologia.2013.01.003; LAM CLK, 1995, FAM PRACT, V12, P149, DOI 10.1093/fampra/12.2.149; Landman GWD, 2010, DIABETES CARE, V33, P2378, DOI 10.2337/dc10-0979; Leung C M, 1993, Int J Psychosom, V40, P29; Lim L, 2012, SOC PSYCH PSYCH EPID, V47, P1047, DOI 10.1007/s00127-011-0420-6; LYONS RA, 1994, J EPIDEMIOL COMMUN H, V48, P388, DOI 10.1136/jech.48.4.388; Maatouk I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031088; Maruish ME, 2009, GUIDE DEV CERTIFIED; Maruish ME, 2009, GUIDE INTEGRATION CE; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mayo NE, 2013, QUAL LIFE RES; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; Netuveli G, 2006, J EPIDEMIOL COMMUN H, V60, P357, DOI 10.1136/jech.2005.040071; Oldridge N, 2005, EUR J CARDIOV PREV R, V12, P87, DOI 10.1097/00149831-200504000-00002; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Schroder A, 2012, J CLIN EPIDEMIOL, V65, P30, DOI 10.1016/j.jclinepi.2011.03.012; Singer MA, 1999, QUAL LIFE RES, V8, P687, DOI 10.1023/A:1008917016998; Singh JA, 2005, J AM GERIATR SOC, V53, P108, DOI 10.1111/j.1532-5415.2005.53020.x; Spertus JA, 2002, CIRCULATION, V106, P43, DOI 10.1161/01.CIR.0000020688.24874.90; SPITZER RL, 1995, JAMA-J AM MED ASSOC, V274, P1511, DOI 10.1001/jama.274.19.1511; Steca P, 2013, PSYCHOL HEALTH, V28, P765, DOI 10.1080/08870446.2012.759223; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; Taft C, 2001, QUAL LIFE RES, V10, P395, DOI 10.1023/A:1012552211996; Tang WK, 2013, ARCH PHYS MED REHAB, V94, P2535, DOI 10.1016/j.apmr.2013.07.012; Tseng HM., 2003, TAIWAN J PUBLIC HLTH, V22, P512, DOI DOI 10.6288/TJPH2003-22-06-10; Tseng Hsu-Min, 2003, Health Qual Life Outcomes, V1, P72, DOI 10.1186/1477-7525-1-72; Tully PJ, 2013, PSYCHOL HEALTH MED, V18, P627, DOI 10.1080/13548506.2012.749355; van Mierlo ML, 2014, INT J STROKE, V9, P341, DOI 10.1111/ijs.12149; WARE JE, 1995, MED CARE, V33, pAS264, DOI 10.1097/00005650-199501001-00005; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WHO, 2011, GLOB STAT REP NONC D; Wikman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018952; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	57	29	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107609	10.1371/journal.pone.0107609	http://dx.doi.org/10.1371/journal.pone.0107609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS5NP	25226168	Green Published, gold, Green Submitted			2022-12-25	WOS:000344317700067
J	Settem, RP; Honma, K; Sharma, A				Settem, Rajendra P.; Honma, Kiyonobu; Sharma, Ashu			Neutrophil Mobilization by Surface-Glycan Altered Th17-Skewing Bacteria Mitigates Periodontal Pathogen Persistence and Associated Alveolar Bone Loss	PLOS ONE			English	Article							TANNERELLA-FORSYTHIA; S-LAYER; PORPHYROMONAS-GINGIVALIS; RESPONSES; DISEASE; POLYSACCHARIDES; INFLAMMATION; RECRUITMENT; LESSONS; MICE	Alveolar bone (tooth-supporting bone) erosion is a hallmark of periodontitis, an inflammatory disease that often leads to tooth loss. Periodontitis is caused by a select group of pathogens that form biofilms in subgingival crevices between the gums and teeth. It is well-recognized that the periodontal pathogen Porphyromonas gingivalis in these biofilms is responsible for modeling a microbial dysbiotic state, which then initiates an inflammatory response destructive to the periodontal tissues and bone. Eradication of this pathogen is thus critical for the treatment of periodontitis. Previous studies have shown that oral inoculation in mice with an attenuated strain of the periodontal pathogen Tannerella forsythia altered in O-glycan surface composition induces a Th17-linked mobilization of neutrophils to the gingival tissues. In this study, we sought to determine if immune priming with such a Th17-biasing strain would elicit a productive neutrophil response against P. gingivalis. Our data show that inoculation with a Th17-biasing T. forsythia strain is effective in blocking P. gingivalis-persistence and associated alveolar bone loss in mice. This work demonstrates the potential of O-glycan modified Tannerella strains or their O-glycan components for harnessing Th17-mediated immunity against periodontal and other mucosal pathogens.	[Settem, Rajendra P.; Honma, Kiyonobu; Sharma, Ashu] SUNY Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Sharma, A (corresponding author), SUNY Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14260 USA.	sharmaa@buffalo.edu	Homma, Kiyonobu/K-9084-2013	Homma, Kiyonobu/0000-0003-1342-4745; Settem, Rajendra Prasad/0000-0002-3577-7675	U.S. Public Health [DE14749, DE19424]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE019424] Funding Source: NIH RePORTER	U.S. Public Health(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by U.S. Public Health R01 grants DE14749 and DE19424. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz K, 2012, MOL MED, V18, P1190, DOI 10.2119/molmed.2012.00180; Cheng WC, 2014, J CLIN PERIODONTOL; Choi Jeom-Il, 2010, J Periodontal Implant Sci, V40, P153, DOI 10.5051/jpis.2010.40.4.153; Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Glowacki AJ, 2013, P NATL ACAD SCI USA, V110, P18525, DOI 10.1073/pnas.1302829110; Gonzalez-Fernandez A, 2008, VACCINE, V26, P292, DOI 10.1016/j.vaccine.2007.11.042; Hajishengallis E, 2013, J DENT RES; Hajishengallis G, 2012, NAT REV MICROBIOL; Hajishengallis G, 2014, EUR J IMMUNOL, V44, P328, DOI 10.1002/eji.201344202; Hajishengallis G, 2013, ADV EXP MED BIOL, V735, P197, DOI 10.1007/978-1-4614-4118-2_13; Honma K, 2009, MICROBIOL-SGM, V155, P1912, DOI 10.1099/mic.0.027920-0; Ilk N, 2011, CURR OPIN BIOTECH, V22, P824, DOI 10.1016/j.copbio.2011.05.510; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Maue AC, 2012, INFECT IMMUN; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Moutsopoulos NM, 2012, J AUTOIMMUN, V39, P294, DOI 10.1016/j.jaut.2012.03.003; Myneni SR, 2011, J IMMUNOL, V187, P501, DOI 10.4049/jimmunol.1100683; Nussbaum G, 2011, J CLIN PERIODONTOL, V38, P49, DOI 10.1111/j.1600-051X.2010.01678.x; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Posch G, 2011, J BIOL CHEM, V286, P38714, DOI 10.1074/jbc.M111.284893; Scott DA, 2012, FRONT ORAL BIOL, V15, P56; Sekot G, 2011, J DENT RES, V90, P109, DOI 10.1177/0022034510384622; Settem RP, 2013, MUCOSAL IMMUNOL, V6, P415, DOI 10.1038/mi.2012.85; Settem RP, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00310; Surana NK, 2012, IMMUNOL REV, V245, P13, DOI 10.1111/j.1600-065X.2011.01075.x; Tzianabos AO, 2000, J BIOL CHEM, V275, P6733, DOI 10.1074/jbc.275.10.6733; Yu JJ, 2007, BLOOD, V109, P3794, DOI 10.1182/blood-2005-09-010116	28	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e108030	10.1371/journal.pone.0108030	http://dx.doi.org/10.1371/journal.pone.0108030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225799	gold, Green Published, Green Submitted			2022-12-25	WOS:000344317700096
J	Koyama, M; Hattori, S; Amano, Y; Watanabe, M; Nakamura, K				Koyama, Masahiro; Hattori, Seiji; Amano, Yoshihiko; Watanabe, Masanori; Nakamura, Kozo			Blood Pressure-Lowering Peptides from Neo-Fermented Buckwheat Sprouts: A New Approach to Estimating ACE-Inhibitory Activity	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; SPONTANEOUSLY HYPERTENSIVE-RATS; SMOOTH-MUSCLE-CELLS; ANTIHYPERTENSIVE ACTION; ATHEROSCLEROSIS; IDENTIFICATION; EXPRESSION; MECHANISM; DISEASE; HEART	Neo-fermented buckwheat sprouts (neo-FBS) contain angiotensin-converting enzyme (ACE) inhibitors and vasodilators with blood pressure-lowering (BPL) properties in spontaneously hypertensive rats (SHRs). In this study, we investigated antihypertensive mechanisms of six BPL peptides isolated from neo-FBS (FBPs) by a vasorelaxation assay and conventional in vitro, in vivo, and a new ex vivo ACE inhibitory assays. Some FBPs demonstrated moderate endothelium-dependent vasorelaxation in SHR thoracic aorta and all FBPs mildly inhibited ACE in vitro. Orally administered FBPs strongly inhibited ACE in SHR tissues. To investigate detailed ACE-inhibitory mechanism of FBPs in living body tissues, we performed the ex vivo assay by using endothelium-denuded thoracic aorta rings isolated from SHRs, which demonstrated that FBPs at low concentration effectively inhibited ACE in thoracic aorta tissue and suppressed angiotensin II-mediated vasoconstriction directly associated with BPL. These results indicate that the main BPL mechanism of FBP was ACE inhibition in living body tissues, suggesting that high FBP's bioavailability including absorption, tissue affinity, and tissue accumulation was responsible for the superior ACE inhibition in vivo. We propose that our ex vivo assay is an efficient and reliable method for evaluating ACE-inhibitory mechanism responsible for BPL activity in vivo.	[Koyama, Masahiro; Nakamura, Kozo] Shinshu Univ, Fac Agr, Dept Biosci & Biotechnol, Nagano, Japan; [Hattori, Seiji; Nakamura, Kozo] Shinshu Univ, Grad Sch Agr, Dept Biosci & Biotechnol, Nagano, Japan; [Amano, Yoshihiko] Shinshu Univ, Fac Engn, Dept Chem & Mat Engn, Nagano 380, Japan; [Watanabe, Masanori] Yamagata Univ, Fac Agr, Dept Food Life & Environm Sci, Tsuruoka, Yamagata, Japan; [Nakamura, Kozo] Shinshu Univ, Inst Agr, Acad Assembly, Nagano, Japan	Shinshu University; Shinshu University; Shinshu University; Yamagata University; Shinshu University	Nakamura, K (corresponding author), Shinshu Univ, Fac Agr, Dept Biosci & Biotechnol, Nagano, Japan.	knakamu@shinshu-u.ac.jp			JSPS [26450154]; Grants-in-Aid for Scientific Research [24592254] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI) from JSPS, Grant Number 26450154. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelband F, 2009, REGUL PEPTIDES, V155, P81, DOI 10.1016/j.regpep.2009.03.014; BURGAUD JL, 1994, J PHARM PHARMACOL, V46, P153, DOI 10.1111/j.2042-7158.1994.tb03762.x; Carey RM, 2004, HYPERTENSION, V43, P943, DOI 10.1161/01.HYP.0000124669.02394.72; FALKENHAHN M, 1995, HYPERTENSION, V25, P219, DOI 10.1161/01.HYP.25.2.219; Feher A, 2013, CIRC J, V77, P1867, DOI 10.1253/circj.CJ-12-1163; Fukuda N, 1999, ARTERIOSCL THROM VAS, V19, P1210, DOI 10.1161/01.ATV.19.5.1210; Fukuda N, 1999, J HYPERTENS, V17, P1099, DOI 10.1097/00004872-199917080-00009; Fukuhara M, 2000, HYPERTENSION, V35, P353, DOI 10.1161/01.HYP.35.1.353; GOHLKE P, 1993, HYPERTENSION, V22, P682, DOI 10.1161/01.HYP.22.5.682; Hayashi A, 2010, J NUTR SCI VITAMINOL, V56, P242, DOI 10.3177/jnsv.56.242; Heeneman S, 2007, CIRC RES, V101, P441, DOI 10.1161/CIRCRESAHA.107.148338; Iwai K, 2005, J AGR FOOD CHEM, V53, P6531, DOI 10.1021/jf050206p; Izzo JL, 2011, J CLIN HYPERTENS, V13, P667, DOI 10.1111/j.1751-7176.2011.00508.x; Jakala P, 2010, PHARMACEUTICALS-BASE, V3, P251, DOI 10.3390/ph3010251; Kouno K, 2005, BIOSCI BIOTECH BIOCH, V69, P911, DOI 10.1271/bbb.69.911; Koyama M, 2013, J AGR FOOD CHEM, V61, P3013, DOI 10.1021/jf305157y; Matsui T, 2004, J PEPT SCI, V10, P535, DOI 10.1002/psc.568; Nakamura K, 2013, J FUNCT FOODS, V5, P406, DOI 10.1016/j.jff.2012.11.013; NAKAMURA Y, 1995, J DAIRY SCI, V78, P1253, DOI 10.3168/jds.S0022-0302(95)76745-5; Olszanecki R, 2008, J PHYSIOL PHARMACOL, V59, P387; Rosendorff C, 2009, CURR OPIN CARDIOL, V24, P318, DOI 10.1097/HCO.0b013e32832bfb48; Russell JC, 2006, CARDIOVASC PATHOL, V15, P318, DOI 10.1016/j.carpath.2006.09.001; SEKI E, 1999, J JPN SOC NUTR FOOD, V52, P271; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; Vermeirssen V, 2004, BRIT J NUTR, V92, P357, DOI 10.1079/BJN20041189; Yoshiji H, 2004, J NARA MED ASS, V55, P63	26	40	42	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e105802	10.1371/journal.pone.0105802	http://dx.doi.org/10.1371/journal.pone.0105802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222748	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774800006
J	Stein, C; Hallett, LM; Harpole, WS; Suding, KN				Stein, Claudia; Hallett, Lauren M.; Harpole, W. Stanley; Suding, Katharine N.			Evaluating Ecosystem Services Provided by Non-Native Species: An Experimental Test in California Grasslands	PLOS ONE			English	Article							MANAGEMENT; BIODIVERSITY; ECOLOGY; FORESTS	The concept of ecosystem services - the benefits that nature provides to human's society - has gained increasing attention over the past decade. Increasing global abiotic and biotic change, including species invasions, is threatening the secure delivery of these ecosystem services. Efficient evaluation methods of ecosystem services are urgently needed to improve our ability to determine management strategies and restoration goals in face of these new emerging ecosystems. Considering a range of multiple ecosystem functions may be a useful way to determine such strategies. We tested this framework experimentally in California grasslands, where large shifts in species composition have occurred since the late 1700's. We compared a suite of ecosystem functions within one historic native and two non-native species assemblages under different grazing intensities to address how different species assemblages vary in provisioning, regulatory and supporting ecosystem services. Forage production was reduced in one non-native assemblage (medusahead). Cultural ecosystem services, such as native species diversity, were inherently lower in both non-native assemblages, whereas most other services were maintained across grazing intensities. All systems provided similar ecosystem services under the highest grazing intensity treatment, which simulated unsustainable grazing intensity. We suggest that applying a more comprehensive ecosystem framework that considers multiple ecosystem services to evaluate new emerging ecosystems is a valuable tool to determine management goals and how to intervene in a changing ecosystem.	[Stein, Claudia; Hallett, Lauren M.; Suding, Katharine N.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Harpole, W. Stanley] Iowa State Univ, Ames, IA USA	University of California System; University of California Berkeley; Iowa State University	Stein, C (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	stein.clp@gmail.com	Suding, Katharine/O-6290-2017; Stein, Claudia/AAV-8970-2020; Harpole, William S/C-2814-2013; HALLETT, LAUREN M/R-1560-2017	Suding, Katharine/0000-0002-5357-0176; Harpole, William S/0000-0002-3404-9174; HALLETT, LAUREN M/0000-0002-0718-0257; Stein, Claudia/0000-0002-9586-8587	National Research Initiative of USDA Cooperative State Research, Education and Extension Service [2006-01350]	National Research Initiative of USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This project was supported by the National Research Initiative of the USDA Cooperative State Research, Education and Extension Service, grant number #2006-01350 in the Managed Ecosystems Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, LINKING RESTORATION, DOI DOI 10.1007/978-0-387-35303-6_5; [Anonymous], 2006, SAS MIXED MODELS; Bartolome J. W., 2002, U CALIFORNIA AG NAT, V8092, P8; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Davies KW, 2008, RANGELAND ECOL MANAG, V61, P623, DOI 10.2111/08-005.1; DiTomaso JM, 2000, WEED SCI, V48, P255, DOI 10.1614/0043-1745(2000)048[0255:IWIRSI]2.0.CO;2; Eagle AJ, 2007, RANGELAND ECOL MANAG, V60, P369, DOI 10.2111/1551-5028(2007)60[369:CALIOC]2.0.CO;2; EPA, 1996, 430R96021 EPA; FERNANDEZ GCJ, 1991, HORTSCIENCE, V26, P339, DOI 10.21273/HORTSCI.26.4.339; Germano DJ, 2001, WILDLIFE SOC B, V29, P551; Hallett Lauren M., 2013, P16; Hamilton Jason G., 1997, Madrono, V44, P311; HEADY HF, 1958, ECOLOGY, V39, P402, DOI 10.2307/1931750; HIRONAKA M., 1961, JOUR RANGE MANAGEMENT, V14, P263, DOI 10.2307/3894744; Hobbs RJ, 2011, BIOSCIENCE, V61, P442, DOI 10.1525/bio.2011.61.6.6; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Huntsinger L., 2007, GRAZING MANAGEMENT C, P233; Jantz PA., 2007, CALIFORNIA GRASSLAND, P297; Katan J., 1984, ACTA HORTIC, V152, P227; Kimball S, 2003, CONSERV BIOL, V17, P1681, DOI 10.1111/j.1523-1739.2003.00205.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Mascaro J, 2012, ECOL MONOGR, V82, P221, DOI 10.1890/11-1014.1; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING AS; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Seastedt TR, 2008, FRONT ECOL ENVIRON, V6, P547, DOI 10.1890/070046; Silver WL, 2010, RANGELAND ECOL MANAG, V63, P128, DOI 10.2111/REM-D-09-00106.1; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Wainger LA, 2010, ECOL ECON, V69, P978, DOI 10.1016/j.ecolecon.2009.12.011; YOUNG JA, 1992, GREAT BASIN NAT, V52, P245	31	13	13	4	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e75396	10.1371/journal.pone.0075396	http://dx.doi.org/10.1371/journal.pone.0075396			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222028	Green Submitted, gold, Green Published			2022-12-25	WOS:000341774800001
J	Yang, LX; Zhang, R; Li, M; Wu, XJ; Wang, JH; Huang, L; Shi, XD; Li, QW; Su, B				Yang, Lixin; Zhang, Rui; Li, Ming; Wu, Xujun; Wang, Jianhong; Huang, Lin; Shi, Xiaodong; Li, Qingwei; Su, Bing			A Functional MiR-124 Binding-Site Polymorphism in IQGAP1 Affects Human Cognitive Performance	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; STATISTICAL TESTS; NATURAL-SELECTION; DNA POLYMORPHISM; HUMAN GENOME; MEMORY; MICRORNAS; RNAS; RECOGNITION; HITCHHIKING	As a product of the unique evolution of the human brain, human cognitive performance is largely a collection of heritable traits. Rather surprisingly, to date there have been no reported cases to highlight genes that underwent adaptive evolution in humans and which carry polymorphisms that have a marked effect on cognitive performance. IQ motif containing GTPase activating protein 1 (IQGAP1), a scaffold protein, affects learning and memory in a dose-dependent manner. Its expression is regulated by miR-124 through the binding sites in the 3'UTR, where a SNP (rs1042538) exists in the core-binding motif. Here we showed that this SNP can influence the miR-target interaction both in vitro and in vivo. Individuals carrying the derived T alleles have higher IQGAP1 expression in the brain as compared to the ancestral A allele carriers. We observed a significant and male-specific association between rs1042538 and tactile performances in two independent cohorts. Males with the derived allele displayed higher tactual performances as compared to those with the ancestral allele. Furthermore, we found a highly diverged allele-frequency distribution of rs1042538 among world human populations, likely caused by natural selection and/or recent population expansion. These results suggest that current human populations still carry sequence variations that affect cognitive performances and that these genetic variants may likely have been subject to comparatively recent natural selection.	[Yang, Lixin; Zhang, Rui; Li, Ming; Wu, Xujun; Huang, Lin; Su, Bing] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Wang, Jianhong] Chinese Acad Sci, Kunming Inst Zool, Lab Primate Neurosci, Kunming, Peoples R China; [Shi, Xiaodong] Qujing Normal Univ, Dept Biochem, Qujing, Peoples R China; [Li, Qingwei] Liaoning Normal Univ, Coll Life Sci, Dalian, Peoples R China; [Yang, Lixin; Li, Ming; Wu, Xujun] Univ Chinese Acad Sci, Kunming Coll Life Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology; Liaoning Normal University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Su, B (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	sub@mail.kiz.ac.cn	wang, jian/GVS-0711-2022		National 973 project of China [2011CBA00401, 2012CBA01300]; National Natural Science Foundation of China [31130051, 31301028, 31321002]; Natural Science Foundation of Yunnan Province [2007C100M, 2009CD107]; West light Doctoral program	National 973 project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province); West light Doctoral program	This work was supported by grants from the National 973 project of China (2011CBA00401 and 2012CBA01300), the National Natural Science Foundation of China (31130051, 31301028 and 31321002) and the Natural Science Foundation of Yunnan Province (2007C100M and 2009CD107). This study was also supported by funding from the West light Doctoral program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balenci L, 2007, J NEUROSCI, V27, P4716, DOI 10.1523/JNEUROSCI.0830-07.2007; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bates TC, 2009, NEUROSCI LETT, V458, P140, DOI 10.1016/j.neulet.2009.04.050; Boivin MJ, 2011, DEV NEUROPSYCHOL, V36, P552, DOI 10.1080/87565641.2010.549874; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cagliani R, 2012, CELL MOL LIFE SCI, V69, P1705, DOI 10.1007/s00018-011-0896-y; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; CAPLAN PJ, 1985, AM PSYCHOL, V40, P786; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Fay JC, 2000, GENETICS, V155, P1405; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Gao C, 2011, J NEUROSCI, V31, P8533, DOI 10.1523/JNEUROSCI.1300-11.2011; Gong Y., 1989, WECHSLER MEMORY SCAL, P2; Harris LJ., 1981, SPATIAL REPRESENTATI, P83; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Laetitia L, 1985, J CLIN EXPT NEUROPSY, V7, P430; Li JJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002578; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu ZL, 2008, J HUAZHONG U SCI-MED, V28, P700, DOI 10.1007/s11596-008-0620-9; Maccoby E.E., 1978, PSYCHOL SEX DIFFEREN, V2; Makeyev EV, 2008, SCIENCE, V319, P1789, DOI 10.1126/science.1152326; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Minguzzi S, 2014, HUM MUTAT, V35, P96, DOI 10.1002/humu.22459; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Postma A, 1999, PSYCHONEUROENDOCRINO, V24, P175, DOI 10.1016/S0306-4530(98)00073-0; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Schrick C, 2007, NEURON, V55, P786, DOI 10.1016/j.neuron.2007.07.034; TAJIMA F, 1989, GENETICS, V123, P585; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Zheng H, 2011, INT J ONCOL, V38, P1153, DOI 10.3892/ijo.2011.940	41	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107065	10.1371/journal.pone.0107065	http://dx.doi.org/10.1371/journal.pone.0107065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222038	gold, Green Published, Green Submitted			2022-12-25	WOS:000341774800041
J	Zhang, J; Ye, ZW; Gao, P; Reyes, L; Jones, EE; Branham-O'Connor, M; Blumer, JB; Drake, RR; Manevich, Y; Townsend, DM; Tew, KD				Zhang, Jie; Ye, Zhi-Wei; Gao, Peng; Reyes, Leticia; Jones, Elizabeth E.; Branham-O'Connor, Melissa; Blumer, Joe B.; Drake, Richard R.; Manevich, Yefim; Townsend, Danyelle M.; Tew, Kenneth D.			Glutathione S-Transferase P Influences Redox and Migration Pathways in Bone Marrow	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; AORTIC ENDOTHELIAL-CELLS; SIGNALING PATHWAYS; DENDRITIC CELLS; NITRIC-OXIDE; PROLIFERATION; RECEPTOR; NICHE; MAINTENANCE; REGULATOR	To interrogate why redox homeostasis and glutathione S-transferase P (GSTP) are important in regulating bone marrow cell proliferation and migration, we isolated crude bone marrow, lineage negative and bone marrow derived-dendritic cells (BMDDCs) from both wild type (WT) and knockout (Gstp1/p2(-/-)) mice. Comparison of the two strains showed distinct thiol expression patterns. WT had higher baseline and reactive oxygen species-induced levels of S-glutathionylated proteins, some of which (sarco-endoplasmic reticulum Ca2+-ATPase) regulate Ca2+ fluxes and subsequently influence proliferation and migration. Redox status is also a crucial determinant in the regulation of the chemokine system. CXCL12 chemotactic response was stronger in WT cells, with commensurate alterations in plasma membrane polarization/permeability and intracellular calcium fluxes; activities of the downstream kinases, ERK and Akt were also higher in WT. In addition, expression levels of the chemokine receptor CXCR4 and its associated phosphatase, SHP-2, were higher in WT. Inhibition of CXCR4 or SHP2 decreased the extent of CXCL12-induced migration in WT BMDDCs. The differential surface densities of CXCR4, SHP-2 and inositol trisphosphate receptor in WT and Gstp1/p2(-/-) cells correlated with the differential CXCR4 functional activities, as measured by the extent of chemokine-induced directional migration and differences in intracellular signaling. These observed differences contribute to our understanding of how genetic ablation of GSTP causes higher levels of myeloproliferation and migration.	[Zhang, Jie; Ye, Zhi-Wei; Gao, Peng; Reyes, Leticia; Jones, Elizabeth E.; Branham-O'Connor, Melissa; Blumer, Joe B.; Drake, Richard R.; Manevich, Yefim; Tew, Kenneth D.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Townsend, Danyelle M.] Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Tew, KD (corresponding author), Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA.	tewk@musc.edu	Zhang, Jie/F-1540-2011	Zhang, Jie/0000-0002-0466-2955; Blumer, Joe/0000-0002-0020-3815	National Institutes of Health [CA08660, CA117259, NCRR P20RR024485]; South Carolina Centers of Excellence program; National Institutes of Health; Extramural Research Facilities Program of the National Center for Research Resources [C06 RR015455]; Drug Metabolism and Clinical Pharmacology shared Resource, Hollings Cancer Center, Medical University of South Carolina; Swedish Research Council [524-2011-6998]; NATIONAL CANCER INSTITUTE [R41CA117259] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Centers of Excellence program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Extramural Research Facilities Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Drug Metabolism and Clinical Pharmacology shared Resource, Hollings Cancer Center, Medical University of South Carolina; Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (CA08660, CA117259, NCRR P20RR024485 - COBRE in Oxidants, Redox Balance and Stress Signaling) and support from the South Carolina Centers of Excellence program, and was conducted in a facility constructed with the support from the National Institutes of Health, Grant Number C06 RR015455 from the Extramural Research Facilities Program of the National Center for Research Resources. Supported in part by the Drug Metabolism and Clinical Pharmacology shared Resource, Hollings Cancer Center, Medical University of South Carolina. J.Z. was supported by the Swedish Research Council (No. 524-2011-6998). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Arai F, 2009, ANN NY ACAD SCI, V1176, P36, DOI 10.1111/j.1749-6632.2009.04561.x; BALDINI M, 1953, Rev Hematol, V8, P3; Basu S, 2009, J IMMUNOL, V183, P7478, DOI 10.4049/jimmunol.0900542; Bindoli A, 2013, ANTIOXID REDOX SIGN, V18, P1557, DOI 10.1089/ars.2012.4655; Bowers RR, 2012, BIOCHEMISTRY-US, V51, P7740, DOI 10.1021/bi301006w; Branham-O'Connor M, 2014, J BIOL CHEM, V289, P10738, DOI 10.1074/jbc.M113.515031; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chen S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.253; Chernock RD, 2001, BLOOD, V97, P608, DOI 10.1182/blood.V97.3.608; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Chiu J, 2012, TRENDS CELL BIOL, V22, P592, DOI 10.1016/j.tcb.2012.08.002; Chiurchiu V, 2011, ANTIOXID REDOX SIGN, V15, P2605, DOI 10.1089/ars.2010.3547; CIPOLLESCHI MG, 1993, BLOOD, V82, P2031; Findlay VJ, 2004, MOL PHARMACOL, V65, P1070, DOI 10.1124/mol.65.5.1070; Gate L, 2004, J BIOL CHEM, V279, P8608, DOI 10.1074/jbc.M308613200; Giles GI, 2006, CURR PHARM DESIGN, V12, P4427, DOI 10.2174/138161206779010549; Grek CL, 2013, J BIOL CHEM, V288, P26497, DOI 10.1074/jbc.R113.461368; Hellmuth K, 2008, P NATL ACAD SCI USA, V105, P7275, DOI 10.1073/pnas.0710468105; Henderson CJ, 1998, P NATL ACAD SCI USA, V95, P5275, DOI 10.1073/pnas.95.9.5275; Humrich JY, 2006, IMMUNOLOGY, V117, P238, DOI 10.1111/j.1365-2567.2005.02292.x; Iwasaki H, 2009, CANCER SCI, V100, P1166, DOI 10.1111/j.1349-7006.2009.01177.x; Lei K, 2008, ONCOGENE, V27, P4877, DOI 10.1038/onc.2008.132; Lo Celso C, 2009, J BIOPHOTONICS, V2, P619, DOI 10.1002/jbio.200910072; Lock JT, 2012, J PHYSIOL-LONDON, V590, P3431, DOI [10.1113/jphysiol.2012.230656, 10.1113/jphysiol.2012.232645]; Lock JT, 2011, AM J PHYSIOL-HEART C, V300, pH493, DOI 10.1152/ajpheart.01073.2010; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lyons RM, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-43; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Moll NM, 2010, EXPERT REV HEMATOL, V3, P315, DOI 10.1586/EHM.10.16; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Okabe S, 2006, BLOOD CELL MOL DIS, V36, P308, DOI 10.1016/j.bcmd.2005.12.035; Peterson JD, 1998, P NATL ACAD SCI USA, V95, P3071, DOI 10.1073/pnas.95.6.3071; Raza A, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-20; Rinna A, 2006, FREE RADICAL BIO MED, V41, P86, DOI 10.1016/j.freeradbiomed.2006.03.010; Ruscoe JE, 2001, J PHARMACOL EXP THER, V298, P339; Saavedra JE, 2006, J MED CHEM, V49, P1157, DOI 10.1021/jm050700k; Saccani A, 2000, P NATL ACAD SCI USA, V97, P2761, DOI 10.1073/pnas.97.6.2761; Smith CV, 1996, TOXICOL APPL PHARM, V140, P1, DOI 10.1006/taap.1996.0191; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Townsend DM, 2008, EXPERT OPIN INV DRUG, V17, P1075, DOI [10.1517/13543784.17.7.1075, 10.1517/13543784.17.7.1075 ]; Townsend DM, 2008, CANCER RES, V68, P2870, DOI 10.1158/0008-5472.CAN-07-5957; Townsend DM, 2007, MOL INTERV, V7, P313, DOI 10.1124/mi.7.6.7; Townsend DM, 2009, J BIOL CHEM, V284, P436, DOI 10.1074/jbc.M805586200; Townsend DM, 2006, MOL PHARMACOL, V69, P501, DOI 10.1124/mol.105.018523; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Wetzelberger K, 2010, J BIOL CHEM, V285, P26135, DOI 10.1074/jbc.M110.146423; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhang J, 2014, ADV CANCER RES, V122, P143, DOI 10.1016/B978-0-12-420117-0.00004-9	52	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107478	10.1371/journal.pone.0107478	http://dx.doi.org/10.1371/journal.pone.0107478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216273	Green Submitted, gold, Green Published			2022-12-25	WOS:000341774300069
J	Jin, R; Yamashita, H; Yu, X; Wang, J; Franco, OE; Wang, Y; Hayward, SW; Matusik, RJ				Jin, R.; Yamashita, H.; Yu, X.; Wang, J.; Franco, O. E.; Wang, Y.; Hayward, S. W.; Matusik, R. J.			Inhibition of NF-kappa B signaling restores responsiveness of castrate-resistant prostate cancer cells to anti-androgen treatment by decreasing androgen receptor-variant expression	ONCOGENE			English	Article							TRAIL-INDUCED APOPTOSIS; LYMPH-NODE METASTASES; SPLICE VARIANTS; NUCLEAR-LOCALIZATION; ANTITUMOR-ACTIVITY; CHROMOGRANIN-A; SOLID TUMORS; PROGRESSION; ACTIVATION; MECHANISMS	Androgen receptor splicing variants (ARVs) that lack the ligand-binding domain (LBD) are associated with the development of castration-resistant prostate cancer (CRPC), including resistance to the new generation of high-affinity anti-androgens. However, the mechanism by which ARV expression is regulated is not fully understood. In this study, we show that the activation of classical nuclear factor-kappa B (NF-kappa B) signaling increases the expression of ARVs in prostate cancer (PCa) cells and converts androgen-sensitive PCa cells to become androgen-insensitive, whereas downregulation of NF-kappa B signaling inhibits ARV expression and restores responsiveness of CRPC to anti-androgen therapy. In addition, we demonstrated that combination of anti-androgen with NF-kappa B-targeted therapy inhibits efficiently tumor growth of human CRPC xenografts. These results indicate that induction of ARVs by activated NF-kappa B signaling in PCa cells is a critical mechanism by which the PCa progresses to CRPC. This has important implications as it can prolong the survival of CRPC patients by restoring the tumors to once again respond to conventional androgen-deprivation therapy (ADT).	[Jin, R.; Yamashita, H.; Yu, X.; Wang, J.; Franco, O. E.; Wang, Y.; Hayward, S. W.; Matusik, R. J.] Vanderbilt Univ, Med Ctr, Vanderbilt Prostate Canc Ctr, Dept Urol Surg, Nashville, TN 37232 USA	Vanderbilt University	Jin, R (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Prostate Canc Ctr, Dept Urol Surg, A1329,MCN,1161 21st Ave South, Nashville, TN 37232 USA.	renjie.jin@vanderbilt.edu		Matusik, Robert/0000-0003-2057-9892; Yamashita, Hironobu/0000-0003-2587-7100; Hayward, Simon/0000-0002-6059-6550; Yu, Xiuping/0000-0003-2844-7026	Department of Defense (DOD) Prostate Cancer Research Program (PCRP) [W81XWH-10-1-0236]; National Cancer Institute [4R01 CA076142-14]; Frances Preston Laboratories of the TJ Martell Foundation; NATIONAL CANCER INSTITUTE [R01CA076142] Funding Source: NIH RePORTER	Department of Defense (DOD) Prostate Cancer Research Program (PCRP); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Frances Preston Laboratories of the TJ Martell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Martin Leverkus (University of Magdeburg, Germany) for providing us with IKK2-EE and IKK2-KD retroviral vectors, and Tom C Case and Manik Paul for technical assistance. This work was supported to RJ by the Department of Defense (DOD) Prostate Cancer Research Program (PCRP; W81XWH-10-1-0236); to RJM by the National Cancer Institute (4R01 CA076142-14) and the Frances Preston Laboratories of the TJ Martell Foundation.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Akfirat C, 2013, J PATHOL, V230, P291, DOI 10.1002/path.4180; Berruti A, 2005, ENDOCR-RELAT CANCER, V12, P109, DOI 10.1677/erc.1.00876; Claessens Frank, 2008, Nucl Recept Signal, V6, pe008, DOI 10.1621/nrs.06008; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; di Sant'Agnese PA, 1998, PROSTATE, P74; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Diessenbacher P, 2008, J INVEST DERMATOL, V128, P1134, DOI 10.1038/sj.jid.5701141; Domingo-Domenech J, 2005, BRIT J CANCER, V93, P1285, DOI 10.1038/sj.bjc.6602851; Domingo-Domenech J, 2006, CLIN CANCER RES, V12, P5578, DOI 10.1158/1078-0432.CCR-05-2767; Everhart MB, 2006, J IMMUNOL, V176, P4995, DOI 10.4049/jimmunol.176.8.4995; Gannon PO, 2013, EUR J CANCER, V49, P2441, DOI 10.1016/j.ejca.2013.02.026; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Hu R, 2011, PROSTATE, V71, P1656, DOI 10.1002/pros.21382; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Inoue J, 2007, CANCER SCI, V98, P268, DOI 10.1111/j.1349-7006.2007.00389.x; Ismail H, 2004, PROSTATE, V58, P308, DOI 10.1002/pros.10335; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Jin RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060983; Jin RJ, 2004, CANCER RES, V64, P5489, DOI 10.1158/0008-5472.CAN-03-3117; Karin M, 2006, MOL CARCINOGEN, V45, P355, DOI 10.1002/mc.20217; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Knudsen KE, 2009, CLIN CANCER RES, V15, P4792, DOI 10.1158/1078-0432.CCR-08-2660; Kraft AS, 2011, CANCER BIOL THER, V12, P119, DOI 10.4161/cbt.12.2.15723; Lessard L, 2005, BRIT J CANCER, V93, P1019, DOI 10.1038/sj.bjc.6602796; Lessard L, 2006, CLIN CANCER RES, V12, P5741, DOI 10.1158/1078-0432.CCR-06-0330; Leverkus M, 2003, J INVEST DERMATOL, V121, P149, DOI 10.1046/j.1523-1747.2003.12332.x; Li Y, 2012, ONCOGENE, V31, P4759, DOI 10.1038/onc.2011.637; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Li YM, 2011, CANCER RES, V71, P2108, DOI 10.1158/0008-5472.CAN-10-1998; Lin DL, 2001, PROSTATE, V47, P212, DOI 10.1002/pros.1065; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; McCall P, 2012, BRIT J CANCER, V107, P1554, DOI 10.1038/bjc.2012.372; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Morris MJ, 2007, J UROLOGY, V178, P2378, DOI 10.1016/j.juro.2007.08.015; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Nadiminty N, 2013, MOL CANCER THER, V12, P1629, DOI 10.1158/1535-7163.MCT-13-0027; Pacifico F, 2006, BIOCHEM PHARMACOL, V72, P1142, DOI 10.1016/j.bcp.2006.07.032; Papandreou CN, 2004, J CLIN ONCOL, V22, P2108, DOI 10.1200/JCO.2004.02.106; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Ross JS, 2004, CLIN CANCER RES, V10, P2466, DOI 10.1158/1078-0432.CCR-0543-3; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Setlur SR, 2007, CANCER RES, V67, P10296, DOI 10.1158/0008-5472.CAN-07-2173; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Taplin ME, 2005, UROLOGY, V66, P386, DOI 10.1016/j.urology.2005.03.040; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Yu X, 2011, ONCOGENE, V30, P1868, DOI 10.1038/onc.2010.560; Yuan X, 2014, ONCOGENE, V33, P2815, DOI 10.1038/onc.2013.235; Yuan X, 2009, UROL ONCOL-SEMIN ORI, V27, P36, DOI 10.1016/j.urolonc.2008.03.021; Zhang LY, 2009, AM J PATHOL, V175, P489, DOI 10.2353/ajpath.2009.080727	61	62	64	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	28					3700	3710		10.1038/onc.2014.302	http://dx.doi.org/10.1038/onc.2014.302			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM4TZ	25220414	Green Accepted			2022-12-25	WOS:000357679100008
J	Onish, C; Mori-Kimachi, S; Hirade, T; Abe, M; Taketani, T; Suzumiya, J; Sugimoto, T; Yamaguchi, S; Kapur, R; Fukuda, S				Onish, Chie; Mori-Kimachi, Satomi; Hirade, Tomohiro; Abe, Mariko; Taketani, Takeshi; Suzumiya, Junji; Sugimoto, Toshitsugu; Yamaguchi, Seiji; Kapur, Reuben; Fukuda, Seiji			Internal Tandem Duplication Mutations in FLT3 Gene Augment Chernotaxis to Cxcl12 Protein by Blocking the Down-regulation of the Rho-associated Kinase via the Cxcl12/Cxcr4 Signaling Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA STEM-CELLS; CHEMOKINE RECEPTOR; CXCR4; EXPRESSION; INHIBITOR; MIGRATION; SURVIVAL; ADHESION; BEHAVIOR; MODEL	Internal tandem duplication mutations in the Flt3 gene (ITD-FLT3) enhance cell migration toward the chemokine Cxcl12, which is highly expressed in the therapy-protective bone marrow niche, providing a potential mechanism underlying the poor prognosis of ITD-FLT3(+) acute myeloid leukemia. We aimed to investigate the mechanisms linking ITD-FLT3 to increased cell migration toward Cxcl12. Classification of the expression of Cxcl12-regulated genes in ITD-FLT3(+) cells demonstrated that the enhanced migration of ITD-FLT3(+) cells toward Cxcl12 was associated with the differential expression of genes downstream of Cxcl12/Cxcr4, which are functionally distinct from those expressed in ITD-FLT3(-) cells but are independent of the Cxcr4 expression levels. Among these differentially regulated genes, the expression of Rock] in the ITD-FLT3(+) cells that migrated toward Cxcl12 was significantly higher than in ITD-FLT3(-) cells that migrated toward Cxcl12. In ITD-FLT3(-) cells, Rock1 expression and Mypt1 phosphorylation were transiently up-regulated but were subsequently down-regulated by Cxcl12. In contrast, the presence of ITD-FLT3 blocked the Cxcl12-induced down-regulation of Rock1 and early Mypt1 dephosphorylation. Likewise, the FLT3 ligand counteracted the Cxcl12-induced down-regulation of Rock1 in ITD-FLT3(-) cells, which coincided with enhanced cell migration toward Cxcl12. Rock1 antagonists or Rock1 shRNA abolished the enhanced migration of ITD-FLT3(+) cells toward Cxcl12. Our findings demonstrate that ITD-FLT3 increases cell migration toward Cxcl12 by antagonizing the down-regulation of Rock1 expression. These findings suggest that the aberrant modulation of Rock1 expression and activity induced by ITD-FLT3 may enhance acute myeloid leukemia cell chemotaxis to the therapy-protective bone marrow niche, where Cxcl12 is abundantly expressed.	[Onish, Chie; Suzumiya, Junji] Shimane Univ, Sch Med, Dept Oncol Hematol, Izumo, Shimane 6938501, Japan; [Mori-Kimachi, Satomi; Hirade, Tomohiro; Abe, Mariko; Yamaguchi, Seiji; Fukuda, Seiji] Shimane Univ, Sch Med, Dept Pediat, Izumo, Shimane 6938501, Japan; [Sugimoto, Toshitsugu] Shimane Univ, Sch Med, Dept Internal Med 1, Izumo, Shimane 6938501, Japan; [Taketani, Takeshi] Shimane Univ Hosp, Div Blood Transfus, Izumo, Shimane 6938501, Japan; [Kapur, Reuben] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Kapur, Reuben] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA	Shimane University; Shimane University; Shimane University; Shimane University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Onish, C (corresponding author), Shimane Univ, Sch Med, Dept Oncol Hematol, Izumo, Shimane 6938501, Japan.	mikami@med.shimane-u.ac.jp; sfukuda@med.shimane-u.ac.jp		mori, satomi/0000-0002-8026-6954	Medical and Pharmaceutical Research Fund; Sankyo Biomedical Research Foundation; Mitsubishi Mother and Pharma Research Foundation; Japanese Leukemia Research Fund; Naito Foundation [20390298, 25461 593]; Japanese Society for the Promotion of Science [24791064]; NATIONAL CANCER INSTITUTE [R01CA173852, R01CA134777] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077177] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25461593] Funding Source: KAKEN	Medical and Pharmaceutical Research Fund; Sankyo Biomedical Research Foundation; Mitsubishi Mother and Pharma Research Foundation; Japanese Leukemia Research Fund; Naito Foundation(Naito Memorial Foundation); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research support funds from the Medical and Pharmaceutical Research Fund, the Sankyo Biomedical Research Foundation, the Mitsubishi Mother and Pharma Research Foundation, the Japanese Leukemia Research Fund, the Naito Foundation, Grants-in-aid for Scientific Research 20390298 and 25461 593 (to S. F.), and Grant-in-aid for Young Investigators 24791064 (to C.O.) from the Japanese Society for the Promotion of Science.	Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Basu S, 2005, BLOOD, V106, P485, DOI 10.1182/blood-2004-10-4145; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Choi YH, 2014, MOL CANCER RES, V12, P38, DOI 10.1158/1541-7786.MCR-12-0334; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Fiedler W, 2003, BLOOD, V102, P2763, DOI 10.1182/blood-2002-10-2998; Fukuda S, 2005, BLOOD, V105, P3117, DOI 10.1182/blood-2004-04-1440; Fukuda S, 2009, BLOOD, V114, P394, DOI 10.1182/blood-2008-11-188714; Fukumoto Y, 2013, CIRC J, V77, P2619, DOI 10.1253/circj.CJ-13-0443; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jacobi A, 2010, EXP HEMATOL, V38, P180, DOI 10.1016/j.exphem.2009.12.003; Ji Z, 2014, J IMMUNOL, V193, P2157, DOI 10.4049/jimmunol.1302702; Kelly LM, 2002, BLOOD, V99, P310, DOI 10.1182/blood.V99.1.310; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Mali RS, 2011, CANCER CELL, V20, P357, DOI 10.1016/j.ccr.2011.07.016; Mohle R, 2000, BRIT J HAEMATOL, V110, P563, DOI 10.1046/j.1365-2141.2000.02157.x; Moyer RA, 2007, LAB INVEST, V87, P807, DOI 10.1038/labinvest.3700595; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; Rombouts EJC, 2004, BLOOD, V104, P550, DOI 10.1182/blood-2004-02-0566; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Smith BD, 2004, BLOOD, V103, P3669, DOI 10.1182/blood-2003-11-3775; Smith CC, 2012, NATURE, V485, P260, DOI 10.1038/nature11016; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Struckhoff AP, 2010, J CELL SCI, V123, P401, DOI 10.1242/jcs.052167; Tavor S, 2004, CANCER RES, V64, P2817, DOI 10.1158/0008-5472.CAN-03-3693; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Vicente-Manzanares M, 2002, J IMMUNOL, V168, P400, DOI 10.4049/jimmunol.168.1.400; Voermans C, 2002, LEUKEMIA, V16, P650, DOI 10.1038/sj.leu.2402431; Wijtmans M, 2012, EUR J MED CHEM, V51, P184, DOI 10.1016/j.ejmech.2012.02.041; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311	32	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31053	31065		10.1074/jbc.M114.568287	http://dx.doi.org/10.1074/jbc.M114.568287			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25237195	hybrid, Green Published			2022-12-25	WOS:000344549900015
J	Jansen, S; Collins, A; Golden, L; Sokolova, O; Goode, BL				Jansen, Silvia; Collins, Agnieszka; Golden, Leslie; Sokolova, Olga; Goode, Bruce L.			Structure and Mechanism of Mouse Cyclase-associated Protein (CAP1) in Regulating Actin Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACANTHAMOEBA ACTOPHORIN ADF/COFILIN; FILAMENT TURNOVER; IN-VIVO; F-ACTIN; SRV2/CYCLASE-ASSOCIATED PROTEIN; SRV2/CAP COMPLEX; PORCINE BRAIN; COFILIN; PROFILIN; MONOMERS	Srv2/CAP is a conserved actin-binding protein with important roles in driving cellular actin dynamics in diverse animal, fungal, and plant species. However, there have been conflicting reports about whether the activities of Srv2/CAP are conserved, particularly between yeast and mammalian homologs. Yeast Srv2 has two distinct functions in actin turnover: its hexameric N-terminal-half enhances cofilin-mediated severing of filaments, while its C-terminal-half catalyzes dissociation of cofilin from ADP-actin monomers and stimulates nucleotide exchange. Here, we dissected the structure and function of mouse CAP1 to better understand its mechanistic relationship to yeast Srv2. Although CAP1 has a shorter N-terminal oligomerization sequence compared with Srv2, we find that the N-terminal-half of CAP1 (N-CAP1) forms hexameric structures with six protrusions, similar to N-Srv2. Further, N-CAP1 autonomously binds to F-actin and decorates the sides and ends of filaments, altering F-actin structure and enhancing cofilin-mediated severing. These activities depend on conserved surface residues on the helical-folded domain. Moreover, N-CAP1 enhances yeast cofilin-mediated severing, and conversely, yeast N-Srv2 enhances human cofilin-mediated severing, highlighting the mechanistic conservation between yeast and mammals. Further, we demonstrate that the C-terminal actin-binding beta-sheet domain of CAP1 is sufficient to catalyze nucleotide-exchange of ADP-actin monomers, while in the presence of cofilin this activity additionally requires the WH2 domain. Thus, the structures, activities, and mechanisms of mouse and yeast Srv2/CAP homologs are remarkably well conserved, suggesting that the same activities and mechanisms underlie many of the diverse actin-based functions ascribed to Srv2/CAP homologs in different organisms.	[Jansen, Silvia; Collins, Agnieszka; Golden, Leslie; Goode, Bruce L.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biol, Waltham, MA 02454 USA; [Sokolova, Olga] Moscow MV Lomonosov State Univ, Fac Biol, Moscow 119991, Russia	Brandeis University; Lomonosov Moscow State University	Goode, BL (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, 415 South St, Waltham, MA 02454 USA.	goode@brandeis.edu	Sokolova, Olga S/G-7794-2016		Russian Scientific Foundation [14-14-00234]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063691] Funding Source: NIH RePORTER	Russian Scientific Foundation(Russian Science Foundation (RSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Chen Xu for assistance with the Morgani electron microscope. The three-dimensional reconstruction of N-CAP1 was accomplished with grant support from the Russian Scientific Foundation (Project 14-14-00234) (to O. S.).	Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Balcer HI, 2003, CURR BIOL, V13, P2159, DOI 10.1016/S0960-9822(03)00907-2; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; Blanchoin L, 1998, J BIOL CHEM, V273, P25106, DOI 10.1074/jbc.273.39.25106; Brieher W, 2013, MOL BIOL CELL, V24, P2299, DOI 10.1091/mbc.E12-09-0694; Chaudhry F, 2014, CYTOSKELETON, V71, P351, DOI 10.1002/cm.21170; Chaudhry F, 2013, MOL BIOL CELL, V24, P31, DOI 10.1091/mbc.E12-08-0589; Chaudhry F, 2010, CYTOSKELETON, V67, P120, DOI 10.1002/cm.20429; Elam WA, 2013, FEBS LETT, V587, P1215, DOI 10.1016/j.febslet.2013.01.062; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; Graziano BR, 2013, J CELL BIOL, V201, P595, DOI 10.1083/jcb.201212059; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MABUCHI I, 1983, J CELL BIOL, V97, P1612, DOI 10.1083/jcb.97.5.1612; MACIVER SK, 1991, J CELL BIOL, V115, P1611, DOI 10.1083/jcb.115.6.1611; Makkonen M, 2013, J BIOL CHEM, V288, P984, DOI 10.1074/jbc.M112.435719; Mattila PK, 2004, MOL BIOL CELL, V15, P5158, DOI 10.1091/mbc.E04-06-0444; McCullough BR, 2008, J MOL BIOL, V381, P550, DOI 10.1016/j.jmb.2008.05.055; McCullough BR, 2011, BIOPHYS J, V101, P151, DOI 10.1016/j.bpj.2011.05.049; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; MINTZER KA, 1994, CELL SIGNAL, V6, P681, DOI 10.1016/0898-6568(94)90050-7; Moriyama K, 2002, BIOCHEM J, V365, P147, DOI 10.1042/BJ20020231; NISHIDA E, 1984, J BIOCHEM-TOKYO, V95, P399, DOI 10.1093/oxfordjournals.jbchem.a134620; NISHIDA E, 1985, BIOCHEMISTRY-US, V24, P1160, DOI 10.1021/bi00326a015; Normoyle KPM, 2012, J BIOL CHEM, V287, P35722, DOI 10.1074/jbc.M112.396051; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Ono S, 2013, J CELL SCI, V126, P3249, DOI 10.1242/jcs.128231; Quintero-Monzon O, 2009, J BIOL CHEM, V284, P10923, DOI 10.1074/jbc.M808760200; Shima F, 2000, MOL CELL BIOL, V20, P26, DOI 10.1128/MCB.20.1.26-33.2000; Suarez C, 2011, CURR BIOL, V21, P862, DOI 10.1016/j.cub.2011.03.064; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P111, DOI 10.1016/0304-3991(87)90078-7; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004	36	39	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30732	30742		10.1074/jbc.M114.601765	http://dx.doi.org/10.1074/jbc.M114.601765			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25228691	Green Published, hybrid			2022-12-25	WOS:000344549700048
J	Ugarte-Uribe, B; Muller, HM; Otsuki, M; Nickel, W; Garcia-Saez, AJ				Ugarte-Uribe, Begona; Mueller, Hans-Michael; Otsuki, Miki; Nickel, Walter; Garcia-Saez, Ana J.			Dynamin-related Protein 1 (Drp1) Promotes Structural Intermediates of Membrane Division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL FISSION; CONFORMATIONAL-CHANGES; PEROXISOMAL FISSION; CRYSTAL-STRUCTURE; MIDDLE DOMAIN; GTPASE; FIS1; MFF; RECRUITMENT; MID51	Drp1 is a dynamin-like GTPase that mediates mitochondrial and peroxisomal division in a process dependent on self-assembly and coupled to GTP hydrolysis. Despite the link between Drp1 malfunction and human disease, the molecular details of its membrane activity remain poorly understood. Here we reconstituted and directly visualized Drp1 activity in giant unilamellar vesicles. We quantified the effect of lipid composition and GTP on membrane binding and remodeling activity by fluorescence confocal microscopy and flow cytometry. In contrast to other dynamin relatives, Drp1 bound to both curved and flat membranes even in the absence of nucleotides. We also found that Drp1 induced membrane tubulation that was stimulated by cardiolipin. Moreover, Drp1 promoted membrane tethering dependent on the intrinsic curvature of the membrane lipids and on GTP. Interestingly, Drp1 concentrated at membrane contact surfaces and, in the presence of GTP, formed discrete clusters on the vesicles. Our findings support a role of Drp1 not only in the formation of lipid tubes but also on the stabilization of tightly apposed membranes, which are intermediate states in the process of mitochondrial fission.	[Ugarte-Uribe, Begona; Otsuki, Miki; Garcia-Saez, Ana J.] Max Planck Inst Intelligent Syst, D-70569 Stuttgart, Germany; [Ugarte-Uribe, Begona; Garcia-Saez, Ana J.] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Mueller, Hans-Michael; Nickel, Walter] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Ruprecht Karls University Heidelberg	Garcia-Saez, AJ (corresponding author), Interfac Inst Biochem, Hoppe Seyler Str 4, D-72076 Tubingen, Germany.	ana.garcia@uni-tuebingen.de	Saez, Ana J. Garcia/U-1611-2019	Muller, Hans-Michael/0000-0002-2384-7285	Max Planck Society; German Cancer Research Center; German Ministry for Education and Research (BMBF) [N.0312040]	Max Planck Society(Max Planck Society); German Cancer Research Center(Helmholtz Association); German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Max Planck Society, by the German Cancer Research Center, and by German Ministry for Education and Research (BMBF) Grant N.0312040.	Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Bhar D, 2006, J BIOL CHEM, V281, P17312, DOI 10.1074/jbc.M513530200; Bleicken S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035910; Bossy B, 2010, J ALZHEIMERS DIS, V20, pS513, DOI 10.3233/JAD-2010-100552; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Bustillo-Zabalbeitia I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102738; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chang CR, 2010, J BIOL CHEM, V285, P32494, DOI 10.1074/jbc.M110.142430; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Frohlich C, 2013, EMBO J, V32, P1280, DOI 10.1038/emboj.2013.74; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Garcia-Saez AJ, 2009, NAT STRUCT MOL BIOL, V16, P1178, DOI 10.1038/nsmb.1671; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Guo T, 2007, J CELL BIOL, V177, P289, DOI 10.1083/jcb.200609072; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Itoyama A, 2013, BIOL OPEN, V2, P998, DOI 10.1242/bio.20135298; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kobayashi S, 2007, EXP CELL RES, V313, P1675, DOI 10.1016/j.yexcr.2007.02.028; Koch A, 2005, MOL BIOL CELL, V16, P5077, DOI 10.1091/mbc.E05-02-0159; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Kozlovsky Y, 2003, BIOPHYS J, V85, P85, DOI 10.1016/S0006-3495(03)74457-9; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lackner LL, 2009, SCIENCE, V325, P874, DOI 10.1126/science.1176921; LEE YC, 1993, BIOPHYS J, V65, P1429, DOI 10.1016/S0006-3495(93)81206-2; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Lewis RNAH, 2000, BIOPHYS J, V79, P1455, DOI 10.1016/S0006-3495(00)76397-1; Li XL, 2003, J BIOL CHEM, V278, P17012, DOI 10.1074/jbc.M212031200; Loson OC, 2014, STRUCTURE, V22, P367, DOI 10.1016/j.str.2014.01.001; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Macdonald PJ, 2014, MOL BIOL CELL, V25, P1905, DOI 10.1091/mbc.E14-02-0728; Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Morlot S, 2013, ANNU REV BIOPHYS, V42, P629, DOI 10.1146/annurev-biophys-050511-102247; Morlot S, 2012, CELL, V151, P619, DOI 10.1016/j.cell.2012.09.017; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Naylor K, 2006, J BIOL CHEM, V281, P2177, DOI 10.1074/jbc.M507943200; Neumann S, 2013, J BIOL CHEM, V288, P25119, DOI 10.1074/jbc.M113.490474; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Palmer CS, 2013, J BIOL CHEM, V288, P27584, DOI 10.1074/jbc.M113.479873; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Rappoport JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002416; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Schrader M, 2012, BBA-MOL BASIS DIS, V1822, P1343, DOI 10.1016/j.bbadis.2011.12.014; Schumann U, 2008, TRENDS CELL BIOL, V18, P253, DOI 10.1016/j.tcb.2008.04.002; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Sever S, 2006, EMBO J, V25, P4163, DOI 10.1038/sj.emboj.7601298; Shnyrova AV, 2013, SCIENCE, V339, P1433, DOI 10.1126/science.1233920; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Strack S, 2012, J BIOL CHEM, V287, P10990, DOI 10.1074/jbc.M112.342105; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Temmerman K, 2009, J LIPID RES, V50, P1245, DOI 10.1194/jlr.D800043-JLR200; Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Wenger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071835; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200	75	44	44	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30645	30656		10.1074/jbc.M114.575779	http://dx.doi.org/10.1074/jbc.M114.575779			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25237193	Green Published, hybrid			2022-12-25	WOS:000344549700041
J	Du, X; Wang, JY; Diao, WT; Wang, L; Long, JF; Zhou, H				Du, Xiao; Wang, Jingyu; Diao, Wentao; Wang, Ling; Long, Jiafu; Zhou, Hao			A Genetically Modified Protein-Based Hydrogel for 3D Culture of AD293 Cells	PLOS ONE			English	Article							MOLECULAR HYDROGELS; DESIGN; ENCAPSULATION; SCAFFOLDS; BIOMATERIALS; RELEASE	Hydrogels have strong application prospects for drug delivery, tissue engineering and cell therapy because of their excellent biocompatibility and abundant availability as scaffolds for drugs and cells. In this study, we created hybrid hydrogels based on a genetically modified tax interactive protein-1 (TIP1) by introducing two or four cysteine residues in the primary structure of TIP1. The introduced cysteine residues were crosslinked with a four-armed poly (ethylene glycol) having their arm ends capped with maleimide residues (4-armed-PEG-Mal) to form hydrogels. In one form of the genetically modification, we incorporated a peptide sequence 'GRGDSP' to introduce bioactivity to the protein, and the resultant hydrogel could provide an excellent environment for a three dimensional cell culture of AD293 cells. The AD293 cells continued to divide and displayed a polyhedron or spindle-shape during the 3-day culture period. Besides, AD293 cells could be easily separated from the cell-gel constructs for future large-scale culture after being cultured for 3 days and treating hydrogel with trypsinase. This work significantly expands the toolbox of recombinant proteins for hydrogel formation, and we believe that our hydrogel will be of considerable interest to those working in cell therapy and controlled drug delivery.	[Du, Xiao; Wang, Jingyu; Diao, Wentao; Wang, Ling; Long, Jiafu; Zhou, Hao] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Du, Xiao; Wang, Jingyu; Diao, Wentao; Long, Jiafu; Zhou, Hao] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Wang, Ling] Nankai Univ, Coll Pharm, Tianjin 300071, Peoples R China	Nankai University; Nankai University; Nankai University	Long, JF (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	jflong@nankai.edu.cn; haozhou@nankai.edu.cn	Long, Jiafu/B-7420-2012; Zhou, Hao/G-9693-2019	Long, Jiafu/0000-0002-6625-0147; Zhou, Hao/0000-0001-6813-648X	National Natural Science Foundation of China [31370964, 31270815, 31100527]; State Key Laboratory of Medicinal Chemical Biology [20140211]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Medicinal Chemical Biology	This work was partially supported by the National Natural Science Foundation of China (31370964 to LW, 31270815 to JL and 31100527 to HZ) and the Open Fund of State Key Laboratory of Medicinal Chemical Biology (20140211 to HZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047; Bahney CS, 2011, FASEB J, V25, P1486, DOI 10.1096/fj.10-165514; Branco MC, 2010, BIOMATERIALS, V31, P9527, DOI 10.1016/j.biomaterials.2010.08.047; Chien HW, 2012, BIOMATERIALS, V33, P5706, DOI 10.1016/j.biomaterials.2012.04.031; DiMarco RL, 2012, ADV MATER, V24, P3923, DOI 10.1002/adma.201200051; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Esser-Kahn AP, 2008, ANGEW CHEM INT EDIT, V47, P3751, DOI 10.1002/anie.200705564; Esser-Kahn AP, 2008, J AM CHEM SOC, V130, P15820, DOI 10.1021/ja807095r; Foo CTSWP, 2009, P NATL ACAD SCI USA, V106, P22067, DOI 10.1073/pnas.0904851106; Gonen-Wadmany M, 2007, BIOMATERIALS, V28, P3876, DOI 10.1016/j.biomaterials.2007.05.005; Grove TZ, 2010, J AM CHEM SOC, V132, P14024, DOI 10.1021/ja106619w; Gu Z, 2011, ANAL CHEM, V83, P2324, DOI 10.1021/ac103236g; Hoyle CE, 2010, ANGEW CHEM INT EDIT, V49, P1540, DOI 10.1002/anie.200903924; Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044; Lim DW, 2007, BIOMACROMOLECULES, V8, P1463, DOI 10.1021/bm061059m; Liu JC, 2004, BIOMACROMOLECULES, V5, P497, DOI 10.1021/bm034340z; Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100; Lv LN, 2013, COLLOID SURFACE B, V108, P352, DOI 10.1016/j.colsurfb.2013.03.013; Mather BD, 2006, PROG POLYM SCI, V31, P487, DOI 10.1016/j.progpolymsci.2006.03.001; Mosiewicz KA, 2010, J AM CHEM SOC, V132, P5972, DOI 10.1021/ja9098164; Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332; Sengupta D, 2010, TISSUE ENG PART B-RE, V16, P285, DOI 10.1089/ten.teb.2009.0591; Straley KS, 2009, SOFT MATTER, V5, P114, DOI 10.1039/b808504h; Sui ZJ, 2007, ADV MATER, V19, P3377, DOI 10.1002/adma.200700092; Wang HM, 2014, ACS NANO, V8, P1475, DOI 10.1021/nn4054914; Wang HM, 2013, CHEM COMMUN, V49, P7448, DOI 10.1039/c3cc43711f; Wang HM, 2012, NANOSCALE, V4, P5259, DOI 10.1039/c2nr31149f; Wang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075727; Yamaguchi N, 2007, J AM CHEM SOC, V129, P3040, DOI 10.1021/ja0680358; Yan XJ, 2009, J MOL BIOL, V392, P967, DOI 10.1016/j.jmb.2009.07.060; Yang CB, 2013, ORG BIOMOL CHEM, V11, P6946, DOI 10.1039/c3ob40969d; Yang CH, 2012, J PHYS CHEM B, V116, P633, DOI 10.1021/jp209441r; Yu Donghyeon, 2013, Genomics & Informatics, V11, P200, DOI 10.5808/GI.2013.11.4.200; Yuan WW, 2008, J AM CHEM SOC, V130, P15760, DOI 10.1021/ja805634x; Zhang XL, 2012, ANGEW CHEM INT EDIT, V51, P4388, DOI 10.1002/anie.201108612; Zhu JM, 2012, BIOMACROMOLECULES, V13, P706, DOI 10.1021/bm201596w	36	4	4	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107949	10.1371/journal.pone.0107949	http://dx.doi.org/10.1371/journal.pone.0107949			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233088	Green Published, Green Submitted, gold			2022-12-25	WOS:000342921200066
J	Eder, SHK; Gigler, AM; Hanzlik, M; Winklhofer, M				Eder, Stephan H. K.; Gigler, Alexander M.; Hanzlik, Marianne; Winklhofer, Michael			Sub-Micrometer-Scale Mapping of Magnetite Crystals and Sulfur Globules in Magnetotactic Bacteria Using Confocal Raman Micro-Spectrometry	PLOS ONE			English	Article							RAY-ABSORPTION SPECTROSCOPY; GREIGITE FE3S4; CYTOCHROME-C; INDEPENDENT CHARACTERIZATION; VIBRATIONAL-SPECTRA; IRON-OXIDES; THIN-FILMS; BIOMINERALIZATION; DYNAMICS; MARINE	The ferrimagnetic mineral magnetite Fe3O4 is biomineralized by magnetotactic microorganisms and a diverse range of animals. Here we demonstrate that confocal Raman microscopy can be used to visualize chains of magnetite crystals in magnetotactic bacteria, even though magnetite is a poor Raman scatterer and in bacteria occurs in typical grain sizes of only 35-120 nm, well below the diffraction-limited optical resolution. When using long integration times together with low laser power (<0.25 mW) to prevent laser induced damage of magnetite, we can identify and map magnetite by its characteristic Raman spectrum (303, 535, 665 cm(-1)) against a large autofluorescence background in our natural magnetotactic bacteria samples. While greigite (cubic Fe3S4; Raman lines of 253 and 351 cm(-1)) is often found in the Deltaproteobacteria class, it is not present in our samples. In intracellular sulfur globules of Candidatus Magnetobacterium bavaricum (Nitrospirae), we identified the sole presence of cyclo-octasulfur (S-8: 151, 219, 467 cm(-1)), using green (532 nm), red (638 nm) and near-infrared excitation (785 nm). The Raman-spectra of phosphorous-rich intracellular accumulations point to orthophosphate in magnetic vibrios and to polyphosphate in magnetic cocci. Under green excitation, the cell envelopes are dominated by the resonant Raman lines of the heme cofactor of the b or c-type cytochrome, which can be used as a strong marker for label-free live-cell imaging of bacterial cytoplasmic membranes, as well as an indicator for the redox state.	[Eder, Stephan H. K.; Gigler, Alexander M.; Winklhofer, Michael] Univ Munich, Dept Earth & Environm Sci, Munich, Germany; [Gigler, Alexander M.] Ctr NanoSci CeNS, Munich, Germany; [Hanzlik, Marianne] Tech Univ Munich, Dept Chem, D-80290 Munich, Germany	University of Munich; Technical University of Munich; University of Munich	Winklhofer, M (corresponding author), Univ Munich, Dept Earth & Environm Sci, Munich, Germany.	michael@geophysik.uni-muenchen.de	Winklhofer, Michael/B-7349-2009	Winklhofer, Michael/0000-0003-1352-9723	Deutsche Forschungsgemeinschaft [Ed258/1-1, Wi1828/4-2]; Human Frontier Science Programme [RGP 13/2013]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontier Science Programme(Human Frontier Science Program)	This work was supported by Deutsche Forschungsgemeinschaft, www.dfg.de, grants Ed258/1-1 (to S.E.) and Wi1828/4-2 (to M.W.), and Human Frontier Science Programme, www.hfsp.org, grant RGP 13/2013 (to M.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAR F, 1974, ARCH BIOCHEM BIOPHYS, V165, P570, DOI 10.1016/0003-9861(74)90284-7; ADAR F, 1978, J PHYS CHEM-US, V82, P230, DOI 10.1021/j100491a019; Bazylinski DA, 2004, ARCH MICROBIOL, V182, P373, DOI 10.1007/s00203-004-0716-y; BAZYLINSKI DA, 1993, NATURE, V366, P218, DOI 10.1038/366218a0; Bazylinski DA, 2000, CHEM GEOL, V169, P319, DOI 10.1016/S0009-2541(00)00211-4; BICKNELLBROWN E, 1982, J RAMAN SPECTROSC, V12, P180, DOI 10.1002/jrs.1250120218; Bourdoiseau JA, 2011, J RAMAN SPECTROSC, V42, P496, DOI 10.1002/jrs.2729; Brem F, 2006, J R SOC INTERFACE, V3, P833, DOI 10.1098/rsif.2006.0133; BULKIN BJ, 1972, J AM CHEM SOC, V94, P1109, DOI 10.1021/ja00759a013; Chang L, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL032114; Chen SC, 2009, IEEE T MAGN, V45, P2280, DOI 10.1109/TMAG.2009.2016446; CORNILSEN BC, 1984, J MOL STRUCT, V117, P1, DOI 10.1016/0022-2860(84)87237-3; Dahl Christiane, 2006, V1, P21, DOI 10.1007/7171_002; De Gelder J, 2007, J RAMAN SPECTROSC, V38, P1133, DOI 10.1002/jrs.1734; de Jager HJ, 1998, J PHYS CHEM A, V102, P2838, DOI 10.1021/jp9730252; DEARAUJO FFT, 1986, BIOPHYS J, V50, P375, DOI 10.1016/S0006-3495(86)83471-3; deFaria DLA, 1997, J RAMAN SPECTROSC, V28, P873, DOI 10.1002/(SICI)1097-4555(199711)28:11<873::AID-JRS177>3.0.CO;2-B; Diebel CE, 2000, NATURE, V406, P299, DOI 10.1038/35018561; Docampo Roberto, 2006, V1, P53, DOI 10.1007/7171_003; Dunin-Borkowski RE, 1998, SCIENCE, V282, P1868, DOI 10.1126/science.282.5395.1868; Eckert B, 2003, TOP CURR CHEM, V231, P31, DOI 10.1007/b13181; Eder SHK, 2012, P NATL ACAD SCI USA, V109, P12022, DOI 10.1073/pnas.1205653109; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; FARINA M, 1990, NATURE, V343, P256, DOI 10.1038/343256a0; FRANK CJ, 1995, ANAL CHEM, V67, P777, DOI 10.1021/ac00101a001; FRANKEL RB, 1979, SCIENCE, V203, P1355, DOI 10.1126/science.203.4387.1355; GABER BP, 1978, BIOPHYS J, V22, P191, DOI 10.1016/S0006-3495(78)85484-8; Garrels R.M., 1965, SOLUTIONS MINERALS E; Gautier G, 1973, SPECTROCHIM ACTA, V80, P1193; George GN, 2008, J BACTERIOL, V190, P6376, DOI 10.1128/JB.00539-08; HAN S, 1989, J AM CHEM SOC, V111, P3505, DOI 10.1021/ja00192a003; Hanesch M, 2009, GEOPHYS J INT, V177, P941, DOI 10.1111/j.1365-246X.2009.04122.x; Hanzlik M, 2002, J MAGN MAGN MATER, V248, P258, DOI 10.1016/S0304-8853(02)00353-0; Hanzlik M, 2000, BIOMETALS, V13, P325, DOI 10.1023/A:1009214526685; Hanzlik M, 1996, EARTH PLANET SC LETT, V145, P125, DOI 10.1016/S0012-821X(96)00191-4; HEYWOOD BR, 1990, NATURWISSENSCHAFTEN, V77, P536, DOI 10.1007/BF01139266; Himmel D, 2009, BIOL CELL, V101, P43, DOI 10.1042/BC20080051; Jogler C, 2010, ENVIRON MICROBIOL, V12, P2466, DOI 10.1111/j.1462-2920.2010.02220.x; Jogler C, 2011, P NATL ACAD SCI USA, V108, P1134, DOI 10.1073/pnas.1012694108; Kalirai SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053368; Kalirai SS, 2012, CHEM GEOL, V300, P14, DOI 10.1016/j.chemgeo.2012.01.005; Kasama T, 2006, AM MINERAL, V91, P1216, DOI 10.2138/am.2006.2227; Keim CN, 2005, INT MICROBIOL, V8, P111; KIRSCHVINK JL, 1979, EARTH PLANET SC LETT, V44, P193, DOI 10.1016/0012-821X(79)90168-7; Klein K, 2012, BIOPHYS J, V102, P360, DOI 10.1016/j.bpj.2011.12.027; Kornig A, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/23/235403; Komeili A, 2012, FEMS MICROBIOL REV, V36, P232, DOI 10.1111/j.1574-6976.2011.00315.x; Lam KP, 2010, CHEM GEOL, V270, P110, DOI 10.1016/j.chemgeo.2009.11.009; Le Sage D, 2013, NATURE, V496, P486, DOI 10.1038/nature12072; Lee AP, 1998, J BIOL INORG CHEM, V3, P614, DOI 10.1007/s007750050274; Lee YJ, 2007, J BACTERIOL, V189, P7525, DOI 10.1128/JB.00782-07; Lefevre CT, 2013, ENVIRON MICROBIOL, V15, P2712, DOI 10.1111/1462-2920.12128; Lefevre CT, 2012, ISME J, V6, P440, DOI 10.1038/ismej.2011.97; Lefevre CT, 2011, ENVIRON MICROBIOL, V13, P538, DOI 10.1111/j.1462-2920.2010.02361.x; Li JH, 2010, EARTH PLANET SC LETT, V293, P368, DOI 10.1016/j.epsl.2010.03.007; Li YS, 2012, J MAGN MAGN MATER, V324, P1543, DOI 10.1016/j.jmmm.2011.11.065; Lin W, 2012, APPL ENVIRON MICROB, V78, P668, DOI 10.1128/AEM.06764-11; Lins U, 2004, ANTON LEEUW INT J G, V85, P335, DOI 10.1023/B:ANTO.0000020393.71843.b0; Lins U, 2007, GEOMICROBIOL J, V24, P43, DOI 10.1080/01490450601134317; LOWENSTAM HA, 1962, GEOL SOC AM BULL, V73, P435, DOI 10.1130/0016-7606(1962)73[435:MIDCIR]2.0.CO;2; Lubbe M, 2010, SURF SCI, V604, P679, DOI 10.1016/j.susc.2010.01.015; Majed N, 2010, ENVIRON SCI TECHNOL, V44, P8601, DOI 10.1021/es1016526; Majed N, 2009, ENVIRON SCI TECHNOL, V43, P5436, DOI 10.1021/es900251n; Maki JS, 2013, J MOL MICROB BIOTECH, V23, P270, DOI 10.1159/000351335; MANN S, 1990, NATURE, V343, P258, DOI 10.1038/343258a0; Mao XG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102810; Naresh M, 2009, IEEE T MAGN, V45, P4861, DOI 10.1109/TMAG.2009.2025184; Ogawa M, 2009, BIOCHEM BIOPH RES CO, V382, P370, DOI 10.1016/j.bbrc.2009.03.028; OKABAYASHI H, 1982, J AM CHEM SOC, V104, P5399, DOI 10.1021/ja00384a026; Okada M, 2012, P NATL ACAD SCI USA, V109, P28, DOI 10.1073/pnas.1107524108; Pan YX, 2005, EARTH PLANET SC LETT, V232, P109, DOI 10.1016/j.epsl.2005.01.006; Pasteris JD, 2001, CHEM GEOL, V180, P3, DOI 10.1016/S0009-2541(01)00302-3; Pickering IJ, 2001, BIOCHEMISTRY-US, V40, P8138, DOI 10.1021/bi0105532; Posfai M, 1998, AM MINERAL, V83, P1469, DOI 10.2138/am-1998-11-1235; Posfai M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00344; Prange A, 2002, MICROBIOL-SGM, V148, P267, DOI 10.1099/00221287-148-1-267; PRESTON CM, 1979, J PHYS CHEM-US, V83, P814, DOI 10.1021/j100470a011; PROKSCH RB, 1995, APPL PHYS LETT, V66, P2582, DOI 10.1063/1.113508; Prozorov T, 2013, MAT SCI ENG R, V74, P133, DOI 10.1016/j.mser.2013.04.002; Quintana C, 2004, J STRUCT BIOL, V147, P166, DOI 10.1016/j.jsb.2004.03.001; Rickard D, 2007, CHEM REV, V107, P514, DOI 10.1021/cr0503658; SCHACHTSCHNEIDER JH, 1963, SPECTROCHIM ACTA, V19, P117, DOI 10.1016/0371-1951(63)80096-X; SCOTT DW, 1964, J MOL SPECTROSC, V13, P313, DOI 10.1016/0022-2852(64)90079-7; Shebanova ON, 2003, J RAMAN SPECTROSC, V34, P845, DOI 10.1002/jrs 1056; Shebanova ON, 2003, J SOLID STATE CHEM, V174, P424, DOI 10.1016/S0022-4596(03)00294-9; Siponen MI, 2013, NATURE, V502, P681, DOI 10.1038/nature12573; SPIRO TG, 1972, P NATL ACAD SCI USA, V69, P2622, DOI 10.1073/pnas.69.9.2622; SPRING S, 1993, APPL ENVIRON MICROB, V59, P2397, DOI 10.1128/AEM.59.8.2397-2403.1993; Suzuki H, 1998, JPN J APPL PHYS 2, V37, pL1343, DOI 10.1143/JJAP.37.L1343; Tang Y, 2007, CHINESE J INORG CHEM, V23, P941; VALI H, 1987, EARTH PLANET SC LETT, V86, P389, DOI 10.1016/0012-821X(87)90235-4; WALCOTT C, 1979, SCIENCE, V205, P1027, DOI 10.1126/science.472725; WALKER MM, 1984, SCIENCE, V224, P751, DOI 10.1126/science.224.4650.751; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; Wang A, 1998, 29 ANN LUN PLAN SCI; Wang YZ, 2013, APPL ENVIRON MICROB, V79, P2813, DOI 10.1128/AEM.03635-12; Watanabe S, 2009, J JPN I MET, V73, P334, DOI 10.2320/jinstmet.73.334; Wenter R, 2009, ENVIRON MICROBIOL, V11, P1493, DOI 10.1111/j.1462-2920.2009.01877.x; WILLIAMS AC, 1994, J RAMAN SPECTROSC, V25, P95, DOI 10.1002/jrs.1250250113; Winklhofer M, 2014, GEOCHEM GEOPHY GEOSY, V15, P1558, DOI 10.1002/2013GC005121; WONG PTT, 1984, ANNU REV BIOPHYS BIO, V13, P1	101	25	25	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107356	10.1371/journal.pone.0107356	http://dx.doi.org/10.1371/journal.pone.0107356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233081	Green Submitted, Green Published, gold			2022-12-25	WOS:000342921200025
J	Kopera, E; Bal, W; Zivkovic, ML; Dvornyk, A; Kludkiewicz, B; Grzelak, K; Zhukov, I; Zagorski-Ostoja, W; Jaskolski, M; Krzywda, S				Kopera, Edyta; Bal, Wojciech; Zivkovic, Martina Lenarcic; Dvornyk, Angela; Kludkiewicz, Barbara; Grzelak, Krystyna; Zhukov, Igor; Zagorski-Ostoja, Wlodzimierz; Jaskolski, Mariusz; Krzywda, Szymon			Atomic Resolution Structure of a Protein Prepared by Non-Enzymatic His-Tag Removal. Crystallographic and NMR Study of GmSPI-2 Inhibitor	PLOS ONE			English	Article							CLEAVAGE; COMPLEX; FUSION; EFFICIENT; REAGENTS; PROGRAM; TRYPSIN	Purification of suitable quantity of homogenous protein is very often the bottleneck in protein structural studies. Overexpression of a desired gene and attachment of enzymatically cleavable affinity tags to the protein of interest made a breakthrough in this field. Here we describe the structure of Galleria mellonella silk proteinase inhibitor 2 (GmSPI-2) determined both by X-ray diffraction and NMR spectroscopy methods. GmSPI-2 was purified using a new method consisting in non-enzymatic His-tag removal based on a highly specific peptide bond cleavage reaction assisted by Ni(II) ions. The X-ray crystal structure of GmSPI-2 was refined against diffraction data extending to 0.98 angstrom resolution measured at 100 K using synchrotron radiation. Anisotropic refinement with the removal of stereochemical restraints for the well-ordered parts of the structure converged with R factor of 10.57% and R-free of 12.91%. The 3D structure of GmSPI-2 protein in solution was solved on the basis of 503 distance constraints, 10 hydrogen bonds and 26 torsion angle restraints. It exhibits good geometry and side-chain packing parameters. The models of the protein structure obtained by X-ray diffraction and NMR spectroscopy are very similar to each other and reveal the same beta(2)alpha beta fold characteristic for Kazal-family serine proteinase inhibitors.	[Kopera, Edyta; Bal, Wojciech; Dvornyk, Angela; Kludkiewicz, Barbara; Grzelak, Krystyna; Zhukov, Igor; Zagorski-Ostoja, Wlodzimierz] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Zivkovic, Martina Lenarcic] Natl Inst Chem, Slovenian NMR Ctr, Ljubljana, Slovenia; [Zhukov, Igor] Adam Mickiewicz Univ, NanoBioMed Ctr, Poznan, Poland; [Jaskolski, Mariusz; Krzywda, Szymon] Adam Mickiewicz Univ, Fac Chem, Dept Crystallog, PL-60780 Poznan, Poland; [Jaskolski, Mariusz] Polish Acad Sci, Inst Bioorgan Chem, Ctr Biocrystallog Res, Poznan, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; National Institute of Chemistry - Slovenia; Adam Mickiewicz University; Adam Mickiewicz University; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Krzywda, S (corresponding author), Adam Mickiewicz Univ, Fac Chem, Dept Crystallog, Grunwaldzka 6, PL-60780 Poznan, Poland.	szymon@amu.edu.pl	Zhukov, Igor/J-4069-2015	Zhukov, Igor/0000-0002-9912-1018; Jaskolski, Mariusz/0000-0003-1587-6489; Bal, Wojciech/0000-0003-3780-083X; Krzywda, Szymon/0000-0002-1216-3187	project "Metal-dependent peptide hydrolysis. Tools and mechanisms for biotechnology, toxicology and supramolecular chemistry" from the Foundation for Polish Science [TEAM/2009-4/1]; European Regional Development Fund resources within the framework of Operational Program Innovative Economy [POIG.01.01.02-14-007/08-00]; Centre for Preclinical Research and Technology (CePT); European Regional Development Fund; Innovative Economy, The National Cohesion Strategy of Poland; Slovenian Research Agency; Ministry of Higher Education, Science, and Technology of Republic of Slovenia [P1-242]; EN-FIST Center of Excellence	project "Metal-dependent peptide hydrolysis. Tools and mechanisms for biotechnology, toxicology and supramolecular chemistry" from the Foundation for Polish Science; European Regional Development Fund resources within the framework of Operational Program Innovative Economy; Centre for Preclinical Research and Technology (CePT); European Regional Development Fund(European Commission); Innovative Economy, The National Cohesion Strategy of Poland; Slovenian Research Agency(Slovenian Research Agency - Slovenia); Ministry of Higher Education, Science, and Technology of Republic of Slovenia; EN-FIST Center of Excellence	This research was supported in part by the project "Metal-dependent peptide hydrolysis. Tools and mechanisms for biotechnology, toxicology and supramolecular chemistry" (TEAM/2009-4/1) to WB from the Foundation for Polish Science, and by the project POIG.01.01.02-14-007/08-00 to WOZ, both co-financed from European Regional Development Fund resources within the framework of Operational Program Innovative Economy. The equipment used was sponsored in part by the Centre for Preclinical Research and Technology (CePT), a project co-sponsored by European Regional Development Fund and Innovative Economy, The National Cohesion Strategy of Poland, to IBB PAS. This work was also partly supported by Slovenian Research Agency and Ministry of Higher Education, Science, and Technology of Republic of Slovenia (www.arrs.gov.si), Program P1-242, to MLZ. and by the EN-FIST Center of Excellence (www.enfist.si), to IZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addlagatta A, 2001, ACTA CRYSTALLOGR D, V57, P649, DOI 10.1107/S0907444901003468; Allen G, 1996, INT J PEPT PROT RES, V48, P265; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diederichs K, 2006, ACTA CRYSTALLOGR D, V62, P96, DOI 10.1107/S0907444905031537; DiMarco S, 1997, STRUCTURE, V5, P1465; Dou F, 2000, PREP BIOCHEM BIOTECH, V30, P69, DOI 10.1080/10826060008544946; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hemmi H, 2005, BIOCHEMISTRY-US, V44, P9626, DOI 10.1021/bi0472806; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Humphreys DP, 1999, PROTEIN ENG, V12, P179, DOI 10.1093/protein/12.2.179; Humphreys DP, 2000, PROTEIN ENG, V13, P201, DOI 10.1093/protein/13.3.201; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Jenny RJ, 2003, PROTEIN EXPRES PURIF, V31, P1, DOI 10.1016/S1046-5928(03)00168-2; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kludkiewicz B, 2005, PROTEIN EXPRES PURIF, V43, P94, DOI 10.1016/j.pep.2005.06.011; Kopera E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036350; Kopera E, 2010, INORG CHEM, V49, P6636, DOI 10.1021/ic1005709; Krezel A, 2010, J AM CHEM SOC, V132, P3355, DOI 10.1021/ja907567r; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee TW, 2007, J MOL BIOL, V367, P527, DOI 10.1016/j.jmb.2007.01.008; Milner M, 2007, ACTA BIOCHIM POL, V54, P523, DOI 10.18388/abp.2007_3226; Milovic NM, 2003, CHEM-EUR J, V9, P5097, DOI 10.1002/chem.200304772; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nirmala X, 2001, EUR J BIOCHEM, V268, P2064, DOI 10.1046/j.1432-1327.2001.02084.x; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Redkiewicz P, 2012, PLANT BIOTECHNOL J, V10, P806, DOI 10.1111/j.1467-7652.2012.00698.x; Rimphanitchayakit V, 2010, DEV COMP IMMUNOL, V34, P377, DOI 10.1016/j.dci.2009.12.004; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shenoy RT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018838; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Thaimattam R, 2002, ACTA CRYSTALLOGR D, V58, P1448, DOI 10.1107/S0907444902011769; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang DD, 2005, ACTA CRYSTALLOGR E, V61, pM2610, DOI 10.1107/S1600536805036597; Wang JW, 2007, ACTA CRYSTALLOGR D, V63, P1254, DOI 10.1107/S0907444907054224; Waugh DS, 2011, PROTEIN EXPRES PURIF, V80, P283, DOI 10.1016/j.pep.2011.08.005; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wlodawer A, 2013, FEBS J, V280, P5705, DOI 10.1111/febs.12495; Wojtkowiak A, 2012, ACTA CRYSTALLOGR D, V68, P713, DOI 10.1107/S090744491200995X; Wuthrich K, 1986, NMR PROTEINS NUCL AC; YASHIRO M, 1997, J INORG BIOCHEM, V67, P225	47	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e106936	10.1371/journal.pone.0106936	http://dx.doi.org/10.1371/journal.pone.0106936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233114	gold, Green Submitted, Green Published			2022-12-25	WOS:000342921200011
J	Buckmaster, T; Dickman, CR; Johnston, MJ				Buckmaster, Tony; Dickman, Christopher R.; Johnston, Michael J.			Assessing Risks to Non-Target Species during Poison Baiting Programs for Feral Cats	PLOS ONE			English	Article							SMALL VERTEBRATE FAUNA; ORAL RABIES VACCINE; AUSTRALIAN ANIMALS; FELIS-CATUS; SODIUM FLUOROACETATE; TARGET-SPECIFICITY; WESTERN-AUSTRALIA; HEIRISSON PRONG; SENSITIVITY; PREY	Poison baiting is used frequently to reduce the impacts of pest species of mammals on agricultural and biodiversity interests. However, baiting may not be appropriate if non-target species are at risk of poisoning. Here we use a desktop decision tree approach to assess the risks to non-target vertebrate species in Australia that arise from using poison baits developed to control feral house cats (Felis catus). These baits are presented in the form of sausages with toxicant implanted in the bait medium within an acid-soluble polymer capsule (hard shell delivery vehicle, or HSDV) that disintegrates after ingestion. Using criteria based on body size, diet and feeding behaviour, we assessed 221 of Australia's 3,769 native vertebrate species as likely to consume cat-baits, with 47 of these likely to ingest implanted HSDVs too. Carnivorous marsupials were judged most likely to consume both the baits and HSDVs, with some large-bodied and ground-active birds and reptiles also consuming them. If criteria were relaxed, a further 269 species were assessed as possibly able to consume baits and 343 as possibly able to consume HSDVs; most of these consumers were birds. One threatened species, the Tasmanian devil (Sarcophilus harrisii) was judged as definitely able to consume baits with implanted HSDVs, whereas five threatened species of birds and 21 species of threatened mammals were rated as possible consumers. Amphibia were not considered to be at risk. We conclude that most species of native Australian vertebrates would not consume surface-laid baits during feral cat control programs, and that significantly fewer would be exposed to poisoning if HSDVs were employed. However, risks to susceptible species should be quantified in field or pen trials prior to the implementation of a control program, and minimized further by applying baits at times and in places where non-target species have little access.	[Buckmaster, Tony; Dickman, Christopher R.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Buckmaster, Tony] Univ Canberra, Invas Anim Cooperat Res Ctr, Canberra, ACT 2601, Australia; [Johnston, Michael J.] Dept Pk & Wildlife, Wanneroo, WA, Australia	University of Sydney; University of Canberra	Buckmaster, T (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	tony.buckmaster@canberra.edu.au	Buckmaster, Tony/S-2764-2019; Dickman, Christopher/Q-4662-2019	Dickman, Christopher/0000-0002-1067-3730; Buckmaster, Tony/0000-0001-9675-5763	Department of the Environment; Invasive Animals Cooperative Research Centre	Department of the Environment; Invasive Animals Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by the Department of the Environment, Water, Heritage and the Arts (Now Department of the Environment http://www.environment.gov.au) and the Invasive Animals Cooperative Research Centre (http://www.invasiveanimals.com/). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript	Algar D., 2007, Conservation Science Western Australia, V6, P109; Algar D, 2008, WILDLIFE RES, V35, P471, DOI 10.1071/WR07167; Algar D., 2004, Conservation Science Western Australia, V5, P131; Australian Pesticides and Veterinary Medicines Authority, 2010, REG PROC FACT SHEET; Banks PB, 2007, TRENDS ECOL EVOL, V22, P229, DOI 10.1016/j.tree.2007.02.006; Bergstrom DM, 2009, J APPL ECOL, V46, P73, DOI 10.1111/j.1365-2664.2008.01601.x; Bradshaw JWS, 2006, J NUTR, V136, p1927S, DOI 10.1093/jn/136.7.1927S; BRUNNER H, 1983, AUST WILDLIFE RES, V10, P129; Buckmaster T., 2010, IDENTIFICATION SITES; Burbidge AA, 2008, AUST J ZOOL, V56, P411, DOI 10.1071/ZO08027; CALVER MC, 1989, AUST WILDLIFE RES, V16, P625; Christidis L, 2008, SYSTEMATICS TAXONOMY; Clayton M, 2006, CSIRO LIST AUSTR VER; Cogger H, 2000, REPTILES AMPHIBIANS; Cox JG, 2006, TRENDS ECOL EVOL, V21, P674, DOI 10.1016/j.tree.2006.07.011; Croft David B., 2003, P332; Denny E., 2010, REV CAT ECOLOGY MANA; Department of the Environment Water Heritage and the Arts, 2009, AUSTR BIOL RES STUD; Department of the Environment Water Heritage and the Arts, 2008, BACKGR DOC THREAT AB; Dexter N, 1998, WILDLIFE RES, V25, P147, DOI 10.1071/WR97020; Dickman C., 1996, OVERVIEW IMPACTS FER; Dickman CR, 2006, MARSUPIALS, P199, DOI 10.1017/CBO9780511541889.009; Dickman CR., 2014, CARNIVORES AUSTR PRE, P241; Diment AN, 2010, THESIS U SYDNEY SYDN; EASON CT, 1991, WILDLIFE RES, V18, P445, DOI 10.1071/WR9910445; Fairbridge David, 2003, Australian Mammalogy, V25, P31; Fisher PM, 2005, NEW ZEAL J ZOOL, V32, P163, DOI 10.1080/03014223.2005.9518409; Forster G, 2010, THESIS LA TROBE U ME; GARNETT S, 1992, THREATENED EXTINCT B; Glen AS, 2007, MAMMAL REV, V37, P191, DOI 10.1111/j.1365-2907.2007.00108.x; Harding R, 1994, INTERPRETING PRECAUT, P252; Hetherington CA, 2007, WILDLIFE RES, V34, P467, DOI 10.1071/WR06140; Hughes C, 2011, J WILDLIFE MANAGE, V75, P385, DOI 10.1002/jwmg.47; Johnston M., 2011, Occasional Papers of the IUCN Species Survival Commission, V42, P182; Johnston M, 2010, A RYLAH I ENV RES TE; Johnston M., 2014, A RYLAH I ENV RES TE, V253; Johnston M., 2013, A RYLAH I ENV RES TE, V245; Johnston MJ, 2009, FIELD EFFICACY TRIAL; Johnston MJ, 1997, VERTEBRATE PEST RES, V3; Johnston MJ, 2008, P 14 AUSTR VERT PEST, P114; King C., 1984, IMMIGRANT KILLERS IN; Long JL, 2003, INTRO MAMMALS WORLD; Mahon Paul S., 2009, Ecological Management & Restoration, V10, pS59, DOI 10.1111/j.1442-8903.2009.00455.x; Marks CA, 2006, J WILDLIFE MANAGE, V70, P1119, DOI 10.2193/0022-541X(2006)70[1119:DPSIPT]2.0.CO;2; Martin GR, 2002, WILDLIFE RES, V29, P489, DOI 10.1071/WR01065; Martin GR, 2002, WILDLIFE RES, V29, P75, DOI 10.1071/WR00117; MCILROY JC, 1981, AUST WILDLIFE RES, V8, P385, DOI 10.1071/WR9810385; MCILROY JC, 1982, AUST WILDLIFE RES, V9, P505; MCILROY JC, 1982, AUST WILDLIFE RES, V9, P487, DOI 10.1071/WR9820487; MCILROY JC, 1981, AUST WILDLIFE RES, V8, P369; Menkhorst, 2001, FIELD GUIDE MAMMALS, V110; Miller LA, 1999, AM J REPROD IMMUNOL, V41, P279; Molsher R, 1999, WILDLIFE RES, V26, P593, DOI 10.1071/WR98058; Murphy Elaine C., 2007, P469; Oliver PM, 2007, AUST J ZOOL, V55, P197, DOI 10.1071/ZO07008; Olsen P., 1998, AUSTR PEST ANIMALS N; Olson CA, 2000, J WILDLIFE DIS, V36, P734, DOI 10.7589/0090-3558-36.4.734; Pizzey G., 1997, FIELD GUIDE BIRDS AU; Risbey DA, 1999, WILDLIFE RES, V26, P621; Risbey DA, 2000, WILDLIFE RES, V27, P223, DOI 10.1071/WR98092; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Salo P, 2010, ECOL MONOGR, V80, P531, DOI 10.1890/09-1260.1; SAVARIE PJ, 1983, B ENVIRON CONTAM TOX, V30, P122, DOI 10.1007/BF01610109; Steelman HG, 2000, J WILDLIFE DIS, V36, P744, DOI 10.7589/0090-3558-36.4.744; Tonkin B.A., 1979, CAT BEHAV PREDATORY; TWIGG LE, 1991, OIKOS, V61, P412, DOI 10.2307/3545249; TWIGG LE, 1989, AUST WILDLIFE RES, V16, P49; Wilson S., 2008, COMPLETE GUIDE REPTI; Woolley P.A., 1982, P13; Wroe S, 2004, P ROY SOC B-BIOL SCI, V271, P1203, DOI 10.1098/rspb.2004.2694	70	19	20	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107788	10.1371/journal.pone.0107788	http://dx.doi.org/10.1371/journal.pone.0107788			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229348	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900073
J	Hsu, CC; Chen, SC; Liu, CJ; Lu, T; Shen, CC; Hu, YW; Yeh, CM; Chen, PM; Chen, TJ; Hu, LY				Hsu, Chih-Chao; Chen, San-Chi; Liu, Chia-Jen; Lu, Ti; Shen, Cheng-Che; Hu, Yu-Wen; Yeh, Chiu-Mei; Chen, Pan-Ming; Chen, Tzeng-Ji; Hu, Li-Yu			Rheumatoid Arthritis and the Risk of Bipolar Disorder: A Nationwide Population-Based Study	PLOS ONE			English	Article							INFLAMMATORY DISEASE; DEPRESSION; AUTOIMMUNITY; IMMUNE; PATHOPHYSIOLOGY; ASSOCIATION; SYSTEM	Background: Studies have suggested that chronic inflammation plays an essential role in the pathophysiology of both rheumatoid arthritis (RA) and bipolar disorder. The most common clinical features associated with RA are anxiety and depression. The risk of bipolar disorder among patients with RA has not been characterized adequately. Objective: To determine the association between RA and the subsequent development of bipolar disorder and examine the risk factors for bipolar disorder among patients with RA. Methods: We identified patients who were diagnosed with RA in the Taiwan National Health Insurance Research Database. A comparison cohort was created by matching patients without RA with those with RA according to age, sex, and comorbidities. The occurrence of bipolar disorder was evaluated in both cohorts. Results: The RA cohort consisted of 2,570 patients, and the comparison cohort consisted of 2,570 matched control patients without RA. The incidence of bipolar disorder (incidence rate ratio = 2.13, 95% confidence interval [CI] = 1.12-4.24, P = .013) was higher among patients with RA than among control patients. Multivariate, matched regression models revealed that asthma (hazard ratio [HR] = 2.76, 95% CI 1.27-5.96, P = .010), liver cirrhosis (HR = 3.81, 95% CI = 1.04-14.02, P = .044), and alcohol use disorders (HR = 5.29, 95% CI = 1.71-16.37, P = .004) were independent risk factors for the development of bipolar disorder among patients with RA. Conclusion: RA might increase the incidence of bipolar disorder development. Based on our data, we suggest that, following RA diagnosis, greater attention be focused on women with asthma, liver cirrhosis, and alcohol use disorder. Prospective clinical studies of the relationship between RA and bipolar disorder are warranted.	[Hsu, Chih-Chao; Lu, Ti; Hu, Li-Yu] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Chen, San-Chi; Liu, Chia-Jen] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Liu, Chia-Jen; Hu, Yu-Wen; Hu, Li-Yu] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Liu, Chia-Jen; Hu, Yu-Wen; Hu, Li-Yu] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Shen, Cheng-Che] Taichung Vet Gen Hosp, Dept Psychiat, Chiayi Branch, Chiayi, Taiwan; [Hu, Yu-Wen] Taipei Vet Gen Hosp, Ctr Canc, Taipei, Taiwan; [Yeh, Chiu-Mei; Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Chen, Pan-Ming] Taipei Vet Gen Hosp, Yuanshan Branch, Dept Psychiat, Yilan, Taiwan; [Chen, Tzeng-Ji] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	Kaohsiung Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Hu, LY (corresponding author), Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan.	chrishuly@gmail.com	Chen, TJ/AAH-8430-2021	Hu, Yu-Wen/0000-0002-7983-415X	Taipei Veterans General Hospital [V103B-022, V103E10-001]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study was supported by a grant from Taipei Veterans General Hospital (V103B-022 and V103E10-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Bergman S, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-218; Berk M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-200; Brietzke E, 2009, J AFFECT DISORDERS, V116, P214, DOI 10.1016/j.jad.2008.12.001; Calabrese Leonard H., 1999, Journal of the American Osteopathic Association, V99, P313; Cutolo M, 2004, LUPUS, V13, P635, DOI 10.1191/0961203304lu1094oa; Cutolo M, 2004, AUTOIMMUN REV, V3, P193, DOI 10.1016/j.autrev.2003.08.003; Cutolo M, 2012, AUTOIMMUN REV, V11, pA460, DOI 10.1016/j.autrev.2011.11.014; Dickens C, 2002, PSYCHOSOM MED, V64, P52, DOI 10.1097/00006842-200201000-00008; Drake C, 2011, BRAIN BEHAV IMMUN, V25, P1113, DOI 10.1016/j.bbi.2011.02.008; Farren CK, 2012, CURR PSYCHIAT REP, V14, P659, DOI 10.1007/s11920-012-0320-9; Goldstein BI, 2009, J CLIN PSYCHIAT, V70, P1078, DOI 10.4088/JCP.08r04505; Hamdani Nora, 2012, Front Biosci (Elite Ed), V4, P2170; Hu LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073057; Khan NF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-1; Kivimaki M, 2013, MOL PSYCHIAT; Ko FY, 2013, INT J PSYCHIAT MED, V45, P15, DOI 10.2190/PM.45.1.b; Kocabayoglu Peri, 2013, Front Biosci (Schol Ed), V5, P217; Lai CH, 2012, CLIN EXP RHEUMATOL, V30, P358; Lai NS, 2013, ARTHRIT CARE RES, V27, P22146; Lampa J, 2012, P NATL ACAD SCI USA, V109, P12728, DOI 10.1073/pnas.1118748109; Liu HC, 2004, J NEUROIMMUNOL, V150, P116, DOI 10.1016/j.jneuroim.2004.01.006; Lu B, 2013, J RHEUMATOL; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Naik SR, 2013, RECENT PATENTS INFLA, V7, P62, DOI 10.2174/1872213X11307010062; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-43; Nicassio PM, 2010, J PSYCHOSOM RES, V68, P183, DOI 10.1016/j.jpsychores.2009.09.008; Pettinati HM, 2013, AM J PSYCHIAT, V170, P23, DOI 10.1176/appi.ajp.2012.12010112; Price AL, 2012, AM FAM PHYSICIAN, V85, P483; Rege S, 2013, AUST NZ J PSYCHIAT, V47, P1136, DOI 10.1177/0004867413499077; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Schoeyen HK, 2011, J AFFECT DISORDERS, V129, P68, DOI 10.1016/j.jad.2010.08.012; Shukla S, 2013, RECENT PATENTS INFLA, V7, P135, DOI 10.2174/1872213X11307020005; Stertz L, 2013, CURR OPIN PSYCHIATR, V26, P19, DOI 10.1097/YCO.0b013e32835aa4b4; Thomsen AF, 2005, BIPOLAR DISORD, V7, P351, DOI 10.1111/j.1399-5618.2005.00205.x; Torrey EF, 2001, BRAIN BEHAV IMMUN, V15, P401, DOI 10.1006/brbi.2001.0649; Wasserman AM, 2011, AM FAM PHYSICIAN, V84, P1245; Waxmonsky JA, 2005, GEN HOSP PSYCHIAT, V27, P321, DOI 10.1016/j.genhosppsych.2005.05.003; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975	39	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107512	10.1371/journal.pone.0107512	http://dx.doi.org/10.1371/journal.pone.0107512			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP5MS	25229610	Green Submitted, gold, Green Published			2022-12-25	WOS:000342123900045
J	Kim, D; Seo, H; Kim, HI; Jun, SC				Kim, Donghyeon; Seo, Hyeon; Kim, Hyoung-Ihl; Jun, Sung Chan			Computational Study on Subdural Cortical Stimulation - The Influence of the Head Geometry, Anisotropic Conductivity, and Electrode Configuration	PLOS ONE			English	Article							MOTOR CORTEX STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; ELECTRICAL-STIMULATION; WHITE-MATTER; RECOVERY; STROKE; BRAIN; MODEL; EXCITABILITY; ACTIVATION	Subdural cortical stimulation (SuCS) is a method used to inject electrical current through electrodes beneath the dura mater, and is known to be useful in treating brain disorders. However, precisely how SuCS must be applied to yield the most effective results has rarely been investigated. For this purpose, we developed a three-dimensional computational model that represents an anatomically realistic brain model including an upper chest. With this computational model, we investigated the influence of stimulation amplitudes, electrode configurations (single or paddle-array), and white matter conductivities (isotropy or anisotropy). Further, the effects of stimulation were compared with two other computational models, including an anatomically realistic brain-only model and the simplified extruded slab model representing the precentral gyrus area. The results of voltage stimulation suggested that there was a synergistic effect with the paddle-array due to the use of multiple electrodes; however, a single electrode was more efficient with current stimulation. The conventional model (simplified extruded slab) far overestimated the effects of stimulation with both voltage and current by comparison to our proposed realistic upper body model. However, the realistic upper body and full brain-only models demonstrated similar stimulation effects. In our investigation of the influence of anisotropic conductivity, model with a fixed ratio (1:10) anisotropic conductivity yielded deeper penetration depths and larger extents of stimulation than others. However, isotropic and anisotropic models with fixed ratios (1:2, 1:5) yielded similar stimulation effects. Lastly, whether the reference electrode was located on the right or left chest had no substantial effects on stimulation.	[Kim, Donghyeon; Seo, Hyeon; Jun, Sung Chan] Gwangju Inst Sci & Technol, Sch Informat & Commun, Kwangju, South Korea; [Kim, Hyoung-Ihl] Gwangju Inst Sci & Technol, Dept Med Syst Engn, Kwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Jun, SC (corresponding author), Gwangju Inst Sci & Technol, Sch Informat & Commun, Kwangju, South Korea.	scjun@gist.ac.kr	JUN, SUNG/AAJ-2677-2020	JUN, SUNG/0000-0001-5357-4436; Kim, Donghyeon/0000-0003-0047-0259	National Research Foundation (NRF) - Korean Government [NRF-2010-0026438]; PLSI supercomputing resources of Korea Institute of Science and Technology Information	National Research Foundation (NRF) - Korean Government(Korean Government); PLSI supercomputing resources of Korea Institute of Science and Technology Information	This work was supported by the National Research Foundation (NRF) funded by the Korean Government (NRF-2010-0026438) and PLSI supercomputing resources of Korea Institute of Science and Technology Information. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Muir DL, 2003, NEUROL RES, V25, P780, DOI 10.1179/016164103771953853; Attene M, 2010, VISUAL COMPUT, V26, P1393, DOI 10.1007/s00371-010-0416-3; BARKER AT, 1985, LANCET, V1, P1106; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Benabid AL, 1996, J NEUROSURG, V84, P203, DOI 10.3171/jns.1996.84.2.0203; Bezard E, 1999, NEUROSURGERY, V45, P346, DOI 10.1097/00006123-199908000-00030; Bikson M, 2004, J PHYSIOL-LONDON, V557, P175, DOI 10.1113/jphysiol.2003.055772; Brown JA, 2006, NEUROSURGERY, V58, P464, DOI 10.1227/01.NEU.0000197100.63931.04; Butefisch CM, 2004, J NEUROPHYSIOL, V91, P2110, DOI 10.1152/jn.01038.2003; Canavero S, 2002, J NEUROSURG, V97, P1208, DOI 10.3171/jns.2002.97.5.1208; Cherney LR, 2012, APHASIOLOGY, V26, P1192, DOI 10.1080/02687038.2011.603719; Datta A, 2011, BRAIN STIMUL, V4, P169, DOI 10.1016/j.brs.2010.11.001; Dmochowski JP, 2013, NEUROIMAGE, V75, P12, DOI 10.1016/j.neuroimage.2013.02.049; Fang QQ, 2009, I S BIOMED IMAGING, P1142, DOI 10.1109/ISBI.2009.5193259; Furlan M, 1996, ANN NEUROL, V40, P216, DOI 10.1002/ana.410400213; Gullmar D, 2010, NEUROIMAGE, V51, P145, DOI 10.1016/j.neuroimage.2010.02.014; Han X, 2007, IEEE T MED IMAGING, V26, P479, DOI 10.1109/TMI.2007.893282; Hosomi K, 2008, CLIN NEUROPHYSIOL, V119, P993, DOI 10.1016/j.clinph.2007.12.022; Im CH, 2012, PHYS MED BIOL, V57, P2137, DOI 10.1088/0031-9155/57/8/2137; Katayama Y, 1997, STEREOT FUNCT NEUROS, V69, P73, DOI 10.1159/000099855; Kim D, 2012, IEEE ENG MED BIO, P867, DOI 10.1109/EMBC.2012.6346069; Kim DY, 2011, IEEE ENG MED BIO, P7226, DOI 10.1109/IEMBS.2011.6091826; Kim HI, 2008, SURG NEUROL, V69, P77, DOI 10.1016/j.surneu.2006.12.055; Kowalski T, 2002, BIOELECTROMAGNETICS, V23, P421, DOI 10.1002/bem.10036; Lee WH, 2012, NEUROIMAGE, V59, P2110, DOI 10.1016/j.neuroimage.2011.10.029; Manola L, 2005, MED BIOL ENG COMPUT, V43, P335, DOI 10.1007/BF02345810; Manola L, 2007, CLIN NEUROPHYSIOL, V118, P464, DOI 10.1016/j.clinph.2006.09.012; Moro E, 2011, BRAIN, V134, P2096, DOI 10.1093/brain/awr072; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; Nahas Z, 2010, BIOL PSYCHIAT, V67, P101, DOI 10.1016/j.biopsych.2009.08.021; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Park JS, 2006, CLIN ANAT, V19, P216, DOI 10.1002/ca.20275; Priori A, 2007, LANCET NEUROL, V6, P279, DOI 10.1016/S1474-4422(07)70056-X; Radman T, 2009, BRAIN STIMUL, V2, P215, DOI 10.1016/j.brs.2009.03.007; Rahman A, 2013, J PHYSIOL-LONDON, V591, P2563, DOI 10.1113/jphysiol.2012.247171; Rainov NG, 1997, CLIN NEUROL NEUROSUR, V99, P205, DOI 10.1016/S0303-8467(97)00017-6; Rattay F, 1999, NEUROSCIENCE, V89, P335, DOI 10.1016/S0306-4522(98)00330-3; RATTAY F, 1986, IEEE T BIO-MED ENG, V33, P974, DOI 10.1109/TBME.1986.325670; Rossini PM, 2003, LANCET NEUROL, V2, P493, DOI 10.1016/S1474-4422(03)00485-X; Salvador R, 2011, CLIN NEUROPHYSIOL, V122, P748, DOI 10.1016/j.clinph.2010.09.022; Seo H, 2012, IEEE ENG MED BIO, P1892, DOI 10.1109/EMBC.2012.6346322; Si H, 2006, PROCEEDINGS OF THE 15TH INTERNATIONAL MESHING ROUNDTABLE, P509, DOI 10.1007/978-3-540-34958-7_29; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135; Suh HS, 2012, PHYS MED BIOL, V57, P6961, DOI 10.1088/0031-9155/57/21/6961; Vingerhoets FJG, 2002, NEUROLOGY, V58, P396, DOI 10.1212/WNL.58.3.396; Vonck K, 2002, ANN NEUROL, V52, P556, DOI 10.1002/ana.10323; Wagner T, 2006, NEUROIMAGE, V30, P857, DOI 10.1016/j.neuroimage.2005.04.046; Ward NS, 2004, ARCH NEUROL-CHICAGO, V61, P1844, DOI 10.1001/archneur.61.12.1844; Windhoff M, 2013, HUM BRAIN MAPP, V34, P923, DOI 10.1002/hbm.21479; Wongsarnpigoon A, 2012, CLIN NEUROPHYSIOL, V123, P160, DOI 10.1016/j.clinph.2011.06.005; Wongsarnpigoon A, 2008, J NEURAL ENG, V5, P443, DOI 10.1088/1741-2560/5/4/009; Zwartjes DGM, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/5/056005	54	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e108028	10.1371/journal.pone.0108028	http://dx.doi.org/10.1371/journal.pone.0108028			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229673	Green Submitted, Green Published, gold			2022-12-25	WOS:000342123900092
J	Resende, AL; dos Reis, LM; Dias, CB; Custodio, MR; Jorgetti, V; Woronik, V				Resende, Aline Lazara; dos Reis, Luciene Machado; Dias, Cristiane Bitencourt; Custodio, Melani Ribeiro; Jorgetti, Vanda; Woronik, Viktoria			Bone Disease in Newly Diagnosed Lupus Nephritis Patients	PLOS ONE			English	Article							GLUCOCORTICOID-INDUCED OSTEOPOROSIS; VITAMIN-D DEFICIENCY; MINERAL DENSITY; RHEUMATOID-ARTHRITIS; NEPHROTIC SYNDROME; IMMUNE-SYSTEM; RISK-FACTORS; ERYTHEMATOSUS PATIENTS; PREMENOPAUSAL WOMEN; TRABECULAR BONE	Introduction: Bone loss in Lupus Nephritis (LN) patients is common and multifactorial. The aim of this study was to evaluate the bone status of newly diagnosed LN patients and their correlation with inflammatory factors involved in LN physiopathology. Methods: We studied 15 pre-menopausal patients with <= 2 months of diagnosed SLE and LN. Patients with prior kidney or bone disease were excluded. In addition to biochemical evaluation (including 25-hydroxyvitamin D-3 [25(OH)D] and Monocyte Chemotactic Protein (MCP1) dosage), we performed bone biopsies followed by osteoblast culture, histomorphometric and immunohistochemistry analysis. Results: LN patients presented a mean age of 29.5 +/- 10 years, a proteinuria of 4.7 +/- 2.9 g/day and an estimated glomerular filtration rate (GFR) of 37(31-87) ml/min/1,73 m(2). They were on glucocorticoid therapy for 34 +/- 12 days. All patients presented vitamin D insufficiency (9.9 +/- 4.4 ng/ml, range 4-20). Urinary MCP1 correlated negatively with 25(OH)D (r = -0.53, p = 0.003) and positively with serum deoxypyridinoline (r = -0.53, p = 0.004). Osteoblasts isolated from LN bone biopsies presented a significantly higher expression of MCP-1 when compared to controls (32.0 +/- 9.1 vs. 22.9 +/- 5.3 mean fluorescence intensities, p = 0.01). LN patients presented a significantly reduced osteoid volume, osteoid thickness, osteoid surface, mineralization surface and bone formation rate, associated with an increased eroded surface and osteoclast surface. Patient's bone specimens demonstrated a reduced immunostaining for osteoprotegerin (0.61 +/- 0.82 vs. 1.08 +/- 0.50%, p = 0.003), and an increased expression of Receptor Activator of NF-kappa B ligand (RANKL) (1.76 +/- 0.92 vs. 0.41 +/- 0.28%, p<0.001) when compared to controls. Discussion: Newly diagnosed LN patients presented a significant disturbance in bone metabolism, characterized by an impaired bone formation and mineralization, associated with an increase in resorption parameters. Glucocorticoid use, vitamin D insufficiency and inflammation might be involved in the physiopathology of bone metabolism disturbance.	[Resende, Aline Lazara; dos Reis, Luciene Machado; Dias, Cristiane Bitencourt; Custodio, Melani Ribeiro; Jorgetti, Vanda; Woronik, Viktoria] Univ Sao Paulo, Sch Med, Div Nephrol, Sao Paulo, Brazil	Universidade de Sao Paulo	Resende, AL (corresponding author), Univ Sao Paulo, Sch Med, Div Nephrol, Sao Paulo, Brazil.	alinelr@usp.br	Woronik, Viktoria/AAY-4763-2020; dos Reis, Luciene M/C-7143-2013; JORGETTI, VANDA/C-9470-2012; Custodio, Melani R/L-9509-2015	dos Reis, Luciene M/0000-0001-8476-6780; JORGETTI, VANDA/0000-0002-4824-8879; Ribeiro Custodio, Melani/0000-0001-6358-8727; Woronik, Viktoria/0000-0002-8318-142X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/15409-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial support was provided by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Foundation for the Support of Research in the state of Sao Paulo) (Grant number 2010/15409-3). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Raya A, 2013, J RHEUMATOL, V40, P265, DOI 10.3899/jrheum.111594; Aggarwal R, 2006, EXP HEMATOL, V34, P1289, DOI 10.1016/j.exphem.2006.06.017; Al-Badr W, 2008, CLIN J AM SOC NEPHRO, V3, P1555, DOI 10.2215/CJN.01150308; Alele JD, 2010, AUTOIMMUN REV, V9, P137, DOI 10.1016/j.autrev.2009.05.001; Almehed K, 2007, RHEUMATOLOGY, V46, P1185, DOI 10.1093/rheumatology/kem105; Atkins GJ, 2007, BONE, V40, P1517, DOI 10.1016/j.bone.2007.02.024; Bogaczewicz J, 2012, LUPUS, V21, P477, DOI 10.1177/0961203311427549; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Borba VZC, 2009, OSTEOPOROSIS INT, V20, P427, DOI 10.1007/s00198-008-0676-1; Bultink IEM, 2005, ARTHRITIS RHEUM, V52, P2044, DOI 10.1002/art.21110; Bultink IEM, 2012, ARTHRIT CARE RES, V64, P2, DOI 10.1002/acr.20568; Caetano-Lopes J, 2009, AUTOIMMUN REV, V8, P250, DOI 10.1016/j.autrev.2008.07.038; Carbonare LD, 2005, MICRON, V36, P645, DOI 10.1016/j.micron.2005.07.009; Chun HY, 2007, J CLIN IMMUNOL, V27, P461, DOI 10.1007/s10875-007-9104-0; Clowes JA, 2005, IMMUNOL REV, V208, P207, DOI 10.1111/j.0105-2896.2005.00334.x; Cutolo M, 2007, AUTOIMMUN REV, V7, P59, DOI 10.1016/j.autrev.2007.07.001; Davas EM, 1999, CLIN RHEUMATOL, V18, P17, DOI 10.1007/s100670050045; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; DEMPSTER DW, 1989, J BONE MINER RES, V4, P137; DHILLON VB, 1990, ANN RHEUM DIS, V49, P624, DOI 10.1136/ard.49.8.624; Dias CB, 2007, KIDNEY INT, V71, P562, DOI 10.1038/sj.ki.5002084; Ding C, 2008, J CLIN ENDOCR METAB, V93, P1952, DOI 10.1210/jc.2007-2325; Dos Reis LM, 2007, J BONE MINER METAB, V25, P400, DOI 10.1007/s00774-007-0778-4; Edwards CJ, 2010, OSTEOPOROSIS INT, V21, P1287, DOI 10.1007/s00198-010-1192-7; FORMIGA F, 1995, ANN RHEUM DIS, V54, P274, DOI 10.1136/ard.54.4.274; Foundation NO, 2009, NAT OST FDN CLIN GUI; Gilboe IM, 2000, ANN RHEUM DIS, V59, P110, DOI 10.1136/ard.59.2.110; Gomes SA, 2008, J BONE MINER METAB, V26, P110, DOI 10.1007/s00774-007-0788-2; Graves Dana T., 1999, Frontiers in Bioscience, V4, pd571, DOI 10.2741/Graves; Grossman JM, 2010, ARTHRIT CARE RES, V62, P1515, DOI 10.1002/acr.20295; Hansen M, 1998, SCAND J RHEUMATOL, V27, P197; Holick MF, 2006, VITAMIN D PHOTOBIOLO, P106; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; HORTON JE, 1972, SCIENCE, V177, P793, DOI 10.1126/science.177.4051.793; Houssiau FA, 1996, BRIT J RHEUMATOL, V35, P244; Jardinet D, 2000, RHEUMATOLOGY, V39, P389, DOI 10.1093/rheumatology/39.4.389; KALLA AA, 1993, ARTHRITIS RHEUM, V36, P1726, DOI 10.1002/art.1780361212; KHAMISEH G, 1991, P SOC EXP BIOL MED, V196, P210, DOI 10.3181/00379727-196-43181; Kiani AN, 2009, J RHEUMATOL, V36, P2224, DOI 10.3899/jrheum.081112; Kim MS, 2006, J CELL BIOCHEM, V97, P512, DOI 10.1002/jcb.20649; Kipen Y, 1997, J RHEUMATOL, V24, P1922; KOCH AE, 1992, J CLIN INVEST, V90, P772, DOI 10.1172/JCI115950; Lakshminarayanan S, 2001, J RHEUMATOL, V28, P102; Lee C, 2006, RHEUMATOLOGY, V45, P53, DOI 10.1093/rheumatology/kei079; Lee C, 2005, RHEUM DIS CLIN N AM, V31, P363, DOI 10.1016/j.rdc.2005.01.004; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li X, 2007, J BIOL CHEM, V282, P33098, DOI 10.1074/jbc.M611781200; Li Y, 2006, AUTOIMMUN REV, V5, P383, DOI 10.1016/j.autrev.2005.10.006; LOCASCIO V, 1990, BONE MINER, V8, P39, DOI 10.1016/0169-6009(91)90139-Q; Lu Y, 2007, CANCER RES, V67, P3646, DOI 10.1158/0008-5472.CAN-06-1210; MALLUCHE HH, 1979, J CLIN INVEST, V63, P494, DOI 10.1172/JCI109327; MALLUCHE HH, 1986, ATLAS MINERALIZED BO, P17; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; McLean Robert R, 2009, Curr Osteoporos Rep, V7, P134; MELSEN F, 1978, CALC TISS RES, V26, P99, DOI 10.1007/BF02013242; Mittal SK, 1999, KIDNEY INT, V55, P1912, DOI 10.1046/j.1523-1755.1999.00413.x; Mok CC, 2012, RHEUMATOLOGY, V51, P644, DOI 10.1093/rheumatology/ker212; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Okamoto K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3323; Orlic ZC, 2010, J CLIN DENSITOM, V13, P36, DOI 10.1016/j.jocd.2009.12.002; Ormsby R.T., 2013, J STEROID BIOCH MOL; PACIFICI R, 1987, P NATL ACAD SCI USA, V84, P4616, DOI 10.1073/pnas.84.13.4616; Physicians RCo, 2003, GUID PREV TREATM GLU; Redlich K, 2000, ANN RHEUM DIS, V59, P308, DOI 10.1136/ard.59.4.308; ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826; Rosa RF, 2012, J RHEUMATOL, V39, P1948, DOI 10.3899/jrheum.110201; Rovin BH, 2005, J AM SOC NEPHROL, V16, P467, DOI 10.1681/ASN.2004080658; Rovin BH, 2008, FRONT BIOSCI-LANDMRK, V13, P904, DOI 10.2741/2731; Rovin BH, 2009, CLIN J AM SOC NEPHRO, V4, P1858, DOI 10.2215/CJN.03530509; Ruiz-Irastorza G, 2008, RHEUMATOLOGY, V47, P920, DOI 10.1093/rheumatology/ken121; Sabry A, 2006, CYTOKINE, V35, P148, DOI 10.1016/j.cyto.2006.07.023; Saraiva GL, 2005, OSTEOPOROSIS INT, V16, P1649, DOI 10.1007/s00198-005-1895-3; SCHMIDTGAYK H, 1977, LANCET, V2, P105; Schoppet M, 2002, ARTERIOSCL THROM VAS, V22, P549, DOI 10.1161/01.ATV.0000012303.37971.DA; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Sels F, 1996, LUPUS, V5, P89, DOI 10.1177/096120339600500202; Sims NA, 2012, CURR OSTEOPOROS REP, V10, P109, DOI 10.1007/s11914-012-0096-1; Sinigaglia L, 1999, J RHEUMATOL, V26, P1280; Sumethkul K, 2013, RHEUMATOL INT, V33, P1461, DOI 10.1007/s00296-012-2537-7; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Unger MD, 2010, CLIN NUTR, V29, P784, DOI 10.1016/j.clnu.2010.06.009; Van Staa TP, 2003, ARTHRITIS RHEUM, V48, P3224, DOI 10.1002/art.11283; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Weinstein RS, 2012, ENDOCRIN METAB CLIN, V41, P595, DOI 10.1016/j.ecl.2012.04.004; Weinstein RS, 2011, NEW ENGL J MED, V365, P62, DOI 10.1056/NEJMcp1012926; Weinstein RS, 2010, AGING CELL, V9, P147, DOI 10.1111/j.1474-9726.2009.00545.x; Weisinger JR, 1996, KIDNEY INT, V49, P244, DOI 10.1038/ki.1996.34; WERGEDAL JE, 1984, P SOC EXP BIOL MED, V176, P60; Wise GE, 2002, CRIT REV ORAL BIOL M, V13, P323, DOI 10.1177/154411130201300403; Zhou SH, 2013, J STEROID BIOCHEM, V136, P342, DOI 10.1016/j.jsbmb.2012.09.009	93	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e106728	10.1371/journal.pone.0106728	http://dx.doi.org/10.1371/journal.pone.0106728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229495	gold, Green Published, Green Submitted			2022-12-25	WOS:000342123900011
J	Weaver, ERN; Pane, M; Wandra, T; Windiyaningsih, C; Samaan, HG				Weaver, Emma Rosamond Nony; Pane, Masdalina; Wandra, Toni; Windiyaningsih, Cicilia; Samaan, Herlina Gina			Factors that Influence Adherence to Antiretroviral Treatment in an Urban Population, Jakarta, Indonesia	PLOS ONE			English	Article							THERAPY; PREDICTORS; HIV/AIDS; PROTEASE	Introduction: Although the number of people receiving antiretroviral therapy (ART) in Indonesia has increased in recent years, little is known about the specific characteristics affecting adherence in this population. Indonesia is different from most of its neighbors given that it is a geographically and culturally diverse country, with a large Muslim population. We aimed to identify the current rate of adherence and explore factors that influence ART adherence. Methods: Data were collected from ART-prescribed outpatients on an HIV registry at a North Jakarta hospital in 2012. Sociodemographic and behavioral characteristics were explored as factors associated with adherence using logistics regression analyses. Chi squared test was used to compare the difference between proportions. Reasons for missing medication were analyzed descriptively. Results: Two hundred and sixty-one patients participated, of whom 77% reported ART adherence in the last 3 months. The level of social support experienced was independently associated with adherence where some social support (p = 0.018) and good social support (p = 0.039) improved adherence compared to poor social support. Frequently cited reasons for not taking ART medication included forgetting to take medication (67%), busy with something else (63%) and asleep at medication time (60%). Discussion: This study identified that an increase in the level of social support experienced by ART-prescribed patients was positively associated with adherence. Social support may minimize the impact of stigma among ART prescribed patients. Based on these findings, if social support is not available, alternative support through community-based organizations is recommended to maximize treatment success.	[Pane, Masdalina; Wandra, Toni; Windiyaningsih, Cicilia] Minist Hlth Republ Indonesia, Sulianti Saroso Infect Dis Hosp, North Jakarta, Jakarta Provinc, Indonesia; [Samaan, Herlina Gina] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia	Ministry of Health - Indonesia; Australian National University	Pane, M (corresponding author), Minist Hlth Republ Indonesia, Sulianti Saroso Infect Dis Hosp, North Jakarta, Jakarta Provinc, Indonesia.	masdalina.pane@gmail.com	WANDRA, TONI/AAD-5736-2021; Pane, M/AGP-8366-2022	Pane, M/0000-0002-3697-4945; Wandra, Toni/0000-0002-4606-5411; cicilia, windiyaningsih/0000-0003-2193-2627				Ammassari A, 2002, JAIDS, V31, pS123, DOI 10.1097/00126334-200212153-00007; Bangsberg D, 2000, AIDS PATIENT CARE ST, V14; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Chesney MA, 2000, CLIN INFECT DIS, V30, pS171, DOI 10.1086/313849; Habib AG, 2009, AIDS BEHAV, V13, P42, DOI 10.1007/s10461-008-9412-2; Hardon A., 2006, ACCESS ADHERENCE CHA; Kimmerling M, 2003, INT J STD AIDS, V14, P281, DOI 10.1258/095646203321264917; Kleeberger CA, 2001, J ACQ IMMUN DEF SYND, V26, P82, DOI 10.1097/00126334-200101010-00012; Konkle-Parker DJ, 2008, J ASSOC NURSE AIDS C, V19, P98, DOI 10.1016/j.jana.2007.09.005; Kranzer K, 2011, TROP MED INT HEALTH, V16, P1297, DOI 10.1111/j.1365-3156.2011.02828.x; Li L, 2010, NURS HEALTH SCI, V12, P212, DOI 10.1111/j.1442-2018.2010.00521.x; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Murphy DA, 2004, AIDS CARE, V16, P471, DOI 10.1080/09540120410001683402; National AIDS Commision, 2012, REP IND COUNTR REP F; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Paxton S, 2007, ASIA-PAC J PUBLIC HE, V19, P8, DOI 10.1177/10105395070190010301; Reidpath DD, 2005, AIDS CARE, V17, pS117, DOI 10.1080/09540120500120195; Reynolds NR, 2004, CURR HIV RES, V2, P207, DOI 10.2174/1570162043351309; Shah B, 2007, CLIN INFECT DIS, V44, P1235, DOI 10.1086/513429; StataCorp, 2019, STATA STAT SOFTWARE; Trzynka E, 2007, PSYCHOL PHYSL PREDIC; Wang HH, 2008, AIDS PATIENT CARE ST, V22, P71, DOI 10.1089/apc.2007.0047; Wasti SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035547; Wasti SP, 2012, TROP MED INT HEALTH, V17, P71, DOI 10.1111/j.1365-3156.2011.02888.x; WHO, 2013, DAT HIV AIDS RESP AN; World Health Organization, 2003, SCAL ANT THER RES LT	26	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107543	10.1371/journal.pone.0107543	http://dx.doi.org/10.1371/journal.pone.0107543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP5MS	25229671	Green Published, Green Submitted, gold			2022-12-25	WOS:000342123900047
J	Gatfield, J; Grandjean, CM; Bur, D; Bolli, MH; Nayler, O				Gatfield, John; Grandjean, Celia Mueller; Bur, Daniel; Bolli, Martin H.; Nayler, Oliver			Distinct ETA Receptor Binding Mode of Macitentan As Determined by Site Directed Mutagenesis	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; SMOOTH-MUSCLE-CELLS; ENDOTHELIN-RECEPTOR; ANTAGONIST BOSENTAN; PHARMACOLOGY; PROLIFERATION; EXPRESSION; DISCOVERY; EFFICACY; COMPLEX	The competitive endothelin receptor antagonists (ERA) bosentan and ambrisentan, which have long been approved for the treatment of pulmonary arterial hypertension, are characterized by very short (1 min) occupancy half-lives at the ETA receptor. The novel ERA macitentan, displays a 20-fold increased receptor occupancy half-life, causing insurmountable antagonism of ET-1-induced signaling in pulmonary arterial smooth muscle cells. We show here that the slow ETA receptor dissociation rate of macitentan was shared with a set of structural analogs, whereas compounds structurally related to bosentan displayed fast dissociation kinetics. NMR analysis showed that macitentan adopts a compact structure in aqueous solution and molecular modeling suggests that this conformation tightly fits into a well-defined ETA receptor binding pocket. In contrast the structurally different and negatively charged bosentan-type molecules only partially filled this pocket and expanded into an extended endothelin binding site. To further investigate these different ETA receptor-antagonist interaction modes, we performed functional studies using ETA receptor variants harboring amino acid point mutations in the presumed ERA interaction site. Three ETA receptor residues significantly and differentially affected ERA activity: Mutation R326Q did not affect the antagonist activity of macitentan, however the potencies of bosentan and ambrisentan were significantly reduced; mutation L322A rendered macitentan less potent, whereas bosentan and ambrisentan were unaffected; mutation I355A significantly reduced bosentan potency, but not ambrisentan and macitentan potencies. This suggests that - in contrast to bosentan and ambrisentan - macitentan-ETA receptor binding is not dependent on strong charge-charge interactions, but depends predominantly on hydrophobic interactions. This different binding mode could be the reason for macitentan's sustained target occupancy and insurmountable antagonism.	[Gatfield, John; Grandjean, Celia Mueller; Bur, Daniel; Bolli, Martin H.; Nayler, Oliver] Actel Pharmaceut Ltd, Allschwil, Switzerland	Actelion Pharmaceuticals Ltd	Gatfield, J (corresponding author), Actel Pharmaceut Ltd, Allschwil, Switzerland.	john.gatfield@actelion.com			Actelion Pharmaceuticals Ltd.	Actelion Pharmaceuticals Ltd.	This study was funded by Actelion Pharmaceuticals Ltd. The funder provided support in the form of salaries for authors JG, CMG, DB, MHB and ON, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolli MH, 2012, J MED CHEM, V55, P7849, DOI 10.1021/jm3009103; Bouallegue A, 2007, CURR VASC PHARMACOL, V5, P45, DOI 10.2174/157016107779317161; BREU V, 1995, EUR J BIOCHEM, V231, P266, DOI 10.1111/j.1432-1033.1995.0266f.x; Channick RN, 2001, LANCET, V358, P1119, DOI 10.1016/S0140-6736(01)06250-X; Clozel M, 1999, J PHARMACOL EXP THER, V290, P840; Davie N, 2002, AM J RESP CRIT CARE, V165, P398, DOI 10.1164/ajrccm.165.3.2104059; Forrest LR, 2006, BIOPHYS J, V91, P508, DOI 10.1529/biophysj.106.082313; Galie N, 2008, CIRCULATION, V117, P3010, DOI 10.1161/CIRCULATIONAHA.107.742510; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Gatfield J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047662; Gerber PR, 1998, J COMPUT AID MOL DES, V12, P37, DOI 10.1023/A:1007902804814; GIAID A, 1993, NEW ENGL J MED, V328, P1732, DOI 10.1056/NEJM199306173282402; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Haynes WG, 1998, J HYPERTENS, V16, P1081, DOI 10.1097/00004872-199816080-00001; Horn JR, 2009, P NATL ACAD SCI USA, V106, P2559, DOI 10.1073/pnas.0809800106; HOSODA K, 1991, FEBS LETT, V287, P23, DOI 10.1016/0014-5793(91)80007-P; Iglarz M, 2008, J PHARMACOL EXP THER, V327, P736, DOI 10.1124/jpet.108.142976; JANAKIDEVI K, 1992, AM J PHYSIOL, V263, pC1295, DOI 10.1152/ajpcell.1992.263.6.C1295; Lattig J, 2009, J PEPT SCI, V15, P479, DOI 10.1002/psc.1146; Le MT, 2007, BRIT J PHARMACOL, V151, P952, DOI 10.1038/sj.bjp.0707323; Lobmaier P, 2010, EUR J CLIN PHARMACOL, V66, P537, DOI 10.1007/s00228-010-0793-6; Lu H, 2010, CURR OPIN CHEM BIOL, V14, P467, DOI 10.1016/j.cbpa.2010.06.176; Meens MJPMT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010917; Mobarec JC, 2009, J MED CHEM, V52, P5207, DOI 10.1021/jm9005252; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; OGAWA Y, 1991, BIOCHEM BIOPH RES CO, V178, P248, DOI 10.1016/0006-291X(91)91806-N; Price LC, 2008, AM J CARDIOVASC DRUG, V8, P171, DOI 10.2165/00129784-200808030-00004; Pulido T, 2013, NEW ENGL J MED, V369, P809, DOI 10.1056/NEJMoa1213917; Roux S, 1997, J PHARMACOL EXP THER, V283, P1110; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Swinney DC, 2006, CURR TOP MED CHEM, V6, P461, DOI 10.2174/156802606776743093; Swinney DC, 2011, ANNU REP MED CHEM, V46, P301, DOI 10.1016/B978-0-12-386009-5.00009-6; Tajsic T, 2011, COMPR PHYSIOL, V1, P295, DOI 10.1002/cphy.c100026; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Thorin E, 2010, ADV PHARMACOL, V60, P1, DOI [10.1016/S1054-3589(10)60009-9, 10.1016/B978-0-12-385061-4.00001-5]; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701	36	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107809	10.1371/journal.pone.0107809	http://dx.doi.org/10.1371/journal.pone.0107809			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226600	Green Submitted, Green Published, gold			2022-12-25	WOS:000344317700087
J	Lu, L; Lycett, SJ; Brown, AJL				Lu, Lu; Lycett, Samantha J.; Brown, Andrew J. Leigh			Determining the Phylogenetic and Phylogeographic Origin of Highly Pathogenic Avian Influenza (H7N3) in Mexico	PLOS ONE			English	Article							CLEAVAGE SITE; VIRUS; HEMAGGLUTININ; OUTBREAK; POULTRY; RECOMBINATION; ACCURACY; DISTANCE; MODELS; STRAIN	Highly pathogenic (HP) avian influenza virus (AIV) H7N3 outbreaks occurred 3 times in the Americas in the past 10 years and caused severe economic loss in the affected regions. In June/July 2012, new HP H7N3 outbreaks occurred at commercial farms in Jalisco, Mexico. Outbreaks continued to be identified in neighbouring states in Mexico till August 2013. To explore the origin of this outbreak, time resolved phylogenetic trees were generated from the eight segments of full-length AIV sequences in North America using BEAST. Location, subtype, avian host species and pathogenicity were modelled as discrete traits upon the trees using continuous time Markov chains. A further joint analysis among segments was performed using a hierarchical phylogenetic model (HPM) which allowed trait rates (location, subtype, host species) to be jointly inferred across different segments. The complete spatial diffusion process was visualised through virtual globe software. Our result indicated the Mexico HP H7N3 originated from the large North America low pathogenicity AIV pool through complicated reassortment events. Different segments were contributed by wild waterfowl from different N. American flyways. Five of the eight segments (HA, NA, NP, M, NS) were introduced from wild birds migrating along the central North American flyway, and PB2, PB1 and PA were introduced via the western North American flyway. These results highlight a potential role for Mexico as a hotspot of virus reassortment as it is where wild birds from different migration routes mix during the winter.	[Lu, Lu; Brown, Andrew J. Leigh] Univ Edinburgh, Ashworth Labs, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Lycett, Samantha J.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland	University of Edinburgh; University of Glasgow	Brown, AJL (corresponding author), Univ Edinburgh, Ashworth Labs, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.	A.Leigh-Brown@ed.ac.uk	Lycett, Samantha/F-9598-2013; Brown, Andrew Leigh/ABF-8269-2020; Leigh Brown, Andrew/F-3802-2010	Lycett, Samantha/0000-0003-3159-596X; Brown, Andrew Leigh/0000-0002-5700-3128; Leigh Brown, Andrew/0000-0002-5700-3128; Lu, Lu/0000-0002-9330-7022	China Scholarships Council; University of Edinburgh; Wellcome Trust [092807]	China Scholarships Council; University of Edinburgh; Wellcome Trust(Wellcome Trust)	This work was funded by a China Scholarships Council (www.csc.edu.cn) and the University of Edinburgh (www.ed.ac.uk) Scholarship to LL. SJL was supported by the Wellcome Trust (www.wellcome.ac.uk; grant number 092807). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EMPRESS WATCH; Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bahl J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003570; Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Berhane Y, 2009, EMERG INFECT DIS, V15, P1492, DOI 10.3201/eid1509.080231; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Campitelli L, 2004, VIROLOGY, V323, P24, DOI 10.1016/j.virol.2004.02.015; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Cybis GB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0206; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duan L, 2007, J VIROL, V81, P7529, DOI 10.1128/JVI.00327-07; Dugan VG, 2011, VIROLOGY, V417, P98, DOI 10.1016/j.virol.2011.05.004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edo-Matas D, 2011, MOL BIOL EVOL, V28, P1605, DOI 10.1093/molbev/msq326; Goldberg EE, 2008, EVOLUTION, V62, P2727, DOI 10.1111/j.1558-5646.2008.00505.x; Gonzalez-Reiche AS, 2012, AVIAN DIS, V56, P1025, DOI 10.1637/10203-041412-Reg.1; Gunnarsson G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035679; Hirst M, 2004, EMERG INFECT DIS, V10, P2192, DOI 10.3201/eid1012.040743; HORIMOTO T, 1995, VIROLOGY, V213, P223, DOI 10.1006/viro.1995.1562; Kapczynski DR, 2013, J VIROL, V87, P9086, DOI 10.1128/JVI.00666-13; Kitakado T, 2006, GENETICS, V173, P2073, DOI 10.1534/genetics.106.055350; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Krauss S, 2012, SCIENCE, V337, P644, DOI 10.1126/science.337.6095.644-a; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Lam TTY, 2012, ECOL LETT, V15, P24, DOI 10.1111/j.1461-0248.2011.01703.x; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Lopez-Martinez I, 2013, EMERG INFECT DIS, V19, P1531, DOI 10.3201/eid1909.130087; Lu L, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-16; Maurer-Stroh S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-139; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Pasick J, 2009, REV SCI TECH OIE, V28, P349, DOI 10.20506/rst.28.1.1875; Schnebel B, 2007, AVIAN DIS, V51, P432, DOI 10.1637/7546-033106R.1; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; Suarez DL, 2004, EMERG INFECT DIS, V10, P693, DOI 10.3201/eid1004.030396; Suchard MA, 2003, SYST BIOL, V52, P649, DOI 10.1080/10635150390238879; Tweed SA, 2004, EMERG INFECT DIS, V10, P2196, DOI 10.3201/eid1012.040961; Webster RG, 2002, VACCINE, V20, pS16, DOI 10.1016/S0264-410X(02)00123-8; Wilke CO, 2011, PLOS PATHOG, V7	46	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107330	10.1371/journal.pone.0107330	http://dx.doi.org/10.1371/journal.pone.0107330			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226523	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700046
J	Meijer, TWH; Bussink, J; Zatovicova, M; Span, PN; Lok, J; Supuran, CT; Kaanders, JHAM				Meijer, Tineke W. H.; Bussink, Johan; Zatovicova, Miriam; Span, Paul N.; Lok, Jasper; Supuran, Claudiu T.; Kaanders, Johannes H. A. M.			Tumor Microenvironmental Changes Induced by the Sulfamate Carbonic Anhydrase IX Inhibitor S4 in a Laryngeal Tumor Model	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; INTRACELLULAR PH; HUMAN HEAD; HYPOXIA; PROLIFERATION; GROWTH; NECK; EXPRESSION; XII; IRRADIATION	Background and Purpose: Carbonic anhydrase IX (CAIX) plays a pivotal role in pH homeostasis, which is essential for tumor cell survival. We examined the effect of the CAIX inhibitor 4-(3'(3 '',5 ''-dimethylphenyl)-ureido)phenyl sulfamate (S4) on the tumor microenvironment in a laryngeal tumor model by analyzing proliferation, apoptosis, necrosis, hypoxia, metabolism and CAIX ectodomain shedding. Methods: SCCNij202 tumor bearing-mice were treated with S4 for 1, 3 or 5 days. CAIX ectodomain shedding was measured in the serum after therapy. Effects on tumor cell proliferation, apoptosis, necrosis, hypoxia (pimonidazole) and CAIX were investigated with quantitative immunohistochemistry. Metabolic transporters and enzymes were quantified with qPCR. Results: CAIX ectodomain shedding decreased after treatment with S4 (p<0.01). S4 therapy did neither influence tumor cell proliferation nor the amount of apoptosis and necrosis. Hypoxia (pimonidazole) and CAIX expression were also not affected by S4. CHOP and MMP9 mRNA as a reference of intracellular pH did not change upon treatment with S4. Compensatory mechanisms of pH homeostasis at the mRNA level were not observed. Conclusion: As the clinical and biological meaning of the decrease in CAIX ectodomain shedding after S4 therapy is not clear, studies are required to elucidate whether the CAIX ectodomain has a paracrine or autocrine signaling function in cancer biology. S4 did not influence the amount of proliferation, apoptosis, necrosis and hypoxia. Therefore, it is unlikely that S4 can be used as single agent to influence tumor cell kill and proliferation, and to target primary tumor growth.	[Meijer, Tineke W. H.; Bussink, Johan; Span, Paul N.; Lok, Jasper; Kaanders, Johannes H. A. M.] 874 Radboud Univ, Med Ctr, Dept Radiat Oncol, Nijmegen, Netherlands; [Zatovicova, Miriam] Slovak Acad Sci, Inst Virol, Dept Mol Med, Bratislava, Slovakia; [Supuran, Claudiu T.] Univ Florence, Lab Chim Bioinorgan, Florence, Italy	Slovak Academy of Sciences; University of Florence	Meijer, TWH (corresponding author), 874 Radboud Univ, Med Ctr, Dept Radiat Oncol, Nijmegen, Netherlands.	Tineke.vanZon-Meijer@radboudumc.nl	Meijer, Tineke/G-7829-2016; Span, Paul/G-4710-2012; Bussink, Jan/N-3584-2014; Kaanders, Hans/A-7432-2014; Zaťovičová, Miriam/ABA-3268-2021; Lok, Jasper/E-1569-2016	Span, Paul/0000-0002-1930-6638; Kaanders, Hans/0000-0001-5374-9558; Zaťovičová, Miriam/0000-0002-8682-4232; Supuran, Claudiu/0000-0003-4262-0323; Bussink, Johan/0000-0002-5751-4796	METOXIA (Metastatic Tumors Facilitated by Hypoxic Tumor Micro-Environment; EU 7th Research Framework Programme - Theme HEALTH) [222741]	METOXIA (Metastatic Tumors Facilitated by Hypoxic Tumor Micro-Environment; EU 7th Research Framework Programme - Theme HEALTH)	Supported by METOXIA (Metastatic Tumors Facilitated by Hypoxic Tumor Micro-Environment; EU 7th Research Framework Programme - Theme HEALTH; Grant No.: 222741). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlskog JKJ, 2009, BIOORG MED CHEM LETT, V19, P4851, DOI 10.1016/j.bmcl.2009.06.022; Bleumer I, 2004, BRIT J CANCER, V90, P985, DOI 10.1038/sj.bjc.6601617; Chiche J, 2010, ADV ENZYME REGUL, V50, P20, DOI 10.1016/j.advenzreg.2009.10.005; Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470; Chien MH, 2012, ORAL ONCOL, V48, P417, DOI 10.1016/j.oraloncology.2011.11.015; Cianchi F, 2010, J PHARMACOL EXP THER, V334, P710, DOI 10.1124/jpet.110.167270; De Simone G, 2013, EXPERT OPIN DRUG DIS, V8, P793, DOI 10.1517/17460441.2013.795145; Dubois L, 2013, RADIOTHER ONCOL; Dubois L, 2011, RADIOTHER ONCOL, V99, P424, DOI 10.1016/j.radonc.2011.05.045; Gieling RG, 2013, J ENZYM INHIB MED CH, V28, P360, DOI 10.3109/14756366.2012.736979; Gieling RG, 2012, J MED CHEM, V55, P5591, DOI 10.1021/jm300529u; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Hoogsteen IJ, 2005, CLIN CANCER RES, V11, P97; Ilie MI, 2011, INT J CANCER, V128, P1614, DOI 10.1002/ijc.25491; Ljungkvist ASE, 2006, RADIAT RES, V165, P326, DOI 10.1667/RR3515.1; Lou YM, 2011, CANCER RES, V71, P3364, DOI 10.1158/0008-5472.CAN-10-4261; McDonald PC, 2012, ONCOTARGET, V3, P84, DOI 10.18632/oncotarget.422; Neri D, 2011, NAT REV DRUG DISCOV, V10, P767, DOI 10.1038/nrd3554; Otero-Rey EM, 2008, ORAL ONCOL, V44, P193, DOI 10.1016/j.oraloncology.2007.02.011; Pacchiano F, 2011, J MED CHEM, V54, P1896, DOI 10.1021/jm101541x; Pastorekova S, 2008, CURR PHARM DESIGN, V14, P685, DOI 10.2174/138161208783877893; Putney LK, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-46; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Siebels M, 2011, WORLD J UROL, V29, P121, DOI 10.1007/s00345-010-0570-2; Stegeman H, 2013, RADIOTHER ONCOL, V106, P383, DOI 10.1016/j.radonc.2013.02.001; Stegeman H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-463; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Touisni N, 2011, J MED CHEM, V54, P8271, DOI 10.1021/jm200983e; Troost EGC, 2005, RADIOTHER ONCOL, V76, P194, DOI 10.1016/j.radonc.2005.06.031; van Laarhoven HWM, 2004, INT J RADIAT ONCOL, V60, P310, DOI 10.1016/j.ijrobp.2004.05.014; Westbury CB, 2007, BRIT J RADIOL, V80, P934, DOI 10.1259/bjr/25046649; Winum JY, 2012, BIOORG MED CHEM LETT, V22, P4681, DOI 10.1016/j.bmcl.2012.05.083; Xu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071177; Zat'ovicova M, 2003, J IMMUNOL METHODS, V282, P117, DOI 10.1016/j.jim.2003.08.011; Zatovicova M, 2013, ACTA VIROL, V57, P257, DOI 10.4149/av_2013_02_257; Zatovicova M, 2005, BRIT J CANCER, V93, P1267, DOI 10.1038/sj.bjc.6602861	36	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e108068	10.1371/journal.pone.0108068	http://dx.doi.org/10.1371/journal.pone.0108068			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225880	gold, Green Published, Green Submitted			2022-12-25	WOS:000344317700097
J	Shen, CJ; Yue, RQ; Yang, YJ; Zhang, L; Sun, T; Xu, LQ; Tie, SG; Wang, HZ				Shen, Chenjia; Yue, Runqing; Yang, Yanjun; Zhang, Lei; Sun, Tao; Xu, Luqin; Tie, Shuanggui; Wang, Huizhong			Genome-Wide Identification and Expression Profiling Analysis of the Aux/IAA Gene Family in Medicago truncatula during the Early Phase of Sinorhizobium meliloti Infection	PLOS ONE			English	Article							LATERAL ROOT-FORMATION; OF-FUNCTION MUTATION; AUXIN TRANSPORT INHIBITORS; PLANT DEVELOPMENT; TRANSCRIPTIONAL REPRESSION; NODULE ORGANOGENESIS; ARABIDOPSIS-THALIANA; PROTEIN; RICE; EVOLUTION	Background: Auxin/indoleacetic acid (Aux/IAA) genes, coding a family of short-lived nuclear proteins, play key roles in wide variety of plant developmental processes, including root system regulation and responses to environmental stimulus. However, how they function in auxin signaling pathway and symbiosis with rhizobial in Medicago truncatula are largely unknown. The present study aims at gaining deeper insight on distinctive expression and function features of Aux/IAA family genes in Medicago truncatula during nodule formation. Principal Findings: Using the latest updated draft of the full Medicago truncatula genome, a comprehensive identification and analysis of IAA genes were performed. The data indicated that MtIAA family genes are distributed in all the M. truncatula chromosomes except chromosome 6. Most of MtIAA genes are responsive to exogenous auxin and express in tissues-specific manner. To understand the biological functions of MtIAA genes involved in nodule formation, quantitative real-time polymerase chain reaction (qRT-PCR) was used to test the expression profiling of MtIAA genes during the early phase of Sinorhizobium meliloti (S. meliloti) infection. The expression patterns of most MtIAA genes were down-regulated in roots and up-regulated in shoots by S. meliloti infection. The differences in expression responses between roots and shoots caused by S. meliloti infection were alleviated by 1-NOA application. Conclusion: The genome-wide identification, evolution and expression pattern analysis of MtIAA genes were performed in this study. The data helps us to understand the roles of MtIAA-mediated auxin signaling in nodule formation during the early phase of S. meliloti infection.	[Shen, Chenjia; Yang, Yanjun; Sun, Tao; Xu, Luqin; Wang, Huizhong] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Yue, Runqing; Tie, Shuanggui] Henan Acad Agr Sci, Zhengzhou, Peoples R China; [Zhang, Lei] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA	Hangzhou Normal University; Henan Academy of Agricultural Sciences; Washington State University	Shen, CJ (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	shencj@hznu.edu.cn; tieshuanggui@126.com; whz62@163.com			Zhejiang Provincial Natural Science Foundation of China [LQ14C060001, LQ14C020002, LQ13C020004]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was funded by the Zhejiang Provincial Natural Science Foundation of China under Grant No. LQ14C060001, LQ14C020002 and LQ13C020004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; Audran-Delalande C, 2012, PLANT CELL PHYSIOL, V53, P659, DOI 10.1093/pcp/pcs022; Berendzen KW, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-125; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Cho H, 2014, NAT CELL BIOL, V16, P66, DOI 10.1038/ncb2893; Chung Y, 2011, PLANT J, V66, P564, DOI 10.1111/j.1365-313X.2011.04513.x; Deinum EE, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00096; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; Engstrom EM, 2002, PLANT PHYSIOL, V128, P1390, DOI 10.1104/pp.010691; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Han XY, 2012, GENE, V503, P83, DOI 10.1016/j.gene.2012.03.069; Jain Mukesh, 2006, Functional & Integrative Genomics, V6, P47, DOI 10.1007/s10142-005-0005-0; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; KIM J, 2013, NATL GEOGR, V224, P8; Kondorosi E, 2005, PLANT PHYSIOL, V137, P1197, DOI 10.1104/pp.105.060004; Korasick DA, 2014, P NATL ACAD SCI USA, V111, P5427, DOI 10.1073/pnas.1400074111; Li X, 2013, NEW PHYTOL; Ljung K, 2013, DEVELOPMENT, V140, P943, DOI 10.1242/dev.086363; Ludwig Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078859; Madsen LH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1009; Mathesius U, 1998, PLANT J, V14, P23, DOI 10.1046/j.1365-313X.1998.00090.x; Molesini B, 2014, J PROTEOME RES, V13, P408, DOI 10.1021/pr4009942; Nakamura A, 2006, PLANT J, V46, P297, DOI 10.1111/j.1365-313X.2006.02693.X; Nallu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060355; Ni J, 2011, PLANT J, V68, P433, DOI 10.1111/j.1365-313X.2011.04698.x; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Ouellet F, 2001, PLANT CELL, V13, P829, DOI 10.1105/tpc.13.4.829; Paponov IA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-126; Parry G, 2001, PLANT J, V25, P399, DOI 10.1046/j.1365-313x.2001.00970.x; Plet J, 2011, PLANT J, V65, P622, DOI 10.1111/j.1365-313X.2010.04447.x; Quint M, 2006, CURR OPIN PLANT BIOL, V9, P448, DOI [10.1016/j.pbi.2006.07.006, 10.1104/pp.17.00765]; RAIKHEL N, 1992, PLANT PHYSIOL, V100, P1627, DOI 10.1104/pp.100.4.1627; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Remington DL, 2004, PLANT PHYSIOL, V135, P1738, DOI 10.1104/pp.104.039669; Rightmyer AP, 2011, MOL PLANT MICROBE IN, V24, P1372, DOI 10.1094/MPMI-04-11-0103; Rinaldi MA, 2012, PLANT MOL BIOL, V79, P359, DOI 10.1007/s11103-012-9917-y; Shen CJ, 2013, PLANT CELL ENVIRON, V36, P607, DOI 10.1111/pce.12001; Song YL, 2009, PLANT MOL BIOL, V70, P297, DOI 10.1007/s11103-009-9474-1; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Takanashi K, 2011, PLANTA, V234, P73, DOI 10.1007/s00425-011-1385-0; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tang HB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-312; Tatematsu K, 2004, PLANT CELL, V16, P379, DOI 10.1105/tpc.018630; Tiwari SB, 2004, PLANT CELL, V16, P533, DOI 10.1105/tpc.017384; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Uberti-Manassero NG, 2012, J EXP BOT, V63, P809, DOI 10.1093/jxb/err305; Uehara T, 2008, PLANT CELL PHYSIOL, V49, P1025, DOI 10.1093/pcp/pcn079; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; van Noorden GE, 2006, PLANT PHYSIOL, V140, P1494, DOI 10.1104/pp.105.075879; van Noorden GE, 2007, PLANT PHYSIOL, V144, P1115, DOI 10.1104/pp.107.099978; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Wang YJ, 2010, MOL BIOL REP, V37, P3991, DOI 10.1007/s11033-010-0058-6; Wasson AP, 2006, PLANT CELL, V18, P1617, DOI 10.1105/tpc.105.038232; Wu Jian, 2014, BMC Res Notes, V7, P218, DOI 10.1186/1756-0500-7-218; Wu J, 2012, MOL GENET GENOMICS, V287, P295, DOI 10.1007/s00438-012-0675-y; Yang XQ, 2004, PLANT J, V40, P772, DOI 10.1111/j.1365-313X.2004.02254.x; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308; Zhu ZX, 2012, MOL PLANT, V5, P154, DOI 10.1093/mp/ssr074	63	30	35	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107495	10.1371/journal.pone.0107495	http://dx.doi.org/10.1371/journal.pone.0107495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226164	gold, Green Published, Green Submitted			2022-12-25	WOS:000344317700059
J	Siebert, N; Seidel, D; Eger, C; Juttner, M; Lode, HN				Siebert, Nikolai; Seidel, Diana; Eger, Christin; Juettner, Madlen; Lode, Holger N.			Functional Bioassays for Immune Monitoring of High-Risk Neuroblastoma Patients Treated with ch14.18/CHO Anti-GD(2) Antibody	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; VALIDATED DETECTION; CHO-CELLS; GROWTH; IMMUNOTHERAPY; MORPHOLOGY; SERUM; GD2	Effective treatment of high-risk neuroblastoma (NB) remains a major challenge in pediatric oncology. Human/mouse chimeric monoclonal anti-GD2 antibody (mAb) ch14.18 is emerging as a treatment option to improve outcome. After establishing a production process in Chinese hamster ovary (CHO) cells, ch14.18/CHO was made available in Europe for clinical trials. Here, we describe validated functional bioassays for the purpose of immune monitoring of these trials and demonstrate GD2-specific immune effector functions of ch14.18/CHO in treated patients. Two calcein-based bioassays for complement-dependent-(CDC) and antibody-dependent cellular cytotoxicity (ADCC) were set up based on patient serum and immune cells tested against NB cells. For this purpose, we identified LA-N-1 NB cells as best suited within a panel of cell lines. Assay conditions were first established using serum and cells of healthy donors. We found an effector-to-target (E:T) cell ratio of 20:1 for PBMC preparations as best suited for GD2-specific ADCC analysis. A simplified method of effector cell preparation by lysis of erythrocytes was evaluated revealing equivalent results at an E:T ratio of 40:1. Optimal results for CDC were found with a serum dilution at 1:8. For validation, both within-assay and inter-assay precision were determined and coefficients of variation (CV) were below 20%. Sample quality following storage at room temperature (RT) showed that sodium-heparin-anticoagulated blood and serum are stable for 48 h and 96 h, respectively. Application of these bioassays to blood samples of three selected high-risk NB patients treated with ch14.18/CHO (100 mg/m(2)) revealed GD2-specific increases in CDC (4.5-9.4 fold) and ADCC (4.6-6.0 fold) on day 8 compared to baseline, indicating assay applicability for the monitoring of multicenter clinical trials requiring sample shipment at RT for central lab analysis.	[Siebert, Nikolai; Seidel, Diana; Eger, Christin; Juettner, Madlen; Lode, Holger N.] Univ Med Greifswald, Dept Pediat Oncol & Hematol, Greifswald, Germany	Greifswald Medical School	Lode, HN (corresponding author), Univ Med Greifswald, Dept Pediat Oncol & Hematol, Greifswald, Germany.	lode@uni-greifswald.de		Lode, Holger/0000-0002-1201-208X	Hector-Stiftung, Germany, University Medicine Greifswald, Germany; Apeiron Biologics, Vienna, Austria	Hector-Stiftung, Germany, University Medicine Greifswald, Germany; Apeiron Biologics, Vienna, Austria	Financial support was provided by the Hector-Stiftung, Germany, University Medicine Greifswald, Germany. Further financial support was provided by Apeiron Biologics, Vienna, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2014, FEBS LETT, V588, P288, DOI 10.1016/j.febslet.2013.11.030; BIEDLER JL, 1973, CANCER RES, V33, P2643; BUMOL TF, 1982, P NATL ACAD SCI-BIOL, V79, P1245, DOI 10.1073/pnas.79.4.1245; CHERESH DA, 1986, CANCER RES, V46, P5112; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; DeSilva B, 2003, PHARM RES-DORDR, V20, P1885, DOI 10.1023/B:PHAM.0000003390.51761.3d; Di Gaetano N, 2003, J IMMUNOL, V171, P1581, DOI 10.4049/jimmunol.171.3.1581; Gelderman KA, 2004, TRENDS IMMUNOL, V25, P158, DOI 10.1016/j.it.2004.01.008; HOMOLYA L, 1993, J BIOL CHEM, V268, P21493; Keshelava N, 1998, CANCER RES, V58, P5396; Ladenstein R, 2013, MABS-AUSTIN, V5, P801, DOI 10.4161/mabs.25215; Lewis S M, 1971, Lab Pract, V20, P787; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; LICHTENFELS R, 1994, J IMMUNOL METHODS, V172, P227, DOI 10.1016/0022-1759(94)90110-4; Lode HN, 2013, CANCER IMMUNOL IMMUN, V62, P999, DOI 10.1007/s00262-013-1413-y; Modak S, 2007, CANCER INVEST, V25, P67, DOI 10.1080/07357900601130763; SAITO M, 1985, BIOCHEM BIOPH RES CO, V127, P1, DOI 10.1016/S0006-291X(85)80117-0; SEEGER RC, 1977, CANCER RES, V37, P1364; Shuptrine CW, 2012, SEMIN CANCER BIOL, V22, P3, DOI 10.1016/j.semcancer.2011.12.009; Siebert N, 2014, J IMMUNOL METHODS, V407, P108, DOI 10.1016/j.jim.2014.04.001; Siebert N, 2013, J IMMUNOL METHODS, V398, P51, DOI 10.1016/j.jim.2013.09.008; Simon T, 2004, J CLIN ONCOL, V22, P3549, DOI 10.1200/JCO.2004.08.143; Simon T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-21; Smolec JoMarie, 2005, Pharm Res, V22, P1425, DOI 10.1007/s11095-005-5917-9; Sorkin LS, 2010, PAIN, V149, P135, DOI 10.1016/j.pain.2010.01.024; Tonini GP, 2012, CANCER LETT, V326, P128, DOI 10.1016/j.canlet.2012.08.017; Yang RK, 2010, DRUG FUTURE, V35, P665, DOI 10.1358/dof.2010.035.08.1513490; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Zeng Y, 2005, MOL IMMUNOL, V42, P1311, DOI 10.1016/j.molimm.2004.12.018	29	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107692	10.1371/journal.pone.0107692	http://dx.doi.org/10.1371/journal.pone.0107692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226154	gold, Green Published, Green Submitted			2022-12-25	WOS:000344317700075
J	Chestnut, T; Anderson, C; Popa, R; Blaustein, AR; Voytek, M; Olson, DH; Kirshtein, J				Chestnut, Tara; Anderson, Chauncey; Popa, Radu; Blaustein, Andrew R.; Voytek, Mary; Olson, Deanna H.; Kirshtein, Julie			Heterogeneous Occupancy and Density Estimates of the Pathogenic Fungus Batrachochytrium dendrobatidis in Waters of North America	PLOS ONE			English	Article							AMPHIBIAN PATHOGEN; BIODIVERSITY LOSS; GLOBAL BIODIVERSITY; ALVEOLATE PATHOGEN; ENVIRONMENTAL DNA; SP-NOV; DISEASE; POPULATION; CHYTRIDIOMYCOSIS; CONSERVATION	Biodiversity losses are occurring worldwide due to a combination of stressors. For example, by one estimate, 40% of amphibian species are vulnerable to extinction, and disease is one threat to amphibian populations. The emerging infectious disease chytridiomycosis, caused by the aquatic fungus Batrachochytrium dendrobatidis (Bd), is a contributor to amphibian declines worldwide. Bd research has focused on the dynamics of the pathogen in its amphibian hosts, with little emphasis on investigating the dynamics of free-living Bd. Therefore, we investigated patterns of Bd occupancy and density in amphibian habitats using occupancy models, powerful tools for estimating site occupancy and detection probability. Occupancy models have been used to investigate diseases where the focus was on pathogen occurrence in the host. We applied occupancy models to investigate free-living Bd in North American surface waters to determine Bd seasonality, relationships between Bd site occupancy and habitat attributes, and probability of detection from water samples as a function of the number of samples, sample volume, and water quality. We also report on the temporal patterns of Bd density from a 4-year case study of a Bd-positive wetland. We provide evidence that Bd occurs in the environment year-round. Bd exhibited temporal and spatial heterogeneity in density, but did not exhibit seasonality in occupancy. Bd was detected in all months, typically at less than 100 zoospores L-1. The highest density observed was similar to 3 million zoospores L-1. We detected Bd in 47% of sites sampled, but estimated that Bd occupied 61% of sites, highlighting the importance of accounting for imperfect detection. When Bd was present, there was a 95% chance of detecting it with four samples of 600 ml of water or five samples of 60 mL. Our findings provide important baseline information to advance the study of Bd disease ecology, and advance our understanding of amphibian exposure to free-living Bd in aquatic habitats over time.	[Chestnut, Tara] Oregon State Univ, Environm Sci Grad Program, Corvallis, OR 97331 USA; [Chestnut, Tara; Anderson, Chauncey] US Geol Survey, Oregon Water Sci Ctr, Portland, OR USA; [Popa, Radu] Univ So Calif, Los Angeles, CA USA; [Blaustein, Andrew R.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Voytek, Mary] Natl Aeronaut & Space Adm Headquarters, Astrobiol Program, Washington, DC USA; [Olson, Deanna H.] US Forest Serv, Pacific NW Res Stn, Corvallis, OR 97331 USA; [Kirshtein, Julie] US Geol Survey, Natl Res Program, Reston, VA 22092 USA	Oregon State University; United States Department of the Interior; United States Geological Survey; University of Southern California; Oregon State University; National Aeronautics & Space Administration (NASA); United States Department of Agriculture (USDA); United States Forest Service; United States Department of the Interior; United States Geological Survey	Chestnut, T (corresponding author), Oregon State Univ, Environm Sci Grad Program, Corvallis, OR 97331 USA.	chestnut@usgs.gov		Anderson, Chauncey/0000-0002-1016-3781	National Science Foundation [0948041]; US Forest Service Pacific Northwest Research Station; US Geological Survey Amphibian Research and Monitoring Initiative (ARMI)	National Science Foundation(National Science Foundation (NSF)); US Forest Service Pacific Northwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); US Geological Survey Amphibian Research and Monitoring Initiative (ARMI)(United States Geological Survey)	Support was provided by the National Science Foundation GK-12 Graduate STEM Fellows in K-12 Education Program (Award #0948041) to TC, US Forest Service Pacific Northwest Research Station and US Geological Survey Amphibian Research and Monitoring Initiative (ARMI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064347; Adams MJ, 2010, ECOL APPL, V20, P289, DOI 10.1890/08-2319.1; Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Ault KK, 2012, DIS AQUAT ORGAN, V99, P127, DOI 10.3354/dao02456; Bancroft BA, 2011, BIODIVERS CONSERV, V20, P1911, DOI 10.1007/s10531-011-0066-4; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; BERVEN KA, 1990, ECOLOGY, V71, P1599, DOI 10.2307/1938295; Blaustein AR, 2012, PHILOS T R SOC B, V367, P1688, DOI 10.1098/rstb.2012.0011; Blaustein AR, 2003, FRONT ECOL ENVIRON, V1, P87, DOI 10.1890/1540-9295(2003)001[0087:TCODA]2.0.CO;2; BLAUSTEIN AR, 1994, BIOL CONSERV, V67, P251, DOI 10.1016/0006-3207(94)90616-5; Blaustein AR, 2002, ECOL LETT, V5, P597, DOI 10.1046/j.1461-0248.2002.00352.x; Blaustein AR, 2004, ECOLOGY, V85, P1747, DOI 10.1890/03-3070; BRADFORD DF, 1991, J HERPETOL, V25, P174, DOI 10.2307/1564645; Browne CL, 2009, ECOSCIENCE, V16, P209, DOI 10.2980/16-2-3220; Buck JC, 2011, BIODIVERS CONSERV, V20, P3549, DOI 10.1007/s10531-011-0147-4; CHAMIER AC, 1987, OECOLOGIA, V71, P491, DOI 10.1007/BF00379287; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Chinchar V. G., 2011, Studies in viral ecology: animal host systems, Volume 2, P231; Chinchar VG, 2002, ARCH VIROL, V147, P447, DOI 10.1007/s007050200000; Clements WH, 2009, ENVIRON TOXICOL CHEM, V28, P1789, DOI 10.1897/09-140.1; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davis AK, 2007, ECOHEALTH, V4, P310, DOI 10.1007/s10393-007-0115-3; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Drew A, 2006, DIS AQUAT ORGAN, V68, P245, DOI 10.3354/dao068245; Duffy MA, 2009, LIMNOL OCEANOGR, V54, P770, DOI 10.4319/lo.2009.54.3.0770; Euliss NH, 2004, WETLANDS, V24, P448, DOI 10.1672/0277-5212(2004)024[0448:TWCACF]2.0.CO;2; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Garmyn A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035038; Gervasi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054490; Gervasi SS, 2013, ECOHEALTH, V10, P166, DOI 10.1007/s10393-013-0832-8; Gleason FH, 2011, MAR FRESHWATER RES, V62, P383, DOI 10.1071/MF10294; Gleason Frank H., 2008, Fungal Biology Reviews, V22, P17, DOI 10.1016/j.fbr.2008.02.001; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Gsell AS, 2013, FRESHWATER BIOL, V58, P523, DOI 10.1111/j.1365-2427.2012.02786.x; HALSTEAD BG, 1982, HYDROBIOLOGIA, V96, P217, DOI 10.1007/BF00010613; HAYES MP, 1986, J HERPETOL, V20, P490, DOI 10.2307/1564246; HERLIHY AT, 1991, WATER RESOUR RES, V27, P629, DOI 10.1029/90WR02768; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Hines JE, 2010, ECOL APPL, V20, P1456, DOI 10.1890/09-0321.1; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hyman OJ, 2012, DIS AQUAT ORGAN, V97, P185, DOI 10.3354/dao02423; Ibelings B, 2007, J PHYCOL, V43, P2; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jancovich JK, 2005, MOL ECOL, V14, P213, DOI 10.1111/j.1365-294X.2004.02387.x; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Johnson ML, 2005, DIS AQUAT ORGAN, V65, P181, DOI 10.3354/dao065181; Johnson PTJ, 2002, ECOL MONOGR, V72, P151, DOI 10.1890/0012-9615(2002)072[0151:PROILT]2.0.CO;2; Jones JPG, 2011, CONSERV BIOL, V25, P450, DOI 10.1111/j.1523-1739.2010.01605.x; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Jones MEB, 2012, DIS AQUAT ORGAN, V102, P163, DOI 10.3354/dao02539; Kagami M, 2004, LIMNOL OCEANOGR, V49, P680, DOI 10.4319/lo.2004.49.3.0680; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Kirshtein JD, 2007, DIS AQUAT ORGAN, V77, P11, DOI 10.3354/dao01831; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Lannoo MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022211; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Litaor IM, 1988, APPL GEOCHEM, V3, P645, DOI [10.1016/0883-2927(88)90096-0, DOI 10.1016/0883-2927(88)90096-0]; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Maberly SC, 1996, FRESHWATER BIOL, V35, P579, DOI 10.1111/j.1365-2427.1996.tb01770.x; MacKenzie Darryl I., 2004, P149; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mantyka-Pringle CS, 2012, GLOBAL CHANGE BIOL, V18, P1239, DOI 10.1111/j.1365-2486.2011.02593.x; Mao JH, 1999, VIRUS RES, V63, P45, DOI 10.1016/S0168-1702(99)00057-X; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; McCallum ML, 2007, J HERPETOL, V41, P483, DOI 10.1670/0022-1511(2007)41[483:ADOECD]2.0.CO;2; McClintock BT, 2010, ECOL LETT, V13, P659, DOI 10.1111/j.1461-0248.2010.01472.x; McMahon TA, 2013, P NATL ACAD SCI USA, V110, P210, DOI 10.1073/pnas.1200592110; Miller DA, 2011, ECOLOGY, V92, P1422, DOI 10.1890/10-1396.1; Miller DAW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065808; Mitchell KM, 2008, P ROY SOC B-BIOL SCI, V275, P329, DOI 10.1098/rspb.2007.1356; Mora C, 2011, MAR ECOL PROG SER, V434, P251, DOI 10.3354/meps09214; Moss AS, 2008, MYCOLOGIA, V100, P1, DOI 10.3852/mycologia.100.1.1; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Pearl CA, 2007, J HERPETOL, V41, P145, DOI 10.1670/0022-1511(2007)41[145:OOTAPB]2.0.CO;2; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; R Core Team, 2012, R LANG ENV STAT COMP; Raffel TR, 2010, ECOHEALTH, V7, P526, DOI 10.1007/s10393-010-0358-2; REDDY KR, 1981, HYDROBIOLOGIA, V85, P201, DOI 10.1007/BF00017610; Relyea RA, 2005, ECOL APPL, V15, P618, DOI 10.1890/03-5342; Relyea RA, 2009, OECOLOGIA, V159, P363, DOI [10.1007/s00442-008-1141-8, 10.1007/s00442-008-1213-9]; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Rohr JR, 2008, P NATL ACAD SCI USA, V105, P17436, DOI 10.1073/pnas.0806368105; Rohr JR, 2010, P NATL ACAD SCI USA, V107, P8269, DOI 10.1073/pnas.0912883107; Romansic JM, 2011, OECOLOGIA, V166, P1029, DOI 10.1007/s00442-011-1932-1; Rosenblum EB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000550; Royle JA, 2006, ECOLOGY, V87, P835, DOI 10.1890/0012-9658(2006)87[835:GSOMAF]2.0.CO;2; Schmidt BR, 2013, METHODS ECOL EVOL, V4, P646, DOI 10.1111/2041-210X.12052; Schmidt BR, 2010, CONSERV BIOL, V24, P897, DOI 10.1111/j.1523-1739.2010.01507.x; Searle CL, 2013, ECOL EVOL, V3, P4129, DOI 10.1002/ece3.777; Seimon TA, 2007, GLOBAL CHANGE BIOL, V13, P288, DOI 10.1111/j.1365-2486.2006.01278.x; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Shapard EJ, 2012, MYCOPATHOLOGIA, V173, P121, DOI 10.1007/s11046-011-9470-2; Shearer CA, 2007, BIODIVERS CONSERV, V16, P49, DOI 10.1007/s10531-006-9120-z; Simon D, 2005, J MOL EVOL, V60, P434, DOI 10.1007/s00239-004-0152-2; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Thompson KG, 2007, J AQUAT ANIM HEALTH, V19, P8, DOI 10.1577/H06-016.1; U.S. Geological Survey, 2010, NAT FIELD MAN COLL W; Vaughn CC, 2010, BIOSCIENCE, V60, P25, DOI 10.1525/bio.2010.60.1.7; Voyles J, 2012, ECOL EVOL, V2, P2241, DOI 10.1002/ece3.334; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Walker SF, 2007, DIS AQUAT ORGAN, V77, P105, DOI 10.3354/dao01850; Welsh HH, 2002, J WILDLIFE MANAGE, V66, P581, DOI 10.2307/3803126; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1	113	59	59	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e106790	10.1371/journal.pone.0106790	http://dx.doi.org/10.1371/journal.pone.0106790			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222122	Green Submitted, Green Published, gold			2022-12-25	WOS:000341774800026
J	Kim, SY; Kim, KH; Im, CH; Ali, A; Lee, CY; Kong, WS; Ryu, JS				Kim, Sun Young; Kim, Kyung-Hee; Im, Chak Han; Ali, Asjad; Lee, Chang Yun; Kong, Won-Sik; Ryu, Jae-San			Identification of Degenerate Nuclei and Development of a SCAR Marker for Flammulina velutipes	PLOS ONE			English	Article							CULTIVATED MUSHROOM; STRAIN INSTABILITY; HELICASE; RECOMBINATION; OIDIA	Flammulina velutipes is one of the major edible mushrooms in the world. Recently, abnormalities that have a negative impact on crop production have been reported in this mushroom. These symptoms include slow vegetative growth, a compact mycelial mat, and few or even no fruiting bodies. The morphologies and fruiting capabilities of monokaryons of wild-type and degenerate strains that arose through arthrospore formation were investigated through test crossing. Only one monokaryotic group of the degenerate strains and its hybrid strains showed abnormal phenotypes. Because the monokaryotic arthrospore has the same nucleus as the parent strain, these results indicated that only one aberrant nucleus of the two nuclei in the degenerate strain was responsible for the degeneracy. A sequence-characterized amplified region marker that is linked to the degenerate monokaryon was identified based on a polymorphic sequence that was generated using random primers. Comparative analyses revealed the presence of a degenerate-specific genomic region in a telomere, which arose via the transfer of a genomic fragment harboring a putative helicase gene. Our findings have narrowed down the potential molecular targets responsible for this phenotype for future studies and have provided a marker for the detection of degenerate strains.	[Kim, Sun Young; Kim, Kyung-Hee; Im, Chak Han; Ali, Asjad; Ryu, Jae-San] Gyeongsangnam Do Agr Res & Extens Serv, Environm Friendly Res Div, Jinju, South Korea; [Lee, Chang Yun] Greenpeace Mushroom Co, Chungdo, South Korea; [Kong, Won-Sik] Rural Dev Adm, Natl Inst Hort & Herbal Sci, Mushroom Res Div, Eumsung, South Korea	National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Ryu, JS (corresponding author), Gyeongsangnam Do Agr Res & Extens Serv, Environm Friendly Res Div, Jinju, South Korea.	Coolmush88@gmail.com		Ryu, Jae-San/0000-0002-8541-3079; Ali, Asjad/0000-0002-0415-4598; Kong, Won-Sik/0000-0001-6800-2545	Ministry of Agriculture and Forestry, Republic of Korea [608005-05-HD220]; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ00821602014]	Ministry of Agriculture and Forestry, Republic of Korea; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This work was supported by a grant from the Ministry of Agriculture and Forestry (608005-05-HD220), Republic of Korea and the Next-Generation BioGreen 21 Program (No. PJ00821602014), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The last funding source financially supported this work as well.	CHIVUKULA M, 1995, APPL ENVIRON MICROB, V61, P4374, DOI 10.1128/AEM.61.12.4374-4377.1995; da Maia Luciano Carlos, 2008, Int J Plant Genomics, V2008, P412696, DOI 10.1155/2008/412696; Dawe AL, 2001, ANNU REV GENET, V35, P1, DOI 10.1146/annurev.genet.35.102401.085929; Fierro F, 1999, CRIT REV MICROBIOL, V25, P1, DOI 10.1080/10408419991299185; Galagan JE, 2005, GENOME RES, V15, P1620, DOI 10.1101/gr.3767105; HEATH MC, 1995, MYCOLOGIA, V87, P442, DOI 10.2307/3760759; Horgen PA, 1996, FUNGAL GENET BIOL, V20, P229, DOI 10.1006/fgbi.1996.0038; INGOLD CT, 1980, T BRIT MYCOL SOC, V75, P107, DOI 10.1016/S0007-1536(80)80200-2; KALE S, 1992, HDB APPLIED MYCOLOGY, V5, P311; KEMP RFO, 1980, T BRIT MYCOL SOC, V74, P557, DOI 10.1016/S0007-1536(80)80056-8; Ko WC, 2007, J FOOD ENG, V81, P587, DOI 10.1016/j.jfoodeng.2006.12.009; Kudryavtseva OA, 2012, MICROBIOLOGY+, V81, P651, DOI 10.1134/S0026261712020051; Kudryavtseva OA, 2011, MICROBIOLOGY+, V80, P784, DOI 10.1134/S0026261711060105; Lange H, 2011, PLANT J, V68, P51, DOI 10.1111/j.1365-313X.2011.04675.x; LI AM, 1994, APPL ENVIRON MICROB, V60, P2384, DOI 10.1128/AEM.60.7.2384-2388.1994; LOHMAN TM, 1993, J BIOL CHEM, V268, P2269; Magae Y, 2005, APPL ENVIRON MICROB, V71, P6388, DOI 10.1128/AEM.71.10.6388-6389.2005; McEachern MJ, 2001, MOL CELL, V7, P695, DOI 10.1016/S1097-2765(01)00215-5; Moreno AD, 2014, CRIT REV BIOTECHNOL, P1; Nachman MW, 2002, CURR OPIN GENET DEV, V12, P657, DOI 10.1016/S0959-437X(02)00358-1; Park YJ, 2013, KSM NEWSLETTER, V25, P25; Park YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093560; Perez G, 2009, APPL ENVIRON MICROB, V75, P1427, DOI 10.1128/AEM.01889-08; Rogers CW, 2008, MICROBIOL-SGM, V154, P1628, DOI 10.1099/mic.0.2008/017020-0; Rozen S, 2000, Methods Mol Biol, V132, P365; Singer R., 1961, MUSHROOMS TRUFFLES B; Stukenbrock EH, 2014, FUNGAL BIOL REV, V28, P1, DOI 10.1016/j.fbr.2014.02.001; Wang CS, 2005, MICROBIOL-SGM, V151, P3223, DOI 10.1099/mic.0.28148-0; Xu JP, 1996, MYCOL RES, V100, P188, DOI 10.1016/S0953-7562(96)80119-5; Yang JH, 2001, FOOD CHEM, V72, P465, DOI 10.1016/S0308-8146(00)00262-4	30	4	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107207	10.1371/journal.pone.0107207	http://dx.doi.org/10.1371/journal.pone.0107207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25221949	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774800047
J	Rhea, CK; Kiefer, AW; Wittstein, MW; Leonard, KB; MacPherson, RP; Wright, WG; Haran, FJ				Rhea, Christopher K.; Kiefer, Adam W.; Wittstein, Matthew W.; Leonard, Kelsey B.; MacPherson, Ryan P.; Wright, W. Geoffrey; Haran, F. Jay			Fractal Gait Patterns Are Retained after Entrainment to a Fractal Stimulus	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; STRIDE-INTERVAL; SPEED INFLUENCES; 1/F NOISE; DYNAMICS; SYNCHRONIZATION; VARIABILITY; COMPLEXITY; WALKING; FLUCTUATIONS	Previous work has shown that fractal patterns in gait can be altered by entraining to a fractal stimulus. However, little is understood about how long those patterns are retained or which factors may influence stronger entrainment or retention. In experiment one, participants walked on a treadmill for 45 continuous minutes, which was separated into three phases. The first 15 minutes (pre-synchronization phase) consisted of walking without a fractal stimulus, the second 15 minutes consisted of walking while entraining to a fractal visual stimulus (synchronization phase), and the last 15 minutes (post-synchronization phase) consisted of walking without the stimulus to determine if the patterns adopted from the stimulus were retained. Fractal gait patterns were strengthened during the synchronization phase and were retained in the post-synchronization phase. In experiment two, similar methods were used to compare a continuous fractal stimulus to a discrete fractal stimulus to determine which stimulus type led to more persistent fractal gait patterns in the synchronization and post-synchronization (i.e., retention) phases. Both stimulus types led to equally persistent patterns in the synchronization phase, but only the discrete fractal stimulus led to retention of the patterns. The results add to the growing body of literature showing that fractal gait patterns can be manipulated in a predictable manner. Further, our results add to the literature by showing that the newly adopted gait patterns are retained for up to 15 minutes after entrainment and showed that a discrete visual stimulus is a better method to influence retention.	[Rhea, Christopher K.; Wittstein, Matthew W.; Leonard, Kelsey B.; MacPherson, Ryan P.] Univ N Carolina, Dept Kinesiol, Greensboro, NC 27412 USA; [Kiefer, Adam W.] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, Cincinnati, OH 45229 USA; [Kiefer, Adam W.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Kiefer, Adam W.] Univ Cincinnati, Ctr Cognit Act & Percept, Dept Psychol, Cincinnati, OH USA; [Wright, W. Geoffrey] Temple Univ, Dept Phys Therapy, Philadelphia, PA 19122 USA; [Wright, W. Geoffrey] Temple Univ, Dept Bioengn, Philadelphia, PA 19122 USA; [Haran, F. Jay] Biomed Res & Operat Dept, Navy Expt Div Unit, Panama City Beach, FL USA	University of North Carolina; University of North Carolina Greensboro; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania	Rhea, CK (corresponding author), Univ N Carolina, Dept Kinesiol, Greensboro, NC 27412 USA.	ckrhea@uncg.edu	Kiefer, Adam/F-1756-2018; Wittstein, Matthew/AAB-4577-2020	Wittstein, Matthew/0000-0002-8285-5058; Kiefer, Adam/0000-0003-4213-3349	United States Navy [W91CRB-11-D-0001, P010202825]	United States Navy(United States Department of Defense)	Manuscript preparation was funded the United States Navy (W91CRB-11-D-0001; subcontract P010202825). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELAIR J, 1995, CHAOS, V5, P1, DOI 10.1063/1.166069; del Olmo MF, 2005, PARKINSONISM RELAT D, V11, P25, DOI 10.1016/j.parkreldis.2004.09.002; Diniz A, 2011, HUM MOVEMENT SCI, V30, P889, DOI 10.1016/j.humov.2010.07.006; Dubois DM, 2003, LECT NOTES ARTIF INT, V2684, P110; Glass L, 1979, Ann N Y Acad Sci, V316, P214, DOI 10.1111/j.1749-6632.1979.tb29471.x; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; GOLDBERGER AL, 1990, SCI AM, V262, P43; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hausdorff JM, 1999, J APPL PHYSIOL, V86, P1040, DOI 10.1152/jappl.1999.86.3.1040; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Hausdorff JM, 2000, J APPL PHYSIOL, V88, P2045, DOI 10.1152/jappl.2000.88.6.2045; Hove MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032600; Hove MJ, 2010, J EXP PSYCHOL HUMAN, V36, P1525, DOI 10.1037/a0019059; IVRY RB, 1995, J EXP PSYCHOL HUMAN, V21, P3, DOI 10.1037/0096-1523.21.1.3; Jordan K, 2007, GAIT POSTURE, V26, P128, DOI 10.1016/j.gaitpost.2006.08.010; Jordan K, 2007, HUM MOVEMENT SCI, V26, P87, DOI 10.1016/j.humov.2006.10.001; Jordan K, 2006, GAIT POSTURE, V24, P120, DOI 10.1016/j.gaitpost.2005.08.003; Jordan K, 2009, HUM MOVEMENT SCI, V28, P113, DOI 10.1016/j.humov.2008.09.001; Kaipust JP, 2013, ANN BIOMED ENG, V41, P1595, DOI 10.1007/s10439-012-0654-9; Kiefer AW, 2009, J EXP PSYCHOL HUMAN, V35, P1532, DOI 10.1037/a0013546; Lemoine L, 2006, CAN J EXP PSYCHOL, V60, P247, DOI 10.1037/cjep2006023; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Manor B, 2013, PROG NEURO-PSYCHOPH, V45, P287, DOI 10.1016/j.pnpbp.2012.08.020; Marmelat V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091949; Marmelat V, 2012, EXP BRAIN RES, V222, P137, DOI 10.1007/s00221-012-3202-9; Paterson K, 2011, GAIT POSTURE, V33, P251, DOI 10.1016/j.gaitpost.2010.11.014; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Repp BH, 2010, J MOTOR BEHAV, V42, P111, DOI 10.1080/00222890903566418; Rhea C.K., 2014, GAIT BIOMETRICS BASI; Rhea CK, 2014, HUM MOVEMENT SCI, V36, P20, DOI 10.1016/j.humov.2014.04.006; Robertson SD, 1999, J EXP PSYCHOL HUMAN, V25, P1316, DOI 10.1037/0096-1523.25.5.1316; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; Stephen DG, 2008, PHYSICA A, V387, P5271, DOI 10.1016/j.physa.2008.05.015; Stephen DG, 2011, CHAOS SOLITON FRACT, V44, P160, DOI 10.1016/j.chaos.2011.01.005; Stepp N, 2010, COGN SYST RES, V11, P148, DOI 10.1016/j.cogsys.2009.03.003; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Stolze H, 1997, ELECTROMYOGR MOTOR C, V105, P490, DOI 10.1016/S0924-980X(97)00055-6; Studenka BE, 2008, HUM MOVEMENT SCI, V27, P29, DOI 10.1016/j.humov.2007.08.004; Torre K, 2011, PSYCHON B REV, V18, P339, DOI 10.3758/s13423-011-0049-1; Uchitomi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072176; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; Vierordt Kv, 1881, GEHEN MENSCHEN GESUN; von Porat A, 2006, KNEE SURG SPORT TR A, V14, P546, DOI 10.1007/s00167-006-0071-4; West B, 2006, MED WENT WRONG REDIS; Zelaznik HN, 2002, J EXP PSYCHOL HUMAN, V28, P575, DOI 10.1037//0096-1523.28.3.575	47	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e106755	10.1371/journal.pone.0106755	http://dx.doi.org/10.1371/journal.pone.0106755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25221981	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774800024
J	Akcakaya, M; Nam, S; Basha, TA; Kawaji, K; Tarokh, V; Nezafat, R				Akcakaya, Mehmet; Nam, Seunghoon; Basha, Tamer A.; Kawaji, Keigo; Tarokh, Vahid; Nezafat, Reza			An Augmented Lagrangian Based Compressed Sensing Reconstruction for Non-Cartesian Magnetic Resonance Imaging without Gridding and Regridding at Every Iteration	PLOS ONE			English	Article							GRAPHICS PROCESSING UNIT; HEART CORONARY MRA; MOTION; ANGIOGRAPHY; ACQUISITION; ALGORITHM; MINIMIZATION; TRANSFORM; SPIRALS; KERNEL	Background: Non-Cartesian trajectories are used in a variety of fast imaging applications, due to the incoherent image domain artifacts they create when undersampled. While the gridding technique is commonly utilized for reconstruction, the incoherent artifacts may be further removed using compressed sensing (CS). CS reconstruction is typically done using conjugate-gradient (CG) type algorithms, which require gridding and regridding to be performed at every iteration. This leads to a large computational overhead that hinders its applicability. Methods: We sought to develop an alternative method for CS reconstruction that only requires two gridding and one regridding operation in total, irrespective of the number of iterations. This proposed technique is evaluated on phantom images and whole-heart coronary MRI acquired using 3D radial trajectories, and compared to conventional CS reconstruction using CG algorithms in terms of quantitative vessel sharpness, vessel length, computation time, and convergence rate. Results: Both CS reconstructions result in similar vessel length (P = 0.30) and vessel sharpness (P = 0.62). The per-iteration complexity of the proposed technique is approximately 3-fold lower than the conventional CS reconstruction (17.55 vs. 52.48 seconds in C++). Furthermore, for in-vivo datasets, the convergence rate of the proposed technique is faster (60 +/- 13 vs. 455 +/- 320 iterations) leading to a similar to 23-fold reduction in reconstruction time. Conclusions: The proposed reconstruction provides images of similar quality to the conventional CS technique in terms of removing artifacts, but at a much lower computational complexity.	[Akcakaya, Mehmet; Nam, Seunghoon; Basha, Tamer A.; Kawaji, Keigo; Nezafat, Reza] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Cardiovasc, Boston, MA 02138 USA; [Nam, Seunghoon] Medtronic Inc, Surg Technol, Littleton, MA USA; [Kawaji, Keigo] Univ Chicago, Dept Med, Cardiol Sect, Chicago, IL 60637 USA; [Tarokh, Vahid] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Medtronic; University of Chicago; Harvard University	Akcakaya, M (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Cardiovasc, Boston, MA 02138 USA.	makcakay@bidmc.harvard.edu	Kawaji, Keigo/J-5501-2018; Basha, Tamer/AAN-4033-2020; Poor, H. Vincent/S-5027-2016	Kawaji, Keigo/0000-0002-4813-3414; Basha, Tamer/0000-0003-4431-8646; Poor, H. Vincent/0000-0002-2062-131X; Akcakaya, Mehmet/0000-0001-6400-7736	NIH [R01EB008743-01A2, K99HL111410-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL111410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008743] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The project described was supported by NIH R01EB008743-01A2 and NIH K99HL111410-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adluru G, 2011, J MAGN RESON IMAGING, V34, P1465, DOI 10.1002/jmri.22808; Akcakaya M, 2011, MAGN RESON MED, V66, P756, DOI 10.1002/mrm.22841; Barger AV, 2002, MAGN RESON MED, V48, P297, DOI 10.1002/mrm.10212; Becker SR, 2011, MATH PROGRAM COMPUT, V3, P165, DOI 10.1007/s12532-011-0029-5; Bernstein M.A., 2004, HDB MRI PULSE SEQUEN, DOI 10.1016/B978-012092861-3/50021-2; Bertsekas D., 1996, CONSTRAINED OPTIMIZA; Bhat H, 2011, MAGN RESON MED, V65, P1269, DOI 10.1002/mrm.22717; Blaimer M, 2009, MAY HAW P 17 SCI M I, P2713; Buchgraber G, 2010, MAY STOCKH P 18 SCI, P4959; Chambolle A, 2004, J MATH IMAGING VIS, V20, P89; Chan RW, 2012, MAGN RESON MED, V67, P363, DOI 10.1002/mrm.23008; Chartrand R, 2013, NOV AS P 47 AS C SIG, P1; DERICHE R, 1990, IEEE T PATTERN ANAL, V12, P78, DOI 10.1109/34.41386; Doneva M, 2010, MAGN RESON MED, V64, P1114, DOI 10.1002/mrm.22483; Etienne A, 2002, MAGNET RESON MED, V48, P658, DOI 10.1002/mrm.10253; Fischer A, 2009, COMBINATION NONCONVE, P2813; GLOVER GH, 1992, MAGNET RESON MED, V28, P275, DOI 10.1002/mrm.1910280209; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Johnson KO, 2009, MAGN RESON MED, V61, P439, DOI 10.1002/mrm.21840; Katoh M, 2006, J MAGN RESON IMAGING, V23, P757, DOI 10.1002/jmri.20569; Knoll F, 2010, MAGN RESON MATER PHY, V23, P103, DOI 10.1007/s10334-010-0207-x; Lee GR, 2012, MAGN RESON MED; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; MEYER CH, 1992, MAGNET RESON MED, V28, P202, DOI 10.1002/mrm.1910280204; Mistretta CA, 2006, MAGN RESON MED, V55, P30, DOI 10.1002/mrm.20772; Mistretta CA, 2009, J MAGN RESON IMAGING, V29, P501, DOI 10.1002/jmri.21683; Nam S, 2013, MAGN RESON MED, V69, P91, DOI 10.1002/mrm.24234; O'Sullivan JD, 1985, MED IMAGING IEEE T, V4, P200; Peters DC, 2000, MAGNET RESON MED, V43, P91, DOI 10.1002/(SICI)1522-2594(200001)43:1<91::AID-MRM11>3.0.CO;2-4; Pipe JG, 1999, MAGNET RESON MED, V41, P179, DOI 10.1002/(SICI)1522-2594(199901)41:1<179::AID-MRM25>3.0.CO;2-V; Ramani S, 2011, IEEE T MED IMAGING, V30, P694, DOI 10.1109/TMI.2010.2093536; Rasche V, 1999, IEEE T MED IMAGING, V18, P385, DOI 10.1109/42.774166; Santos JM, 2006, MAGN RESON MED, V55, P371, DOI 10.1002/mrm.20765; Scott AD, 2009, RADIOLOGY, V250, P331, DOI 10.1148/radiol.2502071998; Seiberlich N, 2007, MAGN RESON MED, V58, P1257, DOI 10.1002/mrm.21435; Sorensen TS, 2008, IEEE T MED IMAGING, V27, P538, DOI 10.1109/TMI.2007.909834; Sorensen TS, 2009, IEEE T MED IMAGING, V28, P1974, DOI 10.1109/TMI.2009.2027118; Stehning C, 2005, MAGN RESON MED, V54, P476, DOI 10.1002/mrm.20557; Stehning C, 2004, MAGNET RESON MED, V52, P197, DOI 10.1002/mrm.20128; Stone SS, 2008, J PARALLEL DISTR COM, V68, P1307, DOI 10.1016/j.jpdc.2008.05.013; Thedens DR, 1999, MAGN RESON MED, V41, P1170, DOI 10.1002/(SICI)1522-2594(199906)41:6<1170::AID-MRM13>3.0.CO;2-J; Trouard TP, 1996, JMRI-J MAGN RESON IM, V6, P925, DOI 10.1002/jmri.1880060614; van den Berg E, 2008, SIAM J SCI COMPUT, V31, P890, DOI 10.1137/080714488; Wajer F, 2001, MAY GLASG P 8 SCI M, P1798; Wang YL, 2008, SIAM J IMAGING SCI, V1, P248, DOI 10.1137/080724265; Yang JF, 2010, IEEE J-STSP, V4, P288, DOI 10.1109/JSTSP.2010.2042333; Yeh EN, 2005, MAGN RESON MED, V54, P1, DOI 10.1002/mrm.20517; Zwart NR, 2012, MAGN RESON MED, V67, P701, DOI 10.1002/mrm.23041	50	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107107	10.1371/journal.pone.0107107	http://dx.doi.org/10.1371/journal.pone.0107107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215945	gold, Green Published, Green Submitted			2022-12-25	WOS:000341774300042
J	Zhang, WB; Xu, XM; Kao, R; Mele, T; Kvietys, P; Martin, CM; Rui, T				Zhang, Wenbo; Xu, Xuemei; Kao, Raymond; Mele, Tina; Kvietys, Peter; Martin, Claudio M.; Rui, Tao			Cardiac Fibroblasts Contribute to Myocardial Dysfunction in Mice with Sepsis: The Role of NLRP3 Inflammasome Activation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SEPTIC SHOCK; NITRIC-OXIDE; HIGH GLUCOSE; INTERLEUKIN-1-BETA; MYOCYTES; MECHANISMS; DEPRESSION; APOPTOSIS; CYTOKINE	Myocardial contractile dysfunction in sepsis is associated with the increased morbidity and mortality. Although the underlying mechanisms of the cardiac depression have not been fully elucidated, an exaggerated inflammatory response is believed to be responsible. Nucleotide-binding oligomerization domain-like receptor containing pyrin domain 3 (NLRP3) inflammasome is an intracellular platform that is involved in the maturation and release of interleukin (IL)-1 beta. The aim of the present study is to evaluate whether sepsis activates NLRP3 inflammasome/caspase-1/IL-1 beta pathway in cardiac fibroblasts (CFs) and whether this cytokine can subsequently impact the function of cardiomyocytes (cardiac fibroblast-myocyte crosstalk). We show that treatment of CFs with lipopolysaccharide (LPS) induces upregulation of NLRP3, activation of caspase-1, as well as the maturation (activation) and release of IL-1 beta. In addition, the genetic (small interfering ribonucleic acid [siRNA]) and pharmacological (glyburide) inhibition of the NLRP3 inflammasome in CFs can block this signaling pathway. Furthermore, the inhibition of the NLRP3 inflammasome in cardiac fibroblasts ameliorated the ability of LPS-chalenged CFs to impact cardiomyocyte function as assessed by intracellular cyclic adenosine monophosphate (cAMP) responses in cardiomyocytes. Salient features of this the NLP3 inflammasome/ caspase-1 pathway were confirmed in in vivo models of endotoxemia/sepsis. We found that inhibition of the NLRP3 inflammasome attenuated myocardial dysfunction in mice with LPS and increased the survival rate in mice with feces-induced peritonitis. Our results indicate that the activation of the NLRP3 inflammasome in cardiac fibroblasts is pivotal in the induction of myocardial dysfunction in sepsis.	[Zhang, Wenbo; Rui, Tao] Jiangsu Univ, Affiliated Peoples Hosp, Dept Med, Zhenjiang, Jiangsu, Peoples R China; [Zhang, Wenbo; Rui, Tao] Jiangsu Univ, Affiliated Peoples Hosp, Dept Surg, Zhenjiang, Jiangsu, Peoples R China; [Zhang, Wenbo; Xu, Xuemei; Kao, Raymond; Mele, Tina; Martin, Claudio M.; Rui, Tao] Lawson Hlth Res Inst, London, ON, Canada; [Xu, Xuemei; Kao, Raymond; Mele, Tina; Martin, Claudio M.; Rui, Tao] Univ Western Ontario, Schulich Sch Med & Dent, Dept Med, Crit Care Western, London, ON, Canada; [Kvietys, Peter] Alfaisal Univ, Coll Med, Dept Physiol & Biochem, Riyadh, Saudi Arabia; [Rui, Tao] Univ Western Ontario, Schulich Sch Med & Dent, Dept Pathol, London, ON, Canada	Jiangsu University; Jiangsu University; Western University (University of Western Ontario); Western University (University of Western Ontario); Alfaisal University; Western University (University of Western Ontario)	Rui, T (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Med, Zhenjiang, Jiangsu, Peoples R China.	trui@uwo.ca	Kao, Raymond/AAF-6985-2020; Martin, Claudio/G-3327-2011; Rui, Tao/H-7044-2016; Kao, Ray/G-3312-2011		Heart and Stroke Foundation of Ontario [GIA 2012-000212]; Internal Research Fund from Lawson Health Research Institute	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Internal Research Fund from Lawson Health Research Institute	This work was supported by a Grant in Aid from the Heart and Stroke Foundation of Ontario (GIA 2012-000212 to TR) and a Internal Research Fund from Lawson Health Research Institute (To TR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Boost KA, 2007, INTENS CARE MED, V33, P863, DOI 10.1007/s00134-007-0588-0; Cain BS, 1999, CRIT CARE MED, V27, P1309, DOI 10.1097/00003246-199907000-00018; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Fallach R, 2010, J MOL CELL CARDIOL, V48, P1236, DOI 10.1016/j.yjmcc.2010.02.020; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; FISHER CJ, 1994, CRIT CARE MED, V22, P12, DOI 10.1097/00003246-199401000-00008; GULICK T, 1989, P NATL ACAD SCI USA, V86, P6753, DOI 10.1073/pnas.86.17.6753; Hernandez-Cuellar E, 2012, J IMMUNOL, V189, P5113, DOI 10.4049/jimmunol.1202479; HESSE DG, 1988, SURG GYNECOL OBSTET, V166, P147; Ichinose F, 2007, CIRC RES, V100, P130, DOI 10.1161/01.RES.0000253888.09574.7a; Joe EL, 1998, J MOL CELL CARDIOL, V30, P303, DOI 10.1006/jmcc.1997.0593; Kakkar R, 2010, CIRC RES, V106, P47, DOI 10.1161/CIRCRESAHA.109.207456; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Kumar A, 1996, J EXP MED, V183, P949, DOI 10.1084/jem.183.3.949; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Merx MW, 2007, CIRCULATION, V116, P793, DOI 10.1161/CIRCULATIONAHA.106.678359; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Romero-Bermejo FJ, 2011, CURR CARDIOL REV, V7, P163, DOI 10.2174/157340311798220494; Rossini A, 2008, J MOL CELL CARDIOL, V44, P683, DOI 10.1016/j.yjmcc.2008.01.009; Rubartelli A, 2012, J LEUKOCYTE BIOL, V92, P951, DOI 10.1189/jlb.0512265; Rui T, 2005, CARDIOVASC RES, V65, P719, DOI 10.1016/j.cardiores.2004.11.019; Sandanger O, 2013, CARDIOVASC RES, V99, P164, DOI 10.1093/cvr/cvt091; Scott AM, 2007, CELL DEATH DIFFER, V14, P23, DOI 10.1038/sj.cdd.4402026; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Singh VP, 2008, AM J PHYSIOL-HEART C, V294, pH1675, DOI 10.1152/ajpheart.91493.2007; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Takahashi M, 2013, CARDIOVASC RES, V99, P4, DOI 10.1093/cvr/cvt142; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Tokudome T, 2004, METABOLISM, V53, P710, DOI 10.1016/j.metabol.2004.01.006; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; WEISENSEE D, 1993, INT J IMMUNOPHARMACO, V15, P581, DOI 10.1016/0192-0561(93)90075-A; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; Wiersinga WJ, 2011, CURR OPIN CRIT CARE, V17, P480, DOI 10.1097/MCC.0b013e32834a4aeb; Wu LL, 2002, SHOCK, V17, P389, DOI 10.1097/00024382-200205000-00008; Xu H, 2011, AM J PHYSIOL-HEART C, V300, pH913, DOI 10.1152/ajpheart.00703.2010; Xu H, 2010, J IMMUNOL, V184, P1492, DOI 10.4049/jimmunol.0902660; Yang M, 2008, AM J PHYSIOL-HEART C, V294, pH994, DOI 10.1152/ajpheart.01044.2007; Yao YW, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0267-3; Yazdi AS, 2010, J CLIN IMMUNOL, V30, P623, DOI 10.1007/s10875-010-9437-y; Zhang P, 2012, AM J PHYSIOL-HEART C, V303, pH1385, DOI 10.1152/ajpheart.01167.2011; Zhang ZR, 2013, J IMMUNOL, V190, P3517, DOI 10.4049/jimmunol.1202628	47	57	59	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107639	10.1371/journal.pone.0107639	http://dx.doi.org/10.1371/journal.pone.0107639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216263	gold, Green Submitted, Green Published			2022-12-25	WOS:000341774300092
J	Liu, ZY; Galemmo, RA; Fraser, KB; Moehle, MS; Sen, S; Volpicelli-Daley, LA; DeLucas, LJ; Ross, LJ; Valiyaveettil, J; Moukha-Chafiq, O; Pathak, AK; Ananthan, S; Kezar, H; White, EL; Gupta, V; Maddry, JA; Suto, MJ; West, AB				Liu, Zhiyong; Galemmo, Robert A., Jr.; Fraser, Kyle B.; Moehle, Mark S.; Sen, Saurabh; Volpicelli-Daley, Laura A.; DeLucas, Lawrence J.; Ross, Larry J.; Valiyaveettil, Jacob; Moukha-Chafiq, Omar; Pathak, Ashish K.; Ananthan, Subramaniam; Kezar, Hollis; White, E. Lucile; Gupta, Vandana; Maddry, Joseph A.; Suto, Mark J.; West, Andrew B.			Unique Functional and Structural Properties of the LRRK2 Protein ATP-binding Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPEAT KINASE 2; DISEASE-ASSOCIATED MUTATIONS; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; NEURONAL TOXICITY; P-GLYCOPROTEIN; GTPASE DOMAIN; ACTIVE STATE; INHIBITOR; MUTANT	Pathogenic mutations in the LRRK2 gene can cause late-onset Parkinson disease. The most common mutation, G2019S, resides in the kinase domain and enhances activity. LRRK2 possesses the unique property of cis-autophosphorylation of its own GTPase domain. Because high-resolution structures of the human LRRK2 kinase domain are not available, we used novel high-throughput assays that measured both cis-autophosphorylation and trans-peptide phosphorylation to probe the ATP-binding pocket. We disclose hundreds of commercially available activity-selective LRRK2 kinase inhibitors. Some compounds inhibit cis-autophosphorylation more strongly than trans-peptide phosphorylation, and other compounds inhibit G2019S-LRRK2 more strongly than WT-LRRK2. Through exploitation of structure-activity relationships revealed through high-throughput analyses, we identified a useful probe inhibitor, SRI-29132 (11). SRI-29132 is exquisitely selective for LRRK2 kinase activity and is effective in attenuating proinflammatory responses in macrophages and rescuing neurite retraction phenotypes in neurons. Furthermore, the compound demonstrates excellent potency, is highly blood-brain barrier-permeant, but suffers from rapid first-pass metabolism. Despite the observed selectivity of SRI-29132, docking models highlighted critical interactions with residues conserved in many protein kinases, implying a unique structural configuration for the LRRK2 ATP-binding pocket. Although the human LRRK2 kinase domain is unstable and insoluble, we demonstrate that the LRRK2 homolog from ameba can be mutated to approximate some aspects of the human LRRK2 ATP-binding pocket. Our results provide a rich resource for LRRK2 small molecule inhibitor development. More broadly, our results provide a precedent for the functional interrogation of ATP-binding pockets when traditional approaches to ascertain structure prove difficult.	[Liu, Zhiyong; Fraser, Kyle B.; Moehle, Mark S.; Sen, Saurabh; Volpicelli-Daley, Laura A.; West, Andrew B.] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Dept Neurol, Birmingham, AL 35294 USA; [Liu, Zhiyong] Univ Alabama Birmingham, Ctr Biophys Sci & Engn, Dept Optometry, Birmingham, AL 35294 USA; [Galemmo, Robert A., Jr.; DeLucas, Lawrence J.; Ross, Larry J.; Valiyaveettil, Jacob; Moukha-Chafiq, Omar; Pathak, Ashish K.; Ananthan, Subramaniam; Kezar, Hollis; White, E. Lucile; Gupta, Vandana; Maddry, Joseph A.; Suto, Mark J.] So Res Inst, Drug Discovery Div, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	West, AB (corresponding author), Civitan Int Res Bldg,5th Floor,1719 6th Ave S, Birmingham, AL USA.	abwest@uab.edu	Moehle, Mark/GNH-1825-2022	Moehle, Mark/0000-0002-8023-1313; West, Andrew/0000-0002-3034-4061; Pathak, Ashish/0000-0003-0143-7979	NINDS, National Institutes of Health [R01NS064934]; Alabama Drug Discovery Alliance; UAB Center for Clinical and Translational Science Grant [UL1R00165]; American Parkinson Disease Association; Southern Research Strategic Investment Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064934] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alabama Drug Discovery Alliance; UAB Center for Clinical and Translational Science Grant; American Parkinson Disease Association; Southern Research Strategic Investment Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by NINDS, National Institutes of Health Grant R01NS064934. This work was also supported by the Alabama Drug Discovery Alliance, by the UAB Center for Clinical and Translational Science Grant UL1R00165, by John A. and Ruth R. Jurenko, by the American Parkinson Disease Association, and by the Southern Research Strategic Investment Fund.	Andres-Mateos E, 2009, J NEUROSCI, V29, P15846, DOI 10.1523/JNEUROSCI.4357-09.2009; Baptista MAS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080705; Choi HG, 2012, ACS MED CHEM LETT, V3, P658, DOI 10.1021/ml300123a; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Covy JP, 2009, BIOCHEM BIOPH RES CO, V378, P473, DOI 10.1016/j.bbrc.2008.11.048; Daher JPL, 2014, P NATL ACAD SCI USA, V111, P9289, DOI 10.1073/pnas.1403215111; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Franzini M, 2013, BIOORG MED CHEM LETT, V23, P1967, DOI 10.1016/j.bmcl.2013.02.043; Gilsbach BK, 2012, P NATL ACAD SCI USA, V109, P10322, DOI 10.1073/pnas.1203223109; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Hakimi M, 2011, J NEURAL TRANSM, V118, P795, DOI 10.1007/s00702-011-0653-2; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; Lemaire S, 2007, ANTIMICROB AGENTS CH, V51, P2748, DOI 10.1128/AAC.00090-07; Liao JL, 2014, P NATL ACAD SCI USA, V111, P4055, DOI 10.1073/pnas.1323285111; Liu M, 2011, BIOCHEMISTRY-US, V50, P9399, DOI 10.1021/bi201173d; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Misra S, 1999, P NATL ACAD SCI USA, V96, P5814, DOI 10.1073/pnas.96.10.5814; Moehle MS, 2012, J NEUROSCI, V32, P1602, DOI 10.1523/JNEUROSCI.5601-11.2012; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Ramsden N, 2011, ACS CHEM BIOL, V6, P1021, DOI 10.1021/cb2002413; Ray S, 2014, J BIOL CHEM, V289, P13042, DOI 10.1074/jbc.M113.537811; Ray S, 2012, FUTURE MED CHEM, V4, P1701, DOI [10.4155/fmc.12.110, 10.4155/FMC.12.110]; Reith AD, 2012, BIOORG MED CHEM LETT, V22, P5625, DOI 10.1016/j.bmcl.2012.06.104; Santner AA, 2012, BIOCHEMISTRY-US, V51, P7250, DOI 10.1021/bi300653m; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Sheng DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000914; Sheng ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004485; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Stafa K, 2014, HUM MOL GENET, V23, P2055, DOI 10.1093/hmg/ddt600; Thevenet J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021519; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Treiber DK, 2013, CHEM BIOL, V20, P745, DOI 10.1016/j.chembiol.2013.06.001; Vallotton P, 2007, CYTOM PART A, V71A, P889, DOI 10.1002/cyto.a.20462; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Webber PJ, 2011, J MOL BIOL, V412, P94, DOI 10.1016/j.jmb.2011.07.033; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Zhang JW, 2012, BIOORG MED CHEM LETT, V22, P1864, DOI 10.1016/j.bmcl.2012.01.084; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	45	21	21	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.602318	http://dx.doi.org/10.1074/jbc.M114.602318			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25228699	hybrid, Green Published			2022-12-25	WOS:000345335000045
J	Chu, NK; Shabbir, W; Bove-Fenderson, E; Araman, C; Lemmens-Gruber, R; Harris, DA; Becker, CFW				Chu, Nam K.; Shabbir, Waheed; Bove-Fenderson, Erin; Araman, Can; Lemmens-Gruber, Rosa; Harris, David A.; Becker, Christian F. W.			A C-terminal Membrane Anchor Affects the Interactions of Prion Proteins with Lipid Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Liposome; Prion; Protein Aggregation; Protein Chemistry; Protein Conformation; lipid-Protein Interactions; Membrane Anchor; Pore Formation; Protein Semisynthesis	GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR; CELLULAR MEMBRANES; CULTURED-CELLS; CONVERSION; BINDING; PRPSC; RECOMBINANT; SEMISYNTHESIS; FLUORESCENCE; PENETRATION	Background: Membrane attachment of PrP via a GPI anchor is critical for conversion into PrPSc. Results: Semisynthetic membrane-anchored PrP variants are generated and analyzed in different lipid environments. Conclusion: A membrane anchor drastically changes PrP interactions with membranes and enables pore formation. Significance: Membrane-induced conformational changes and pore formation of PrP play a role in the conversion into PrPSc and its toxic effects. Membrane attachment via a C-terminal glycosylphosphatidylinositol anchor is critical for conversion of PrPC into pathogenic PrPSc. Therefore the effects of the anchor on PrP structure and function need to be deciphered. Three PrP variants, including full-length PrP (residues 23-231, FL_PrP), N-terminally truncated PrP (residues 90-231, T_PrP), and PrP missing its central hydrophobic region (105-125, CR_PrP), were equipped with a C-terminal membrane anchor via a semisynthesis strategy. Analyses of the interactions of lipidated PrPs with phospholipid membranes demonstrated that C-terminal membrane attachment induces a different binding mode of PrP to membranes, distinct from that of non-lipidated PrPs, and influences the biochemical and conformational properties of PrPs. Additionally, fluorescence-based assays indicated pore formation by lipidated CR_PrP, a variant that is known to be highly neurotoxic in transgenic mice. This finding was supported by using patch clamp electrophysiological measurements of cultured cells. These results provide new evidence for the role of the membrane anchor in PrP-lipid interactions, highlighting the importance of the N-terminal and the central hydrophobic domain in these interactions.	[Chu, Nam K.; Araman, Can; Becker, Christian F. W.] Univ Vienna, Fac Chem, Inst Biol Chem, A-1090 Vienna, Austria; [Shabbir, Waheed; Lemmens-Gruber, Rosa] Univ Vienna, Dept Pharmacol & Toxicol, A-1090 Vienna, Austria; [Bove-Fenderson, Erin; Harris, David A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	University of Vienna; University of Vienna; Boston University	Becker, CFW (corresponding author), Univ Vienna, Fac Chem, Inst Biol Chem, Wahringer Str 38, A-1090 Vienna, Austria.	christian.becker@univie.ac.at	Becker, Christian F/A-4891-2010; Chu, Nam/AAY-8247-2021	Becker, Christian F/0000-0002-8890-7082; Lemmens-Gruber, Rosa/0000-0002-4817-6748; Harris, David/0000-0002-6985-5790; Araman, Can/0000-0002-6961-5607; Chu, Nam/0000-0001-9717-5007	National Institutes of Health [R01 NS065244]; Deutsche Forschungsgemeinschaft (DFG) [BE3270/6-1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065244, R01NS040975] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS065244 (to D. A. H.). This work was also supported by Deutsche Forschungsgemeinschaft (DFG) Grant BE3270/6-1 (to C. F. W. B.).	Aguzzi A, 2000, CELL DEATH DIFFER, V7, P889, DOI 10.1038/sj.cdd.4400737; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Baron GS, 2003, J BIOL CHEM, V278, P14883, DOI 10.1074/jbc.M210840200; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Becker CFW, 2008, ANGEW CHEM INT EDIT, V47, P8215, DOI 10.1002/anie.200802161; Biasini E, 2013, J NEUROSCI, V33, P2408, DOI 10.1523/JNEUROSCI.3406-12.2013; Biasini E, 2012, TRENDS NEUROSCI, V35, P92, DOI 10.1016/j.tins.2011.10.002; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Breydo L, 2007, BIOCHEMISTRY-US, V46, P852, DOI 10.1021/bi061923v; Butko P, 1996, BIOCHEMISTRY-US, V35, P11355, DOI 10.1021/bi960970s; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Christensen HM, 2009, J NEUROCHEM, V108, P44, DOI 10.1111/j.1471-4159.2008.05719.x; Chu NK, 2009, METHOD ENZYMOL, V462, P177, DOI 10.1016/S0076-6879(09)62009-7; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; Critchley P, 2004, BIOCHEM BIOPH RES CO, V313, P559, DOI 10.1016/j.bbrc.2003.12.004; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Eberl H, 2004, J BIOL CHEM, V279, P25058, DOI 10.1074/jbc.M400952200; EFTINK MR, 1991, METHOD BIOCHEM ANAL, V35, P127; Garg P, 2013, BBA-BIOMEMBRANES, V1828, P732, DOI 10.1016/j.bbamem.2012.08.006; Gerlach H, 2010, NAT CHEM BIOL, V6, P46, DOI [10.1038/NCHEMBIO.268, 10.1038/nchembio.268]; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Goold R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1282; Goold R, 2013, J CELL SCI, V126, P3552, DOI 10.1242/jcs.120477; Halevy R, 2003, PEPTIDES, V24, P1753, DOI 10.1016/j.peptides.2003.08.019; Herce HD, 2007, P NATL ACAD SCI USA, V104, P20805, DOI 10.1073/pnas.0706574105; Hicks MR, 2006, FEBS J, V273, P1285, DOI 10.1111/j.1742-4658.2006.05152.x; Hornemann S, 1997, FEBS LETT, V413, P277, DOI 10.1016/S0014-5793(97)00921-6; Katz M, 2003, BIOCHEM J, V375, P405, DOI 10.1042/BJ20030784; Kim JI, 2009, FEBS LETT, V583, P3671, DOI 10.1016/j.febslet.2009.10.049; LANGNER M, 1993, CHEM PHYS LIPIDS, V65, P23, DOI 10.1016/0009-3084(93)90078-H; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; Mingeot-Leclercq MP, 2002, CHEM PHYS LIPIDS, V120, P57, DOI 10.1016/S0009-3084(02)00108-1; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Olschewski D, 2007, CHEM BIOL, V14, P994, DOI 10.1016/j.chembiol.2007.08.007; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Priola SA, 2009, PRION, V3, P134, DOI 10.4161/pri.3.3.9771; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Raja SM, 1999, BIOPHYS J, V76, P1469, DOI 10.1016/S0006-3495(99)77307-8; Robinson PJ, 2010, BIOPHYS J, V98, P1520, DOI 10.1016/j.bpj.2009.12.4304; Sanghera N, 2002, J MOL BIOL, V315, P1241, DOI 10.1006/jmbi.2001.5322; Sanghera N, 2011, CHEM BIOL, V18, P1422, DOI 10.1016/j.chembiol.2011.08.016; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Solomon IH, 2011, J BIOL CHEM, V286, P14724, DOI 10.1074/jbc.M110.214973; Solomon IH, 2010, J BIOL CHEM, V285, P26719, DOI 10.1074/jbc.M110.134619; STAHL N, 1990, BIOCHEMISTRY-US, V29, P5405, DOI 10.1021/bi00474a028; Stern O, 1919, PHYS Z, V20, P183; Turnbaugh JA, 2012, J NEUROSCI, V32, P8817, DOI 10.1523/JNEUROSCI.1103-12.2012; Turnbaugh JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025675; Vogt TCB, 1999, J BIOL CHEM, V274, P29115, DOI 10.1074/jbc.274.41.29115; Wadia JS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003314; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Wang F, 2010, BIOCHEMISTRY-US, V49, P8169, DOI 10.1021/bi101146v; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Westergard L, 2011, J NEUROSCI, V31, P14005, DOI 10.1523/JNEUROSCI.1243-11.2011	59	23	23	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					30144	30160		10.1074/jbc.M114.587345	http://dx.doi.org/10.1074/jbc.M114.587345			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25217642	Green Published, hybrid			2022-12-25	WOS:000344370800053
J	Li, C; Li, CG; Zhang, AJX; To, KKW; Lee, ACY; Zhu, HS; Wu, HWL; Chan, JFW; Chen, HL; Hung, IFN; Li, LJ; Yuen, KY				Li, Can; Li, Chuangen; Zhang, Anna J. X.; To, Kelvin K. W.; Lee, Andrew C. Y.; Zhu, Houshun; Wu, Hazel W. L.; Chan, Jasper F. W.; Chen, Honglin; Hung, Ivan F. N.; Li, Lanjuan; Yuen, Kwok-Yung			Avian Influenza A H7N9 Virus Induces Severe Pneumonia in Mice without Prior Adaptation and Responds to a Combination of Zanamivir and COX-2 Inhibitor	PLOS ONE			English	Article							HUMAN INFECTIONS; CLINICAL-FEATURES; H5N1 VIRUS; FERRETS; PATHOGENESIS; VIRULENCE; HEMAGGLUTININ; TRANSMISSION; REPLICATION; ACTIVATION	Background: Human infection caused by the avian influenza A H7N9 virus has a case-fatality rate of over 30%. Systematic study of the pathogenesis of avian H7N9 isolate and effective therapeutic strategies are needed. Methods: BALB/c mice were inoculated intranasally with an H7N9 virus isolated from a chicken in a wet market epidemiologically linked to a fatal human case, (A/chicken/Zhejiang/DTID-ZJU01/2013 [CK1]), and with an H7N9 virus isolated from a human (A/Anhui/01/2013 [AH1]). The pulmonary viral loads, cytokine/chemokine profiles and histopathological changes of the infected mice were compared. The therapeutic efficacy of a non-steroidal anti-inflammatory drug (NSAID), celecoxib, was assessed. Results: Without prior adaptation, intranasal inoculation of 10 6 plaque forming units (PFUs) of CK1 caused a mortality rate of 82% (14/17) in mice. Viral nucleoprotein and RNA expression were limited to the respiratory system and no viral RNA could be detected from brain, liver and kidney tissues. CK1 caused heavy alveolar inflammatory exudation and pulmonary hemorrhage, associated with high pulmonary levels of proinflammatory cytokines. In the mouse lung cell line LA-4, CK1 also induced high levels of interleukin-6 (IL-6) and cyclooxygenase-2 (COX-2) mRNA. Administration of the antiviral zanamivir did not significantly improve survival in mice infected with CK1, but co-administration of the non-steroidal anti-inflammatory drug (NSAID) celecoxib in combination with zanamivir improved survival and lung pathology. Conclusions: Our findings suggested that H7N9 viruses isolated from chicken without preceding trans-species adaptation can cause lethal mammalian pulmonary infection. The severe proinflammatory responses might be a factor contributing to the mortality. Treatment with combination of antiviral and NSAID could ameliorate pulmonary inflammation and may improve survival.	[Li, Can; Li, Chuangen; Zhang, Anna J. X.; To, Kelvin K. W.; Lee, Andrew C. Y.; Wu, Hazel W. L.; Chan, Jasper F. W.; Chen, Honglin; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Anna J. X.; To, Kelvin K. W.; Wu, Hazel W. L.; Chan, Jasper F. W.; Chen, Honglin; Yuen, Kwok-Yung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Zhang, Anna J. X.; To, Kelvin K. W.; Chan, Jasper F. W.; Chen, Honglin; Hung, Ivan F. N.; Yuen, Kwok-Yung] Univ Hong Kong, Res Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China; [Zhu, Houshun; Hung, Ivan F. N.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Li, Lanjuan] Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Honglin; Li, Lanjuan; Yuen, Kwok-Yung] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Chen, Honglin; Li, Lanjuan; Yuen, Kwok-Yung] Zhejiang Univ, Hangzhou 310003, Zhejiang, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Zhang, AJX (corresponding author), Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	zhangajx@hku.hk; kyyuen@hkucc.hku.hk	Hung, Ivan FN/ABD-5916-2021; Chan, Jasper F. W./D-8007-2013; Chen, Honglin/C-4224-2009; To, Kelvin/AAV-7007-2020	Hung, Ivan FN/0000-0002-1556-2538; Chan, Jasper F. W./0000-0001-6336-6657; Chen, Honglin/0000-0001-5108-8338; To, Kelvin/0000-0002-1921-5824; Lee, Andrew Chak Yiu/0000-0002-8432-3282; Yuen, Kwok-yung/0000-0002-2083-1552	Providence Foundation Ltd	Providence Foundation Ltd	This work was supported by the Providence Foundation Ltd, in memory of the late Lui Hac Minh, and a donation from Larry Chi-Kin Yung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, RAP RISK ASS HUM INF; Baranovich T, 2013, J INFECT DIS; Belser JA, 2013, NATURE, V501, P556, DOI 10.1038/nature12391; Camp JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056602; Chan KH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013757; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dybing JK, 2000, J VIROL, V74, P1443, DOI 10.1128/JVI.74.3.1443-1450.2000; Ehrentraut H, 2013, FASEB J, V27, P2207, DOI 10.1096/fj.12-225201; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Kreijtz JHCM, 2013, VACCINE, V31, P4995, DOI 10.1016/j.vaccine.2013.06.071; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Lee SMY, 2011, ANTIVIR RES, V91, P330, DOI 10.1016/j.antiviral.2011.07.011; Li IWS, 2009, J CLIN VIROL, V46, P325, DOI 10.1016/j.jcv.2009.09.013; Liu D, 2014, LANCET; Marty FM, 2014, J INFECT DIS, V209, P542, DOI 10.1093/infdis/jit467; Mok CKP, 2013, MBIO, V4, DOI 10.1128/mBio.00362-13; Moltedo B, 2009, J IMMUNOL, V183, P3569, DOI 10.4049/jimmunol.0900091; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Ruckle A, 2012, J VIROL, V86, P10211, DOI 10.1128/JVI.00323-12; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Suguitan AL, 2012, J VIROL, V86, P2706, DOI 10.1128/JVI.05546-11; To KKW, 2014, CURR OPIN PULM MED, V20, P225, DOI 10.1097/MCP.0000000000000047; To KKW, 2013, LANCET INFECT DIS, V13, P809, DOI 10.1016/S1473-3099(13)70167-1; To KKW, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.24; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; To KKW, 2014, J INFECTION, V69, P60, DOI 10.1016/j.jinf.2014.02.012; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; Xu LL, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-253; Xu T, 2009, EUR RESPIR J, V33, P852, DOI 10.1183/09031936.00130507; Yu L, 2013, CLIN INFECT DIS, V57, P1449, DOI 10.1093/cid/cit541; Yu XF, 2014, J VIROL, V88, P3423, DOI 10.1128/JVI.02059-13; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhang AJX, 2014, CLIN VACCINE IMMUNOL, V21, P570, DOI 10.1128/CVI.00816-13; Zhang AJX, 2013, J INFECT DIS, V207, P1270, DOI 10.1093/infdis/jit031; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105; Zheng BJ, 2010, EXP BIOL MED, V235, P981, DOI 10.1258/ebm.2010.010071; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844; Zielecki F, 2010, J VIROL, V84, P10708, DOI 10.1128/JVI.00610-10	44	30	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107966	10.1371/journal.pone.0107966	http://dx.doi.org/10.1371/journal.pone.0107966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232731	Green Published, Green Submitted, gold			2022-12-25	WOS:000342921200070
J	Morisaki, T; McNally, JG				Morisaki, Tatsuya; McNally, James G.			Photoswitching-Free FRAP Analysis with a Genetically Encoded Fluorescent Tag	PLOS ONE			English	Article							CHROMATIN PROTEINS; LIVING CELLS; DNA-DAMAGE; IN-VIVO; RECOVERY; BINDING; MICROSCOPY; DIFFUSION; DYNAMICS; MOBILITY	Fluorescence recovery after photobleaching (FRAP) is a widely used imaging technique for measuring protein dynamics in live cells that has provided many important biological insights. Although FRAP presumes that the conversion of a fluorophore from a bright to a dark state is irreversible, GFP as well as other genetically encoded fluorescent proteins now in common use can also exhibit a reversible conversion known as photoswitching. Various studies have shown how photoswitching can cause at least four different artifacts in FRAP, leading to false conclusions about various biological phenomena, including the erroneous identification of anomalous diffusion or the overestimation of the freely diffusible fraction of a cellular protein. Unfortunately, identifying and then correcting these artifacts is difficult. Here we report a new characteristic of an organic fluorophore tetramethylrhodamine bound to the HaloTag protein (TMR-HaloTag), which like GFP can be genetically encoded, but which directly and simply overcomes the artifacts caused by photoswitching in FRAP. We show that TMR exhibits virtually no photoswitching in live cells under typical imaging conditions for FRAP. We also demonstrate that TMR eliminates all of the four reported photoswitching artifacts in FRAP. Finally, we apply this photoswitching-free FRAP with TMR to show that the chromatin decondensation following UV irradiation does not involve loss of nucleosomes from the damaged DNA. In sum, we demonstrate that the TMR Halo label provides a genetically encoded fluorescent tag very well suited for accurate FRAP experiments.	[Morisaki, Tatsuya; McNally, James G.] NCI, Fluorescence Imaging Grp, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	McNally, JG (corresponding author), Helmholtz Ctr Berlin, Inst Soft Matter & Funct Mat, Berlin, Germany.	james.mcnally@helmholtz-berlin.de		Morisaki, Tatsuya/0000-0001-7401-4673	intramural program of the Center for Cancer Research, National Cancer Institute, US National Institutes of Health; Japan Society for the Promotion of Science; Helmholtz-Zentrum Berlin; NATIONAL CANCER INSTITUTE [ZICBC011571] Funding Source: NIH RePORTER	intramural program of the Center for Cancer Research, National Cancer Institute, US National Institutes of Health; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Helmholtz-Zentrum Berlin(Helmholtz Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	TM and JGM were supported by the intramural program of the Center for Cancer Research, National Cancer Institute, US National Institutes of Health. TM was supported by the Japan Society for the Promotion of Science. JGM was supported by the Helmholtz-Zentrum Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bancaud Aurelien, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.top90; Catez F, 2010, BBA-GENE REGUL MECH, V1799, P15, DOI 10.1016/j.bbagrm.2009.11.001; Daddysman MK, 2013, J PHYS CHEM B, V117, P1241, DOI 10.1021/jp310348s; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Dinant C, 2013, MOL CELL, V51, P469, DOI 10.1016/j.molcel.2013.08.007; Henderson JN, 2007, P NATL ACAD SCI USA, V104, P6672, DOI 10.1073/pnas.0700059104; Houtsmuller AB, 2005, ADV BIOCHEM ENG BIOT, V95, P177, DOI 10.1007/b102214; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Lemmer P, 2009, J MICROSC-OXFORD, V235, P163, DOI 10.1111/j.1365-2818.2009.03196.x; Mazza D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks701; Mueller F, 2008, BIOPHYS J, V94, P3323, DOI 10.1529/biophysj.107.123182; Mueller F, 2012, BIOPHYS J, V102, P1656, DOI 10.1016/j.bpj.2012.02.029; Mueller F, 2012, METHODS MOL BIOL, V833, P153, DOI 10.1007/978-1-61779-477-3_11; Owen DM, 2009, TRAFFIC, V10, P962, DOI 10.1111/j.1600-0854.2009.00908.x; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Sinnecker D, 2005, BIOCHEMISTRY-US, V44, P7085, DOI 10.1021/bi047881x; Soria G, 2012, MOL CELL, V46, P722, DOI 10.1016/j.molcel.2012.06.002; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Stasevich TJ, 2011, CHROMOSOMA, V120, P533, DOI 10.1007/s00412-011-0340-y; Urh Marjeta, 2012, Curr Chem Genomics, V6, P72, DOI 10.2174/1875397301206010072; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336	25	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107730	10.1371/journal.pone.0107730	http://dx.doi.org/10.1371/journal.pone.0107730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233348	Green Published, Green Submitted, gold			2022-12-25	WOS:000342921200048
J	Jing, J; Wu, JJ; Liu, W; Xiong, ST; Ma, WG; Zhang, J; Wang, WM; Gui, JF; Mei, J				Jing, Jing; Wu, Junjie; Liu, Wei; Xiong, Shuting; Ma, Wenge; Zhang, Jin; Wang, Weimin; Gui, Jian-Fang; Mei, Jie			Sex-Biased miRNAs in Gonad and Their Potential Roles for Testis Development in Yellow Catfish	PLOS ONE			English	Article							PELTEOBAGRUS-FULVIDRACO RICHARDSON; HALIBUT HIPPOGLOSSUS-HIPPOGLOSSUS; GERMLINE MESSENGER-RNAS; MICRORNA EXPRESSION; CARASSIUS-AURATUS; ZEBRAFISH MIR-430; CELL DEVELOPMENT; GRANULOSA-CELLS; DIFFERENTIATION; GROWTH	Recently, YY super-male yellow catfish had been created by hormonal-induced sex reversal and sex-linked markers, which provides a promising research model for fish sex differentiation and gonad development, especially for testis development. MicroRNAs (miRNAs) have been revealed to play crucial roles in the gene regulation and gonad development in vertebrates. In this study, three small RNA libraries constructed from gonad tissues of XX female, XY male and YY super-male yellow catfish were sequenced. The sequencing data generated a total of 384 conserved miRNAs and 113 potential novel miRNAs, among which 23, 30 and 14 miRNAs were specifically detected in XX ovary, XY testis, and YY testis, respectively. We observed relative lower expression of several miR-200 family members, including miR-141 and miR-429 in YY testis compared with XY testis. Histological analysis indicated a higher degree of testis maturity in YY super-males compared with XY males, as shown by larger spermatogenic cyst, more spermatids and fewer spermatocytes in the spermatogenic cyst. Moreover, five miR-200 family members were significantly up-regulated in testis when treated by 17 alpha-ethinylestradiol (EE2), high dose of which will impair testis development and cell proliferation. The down-regulation of miR-141 and 429 coincides with the progression of testis development in both yellow catfish and human. At last, the expression pattern of nine arbitrarily selected miRNAs detected by quantitative RT-PCR was consistent with the Solexa sequencing results. Our study provides a comprehensive miRNA transcriptome analysis for gonad of yellow catfish with different sex genotypes, and identifies a number of sex-biased miRNAs, some of that are potentially involved in testis development and spermatogenesis.	[Jing, Jing; Wu, Junjie; Xiong, Shuting; Ma, Wenge; Zhang, Jin; Wang, Weimin; Gui, Jian-Fang; Mei, Jie] Huazhong Agr Univ, Coll Fisheries, Minist Agr, Key Lab Freshwater Anim Breeding,Freshwater Aquac, Wuhan, Peoples R China; [Liu, Wei; Gui, Jian-Fang] Chinese Acad Sci, Univ Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; University of Chinese Academy of Sciences, CAS	Gui, JF (corresponding author), Huazhong Agr Univ, Coll Fisheries, Minist Agr, Key Lab Freshwater Anim Breeding,Freshwater Aquac, Wuhan, Peoples R China.	jfgui@ihb.ac.cn; jmei@mail.hzau.edu.cn			Fundamental Research Funds for the Central Universities [52204-12018, 2013PY068]; National Natural Science Foundation of China [31301931]; special Fund for Agro-scientific Research in the Public Interest from the Ministry of Agriculture of China [2009030406]; National Key Basic Research Program [2010CB126301]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special Fund for Agro-scientific Research in the Public Interest from the Ministry of Agriculture of China; National Key Basic Research Program(National Basic Research Program of China)	This work was supported by grants to Jie Mei from the Fundamental Research Funds for the Central Universities (52204-12018, 2013PY068) and the National Natural Science Foundation of China (31301931); and to Jian-Fang Gui from the special Fund for Agro-scientific Research in the Public Interest from the Ministry of Agriculture of China (2009030406), the National Key Basic Research Program (2010CB126301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Halima M, 2013, FERTIL STERIL, V99, P1249, DOI 10.1016/j.fertnstert.2012.11.054; Baley J, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-8; Bannister SC, 2009, BIOL REPROD, V81, P165, DOI 10.1095/biolreprod.108.074005; Bizuayehu TT, 2012, SEX DEV, V6, P257, DOI 10.1159/000341378; Carletti MZ, 2010, BIOL REPROD, V83, P286, DOI 10.1095/biolreprod.109.081448; Chaves-Pozo E, 2007, BIOL REPROD, V76, P142, DOI 10.1095/biolreprod.106.056036; Chen SL, 2008, AQUACULTURE, V283, P7, DOI 10.1016/j.aquaculture.2008.07.015; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Cohen A, 2013, ZEBRAFISH; Dan C, 2013, INT J BIOL SCI, V9, P1043, DOI 10.7150/ijbs.7203; de Waal PP, 2009, J ENDOCRINOL, V202, P287, DOI 10.1677/JOE-09-0050; Denslow ND, 2001, COMP BIOCHEM PHYS B, V129, P277, DOI 10.1016/S1096-4959(01)00322-0; Fiedler SD, 2008, BIOL REPROD, V79, P1030, DOI 10.1095/biolreprod.108.069690; Flynt AS, 2009, J CELL BIOL, V185, P115, DOI 10.1083/jcb.200807026; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Grentzinger T, 2012, GENOME RES, V22, P1877, DOI 10.1101/gr.136614.111; Gui JF, 2012, CHINESE SCI BULL, V57, P1751, DOI 10.1007/s11434-012-5213-0; Gui JF, 2010, SCI CHINA LIFE SCI, V53, P409, DOI 10.1007/s11427-010-0092-6; Haffray P, 1998, AQUAT LIVING RESOUR, V11, P341, DOI 10.1016/S0990-7440(98)80005-3; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; He XJ, 2011, DEV BIOL, V357, P463, DOI 10.1016/j.ydbio.2011.07.014; HENKEN AM, 1987, AQUACULTURE, V63, P233, DOI 10.1016/0044-8486(87)90075-5; Huang JM, 2011, INT J BIOL SCI, V7, P1016, DOI 10.7150/ijbs.7.1016; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kashiwada S, 2007, COMP BIOCHEM PHYS C, V145, P370, DOI 10.1016/j.cbpc.2007.01.009; Kawaoka S, 2011, RNA, V17, P2144, DOI 10.1261/rna.027565.111; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kobayashi Y, 2013, SEX DEV, V7, P115, DOI 10.1159/000342009; Lahnsteiner F, 2006, AQUAT TOXICOL, V79, P124, DOI 10.1016/j.aquatox.2006.05.011; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li MZ, 2011, INT J BIOL SCI, V7, P1045, DOI 10.7150/ijbs.7.1045; Liu Han-Qin, 2007, Acta Hydrobiologica Sinica, V31, P718; Liu HQ, 2013, MAR BIOTECHNOL, V15, P321, DOI 10.1007/s10126-012-9487-7; Maatouk DM, 2008, BIOL REPROD, V79, P696, DOI 10.1095/biolreprod.108.067827; Mei J, 2008, DEV BIOL, V319, P273, DOI 10.1016/j.ydbio.2008.04.022; Mei J, 2014, INT J BIOL SCI, V10, P15, DOI 10.7150/ijbs.7490; Mei J, 2011, MOL CELL BIOL, V31, P3584, DOI 10.1128/MCB.05821-11; Mishima T, 2008, REPRODUCTION, V136, P811, DOI 10.1530/REP-08-0349; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Pan Q, 2007, MOL HUM REPROD, V13, P797, DOI 10.1093/molehr/gam063; Peng HY, 2012, CELL RES, V22, P1609, DOI 10.1038/cr.2012.141; Rawat VS, 2013, FISH PHYSIOL BIOCHEM, V39, P39, DOI 10.1007/s10695-012-9626-0; Sheehan RJ, 1999, T AM FISH SOC, V128, P491, DOI 10.1577/1548-8659(1999)128&lt;0491:BGIAFD&gt;2.0.CO;2; Staton AA, 2011, NAT GENET, V43, P204, DOI 10.1038/ng.758; Sun KL, 2013, NAT REV GENET, V14, P535, DOI 10.1038/nrg3471; Takeda Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007513; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Toledano H, 2012, NATURE, V485, P605, DOI 10.1038/nature11061; Tvedt HB, 2006, AQUACULTURE, V252, P573, DOI 10.1016/j.aquaculture.2005.06.042; Wang D, 2009, ANIM GENET, V40, P978, DOI 10.1111/j.1365-2052.2009.01941.x; Wei ZL, 2011, INT J BIOL SCI, V7, P180, DOI 10.7150/ijbs.7.180; Wu W, 2013, HUM REPROD, V28, P1827, DOI 10.1093/humrep/det099; Xiao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086821; Xu S, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105130; Xu ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054174; Yi SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-754	57	75	79	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107946	10.1371/journal.pone.0107946	http://dx.doi.org/10.1371/journal.pone.0107946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229553	Green Published, Green Submitted, gold			2022-12-25	WOS:000342123900089
J	So, JY; Lin, JJ; Wahler, J; Liby, KT; Sporn, MB; Suh, N				So, Jae Young; Lin, Janice J.; Wahler, Joseph; Liby, Karen T.; Sporn, Michael B.; Suh, Nanjoo			A Synthetic Triterpenoid CDDO-Im Inhibits Tumorsphere Formation by Regulating Stem Cell Signaling Pathways in Triple-Negative Breast Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; VITAMIN-D ANALOG; SELF-RENEWAL; MAMMARY TUMORIGENESIS; PANCREATIC-CANCER; INDUCE APOPTOSIS; DNA-DAMAGE; IMIDAZOLIDE; EXPRESSION; GROWTH	Triple-negative breast cancer is associated with poor prognosis because of a high rate of tumor recurrence and metastasis. Previous studies demonstrated that the synthetic triterpenoid, CDDO-Imidazolide (CDDO-Im) induced cell cycle arrest and apoptosis in triple-negative breast cancer. Since a small subpopulation of cancer stem cells has been suggested to be responsible for drug resistance and metastasis of tumors, our present study determined whether the effects of CDDO-Im in triple-negative breast cancer are due to the inhibition of a cancer stem cell subpopulation. CDDO-Im treatment markedly induced cell cycle arrest at G2/M-phase and apoptosis in the triple-negative breast cancer cell lines, SUM159 and MDA-MB-231. Because SUM159 cells were more sensitive to CDDO-Im than MDA-MB-231 cells, the effects of CDDO-Im on the cancer stem cell subpopulation were further investigated in SUM159 cells. SUM159 cells formed tumorspheres in culture, and the cancer stem cell subpopulation, CD242/EpCAM+ cells, was markedly enriched in SUM159 tumorspheres. The CD242/EpCAM+ cells in SUM159 tumorspheres were significantly inhibited by CDDO-Im treatment. CDDO-Im also significantly decreased sphere forming efficiency and tumorsphere size in both primary and secondary sphere cultures. PCR array of stem cell signaling genes showed that expression levels of many key molecules in the stem cell signaling pathways, such as Notch, TGF-beta/Smad, Hedgehog and Wnt, were significantly down-regulated by CDDO-Im in SUM159 tumorspheres. Protein levels of Notch receptors (c-Notch1, Notch1 and Notch3), TGF-beta/Smad (pSmad2/3) and Hedgehog downstream effectors (GLI1) also were markedly reduced by CDDO-Im. In conclusion, the present study demonstrates that the synthetic triterpenoid, CDDO-Im, is a potent anti-cancer agent against triple-negative breast cancer cells by targeting the cancer stem cell subpopulation.	[So, Jae Young; Lin, Janice J.; Wahler, Joseph; Suh, Nanjoo] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Piscataway, NJ 08854 USA; [Liby, Karen T.; Sporn, Michael B.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pharmacol, Hanover, NH 03756 USA; [Suh, Nanjoo] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA	Rutgers State University New Brunswick; Dartmouth College; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Suh, N (corresponding author), Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Piscataway, NJ 08854 USA.	nsuh@pharmacy.rutgers.edu		Liby, Karen/0000-0003-3317-3437	NIH National Cancer Institute [R01-CA127645]; NATIONAL CANCER INSTITUTE [P30CA072720, R01CA127645] Funding Source: NIH RePORTER	NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH National Cancer Institute R01-CA127645 (N.S.). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Alli E, 2009, CANCER RES, V69, P3589, DOI 10.1158/0008-5472.CAN-08-4016; Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; Badve S, 2012, LANCET ONCOL, V13, pE43, DOI 10.1016/S1470-2045(11)70191-7; Bosch A, 2010, CANCER TREAT REV, V36, P206, DOI 10.1016/j.ctrv.2009.12.002; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Forozan F, 1999, BRIT J CANCER, V81, P1328, DOI 10.1038/sj.bjc.6695007; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Goel HL, 2013, EMBO MOL MED, V5, P488, DOI 10.1002/emmm.201202078; Han JX, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2875; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; Honda T, 2002, BIOORG MED CHEM LETT, V12, P1027, DOI 10.1016/S0960-894X(02)00105-1; Hui L, 2006, ONCOGENE, V25, P7305, DOI 10.1038/sj.onc.1209735; Hyer ML, 2005, CANCER RES, V65, P4799, DOI 10.1158/0008-5472.CAN-04-3319; Idowu MO, 2012, HUM PATHOL, V43, P364, DOI 10.1016/j.humpath.2011.05.005; Kim EH, 2011, CANCER PREV RES, V4, P425, DOI 10.1158/1940-6207.CAPR-10-0153; Lee HJ, 2006, BIOCHEM PHARMACOL, V72, P332, DOI 10.1016/j.bcp.2006.04.030; Lee HJ, 2009, CLIN CANCER RES, V15, P4242, DOI 10.1158/1078-0432.CCR-08-3028; Lee J, 2012, BREAST CANCER RES TR, V136, P45, DOI 10.1007/s10549-012-2239-6; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liby K, 2005, CANCER RES, V65, P4789, DOI 10.1158/0008-5472.CAN-04-4539; Liby K, 2006, CLIN CANCER RES, V12, P4288, DOI 10.1158/1078-0432.CCR-06-0215; Liby KT, 2012, PHARMACOL REV, V64, P972, DOI 10.1124/pr.111.004846; Ling H, 2013, CANCER RES, V73, P5963, DOI 10.1158/0008-5472.CAN-13-0409; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McGowan PM, 2011, MOL CANCER RES, V9, P834, DOI 10.1158/1541-7786.MCR-10-0457; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; O'Neill CF, 2007, AM J PATHOL, V171, P1023, DOI 10.2353/ajpath.2007.061029; Parr C, 2004, INT J MOL MED, V14, P779; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Place AE, 2003, CLIN CANCER RES, V9, P2798; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Samudio I, 2005, J BIOL CHEM, V280, P36273, DOI 10.1074/jbc.M507518200; So JY, 2013, CANCER PREV RES, V6, P959, DOI 10.1158/1940-6207.CAPR-13-0087; So JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054020; So JY, 2011, MOL PHARMACOL, V79, P360, DOI 10.1124/mol.110.068403; Sporn MB, 2011, J NAT PROD, V74, P537, DOI 10.1021/np100826q; Suh NJ, 1999, CANCER RES, V59, P336; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Tanaka H, 2009, ANTICANCER RES, V29, P2147; ten Haaf A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-298; To C, 2008, J BIOL CHEM, V283, P11700, DOI 10.1074/jbc.M704064200; Xiao Y, 2011, ONCOGENE, V30, P287, DOI 10.1038/onc.2010.405; Xu LS, 2010, BREAST CANCER RES TR, V123, P59, DOI 10.1007/s10549-009-0617-5; Yin B, 2014, ONCOGENE; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	53	23	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107616	10.1371/journal.pone.0107616	http://dx.doi.org/10.1371/journal.pone.0107616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229616	Green Submitted, Green Published, gold			2022-12-25	WOS:000342123900056
J	Kuo, PH; Tzeng, TH; Huang, YC; Chen, YH; Chang, YC; Ho, YL; Wu, JT; Lee, HH; Lai, PJ; Liu, KY; Cheng, YC; Lu, SS				Kuo, Po-Hung; Tzeng, Te-Hsuen; Huang, Yi-Chun; Chen, Yu-Hao; Chang, Yi-Chung; Ho, Yi-Lwun; Wu, June-Tai; Lee, Hsiu-Hsian; Lai, Po-Jung; Liu, Kwei-Yan; Cheng, Ya-Chen; Lu, Shey-Shi			Non-Invasive Drosophila ECG Recording by Using Eutectic Gallium-Indium Alloy Electrode: A Feasible Tool for Future Research on the Molecular Mechanisms Involved in Cardiac Arrhythmia	PLOS ONE			English	Article							HEART-RATE; MUTATIONS	Background: Drosophila heart tube is a feasible model for cardiac physiological research. However, obtaining Drosophila electrocardiograms (ECGs) is difficult, due to the weak signals and limited contact area to apply electrodes. This paper presents a non-invasive Gallium-Indium (GaIn) based recording system for Drosophila ECG measurement, providing the heart rate and heartbeat features to be observed. This novel, high-signal-quality system prolongs the recording time of insect ECGs, and provides a feasible platform for research on the molecular mechanisms involved in cardiovascular diseases. Methods: In this study, two types of electrode, tungsten needle probes and GaIn electrodes, were used respectively to noiselessly conduct invasive and noninvasive ECG recordings of Drosophila. To further analyze electrode properties, circuit models were established and simulated. By using electromagnetic shielded heart signal acquiring system, consisted of analog amplification and digital filtering, the ECG signals of three phenotypes that have different heart functions were recorded without dissection. Results and Discussion: The ECG waveforms of different phenotypes of Drosophila recorded invasively and repeatedly with n value (n>5) performed obvious difference in heart rate. In long period ECG recordings, non-invasive method implemented by GaIn electrodes acts relatively stable in both amplitude and period. To analyze GaIn electrode, the correctness of GaIn electrode model established by this paper was validated, presenting accuracy, stability, and reliability. Conclusions: Noninvasive ECG recording by GaIn electrodes was presented for recording Drosophila pupae ECG signals within a limited contact area and signal strength. Thus, the observation of ECG changes in normal and SERCA-depleted Drosophila over an extended period is feasible. This method prolongs insect survival time while conserving major ECG features, and provides a platform for electrophysiological signal research on the molecular mechanism involved in cardiac arrhythmia, as well as research related to drug screening and development.	[Kuo, Po-Hung; Tzeng, Te-Hsuen; Chen, Yu-Hao; Lu, Shey-Shi] Natl Taiwan Univ, Grad Inst Elect Engn, Taipei 10764, Taiwan; [Huang, Yi-Chun] Natl Taiwan Univ, Grad Inst Biomed Elect & Informat, Taipei 10764, Taiwan; [Chang, Yi-Chung] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Taoyuan, Taiwan; [Chang, Yi-Chung] Natl Cent Univ, Res Ctr Adapt Data Anal, Taoyuan, Taiwan; [Ho, Yi-Lwun] Natl Taiwan Univ Hosp, Dept Internal Med, Cardiol Sect, Taipei 100, Taiwan; [Ho, Yi-Lwun] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Wu, June-Tai; Lee, Hsiu-Hsian; Lai, Po-Jung; Liu, Kwei-Yan; Cheng, Ya-Chen] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Central University; National Central University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Ho, YL (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Cardiol Sect, Taipei 100, Taiwan.	ylho@ntu.edu.tw; sslu@ntu.edu.tw	Wang, Pa-Chun/AAD-4094-2019	HO, YI-LWUN/0000-0002-8936-9570; WU, JUNE-TAI/0000-0002-4023-7315; Lu, Shey-Shi/0000-0003-3106-3154	National Taiwan University Smart Health Technology Research and Development Center [103R7608]; National Taiwan University Cutting-Edge Steering Research; National Science Council, ROC [NSC 100-2221-E-002-247-MY3]	National Taiwan University Smart Health Technology Research and Development Center; National Taiwan University Cutting-Edge Steering Research; National Science Council, ROC(Ministry of Science and Technology, Taiwan)	The authors gratefully acknowledge National Taiwan University Smart Health Technology Research and Development Center (103R7608), National Taiwan University Cutting-Edge Steering Research and National Science Council, ROC (NSC 100-2221-E-002-247-MY3) for supporting this research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba A, 2008, INT J BIOL BIOMED EN, V3, P89; Campan R., 1972, Monitore Zoologico Italiano, V6, P269; Chi Y. M., 2010, IEEE REV BIOMED ENG, V3, P106, DOI DOI 10.1109/RBME.2010.2084078; Dickey MD, 2008, ADV FUNCT MATER, V18, P1097, DOI 10.1002/adfm.200701216; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Gao YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045485; Lalevee N, 2006, CURR BIOL, V16, P1502, DOI 10.1016/j.cub.2006.05.064; Levine HJ, 1997, J AM COLL CARDIOL, V30, P1104; Ma LS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014348; Marik PE, 2013, J CARDIOTHOR VASC AN, V27, P121, DOI 10.1053/j.jvca.2012.03.022; Neuman M, 1988, MED INSTRUM APPL DES, V1, P189; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Papaefthimiou C, 2001, IN VITRO CELL DEV-AN, V37, P445; Rizki T.M., 1978, P397; Sanyal S, 2006, J COMP PHYSIOL B, V176, P253, DOI 10.1007/s00360-005-0046-7; Sanyal S, 2005, GENETICS, V169, P737, DOI 10.1534/genetics.104.031930; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Yu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058771	18	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e104543	10.1371/journal.pone.0104543	http://dx.doi.org/10.1371/journal.pone.0104543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226390	gold, Green Submitted, Green Published			2022-12-25	WOS:000344317700005
J	Pansonato-Alves, JC; Serrano, EA; Utsunomia, R; Camacho, JPM; Silva, GJD; Vicari, MR; Artoni, RF; Oliveira, C; Foresti, F				Pansonato-Alves, Jose Carlos; Serrano, Erica Alves; Utsunomia, Ricardo; Camacho, Juan Pedro M.; da Costa Silva, Guilherme Jose; Vicari, Marcelo Ricardo; Artoni, Roberto Ferreira; Oliveira, Claudio; Foresti, Fausto			Single Origin of Sex Chromosomes and Multiple Origins of B Chromosomes in Fish Genus Characidium	PLOS ONE			English	Article							NEW-ZEALAND FROG; ASTYANAX-SCABRIPINNIS; BANDING-PATTERN; DNA; CHARACIFORMES; EVOLUTION; SYSTEM; CRENUCHIDAE; PISCES; DIVERSIFICATION	Chromosome painting with DNA probes obtained from supernumerary (B) and sex chromosomes in three species of fish genus Characidium (C. gomesi, C. pterostictum and C. oiticicai) showed a close resemblance in repetitive DNA content between B and sex chromosomes in C. gomesi and C. pterostictum. This suggests an intraspecific origin for B chromosomes in these two species, probably deriving from sex chromosomes. In C. oiticicai, however, a DNA probe obtained from its B chromosome hybridized with the B but not with the A chromosomes, suggesting that the B chromosome in this species could have arisen interspecifically, although this hypothesis needs further investigation. A molecular phylogenetic analysis performed on nine Characidium species, with two mtDNA genes, showed that the presence of heteromorphic sex chromosomes in these species is a derived condition, and that their origin could have been unique, a conclusion also supported by interspecific chromosome painting with a CgW probe derived from the W chromosome in C. gomesi. Summing up, our results indicate that whereas heteromorphic sex chromosomes in the genus Characidium appear to have had a common and unique origin, B chromosomes may have had independent origins in different species. Our results also show that molecular phylogenetic analysis is an excellent complement for cytogenetic studies by unveiling the direction of evolutionary chromosome changes.	[Pansonato-Alves, Jose Carlos; Serrano, Erica Alves; Utsunomia, Ricardo; da Costa Silva, Guilherme Jose; Oliveira, Claudio; Foresti, Fausto] Univ Estadual Paulista UNESP, IB, Dept Morfol, Sao Paulo, Brazil; [Camacho, Juan Pedro M.] Univ Granada, Dept Genet, Granada, Spain; [Vicari, Marcelo Ricardo; Artoni, Roberto Ferreira] Univ Estadual Ponta Grossa, Dept Biol Estrutural Mol & Genet, Ponta Grossa, Parana, Brazil	Universidade Estadual Paulista; University of Granada; Universidade Estadual de Ponta Grossa	Pansonato-Alves, JC (corresponding author), Univ Estadual Paulista UNESP, IB, Dept Morfol, Sao Paulo, Brazil.	pansonato@ibb.unesp.br	Artoni, Roberto Ferreira/N-1693-2019; Utsunomia, Ricardo/O-8955-2015; Pansonato Alves, Jose Carlos/C-3062-2014; Oliveira, Claudio/D-7713-2012; Vicari, Marcelo Ricardo/I-2299-2015; Camacho, Juan Pedro M/L-6869-2014; Artoni, Roberto F/H-6651-2013	Artoni, Roberto Ferreira/0000-0002-2528-9846; Pansonato Alves, Jose Carlos/0000-0003-3580-7384; Oliveira, Claudio/0000-0002-7010-8880; Vicari, Marcelo Ricardo/0000-0003-3913-9889; Camacho, Juan Pedro M/0000-0002-2507-9814; Artoni, Roberto F/0000-0002-2528-9846; Utsunomia, Ricardo/0000-0003-4565-6065	State of Sao Paulo Research Foundation (FAPESP) [2013/02143-3]; National Council for Research and Development (CNPq) [480449/2012-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	State of Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Research and Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was funded by grants from the State of Sao Paulo Research Foundation (FAPESP) to EAS (2013/02143-3), grants from National Council for Research and Development (CNPq) to FF (480449/2012-0), and by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artoni RF, 2002, HEREDITY, V89, P15, DOI 10.1038/sj.hdy.6800081; Artoni RF, 2006, GENETICA, V127, P277, DOI 10.1007/s10709-005-4846-1; Banaei-Moghaddam AM, 2013, PLANT CELL, V25, P2536, DOI 10.1105/tpc.113.111856; Bougourd SM, 1997, NEW PHYTOL, V137, P43, DOI 10.1046/j.1469-8137.1997.00823.x; Bugrov AG, 2003, FOLIA BIOL-KRAKOW, V51, P1; Camacho JPM, 2000, PHILOS T R SOC B, V355, P163, DOI 10.1098/rstb.2000.0556; Camacho Juan Pedro M., 2005, P223, DOI 10.1016/B978-012301463-4/50006-1; Centofante L, 2003, HEREDITAS, V138, P213, DOI 10.1034/j.1601-5223.2003.01714.x; Centofante L, 2001, CARYOLOGIA, V54, P253, DOI 10.1080/00087114.2001.10589233; de Jesus CM, 2003, GENETICA, V118, P25; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fantinatti BEA, 2011, GENETICA, V139, P1273, DOI 10.1007/s10709-012-9629-x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FORESTI F, 1981, CYTOGENET CELL GENET, V31, P137, DOI 10.1159/000131639; FORESTI F, 1989, GENETICA, V79, P107, DOI 10.1007/BF00057927; Graphodatsky AS, 2005, CHROMOSOME RES, V13, P113, DOI 10.1007/s10577-005-7474-9; GREEN DM, 1993, J EVOLUTION BIOL, V6, P417, DOI 10.1046/j.1420-9101.1993.6030417.x; Gribble S, 2004, CHROMOSOME RES, V12, P143, DOI 10.1023/B:CHRO.0000013167.12527.f0; Henning F, 2011, HEREDITY, V106, P391, DOI 10.1038/hdy.2010.82; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Lopez-Leon MD, 1994, CHROMOSOME RES, V2, P87, DOI 10.1007/BF01553487; Machado TC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-65; Maistro Edson Luis, 2004, Cytologia (Tokyo), V69, P181, DOI 10.1508/cytologia.69.181; MAISTRO EL, 1992, GENETICA, V87, P101, DOI 10.1007/BF00120999; Matsubara K, 2008, CHROMOSOME RES, V16, P1013, DOI 10.1007/s10577-008-1259-x; McAllister BF, 1997, CHROMOSOMA, V106, P243, DOI 10.1007/s004120050245; Mestriner CA, 2000, HEREDITY, V85, P1, DOI 10.1046/j.1365-2540.2000.00702.x; Miyazawa C. S., 1994, Cytologia (Tokyo), V59, P73; Noleto RB, 2009, J FISH BIOL, V75, P448, DOI 10.1111/j.1095-8649.2009.02342.x; Ogilvie CM, 2001, CYTOGENET CELL GENET, V92, P69, DOI 10.1159/000056871; Oliveira Claudio, 2007, P111; Alves JCP, 2010, NEOTROP ICHTHYOL, V8, P77, DOI 10.1590/S1679-62252010000100010; Pansonato-Alves JC, 2011, J FISH BIOL, V78, P183, DOI 10.1111/j.1095-8649.2010.02847.x; Pansonato-Alves JC, 2011, GENET MOL BIOL, V34, P208, DOI 10.1590/S1415-47572011005000005; PAULS E, 1983, CARYOLOGIA, V36, P307, DOI 10.1080/00087114.1983.10797671; Perfectti F, 2001, EVOLUTION, V55, P1069, DOI 10.1554/0014-3820(2001)055[1069:TIOOBC]2.0.CO;2; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Poletto AB, 2010, BMC GENET, V11, DOI [10.1186/1471-2156-11-1, 10.1186/1471-2156-11-50]; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pucci MB, 2014, BIOL J LINN SOC, V111, P541, DOI 10.1111/bij.12218; RAMBAUT A, 2004, TRACER V1 4; Ruiz-Estevez M, 2013, GENETICA, V141, P337, DOI 10.1007/s10709-013-9733-6; Ruiz-Estevez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036600; SALVADOR LB, 1992, HEREDITY, V69, P50, DOI 10.1038/hdy.1992.93; SCHARTL M, 1995, NATURE, V373, P68, DOI 10.1038/373068a0; Sharbel TF, 1998, GENOME, V41, P14, DOI 10.1139/gen-41-1-14; Silva AR, 2006, GENET MOL BIOL, V29, P459, DOI DOI 10.1590/S1415-47572006000300010; Silva DMZD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094896; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Teruel M, 2014, HEREDITY, V112, P531, DOI 10.1038/hdy.2013.135; Teruel M, 2009, CYTOGENET GENOME RES, V125, P286, DOI 10.1159/000235935; Teruel M, 2010, CHROMOSOMA, V119, P217, DOI 10.1007/s00412-009-0251-3; Teruel M, 2009, CHROMOSOME RES, V17, P11, DOI 10.1007/s10577-008-9001-2; Trifonov VA, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-90; Van Vugt JJFA, 2009, P ROY SOC B-BIOL SCI, V276, P4149, DOI 10.1098/rspb.2009.1238; Vicari MR, 2008, GENETICA, V134, P311, DOI 10.1007/s10709-007-9238-2; Vicari MR, 2011, GENETICA, V139, P1073, DOI 10.1007/s10709-011-9611-z; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yoshida K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002203; Yudkin DV, 2007, CYTOGENET GENOME RES, V116, P100, DOI 10.1159/000097424; Zhou Q, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-109; Ziegler CG, 2003, CHROMOSOME RES, V11, P23, DOI 10.1023/A:1022053931308	66	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107169	10.1371/journal.pone.0107169	http://dx.doi.org/10.1371/journal.pone.0107169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226580	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700031
J	Goncalves, JG; de Braganca, AC; Canale, D; Shimizu, MHM; Sanches, TR; Moyses, RMA; Andrade, L; Seguro, AC; Volpini, RA				Goncalves, Janaina Garcia; de Braganca, Ana Carolina; Canale, Daniele; Massola Shimizu, Maria Heloisa; Sanches, Talita Rojas; Affonso Moyses, Rosa Maria; Andrade, Lucia; Seguro, Antonio Carlos; Volpini, Rildo Aparecido			Vitamin D Deficiency Aggravates Chronic Kidney Disease Progression after Ischemic Acute Kidney Injury	PLOS ONE			English	Article							D-RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; GENE-EXPRESSION; NATIONAL-HEALTH; FGF-23; PATHOPHYSIOLOGY; METABOLISM; MECHANISMS; REGULATOR; PHOSPHATE	Background: Despite a significant improvement in the management of chronic kidney disease (CKD), its incidence and prevalence has been increasing over the years. Progressive renal fibrosis is present in CKD and involves the participation of several cytokines, including Transforming growth factor-beta 1 (TGF-beta 1). Besides cardiovascular diseases and infections, several studies show that Vitamin D status has been considered as a non-traditional risk factor for the progression of CKD. Given the importance of vitamin D in the maintenance of essential physiological functions, we studied the events involved in the chronic kidney disease progression in rats submitted to ischemia/reperfusion injury under vitamin D deficiency (VDD). Methods: Rats were randomized into four groups: Control; VDD; ischemia/reperfusion injury (IRI); and VDD+IRI. At the 62 day after sham or IRI surgery, we measured inulin clearance, biochemical variables and hemodynamic parameters. In kidney tissue, we performed immunoblotting to quantify expression of Klotho, TGF-beta, and vitamin D receptor (VDR); gene expression to evaluate renin, angiotensinogen, and angiotensin-converting enzyme; and immunohistochemical staining for ED1 (macrophages), type IV collagen, fibronectin, vimentin, and alpha-smooth mucle actin. Histomorphometric studies were performed to evaluate fractional interstitial area. Results: IRI animals presented renal hypertrophy, increased levels of mean blood pressure and plasma PTH. Furthermore, expansion of the interstitial area, increased infiltration of ED1 cells, increased expression of collagen IV, fibronectin, vimentin and alpha-actin, and reduced expression of Klotho protein were observed. VDD deficiency contributed to increased levels of plasma PTH as well as for important chronic tubulointerstitial changes (fibrosis, inflammatory infiltration, tubular dilation and atrophy), increased expression of TGF-beta 1 and decreased expression of VDR and Klotho protein observed in VDD+IRI animals. Conclusion: Through inflammatory pathways and involvement of TGF-beta 1 growth factor, VDD could be considered as an aggravating factor for tubulointerstitial damage and fibrosis progression following acute kidney injury induced by ischemia/reperfusion.	[Goncalves, Janaina Garcia; de Braganca, Ana Carolina; Canale, Daniele; Massola Shimizu, Maria Heloisa; Sanches, Talita Rojas; Affonso Moyses, Rosa Maria; Andrade, Lucia; Seguro, Antonio Carlos; Volpini, Rildo Aparecido] Univ Sao Paulo, Sch Med, Dept Nephrol, Sao Paulo, Brazil	Universidade de Sao Paulo	Volpini, RA (corresponding author), Univ Sao Paulo, Sch Med, Dept Nephrol, Sao Paulo, Brazil.	rildovolpini@yahoo.com.br	Garcia Gonçalves, Janaina/C-6218-2015; de Braganca, Ana Carolina/E-7892-2014; Andrade, Lucia C/C-5223-2014; Volpini, Rildo A/B-7521-2013; Sanches, Talita R/A-2953-2015; Volpini, Rildo Aparecido/L-5690-2019; Shimizu, Maria/B-7887-2013; Moyses, Rosa M A/F-8268-2012; Canale, Daniele/E-8922-2014	Andrade, Lucia C/0000-0002-3078-8957; Volpini, Rildo A/0000-0001-6611-2249; Volpini, Rildo Aparecido/0000-0001-6611-2249; Moyses, Rosa M A/0000-0002-7902-2127; de Braganca, Ana Carolina/0000-0002-1398-2512; Canale, Daniele/0000-0001-8609-683X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2010/52294-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (www.fapesp.br) Grant number: 2010/52294-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andress DL, 2006, KIDNEY INT, V69, P33, DOI 10.1038/sj.ki.5000045; Baeke F, 2010, PEDIATR NEPHROL, V25, P1597, DOI 10.1007/s00467-010-1452-y; Bonventre JV, 2010, CONTRIB NEPHROL, V165, P9, DOI 10.1159/000313738; Braun Andrea B., 2013, Inflammation & Allergy Drug Targets, V12, P262; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Campanholle G, 2013, AM J PHYSIOL-CELL PH, V304, pC591, DOI 10.1152/ajpcell.00414.2012; Campos R, 2012, AM J PHYSIOL-LUNG C, V302, P1640, DOI 10.1152/ajplung.00097.2011; Coimbra TM, 2000, KIDNEY INT, V57, P167, DOI 10.1046/j.1523-1755.2000.00836.x; Cuppari L, 2011, J RENAL NUTR, V21, P113, DOI 10.1053/j.jrn.2010.10.007; de Araujo M, 2005, J AM SOC NEPHROL, V16, P3339, DOI 10.1681/ASN.2004100832; de Boer IH, 2007, AM J KIDNEY DIS, V50, P69, DOI 10.1053/j.ajkd.2007.04.015; Francois H, 2011, J NEPHROL, V24, P133, DOI 10.5301/JN.2011.6355; Freundlich M, 2008, KIDNEY INT, V74, P1394, DOI 10.1038/ki.2008.408; Gonzalez EA, 2004, AM J NEPHROL, V24, P503, DOI 10.1159/000081023; Grgic I, 2012, PEDIATR NEPHROL, V27, P183, DOI 10.1007/s00467-011-1772-6; Hagiwara S, 2012, CURR HYPERTENS REP, V14, P100, DOI 10.1007/s11906-012-0251-1; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Isakova T, 2010, KIDNEY INT, V78, P947, DOI 10.1038/ki.2010.281; John GB, 2011, AM J KIDNEY DIS, V58, P127, DOI 10.1053/j.ajkd.2010.12.027; Kisseleva T, 2008, EXP BIOL MED, V233, P109, DOI 10.3181/0707-MR-190; Kuhlmann A, 2004, AM J PHYSIOL-RENAL, V286, pF526, DOI 10.1152/ajprenal.00316.2003; Kuro-o M, 2013, NAT REV NEPHROL, V9, P650, DOI 10.1038/nrneph.2013.111; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Lee DR, 2011, TRANSPL P, V43, P3723, DOI 10.1016/j.transproceed.2011.08.081; Li YC, 2011, CURR DIABETES REV, V7, P35, DOI 10.2174/157339911794273964; Li YC, 2003, J CELL BIOCHEM, V88, P327, DOI 10.1002/jcb.10343; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucisano S, 2013, KIDNEY BLOOD PRESS R, V37, P667, DOI 10.1159/000355747; Moe SM, 2008, PRIMARY CARE, V35, P215, DOI 10.1016/j.pop.2008.01.007; Patel TV, 2009, SEMIN NEPHROL, V29, P113, DOI 10.1016/j.semnephrol.2009.01.004; Perwad F, 2005, ENDOCRINOLOGY, V146, P5358, DOI 10.1210/en.2005-0777; Powers JG, 2012, SEMIN CUTAN MED SURG, V31, P2, DOI [10.1016/j.sder.2011.12.001, 10.1016/j.sder.2011.11.008]; Rodriguez-Ortiz ME, 2012, J AM SOC NEPHROL, V23, P1190, DOI 10.1681/ASN.2011101006; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Silver J, 2013, NAT REV NEPHROL, V9, P641, DOI 10.1038/nrneph.2013.147; Snyder JJ, 2009, AM J KIDNEY DIS, V53, P218, DOI 10.1053/j.ajkd.2008.07.034; Tamez H, 2013, CURR OPIN NEPHROL HY, V22, P204, DOI 10.1097/MNH.0b013e32835d919b; Tan XY, 2006, J AM SOC NEPHROL, V17, P3382, DOI 10.1681/ASN.2006050520; Ulerich Linda, 2010, Nephrol Nurs J, V37, P429; Vaidya A, 2012, METABOLISM, V61, P450, DOI 10.1016/j.metabol.2011.09.007; VOLPINI RA, 2004, NEPHRON PHYSIOL, V98, P97, DOI DOI 10.1159/000081558; Xiong M, 2012, AM J PHYSIOL-RENAL, V303, pF1107, DOI 10.1152/ajprenal.00151.2012; Zhang Y, 2010, J AM SOC NEPHROL, V21, P966, DOI 10.1681/ASN.2009080872	45	49	51	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107228	10.1371/journal.pone.0107228	http://dx.doi.org/10.1371/journal.pone.0107228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222475	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774800051
J	Janezic, S; Indra, A; Rattei, T; Weinmaier, T; Rupnik, M				Janezic, Sandra; Indra, Alexander; Rattei, Thomas; Weinmaier, Thomas; Rupnik, Maja			Recombination Drives Evolution of the Clostridium difficile 16S-23S rRNA Intergenic Spacer Region	PLOS ONE			English	Article							PCR-RIBOTYPING METHOD; HAEMOPHILUS-PARAINFLUENZAE; GEL-ELECTROPHORESIS; INFECTION; PROGRAM; IDENTIFICATION; EPIDEMIOLOGY; EMERGENCE; SEQUENCES; OPERONS	PCR-ribotyping, a typing method based on size variation in 16S-23S rRNA intergenic spacer region (ISR), has been used widely for molecular epidemiological investigations of C. difficile infections. In the present study, we describe the sequence diversity of ISRs from 43 C. difficile strains, representing different PCR-ribotypes and suggest homologous recombination as a possible mechanism driving the evolution of 16S-23S rRNA ISRs. ISRs of 45 different lengths (ranging from 185 bp to 564 bp) were found among 458 ISRs. All ISRs could be described with one of the 22 different structural groups defined by the presence or absence of different sequence modules; tRNA(Ala) genes and different combinations of spacers of different lengths (33 bp, 53 bp or 20 bp) and 9 bp direct repeats separating the spacers. The ISR structural group, in most cases, coincided with the sequence length. ISRs that were of the same lengths had also very similar nucleotide sequence, suggesting that ISRs were not suitable for discriminating between different strains based only on the ISR sequence. Despite large variations in the length, the alignment of ISR sequences, based on the primary sequence and secondary structure information, revealed many conserved regions which were mainly involved in maturation of pre-rRNA. Phylogenetic analysis of the ISR alignment yielded strong evidence for intra-and inter-homologous recombination which could be one of the mechanisms driving the evolution of C. difficile 16S-23S ISRs. The modular structure of the ISR, the high sequence similarities of ISRs of the same sizes and the presence of homologous recombination also suggest that different copies of C. difficile 16S-23S rRNA ISR are evolving in concert.	[Janezic, Sandra; Rupnik, Maja] Natl Lab Hlth Environm & Food, Maribor, Slovenia; [Indra, Alexander] Austrian Agcy Hlth & Food Safety AGES, Vienna, Austria; [Rattei, Thomas; Weinmaier, Thomas] Univ Vienna, Fac Life Sci, Vienna, Austria; [Rupnik, Maja] Univ Maribor, Fac Med, SLO-2000 Maribor, Slovenia; [Rupnik, Maja] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia	University of Vienna; University of Maribor	Janezic, S (corresponding author), Natl Lab Hlth Environm & Food, Maribor, Slovenia.	sandra.janezic@nlzoh.si	Rattei, Thomas/F-1366-2011; Weinmaier, Thomas/K-5780-2013	Rattei, Thomas/0000-0002-0592-7791; Weinmaier, Thomas/0000-0002-9552-3220	Slovenian Research Agency [1000-08-310144]; ERA-NET PathoGenoMics CDIFFGEN [3211-09-000141, 818480]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); ERA-NET PathoGenoMics CDIFFGEN	SJ was supported by grant 1000-08-310144 from the Slovenian Research Agency. MR and AI were supported by ERA-NET PathoGenoMics CDIFFGEN (grant 3211-09-000141 in Slovenia and 818480 in Austria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APIRION D, 1993, BIOESSAYS, V15, P113, DOI 10.1002/bies.950150207; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Bidet P, 1999, FEMS MICROBIOL LETT, V175, P261, DOI 10.1016/S0378-1097(99)00204-9; Braun V, 1996, GENE, V181, P29, DOI 10.1016/S0378-1119(96)00398-8; Brouwer MSM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3601; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Clarke LA, 2001, J CLIN PATHOL-MOL PA, V54, P351, DOI 10.1136/mp.54.5.351; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dubberke ER, 2007, CLIN INFECT DIS, V45, P1543, DOI 10.1086/523582; Giannino V, 2001, RES MICROBIOL, V152, P461, DOI 10.1016/S0923-2508(01)01219-0; Goorhuis A, 2008, CLIN INFECT DIS, V47, P1162, DOI 10.1086/592257; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gupta A, 2014, INFECT DRUG RESIST, V7, P63, DOI 10.2147/IDR.S46780; Gurtler V, 1999, GENE, V238, P241, DOI 10.1016/S0378-1119(99)00224-3; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Houpikian P, 2001, J CLIN MICROBIOL, V39, P2768, DOI 10.1128/JCM.39.8.2768-2778.2001; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Indra A, 2008, J MED MICROBIOL, V57, P1377, DOI 10.1099/jmm.0.47714-0; Indra A, 2010, J MED MICROBIOL, V59, P1317, DOI 10.1099/jmm.0.020792-0; Iteman I, 2000, MICROBIOL-SGM, V146, P1275, DOI 10.1099/00221287-146-6-1275; Jakobsen IB, 1996, COMPUT APPL BIOSCI, V12, P291; Janezic S, 2011, J CLIN MICROBIOL, V49, P3024, DOI 10.1128/JCM.01013-11; Janezic S, 2010, METHODS MOL BIOL, V646, P55, DOI 10.1007/978-1-60327-365-7_4; KOSTMAN JR, 1992, J CLIN MICROBIOL, V30, P2084, DOI 10.1128/JCM.30.8.2084-2087.1992; KUIJPER EJ, 2008, UPDATE CLOSTRIDIUM D; Kurka H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086535; Lan RT, 1998, MICROBIOL-UK, V144, P1213, DOI 10.1099/00221287-144-5-1213; LeblondBourget N, 1996, INT J SYST BACTERIOL, V46, P102, DOI 10.1099/00207713-46-1-102; Lemee L, 2005, MICROBIOL-SGM, V151, P3171, DOI 10.1099/mic.0.28155-0; Letsch HO, 2010, MOL BIOL EVOL, V27, P2507, DOI 10.1093/molbev/msq140; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liguori AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029323; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; ONeill GL, 1996, ANAEROBE, V2, P205, DOI 10.1006/anae.1996.0028; Osorio CR, 2005, APPL ENVIRON MICROB, V71, P636, DOI 10.1128/AEM.71.2.636-645.2005; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Privitera A, 1998, FEMS MICROBIOL LETT, V164, P289, DOI 10.1016/S0378-1097(98)00228-6; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Sadeghifard N, 2006, APPL ENVIRON MICROB, V72, P7311, DOI 10.1128/AEM.01179-06; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Siarkou VI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019813; Smith C, 2010, NUCLEIC ACIDS RES, V38, pW373, DOI 10.1093/nar/gkq316; SMITH JM, 1992, J MOL EVOL, V34, P126; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Valiente E, 2012, J MED MICROBIOL, V61, P49, DOI 10.1099/jmm.0.036194-0	50	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e106545	10.1371/journal.pone.0106545	http://dx.doi.org/10.1371/journal.pone.0106545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222120	Green Submitted, Green Published, gold			2022-12-25	WOS:000341774800017
J	Jimenez-Gonzalez, AS; Fernandez, N; Martinez-Salas, E; de Jimenez, ES				Jimenez-Gonzalez, Augusto Samuel; Fernandez, Noemi; Martinez-Salas, Encarnacion; de Jimenez, Estela Sanchez			Functional and Structural Analysis of Maize Hsp101 IRES	PLOS ONE			English	Article							INTERNAL RIBOSOME ENTRY; CAP-INDEPENDENT TRANSLATION; C-MYC-IRES; IN-VIVO; INITIATION-FACTOR; GENE-EXPRESSION; 5'-UNTRANSLATED REGION; MEDIATED TRANSLATION; SECONDARY STRUCTURE; MESSENGER-RNAS	Maize heat shock protein of 101 KDa (HSP101) is essential for thermotolerance induction in this plant. The mRNA encoding this protein harbors an IRES element in the 5'UTR that mediates cap-independent translation initiation. In the current work it is demonstrated that hsp101 IRES comprises the entire 5'UTR sequence (150 nts), since deletion of 17 nucleotides from the 59 end decreased translation efficiency by 87% compared to the control sequence. RNA structure analysis of maize hsp101 IRES revealed the presence of three stem-loops toward its 59 end, whereas the remainder sequence contains a great proportion of unpaired nucleotides. Furthermore, HSP90 protein was identified by mass spectrometry as the protein preferentially associated with the maize hsp101 IRES. In addition, it has been found that eIFiso4G rather than eIF4G initiation factor mediates translation of the maize hsp101 mRNA.	[Jimenez-Gonzalez, Augusto Samuel; de Jimenez, Estela Sanchez] Univ Nacl Autonoma Mexico, Fac Quim, Dept Bioquim, Mexico City 04510, DF, Mexico; [Fernandez, Noemi; Martinez-Salas, Encarnacion] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain	Universidad Nacional Autonoma de Mexico; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Martinez-Salas, E (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain.	emartinez@cbm.csic.es; estelas@unam.mx	Martinez-Salas, Encarna/J-5733-2014	Martinez-Salas, Encarna/0000-0002-8432-5587	Dereuion General de Apoyo al Personal Academico (DGAPA), UNAM [IN212910]; CONACyT Mexico [173696]; Ministerio de Economia y Competitividad (MINECO) [BFU2011-25437]	Dereuion General de Apoyo al Personal Academico (DGAPA), UNAM; CONACyT Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ministerio de Economia y Competitividad (MINECO)	This work was supported by the Dereuion General de Apoyo al Personal Academico (DGAPA), UNAM, grant IN212910, CONACyT Mexico scholarship 173696, and Ministerio de Economia y Competitividad (MINECO), grant BFU2011-25437. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Chappell SA, 2000, ONCOGENE, V19, P4437, DOI 10.1038/sj.onc.1203791; Chen B, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-156; Cobbold LC, 2008, MOL CELL BIOL, V28, P40, DOI 10.1128/MCB.01298-07; De Quinto SL, 2000, RNA, V6, P1380, DOI 10.1017/S1355838200000753; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Dinkova TD, 2005, PLANT J, V41, P722, DOI 10.1111/j.1365-313X.2005.02333.x; Dorokhov YL, 2006, J GEN VIROL, V87, P2693, DOI 10.1099/vir.0.82095-0; Dotu I, 2013, RNA BIOL, V10, P1842, DOI 10.4161/rna.26994; Echevarria-Zomeno S, 2013, INT J MOL SCI, V14, P4670, DOI 10.3390/ijms14034670; Fernandez N, 2011, NUCLEIC ACIDS RES, V39, P8572, DOI 10.1093/nar/gkr560; Fernandez N, 2011, VIROLOGY, V409, P251, DOI 10.1016/j.virol.2010.10.013; Fernandez-Miragall O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022617; Filbin ME, 2009, CURR OPIN STRUC BIOL, V19, P267, DOI 10.1016/j.sbi.2009.03.005; Gallie DR, 2001, J BIOL CHEM, V276, P36951, DOI 10.1074/jbc.M103869200; Graber TE, 2007, MOL BIOSYST, V3, P825, DOI 10.1039/b708867a; GUPTA RS, 1995, MOL BIOL EVOL, V12, P1063; Hernandez G, 2004, RNA, V10, P1783, DOI 10.1261/rna.7154104; Jaag HM, 2003, P NATL ACAD SCI USA, V100, P8939, DOI 10.1073/pnas.1332697100; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Karetnikov A, 2007, J GEN VIROL, V88, P286, DOI 10.1099/vir.0.82307-0; KIRCHWEGER R, 1994, J VIROL, V68, P5677, DOI 10.1128/JVI.68.9.5677-5684.1994; Koh DCY, 2003, J BIOL CHEM, V278, P20565, DOI 10.1074/jbc.M210212200; Kolupaeva VG, 1998, J BIOL CHEM, V273, P18599, DOI 10.1074/jbc.273.29.18599; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; Le Quesne JPC, 2001, J MOL BIOL, V310, P111, DOI 10.1006/jmbi.2001.4745; Lellis AD, 2010, PLANT MOL BIOL, V74, P249, DOI 10.1007/s11103-010-9670-z; Mardanova ES, 2008, GENE, V420, P11, DOI 10.1016/j.gene.2008.04.008; Martinez-Salas E, 2008, TRENDS MICROBIOL, V16, P230, DOI 10.1016/j.tim.2008.01.013; Martinez-Salas E, 2008, J GEN VIROL, V89, P611, DOI 10.1099/vir.0.83426-0; Martinez-Salas E, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/391546; MARTINEZSALAS E, 1993, J VIROL, V67, P3748; Matsumoto K, 2011, BIOCHEM BIOPH RES CO, V407, P720, DOI 10.1016/j.bbrc.2011.03.088; Mayberry LK, 2011, J BIOL CHEM, V286, P42566, DOI 10.1074/jbc.M111.280099; Nieto-Sotelo J, 2002, PLANT CELL, V14, P1621, DOI 10.1105/tpc.010487; Patrick RM, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/287814; Rubtsova MP, 2003, J BIOL CHEM, V278, P22350, DOI 10.1074/jbc.M303213200; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Spriggs KA, 2009, MOL CELL BIOL, V29, P1565, DOI 10.1128/MCB.01283-08; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Uehara Y, 2003, CURR CANCER DRUG TAR, V3, P325, DOI 10.2174/1568009033481796; Ujino S, 2012, VIRUS RES, V163, P390, DOI 10.1016/j.virusres.2011.10.003; Urwin P, 2000, PLANT J, V24, P583, DOI 10.1046/j.1365-313x.2000.00904.x; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wong Sek-Man, 2008, V451, P125, DOI 10.1007/978-1-59745-102-4_9; Woolaway KE, 2001, J VIROL, V75, P10244, DOI 10.1128/JVI.75.21.10244-10249.2001; Xia XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004136; Yanguez E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071425; Zeenko V, 2005, J BIOL CHEM, V280, P26813, DOI 10.1074/jbc.M503576200	50	8	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107459	10.1371/journal.pone.0107459	http://dx.doi.org/10.1371/journal.pone.0107459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222534	Green Submitted, Green Published, gold			2022-12-25	WOS:000341774800068
J	Sabino, FC; Ribeiro, AO; Tufik, S; Torres, LB; Oliveira, JA; Mello, LEAM; Cavalcante, JS; Pedrazzoli, M				Sabino, Flavia Cal; Ribeiro, Amanda Oliveira; Tufik, Sergio; Torres, Laila Brito; Oliveira, Jose Americo; Araujo Moraes Mello, Luiz Eugenio; Cavalcante, Jeferson Souza; Pedrazzoli, Mario			Evolutionary History of the PER3 Variable Number of Tandem Repeats (VNTR): Idiosyncratic Aspect of Primate Molecular Circadian Clock	PLOS ONE			English	Article							SLEEP-PHASE SYNDROME; GENOME EVOLUTION; TRANSPOSABLE ELEMENTS; LENGTH POLYMORPHISM; GENETIC MODULATORS; DIURNAL PREFERENCE; MOBILE ELEMENTS; ASSOCIATION; SEQUENCE; RHYTHMS	The PER3 gene is one of the clock genes, which function in the core mammalian molecular circadian system. A variable number of tandem repeats (VNTR) locus in the 18th exon of this gene has been strongly associated to circadian rhythm phenotypes and sleep organization in humans, but it has not been identified in other mammals except primates. To better understand the evolution and the placement of the PER3 VNTR in a phylogenetical context, the present study enlarges the investigation about the presence and the structure of this variable region in a large sample of primate species and other mammals. The analysis of the results has revealed that the PER3 VNTR occurs exclusively in simiiforme primates and that the number of copies of the primitive unit ranges from 2 to 11 across different primate species. Two transposable elements surrounding the 18th exon of PER3 were found in primates with published genome sequences, including the tarsiiforme Tarsius syrichta, which lacks the VNTR. These results suggest that this VNTR may have evolved in a common ancestor of the simiiforme branch and that the evolutionary copy number differentiation of this VNTR may be associated with primate simiiformes sleep and circadian phenotype patterns.	[Sabino, Flavia Cal; Tufik, Sergio] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil; [Ribeiro, Amanda Oliveira] Univ Fed Sao Paulo, Dept Genet & Evolutionary Biol, Sao Paulo, Brazil; [Torres, Laila Brito] Primate Natl Ctr IEC CENP, Brazilian Minist Hlth, Hlth Surveillance Secretariat, Ananindeua, Para, Brazil; [Oliveira, Jose Americo] Sao Paulo State Univ, Aracatuba Dent Sch, Dept Basic Sci, Div Anat, Aracatuba, Brazil; [Araujo Moraes Mello, Luiz Eugenio] Univ Fed Sao Paulo, Dept Physiol, Sao Paulo, Brazil; [Cavalcante, Jeferson Souza] Univ Fed Rio Grande do Norte, Lab Neurochem Studies, BR-59072970 Natal, RN, Brazil; [Pedrazzoli, Mario] Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio Grande do Norte; Universidade de Sao Paulo	Cavalcante, JS (corresponding author), Univ Fed Rio Grande do Norte, Lab Neurochem Studies, BR-59072970 Natal, RN, Brazil.	jefsc@uol.com.br	Torres, Laila Brito/O-2599-2013; Ribeiro, Amanda O/F-8367-2013; Pedrazzoli, Mario/B-3757-2013; Mello, Luiz/B-4177-2009	Ribeiro, Amanda O/0000-0002-1396-391X; Pedrazzoli, Mario/0000-0002-5257-591X; Mello, Luiz/0000-0002-6969-1108; OLIVEIRA, JOSE AMERICO DE/0000-0002-0158-7785	Foundation for Research Support of the State of Sao Paulo (FAPESP); association incentive fund psychopharmacology (AFIP); center for research innovation and diffusion (CEPID)	Foundation for Research Support of the State of Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); association incentive fund psychopharmacology (AFIP); center for research innovation and diffusion (CEPID)	This work was supported by the Foundation for Research Support of the State of Sao Paulo (FAPESP); association incentive fund psychopharmacology (AFIP); center for research innovation and diffusion (CEPID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/947089; Albrecht U, 2002, J APPL PHYSIOL, V92, P1348, DOI 10.1152/japplphysiol.00759.2001; Ankel-Simons F, 2008, YEARB PHYS ANTHROPOL, V51, P100, DOI 10.1002/ajpa.20957; Archer SN, 2003, SLEEP, V26, P413, DOI 10.1093/sleep/26.4.413; ASCHOFF J, 1965, SCIENCE, V148, P1427, DOI 10.1126/science.148.3676.1427; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Curtis DJ, 2006, FOLIA PRIMATOL, V77, P178, DOI 10.1159/000089703; Ebisawa T, 2001, EMBO REP, V2, P342, DOI 10.1093/embo-reports/kve070; Eickbush TH, 2006, TRANSPOSABLE ELEMENT; Ellis J, 2009, CHRONOBIOL INT, V26, P464, DOI 10.1080/07420520902820970; Fernandez-Duque E, 2003, BEHAV ECOL SOCIOBIOL, V54, P431, DOI 10.1007/s00265-003-0637-9; FINNEGAN DJ, 1989, TRENDS GENET, V5, P103, DOI 10.1016/0168-9525(89)90039-5; Fondon JW, 2008, TRENDS NEUROSCI, V31, P328, DOI 10.1016/j.tins.2008.03.006; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Green P, 2007, GENOME RES, V17, P1547, DOI 10.1101/gr.7050807; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; Hedges DJ, 2005, BIOESSAYS, V27, P785, DOI 10.1002/bies.20268; Heesy CP, 2010, BRAIN BEHAV EVOLUT, V75, P195, DOI 10.1159/000314278; Jenkins A, 2005, J BIOL RHYTHM, V20, P470, DOI 10.1177/0748730405278442; Kay RF, 1997, SCIENCE, V275, P797, DOI 10.1126/science.275.5301.797; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Matsushima N, 2008, CURR PROTEIN PEPT SC, V9, P591, DOI 10.2174/138920308786733886; Medstrand P, 2005, CYTOGENET GENOME RES, V110, P342, DOI 10.1159/000084966; Nakamura Y, 1998, J HUM GENET, V43, P149, DOI 10.1007/s100380050059; Nithianantharajah J, 2007, BIOESSAYS, V29, P525, DOI 10.1002/bies.20589; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Peixoto AA, 1998, P NATL ACAD SCI USA, V95, P4475, DOI 10.1073/pnas.95.8.4475; Pereira DS, 2005, SLEEP, V28, P29; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Roenneberg T, 2007, CURR BIOL, V17, pR44, DOI 10.1016/j.cub.2006.12.011; Sawyer LA, 2006, GENETICS, V174, P465, DOI 10.1534/genetics.106.058792; Takumi T, 1998, EMBO J, V17, P4753, DOI 10.1093/emboj/17.16.4753; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOBLER I, 1995, BEHAV BRAIN RES, V69, P35, DOI 10.1016/0166-4328(95)00025-O; Viola AU, 2008, AM J PHYSIOL-HEART C, V295, pH2156, DOI 10.1152/ajpheart.00662.2008; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; Xing J, 2007, YEARB PHYS ANTHROPOL, V50, P2, DOI 10.1002/ajpa.20722; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	40	12	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107198	10.1371/journal.pone.0107198	http://dx.doi.org/10.1371/journal.pone.0107198			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222750	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774800046
J	Bahmani, H; Murayama, Y; Logothetis, NK; Keliris, GA				Bahmani, Hamed; Murayama, Yusuke; Logothetis, Nikos K.; Keliris, Georgios A.			Binocular Flash Suppression in the Primary Visual Cortex of Anesthetized and Awake Macaques	PLOS ONE			English	Article							REFLECTS PERCEPTUAL SUPPRESSION; INTERMODAL SELECTIVE ATTENTION; FUNCTIONAL ARCHITECTURE; ACTIVITY FLUCTUATIONS; SPATIAL ATTENTION; NEURAL ACTIVITY; RIVALRY; MONKEY; V1; CONSCIOUSNESS	Primary visual cortex (V1) was implicated as an important candidate for the site of perceptual suppression in numerous psychophysical and imaging studies. However, neurophysiological results in awake monkeys provided evidence for competition mainly between neurons in areas beyond V1. In particular, only a moderate percentage of neurons in V1 were found to modulate in parallel with perception with magnitude substantially smaller than the physical preference of these neurons. It is yet unclear whether these small modulations are rooted from local circuits in V1 or influenced by higher cognitive states. To address this question we recorded multi-unit spiking activity and local field potentials in area V1 of awake and anesthetized macaque monkeys during the paradigm of binocular flash suppression. We found that a small but significant modulation was present in both the anesthetized and awake states during the flash suppression presentation. Furthermore, the relative amplitudes of the perceptual modulations were not significantly different in the two states. We suggest that these early effects of perceptual suppression might occur locally in V1, in prior processing stages or within early visual cortical areas in the absence of top-down feedback from higher cognitive stages that are suppressed under anesthesia.	[Bahmani, Hamed; Murayama, Yusuke; Logothetis, Nikos K.; Keliris, Georgios A.] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Bahmani, Hamed; Keliris, Georgios A.] Bernstein Ctr Computat Neurosci, Tubingen, Germany; [Logothetis, Nikos K.] Univ Manchester, Manchester, Lancs, England	Max Planck Society; University of Manchester	Keliris, GA (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	georgios.keliris@tuebingen.mpg.de	Keliris, Georgios A/B-6692-2008; Logothetis, Nikos/U-9282-2019	Keliris, Georgios A/0000-0001-6732-1261; 	Max Planck Society; Bernstein Center for Computational Neuroscience, Tuebingen [FKZ 01GQ1002]	Max Planck Society(Max Planck Society); Bernstein Center for Computational Neuroscience, Tuebingen	This study was supported by the Max Planck Society and the Bernstein Center for Computational Neuroscience, Tuebingen (grant number FKZ 01GQ1002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABADI RV, 1976, VISION RES, V16, P269, DOI 10.1016/0042-6989(76)90110-3; Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; ATTNEAVE F, 1971, SCI AM, V225, P62, DOI 10.1038/scientificamerican1271-62; Bhardwaj R, 2008, J VISION, V8, DOI 10.1167/8.11.2; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Blake R, 2006, P NATL ACAD SCI USA, V103, P4783, DOI 10.1073/pnas.0509634103; Brascamp JW, 2012, PSYCHOL SCI, V23, P1159, DOI 10.1177/0956797612440100; Brascamp JW, 2007, J VISION, V7, DOI 10.1167/7.12.12; Breese BB, 1909, PSYCHOL REV, V16, P410, DOI 10.1037/h0075805; Breese BB., 1899, PSYCHOL REV-MONOGR S, V3, DOI [10.1037/h0092990, DOI 10.1037/H0092990]; Buracas GT, 2007, J NEUROSCI, V27, P93, DOI 10.1523/JNEUROSCI.3162-06.2007; COGAN AI, 1987, VISION RES, V27, P2125, DOI 10.1016/0042-6989(87)90127-1; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; Crick F, 2003, NAT NEUROSCI, V6, P119, DOI 10.1038/nn0203-119; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Dayan P, 1998, NEURAL COMPUT, V10, P1119, DOI 10.1162/089976698300017377; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; DUTOUR M, 1760, MEMOIRES MATH PHYS P; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; ECKHORN R, 1993, J NEUROSCI METH, V49, P175, DOI 10.1016/0165-0270(93)90121-7; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gail A, 2004, CEREB CORTEX, V14, P300, DOI 10.1093/cercor/bhg129; GILBERT CD, 1993, CEREB CORTEX, V3, P373, DOI 10.1093/cercor/3.5.373; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; Guo K, 2004, EUR J NEUROSCI, V19, P1055, DOI 10.1111/j.1460-9568.2004.03212.x; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Huk AC, 2001, NEURON, V32, P161, DOI 10.1016/S0896-6273(01)00452-4; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Keliris GA, 2010, J NEUROSCI, V30, P12353, DOI 10.1523/JNEUROSCI.0677-10.2010; Koch C, 2012, TRENDS COGN SCI, V16, P103, DOI 10.1016/j.tics.2011.11.012; Lamme VAF, 1998, P NATL ACAD SCI USA, V95, P3263, DOI 10.1073/pnas.95.6.3263; Lamme VAF, 2000, FRONT BIOSCI, V5, pD232, DOI 10.2741/Lamme; Lee SH, 2002, J VISION, V2, P618, DOI 10.1167/2.9.4; Lee SH, 2007, NAT NEUROSCI, V10, P1048, DOI 10.1038/nn1939; LEHKY SR, 1988, PERCEPTION, V17, P215, DOI 10.1068/p170215; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Logothetis NK, 1998, PHILOS T R SOC B, V353, P1801, DOI 10.1098/rstb.1998.0333; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Logothetis NK, 1999, SCI AM, V281, P68, DOI 10.1038/scientificamerican1199-68; Maier A, 2008, NAT NEUROSCI, V11, P1193, DOI 10.1038/nn.2173; Mehta AD, 2000, CEREB CORTEX, V10, P359, DOI 10.1093/cercor/10.4.359; Mehta SD, 2000, CEREB CORTEX, V10, P343, DOI 10.1093/cercor/10.4.343; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Pitts MA, 2007, J VISION, V7, DOI 10.1167/7.1.6; POLLEN DA, 1995, NATURE, V377, P293, DOI 10.1038/377293b0; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Ramalingam N, 2013, J NEUROSCI, V33, P1773, DOI 10.1523/JNEUROSCI.3825-12.2013; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; ROCK I, 1994, ACTA PSYCHOL, V87, P33, DOI 10.1016/0001-6918(94)90065-5; Rock I, 1995, PERCEPTION SCI AM LI; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Silver MA, 2007, VISION RES, V47, P532, DOI 10.1016/j.visres.2006.10.011; Sincich LC, 2005, ANNU REV NEUROSCI, V28, P303, DOI 10.1146/annurev.neuro.28.061604.135731; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Tolias AS, 2007, J NEUROPHYSIOL, V98, P3780, DOI 10.1152/jn.00260.2007; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Tsuchiya N, 2006, J VISION, V6, P1068, DOI 10.1167/6.10.6; Watanabe M, 2011, SCIENCE, V334, P829, DOI 10.1126/science.1203161; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; Wilke M, 2003, NEURON, V39, P1043, DOI 10.1016/j.neuron.2003.08.003; Wilke M, 2006, P NATL ACAD SCI USA, V103, P17507, DOI 10.1073/pnas.0604673103; Wilke M, 2009, P NATL ACAD SCI USA, V106, P9465, DOI 10.1073/pnas.0900714106; WOLFE JM, 1984, VISION RES, V24, P471, DOI 10.1016/0042-6989(84)90044-0; Yuval-Greenberg S, 2013, J NEUROSCI, V33, P9635, DOI 10.1523/JNEUROSCI.4612-12.2013; Zhang P, 2011, NEURON, V71, P362, DOI 10.1016/j.neuron.2011.05.035	72	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107628	10.1371/journal.pone.0107628	http://dx.doi.org/10.1371/journal.pone.0107628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216188	Green Submitted, Green Published, gold			2022-12-25	WOS:000341774300091
J	Kyndt, T; Denil, S; Bauters, L; Van Criekinge, W; De Meyer, T				Kyndt, Tina; Denil, Simon; Bauters, Lander; Van Criekinge, Wim; De Meyer, Tim			Systemic Suppression of the Shoot Metabolism upon Rice Root Nematode Infection	PLOS ONE			English	Article							HIRSCHMANNIELLA-ORYZAE; TRANSCRIPTION FACTOR; BRASSINOSTEROIDS; RESPONSES; EXPRESSION; DEFENSE; KNOT; RESISTANCE; PATHWAY; GROWTH	Hirschmanniella oryzae is the most common plant-parasitic nematode in flooded rice cultivation systems. These migratory animals penetrate the plant roots and feed on the root cells, creating large cavities, extensive root necrosis and rotting. The objective of this study was to investigate the systemic response of the rice plant upon root infection by this nematode. RNA sequencing was applied on the above-ground parts of the rice plants at 3 and 7 days post inoculation. The data revealed significant modifications in the primary metabolism of the plant shoot, with a general suppression of for instance chlorophyll biosynthesis, the brassinosteroid pathway, and amino acid production. In the secondary metabolism, we detected a repression of the isoprenoid and shikimate pathways. These molecular changes can have dramatic consequences for the growth and yield of the rice plants, and could potentially change their susceptibility to above-ground pathogens and pests.	[Kyndt, Tina; Bauters, Lander] Univ Ghent, Dept Mol Biotechnol, B-9000 Ghent, Belgium; [Denil, Simon; Van Criekinge, Wim; De Meyer, Tim] Univ Ghent, Dept Math Modelling Stat & Bioinformat, B-9000 Ghent, Belgium; [Van Criekinge, Wim] Ghent Univ Hosp, NXTGNT, Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University Hospital	Kyndt, T (corresponding author), Univ Ghent, Dept Mol Biotechnol, B-9000 Ghent, Belgium.	tina.kyndt@ugent.be	Kyndt, Tina/E-4346-2013; De Meyer, Tim/D-3892-2011	Kyndt, Tina/0000-0002-5267-5013; De Meyer, Tim/0000-0003-2994-9693	Fund for Scientific Research Flanders; IWT doctoral grant [SB101371]; Ghent University Multidisciplinary Research Partnership "Bioinformatics: from nucleotides to networks'' [BOF_01GA0805]	Fund for Scientific Research Flanders(FWO); IWT doctoral grant; Ghent University Multidisciplinary Research Partnership "Bioinformatics: from nucleotides to networks''(Ghent University)	TK is funded by a postdoctoral fellowship of the Fund for Scientific Research Flanders (http://www.fwo.be/). SD received an IWT doctoral grant SB101371 (http://www.iwt.be/). TDM is supported by the Ghent University Multidisciplinary Research Partnership "Bioinformatics: from nucleotides to networks'', BOF_01GA0805. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2012, P NATL ACAD SCI USA, V109, P303, DOI 10.1073/pnas.1109921108; ALSTON DG, 1991, J ECON ENTOMOL, V84, P267, DOI 10.1093/jee/84.1.267; BABATOLA JO, 1980, J NEMATOL, V12, P48; Bajguz A, 2009, PLANT PHYSIOL BIOCH, V47, P1, DOI 10.1016/j.plaphy.2008.10.002; Bar-Or C, 2005, EUR J PLANT PATHOL, V111, P181, DOI 10.1007/s10658-004-2134-z; Barcala M, 2010, PLANT J, V61, P698, DOI 10.1111/j.1365-313X.2009.04098.x; Bauters L, 2014, MOL PLANT PATHOL, V15, P352, DOI 10.1111/mpp.12098; Belkhadir Y, 2012, P NATL ACAD SCI USA, V109, P297, DOI 10.1073/pnas.1112840108; Bezemer TM, 2005, TRENDS ECOL EVOL, V20, P617, DOI 10.1016/j.tree.2005.08.006; Bezemer TM, 2005, ECOL LETT, V8, P652, DOI 10.1111/j.1461-0248.2005.00762.x; Bezemer TM, 2004, J CHEM ECOL, V30, P53, DOI 10.1023/B:JOEC.0000013182.50662.2a; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Bridge John, 2005, P87, DOI 10.1079/9780851997278.0087; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Djamei A, 2011, NATURE, V478, P395, DOI 10.1038/nature10454; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Erb M, 2009, PLANT J, V59, P292, DOI 10.1111/j.1365-313X.2009.03868.x; Gheysen G, 1996, PESTIC SCI, V47, P95, DOI 10.1002/(SICI)1096-9063(199605)47:1&lt;95::AID-PS390&gt;3.0.CO;2-I; Hamamouch N, 2011, MOL PLANT PATHOL, V12, P355, DOI 10.1111/j.1364-3703.2010.00675.x; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Hofmann J, 2010, PLANT J, V62, P1058, DOI 10.1111/j.1365-313X.2010.04217.x; Hooper D. J., 2005, PLANT PARASIT NEMAT, V2, P53, DOI DOI 10.1079/9780851997278.0053; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P510, DOI 10.1094/MPMI-20-5-0510; Jammes F, 2005, PLANT J, V44, P447, DOI 10.1111/j.1365-313X.2005.02532.x; Ji HL, 2013, J EXP BOT, V64, P3885, DOI 10.1093/jxb/ert219; Kaplan I, 2009, ECOL ENTOMOL, V34, P262, DOI 10.1111/j.1365-2311.2008.01062.x; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Kutyniok M, 2012, J EXP BOT, V63, P6199, DOI 10.1093/jxb/ers274; Kyndt T, 2012, PLANT BIOLOGY, V14, P73, DOI 10.1111/j.1438-8677.2011.00524.x; Kyndt T., 2014, ANNU REV PHYTOPATHOL, V52, p7 1; Kyndt T, 2013, PLANTA, V238, P807, DOI 10.1007/s00425-013-1923-z; Kyndt T, 2012, NEW PHYTOL, V196, P887, DOI 10.1111/j.1469-8137.2012.04311.x; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Manninen AM, 1998, J CHEM ECOL, V24, P1315, DOI 10.1023/A:1021222731991; Narsai R, 2010, BMC PLANT BIOL, V10; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Quan RD, 2010, PLANT BIOTECHNOL J, V8, P476, DOI 10.1111/j.1467-7652.2009.00492.x; Rashid M, 2012, EVOL BIOINFORM, V8, P321, DOI 10.4137/EBO.S9369; Reversat G, 1999, NEMATOLOGY, V1, P209, DOI 10.1163/156854199508027; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Torii KU, 2004, INT REV CYTOLOGY SUR, V234, P234; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Dam NM, 2009, ANNU REV ECOL EVOL S, V40, P373, DOI 10.1146/annurev.ecolsys.110308.120314; Vranova E, 2012, MOL PLANT, V5, P318, DOI 10.1093/mp/sss015; Wondafrash M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00087	48	13	13	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106858	10.1371/journal.pone.0106858	http://dx.doi.org/10.1371/journal.pone.0106858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216177	Green Published, gold			2022-12-25	WOS:000341774300027
J	Yun, HM; Lathrop, KL; Yang, EZ; Sun, M; Kagemann, L; Fu, V; Stolz, DB; Schuman, JS; Du, YQ				Yun, Hongmin; Lathrop, Kira L.; Yang, Enzhi; Sun, Ming; Kagemann, Larry; Fu, Valeria; Stolz, Donna B.; Schuman, Joel S.; Du, Yiqin			A Laser-Induced Mouse Model with Long-Term Intraocular Pressure Elevation	PLOS ONE			English	Article							PHOTOPIC NEGATIVE RESPONSE; RETINAL GANGLION-CELLS; TRABECULAR MESHWORK CELLULARITY; OPTICAL COHERENCE TOMOGRAPHY; CANAL ENDOTHELIAL-CELLS; OPEN-ANGLE GLAUCOMA; OCULAR HYPERTENSION; AQUEOUS-HUMOR; RAT MODEL; EXTRACELLULAR-MATRIX	Purpose: To develop and characterize a mouse model with intraocular pressure (IOP) elevation after laser photocoagulation on the trabecular meshwork (TM), which may serve as a model to investigate the potential of stem cell-based therapies for glaucoma. Methods: IOP was measured in 281 adult C57BL/6 mice to determine normal IOP range. IOP elevation was induced unilaterally in 50 adult mice, by targeting the TM through the limbus with a 532-nm diode laser. IOP was measured up to 24 weeks post-treatment. The optic nerve damage was detected by electroretinography and assessed by semiautomatic counting of optic nerve axons. Effects of laser treatment on the TM were evaluated by histology, immunofluorescence staining, optical coherence tomography (OCT) and transmission electron microscopy (TEM). Results: The average IOP of C57BL/6 mice was 14.5 +/- 2.6 mmHg (Mean +/- SD). After laser treatment, IOP averaged above 20 mmHg throughout the follow-up period of 24 weeks. At 24 weeks, 57% of treated eyes had elevated IOP with the mean IOP of 22.5 +/- 2.5 mmHg (Mean +/- SED). The difference of average axon count (59.0%) between laser treated and untreated eyes was statistically significant. Photopic negative response (PhNR) by electroretinography was significantly decreased. CD45+ inflammatory cells invaded the TM within 1 week. The expression of SPARC was increased in the TM from 1 to 12 weeks. Histology showed the anterior chamber angle open after laser treatment. OCT indicated that most of the eyes with laser treatment had no synechia in the anterior chamber angles. TEM demonstrated disorganized and compacted extracellular matrix in the TM. Conclusions: An experimental murine ocular hypertension model with an open angle and optic nerve axon loss was produced with laser photocoagulation, which could be used to investigate stem cell-based therapies for restoration of the outflow pathway integrity for ocular hypertension or glaucoma.	[Yun, Hongmin; Lathrop, Kira L.; Yang, Enzhi; Kagemann, Larry; Fu, Valeria; Schuman, Joel S.; Du, Yiqin] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA; [Yun, Hongmin; Yang, Enzhi; Schuman, Joel S.; Du, Yiqin] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Sun, Ming; Stolz, Donna B.] Univ Pittsburgh, Dept Cell Biol, Ctr Biol Imaging, Pittsburgh, PA USA; [Stolz, Donna B.; Schuman, Joel S.; Du, Yiqin] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Lathrop, Kira L.; Kagemann, Larry; Schuman, Joel S.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA USA; [Du, Yiqin] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Du, YQ (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA.	duy@upmc.edu	Schuman, Joel S/M-2389-2019; Du, Yiqin/A-7727-2018; Schuman, Joel S/K-7304-2012; DU, YIQIN/AAO-1566-2020	Schuman, Joel S/0000-0002-8885-3766; Schuman, Joel S/0000-0002-8885-3766; DU, YIQIN/0000-0002-4330-0957; Kagemann, Larry/0000-0001-8961-0187; YUN, HONGMIN/0000-0002-2975-3941	NIH [P30-EY008098]; Eye and Ear Foundation (Pittsburgh, Pennsylvania); Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY008098] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eye and Ear Foundation (Pittsburgh, Pennsylvania); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work has been supported by an anonymous philanthropic donation for stem cells and glaucoma research (YD); NIH Grant P30-EY008098; Eye and Ear Foundation (Pittsburgh, Pennsylvania); and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; Aihara M, 2003, INVEST OPHTH VIS SCI, V44, P4314, DOI 10.1167/iovs.03-0137; ALVARADO J, 1981, INVEST OPHTH VIS SCI, V21, P714; ALVARADO J, 1984, OPHTHALMOLOGY, V91, P564; Alvarado JA, 2005, BRIT J OPHTHALMOL, V89, P1500, DOI 10.1136/bjo.2005.081307; Alvarado JA, 2004, AM J PHYSIOL-CELL PH, V286, pC621, DOI 10.1152/ajpcell.00108.2003; Alvarado Jorge A, 2005, Trans Am Ophthalmol Soc, V103, P148; Alvarado JA, 2010, AM J OPHTHALMOL, V150, P254, DOI 10.1016/j.ajo.2010.03.012; Baleriola J, 2008, MOL VIS, V14, P1513; Biermann J, 2012, EXP EYE RES, V104, P7, DOI 10.1016/j.exer.2012.08.011; BULLER C, 1990, INVEST OPHTH VIS SCI, V31, P2156; Camras LJ, 2010, CURR EYE RES, V35, P819, DOI 10.3109/02713683.2010.494241; Chiu K, 2007, J VIS EXP, V549; Chrysostomou V, 2013, INVEST OPHTH VIS SCI, V54, P4691, DOI 10.1167/iovs.13-12415; Du YQ, 2013, INVEST OPHTH VIS SCI, V54, P1450, DOI 10.1167/iovs.12-11056; Du YQ, 2012, INVEST OPHTH VIS SCI, V53, P1566, DOI 10.1167/iovs.11-9134; Du YQ, 2009, STEM CELLS, V27, P1635, DOI 10.1002/stem.91; Ethier CR, 2004, BIOPHYS J, V87, P2828, DOI 10.1529/biophysj.103.038133; Feng L, 2013, INVEST OPHTH VIS SCI, V54, P1106, DOI 10.1167/iovs.12-10791; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Friedlander M, 2012, INVEST OPHTH VIS SCI, V53, P2511, DOI 10.1167/iovs.12-9483p; Fu CT, 2012, J NEUROSCI, V32, P15859, DOI 10.1523/JNEUROSCI.0038-12.2012; Fu CT, 2010, INVEST OPHTH VIS SCI, V51, P980, DOI 10.1167/iovs.09-4324; Gabelt BT, 2005, PROG RETIN EYE RES, V24, P612, DOI 10.1016/j.preteyeres.2004.10.003; Gabriele ML, 2011, INVEST OPHTH VIS SCI, V52, P2250, DOI 10.1167/iovs.10-6311; Gabriele ML, 2010, INVEST OPHTH VIS SCI, V51, P6519, DOI 10.1167/iovs.10-5662; Gallego BI, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-92; Gasiorowski JZ, 2009, EXP EYE RES, V88, P671, DOI 10.1016/j.exer.2008.08.006; Grozdanic SD, 2003, INVEST OPHTH VIS SCI, V44, P4337, DOI 10.1167/iovs.03-0015; Gunn DJ, 2011, CLIN EXP OPHTHALMOL, V39, P555, DOI 10.1111/j.1442-9071.2010.02488.x; GUPTA D, 2004, GLAUCOMA DIAGNOSIS M, P31; Haddadin RI, 2009, INVEST OPHTH VIS SCI, V50, P3771, DOI 10.1167/iovs.08-2489; He Y, 2008, INVEST OPHTH VIS SCI, V49, P1447, DOI 10.1167/iovs.07-1361; Holder GE, 2001, PROG RETIN EYE RES, V20, P531, DOI 10.1016/S1350-9462(00)00030-6; Ji JZ, 2005, VISION RES, V45, P169, DOI 10.1016/j.visres.2004.08.008; Johnson M, 2006, EXP EYE RES, V82, P545, DOI 10.1016/j.exer.2005.10.011; Ko MK, 2013, MOL VIS, V19, P2561; Kwong JMK, 2013, EXP EYE RES, V112, P21, DOI 10.1016/j.exer.2013.04.008; Levkovitch-Verbin H, 2004, EYE, V18, P1066, DOI 10.1038/sj.eye.6701576; Levkovitch-Verbin H, 2002, INVEST OPHTH VIS SCI, V43, P402; Liton PB, 2005, EXP GERONTOL, V40, P745, DOI 10.1016/j.exger.2005.06.005; Lutjen-Drecoll E, 2005, EXP EYE RES, V81, P1, DOI 10.1016/j.exer.2005.02.008; MAFFEI L, 1981, SCIENCE, V211, P953, DOI 10.1126/science.7466368; Marina N, 2010, NAT PROTOC, V5, P1642, DOI 10.1038/nprot.2010.128; Oh DJ, 2013, INVEST OPHTH VIS SCI, V54, P3309, DOI 10.1167/iovs.12-11362; Preiser D, 2013, INVEST OPHTH VIS SCI, V54, P1182, DOI 10.1167/iovs.12-11201; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Read AT, 2007, EXP EYE RES, V84, P213, DOI 10.1016/j.exer.2006.10.001; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Stamer WD, 2012, CURR OPIN OPHTHALMOL, V23, P135, DOI 10.1097/ICU.0b013e32834ff23e; Swaminathan SS, 2013, INVEST OPHTH VIS SCI, V54, P2035, DOI 10.1167/iovs.12-10950; Tamm ER, 2009, EXP EYE RES, V88, P648, DOI 10.1016/j.exer.2009.02.007; TRIPATHI RC, 1977, EXP EYE RES, V25, P403, DOI 10.1016/S0014-4835(77)80035-3; Tsuruga H, 2012, MOL VIS, V18, P2468; Viswanathan S, 2001, INVEST OPHTH VIS SCI, V42, P514; Viswanathan S, 1999, INVEST OPHTH VIS SCI, V40, P1124; Zhang YL, 2013, AFR J TRADIT COMPLEM, V10, P258, DOI 10.4314/ajtcam.v10i2.10	57	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107446	10.1371/journal.pone.0107446	http://dx.doi.org/10.1371/journal.pone.0107446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216052	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000341774300066
J	Ning, FK; Wang, C; Berry, KZ; Kandasamy, P; Liu, HL; Murphy, RC; Voelker, DR; Nho, CW; Pan, CH; Dai, SD; Niu, LW; Chu, HW; Zhang, GY				Ning, Fangkun; Wang, Chao; Berry, Karin Zemski; Kandasamy, Pitchaimani; Liu, Haolin; Murphy, Robert C.; Voelker, Dennis R.; Nho, Chu Won; Pan, Choel-Ho; Dai, Shaodong; Niu, Liwen; Chu, Hong-Wei; Zhang, Gongyi			Structural characterization of the pulmonary innate immune protein SPLUNC1 and identification of lipid ligands	FASEB JOURNAL			English	Article						lipid ligand; SM; DPPC	BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN; PSEUDOMONAS-AERUGINOSA INFECTION; BINDS MYCOPLASMA-PNEUMONIAE; CYSTIC-FIBROSIS AIRWAYS; GRAM-NEGATIVE BACTERIA; SURFACTANT-PROTEIN; CRYSTAL-STRUCTURE; MASS-SPECTROMETRY; HIGH-AFFINITY; HOST-DEFENSE	The short palate, lung and nasal epithelial clone 1 (SPLUNC1) protein is a member of the palate, lung, and nasal epithelium clone (PLUNC) family, also known as bactericidal/permeability-increasing (BPI) fold-containing protein, family A, member 1 (BPIFA1). SPLUNC1 is an abundant protein in human airways, but its function remains poorly understood. The lipid ligands of SPLUNC1 as well as other PLUNC family members are largely unknown, although some reports provide evidence that lipopolysaccharide (LPS) could be a lipid ligand. Unlike previous hypotheses, we found significant structural differences between SPLUNC1 and BPI. Recombinant SPLUNC1 produced in HEK 293 cells harbored several molecular species of sphingomyelin and phosphatidylcholine as its ligands. Significantly, in vitro lipid-binding studies failed to demonstrate interactions between SPLUNC1 and LPS, lipoteichoic acid, or polymyxin B. Instead, one of the major and most important pulmonary surfactant phospholipids, dipalmitoylphosphatidylcholine (DPPC), bound to SPLUNC1 with high affinity and specificity. We found that SPLUNC1 could be the first protein receptor for DPPC. These discoveries provide insight into the specific determinants governing the interaction between SPLUNC1 and lipids and also shed light on novel functions that SPLUNC1 and other PLUNC family members perform in host defense.	[Ning, Fangkun; Niu, Liwen] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Ning, Fangkun; Wang, Chao; Liu, Haolin; Dai, Shaodong; Chu, Hong-Wei; Zhang, Gongyi] Natl Jewish Hlth Denver, Integrated Dept Immunol, Denver, CO USA; [Ning, Fangkun; Wang, Chao; Liu, Haolin; Dai, Shaodong; Chu, Hong-Wei; Zhang, Gongyi] Univ Colorado, Denver, CO 80202 USA; [Berry, Karin Zemski; Murphy, Robert C.] Univ Colorado, Dept Pharmacol, Denver, CO USA; [Kandasamy, Pitchaimani; Voelker, Dennis R.; Chu, Hong-Wei] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Nho, Chu Won; Pan, Choel-Ho] Korea Inst Sci & Technol, Funct Food Ctr, Gang Neung, South Korea	Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver; National Jewish Health; Korea Institute of Science & Technology (KIST)	Niu, LW (corresponding author), Univ Sci & Technol China, Sch Life Sci, 96 Jinzhai Rd, Hefei 230027, Anhui, Peoples R China.	lwniu@ustc.edu.cn; chuh@njhealth.org	Murphy, Robert/AAO-5349-2020	Murphy, Robert/0000-0002-9430-6515	U.S. National Institutes of Health [HL088264, AI109219, GM80719, AI22295]; Korea Institute of Science and Technology [2Z03300]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI109219, T32AI074491, P01AI022295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080719] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Institute of Science and Technology(Korea Institute of Science & Technology (KIST)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the Howard Hughes Medical Institute, the Zuckerman/Canyon Ranch, and Alan Lapporte for supporting their X-ray and computing facilities; Dr. Philippa C. Marrack, Dr. John Kappler, Dr. Lei Yin, Dr. Laurel Lenz, and other researchers at National Jewish for their kind support; and Dr. Jennifer Kemp for editing. All datasets were collected from Howard Hughes Medical Institute beamlines 8.2.1 and 8.2.2 at the Advanced Light Source (Berkeley, CA, USA). This work was supported by the U.S. National Institutes of Health (grants HL088264 to H.W.C., AI109219 to G.Z, and GM80719 and AI22295 to P.M.) and by an intramural grant (2Z03300) from the Korea Institute of Science and Technology. The structure factors and coordinates have been deposited in PDB (identification codes 4KEG and 4N4X).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Balakrishnan A, 2013, INNATE IMMUN-LONDON, V19, P339, DOI 10.1177/1753425912465098; Bartlett J, 2011, BIOCHEM SOC T, V39, P1012, DOI 10.1042/BST0391012; Beamer LJ, 1997, SCIENCE, V276, P1861, DOI 10.1126/science.276.5320.1861; Bingle C. D., BIOCH SOC T, V39, P977; Bingle CD, 2000, BBA-GENE STRUCT EXPR, V1493, P363, DOI 10.1016/S0167-4781(00)00196-2; Bingle CD, 2011, BIOCHEM SOC T, V39, P977, DOI 10.1042/BST0390977; Bingle CD, 2011, BIOCHEM SOC T, V39, P961, DOI 10.1042/BST0390961; Bingle L, 2011, BIOCHEM SOC T, V39, P1023, DOI 10.1042/BST0391023; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Campos MA, 2004, AM J RESP CELL MOL, V30, P184, DOI 10.1165/rcmb.2003-0142OC; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Chiba H, 2002, J BIOL CHEM, V277, P20379, DOI 10.1074/jbc.M201089200; Chu HW, 2007, J IMMUNOL, V179, P3995, DOI 10.4049/jimmunol.179.6.3995; Chu HW, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-155; Di YP, 2011, BIOCHEM SOC T, V39, P1051, DOI 10.1042/BST0391051; DiBlasi, 2011, RESP CARE, V56, P1386; Elsbach P, 1998, CURR OPIN IMMUNOL, V10, P45, DOI 10.1016/S0952-7915(98)80030-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gaillard EA, 2010, PFLUG ARCH EUR J PHY, V460, P1, DOI 10.1007/s00424-010-0827-z; Gakhar L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009098; Gally F, 2011, AM J PATHOL, V178, P2159, DOI 10.1016/j.ajpath.2011.01.026; Garland AL, 2013, P NATL ACAD SCI USA, V110, P15973, DOI 10.1073/pnas.1311999110; Ghafouri B, 2004, BBA-PROTEINS PROTEOM, V1699, P57, DOI 10.1016/j.bbapap.2004.01.001; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hobbs CA, 2012, FASEB J, V26, P4348, DOI 10.1096/fj.12-207431; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kleiger G, 2000, J MOL BIOL, V299, P1019, DOI 10.1006/jmbi.2000.3805; Kopec KO, 2011, BIOCHEM SOC T, V39, P1033, DOI 10.1042/BST0391033; LeClair EE, 2003, J DENT RES, V82, P944, DOI 10.1177/154405910308201202; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Liu YF, 2001, P NATL ACAD SCI USA, V98, P6877, DOI 10.1073/pnas.121013398; Lukinskiene L, 2011, J IMMUNOL, V187, P382, DOI 10.4049/jimmunol.1001769; McGillivary G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013224; Mueller GA, 2010, J ALLERGY CLIN IMMUN, V125, P909, DOI 10.1016/j.jaci.2009.12.016; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Piboonpocanun S, 2005, J BIOL CHEM, V280, P9, DOI 10.1074/jbc.M411570200; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Sayeed S, 2013, INFECT IMMUN, V81, P285, DOI 10.1128/IAI.00500-12; Schumann RR, 2011, BIOCHEM SOC T, V39, P989, DOI 10.1042/BST0390989; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Thaikoottathil JV, 2012, AM J RESP CELL MOL, V47, P253, DOI 10.1165/rcmb.2012-0064OC; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Weiss J, 2003, BIOCHEM SOC T, V31, P785, DOI 10.1042/BST0310785; Weston WM, 1999, J BIOL CHEM, V274, P13698, DOI 10.1074/jbc.274.19.13698; Willson DF, 2011, RESP CARE, V56, P1369, DOI 10.4187/respcare.01306; Zhou HD, 2006, MOL IMMUNOL, V43, P1864, DOI 10.1016/j.molimm.2005.10.021; Zhou HD, 2006, HISTOCHEM CELL BIOL, V125, P315, DOI 10.1007/s00418-005-0070-4; Zhou HD, 2008, MOL CELL BIOCHEM, V309, P191, DOI 10.1007/s11010-007-9659-3; Zhou Hou-de, 2006, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V31, P464	52	15	16	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2014	28	12					5349	5360		10.1096/fj.14-259291	http://dx.doi.org/10.1096/fj.14-259291			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AU9EN	25223608	Green Published			2022-12-25	WOS:000345894500028
J	Zhang, XY; Ji, F; Wang, N; Chen, LL; Tian, T; Lu, W				Zhang, Xiao-Yan; Ji, Fang; Wang, Ning; Chen, Lin-Lin; Tian, Tian; Lu, Wei			Glycine Induces Bidirectional Modifications in N-Methyl-D-aspartate Receptor-mediated Synaptic Responses in Hippocampal CA1 Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-ATPASE; NA+-ATPASE; ENTEROCOCCUS-HIRAE; SUBUNIT ROTATION; ROTOR RING; THERMUS-THERMOPHILUS; TORQUE GENERATION; PROTEOLIPID RING; ROTARY MECHANISM; MOLECULAR MOTOR	Glycine can persistently potentiate or depress AMPA responses through differential actions on two binding sites: NMDA and glycine receptors. Whether glycine can induce long-lasting modifications in NMDA responses, however, remains unknown. Here, we report that glycine induces long-term potentiation (LTP) or long-term depression (LTD) of NMDA responses (Gly-LTPNMDA or Gly-LTDNMDA) in a dose-dependent manner in hippocampal CA1 neurons. These modifications of NMDA responses depend on NMDAR activation. In addition, the induction of Gly-LTPNMDA requires binding of glycine with NMDARs, whereas Gly-LTDNMDA requires that glycine bind with both sites on NMDARs and GlyRs. Moreover, activity-dependent exocytosis and endocytosis of postsynaptic NMDARs underlie glycine-induced bidirectional modification of NMDA excitatory postsynaptic currents. Thus, we conclude that glycine at different levels induces bidirectional plasticity of NMDA responses through differentially regulating NMDA receptor trafficking. Our present findings reveal important functions of the two glycine binding sites in gating the direction of synaptic plasticity in NMDA responses.	[Zhang, Xiao-Yan; Ji, Fang; Wang, Ning; Chen, Lin-Lin; Tian, Tian; Lu, Wei] Nanjing Med Univ, Dept Neurobiol, Nanjing 210029, Jiangsu, Peoples R China; [Wang, Ning; Lu, Wei] Southeast Univ, Inst Life Sci, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing 210096, Jiangsu, Peoples R China; [Lu, Wei] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China	Nanjing Medical University; Southeast University - China; Nantong University	Lu, W (corresponding author), Nanjing Med Univ, Dept Neurobiol, Nanjing 210029, Jiangsu, Peoples R China.	lu@njmu.edu.cn			National Natural Science Foundation of China (NSFC) [31025011]; Major State Basic Research Program of China [2013CB733801]; Doctoral Fund of the Ministry of Education of China [20103234110004]; Open Research Fund of State Key Laboratory of Bioelectronics, Southeast University	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major State Basic Research Program of China(National Basic Research Program of China); Doctoral Fund of the Ministry of Education of China(Ministry of Education, China); Open Research Fund of State Key Laboratory of Bioelectronics, Southeast University	This work was supported by National Natural Science Foundation of China (NSFC) Grant 31025011, Major State Basic Research Program of China Grant 2013CB733801, the Doctoral Fund of the Ministry of Education of China Grant 20103234110004, and the Open Research Fund of State Key Laboratory of Bioelectronics, Southeast University (to W.L.).	Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Ariga T, 2007, NAT STRUCT MOL BIOL, V14, P841, DOI 10.1038/nsmb1296; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bilyard T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0023; Bowman EJ, 2005, J BIOENERG BIOMEMBR, V37, P431, DOI 10.1007/s10863-005-9485-9; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Cook GM, 2003, J BACTERIOL, V185, P4442, DOI 10.1128/JB.185.15.4442-4449.2003; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Furuike S, 2008, SCIENCE, V319, P955, DOI 10.1126/science.1151343; Furuike S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1215; Halir R., 1998, P 6 INT C CENTR EUR; Hayashi K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218103; Hirata T, 2000, J BIOL CHEM, V275, P386, DOI 10.1074/jbc.275.1.386; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Imamura H, 2005, P NATL ACAD SCI USA, V102, P17929, DOI 10.1073/pnas.0507764102; Ishmukhametov R, 2010, EMBO J, V29, P3911, DOI 10.1038/emboj.2010.259; KAKINUMA Y, 1994, J BIOCHEM-TOKYO, V116, P1302, DOI 10.1093/oxfordjournals.jbchem.a124679; Maher MJ, 2009, EMBO J, V28, P3771, DOI 10.1038/emboj.2009.310; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Marshansky V, 2014, BBA-BIOENERGETICS, V1837, P857, DOI 10.1016/j.bbabio.2014.01.018; Minagawa Y, 2013, J BIOL CHEM, V288, P32700, DOI 10.1074/jbc.M113.506329; Mizutani K, 2011, P NATL ACAD SCI USA, V108, P13474, DOI 10.1073/pnas.1103287108; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Murata T, 2005, J BIOENERG BIOMEMBR, V37, P411, DOI 10.1007/s10863-005-9481-0; Murata T, 2000, J BIOL CHEM, V275, P13415, DOI 10.1074/jbc.275.18.13415; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Murata T, 1997, J BIOL CHEM, V272, P24885, DOI 10.1074/jbc.272.40.24885; Murata T, 1999, J BIOCHEM, V125, P414, DOI 10.1093/oxfordjournals.jbchem.a022302; Murata T, 2008, P NATL ACAD SCI USA, V105, P8607, DOI 10.1073/pnas.0800992105; Nagamatsu Y, 2013, J MOL BIOL, V425, P2699, DOI 10.1016/j.jmb.2013.04.022; Nakano M, 2008, J BIOL CHEM, V283, P20789, DOI 10.1074/jbc.M801276200; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nishio K, 2002, P NATL ACAD SCI USA, V99, P13448, DOI 10.1073/pnas.202149599; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Noji H, 1999, BIOCHEM BIOPH RES CO, V260, P597, DOI 10.1006/bbrc.1999.0885; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Omote H, 1999, P NATL ACAD SCI USA, V96, P7780, DOI 10.1073/pnas.96.14.7780; Panke O, 2001, BIOPHYS J, V81, P1220, DOI 10.1016/S0006-3495(01)75780-3; Pogoryelov D, 2010, NAT CHEM BIOL, V6, P891, DOI 10.1038/NCHEMBIO.457; Sakaki N, 2005, BIOPHYS J, V88, P2047, DOI 10.1529/biophysj.104.054668; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Soga N, 2012, J BIOL CHEM, V287, P9633, DOI 10.1074/jbc.M111.335356; Stewart AG, 2014, CURR OPIN STRUC BIOL, V25, P40, DOI 10.1016/j.sbi.2013.11.013; Stewart AG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1693; Suzuki T, 2002, J BIOL CHEM, V277, P13281, DOI 10.1074/jbc.M111210200; Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105; Toei M, 2013, J BIOL CHEM, V288, P25717, DOI 10.1074/jbc.M113.482455; Toyabe S, 2011, P NATL ACAD SCI USA, V108, P17951, DOI 10.1073/pnas.1106787108; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P898, DOI 10.1073/pnas.031564198; Ueno H, 2005, P NATL ACAD SCI USA, V102, P1333, DOI 10.1073/pnas.0407857102; Ueno H, 2010, BIOPHYS J, V98, P2014, DOI 10.1016/j.bpj.2010.01.011; Usukura E, 2012, J BIOL CHEM, V287, P1884, DOI 10.1074/jbc.M111.305938; Wachter A, 2011, P NATL ACAD SCI USA, V108, P3924, DOI 10.1073/pnas.1011581108; Watanabe R, 2010, NAT CHEM BIOL, V6, P814, DOI 10.1038/NCHEMBIO.443; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yokoyama K, 2005, J BIOENERG BIOMEMBR, V37, P405, DOI 10.1007/s10863-005-9480-1; Yokoyama K, 2003, J BIOL CHEM, V278, P24255, DOI 10.1074/jbc.M303104200; Yokoyama K, 1998, J BIOL CHEM, V273, P20504, DOI 10.1074/jbc.273.32.20504	63	14	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31200	31223		10.1074/jbc.M114.570630	http://dx.doi.org/10.1074/jbc.M114.570630			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25231980	Green Published, hybrid			2022-12-25	WOS:000344549900027
J	Suzuki, J; Imanishi, E; Nagata, S				Suzuki, Jun; Imanishi, Eiichi; Nagata, Shigekazu			Exposure of Phosphatidylserine by Xk-related Protein Family Members during Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID SCRAMBLASE; CASPASE CLEAVAGE; DNA-DEGRADATION; PANNEXIN 1; FIND-ME; IDENTIFICATION; CLEARANCE; CELLS; GENE; ACTIVATION	Apoptotic cells expose phosphatidylserine (PtdSer) on their surface as an "eat me" signal. Mammalian Xk-related (Xkr) protein 8, which is predicted to contain six transmembrane regions, and its Caenorhabditis elegans homolog CED-8 promote apoptotic PtdSer exposure. The mouse and human Xkr families consist of eight and nine members, respectively. Here, we found that mouse Xkr family members, with the exception of Xkr2, are localized to the plasma membrane. When Xkr8-deficient cells, which do not expose PtdSer during apoptosis, were transformed by Xkr family members, the transformants expressing Xkr4, Xkr8, or Xkr9 responded to apoptotic stimuli by exposing cell surface PtdSer and were efficiently engulfed by macrophages. Like Xkr8, Xkr4 and Xkr9 were found to possess a caspase recognition site in the C-terminal region and to require its direct cleavage by caspases for their function. Site-directed mutagenesis of the amino acid residues conserved among CED-8, Xkr4, Xkr8, and Xkr9 identified several essential residues in the second transmembrane and second cytoplasmic regions. Real time PCR analysis indicated that unlike Xkr8, which is ubiquitously expressed, Xkr4 and Xkr9 expression is tissue-specific.	[Suzuki, Jun; Imanishi, Eiichi; Nagata, Shigekazu] Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Nagata, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.	snagata@mfour.med.kyoto-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426	Japan Society for the Promotion of Science; Takeda Science Foundation; Grants-in-Aid for Scientific Research [22000013] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for specially promoted research from the Japan Society for the Promotion of Science (to S. N.) and by a grant-in-aid for young scientists (B) from the Japan Society for the Promotion of Science and a research grant from the Takeda Science Foundation (to J. S.).	Alonso-Perez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045356; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Bullen TF, 2006, LAB INVEST, V86, P1052, DOI 10.1038/labinvest.3700464; Calenda G, 2006, GENE, V370, P6, DOI 10.1016/j.gene.2005.10.037; Castoldi E, 2011, BLOOD, V117, P4399, DOI 10.1182/blood-2011-01-332502; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen YZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3726; Coleman JA, 2013, BBA-MOL CELL BIOL L, V1831, P555, DOI 10.1016/j.bbalip.2012.10.006; Crawford ED, 2011, ANNU REV BIOCHEM, V80, P1055, DOI 10.1146/annurev-biochem-061809-121639; Cusack CL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2910; FUKUNAGA R, 1990, J BIOL CHEM, V265, P14008; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Han C, 2014, NEURON, V81, P544, DOI 10.1016/j.neuron.2013.11.021; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2005, P NATL ACAD SCI USA, V102, P16886, DOI 10.1073/pnas.0508599102; HO MF, 1994, CELL, V77, P869, DOI 10.1016/0092-8674(94)90136-8; Kunzelmann K, 2014, PFLUG ARCH EUR J PHY, V466, P407, DOI 10.1007/s00424-013-1305-1; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; McCarty JS, 1999, BIOCHEM BIOPH RES CO, V264, P181, DOI 10.1006/bbrc.1999.1498; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nagata S, 2005, ANNU REV IMMUNOL, V23, P853, DOI 10.1146/annurev.immunol.23.021704.115811; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Neto LRP, 2012, ANIM GENET, V43, P785, DOI 10.1111/j.1365-2052.2012.02330.x; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Rivera A, 2013, BLOOD CELL MOL DIS, V50, P80, DOI 10.1016/j.bcmd.2012.10.002; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Sandilos JK, 2012, J BIOL CHEM, V287, P11303, DOI 10.1074/jbc.M111.323378; Shiraishi T, 2004, BIOCHEM BIOPH RES CO, V322, P197, DOI 10.1016/j.bbrc.2004.07.098; Stanfield GM, 2000, MOL CELL, V5, P423, DOI 10.1016/S1097-2765(00)80437-2; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Toda S, 2012, MOL CELL BIOL, V32, P118, DOI 10.1128/MCB.05993-11; TUCKER KA, 1987, BLOOD, V70, P372; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; van Meer G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004671; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Yamaguchi H, 2014, ELIFE, V3, DOI 10.7554/eLife.02172; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003	49	88	91	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30257	30267		10.1074/jbc.M114.583419	http://dx.doi.org/10.1074/jbc.M114.583419			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25231987	Green Published, hybrid			2022-12-25	WOS:000344549700010
J	Bean, WT; Stafford, R; Butterfield, HS; Brashares, JS				Bean, William T.; Stafford, Robert; Butterfield, H. Scott; Brashares, Justin S.			A Multi-Scale Distribution Model for Non-Equilibrium Populations Suggests Resource Limitation in an Endangered Rodent	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; SELECTING THRESHOLDS; HABITAT QUALITY; CLIMATE; NICHE; PREDICTION; NDVI; ACCURACY; FORAGE; SHIFTS	Species distributions are known to be limited by biotic and abiotic factors at multiple temporal and spatial scales. Species distribution models, however, frequently assume a population at equilibrium in both time and space. Studies of habitat selection have repeatedly shown the difficulty of estimating resource selection if the scale or extent of analysis is incorrect. Here, we present a multi-step approach to estimate the realized and potential distribution of the endangered giant kangaroo rat. First, we estimate the potential distribution by modeling suitability at a range-wide scale using static bioclimatic variables. We then examine annual changes in extent at a population-level. We define "available'' habitat based on the total suitable potential distribution at the range-wide scale. Then, within the available habitat, model changes in population extent driven by multiple measures of resource availability. By modeling distributions for a population with robust estimates of population extent through time, and ecologically relevant predictor variables, we improved the predictive ability of SDMs, as well as revealed an unanticipated relationship between population extent and precipitation at multiple scales. At a range-wide scale, the best model indicated the giant kangaroo rat was limited to areas that received little to no precipitation in the summer months. In contrast, the best model for shorter time scales showed a positive relation with resource abundance, driven by precipitation, in the current and previous year. These results suggest that the distribution of the giant kangaroo rat was limited to the wettest parts of the drier areas within the study region. This multi-step approach reinforces the differing relationship species may have with environmental variables at different scales, provides a novel method for defining "available'' habitat in habitat selection studies, and suggests a way to create distribution models at spatial and temporal scales relevant to theoretical and applied ecologists.	[Bean, William T.] Humboldt State Univ, Arcata, CA 95521 USA; [Stafford, Robert] Calif Dept Fish & Game, Los Osos, CA USA; [Butterfield, H. Scott] Nature Conservancy, San Francisco, CA USA; [Brashares, Justin S.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	California State University System; California State Polytechnic University, Humboldt; Nature Conservancy; University of California System; University of California Berkeley	Bean, WT (corresponding author), Humboldt State Univ, Arcata, CA 95521 USA.	bean@humboldt.edu			Nature Conservancy; U.S. Department of Agriculture; Bureau of Land Management; California Department of Fish and Game; A. Starker Leopold Wildlife Graduate Student Fund	Nature Conservancy; U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Bureau of Land Management; California Department of Fish and Game; A. Starker Leopold Wildlife Graduate Student Fund	Funding was provided by The Nature Conservancy, U.S. Department of Agriculture, Bureau of Land Management, California Department of Fish and Game, and the A. Starker Leopold Wildlife Graduate Student Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson BJ, 2009, BIOL CONSERV, V142, P488, DOI 10.1016/j.biocon.2008.10.036; Andreo V, 2009, POPULATION DYNAMICS; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Basille M, 2013, ECOGRAPHY, V36, P220, DOI 10.1111/j.1600-0587.2011.07367.x; Bean WT, 2014, J APPL ECOL, V51, P1116, DOI 10.1111/1365-2664.12281; Bean WT, 2012, WILDLIFE SOC B, V36, P587, DOI 10.1002/wsb.171; Bean WT, 2012, ECOGRAPHY, V35, P250, DOI 10.1111/j.1600-0587.2011.06545.x; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Bissonette J. A., 2007, TEMPORAL DIMENSIONS; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Butterfield HS, 2009, INT J REMOTE SENS, V30, P3133, DOI 10.1080/01431160802558774; Cao L, 2011, GLOBAL ECOL BIOGEOGR, V20, P620, DOI 10.1111/j.1466-8238.2010.00630.x; Carroll ML, 250M MODIS NORMALIZE; Falcucci A, 2009, J APPL ECOL, V46, P600, DOI 10.1111/j.1365-2664.2009.01634.x; Fernandez-Gimenez ME, 1999, J APPL ECOL, V36, P871, DOI 10.1046/j.1365-2664.1999.00447.x; Franklin J, 2013, DIVERS DISTRIB, V19, P1217, DOI 10.1111/ddi.12125; Franklin J, 2010, DIVERS DISTRIB, V16, P321, DOI 10.1111/j.1472-4642.2010.00641.x; Freeman EA, 2008, J STAT SOFTWARE, V23; Fryxell JM, 2004, ECOLOGY, V85, P2429, DOI 10.1890/04-0147; Garshelis DL, 2000, METH C CONS, P111; Germano DJ, 2012, J WILDLIFE MANAGE, V76, P670, DOI 10.1002/jwmg.316; Goldingay RL, 1997, KANGAROO RATS CALIFO, V3, P47; Grinnell J, 1917, AM NAT, V51, P115, DOI 10.1086/279591; GRINNELL JOSEPH, 1932, JOUR MAMMALOGY, V13, P305, DOI 10.2307/1374134; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hamel S, 2009, J APPL ECOL, V46, P582, DOI 10.1111/j.1365-2664.2009.01643.x; Hanski I., 1999, METAPOPULATION ECOLO; Hawbecker A. C., 1944, JOUR OF WILDLIFE MANAGEMENT, V8, P161, DOI 10.2307/3796448; Hijmans R.J., PACKAGE DISMO; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Hutchinson G.E., 1957, COLD SPRING HARBOR S; Ito TY, 2006, J ZOOL, V269, P291, DOI 10.1111/j.1469-7998.2006.00077.x; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kawamura K, 2005, INT J REMOTE SENS, V26, P1423, DOI 10.1080/01431160512331326783; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Mueller T, 2008, J APPL ECOL, V45, P649, DOI 10.1111/j.1365-2664.2007.01371.x; Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pettorelli N, 2013, NORMALIZED DIFFERENCE VEGETATION INDEX, P1, DOI 10.1093/acprof:osobl/9780199693160.001.0001; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Prugh LR, 2012, J ANIM ECOL, V81, P667, DOI 10.1111/j.1365-2656.2011.01930.x; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; R Core Team, 2012, R LANG ENV STAT COMP; Rushton SP, 2004, J APPL ECOL, V41, P193, DOI 10.1111/j.0021-8901.2004.00903.x; Ryan SJ, 2006, J WILDLIFE MANAGE, V70, P764, DOI 10.2193/0022-541X(2006)70[764:RAHSOA]2.0.CO;2; SHAW WILLIAM T., 1934, JOUR MAMMAL, V15, P275, DOI 10.2307/1374514; Soberon J, 2005, BIODIVERSITY INFORM; Soil Survey Staff Natural Resources Conservation Service United States Department of Agriculture, 2012, SOIL SURV GEOG SSURG; Steiner FM, 2008, DIVERS DISTRIB, V14, P538, DOI 10.1111/j.1472-4642.2008.00472.x; Suarez-Seoane S, 2008, ECOL MODEL, V219, P17, DOI 10.1016/j.ecolmodel.2008.07.035; Thomas DL, 2006, J WILDLIFE MANAGE, V70, P324, DOI 10.2193/0022-541X(2006)70[324:SDATFC]2.0.CO;2; US Geological Survey, SHUTTL RAD TOP MISS; Vina A, 2008, REMOTE SENS ENVIRON, V112, P2160, DOI 10.1016/j.rse.2007.09.012; WIENS JA, 1987, OIKOS, V48, P132, DOI 10.2307/3565849; WILLIAMS D F, 1991, Mammalian Species, P1; Williams D. F., 1992, ENDANGERED SENSITIVE, P301, DOI DOI 10.1111/J.1365-2656.2011.01930.X/FULL	66	8	8	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e106638	10.1371/journal.pone.0106638	http://dx.doi.org/10.1371/journal.pone.0106638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25237807	gold, Green Published, Green Submitted			2022-12-25	WOS:000342491600011
J	Fan, X; Wang, XS; Li, N; Cui, HL; Hou, BD; Gao, B; Cleary, PP; Wang, BN				Fan, Xin; Wang, Xiaoshuang; Li, Ning; Cui, Honglian; Hou, Baidong; Gao, Bin; Cleary, Paul Patrick; Wang, Beinan			Sortase A Induces Th17-Mediated and Antibody-Independent Immunity to Heterologous Serotypes of Group A Streptococci	PLOS ONE			English	Article							UPPER RESPIRATORY-TRACT; M PROTEIN VACCINE; SURFACE-PROTEINS; STAPHYLOCOCCUS-AUREUS; TH17 CELLS; PYOGENES; PROTECTION; CHALLENGE; INFECTION; COLONIZATION	Group A streptococci (GAS) are associated with a variety of mucosal and invasive human infections. Recurrent infections by highly heterologous serotypes indicate that cross-serotype immunity is critical for prevention of GAS infections; however, mechanisms underlying serotype-independent protection are poorly understood. Here we report that intranasal vaccination of mice with Sortase A (SrtA), a conserved cell wall bound protein, reduced colonization of nasal-associated lymphoid tissue (NALT) by heterologous serotypes of GAS. Vaccination significantly increased CD4(+) IL-17A(+) cells in NALT and depletion of IL-17A by neutralizing antibody prevented GAS clearance from NALT which was dependent on immunization with SrtA. Vaccination also induced high levels of SrtA-specific antibodies; however, immunized, B cell-deficient mice cleared streptococcal challenges as efficiently as wild type mice, indicating that the cross-serotype protection is Th17-biased and antibody-independent. Furthermore, efficient GAS clearance from NALT was associated with a rapid neutrophil influx into NALT of immunized mice. These results suggest that serotype independent immune protection against GAS mucosal infection can be achieved by intranasal vaccination with SrtA and enhanced neutrophil function is critical for anti-GAS defense and might be a target for prevention of GAS infections.	[Fan, Xin; Wang, Xiaoshuang; Li, Ning; Cui, Honglian; Gao, Bin; Wang, Beinan] Acad Sinica, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Hou, Baidong] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China; [Cleary, Paul Patrick] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Minnesota System; University of Minnesota Twin Cities	Wang, BN (corresponding author), Acad Sinica, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	wangbn@im.ac.cn		Wang, Beinan/0000-0002-9260-7197	National Natural Science Foundation of China Grant [31170845]	National Natural Science Foundation of China Grant(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China Grant 31170845 to BW (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashbaugh CD, 2000, CELL MICROBIOL, V2, P283, DOI 10.1046/j.1462-5822.2000.00050.x; Barnett TC, 2004, J BACTERIOL, V186, P5865, DOI 10.1128/JB.186.17.5865-5875.2004; Barnett TC, 2002, J BACTERIOL, V184, P2181, DOI 10.1128/JB.184.8.2181-2191.2002; Basset A, 2007, INFECT IMMUN, V75, P5460, DOI 10.1128/IAI.00773-07; Chen K, 2011, IMMUNITY, V35, P997, DOI 10.1016/j.immuni.2011.10.018; Cossart P, 2000, P NATL ACAD SCI USA, V97, P5013, DOI 10.1073/pnas.97.10.5013; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dileepan T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002252; FOX EN, 1973, J CLIN INVEST, V52, P1885, DOI 10.1172/JCI107372; Garandeau C, 2002, INFECT IMMUN, V70, P1382, DOI 10.1128/IAI.70.3.1382-1390.2002; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; GUIRGUIS N, 1982, AM J EPIDEMIOL, V116, P933, DOI 10.1093/oxfordjournals.aje.a113495; Hyland KA, 2009, FEMS IMMUNOL MED MIC, V55, P422, DOI 10.1111/j.1574-695X.2009.00540.x; Kang H, 2000, J IMMUNOL, V164, P2629, DOI 10.4049/jimmunol.164.5.2629; KAPLAN EL, 1992, B WORLD HEALTH ORGAN, V70, P433; Kharat AS, 2003, INFECT IMMUN, V71, P2758, DOI 10.1128/IAI.71.5.2758-2765.2003; Kwinn LA, 2007, FUTURE MICROBIOL, V2, P75, DOI 10.2217/17460913.2.1.75; Lee JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005190; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Luk EYY, 2012, EMERG INFECT DIS, V18, P1658, DOI 10.3201/eid1810.111900; MASSELL BF, 1969, J AMER MED ASSOC, V207, P1115, DOI 10.1001/jama.207.6.1115; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; Misstear K, 2014, J INFECT DIS, V209, P1479, DOI 10.1093/infdis/jit636; Movert E, 2011, J IMMUNOL, V187, P6437, DOI 10.4049/jimmunol.1100499; Park HS, 2003, J IMMUNOL, V171, P2532, DOI 10.4049/jimmunol.171.5.2532; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; POLLY SM, 1975, J INFECT DIS, V131, P217, DOI 10.1093/infdis/131.3.217; QUINN RW, 1985, PEDIATR INFECT DIS J, V4, P374, DOI 10.1097/00006454-198507000-00008; Race PR, 2009, J BIOL CHEM, V284, P6924, DOI 10.1074/jbc.M805406200; Raz A, 2008, P NATL ACAD SCI USA, V105, P18549, DOI 10.1073/pnas.0808301105; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; Suvorov AN, 2009, FEMS MICROBIOL LETT, V294, P9, DOI 10.1111/j.1574-6968.2009.01538.x; Wang BN, 2010, P NATL ACAD SCI USA, V107, P5937, DOI 10.1073/pnas.0904831107; Wang CJ, 2009, ARCH MICROBIOL, V191, P23, DOI 10.1007/s00203-008-0425-z; WANNAMAKER LW, 1953, AMA AM J DIS CHILD, V86, P347; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612	36	21	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107638	10.1371/journal.pone.0107638	http://dx.doi.org/10.1371/journal.pone.0107638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232948	Green Published, Green Submitted, gold			2022-12-25	WOS:000342921200038
J	Ayala, E; Downey, JS; Mashburn-Warren, L; Senadheera, DB; Cvitkovitch, DG; Goodman, SD				Ayala, Eduardo; Downey, Jennifer S.; Mashburn-Warren, Lauren; Senadheera, Dilani B.; Cvitkovitch, Dennis G.; Goodman, Steven D.			A Biochemical Characterization of the DNA Binding Activity of the Response Regulator VicR from Streptococcus mutans	PLOS ONE			English	Article							YYCG/YYCF 2-COMPONENT SYSTEM; BIOFILM FORMATION; GENETIC COMPETENCE; SEQUENCE-ANALYSIS; PROTEIN; PHOSPHORYLATION; TRANSCRIPTION; EXPRESSION; PROMOTER; IDENTIFICATION	Two-component systems (TCSs) are ubiquitous among bacteria and are among the most elegant and effective sensing systems in nature. They allow for efficient adaptive responses to rapidly changing environmental conditions. In this study, we investigated the biochemical characteristics of the Streptococcus mutans protein VicR, an essential response regulator that is part of the VicRK TCS. We dissected the DNA binding requirements of the recognition sequences for VicR in its phosphorylated and unphosphorylated forms. In doing so, we were able to make predictions for the expansion of the VicR regulon within S. mutans. With the ever increasing number of bacteria that are rapidly becoming resistant to even the antibiotics of last resort, TCSs such as the VicRK provide promising targets for a new class of antimicrobials.	[Ayala, Eduardo; Downey, Jennifer S.; Goodman, Steven D.] Univ So Calif, Dept Mol & Computat Biol, Div Biomed Sci, Herman Ostrow Sch Dent, Los Angeles, CA 90045 USA; [Mashburn-Warren, Lauren; Goodman, Steven D.] Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH USA; [Senadheera, Dilani B.; Cvitkovitch, Dennis G.] Univ Toronto, Fac Dent, Dent Res Inst, Toronto, ON, Canada	University of Southern California; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Toronto	Goodman, SD (corresponding author), Univ So Calif, Dept Mol & Computat Biol, Div Biomed Sci, Herman Ostrow Sch Dent, Los Angeles, CA 90045 USA.	steven.goodman@nationwidechildrens.org	Goodman, Steven/C-5732-2013; Cvitkovitch, Dennis/AAF-9311-2020		NIH [5R01DE014711-09, 5R01DE013230-11]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013230] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH grants 5R01DE014711-09 (to S.D.G.) and 5R01DE013230-11 to (D.G.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2007, J BACTERIOL, V189, P6293, DOI 10.1128/JB.00546-07; BALDUS JM, 1994, J BACTERIOL, V176, P296, DOI 10.1128/JB.176.2.296-306.1994; Barbas III C.F., 2007, CSH PROTOC, V2007; Barbieri CM, 2013, J MOL BIOL; Bisicchia P, 2007, MOL MICROBIOL, V65, P180, DOI 10.1111/j.1365-2958.2007.05782.x; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Burne RA, 1999, J BACTERIOL, V181, P2863, DOI 10.1128/JB.181.9.2863-2871.1999; BUSBY S, 1994, CELL, V79, P743, DOI 10.1016/0092-8674(94)90063-9; Casino P, 2010, CURR OPIN STRUC BIOL, V20, P763, DOI 10.1016/j.sbi.2010.09.010; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; Chong P, 2008, J BACTERIOL, V190, P4478, DOI 10.1128/JB.01961-07; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deng DM, 2007, J DENT RES, V86, P606, DOI 10.1177/154405910708600705; Dubrac S, 2004, J BACTERIOL, V186, P1175, DOI 10.1128/JB.186.4.1175-1181.2004; Dubrac S, 2008, MOL MICROBIOL, V70, P1307, DOI 10.1111/j.1365-2958.2008.06483.x; Dunning DW, 2008, MICROBIOL-SGM, V154, P1132, DOI 10.1099/mic.0.2007/012492-0; Duque C, 2011, INFECT IMMUN, V79, P786, DOI 10.1128/IAI.00725-10; Eguchi Y, 2011, ANTIMICROB AGENTS CH, V55, P1475, DOI 10.1128/AAC.01646-10; FERRETTI JJ, 1989, MOL MICROBIOL, V3, P469, DOI 10.1111/j.1365-2958.1989.tb00193.x; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gotoh Y, 2010, J ANTIBIOT, V63, P127, DOI 10.1038/ja.2010.4; Gusa AA, 2006, J BACTERIOL, V188, P4620, DOI 10.1128/JB.00198-06; GUSTKE N, 1992, FEBS LETT, V307, P199, DOI 10.1016/0014-5793(92)80767-B; Head CG, 1998, J MOL BIOL, V281, P857, DOI 10.1006/jmbi.1998.1985; Hoch JA, 1995, 2 COMPONENT SIGNAL T; Howell A, 2003, MOL MICROBIOL, V49, P1639, DOI 10.1046/j.1365-2958.2003.03661.x; Hung DCI, 2012, J BACTERIOL, V194, P1127, DOI 10.1128/JB.06565-11; Kovacs KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200; Krastel K, 2010, J BACTERIOL, V192, P984, DOI 10.1128/JB.01169-09; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Mack TR, 2009, J MOL BIOL, V389, P349, DOI 10.1016/j.jmb.2009.04.014; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; MartinezHackert E, 1997, J MOL BIOL, V269, P301, DOI 10.1006/jmbi.1997.1065; Mattos-Graner RO, 2001, INFECT IMMUN, V69, P6931, DOI 10.1128/IAI.69.11.6931-6941.2001; Molle V, 2003, MOL MICROBIOL, V50, P1683, DOI 10.1046/j.1365-2958.2003.03818.x; Narayanan A, 2012, PLOS ONE; Okada A, 2010, J ANTIBIOT, V63, P89, DOI 10.1038/ja.2009.128; Qin Z, 2006, BMC MICROBIOL ENGLAN, V96; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Seaton K, 2011, J BACTERIOL, V193, P862, DOI 10.1128/JB.01257-10; Senadheera D, 2009, J BACTERIOL, V191, P6415, DOI 10.1128/JB.00793-09; Senadheera DB, 2012, J BACTERIOL, V194, P1307, DOI 10.1128/JB.06071-11; Senadheera MD, 2007, J BACTERIOL, V189, P1451, DOI 10.1128/JB.01161-06; Senadheera MD, 2005, J BACTERIOL, V187, P4064, DOI 10.1128/JB.187.12.4064-4076.2005; Seredick SD, 2007, J MOL BIOL, V366, P19, DOI 10.1016/j.jmb.2006.11.010; SMORAWINSKA M, 1995, ORAL MICROBIOL IMMUN, V10, P188, DOI 10.1111/j.1399-302X.1995.tb00141.x; Stipp RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058271; UEDA S, 1988, MOL MICROBIOL, V2, P135, DOI 10.1111/j.1365-2958.1988.tb00014.x; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; Vats N, 2001, MICROBIOL-UK, V147, P653, DOI 10.1099/00221287-147-3-653; Wagner C, 2002, INFECT IMMUN, V70, P6121, DOI 10.1128/IAI.70.11.6121-6128.2002; Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493; WEGENER AD, 1984, J BIOL CHEM, V259, P1834	55	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e108027	10.1371/journal.pone.0108027	http://dx.doi.org/10.1371/journal.pone.0108027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229632	Green Submitted, Green Published, gold			2022-12-25	WOS:000342123900091
J	Hu, J; He, X; Yu, DJ; Yang, XB; Yang, JY; Shen, HB				Hu, Jun; He, Xue; Yu, Dong-Jun; Yang, Xi-Bei; Yang, Jing-Yu; Shen, Hong-Bin			A New Supervised Over-Sampling Algorithm with Application to Protein-Nucleotide Binding Residue Prediction	PLOS ONE			English	Article							ATP-BINDING; INTRINSIC DISORDER; SITES; SEQUENCE; CLASSIFIER; ENSEMBLE; DISCRIMINATION; IDENTIFICATION; RECOGNITION; MACHINES	Protein-nucleotide interactions are ubiquitous in a wide variety of biological processes. Accurately identifying interaction residues solely from protein sequences is useful for both protein function annotation and drug design, especially in the post-genomic era, as large volumes of protein data have not been functionally annotated. Protein-nucleotide binding residue prediction is a typical imbalanced learning problem, where binding residues are extremely fewer in number than non-binding residues. Alleviating the severity of class imbalance has been demonstrated to be a promising means of improving the prediction performance of a machine-learning-based predictor for class imbalance problems. However, little attention has been paid to the negative impact of class imbalance on protein-nucleotide binding residue prediction. In this study, we propose a new supervised over-sampling algorithm that synthesizes additional minority class samples to address class imbalance. The experimental results from protein-nucleotide interaction datasets demonstrate that the proposed supervised over-sampling algorithm can relieve the severity of class imbalance and help to improve prediction performance. Based on the proposed over-sampling algorithm, a predictor, called TargetSOS, is implemented for protein-nucleotide binding residue prediction. Cross-validation tests and independent validation tests demonstrate the effectiveness of TargetSOS. The web-server and datasets used in this study are freely available at http://www.csbio.sjtu.edu.cn/bioinf/TargetSOS/.	[Hu, Jun; He, Xue; Yu, Dong-Jun; Yang, Xi-Bei; Yang, Jing-Yu] Nanjing Univ Sci & Technol, Sch Comp Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Shen, Hong-Bin] Shanghai Jiao Tong Univ, Inst Image Proc & Pattern Recognit, Shanghai 200030, Peoples R China; [Yu, Dong-Jun] Nanjing Univ Sci & Technol, Changshu Inst, Changshu, Jiangsu, Peoples R China; [Yang, Xi-Bei] Jiangsu Univ Sci & Technol, Sch Comp Sci & Engn, Zhenjiang, Jiangsu, Peoples R China	Nanjing University of Science & Technology; Shanghai Jiao Tong University; Nanjing University of Science & Technology; Jiangsu University of Science & Technology	Yu, DJ (corresponding author), Nanjing Univ Sci & Technol, Sch Comp Sci & Engn, Nanjing, Jiangsu, Peoples R China.	njyudj@njust.edu.cn; hbshen@sjtu.edu.cn		Hu, Jun/0000-0001-9202-7515	National Natural Science Foundation of China [61373062, 61222306, 61175024, 91130033, 61100116, 61233011]; Natural Science Foundation of Jiangsu [BK20141403]; "The Six Top Talents" of Jiangsu Province [2013-XXRJ-022]; Fundamental Research Funds for the Central Universities [30920130111010]; China Postdoctoral Science Foundation [2013M530260, 2014T70526]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu(Natural Science Foundation of Jiangsu Province); "The Six Top Talents" of Jiangsu Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	DJY was supported by: The National Natural Science Foundation of China (No. 61373062, http://isisn.nsfc.gov.cn/egrantweb/); The Natural Science Foundation of Jiangsu (No. BK20141403, http://www.jstd.gov.cn/); "The Six Top Talents" of Jiangsu Province (No. 2013-XXRJ-022, http://www.jshrss.gov.cn); the Fundamental Research Funds for the Central Universities (No. 30920130111010, http://www.moe.edu.cn/); and China Postdoctoral Science Foundation (No. 2013M530260, 2014T70526, http://www.jshrss.gov.cn). HBS was supported by: The National Natural Science Foundation of China (No. 61222306, 61175024, and 91130033, http://isisn.nsfc.gov.cn/egrantweb/). XBY was supported by: The National Natural Science Foundation of China (No. 61100116, http://isisn.nsfc.gov.cn/egrantweb/). JYY: The National Natural Science Foundation of China (No. 61233011, http://isisn.nsfc.gov.cn/egrantweb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2008, MOL BIOL CELL, P1569; Boulesteix AL, 2010, BIOINFORMATICS, V26, P437, DOI 10.1093/bioinformatics/btp648; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Chauhan JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-301; Chauhan JS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-434; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen K, 2012, BIOINFORMATICS, V28, P331, DOI 10.1093/bioinformatics/btr657; Chen K, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S4; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Ertekin S, 2007, P 30 ANN INT ACM SIG, P823, DOI DOI 10.1145/1277741.1277927; Ertelcin S., 2007, P 16 ACM C INF KNOWL, P127, DOI DOI 10.1145/1321440.1321461; Estabrooks A, 2004, COMPUT INTELL-US, V20, P18, DOI 10.1111/j.0824-7935.2004.t01-1-00228.x; Fan RE, 2005, J MACH LEARN RES, V6, P1889; Firoz A, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-20; Gao M, 2012, P NATL ACAD SCI USA, V109, P3784, DOI 10.1073/pnas.1117768109; Gromiha MM, 2012, CURR BIOINFORM, V7, P173; Gromiha MM, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S13; Gromiha MM, 2011, J CHEM INF MODEL, V51, P721, DOI 10.1021/ci1003703; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; He HB, 2008, IEEE IJCNN, P1322, DOI 10.1109/IJCNN.2008.4633969; Hirokawa N, 2003, TRENDS BIOCHEM SCI, V28, P558, DOI 10.1016/j.tibs.2003.08.006; Hong X, 2007, IEEE T NEURAL NETWOR, V18, P28, DOI 10.1109/TNN.2006.882812; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kang PS, 2006, LECT NOTES COMPUT SC, V4232, P837; Kokubo H, 2011, J COMPUT CHEM, V32, P2810, DOI 10.1002/jcc.21860; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Laurikkala J, 2001, LECT NOTES ARTIF INT, V2101, P63, DOI 10.1007/3-540-48229-6_9; Leis S, 2010, CURR MED CHEM, V17, P1550, DOI 10.2174/092986710790979944; Mao LS, 2004, J MOL BIOL, V336, P787, DOI 10.1016/j.jmb.2003.12.056; Maxwell A, 2003, CURR TOP MED CHEM, V3, P283, DOI 10.2174/1568026033452500; Mease D, 2007, J MACH LEARN RES, V8, P409; Moodie SL, 1996, J MOL BIOL, V263, P486, DOI 10.1006/jmbi.1996.0591; Nobeli I, 2001, NUCLEIC ACIDS RES, V29, P4294, DOI 10.1093/nar/29.21.4294; Peng Z, 2013, CELL DEATH DIFFER, V20, P1257, DOI 10.1038/cdd.2013.65; Peng ZL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094331; Peng ZL, 2012, MOL BIOSYST, V8, P1886, DOI 10.1039/c2mb25102g; Saito M, 2006, PROTEIN ENG DES SEL, V19, P67, DOI 10.1093/protein/gzj002; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schmidtke P, 2010, J MED CHEM, V53, P5858, DOI 10.1021/jm100574m; Soto-Liebe K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055664; Stamm M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057731; Ting KM, 2002, IEEE T KNOWL DATA EN, V14, P659, DOI 10.1109/TKDE.2002.1000348; Vapnik V., 1998, STAT LEARNING THEORY; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang BX, 2010, KNOWL INF SYST, V25, P1, DOI 10.1007/s10115-009-0198-y; Wu G, 2005, IEEE T KNOWL DATA EN, V17, P786, DOI 10.1109/TKDE.2005.95; Yan J, 2014, J BIOMOL STRUCT DYN, V32, P36, DOI 10.1080/07391102.2012.746945; Yang J, 2013, BIOINFORMATICS; Yang JY, 2013, BIOINFORMATICS, V29, P2588, DOI 10.1093/bioinformatics/btt447; You ZH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S8-S10; You ZH, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON CONTROL SYSTEM, COMPUTING AND ENGINEERING (ICCSCE 2012), P210, DOI 10.1109/ICCSCE.2012.6487143; Yu DJ, 2013, IEEE ACM T COMPUT BI, V10, P994, DOI 10.1109/TCBB.2013.104; Yu DJ, 2013, NEUROCOMPUTING, V104, P180, DOI 10.1016/j.neucom.2012.10.012; Yu DJ, 2013, J COMPUT CHEM, V34, P974, DOI 10.1002/jcc.23219; Yu DJ, 2012, AMINO ACIDS, V42, P2195, DOI 10.1007/s00726-011-0959-2; Yu DJ, 2011, IEEE T NANOBIOSCI, V10, P121, DOI 10.1109/TNB.2011.2160730; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou ZH, 2010, COMPUT INTELL-US, V26, P232, DOI 10.1111/j.1467-8640.2010.00358.x	58	25	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107676	10.1371/journal.pone.0107676	http://dx.doi.org/10.1371/journal.pone.0107676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229688	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900058
J	Lin, HC; Lin, TH; Wu, MY; Chiu, YC; Tang, CH; Hour, MJ; Liou, HC; Tu, HJ; Yang, RS; Fu, WM				Lin, Han-Ching; Lin, Tzu-Hung; Wu, Ming-Yueh; Chiu, Yung-Cheng; Tang, Chih-Hsin; Hour, Mann-Jen; Liou, Houng-Chi; Tu, Huang-Ju; Yang, Rong-Sen; Fu, Wen-Mei			5-Lipoxygenase Inhibitors Attenuate TNF-alpha-Induced Inflammation in Human Synovial Fibroblasts	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; MONOCYTE CHEMOATTRACTANT PROTEIN-1; NF-KAPPA-B; RHEUMATOID-ARTHRITIS; LEUKOTRIENE B-4; EXPRESSION; RECEPTOR; CELLS; PHOSPHOLIPASE-A2; OSTEOARTHRITIS	The lipoxygenase isoform of 5-lipoxygenase (5-LOX) is reported to be overexpressed in human rheumatoid arthritis synovial tissue and involved in the progress of inflammatory arthritis. However, the detailed mechanism of how 5-lipoxygenase regulates the inflammatory response in arthritis synovial tissue is still unclear. The aim of this study was to investigate the involvement of lipoxygenase pathways in TNF-alpha-induced production of cytokines and chemokines. Human synovial fibroblasts from rheumatoid patients were used in this study. 5-LOX inhibitors and shRNA were used to examine the involvement of 5-LOX in TNF-alpha-induced cytokines and chemokines expression. The signaling pathways were examined by Western Blotting or immunofluorescence staining. The effect of 5-LOX inhibitor on TNF-alpha-induced chemokine expression and paw edema was also explored in vivo in C57BL/6 mice. Treatment with 5-LOX inhibitors significantly decreased TNF-alpha-induced pro-inflammatory mediators including interleukin-6 (IL-6) and monocyte chemo-attractant protein-1 (MCP-1) in human synovial fibroblasts. Knockdown of 5-LOX using shRNA exerted similar inhibitory effects. The abrogation of NF-kappa B activation was involved in the antagonizing effects of these inhibitors. Furthermore, 5-LOX inhibitor decreased TNF-alpha-induced up-regulation of serum MCP-1 level and paw edema in mouse model. Our results provide the evidence that the administration of 5-LOX inhibitors is able to ameliorate TNF-alpha-induced cytokine/chemokine release and paw edema, indicating that 5-LOX inhibitors may be developed for therapeutic treatment of inflammatory arthritis.	[Lin, Han-Ching; Lin, Tzu-Hung; Wu, Ming-Yueh; Liou, Houng-Chi; Tu, Huang-Ju; Fu, Wen-Mei] Natl Taiwan Univ & Hosp, Coll Med, Dept Pharmacol, Taipei, Taiwan; [Chiu, Yung-Cheng] Taichung Vet Gen Hosp, Dept Orthopaed, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Coll Med, Dept Pharmacol, Taichung, Taiwan; [Hour, Mann-Jen] China Med Univ, Coll Med, Sch Pharm, Taichung, Taiwan; [Yang, Rong-Sen] Natl Taiwan Univ & Hosp, Coll Med, Dept Orthoped, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Taiwan; National Taiwan University; National Taiwan University Hospital	Yang, RS (corresponding author), Natl Taiwan Univ & Hosp, Coll Med, Dept Orthoped, Taipei, Taiwan.	rsyang@ntuh.gov.tw; wenmei@ntu.edu.tw	Tang, Chih Hsin/O-5212-2015	Tang, Chih Hsin/0000-0002-7113-8352; Yang, Rong-Sen/0000-0002-0553-4779; FU, WEN-MEI/0000-0003-4157-8987	National Science Council (NSC) [102-2314-B-002-045-MY3]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	The work was supported by a grant from National Science Council (NSC 102-2314-B-002-045-MY3). RNAi reagents were obtained from the National RNAi Core Facility located at the Institute of Molecular Biology/Genomic Research Center, Academia Sinica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles AM, 2006, ARTHRITIS RHEUM-US, V54, P393, DOI 10.1002/art.21521; AHMADZADEH N, 1991, INFLAMMATION, V15, P497, DOI 10.1007/BF00923346; Anderson GD, 2009, INFLAMM RES, V58, P109, DOI 10.1007/s00011-009-8149-3; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; BOMALASKI JS, 1993, ARTHRITIS RHEUM-US, V36, P190, DOI 10.1002/art.1780360208; Bondeson J, 2007, J RHEUMATOL, V34, P523; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Brune K, 2004, RHEUMATOLOGY, V43, pI16, DOI 10.1093/rheumatology/keh104; Cakmak H, 2012, REPROD SCI, V19, P572, DOI 10.1177/1933719111430998; Canetti C, 2001, BRIT J PHARMACOL, V134, P1619, DOI 10.1038/sj.bjp.0704403; Chen M, 2006, J EXP MED, V203, P837, DOI 10.1084/jem.20052371; DAVIDSON EM, 1983, ANN RHEUM DIS, V42, P677, DOI 10.1136/ard.42.6.677; Di Gennaro A, 2012, ADV IMMUNOL, V116, P51, DOI 10.1016/B978-0-12-394300-2.00002-8; Dixon WG, 2010, ANN RHEUM DIS, V69, P522, DOI 10.1136/ard.2009.118935; Folco EJ, 2011, J AM COLL CARDIOL, V58, P603, DOI 10.1016/j.jacc.2011.03.044; Gheorghe KR, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2717; GILMAN SC, 1988, ARTHRITIS RHEUM, V31, P127, DOI 10.1002/art.1780310118; Gilston Vanessa, 1997, Biochemical Society Transactions, V25, p518S; Gursel T, 1997, PROSTAG LEUKOTR ESS, V56, P205, DOI 10.1016/S0952-3278(97)90535-4; Haringman JJ, 2006, ANN RHEUM DIS, V65, P294, DOI 10.1136/ard.2005.037176; Hashimoto A, 2007, BIOMED PHARMACOTHER, V61, P81, DOI 10.1016/j.biopha.2006.06.023; Kanda N, 2007, CLIN EXP ALLERGY, V37, P1074, DOI 10.1111/j.1365-2222.2007.02743.x; Kim SY, 2008, EXP MOL MED, V40, P461, DOI 10.3858/emm.2008.40.4.461; KOCH AE, 1992, J CLIN INVEST, V90, P772, DOI 10.1172/JCI115950; Kunisch E, 2012, INT J MOL MED, V29, P530, DOI 10.3892/ijmm.2012.883; Kunisch E, 2009, J IMMUNOL, V183, P1328, DOI 10.4049/jimmunol.0900801; Lee SJ, 2013, CARDIOVASC RES, V99, P724, DOI 10.1093/cvr/cvt135; Leone S, 2007, CURR TOP MED CHEM, V7, P265, DOI 10.2174/156802607779941341; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; Lin TH, 2011, J CELL PHYSIOL, V226, P3242, DOI 10.1002/jcp.22685; Martel-Pelletier J, 2003, ANN RHEUM DIS, V62, P501, DOI 10.1136/ard.62.6.501; Masferrer JL, 2010, J PHARMACOL EXP THER, V334, P294, DOI 10.1124/jpet.110.166967; Mathis S, 2007, AUTOIMMUN REV, V7, P12, DOI 10.1016/j.autrev.2007.03.005; Miller TA, 2000, BIOORG MED CHEM LETT, V10, P1913, DOI 10.1016/S0960-894X(00)00370-X; Muller-Ladner U, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2337; Neumann E, 2010, TRENDS MOL MED, V16, P458, DOI 10.1016/j.molmed.2010.07.004; Noss EH, 2008, IMMUNOL REV, V223, P252, DOI 10.1111/j.1600-065X.2008.00648.x; Park JY, 2007, BULL HOSP JT DIS, V65, pS4; Patel NSA, 2004, MOL PHARMACOL, V66, P220, DOI 10.1124/mol.66.2.220; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Philippe L, 2012, J IMMUNOL, V188, P454, DOI 10.4049/jimmunol.1102348; Powell WS, 2005, PROG LIPID RES, V44, P154, DOI 10.1016/j.plipres.2005.04.002; PRUZANSKI W, 1985, J RHEUMATOL, V12, P211; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Sanchez-Galan E, 2009, CARDIOVASC RES, V81, P216, DOI 10.1093/cvr/cvn277; Serezani CH, 2011, J CLIN INVEST, V121, P671, DOI 10.1172/JCI43302; Strangfeld A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2904; Tang CH, 2007, J IMMUNOL, V179, P5483, DOI 10.4049/jimmunol.179.8.5483; Tu XK, 2010, INFLAMMATION, V33, P344, DOI 10.1007/s10753-010-9191-6; VILLIGER PM, 1992, J IMMUNOL, V149, P722; Xu SH, 2010, RHEUMATOL INT, V30, P1183, DOI 10.1007/s00296-009-1125-y; Zhang WY, 1996, PROSTAG LEUKOTR ESS, V54, P427, DOI 10.1016/S0952-3278(96)90026-5	53	35	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107890	10.1371/journal.pone.0107890	http://dx.doi.org/10.1371/journal.pone.0107890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229347	gold, Green Published, Green Submitted			2022-12-25	WOS:000342123900084
J	Ren, H; Li, LJ; Liu, Q; Wang, X; Li, YD; Hui, DF; Jian, SG; Wang, J; Yang, H; Lu, HF; Zhou, GY; Tang, XL; Zhang, QM; Wang, D; Yuan, LL; Chen, XB				Ren, Hai; Li, Linjun; Liu, Qiang; Wang, Xu; Li, Yide; Hui, Dafeng; Jian, Shuguang; Wang, Jun; Yang, Huai; Lu, Hongfang; Zhou, Guoyi; Tang, Xuli; Zhang, Qianmei; Wang, Dong; Yuan, Lianlian; Chen, Xubing			Spatial and Temporal Patterns of Carbon Storage in Forest Ecosystems on Hainan Island, Southern China	PLOS ONE			English	Article							BIOMASS; UNCERTAINTY	Spatial and temporal patterns of carbon (C) storage in forest ecosystems significantly affect the terrestrial C budget, but such patterns are unclear in the forests in Hainan Province, the largest tropical island in China. Here, we estimated the spatial and temporal patterns of C storage from 1993-2008 in Hainan's forest ecosystems by combining our measured data with four consecutive national forest inventories data. Forest coverage increased from 20.7% in the 1950s to 56.4% in the 2010s. The average C density of 163.7 Mg C/ha in Hainan's forest ecosystems in this study was slightly higher than that of China's mainland forests, but was remarkably lower than that in the tropical forests worldwide. Total forest ecosystem C storage in Hainan increased from 109.51 Tg in 1993 to 279.17 Tg in 2008. Soil C accounted for more than 70% of total forest ecosystem C. The spatial distribution of forest C storage in Hainan was uneven, reflecting differences in land use change and forest management. The potential carbon sequestration of forest ecosystems was 77.3 Tg C if all forested lands were restored to natural tropical forests. To increase the C sequestration potential on Hainan Island, future forest management should focus on the conservation of natural forests, selection of tree species, planting of understory species, and implementation of sustainable practices.	[Ren, Hai; Li, Linjun; Jian, Shuguang; Wang, Jun; Lu, Hongfang; Zhou, Guoyi; Tang, Xuli; Zhang, Qianmei; Yuan, Lianlian; Chen, Xubing] Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Liu, Qiang] Hainan Normal Univ, Coll Life Sci, Haikou, Peoples R China; [Wang, Xu] Hainan Univ, Coll Environm & Plant Protect, Haikou, Peoples R China; [Li, Yide; Yang, Huai] Chinese Acad Forestry, Res Inst Trop Forestry, Guangzhou, Guangdong, Peoples R China; [Hui, Dafeng] Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA; [Wang, Dong] Cent China Normal Univ, Sch Life Sci, Wuhan, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Hainan Normal University; Hainan University; Chinese Academy of Forestry; Research Institute of Tropical Forestry, CAF; Tennessee State University; Central China Normal University	Ren, H (corresponding author), Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	renhai@scbg.ac.cn	Liu, Qiang/HHZ-3181-2022	Hui, Dafeng/0000-0002-5284-2897	Chinese Academy of Sciences [XDA05050206]	Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by the "Strategic Priority Research Program'' of the Chinese Academy of Sciences, grant No. XDA05050206. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2001, INT J REMOTE SENS, V22, P2741, DOI 10.1080/01431160010014251; Cao JH, 2009, CHINESE J TROPICAL A, V29, P1; [曹军 Cao Jun], 2002, [地理研究, Geographical Research], V21, P551; CIAIS P, 1995, SCIENCE, V269, P1098, DOI 10.1126/science.269.5227.1098; Cox M, 2003, MEAS TECH+, V46, P824, DOI 10.1023/B:METE.0000008439.82231.ad; Deng F, 2007, J S CHINA U TROP AGR, V13, P19; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Fang JY., 1996, ACTA ECOL SIN, V16, P497, DOI DOI 10.1016/j.chnaes.2015.03.001; Guo ZD, 2010, FOREST ECOL MANAG, V259, P1225, DOI 10.1016/j.foreco.2009.09.047; Hainan Bureau of Forestry, 1999, FOR RES STAT CHIN 19; Han Fei-yang, 2010, Forest Research, V23, P690; Hou X., 2001, VEGETATION ATLAS CHI; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; Houghton RA, 1992, INT WORKSH EC CONS M; IPCC (Intergovernmental Panel on Climate change), 2000, LAND USE LAND USE CH; Jobin B, 2003, LANDSCAPE ECOL, V18, P575, DOI 10.1023/A:1026047625427; Krouwer JS, 2003, CLIN CHEM, V49, P1818, DOI 10.1373/clinchem.2003.019505; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; Lee TM, 2009, ECOL ENG, V35, P487, DOI 10.1016/j.ecoleng.2008.01.007; Li H., 2010, ASSESSMENT FOREST VE; Li YD, 1998, ACTA ECOLOGICA SINIC, V18, P371; Liu G., 1996, SOIL PHYS CHEM ANAL; Liu HX, 2014, J ENVIRON MANAGE, V133, P86, DOI 10.1016/j.jenvman.2013.11.037; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; Ren Hai, 2007, Landscape and Ecological Engineering, V3, P1, DOI 10.1007/s11355-006-0018-4; Ren H, 2013, PLANT SOIL, V363, P123, DOI 10.1007/s11104-012-1302-8; Song QH, 2013, IFOREST, V7, P42, DOI 10.3832/ifor0891-007; Tyrrell M.L., 2012, MANAGING EST CARB, P377; Wang Xiaoke, 2001, Yingyong Shengtai Xuebao, V12, P13; YD Li, 1993, ACTA ECOL SIN, V13, P314; Zhang JP, 2012, PEDOSPHERE, V22, P58, DOI 10.1016/S1002-0160(11)60191-4; Zhao M, 2004, SCI GEOGR SIN, V4, P50; Zhou CY, 2008, FOREST ECOL MANAG, V255, P847, DOI 10.1016/j.foreco.2007.09.081; ZHOU GY, 1995, ECOL ENG, V4, P223; 郭兆迪, 2013, [中国科学. 生命科学, Scientia Sinica Vitae], V43, P421	35	14	22	10	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e108163	10.1371/journal.pone.0108163	http://dx.doi.org/10.1371/journal.pone.0108163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229628	Green Published, Green Submitted, gold			2022-12-25	WOS:000342123900099
J	Peterson, KR; Costa, FC; Fedosyuk, H; Neades, RY; Chazelle, AM; Zelenchuk, L; Fonteles, AH; Dalal, P; Roy, A; Chaguturu, R; Li, BR; Pace, BS				Peterson, Kenneth R.; Costa, Flavia C.; Fedosyuk, Halyna; Neades, Renee Y.; Chazelle, Allen M.; Zelenchuk, Lesya; Fonteles, Andrea H.; Dalal, Parmita; Roy, Anuradha; Chaguturu, Rathnam; Li, Biaoru; Pace, Betty S.			A Cell-Based High-Throughput Screen for Novel Chemical Inducers of Fetal Hemoglobin for Treatment of Hemoglobinopathies	PLOS ONE			English	Article							YEAST ARTIFICIAL CHROMOSOMES; GLOBIN GENE-EXPRESSION; TRANSGENIC MICE; DISEASE; HYDROXYUREA; YACS; TRANSCRIPTION; MANAGEMENT; MECHANISM; BABOONS	Decades of research have established that the most effective treatment for sickle cell disease (SCD) is increased fetal hemoglobin (HbF). Identification of a drug specific for inducing gamma-globin expression in pediatric and adult patients, with minimal off-target effects, continues to be an elusive goal. One hurdle has been an assay amenable to a high-throughput screen (HTS) of chemicals that displays a robust gamma-globin off-on switch to identify potential lead compounds. Assay systems developed in our labs to understand the mechanisms underlying the gamma- to beta-globin gene expression switch during development has allowed us to generate a cell-based assay that was adapted for a HTS of 121,035 compounds. Using chemical inducer of dimerization (CID)-dependent bone marrow cells (BMCs) derived from human gamma-globin promoter-firefly luciferase beta-globin promoter-Renilla luciferase beta-globin yeast artificial chromosome (gamma-luc beta-luc beta-YAC) transgenic mice, we were able to identify 232 lead chemical compounds that induced gamma-globin 2-fold or higher, with minimal or no beta-globin induction, minimal cytotoxicity and that did not directly influence the luciferase enzyme. Secondary assays in CID-dependent wild-type beta-YAC BMCs and human primary erythroid progenitor cells confirmed the induction profiles of seven of the 232 hits that were cherry-picked for further analysis.	[Peterson, Kenneth R.; Costa, Flavia C.; Fedosyuk, Halyna; Neades, Renee Y.; Chazelle, Allen M.; Zelenchuk, Lesya; Fonteles, Andrea H.; Dalal, Parmita] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Peterson, Kenneth R.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Roy, Anuradha; Chaguturu, Rathnam] Univ Kansas, High Throughput Screening Lab, Lawrence, KS 66045 USA; [Li, Biaoru; Pace, Betty S.] Georgia Regents Univ, Dept Pediat, Augusta, GA USA; [Pace, Betty S.] Georgia Regents Univ, Dept Mol & Cell Biol, Augusta, GA USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Peterson, KR (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA.	kpeterson@kumc.edu		Roy, Anuradha/0000-0002-1057-1443; Li, Biaoru/0000-0002-5626-9557; Pace, Betty/0000-0002-1275-4112	Public Health Service National Institutes of Health [HL069234, HL067336, DK061804, DK081290]; National Intitutes of Health COBRE Grant [8 P30 GM103495]; NCI [5 P30 CA168524]; NATIONAL CANCER INSTITUTE [P30CA168524] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015563] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL067336, R01HL069234, R01HL067336, R01HL111264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK081290, R01DK081290, R01DK061804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103495, P30GM103326] Funding Source: NIH RePORTER	Public Health Service National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); National Intitutes of Health COBRE Grant; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Service National Institutes of Health (NIH.gov) grants HL069234 to BSP (subcontract to KRP), and HL067336, DK061804, and DK081290 to KRP. KU-HTSL is a KU Cancer Center Shared Resource, and is funded in part by National Intitutes of Health COBRE Grant 8 P30 GM103495 (B. Timmermann, PI) and the NCI Cancer Support Grant, 5 P30 CA168524 (R. Jensen, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley-Koch A, 2000, AM J EPIDEMIOL, V151, P839; Auld DS, 2008, ACS CHEM BIOL, V3, P463, DOI 10.1021/cb8000793; Blau C. Anthony, 2006, V349, P163; Blau CA, 2005, J BIOL CHEM, V280, P36642, DOI 10.1074/jbc.M504402200; Boosalis MS, 2011, BLOOD CELL MOL DIS, V47, P107, DOI 10.1016/j.bcmd.2011.04.008; Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; Charache S, 1997, SEMIN HEMATOL, V34, P15; Cheng DH, 2004, J BIOL CHEM, V279, P23892, DOI 10.1074/jbc.M401853200; CONSTANTOULAKIS P, 1988, BLOOD, V72, P1961; Davies SC, 2003, BLOOD REV, V17, P99, DOI 10.1016/S0268-960X(02)00074-7; DESIMONE J, 1982, P NATL ACAD SCI-BIOL, V79, P4428, DOI 10.1073/pnas.79.14.4428; Fox S, 2002, J BIOMOL SCREEN, V7, P313, DOI 10.1089/108705702320351150; GAENSLER KML, 1991, GENOMICS, V10, P976, DOI 10.1016/0888-7543(91)90188-K; Graslund T, 2005, J BIOL CHEM, V280, P3707, DOI 10.1074/jbc.M406809200; Haley JD, 2003, BIOCHEM PHARMACOL, V66, P1755, DOI 10.1016/S0006-2952(03)00542-2; Hebiguchi M, 2008, INT J HEMATOL, V88, P498, DOI 10.1007/s12185-008-0200-6; Hertzberg RP, 2000, CURR OPIN CHEM BIOL, V4, P445, DOI 10.1016/S1367-5931(00)00110-1; Jin LQ, 1998, P NATL ACAD SCI USA, V95, P8093, DOI 10.1073/pnas.95.14.8093; Kalra IS, 2011, BRIT J HAEMATOL, V154, P248, DOI 10.1111/j.1365-2141.2011.08710.x; KUHN RM, 1994, GENE, V141, P125, DOI 10.1016/0378-1119(94)90139-2; Lancaster JR, 2003, TRENDS PHARMACOL SCI, V24, P389, DOI 10.1016/S0165-6147(03)00199-8; LETVIN NL, 1984, NEW ENGL J MED, V310, P869, DOI 10.1056/NEJM198404053101401; LEY TJ, 1982, NEW ENGL J MED, V307, P1469, DOI 10.1056/NEJM198212093072401; LIAKOPOULOU E, 1995, BLOOD, V86, P3227; LITTLE JA, 1995, BLOOD, V85, P1712, DOI 10.1182/blood.V85.7.1712.bloodjournal8571712; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Muralidhar SA, 2011, J BIOL CHEM, V286, P2343, DOI 10.1074/jbc.M110.115725; Pais E, 2009, J BIOMOL SCREEN, V14, P330, DOI 10.1177/1087057109333975; PAPAYANNOPOULOU T, 1984, SCIENCE, V224, P617, DOI 10.1126/science.6200940; PERRINE SP, 1988, P NATL ACAD SCI USA, V85, P8540, DOI 10.1073/pnas.85.22.8540; PETERSON KR, 1995, P NATL ACAD SCI USA, V92, P5655, DOI 10.1073/pnas.92.12.5655; PETERSON KR, 1993, P NATL ACAD SCI USA, V90, P7593, DOI 10.1073/pnas.90.16.7593; Peterson KR, 1998, HUM MOL GENET, V7, P2079, DOI 10.1093/hmg/7.13.2079; PETERSON KR, 1993, P NATL ACAD SCI USA, V90, P11207, DOI 10.1073/pnas.90.23.11207; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Roy A., 2009, HDB DRUG SCREENING, P21; Steinberg MH, 1997, BLOOD, V89, P1078, DOI 10.1182/blood.V89.3.1078; Tschulena U, 2009, NAT STRUCT MOL BIOL, V16, P1195, DOI 10.1038/nsmb.1677; Vassilopoulos G, 1999, BLOOD, V93, P703, DOI 10.1182/blood.V93.2.703.402k07_703_712; Vichinsky E, 2002, LANCET, V360, P629, DOI 10.1016/S0140-6736(02)09776-3; Ye OZ, 2004, J AM CHEM SOC, V126, P13940, DOI 10.1021/ja045864; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	42	15	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107006	10.1371/journal.pone.0107006	http://dx.doi.org/10.1371/journal.pone.0107006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225870	gold, Green Submitted, Green Published			2022-12-25	WOS:000344317700025
J	Weerasooriya, S; Jasti, VP; Basu, AK				Weerasooriya, Savithri; Jasti, Vijay P.; Basu, Ashis K.			Replicative Bypass of Abasic Site in Escherichia coli and Human Cells: Similarities and Differences	PLOS ONE			English	Article							TRANSLESION DNA-SYNTHESIS; APURINIC APYRIMIDINIC SITE; SINGLE-STRANDED VECTOR; SIMIAN KIDNEY-CELLS; MAMMALIAN-CELLS; POLYMERASE-IV; SACCHAROMYCES-CEREVISIAE; MUTATIONAL SPECIFICITY; MUTAGENIC PROPERTIES; CYCLOBUTANE DIMER	Abasic [apurinic/apyrimidinic (AP)] sites are the most common DNA damages, opposite which dAMP is frequently inserted ('A-rule') in Escherichia coli. Nucleotide insertion opposite the AP-site in eukaryotic cells depends on the assay system and the type of cells. Accordingly, a 'C-rule', 'A-rule', or the lack of specificity has been reported. DNA sequence context also modulates nucleotide insertion opposite AP-site. Herein, we have compared replication of tetrahydrofuran (Z), a stable analog of AP-site, in E. coli and human embryonic kidney 293T cells in two different sequences. The efficiency of translesion synthesis or viability of the AP-site construct in E. coli was less than 1%, but it was 7- to 8-fold higher in the GZGTC sequence than in the GTGZC sequence. The difference in viability increased even more in pol V-deficient strains. Targeted one-base deletions occurred in 63% frequency in the GZG and 68% frequency in GZC sequence, which dropped to 49% and 21%, respectively, upon induction of SOS. The full-length products with SOS primarily involved dAMP insertion opposite the AP-site, which occurred in 49% and 71% frequency, respectively, in the GZG and GZC sequence. dAMP insertion, largely carried out by pol V, was more efficient when the AP-site was a stronger replication block. In contrast to these results in E. coli, viability was 2 to 3 orders of magnitude higher in human cells, and the 'A-rule' was more rigidly followed. The AP-site in the GZG and GZC sequences gave 76% and 89%, respectively, Z -> T substitutions. In human cells, targeted one-base deletion was undetectable, and dTMP>dCMP were the next preferred nucleotides inserted opposite Z. siRNA knockdown of Rev1 or pol zeta established that both these polymerases are vital for AP-site bypass, as demonstrated by 36-67% reduction in bypass efficiency. However, neither polymerase was indispensable, suggesting roles of additional DNA polymerases in AP-site bypass in human cells.	[Weerasooriya, Savithri; Jasti, Vijay P.; Basu, Ashis K.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA	University of Connecticut	Basu, AK (corresponding author), Univ Connecticut, Dept Chem, U-60, Storrs, CT 06269 USA.	ashis.basu@uconn.edu			National Institute of Environmental Health Sciences [ES09127, ES021762, ES023350]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021762, R56ES009127, R01ES009127, R01ES023350] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences (grants ES09127, ES021762, and ES023350) to AKB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avkin S, 2002, P NATL ACAD SCI USA, V99, P3764, DOI 10.1073/pnas.062038699; BANERJEE SK, 1988, P NATL ACAD SCI USA, V85, P8141, DOI 10.1073/pnas.85.21.8141; Blanca G, 2004, BIOCHEMISTRY-US, V43, P11605, DOI 10.1021/bi049050x; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; BRAMMER KW, 1968, BIOCHIM BIOPHYS ACTA, V166, P732, DOI 10.1016/0005-2787(68)90388-2; Choi JY, 2010, J MOL BIOL, V404, P34, DOI 10.1016/j.jmb.2010.09.015; Fang HF, 2008, NUCLEIC ACIDS RES, V36, P6004, DOI 10.1093/nar/gkn595; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Friedberg EC, 2006, DNA REPAIR, V5, P986, DOI 10.1016/j.dnarep.2006.05.005; GENTIL A, 1990, BIOCHEM BIOPH RES CO, V173, P704, DOI 10.1016/S0006-291X(05)80092-0; GENTIL A, 1992, J MOL BIOL, V227, P981, DOI 10.1016/0022-2836(92)90513-J; GIBBS PEM, 1995, J MOL BIOL, V251, P229, DOI 10.1006/jmbi.1995.0430; Gibbs PEM, 2005, GENETICS, V169, P575, DOI 10.1534/genetics.104.034611; Haracska L, 2002, MOL CELL BIOL, V22, P784, DOI 10.1128/MCB.22.3.784-791.2002; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; Haracska L, 2001, J BIOL CHEM, V276, P6861, DOI 10.1074/jbc.M008021200; Hilario P, 2002, J BIOL CHEM, V277, P45068, DOI 10.1074/jbc.M208103200; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Kalam MA, 2005, CHEM RES TOXICOL, V18, P1187, DOI 10.1021/tx050119r; Kroeger KM, 2004, NUCLEIC ACIDS RES, V32, P5480, DOI 10.1093/nar/gkh873; LAWRENCE CW, 1990, NUCLEIC ACIDS RES, V18, P2153, DOI 10.1093/nar/18.8.2153; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; Loeb L A, 1986, Basic Life Sci, V38, P341; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; Malina J, 2014, CHEM-EUR J, V20, P7566, DOI 10.1002/chem.201402600; Maor-Shoshani A, 2003, DNA REPAIR, V2, P1227, DOI 10.1016/S1568-7864(03)00142-3; MORIYA M, 1993, P NATL ACAD SCI USA, V90, P1122, DOI 10.1073/pnas.90.3.1122; MORIYA M, 1991, MUTAT RES, V254, P281, DOI 10.1016/0921-8777(91)90067-Y; NETO JBC, 1994, J MOL BIOL, V240, P416, DOI 10.1006/jmbi.1994.1457; Pages V, 2008, P NATL ACAD SCI USA, V105, P1170, DOI 10.1073/pnas.0711227105; Pandya GA, 1996, BIOCHEMISTRY-US, V35, P11487, DOI 10.1021/bi960170h; Pednekar V, 2014, CHEM RES TOXICOL, V27, P200, DOI 10.1021/tx4002786; Raychaudhury P, 2011, BIOCHEMISTRY-US, V50, P2330, DOI 10.1021/bi102064z; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; SCHAAPER RM, 1982, MUTAT RES, V106, P1, DOI 10.1016/0027-5107(82)90186-5; SCHAAPER RM, 1986, J MOL BIOL, V189, P273, DOI 10.1016/0022-2836(86)90509-7; SCHAAPER RM, 1982, CANCER RES, V42, P3480; SCHAAPER RM, 1987, MUTAT RES, V177, P179, DOI 10.1016/0027-5107(87)90001-7; Strauss BS, 2002, DNA REPAIR, V1, P125, DOI 10.1016/S1568-7864(01)00014-3; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Wojtaszek J, 2012, J BIOL CHEM, V287, P33836, DOI 10.1074/jbc.M112.394841; Wojtaszek J, 2012, J BIOL CHEM, V287, P26400, DOI 10.1074/jbc.M112.380998; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4717, DOI 10.1093/nar/28.23.4717	45	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107915	10.1371/journal.pone.0107915	http://dx.doi.org/10.1371/journal.pone.0107915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226389	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700093
J	Yousuf, B; Kumar, R; Mishra, A; Jha, B				Yousuf, Basit; Kumar, Raghawendra; Mishra, Avinash; Jha, Bhavanath			Unravelling the Carbon and Sulphur Metabolism in Coastal Soil Ecosystems Using Comparative Cultivation-Independent Genome-Level Characterisation of Microbial Communities	PLOS ONE			English	Article							RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE GENES; 16S RIBOSOMAL-RNA; FORM-II RUBISCO; OXIDIZING BACTERIA; MOLECULAR ANALYSIS; FUNCTIONAL GENES; SOXB GENE; DIVERSITY; OXIDATION; PHYLOGENY	Bacterial autotrophy contributes significantly to the overall carbon balance, which stabilises atmospheric CO2 concentration and decelerates global warming. Little attention has been paid to different modes of carbon/sulphur metabolism mediated by autotrophic bacterial communities in terrestrial soil ecosystems. We studied these pathways by analysing the distribution and abundance of the diagnostic metabolic marker genes cbbM, apsA and soxB, which encode for ribulose-1,5-bisphosphate carboxylase/oxygenase, adenosine phosphosulphate reductase and sulphate thiohydrolase, respectively, among different contrasting soil types. Additionally, the abundance of community members was assessed by quantifying the gene copy numbers for 16S rRNA, cbbL, cbbM, apsA and soxB. Distinct compositional differences were observed among the clone libraries, which revealed a dominance of phylotypes associated with carbon and sulphur cycling, such as Gammaproteobacteria (Thiohalomonas, Allochromatium, Chromatium, Thiomicrospira) and Alphaproteobacteria (Rhodopseudomonas, Rhodovulum, Paracoccus). The rhizosphere soil was devoid of sulphur metabolism, as the soxB and apsA genes were not observed in the rhizosphere metagenome, which suggests the absence or inadequate representation of sulphur-oxidising bacteria. We hypothesise that the novel Gammaproteobacteria sulphur oxidisers might be actively involved in sulphur oxidation and inorganic carbon fixation, particularly in barren saline soil ecosystems, suggesting their significant putative ecological role and contribution to the soil carbon pool.	[Yousuf, Basit; Kumar, Raghawendra; Mishra, Avinash; Jha, Bhavanath] Cent Salt & Marine Chem Res Inst, CSIR, Discipline Marine Biotechnol & Ecol, Bhavnagar 364002, Gujarat, India; [Yousuf, Basit; Kumar, Raghawendra; Mishra, Avinash; Jha, Bhavanath] CSIR, Acad Sci & Innovat Res, New Delhi 110001, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Salt & Marine Chemical Research Institute (CSMCRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India	Mishra, A (corresponding author), Cent Salt & Marine Chem Res Inst, CSIR, Discipline Marine Biotechnol & Ecol, Bhavnagar 364002, Gujarat, India.	avinash@csmcri.org; bjha@csmcri.org	Mishra, Avinash/AAG-2961-2019; Yousuf, Basit/F-8074-2011; Mishra, Avinash/C-3210-2009	Mishra, Avinash/0000-0003-0342-010X; Mishra, Avinash/0000-0003-0342-010X; kumar, Raghawendra/0000-0002-7295-7827	Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi [CSC0102-TapCoal]	Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by the Council of Scientific and Industrial Research (CSIR; www.csir.res.in), Government of India, New Delhi [CSC0102-TapCoal; Senior Research Fellowship to BY]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Alfreider A, 2012, FEMS MICROBIOL ECOL, V79, P649, DOI 10.1111/j.1574-6941.2011.01246.x; Anandham R, 2008, RES MICROBIOL, V159, P579, DOI 10.1016/j.resmic.2008.08.007; Andreote FD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038600; Badger MR, 2008, J EXP BOT, V59, P1525, DOI 10.1093/jxb/erm297; Bayer C, 2009, ENV MICROBIOL REP, V1, P136, DOI 10.1111/j.1758-2229.2009.00019.x; Beller HR, 2006, J BACTERIOL, V188, P7005, DOI 10.1128/JB.00568-06; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Blazejak A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00253; Brinkhoff T, 1999, INT J SYST BACTERIOL, V49, P385, DOI 10.1099/00207713-49-2-385; Chen Y, 2009, ISME J, V3, P1093, DOI 10.1038/ismej.2009.57; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Geets J, 2006, J MICROBIOL METH, V66, P194, DOI 10.1016/j.mimet.2005.11.002; Ghosh W, 2009, FEMS MICROBIOL REV, V33, P999, DOI 10.1111/j.1574-6976.2009.00187.x; Hall JR, 2008, APPL ENVIRON MICROB, V74, P4910, DOI 10.1128/AEM.00233-08; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Headd B, 2013, APPL ENVIRON MICROB, V79, P1171, DOI 10.1128/AEM.02812-12; Henry S, 2006, APPL ENVIRON MICROB, V72, P5181, DOI 10.1128/AEM.00231-06; Hugler M, 2010, FEMS MICROBIOL ECOL, V73, P526, DOI 10.1111/j.1574-6941.2010.00919.x; Kato S, 2012, EXTREMOPHILES, V16, P277, DOI 10.1007/s00792-011-0428-6; Keshri J, 2013, MICROBIOL RES, V168, P165, DOI 10.1016/j.micres.2012.09.005; Kong WD, 2012, FEMS MICROBIOL ECOL, V82, P491, DOI 10.1111/j.1574-6941.2012.01431.x; Kovaleva OL, 2011, FEMS MICROBIOL ECOL, V75, P37, DOI 10.1111/j.1574-6941.2010.00996.x; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Lenk S, 2011, ENVIRON MICROBIOL, V13, P758, DOI 10.1111/j.1462-2920.2010.02380.x; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; McDevitt CA, 2002, BIOCHEMISTRY-US, V41, P15234, DOI 10.1021/bi026221u; Meyer B, 2007, ENVIRON MICROBIOL, V9, P2957, DOI 10.1111/j.1462-2920.2007.01407.x; Meyer B, 2007, MICROBIOL-SGM, V153, P3478, DOI 10.1099/mic.0.2007/008250-0; MORSE D, 1995, SCIENCE, V268, P1622, DOI 10.1126/science.7777861; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Petri R, 2001, FEMS MICROBIOL LETT, V197, P171, DOI 10.1111/j.1574-6968.2001.tb10600.x; Ruehland C, 2008, ENVIRON MICROBIOL, V10, P3404, DOI 10.1111/j.1462-2920.2008.01728.x; Schloss PD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-34; Selesi D, 2007, J MICROBIOL METH, V69, P497, DOI 10.1016/j.mimet.2007.03.002; Smith CJ, 2006, ENVIRON MICROBIOL, V8, P804, DOI 10.1111/j.1462-2920.2005.00963.x; Sorokin DY, 2008, MICROBIAL SULFUR METABOLISM, P225, DOI 10.1007/978-3-540-72682-1_18; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thauer RK, 2007, SCIENCE, V318, P1732, DOI 10.1126/science.1152209; Tourova TP, 2006, MICROBIOL-SGM, V152, P2159, DOI 10.1099/mic.0.28699-0; Tourova TP, 2013, FEMS MICROBIOL ECOL, V84, P280, DOI 10.1111/1574-6941.12056; Tourova TP, 2010, MICROBIOL-SGM, V156, P2016, DOI 10.1099/mic.0.034603-0; VIALE AM, 1989, J BACTERIOL, V171, P2391, DOI 10.1128/jb.171.5.2391-2400.1989; Videmsek U, 2009, MICROB ECOL, V58, P1, DOI 10.1007/s00248-008-9442-3; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; Wu QL, 2006, APPL ENVIRON MICROB, V72, P5478, DOI 10.1128/AEM.00767-06; Xiao KQ, 2014, FEMS MICROBIOL ECOL, V87, P89, DOI 10.1111/1574-6941.12193; Yang J, 2013, GEOMICROBIOL J, V30, P758, DOI [10.1080/01490451.2013.790921, 10.1080/01490451.2013.769652]; Yousuf B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-150; Yousuf B, 2012, GENE, V506, P18, DOI 10.1016/j.gene.2012.06.083; Yuan HZ, 2012, APPL MICROBIOL BIOT, V95, P1061, DOI 10.1007/s00253-011-3760-y; Yuan HZ, 2012, APPL ENVIRON MICROB, V78, P2328, DOI 10.1128/AEM.06881-11	54	19	21	10	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107025	10.1371/journal.pone.0107025	http://dx.doi.org/10.1371/journal.pone.0107025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225969	Green Submitted, Green Published, gold			2022-12-25	WOS:000344317700026
J	Parreiras, LS; Breuer, RJ; Narasimhan, RA; Higbee, AJ; La Reau, A; Tremaine, M; Qin, L; Willis, LB; Bice, BD; Bonfert, BL; Pinhancos, RC; Balloon, AJ; Uppugundla, N; Liu, TJ; Li, CL; Tanjore, D; Ong, IM; Li, HB; Pohlmann, EL; Serate, J; Withers, ST; Simmons, BA; Hodge, DB; Westphall, MS; Coon, JJ; Dale, BE; Balan, V; Keating, DH; Zhang, YP; Landick, R; Gasch, AP; Sato, TK				Parreiras, Lucas S.; Breuer, Rebecca J.; Narasimhan, Ragothaman Avanasi; Higbee, Alan J.; La Reau, Alex; Tremaine, Mary; Qin, Li; Willis, Laura B.; Bice, Benjamin D.; Bonfert, Brandi L.; Pinhancos, Rebeca C.; Balloon, Allison J.; Uppugundla, Nirmal; Liu, Tongjun; Li, Chenlin; Tanjore, Deepti; Ong, Irene M.; Li, Haibo; Pohlmann, Edward L.; Serate, Jose; Withers, Sydnor T.; Simmons, Blake A.; Hodge, David B.; Westphall, Michael S.; Coon, Joshua J.; Dale, Bruce E.; Balan, Venkatesh; Keating, David H.; Zhang, Yaoping; Landick, Robert; Gasch, Audrey P.; Sato, Trey K.			Engineering and Two-Stage Evolution of a Lignocellulosic Hydrolysate-Tolerant Saccharomyces cerevisiae Strain for Anaerobic Fermentation of Xylose from AFEX Pretreated Corn Stover	PLOS ONE			English	Article							ENZYMATIC-HYDROLYSIS; ETHANOL-PRODUCTION; GENE DISRUPTION; SCALE-UP; YEAST; BIOMASS; ISOMERASE; GROWTH; PERFORMANCE; EXPRESSION	The inability of the yeast Saccharomyces cerevisiae to ferment xylose effectively under anaerobic conditions is a major barrier to economical production of lignocellulosic biofuels. Although genetic approaches have enabled engineering of S. cerevisiae to convert xylose efficiently into ethanol in defined lab medium, few strains are able to ferment xylose from lignocellulosic hydrolysates in the absence of oxygen. This limited xylose conversion is believed to result from small molecules generated during biomass pretreatment and hydrolysis, which induce cellular stress and impair metabolism. Here, we describe the development of a xylose-fermenting S. cerevisiae strain with tolerance to a range of pretreated and hydrolyzed lignocellulose, including Ammonia Fiber Expansion (AFEX)-pretreated corn stover hydrolysate (ACSH). We genetically engineered a hydrolysate-resistant yeast strain with bacterial xylose isomerase and then applied two separate stages of aerobic and anaerobic directed evolution. The emergent S. cerevisiae strain rapidly converted xylose from lab medium and ACSH to ethanol under strict anaerobic conditions. Metabolomic, genetic and biochemical analyses suggested that a missense mutation in GRE3, which was acquired during the anaerobic evolution, contributed toward improved xylose conversion by reducing intracellular production of xylitol, an inhibitor of xylose isomerase. These results validate our combinatorial approach, which utilized phenotypic strain selection, rational engineering and directed evolution for the generation of a robust S. cerevisiae strain with the ability to ferment xylose anaerobically from ACSH.	[Parreiras, Lucas S.; Breuer, Rebecca J.; Narasimhan, Ragothaman Avanasi; Higbee, Alan J.; La Reau, Alex; Tremaine, Mary; Qin, Li; Bice, Benjamin D.; Ong, Irene M.; Li, Haibo; Pohlmann, Edward L.; Serate, Jose; Withers, Sydnor T.; Keating, David H.; Zhang, Yaoping; Landick, Robert; Gasch, Audrey P.; Sato, Trey K.] Univ Wisconsin, DOE Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Higbee, Alan J.; Bonfert, Brandi L.; Pinhancos, Rebeca C.; Balloon, Allison J.; Westphall, Michael S.; Coon, Joshua J.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Willis, Laura B.; Landick, Robert] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Uppugundla, Nirmal; Liu, Tongjun; Hodge, David B.; Dale, Bruce E.; Balan, Venkatesh] Michigan State Univ, DOE Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Uppugundla, Nirmal; Dale, Bruce E.; Balan, Venkatesh] Michigan State Univ, Dept Chem Engn & Mat Sci, Biomass Convers Res Lab, E Lansing, MI 48824 USA; [Liu, Tongjun] Qilu Univ Technol, Sch Food & Bioengn, Jinan, Peoples R China; [Tanjore, Deepti] Lawrence Berkeley Natl Lab, Adv Biofuels Proc Demonstrat Unit, Emeryville, CA USA; [Simmons, Blake A.] Joint BioEnergy Inst, Deconstruct Div, Emeryville, CA USA; [Hodge, David B.] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Hodge, David B.] Michigan State Univ, Dept Biosyst & Agr Engn, E Lansing, MI 48824 USA; [Hodge, David B.] Lulea Univ Technol, Div Sustainable Proc Engn, S-95187 Lulea, Sweden; [Landick, Robert] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Gasch, Audrey P.] Univ Wisconsin, Genet Lab, Madison, WI 53705 USA	United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Michigan State University; United States Department of Energy (DOE); Michigan State University; Qilu University of Technology; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Michigan State University; Michigan State University; Lulea University of Technology; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sato, TK (corresponding author), Univ Wisconsin, DOE Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA.	tksato@glbrc.wisc.edu	Simmons, Blake/N-6022-2016; Balan, Venkatesh/AAG-8332-2020; Hodge, David/Y-6828-2019; Gasch, Audrey P./AAS-5924-2021; Avanasi Narasimhan, Ragothaman/AHA-3552-2022	Simmons, Blake/0000-0002-1332-1810; Balan, Venkatesh/0000-0003-3109-5156; Hodge, David/0000-0002-9313-941X; Gasch, Audrey P./0000-0002-8182-257X; Simdon, Laura/0000-0002-4422-6939; Li, Haibo/0000-0002-6343-7213; Parreiras, Lucas/0000-0001-6156-4780; Ong, Irene/0000-0002-9353-6941	Department of Energy (DOE) Great Lakes Bioenergy Research Center (DOE BER Office of Science) [BER DE-FC02-07ER64494]; Office of Science, Office of Biological and Environmental Research, of the United States Department of Energy [DE-AC02-05CH11231]; Office of Biomass Program within the United States DOE's Office of Energy Efficiency and Renewable Energy; American Recovery and Reinvestment Act	Department of Energy (DOE) Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE)); Office of Science, Office of Biological and Environmental Research, of the United States Department of Energy(United States Department of Energy (DOE)); Office of Biomass Program within the United States DOE's Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE)); American Recovery and Reinvestment Act	This work was funded in part by the Department of Energy (DOE) Great Lakes Bioenergy Research Center (DOE BER Office of Science BER DE-FC02-07ER64494). The portion of work conducted by the Joint BioEnergy Institute was supported by the Office of Science, Office of Biological and Environmental Research, of the United States Department of Energy under Contract No. DE-AC02-05CH11231. The portion of the work conducted by the Advanced Biofuels Process Demonstration Unit was funded by support from Office of Biomass Program within the United States DOE's Office of Energy Efficiency and Renewable Energy, and also the funding support from the American Recovery and Reinvestment Act. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JRM, 2011, BIOTECHNOL J, V6, P286, DOI 10.1002/biot.201000301; Amador-Noguez D, 2011, APPL ENVIRON MICROB, V77, P7984, DOI 10.1128/AEM.05374-11; Balan V, 2009, METHODS MOL BIOL, V581, P61, DOI 10.1007/978-1-60761-214-8_5; Banerjee G, 2012, BIOTECHNOL BIOENG, V109, P922, DOI 10.1002/bit.24385; Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564; Bera AK, 2011, J IND MICROBIOL BIOT, V38, P617, DOI 10.1007/s10295-010-0806-6; Blanch HW, 2011, BIOTECHNOL J, V6, P1086, DOI 10.1002/biot.201000180; Brachmann CB, 1998, YEAST, V14, P115; Brat D, 2009, APPL ENVIRON MICROB, V75, P2304, DOI 10.1128/AEM.02522-08; Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d; Chundawat SPS, 2010, BIORESOURCE TECHNOL, V101, P8429, DOI 10.1016/j.biortech.2010.06.027; Demeke MM, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-89; Diao LY, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-110; Fay JC, 2005, GENETICS, V170, P1575, DOI 10.1534/genetics.105.042283; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hahn-Hagerdal B, 2007, APPL MICROBIOL BIOT, V74, P937, DOI 10.1007/s00253-006-0827-2; Ismail KSK, 2013, J BIOTECHNOL, V163, P50, DOI 10.1016/j.jbiotec.2012.10.017; Jeffries TW, 2004, APPL MICROBIOL BIOT, V63, P495, DOI 10.1007/s00253-003-1450-0; Jin MJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-108; Jin YS, 2003, APPL BIOCHEM BIOTECH, V105, P277; Karhumaa K, 2005, YEAST, V22, P359, DOI 10.1002/yea.1216; Kim SR, 2013, BIOTECHNOL ADV, V31, P851, DOI 10.1016/j.biotechadv.2013.03.004; Kim SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057048; Klimacek M, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-37; Koppram R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-32; KUHN A, 1995, APPL ENVIRON MICROB, V61, P1580, DOI 10.1128/AEM.61.4.1580-1585.1995; Kuyper M, 2005, FEMS YEAST RES, V5, P399, DOI 10.1016/j.femsyr.2004.09.010; Kuyper M, 2004, FEMS YEAST RES, V4, P655, DOI 10.1016/j.femsyr.2004.01.003; Laluce C, 2012, APPL BIOCHEM BIOTECH, V166, P1908, DOI 10.1007/s12010-012-9619-6; Lau MW, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-11; Lee SM, 2012, APPL ENVIRON MICROB, V78, P5708, DOI 10.1128/AEM.01419-12; Lewis JA, 2010, GENETICS, V186, P1197, DOI 10.1534/genetics.110.121871; Li CL, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-154; Li MY, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-38; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Liu ZL, 2006, APPL MICROBIOL BIOT, V73, P27, DOI 10.1007/s00253-006-0567-3; Madhavan A, 2012, CRIT REV BIOTECHNOL, V32, P22, DOI 10.3109/07388551.2010.539551; MORTIMER RK, 1986, GENETICS, V113, P35; Ni HY, 2007, APPL ENVIRON MICROB, V73, P2061, DOI 10.1128/AEM.02564-06; Ouellet M, 2011, GREEN CHEM, V13, P2743, DOI 10.1039/c1gc15327g; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Piotrowski JS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00090; Rasmussen H, 2014, CARBOHYD RES, V385, P45, DOI 10.1016/j.carres.2013.08.029; Runquist D, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-5; Sanchez RG, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-13; Sato TK, 2014, APPL ENVIRON MICROB, V80, P540, DOI 10.1128/AEM.01885-13; Scalcinati G, 2012, FEMS YEAST RES, V12, P582, DOI 10.1111/j.1567-1364.2012.00808.x; Schwalbach MS, 2012, APPL ENVIRON MICROB, V78, P3442, DOI 10.1128/AEM.07329-11; Sheehan JJ, 2009, CURR OPIN BIOTECH, V20, P318, DOI 10.1016/j.copbio.2009.05.010; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Toivari MH, 2004, APPL ENVIRON MICROB, V70, P3681, DOI 10.1128/aem.70.6.3681-3686.2004; Traff KL, 2002, YEAST, V19, P1233, DOI 10.1002/yea.913; Traff KL, 2001, APPL ENVIRON MICROB, V67, P5668, DOI 10.1128/AEM.67.12.5668-5674.2001; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; van Maris AJA, 2007, ADV BIOCHEM ENG BIOT, V108, P179, DOI 10.1007/10_2007_057; Van Vleet JH, 2008, METAB ENG, V10, P360, DOI 10.1016/j.ymben.2007.12.002; Voth WP, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e59; WALFRIDSSON M, 1995, APPL ENVIRON MICROB, V61, P4184, DOI 10.1128/AEM.61.12.4184-4190.1995; Wenger JW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000942; WITTEVEEN CFB, 1989, J GEN MICROBIOL, V135, P2163; Wohlbach DJ, 2011, P NATL ACAD SCI USA, V108, P13212, DOI 10.1073/pnas.1103039108; Wyman CE, 2007, TRENDS BIOTECHNOL, V25, P153, DOI 10.1016/j.tibtech.2007.02.009; YAMANAKA K, 1969, ARCH BIOCHEM BIOPHYS, V131, P502, DOI 10.1016/0003-9861(69)90422-6; Young EM, 2014, P NATL ACAD SCI USA, V111, P131, DOI 10.1073/pnas.1311970111; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171	65	61	66	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107499	10.1371/journal.pone.0107499	http://dx.doi.org/10.1371/journal.pone.0107499			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222864	gold, Green Submitted, Green Published			2022-12-25	WOS:000341774800077
J	Chen, ZQ; Li, KB; Luo, L; Lu, EJ; Yuan, J; Liu, H; Lu, JY; Di, B; Xiao, XC; Yang, ZC				Chen, Zongqiu; Li, Kuibiao; Luo, Lei; Lu, Enjie; Yuan, Jun; Liu, Hui; Lu, Jianyun; Di, Biao; Xiao, Xincai; Yang, Zhicong			Detection of Avian Influenza A(H7N9) Virus from Live Poultry Markets in Guangzhou, China: A Surveillance Report	PLOS ONE			English	Article							A H7N9 VIRUS; HUMAN INFECTION	Purpose: A virologic surveillance program for A(H7N9) virus was conducted from April 15, 2013 to February 14, 2014 in Guangzhou, aiming to clarify the geographical distribution of A(H7N9) viruses among live poultry markets (LPMs) and poultry farms in Guangzhou. Virological and serological surveys of poultry workers were also conducted to evaluate the risk of poultry-to-human transmission of the A(H7N9) virus. Methods: 36 retail LPMs, 6 wholesale LPMs and 8 poultry farms were involved in our surveillance program. About 20 live poultry and environmental samples were obtained from each surveillance site at every sampling time. Different environmental samples were collected to represent different poultry-related work activities. RT-PCR and virus culture were performed to identify the A(H7N9) virus. Hemagglutinin inhibition assay and RT-PCR were conducted to detect possible A(H7N9) infection among poultry workers. Results: A total of 8900 live poultry and environmental samples were collected, of which 131(1.5%) were tested positive for A(H7N9) virus. 44.4% (16/36) of retail LPMs and 50.0% (3/6) of wholesale LPMs were confirmed to be contaminated. No positive samples was detected from poultry farms. A significant higher positive sample rate was found in environmental samples related to poultry selling (2.6%) and slaughtering (2.4%), compared to poultry holding (0.9%). Correspondingly, A(H7N9) viruses were isolated most frequently from slaughter zone. In addition, 316 poultry workers associated with the 19 contaminated-LPMs were recruited and a low seroprevalence (1.6%) of antibody against A(H7N9) virus was detected. An asymptomatic A(H7N9) infection was also identified by RT-PCR. Conclusions: Our study highlights the importance of conducting effective surveillance for A(H7N9) virus and provides evidence to support the assumption that slaughtering is the key process for the propagation of A(H7N9) virus in retail LPMs. Moreover, the ability of A(H7N9) virus to cross species barrier is proved to be still limited.	[Chen, Zongqiu; Li, Kuibiao; Luo, Lei; Lu, Enjie; Yuan, Jun; Liu, Hui; Lu, Jianyun; Di, Biao; Xiao, Xincai; Yang, Zhicong] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China		Xiao, XC (corresponding author), Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.	Biotin2001@163.com; yangzc@gzcdc.org.cn	Lu, Jianyun/AAU-4620-2020	Lu, Jianyun/0000-0002-1721-1862	National Science and Technology Major Projects of China [2012ZX100004213-005]; Science and Technology Program of Guangzhou, China [201102A213222]	National Science and Technology Major Projects of China; Science and Technology Program of Guangzhou, China	This work was supported by grants from the National Science and Technology Major Projects of China (No. 2012ZX100004213-005) and Science and Technology Program of Guangzhou, China (No. 201102A213222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai J, 2013, EUROSURVEILLANCE, V18, P4, DOI 10.2807/1560-7917.ES2013.18.26.20510; [Anonymous], 2013, LANCET INFECT DIS, V13, P465, DOI [10.1016/S1473-3099(13)70134-8, 10.1016/1473-3099(13)70134-8]; [Anonymous], WHO SER DET AV INFL; [Anonymous], WHO REAL TIM RT PCR; Bao CJ, 2013, N ENGL J MED; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Li Chuan-hua, 2004, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V18, P213; Li JE, 2013, SCI CHINA LIFE SCI, V56, P619, DOI 10.1007/s11427-013-4504-2; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Liao QY, 2009, EPIDEMICS-NETH, V1, P207, DOI 10.1016/j.epidem.2009.09.002; Liu Yang, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P1111; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Shi JZ, 2013, CHINESE SCI BULL, V58, P1857, DOI 10.1007/s11434-013-5873-4; SHORTRIDGE KF, 1982, LANCET, V2, P812; Wang M, 2006, EMERG INFECT DIS, V12, P1773, DOI 10.3201/eid1211.060675; Wang M, 2009, NEW ENGL J MED, V360, P2583, DOI 10.1056/NEJMc0900358; Wu H, 2013, N ENGL J MED; Yang SG, 2014, J INFECT DIS, V209, P265, DOI 10.1093/infdis/jit430; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6; Yuan Jun, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P1159; Zhang C, 2013, EURO SURVEILL, V18	23	24	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107266	10.1371/journal.pone.0107266	http://dx.doi.org/10.1371/journal.pone.0107266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216284	gold, Green Published, Green Submitted			2022-12-25	WOS:000341774300053
J	Meng, E; Mitra, A; Tripathi, K; Finan, MA; Scalici, J; McClellan, S; da Silva, LM; Reed, E; Shevde, LA; Palle, K; Rocconi, RP				Meng, Erhong; Mitra, Aparna; Tripathi, Kaushlendra; Finan, Michael A.; Scalici, Jennifer; McClellan, Steve; da Silva, Luciana Madeira; Reed, Eddie; Shevde, Lalita A.; Palle, Komaraiah; Rocconi, Rodney P.			ALDH1A1 Maintains Ovarian Cancer Stem Cell-Like Properties by Altered Regulation of Cell Cycle Checkpoint and DNA Repair Network Signaling	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE; BREAST-CANCER; CISPLATIN; RESISTANCE; CARCINOMA; MARKER; SUSCEPTIBILITY; IDENTIFICATION; COMBINATION; TRANSITION	Objective: Aldehyde dehydrogenase (ALDH) expressing cells have been characterized as possessing stem cell-like properties. We evaluated ALDH+ ovarian cancer stem cell-like properties and their role in platinum resistance. Methods: Isogenic ovarian cancer cell lines for platinum sensitivity (A2780) and platinum resistant (A2780/CP70) as well as ascites from ovarian cancer patients were analyzed for ALDH+ by flow cytometry to determine its association to platinum resistance, recurrence and survival. A stable shRNA knockdown model for ALDH1A1 was utilized to determine its effect on cancer stem cell-like properties, cell cycle checkpoints, and DNA repair mediators. Results: ALDH status directly correlated to platinum resistance in primary ovarian cancer samples obtained from ascites. Patients with ALDH(HIGH) displayed significantly lower progression free survival than the patients with ALDH(LOW) cells (9 vs. 3 months, respectively p<0.01). ALDH1A1-knockdown significantly attenuated clonogenic potential, PARP-1 protein levels, and reversed inherent platinum resistance. ALDH1A1-knockdown resulted in dramatic decrease of KLF4 and p21 protein levels thereby leading to S and G2 phase accumulation of cells. Increases in S and G2 cells demonstrated increased expression of replication stress associated Fanconi Anemia DNA repair proteins (FANCD2, FANCJ) and replication checkpoint (pS317 Chk1) were affected. ALDH1A1-knockdown induced DNA damage, evidenced by robust induction of gamma-H2AX and BAX mediated apoptosis, with significant increases in BRCA1 expression, suggesting ALDH1A1-dependent regulation of cell cycle checkpoints and DNA repair networks in ovarian cancer stem-like cells. Conclusion: This data suggests that ovarian cancer cells expressing ALDH1A1 may maintain platinum resistance by altered regulation of cell cycle checkpoint and DNA repair network signaling.	[Meng, Erhong; Mitra, Aparna; Tripathi, Kaushlendra; Finan, Michael A.; Scalici, Jennifer; McClellan, Steve; da Silva, Luciana Madeira; Palle, Komaraiah; Rocconi, Rodney P.] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA; [Reed, Eddie] Natl Inst Minor Hlth & Hlth Dispar, NIH, Bethesda, MD USA; [Shevde, Lalita A.] Univ Alabama Birmingham, Birmingham, AL USA	University of South Alabama; National Institutes of Health (NIH) - USA; NIH National Institute on Minority Health & Health Disparities (NIMHD); University of Alabama System; University of Alabama Birmingham	Palle, K (corresponding author), Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA.	kpalle@health.southalabama.edu; rocconi@health.southalabama.edu	tripathi, kaushlendra/O-3022-2013	tripathi, kaushlendra/0000-0002-3578-2917	Gynecologic Cancer Foundation Sherri's From a Whisper to a Roar; Women's Motorcycle Foundation Ovarian Cancer Research Award; Eleanor Ruth Frenkel Fund for Ovarian Cancer Research; NIH [R01GM098956]; Abraham Mitchell Endowment grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098956] Funding Source: NIH RePORTER	Gynecologic Cancer Foundation Sherri's From a Whisper to a Roar; Women's Motorcycle Foundation Ovarian Cancer Research Award; Eleanor Ruth Frenkel Fund for Ovarian Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abraham Mitchell Endowment grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Gynecologic Cancer Foundation Sherri's From a Whisper to a Roar, Women's Motorcycle Foundation Ovarian Cancer Research Award and The Eleanor Ruth Frenkel Fund for Ovarian Cancer Research (R.P.R); NIH grant R01GM098956, and Abraham Mitchell Endowment grant (K.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Bapat SA, 2010, REPRODUCTION, V140, P33, DOI 10.1530/REP-09-0389; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Cartee L, 1998, APOPTOSIS, V3, P439, DOI 10.1023/A:1009614703977; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; D'Andrea AD, 2003, CELL CYCLE, V2, P290, DOI 10.4161/cc.2.4.413; Eisenhauer EA, 1997, ANN ONCOL, V8, P963, DOI 10.1023/A:1008240421028; Er E, 2006, BBA-BIOENERGETICS, V1757, P1301, DOI 10.1016/j.bbabio.2006.05.032; Ghaleb AM, 2007, ONCOGENE, V26, P2365, DOI 10.1038/sj.onc.1210022; HARPER JW, 1993, CELL, V75, P805; He QZ, 2014, CELL PHYSIOL BIOCHEM, V33, P173, DOI 10.1159/000356660; Jia YS, 2012, CANCER CHEMOTH PHARM, V69, P377, DOI 10.1007/s00280-011-1708-7; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Kakarougkas A, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130685; Landen CN, 2010, MOL CANCER THER, V9, P3186, DOI 10.1158/1535-7163.MCT-10-0563; Li QTQ, 2013, INT J ONCOL, V43, P721, DOI 10.3892/ijo.2013.1996; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Mabuchi S, 2011, CLIN CANCER RES, V17, P4462, DOI 10.1158/1078-0432.CCR-10-2987; Madjd Z, 2013, ASIAN PAC J CANCER P, V14, P2789, DOI 10.7314/APJCP.2013.14.5.2789; Meng EH, 2012, CLIN EXP METASTAS, V29, P939, DOI 10.1007/s10585-012-9482-4; Palle K, 2011, CELL CYCLE, V10, P1625, DOI 10.4161/cc.10.10.15617; PARKER RJ, 1991, J CLIN INVEST, V87, P772, DOI 10.1172/JCI115080; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Shi MF, CELL MOL LIFE SCI CM, V67, P3915; Silva IA, 2011, CANCER RES, V71, P3991, DOI 10.1158/0008-5472.CAN-10-3175; Soltanian S, 2011, TUMOR BIOL, V32, P425, DOI 10.1007/s13277-011-0155-8; Steg AD, 2012, CLIN CANCER RES, V18, P869, DOI 10.1158/1078-0432.CCR-11-2188; Suman S, 2013, BRIT J CANCER, V109, P2587, DOI 10.1038/bjc.2013.642; Todaro M, 2010, CANCER RES, V70, P8874, DOI 10.1158/0008-5472.CAN-10-1994; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang YC, 2012, AM J PATHOL, V180, P1159, DOI 10.1016/j.ajpath.2011.11.015; Wu YL, 2009, CURR MOL MED, V9, P470, DOI 10.2174/156652409788167159; Xiang T, 2013, ONCOGENE; Yokota A, 2009, INT IMMUNOL, V21, P361, DOI 10.1093/intimm/dxp003; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhang ZC, 2014, CANCER RES, V74, P2869, DOI 10.1158/0008-5472.CAN-13-2032; ZHEN WP, 1992, MOL CELL BIOL, V12, P3689, DOI 10.1128/MCB.12.9.3689; Zhou QB, 2009, CANCER RES, V69, P8284, DOI 10.1158/0008-5472.CAN-09-1345; Zhou W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087409	45	98	100	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107142	10.1371/journal.pone.0107142	http://dx.doi.org/10.1371/journal.pone.0107142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216266	gold, Green Published, Green Submitted			2022-12-25	WOS:000341774300045
J	van der Wielen, N; van Avesaat, M; de Wit, NJW; Vogels, JTWE; Troost, F; Masclee, A; Koopmans, SJ; van der Meulen, J; Boekschoten, MV; Muller, M; Hendriks, HFJ; Witkamp, RF; Meijerink, J				van der Wielen, Nikkie; van Avesaat, Mark; de Wit, Nicole J. W.; Vogels, Jack T. W. E.; Troost, Freddy; Masclee, Ad; Koopmans, Sietse-Jan; van der Meulen, Jan; Boekschoten, Mark V.; Muller, Michael; Hendriks, Henk F. J.; Witkamp, Renger F.; Meijerink, Jocelijn			Cross-Species Comparison of Genes Related to Nutrient Sensing Mechanisms Expressed along the Intestine	PLOS ONE			English	Article							GLUCOSE COTRANSPORTER SGLT1; PEPTIDE-1 SECRETION; DIETARY-REGULATION; MOLECULAR-MECHANISMS; RECEPTOR EXPRESSION; SUCRASE-ISOMALTASE; TASTE RECEPTORS; AMINO-ACIDS; GUT; PIG	Introduction: Intestinal chemosensory receptors and transporters are able to detect food-derived molecules and are involved in the modulation of gut hormone release. Gut hormones play an important role in the regulation of food intake and the control of gastrointestinal functioning. This mechanism is often referred to as "nutrient sensing''. Knowledge of the distribution of chemosensors along the intestinal tract is important to gain insight in nutrient detection and sensing, both pivotal processes for the regulation of food intake. However, most knowledge is derived from rodents, whereas studies in man and pig are limited, and cross-species comparisons are lacking. Aim: To characterize and compare intestinal expression patterns of genes related to nutrient sensing in mice, pigs and humans. Methods: Mucosal biopsy samples taken at six locations in human intestine (n = 40) were analyzed by qPCR. Intestinal scrapings from 14 locations in pigs (n = 6) and from 10 locations in mice (n = 4) were analyzed by qPCR and microarray, respectively. The gene expression of glucagon, cholecystokinin, peptide YY, glucagon-like peptide-1 receptor, taste receptor T1R3, sodium/glucose cotransporter, peptide transporter-1, GPR120, taste receptor T1R1, GPR119 and GPR93 was investigated. Partial least squares (PLS) modeling was used to compare the intestinal expression pattern between the three species. Results and conclusion: The studied genes were found to display specific expression patterns along the intestinal tract. PLS analysis showed a high similarity between human, pig and mouse in the expression of genes related to nutrient sensing in the distal ileum, and between human and pig in the colon. The gene expression pattern was most deviating between the species in the proximal intestine. Our results give new insights in interspecies similarities and provide new leads for translational research and models aiming to modulate food intake processes in man.	[van der Wielen, Nikkie; van Avesaat, Mark; Troost, Freddy; Masclee, Ad; Boekschoten, Mark V.; Hendriks, Henk F. J.] Top Inst Food & Nutr, Wageningen, Netherlands; [van der Wielen, Nikkie; de Wit, Nicole J. W.; Boekschoten, Mark V.; Muller, Michael; Witkamp, Renger F.; Meijerink, Jocelijn] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [van Avesaat, Mark; Troost, Freddy; Masclee, Ad] Maastricht Univ, Med Ctr, NUTRIM, Dept Internal Med,Div Gastroenterol & Hepatol, Maastricht, Netherlands; [Koopmans, Sietse-Jan] Wageningen Univ, Dept Anim Sci, NL-6700 AP Wageningen, Netherlands; [Koopmans, Sietse-Jan; van der Meulen, Jan] Univ Wageningen & Res Ctr, Anim Sci Grp, Lelystad, Netherlands; [Hendriks, Henk F. J.] TNO, Netherlands Org Appl Sci Res, NL-3700 AJ Zeist, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research; Maastricht University; Wageningen University & Research; Animal Sciences Group of Wageningen UR; Wageningen University & Research; Netherlands Organization Applied Science Research	Meijerink, J (corresponding author), Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands.	jocelijn.meijerink@wur.nl	Witkamp, Renger/I-7622-2012; Muller, Michael/M-5724-2019; Muller, Michael/B-5795-2008; Hendriks, Henk/AAU-5987-2021; Boekschoten, Mark/AAS-4597-2021; Troost, Freddy/B-2782-2015	Witkamp, Renger/0000-0002-7935-8261; Muller, Michael/0000-0002-5930-9905; Muller, Michael/0000-0002-5930-9905; Boekschoten, Mark/0000-0002-2139-0795; van der Wielen, Nikkie/0000-0001-8450-5556; van der Meulen, Jan/0000-0002-9451-2335	program council of TI Food and Nutrition [WM-001]	program council of TI Food and Nutrition	This study was funded by the program council of TI Food and Nutrition (http://www.tifn.nl/) (grant WM-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balen D, 2008, AM J PHYSIOL-CELL PH, V295, pC475, DOI 10.1152/ajpcell.00180.2008; Berthoud HR, 2008, NEUROGASTROENT MOTIL, V20, P64, DOI 10.1111/j.1365-2982.2008.01104.x; Bezencon C, 2007, CHEM SENSES, V32, P41, DOI 10.1093/chemse/bjl034; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breen DM, 2013, DIABETES, V62, P3005, DOI 10.2337/db13-0523; Breer H, 2012, HISTOCHEM CELL BIOL, V138, P13, DOI 10.1007/s00418-012-0954-z; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Daly K, 2013, AM J PHYSIOL-GASTR L, V304, pG271, DOI 10.1152/ajpgi.00074.2012; Davidov E, 2004, OMICS, V8, P267, DOI 10.1089/omi.2004.8.267; de Wit NJW, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-14; de Wit NJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019145; Diakogiannaki E, 2013, DIABETOLOGIA, V56, P2688, DOI 10.1007/s00125-013-3037-3; Duca FA, 2013, INT J OBESITY, V37, P375, DOI 10.1038/ijo.2012.45; Dyer J, 2005, BIOCHEM SOC T, V33, P302, DOI 10.1042/BST0330302; ERICKSON RH, 1995, BIOCHEM BIOPH RES CO, V216, P249, DOI 10.1006/bbrc.1995.2617; Ezcurra M, 2013, CURR OPIN PHARMACOL, V13, P922, DOI 10.1016/j.coph.2013.08.013; Geraedts MCP, 2012, AM J PHYSIOL-ENDOC M, V303, pE464, DOI 10.1152/ajpendo.00163.2012; Goodman BE, 2010, ADV PHYSIOL EDUC, V34, P44, DOI 10.1152/advan.00094.2009; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Gribble FM, 2003, DIABETES, V52, P1147, DOI 10.2337/diabetes.52.5.1147; Guilloteau P, 2010, NUTR RES REV, V23, P4, DOI 10.1017/S0954422410000077; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Haid D, 2013, HISTOCHEM CELL BIOL, V140, P137, DOI 10.1007/s00418-013-1080-2; Hendriks WH, 2012, BRIT J NUTR, V108, pS247, DOI 10.1017/S0007114512002395; Herrera-Ruiz D, 2001, AAPS PHARMSCI, V3; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hudson BD, 2013, MOL PHARMACOL, V84, P710, DOI 10.1124/mol.113.087783; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Janssen S, 2013, TRENDS ENDOCRIN MET, V24, P92, DOI 10.1016/j.tem.2012.11.006; Jonsdottir K, 2008, OPEN PATHOLOGY J, V2; Kishi K, 1999, J NUTR, V129, P953, DOI 10.1093/jn/129.5.953; Korner M, 2007, J NUCL MED, V48, P736, DOI 10.2967/jnumed.106.038679; Kolodziejczak D, 2013, AM J PHYSIOL-GASTR L, V304, pG897, DOI 10.1152/ajpgi.00160.2012; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; Liou AP, 2013, J ANIM SCI, V91, P1946, DOI 10.2527/jas.2012-5910; Ma K, 2012, PHARM RES-DORDR, V29, P535, DOI 10.1007/s11095-011-0580-9; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Martens H., 1992, MULTIVARIATE CALIBRA; Masubuchi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054500; Moran AW, 2010, BRIT J NUTR, V104, P637, DOI 10.1017/S0007114510000917; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Perrier E, 2013, EUR J CLIN NUTR, V67, P939, DOI 10.1038/ejcn.2013.93; Rasoamanana R, 2012, P NUTR SOC, V71, P446, DOI 10.1017/S0029665112000110; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Richards P, 2013, DIABETES; ROWAN AM, 1994, BRIT J NUTR, V71, P29, DOI 10.1079/BJN19940108; Shiraga T, 1999, GASTROENTEROLOGY, V116, P354, DOI 10.1016/S0016-5085(99)70132-0; SJOLUND K, 1983, GASTROENTEROLOGY, V85, P1120; Tanaka T, 2008, N-S ARCH PHARMACOL, V377, P523, DOI 10.1007/s00210-007-0200-8; Thamotharan M, 1999, METABOLISM, V48, P681, DOI 10.1016/S0026-0495(99)90164-6; van den Bosch HM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-267; Van Haver ER, 2005, VLAAMS DIERGENEESKD, P65; Wang W, 2009, AMINO ACIDS, V37, P593, DOI 10.1007/s00726-008-0178-7; Widmayer P, 2012, INT J OBESITY, V36, P1353, DOI 10.1038/ijo.2011.216; Wopereis S, 2012, PHYSIOL GENOMICS, V44, P293, DOI 10.1152/physiolgenomics.00072.2011; YASUTAKE H, 1995, BBA-GEN SUBJECTS, V1243, P270, DOI 10.1016/0304-4165(94)00143-L; Young RL, 2013, DIABETES, V62, P3532, DOI 10.2337/db13-0581; Ziegler TR, 2002, AM J CLIN NUTR, V75, P922, DOI 10.1093/ajcn/75.5.922	61	35	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107531	10.1371/journal.pone.0107531	http://dx.doi.org/10.1371/journal.pone.0107531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216051	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000341774300074
J	Bolos, M; Hu, YL; Young, KM; Foa, L; Small, DH				Bolos, Marta; Hu, Yanling; Young, Kaylene M.; Foa, Lisa; Small, David H.			Neurogenin 2 Mediates Amyloid-beta Precursor Protein-stimulated Neurogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; ALZHEIMERS-DISEASE; NEURITE OUTGROWTH; INTRACELLULAR DOMAIN; PYRAMIDAL NEURONS; BHLH GENES; DIFFERENTIATION; PROLIFERATION; EXPRESSION	Amyloid-beta precursor protein (APP) is well studied for its role in Alzheimer disease, although its normal function remains uncertain. It has been reported that APP stimulates the proliferation and neuronal differentiation of neural stem/progenitor cells (NSPCs). In this study we examined the role of APP in NSPC differentiation. To identify proteins that may mediate the effect of APP on NSPC differentiation, we used a gene array approach to find genes whose expression correlated with APP-induced neurogenesis. We found that the expression of neurogenin 2 (Ngn2), a basic helix-loop-helix transcription factor, was significantly down-regulated in NSPCs from APP knock-out mice (APPKO) and increased in APP transgenic (Tg2576) mice. Ngn2 overexpression in APPKO NSPCs promoted neuronal differentiation, whereas siRNA knockdown of Ngn2 expression in wild-type NSPCs decreased neuronal differentiation. The results demonstrate that APP-stimulated neuronal differentiation of NSPCs is mediated by Ngn2.	[Bolos, Marta; Hu, Yanling; Young, Kaylene M.; Foa, Lisa; Small, David H.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas 7000, Australia; [Foa, Lisa] Univ Tasmania, Sch Med, Hobart, Tas 7000, Australia	University of Tasmania; University of Tasmania	Small, DH (corresponding author), Private Bag 23, Hobart, Tas 7001, Australia.	d.h.small@menzies.utas.edu.au	Foa, Lisa/J-7781-2014; Bolos, Marta/J-7620-2014	Foa, Lisa/0000-0003-4131-8341; Young, Kaylene/0000-0002-1686-3463; Bolos, Marta/0000-0003-2652-8607	National Health and Medical Research Council of Australia; BUPA/Alzheimer's Society UK; Multiple Sclerosis Research Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); BUPA/Alzheimer's Society UK; Multiple Sclerosis Research Australia	This work was supported by project grants from the National Health and Medical Research Council of Australia, BUPA/Alzheimer's Society UK and Multiple Sclerosis Research Australia.	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Ali F, 2011, DEVELOPMENT, V138, P4267, DOI 10.1242/dev.067900; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Chasseigneaux S, 2012, J NEUROCHEM, V120, P99, DOI 10.1111/j.1471-4159.2011.07584.x; CLARRIS HJ, 1995, DEV BRAIN RES, V88, P87, DOI 10.1016/0165-3806(95)00083-P; COCHRAN E, 1991, AM J PATHOL, V139, P485; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; CRAS P, 1991, P NATL ACAD SCI USA, V88, P7552, DOI 10.1073/pnas.88.17.7552; Dawkins E, 2014, J NEUROCHEM, V129, P756, DOI 10.1111/jnc.12675; Demars MP, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt77; Florio M, 2012, DEVELOPMENT, V139, P2308, DOI 10.1242/dev.075861; Freude KK, 2011, J BIOL CHEM, V286, P24264, DOI 10.1074/jbc.M111.227421; Galichet C, 2008, DEVELOPMENT, V135, P2031, DOI 10.1242/dev.015115; GENTLEMAN SM, 1993, PROG BRAIN RES, V96, P237; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hand R, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-30; HAYASHI Y, 1994, BIOCHEM BIOPH RES CO, V205, P936, DOI 10.1006/bbrc.1994.2755; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Hornsten A, 2007, P NATL ACAD SCI USA, V104, P1971, DOI 10.1073/pnas.0603997104; Hu YL, 2013, J BIOL CHEM, V288, P18853, DOI 10.1074/jbc.M112.443671; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Joshi P, 2009, DEV BIOL, V335, P1, DOI 10.1016/j.ydbio.2009.07.041; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Lassek M, 2013, J NEUROCHEM, V127, P48, DOI 10.1111/jnc.12358; Lee JA, 2007, ZEBRAFISH, V4, P277, DOI 10.1089/zeb.2007.0516; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; Li SQ, 2012, J NEUROSCI, V32, P7791, DOI 10.1523/JNEUROSCI.1309-12.2012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Toledano MA, 2004, J NEUROSCI, V24, P5439, DOI 10.1523/JNEUROSCI.0974-04.2004; Lopez-Toledano MA, 2007, J ALZHEIMERS DIS, V12, P229; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma YC, 2008, NEURON, V58, P65, DOI 10.1016/j.neuron.2008.01.037; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Megason SG, 2002, DEVELOPMENT, V129, P2087; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Octave JN, 2013, J NEUROCHEM, V126, P183, DOI 10.1111/jnc.12239; Porayette P, 2009, J BIOL CHEM, V284, P23806, DOI 10.1074/jbc.M109.026328; Ribes V, 2008, DEV BIOL, V321, P470, DOI 10.1016/j.ydbio.2008.06.003; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; SALBAUM JM, 1994, J EXP ZOOL, V269, P116, DOI 10.1002/jez.1402690205; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; Small D H, 1999, J Alzheimers Dis, V1, P275; Small DH, 2014, NEURODEGENER DIS, V13, P96, DOI 10.1159/000353686; SMALL DH, 1994, J NEUROSCI, V14, P2117; SMALL DH, 1992, J NEUROSCI, V12, P4143; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; TABATON M, 1992, BRAIN RES, V593, P299, DOI 10.1016/0006-8993(92)91323-7; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Tyan SH, 2012, MOL CELL NEUROSCI, V51, P43, DOI 10.1016/j.mcn.2012.07.009; Vogt DL, 2011, NEUROBIOL AGING, V32, P1725, DOI 10.1016/j.neurobiolaging.2009.09.002; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; Wilkinson G, 2013, NEUROSCIENCE, V253, P256, DOI 10.1016/j.neuroscience.2013.08.029; Williamson TG, 1996, J BIOL CHEM, V271, P31215, DOI 10.1074/jbc.271.49.31215; Yi SH, 2008, MOL THER, V16, P1873, DOI 10.1038/mt.2008.189; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Zhou FF, 2012, BBA-MOL CELL RES, V1823, P1233, DOI 10.1016/j.bbamcr.2012.05.011; Zhou ZD, 2011, CELL ADHES MIGR, V5, P280, DOI 10.4161/cam.5.4.16986	64	13	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31253	31261		10.1074/jbc.M114.581918	http://dx.doi.org/10.1074/jbc.M114.581918			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25217641	Green Published, hybrid			2022-12-25	WOS:000344549900030
J	Zhang, YS; Xia, JX; Li, QL; Yao, Y; Fades, G; Gernapudi, R; Duru, N; Kensler, TW; Zhou, Q				Zhang, Yongshu; Xia, Jixiang; Li, Qinglin; Yao, Yuan; Fades, Gabriel; Gernapudi, Ramkishore; Duru, Nadire; Kensler, Thomas W.; Zhou, Qun			NRF2/Long Noncoding RNA ROR Signaling Regulates Mammary Stem Cell Expansion and Protects against Estrogen Genotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; NRF2; KEAP1; IDENTIFICATION; ELECTROPHILE; EXPRESSION; INDUCTION; CYSTEINES; PATHWAY; STRESS	Long noncoding RNAs (lncRNAs) have emerged as key regulators of gene expression in embryonic stem cell (ESC) self-renewal and differentiation. In ESCs, lncRNAs are regulated at the genetic level via transcription factor binding to lncRNA gene promoters. Here we demonstrate that the key cytoprotective transcription factor NRF2 controls lncRNA expression in mammary stem cells. By profiling lncRNAs in wild-type and NRF2 knockdown mammary stem cells, we demonstrate that the lncRNA ROR, a regulator of embryonic stem cell pluripotency, is overexpressed upon NRF2 knockdown. We performed promoter analyses and examined predicted NRF2 binding elements in the ROR promoter using luciferase reporter constructs of a ROR promoter deletion series. Our studies revealed that NRF2 binds to two specific NRF2 response elements flanking the ROR promoter and that these two NRF2 response elements are equally important to suppress ROR transcription. In addition, we identified associated H3K27me3 chromatin modification and EZH2 binding at the ROR promoter that was dependent on NRF2 binding. We observed that NRF2 knockdown or ROR overexpression leads to increased stem cell self-renewal in mammary stem cells. Furthermore, we demonstrate Nrf2 regulation of the mammary stem cell population in vivo. These observations provide further evidence for the critical role of NRF2 in maintaining normal stem cell subpopulations in mammary epithelium.	[Zhang, Yongshu; Xia, Jixiang; Li, Qinglin; Yao, Yuan; Fades, Gabriel; Gernapudi, Ramkishore; Duru, Nadire; Zhou, Qun] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Kensler, Thomas W.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhou, Q (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	qzhou@som.umaryland.edu	Li, Qinglin/K-2570-2015; Kensler, Thomas W/D-8686-2014	Li, Qinglin/0000-0002-4125-1944; Kensler, Thomas W/0000-0002-6676-261X	National Institutes of Health from the NCI [R01 CA157779, 1F31CA183522]; American Cancer Society; NATIONAL CANCER INSTITUTE [T32CA154274, P30CA134274, F31CA183522, R01CA157779, R01CA094076] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA157779 from the NCI (to Q.Z.) and NCI 1F31CA183522 (to G. E.) and the American Cancer Society (to Q.Z.).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Baird L, 2013, P NATL ACAD SCI USA, V110, P15259, DOI 10.1073/pnas.1305687110; Chartoumpekis DV, 2011, DIABETES, V60, P2465, DOI 10.2337/db11-0112; Cuendet M, 2004, MUTAT RES-FUND MOL M, V550, P109, DOI 10.1016/j.mrfmmm.2004.02.005; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dontu G, 2005, J MAMMARY GLAND BIOL, V10, P75, DOI 10.1007/s10911-005-2542-5; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Li QL, 2014, J BIOL CHEM, V289, P1303, DOI 10.1074/jbc.M113.502278; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Niture SK, 2010, TOXICOL APPL PHARM, V244, P37, DOI 10.1016/j.taap.2009.06.009; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Tsai JJ, 2013, NAT CELL BIOL, V15, P309, DOI 10.1038/ncb2699; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Yao YA, 2010, BREAST CANCER RES TR, V124, P585, DOI 10.1007/s10549-010-1023-8; Yu SW, 2007, CURR CANCER DRUG TAR, V7, P416; Zhang YS, 2012, J BIOL CHEM, V287, P41514, DOI 10.1074/jbc.M112.404871	30	34	39	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31310	31318		10.1074/jbc.M114.604868	http://dx.doi.org/10.1074/jbc.M114.604868			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25231996	Green Published, hybrid			2022-12-25	WOS:000344549900035
J	Manicki, M; Majewska, J; Ciesielski, S; Schilke, B; Blenska, A; Kominek, J; Marszalek, J; Craig, EA; Dutkiewicz, R				Manicki, Mateusz; Majewska, Julia; Ciesielski, Szymon; Schilke, Brenda; Blenska, Anna; Kominek, Jacek; Marszalek, Jaroslaw; Craig, Elizabeth A.; Dutkiewicz, Rafal			Overlapping Binding Sites of the Frataxin Homologue Assembly Factor and the Heat Shock Protein 70 Transfer Factor on the Isu Iron-Sulfur Cluster Scaffold Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL CYSTEINE DESULFURASE; YEAST FRATAXIN; SACCHAROMYCES-CEREVISIAE; INTERACTING PROTEIN; BACTERIAL FRATAXIN; FRIEDREICH ATAXIA; COCHAPERONE HSCB; CHAPERONE JAC1; IN-VIVO; BIOGENESIS	In mitochondria FeS clusters, prosthetic groups critical for the activity of many proteins, are first assembled on Isu, a 14-kDa scaffold protein, and then transferred to recipient apo-proteins. The assembly process involves interaction of Isu with both Nfs1, the cysteine desulfurase serving as a sulfur donor, and the yeast frataxin homolog (Yfh1) serving as a regulator of desulfurase activity and/or iron donor. Here, based on the results of biochemical experiments with purified wild-type and variant proteins, we report that interaction of Yfh1 with both Nfs1 and Isu are required for formation of a stable tripartite assembly complex. Disruption of either Yfh1-Isu or Nfs1-Isu interactions destabilizes the complex. Cluster transfer to recipient apoprotein is known to require the interaction of Isu with the J-protein/ Hsp70 molecular chaperone pair, Jac1 and Ssq1. Here we show that the Yfh1 interaction with Isu involves the PVK sequence motif, which is also the site key for the interaction of Isu with Hsp70 Ssq1. Coupled with our previous observation that Nfs1 and Jac1 binding to Isu is mutually exclusive due to partially overlapping binding sites, we propose that such mutual exclusivity of cluster assembly factor (Nfs1/Yfh1) and cluster transfer factor (Jac1/Ssq1) binding to Isu has functional consequences for the transition from the assembly process to the transfer process, and thus regulation of the biogenesis of FeS cluster proteins.	[Manicki, Mateusz; Majewska, Julia; Blenska, Anna; Kominek, Jacek; Marszalek, Jaroslaw; Dutkiewicz, Rafal] Univ Gdansk, Intercollegiate Fac Biotechnol, PL-80822 Gdansk, Poland; [Manicki, Mateusz; Majewska, Julia; Blenska, Anna; Kominek, Jacek; Marszalek, Jaroslaw; Dutkiewicz, Rafal] Med Univ Gdansk, PL-80822 Gdansk, Poland; [Majewska, Julia; Ciesielski, Szymon; Schilke, Brenda; Marszalek, Jaroslaw; Craig, Elizabeth A.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; University of Wisconsin System; University of Wisconsin Madison	Marszalek, J (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, PL-80822 Gdansk, Poland.	jaroslaw.marszalek@biotech.ug.edu.pl; ecraig@wisc.edu	Dutkiewicz, Rafal/ABE-6979-2020	Dutkiewicz, Rafal/0000-0003-4150-0450; Kominek, Jacek/0000-0002-1916-0122; Marszalek, Jaroslaw/0000-0002-6978-1189; Ciesielski, Szymon/0000-0002-9041-7162	National Institutes of Health [GM27870]; Polish National Science Center [DEC-2012/06/A/NZ1/00002]; Foundation for Polish Science International [MPD/2010/5]; European Union European Regional Development Fund, Operational Program Innovative Economy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish National Science Center; Foundation for Polish Science International; European Union European Regional Development Fund, Operational Program Innovative Economy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM27870 (to E. A. C), Polish National Science Center Grant DEC-2012/06/A/NZ1/00002 (to J. M.), and Foundation for Polish Science International Ph.D. Projects Grant MPD/2010/5 co-financed by the European Union European Regional Development Fund, Operational Program Innovative Economy 2007-2013 (to J. M.).	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Andrew AJ, 2006, J BIOL CHEM, V281, P14580, DOI 10.1074/jbc.M600842200; Bonomi F, 2011, BIOCHEMISTRY-US, V50, P9641, DOI 10.1021/bi201123z; Bonomi F, 2008, BIOCHEMISTRY-US, V47, P12795, DOI 10.1021/bi801565j; Bridwell-Rabb J, 2014, BIOCHEMISTRY-US, V53, P4904, DOI 10.1021/bi500532e; Bridwell-Rabb J, 2012, BIOCHEMISTRY-US, V51, P2506, DOI 10.1021/bi201628j; Bridwell-Rabb J, 2011, BIOCHEMISTRY-US, V50, P7265, DOI 10.1021/bi200895k; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Chandramouli K, 2006, BIOCHEMISTRY-US, V45, P11087, DOI 10.1021/bi061237w; Ciesielski SJ, 2012, J MOL BIOL, V417, P1, DOI 10.1016/j.jmb.2012.01.022; Colin F, 2013, J AM CHEM SOC, V135, P733, DOI 10.1021/ja308736e; Cook JD, 2010, BIOCHEMISTRY-US, V49, P8756, DOI 10.1021/bi1008613; Dutkiewicz R, 2004, J BIOL CHEM, V279, P29167, DOI 10.1074/jbc.M402947200; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; Foury F, 2007, EMBO REP, V8, P194, DOI 10.1038/sj.embor.7400881; Fuzery AK, 2008, BIOCHEMISTRY-US, V47, P9394, DOI 10.1021/bi800502r; Garland SA, 1999, J MOL BIOL, V294, P897, DOI 10.1006/jmbi.1999.3294; Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hoff KG, 2003, J BIOL CHEM, V278, P37582, DOI 10.1074/jbc.M305292200; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jaschkowitz K, 2000, BIOCHEMISTRY-US, V39, P3416, DOI 10.1021/bi992147c; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim JH, 2013, J AM CHEM SOC, V135, P8117, DOI 10.1021/ja401950a; Kim JH, 2009, BIOCHEMISTRY-US, V48, P6062, DOI 10.1021/bi9002277; Leidgens S, 2010, HUM MOL GENET, V19, P276, DOI 10.1093/hmg/ddp495; Li HQ, 2013, J BIOL CHEM, V288, P4116, DOI 10.1074/jbc.M112.435263; Li HQ, 2009, J BIOL CHEM, V284, P21971, DOI 10.1074/jbc.M109.011197; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Majewska J, 2013, J BIOL CHEM, V288, P29134, DOI 10.1074/jbc.M113.503524; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Martelli A, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00130; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Naamati A, 2009, J BIOL CHEM, V284, P30200, DOI 10.1074/jbc.M109.034694; Nakai Y, 2001, J BIOL CHEM, V276, P8314, DOI 10.1074/jbc.M007878200; Pandey A, 2013, J BIOL CHEM, V288, P36773, DOI 10.1074/jbc.M113.525857; Pandey A, 2012, BIOCHEM J, V448, P171, DOI 10.1042/BJ20120951; Pareek G, 2011, J BIOL CHEM, V286, P19001, DOI 10.1074/jbc.M110.197434; Pastore A, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00020; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Richards TA, 2006, MOL BIOL EVOL, V23, P1341, DOI 10.1093/molbev/msl001; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038; SHERMAN F, 1991, METHODS ENZYMOL, V194, P3; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; Smith AD, 2001, J AM CHEM SOC, V123, P11103, DOI 10.1021/ja016757n; Stehling O, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011312; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; THORPE GHG, 1985, CLIN CHEM, V31, P1335; Tsai CL, 2011, BIOCHEMISTRY-US, V50, P6478, DOI 10.1021/bi200666h; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; Vaubel RA, 2013, MOL CELL NEUROSCI, V55, P50, DOI 10.1016/j.mcn.2012.08.003; Vickery LE, 2007, CRIT REV BIOCHEM MOL, V42, P95, DOI 10.1080/10409230701322298; Voisine C, 2000, MOL CELL BIOL, V20, P3677, DOI 10.1128/MCB.20.10.3677-3684.2000; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Yan R, 2013, J BIOL CHEM, V288, P24777, DOI 10.1074/jbc.M113.480327	62	33	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30268	30278		10.1074/jbc.M114.596726	http://dx.doi.org/10.1074/jbc.M114.596726			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25228696	hybrid, Green Published			2022-12-25	WOS:000344549700011
J	Srivastava, SK; Wolinski, P; Pereira, A				Srivastava, Subodh K.; Wolinski, Pawel; Pereira, Andy			A Strategy for Genome-Wide Identification of Gene Based Polymorphisms in Rice Reveals Non-Synonymous Variation and Functional Genotypic Markers	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; SEQUENCE; SNP; DISCOVERY; EVOLUTION; VARIETIES; MAP	The genetic diversity of plants has traditionally been employed to improve crop plants to suit human needs, and in the future feed the increasing population and protect crops from environmental stresses and climate change. Genome-wide sequencing is a reality and can be used to make association to crop traits to be utilized by high-throughput marker based selection methods. This study describes a strategy of using next generation sequencing (NGS) data from the rice genome to make comparisons to the high-quality reference genome, identify functional polymorphisms within genes that might result in function changes and be used to study correlations to traits and employed in genetic mapping. We analyzed the NGS data of Oryza sativa ssp indica cv. G4 covering 241 Mb with similar to 20X coverage and compared to the reference genome of Oryza sativa ssp. japonica to describe the genome-wide distribution of gene-based single nucleotide polymorphisms (SNPs). The analysis shows that the 63% covered genome consists of 1.6 million SNPs with 6.9 SNPs/Kb, and including 80,146 insertions and 92,655 deletions (INDELs) genome-wide. There are a total of 1,139,801 intergenic SNPs, 295,136 SNPs in intronic/non-coding regions, 195,098 in coding regions, 23,242 SNPs at the five-prime (5') UTR regions and 22,686 SNPs at the three-prime (39) UTR region. SNP variation was found in 40,761 gene loci, which include 75,262 synonymous and 119,836 non-synonymous changes, and functional reading frame changes through 3,886 inducing STOP-codon (isSNP) and 729 preventing STOP-codon (psSNP) variation. There are quickly evolving 194 high SNP hotspot genes (>100 SNPs/gene), and 1,513 out of 2,458 transcription factors displaying 2,294 non-synonymous SNPs that can be a major source of phenotypic diversity within the species. All data is searchable at https://plantstress-pereira.uark.edu/oryza2. We envision that this strategy will be useful for the identification of genes for crop traits and molecular breeding of rice cultivars.	[Srivastava, Subodh K.; Pereira, Andy] Univ Arkansas, Fayetteville, AR 72701 USA; [Wolinski, Pawel] Univ Arkansas, Arkansas High Performance Comp Ctr, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Pereira, A (corresponding author), Univ Arkansas, Fayetteville, AR 72701 USA.	apereira@uark.edu	Pereira, Andy/AAF-4781-2020	Pereira, Andy/0000-0003-1378-4273	AP National Science Foundation, Plant Genome Research Program award [DBI-0922747]	AP National Science Foundation, Plant Genome Research Program award	This work is supported by AP National Science Foundation, Plant Genome Research Program award DBI-0922747, http://www.nsf.gov/awardsearch/showAward?AWD_ID=0922747. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Blanco C, 2005, INT J DEV BIOL, V49, P717, DOI 10.1387/ijdb.051994ca; Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; Arai-Kichise Y, 2011, PLANT CELL PHYSIOL, V52, P274, DOI 10.1093/pcp/pcr003; Bent AF, 2001, P NATL ACAD SCI USA, V98, P784, DOI 10.1073/pnas.98.3.784; Bevan M, 2011, NATURE, V477, P415, DOI 10.1038/477415a; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Cannon Ethalinda K S, 2011, Int J Plant Genomics, V2011, P373875, DOI 10.1155/2011/373875; Chen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013574; Choisne N, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-20; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Dunand C, 2011, PLANT SIGNAL BEHAV, V6, P1908, DOI 10.4161/psb.6.12.18098; Feltus FA, 2004, GENOME RES, V14, P1812, DOI 10.1101/gr.2479404; Ganal MW, 2009, CURR OPIN PLANT BIOL, V12, P211, DOI 10.1016/j.pbi.2008.12.009; Gao G, 2006, BIOINFORMATICS, V22, P1286, DOI 10.1093/bioinformatics/btl107; Gerke J, 2009, SCIENCE, V323, P498, DOI 10.1126/science.1166426; Han B, 2003, CURR OPIN PLANT BIOL, V6, P134, DOI 10.1016/S1369-5266(03)00004-9; Han B, 2007, PHILOS T R SOC B, V362, P1009, DOI 10.1098/rstb.2007.2030; Huang XH, 2008, PLANT PHYSIOL, V148, P25, DOI 10.1104/pp.108.121491; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jain M, 2006, FEBS J, V273, P5245, DOI 10.1111/j.1742-4658.2006.05518.x; Jiang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063551; Jiang YH, 2012, BIOTECHNOL ADV, V30, P1059, DOI 10.1016/j.biotechadv.2011.08.013; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Lazzarotto F, 2011, NEW PHYTOL, V191, P234, DOI 10.1111/j.1469-8137.2011.03659.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Lu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034021; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; McNally KL, 2006, PLANT PHYSIOL, V141, P26, DOI 10.1104/pp.106.077313; Monna L, 2002, DNA RES, V9, P11, DOI 10.1093/dnares/9.1.11; Mottagui-Tabar S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-18; Ng M, 2001, NAT REV GENET, V2, P186, DOI 10.1038/35056041; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Nowick K, 2010, BRIEF FUNCT GENOMICS, V9, P65, DOI 10.1093/bfgp/elp056; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Parry MAJ, 2009, J EXP BOT, V60, P2817, DOI 10.1093/jxb/erp189; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Sahu BB, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-20; Salisbury BA, 2003, MUTAT RES-FUND MOL M, V526, P53, DOI 10.1016/S0027-5107(03)00014-9; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Sumit R, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-87; TANAKA KI, 1995, PLANT PHYSIOL, V108, P677, DOI 10.1104/pp.108.2.677; Tripathi LP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-200; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Xu SQ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-93; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050	50	6	6	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e105335	10.1371/journal.pone.0105335	http://dx.doi.org/10.1371/journal.pone.0105335			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25237817	Green Published, gold, Green Submitted			2022-12-25	WOS:000342491600003
J	Onwuamah, CK; Ezechi, OC; Herbertson, EC; Audu, RA; Ujah, IAO; Odeigah, PGC				Onwuamah, Chika K.; Ezechi, Oliver C.; Herbertson, Ebiere C.; Audu, Rosemary A.; Ujah, Innocent A. O.; Odeigah, Peter G. C.			Foetal Loss and Enhanced Fertility Observed in Mice Treated with Zidovudine or Nevirapine	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; HUMAN LYMPHOBLASTOID-CELLS; HUMAN-IMMUNODEFICIENCY-VIRUS; IN-VITRO FERTILIZATION; HIV-INFECTED WOMEN; DNA INCORPORATION; LONG-TERM; PERINATAL EXPOSURE; 3'-AZIDO-3'-DEOXYTHYMIDINE AZT; MUTANT FREQUENCY	Background: Health concerns for HIV-infected persons on antiretroviral therapy (ART) have moved from morbidity to the challenges of long-term ART. We investigated the effect of Zidovudine or Nevirapine on reproductive capacity across two mouse generations. Methods: A prospective mouse study with drugs administered through one spermatogenic cycle. Mouse groups (16 males and 10 females) were given Zidovudine or Nevirapine for 56 days. Males were mated to untreated virgin females to determine dominant lethal effects. Twenty females (10 treated and 10 untreated) mated with the treated males per dose and gave birth to the F-1 generation. Parental mice were withdrawn from drugs for one spermatogenic cycle and mated to the same dams to ascertain if effects are reversible. The F-1 generation were exposed for another 56 days and mated to produce the F-2 generation. Results: Foetal loss was indicated in the dominant lethal assay as early as four weeks into drug administration to the males. At the first mating of the parental generation to produce the F-1 generation, births from 10 dams/dose when the 'father-only' was exposed to Zidovudine (10, 100 and 250 mg/kg) was 3, 2 and 1 while it was 7, 1 and 4 respectively when 'both-parents' were exposed. Similarly births from the parental generation first mating when the 'father-only' was exposed to Nevirapine (5, 50 and 150 mg/kg) was 2, 2 and 0 while it was 6, 5 and 9 respectively when 'both-parents' were exposed. However, fertility was not significantly different neither by dose nor by the parental exposure. The F-1 mice mated to produce the F-2 generation recorded only one birth. Conclusion: The dominant lethal analysis showed foetal loss occurred when the "fathers-only'' were treated while fertility was enhanced when "both-parents'' were on therapy at the time of mating.	[Onwuamah, Chika K.; Audu, Rosemary A.] Nigerian Inst Med Res, Human Virol Lab, Lagos, Nigeria; [Ezechi, Oliver C.; Herbertson, Ebiere C.; Ujah, Innocent A. O.] Nigerian Inst Med Res, Div Clin Sci, Lagos, Nigeria; [Odeigah, Peter G. C.] Univ Lagos, Dept Cell Biol & Genet, Fac Sci, Lagos, Nigeria	University of Lagos	Onwuamah, CK (corresponding author), Nigerian Inst Med Res, Human Virol Lab, Lagos, Nigeria.	chikaonwuamah@yahoo.com	Audu, Rosemary A/G-1726-2017; HERBERTSON, Ebiere Clara/GON-5820-2022; Onwuamah, Chika Kingsley/ABB-9926-2020	Audu, Rosemary A/0000-0002-0330-5219; HERBERTSON, Ebiere Clara/0000-0002-8219-8035; Onwuamah, Chika Kingsley/0000-0002-5111-1822	Centre for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA	Centre for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA	There were no external funding sources for this study. This work was self-sponsored by Dr Onwuamah as part of his doctoral research. Dr Poirier also provided some reagents and she is supported by the Intramural research program of the Centre for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ba A, 2013, NUTR NEUROSCI, V16, P69, DOI 10.1179/1476830512Y.0000000032; Biotechnology and Biological Sciences Research Council (BBSRC), REPL REF RED 3RS RES; Birungi H, 2009, J ADOLESCENT HEALTH, V44, P184, DOI 10.1016/j.jadohealth.2008.06.004; Borojerdi JP, 2009, MUTAT RES-FUND MOL M, V665, P67, DOI 10.1016/j.mrfmmm.2009.03.004; Coll O, 2006, AIDS, V20, P121, DOI 10.1097/01.aids.0000196161.25647.35; Council for International Organization of Medical Sciences (CIOMS), 1985, INT GUID PRINC BIOM; Culnane M, 1999, JAMA-J AM MED ASSOC, V281, P151, DOI 10.1001/jama.281.2.151; Divi RL, 2007, ENVIRON MOL MUTAGEN, V48, P179, DOI 10.1002/em.20245; Diwan BA, 1999, TOXICOL APPL PHARM, V161, P82, DOI 10.1006/taap.1999.8782; Diwan BA, 2000, TOXICOL LETT, V115, P9, DOI 10.1016/S0378-4274(99)00298-2; Dutra A, 2010, CYTOGENET GENOME RES, V128, P105, DOI 10.1159/000298794; Enzmann EV, 1935, J GEN PHYSIOL, V18, P791, DOI 10.1085/jgp.18.6.791; Escobar PA, 2007, ENVIRON MOL MUTAGEN, V48, P330, DOI 10.1002/em.20285; Frodsham LCG, 2004, HUM REPROD, V19, P2420, DOI 10.1093/humrep/deh358; Manigart Y, 2006, HUM REPROD, V21, P2935, DOI 10.1093/humrep/del277; MANN MA, 1983, PHYSIOL BEHAV, V30, P697, DOI 10.1016/0031-9384(83)90165-8; Meng QX, 2000, P NATL ACAD SCI USA, V97, P12667, DOI 10.1073/pnas.220203197; Meng QX, 2000, TOXICOL SCI, V54, P322, DOI 10.1093/toxsci/54.2.322; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; Odeigah PGC, 1997, MUTAT RES-GEN TOX EN, V389, P141, DOI 10.1016/S1383-5718(96)00136-2; OECD/OCDE, 2001, 2 GEN REPR TOX STUD; OECD/OCDE, 1984, GEN TOX ROD DOM LETH; Olivero OA, 2005, MUTAGENESIS, V20, P139, DOI 10.1093/mutage/gei019; OLIVERO OA, 1994, CANCER RES, V54, P6235; Olivero OA, 1999, AIDS, V13, P919, DOI 10.1097/00002030-199905280-00007; Olivero OA, 2000, ANN NY ACAD SCI, V918, P262; Olivero OA, 1997, J NATL CANCER I, V89, P1602, DOI 10.1093/jnci/89.21.1602; Olivero OA, 1999, MUTAT RES-FUND MOL M, V428, P41, DOI 10.1016/S1383-5742(99)00030-7; OLIVERO OA, 1993, MOL CARCINOGEN, V8, P81, DOI 10.1002/mc.2940080204; Olivero OA, 2014, ENVIRON MOL MUTAGEN, V55, P566, DOI 10.1002/em.21872; Olivero OA, 2013, J INFECT DIS, V208, P244, DOI 10.1093/infdis/jit146; Olivero OA, 2010, TOXICOL SCI, V115, P109, DOI 10.1093/toxsci/kfq023; Poirier MC, 1999, J ACQ IMMUN DEF SYND, V22, P477; Poirier MC, 2003, JAIDS-J ACQ IMM DEF, V33, P175, DOI 10.1097/00126334-200306010-00010; REYNOLDS RD, 1981, SCIENCE, V213, P1146, DOI 10.1126/science.7268426; Sauer MV, 2009, FERTIL STERIL, V91, P2455, DOI 10.1016/j.fertnstert.2008.04.013; SCHARDEIN JL, 1978, LAB ANIM, V12, P81, DOI 10.1258/002367778780953080; Sussman HE, 1999, MUTAT RES-FUND MOL M, V429, P249, DOI 10.1016/S0027-5107(99)00111-6; Vernazza P, 2008, AIDS, V22, P647, DOI 10.1097/QAD.0b013e3282f4de4d; Walker VE, 2007, ENVIRON MOL MUTAGEN, V48, P159, DOI 10.1002/em.20296; Yu M, 2009, ENVIRON MOL MUTAGEN, V50, P718, DOI 10.1002/em.20509	41	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107899	10.1371/journal.pone.0107899	http://dx.doi.org/10.1371/journal.pone.0107899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233270	Green Published, gold, Green Submitted			2022-12-25	WOS:000342921200060
J	Savalli, C; Ades, C; Gaunet, F				Savalli, Carine; Ades, Cesar; Gaunet, Florence			Are Dogs Able to Communicate with Their Owners about a Desirable Food in a Referential and Intentional Way?	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; ORANGUTANS PONGO-PYGMAEUS; FALSE DISCOVERY RATE; CANIS-FAMILIARIS; DOMESTIC DOGS; GAZE ALTERNATION; PET DOGS; HUMANS; COMPREHENSION; ELABORATION	The ability of dogs to use human communicative signals has been exhaustively studied. However, few studies have focused on the production of communicative signals by dogs. The current study investigated if dogs are able to communicate by using directional signals towards some desirable object in the environment and also if they show an apparent intention to manipulate their owner's behavior in order to receive it. Some operational criteria were used to investigate referential and intentional communication: the signal should be influenced by the audience and by the recipient's direction of visual attention; the sender should display gaze alternations between the recipient and the object and attention-getting behaviors, and, finally, the sender should persist and elaborate the communication when attempts to manipulate the recipient failed. Aiming to investigate these criteria in dogs, 29 subjects were tested using an experimental set up in which they could see a desirable but unreachable food and they needed the cooperation of their owners in order to receive it. This study found evidence of all operational criteria, especially for gaze alternation between the owner and the food, which suggested that some dogs' communicative behaviors could be functionally referential and intentional. Nevertheless, similar to other studies about social cognition in animals, it is not possible to distinguish if the dog's behaviors are based on simple mechanisms or on a theory of mind about their owners.	[Savalli, Carine] Univ Fed Sao Paulo, Dept Publ Polit & Publ Hlth, Santos, SP, Brazil; [Ades, Cesar] Univ Sao Paulo, Dept Expt Psychol, Sao Paulo, Brazil; [Gaunet, Florence] Aix Marseille Univ, CNRS, Lab Psychol Cognit, UMR7290, Marseille, France	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Savalli, C (corresponding author), Univ Fed Sao Paulo, Dept Publ Polit & Publ Hlth, Santos, SP, Brazil.	carine.savalli@unifesp.br	Savalli, Carine/AAN-4137-2021	Savalli, Carine/0000-0001-7388-7616				Anderson JR, 2007, ANIM COGN, V10, P267, DOI 10.1007/s10071-006-0065-0; BATES E, 1975, MERRILL PALMER QUART, V21, P205; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentosela M, 2008, BEHAV PROCESS, V78, P464, DOI 10.1016/j.beproc.2008.03.004; Brauer J, 2004, APPL ANIM BEHAV SCI, V88, P299, DOI 10.1016/j.applanim.2004.03.004; CALL J, 1994, J COMP PSYCHOL, V108, P307, DOI 10.1037/0735-7036.108.4.307; Call J, 2003, J COMP PSYCHOL, V117, P257, DOI 10.1037/0735-7036.117.3.257; Cartmill EA, 2007, CURR BIOL, V17, P1345, DOI 10.1016/j.cub.2007.06.069; Cartmill EA, 2010, ANIM COGN, V13, P793, DOI 10.1007/s10071-010-0328-7; Fiset S, 2003, ANIM COGN, V6, P1, DOI 10.1007/s10071-002-0157-4; Fiset S, 2007, ANIM COGN, V10, P211, DOI 10.1007/s10071-006-0060-5; Gacsi M, 2004, ANIM COGN, V7, P144, DOI 10.1007/s10071-003-0205-8; Gaunet F, 2008, ANIM COGN, V11, P475, DOI 10.1007/s10071-008-0138-3; Gaunet F, 2014, ANIM COGN, V17, P1137, DOI 10.1007/s10071-014-0746-z; Gaunet F, 2011, ANIM COGN, V14, P849, DOI 10.1007/s10071-011-0418-1; Gaunet F, 2010, ANIM COGN, V13, P311, DOI 10.1007/s10071-009-0279-z; Genty E, 2009, ANIM COGN, V12, P527, DOI 10.1007/s10071-009-0213-4; Hare B., 1998, EVOL COMMUN, V2, P137; Hopkins WD, 2007, ANIM BEHAV, V73, P281, DOI 10.1016/j.anbehav.2006.08.004; Hostetter AB, 2001, J COMP PSYCHOL, V115, P337, DOI 10.1037//0735-7036.115.4.337; Kaminski J, 2004, ANIM COGN, V7, P216, DOI 10.1007/s10071-004-0214-2; Kaminski J, 2011, ANIM BEHAV, V82, P651, DOI 10.1016/j.anbehav.2011.06.015; Kaminski J, 2009, BEHAVIOUR, V146, P979, DOI 10.1163/156853908X395530; Kubinyi E, 2007, COMP COGN BEHAV REV, V2, P26; Leavens DA, 2005, CURR DIR PSYCHOL SCI, V14, P185, DOI 10.1111/j.0963-7214.2005.00361.x; Leavens DA, 2005, CHILD DEV, V76, P291, DOI 10.1111/j.1467-8624.2005.00845.x; Leavens DA, 2004, J COMP PSYCHOL, V118, P48, DOI 10.1037/0735-7036.118.1.48; Leavens DA, 2010, ANIM COGN, V13, P33, DOI 10.1007/s10071-009-0242-z; Liebal K, 2004, AM J PRIMATOL, V64, P377, DOI 10.1002/ajp.20087; Liszkowski U, 2011, J COGN EDUC PSYCHOL, V10, P32, DOI 10.1891/1945-8959.10.1.32; Marshall-Pescini S, 2013, ANIM COGN, V16, P933, DOI 10.1007/s10071-013-0627-x; Merola I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047653; Meunier H, 2013, ANIM COGN, V16, P155, DOI 10.1007/s10071-012-0558-y; Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1; MikluEsi A., 2000, ANIM COGN, V3, P159, DOI [DOI 10.1007/S100710000072, 10.1007/s100710000072]; Roberts AI, 2013, ANIM COGN, V16, P187, DOI 10.1007/s10071-012-0563-1; Rossi AP, 2008, ANIM COGN, V11, P329, DOI 10.1007/s10071-007-0122-3; Russell JL, 2005, ANIM COGN, V8, P263, DOI 10.1007/s10071-005-0253-3; Savalli C, 2009, J VET BEHAV, V4, P55; Schel AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076674; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Tomasello M, 2007, CHILD DEV, V78, P705, DOI 10.1111/j.1467-8624.2007.01025.x; Viranyi Z, 2004, BEHAV PROCESS, V66, P161, DOI 10.1016/j.beproc.2004.01.012; Wynne CDL, 2008, ANIM BEHAV, V76, pE1, DOI 10.1016/j.anbehav.2008.03.010; Zimmermann F, 2009, ANIM COGN, V12, P347, DOI 10.1007/s10071-008-0194-8	46	28	28	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e108003	10.1371/journal.pone.0108003	http://dx.doi.org/10.1371/journal.pone.0108003			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ6KR	25232956	Green Published, gold, Green Submitted			2022-12-25	WOS:000342921200072
J	Langiu, M; Dadparvar, M; Kreuter, J; Ruonala, MO				Langiu, Monica; Dadparvar, Miriam; Kreuter, Joerg; Ruonala, Mika O.			Human Serum Albumin-Based Nanoparticle-Mediated In Vitro Gene Delivery	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; MOUSE MODEL; TRANSPORT; POLYETHYLENIMINE; DRUGS; COMPLEXES; KINETICS; THERAPY; ENTER; RATS	The genetic treatment of neurodegenerative diseases still remains a challenging task since many approaches fail to deliver the therapeutic material in relevant concentrations into the brain. As viral vectors comprise the risk of immune and inflammatory responses, human serum albumin (HSA) nanoparticles were found to represent a safer and more convenient alternative. Their ability to cross the blood-brain barrier (BBB) and deliver drugs into the brain in order to enhance gene-based therapy has been previously demonstrated. The present study deals with the development of pGL3-PEI-coated HSA nanoparticles and subsequent in vitro testing in cerebellar granular and HeLa cells. The luciferase control vector pGL3 was chosen as reporter plasmid encoding for the firefly luciferase protein, linear polyethylenimine (22 kDa) as endosomolytic agent for enhancing the cells' transfection. Studies on particle characteristics, their cellular uptake into aforementioned cell lines and on subcellular localisation, and transfection efficiency in the cerebellar cells proved the feasibility of nanoparticle-based gene delivery.	[Langiu, Monica; Dadparvar, Miriam; Ruonala, Mika O.] Goethe Univ Frankfurt, Ctr Membrane Prote, D-60054 Frankfurt, Germany; [Dadparvar, Miriam; Kreuter, Joerg] Goethe Univ Frankfurt, Inst Pharmaceut Technol, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Ruonala, MO (corresponding author), Goethe Univ Frankfurt, Ctr Membrane Prote, D-60054 Frankfurt, Germany.	ruonala@em.uni-frankfurt.de		Langiu, Monica/0000-0003-0719-8999	Foundation for JNCL Research (Oulu, Finland); ZZF (Den Haag, Netherlands); BeatBatten! Foundation (Driebergen-Zeist, Netherlands); Center for Membrane Proteomics (Frankfurt, Germany)	Foundation for JNCL Research (Oulu, Finland); ZZF (Den Haag, Netherlands); BeatBatten! Foundation (Driebergen-Zeist, Netherlands)(Netherlands Government); Center for Membrane Proteomics (Frankfurt, Germany)	This work was financially supported by Foundation for JNCL Research (Oulu, Finland), ZZF (Den Haag, Netherlands), BeatBatten! Foundation (Driebergen-Zeist, Netherlands), and the Center for Membrane Proteomics (Frankfurt, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi S, 2011, CELL BIOCH BIOPHYS; Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]; Beck M, 2007, HUM GENET, V121, P1, DOI 10.1007/s00439-006-0280-4; Begley DJ, 1996, J PHARM PHARMACOL, V48, P136, DOI 10.1111/j.2042-7158.1996.tb07112.x; Brightman M W, 1992, NIDA Res Monogr, V120, P87; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Coppede F, 2006, BIOSCIENCE REP, V26, P341, DOI 10.1007/s10540-006-9028-6; Crystal RG, 2004, HUM GENE THER, V15, P1131; Dadparvar M, 2011, TOXICOL LETT, V206, P60, DOI 10.1016/j.toxlet.2011.06.027; Goula D, 1998, GENE THER, V5, P712, DOI 10.1038/sj.gt.3300635; Kreuter J, 2004, J NANOSCI NANOTECHNO, V4, P484, DOI 10.1166/jnn.2003.077; Kreuter J., 2013, ADV DRUG DELIV REV; Langer K, 2008, INT J PHARMACEUT, V347, P109, DOI 10.1016/j.ijpharm.2007.06.028; Langer K, 2003, INT J PHARM, V257, P169, DOI 10.1016/S0378-5173(03)00134-0; Lu W, 2006, CANCER RES, V66, P11878, DOI 10.1158/0008-5472.CAN-06-2354; Lungwitz U, 2005, EUR J PHARM BIOPHARM, V60, P247, DOI 10.1016/j.ejpb.2004.11.011; Moret I, 2001, J CONTROL RELEASE, V76, P169, DOI 10.1016/S0168-3659(01)00415-1; Passini MA, 2006, J NEUROSCI, V26, P1334, DOI 10.1523/JNEUROSCI.2676-05.2006; Remy JS, 1998, ADV DRUG DELIVER REV, V30, P85, DOI 10.1016/S0169-409X(97)00109-9; Rhaese S, 2003, J CONTROL RELEASE, V92, P199, DOI 10.1016/S0168-3659(03)00302-X; Saha K, 2013, SMALL, V9, P300, DOI 10.1002/smll.201201129; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Somia N, 2000, NAT REV GENET, V1, P91, DOI 10.1038/35038533; Sondhi D, 2007, MOL THER, V15, P481, DOI 10.1038/sj.mt.6300049; Sondhi D, 2012, HUM GENE THER METHOD, V23, P324, DOI 10.1089/hgtb.2012.120; Steinhauser I, 2009, J DRUG TARGET, V17, P627, DOI 10.1080/10611860903118823; Steiniger SCJ, 2004, INT J CANCER, V109, P759, DOI 10.1002/ijc.20048; Ulbrich K, 2011, J DRUG TARGET, V19, P125, DOI 10.3109/10611861003734001; Ulbrich K, 2009, EUR J PHARM BIOPHARM, V71, P251, DOI 10.1016/j.ejpb.2008.08.021; Ungaro F, 2003, J PHARMACEUT BIOMED, V31, P143, DOI 10.1016/S0731-7085(02)00571-X; Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410; Wagner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032568; Wohlfart S, 2012, J CONTROL RELEASE, V161, P264, DOI 10.1016/j.jconrel.2011.08.017; Wohlfart S, 2011, J CONTROL RELEASE, V154, P103, DOI 10.1016/j.jconrel.2011.05.010; Zensi A, 2010, J DRUG TARGET, V18, P842, DOI 10.3109/1061186X.2010.513712; Zensi A, 2009, J CONTROL RELEASE, V137, P78, DOI 10.1016/j.jconrel.2009.03.002	36	22	22	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107603	10.1371/journal.pone.0107603	http://dx.doi.org/10.1371/journal.pone.0107603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229502	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900054
J	Dayal, S; Blokhin, IO; Erger, RA; Jensen, M; Arning, E; Stevens, JW; Bottiglieri, T; Faraci, FM; Lentz, SR				Dayal, Sanjana; Blokhin, Ilya O.; Erger, Rochelle A.; Jensen, Melissa; Arning, Erland; Stevens, Jeff W.; Bottiglieri, Teodoro; Faraci, Frank M.; Lentz, Steven R.			Protective Vascular and Cardiac Effects of Inducible Nitric Oxide Synthase in Mice with Hyperhomocysteinemia	PLOS ONE			English	Article							NF-KAPPA-B; DEFICIENT MICE; ISCHEMIA/REPERFUSION INJURY; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; GENE-EXPRESSION; SMOOTH-MUSCLE; NO-SYNTHASE; RISK-FACTOR; HOMOCYSTEINE	Diet-induced hyperhomocysteinemia produces endothelial and cardiac dysfunction and promotes thrombosis through a mechanism proposed to involve oxidative stress. Inducible nitric oxide synthase (iNOS) is upregulated in hyperhomocysteinemia and can generate superoxide. We therefore tested the hypothesis that iNOS mediates the adverse oxidative, vascular, thrombotic, and cardiac effects of hyperhomocysteinemia. Mice deficient in iNOS (Nos2-/-) and their wild-type (Nos2+/+) littermates were fed a high methionine/low folate (HM/LF) diet to induce mild hyperhomocysteinemia, with a 2-fold increase in plasma total homocysteine (P < 0.001 vs. control diet). Hyperhomocysteinemic Nos2+/+ mice exhibited endothelial dysfunction in cerebral arterioles, with impaired dilatation to acetylcholine but not nitroprusside, and enhanced susceptibility to carotid artery thrombosis, with shortened times to occlusion following photochemical injury (P<0.05 vs. control diet). Nos2-/- mice had decreased rather than increased dilatation responses to acetylcholine (P<0.05 vs. Nos2+/+ mice). Nos2-/- mice fed control diet also exhibited shortened times to thrombotic occlusion (P<0.05 vs. Nos2+/+ mice), and iNOS deficiency failed to protect from endothelial dysfunction or accelerated thrombosis in mice with hyperhomocysteinemia. Deficiency of iNOS did not alter myocardial infarct size in mice fed the control diet but significantly increased infarct size and cardiac superoxide production in mice fed the HM/LF diet (P<0.05 vs. Nos2+/+ mice). These findings suggest that endogenous iNOS protects from, rather than exacerbates, endothelial dysfunction, thrombosis, and hyperhomocysteinemia-associated myocardial ischemia-reperfusion injury. In the setting of mild hyperhomocysteinemia, iNOS functions to blunt cardiac oxidative stress rather than functioning as a source of superoxide.	[Dayal, Sanjana; Blokhin, Ilya O.; Erger, Rochelle A.; Jensen, Melissa; Stevens, Jeff W.; Faraci, Frank M.; Lentz, Steven R.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Faraci, Frank M.] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA; [Blokhin, Ilya O.] Univ Iowa, Interdisciplinary Grad Program Mol & Cellular Bio, Carver Coll Med, Iowa City, IA 52242 USA; [Faraci, Frank M.] Univ Iowa, Francois M Abboud Cardiovasc Ctr, Carver Coll Med, Iowa City, IA 52242 USA; [Erger, Rochelle A.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA; [Arning, Erland; Bottiglieri, Teodoro] Baylor Inst Metab Dis, Dallas, TX USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Lentz, SR (corresponding author), Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA.	steven-lentz@uiowa.edu		Faraci, Frank/0000-0002-0203-1690; dayal, sanjana/0000-0001-6156-2996; Lentz, Steven/0000-0002-8885-4718	National Institutes of Health [HL063943, HL062984]; American Heart Association [0860052Z, 13SDG140500021, 14PRE18850045]; Department of Veterans Affairs [BX001399]; American Society of Hematology; Foundation Leducq; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063943, P01HL062984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Department of Veterans Affairs(US Department of Veterans Affairs); American Society of Hematology; Foundation Leducq(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by research funding from National Institutes of Health grants HL063943 (to SRL) and HL062984 (to SRL and FMF), American Heart Association grants 0860052Z, 13SDG140500021 (to SD) and 14PRE18850045 (to IOB), the Department of Veterans Affairs (BX001399 to FMF), the American Society of Hematology (to SRL), and a grant from the Foundation Leducq (to FMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Bardell AL, 2001, J PHARMACOL EXP THER, V296, P252; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; Behr-Roussel D, 2000, CIRCULATION, V102, P1033, DOI 10.1161/01.CIR.102.9.1033; Bottiglieri T, 1987, Biomed Chromatogr, V2, P195, DOI 10.1002/bmc.1130020505; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Celotto AC, 2010, AMINO ACIDS, V38, P1515, DOI 10.1007/s00726-009-0368-y; Channon KM, 2004, TRENDS CARDIOVAS MED, V14, P323, DOI 10.1016/j.tcm.2004.10.003; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Dayal S, 2005, CIRCULATION, V112, P737, DOI 10.1161/CIRCULATIONAHA.104.529248; Dayal S, 2004, STROKE, V35, P1957, DOI 10.1161/01.STR.0000131749.81508.18; Dayal S, 2006, BLOOD, V108, P2237, DOI 10.1182/blood-2006-02-005991; Dayali S, 2007, ANTIOXID REDOX SIGN, V9, P1899, DOI 10.1089/ars.2007.1806; Detmers PA, 2000, J IMMUNOL, V165, P3430, DOI 10.4049/jimmunol.165.6.3430; Devlin AM, 2004, BLOOD, V103, P2624, DOI 10.1182/blood-2003-09-3078; Dhillon B, 2003, MOL CELL BIOCHEM, V247, P223, DOI 10.1023/A:1024146501743; Eguchi D, 2002, AM J PHYSIOL-HEART C, V283, pH2560, DOI 10.1152/ajpheart.00415.2002; Gandhi C, 2012, BLOOD, V120, P5224, DOI 10.1182/blood-2012-06-440255; Gunnett CA, 2003, STROKE, V34, P2970, DOI 10.1161/01.STR.0000099123.55171.3F; Gunnett CA, 2002, STROKE, V33, P2292, DOI 10.1161/01.STR.0000027427.86177.D4; Gunnett CA, 2001, ARTERIOSCL THROM VAS, V21, P1281, DOI 10.1161/hq0801.093509; Hassan A, 2004, BRAIN, V127, P212, DOI 10.1093/brain/awh023; Hollenberg SM, 2000, CIRC RES, V86, P774, DOI 10.1161/01.RES.86.7.774; Kitayama J, 2006, STROKE, V37, P2129, DOI 10.1161/01.STR.0000231654.79017.df; Kuhlencordt PJ, 2001, CIRCULATION, V103, P3099, DOI 10.1161/01.CIR.103.25.3099; Lange M, 2010, BIOCHEM BIOPH RES CO, V399, P286, DOI 10.1016/j.bbrc.2010.07.071; Li QH, 2003, CIRC RES, V92, P741, DOI 10.1161/01.RES.0000065441.72685.29; Li QH, 2009, CIRCULATION, V120, P1222, DOI 10.1161/CIRCULATIONAHA.108.778688; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marfella R, 2004, DIABETES, V53, P454, DOI 10.2337/diabetes.53.2.454; Mudd SH, 2000, ARTERIOSCL THROM VAS, V20, P1704, DOI 10.1161/01.ATV.20.7.1704; Okazaki T, 2011, J MOL CELL CARDIOL, V50, P534, DOI 10.1016/j.yjmcc.2010.12.010; Shah AM, 2000, CARDIOVASC RES, V45, P148, DOI 10.1016/S0008-6363(99)00316-8; Thiengburanatham Sanya, 2009, Asian Cardiovasc Thorac Ann, V17, P483, DOI 10.1177/0218492309348635; Tyagi N, 2005, AM J PHYSIOL-HEART C, V289, pH2649, DOI 10.1152/ajpheart.00548.2005; UBBINK JB, 1991, J CHROMATOGR-BIOMED, V565, P441, DOI 10.1016/0378-4347(91)80407-4; Ungvari Z, 2003, ARTERIOSCL THROM VAS, V23, P418, DOI 10.1161/01.ATV.0000061735.85377.40; Upmacis RK, 2007, AM J PHYSIOL-HEART C, V293, pH2878, DOI 10.1152/ajpheart.01144.2006; Upmacis RK, 2011, AM J PHYSIOL-HEART C, V301, pH617, DOI 10.1152/ajpheart.00667.2010; Wang X, 2012, J MOL CELL CARDIOL, V52, P753, DOI 10.1016/j.yjmcc.2011.12.009; Welch GN, 1998, P ASSOC AM PHYSICIAN, V110, P22; Wilson KM, 2003, J THROMB HAEMOST, V1, P2669, DOI 10.1111/j.1538-7836.2003.00482.x; Zhang F, 2004, KIDNEY INT, V65, P1327, DOI 10.1111/j.1523-1755.2004.00510.x	43	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107734	10.1371/journal.pone.0107734	http://dx.doi.org/10.1371/journal.pone.0107734			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226386	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700077
J	Subauste, A; Gianani, R; Chang, AM; Plunkett, C; Pietropaolo, SL; Zhang, YJ; Barinas-Mitchell, E; Kuller, LH; Galecki, A; Halter, JB; Pietropaolo, M				Subauste, Angela; Gianani, Roberto; Chang, Annette M.; Plunkett, Cynthia; Pietropaolo, Susan L.; Zhang, Ying-Jian; Barinas-Mitchell, Emma; Kuller, Lewis H.; Galecki, Andrzej; Halter, Jeffrey B.; Pietropaolo, Massimo			Islet Autoimmunity Identifies a Unique Pattern of Impaired Pancreatic Beta-Cell Function, Markedly Reduced Pancreatic Beta Cell Mass and Insulin Resistance in Clinically Diagnosed Type 2 Diabetes	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; ENDOPLASMIC-RETICULUM STRESS; SKELETAL-MUSCLE; ADULT-ONSET; OXIDATIVE STRESS; ELDERLY-PATIENTS; INFLAMMATION; AUTOANTIBODIES; MELLITUS; GLUCOSE	There is a paucity of literature describing metabolic and histological data in adult-onset autoimmune diabetes. This subgroup of diabetes mellitus affects at least 5% of clinically diagnosed type 2 diabetic patients (T2DM) and it is termed Latent Autoimmune Diabetes in Adults (LADA). We evaluated indexes of insulin secretion, metabolic assessment, and pancreatic pathology in clinically diagnosed T2DM patients with and without the presence of humoral islet autoimmunity (Ab). A total of 18 patients with at least 5-year duration of clinically diagnosed T2DM were evaluated in this study. In those subjects we assessed acute insulin responses to arginine, a glucose clamp study, whole-body fat mass and fat-free mass. We have also analyzed the pancreatic pathology of 15 T2DM and 43 control cadaveric donors, using pancreatic tissue obtained from all the T2DM organ donors available from the nPOD network through December 31, 2013. The presence of islet Ab correlated with severely impaired beta-cell function as demonstrated by remarkably low acute insulin response to arginine (AIR) when compared to that of the Ab negative group. Glucose clamp studies indicated that both Ab positive and Ab negative patients exhibited peripheral insulin resistance in a similar fashion. Pathology data from T2DM donors with Ab or the autoimmune diabetes associated DR3/DR4 allelic class II combination showed reduction in beta cell mass as well as presence of autoimmune-associated pattern A pathology in subjects with either islet autoantibodies or the DR3/DR4 genotype. In conclusion, we provide compelling evidence indicating that islet Ab positive long-term T2DM patients exhibit profound impairment of insulin secretion as well as reduced beta cell mass seemingly determined by an immune-mediated injury of pancreatic beta-cells. Deciphering the mechanisms underlying beta cell destruction in this subset of diabetic patients may lead to the development of novel immunologic therapies aimed at halting the disease progression in its early stage.	[Gianani, Roberto; Pietropaolo, Susan L.; Pietropaolo, Massimo] Baylor Coll Med, Dept Med, Div Diabet Endocrinol & Metab, Houston, TX 77030 USA; [Subauste, Angela; Gianani, Roberto; Chang, Annette M.; Plunkett, Cynthia; Pietropaolo, Susan L.; Zhang, Ying-Jian; Pietropaolo, Massimo] Univ Michigan, Sch Med, Dept Internal Med, Brehm Ctr Diabet Res,Div Metab Endocrinol & Diabe, Ann Arbor, MI USA; [Galecki, Andrzej; Halter, Jeffrey B.] Univ Michigan, Sch Med, Geriatr Ctr, Ann Arbor, MI USA; [Galecki, Andrzej; Halter, Jeffrey B.] Univ Michigan, Sch Med, Dept Internal Med, Inst Gerontol, Ann Arbor, MI USA; [Barinas-Mitchell, Emma; Kuller, Lewis H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Subauste, Angela] Univ Mississippi, Med Ctr, Dept Med, Div Endocrinol, Jackson, MS 39216 USA	Baylor College of Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Mississippi; University of Mississippi Medical Center	Pietropaolo, M (corresponding author), Baylor Coll Med, Dept Med, Div Diabet Endocrinol & Metab, Houston, TX 77030 USA.	Massimo.Pietropaolo@bcm.edu		Barinas-Mitchell, Emma/0000-0002-7280-7781	National Institutes of Health [R01 DK53456, R01 DK56200]; Michigan Institute for Clinical & Health Research (MICHR); Clinical and Translational Science Award (CTSA) program [UL1RR024986]; National Institute of Diabetes and Digestive and Kidney Diseases [P30DK020572: MDRC, P30DK092926: MCDTR]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053456, P30DK092926, R01DK056200, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Institute for Clinical & Health Research (MICHR); Clinical and Translational Science Award (CTSA) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The present study was supported by the National Institutes of Health (Grant Number: R01 DK53456, R01 DK56200), the Michigan Institute for Clinical & Health Research (MICHR), and the Clinical and Translational Science Award (CTSA) program: UL1RR024986 (MP), and by the National Institute of Diabetes and Digestive and Kidney Diseases (Grant Number P30DK020572: MDRC, P30DK092926: MCDTR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Barinas-Mitchell E, 2004, DIABETES, V53, P1293, DOI 10.2337/diabetes.53.5.1293; Barinas-Mitchell E, 2006, J CLIN ENDOCR METAB, V91, P2871, DOI 10.1210/jc.2005-2667; Bergman BC, 2012, J CLIN ENDOCR METAB, V97, P1663, DOI 10.1210/jc.2011-3172; Brooks-Worrell B, 2012, CLIN EXP IMMUNOL, V167, P40, DOI 10.1111/j.1365-2249.2011.04501.x; Brooks-Worrell BM, 2011, DIABETES CARE, V34, P168, DOI 10.2337/dc10-0579; Campbell-Thompson ML, 2013, DIABETOLOGIA, V56, P2541, DOI 10.1007/s00125-013-3043-5; Cassese A, 2008, J BIOL CHEM, V283, P36088, DOI 10.1074/jbc.M801698200; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; Cervin C, 2008, DIABETES, V57, P1433, DOI 10.2337/db07-0299; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Gianani R, 2010, DIABETOLOGIA, V53, P690, DOI 10.1007/s00125-009-1642-y; GOTTSATER A, 1994, ACTA DIABETOL, V31, P226, DOI 10.1007/BF00571956; Grant SFA, 2010, ENDOCR REV, V31, P183, DOI 10.1210/er.2009-0029; HARRIS M, 1979, DIABETES, V28, P1039; Hawa MI, 2013, DIABETES CARE, V36, P908, DOI 10.2337/dc12-0931; Hawa MI, 2009, DIABETES CARE, V32, P160, DOI 10.2337/dc08-1419; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Huang CJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1656, DOI 10.1152/ajpendo.00318.2007; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Lee CC, 2009, DIABETOLOGIA, V52, P1040, DOI 10.1007/s00125-009-1338-3; Leslie RDG, 2008, DIABETES-METAB RES, V24, P511, DOI 10.1002/dmrr.877; Leslie RDG, 2006, J CLIN ENDOCR METAB, V91, P1654, DOI 10.1210/jc.2005-1623; Liu F, 2012, CELL BIOCHEM BIOPHYS, V62, P273, DOI 10.1007/s12013-011-9291-4; Maioli M, 2002, DIABETES RES CLIN PR, V56, P41, DOI 10.1016/S0168-8227(01)00348-5; Monnier L, 2008, DIABETES METAB, V34, P207, DOI 10.1016/j.diabet.2008.01.011; Naik RG, 2009, J CLIN ENDOCR METAB, V94, P4635, DOI 10.1210/jc.2009-1120; Olsson L, 2012, DIABETES RES CLIN PR, V98, P302, DOI 10.1016/j.diabres.2012.09.011; Palmer JP, 2003, DIABETES CARE, V26, P536, DOI 10.2337/diacare.26.2.536; Pereira RI, 2012, J CLIN ENDOCR METAB, V97, pE642, DOI 10.1210/jc.2011-2542; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Pietropaolo M, 2000, DIABETES, V49, P32, DOI 10.2337/diabetes.49.1.32; Pietropaolo M, 2007, DIABETES, V56, P1189, DOI 10.2337/db06-0880; Pietropaolo M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012831; Polonsky KS, 1996, NEW ENGL J MED, V334, P777, DOI 10.1056/NEJM199603213341207; Pugliese A, 2014, PEDIATR DIABETES, V15, P1, DOI 10.1111/pedi.12097; Rakotoambinina B, 1997, DIABETES METAB, V23, P43; Schmitz-Peiffer C, 2008, DIABETES, V57, P1774, DOI 10.2337/db07-1769; Simoneau JA, 1999, FASEB J, V13, P2051, DOI 10.1096/fasebj.13.14.2051; TAYLOR SI, 1992, DIABETES, V41, P1473, DOI 10.2337/diabetes.41.11.1473; TUOMI T, 1993, DIABETES, V42, P359, DOI 10.2337/diabetes.42.2.359; Tuomi T, 2014, LANCET, V383, P1084, DOI 10.1016/S0140-6736(13)62219-9; Turner R, 1997, LANCET, V350, P1288, DOI 10.1016/S0140-6736(97)03062-6; Uibo R, 2008, ADV IMMUNOL, V100, P39, DOI 10.1016/S0065-2776(08)00803-1; WARD WK, 1984, J CLIN INVEST, V74, P1318, DOI 10.1172/JCI111542; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Zinman B, 2004, DIABETES, V53, P3193, DOI 10.2337/diabetes.53.12.3193	50	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e106537	10.1371/journal.pone.0106537	http://dx.doi.org/10.1371/journal.pone.0106537			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226365	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000344317700013
J	Teraishi, T; Hori, H; Sasayama, D; Matsuo, J; Ogawa, S; Ishida, I; Nagashima, A; Kinoshita, Y; Ota, M; Hattori, K; Kunugi, H				Teraishi, Toshiya; Hori, Hiroaki; Sasayama, Daimei; Matsuo, Junko; Ogawa, Shintaro; Ishida, Ikki; Nagashima, Anna; Kinoshita, Yukiko; Ota, Miho; Hattori, Kotaro; Kunugi, Hiroshi			Relationship between Lifetime Suicide Attempts and Schizotypal Traits in Patients with Schizophrenia	PLOS ONE			English	Article							INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; RISK-FACTORS; PERSONALITY QUESTIONNAIRE; BIPOLAR-DISORDER; YOUNG-PEOPLE; TEMPERAMENT; POPULATION; CHARACTER; SAMPLE; SCALE	Patients with schizophrenia are at increased risk for suicide. Various risk factors for suicide have been reported in schizophrenia; however, few studies have examined the association between personality traits and suicidal behavior. We administered the Schizotypal Personality Questionnaire (SPQ) to 87 Japanese patients with schizophrenia (49 males; mean age 38.1 +/- 10.6 years) with and without a history of suicide attempts (SA and nSA groups, respectively), and 322 controls (158 males; mean age 40.8 +/- 13.9 years). As expected, an analysis of covariance (ANCOVA) controlling for age and sex showed that all SPQ indices (total SPQ score and all three factors, i.e., cognitive-perceptual, interpersonal, and disorganized) were significantly higher in patients with schizophrenia (SA+nSA groups), than controls (p<0.001 for all comparisons). Furthermore, there were significant differences in the total score and the interpersonal and disorganized factors between the SA and nSA groups (nSA<SA, p<0.01 for all comparisons). Receiver operating characteristic analysis showed that a total SPQ score of 33.5 was the optimal cut-off value to discriminate the SA group from the nSA group (chi(2)[1] = 10.6, p = 0.002, odds ratio: 4.7, 95% confidence interval: 1.8-12.1, sensitivity: 0.70, specificity: 0.67). These results suggest that high schizotypy is associated with lifetime suicide attempts, and that the total SPQ score might be useful to assess the risk of suicide attempt in patients with schizophrenia.	[Teraishi, Toshiya; Hori, Hiroaki; Sasayama, Daimei; Matsuo, Junko; Ogawa, Shintaro; Ishida, Ikki; Nagashima, Anna; Kinoshita, Yukiko; Ota, Miho; Hattori, Kotaro; Kunugi, Hiroshi] Natl Inst Neurosci, Natl Ctr Neurol & Psychiat, Dept Mental Disorder Res, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan	Kunugi, H (corresponding author), Natl Inst Neurosci, Natl Ctr Neurol & Psychiat, Dept Mental Disorder Res, Tokyo, Japan.	hkunugi@ncnp.go.jp	Kunugi, Hiroshi/ABC-5260-2021	Hori, Hiroaki/0000-0002-4548-7110; Kunugi, Hiroshi/0000-0002-7209-3790; Ishida, Ikki/0000-0001-7856-156X	Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP, Health and Labour Sciences Research Grants; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [25861041] Funding Source: KAKEN	Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP, Health and Labour Sciences Research Grants; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP, Health and Labour Sciences Research Grants, and the grant for "Understanding of molecular and environmental bases for brain health" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albayrak Y, 2012, COMPR PSYCHIAT, V53, P1130, DOI 10.1016/j.comppsych.2012.04.007; American Psychiatric Association, 1997, PRACT GUID TREATM PA; American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Angst J, 1998, J AFFECT DISORDERS, V51, P55, DOI 10.1016/S0165-0327(98)00156-6; Bagby RM, 1999, PSYCHIAT RES, V86, P211, DOI 10.1016/S0165-1781(99)00041-4; Beautrais AL, 1999, SUICIDE LIFE-THREAT, V29, P37; Bolton JM, 2010, J PSYCHIATR RES, V44, P817, DOI 10.1016/j.jpsychires.2010.01.003; BORNSTEIN RF, 1988, J CLIN PSYCHOL, V44, P322, DOI 10.1002/1097-4679(198805)44:3<322::AID-JCLP2270440304>3.0.CO;2-8; Brezo J, 2006, ACTA PSYCHIAT SCAND, V113, P180, DOI 10.1111/j.1600-0447.2005.00702.x; Calati R, 2008, J PSYCHIATR RES, V42, P938, DOI 10.1016/j.jpsychires.2007.10.006; Conrad R, 2009, PSYCHIAT RES, V170, P212, DOI 10.1016/j.psychres.2008.09.008; Daneluzzo E, 1998, COMPR PSYCHIAT, V39, P143, DOI 10.1016/S0010-440X(98)90073-6; Daneluzzo E, 2005, COMPR PSYCHIAT, V46, P50, DOI 10.1016/j.comppsych.2004.07.010; De Hert M, 2001, SCHIZOPHR RES, V47, P127, DOI 10.1016/S0920-9964(00)00003-7; Engstrom C, 2004, BIPOLAR DISORD, V6, P130, DOI 10.1111/j.1399-5618.2004.00101.x; Fenton WS, 1997, AM J PSYCHIAT, V154, P199; Fujiwara T, 1993, ADV SCHIZOPHRENIA RE, V17, P555; Grunebaum MF, 2001, AM J PSYCHIAT, V158, P742, DOI 10.1176/appi.ajp.158.5.742; Harkavy-Friedman JM, 2003, J CLIN PSYCHIAT, V64, P871, DOI 10.4088/JCP.v64n0803; Hawton K, 2005, BRIT J PSYCHIAT, V187, P9, DOI 10.1192/bjp.187.1.9; Hor K, 2010, J PSYCHOPHARMACOL, V24, P81, DOI 10.1177/1359786810385490; Hori H, 2012, PSYCHIAT RES, V195, P69, DOI 10.1016/j.psychres.2011.07.028; Inagaki A., 1999, EQUIVALENT DOSE PSYC; Inskip HM, 1998, BRIT J PSYCHIAT, V172, P35, DOI 10.1192/bjp.172.1.35; Kao YC, 2011, PSYCHIAT QUART, V82, P207, DOI 10.1007/s11126-010-9161-z; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Leverich GS, 2003, J CLIN PSYCHIAT, V64, P506, DOI 10.4088/JCP.v64n0503; Levine SZ, 2010, PSYCHIAT RES, V177, P55, DOI 10.1016/j.psychres.2010.02.019; Levine SZ, 2014, EUR NEUROPSYCHOPHARM; McLean D, 2012, AUST NZ J PSYCHIAT, V46, P132, DOI 10.1177/0004867411433211; MILES CP, 1977, J NERV MENT DIS, V164, P231, DOI 10.1097/00005053-197704000-00002; Noguchi H, 2008, PSYCHIAT RES, V161, P162, DOI 10.1016/j.psychres.2007.07.023; OCarroll PW, 1996, SUICIDE LIFE-THREAT, V26, P237; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; Palmer BA, 2005, ARCH GEN PSYCHIAT, V62, P247, DOI 10.1001/archpsyc.62.3.247; Preuss UW, 2006, ALCOHOL CLIN EXP RES, V30, P866, DOI 10.1111/j.1530-0277.2006.00073.x; RAINE A, 1994, SCHIZOPHRENIA BULL, V20, P191, DOI 10.1093/schbul/20.1.191; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Reutfor J, 2009, SCHIZOPHR RES, V108, P231, DOI 10.1016/j.schres.2008.12.023; Rossi A, 2002, SCHIZOPHR RES, V54, P67, DOI 10.1016/S0920-9964(01)00353-X; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Steblaj A, 1999, ACTA PSYCHIAT SCAND, V100, P383; Verona E, 2001, J ABNORM PSYCHOL, V110, P462, DOI 10.1037//0021-843X.110.3.462; Vollema MG, 2002, SCHIZOPHR RES, V54, P39, DOI 10.1016/S0920-9964(01)00350-4; *WHO, 2010, WHO MORT DAT; Yamada H, 1991, JAPANESE VERSION POS	47	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107739	10.1371/journal.pone.0107739	http://dx.doi.org/10.1371/journal.pone.0107739			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS5NP	25226584	gold, Green Published			2022-12-25	WOS:000344317700079
J	Guo, JW; Yuan, QQ; Cong, JB; Ma, L; Dong, GF; Yang, GS; Wu, K				Guo Junwang; Yuan Qingquan; Cong Jianbo; Ma Lei; Dong Guofu; Yang Guoshan; Wu Ke			New Developed Cylindrical TM010 Mode EPR Cavity for X-Band In Vivo Tooth Dosimetry	PLOS ONE			English	Article							RADIATION-DOSE ESTIMATION; RESONANCE DOSIMETRY; IONIZING-RADIATION; ACCIDENT DOSIMETRY; ESR; TEETH; BIODOSIMETRY; EXPOSURES; RESIDENTS; ENAMEL	EPR tooth in vivo dosimetry is an attractive approach for initial triage after unexpected nuclear events. An X-band cylindrical TM010 mode resonant cavity was developed for in vivo tooth dosimetry and used in EPR applications for the first time. The cavity had a trapezoidal measuring aperture at the exact position of the cavity's cylindrical wall where strong microwave magnetic field H1 concentrated and weak microwave electric field E1 distributed. Theoretical calculations and simulations were used to design and optimize the cavity parameters. The cavity features were evaluated by measuring DPPH sample, intact incisor samples embed in a gum model and the rhesus monkey teeth. The results showed that the cavity worked at designed frequency and had the ability to make EPR spectroscopy in relative high sensitivity. Sufficient modulation amplitude and microwave power could be applied into the aperture. Radiation induced EPR signal could be observed remarkably from 1 Gy irradiated intact incisor within only 30 seconds, which was among the best in scan time and detection limit. The in vivo spectroscopy was also realized by acquiring the radiation induced EPR signal from teeth of rhesus monkey whose teeth was irradiated by dose of 2 Gy. The results suggested that the cavity was sensitive to meet the demand to assess doses of significant level in short time. This cavity provided a very potential option for the development of X-band in vivo dosimetry.	[Guo Junwang; Yuan Qingquan; Cong Jianbo; Ma Lei; Dong Guofu; Yang Guoshan; Wu Ke] Beijing Inst Radiat Med, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Wu, K (corresponding author), Beijing Inst Radiat Med, Beijing, Peoples R China.	wuke315@126.com			Beijing Institute of Radiation Medicine; National Institute of Allergy and Infectious Diseases [U19-AI091173-04]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI091173] Funding Source: NIH RePORTER	Beijing Institute of Radiation Medicine; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	All the work is initially supported by grant from Beijing Institute of Radiation Medicine. The cavity design is partly funded by the National Institute of Allergy and Infectious Diseases (U19-AI091173-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADY JM, 1968, HEALTH PHYS, V15, P43, DOI 10.1097/00004032-196807000-00007; Cole T, 1963, PRODUCTION HYDROGEN; Flood AB, 2011, RADIAT MEAS, V46, P916, DOI 10.1016/j.radmeas.2011.02.019; Guo JW, 2013, APPL MAGN RESON, V44, P869, DOI 10.1007/s00723-012-0438-2; Haga T, 2013, CONCEPT MAGN RESON B, V43B, P32, DOI 10.1002/cmr.b.21229; IKEYA M, 1986, RADIAT PROT DOSIM, V17, P181; IKEYA M, 1989, APPL RADIAT ISOTOPES, V40, P1021, DOI 10.1016/0883-2889(89)90035-X; ISHII H, 1990, J NUCL SCI TECHNOL, V27, P1153, DOI [10.1080/18811248.1990.9731308, 10.3327/jnst.27.1153]; Iwasaki A, 2005, APPL RADIAT ISOTOPES, V62, P187, DOI 10.1016/j.apradiso.2004.08.042; Ke W., 1996, CHIN J RADIOL MED PR, V16; Miyake M, 2000, APPL RADIAT ISOTOPES, V52, P1031, DOI 10.1016/S0969-8043(00)00053-1; PASS B, 1985, MED PHYS, V12, P305, DOI 10.1118/1.595768; Pollock JD, 2010, HEALTH PHYS, V98, P339, DOI 10.1097/HP.0b013e3181a6dd08; Poole C.P., 1996, ELECT SPIN RESONANCE; Pozar D.M., 2009, MICROWAVE ENG; SHIMANO T, 1989, APPL RADIAT ISOTOPES, V40, P1035, DOI 10.1016/0883-2889(89)90037-3; Sirota K, 2013, APPL MAGN RESON, V44, P671, DOI 10.1007/s00723-012-0435-5; Swartz HM, 2007, RADIAT MEAS, V42, P1075, DOI 10.1016/j.radmeas.2007.05.023; Swartz HM, 2006, RADIAT PROT DOSIM, V120, P163, DOI 10.1093/rpd/nci554; Swartz HM, 2012, HEALTH PHYS, V103, P255, DOI 10.1097/HP.0b013e3182588d92; Swartz HM, 2011, RADIAT MEAS, V46, P742, DOI 10.1016/j.radmeas.2011.03.011; Toyoda S, 2011, RADIAT MEAS, V46, P797, DOI 10.1016/j.radmeas.2011.05.008; Trompier F, 2011, RADIAT PROT DOSIM, V144, P571, DOI 10.1093/rpd/ncq341; Williams BB, 2011, RADIAT MEAS, V46, P772, DOI 10.1016/j.radmeas.2011.03.009; Williams BB, 2011, INT J RADIAT BIOL, V87, P766, DOI 10.3109/09553002.2011.583316; Williams BB, 2010, HEALTH PHYS, V98, P327, DOI 10.1097/HP.0b013e3181a6de5d; Yamanaka C, 1993, APPL RADIAT ISOTOPES, V44, pIN3; Yokoyama H, 2008, APPL MAGN RESON, V35, P127, DOI 10.1007/s00723-008-0148-y; Zhumadilov K, 2006, J RADIAT RES, V47, pA47, DOI 10.1269/jrr.47.A47	29	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e106587	10.1371/journal.pone.0106587	http://dx.doi.org/10.1371/journal.pone.0106587			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222483	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774800019
J	Zampieri, BL; Biselli-Perico, JM; de Souza, JES; Burger, MC; Silva, WA; Goloni-Bertollo, EM; Pavarino, EC				Zampieri, Bruna Lancia; Biselli-Perico, Joice Matos; Santana de Souza, Jorge Estefano; Buerger, Matheus Carvalho; Silva Junior, Wilson Araujo; Goloni-Bertollo, Eny Maria; Pavarino, Erika Cristina			Altered Expression of Immune-Related Genes in Children with Down Syndrome	PLOS ONE			English	Article							NF-KAPPA-B; SIGNAL-TRANSDUCTION; MICROARRAY DATA; T-CELLS; SYSTEM; INTERLEUKIN-10; INFECTIONS; MATURATION; INSIGHTS; DISEASE	Individuals with Down syndrome (DS) have a high incidence of immunological alterations with increased susceptibility to bacterial and viral infections and high frequency of different types of hematologic malignancies and autoimmune disorders. In the current study, we profiled the expression pattern of 92 immune-related genes in peripheral blood mononuclear cells (PBMCs) of two different groups, children with DS and control children, to identify differentially expressed genes that might be of pathogenetic importance for the development and phenotype of the immunological alterations observed in individuals with DS. PBMCs samples were obtained from six DS individuals with karyotypically confirmed full trisomy 21 and six healthy control individuals (ages 2-6 years). Gene expression was profiled in duplicate according to the manufacturer's instructions provided by commercially available TaqMan Human Immune Array representing 92 immune function genes and four reference genes on a 96-plex gene card. A set of 17 differentially expressed genes, not located on chromosome 21 (HSA21), involved in immune and inflammatory pathways was identified including 13 genes (BCL2, CCL3, CCR7, CD19, CD28, CD40, CD40LG, CD80, EDN1, IKBKB, IL6, NOS2 and SKI) significantly down-regulated and four genes (BCL2L1, CCR2, CCR5 and IL10) significantly up-regulated in children with DS. These findings highlight a list of candidate genes for further investigation into the molecular mechanism underlying DS pathology and reinforce the secondary effects of the presence of a third copy of HSA21.	[Zampieri, Bruna Lancia; Biselli-Perico, Joice Matos; Goloni-Bertollo, Eny Maria; Pavarino, Erika Cristina] Fac Med Sao Jose Do Rio Preto FAMERP, Dept Biol Mol, Unidade Pesquisa Genet & Biol Mol, Sao Jose Do Rio Preto, SP, Brazil; [Santana de Souza, Jorge Estefano; Buerger, Matheus Carvalho; Silva Junior, Wilson Araujo] Univ Sao Paulo, Dept Genet, Sao Paulo, Brazil; [Santana de Souza, Jorge Estefano; Buerger, Matheus Carvalho; Silva Junior, Wilson Araujo] Univ Sao Paulo, Ribeirao Preto Med Sch, Sao Paulo, Brazil; [Santana de Souza, Jorge Estefano; Buerger, Matheus Carvalho] Inst Bioinformat & Biotechnol 2bio, Sao Paulo, Brazil; [Santana de Souza, Jorge Estefano; Buerger, Matheus Carvalho; Silva Junior, Wilson Araujo] Natl Inst Sci & Technol Stem Cell & Cell Therapy, Ribeirao Preto, SP, Brazil; [Santana de Souza, Jorge Estefano; Buerger, Matheus Carvalho; Silva Junior, Wilson Araujo] Ctr Cell Based Therapy, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Universidade de Sao Paulo; Universidade de Sao Paulo	Pavarino, EC (corresponding author), Fac Med Sao Jose Do Rio Preto FAMERP, Dept Biol Mol, Unidade Pesquisa Genet & Biol Mol, Sao Jose Do Rio Preto, SP, Brazil.	erika@famerp.br	Biselli, Joice Matos/B-6913-2014; Goloni-Bertollo, Eny Maria/B-8405-2012; Bürger, Matheus/P-6045-2014; Pavarino, Érika C/L-5899-2016; Silva Jr, Wilson Araújo/E-9487-2011; Biselli, Joice/AAZ-6259-2021; Zampieri, Bruna/F-7120-2012; Zampieri, Bruna/GOV-3140-2022; CTC USP, CEPID 13 18/J-8951-2014	Goloni-Bertollo, Eny Maria/0000-0002-2622-4673; Pavarino, Érika C/0000-0003-0959-0695; Silva Jr, Wilson Araújo/0000-0001-9364-2886; Zampieri, Bruna/0000-0003-0091-1894; Zampieri, Bruna/0000-0003-0091-1894; Matos Biselli, Joice/0000-0001-5105-9537; CTC USP, CEPID 13 18/0000-0002-7123-9524	FAPESP [2010/00153-3]; CAPES	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by funding from FAPESP (2010/00153-3). BLZ and JMBP were the recipients of fellowships from CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bour-Jordan H, 2002, J CLIN IMMUNOL, V22, P1, DOI 10.1023/A:1014256417651; Broers CJM, 2012, ACTA PAEDIATR, V101, P862, DOI 10.1111/j.1651-2227.2012.02696.x; Browatzki M, 2000, BASIC RES CARDIOL, V95, P98, DOI 10.1007/s003950050170; Burczynski ME, 2006, PHARMACOGENOMICS, V7, P187, DOI 10.2217/14622416.7.2.187; Charo IF, 2003, MICROCIRCULATION, V10, P259, DOI 10.1038/sj.mn.7800191; Chistiakov D, 2007, J APPL BIOMED, V5, P71; Cocchi G, 2007, ACTA PAEDIATR, V96, P1479, DOI 10.1111/j.1651-2227.2007.00459.x; Cossarizza A, 1990, Am J Med Genet Suppl, V7, P213; Dace DS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007121; De Hingh YCM, 2005, J PEDIATR-US, V147, P744, DOI 10.1016/j.jpeds.2005.07.022; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Elsayed Solaf M, 2009, Immun Ageing, V6, P2, DOI 10.1186/1742-4933-6-2; Englund A, 2013, AM J MED GENET A, V161A, P642, DOI 10.1002/ajmg.a.35706; Fitzgerald P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070401; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GIMMI CD, 1991, P NATL ACAD SCI USA, V88, P6575, DOI 10.1073/pnas.88.15.6575; Granese B, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-24; Guazzarotti L, 2009, AJIDD-AM J INTELLECT, V114, P100, DOI 10.1352/2009.114.100-109; Hofman FM, 1998, BLOOD, V92, P3064, DOI 10.1182/blood.V92.9.3064.421a10_3064_3072; Kusters MAA, 2009, CLIN EXP IMMUNOL, V156, P189, DOI 10.1111/j.1365-2249.2009.03890.x; Kusters MA, 2011, PEDIATR INFECT DIS J, V30, P357, DOI 10.1097/INF.0b013e3181ff85a8; Letourneau A, 2014, NATURE, V508, P345, DOI 10.1038/nature13200; Li C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049130; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockstone HE, 2007, GENOMICS, V90, P647, DOI 10.1016/j.ygeno.2007.08.005; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; Malago W, 2005, CROAT MED J, V46, P647; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mutch DM, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-17; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Oppermann M, 2004, CELL SIGNAL, V16, P1201, DOI 10.1016/j.cellsig.2004.04.007; R Core Team, 2021, R LANG ENV STAT COMP; Ram G, 2011, CLIN EXP IMMUNOL, V164, P9, DOI 10.1111/j.1365-2249.2011.04335.x; Ruetten H, 1997, J PHYSIOL PHARMACOL, V48, P675; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Suttles J, 2009, SEMIN IMMUNOL, V21, P257, DOI 10.1016/j.smim.2009.05.011; Tedder TF, 1997, IMMUNITY, V6, P107, DOI 10.1016/S1074-7613(00)80418-5; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xavier AC, 2010, EXPERT REV HEMATOL, V3, P175, DOI [10.1586/ehm.10.14, 10.1586/EHM.10.14]; Yilmaz C, 2013, CLIN APPL THROMB HEM, DOI 101177/1076029613511521; Zizka Z, 2006, FETAL DIAGN THER, V21, P510, DOI 10.1159/000095663	52	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107218	10.1371/journal.pone.0107218	http://dx.doi.org/10.1371/journal.pone.0107218			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222269	Green Submitted, Green Published, gold			2022-12-25	WOS:000341774800050
J	Lysy, Z; Lovblom, LE; Halpern, EM; Ngo, M; Ng, E; Orszag, A; Breiner, A; Bril, V; Perkins, BA				Lysy, Zoe; Lovblom, Leif E.; Halpern, Elise M.; Ngo, Mylan; Ng, Eduardo; Orszag, Andrej; Breiner, Ari; Bril, Vera; Perkins, Bruce A.			Measurement of Cooling Detection Thresholds for Identification of Diabetic Sensorimotor Polyneuropathy in Type 1 Diabetes	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; DISTAL SYMMETRIC POLYNEUROPATHY; CORNEAL CONFOCAL MICROSCOPY; PERIPHERAL NEUROPATHY; ELECTRODIAGNOSTIC-MEDICINE; AMERICAN-ASSOCIATION; PHYSICAL-MEDICINE; EPIDEMIOLOGY; TESTS; INTERVENTIONS	Objective: Compared to recently-studied novel morphological measures, conventional small nerve fiber functional tests have not been systematically studied for identification of diabetic sensorimotor polyneuropathy (DSP). We aimed to determine and compare the diagnostic performance of cooling detection thresholds (CDT) in a cross-sectional type 1 diabetes cohort. Research Design and Methods: 136 subjects with type 1 diabetes and 52 healthy volunteers underwent clinical and electrophysiological examination for DSP classification concomitantly with the Toronto Clinical Neuropathy Score (TCNS) and three small fiber function tests: CDT, heart rate variability (HRV), and laser doppler imaging of axon-mediated neurogenic flare responses to cutaneous heating (LDIFLARE). Area under the curve (AUC) and optimal thresholds were determined by receiver operating characteristic (ROC) curves in the type 1 diabetes cohort. Results: Type 1 diabetes subjects were 42 +/- 17 years of age with mean HbA1c 7.9 +/- 1.7%. Fifty-nine (45%) met the case definition for DSP. CDT values were lowest in cases with DSP (18.3 +/- 8.4 degrees C) compared to controls without DSP (28.4 +/- 3.5 degrees C) and to healthy volunteers (29.6 +/- 1.8 degrees C; p-value for both comparisons<0.0001). AUC(CDT) was 0.863 which was similar to AUC(TCNS) (0.858, p = 0.24) and AUC(HRV) (0.788, p = 0.05), but exceeded AUC(LDIFLARE) (0.750, p = 0.001). The threshold of <25.1 degrees C was equivalent to the lower bound of the healthy volunteer 95% distribution [25.1, 30.8 degrees C] and performed with 83% sensitivity and 82% specificity. Conclusions: Akin to novel small fiber morphological measures, CDT is a functional test that identifies DSP with very good diagnostic performance. These findings support further research that revisits the role of CDT in early DSP detection.	[Lysy, Zoe; Lovblom, Leif E.; Orszag, Andrej; Perkins, Bruce A.] Univ Toronto, Dept Med, Div Endocrinol & Metab, Toronto, ON, Canada; [Ngo, Mylan; Ng, Eduardo; Breiner, Ari; Bril, Vera] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada	University of Toronto; University of Toronto	Perkins, BA (corresponding author), Univ Toronto, Dept Med, Div Endocrinol & Metab, Toronto, ON, Canada.	bperkins@mtsinai.on.ca	BRIL, vera/ABA-6509-2020; Perkins, Bruce A/L-3726-2017	Lovblom, Leif Erik/0000-0002-6774-8924; Orszag, Andrej/0000-0002-0027-1607	JDRF [17-2008-715]	JDRF(Juvenile Diabetes Research Foundation)	Funding was provided by JDRF (Grant Number 17-2008-715, website http://jdrf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2012, DIABETES CARE, V35, P821, DOI 10.2337/dc11-1396; Albers JW, 2010, DIABETES CARE, V33, P1090, DOI 10.2337/dc09-1941; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Breiner A, 2014, DIABETES CARE, V37, P1418, DOI 10.2337/dc13-2005; Bril V, 2002, DIABETES CARE, V25, P2048, DOI 10.2337/diacare.25.11.2048; Bril V, 2013, CAN J DIABETES, V37, pS142, DOI 10.1016/j.jcjd.2013.01.039; Dyck PJ, 2010, MUSCLE NERVE, V42, P157, DOI 10.1002/mus.21661; DYCK PJ, 1992, NEUROLOGY, V42, P1164, DOI 10.1212/WNL.42.6.1164; DYCK PJ, 1987, DIABETES CARE, V10, P432, DOI 10.2337/diacare.10.4.432; Ekoe JM, 2013, CAN J DIABETES, V37, pS12, DOI 10.1016/j.jcjd.2013.01.012; England JD, 2009, NEUROLOGY, V72, P185, DOI 10.1212/01.wnl.0000336370.51010.a1; England JD, 2005, NEUROLOGY, V64, P199, DOI 10.1212/01.WNL.0000149522.32823.EA; Green AQ, 2010, DIABETES CARE, V33, P174, DOI 10.2337/dc09-0101; Haas L, 2013, DIABETES CARE, V36, pS100, DOI [10.2337/dc13-S100, 10.2337/dc13-S004]; Halpern EM, 2013, J DIABETES COMPLICAT, V27, P240, DOI 10.1016/j.jdiacomp.2012.10.011; Harris SB., 2006, CAN J DIABETES, V30, P1, DOI DOI 10.1016/S1499-2671(06)02005-3; Janes H, 2008, AM J EPIDEMIOL, V168, P89, DOI 10.1093/aje/kwn099; Krishnan STM, 2002, BRIT MED J, V325, P946, DOI 10.1136/bmj.325.7370.946; Malik RA, 2011, DIABETES-METAB RES, V27, P678, DOI 10.1002/dmrr.1222; Martin CL, 2014, DIABETES CARE, V37, P31, DOI 10.2337/dc13-2114; MASER RE, 1989, DIABETES, V38, P1456, DOI 10.2337/diabetes.38.11.1456; MOST RS, 1983, DIABETES CARE, V6, P87, DOI 10.2337/diacare.6.1.87; Orlov S, 2012, DIABETES CARE, V35, P809, DOI 10.2337/dc11-1652; PECORARO RE, 1990, DIABETES CARE, V13, P513, DOI 10.2337/diacare.13.5.513; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Perkins BA, 2001, DIABETES CARE, V24, P250, DOI 10.2337/diacare.24.2.250; Perkins BA, 2010, DIABETES CARE, V33, P1549, DOI 10.2337/dc09-1835; Quattrini C, 2007, DIABETES, V56, P2148, DOI 10.2337/db07-0285; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Singleton JR, 2001, DIABETES CARE, V24, P1448, DOI 10.2337/diacare.24.8.1448; Smith AG, 2008, NEUROLOGIST, V14, P23, DOI 10.1097/NRL.0b013e31815a3956; Smith AG, 2001, NEUROLOGY, V57, P1701, DOI 10.1212/WNL.57.9.1701; STALBERG EV, 1989, MUSCLE NERVE, V12, P993, DOI 10.1002/mus.880121207; Sumner CJ, 2003, NEUROLOGY, V60, P108, DOI 10.1212/WNL.60.1.108; Tavakoli M, 2010, DIABETES CARE, V33, P1792, DOI 10.2337/dc10-0253; Tesfaye S, 2005, NEW ENGL J MED, V352, P341, DOI 10.1056/NEJMoa032782; Tesfaye S, 2013, DIABETES CARE, V36, P2456, DOI 10.2337/dc12-1964; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Umapathi T, 2007, MUSCLE NERVE, V35, P591, DOI 10.1002/mus.20732; Zinman LH, 2004, DIABETES CARE, V27, P1674, DOI 10.2337/diacare.27.7.1674	41	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106995	10.1371/journal.pone.0106995	http://dx.doi.org/10.1371/journal.pone.0106995			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216179	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774300035
J	Seong, BKA; Lau, J; Adderley, T; Kee, L; Chaukos, D; Pienkowska, M; Malkin, D; Thorner, P; Irwin, MS				Seong, B. K. A.; Lau, J.; Adderley, T.; Kee, L.; Chaukos, D.; Pienkowska, M.; Malkin, D.; Thorner, P.; Irwin, M. S.			SATB2 enhances migration and invasion in osteosarcoma by regulating genes involved in cytoskeletal organization	ONCOGENE			English	Article							EPITHELIAL PROTEIN LOST; TUMOR GROWTH; RHO-GTPASES; EXPRESSION; EPLIN; DIFFERENTIATION; CANCER; METASTASIS; PATHOGENESIS; DETERMINANT	Osteosarcoma (OS) is the most common malignant bone tumor and the majority of recurrences are due to metastasis. However, the molecular mechanisms that regulate OS metastatic spread are largely unknown. In this study, we report that special AT-rich-binding protein 2 (SATB2) is highly expressed in OS cells and tumors. Short hairpin RNA-mediated knockdown of SATB2 (sh-SATB2) decreases migration and invasion of OS cells without affecting proliferation or viability. Microarray analysis identified genes that were differentially regulated by SATB2 including the actin-binding protein Epithelial Protein Lost In Neoplasm (EPLIN), which was upregulated in sh-SATB2 cells. Silencing EPLIN rescues the decreased invasion observed in sh-SATB2 cells. Pathway analyses of SATB2-regulated genes revealed enrichment of those involved in cytoskeleton dynamics, and increased stress fiber formation was detected in cells with SATB2 knockdown. Furthermore, sh-SATB2 cells exhibit increased RhoA, decreased Rac1 and increased phosphorylation of focal adhesion kinase (FAK) and paxillin. These findings identify SATB2 as a novel regulator of OS invasion, in part via effects on EPLIN and the cytoskeleton.	[Seong, B. K. A.; Malkin, D.; Irwin, M. S.] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Seong, B. K. A.; Malkin, D.; Irwin, M. S.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Seong, B. K. A.; Lau, J.; Adderley, T.; Kee, L.; Chaukos, D.; Irwin, M. S.] Hosp Sick Children, Res Inst, Peter Gilgan Ctr Res & Learning, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Pienkowska, M.; Malkin, D.] Hosp Sick Children, Res Inst, Peter Gilgan Ctr Res & Learning, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Malkin, D.; Irwin, M. S.] Hosp Sick Children, Dept Pediat, Div Hematol Oncol, Toronto, ON M5G 1X8, Canada; [Thorner, P.] Hosp Sick Children, Dept Pediat Lab Med, Toronto, ON M5G 1X8, Canada; [Thorner, P.; Irwin, M. S.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Irwin, MS (corresponding author), Hosp Sick Children, Dept Paediat & Cell Biol, 555 Univ Ave,Black Wing,9th Floor, Toronto, ON M5G 1X8, Canada.	meredith.irwin@sickkids.ca	Malkin, David/AAW-8715-2021		Canadian Cancer Society Research Institute [2010-700580]; Ontario Research Fund; Canada Research Chair in Cancer Biology; Hospital for Sick Children Research Training Centre (Restracomp)	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Ontario Research Fund; Canada Research Chair in Cancer Biology; Hospital for Sick Children Research Training Centre (Restracomp)	This study was supported by funds from the Canadian Cancer Society Research Institute (#2010-700580, MSI), Ontario Research Fund (MSI, DM) and a Canada Research Chair in Cancer Biology (MSI). BKAS and JL received scholarships from Hospital for Sick Children Research Training Centre (Restracomp). We are grateful for assistance with microarray analyses from Daniel Picard and Dr Annie Huang.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Abou Zeid Nancy, 2006, Cell Commun Signal, V4, P8, DOI 10.1186/1478-811X-4-8; Aprelikova O, 2010, CELL CYCLE, V9, P4387, DOI 10.4161/cc.9.21.13674; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Britanova O, 2006, AM J HUM GENET, V79, P668, DOI 10.1086/508214; Broadhead Matthew L., 2011, Sarcoma, V2011, P959248, DOI 10.1155/2011/959248; Chung J, 2010, EMBO REP, V11, P777, DOI 10.1038/embor.2010.125; Conner JR, 2013, HISTOPATHOLOGY, V63, P36, DOI 10.1111/his.12138; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Eberhard J, 2012, BRIT J CANCER, V106, P931, DOI 10.1038/bjc.2012.34; Flores RJ, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-50; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Khanna C, 2001, CANCER RES, V61, P3750; Latini FRM, 2008, ENDOCR-RELAT CANCER, V15, P787, DOI 10.1677/ERC-08-0079; Leoyklang P, 2007, HUM MUTAT, V28, P732, DOI 10.1002/humu.20515; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; Maul RS, 1999, ONCOGENE, V18, P7838, DOI 10.1038/sj.onc.1203206; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Molyneux SD, 2010, J CLIN INVEST, V120, P3310, DOI 10.1172/JCI42391; O'Donoghue LE, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-506; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Patani N, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-18; Quizi JL, 2013, ONCOGENE, V32, P4656, DOI 10.1038/onc.2012.488; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sanders AJ, 2010, ANGIOGENESIS, V13, P317, DOI 10.1007/s10456-010-9188-7; Satoh Y, 2013, IMMUNITY, V38, P1105, DOI 10.1016/j.immuni.2013.05.014; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Steder M, 2013, CANCER CELL, V24, P512, DOI 10.1016/j.ccr.2013.08.023; Stehn JR, 2013, CANCER RES, V73, P5169, DOI 10.1158/0008-5472.CAN-12-4501; Tsurumi H, 2014, KIDNEY INT, V86, P548, DOI 10.1038/ki.2014.85; Wei JW, 2012, J CELL BIOL, V197, P509, DOI 10.1083/jcb.201201057; Yuan XL, 2013, CANCER RES, V73, P3625, DOI 10.1158/0008-5472.CAN-12-3879; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zech T, 2011, J CELL SCI, V124, P3753, DOI 10.1242/jcs.080986; Zhang S, 2011, ONCOGENE, V30, P4941, DOI 10.1038/onc.2011.199; Zhao XY, 2014, CYTOKINE GROWTH F R, V25, P35, DOI 10.1016/j.cytogfr.2013.12.010; Zucchini C, 2014, ONCOGENE, V33, P1912, DOI 10.1038/onc.2013.152	44	38	39	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2015	34	27					3582	3592		10.1038/onc.2014.289	http://dx.doi.org/10.1038/onc.2014.289			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM1IQ	25220418				2022-12-25	WOS:000357434900010
J	Moll, HP; Lee, A; Minussi, DC; da Silva, CG; Csizmadia, E; Bhasin, M; Ferran, C				Moll, Herwig P.; Lee, Andy; Minussi, Darlan C.; da Silva, Cleide G.; Csizmadia, Eva; Bhasin, Manoj; Ferran, Christiane			A20 Regulates Atherogenic Interferon (IFN)-gamma Signaling in Vascular Cells by Modulating Basal IFN beta Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ENDOTHELIAL-CELLS; GENE-EXPRESSION; ACTIVATION; GAMMA; INDUCTION; ATHEROSCLEROSIS; PROLIFERATION; INHIBITOR; UBIQUITINATION	IFN gamma signaling in endothelial (EC) and smooth muscle cells (SMC) is a key culprit of pathologic vascular remodeling. The impact of NF-kappa B inhibitory protein A20 on IFN gamma signaling in vascular cells remains unknown. In gain-and loss-of-function studies, A20 inversely regulated expression of IFN gamma-induced atherogenic genes in human EC and SMC by modulating STAT1 transcription. In vivo, inadequate A20 expression in A20 heterozygote mice aggravated intimal hyperplasia following partial carotid artery ligation. This outcome uniquely associated with increased levels of Stat1 and super-induction of Ifn gamma-dependent genes. Transcriptome analysis of the aortic media from A20 heterozygote versus wild-type mice revealed increased basal Ifn beta signaling as the likely cause for higher Stat1 transcription. We confirmed higher basal IFN beta levels in A20-silenced human SMC and showed that neutralization or knockdown of IFN beta abrogates heightened STAT1 levels in these cells. Upstream of IFN beta, A20-silenced EC and SMC demonstrated higher levels of phosphorylated/activated TANK-binding kinase-1 (TBK1), a regulator of IFN beta transcription. This suggested that A20 knockdown increased STAT1 transcription by enhancing TBK1 activation and subsequently basal IFN beta levels. Altogether, these results uncover A20 as a key physiologic regulator of atherogenic IFN beta/STAT1 signaling. This novel function of A20 added to its ability to inhibit nuclear factor-kappa B (NF-kappa B) activation solidifies its promise as an ideal therapeutic candidate for treatment and prevention of vascular diseases. In light of recently discovered A20/TNFAIP3 (TNF alpha-induced protein 3) single nucleotide polymorphisms that impart lower A20 expression or function, these results also qualify A20 as a reliable clinical biomarker for vascular risk assessment.	[Moll, Herwig P.; Lee, Andy; Minussi, Darlan C.; da Silva, Cleide G.; Csizmadia, Eva; Ferran, Christiane] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Vasc & Endovasc Surg,Ctr Vasc Biol Res, Boston, MA 02135 USA; [Moll, Herwig P.; Lee, Andy; Minussi, Darlan C.; da Silva, Cleide G.; Csizmadia, Eva; Ferran, Christiane] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Transplant Inst,Dept Surg, Boston, MA 02215 USA; [Ferran, Christiane] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Nephrol,Dept Med, Boston, MA 02215 USA; [Bhasin, Manoj] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Interdisciplinary Med & Biotechnol,Bioinforma, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Ferran, C (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Vasc & Endovasc Surg,Ctr Vasc Biol Res, RN 370 F-G,99 Brookline Ave, Boston, MA 02215 USA.	cferran@caregroup.harvard.edu	Moll, Herwig P./H-2836-2019; Angolano, Cleide/AAZ-4154-2021	Moll, Herwig P./0000-0001-6438-9068; Bhasin, Manoj/0000-0001-5172-420X; Conterno Minussi, Darlan/0000-0001-8856-4625	National Institutes of Health [RO1 HL080130, DK063275]; Austrian Science Fund [J3398-BW23]; National Institutes of Health Fellowship from NRSA [T32 HL07734]; National Council for Scientific and Technological Development (CNPq), Brazil; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080130, T32HL007734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063275, R56DK063275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund(Austrian Science Fund (FWF)); National Institutes of Health Fellowship from NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Council for Scientific and Technological Development (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL080130 and DK063275 (to C. F.).; Supported by the Austrian Science Fund J3398-BW23.; Supported by National Institutes of Health Fellowship T32 HL07734 from NRSA.; Supported by a Science Without Borders fellowship from National Council for Scientific and Technological Development (CNPq), Brazil.	[Anonymous], 2009, J INTERFERON CYTOKIN, V29, P817; Basagoudanavar SH, 2011, J VIROL, V85, P2599, DOI 10.1128/JVI.02213-10; Boonyasrisawat W, 2007, DIABETES, V56, P499, DOI 10.2337/db06-0946; Cheon H, 2013, EMBO J, V32, P2751, DOI 10.1038/emboj.2013.203; Cooper JT, 1996, J BIOL CHEM, V271, P18068, DOI 10.1074/jbc.271.30.18068; Damrauer SM, 2010, ATHEROSCLEROSIS, V211, P404, DOI 10.1016/j.atherosclerosis.2010.03.029; Daniel S, 2004, BLOOD, V104, P2376, DOI 10.1182/blood-2003-02-0635; Dimayuga PC, 2005, ARTERIOSCL THROM VAS, V25, P2528, DOI 10.1161/01.ATV.0000190606.41121.00; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Ferran C, 1998, BLOOD, V91, P2249, DOI 10.1182/blood.V91.7.2249.2249_2249_2258; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008; Gough DJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000361; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; HANSSON GK, 1991, CIRCULATION, V84, P1266, DOI 10.1161/01.CIR.84.3.1266; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Idel S, 2003, P NATL ACAD SCI USA, V100, P14235, DOI 10.1073/pnas.1835672100; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Longo CR, 2003, CIRCULATION, V108, P1113, DOI 10.1161/01.CIR.0000083718.76889.D0; Maelfait J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002570; Meyer O, 2009, JOINT BONE SPINE, V76, P464, DOI 10.1016/j.jbspin.2009.03.012; Niinisalo P, 2010, ANN MED, V42, P55, DOI 10.3109/07853890903321559; Ning SB, 2010, J VIROL, V84, P6130, DOI 10.1128/JVI.00364-10; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Parvatiyar K, 2011, MICROBES INFECT, V13, P209, DOI 10.1016/j.micinf.2010.11.003; Patel VI, 2006, FASEB J, V20, P1418, DOI 10.1096/fj.05-4981com; Paz S, 2006, CELL MOL BIOL, V52, P17, DOI 10.1170/T694; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ranjbaran H, 2007, J IMMUNOL, V178, P592, DOI 10.4049/jimmunol.178.1.592; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59; Shrikhande GV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014240; Sikorski K, 2011, AM J PHYSIOL-CELL PH, V300, pC1337, DOI 10.1152/ajpcell.00276.2010; Siracuse JJ, 2012, TRANSPLANTATION, V93, P373, DOI 10.1097/TP.0b013e3182419829; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stephan D, 1997, MOL MED, V3, P593, DOI 10.1007/BF03401816; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Suzuki S, 2010, J BIOL CHEM, V285, P4441, DOI 10.1074/jbc.M109.031476; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Tellides G, 2000, NATURE, V403, P207, DOI 10.1038/35003221; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Tu DQ, 2013, CELL REP, V3, P747, DOI 10.1016/j.celrep.2013.01.033; Wang F, 2012, CARDIOVASC RES, V93, P190, DOI 10.1093/cvr/cvr260; Wang JM, 2010, J IMMUNOL, V185, P1720, DOI 10.4049/jimmunol.1000114; Wang X, 2013, ACTA NEUROPATHOL, V126, P711, DOI 10.1007/s00401-013-1183-9; Wang YN, 2007, CIRC RES, V101, P560, DOI 10.1161/CIRCRESAHA.107.151068; Wang YY, 2004, FEBS LETT, V576, P86, DOI 10.1016/j.febslet.2004.08.071; Wrighton CJ, 1996, J EXP MED, V183, P1013, DOI 10.1084/jem.183.3.1013; Yuan C, 2012, J BIOL CHEM, V287, P17006, DOI 10.1074/jbc.M112.341198; Zernecke A, 2010, CARDIOVASC RES, V86, P192, DOI 10.1093/cvr/cvp391; Zohlnhofer D, 2001, MOL CELL, V7, P1059, DOI 10.1016/S1097-2765(01)00239-8	57	17	17	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					30912	30924		10.1074/jbc.M114.591966	http://dx.doi.org/10.1074/jbc.M114.591966			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25217635	Green Published, hybrid			2022-12-25	WOS:000344549900004
J	Chen, TJ; Ning, D; Sun, HC; Li, R; Shang, M; Li, XR; Wang, XY; Chen, WJ; Liang, C; Li, WF; Mao, Q; Li, Y; Deng, CH; Wang, LX; Wu, ZD; Huang, Y; Xu, J; Yu, XB				Chen, Tingjin; Ning, Dan; Sun, Hengchang; Li, Ran; Shang, Mei; Li, Xuerong; Wang, Xiaoyun; Chen, Wenjun; Liang, Chi; Li, Wenfang; Mao, Qiang; Li, Ye; Deng, Chuanhuan; Wang, Lexun; Wu, Zhongdao; Huang, Yan; Xu, Jin; Yu, Xinbing			Sequence Analysis and Molecular Characterization of Clonorchis sinensis Hexokinase, an Unusual Trimeric 50-kDa Glucose-6-Phosphate-Sensitive Allosteric Enzyme	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI HEXOKINASE; C-TERMINAL HALVES; FUNCTIONAL-ORGANIZATION; SCHISTOSOMA-MANSONI; TISSUE DISTRIBUTION; MULTIPLE FORMS; CLONING; RAT; PURIFICATION; INHIBITORS	Clonorchiasis, which is induced by the infection of Clonorchis sinensis (C. sinensis), is highly associated with cholangiocarcinoma. Because the available examination, treatment and interrupting transmission provide limited opportunities to prevent infection, it is urgent to develop integrated strategies to prevent and control clonorchiasis. Glycolytic enzymes are crucial molecules for trematode survival and have been targeted for drug development. Hexokinase of C. sinensis (CsHK), the first key regulatory enzyme of the glycolytic pathway, was characterized in this study. The calculated molecular mass (Mr) of CsHK was 50.0 kDa. The obtained recombinant CsHK (rCsHK) was a homotrimer with an Mr of approximately 164 kDa, as determined using native PAGE and gel filtration. The highest activity was obtained with 50 mM glycine-NaOH at pH 10 and 100 mM Tris-HCl at pH 8.5 and 10. The kinetics of rCsHK has a moderate thermal stability. Compared to that of the corresponding negative control, the enzymatic activity was significantly inhibited by praziquantel (PZQ) and anti-rCsHK serum. rCsHK was homotropically and allosterically activated by its substrates, including glucose, mannose, fructose, and ATP. ADP exhibited mixed allosteric effect on rCsHK with respect to ATP, while inorganic pyrophosphate (PPi) displayed net allosteric activation with various allosteric systems. Fructose behaved as a dose-dependent V activator with the substrate glucose. Glucose-6-phosphate (G6P) displayed net allosteric inhibition on rCsHK with respect to ATP or glucose with various allosteric systems in a dose-independent manner. There were differences in both mRNA and protein levels of CsHK among the life stages of adult worm, metacercaria, excysted metacercaria and egg of C. sinensis, suggesting different energy requirements during different development stages. Our study furthers the understanding of the biological functions of CsHK and supports the need to screen for small molecule inhibitors of CsHK to interfere with glycolysis in C. sinensis.	[Chen, Tingjin; Ning, Dan; Sun, Hengchang; Li, Ran; Shang, Mei; Li, Xuerong; Wang, Xiaoyun; Chen, Wenjun; Liang, Chi; Li, Wenfang; Mao, Qiang; Li, Ye; Deng, Chuanhuan; Wu, Zhongdao; Huang, Yan; Xu, Jin; Yu, Xinbing] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Parasitol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Tingjin; Ning, Dan; Sun, Hengchang; Li, Ran; Shang, Mei; Li, Xuerong; Wang, Xiaoyun; Chen, Wenjun; Liang, Chi; Li, Wenfang; Mao, Qiang; Li, Ye; Deng, Chuanhuan; Wu, Zhongdao; Huang, Yan; Xu, Jin; Yu, Xinbing] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Lexun] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Huang, Y (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Parasitol, Guangzhou 510275, Guangdong, Peoples R China.	huang66@mail.sysu.edu.cn; xujin@mail.sysu.edu.cn; yuxb@mail.sysu.edu.cn	Wang, Xiaoyun/F-1212-2015	CHEN, TINGJIN/0000-0003-3346-8307	National Key Basic Research and Development Project (973 project) [2010CB530000]; National S & T Major Program [2012ZX10004-220]; National Natural Science Foundation of China [81101270, 81171602]; Fundamental Research Funds for the Central Universities [3164015]	National Key Basic Research and Development Project (973 project); National S & T Major Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Key Basic Research and Development Project (973 project; No. 2010CB530000), the National S & T Major Program (2012ZX10004-220), the National Natural Science Foundation of China (No. 81101270 and No. 81171602), the Fundamental Research Funds for the Central Universities (NO. 3164015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Anorve LI, 2011, BBA-PROTEINS PROTEOM, V1814, P1846, DOI 10.1016/j.bbapap.2011.07.010; Ardehali H, 1996, J BIOL CHEM, V271, P1849, DOI 10.1074/jbc.271.4.1849; Armstrong RL, 1996, PROTEIN EXPRES PURIF, V8, P374, DOI 10.1006/prep.1996.0113; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; BORK P, 1993, PROTEIN SCI, V2, P31; Bourniquel AA, 2002, INT DAIRY J, V12, P821, DOI 10.1016/S0958-6946(02)00079-1; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Caceres AJ, 2003, MOL BIOCHEM PARASIT, V126, P251, DOI 10.1016/S0166-6851(02)00294-3; Cardenas ML, 1998, BBA-MOL CELL RES, V1401, P242, DOI 10.1016/S0167-4889(97)00150-X; Chambers JW, 2008, BIOCHEM BIOPH RES CO, V365, P420, DOI 10.1016/j.bbrc.2007.10.192; Chaudhuri G, 2013, INDIAN J BIOCHEM BIO, V50, P64; CHAYEN J, 1986, CELL BIOCHEM FUNCT, V4, P249, DOI 10.1002/cbf.290040404; Chen XQ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002606; Choi D, 2006, J HEPATOL, V44, P1066, DOI 10.1016/j.jhep.2005.11.040; Colowick SP., 1973, ENZYMES, V9, P1, DOI DOI 10.1016/S1874-6047(08)60113-4; Copeland L., 1980, METABOLISM RESP, P279; Das B, 2004, PARASITOL RES, V93, P253, DOI 10.1007/s00436-004-1122-8; Fenton AW, 2008, TRENDS BIOCHEM SCI, V33, P420, DOI 10.1016/j.tibs.2008.05.009; Geary TG, 2010, INT J PARASITOL, V40, P1, DOI 10.1016/j.ijpara.2009.11.001; GONZALEZ C, 1967, BIOCHEMISTRY-US, V6, P460, DOI 10.1021/bi00854a014; Harris MT, 2013, ANTIMICROB AGENTS CH, V57, P3731, DOI 10.1128/AAC.00662-13; Hong SJ, 2000, MOL BIOCHEM PARASIT, V108, P207, DOI 10.1016/S0166-6851(00)00220-6; Huang Can, 2009, Chinese Journal of Zoonoses, V25, P1100; Hudock MP, 2006, J MED CHEM, V49, P215, DOI 10.1021/jm0582625; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; KANG I K, 1969, Korean Journal of  Parasitology, V7, P143, DOI 10.3347/kjp.1969.7.3.143; KATZEN HM, 1965, P NATL ACAD SCI USA, V54, P1218, DOI 10.1073/pnas.54.4.1218; Kuser PR, 2000, J BIOL CHEM, V275, P20814, DOI 10.1074/jbc.M910412199; Liang Chi, 2009, Chinese Journal of Parasitology and Parasitic Diseases, V27, P148; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lun ZR, 2005, LANCET INFECT DIS, V5, P31, DOI 10.1016/S1473-3099(04)01252-6; Lv Gang, 2007, Chinese Journal of Parasitology and Parasitic Diseases, V25, P401; MOCHIZUKI Y, 1981, COMP BIOCHEM PHYS B, V70, P745, DOI 10.1016/0305-0491(81)90011-0; Mulichak AM, 1998, NAT STRUCT BIOL, V5, P555, DOI 10.1038/811; OLAFSSON P, 1992, MOL BIOCHEM PARASIT, V56, P89, DOI 10.1016/0166-6851(92)90157-F; Pabon MA, 2007, PARASITOL RES, V100, P803, DOI 10.1007/s00436-006-0351-4; Papachristou GI, 2005, DIGEST DIS SCI, V50, P2159, DOI 10.1007/s10620-005-3024-8; Petrova VY, 2002, ELECTRON J BIOTECHN, V5; PHILLIPS D, 1981, Philosophical Transactions of the Royal Society of London B Biological Sciences, V293, P1; Saito T, 2002, INT J PARASITOL, V32, P961, DOI 10.1016/S0020-7519(02)00059-0; Sanz-Rodriguez CE, 2007, J BIOL CHEM, V282, P12377, DOI 10.1074/jbc.M607286200; Schmitt-Wrede HP, 1999, BBA-GENE STRUCT EXPR, V1444, P439, DOI 10.1016/S0167-4781(99)00009-3; SCHWARTZ DA, 1980, TROP GEOGR MED, V32, P95; SEO B-S, 1971, Chinese Journal of Microbiology, V4, P200; Sharlow ER, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000659; SHOEMAKER CB, 1995, EXP PARASITOL, V80, P36, DOI 10.1006/expr.1995.1005; Singh AR, 2008, PARASITOL INT, V57, P354, DOI 10.1016/j.parint.2008.03.004; TIELENS AGM, 1994, J BIOL CHEM, V269, P24736; Tjhin ET, 2013, FEBS LETT, V587, P3182, DOI 10.1016/j.febslet.2013.07.052; Tsai HJ, 1996, ARCH BIOCHEM BIOPHYS, V329, P17, DOI 10.1006/abbi.1996.0186; Vokral I, 2012, VET PARASITOL, V185, P168, DOI 10.1016/j.vetpar.2011.09.026; Wang XT, 2011, INT J MED ROBOT COMP, V7, P107, DOI 10.1002/rcs.377; WHITE TK, 1989, ARCH BIOCHEM BIOPHYS, V274, P375, DOI 10.1016/0003-9861(89)90451-7; Willson M, 2002, CHEM BIOL, V9, P839, DOI 10.1016/S1074-5521(02)00169-2; WILSON JE, 1995, REV PHYSIOL BIOCH P, V126, P65, DOI 10.1007/BFb0049776; WOOD T, 1986, CELL BIOCHEM FUNCT, V4, P241, DOI 10.1002/cbf.290040403; YANAGAWA HA, 1978, INSECT BIOCHEM, V8, P293, DOI 10.1016/0020-1790(78)90040-9; Yang G, 2006, PARASITOL RES, V99, P55, DOI 10.1007/s00436-005-0125-4	59	16	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107940	10.1371/journal.pone.0107940	http://dx.doi.org/10.1371/journal.pone.0107940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232723	Green Published, gold, Green Submitted			2022-12-25	WOS:000342921200063
J	Drago, L; Bortolin, M; Vassena, C; Romano, CL; Taschieri, S; Del Fabbro, M				Drago, Lorenzo; Bortolin, Monica; Vassena, Christian; Romano, Carlo L.; Taschieri, Silvio; Del Fabbro, Massimo			Plasma Components and Platelet Activation Are Essential for the Antimicrobial Properties of Autologous Platelet-Rich Plasma: An In Vitro Study	PLOS ONE			English	Article							GROWTH-FACTORS; STAPHYLOCOCCUS-AUREUS; GEL; PEPTIDES; BLOOD; PRP; COMPLEMENT; PNEUMONIA; LEUKOCYTE; PROTEINS	Autologous platelet concentrates are successfully adopted in a variety of medical fields to stimulate bone and soft tissue regeneration. The rationale for their use consists in the delivery of a wide range of platelet-derived bioactive molecules that promotes wound healing. In addition, antimicrobial properties of platelet concentrates have been pointed out. In this study, the effect of the platelet concentration, of the activation step and of the presence of plasmatic components on the antimicrobial activity of pure platelet-rich plasma was investigated against gram positive bacteria isolated from oral cavity. The antibacterial activity, evaluated as the minimum inhibitory concentration, was determined through the microdilution two-fold serial method. Results seem to suggest that the antimicrobial activity of platelet-rich plasma against Enterococcus faecalis, Streptococcus agalactiae, Streptococcus oralis and Staphylococcus aureus is sustained by a co-operation between plasma components and platelet-derived factors and that the activation of coagulation is a fundamental step. The findings of this study may have practical implications in the modality of application of platelet concentrates.	[Drago, Lorenzo] Univ Milan, Dept Biomed Sci Hlth, Lab Tech Sci Lab Med, Milan, Italy; [Drago, Lorenzo; Vassena, Christian] IRCCS Galeazzi Orthoped Inst, Lab Clin Chem & Microbiol, Milan, Italy; [Bortolin, Monica; Taschieri, Silvio; Del Fabbro, Massimo] IRCCS Galeazzi Orthoped Inst, Dent Clin, Milan, Italy; [Taschieri, Silvio; Del Fabbro, Massimo] Univ Milan, Dept Biomed Surg & Dent Sci, Milan, Italy; [Romano, Carlo L.] IRCCS Galeazzi Orthoped Inst, Ctr Reconstruct Surg & Osteoarticular Infect, Milan, Italy	University of Milan; IRCCS Istituto Ortopedico Galeazzi; IRCCS Istituto Ortopedico Galeazzi; University of Milan; IRCCS Istituto Ortopedico Galeazzi	Drago, L (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Lab Tech Sci Lab Med, Milan, Italy.	lorenzo.drago@unimi.it	Del Fabbro, Massimo/I-2444-2012	Del Fabbro, Massimo/0000-0001-7144-0984; Lorenzo, Drago/0000-0002-5206-540X				Aktan I, 2013, VET IMMUNOL IMMUNOP, V152, P209, DOI 10.1016/j.vetimm.2012.12.007; Alvarez ME, 2011, ARCH MED VET, V43, P155, DOI 10.4067/S0301-732X2011000200008; Anitua E, 2012, CLIN EXP DERMATOL, V37, P652, DOI 10.1111/j.1365-2230.2011.04303.x; Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440; Bielecki TM, 2007, J BONE JOINT SURG BR, V89B, P417, DOI 10.1302/0301-620X.89B3.18491; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Bomstein MM, 2008, J PERIODONTOL, V79, P2347, DOI [10.1902/jop.2008.080303, 10.1902/jop.2008.080303 ]; Burnie JP, 1996, INFECT IMMUN, V64, P1600, DOI 10.1128/IAI.64.5.1600-1608.1996; Burnouf T, 2013, TRANSFUSION, V53, P138, DOI 10.1111/j.1537-2995.2012.03668.x; Chen LH, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/269527; Cieslik-Bielecka A, 2009, TRANSFUS APHER SCI, V41, P9, DOI 10.1016/j.transci.2009.05.006; Daha MR, 2010, CRIT REV IMMUNOL, V30, P47, DOI 10.1615/CritRevImmunol.v30.i1.30; Del Fabbro M, 2012, J ENDODONT, V38, P733, DOI 10.1016/j.joen.2012.02.022; Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe51, DOI 10.1016/j.tripleo.2005.07.010; Drago L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-47; Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009; El-Sharkawy H, 2007, J PERIODONTOL, V78, P661, DOI 10.1902/jop.2007.060302; El-Solh AA, 2004, CHEST, V126, P1575, DOI 10.1378/chest.126.5.1575; Everts PAM, 2006, ACTA ANAESTH SCAND, V50, P593, DOI 10.1111/j.1399-6576.2006.001005.x; Intini G, 2009, BIOMATERIALS, V30, P4956, DOI 10.1016/j.biomaterials.2009.05.055; JOINER KA, 1984, ANNU REV IMMUNOL, V2, P461, DOI 10.1146/annurev.immunol.2.1.461; Kraemer BF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002355; Levy O, 2000, BLOOD, V96, P2664; Moojen DJF, 2008, J ORTHOP RES, V26, P404, DOI 10.1002/jor.20519; Radek K, 2007, SEMIN IMMUNOPATHOL, V29, P27, DOI 10.1007/s00281-007-0064-5; Rozalski MI, 2013, POSTEP HIG MED DOSW, V67, P321; Schnabel LV, 2007, J ORTHOP RES, V25, P230, DOI 10.1002/jor.20278; Smith AJ, 2003, BRIT DENT J, V195, P701, DOI 10.1038/sj.bdj.4810832; Stuart CH, 2006, J ENDODONT, V32, P93, DOI 10.1016/j.joen.2005.10.049; Tang YQ, 2002, INFECT IMMUN, V70, P6524, DOI 10.1128/IAI.70.12.6524-6533.2002; Terpenning MS, 2001, J AM GERIATR SOC, V49, P557, DOI 10.1046/j.1532-5415.2001.49113.x; Tohidnezhad M, 2011, HISTOCHEM CELL BIOL, V135, P453, DOI 10.1007/s00418-011-0808-0; Tohidnezhad M, 2012, PLATELETS, V23, P217, DOI 10.3109/09537104.2011.610908; Tohidnezhad M, 2011, INJURY, V42, P682, DOI 10.1016/j.injury.2010.12.010; Trowbridge Cody C, 2005, J Extra Corpor Technol, V37, P381; WU T, 1994, ANTIMICROB AGENTS CH, V38, P729, DOI 10.1128/AAC.38.4.729; Yeaman MR, 1997, CLIN INFECT DIS, V25, P951, DOI 10.1086/516120; Yuan T, 2008, TRANSFUS APHER SCI, V38, P167, DOI 10.1016/j.transci.2008.01.006	38	52	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107813	10.1371/journal.pone.0107813	http://dx.doi.org/10.1371/journal.pone.0107813			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232963	Green Published, gold, Green Submitted			2022-12-25	WOS:000342921200051
J	Eloyan, A; Shou, HC; Shinohara, RT; Sweeney, EM; Nebel, MB; Cuzzocreo, JL; Calabresi, PA; Reich, DS; Lindquist, MA; Crainiceanu, CM				Eloyan, Ani; Shou, Haochang; Shinohara, Russell T.; Sweeney, Elizabeth M.; Nebel, Mary Beth; Cuzzocreo, Jennifer L.; Calabresi, Peter A.; Reich, Daniel S.; Lindquist, Martin A.; Crainiceanu, Ciprian M.			Health Effects of Lesion Localization in Multiple Sclerosis: Spatial Registration and Confounding Adjustment	PLOS ONE			English	Article							GRAY-MATTER ATROPHY; LOCATION; ALGORITHMS; DISABILITY; CONVERSION	Brain lesion localization in multiple sclerosis (MS) is thought to be associated with the type and severity of adverse health effects. However, several factors hinder statistical analyses of such associations using large MRI datasets: 1) spatial registration algorithms developed for healthy individuals may be less effective on diseased brains and lead to different spatial distributions of lesions; 2) interpretation of results requires the careful selection of confounders; and 3) most approaches have focused on voxel-wise regression approaches. In this paper, we evaluated the performance of five registration algorithms and observed that conclusions regarding lesion localization can vary substantially with the choice of registration algorithm. Methods for dealing with confounding factors due to differences in disease duration and local lesion volume are introduced. Voxel-wise regression is then extended by the introduction of a metric that measures the distance between a patient-specific lesion mask and the population prevalence map.	[Eloyan, Ani; Sweeney, Elizabeth M.; Reich, Daniel S.; Lindquist, Martin A.; Crainiceanu, Ciprian M.] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Shou, Haochang; Shinohara, Russell T.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Sweeney, Elizabeth M.; Reich, Daniel S.] NINDS, Translat Neurol Unit, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA; [Nebel, Mary Beth] Kennedy Krieger Inst, Lab Neurocognit & Imaging Res, Baltimore, MD USA; [Nebel, Mary Beth; Calabresi, Peter A.; Reich, Daniel S.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Cuzzocreo, Jennifer L.; Reich, Daniel S.] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins University	Eloyan, A (corresponding author), Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	aeloyan1@jhu.edu	Nebel, Mary Beth/D-3305-2015; Reich, Daniel S./E-5701-2010; Calabresi, Peter A./AAF-2288-2019	Nebel, Mary Beth/0000-0003-0185-3382; Reich, Daniel S./0000-0002-2628-4334; Calabresi, Peter/0000-0002-7776-6472	National Institute of Biomedical Imaging And Bioengineering [R01EB012547]; National Institute of Neurological Disorders and Stroke (NINDS) [R01NS060910, RO1 NS08521]; National Institute of Mental Health [RO1 MH095836]; Intramural Research Program of NINDS; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060910, R01NS085211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000247] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging And Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Intramural Research Program of NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The project described was supported by R01EB012547 from the National Institute of Biomedical Imaging And Bioengineering, R01NS060910 and RO1 NS08521 from the National Institute of Neurological Disorders and Stroke (NINDS), and RO1 MH095836 from the National Institute of Mental Health. Dr. Reich's research is supported by the Intramural Research Program of NINDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2014, CATEGORICAL DATA ANA; Ardekani BA, 2005, J NEUROSCI METH, V142, P67, DOI 10.1016/j.jneumeth.2004.07.014; Ashburner J, 1997, NEUROIMAGE, V6, P344, DOI 10.1006/nimg.1997.0299; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ashburner J, 2009, NEUROIMAGE, V45, P333, DOI 10.1016/j.neuroimage.2008.12.008; Avants B, 2011, ADV NORMALIZATION TO; Bendfeldt K, 2010, HUM BRAIN MAPP, V31, P1542, DOI 10.1002/hbm.20951; Bodini B, 2011, J NEUROL NEUROSUR PS, V82, P72, DOI 10.1136/jnnp.2009.201574; Carass A, 2011, NEUROIMAGE, V56, P1982, DOI 10.1016/j.neuroimage.2011.03.045; Ceccarelli A, 2012, AM J NEURORADIOL, V33, P1579, DOI 10.3174/ajnr.A3083; Charil A, 2003, NEUROIMAGE, V19, P532, DOI 10.1016/S1053-8119(03)00117-4; Charil A, 2007, NEUROIMAGE, V34, P509, DOI 10.1016/j.neuroimage.2006.10.006; Charil A, 2013, NEUROLOGY, V80, P230, DOI 10.1212/WNL.0b013e31827dec22; Dalton CM, 2012, MULT SCLER J, V18, P322, DOI 10.1177/1352458511420269; Filli L, 2012, MULTIPLE SCLEROSIS J; Friston K., 2007, STAT PARAMETRIC MAPP, DOI [10.1016/B978-0-12-372560-8.X5000-1, DOI 10.1016/B978-0-12-372560-8.X5000-1]; Giorgio A, 2013, NEUROLOGY, V80, P234, DOI 10.1212/WNL.0b013e31827debeb; Holland C, 2012, J NEUROIMAGING; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lucas BC, 2010, NEUROINFORMATICS, V8, P5, DOI 10.1007/s12021-009-9061-2; Matthews L, 2013, NEUROLOGY; McAuliffe MJ, 2001, COMP MED SY, P381; Riccitelli G, 2011, AM J NEURORADIOL, V32, P874, DOI 10.3174/ajnr.A2412; Rossi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044826; Sepulcre J, 2009, ARCH NEUROL-CHICAGO, V66, P173, DOI 10.1001/archneurol.2008.562; Shiee N, 2008, WORK MED IMAGE ANAL, P71; Shiee N, 2010, NEUROIMAGE, V49, P1524, DOI 10.1016/j.neuroimage.2009.09.005; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sweeney EM, 2013, AM J NEURORADIOL, V34, P68, DOI 10.3174/ajnr.A3172; Sweeney EM, 2013, NEUROIMAGE CLIN; Vellinga MM, 2009, J MAGN RESON IMAGING, V29, P768, DOI 10.1002/jmri.21679	33	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107263	10.1371/journal.pone.0107263	http://dx.doi.org/10.1371/journal.pone.0107263			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233361	Green Published, gold, Green Submitted			2022-12-25	WOS:000342921200020
J	Wang, YN; Wang, Z; Zhang, J; Wei, Q; Tang, R; Qi, JY; Li, LH; Ye, LP; Wang, JJ; Ye, L				Wang, Yini; Wang, Zhao; Zhang, Jia; Wei, Qing; Tang, Ran; Qi, Junyuan; Li, Lihong; Ye, Liping; Wang, Jijun; Ye, Ling			Genetic Features of Late Onset Primary Hemophagocytic Lymphohistiocytosis in Adolescence or Adulthood	PLOS ONE			English	Article							MUTATIONS; PERFORIN; GENOTYPE; MUNC13-4; DEFECTS; PRF1	Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening condition of uncontrolled immune activation leading to extreme inflammation. Primary HLH was once believed to be a disease that occurred only in infancy or young children, and was rarely diagnosed in adults. It is now understood that patients can develop primary HLH in their adolescence or adulthood. This study included 252 adolescent and adult patients with a clinical diagnosis of HLH from 35 general medical institutions across mainland China. All exons and 50 bp of flanking intronic sequence of six HLH-related genes (PRF1, UNC13D, STX11, STXBP2, SH2D1A, and BIRC4) were sequenced in these patients. We identified mutations in 18/252 (7.1%) of the patients, with changes in PRF1 being most common. Late-onset HLH often features viral infection and other predisposing factors. We conclude that late-onset primary HLH is not as rare as previously thought. Older patients should not be delayed to receive HLH-related genes testing when they are suspected with HLH.	[Wang, Yini; Wang, Zhao; Zhang, Jia; Wei, Qing; Tang, Ran] Capital Med Univ, Beijing Friendship Hosp, Dept Hematol, Beijing, Peoples R China; [Qi, Junyuan] Chinese Acad Med Sci, Inst Hematol, Dept Lymphoma, Tianjin, Peoples R China; [Qi, Junyuan] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China; [Li, Lihong] Capital Med Univ, Dept Hematol, Beijing Chao Yang Hosp, Beijing, Peoples R China; [Ye, Liping] Chinese Peoples Liberat Army, Hosp 309, Dept Transplantat, Beijing, Peoples R China; [Wang, Jijun] Peking Univ, Dept Hematol, Hosp 3, Beijing 100871, Peoples R China; [Ye, Ling] Shandong Jining First Peoples Hosp, Dept Hematol, Jinan, Shandong, Peoples R China	Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Capital Medical University; Peking University	Wang, Z (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Hematol, Beijing, Peoples R China.	zhaowww263@yahoo.com			National Natural Science Fund, China [81270653]; Medical Development Research Foundation of the Capital, China [2009-1032]; Scientific Research Foundation of Beijing Friendship Hospital, China [YYQDKT2011-6]; Beijing Talent Cultivation Plan (D)	National Natural Science Fund, China(National Natural Science Foundation of China (NSFC)); Medical Development Research Foundation of the Capital, China; Scientific Research Foundation of Beijing Friendship Hospital, China; Beijing Talent Cultivation Plan (D)	This work was supported by the National Natural Science Fund, China (81270653); Medical Development Research Foundation of the Capital, China (2009-1032); and the Scientific Research Foundation of Beijing Friendship Hospital, China (YYQDKT2011-6); and Beijing Talent Cultivation Plan (D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arico M, 2001, BRIT J HAEMATOL, V114, P761, DOI 10.1046/j.1365-2141.2001.02936.x; Arico M, 2001, BLOOD, V97, P1131, DOI 10.1182/blood.V97.4.1131; Bizario JCS, 2004, J CLIN IMMUNOL, V24, P397, DOI 10.1023/B:JOCI.0000029119.83799.cb; Bryceson YT, 2012, BLOOD, V119, P2754, DOI 10.1182/blood-2011-08-374199; Cetica V, 2010, HAEMATOL-HEMATOL J, V95, P538, DOI 10.3324/haematol.2009.019562; CHANDRA P, 1975, ARCH INTERN MED, V135, P989, DOI 10.1001/archinte.135.7.989; Clementi R, 2002, BLOOD, V100, P2266, DOI 10.1182/blood-2002-04-1030; Enders A, 2006, BLOOD, V108, P81, DOI 10.1182/blood-2005-11-4413; FARQUHAR JW, 1952, ARCH DIS CHILD, V27, P519, DOI 10.1136/adc.27.136.519; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Henter JI, 2002, BLOOD, V100, P2367, DOI 10.1182/blood-2002-01-0172; Janka GE, 2007, EUR J PEDIATR, V166, P95, DOI 10.1007/s00431-006-0258-1; Jordan MB, 2011, BLOOD, V118, P4041, DOI 10.1182/blood-2011-03-278127; Konjevic G, 1999, BRIT J HAEMATOL, V104, P144, DOI 10.1046/j.1365-2141.1999.01129.x; Lykens JE, 2011, BLOOD, V118, P618, DOI 10.1182/blood-2010-12-324533; Mancebo E, 2006, HAEMATOLOGICA, V91, P1257; Nagafuji K, 2007, HAEMATOLOGICA, V92, P978, DOI 10.3324/haematol.11233; Rigaud S, 2006, NATURE, V444, P110, DOI 10.1038/nature05257; Sieni E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044649; Stadt UZ, 2006, HUM MUTAT, V27, P62, DOI 10.1002/humu.20274; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Trizzino A, 2008, J MED GENET, V45, P15, DOI 10.1136/jmg.2007.052670; Wang Zhao, 2008, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V16, P1154; Westbroek W, 2007, J INVEST DERMATOL, V127, P2674, DOI 10.1038/sj.jid.5700899; Woon ST, 2008, SCAND J IMMUNOL, V68, P153, DOI 10.1111/j.1365-3083.2008.02128.x; Zhang KJ, 2011, BLOOD, V118, P5794, DOI 10.1182/blood-2011-07-370148; zur Stadt U, 2005, HUM MOL GENET, V14, P827, DOI 10.1093/hmg/ddi076; zur Stadt U, 2009, AM J HUM GENET, V85, P482, DOI 10.1016/j.ajhg.2009.09.005	29	27	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107386	10.1371/journal.pone.0107386	http://dx.doi.org/10.1371/journal.pone.0107386			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233452	gold, Green Submitted, Green Published			2022-12-25	WOS:000342921200028
J	Nair, SVG; Ziaullah; Rupasinghe, HPV				Nair, Sandhya V. G.; Ziaullah; Rupasinghe, H. P. Vasantha			Fatty Acid Esters of Phloridzin Induce Apoptosis of Human Liver Cancer Cells through Altered Gene Expression	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; IN-VITRO; DIETARY POLYPHENOLS; GROWTH-INHIBITION; HEPG2 CELLS; PATHWAYS; PREVENTION; CHEMOPREVENTION; ANTIOXIDANT; MECHANISMS	Phloridzin (phlorizin or phloretin 2'-O-glucoside) is known for blocking intestinal glucose absorption. We have investigated the anticarcinogenic effect of phloridzin and its novel derivatives using human cancer cell lines. We have synthesised novel acylated derivatives of phloridzin with six different long chain fatty acids by regioselective enzymatic acylation using Candida Antarctica lipase B. The antiproliferative effects of the new compounds were investigated in comparison with the parent compounds, phloridzin, aglycone phloretin, the six free fatty acids and chemotherapeutic drugs (sorafenib, doxorubicin and daunorubicin) using human hepatocellular carcinoma HepG2 cells, human breast adenocarcinoma MDA-MB- 231 cells and acute monocytic leukemia THP-1 cells along with normal human and rat hepatocytes. The fatty acid esters of phloridzin inhibited significantly the growth of the two carcinoma and leukemia cells while similar treatment doses were not toxic to normal human or rat hepatocytes. The antiproliferative potency of fatty esters of phloridzin was comparable to the potency of the chemotherapeutic drugs. The fatty acid esters of phloridzin inhibited DNA topoisomerases II alpha activity that might induce G(0)/G(1) phase arrest, induced apoptosis via activation of caspase-3, and decreased ATP level and mitochondrial membrane potential in HepG2 cells. Based on the high selectivity on cancer cells, decosahexaenoic acid (DHA) ester of phloridzin was selected for gene expression analysis using (RTPCR)-P-2 human cancer drug target array. Antiproliferative effect of DHA ester of phloridzin could be related to the down regulation of anti-apoptotic gene (BCL2), growth factor receptors (EBFR family, IGF1R/IGF2, PDGFR) and its downstream signalling partners (PI3k/AKT/mTOR, Ras/Raf/MAPK), cell cycle machinery (CDKs, TERT, TOP2A, TOP2B) as well as epigenetics regulators (HDACs). These results suggest that fatty esters of phloridzin have potential chemotherapeutic effects mediated through the attenuated expression of several key proteins involved in cell cycle regulation, DNA topoisomerases IIa activity and epigenetic mechanisms followed by cell cycle arrest and apoptosis.	[Nair, Sandhya V. G.; Ziaullah; Rupasinghe, H. P. Vasantha] Dalhousie Univ, Fac Agr, Dept Environm Sci, Truro, NS, Canada	Dalhousie University	Rupasinghe, HPV (corresponding author), Dalhousie Univ, Fac Agr, Dept Environm Sci, Truro, NS, Canada.	vrupasinghe@dal.ca	Rupasinghe, H.P. Vasantha/B-6049-2013	Rupasinghe, H.P. Vasantha/0000-0003-3435-0052	HPVR: Discovery Grant program of the Natural Sciences and Engineering Council (NSERC) of Canada [327056]; Atlantic Innovation Funds (AIF) program of the Atlantic Canada Opportunities Agency (ACOA) [192020]	HPVR: Discovery Grant program of the Natural Sciences and Engineering Council (NSERC) of Canada; Atlantic Innovation Funds (AIF) program of the Atlantic Canada Opportunities Agency (ACOA)	HPVR: Discovery Grant program of the Natural Sciences and Engineering Council (NSERC; Grant Number 327056; http://www.nserc-crsng.gc.ca) of Canada and the Atlantic Innovation Funds (AIF) program of the Atlantic Canada Opportunities Agency (ACOA; Grant Number 192020; http://www.acoa-apeca.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldisserotto A, 2012, MOLECULES, V17, P13275, DOI 10.3390/molecules171113275; Granado-Serrano AB, 2012, CHEM-BIOL INTERACT, V195, P154, DOI 10.1016/j.cbi.2011.12.005; Boccia MM, 1999, NEUROBIOL LEARN MEM, V71, P104, DOI 10.1006/nlme.1998.3856; Breuhahn K, 2006, ONCOGENE, V25, P3787, DOI 10.1038/sj.onc.1209556; Brown EM, 2012, CURR PHARM BIOTECHNO, V13, P200; Cardile V, 2005, BIOORG CHEM, V33, P22, DOI 10.1016/j.bioorg.2004.08.003; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Chen D, 2011, ADV CLIN CHEM, V53, P155, DOI 10.1016/S0065-2423(11)53007-0; CONSTANTINOU A, 1995, J NAT PRODUCTS, V58, P217, DOI 10.1021/np50116a009; Danihelova M, 2012, ACTA CHIMICA SLOVACA, V59; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; El-Awady RA, 2008, SAUDI MED J, V29, P558; Faivre S, 2006, SEMIN ONCOL, V33, P407, DOI 10.1053/j.seminoncol.2006.04.005; Fulda S., 2010, INT J CELL BIOL, V2010, DOI [DOI 10.1155/2010/370835, 10.1155/2010/370835]; Glauert HP, 2010, MOL NUTR FOOD RES, V54, P875, DOI 10.1002/mnfr.200900482; Gu FM, 2011, WORLD J GASTROENTERO, V17, P3922, DOI 10.3748/wjg.v17.i34.3922; Horgan Anne M, 2012, J Gastrointest Cancer, V43, P344, DOI 10.1007/s12029-010-9194-4; HSU IC, 1993, CARCINOGENESIS, V14, P987, DOI 10.1093/carcin/14.5.987; Huang SP, 2009, ANTICANCER RES, V29, P165; Jung E, 2009, FOOD CHEM TOXICOL, V47, P2436, DOI 10.1016/j.fct.2009.06.039; Kang NJ, 2011, PHARMACOL THERAPEUT, V130, P310, DOI 10.1016/j.pharmthera.2011.02.004; Lambert JD, 2006, DRUG METAB DISPOS, V34, P2111, DOI 10.1124/dmd.106.011460; Larsen Annette K, 2003, Prog Cell Cycle Res, V5, P295; Link A, 2010, BIOCHEM PHARMACOL, V80, P1771, DOI 10.1016/j.bcp.2010.06.036; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Miura T, 2008, CARCINOGENESIS, V29, P585, DOI 10.1093/carcin/bgm198; Naasani I, 2003, CANCER RES, V63, P824; Olsen Sonja K, 2010, Therap Adv Gastroenterol, V3, P55, DOI 10.1177/1756283X09346669; Pang R, 2006, CANCER LETT, V240, P157, DOI 10.1016/j.canlet.2005.08.031; Pocobelli G, 2008, LIVER INT, V28, P1272, DOI 10.1111/j.1478-3231.2008.01704.x; Puel C, 2005, CALCIFIED TISSUE INT, V77, P311, DOI 10.1007/s00223-005-0060-5; Rezk BM, 2002, BIOCHEM BIOPH RES CO, V295, P9, DOI 10.1016/S0006-291X(02)00618-6; Ridgway Tim, 1997, Biochemical Society Transactions, V25, p106S; Riss TL, 2004, ASSAY DRUG DEV TECHN, V2, P51, DOI 10.1089/154065804322966315; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Saitou Y, 2005, WORLD J GASTROENTERO, V11, P6258, DOI 10.3748/wjg.v11.i40.6258; Schley PD, 2005, BREAST CANCER RES TR, V92, P187, DOI 10.1007/s10549-005-2415-z; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Stagos D, 2012, FOOD CHEM TOXICOL, V50, P2155, DOI 10.1016/j.fct.2012.04.002; Szliszka E, 2010, MOLECULES, V15, P5336, DOI 10.3390/molecules15085336; Topcu Z, 2001, J CLIN PHARM THER, V26, P405, DOI 10.1046/j.1365-2710.2001.00368.x; Watanuki A, 2002, ANTICANCER RES, V22, P1113; Wild CP, 2009, CANCER LETT, V286, P22, DOI 10.1016/j.canlet.2009.02.053; Zhang Ru-Gang, 2007, Zhonghua Gan Zang Bing Za Zhi, V15, P32; Zhivotosky B, 2001, CURR PROTOC CELL BIO, V18; Zhou Q, 2011, FUTURE ONCOL, V7, P1149, DOI [10.2217/FON.11.95, 10.2217/fon.11.95]; Ziaullah, 2013, BIOORGAN MED CHEM, V21, P684, DOI 10.1016/j.bmc.2012.11.034	48	39	41	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107149	10.1371/journal.pone.0107149	http://dx.doi.org/10.1371/journal.pone.0107149			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229655	Green Published, Green Submitted, gold			2022-12-25	WOS:000342123900026
J	Corral-San Miguel, R; Hernandez-Caselles, T; Alcaraz, AJR; Martinez-Esparza, M; Garcia-Penarrubia, P				Corral-San Miguel, Ruben; Hernandez-Caselles, Trinidad; Ruiz Alcaraz, Antonio Jose; Martinez-Esparza, Maria; Garcia-Penarrubia, Pilar			MHC-I Molecules Selectively Inhibit Cell-Mediated Cytotoxicity Triggered by ITAM-Coupled Activating Receptors and 2B4	PLOS ONE			English	Article							KILLER NK CELLS; HUMAN T-CELLS; SIGNAL-TRANSDUCTION; NATURAL CYTOTOXICITY; CIS-INTERACTIONS; CROSS-LINKING; ANTIBODIES; COMPLEX; ACCESSIBILITY; RECOGNITION	NK cell effector functions are controlled by a combination of inhibitory receptors, which modulate NK cell activation initiated by stimulatory receptors. Most of the canonical NK cell inhibitory receptors recognize allelic forms of classical and non-classical MHC class I molecules. Furthermore, high expression of MHC-I molecules on effector immune cells is also associated with reverse signaling, giving rise to several immune-regulatory functions. Consequently, the inhibitory function of MHC class I expressed on a human NKL cell line and activated primary NK and T cells on different activating receptors are analyzed in this paper. Our results reveal that MHC-I molecules display specific patterns of "selective" inhibition over cytotoxicity and cytokine production induced by ITAM-dependent receptors and 2B4, but not on NKG2D. This contrasts with the best known "canonical" inhibitory receptors, which constitutively inhibit both functions, regardless of the activating receptor involved. Our results support the existence of a new fine-tuner inhibitory function for MHC-I molecules expressed on cytotoxic effector cells that could be involved in establishing self-tolerance in mature activated NK cells, and could also be important in tumor and infected cell recognition.	[Garcia-Penarrubia, Pilar] Univ Murcia, Sch Med, Dept Biochem & Mol Biol & Immunol B, Murcia, Spain; IMIB Inst Murciano Invest Biosanitarias Arrixaca, Murcia, Spain	University of Murcia	Garcia-Penarrubia, P (corresponding author), Univ Murcia, Sch Med, Dept Biochem & Mol Biol & Immunol B, Campus Int Excellence Campus Mare Nostrum, Murcia, Spain.	pigarcia@um.es	Martínez-Esparza, María/R-9646-2019; García-Peñarrubia, Pilar/ABH-2427-2020; Ruiz-Alcaraz, Antonio José/Z-5867-2019; Hernandez-Caselles, Trinidad/R-1065-2018	Martínez-Esparza, María/0000-0001-5765-8231; García-Peñarrubia, Pilar/0000-0002-2922-4804; Ruiz-Alcaraz, Antonio José/0000-0001-6913-0610; Corral San Miguel, Ruben/0000-0003-3947-1064; Hernandez-Caselles, Trinidad/0000-0001-6727-8320	Fundacion Seneca (CARM) project [03112/PI/05]	Fundacion Seneca (CARM) project	This work was supported by the Fundacion Seneca (CARM) project number 03112/PI/05 to PGP (http://fseneca.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KE, 2007, EUR J IMMUNOL, V37, P516, DOI 10.1002/eji.200636693; Andre P, 2004, EUR J IMMUNOL, V34, P961, DOI 10.1002/eji.200324705; Aparicio P., 2004, INMUNOLOGIA, V23, P284; Arosa FA, 2007, TRENDS IMMUNOL, V28, P115, DOI 10.1016/j.it.2007.01.002; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bessoles S, 2013, J IMMUNOL, V191, P5044, DOI 10.4049/jimmunol.1301971; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Caparros E, 2004, EUR J IMMUNOL, V34, P47, DOI 10.1002/eji.200324462; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; DASGUPTA JD, 1994, INT IMMUNOL, V6, P481; Doucey MA, 2004, NAT IMMUNOL, V5, P328, DOI 10.1038/ni1043; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; GEPPERT TD, 1989, J IMMUNOL, V142, P3763; GILLILAND LK, 1989, HUM IMMUNOL, V25, P269, DOI 10.1016/0198-8859(89)90089-X; Goodridge JP, 2010, J IMMUNOL, V184, P6199, DOI 10.4049/jimmunol.1000078; GUR H, 1990, J EXP MED, V172, P1267, DOI 10.1084/jem.172.4.1267; Held W, 2008, NAT REV IMMUNOL, V8, P269, DOI 10.1038/nri2278; Hernandez-Caselles T, 2006, J LEUKOCYTE BIOL, V79, P46, DOI 10.1189/jlb.0205096; Hoglund P, 2010, NAT REV IMMUNOL, V10, P724, DOI 10.1038/nri2835; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Li NL, 2013, EUR J IMMUNOL, V43, P1042, DOI 10.1002/eji.201242607; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Pedersen AE, 1999, APMIS, V107, P887, DOI 10.1111/j.1699-0463.1999.tb01488.x; Penarrubia PG, 2005, IEEE T IMAGE PROCESS, V14, P1151, DOI 10.1109/TIP.2005.851699; PETERSSON MGE, 1995, SCAND J IMMUNOL, V42, P34, DOI 10.1111/j.1365-3083.1995.tb03622.x; Raine T, 2005, BIOESSAYS, V27, P542, DOI 10.1002/bies.20215; Robertson MJ, 1996, EXP HEMATOL, V24, P406; Rubio G, 2004, J LEUKOCYTE BIOL, V76, P116, DOI 10.1189/jlb.1103597; Santos SG, 2004, J BIOL CHEM, V279, P53062, DOI 10.1074/jbc.M408794200; Sivori S, 1997, J EXP MED, V186, P1129, DOI 10.1084/jem.186.7.1129; Skov S, 1998, TISSUE ANTIGENS, V51, P215; Skov S, 1997, J IMMUNOL, V158, P3189; SMITH DM, 1994, J IMMUNOL, V153, P1054; TAYLOR DS, 1987, J IMMUNOL, V139, P1792; TSCHERNING T, 1994, SCAND J IMMUNOL, V39, P117, DOI 10.1111/j.1365-3083.1994.tb03349.x; Woodle ES, 1997, J IMMUNOL, V158, P2156; Xu S, 2012, NAT IMMUNOL, V13, P551, DOI 10.1038/ni.2283; Yokoyama WM, 2006, IMMUNITY, V24, P249, DOI 10.1016/j.immuni.2006.03.006	40	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107054	10.1371/journal.pone.0107054	http://dx.doi.org/10.1371/journal.pone.0107054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226085	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700027
J	Kammanadiminti, S; Patnaikuni, RK; Comer, J; Meister, G; Sinclair, C; Kodihalli, S				Kammanadiminti, Srinivas; Patnaikuni, Ravi Kumar; Comer, Jason; Meister, Gabriel; Sinclair, Chris; Kodihalli, Shantha			Combination Therapy with Antibiotics and Anthrax Immune Globulin Intravenous (AIGIV) Is Potentially More Effective than Antibiotics Alone in Rabbit Model of Inhalational Anthrax	PLOS ONE			English	Article							POSTEXPOSURE PROPHYLAXIS; PROTECTIVE ANTIGEN; CIPROFLOXACIN	Background: We have evaluated the therapeutic efficacy of AIGIV when given in combination with levofloxacin and the effective window of treatment to assess the added benefit provided by AIGIV over standard antibiotic treatment alone in a New Zealand white rabbit model of inhalational anthrax. Methods: Rabbits were exposed to lethal dose of aerosolized spores of Bacillus anthracis (Ames strain) and treated intravenously with either placebo, (normal immune globulin intravenous, IGIV) or 15 U/kg of AIGIV, along with oral levofloxacin treatment at various time points (30-96 hours) after anthrax exposure. Results: The majority of treated animals (>88%) survived in both treatment groups when treatment was initiated within 60 hours of post-exposure. However, reduced survival of 55%, 33% and 25% was observed for placebo + levofloxacin group when the treatment was initiated at 72, 84 and 96 hours post-exposure, respectively. Conversely, a survival rate of 65%, 40% and 71% was observed in the AIGIV + levofloxacin treated groups at these time points. Conclusions: The combination of AIGIV with antibiotics provided an improvement in survival compared to levofloxacin treatment alone when treatment was delayed up to 96 hours post-anthrax exposure. Additionally, AIGIV treatment when given as an adjunct therapy at any of the time points tested did not interfere with the efficacy of levofloxacin.	[Kammanadiminti, Srinivas; Patnaikuni, Ravi Kumar; Sinclair, Chris; Kodihalli, Shantha] Cangene Corp, Dept Clin Res, Winnipeg, MB, Canada; [Comer, Jason; Meister, Gabriel] West Jefferson, Battelle Biomed Res Ctr, Columbus, OH USA		Kodihalli, S (corresponding author), Cangene Corp, Dept Clin Res, Winnipeg, MB, Canada.	skodihalli@ebsi.com			Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (DHHS) [HHSO100200500007C]	Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (DHHS)	This work was funded by the Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (DHHS) under contract HHSO100200500007C. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection, and analysis, decision to publish or preparation of the manuscript.	Altboum Z, 2002, INFECT IMMUN, V70, P6231, DOI 10.1128/IAI.70.11.6231-6241.2002; [Anonymous], 2012, RAXIBACUMAB TREATMEN; [Anonymous], 1989, ILAR NEWS, V31, P5; Barakat LA, 2002, JAMA-J AM MED ASSOC, V287, P863, DOI 10.1001/jama.287.7.863; Comer JE, 2012, CLIN VACCINE IMMUNOL, V19, P1517, DOI 10.1128/CVI.00292-12; Corey A, 2013, TOXINS, V5, P120, DOI 10.3390/toxins5010120; FRIEDLANDER AM, 1993, J INFECT DIS, V167, P1239, DOI 10.1093/infdis/167.5.1239; GOCHENOUR WS, 1962, J HYG-CAMBRIDGE, V60, P29, DOI 10.1017/S0022172400039279; Guide for the Care and Use of Laboratory Animal, 2011, GUIDE CARE USE LAB A; HENDERSON D. W., 1956, JOUR HYG, V54, P28; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; JONES MN, 1996, SALISBURY MED B S, V87, P127; Kao LM, 2006, ANTIMICROB AGENTS CH, V50, P3535, DOI 10.1128/AAC.00090-06; Karginov VA, 2004, FEMS IMMUNOL MED MIC, V40, P71, DOI 10.1016/S0928-8244(03)00302-X; Migone TS, 2009, NEW ENGL J MED, V361, P135, DOI 10.1056/NEJMoa0810603; Peterson JW, 2006, INFECT IMMUN, V74, P1016, DOI 10.1128/IAI.74.2.1016-1024.2006; Shepard CW, 2002, EMERG INFECT DIS, V8, P1124, DOI 10.3201/eid0810.020349; Shoop WL, 2005, P NATL ACAD SCI USA, V102, P7958, DOI 10.1073/pnas.0502159102; Vietri NJ, 2006, P NATL ACAD SCI USA, V103, P7813, DOI 10.1073/pnas.0602748103; Vietri NJ, 2009, J INFECT DIS, V199, P336, DOI 10.1086/596063; Weiss S, 2011, ANTIMICROB AGENTS CH, V55, P1533, DOI 10.1128/AAC.01689-10; Whitby M, 2002, MED J AUSTRALIA, V176, P605, DOI 10.5694/j.1326-5377.2002.tb04594.x; Zaucha GM, 1998, ARCH PATHOL LAB MED, V122, P982	24	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e106393	10.1371/journal.pone.0106393	http://dx.doi.org/10.1371/journal.pone.0106393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226075	Green Published, gold, Green Submitted			2022-12-25	WOS:000344317700011
J	Meyer-Wachsmuth, I; Galletti, MC; Jondelius, U				Meyer-Wachsmuth, Inga; Galletti, Marco Curini; Jondelius, Ulf			Hyper-Cryptic Marine Meiofauna: Species Complexes in Nemertodermatida	PLOS ONE			English	Article							PLATYHELMINTHES-ACOELOMORPHA; SEQUENCE ALIGNMENTS; DNA-SEQUENCES; DIVERSITY; DELIMITATION; PHYLOGEOGRAPHY; TURBELLARIA; RANDOMNESS; WESTBLADI; PHYLOGENY	Nemertodermatida are microscopically small, benthic marine worms. Specimens of two nominal species, Sterreria psammicola and Nemertinoides elongatus from 33 locations worldwide were sequenced for three molecular markers. Species delimitation and validation was done using gene trees, haplotype networks and multilocus Bayesian analysis. We found 20 supported species of which nine: Nemertinoides glandulosum n. sp., N. wolfgangi n. sp., Sterreria boucheti n. sp., S. lundini n. sp., S. martindalei n. sp., S. monolithes n. sp., S. papuensis n. sp., S. variabilis n. sp. and S. ylvae n. sp., are described including nucleotide-based diagnoses. The distribution patterns indicate transoceanic dispersal in some of the species. Sympatric species were found in many cases. The high level of cryptic diversity in this meiofauna group implies that marine diversity may be higher than previously estimated.	[Meyer-Wachsmuth, Inga; Jondelius, Ulf] Swedish Museum Nat Hist, Dept Zool, S-10405 Stockholm, Sweden; [Meyer-Wachsmuth, Inga; Jondelius, Ulf] Stockholm Univ, Dept Zool, Stockholm, Sweden; [Galletti, Marco Curini] Univ Sassari, Dipartimento Sci Nat & Terr, I-07100 Sassari, Italy	Swedish Museum of Natural History; Stockholm University; University of Sassari	Jondelius, U (corresponding author), Swedish Museum Nat Hist, Dept Zool, S-10405 Stockholm, Sweden.	ulf.jondelius@nrm.se	Martinek, Inga Nicole/AAD-5471-2022; Jondelius, Ulf/AAF-7943-2020	Martinek, Inga Nicole/0000-0001-8809-6753; Jondelius, Ulf/0000-0003-2847-2192	Foreningen Riksmusei vanner (riksmuseivanner.se) stipend; Royal Swedish Academy of Sciences [FOA11H-352]; Stiftelsen Lars Hiertas Minne [FO2011-0248]; Systematics Association; Swedish research council (Vetenskapsradet) [2012-3913]	Foreningen Riksmusei vanner (riksmuseivanner.se) stipend; Royal Swedish Academy of Sciences; Stiftelsen Lars Hiertas Minne; Systematics Association; Swedish research council (Vetenskapsradet)(Swedish Research Council)	IMW received funding from the Foreningen Riksmusei vanner (riksmuseivanner.se) stipend 2011, the Royal Swedish Academy of Sciences (http://www.kva.se/) grant application FOA11H-352, the Stiftelsen Lars Hiertas Minne (http://www.larshiertasminne.se), grant FO2011-0248 and the Systematics Association (www.systass.org), Research Fund 2010/2011. MCG received ASSEMBLE grants for on-sitework (www.assemblemarine.org/). UJ also received ASSEMBLE grants for on-site work (www.assemblemarine.org/) and was funded by the Swedish research council (Vetenskapsradet, http://www.vr.se) grant 2012-3913. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2014, SYST BIOL, P1; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baas Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN; Barroso R, 2010, MAR BIOL, V157, P69, DOI 10.1007/s00227-009-1296-9; Bauer AM, 2011, P ROY SOC B-BIOL SCI, V278, P490, DOI 10.1098/rspb.2010.1330; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bik HM, 2012, TRENDS ECOL EVOL, V27, P652, DOI 10.1016/j.tree.2012.09.005; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Casu M, 2006, BIOL J LINN SOC, V87, P553, DOI 10.1111/j.1095-8312.2006.00588.x; Casu M, 2011, BIOL J LINN SOC, V103, P117, DOI 10.1111/j.1095-8312.2011.01630.x; Casu M, 2009, BIOL J LINN SOC, V98, P907, DOI 10.1111/j.1095-8312.2009.01316.x; Clague DA, 1987, HAWAIIAN EMPEROR V 1; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Costello MJ, 2012, SYST BIOL, V61, P871, DOI 10.1093/sysbio/syr080; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Curini Galletti M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033801.t002, DOI 10.1371/JOURNAL.PONE.0033801.T002]; Curini Galletti MC, 1989, HYDROBIOLOGIA, V173, P63; Curini-Galletti M, 1998, HYDROBIOLOGIA, V383, P287, DOI 10.1023/A:1003456102035; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Emerson BC, 2011, PHILOS T R SOC B, V366, P2391, DOI 10.1098/rstb.2011.0057; FAUBEL A, 1976, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V73, P17; Fenchel T, 1997, OIKOS, V80, P220, DOI 10.2307/3546589; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Fujita MK, 2011, P ROY SOC B-BIOL SCI, V278, P493, DOI 10.1098/rspb.2010.1864; Hart MW, 2007, BIOL LETTERS, V3, P509, DOI 10.1098/rsbl.2007.0307; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hooge M, 2007, HYDROBIOLOGIA, V592, P439, DOI 10.1007/s10750-007-0789-0; Hooge MD, 2001, J MORPHOL, V249, P171, DOI 10.1002/jmor.1048; Jorger KM, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-59; Jondelius U, 2004, ZOOMORPHOLOGY, V123, P221, DOI 10.1007/s00435-004-0105-8; Jondelius U, 2002, ZOOL SCR, V31, P201, DOI 10.1046/j.1463-6409.2002.00090.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kennet L, 2000, ZOOL SCR, V29, P65, DOI 10.1046/j.1463-6409.2000.00028.x; Kieneke A, 2012, MOL ECOL, V21, P1239, DOI 10.1111/j.1365-294X.2011.05421.x; Klopfstein S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069344; Kuck P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-10; Leasi F, 2013, ZOOL J LINN SOC-LOND, V168, P17, DOI 10.1111/zoj.12020; Lindeque PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081327; Meyer-Wachsmuth I, 2013, ZOOMORPHOLOGY, V132, P239, DOI 10.1007/s00435-013-0191-6; Misof B, 2009, SYST BIOL, V58, P21, DOI 10.1093/sysbio/syp006; Noren M, 1999, CLADISTICS, V15, P103, DOI 10.1111/j.1096-0031.1999.tb00252.x; Nygren A, 2011, MOL PHYLOGENET EVOL, V58, P132, DOI 10.1016/j.ympev.2010.10.010; Nygren A, 2010, ORG DIVERS EVOL, V10, P193, DOI 10.1007/s13127-010-0014-2; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Rambaut A., 2006, TREE FIGURE DRAWING; Rannala B, 2003, GENETICS, V164, P1645; Riedl R, 1970, FAUNA FLORA MITTELME; RIEGER R, 1968, SARSIA, P75; RISER NW, 1987, P HELM SOC WASH, V54, P60; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Snelgrove PVR, 1999, BIOSCIENCE, V49, P129, DOI 10.2307/1313538; Sterrer W, 1998, BELG J ZOOL, V128, P55; Sterrer W, 1968, ARK ZOOL, P1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang CQ, 2012, P IEEE INT C POW SYS, P1, DOI [10.1073/pnas.1209160109/-/DCSupplemental, DOI 10.1073/PNAS.1209160109/-/DCSUPPLEMENTAL]; Telford MJ, 2003, P ROY SOC B-BIOL SCI, V270, P1077, DOI 10.1098/rspb.2003.2342; Wallberg A, 2007, ZOOL SCR, V36, P509, DOI 10.1111/j.1463-6409.2007.00295.x; WESTBLAD EINAR, 1937, ACTA SOC FAUNA ET FLORA FENNICA, V60, P45; Willems W. R., 2009, Meiofauna Marina, V17, P1; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	68	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107688	10.1371/journal.pone.0107688	http://dx.doi.org/10.1371/journal.pone.0107688			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225981	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700074
J	Mysoet, J; Canu, MH; Cieniewski-Bernard, C; Bastide, B; Dupont, E				Mysoet, Julien; Canu, Marie-Helene; Cieniewski-Bernard, Caroline; Bastide, Bruno; Dupont, Erwan			Hypoactivity Affects IGF-1 Level and PI3K/AKT Signaling Pathway in Cerebral Structures Implied in Motor Control	PLOS ONE			English	Article							GROWTH-FACTOR-I; PRIMARY SOMATOSENSORY CORTEX; RAT-BRAIN; LIMB IMMOBILIZATION; DENDRITIC SPINE; SKELETAL-MUSCLE; 14-DAY PERIOD; SHORT-TERM; EXERCISE; EXPRESSION	A chronic reduction in neuromuscular activity through prolonged body immobilization in human alters motor task performance through a combination of peripheral and central factors. Studies performed in a rat model of sensorimotor restriction have shown functional and biochemical changes in sensorimotor cortex. However, the underlying mechanisms are still unclear. Interest was turned towards a possible implication of Insulin-like Growth Factor 1 (IGF-1), a growth factor known to mediate neuronal excitability and synaptic plasticity by inducing phosphorylation cascades which include the PI3K-AKT pathway. In order to better understand the influence of IGF-1 in cortical plasticity in rats submitted to a sensorimotor restriction, we analyzed the effect of hindlimb unloading on IGF-1 and its main molecular pathway in structures implied in motor control (sensorimotor cortex, striatum, cerebellum). IGF-1 level was determined by ELISA, and phosphorylation of its receptor and proteins of the PI3K-AKT pathway by immunoblot. In the sensorimotor cortex, our results indicate that HU induces a decrease in IGF-1 level; this alteration is associated to a decrease in activation of PI3K-AKT pathway. The same effect was observed in the striatum, although to a lower extent. No variation was noticed in the cerebellum. These results suggest that IGF-1 might contribute to cortical and striatal plasticity induced by a chronic sensorimotor restriction.	[Mysoet, Julien; Canu, Marie-Helene; Cieniewski-Bernard, Caroline; Bastide, Bruno; Dupont, Erwan] Univ Lille Nord France, Lille, France; [Mysoet, Julien; Canu, Marie-Helene; Cieniewski-Bernard, Caroline; Bastide, Bruno; Dupont, Erwan] Univ Lille 1, EA 4488, IFR 114, Phys Act Muscle & Hlth Lab, F-59655 Villeneuve Dascq, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Dupont, E (corresponding author), Univ Lille Nord France, Lille, France.	erwan.dupont@univ-lille1.fr	CANU, Marie-Hélène/AAW-7356-2020; Cieniewski-Bernard, Caroline/AAR-8967-2021; Cieniewski-Bernard, Caroline/AAK-7477-2021	CANU, Marie-Helene/0000-0003-4035-9619; Bastide, bruno/0000-0002-7544-463X; Cieniewski-Bernard, Caroline/0000-0003-1449-0357; Dupont, Erwan/0000-0003-0777-9734	Centre National d'Etudes Spatiales	Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales)	This work was supported by grants from the Centre National d'Etudes Spatiales. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2009, GROWTH FACTORS, V27, P181, DOI 10.1080/08977190902863639; Adkins DL, 2006, J APPL PHYSIOL, V101, P1776, DOI 10.1152/japplphysiol.00515.2006; Awede B, 1999, FEBS LETT, V461, P263, DOI 10.1016/S0014-5793(99)01469-6; Bigbee AJ, 2006, J APPL PHYSIOL, V100, P1037, DOI 10.1152/japplphysiol.00615.2005; Blair LAC, 1997, NEURON, V19, P421, DOI 10.1016/S0896-6273(00)80950-2; Bondy CA, 2004, EUR J PHARMACOL, V490, P25, DOI 10.1016/j.ejphar.2004.02.042; Canu MH, 2010, BEHAV BRAIN RES, V209, P289, DOI 10.1016/j.bbr.2010.02.006; Canu MH, 2009, EXP NEUROL, V218, P98, DOI 10.1016/j.expneurol.2009.04.009; Carro E, 2005, J NEUROSCI, V25, P10884, DOI 10.1523/JNEUROSCI.2909-05.2005; Carro E, 2000, J NEUROSCI, V20, P2926; Chung YH, 2002, NEUROSCI LETT, V330, P65, DOI 10.1016/S0304-3940(02)00740-1; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Cullen KE, 2004, J NEUROPHYSIOL, V91, P1919, DOI 10.1152/jn.00988.2003; Dore S, 1997, TRENDS NEUROSCI, V20, P326; Dupont E, 2005, MOL BRAIN RES, V133, P78, DOI 10.1016/j.molbrainres.2004.09.019; Dupont E, 2003, NEUROSCIENCE, V121, P433, DOI 10.1016/S0306-4522(03)00494-9; Dupont E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017564; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; Glasper ER, 2010, HIPPOCAMPUS, V20, P706, DOI 10.1002/hipo.20672; Haddad F, 2005, J APPL PHYSIOL, V98, P46, DOI 10.1152/japplphysiol.00553.2004; Heinemeier KM, 2009, J APPL PHYSIOL, V106, P178, DOI 10.1152/japplphysiol.91092.2008; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; KAR S, 1993, J COMP NEUROL, V333, P375, DOI 10.1002/cne.903330306; Krasnov I B, 1994, Adv Space Biol Med, V4, P85; Langlet C, 2001, BRAIN RES, V905, P72, DOI 10.1016/S0006-8993(01)02507-0; Langlet C, 2012, EXP NEUROL, V237, P211, DOI 10.1016/j.expneurol.2012.06.018; Lee CC, 2011, NEUROPHARMACOLOGY, V61, P867, DOI 10.1016/j.neuropharm.2011.06.003; Llorens-Martin M, 2008, NEUROMOL MED, V10, P99, DOI 10.1007/s12017-008-8026-1; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Mitschelen M, 2011, NEUROSCIENCE, V185, P50, DOI 10.1016/j.neuroscience.2011.04.032; Moisello C, 2008, J MOTOR BEHAV, V40, P165, DOI 10.3200/JMBR.40.2.165-176; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Niblock MM, 2000, J NEUROSCI, V20, P4165; Nishijima T, 2010, NEURON, V67, P834, DOI 10.1016/j.neuron.2010.08.007; Nunez A, 2003, J NEUROPHYSIOL, V89, P3008, DOI 10.1152/jn.00089.2003; Perrien DS, 2007, AM J PHYSIOL-REG I, V292, pR988, DOI 10.1152/ajpregu.00302.2006; Roberts DR, 2010, AVIAT SPACE ENVIR MD, V81, P30, DOI 10.3357/ASEM.2532.2009; Rolland Y, 2010, CLIN GERIATR MED, V26, P75, DOI 10.1016/j.cger.2009.11.002; ROTWEIN P, 1988, P NATL ACAD SCI USA, V85, P265, DOI 10.1073/pnas.85.1.265; Shan HQ, 2003, J PHYSIOL-LONDON, V553, P49, DOI 10.1113/jphysiol.2003.047746; Sonntag WE, 2005, AGEING RES REV, V4, P195, DOI 10.1016/j.arr.2005.02.001; Suliman IA, 2001, BRAIN RES, V912, P17, DOI 10.1016/S0006-8993(01)02564-1; Trinel D, 2013, BEHAV BRAIN RES, V249, P1, DOI 10.1016/j.bbr.2013.04.015; Vogel T., 2013, TRENDS CELL SIGNALIN; Voss MW, 2011, J APPL PHYSIOL, V111, P1505, DOI 10.1152/japplphysiol.00210.2011; WATENPAUGH DE, 1996, HDB PHYSIOL SECT 4, V1, P631; YAMAGUCHI F, 1990, BRAIN RES, V533, P344, DOI 10.1016/0006-8993(90)91361-J; YAMAMOTO H, 1995, J ENDOCRINOL, V146, P141, DOI 10.1677/joe.0.1460141; Zheng WH, 2004, J NEUROCHEM, V89, P844, DOI 10.1111/j.1471-4159.2004.02350.x	49	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107631	10.1371/journal.pone.0107631	http://dx.doi.org/10.1371/journal.pone.0107631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226394	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700069
J	Camargo, S; Riedl, M; Anteneodo, C; Kurths, J; Penzel, T; Wessel, N				Camargo, Sabrina; Riedl, Maik; Anteneodo, Celia; Kurths, Juergen; Penzel, Thomas; Wessel, Niels			Sleep Apnea-Hypopnea Quantification by Cardiovascular Data Analysis	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; ELECTROCARDIOGRAM	Sleep disorders are a major risk factor for cardiovascular diseases. Sleep apnea is the most common sleep disturbance and its detection relies on a polysomnography, i.e., a combination of several medical examinations performed during a monitored sleep night. In order to detect occurrences of sleep apnea without the need of combined recordings, we focus our efforts on extracting a quantifier related to the events of sleep apnea from a cardiovascular time series, namely systolic blood pressure (SBP). Physiologic time series are generally highly nonstationary and entrap the application of conventional tools that require a stationary condition. In our study, data nonstationarities are uncovered by a segmentation procedure which splits the signal into stationary patches, providing local quantities such as mean and variance of the SBP signal in each stationary patch, as well as its duration L. We analysed the data of 26 apneic diagnosed individuals, divided into hypertensive and normotensive groups, and compared the results with those of a control group. From the segmentation procedure, we identified that the average duration [L], as well as the average variance [sigma(2)], are correlated to the apnea-hypoapnea index (AHI), previously obtained by polysomnographic exams. Moreover, our results unveil an oscillatory pattern in apneic subjects, whose amplitude S* is also correlated with AHI. All these quantities allow to separate apneic individuals, with an accuracy of at least 79%. Therefore, they provide alternative criteria to detect sleep apnea based on a single time series, the systolic blood pressure.	[Camargo, Sabrina; Riedl, Maik; Kurths, Juergen; Wessel, Niels] Humboldt Univ, Dept Phys, Berlin, Germany; [Camargo, Sabrina] Fundacao Getulio Vargas, EMAp, Rio De Janeiro, Brazil; [Camargo, Sabrina; Anteneodo, Celia] Pontificia Univ Catolica Rio de Janeiro, Dept Phys, Rio de Janeiro, Brazil; [Anteneodo, Celia] Natl Inst Sci & Technol Complex Syst, Rio De Janeiro, Brazil; [Kurths, Juergen] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Kurths, Juergen] Univ Aberdeen, Inst Complex Syst & Math Biol, Aberdeen, Scotland; [Penzel, Thomas] Charite, Sleep Ctr, Berlin, Germany	Humboldt University of Berlin; Escola de Pos-Graduacao em Economia (EPGE); Getulio Vargas Foundation; Pontificia Universidade Catolica do Rio de Janeiro; Potsdam Institut fur Klimafolgenforschung; University of Aberdeen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Camargo, S (corresponding author), Humboldt Univ, Dept Phys, Berlin, Germany.	sabrina.camargo@fgv.br	Anteneodo, Celia/C-7179-2013; Penzel, Thomas/M-2344-2014; Camargo, Sabrina/J-3745-2013; Camargo, Sabrina/AAH-4857-2020; Anteneodo, Celia/B-2021-2009	Anteneodo, Celia/0000-0001-9130-2933; Penzel, Thomas/0000-0002-4304-0112; Camargo, Sabrina/0000-0002-0237-3535; Camargo, Sabrina/0000-0002-0237-3535; Anteneodo, Celia/0000-0001-9130-2933; Wessel, Niels/0000-0003-0922-9971	CNPq (Brazilian agency); Deutsche Forschungsgemeinschaft [DFG RI2016/2-1, WE 2834/5-1, KU837/29-2, KU837/35-1]	CNPq (Brazilian agency)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding provided by CNPq (Brazilian agency) http://www.cnpq.br/ and Deutsche Forschungsgemeinschaft, grant numbers DFG RI2016/2-1, WE 2834/5-1, KU837/29-2, and KU837/35-1. http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Angari HM, 2007, IEEE T BIO-MED ENG, V54, P1900, DOI 10.1109/TBME.2006.889772; Camargo S, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046702; Camargo S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00107; Camm AJ, 1996, EUR HEART J, V17, P354; Canisius S, 2008, IEEE ENG MED BIO, P2602, DOI 10.1109/IEMBS.2008.4649733; Caples SM, 2005, ANN INTERN MED, V142, P187, DOI 10.7326/0003-4819-142-3-200502010-00010; Gapelyuk A, 2011, BIOMED TECH, V56, P207, DOI 10.1515/BMT.2011.018; Helland VCF, 2010, METHOD INFORM MED, V49, P467, DOI 10.3414/ME09-02-0052; Mendez MO, 2007, P ANN INT IEEE EMBS, P6106; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Penzel T, 2012, COMPUT BIOL MED, V42, P328, DOI 10.1016/j.compbiomed.2011.09.001; Penzel T, 2003, IEEE T BIO-MED ENG, V50, P1143, DOI 10.1109/TBME.2003.817636; Penzel T, 2002, MED BIOL ENG COMPUT, V40, P402, DOI 10.1007/BF02345072; Penzel T, 2007, CHAOS, V17, DOI 10.1063/1.2711282; Poupard L, 2011, SLEEP BREATH, V15, P837, DOI 10.1007/s11325-010-0446-0; Roche F, 2004, CLIN SCI, V107, P105, DOI 10.1042/CS20040036; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Suhrbier A, 2010, CHAOS, V20, DOI 10.1063/1.3518688; Suhrbier A, 2006, BIOMED TECH, V51, P70, DOI 10.1515/BMT.2006.013; Wessel N, 2007, INT J BIFURCAT CHAOS, V17, P3325, DOI 10.1142/S0218127407019093	21	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107581	10.1371/journal.pone.0107581	http://dx.doi.org/10.1371/journal.pone.0107581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222746	gold, Green Submitted, Green Published			2022-12-25	WOS:000341774800085
J	Dong, GZ; Qiu, M; Ao, CJ; Zhou, J; Khas-Erdene; Wang, X; Zhang, Z; Yang, Y				Dong, Guozhong; Qiu, Min; Ao, Changjin; Zhou, Jun; Khas-Erdene; Wang, Xi; Zhang, Zhu; Yang, You			Feeding a High-Concentrate Corn Straw Diet Induced Epigenetic Alterations in the Mammary Tissue of Dairy Cows	PLOS ONE			English	Article							SUBACUTE RUMINAL ACIDOSIS; INFLAMMATORY RESPONSE; BARLEY-GRAIN; LIPOPOLYSACCHARIDE CONCENTRATION; PLASMA METABOLITES; HIGH PROPORTIONS; MILK; RUMEN; EXPRESSION; ACETYLATION	Purpose: The objective of this study was to investigate the effects of feeding a high-concentrate corn straw (HCS) diet (65% concentrate+35% corn straw) on the epigenetic changes in the mammary tissue of dairy cows in comparison with a low-concentrate corn straw (LCS) diet (46% concentrate+54% corn straw) and with a low-concentrate mixed forage (LMF) diet (46% concentrate+54% mixed forage). Experimental Design: Multiparous mid-lactation Chinese Holstein cows were fed one of these three diets for 6 weeks, at which time blood samples and mammary tissue samples were collected. Mammary arterial and venous blood samples were analyzed for lipopolysaccharide (LPS) concentrations while mammary tissue samples were assayed for histone H3 acetylation and the methylation of specific genes associated with fat and protein synthesis. Results: Extraction of histones and quantification of histone H3 acetylation revealed that acetylation was significantly reduced in cows fed the HCS diet, as compared with cows fed the LCS diet. Cows fed the HCS diet had significantly higher LPS concentrations in the mammary arterial blood, as compared with cows fed the LCS diet. We found that the extent of histone H3 acetylation was negatively correlated with LPS concentrations. The methylation of the stearoyl-coenzyme A desaturase gene associated with milk fat synthesis was increased in cows fed the HCS diet. By contrast, methylation of the gene encoding the signal transducer and activator of transcription 5A was reduced in cows fed the HCS diet, suggesting that feeding a high-concentrate corn straw diet may alter the methylation of specific genes involved in fat and protein synthesis in the mammary tissue of dairy cows. Conclusions: Feeding the high-concentrate diet induced epigenetic changes in the mammary tissues of dairy cows, possibly through effecting the release of differing amounts of LPS into the mammary blood.	[Dong, Guozhong; Qiu, Min; Zhou, Jun; Wang, Xi; Zhang, Zhu; Yang, You] Southwest Univ, Coll Anim Sci & Technol, Chongqing, Peoples R China; [Dong, Guozhong; Qiu, Min; Zhou, Jun; Wang, Xi; Zhang, Zhu; Yang, You] Southwest Univ, Key Lab Grass & Herbivores Chongqing, Chongqing, Peoples R China; [Ao, Changjin; Khas-Erdene] Inner Mongolia Agr Univ, Coll Anim Sci, Hohhot, Inner Mongolia, Peoples R China	Southwest University - China; Southwest University - China; Inner Mongolia Agricultural University	Dong, GZ (corresponding author), Southwest Univ, Coll Anim Sci & Technol, Chongqing, Peoples R China.	g.z.dong@tom.com; changjinao@yahoo.com.cn			National Key Basic Research Program of China [2011CB100803]	National Key Basic Research Program of China(National Basic Research Program of China)	The study was supported by funds from the National Key Basic Research Program of China (No. 2011CB100803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ametaj BN, 2009, J ANIM SCI, V87, P1314, DOI 10.2527/jas.2008-1196; Ametaj BN, 2009, J DAIRY SCI, V92, P1084, DOI 10.3168/jds.2008-1465; Ametaj BN, 2005, CAN J ANIM SCI, V85, P165, DOI 10.4141/A04-043; Baumgard LH, 2002, J DAIRY SCI, V85, P2155, DOI 10.3168/jds.S0022-0302(02)74294-X; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Cheng XD, 2010, BIOCHEMISTRY-US, V49, P2999, DOI 10.1021/bi100213t; Choi YJ, 1998, J NUTR BIOCHEM, V9, P380, DOI 10.1016/S0955-2863(98)00027-8; Colman E, 2013, J DAIRY SCI, V96, P4100, DOI 10.3168/jds.2012-6109; Dong GZ, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-48; Dong HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082850; Emmanuel DGV, 2008, J DAIRY SCI, V91, P606, DOI 10.3168/jds.2007-0256; Emmanuel DGV, 2007, J DAIRY SCI, V90, P5552, DOI 10.3168/jds.2007-0257; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Gozho GN, 2007, J DAIRY SCI, V90, P856, DOI 10.3168/jds.S0022-0302(07)71569-2; Hinz K, 2012, J DAIRY SCI, V95, P1655, DOI 10.3168/jds.2011-4813; Hiss S, 2004, J DAIRY SCI, V87, P3778, DOI 10.3168/jds.S0022-0302(04)73516-X; Horn PJ, 2002, SCIENCE, V297, P1824, DOI 10.1126/science.1074200; Huo WJ, 2013, ASIAN AUSTRAL J ANIM, V26, P1437, DOI 10.5713/ajas.2013.13143; Iqbal S, 2009, J DAIRY SCI, V92, P6023, DOI 10.3168/jds.2009-2380; Isobe N, 2009, J DAIRY SCI, V92, P6046, DOI 10.3168/jds.2009-2594; Keunen JE, 2002, J DAIRY SCI, V85, P3304, DOI 10.3168/jds.S0022-0302(02)74419-6; Khafipour E, 2009, J DAIRY SCI, V92, P1060, DOI 10.3168/jds.2008-1389; Kim JY, 2002, ANAL CHEM, V74, P5443, DOI 10.1021/ac0256080; LI E, 2007, EPIGENETICS, P341; Li S, 2012, CAN J ANIM SCI, V92, P353, DOI 10.4141/CJAS2012-004; Mckay JA, 2011, ACTA PHYSIOL, V202, P103, DOI 10.1111/j.1748-1716.2011.02278.x; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Nocek JE, 1997, J DAIRY SCI, V80, P1005, DOI 10.3168/jds.S0022-0302(97)76026-0; Ollikainen M, 2010, HUM MOL GENET, V19, P4176, DOI 10.1093/hmg/ddq336; Plaizier JC, 2008, VET J, V176, P21, DOI 10.1016/j.tvjl.2007.12.016; Plaizier JC, 2012, ANIM FEED SCI TECH, V172, P9, DOI 10.1016/j.anifeedsci.2011.12.004; Ramsey SA, 2010, BIOINFORMATICS, V26, P2071, DOI 10.1093/bioinformatics/btq405; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Schmitz S, 2004, DOMEST ANIM ENDOCRIN, V26, P111, DOI 10.1016/j.domaniend.2003.09.003; Shamay A, 2005, J DAIRY SCI, V88, P569, DOI 10.3168/jds.S0022-0302(05)72719-3; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Singh K, 2012, ANIMAL, V6, P375, DOI 10.1017/S1751731111002564; Singh K, 2010, J MAMMARY GLAND BIOL, V15, P101, DOI 10.1007/s10911-010-9164-2; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Zebeli Q, 2011, J DAIRY SCI, V94, P2374, DOI 10.3168/jds.2010-3860; Zebeli Q, 2009, J DAIRY SCI, V92, P3800, DOI 10.3168/jds.2009-2178; Zhang RY, 2013, ASIAN AUSTRAL J ANIM, V26, P1137, DOI 10.5713/ajas.2013.13181; Zhou J, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0172-0	43	27	31	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107659	10.1371/journal.pone.0107659	http://dx.doi.org/10.1371/journal.pone.0107659			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222274	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774800090
J	Ochab, JK; Tyburczyk, J; Beldzik, E; Chialvo, DR; Domagalik, A; Fafrowicz, M; Gudowska-Nowak, E; Marek, T; Nowak, MA; Oginska, H; Szwed, J				Ochab, Jeremi K.; Tyburczyk, Jacek; Beldzik, Ewa; Chialvo, Dante R.; Domagalik, Aleksandra; Fafrowicz, Magdalena; Gudowska-Nowak, Ewa; Marek, Tadeusz; Nowak, Maciej A.; Oginska, Halszka; Szwed, Jerzy			Scale-Free Fluctuations in Behavioral Performance: Delineating Changes in Spontaneous Behavior of Humans with Induced Sleep Deficiency	PLOS ONE			English	Article							DYNAMICS; CONSEQUENCES	The timing and dynamics of many diverse behaviors of mammals, e.g., patterns of animal foraging or human communication in social networks exhibit complex self-similar properties reproducible over multiple time scales. In this paper, we analyze spontaneous locomotor activity of healthy individuals recorded in two different conditions: during a week of regular sleep and a week of chronic partial sleep deprivation. After separating activity from rest with a pre-defined activity threshold, we have detected distinct statistical features of duration times of these two states. The cumulative distributions of activity periods follow a stretched exponential shape, and remain similar for both control and sleep deprived individuals. In contrast, rest periods, which follow power-law statistics over two orders of magnitude, have significantly distinct distributions for these two groups and the difference emerges already after the first night of shortened sleep. We have found steeper distributions for sleep deprived individuals, which indicates fewer long rest periods and more turbulent behavior. This separation of power-law exponents is the main result of our investigations, and might constitute an objective measure demonstrating the severity of sleep deprivation and the effects of sleep disorders.	[Ochab, Jeremi K.; Tyburczyk, Jacek; Gudowska-Nowak, Ewa; Nowak, Maciej A.; Szwed, Jerzy] Jagiellonian Univ, M Kac Complex Syst Res Ctr, Krakow, Poland; [Ochab, Jeremi K.; Tyburczyk, Jacek; Gudowska-Nowak, Ewa; Nowak, Maciej A.; Szwed, Jerzy] Jagiellonian Univ, M Smoluchowski Inst Phys, Krakow, Poland; [Beldzik, Ewa; Domagalik, Aleksandra; Fafrowicz, Magdalena; Marek, Tadeusz; Oginska, Halszka] Jagiellonian Univ, Dept Cognit Neurosci & Neuroergon, Krakow, Poland; [Chialvo, Dante R.] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Beldzik, Ewa; Domagalik, Aleksandra; Fafrowicz, Magdalena; Marek, Tadeusz] Jagiellonian Univ, Malopolska Ctr Biotechnol, Dept Neurobiol, Krakow, Poland; [Nowak, Maciej A.] Jagiellonian Univ, Malopolska Ctr Biotechnol, Biocomplex Dept, Krakow, Poland	Jagiellonian University; Jagiellonian University; Jagiellonian University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Jagiellonian University; Jagiellonian University	Ochab, JK (corresponding author), Jagiellonian Univ, M Kac Complex Syst Res Ctr, Krakow, Poland.	jeremi.ochab@uj.edu.pl	Chialvo, Dante R./P-5279-2019; Beldzik, Ewa/V-5522-2019; Domagalik, Aleksandra/E-7980-2013; Chialvo, Dante R/A-4658-2009; Ochab, Jeremi K./K-2438-2012; Gudowska-Nowak, Ewa/A-7622-2014	Chialvo, Dante R./0000-0002-1038-3637; Beldzik, Ewa/0000-0002-5511-4131; Domagalik, Aleksandra/0000-0003-3183-6719; Chialvo, Dante R/0000-0002-1038-3637; Ochab, Jeremi K./0000-0002-7281-1852; Gudowska-Nowak, Ewa/0000-0001-5604-094X; Nowak, Maciej/0000-0002-3548-6499	National Science Center [2011/01/B/HS6/00446, DEC-2011/02/A/ST1/00119]; European Science Foundation via Exploring Physics of Small Devices; Polish Ministry of Science and Higher Education [7150/E 338/M/2014]	National Science Center(National Science Centre, Poland); European Science Foundation via Exploring Physics of Small Devices; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by National Science Center (ncn.gov.pl): grant no. 2011/01/B/HS6/00446 (TM) and in part by grant no. DEC-2011/02/A/ST1/00119 (MAN, JO, JT). This work was also supported by the European Science Foundation (www.esf.org): via the grant Exploring Physics of Small Devices 2009-2014 (E.G-N). Publication financed by the Polish Ministry of Science and Higher Education: decision no. 7150/E 338/M/2014 of 9 April 2014 (JO, JT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anteneodo C, 2009, CHAOS, V19, DOI 10.1063/1.3211189; Bonato P, 1998, IEEE T BIO-MED ENG, V45, P287, DOI 10.1109/10.661154; Buysse D J, 1989, Psychiatry Res, V28, P193; Coffey W.T., 2004, LANGEVIN EQUATION AP, DOI 10.1142/5343; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Eliazar I, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.040602; Groeger JA, 2004, J SLEEP RES, V13, P359, DOI 10.1111/j.1365-2869.2004.00418.x; Gudowska-Nowak E, 2009, EUR PHYS J E, V30, P317, DOI 10.1140/epje/i2009-10522-7; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kageyama T, 2001, PSYCHIAT CLIN NEUROS, V55, P217, DOI 10.1046/j.1440-1819.2001.00831.x; Liebovitch LS, 1996, CRIT REV NEUROBIOL, V10, P169; Littner M, 2003, SLEEP, V26, P337, DOI 10.1093/sleep/26.3.337; Lo JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045987; Maki-Marttunen V, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00024; Mainardi F, 2000, PHYSICA A, V287, P468, DOI 10.1016/S0378-4371(00)00386-1; Nakamura T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138103; Nakamura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002050; National Sleep Foundation, 2011, COMM TECHN BEDR; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Oles K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036026; Pan W, 2004, PHYS REV E, V70; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Proekt A, 2012, P NATL ACAD SCI USA, V109, P10564, DOI 10.1073/pnas.1206894109; Sallinen M, 2013, J SLEEP RES, V22, P273, DOI 10.1111/jsr.12013; Samorodnitsky G., 1994, STABLE NONGAUSSIAN R; Sano W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043539; Sekine M, 2004, J NEURAL ENG, V1, DOI 10.1088/1741-2560/1/1/002; Short M.A., 2014, SLEEP DEPRIVATION DI, DOI [10.1007/978-1-4614-9087-6_2, DOI 10.1007/978-1-4614-9087-6_2, 10.1007/978-146149087-6_2]; Stanislavsky A, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4863995; Stefani FD, 2009, PHYS TODAY, V62, P34, DOI 10.1063/1.3086100; Struzik ZR, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.050901; Sun Y, 2013, INT J INTEGRATIVE ME, V1, P1, DOI DOI 10.1080/19401493.2012.757368; Watts Duncan J., 2003, SMALL WORLDS DYNAMIC; Werner G, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00015; Wolfram Research Inc., 2012, MATH VERS 9 0; Yang H, 2003, SCIENCE, V302, P262, DOI 10.1126/science.1086911; Zempel John M, 2012, Front Neurol, V3, P76, DOI 10.3389/fneur.2012.00076	37	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107542	10.1371/journal.pone.0107542	http://dx.doi.org/10.1371/journal.pone.0107542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222128	gold, Green Published, Green Submitted			2022-12-25	WOS:000341774800081
J	Wendt, L; Albring, A; Benson, S; Engler, H; Engler, A; Hinney, A; Rief, W; Witzke, O; Schedlowski, M				Wendt, Laura; Albring, Antje; Benson, Sven; Engler, Harald; Engler, Andrea; Hinney, Anke; Rief, Winfried; Witzke, Oliver; Schedlowski, Manfred			Catechol-O-Methyltransferase Val158Met Polymorphism Is Associated with Somatosensory Amplification and Nocebo Responses	PLOS ONE			English	Article							PLACEBO-RESPONSE; LEARNED IMMUNOSUPPRESSION; ANXIETY; PAIN; COMT; HYPERALGESIA; EXPECTATIONS; GENE; QUESTIONNAIRE; PERSONALITY	A large number of unwanted adverse events and symptoms reported by patients in clinical trials are not caused by the drug provided, since most of adverse events also occur in corresponding placebo groups. These nocebo effects also play a major role in drug discontinuation in clinical practice, negatively affecting treatment efficacy as well as patient adherence and compliance. Experimental and clinical data document a large interindividual variability in nocebo responses, however, data on psychological, biological or genetic predictors of nocebo responses are lacking. Thus, with an established paradigm of behaviorally conditioned immunosuppressive effects we analyzed possible genetic predictors for nocebo responses. We focused on the genetic polymorphisms in the catechol-O-methyltransferase (COMT) gene (Val158Met) and analyzed drug specific and general side effects before and after immunosuppressive medication and subsequent placebo intake in 62 healthy male subjects. Significantly more drug-specific as well as general side effects were reported from homozygous carriers of the Val158 variant during medication as well as placebo treatment compared to the other genotype groups. Val158/Val158 carriers also had significantly higher scores in the somatosensory amplification scale (SSAS) and the BMQ (beliefs about medicine questionnaire). Together these data demonstrate potential genetic and psychological variables predicting nocebo responses after drug and placebo intake, which might be utilized to minimize nocebo effects in clinical trials and medical practice.	[Wendt, Laura; Albring, Antje; Benson, Sven; Engler, Harald; Engler, Andrea; Schedlowski, Manfred] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Psychol & Behav Immunobiol, Essen, Germany; [Witzke, Oliver] Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany; [Hinney, Anke] Univ Hosp Essen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Essen, Germany; [Rief, Winfried] Univ Marburg, Div Clin Psychol, Marburg, Germany; [Engler, Andrea] Univ Duisburg Essen, Univ Hosp Essen, Clin Anesthesiol & Intens Care, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Philipps University Marburg; University of Duisburg Essen	Schedlowski, M (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Med Psychol & Behav Immunobiol, Essen, Germany.	Manfred.schedlowski@uk-essen.de	Benson, Sven/O-7201-2019; Engler, Harald/H-8773-2017; Benson, Sven/I-1981-2014; Hinney, Anke/D-6953-2011; Rief, Winfried/ABD-4994-2021	Benson, Sven/0000-0002-4487-4258; Engler, Harald/0000-0001-6329-1990; Benson, Sven/0000-0002-4487-4258; Hinney, Anke/0000-0001-5659-0706; Rief, Winfried/0000-0002-7019-2250	German Research Foundation [FOR 1328, SCHE 341/17-1, SCHE 341/17-2]	German Research Foundation(German Research Foundation (DFG))	This work was supported by a grant of the German Research Foundation (FOR 1328; SCHE 341/17-1; SCHE 341/17-2; URL: www.dfg.de). Authors who received the funding: LW AA HE MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albring A, 2014, CLIN PHARM IN PRESS; BARSKY AJ, 1988, PSYCHOSOM MED, V50, P510, DOI 10.1097/00006842-198809000-00007; BARSKY AJ, 1990, J PSYCHIAT RES, V24, P323, DOI 10.1016/0022-3956(90)90004-A; Barsky AJ, 1999, PSYCHOSOMATICS, V40, P396, DOI 10.1016/S0033-3182(99)71204-1; Benedetti F, 2011, PATIENT EDUC COUNS, V84, P413, DOI 10.1016/j.pec.2011.04.034; Colloca L, 2012, JAMA-J AM MED ASSOC, V307, P567, DOI 10.1001/jama.2012.115; DANIELS AM, 1981, LANCET, V1, P1003; DAVIS C, 1995, J CLIN PSYCHOPHARM, V15, P347, DOI 10.1097/00004714-199510000-00007; Doll BB, 2011, J NEUROSCI, V31, P6188, DOI 10.1523/JNEUROSCI.6486-10.2011; Elsenbruch S, 2012, Neurogastroenterol Motil, V24, P914, DOI 10.1111/j.1365-2982.2012.01950.x; Enck P, 2013, NAT REV DRUG DISCOV, V12, P191, DOI 10.1038/nrd3923; Frey I, 1999, SOZ PRAVENTIV MED, V44, P55, DOI 10.1007/BF01667127; Furmark T, 2008, J NEUROSCI, V28, P13066, DOI 10.1523/JNEUROSCI.2534-08.2008; Geers AL, 2005, J PSYCHOSOM RES, V58, P121, DOI 10.1016/j.jpsychores.2004.08.011; Goebel MU, 2002, FASEB J, V16, P1869, DOI 10.1096/fj.02-0389com; GROSSMAN MH, 1992, GENOMICS, V12, P822, DOI 10.1016/0888-7543(92)90316-K; Hauser W, 2012, DTSCH ARZTEBL INT, V109, P459, DOI 10.3238/arztebl.2012.0459; Hall Kathryn T, 2013, Clin Investig (Lond), V3, P311; Hall KT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048135; Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311; Jensen KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006016; JOYCE CRB, 1959, BRIT J PHARM CHEMOTH, V14, P512, DOI 10.1111/j.1476-5381.1959.tb00958.x; KENDALL PC, 1976, J CONSULT CLIN PSYCH, V44, P406, DOI 10.1037/0022-006X.44.3.406; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Lancaster TM, 2012, GENES BRAIN BEHAV, V11, P986, DOI 10.1111/j.1601-183X.2012.00838.x; Lang EV, 2005, PAIN, V114, P303, DOI 10.1016/j.pain.2004.12.028; Leuchter AF, 2009, J CLIN PSYCHOPHARM, V29, P372, DOI 10.1097/JCP.0b013e3181ac4aaf; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Mitsikostas DD, 2011, CEPHALALGIA, V31, P550, DOI 10.1177/0333102410391485; Mondaini N, 2007, J SEX MED, V4, P1708, DOI 10.1111/j.1743-6109.2007.00563.x; MYERS MG, 1987, CLIN PHARMACOL THER, V42, P250, DOI 10.1038/clpt.1987.142; Ober K, 2012, CLIN PHARMACOL THER, V91, P220, DOI 10.1038/clpt.2011.214; OConnor AM, 1996, J CLIN EPIDEMIOL, V49, P1271, DOI 10.1016/S0895-4356(96)00177-1; Pacheco-Lopez G, 2006, BRAIN BEHAV IMMUN, V20, P430, DOI 10.1016/j.bbi.2006.05.003; Pecina M, 2014, MOL PSYCHIATR, V19, P385, DOI 10.1038/mp.2013.124; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rakvag TT, 2005, PAIN, V116, P73, DOI 10.1016/j.pain.2005.03.032; Rief W, 2006, ARCH INTERN MED, V166, P155, DOI 10.1001/archinte.166.2.155; Rief W, 2011, CLIN PHARMACOL THER, V90, P722, DOI 10.1038/clpt.2011.204; Rief W, 2011, PHARMACOEPIDEM DR S, V20, P405, DOI 10.1002/pds.2067; Rief W, 2008, SOC PERSONAL PSYCHOL, V2, P1624, DOI 10.1111/j.1751-9004.2008.00121.x; Silvestri A, 2003, EUR HEART J, V24, P1928, DOI 10.1016/j.ehj.2003.08.016; Swider K, 2013, PAIN, V154, P1312, DOI 10.1016/j.pain.2013.04.001; Varelmann D, 2010, ANESTH ANALG, V110, P868, DOI 10.1213/ANE.0b013e3181cc5727; Vogtle E, 2013, PAIN, V154, P1427, DOI 10.1016/j.pain.2013.04.041; Wells RE, 2012, AM J BIOETHICS, V12, P22, DOI 10.1080/15265161.2011.652798; WILSON L, 1994, PAIN, V57, P55, DOI 10.1016/0304-3959(94)90107-4; Wirth T, 2011, BRAIN BEHAV IMMUN, V25, P1444, DOI 10.1016/j.bbi.2011.05.011; Wray NR, 2008, AM J MED GENET B, V147B, P1314, DOI 10.1002/ajmg.b.30744; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546	51	38	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107665	10.1371/journal.pone.0107665	http://dx.doi.org/10.1371/journal.pone.0107665			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222607	gold, Green Published, Green Submitted			2022-12-25	WOS:000341774800092
J	Zhang, J; Chen, XM; Zhang, CD; He, Q; Dong, ZQ; Cao, MY; Dong, XL; Pan, CX; Lu, C; Pan, MH				Zhang, Jun; Chen, Xue-Mei; Zhang, Chun-Dong; He, Qian; Dong, Zhan-Qi; Cao, Ming-Ya; Dong, Xiao-Long; Pan, Cai-Xia; Lu, Cheng; Pan, Min-Hui			Differential Susceptibilities to BmNPV Infection of Two Cell Lines Derived from the Same Silkworm Ovarian Tissues	PLOS ONE			English	Article							BOMBYX-MORI NUCLEOPOLYHEDROVIRUS; NUCLEAR POLYHEDROSIS-VIRUS; BACULOVIRUS GP64; RECEPTOR-BINDING; FUSION PROTEIN; VIRAL-DNA; SEQUENCE; IDENTIFICATION; TRANSMISSION; REPLICATION	We previously established and characterized two insect cell lines (BmN-SWU1 and BmN-SWU2) from Bombyx mori ovaries. Here, we examined their differential susceptibilities to Bombyx mori nucleopolyhedrovirus (BmNPV) despite having originated from the same tissue source. BmN-SWU1 cells were susceptible and supported high titers of BmNPV replication, while BmN-SWU2 cells were resistant to BmNPV infection. Subcellular localization analysis demonstrated that very few BmNPV particles could be imported into BmN-SWU2 cells. However, initiation of BmNPV DNA replication but not amplification was detected in BmN-SWU2 cells after transfection with vA4(prm)-VP39-EGFP bacmid DNA. BmNPV transcription assays showed that late and very late but not early viral genes apparently were blocked in BmNSWU2 cells by unknown mechanisms. Further syncytium formation assays demonstrated that the BmNPV envelope fusion protein GP64 could not mediate BmN-SWU2 host cell-cell membrane fusion. Taken together, these results indicate that these two cell lines represent optimal tools for investigating host-virus interactions and insect antiviral mechanisms.	[Zhang, Jun; Chen, Xue-Mei; He, Qian; Dong, Zhan-Qi; Cao, Ming-Ya; Dong, Xiao-Long; Pan, Cai-Xia; Lu, Cheng; Pan, Min-Hui] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Zhang, Jun] Chongqing Med Univ, Inst Life Sci, Chongqing, Peoples R China; [Zhang, Chun-Dong] Chongqing Med Univ, Dept Biochem & Mol Biol, Chongqing, Peoples R China	Southwest University - China; Chongqing Medical University; Chongqing Medical University	Lu, C (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	lucheng@swu.edu.cn; pmh0476@hotmail.com	Zhang, Jun/AGZ-7722-2022	Zhang, Jun/0000-0002-5843-8705	National High-tech R&D Program of China [2013AA102507]; National Natural Science Foundation of China [30972146, 31172269, 31272505]	National High-tech R&D Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National High-tech R&D Program of China (No. 2013AA102507) and the National Natural Science Foundation of China (Nos. 30972146, 31172269, and 31272505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya A, 2002, J GEN VIROL, V83, P2015, DOI 10.1099/0022-1317-83-8-2015; BLISSARD GW, 1992, J VIROL, V66, P6829, DOI 10.1128/JVI.66.11.6829-6835.1992; Clarke TE, 2003, J VIROL, V77, P2227, DOI 10.1128/JVI.77.3.2227-2232.2003; Goley ED, 2006, SCIENCE, V314, P464, DOI 10.1126/science.1133348; Hefferon KL, 1999, VIROLOGY, V258, P455, DOI 10.1006/viro.1999.9758; Hori T, 2013, J INVERTEBR PATHOL, V112, P102, DOI 10.1016/j.jip.2012.09.004; Kadlec J, 2008, NAT STRUCT MOL BIOL, V15, P1024, DOI 10.1038/nsmb.1484; Katou Y, 2006, VIROLOGY, V347, P455, DOI 10.1016/j.virol.2005.11.043; Katsuma S, 2012, J VIROL, V86, P2545, DOI 10.1128/JVI.06308-11; Katsuma S, 2011, J GEN VIROL, V92, P699, DOI 10.1099/vir.0.027573-0; KEDDIE BA, 1989, SCIENCE, V243, P1728, DOI 10.1126/science.2648574; Khurad AM, 2004, J INVERTEBR PATHOL, V87, P8, DOI 10.1016/j.jip.2004.05.008; KOOL M, 1994, P NATL ACAD SCI USA, V91, P11212, DOI 10.1073/pnas.91.23.11212; Li ZF, 2009, J VIROL, V83, P4447, DOI 10.1128/JVI.02252-08; Luz-Madrigal A, 2013, J VIROL, V87, P11894, DOI 10.1128/JVI.01356-13; Markovic I, 1998, J CELL BIOL, V143, P1155, DOI 10.1083/jcb.143.5.1155; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Monsma SA, 1996, J VIROL, V70, P4607, DOI 10.1128/JVI.70.7.4607-4616.1996; Mueller J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001765; Ohkawa T, 2010, J CELL BIOL, V190, P187, DOI 10.1083/jcb.201001162; Pan MH, 2010, TISSUE CELL, V42, P42, DOI 10.1016/j.tice.2009.07.002; Rahman MM, 2004, VIRUS RES, V101, P109, DOI 10.1016/j.virusres.2003.12.027; Raz E, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; TJIA ST, 1979, VIROLOGY, V99, P399, DOI 10.1016/0042-6822(79)90018-7; Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771; Wang F, 2013, TRANSGENIC RES; Wu CP, 2010, J VIROL, V84, P5015, DOI 10.1128/JVI.02423-09; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xue J, 2012, J VIROL, V86, P7345, DOI 10.1128/JVI.07217-12; Yang YN, 2009, ADV SPACE RES, V43, P1236, DOI 10.1016/j.asr.2008.12.009; Zhou J, 2008, J VIROL, V82, P4449, DOI 10.1128/JVI.02490-07	31	18	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e105986	10.1371/journal.pone.0105986	http://dx.doi.org/10.1371/journal.pone.0105986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25221982	gold, Green Submitted, Green Published			2022-12-25	WOS:000341774800008
J	Zhou, X; Zeng, XY; Wang, H; Li, SP; Jo, EJ; Xue, CCL; Tan, MJ; Molero, JC; Ye, JM				Zhou, Xiu; Zeng, Xiao-Yi; Wang, Hao; Li, Songpei; Jo, Eunjung; Xue, Charlie C. L.; Tan, Minjia; Molero, Juan C.; Ye, Ji-Ming			Hepatic FoxO1 Acetylation Is Involved in Oleanolic Acid-Induced Memory of Glycemic Control: Novel Findings from Study 2	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR FOXO1; HISTONE DEACETYLASE 4; INSULIN SENSITIVITY; SKELETAL-MUSCLE; DNA-BINDING; AMP; PHOSPHORYLATION; LOCALIZATION; GLUCOSE	Our recent study (referred as Study 1) showed that the triterpenoid oleanolic acid (OA) was able to produce a sustained correction of hyperglycemia beyond treatment period in type 2 diabetes (T2D) mice with liver as a responsible site. To follow up the previous observations, the present study (referred as Study 2) investigated the possible role of acetylation of FoxO1 and associated events in this therapeutic memory by characterizing the pathways regulating the acetylation status during and post-OA treatments. OA treatment (100 mg/kg/day for 4 weeks, during OA treatment) reduced hyperglycemia in T2D mice by similar to 87% and this effect was largely (similar to 70%) maintained even 4 weeks after the cessation of OA administration (post-OA treatment). During OA treatment, the acetylation and phosphorylation of FoxO1 were markedly increased (1.5 to 2.5-fold) while G6Pase expression was suppressed by similar to 80%. Consistent with this, OA treatment reversed pyruvate intolerance in high-fat fed mice. Histone acetyltransferase 1 (HAT1) content was increased (>50%) and histone deacetylases (HDACs) 4 and 5 (not HDAC1) were reduced by 30-50%. The OA-induced changes in FoxO1, G6Pase, HAT1 and HDACs persisted during the post-OA treatment period when the increased phosphorylation of AMPK, SIRT1 content and reduced liver triglyceride had subsided. These results confirmed the ability of OA to control hyperglycemia far beyond treatment period in T2D mice. Most importantly, in the present study we demonstrated acetylation of FoxO1 in the liver is involved in OA-induced memory for the control of hyperglycemia. Our novel findings suggest that acetylation of the key regulatory proteins of hepatic gluconeogenesis is a plausible mechanism by the triterpenoid to achieve a sustained glycemic control for T2D.	[Zhou, Xiu; Zeng, Xiao-Yi; Wang, Hao; Li, Songpei; Jo, Eunjung; Xue, Charlie C. L.; Molero, Juan C.; Ye, Ji-Ming] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic, Australia; [Zhou, Xiu; Zeng, Xiao-Yi; Wang, Hao; Li, Songpei; Jo, Eunjung; Xue, Charlie C. L.; Molero, Juan C.; Ye, Ji-Ming] RMIT Univ, Sch Hlth Sci, Melbourne, Vic, Australia; [Tan, Minjia] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Ye, JM (corresponding author), RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic, Australia.	jiming.ye@rmit.edu.au	Tan, Minjia/C-4491-2014; ZHOU, XIU/AAX-5312-2020; Xue, Charlie C/F-1244-2014	Tan, Minjia/0000-0002-6784-9653; ZHOU, XIU/0000-0002-5495-2803; Wang, Hao/0000-0002-0901-5183; Xue, Charlie/0000-0001-6937-9088	National Health and Medical Research Council of Australia Program [535921]; Australian Research Council Funding [DP110102396]; RMIT VC fellowship; Australian Postgraduate Scholarship	National Health and Medical Research Council of Australia Program(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Funding(Australian Research Council); RMIT VC fellowship; Australian Postgraduate Scholarship(Australian Government)	This study was supported by the National Health and Medical Research Council of Australia Program (Grant 535921 to JMY http://www.nhmrc.gov.au/grants), and Australian Research Council Funding (DP110102396 to JMY http://www.arc.gov.au). JCM is supported by a RMIT VC fellowship and XYZ was supported by an Australian Postgraduate Scholarship mentored by JMY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2013, DIAB GUID; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Canto C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z; Castellano JM, 2013, DIABETES, V62, P1791, DOI 10.2337/db12-1215; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Gray SP, 2011, NAT REV NEPHROL, V7, P71, DOI 10.1038/nrneph.2010.176; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Hutton JC, 2009, J BIOL CHEM, V284, P29241, DOI 10.1074/jbc.R109.025544; Iseli TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062309; Jager S, 2009, MOLECULES, V14, P2016, DOI 10.3390/molecules14062016; Juengel E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053100; Kaiser C, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-23; Kusakabe T, 2009, DIABETOLOGIA, V52, P675, DOI 10.1007/s00125-009-1258-2; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; McArdle J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002502; McGee SL, 2010, CLIN EXP PHARMACOL P, V37, P392, DOI 10.1111/j.1440-1681.2009.05311.x; Mihaylova MM, 2013, TRENDS ENDOCRIN MET, V24, P48, DOI 10.1016/j.tem.2012.09.003; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Qiang L, 2010, J BIOL CHEM, V285, P27396, DOI 10.1074/jbc.M110.140228; Ren LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030816; Saha AK, 2004, BIOCHEM BIOPH RES CO, V314, P580, DOI 10.1016/j.bbrc.2003.12.120; Saha PK, 2010, J BIOL CHEM, V285, P40581, DOI 10.1074/jbc.M110.176545; Senf SM, 2011, AM J PHYSIOL-CELL PH, V300, pC1490, DOI 10.1152/ajpcell.00255.2010; Siebel AL, 2010, BIOCHEM PHARMACOL, V80, P1853, DOI 10.1016/j.bcp.2010.06.005; Takigawa-Imamura H, 2003, BIOSCI BIOTECH BIOCH, V67, P1499, DOI 10.1271/bbb.67.1499; Tan MJ, 2008, CHEM BIOL, V15, P263, DOI 10.1016/j.chembiol.2008.01.013; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Wang X, 2013, MOL CELL ENDOCRINOL, V376, P70, DOI 10.1016/j.mce.2013.06.014; Ye JM, 2011, BRIT J PHARMACOL, V163, P556, DOI 10.1111/j.1476-5381.2011.01240.x; Zeng XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042115; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang L, 2012, J PHARMACOL EXP THER, V341, P285, DOI 10.1124/jpet.111.189910; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zhao Y, 2011, J MOL CELL BIOL, V3, P276, DOI 10.1093/jmcb/mjr013; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	48	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107231	10.1371/journal.pone.0107231	http://dx.doi.org/10.1371/journal.pone.0107231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222566	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774800052
J	Boyle, KE; Hwang, H; Janssen, RC; DeVente, JM; Barbour, LA; Hernandez, TL; Mandarino, LJ; Lappas, M; Friedman, JE				Boyle, Kristen E.; Hwang, Hyonson; Janssen, Rachel C.; DeVente, James M.; Barbour, Linda A.; Hernandez, Teri L.; Mandarino, Lawrence J.; Lappas, Martha; Friedman, Jacob E.			Gestational Diabetes Is Characterized by Reduced Mitochondrial Protein Expression and Altered Calcium Signaling Proteins in Skeletal Muscle	PLOS ONE			English	Article							INSULIN-RESISTANCE; OBESE WOMEN; LONGITUDINAL CHANGES; DYSTROPHIN COMPLEX; GLUCOSE-METABOLISM; MATERNAL OBESITY; ADIPOSE-TISSUE; AMPK ACTIVITY; FIBER-TYPE; PREGNANCY	The rising prevalence of gestational diabetes mellitus (GDM) affects up to 18% of pregnant women with immediate and long-term metabolic consequences for both mother and infant. Abnormal glucose uptake and lipid oxidation are hallmark features of GDM prompting us to use an exploratory proteomics approach to investigate the cellular mechanisms underlying differences in skeletal muscle metabolism between obese pregnant women with GDM (OGDM) and obese pregnant women with normal glucose tolerance (ONGT). Functional validation was performed in a second cohort of obese OGDM and ONGT pregnant women. Quantitative proteomic analysis in rectus abdominus skeletal muscle tissue collected at delivery revealed reduced protein content of mitochondrial complex I (C-I) subunits (NDUFS3, NDUFV2) and altered content of proteins involved in calcium homeostasis/signaling (calcineurin A, alpha 1-syntrophin, annexin A4) in OGDM (n = 6) vs. ONGT (n = 6). Follow-up analyses showed reduced enzymatic activity of mitochondrial complexes C-I, C-III, and C-IV (-60-75%) in the OGDM (n = 8) compared with ONGT (n = 10) subjects, though no differences were observed for mitochondrial complex protein content. Upstream regulators of mitochondrial biogenesis and oxidative phosphorylation were not different between groups. However, AMPK phosphorylation was dramatically reduced by 75% in the OGDM women. These data suggest that GDM is associated with reduced skeletal muscle oxidative phosphorylation and disordered calcium homeostasis. These relationships deserve further attention as they may represent novel risk factors for development of GDM and may have implications on the effectiveness of physical activity interventions on both treatment strategies for GDM and for prevention of type 2 diabetes postpartum.	[Boyle, Kristen E.; Janssen, Rachel C.; Friedman, Jacob E.] Univ Colorado, Denver Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Barbour, Linda A.; Hernandez, Teri L.] Univ Colorado, Denver Sch Med, Dept Med, Aurora, CO USA; [Barbour, Linda A.] Univ Colorado, Denver Sch Med, Dept Obstet & Gynecol, Aurora, CO USA; [Hwang, Hyonson] Harvard Univ, Sch Med, Boston Childrens Hosp, Boston, MA USA; [DeVente, James M.] E Carolina Univ, Brody Sch Med, Dept Obstet & Gynecol, Greenville, NC USA; [Mandarino, Lawrence J.] Arizona State Univ, Dept Kinesiol, Tempe, AZ USA; [Mandarino, Lawrence J.] Mayo Clin Arizona, Dept Med, Tempe, AZ USA; [Lappas, Martha] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Lappas, Martha] Mercy Hosp Women, Mercy Perinatal Res Ctr, Heidelberg, Vic, Australia	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Boston Children's Hospital; Harvard Medical School; University of North Carolina; East Carolina University; Arizona State University; Arizona State University-Tempe; University of Melbourne	Boyle, KE (corresponding author), Univ Colorado, Denver Sch Med, Dept Pediat, Aurora, CO 80045 USA.	kristen.boyle@ucdenver.edu	Boyle, Kristen/N-7442-2018	Boyle, Kristen/0000-0001-9689-3322	National Institutes of Health [5R01 DK062155, F32 DK089743, K12 HD057022]; Colorado Nutrition Obesity Research Center [P30 DK048520, R01 DK078645]; Medical Research Foundation for Women and Babies; Diabetes Australia Research Trust; National Health and Medical Research Council [1047025]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD057022] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062155, T32DK007658, P30DK048520, R01DK047936, R01DK078645, F32DK089743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado Nutrition Obesity Research Center; Medical Research Foundation for Women and Babies; Diabetes Australia Research Trust; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from the National Institutes of Health 5R01 DK062155 (J.E.F.), Colorado Nutrition Obesity Research Center, P30 DK048520 (J.E.F.), and R01 DK078645 (L.A.B.) [http://www.nih.gov], and from the Medical Research Foundation for Women and Babies; (M.L.) [http://www.mrfwb.org.au] and the Diabetes Australia Research Trust; (M.L.) [http://www.diabetesaustralia.com.au]. M.L. was supported by a Career Development Fellowship from the National Health and Medical Research Council, grant no. 1047025 [https://www.nhmrc.gov.au]. K.E.B. was supported by the National Institutes of Health F32 DK089743 and K12 HD057022 [http://www.nih.gov]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Barbour LA, 2007, DIABETES CARE, V30, pS112, DOI 10.2337/dc07-s202; Barbour LA, 2011, J CLIN ENDOCR METAB, V96, P1431, DOI 10.1210/jc.2010-2116; Battiprolu PK., 2010, DRUG DISCOV TODAY DI, V7, pE135, DOI [10.1016/j.ddmec.2010.08.001, DOI 10.1016/J.DDMEC.2010.08.001]; Bentley-Lewis R, 2014, AM J CARDIOL, V113, P1364, DOI 10.1016/j.amjcard.2014.01.411; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Boyle KE, 2013, J CLIN ENDOCR METAB, V98, pE1601, DOI 10.1210/jc.2013-1943; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Buchanan TA, 2012, NAT REV ENDOCRINOL, V8, P639, DOI 10.1038/nrendo.2012.96; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; CARPENTER MW, 1982, AM J OBSTET GYNECOL, V144, P768, DOI 10.1016/0002-9378(82)90349-0; Catalano PM, 1999, AM J OBSTET GYNECOL, V180, P903, DOI 10.1016/S0002-9378(99)70662-9; Catalano PM, 2002, AM J PHYSIOL-ENDOC M, V282, pE522, DOI 10.1152/ajpendo.00124.2001; Colomiere M, 2010, J MOL ENDOCRINOL, V44, P213, DOI 10.1677/JME-09-0091; Constantin B, 2014, BBA-BIOMEMBRANES, V1838, P635, DOI 10.1016/j.bbamem.2013.08.023; Dabelea D, 2011, DIABETES, V60, P1849, DOI 10.2337/db11-0400; DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938; Fitts RH, 2011, J APPL PHYSIOL, V111, P345, DOI 10.1152/japplphysiol.00720.2011; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Frazier AE, 2012, METHODS MOL BIOL, V837, P49, DOI 10.1007/978-1-61779-504-6_4; Friedman JE, 2008, DIABETES, V57, P606, DOI 10.2337/db07-1356; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Ghanassia E, 2007, CLIN CHIM ACTA, V383, P1, DOI 10.1016/j.cca.2007.04.006; Guha M, 2007, J BIOL CHEM, V282, P14536, DOI 10.1074/jbc.M611693200; Hartling L, 2014, DIABETIC MED, V31, P319, DOI 10.1111/dme.12357; Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010; Herrera E, 2000, EUR J CLIN NUTR, V54, pS47, DOI 10.1038/sj.ejcn.1600984; Hwang H, 2010, DIABETES, V59, P33, DOI 10.2337/db09-0214; Jeon YJ, 2010, CELL MOL LIFE SCI, V67, P2271, DOI 10.1007/s00018-010-0331-9; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Liu HY, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-29; Long YC, 2007, J BIOL CHEM, V282, P1607, DOI 10.1074/jbc.M609208200; Lovering RM, 2008, ANAT SCI INT, V83, P294, DOI 10.1111/j.1447-073X.2007.00226.x; Mallouk N, 2000, P NATL ACAD SCI USA, V97, P4950, DOI 10.1073/pnas.97.9.4950; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Mulvey C, 2005, EUR J CELL BIOL, V84, P867, DOI 10.1016/j.ejcb.2005.06.007; Murray J, 2003, J BIOL CHEM, V278, P13619, DOI 10.1074/jbc.C300064200; Nair KS, 2008, DIABETES, V57, P1166, DOI 10.2337/db07-1556; Okereke NC, 2004, AM J PHYSIOL-ENDOC M, V287, pE472, DOI 10.1152/ajpendo.00589.2003; Oliva K, 2013, J ENDOCRINOL, V218, P165, DOI 10.1530/JOE-13-0010; Park S, 2013, CELL CALCIUM, V53, P217, DOI 10.1016/j.ceca.2012.12.001; Park S, 2011, CELL CALCIUM, V50, P73, DOI 10.1016/j.ceca.2011.05.009; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Ratner RE, 2008, J CLIN ENDOCR METAB, V93, P4774, DOI 10.1210/jc.2008-0772; Reece EA, 2009, LANCET, V373, P1789, DOI 10.1016/S0140-6736(09)60515-8; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Ruchat SM, 2013, DIABETES-METAB RES, V29, P334, DOI 10.1002/dmrr.2402; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Rullman E, 2013, J HEART LUNG TRANSPL, V32, P925, DOI 10.1016/j.healun.2013.06.026; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sabourin J, 2012, CELL CALCIUM, V52, P445, DOI 10.1016/j.ceca.2012.08.003; Sabourin J, 2009, J BIOL CHEM, V284, P36248, DOI 10.1074/jbc.M109.012872; Saydah SH, 2005, DIABETES CARE, V28, P1035, DOI 10.2337/diacare.28.5.1035; Suhane S, 2013, BIOL OPEN, V2, P295, DOI 10.1242/bio.20133244; Tanner CJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE1191, DOI 10.1152/ajpendo.00416.2001; Vandebrouck A, 2007, FASEB J, V21, P608, DOI 10.1096/fj.06-6683com	60	43	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106872	10.1371/journal.pone.0106872	http://dx.doi.org/10.1371/journal.pone.0106872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216282	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774300029
J	Mardanov, AV; Beletsky, AV; Kadnikov, VV; Ignatov, AN; Ravin, NV				Mardanov, Andrey V.; Beletsky, Alexey V.; Kadnikov, Vitaly V.; Ignatov, Alexander N.; Ravin, Nikolai V.			The 203 kbp Mitochondrial Genome of the Phytopathogenic Fungus Sclerotinia borealis Reveals Multiple Invasions of Introns and Genomic Duplications	PLOS ONE			English	Article							B DNA-POLYMERASE; GROUP-I INTRON; HOMING ENDONUCLEASES; AGARICUS-BISPORUS; AA-POLB; GENE; EVOLUTION; SEQUENCES; PLASMID; RNA	Here we report the complete sequence of the mitochondrial (mt) genome of the necrotrophic phytopathogenic fungus Sclerotinia borealis, a member of the order Helotiales of Ascomycetes. The 203,051 bp long mtDNA of S. borealis represents one of the largest sequenced fungal mt genomes. The large size is mostly determined by the presence of mobile genetic elements, which include 61 introns. Introns contain a total of 125,394 bp, are scattered throughout the genome, and are found in 12 protein-coding genes and in the ribosomal RNA genes. Most introns contain complete or truncated ORFs that are related to homing endonucleases of the LAGLIDADG and GIY-YIG families. Integrations of mobile elements are also evidenced by the presence of two regions similar to fragments of inverton-like plasmids. Although duplications of some short genome regions, resulting in the appearance of truncated extra copies of genes, did occur, we found no evidences of extensive accumulation of repeat sequences accounting for mitochondrial genome size expansion in some other fungi. Comparisons of mtDNA of S. borealis with other members of the order Helotiales reveal considerable gene order conservation and a dynamic pattern of intron acquisition and loss during evolution. Our data are consistent with the hypothesis that horizontal DNA transfer has played a significant role in the evolution and size expansion of the S. borealis mt genome.	[Mardanov, Andrey V.; Beletsky, Alexey V.; Kadnikov, Vitaly V.; Ignatov, Alexander N.; Ravin, Nikolai V.] Russian Acad Sci, Ctr Bioengn, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences	Ravin, NV (corresponding author), Russian Acad Sci, Ctr Bioengn, Moscow, Russia.	nravin@biengi.ac.ru	Mardanov, Andrey/S-2294-2016; Kadnikov, Vitaly V/E-2359-2014; Ignatov, Alexander N./L-3438-2013; Beletsky, Alexey/AAA-5366-2019; Ravin, Nikolai V/C-5907-2014	Mardanov, Andrey/0000-0002-8245-8757; Kadnikov, Vitaly V/0000-0002-3022-9784; Ignatov, Alexander N./0000-0003-2948-753X; Beletsky, Alexey/0000-0002-7611-2354; Ravin, Nikolai/0000-0002-1456-1832	Russian Foundation for Basic Research [12-04-33122]; "Molecular and Cellular Biology'' program of the Russian Academy of Science	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); "Molecular and Cellular Biology'' program of the Russian Academy of Science	This work was supported by the Russian Foundation for Basic Research (grant 12-04-33122) and by the "Molecular and Cellular Biology'' program of the Russian Academy of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barroso G, 2001, APPL ENVIRON MICROB, V67, P1739, DOI 10.1128/AEM.67.4.1739-1743.2001; Basse CW, 2010, CURR OPIN MICROBIOL, V13, P712, DOI 10.1016/j.mib.2010.09.003; Bois F, 1999, MOL GEN GENET, V261, P508, DOI 10.1007/s004380050994; Bullerwell CE, 2004, CURR OPIN MICROBIOL, V7, P528, DOI 10.1016/j.mib.2004.08.008; Bullerwell CE, 2003, NUCLEIC ACIDS RES, V31, P1614, DOI 10.1093/nar/gkg264; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Cahan P, 2005, MOL GENET GENOMICS, V273, P462, DOI 10.1007/s00438-005-1133-x; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cardoso MAG, 2007, YEAST, V24, P607, DOI 10.1002/yea.1500; CUMMINGS DJ, 1990, CURR GENET, V17, P375, DOI 10.1007/BF00334517; Cusimano N, 2008, MOL BIOL EVOL, V25, P265, DOI 10.1093/molbev/msm241; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Duo A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-166; Ferandon C, 2013, FUNGAL GENET BIOL, V55, P85, DOI 10.1016/j.fgb.2013.01.009; Ferandon C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014048; Formighieri EF, 2008, MYCOL RES, V112, P1136, DOI 10.1016/j.mycres.2008.04.014; Gibb EA, 2005, MYCOL RES, V109, P1112, DOI 10.1017/S095375620500376X; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; GRIFFITHS AJF, 1995, MICROBIOL REV, V59, P673, DOI 10.1128/MMBR.59.4.673-685.1995; Hoshino T, 2010, MYCOSCIENCE, V51, P98, DOI 10.1007/s10267-009-0013-3; Korab-Laskowska M, 1998, NUCLEIC ACIDS RES, V26, P138, DOI 10.1093/nar/26.1.138; Kouvelis VN, 2008, MYCOL RES, V112, P829, DOI 10.1016/j.mycres.2008.01.016; Kouvelis VN, 2004, FUNGAL GENET BIOL, V41, P930, DOI 10.1016/j.fgb.2004.07.003; Lavin JL, 2008, FUNGAL GENET BIOL, V45, P1248, DOI 10.1016/j.fgb.2008.06.005; Losada L, 2014, FEMS MICROBIOL LETT, V352, P165, DOI 10.1111/1574-6968.12387; Lumbsch HT, 2005, MOL PHYLOGENET EVOL, V34, P512, DOI 10.1016/j.ympev.2004.11.007; Milligan B, 1998, MOL GENETIC ANAL POP, P29; Monteiro-Vitorello CB, 2009, FUNGAL GENET BIOL, V46, P837, DOI 10.1016/j.fgb.2009.07.005; Mouhamadou B, 2004, MOL GENET GENOMICS, V272, P257, DOI 10.1007/s00438-004-1050-4; OBrien EA, 2009, NUCLEIC ACIDS RES, V37, pD946, DOI 10.1093/nar/gkn819; Pantou MP, 2006, CURR GENET, V50, P125, DOI 10.1007/s00294-006-0079-9; ROBISON MM, 1991, CURR GENET, V19, P495, DOI 10.1007/BF00312742; Robison MM, 1996, CURR GENET, V29, P370, DOI 10.1007/BF02208618; Seif ER, 2003, RNA, V9, P1073, DOI 10.1261/rna.5880403; Sethuraman J, 2009, MOL BIOL EVOL, V26, P2299, DOI 10.1093/molbev/msp145; Sethuraman J, 2009, J MOL EVOL, V69, P372, DOI 10.1007/s00239-009-9291-9; Spatafora JW, 2006, MYCOLOGIA, V98, P1018, DOI 10.3852/mycologia.98.6.1018; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TOMIYAMA K, 1955, HOKKAIDO NATL AGR EX, V47, P1; Torriani SFF, 2014, FUNGAL GENET BIOL, V62, P34, DOI 10.1016/j.fgb.2013.11.001; van de Sande WWJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038654; Wang Y, 2008, FEMS MICROBIOL LETT, V280, P34, DOI 10.1111/j.1574-6968.2007.01048.x; WEBER F, 1990, NUCLEIC ACIDS RES, V18, P5027, DOI 10.1093/nar/18.17.5027; Wibberg D, 2012, J BIOTECHNOL, V167, P142; Wu Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-238; Xavier BB, 2012, FUNGAL BIOL-UK, V116, P802, DOI 10.1016/j.funbio.2012.04.013; Youssar L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074792	50	51	52	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107536	10.1371/journal.pone.0107536	http://dx.doi.org/10.1371/journal.pone.0107536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216190	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774300075
J	Kim, MS; Shutov, LP; Gnanasekaran, A; Lin, ZH; Rysted, JE; Ulrich, JD; Usachev, YM				Kim, Man-Su; Shutov, Leonid P.; Gnanasekaran, Aswini; Lin, Zhihong; Rysted, Jacob E.; Ulrich, Jason D.; Usachev, Yuriy M.			Nerve Growth Factor (NGF) Regulates Activity of Nuclear Factor of Activated T-cells (NFAT) in Neurons via the Phosphatidylinositol 3-Kinase (PI3K)-Akt-Glycogen Synthase Kinase 3 beta (GSK3 beta) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; RAT SENSORY NEURONS; TRANSCRIPTION FACTOR; DEPENDENT TRANSCRIPTION; PROSTAGLANDIN E-2; TRK RECEPTORS; IN-VITRO; CALCIUM; CALCINEURIN; INACTIVATION	The Ca2+/calcineurin-dependent transcription factor nuclear factor of activated T-cells (NFAT) plays an important role in regulating many neuronal functions, including excitability, axonal growth, synaptogenesis, and neuronal survival. NFAT can be activated by action potential firing or depolarization that leads to Ca2+/calcineurin-dependent dephosphorylation of NFAT and its translocation to the nucleus. Recent data suggest that NFAT and NFAT-dependent functions in neurons can also be potently regulated by NGF and other neurotrophins. However, the mechanisms of NFAT regulation by neurotrophins are not well understood. Here, we show that in dorsal root ganglion sensory neurons, NGF markedly facilitates NFAT-mediated gene expression induced by mild depolarization. The effects of NGF were not associated with changes in [Ca2+](i) and were independent of phospholipase C activity. Instead, the facilitatory effect of NGF depended on activation of the PI3K/Akt pathway downstream of the TrkA receptor and on inhibition of glycogen synthase kinase 3 beta (GSK3 beta), a protein kinase known to phosphorylate NFAT and promote its nuclear export. Knockdown or knockout of NFATc3 eliminated this facilitatory effect. Simultaneous monitoring of EGFP-NFATc3 nuclear translocation and [Ca2+](i) changes in dorsal root ganglion neurons indicated that NGF slowed the rate of NFATc3 nuclear export but did not affect its nuclear import rate. Collectively, our data suggest that NGF facilitates depolarization-induced NFAT activation by stimulating PI3K/Akt signaling, inactivating GSK3 beta, and thereby slowing NFATc3 export from the nucleus. We propose that NFAT serves as an integrator of neurotrophin action and depolarization-driven calcium signaling to regulate neuronal gene expression.	[Kim, Man-Su; Shutov, Leonid P.; Gnanasekaran, Aswini; Lin, Zhihong; Rysted, Jacob E.; Ulrich, Jason D.; Usachev, Yuriy M.] Univ Iowa, Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA; [Kim, Man-Su] Inje Univ, Coll Pharm, Gimhae 621749, Gyeongnam, South Korea	University of Iowa; Inje University	Kim, MS (corresponding author), Inje Univ, Coll Pharm, Inje Ro 197, Gimhae 621749, Gyeongnam, South Korea.	mansu-kim@inje.ac.kr; yuriy-usachev@uiowa.edu	Gnanasekaran, Aswini/N-1936-2016	Gnanasekaran, Aswini/0000-0002-0035-9553; Usachev, Yuriy/0000-0002-6948-4627; Rysted, Jacob/0000-0001-5632-4176	National Institutes of Health [NS072432, NS087068]; Fraternal Order of Eagles Diabetes Research Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087068, R01NS072432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fraternal Order of Eagles Diabetes Research Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS072432 and NS087068. This work was also supported by the Fraternal Order of Eagles Diabetes Research Center.	Abdul HM, 2009, J NEUROSCI, V29, P12957, DOI 10.1523/JNEUROSCI.1064-09.2009; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Benedito AB, 2005, J BIOL CHEM, V280, P2818, DOI 10.1074/jbc.M408741200; Blair LAC, 1999, J NEUROSCI, V19, P1940; Cai YQ, 2013, J PHARMACOL EXP THER, V345, P161, DOI 10.1124/jpet.112.202192; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Eibl JK, 2012, NEUROCHEM INT, V61, P1266, DOI 10.1016/j.neuint.2012.10.008; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Gomez-Sintes R, 2010, J CLIN INVEST, V120, P2432, DOI 10.1172/JCI37873; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Groth RD, 2007, J NEUROCHEM, V102, P1162, DOI 10.1111/j.1471-4159.2007.04632.x; Groth RD, 2003, J NEUROSCI, V23, P8125; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; Hudry E, 2012, J NEUROSCI, V32, P3176, DOI 10.1523/JNEUROSCI.6439-11.2012; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Jackson JG, 2007, MOL PHARMACOL, V72, P303, DOI 10.1124/mol.107.035048; Jones DM, 2003, J NEUROCHEM, V86, P1116, DOI 10.1046/j.1471-4159.2003.01925.x; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Khasabova IA, 2004, J NEUROSCI, V24, P1744, DOI 10.1523/JNEUROSCI.4298-03.2004; Khasabova IA, 2002, NEUROSCIENCE, V115, P613, DOI 10.1016/S0306-4522(02)00449-9; Kim MS, 2009, J NEUROSCI, V29, P12101, DOI 10.1523/JNEUROSCI.3384-09.2009; KNUSEL B, 1992, J NEUROCHEM, V59, P1987; Kress M, 2004, NEUROSCI LETT, V354, P127, DOI 10.1016/j.neulet.2003.10.003; Li HM, 2012, NAT STRUCT MOL BIOL, V19, P337, DOI 10.1038/nsmb.2238; Linhart O, 2003, NEUROSCIENCE, V118, P69, DOI 10.1016/S0306-4522(02)00960-0; Malin SA, 2006, J NEUROSCI, V26, P8588, DOI 10.1523/JNEUROSCI.1726-06.2006; Marsh HN, 2003, J CELL BIOL, V163, P999, DOI 10.1083/jcb.200309036; Martin KJ, 2011, NEUROPHARMACOLOGY, V61, P148, DOI 10.1016/j.neuropharm.2011.03.021; Meyer RA, 2006, WALL MELZACKS TXB PA, V5, P3; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Nguyen T, 2008, INT J DEV NEUROSCI, V26, P141, DOI 10.1016/j.ijdevneu.2007.10.004; Nieves-Cintron M, 2007, J BIOL CHEM, V282, P3231, DOI 10.1074/jbc.M608822200; Oh SB, 2001, J NEUROSCI, V21, P5027, DOI 10.1523/JNEUROSCI.21-14-05027.2001; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Ozaki Y, 2009, CELL CALCIUM, V45, P209, DOI 10.1016/j.ceca.2008.10.002; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Quadrato G, 2012, P NATL ACAD SCI USA, V109, pE1499, DOI 10.1073/pnas.1202068109; Rossow CF, 2004, CIRC RES, V94, P1340, DOI 10.1161/01.RES.0000128406.08418.34; Schnizler K, 2008, J NEUROSCI, V28, P4904, DOI 10.1523/JNEUROSCI.0233-08.2008; Schwartz N, 2009, NEURON, V62, P655, DOI 10.1016/j.neuron.2009.05.007; Shioda N, 2007, J NEUROCHEM, V102, P1506, DOI 10.1111/j.1471-4159.2007.04600.x; SHUTTLEWORTH TJ, 1991, J BIOL CHEM, V266, P1410; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Stefos GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067470; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Stucky CL, 1996, NEUROSCIENCE, V74, P1111, DOI 10.1016/S0306-4522(96)00264-3; Sugden PH, 2008, BRIT J PHARMACOL, V153, pS137, DOI 10.1038/sj.bjp.0707659; Svichar N, 1997, NEUROREPORT, V8, P1555, DOI 10.1097/00001756-199705060-00002; THAYER SA, 1988, J NEUROSCI, V8, P4089; THAYER SA, 1990, J PHYSIOL-LONDON, V425, P85, DOI 10.1113/jphysiol.1990.sp018094; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Ulrich JD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.365197; Usachev YM, 2002, NEURON, V33, P113, DOI 10.1016/S0896-6273(01)00557-8; Usachev YM, 1999, J PHYSIOL-LONDON, V519, P115, DOI 10.1111/j.1469-7793.1999.0115o.x; van der Velden JLJ, 2008, J BIOL CHEM, V283, P358, DOI 10.1074/jbc.M707812200; Vashishta A, 2009, J NEUROSCI, V29, P15331, DOI 10.1523/JNEUROSCI.4873-09.2009; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; Watson JJ, 2008, BIODRUGS, V22, P349, DOI 10.2165/0063030-200822060-00002; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Wilkins BJ, 2002, MOL CELL BIOL, V22, P7603, DOI 10.1128/MCB.22.21.7603-7613.2002; Wood ER, 2004, BIOORG MED CHEM LETT, V14, P953, DOI 10.1016/j.bmcl.2003.12.002; Yan HQ, 2014, BRAIN RES, V1548, P63, DOI 10.1016/j.brainres.2013.12.028; Yang TTC, 2008, MOL CELL BIOL, V28, P3489, DOI 10.1128/MCB.01847-07; Zhang J, 2012, NEURON, V76, P1133, DOI 10.1016/j.neuron.2012.10.019; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011; Zhu JY, 1999, NATURE, V398, P256, DOI 10.1038/18473	75	46	49	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31349	31360		10.1074/jbc.M114.587188	http://dx.doi.org/10.1074/jbc.M114.587188			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25231981	Green Published, hybrid			2022-12-25	WOS:000344549900039
J	Dzialo, MC; Travaglini, KJ; Shen, S; Roy, K; Chanfreau, GF; Loo, JA; Clarke, SG				Dzialo, Maria C.; Travaglini, Kyle J.; Shen, Sean; Roy, Kevin; Chanfreau, Guillaume F.; Loo, Joseph A.; Clarke, Steven G.			Translational Roles of Elongation Factor 2 Protein Lysine Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; METHYLTRANSFERASE; INHIBITION; YEAST; RIBOSOME; IDENTIFICATION; TRANSLOCATION; ANTIBIOTICS	Methylation of various components of the translational machinery has been shown to globally affect protein synthesis. Little is currently known about the role of lysine methylation on elongation factors. Here we show that in Saccharomyces cerevisiae, the product of the EFM3/YJR129C gene is responsible for the trimethylation of lysine 509 on elongation factor 2. Deletion of EFM3 or of the previously described EFM2 increases sensitivity to antibiotics that target translation and decreases translational fidelity. Furthermore, the amino acid sequences of Efm3 and Efm2, as well as their respective methylation sites on EF2, are conserved in other eukaryotes. These results suggest the importance of lysine methylation modification of EF2 in fine tuning the translational apparatus.	[Dzialo, Maria C.; Travaglini, Kyle J.; Shen, Sean; Roy, Kevin; Chanfreau, Guillaume F.; Loo, Joseph A.; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Dzialo, Maria C.; Travaglini, Kyle J.; Shen, Sean; Roy, Kevin; Chanfreau, Guillaume F.; Loo, Joseph A.; Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Loo, Joseph A.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Loo, Joseph A.] Univ Calif Los Angeles, Dept Energy Inst Genom & Prote, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr East, Los Angeles, CA 90095 USA.	clarke@chem.ucla.edu	Chanfreau, Guillaume/S-7421-2019	Travaglini, Kyle/0000-0003-3164-6448; Roy, Kevin/0000-0001-8799-6207	National Institutes of Health [GM026020, GM007185]; Ruth L. Kirschstein National Research Service Award; UCLA Department of Chemistry and Biochemistry Alumni Undergraduate Summer Research Fellowship; UCLA College Honors Summer Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, T32GM007185, R01GM103479, R01GM061518, R37GM026020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Department of Chemistry and Biochemistry Alumni Undergraduate Summer Research Fellowship; UCLA College Honors Summer Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM026020 (to S. G. C.) and GM007185, a Ruth L. Kirschstein National Research Service Award (to M. C. D.).; Supported by a UCLA Department of Chemistry and Biochemistry Alumni Undergraduate Summer Research Fellowship and a UCLA College Honors Summer Research Fellowship.	Al-Hadid Q, 2014, MOL CELL BIOL, V34, P2903, DOI 10.1128/MCB.01634-13; ALLEN DW, 1962, BIOCHIM BIOPHYS ACTA, V55, P865; BELFIELD GP, 1993, MOL MICROBIOL, V9, P411, DOI 10.1111/j.1365-2958.1993.tb01702.x; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; CARRASCO L, 1973, BIOCHIM BIOPHYS ACTA, V312, P368, DOI 10.1016/0005-2787(73)90381-X; Chan SW, 2005, FASEB J, V19, P1510, DOI 10.1096/fj.04-3455fje; Chang YQ, 2011, NUCLEIC ACIDS RES, V39, P6380, DOI 10.1093/nar/gkr256; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Couttas TA, 2012, PROTEOMICS, V12, P960, DOI 10.1002/pmic.201100570; CUNDLIFFE E, 1974, P NATL ACAD SCI USA, V71, P30, DOI 10.1073/pnas.71.1.30; Del Rizzo PA, 2014, BBA-GENE REGUL MECH, V1839, P1404, DOI 10.1016/j.bbagrm.2014.06.008; Erce MA, 2012, PROTEOMICS, V12, P564, DOI 10.1002/pmic.201100397; Graille M, 2012, BIOCHIMIE, V94, P1533, DOI 10.1016/j.biochi.2012.01.005; Gulshan K, 2008, MOL CELL BIOL, V28, P5851, DOI 10.1128/MCB.00405-08; Harger JW, 2002, TRENDS BIOCHEM SCI, V27, P448, DOI 10.1016/S0968-0004(02)02149-7; Heurgue-Hamard V, 1998, EMBO J, V17, P808, DOI 10.1093/emboj/17.3.808; Hiramatsu N, 2011, METHOD ENZYMOL, V491, P183, DOI 10.1016/B978-0-12-385928-0.00011-0; Horowitz S, 2014, ACS CHEM BIOL, V9, P1692, DOI 10.1021/cb5001185; Horowitz S, 2013, J AM CHEM SOC, V135, P15536, DOI 10.1021/ja407140k; Jackman JE, 2013, WIRES RNA, V4, P35, DOI 10.1002/wrna.1144; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Jorgensen R, 2004, J BIOL CHEM, V279, P45919, DOI 10.1074/jbc.M406218200; Justice MC, 1998, J BIOL CHEM, V273, P3148, DOI 10.1074/jbc.273.6.3148; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; Kirillov S, 1997, FEBS LETT, V406, P223, DOI 10.1016/S0014-5793(97)00261-5; Kurata S, 2013, NUCLEIC ACIDS RES, V41, P264, DOI 10.1093/nar/gks958; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Lipson RS, 2010, ARCH BIOCHEM BIOPHYS, V500, P137, DOI 10.1016/j.abb.2010.05.023; Liu J, 2014, J GENET GENOMICS, V41, P21, DOI 10.1016/j.jgg.2013.10.002; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79; Ortiz PA, 2006, J BIOL CHEM, V281, P32639, DOI 10.1074/jbc.M607076200; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; Plant EP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000517; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Roy S, 2010, J MOL BIOL, V398, P489, DOI 10.1016/j.jmb.2010.03.024; Salas-Marco J, 2005, J MOL BIOL, V348, P801, DOI 10.1016/j.jmb.2005.03.025; Schalch T, 2009, MOL CELL, V34, P36, DOI 10.1016/j.molcel.2009.02.024; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Sharma S, 2013, NUCLEIC ACIDS RES, V41, P9062, DOI 10.1093/nar/gkt679; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Studte P, 2008, MOL MICROBIOL, V69, P1266, DOI 10.1111/j.1365-2958.2008.06358.x; Szczepinska T, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003514; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; van Ingen H, 2008, STRUCTURE, V16, P1245, DOI 10.1016/j.str.2008.04.015; Vicens Q, 2001, STRUCTURE, V9, P647, DOI 10.1016/S0969-2126(01)00629-3; Wlodarski T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023168; YARMOLINSKY MB, 1959, P NATL ACAD SCI USA, V45, P1721, DOI 10.1073/pnas.45.12.1721; Zhang LL, 2014, BIOCHEM BIOPH RES CO, V451, P229, DOI 10.1016/j.bbrc.2014.07.110; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509; Zhang XT, 2001, J BIOL CHEM, V276, P47844, DOI 10.1074/jbc.M106285200; Zobel-Thropp P, 2000, J BIOL CHEM, V275, P37150, DOI 10.1074/jbc.M001005200; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	57	17	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30511	30524		10.1074/jbc.M114.605527	http://dx.doi.org/10.1074/jbc.M114.605527			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25231983	Green Published, hybrid			2022-12-25	WOS:000344549700030
J	Goncalves, A; Margier, M; Roi, S; Collet, X; Niot, I; Goupy, P; Caris-Veyrat, C; Reboul, E				Goncalves, Aurelie; Margier, Marielle; Roi, Stephanie; Collet, Xavier; Niot, Isabelle; Goupy, Pascale; Caris-Veyrat, Catherine; Reboul, Emmanuelle			Intestinal Scavenger Receptors Are Involved in Vitamin K-1 Absorption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B TYPE-I; SR-BI; PHYLLOQUINONE VITAMIN-K-1; MENAQUINONE-4 VITAMIN-K-2; CD36 DEFICIENCY; HUMAN PLASMA; CELL-LINE; TRANSPORT; CACO-2; CAROTENOIDS	Vitamin K-1 (phylloquinone) intestinal absorption is thought to be mediated by a carrier protein that still remains to be identified. Apical transport of vitamin K-1 was examined using Caco-2 TC-7 cell monolayers as a model of human intestinal epithelium and in transfected HEK cells. Phylloquinone uptake was then measured ex vivo using mouse intestinal explants. Finally, vitamin K-1 absorption was compared between wild-type mice and mice overexpressing scavenger receptor class B type I (SR-BI) in the intestine and mice deficient in cluster determinant 36 (CD36). Phylloquinone uptake by Caco-2 cells was saturable and was significantly impaired by co-incubation with alpha-tocopherol (and vice versa). Anti-human SR-BI antibodies and BLT1 (a chemical inhibitor of lipid transport via SR-BI) blocked up to 85% of vitamin K-1 uptake. BLT1 also decreased phylloquinone apical efflux by similar to 80%. Transfection of HEK cells with SR-BI and CD36 significantly enhanced vitamin K-1 uptake, which was subsequently decreased by the addition of BLT1 or sulfo-N-succinimidyl oleate (CD36 inhibitor), respectively. Similar results were obtained in mouse intestinal explants. In vivo, the phylloquinone postprandial response was significantly higher, and the proximal intestine mucosa phylloquinone content 4 h after gavage was increased in mice overexpressing SR-BI compared with controls. Phylloquinone postprandial response was also significantly increased in CD36-deficient mice compared with wild-type mice, but their vitamin K-1 intestinal content remained unchanged. Overall, the present data demonstrate for the first time that intestinal scavenger receptors participate in the absorption of dietary phylloquinone.	[Goncalves, Aurelie; Margier, Marielle; Roi, Stephanie; Reboul, Emmanuelle] INRA, UMR Nutr Obes & Risk Thrombosis 1260, F-13385 Marseille, France; [Goncalves, Aurelie; Margier, Marielle; Roi, Stephanie; Reboul, Emmanuelle] INSERM, UMR 1062, F-13385 Marseille, France; [Goncalves, Aurelie; Margier, Marielle; Roi, Stephanie; Reboul, Emmanuelle] Aix Marseille Univ, F-13385 Marseille, France; [Collet, Xavier] Hop Rangueil, INSERM, UPS U1048, F-31432 Toulouse, France; [Niot, Isabelle] Univ Bourgogne Physiol Nutr, INSERM, AgroSup Dijon, UMR 866, F-21000 Dijon, France; [Goupy, Pascale; Caris-Veyrat, Catherine] INRA, UMR Securite & Qualite Prod Origine Vegetale 408, F-84000 Avignon, France; [Goupy, Pascale; Caris-Veyrat, Catherine] Univ Avignon & Pays Vaucluse, F-84000 Avignon, France	INRAE; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; INRAE; Avignon Universite	Reboul, E (corresponding author), Aix Marseille Univ, INRA 1260, INSERM, Fac Med Timone,UMR 1062, 27 Blvd Jean Moulin, F-13385 Marseille 5, France.	Emmanuelle.Reboul@univ-amu.fr	Reboul, Emmanuelle/K-6637-2017; GONCALVES, Aurelie/ABC-5817-2021; Collet, Xavier/M-6938-2017	Reboul, Emmanuelle/0000-0002-4576-1992; GONCALVES, Aurelie/0000-0003-0843-4578; 	Societe Francaise de Nutrition (Lu/SFN grant)	Societe Francaise de Nutrition (Lu/SFN grant)	This work was supported by a grant from the Societe Francaise de Nutrition (Lu/SFN grant).	Adams J, 2005, AM J HEALTH-SYST PH, V62, P1574, DOI 10.2146/ajhp040357; ARTURSSON P, 1995, EPITHELIA CELL CULTU, P111; Bietrix F, 2006, J BIOL CHEM, V281, P7214, DOI 10.1074/jbc.M508868200; Bolton-Smith C, 2000, BRIT J NUTR, V83, P389; Borel P, 2001, AM J PHYSIOL-GASTR L, V280, pG95, DOI 10.1152/ajpgi.2001.280.1.G95; Borel P, 2013, J NUTR, V143, P448, DOI 10.3945/jn.112.172734; CHANTRET I, 1994, J CELL SCI, V107, P213; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; Goncalves A, 2014, MOL NUTR FOOD RES, V58, P2297, DOI 10.1002/mnfr.201400339; Goncalves A, 2013, J NUTR BIOCHEM, V24, P1751, DOI 10.1016/j.jnutbio.2013.03.004; Goudriaan JR, 2005, J LIPID RES, V46, P2175, DOI 10.1194/jlr.M500112-JLR200; Hanzawa F, 2014, MOL NUTR FOOD RES, V58, P1601, DOI 10.1002/mnfr.201300710; Hirota Y, 2013, J BIOL CHEM, V288, P33071, DOI 10.1074/jbc.M113.477356; HOLLANDER D, 1973, AM J PHYSIOL, V225, P360, DOI 10.1152/ajplegacy.1973.225.2.360; HOLLANDER D, 1977, AM J PHYSIOL, V232, pE69, DOI 10.1152/ajpendo.1977.232.1.E69; Kamao M, 2005, J CHROMATOGR B, V816, P41, DOI 10.1016/j.jchromb.2004.11.003; Kopec RE, 2013, RAPID COMMUN MASS SP, V27, P1393, DOI 10.1002/rcm.6576; Martin A., 2001, APPORTS NUTR CONSEIL, P244; Nieland TJF, 2004, J LIPID RES, V45, P1256, DOI 10.1194/jlr.M300358-JLR200; Nieland TJF, 2002, P NATL ACAD SCI USA, V99, P15422, DOI 10.1073/pnas.222421399; Okano T, 2008, J BIOL CHEM, V283, P11270, DOI 10.1074/jbc.M702971200; Reboul E, 2005, BIOCHEM J, V387, P455, DOI 10.1042/BJ20040554; Reboul E, 2006, J BIOL CHEM, V281, P4739, DOI 10.1074/jbc.M509042200; Reboul E, 2012, BRIT J NUTR, V107, P1296, DOI 10.1017/S0007114511004405; Reboul E, 2011, PROG LIPID RES, V50, P388, DOI 10.1016/j.plipres.2011.07.001; Reboul E, 2011, MOL NUTR FOOD RES, V55, P691, DOI 10.1002/mnfr.201000553; Reboul E, 2009, AM J CLIN NUTR, V89, P177, DOI 10.3945/ajcn.2008.26559; Salvini S, 2002, BRIT J NUTR, V87, P211, DOI 10.1079/BJN2001507; SAUPE J, 1993, AM J CLIN NUTR, V58, P204, DOI 10.1093/ajcn/58.2.204; Shearer MJ, 2014, J LIPID RES, V55, P345, DOI 10.1194/jlr.R045559; Song QX, 2008, J CHROMATOGR B, V875, P541, DOI 10.1016/j.jchromb.2008.10.009; STAGGERS JE, 1990, BIOCHEMISTRY-US, V29, P2028, DOI 10.1021/bi00460a011; Thi TTT, 2011, J BIOL CHEM, V286, P25201, DOI 10.1074/jbc.M111.233551; Thijssen HHW, 2006, BRIT J NUTR, V95, P260, DOI 10.1079/BJN20051630; Thijssen HHW, 1996, BRIT J NUTR, V75, P121, DOI 10.1079/BJN19960115; Traber MG, 2008, NUTR REV, V66, P624, DOI 10.1111/j.1753-4887.2008.00123.x; Tyssandier V, 2003, AM J PHYSIOL-GASTR L, V284, pG913, DOI 10.1152/ajpgi.00410.2002; Willems BAG, 2014, MOL NUTR FOOD RES, V58, P1620, DOI 10.1002/mnfr.201300743; Yu M, 2011, P NATL ACAD SCI USA, V108, P12243, DOI 10.1073/pnas.1109078108	39	42	42	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30743	30752		10.1074/jbc.M114.587659	http://dx.doi.org/10.1074/jbc.M114.587659			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25228690	Green Published, hybrid			2022-12-25	WOS:000344549700049
J	Acevedo-Arcique, CM; Ibancovichi, JA; Chavez, JR; Gutierrez-Blanco, E; Moran-Munoz, R; Victoria-Mora, JM; Tendillo-Cortijo, F; Santos-Gonzalez, M; Sanchez-Aparicio, P				Acevedo-Arcique, Carlos M.; Ibancovichi, Jose A.; Chavez, Julio R.; Gutierrez-Blanco, Eduardo; Moran-Munoz, Rafael; Victoria-Mora, Jose M.; Tendillo-Cortijo, Francisco; Santos-Gonzalez, Martin; Sanchez-Aparicio, Pedro			Lidocaine, Dexmedetomidine and Their Combination Reduce Isoflurane Minimum Alveolar Concentration in Dogs	PLOS ONE			English	Article							CONSTANT RATE INFUSION; INTRAVENOUS LIDOCAINE; MEDETOMIDINE; SEVOFLURANE; KETAMINE; CARDIOPULMONARY; ANESTHESIA; RATES	The effects of intravenous (IV) lidocaine, dexmedetomidine and their combination delivered as a bolus followed by a constant rate infusion (CRI) on the minimum alveolar concentration of isoflurane (MAC(ISO)) in dogs were evaluated. Seven healthy adult dogs were included. Anaesthesia was induced with propofol and maintained with isoflurane. For each dog, baseline MAC (MAC(ISO/BASAL)) was determined after a 90-minute equilibration period. Thereafter, each dog received one of the following treatments (loading dose, CRI): lidocaine 2 mg kg(-1), 100 mu g kg(-1) minute(-1); dexmedetomidine 2 mu g kg(-1), 2 mu g kg(-1) hour(-1); or their combination. MAC was then determined again after 45-minutes of treatment by CRI. At the doses administered, lidocaine, dexmedetomidine and their combination significantly reduced MAC(ISO) by 27.3% (range: 12.5-39.2%), 43.4% (33.3-53.3%) and 60.9% (46.1-78.1%), respectively, when compared to MAC(ISO/BASAL). The combination resulted in a greater MAC(ISO) reduction than the two drugs alone. Their use, at the doses studied, provides a clinically important reduction in the concentration of ISO during anaesthesia in dogs.	[Acevedo-Arcique, Carlos M.; Ibancovichi, Jose A.; Chavez, Julio R.; Moran-Munoz, Rafael; Sanchez-Aparicio, Pedro] Univ Autonoma Estado Mexico, Fac Vet Med, Dept Anaesthesia & Analgesia, Toluca, State Of Mexico, Mexico; [Victoria-Mora, Jose M.] Univ Autonoma Estado Mexico, Fac Vet Med, Dept Orthopaed Surg & Trauma, Toluca, State Of Mexico, Mexico; [Gutierrez-Blanco, Eduardo] Univ Autonoma Yucatan, Fac Vet Med, Dept Anim Hlth & Prevent Med, Merida, State Of Yucata, Mexico; [Tendillo-Cortijo, Francisco; Santos-Gonzalez, Martin] Hosp Univ Clin Puerta Hierro, Madrid, Spain	Universidad Autonoma de Yucatan; Hospital Puerta de Hierro-Majadahonda	Ibancovichi, JA (corresponding author), Univ Autonoma Estado Mexico, Fac Vet Med, Dept Anaesthesia & Analgesia, Toluca, State Of Mexico, Mexico.	ibanvet@gmail.com	Gutierrez-Blanco, Eduardo/AAS-3933-2021; Santos, Martín/AAM-7198-2021; aparicio, pedro sanchez/AAS-4265-2021	Gutierrez-Blanco, Eduardo/0000-0002-8370-8367; Santos, Martín/0000-0002-5928-6010; aparicio, pedro sanchez/0000-0002-6511-6595; Ibancovichi, Jose Antonio/0000-0003-1760-687X; Chavez Monteagudo, Julio Raul/0000-0002-2078-1217	Autonomous University of State of Mexico [2762/2009]	Autonomous University of State of Mexico	The resources of this study were awarded by the Autonomous University of State of Mexico through the research project number 2762/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado D, 2011, VET J, V189, P63, DOI 10.1016/j.tvjl.2010.05.029; BADOER E, 1983, J CARDIOVASC PHARM, V5, P760, DOI 10.1097/00005344-198309000-00009; BLOOR BC, 1992, J PHARMACOL EXP THER, V263, P690; Campagnol D, 2007, AM J VET RES, V68, P1308, DOI 10.2460/ajvr.68.12.1308; Columbano N, 2012, VET J, V193, P448, DOI 10.1016/j.tvjl.2011.12.005; Doherty T, 2007, VET ANAESTH ANALG, V34, P125, DOI 10.1111/j.1467-2995.2006.00301.x; Dzikiti TB, 2003, J VET MED A, V50, P190, DOI 10.1046/j.1439-0442.2003.00523.x; EGER EI, 1965, ANESTHESIOLOGY, V26, P756, DOI 10.1097/00000542-196511000-00010; Gomez-Villamandos RJ, 2008, RES VET SCI, V84, P68, DOI 10.1016/j.rvsc.2007.02.004; Gutierrez-Blanco E, 2013, VET ANAESTH ANALG, V40, P599, DOI 10.1111/vaa.12079; Kamibayashi T, 2000, ANESTHESIOLOGY, V93, P1345, DOI 10.1097/00000542-200011000-00030; Kuusela E, 2000, J VET PHARMACOL THER, V23, P15, DOI 10.1046/j.1365-2885.2000.00245.x; Lin GY, 2008, VET ANAESTH ANALG, V35, P141, DOI 10.1111/j.1467-2995.2007.00365.x; MacDougall LM, 2009, VET ANAESTH ANALG, V36, P512, DOI 10.1111/j.1467-2995.2009.00480.x; Matsubara LM, 2009, VET ANAESTH ANALG, V36, P407, DOI 10.1111/j.1467-2995.2009.00471.x; Muir WW, 2003, AM J VET RES, V64, P1155, DOI 10.2460/ajvr.2003.64.1155; Murrell JC, 2005, VET ANAESTH ANALG, V32, P117, DOI 10.1111/j.1467-2995.2005.00233.x; Pascoe PJ, 2006, VET ANAESTH ANALG, V33, P97, DOI 10.1111/j.1467-2995.2005.00236.x; Pypendop BH, 2005, ANESTHESIOLOGY, V53, P315; QUASHA AL, 1980, ANESTHESIOLOGY, V53, P315, DOI 10.1097/00000542-198010000-00008; Shaughnessy MR, 2014, VET ANAESTH ANALG, V41, P1, DOI 10.1111/vaa.12083; Steagall PVM, 2006, JAVMA-J AM VET MED A, V229, P522, DOI 10.2460/javma.229.4.522; Uilenreef JJ, 2008, VET ANAESTH ANALG, V35, P1, DOI 10.1111/j.1467-2995.2007.00344.x; Valverde A, 2004, VET ANAESTH ANALG, V31, P264, DOI 10.1111/j.1467-2995.2004.00165.x; Valverde A, 2003, AM J VET RES, V64, P957, DOI 10.2460/ajvr.2003.64.957; VIRTANEN R, 1985, J VET PHARMACOL THER, V8, P30, DOI 10.1111/j.1365-2885.1985.tb00921.x; Weitz J D, 1991, Nurse Anesth, V2, P19; Wilson J, 2008, VET ANAESTH ANALG, V35, P289, DOI 10.1111/j.1467-2995.2007.00389.x	28	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e106620	10.1371/journal.pone.0106620	http://dx.doi.org/10.1371/journal.pone.0106620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232737	Green Submitted, Green Published, gold			2022-12-25	WOS:000342921200008
J	Kong, QR; Hai, T; Ma, J; Huang, TQ; Jiang, DD; Xie, BT; Wu, ML; Wang, JQ; Song, YR; Wang, Y; He, YL; Sun, JL; Hu, K; Guo, RF; Wang, L; Zhou, Q; Mu, YS; Liu, ZH				Kong, Qingran; Hai, Tang; Ma, Jing; Huang, Tianqing; Jiang, Dandan; Xie, Bingteng; Wu, Meiling; Wang, Jiaqiang; Song, Yuran; Wang, Ying; He, Yilong; Sun, Jialu; Hu, Kui; Guo, Runfa; Wang, Liu; Zhou, Qi; Mu, Yanshuang; Liu, Zhonghua			Rosa26 Locus Supports Tissue-Specific Promoter Driving Transgene Expression Specifically in Pig	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; EMBRYONIC STEM-CELLS; IN-VITRO; GENE; GENERATION; MOUSE; IDENTIFICATION; TOXICITY; PATTERNS; KNOCKOUT	Genetically modified pigs have become a popular model system in fundamental research, agricultural and biomedical applications. However, random integration often result in unstable expression of transgene and unpredictable phenotypes. The Rosa26 locus has been widely used to produce genetic modified animals with high and consistent expressing of transgene in mouse, human and rat, as it can be targeted efficiently and is not subject to gene-silencing effects. Recently, the first case of reporter gene targeting pigs in porcine Rosa26 (pRosa26) locus was reported. In the study, full sequence of pRosa26 locus was further characterized, and the pRosa26 promoter (pR26) was cloned and we evidenced that the new porcine endogenous promoter is suitable for driving transgene expression in a high and stable manner by avoiding DNA methylation. Furthermore, elongation factor 1a promoter (EF1a) -driven GFP reporter and Myostatin promoter (MyoP)-driven Follistatin (Fst) were successfully targeted into the pRosa26 locusby traditional homologous recombination (HR) strategy. EF1a showed high activity and hypomethylation at the locus. And, muscle-specific promoter MyoP was activated strictly in muscle of the pRosa26 targeted pigs, indicating Rosa26 locus supports tissue-specific promoter driving transgene expression in its own manner. The study provided further demonstration on biomedical and agricultural applications of porcine Rosa26 promoter and locus.	[Kong, Qingran; Ma, Jing; Huang, Tianqing; Jiang, Dandan; Xie, Bingteng; Wu, Meiling; Wang, Jiaqiang; He, Yilong; Sun, Jialu; Hu, Kui; Guo, Runfa; Mu, Yanshuang; Liu, Zhonghua] Northeast Agr Univ, Coll Life Sci, Lab Embryo Biotechnol, Harbin, Peoples R China; [Hai, Tang; Song, Yuran; Wang, Ying; Wang, Liu; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Song, Yuran] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Northeast Agricultural University - China; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Mu, YS (corresponding author), Northeast Agr Univ, Coll Life Sci, Lab Embryo Biotechnol, Harbin, Peoples R China.	liu086@126.com; muyanshuang@163.com	Wang, Jiaqiang/GQP-0997-2022; Liu, Zhunghua/F-2485-2010; Liu, Zhonghua/AAO-3590-2021	Liu, Zhunghua/0000-0002-9199-6493; Liu, Zhonghua/0000-0002-9199-6493; Wang, Jiaqiang/0000-0002-1758-3316; , Haitang/0000-0002-3192-0753	National Basic Research Program of China (973 Program) [2011CBA01006]; State Transgenic Research Program of China [2011ZX08006-002, 2013ZX08009003-006]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); State Transgenic Research Program of China	This work is supported by the National Basic Research Program of China (973 Program) (2011CBA01006) (to ZHL) (http://www.nsfc.gov.cn/); State Transgenic Research Program of China (2011ZX08006-002 and 2013ZX08009003-006) (to ZHL) (http://www.863.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burket CT, 2008, TRANSGENIC RES, V17, P265, DOI 10.1007/s11248-007-9152-5; Capecchi MR, 2000, P NATL ACAD SCI USA, V97, P956, DOI 10.1073/pnas.97.3.956; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023376; Chiaromonte F, 2003, GENOME RES, V13, P2602, DOI 10.1101/gr.1169203; Cornu TI, 2008, MOL THER, V16, P352, DOI 10.1038/sj.mt.6300357; Cornu TI, 2010, METHODS MOL BIOL, V649, P237, DOI 10.1007/978-1-60761-753-2_14; Eszterhas SK, 2002, MOL CELL BIOL, V22, P469, DOI 10.1128/MCB.22.2.469-479.2002; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Gross JB, 2006, J ANAT, V209, P401, DOI 10.1111/j.1469-7580.2006.00608.x; Gupta A, 2011, NUCLEIC ACIDS RES, V39, P381, DOI 10.1093/nar/gkq787; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Kobayashi T, 2012, STEM CELLS DEV, V21, P2981, DOI 10.1089/scd.2012.0065; Lai LX, 2006, NAT BIOTECHNOL, V24, P435, DOI 10.1038/nbt1198; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Li D, 2008, NUCLEIC ACIDS RES, V36, P330, DOI 10.1093/nar/gkm1028; Li X, 2014, CELL RES; Nyabi O, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp112; Olsen PA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-35; Owens JB, 2013, NUCLEIC ACIDS RES, V41, P9197, DOI 10.1093/nar/gkt677; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Radecke S, 2010, MOL THER, V18, P743, DOI 10.1038/mt.2009.304; Rao PC, 2009, DEV NEUROBIOL, V69, P401, DOI 10.1002/dneu.20714; Schumacher A, 2000, J BIOL CHEM, V275, P37915, DOI 10.1074/jbc.M004839200; Spiller MP, 2002, MOL CELL BIOL, V22, P7066, DOI 10.1128/MCB.22.20.7066-7082.2002; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tchorz JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030011; Vandenbon A, 2010, NUCLEIC ACIDS RES, V38, P17, DOI 10.1093/nar/gkp866; Wang P, 2006, J CELL BIOCHEM, V97, P275, DOI 10.1002/jcb.20643; Whyte JJ, 2011, MOL REPROD DEV, V78, P879, DOI 10.1002/mrd.21333; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Xin JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084250	34	20	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107945	10.1371/journal.pone.0107945	http://dx.doi.org/10.1371/journal.pone.0107945			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232950	Green Submitted, gold, Green Published			2022-12-25	WOS:000342921200065
J	Bai, QF; Shao, YH; Pan, DB; Zhang, Y; Liu, HX; Yao, XJ				Bai, Qifeng; Shao, Yonghua; Pan, Dabo; Zhang, Yang; Liu, Huanxiang; Yao, Xiaojun			Search for beta(2) Adrenergic Receptor Ligands by Virtual Screening via Grid Computing and Investigation of Binding Modes by Docking and Molecular Dynamics Simulations	PLOS ONE			English	Article							HUMAN SMOOTHENED RECEPTOR; HIGH-PERFORMANCE; ANTAGONIST; POLYMORPHISMS; INTEGRATION; CHEMISTRY; MECHANISM; SYSTEM; STATE; ZINC	We designed a program called MolGridCal that can be used to screen small molecule database in grid computing on basis of JPPF grid environment. Based on MolGridCal program, we proposed an integrated strategy for virtual screening and binding mode investigation by combining molecular docking, molecular dynamics (MD) simulations and free energy calculations. To test the effectiveness of MolGridCal, we screened potential ligands for beta(2) adrenergic receptor (beta(2)AR) from a database containing 50,000 small molecules. MolGridCal can not only send tasks to the grid server automatically, but also can distribute tasks using the screensaver function. As for the results of virtual screening, the known agonist BI-167107 of beta(2)AR is ranked among the top 2% of the screened candidates, indicating MolGridCal program can give reasonable results. To further study the binding mode and refine the results of MolGridCal, more accurate docking and scoring methods are used to estimate the binding affinity for the top three molecules (agonist BI-167107, neutral antagonist alprenolol and inverse agonist ICI 118,551). The results indicate agonist BI-167107 has the best binding affinity. MD simulation and free energy calculation are employed to investigate the dynamic interaction mechanism between the ligands and beta(2)AR. The results show that the agonist BI-167107 also has the lowest binding free energy. This study can provide a new way to perform virtual screening effectively through integrating molecular docking based on grid computing, MD simulations and free energy calculations.	[Bai, Qifeng; Shao, Yonghua; Pan, Dabo; Yao, Xiaojun] Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China; [Zhang, Yang] Lanzhou Univ, Sch Informat Sci & Engn, Lanzhou 730000, Peoples R China; [Liu, Huanxiang] Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China; [Bai, Qifeng] Lanzhou Univ, Sch Basic Med Sci, Lanzhou 730000, Peoples R China; [Yao, Xiaojun] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University; Lanzhou University; Macau University of Science & Technology	Yao, XJ (corresponding author), Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China.	xjyao@lzu.edu.cn	Bai, Qifeng/A-2950-2019	Bai, Qifeng/0000-0001-7296-6187; Liu, Huanxiang/0000-0002-9284-3667	National Natural Science Foundation of China [21175063]; Program for Changjiang Scholars and Innovative Research Team in University [PCSIRT: IRT1137]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (Grant No. 21175063) and the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT: IRT1137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose HJ, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-37; Angiuoli SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026624; Bai QF, 2014, PHYS CHEM CHEM PHYS, V16, P15874, DOI 10.1039/c4cp01185f; Bai QF, 2014, BBA-GEN SUBJECTS, V1840, P2128, DOI 10.1016/j.bbagen.2014.03.010; Bai QF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068138; Bai QF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019856; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Baker JG, 2003, MOL PHARMACOL, V64, P679, DOI 10.1124/mol.64.3.679; Brown SP, 2006, J CHEM INF MODEL, V46, P999, DOI 10.1021/ci050488t; Bullard D, 2008, J CHEM INF MODEL, V48, P811, DOI 10.1021/ci700396b; Busse WW, 2013, THORAX, V68, P513, DOI 10.1136/thoraxjnl-2012-202606; Chien A, 2002, DRUG DISCOV TODAY, V7, pS176, DOI 10.1016/S1359-6446(02)02369-3; Claus BL, 2008, DRUG DISCOV TODAY, V13, P578, DOI 10.1016/j.drudis.2008.03.006; Cosconati S, 2012, J CHEM INF MODEL, V52, P2697, DOI 10.1021/ci300390h; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978; Darve E, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2829861; Diomidous M, 2012, STUD HEALTH TECHNOL, V174, P116, DOI 10.3233/978-1-61499-052-9-116; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Durrant JD, 2009, CHEM BIOL DRUG DES, V73, P168, DOI 10.1111/j.1747-0285.2008.00761.x; Espinosa E, 1998, CHEM PHYS LETT, V285, P170, DOI 10.1016/S0009-2614(98)00036-0; Eugster MJA, 2013, METHOD INFORM MED, V52, P62; Fanelli F, 2011, CHEM REV, V111, pPR438, DOI 10.1021/cr100437t; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Feng ZW, 2012, J CHEM INF MODEL, V52, P1005, DOI 10.1021/ci200594d; Frisch G.W., 2016, GAUSSIAN 16 REVISION; Geddes N, 2012, PHILOS T R SOC A, V370, P965, DOI 10.1098/rsta.2011.0465; Gonzalez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023815; Gonzalez R, 2012, J INTEGR BIOINFORMAT, V9, DOI 10.2390/biecoll-jib-2012-206; Guixa-Gonzalez R, 2014, BIOINFORMATICS, V30, P1478, DOI 10.1093/bioinformatics/btu037; Henin J, 2010, J CHEM THEORY COMPUT, V6, P35, DOI 10.1021/ct9004432; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter AA, 2012, SOURCE CODE BIOL MED, V7, DOI 10.1186/1751-0473-7-1; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Isea R, 2010, STUD HEALTH TECHNOL, V159, P234, DOI 10.3233/978-1-60750-583-9-234; Isin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050186; Janson C, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3306; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kayser K, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S12; Kepper N, 2010, STUD HEALTH TECHNOL, V159, P264, DOI 10.3233/978-1-60750-583-9-264; Lee HC, 2006, IEEE T NANOBIOSCI, V5, P288, DOI 10.1109/TNB.2006.887943; Liu XF, 2010, NUCLEIC ACIDS RES, V38, pW609, DOI 10.1093/nar/gkq300; Louis SNS, 1999, EUR J PHARMACOL, V367, P431, DOI 10.1016/S0014-2999(99)00019-9; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mareuil F, 2011, BIOINFORMATICS, V27, P1713, DOI 10.1093/bioinformatics/btr255; Matsuda K, 2012, J ASTHMA, V49, P1071, DOI 10.3109/02770903.2012.729631; Mihasan M, 2012, J BIOSCIENCES, V37, P1089, DOI 10.1007/s12038-012-9273-8; Mills PJ, 2004, AM J GERIAT PSYCHIAT, V12, P281, DOI 10.1176/appi.ajgp.12.3.281; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Pernomian L, 2013, J PHARM PHARMACOL, V65, P1337, DOI 10.1111/jphp.12105; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plusa Tadeusz, 2010, Pol Merkur Lekarski, V28, P8; Prabhakaran S, 2011, PHARMACOTHERAPY, V31, P449, DOI 10.1592/phco.31.5.449; Provasi D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002193; Ramos-Pollan R, 2012, J MED SYST, V36, P2245, DOI 10.1007/s10916-011-9692-3; Rao SN, 2007, J CHEM INF MODEL, V47, P2159, DOI 10.1021/ci6004299; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Richards WG, 2002, NAT REV DRUG DISCOV, V1, P551, DOI 10.1038/nrd841; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Saam J, 2007, P NATL ACAD SCI USA, V104, P13319, DOI 10.1073/pnas.0702401104; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanchez-Linares I, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S13; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Seifert MHJ, 2007, CURR OPIN DRUG DISC, V10, P298; Shirts M, 2000, SCIENCE, V290, P1903, DOI 10.1126/science.290.5498.1903; Sroka J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-196; Taylor RD, 2002, J COMPUT AID MOL DES, V16, P151, DOI 10.1023/A:1020155510718; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vanni S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001053; von Korff M, 2011, EXPERT OPIN DRUG DIS, V6, P103, DOI 10.1517/17460441.2011.538046; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Wang ZH, 2013, WIRES SYST BIOL MED, V5, P135, DOI 10.1002/wsbm.1200; Williams AJ, 2008, DRUG DISCOV TODAY, V13, P495, DOI 10.1016/j.drudis.2008.03.017; Woods CJ, 2005, PHILOS T R SOC A, V363, P2017, DOI 10.1098/rsta.2005.1626; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Yim W, 2010, STUD HEALTH TECHNOL, V159, P181, DOI 10.3233/978-1-60750-583-9-181; Yu JT, 2008, BRAIN RES, V1210, P216, DOI 10.1016/j.brainres.2008.03.019; Zhou SY, 2013, J CHEM INF MODEL, V53, P982, DOI 10.1021/ci400065e	81	10	10	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107837	10.1371/journal.pone.0107837	http://dx.doi.org/10.1371/journal.pone.0107837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229694	gold, Green Published, Green Submitted			2022-12-25	WOS:000342123900080
J	Ghaddab-Zroud, R; Seugnet, I; Steffensen, KR; Demeneix, BA; Clerget-Froidevaux, MS				Ghaddab-Zroud, Rym; Seugnet, Isabelle; Steffensen, Knut R.; Demeneix, Barbara A.; Clerget-Froidevaux, Marie-Stephanie			Liver X Receptor Regulation of Thyrotropin-Releasing Hormone Transcription in Mouse Hypothalamus Is Dependent on Thyroid Status	PLOS ONE			English	Article							STEAROYL-COA DESATURASE; PROTEIN GENE-EXPRESSION; LIPOPROTEIN-LIPASE; NUCLEAR RECEPTORS; ACID-METABOLISM; MESSENGER-RNA; MICE LACKING; ALPHA; CHOLESTEROL; ACTIVATION	Reversing the escalating rate of obesity requires increased knowledge of the molecular mechanisms controlling energy balance. Liver X receptors (LXRs) and thyroid hormone receptors (TRs) are key physiological regulators of energetic metabolism. Analysing interactions between these receptors in the periphery has led to a better understanding of the mechanisms involved in metabolic diseases. However, no data is available on such interactions in the brain. We tested the hypothesis that hypothalamic LXR/TR interactions could co-regulate signalling pathways involved in the central regulation of metabolism. Using in vivo gene transfer we show that LXR activation by its synthetic agonist GW3965 represses the transcriptional activity of two key metabolic genes, Thyrotropin-releasing hormone (Trh) and Melanocortin receptor type 4 (Mc4r) in the hypothalamus of euthyroid mice. Interestingly, this repression did not occur in hypothyroid mice but was restored in the case of Trh by thyroid hormone (TH) treatment, highlighting the role of the triiodothyronine (T-3) and TRs in this dialogue. Using shLXR to knock-down LXRs in vivo in euthyroid newborn mice, not only abrogated Trh repression but actually increased Trh transcription, revealing a potential inhibitory effect of LXR on the Hypothalamic-Pituitary-Thyroid axis. In vivo chromatin immunoprecipitation (ChIP) revealed LXR to be present on the Trh promoter region in the presence of T-3 and that Retinoid X Receptor (RXR), a heterodimerization partner for both TR and LXR, was never recruited simultaneously with LXR. Interactions between the TR and LXR pathways were confirmed by qPCR experiments. T-3 treatment of newborn mice induced hypothalamic expression of certain key LXR target genes implicated in metabolism and inflammation. Taken together the results indicate that the crosstalk between LXR and TR signalling in the hypothalamus centres on metabolic and inflammatory pathways.	[Ghaddab-Zroud, Rym; Seugnet, Isabelle; Demeneix, Barbara A.; Clerget-Froidevaux, Marie-Stephanie] Museum Natl Hist Nat, CNRS, UMR USM Evolut Endocrine Regulat 7221 501, Regulat Dev & Mol Div Dept, Paris, France; [Steffensen, Knut R.] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Div Clin Chem, Stockholm, Sweden	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Karolinska Institutet; Karolinska University Hospital	Clerget-Froidevaux, MS (corresponding author), Museum Natl Hist Nat, CNRS, UMR USM Evolut Endocrine Regulat 7221 501, Regulat Dev & Mol Div Dept, CP32, Paris, France.	clerget@mnhn.fr	Clerget-Froidevaux, Marie-Stéphanie/B-7569-2012; Clerget-Froidevaux/P-4252-2019	Clerget-Froidevaux, Marie-Stéphanie/0000-0003-1192-0243; Clerget-Froidevaux/0000-0003-1192-0243	European Union CRESCENDO [LSHM-CT-2005-018652]; French government AMBre [09.2.90.6054]	European Union CRESCENDO(European Commission); French government AMBre	This work was supported by European Union CRESCENDO contract (LSHM-CT-2005-018652). RGZ received a PhD fellowship from a French government contract AMBre (09.2.90.6054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abildayeva K, 2006, J BIOL CHEM, V281, P12799, DOI 10.1074/jbc.M601019200; Alkemade A, 2008, CURR OPIN ENDOCRINOL, V15, P453, DOI 10.1097/MED.0b013e32830eb887; Baldan A, 2009, J LIPID RES, V50, pS80, DOI 10.1194/jlr.R800044-JLR200; Balkan W, 1998, ENDOCRINOLOGY, V139, P252, DOI 10.1210/en.139.1.252; Blaschke F, 2006, CIRC RES, V99, pE88, DOI 10.1161/01.RES.0000252878.34269.06; Chen YL, 2012, J BIOL CHEM, V287, P43340, DOI 10.1074/jbc.M112.403394; Christoffolete MA, 2010, J ENDOCRINOL, V205, P179, DOI 10.1677/JOE-09-0448; Cintra DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030571; Clerget-Froidevaux MS, 2004, FEBS LETT, V569, P341, DOI 10.1016/j.febslet.2004.05.076; Crupi R, 2013, PHARMACOL RES, V70, P80, DOI 10.1016/j.phrs.2012.12.009; Decherf S, 2013, MOL CELL ENDOCRINOL, V381, P115, DOI 10.1016/j.mce.2013.07.016; Decherf S, 2010, P NATL ACAD SCI USA, V107, P4471, DOI 10.1073/pnas.0905190107; Dobrzyn P, 2010, BBA-BIOENERGETICS, V1797, P1189, DOI 10.1016/j.bbabio.2010.02.007; Fekete C, 2000, J NEUROSCI, V20, P1550; Fernandez V, 2002, FREE RADICAL RES, V36, P719, DOI 10.1080/10715760290032566; Flores-Morales A, 2002, MOL ENDOCRINOL, V16, P1257, DOI 10.1210/me.16.6.1257; Flowers MI, 2009, BBA-MOL CELL BIOL L, V1791, P85, DOI 10.1016/j.bbalip.2008.12.011; Fowler AJ, 2003, J INVEST DERMATOL, V120, P246, DOI 10.1046/j.1523-1747.2003.12033.x; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Froidevaux MSC, 2006, EMBO REP, V7, P1035, DOI 10.1038/sj.embor.7400778; Gofflot F, 2007, CELL, V131, P405, DOI 10.1016/j.cell.2007.09.012; GOLDBERG IJ, 1989, J LIPID RES, V30, P1569; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Guissouma H, 1998, FASEB J, V12, P1755, DOI 10.1096/fasebj.12.15.1755; Guo FF, 2004, ENDOCRINOLOGY, V145, P2221, DOI 10.1210/en.2003-1312; Hashimoto K, 2007, ENDOCRINOLOGY, V148, P4667, DOI 10.1210/en.2007-0150; Hashimoto K, 2006, ENDOCRINOLOGY, V147, P4292, DOI 10.1210/en.2006-0116; Hashimoto K, 2009, ENDOCRINOLOGY, V150, P3417, DOI 10.1210/en.2009-0059; HOLLENBERG AN, 1995, MOL ENDOCRINOL, V9, P540, DOI 10.1210/me.9.5.540; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Ishida E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054901; Jakobsson T, 2012, TRENDS PHARMACOL SCI, V33, P394, DOI 10.1016/j.tips.2012.03.013; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kawai K, 2004, ENDOCRINOLOGY, V145, P5515, DOI 10.1210/en.2004-0382; KOLLER KJ, 1987, P NATL ACAD SCI USA, V84, P7329, DOI 10.1073/pnas.84.20.7329; Korach-Andre M, 2011, P NATL ACAD SCI USA, V108, P403, DOI 10.1073/pnas.1017884108; Kouidhi S, 2010, MOL CELL ENDOCRINOL, V317, P44, DOI 10.1016/j.mce.2009.11.001; Lechan RM, 2006, PROG BRAIN RES, V153, P209, DOI 10.1016/S0079-6123(06)53012-2; Liu YY, 2010, TRENDS ENDOCRIN MET, V21, P166, DOI 10.1016/j.tem.2009.11.004; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; Matsuzawa Y, 1999, ANN NY ACAD SCI, V892, P146, DOI 10.1111/j.1749-6632.1999.tb07793.x; Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Pelletier P, 2008, ENDOCRINOLOGY, V149, P6471, DOI 10.1210/en.2008-0718; Perez-Tilve D, 2010, NAT NEUROSCI, V13, P877, DOI 10.1038/nn.2569; Pramfalk C, 2011, BBA-MOL BASIS DIS, V1812, P929, DOI 10.1016/j.bbadis.2010.12.019; Shibusawa N, 2003, J BIOL CHEM, V278, P732, DOI 10.1074/jbc.M207264200; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Sodhi RK, 2013, PHARMACOL RES, V72, P45, DOI 10.1016/j.phrs.2013.03.008; Thaler JP, 2010, FRONT NEUROENDOCRIN, V31, P79, DOI 10.1016/j.yfrne.2009.10.002; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wang M, 2012, AUTOPHAGY, V8, P1273, DOI 10.4161/auto.20917; Xu JH, 2005, J NEUROSCI RES, V81, P403, DOI 10.1002/jnr.20518; Fokko ZA, 2007, BBA-MOL CELL BIOL L, V1771, P972, DOI 10.1016/j.bbalip.2007.04.021; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zhang F, 2012, J CLIN NEUROSCI, V19, P946, DOI 10.1016/j.jocn.2011.12.022; Zhang Y, 2001, J BIOL CHEM, V276, P43018, DOI 10.1074/jbc.M107823200; Zhao CY, 2010, J ENDOCRINOL, V204, P233, DOI 10.1677/JOE-09-0271	60	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e106983	10.1371/journal.pone.0106983	http://dx.doi.org/10.1371/journal.pone.0106983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229406	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900019
J	Lu, WC; Kao, SY; Yang, CC; Tu, HF; Wu, CH; Chang, KW; Lin, SC				Lu, Wen-Cheng; Kao, Shou-Yen; Yang, Cheng-Chieh; Tu, Hsi-Feng; Wu, Cheng-Hsien; Chang, Kuo-Wei; Lin, Shu-Chun			EGF Up-Regulates miR-31 through the C/EBP beta Signal Cascade in Oral Carcinoma	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; LYMPH-NODE METASTASIS; ONCOGENIC RAS; COPY NUMBER; HEAD; CANCER; EXPRESSION; GROWTH; MICRORNA; CURCUMIN	Oral squamous cell carcinoma (OSCC) is one of the most prevalent carcinomas worldwide. MicroRNAs (miRNAs) are short, non-coding RNAs that regulate gene expression and modulate physiological or pathological processes including OSCC carcinogenesis. miR-31 has been found to be up-regulated in OSCC and to act as an oncogenic miRNA. However, the molecular mechanism underlying miR-31 up-regulation in OSCC is still obscure. The activation of epidermal growth factor receptor (EGFR) signaling axis plays key roles in driving oral carcinogenesis. Our screening identified that there is up-regulation of miR-31, miR-181b and miR-222 in OSCC cells following EGF treatment. Subsequent analysis showed that EGF treatment led to AKT activation, which then resulted in miR-31 up-regulation. Moreover, EGF treatment and the AKT activation induced by exogenous expression up-regulated C/EBP beta expression. The miR-31 up-regulation induced by EGF was abrogated by AKT inhibition or by the knockdown of C/EBP beta expression. In OSCC cell subclones stably overexpressing the functional isoform of C/EBP beta, miR-31 expression was up-regulated. Curcumin is a natural ingredient exhibiting anticancer potential. It was found that curcumin attenuated AKT activation and the up-regulation of C/EBP beta and miR-31 caused by EGF stimulation in OSCC cells. Lastly, concordance across the expression of EGFR, the expression of C/EBPb and the expression of miR-31 in OSCC tissues was found. This study describes a novel scenario where the up-regulation of miR-31 expression in OSCC is, at least in part, a consequence of EGFR oncogenic activation. Although the AKT activation and C/EBP beta expression after EGF treatment might not be directly linked, both events are the crucial mediators underlying miR-31 up-regulation in the EGFR signaling axis.	[Lu, Wen-Cheng; Yang, Cheng-Chieh; Chang, Kuo-Wei; Lin, Shu-Chun] Natl Yang Ming Univ, Inst Oral Biol, Taipei 112, Taiwan; [Kao, Shou-Yen; Yang, Cheng-Chieh; Tu, Hsi-Feng; Wu, Cheng-Hsien; Chang, Kuo-Wei; Lin, Shu-Chun] Natl Yang Ming Univ, Dept Dent, Taipei 112, Taiwan; [Tu, Hsi-Feng] Natl Yang Ming Univ Hosp, Dept Dent, Yilan, Taiwan; [Kao, Shou-Yen; Yang, Cheng-Chieh; Wu, Cheng-Hsien; Chang, Kuo-Wei; Lin, Shu-Chun] Taipei Vet Gen Hosp, Dept Stomatol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Chang, KW (corresponding author), Natl Yang Ming Univ, Inst Oral Biol, Taipei 112, Taiwan.	ckcw@ym.edu.tw; sclin@ym.edu.tw	Wu, Cheng-Hsien/GLR-7361-2022		National Science Council [NSC-102-2628-B-010-011-MY3, NSC-102-2314-B-010-035]; Taipei Veterans General Hospital [V102C-062]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study was supported by grants NSC-102-2628-B-010-011-MY3 and NSC-102-2314-B-010-035 from National Science Council and Taipei Veterans General Hospital grant V102C-062. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augoff K, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-5; Bagan JV, 2012, J ORAL PATHOL MED, V41, P662, DOI 10.1111/j.1600-0714.2012.01137.x; Balasubramanian S, 2007, TOXICOL APPL PHARM, V224, P214, DOI 10.1016/j.taap.2007.03.020; Bennett KL, 2007, CANCER RES, V67, P4657, DOI 10.1158/0008-5472.CAN-06-4793; Bronisz A, 2012, NAT CELL BIOL, V14, P159, DOI 10.1038/ncb2396; Campion CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095087; Chang KW, 2010, INT J CANCER, V127, P9, DOI 10.1002/ijc.25220; Chiang WF, 2008, ORAL ONCOL, V44, P270, DOI 10.1016/j.oraloncology.2007.02.008; Chu TH, 2013, CANCER LETT, V337, P115, DOI 10.1016/j.canlet.2013.05.032; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Ewing SJ, 2008, CELL DEATH DIFFER, V15, P1734, DOI 10.1038/cdd.2008.105; Freier K, 2003, CANCER RES, V63, P1179; Gorenchtein M, 2012, J DENT RES, V91, P440, DOI 10.1177/0022034511431261; Hiraishi Y, 2006, PATHOL ONCOL RES, V12, P87, DOI 10.1007/BF02893450; Hung PS, 2014, CARCINOGENESIS, V35, DOI 10.1093/carcin/bgu024; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Kao SY, 2010, J PATHOL, V222, P99, DOI 10.1002/path.2737; Laimer K, 2007, ORAL ONCOL, V43, P193, DOI 10.1016/j.oraloncology.2006.02.009; Lin SC, 2010, ORAL ONCOL, V46, P204, DOI 10.1016/j.oraloncology.2009.12.005; Liu CJ, 2010, ORAL DIS, V16, P360, DOI 10.1111/j.1601-0825.2009.01646.x; Liu CJ, 2014, INT J CANCER, V134, P811, DOI 10.1002/ijc.28358; Liu CJ, 2013, ANN SURG ONCOL, V20, pS406, DOI 10.1245/s10434-012-2618-6; Liu CJ, 2012, HEAD NECK-J SCI SPEC, V34, P219, DOI 10.1002/hed.21713; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Mehra Ranee, 2008, Clin Adv Hematol Oncol, V6, P742; Pham NA, 2007, DIAGN PATHOL, V2, DOI 10.1186/1746-1596-2-8; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Reis PP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-238; Rogers SJ, 2005, CANCER METAST REV, V24, P47, DOI 10.1007/s10555-005-5047-1; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Sun M, 2008, MOL CANCER THER, V7, P464, DOI 10.1158/1535-7163.MCT-07-2272; Tu HF, 2013, CURR OPIN OTOLARYNGO, V21, P104, DOI 10.1097/MOO.0b013e32835e1d6e; Wang N, 2014, GYNECOL ONCOL, V134, P129, DOI 10.1016/j.ygyno.2014.04.047; Weir NM, 2007, CANCER BIOL THER, V6, P178, DOI 10.4161/cbt.6.2.3577; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Xi SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013764; Yang CC, 2011, J ORAL PATHOL MED, V40, P397, DOI 10.1111/j.1600-0714.2010.01003.x; Yang CJ, 2011, J ORAL PATHOL MED, V40, P560, DOI 10.1111/j.1600-0714.2010.01005.x; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299; Zhu SY, 1999, MOL CELL BIOL, V19, P7181	42	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e108049	10.1371/journal.pone.0108049	http://dx.doi.org/10.1371/journal.pone.0108049			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229239	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900094
J	Lim, SW; Won, HH; Kim, H; Myung, W; Kim, S; Kim, KK; Carroll, BJ; Kim, JW; Kim, DK				Lim, Shinn-Won; Won, Hong-Hee; Kim, Hyeran; Myung, Woojae; Kim, Seonwoo; Kim, Ka-Kyung; Carroll, Bernard J.; Kim, Jong-Won; Kim, Doh Kwan			Genetic Prediction of Antidepressant Drug Response and Nonresponse in Korean Patients	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; STAR-ASTERISK-D; POLYMORPHISM 5-HTTLPR ASSOCIATION; TRYPTOPHAN HYDROXYLASE-2; MAJOR DEPRESSION; MESSENGER-RNA; PROMOTER; EXPRESSION; BRAIN; METAANALYSIS	Genetic polymorphism contributes to variation in response to drug treatment of depression. We conducted three independent 6-week treatment studies in outpatients with major depressive disorder (MDD) to develop a pharmacogenomic model predicting response and nonresponse. We screened candidate genomic markers for association with response to selective serotonin reuptake inhibitors (SSRIs). No patients had received any antidepressant drug treatment in the current episode of depression. Outcome evaluation was blinded to drug and genotype data. The prediction model derived from a development sample of 239 completer cases treated with SSRIs comprised haplotypes and polymorphisms related to serotonin synthesis, serotonin transport, glutamate receptors, and GABA synthesis. The model was evaluated prospectively for prediction of outcome in a validation sample of 176 new SSRI-treated completer cases. The model gave a prediction in 60% of these cases. Predictive values were 85% for predicted responders and 86% for predicted nonresponders, compared to prior probabilities of 66% for observed response and 34% for observed nonresponse in those cases (both P<0.001). Convergent cross-validation was obtained through failure of the model to predict outcomes in a third independent sample of 189 completer cases who received non-SSRI antidepressants. We suggest proof of principle for genetic guidance to use or avoid SSRIs in a majority of Korean depressed patients.	[Lim, Shinn-Won; Won, Hong-Hee] Samsung Biomed Res Inst, Clin Res Ctr, Seoul, South Korea; [Kim, Hyeran; Myung, Woojae; Kim, Doh Kwan] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Psychiat, Seoul, South Korea; [Kim, Seonwoo] Samsung Biomed Res Inst, Biostat Unit, Seoul, South Korea; [Kim, Ka-Kyung; Kim, Jong-Won] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul, South Korea; [Carroll, Bernard J.] Pacific Behav Res Fdn, Carmel, CA USA	Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, JW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul, South Korea.	kimjw@skku.edu; paulkim@skku.edu	Won, Hong-Hee/D-2672-2011; Kim, Doh Kwan/F-4616-2014; Myung, Woojae/AAD-3016-2021	Won, Hong-Hee/0000-0001-5719-0552; Kim, Doh Kwan/0000-0002-2302-6153; Myung, Woojae/0000-0001-9985-2032	National Research Foundation of Korea - Korea government (MEST) [R0A 2007-000-20129-0]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A110339]; Brain Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning [NRF-2013M3C7A1073000]	National Research Foundation of Korea - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Brain Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning	This study was supported by grants from National Research Foundation of Korea funded by the Korea government (MEST, R0A 2007-000-20129-0, to D.K.K.), the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A110339, to D.K.K.), and the Brain Research Program through the National Research Foundation of Korea, funded by the Ministry of Science, ICT, and Future Planning (NRF-2013M3C7A1073000, to J.W.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Barbon A, 2006, BIOL PSYCHIAT, V59, P713, DOI 10.1016/j.biopsych.2005.10.018; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; CARROLL BJ, 1984, J CLIN PSYCHIAT, V45, P14; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Demitrack MA, 1998, PSYCHOPHARMACOL BULL, V34, P19; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garriock HA, 2010, BIOL PSYCHIAT, V67, P133, DOI 10.1016/j.biopsych.2009.08.029; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Ising M, 2009, ARCH GEN PSYCHIAT, V66, P966, DOI 10.1001/archgenpsychiatry.2009.95; Kalueff AV, 2007, DEPRESS ANXIETY, V24, P495, DOI 10.1002/da.20262; Karasu TB, 2000, AM PSYCHIAT ASS PRAC, P413; Kato M, 2010, MOL PSYCHIATR, V15, P473, DOI 10.1038/mp.2008.116; Keller MB, 2000, NEW ENGL J MED, V342, P1462, DOI 10.1056/NEJM200005183422001; Kim DK, 2000, NEUROREPORT, V11, P215, DOI 10.1097/00001756-200001170-00042; Kim H, 2006, JAMA-J AM MED ASSOC, V296, P1609, DOI 10.1001/jama.296.13.1609; Kraemer HC, 2009, AM J PSYCHIAT, V166, P1222, DOI 10.1176/appi.ajp.2009.08121809; Kraft JB, 2007, BIOL PSYCHIAT, V61, P734, DOI 10.1016/j.biopsych.2006.07.017; Laje G, 2009, PSYCHIAT SERV, V60, P1446, DOI 10.1176/appi.ps.60.11.1446; Lawrenson RA, 2000, J AFFECT DISORDERS, V59, P149, DOI 10.1016/S0165-0327(99)00147-0; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Licinio J, 2010, MOL PSYCHIATR, V15, P445, DOI 10.1038/mp.2010.58; Lim JE, 2007, MOL PSYCHIATR, V12, P491, DOI 10.1038/sj.mp.4001923; Lingjaerde O, 1987, Acta Psychiatr Scand Suppl, V334, P1; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Martinez-Turrillas R, 2002, NEUROPHARMACOLOGY, V43, P1230, DOI 10.1016/S0028-3908(02)00299-X; McMahon FJ, 2006, AM J HUM GENET, V78, P804, DOI 10.1086/503820; McMahon FJ, 2010, BIOL PSYCHIAT, V67, P99, DOI 10.1016/j.biopsych.2009.11.010; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Myung W, 2013, PSYCHOPHARMACOLOGY, V225, P283, DOI 10.1007/s00213-012-2813-y; Paddock S, 2007, AM J PSYCHIAT, V164, P1181, DOI 10.1176/appi.ajp.2007.06111790; Perlis RH, 2010, BIOL PSYCHIAT, V67, P1110, DOI 10.1016/j.biopsych.2009.12.010; Peters EJ, 2004, MOL PSYCHIATR, V9, P879, DOI 10.1038/sj.mp.4001502; Peters EJ, 2009, PHARMACOGENET GENOM, V19, P1, DOI 10.1097/FPC.0b013e3283163ecd; Pollock BG, 2000, NEUROPSYCHOPHARMACOL, V23, P587, DOI 10.1016/S0893-133X(00)00132-9; Porcelli S, 2012, EUR NEUROPSYCHOPHARM, V22, P239, DOI 10.1016/j.euroneuro.2011.10.003; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg DR, 2004, J AM ACAD CHILD PSY, V43, P1146, DOI 10.1097/01.chi.0000132812.44664.2d; Serretti A, 2007, MOL PSYCHIATR, V12, P247, DOI 10.1038/sj.mp.4001926; Shishkina GT, 2007, NEUROSCIENCE, V150, P404, DOI 10.1016/j.neuroscience.2007.09.017; Smeraldi E, 1998, MOL PSYCHIATR, V3, P508, DOI 10.1038/sj.mp.4000425; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Katherine E, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001326; Taylor MJ, 2010, BIOL PSYCHIAT, V68, P536, DOI 10.1016/j.biopsych.2010.04.034; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Tsai SJ, 2009, PROG NEURO-PSYCHOPH, V33, P637, DOI 10.1016/j.pnpbp.2009.02.020; Tzvetkov MV, 2008, PHARMACOGENET GENOM, V18, P495, DOI 10.1097/FPC.0b013e3282fb02cb; Uher R, 2013, AM J PSYCHIAT, V170, P207, DOI 10.1176/appi.ajp.2012.12020237; Walkup JT, 2008, NEW ENGL J MED, V359, P2753, DOI 10.1056/NEJMoa0804633; Walsh BT, 2002, JAMA-J AM MED ASSOC, V287, P1840, DOI 10.1001/jama.287.14.1840; WIGTON RS, 1986, ARCH INTERN MED, V146, P81, DOI 10.1001/archinte.146.1.81; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540	54	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107098	10.1371/journal.pone.0107098	http://dx.doi.org/10.1371/journal.pone.0107098			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226239	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700028
J	Guan, XY; Lin, P; Knoll, E; Chakrabarti, R				Guan, Xiangying; Lin, Ping; Knoll, Eric; Chakrabarti, Raj			Mechanism of Inhibition of the Human Sirtuin Enzyme SIRT3 by Nicotinamide: Computational and Experimental Studies	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; FATTY-ACID OXIDATION; LIFE-SPAN EXTENSION; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; PROTEIN DEACETYLASES; LIGAND-BINDING; CONFORMATIONAL-CHANGES; LYSINE ACETYLATION; SIR2-LIKE PROTEINS	Sirtuins are key regulators of many cellular functions including cell growth, apoptosis, metabolism, and genetic control of age-related diseases. Sirtuins are themselves regulated by their cofactor nicotinamide adenine dinucleotide (NAD(+)) as well as their reaction product nicotinamide (NAM), the physiological concentrations of which vary during the process of aging. Nicotinamide inhibits sirtuins through the so-called base exchange pathway, wherein rebinding of the reaction product to the enzyme accelerates the reverse reaction. We investigated the mechanism of nicotinamide inhibition of human SIRT3, the major mitochondrial sirtuin deacetylase, in vitro and in silico using experimental kinetic analysis and Molecular Mechanics-Poisson Boltzmann/Generalized Born Surface Area (MM-PB(GB) SA) binding affinity calculations with molecular dynamics sampling. Through experimental kinetic studies, we demonstrate that NAM inhibition of SIRT3 involves apparent competition between the inhibitor and the enzyme cofactor NAD(+), contrary to the traditional characterization of base exchange as noncompetitive inhibition. We report a model for base exchange inhibition that relates such kinetic properties to physicochemical properties, including the free energies of enzyme-ligand binding, and estimate the latter through the first reported computational binding affinity calculations for SIRT3:NAD(+), SIRT3:NAM, and analogous complexes for Sir2. The computational results support our kinetic model, establishing foundations for quantitative modeling of NAD(+)/NAM regulation of mammalian sirtuins during aging and the computational design of sirtuin activators that operate through alleviation of base exchange inhibition.	[Guan, Xiangying; Lin, Ping; Knoll, Eric; Chakrabarti, Raj] PMC Adv Technol LLC, Div Fundamental Res, Mt Laurel, NJ 08054 USA; [Chakrabarti, Raj] Carnegie Mellon Univ, Dept Chem Engn, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Chakrabarti, R (corresponding author), PMC Adv Technol LLC, Div Fundamental Res, Mt Laurel, NJ 08054 USA.	raj@pmc-group.com		Lin, Ping/0000-0002-6141-5424				Adams JD, 2007, LETT DRUG DES DISCOV, V4, P44; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Aqvist J, 2002, ACCOUNTS CHEM RES, V35, P358, DOI 10.1021/ar010014p; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Avalos JL, 2004, MOL CELL, V13, P639, DOI 10.1016/S1097-2765(04)00082-6; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Cen Y, 2011, CURR MED CHEM, V18, P1919, DOI 10.2174/092986711795590084; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Chakrabarti R, 2005, P NATL ACAD SCI USA, V102, P12035, DOI 10.1073/pnas.0505397102; Chakrabarti R, 2005, P NATL ACAD SCI USA, V102, P10153, DOI 10.1073/pnas.0504023102; Copeland R. A., 2005, EVALUATION ENZYME IN; Cosgrove MS, 2006, BIOCHEMISTRY-US, V45, P7511, DOI 10.1021/bi0526332; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davenport AM, 2014, J MOL BIOL, V426, P526, DOI 10.1016/j.jmb.2013.10.009; DIETRICH LS, 1971, AM J CLIN NUTR, V24, P800; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Fischer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045098; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gertz M, 2013, P NATL ACAD SCI USA, V110, pE2772, DOI 10.1073/pnas.1303628110; Giralt A, 2012, BIOCHEM J, V444, P1, DOI 10.1042/BJ20120030; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Grubisha O, 2005, FEBS J, V272, P4607, DOI 10.1111/j.1742-4658.2005.04862.x; Guarente L, 2014, NAT MED, V20, P24, DOI 10.1038/nm.3438; Guimaraes CRW, 2008, J CHEM INF MODEL, V48, P958, DOI 10.1021/ci800004w; HAGINO Y, 1968, J BIOL CHEM, V243, P4980; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hou TJ, 2011, J COMPUT CHEM, V32, P866, DOI 10.1002/jcc.21666; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hu P, 2008, J AM CHEM SOC, V130, P16721, DOI 10.1021/ja807269j; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Imai S, 2013, DIABETES OBES METAB, V15, P26, DOI 10.1111/dom.12171; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Jin L, 2009, J BIOL CHEM, V284, P24394, DOI 10.1074/jbc.M109.014928; Jin L, 2009, PROTEIN SCI, V18, P514, DOI 10.1002/pro.50; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Liang ZJ, 2010, J PHYS CHEM B, V114, P11927, DOI 10.1021/jp1054183; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Lu Q, 2007, J PHYS CHEM B, V111, P11538, DOI 10.1021/jp0742261; Lu ZP, 2011, EMBO REP, V12, P840, DOI 10.1038/embor.2011.121; Lyne PD, 2006, J MED CHEM, V49, P4805, DOI 10.1021/jm060522a; Massudi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042357; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Minino Arialdi M, 2011, Natl Vital Stat Rep, V59, P1; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Papamokos GV, 2012, BIOPHYS J, V102, P1926, DOI 10.1016/j.bpj.2012.03.030; Pavelites JJ, 1997, J COMPUT CHEM, V18, P221, DOI 10.1002/(SICI)1096-987X(19970130)18:2<221::AID-JCC7>3.0.CO;2-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Rastelli G, 2010, J COMPUT CHEM, V31, P797, DOI 10.1002/jcc.21372; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Rye PT, 2011, J BIOMOL SCREEN, V16, P1217, DOI 10.1177/1087057111420291; Sauve AA, 2005, MOL CELL, V17, P595, DOI 10.1016/j.molcel.2004.12.032; Sauve AA, 2003, BIOCHEMISTRY-US, V42, P9249, DOI 10.1021/bi034959l; Sauve AA, 2010, BBA-PROTEINS PROTEOM, V1804, P1591, DOI 10.1016/j.bbapap.2010.01.021; Schmidt MT, 2004, J BIOL CHEM, V279, P40122, DOI 10.1074/jbc.M407484200; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Segel IH., 1993, ENZYME KINETICS BEHA; Shi YW, 2013, J PHYS CHEM LETT, V4, P491, DOI 10.1021/jz302015s; Smith DL, 2009, AGING CELL, V8, P633, DOI 10.1111/j.1474-9726.2009.00516.x; Smythe GA, 2002, ANAL BIOCHEM, V301, P21, DOI 10.1006/abio.2001.5490; Tervo AJ, 2004, J MED CHEM, V47, P6292, DOI 10.1021/jm049933m; Walker RC, 2002, J PHYS CHEM B, V106, P11658, DOI 10.1021/jp0261814; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Zhao X, 2013, J MED CHEM, V56, P963, DOI 10.1021/jm301431y	82	40	43	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107729	10.1371/journal.pone.0107729	http://dx.doi.org/10.1371/journal.pone.0107729			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25221980	gold, Green Published, Green Submitted			2022-12-25	WOS:000341774800096
J	Jabaji, Z; Brinkley, GJ; Khalil, HA; Sears, CM; Lei, NY; Lewis, M; Stelzner, M; Martin, MG; Dunn, JCY				Jabaji, Ziyad; Brinkley, Garrett J.; Khalil, Hassan A.; Sears, Connie M.; Lei, Nan Ye; Lewis, Michael; Stelzner, Matthias; Martin, Martin G.; Dunn, James C. Y.			Type I Collagen as an Extracellular Matrix for the In Vitro Growth of Human Small Intestinal Epithelium	PLOS ONE			English	Article							BASEMENT-MEMBRANE MATRIX; ALKALINE-PHOSPHATASE; CELLS; EXPANSION; CULTURE; MODEL	Background: We previously reported in vitro maintenance and proliferation of human small intestinal epithelium using Matrigel, a proprietary basement membrane product. There are concerns over the applicability of Matrigel-based methods for future human therapies. We investigated type I collagen as an alternative for the culture of human intestinal epithelial cells. Methods: Human small intestine was procured from fresh surgical pathology specimens. Small intestinal crypts were isolated using EDTA chelation. Intestinal subepithelial myofibroblasts were isolated from a pediatric sample and expanded in vitro. After suspension in Matrigel or type I collagen gel, crypts were co-cultured above a confluent layer of myofibroblasts. Crypts were also grown in monoculture with exposure to myofibroblast conditioned media; these were subsequently sub-cultured in vitro and expanded with a 1:2 split ratio. Cultures were assessed with light microscopy, RTPCR, histology, and immunohistochemistry. Results: Collagen supported viable human epithelium in vitro for at least one month in primary culture. Sub-cultured epithelium expanded through 12 passages over 60 days. Histologic sections revealed polarized columnar cells, with apical brush borders and basolaterally located nuclei. Collagen-based cultures gave rise to monolayer epithelial sheets at the gel-liquid interface, which were not observed with Matrigel. Immunohistochemical staining identified markers of differentiated intestinal epithelium and myofibroblasts. RT-PCR demonstrated expression of alpha-smooth muscle actin and vimentin in myofibroblasts and E-Cadherin, CDX2, villin 1, intestinal alkaline phosphatase, chromogranin A, lysozyme, and Lgr5 in epithelial cells. These markers were maintained through several passages. Conclusion: Type I collagen gel supports long-term in vitro maintenance and expansion of fully elaborated human intestinal epithelium. Collagen-based methods yield familiar enteroid structures as well as a new pattern of sheet-like growth, and they eliminate the need for Matrigel for in vitro human intestinal epithelial growth. Future research is required to further develop this cell culture system for tissue engineering applications.	[Jabaji, Ziyad; Brinkley, Garrett J.; Khalil, Hassan A.; Sears, Connie M.; Lei, Nan Ye; Stelzner, Matthias; Dunn, James C. Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Div Pediat Surg, Los Angeles, CA 90095 USA; [Lei, Nan Ye; Dunn, James C. Y.] Univ Calif Los Angeles, Henry Samueli Sch Engn, Dept Bioengn, Los Angeles, CA USA; [Lewis, Michael] Vet Affairs Greater Los Angeles Healthcare Syst, Dept Pathol, Los Angeles, CA USA; [Martin, Martin G.] Univ Calif Los Angeles, Dept Pediat, Div Gastroenterol & Nutr, Mattel Childrens Hosp, Los Angeles, CA 90024 USA; [Martin, Martin G.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Stelzner, Matthias] Vet Affairs Greater Los Angeles Healthcare Syst, Dept Surg, Los Angeles, CA USA; [Martin, Martin G.] Univ Calif Los Angeles, Eli & Edythe Broad, Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles	Dunn, JCY (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Div Pediat Surg, Los Angeles, CA 90095 USA.	JDunn@mednet.ucla.edu	Khalil, Hassan A/AAM-7914-2021; Martín, María/HDL-9512-2022	Khalil, Hassan A/0000-0002-3835-1290; Sears, Connie/0000-0003-0727-8198; Brinkley, Garrett/0000-0003-2622-3416	National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases [DK085535-01, DK085535-02S2, DK083762, DK083319]; California Institute for Regenerative Medicine [RT2-01985]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083319, R01DK083762, U01DK085535, P30DK041301] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was performed as a project of the Intestinal Stem Cell Consortium (https://iscc.coh.org), a collaborative research project funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institute of Allergy and Infectious Diseases (DK085535-01 and DK085535-02S2, DK083762, and DK083319), and the California Institute for Regenerative Medicine (RT2-01985). The funding agencies have an internet presence at http://www.niddk.nih.gov, http://www.niaid.nih.gov, http://www.nih.gov, and http://www.cirm.ca.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen KT, 2011, DIGEST DIS SCI, V56, P1020, DOI 10.1007/s10620-010-1396-x; Dienstknecht T, 2013, J HAND SURG-AM, V38A, P1119, DOI 10.1016/j.jhsa.2013.03.028; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; HILBERT SL, 1992, J LONG-TERM EFF MED, V2, P99; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Jabaji Z, 2013, TISSUE ENG PART C-ME, V19, P961, DOI [10.1089/ten.tec.2012.0710, 10.1089/ten.TEC.2012.0710]; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kissane NA, 2012, PLAST RECONSTR SURG, V130, p194S, DOI 10.1097/PRS.0b013e318265a5ec; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; Lahar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026898; Lei NY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084651; Levin DE, 2013, J PEDIATR SURG, V48, P129, DOI 10.1016/j.jpedsurg.2012.10.029; Mahida YR, 1997, AM J PHYSIOL-GASTR L, V273, pG1341, DOI 10.1152/ajpgi.1997.273.6.G1341; Mifflin RC, 2011, AM J PHYSIOL-GASTR L, V300, pG684, DOI 10.1152/ajpgi.00474.2010; Nagaoka M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-60; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N; Powell DW, 2011, ANNU REV PHYSIOL, V73, P213, DOI 10.1146/annurev.physiol.70.113006.100646; Ramshaw JAM, 2009, J MATER SCI-MATER M, V20, P3, DOI 10.1007/s10856-008-3415-4; Salerno-Goncalves R, 2011, GASTROENTEROLOGY, V141, pE18, DOI 10.1053/j.gastro.2011.04.062; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scholz JAC, 2011, COMPARATIVE MED, V61, P404; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Stelzner M, 2012, AM J PHYSIOL-GASTR L, V302, pG1359, DOI 10.1152/ajpgi.00493.2011; Sung JH, 2011, LAB CHIP, V11, P389, DOI [10.1039/c0lc00273a, 10.1039/c01c00273a]; Takezawa T, 2004, CELL TRANSPLANT, V13, P463, DOI 10.3727/000000004783983882; Titushkin Igor A., 2010, Critical Reviews in Biomedical Engineering, V38, P393, DOI 10.1615/CritRevBiomedEng.v38.i5.10; Yu JJ, 2012, BIOTECHNOL BIOENG, V109, P2173, DOI 10.1002/bit.24518	34	69	72	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107814	10.1371/journal.pone.0107814	http://dx.doi.org/10.1371/journal.pone.0107814			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222024	gold, Green Submitted, Green Published			2022-12-25	WOS:000341774800097
J	Lu, Y; Ran, JH; Guo, DM; Yang, ZY; Wang, XQ				Lu, Ying; Ran, Jin-Hua; Guo, Dong-Mei; Yang, Zu-Yu; Wang, Xiao-Quan			Phylogeny and Divergence Times of Gymnosperms Inferred from Single-Copy Nuclear Genes	PLOS ONE			English	Article							SEED PLANT PHYLOGENY; CHLOROPLAST MATK GENE; EXTANT GYMNOSPERMS; MAXIMUM-LIKELIHOOD; DNA-SEQUENCE; EVOLUTION; GNETALES; CUPRESSACEAE; INFERENCE; CYCADS	Phylogenetic reconstruction is fundamental to study evolutionary biology and historical biogeography. However, there was not a molecular phylogeny of gymnosperms represented by extensive sampling at the genus level, and most published phylogenies of this group were constructed based on cytoplasmic DNA markers and/or the multi-copy nuclear ribosomal DNA. In this study, we use LFY and NLY, two single-copy nuclear genes that originated from an ancient gene duplication in the ancestor of seed plants, to reconstruct the phylogeny and estimate divergence times of gymnosperms based on a complete sampling of extant genera. The results indicate that the combined LFY and NLY coding sequences can resolve interfamilial relationships of gymnosperms and intergeneric relationships of most families. Moreover, the addition of intron sequences can improve the resolution in Podocarpaceae but not in cycads, although divergence times of the cycad genera are similar to or longer than those of the Podocarpaceae genera. Our study strongly supports cycads as the basal-most lineage of gymnosperms rather than sister to Ginkgoaceae, and a sister relationship between Podocarpaceae and Araucariaceae and between Cephalotaxaceae-Taxaceae and Cupressaceae. In addition, intergeneric relationships of some families that were controversial, and the relationships between Taxaceae and Cephalotaxaceae and between conifers and Gnetales are discussed based on the nuclear gene evidence. The molecular dating analysis suggests that drastic extinctions occurred in the early evolution of gymnosperms, and extant coniferous genera in the Northern Hemisphere are older than those in the Southern Hemisphere on average. This study provides an evolutionary framework for future studies on gymnosperms.	[Lu, Ying; Ran, Jin-Hua; Guo, Dong-Mei; Yang, Zu-Yu; Wang, Xiao-Quan] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS	Wang, XQ (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	xiaoq_wang@ibcas.ac.cn		yang, zuyu/0000-0002-0651-848X; Wang, Xiao-Quan/0000-0003-3978-0828	National Natural Science Foundation of China [31170197, 31330008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant Nos. 31170197, 31330008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulenback KR, 1998, INT J PLANT SCI, V159, P367, DOI 10.1086/297558; Biffin E, 2012, P ROY SOC B-BIOL SCI, V279, P341, DOI 10.1098/rspb.2011.0559; Bowe LM, 2000, P NATL ACAD SCI USA, V97, P4092, DOI 10.1073/pnas.97.8.4092; Braukmann TWA, 2009, CURR GENET, V55, P323, DOI 10.1007/s00294-009-0249-7; Burleigh JG, 2007, INT J PLANT SCI, V168, P111, DOI 10.1086/509586; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Cambell V, 2009, J CLASSIF, V26, P103, DOI 10.1007/s00357-009-9028-x; Carlsbecker A, 2004, PLANT J, V40, P546, DOI 10.1111/j.1365-313X.2004.02226.x; Chaw SM, 2000, P NATL ACAD SCI USA, V97, P4086, DOI 10.1073/pnas.97.8.4086; Chaw SM, 1997, MOL BIOL EVOL, V14, P56, DOI 10.1093/oxfordjournals.molbev.a025702; Chaw SM, 2005, MOL PHYLOGENET EVOL, V37, P214, DOI 10.1016/j.ympev.2005.01.006; Cheng YC, 2000, MOL PHYLOGENET EVOL, V14, P353, DOI 10.1006/mpev.1999.0710; Christenhusz MJM, 2011, PHYTOTAXA, V19, P55, DOI 10.11646/phytotaxa.19.1.3; Conran JG, 2000, AUST J BOT, V48, P715, DOI 10.1071/BT99062; Crisp MD, 2011, NEW PHYTOL, V192, P997, DOI 10.1111/j.1469-8137.2011.03862.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Donoghue MJ, 2000, CURR BIOL, V10, pR106, DOI 10.1016/S0960-9822(00)00304-3; Dornelas MC, 2005, GENET MOL BIOL, V28, P299, DOI 10.1590/S1415-47572005000200021; DOYLE JA, 1986, BOT REV, V52, P321, DOI 10.1007/BF02861082; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Eckenwalder JE, 2009, CONIFERS WORLD COMPL; Escapa IH, 2013, INT J PLANT SCI, V174, P1153, DOI 10.1086/672369; Farjon A, 2010, HDB WORLD CONIFERS, V2.; Farjon A, 1990, PINACEAE DRAWINGS DE; Farjon A, 2010, HDB WORLD CONIFERS, V1; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Florin R., 1958, ACTA HORI BERGIANI, V17, P257; Frohlich MW, 2000, SYST BOT, V25, P155, DOI 10.2307/2666635; Frohlich MW, 2003, NAT REV GENET, V4, P559, DOI 10.1038/nrg1114; Gadek PA, 2000, AM J BOT, V87, P1044, DOI 10.2307/2657004; Ghimire B, 2014, PLANT SYST EVOL, V300, P217, DOI 10.1007/s00606-013-0874-y; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hajibabaei M, 2006, MOL PHYLOGENET EVOL, V40, P208, DOI 10.1016/j.ympev.2006.03.006; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hao DC, 2008, PLANT SYST EVOL, V276, P89, DOI 10.1007/s00606-008-0069-0; Harris T.M., 1979, YORKSHIRE JURASSIC F; HENDY MD, 1989, SYST ZOOL, V38, P297, DOI 10.2307/2992396; Hill KD, 2003, INT J PLANT SCI, V164, P933, DOI 10.1086/378538; HILL RS, 1993, ALCHERINGA, V17, P285, DOI 10.1080/03115519308619596; HILL RS, 1980, AUST J BOT, V28, P105, DOI 10.1071/BT9800105; HUELSENBECK JP, 1995, SYST BIOL, V44, P17, DOI 10.2307/2413481; Kelch DG, 1998, AM J BOT, V85, P986, DOI 10.2307/2446365; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Klymiuk AA, 2012, AM J BOT, V99, P1069, DOI 10.3732/ajb.1100568; Knopf P, 2012, CLADISTICS, V28, P271, DOI 10.1111/j.1096-0031.2011.00381.x; KRASSILOV V, 1982, Palaeontographica Abteilung B Palaeophytologie, V181, P1; KRASSILOV VA, 1986, REV PALAEOBOT PALYNO, V47, P9, DOI 10.1016/0034-6667(86)90003-5; Kusumi J, 2000, AM J BOT, V87, P1480, DOI 10.2307/2656874; Kvacek Z., 2002, Feddes Repertorium, V113, P492, DOI 10.1002/fedr.200290001; Lang XD, 2013, PHYTOTAXA, V84, P1, DOI 10.11646/phytotaxa.84.1.1; Lee EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002411; Leigh JW, 2008, SYST BIOL, V57, P104, DOI 10.1080/10635150801910436; Leslie AB, 2012, P NATL ACAD SCI USA, V109, P16217, DOI 10.1073/pnas.1213621109; Lin CP, 2010, GENOME BIOL EVOL, V2, P504, DOI 10.1093/gbe/evq036; Liu N, 2009, CHINESE SCI BULL, V54, P2648, DOI 10.1007/s11434-009-0373-2; Ma QW, 2005, REV PALAEOBOT PALYNO, V135, P117, DOI 10.1016/j.revpalbo.2005.03.002; Magallon S, 2013, AM J BOT, V100, P556, DOI 10.3732/ajb.1200416; Mao KS, 2012, P NATL ACAD SCI USA, V109, P7793, DOI 10.1073/pnas.1114319109; Mciver EE, 2001, INT J PLANT SCI, V162, P937, DOI 10.1086/320776; Mellerowicz EJ, 1998, PLANTA, V206, P619, DOI 10.1007/s004250050440; MILLER CN, 1977, BOT REV, V43, P217, DOI 10.1007/BF02860718; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; Mouradov A, 1998, P NATL ACAD SCI USA, V95, P6537, DOI 10.1073/pnas.95.11.6537; Moyroud E, 2010, TRENDS PLANT SCI, V15, P346, DOI 10.1016/j.tplants.2010.03.007; Mundry M, 2004, ORG DIVERS EVOL, V4, P91, DOI 10.1016/j.ode.2004.01.002; Nagalingum NS, 2011, SCIENCE, V334, P796, DOI 10.1126/science.1209926; Nylander J. A. A., 2004, MRMODELTEST V2; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Peng D, 2008, MOL PHYLOGENET EVOL, V47, P1190, DOI 10.1016/j.ympev.2008.02.001; PENNY JS, 1947, AM J BOT, V34, P281, DOI 10.2307/2437708; Peppers RA, 1996, GEOLOGICAL SOC AM ME, V188, P1, DOI DOI 10.1130/0-8137-1188-6.1; Quinn C. J., 2002, Kew Bulletin, V57, P513, DOI 10.2307/4110984; Rai HS, 2008, BOTANY, V86, P658, DOI 10.1139/B08-062; Rai HS, 2003, MOL PHYLOGENET EVOL, V29, P350, DOI 10.1016/S1055-7903(03)00131-3; Ran JH, 2010, MOL PHYLOGENET EVOL, V54, P136, DOI 10.1016/j.ympev.2009.09.011; Ravn RL, 1984, IOWA GEOLOGICAL SURV; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROTHWELL GW, 1989, BOT GAZ, V150, P170, DOI 10.1086/337763; Royer D.L., 2004, GSA TODAY, V14, P4, DOI DOI 10.1130/1052-5173(2004)014; Ruhfel BR, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-23; Salas-Leiva DE, 2013, ANN BOT-LONDON, V112, P1263, DOI 10.1093/aob/mct192; Sauquet H, 2012, SYST BIOL, V61, P289, DOI 10.1093/sysbio/syr116; Schmidt M, 2002, J MOL EVOL, V54, P715, DOI 10.1007/s00239-001-0042-9; Setoguchi H, 1998, AM J BOT, V85, P1507, DOI 10.2307/2446478; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shindo S, 2001, INT J PLANT SCI, V162, P1199, DOI 10.1086/323417; Shiokawa T, 2008, TREE PHYSIOL, V28, P21, DOI 10.1093/treephys/28.1.21; Shu Y, 2000, ACTA PHYTOTAX SINICA, V38, P201; STEVENSON DW, 1992, BRITTONIA, V44, P220, DOI 10.2307/2806837; STEVENSON DW, 1990, MEMOIRS NEW YORK BOT, V57, P8, DOI DOI 10.21135/893273507.003; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Syring J, 2007, SYST BIOL, V56, P163, DOI 10.1080/10635150701258787; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vazquez-Lobo A, 2007, EVOL DEV, V9, P446, DOI 10.1111/j.1525-142X.2007.00182.x; Wang XQ, 2014, MOL PHYLOGENET EVOL, V75, P24, DOI 10.1016/j.ympev.2014.02.005; Wang XQ, 2000, MOL BIOL EVOL, V17, P773, DOI 10.1093/oxfordjournals.molbev.a026356; Wei XX, 2010, MOL PHYLOGENET EVOL, V55, P776, DOI 10.1016/j.ympev.2010.03.007; Winter KU, 1999, P NATL ACAD SCI USA, V96, P7342, DOI 10.1073/pnas.96.13.7342; Won H, 2006, SYST BIOL, V55, P610, DOI 10.1080/10635150600812619; Wu CS, 2013, GENOME BIOL EVOL, V5, P243, DOI 10.1093/gbe/evt001; Wu CS, 2011, GENOME BIOL EVOL, V3, P309, DOI 10.1093/gbe/evr026; Xi ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080870; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yang ZY, 2012, MOL PHYLOGENET EVOL, V64, P452, DOI 10.1016/j.ympev.2012.05.004; Zgurski JM, 2008, MOL PHYLOGENET EVOL, V47, P1232, DOI 10.1016/j.ympev.2008.03.002; Zhang N, 2012, NEW PHYTOL, V195, P923, DOI 10.1111/j.1469-8137.2012.04212.x; Zhong BJ, 2011, GENOME BIOL EVOL, V3, P1340, DOI 10.1093/gbe/evr105; Zhong BJ, 2010, MOL BIOL EVOL, V27, P2855, DOI 10.1093/molbev/msq170	112	114	123	3	159	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107679	10.1371/journal.pone.0107679	http://dx.doi.org/10.1371/journal.pone.0107679			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222863	gold, Green Submitted, Green Published			2022-12-25	WOS:000341774800094
J	Teoh, NC; Ajamieh, H; Wong, HJ; Croft, K; Mori, T; Allison, AC; Farrell, GC				Teoh, Narci C.; Ajamieh, Hussam; Wong, Heng Jian; Croft, Kevin; Mori, Trevor; Allison, Anthony C.; Farrell, Geoffrey C.			Microparticles Mediate Hepatic Ischemia-Reperfusion Injury and Are the Targets of Diannexin (ASP8597)	PLOS ONE			English	Article							CIRCULATING MICROPARTICLES; ENDOTHELIAL-CELLS; ACTIVATION; PLATELETS; MEMBRANE; HEPATOCYTES; BLOOD; MICE	Background & Aims: Ischemia-reperfusion injury (IRI) can cause hepatic failure after liver surgery or transplantation. IRI causes oxidative stress, which injures sinusoidal endothelial cells (SECs), leading to recruitment and activation of Kupffer cells, platelets and microcirculatory impairment. We investigated whether injured SECs and other cell types release microparticles during post-ischemic reperfusion, and whether such microparticles have pro-inflammatory, platelet-activating and pro-injurious effects that could contribute to IRI pathogenesis. Methods: C57BL6 mice underwent 60 min of partial hepatic ischemia followed by 15 min-24 hrs of reperfusion. We collected blood and liver samples, isolated circulating microparticles, and determined protein and lipid content. To establish mechanism for microparticle production, we subjected murine primary hepatocytes to hypoxia-reoxygenation. Because microparticles express everted phosphatidylserine residues that are the target of annexin V, we analyzed the effects of an annexin V-homodimer (Diannexin or ASP8597) on post-ischemia microparticle production and function. Results: Microparticles were detected in the circulation 15-30 min after post-ischemic reperfusion, and contained markers of SECs, platelets, natural killer T cells, and CD8(+) cells; 4 hrs later, they contained markers of macrophages. Microparticles contained F2-isoprostanes, indicating oxidative damage to membrane lipids. Injection of mice with TNF-alpha increased microparticle formation, whereas Diannexin substantially reduced microparticle release and prevented IRI. Hypoxia-reoxygenation generated microparticles from primary hepatocytes by processes that involved oxidative stress. Exposing cultured hepatocytes to preparations of microparticles isolated from the circulation during IRI caused injury involving mitochondrial membrane permeability transition. Microparticles also activated platelets and induced neutrophil migration in vitro. The inflammatory properties of microparticles involved activation of NF-kappa B and JNK, increased expression of E-selectin, P-selectin, ICAM-1 and VCAM-1. All these processes were blocked by coating microparticles with Diannexin. Conclusions: Following hepatic IRI, microparticles circulate and can be taken up by hepatocytes, where they activate signaling pathways that mediate inflammation and hepatocyte injury. Diannexin prevents microparticle formation and subsequent inflammation.	[Teoh, Narci C.; Ajamieh, Hussam; Wong, Heng Jian; Farrell, Geoffrey C.] Australian Natl Univ, Canberra Hosp, Sch Med, Canberra, ACT, Australia; [Croft, Kevin; Mori, Trevor] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Allison, Anthony C.] Alavita Inc, Palo Alto, CA USA	Australian National University; Canberra Hospital; University of Western Australia	Farrell, GC (corresponding author), Australian Natl Univ, Canberra Hosp, Sch Med, Canberra, ACT, Australia.	geoff.farrell@anu.edu.au	Mori, Trevor/H-5485-2014	Mori, Trevor/0000-0002-5264-9229; Croft, Kevin/0000-0003-1596-4913	Australian National Health and Medical Research Council's (NHMRC) [1008958, 585414]; Australian Capital Territory's Health and Medical Research [2009-2010]	Australian National Health and Medical Research Council's (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Capital Territory's Health and Medical Research	This work was supported by the Australian National Health and Medical Research Council's (NHMRC) project grants #1008958, #585414 and the Australian Capital Territory's Health and Medical Research seed grant 2009-2010. Emeritus Professor Allison's most recent affiliation was with Alavita Inc, years before the time of the study. Alavita Inc. gifted the Diannexin for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albano E, 2007, GASTROENTEROLOGY, V133, P713, DOI 10.1053/j.gastro.2007.06.030; Barry OP, 1997, J CLIN INVEST, V99, P2118, DOI 10.1172/JCI119385; Boulanger CM, 2001, CIRCULATION, V104, P2649, DOI 10.1161/hc4701.100516; Combes V, 2006, INT J PARASITOL, V36, P541, DOI 10.1016/j.ijpara.2006.02.005; Dillon SR, 2000, J IMMUNOL, V164, P1322, DOI 10.4049/jimmunol.164.3.1322; Esch JSA, 2010, PLATELETS, V21, P348, DOI 10.3109/09537101003739897; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; Han MS, 2008, J LIPID RES, V49, P84, DOI 10.1194/jlr.M700184-JLR200; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Jaeschke H, 2002, FREE RADICAL BIO MED, V33, P210, DOI 10.1016/S0891-5849(02)00867-5; Jaeschke H, 2012, TRANSPLANT REV-ORLAN, V26, P103, DOI 10.1016/j.trre.2011.10.006; Jy W, 2004, J THROMB HAEMOST, V2, P1842, DOI 10.1111/j.1538-7836.2004.00936.x; Kornek M, 2011, HEPATOLOGY, V53, P230, DOI 10.1002/hep.23999; Mallat Z, 1999, CIRCULATION, V99, P348, DOI 10.1161/01.CIR.99.3.348; Morel O, 2004, CURR OPIN HEMATOL, V11, P156, DOI 10.1097/01.moh.0000131441.10020.87; Pasquet JM, 1996, EUR J BIOCHEM, V239, P647, DOI 10.1111/j.1432-1033.1996.0647u.x; Piccin A, 2007, BLOOD REV, V21, P157, DOI 10.1016/j.blre.2006.09.001; Proudfoot JM, 2009, J LIPID RES, V50, P716, DOI 10.1194/jlr.M800607-JLR200; Qian T, 1997, AM J PHYSIOL-CELL PH, V273, pC1783, DOI 10.1152/ajpcell.1997.273.6.C1783; Rand ML, 2012, J THROMB HAEMOST, V10, P1109, DOI 10.1111/j.1538-7836.2012.04716.x; Rautou PE, 2012, GASTROENTEROLOGY, V143, P166, DOI 10.1053/j.gastro.2012.03.040; Sabatier F, 2002, BLOOD, V99, P3962, DOI 10.1182/blood.V99.11.3962; Samarasinghe DA, 2000, HEPATOLOGY, V31, P160, DOI 10.1002/hep.510310124; Teoh N, 2004, HEPATOLOGY, V39, P412, DOI 10.1002/hep.20035; Teoh NC, 2007, GASTROENTEROLOGY, V133, P632, DOI 10.1053/j.gastro.2007.05.027; Teoh NC, 2003, J GASTROEN HEPATOL, V18, P891, DOI 10.1046/j.1440-1746.2003.03056.x; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tsai IJ, 2009, FREE RADICAL BIO MED, V46, P263, DOI 10.1016/j.freeradbiomed.2008.10.028; Uehara T, 2005, J HEPATOL, V42, P850, DOI 10.1016/j.jhep.2005.01.030; van Velzen JF, 2012, THROMB RES, V130, P92, DOI 10.1016/j.thromres.2012.02.041; VOLLMAR B, 1995, SURGERY, V117, P195, DOI 10.1016/S0039-6060(05)80085-6; Vollmar B, 2009, PHYSIOL REV, V89, P1269, DOI 10.1152/physrev.00027.2008; YANO Y, 1993, THROMB RES, V71, P385, DOI 10.1016/0049-3848(93)90163-I	33	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e104376	10.1371/journal.pone.0104376	http://dx.doi.org/10.1371/journal.pone.0104376			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222287	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774800003
J	Jolivet, G; Braud, S; DaSilva, B; Passet, B; Harscoet, E; Viglietta, C; Gautier, T; Lagrost, L; Daniel-Carlier, N; Houdebine, LM; Harosh, I				Jolivet, Genevieve; Braud, Sandrine; DaSilva, Bruno; Passet, Bruno; Harscoet, Erwana; Viglietta, Celine; Gautier, Thomas; Lagrost, Laurent; Daniel-Carlier, Nathalie; Houdebine, Louis-Marie; Harosh, Itzik			Induction of Body Weight Loss through RNAi-Knockdown of APOBEC1 Gene Expression in Transgenic Rabbits	PLOS ONE			English	Article							APOLIPOPROTEIN-B; EDITING ENZYME; ANDERSONS-DISEASE; MICE; B100; DIET; B48	In the search of new strategies to fight against obesity, we targeted a gene pathway involved in energy uptake. We have thus investigated the APOB mRNA editing protein (APOBEC1) gene pathway that is involved in fat absorption in the intestine. The APOB gene encodes two proteins, APOB100 and APOB48, via the editing of a single nucleotide in the APOB mRNA by the APOBEC1 enzyme. The APOB48 protein is mandatory for the synthesis of chylomicrons by intestinal cells to transport dietary lipids and cholesterol. We produced transgenic rabbits expressing permanently and ubiquitously a small hairpin RNA targeting the rabbit APOBEC1 mRNA. These rabbits exhibited a moderately but significantly reduced level of APOBEC1 gene expression in the intestine, a reduced level of editing of the APOB mRNA, a reduced level of synthesis of chylomicrons after a food challenge, a reduced total mass of body lipids and finally presented a sustained lean phenotype without any obvious physiological disorder. Interestingly, no compensatory mechanism opposed to the phenotype. These lean transgenic rabbits were crossed with transgenic rabbits expressing in the intestine the human APOBEC1 gene. Double transgenic animals did not present any lean phenotype, thus proving that the intestinal expression of the human APOBEC1 transgene was able to counterbalance the reduction of the rabbit APOBEC1 gene expression. Thus, a moderate reduction of the APOBEC1 dependent editing induces a lean phenotype at least in the rabbit species. This suggests that the APOBEC1 gene might be a novel target for obesity treatment.	[Jolivet, Genevieve; DaSilva, Bruno; Harscoet, Erwana; Viglietta, Celine; Daniel-Carlier, Nathalie; Houdebine, Louis-Marie] INRA, UMR1198, Jouy En Josas, France; [Braud, Sandrine; Harosh, Itzik] ObeTherapy Biotechnol, Evry, France; [Gautier, Thomas; Lagrost, Laurent] Univ Bourgogne, INSERM, UMR866, Dijon, France; [Passet, Bruno] INRA, UMR1313, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Jolivet, G (corresponding author), INRA, UMR1198, Jouy En Josas, France.	genevieve.jolivet@jouy.inra.fr; harosh@obetherapy.com	Gautier, Thomas/Q-5371-2018	Gautier, Thomas/0000-0003-1119-7382	Agence Nationale de la Recherche [ANR-06-RIB-FATSTOP]; ObeTherapy Biotechnology	Agence Nationale de la Recherche(French National Research Agency (ANR)); ObeTherapy Biotechnology	This study was funded by Agence Nationale de la Recherche (ANR-06-RIB-FATSTOP) to ObeTherapy as leader of the program and to INRA. Sandrine Braud and Itzik Harosh are employees of and shareholders in ObeTherapy Biotechnology. ObeTherapy Biotechnology provided support in the form of salaries for authors SB and IH, had a direct role in the study design, and analysis, decision to publish, and preparation of the manuscript.	Anant S, 2002, TRENDS CARDIOVAS MED, V12, P311, DOI 10.1016/S1050-1738(02)00180-9; Anant S, 2001, CURR OPIN LIPIDOL, V12, P159, DOI 10.1097/00041433-200104000-00009; Blanc V, 2012, J LIPID RES, V53, P2643, DOI 10.1194/jlr.M030494; CHAN L, 1995, BIOCHIMIE, V77, P75, DOI 10.1016/0300-9084(96)88107-7; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Daniel-Carlier N, 2013, TRANSGENIC RES, V22, P489, DOI 10.1007/s11248-012-9649-4; Dannoura AH, 1999, ARTERIOSCL THROM VAS, V19, P2494, DOI 10.1161/01.ATV.19.10.2494; Davidson NO, 2000, ANNU REV NUTR, V20, P169, DOI 10.1146/annurev.nutr.20.1.169; Fortun-Lamothe L, 2002, LIVEST PROD SCI, V78, P133, DOI 10.1016/S0301-6226(02)00087-8; Georges A, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-1; Gonzalez Jimenez Emilio, 2011, Endocrinol Nutr, V58, P492, DOI 10.1016/j.endonu.2011.06.004; Greeve J, 1996, J LIPID RES, V37, P2001; GREEVE J, 1993, J LIPID RES, V34, P1367; Hatch F T, 1968, Adv Lipid Res, V6, P1; Hirano K, 1996, J BIOL CHEM, V271, P9887, DOI 10.1074/jbc.271.17.9887; Kendrick JS, 2001, BIOCHEM J, V356, P821, DOI 10.1042/0264-6021:3560821; Kinoshita M, 2010, EXP ANIM TOKYO, V59, P459, DOI 10.1538/expanim.59.459; Lo CM, 2008, AM J PHYSIOL-GASTR L, V294, pG344, DOI 10.1152/ajpgi.00123.2007; Lu ZJ, 2008, NUCLEIC ACIDS RES, V36, pW104, DOI 10.1093/nar/gkn250; Mathus-Vliegen EMH, 2012, OBESITY FACTS, V5, P460, DOI 10.1159/000341193; Morrison JR, 1996, P NATL ACAD SCI USA, V93, P7154, DOI 10.1073/pnas.93.14.7154; Nakamuta M, 1996, J BIOL CHEM, V271, P25981, DOI 10.1074/jbc.271.42.25981; NAKAMUTA M, 1995, J BIOL CHEM, V270, P13042, DOI 10.1074/jbc.270.22.13042; Okada T, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-78; Picone O, 2011, THERIOGENOLOGY, V75, P287, DOI 10.1016/j.theriogenology.2010.08.015; Reed DR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-4; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Yamamoto T, 2009, BIOTECHNOL LETT, V31, P1695, DOI 10.1007/s10529-009-0065-7; YAMANAKA S, 1994, J BIOL CHEM, V269, P21725; Zhang XJ, 2008, J NUTR, V138, P515, DOI 10.1093/jn/138.3.515	31	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106655	10.1371/journal.pone.0106655	http://dx.doi.org/10.1371/journal.pone.0106655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216115	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774300019
J	Wei, K; Wang, LY; Wu, LY; Zhang, CC; Li, HL; Tan, LQ; Cao, HL; Cheng, H				Wei, Kang; Wang, Li-Yuan; Wu, Li-Yun; Zhang, Cheng-Cai; Li, Hai-Lin; Tan, Li-Qiang; Cao, Hong-Li; Cheng, Hao			Transcriptome Analysis of Indole-3-Butyric Acid-Induced Adventitious Root Formation in Nodal Cuttings of Camellia sinensis (L.)	PLOS ONE			English	Article							VITIS-VINIFERA L.; ISOPRENOID BIOSYNTHESIS; GENE-EXPRESSION; WEB TOOL; ARABIDOPSIS; AUXIN; GLUTATHIONE; PATHWAYS; IDENTIFICATION; MODULATION	Tea (Camellia sinensis L.) is a popular world beverage, and propagation of tea plants chiefly depends on the formation of adventitious roots in cuttings. To better understand potential mechanisms involved in adventitious root formation, we performed transcriptome analysis of single nodal cuttings of C. sinensis treated with or without indole-3-butyric acid (IBA) using the Illumina sequencing method. Totally 42.5 million RNA-Seq reads were obtained and these were assembled into 59,931 unigenes, with an average length of 732 bp and an N50 of 1292 bp. In addition, 1091 differentially expressed unigenes were identified in the tea cuttings treated with IBA compared to controls, including 656 up- and 435 down-regulated genes. Further real time RT-PCR analysis confirmed RNA-Seq data. Functional annotation analysis showed that many genes were involved in plant hormone signal transduction, secondary metabolism, cell wall organization and glutathione metabolism, indicating potential contributions to adventitious rooting. Our study presents a global view of transcriptome profiles of tea cuttings in response to IBA treatment and provides new insights into the fundamental mechanisms associated with auxin-induced adventitious rooting. Our data will be a valuable resource for genomic research about adventitious root formation in tea cuttings, which can be used to improve rooting for difficult-to-root varieties.	[Wei, Kang; Wang, Li-Yuan; Wu, Li-Yun; Zhang, Cheng-Cai; Li, Hai-Lin; Cheng, Hao] Natl Ctr Tea Improvement, Key Lab Tea Biol & Resources Utilizat, Minist Agr, Hangzhou, Zhejiang, Peoples R China; [Wei, Kang; Wang, Li-Yuan; Wu, Li-Yun; Zhang, Cheng-Cai; Tan, Li-Qiang; Cao, Hong-Li; Cheng, Hao] TRICAAS, Natl Ctr Tea Improvement, Hangzhou, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS	Cheng, H (corresponding author), Natl Ctr Tea Improvement, Key Lab Tea Biol & Resources Utilizat, Minist Agr, Hangzhou, Zhejiang, Peoples R China.	chenghao@mail.tricaas.com			Zhejiang Provincial Natural Science Foundation of China [LY14C020001]; Modern Agro-industry Technology Research System of China [nycytx-23]; Fundamental Research Funds of National Nonprofit Research Institute [2012ZL049]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Modern Agro-industry Technology Research System of China; Fundamental Research Funds of National Nonprofit Research Institute	This project was supported by Zhejiang Provincial Natural Science Foundation of China (LY14C020001), Modern Agro-industry Technology Research System of China (no. nycytx-23) and Fundamental Research Funds of National Nonprofit Research Institute (no. 2012ZL049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahkami AH, 2009, NEW PHYTOL, V181, P613, DOI 10.1111/j.1469-8137.2008.02704.x; Bao F, 2004, PLANT PHYSIOL, V134, P1624, DOI 10.1104/pp.103.036897; Bashandy T, 2010, PLANT CELL, V22, P376, DOI 10.1105/tpc.109.071225; Brinker M, 2004, PLANT PHYSIOL, V135, P1526, DOI 10.1104/pp.103.032235; Chen L, 2012, PREP BIOCHEM BIOTECH, V42, P87, DOI 10.1080/10826068.2011.566297; da Costa CT, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00133; De Klerk GJ, 1999, IN VITRO CELL DEV-PL, V35, P189, DOI 10.1007/s11627-999-0076-z; Geiss G, 2010, ANNU PLANT REV, V37, P127, DOI 10.1002/9781444310023.ch5; Gou JQ, 2010, PLANT CELL, V22, P623, DOI 10.1105/tpc.109.073239; Guryev V, 2009, FEBS LETT, V583, P1668, DOI 10.1016/j.febslet.2009.04.020; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hemmerlin A, 2012, PROG LIPID RES, V51, P95, DOI 10.1016/j.plipres.2011.12.001; Jiang HW, 2010, PLANT PHYSIOL, V154, P1646, DOI 10.1104/pp.110.159152; Jiang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062315; Katiyar SK, 1996, INT J ONCOL, V8, P221; Lanteri ML, 2006, J EXP BOT, V57, P1341, DOI 10.1093/jxb/erj109; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Lewis DR, 2013, PLANT CELL, V25, P3329, DOI 10.1105/tpc.113.114868; Li L, 2005, PLANT CELL, V17, P2738, DOI 10.1105/tpc.105.034397; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Ludwig-Muller J, 2005, J EXP BOT, V56, P2095, DOI 10.1093/jxb/eri208; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matus JT, 2010, PLANT MOL BIOL, V72, P607, DOI 10.1007/s11103-010-9597-4; Moody D.E., 2001, J ANIM SCI, V79, pE128, DOI [10.2527/jas2001.79E-SupplE128x, DOI 10.2527/JAS2001.79E-SUPPLE128X]; Moubayidin L, 2009, TRENDS PLANT SCI, V14, P557, DOI 10.1016/j.tplants.2009.06.010; Muday GK, 2012, TRENDS PLANT SCI, V17, P181, DOI 10.1016/j.tplants.2012.02.001; Negi S, 2010, PLANT J, V61, P3, DOI 10.1111/j.1365-313X.2009.04027.x; Nemhauser JL, 2004, PLOS BIOL, V2, P1460, DOI 10.1371/journal.pbio.0020258; Peat TS, 2012, PLANT CELL, V24, P4525, DOI 10.1105/tpc.112.102921; Perrot-Rechenmann C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001446; Rodriguez-Concepion M, 2004, CURR PHARM DESIGN, V10, P2391, DOI 10.2174/1381612043384006; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Rout GR, 2006, PLANT GROWTH REGUL, V48, P111, DOI 10.1007/s10725-005-5665-1; Sorin C, 2005, PLANT CELL, V17, P1343, DOI 10.1105/tpc.105.031625; Suzuki M, 2004, PLANT J, V37, P750, DOI 10.1111/j.1365-313X.2004.02003.x; Swarup R, 2002, PLANT MOL BIOL, V49, P411; Thomas P, 2003, PLANT CELL ENVIRON, V26, P1497, DOI 10.1046/j.1365-3040.2003.01071.x; Tyburski J, 2010, ACTA PHYSIOL PLANT, V32, P411, DOI 10.1007/s11738-009-0418-9; Vellosillo T, 2007, PLANT CELL, V19, P831, DOI 10.1105/tpc.106.046052; Vranova E, 2013, ANNU REV PLANT BIOL, V64, P665, DOI 10.1146/annurev-arplant-050312-120116; Wang H, 2009, PLANT CELL, V21, P3781, DOI 10.1105/tpc.109.072504; Wang XC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-415; Wei K, 2013, GENE, V514, P91, DOI 10.1016/j.gene.2012.11.008; Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu X, 2013, PLANT CELL, V25, P4451, DOI 10.1105/tpc.113.117028; Zeng DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057515; Zhang SW, 2009, PLANT PHYSIOL, V151, P1889, DOI 10.1104/pp.109.146803; Zhao N, 2008, PLANT PHYSIOL, V146, P455, DOI 10.1104/pp.107.110049	49	35	42	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107201	10.1371/journal.pone.0107201	http://dx.doi.org/10.1371/journal.pone.0107201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216187	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774300051
J	Keerthy, HK; Mohan, CD; Siveen, KS; Fuchs, JE; Rangappa, S; Sundaram, MS; Li, F; Girish, KS; Sethi, G; Basappa,; Bender, A; Rangappa, KS				Keerthy, Hosadurga Kumar; Mohan, Chakrabhavi Dhananjaya; Siveen, Kodappully Sivaraman; Fuchs, Julian E.; Rangappa, Shobith; Sundaram, Mahalingam S.; Li, Feng; Girish, Kesturu S.; Sethi, Gautam; Basappa; Bender, Andreas; Rangappa, Kanchugarakoppal Subbegowda			Novel Synthetic Biscoumarins Target Tumor Necrosis Factor-alpha in Hepatocellular Carcinoma in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Therapy; Cell Invasion; Hepatocellular Carcinoma; Inflammatory Bowel Disease (IBD); NF-kappa B (NF-KB); Tumor Necrosis Factor (TNF)	NF-KAPPA-B; MODE-OF-ACTION; TNF-ALPHA; BIOLOGICAL EVALUATION; RHEUMATOID-ARTHRITIS; FORCE-FIELD; CANCER; CURCUMIN; PATHWAY; INHIBITION	Background: TNF--induced NF-B pathway is associated with the progression of several cancers and abrogation of TNF signaling a potential target for cancer treatment. Results: Novel biscoumarin inhibits TNF signaling in vitro and in vivo in IBD model. Conclusion: The lead compound interrupts the trimeric structure of TNF to achieve this effect. Significance: This study introduces a novel TNF inhibitor with the potential to target pro-inflammatory diseases. TNF is a pleotropic cytokine known to be involved in the progression of several pro-inflammatory disorders. Many therapeutic agents have been designed to counteract the effect of TNF in rheumatoid arthritis as well as a number of cancers. In the present study we have synthesized and evaluated the anti-cancer activity of novel biscoumarins in vitro and in vivo. Among new compounds, BIHC was found to be the most cytotoxic agent against the HepG2 cell line while exhibiting less toxicity toward normal hepatocytes. Furthermore, BIHC inhibited the proliferation of various hepatocellular carcinoma (HCC) cells in a dose- and time-dependent manner. Subsequently, using in silico target prediction, BIHC was predicted as a TNF blocker. Experimental validation was able to confirm this hypothesis, where BIHC could significantly inhibit the recombinant mouse TNF- binding to its antibody with an IC50 of 16.5 m. Furthermore, in silico docking suggested a binding mode of BIHC similar to a ligand known to disrupt the native, trimeric structure of TNF, and also validated with molecular dynamics simulations. Moreover, we have demonstrated the down-regulation of p65 phosphorylation and other NF-B-regulated gene products upon BIHC treatment, and on the phenotypic level the compound shows inhibition of CXCL12-induced invasion of HepG2 cells. Also, we demonstrate that BIHC inhibits infiltration of macrophages to the peritoneal cavity and suppresses the activity of TNF- in vivo in mice primed with thioglycollate broth and lipopolysaccharide. We comprehensively validated the TNF- inhibitory efficacy of BIHC in an inflammatory bowel disease mice model.	[Keerthy, Hosadurga Kumar; Basappa] Bangalore Univ, Dept Chem, Biol Chem Lab, Bangalore 560001, Karnataka, India; [Mohan, Chakrabhavi Dhananjaya; Rangappa, Kanchugarakoppal Subbegowda] Univ Mysore, Dept Studies Chem, Mysore 570006, Karnataka, India; [Sundaram, Mahalingam S.; Girish, Kesturu S.] Univ Mysore, Dept Studies Biochem, Mysore 570006, Karnataka, India; [Siveen, Kodappully Sivaraman; Li, Feng; Sethi, Gautam] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117597, Singapore; [Fuchs, Julian E.; Bender, Andreas] Univ Cambridge, Dept Chem, Unilever Ctr Mol Sci Informat, Cambridge CB2 1EW, England; [Rangappa, Shobith] Singapore MIT Alliance Res & Technol Ctr SMART, Interdisciplinary Res Grp Infect Dis, Singapore 138602, Singapore; [Sethi, Gautam] Natl Univ Singapore, Canc Sci Inst Singapore, Yong Loo Lin Sch Med, Singapore 117599, Singapore	Bangalore University; University of Mysore; University of Mysore; National University of Singapore; University of Cambridge; Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore	Basappa, (corresponding author), Bangalore Univ, Dept Chem, Biol Chem Lab, Palace Rd, Bangalore 560001, Karnataka, India.	salundibasappa@gmail.com; ab454@cam.ac.uk; rangappaks@yahoo.com	Mohan, Chakrabhavi Dhananjaya/AGO-1276-2022; Bender, Andreas/C-6942-2009; Rangappa, Shobith/AAI-2169-2020; KS, Girish/GWZ-7128-2022; Sethi, Gautam/F-2372-2011	Bender, Andreas/0000-0002-6683-7546; Rangappa, Shobith/0000-0002-9800-7192; Sethi, Gautam/0000-0002-8677-8475; /0000-0001-6121-0771	National University of Singapore (NUS) Academic Research Fund [R-184-000-207-112]; University Grants Commission [41-257-2012-SR]; Vision Group Science and Technology; Department of Science and Technology [SR/FT/LS-142/2012]; University Grants Commission (UGC); Department of Science and Technology (DST); Karnataka University, India	National University of Singapore (NUS) Academic Research Fund; University Grants Commission(University Grants Commission, India); Vision Group Science and Technology; Department of Science and Technology(Department of Science & Technology (India)); University Grants Commission (UGC)(University Grants Commission, India); Department of Science and Technology (DST)(Department of Science & Technology (India)); Karnataka University, India	This work was supported by grants from National University of Singapore (NUS) Academic Research Fund (Grant R-184-000-207-112) (to G. S.). This research was also supported by the University Grants Commission (41-257-2012-SR), Vision Group Science and Technology, and Department of Science and Technology (Grant SR/FT/LS-142/2012) (to Basappa).; Recipient of a Basic Scientific Research (BSR) fellowship from the University Grants Commission (UGC).; Recipient of an INSPIRE fellowship from the Department of Science and Technology (DST).; Recipient of a PAVATE fellowship from Karnataka University, India.	Alli-Akintade L, 2015, J CLIN GASTROENTEROL, V49, pE21, DOI 10.1097/MCG.0000000000000117; [Anonymous], 2013, MOL OP ENV MOE; Askling J, 2009, ARTHRITIS RHEUM-US, V60, P3180, DOI 10.1002/art.24941; Basappa, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039444; Basappa, 2010, CANCER LETT, V297, P231, DOI 10.1016/j.canlet.2010.05.016; Basappa, 2009, GLYCOBIOLOGY, V19, P735, DOI 10.1093/glycob/cwp041; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bharathkumar H, 2014, RSC ADV, V4, P45143, DOI 10.1039/c4ra08713e; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Chen YR, 1998, ONCOGENE, V17, P173, DOI 10.1038/sj.onc.1201941; COOPER HS, 1993, LAB INVEST, V69, P238; Cravotto G, 2003, SYNTHESIS-STUTTGART, P1286; Dasgupta B, 2014, ARTHRIT CARE RES, V66, P1799, DOI 10.1002/acr.22371; Essayan DM, 2001, J ALLERGY CLIN IMMUN, V108, P671, DOI 10.1067/mai.2001.119555; Fauzi FM, 2013, J CHEM INF MODEL, V53, P661, DOI 10.1021/ci3005513; Feuerstein JD, 2014, MAYO CLIN PROC, V89, P1553, DOI 10.1016/j.mayocp.2014.07.002; Fongmoon D, 2007, J BIOL CHEM, V282, P36895, DOI 10.1074/jbc.M707082200; Frisch M.J., 2009, GAUSSIAN 09 REV A02; Fuchs JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053005; Gonzalez-Rey E, 2006, GASTROENTEROLOGY, V130, P1707, DOI 10.1053/j.gastro.2006.01.041; Hagiwara H, 2000, HETEROCYCLES, V53, P549, DOI 10.3987/COM-99-8817; HAWES AS, 1993, ANN SURG, V218, P79, DOI 10.1097/00000658-199307000-00013; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Iqbal M, 2013, PHYTOCHEM REV, V12, P65, DOI 10.1007/s11101-012-9251-7; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kim HY, 2003, J IMMUNOL, V171, P6072, DOI 10.4049/jimmunol.171.11.6072; Kobayashi T, 2014, J PERIODONTOL, V85, P1480, DOI 10.1902/jop.2014.140194; Koutsoukas A, 2013, J CHEM INF MODEL, V53, P1957, DOI 10.1021/ci300435j; Koutsoukas A, 2011, J PROTEOMICS, V74, P2554, DOI 10.1016/j.jprot.2011.05.011; Le Grand S, 2013, COMPUT PHYS COMMUN, V184, P374, DOI 10.1016/j.cpc.2012.09.022; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu J, 2007, PHYTOCHEMISTRY, V68, P1775, DOI 10.1016/j.phytochem.2007.05.001; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mehrabi H, 2010, J IRAN CHEM SOC, V7, P890, DOI 10.1007/BF03246084; NABEL GJ, 1993, GENE DEV, V7, P2063, DOI 10.1101/gad.7.11.2063; Nemchenko A, 2010, CIRC RES, V106, P10, DOI 10.1161/CIRCRESAHA.109.211185; Olivier S, 2006, BIOCHEM PHARMACOL, V72, P1054, DOI 10.1016/j.bcp.2006.07.023; Pettipher ER, 1996, BRIT J PHARMACOL, V117, P1530, DOI 10.1111/j.1476-5381.1996.tb15317.x; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Revanna CN, 2014, MEDCHEMCOMM, V5, P32, DOI 10.1039/c3md00119a; Rungeler P, 1999, BIOORGAN MED CHEM, V7, P2343, DOI 10.1016/S0968-0896(99)00195-9; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Sethi G, 2009, ADV EXP MED BIOL, V647, P37, DOI 10.1007/978-0-387-89520-8_3; Sethi G, 2009, TRENDS PHARMACOL SCI, V30, P313, DOI 10.1016/j.tips.2009.03.004; Shrimali D, 2013, CANCER LETT, V341, P139, DOI 10.1016/j.canlet.2013.08.023; Siddiqui AM, 2006, CRIT CARE MED, V34, P1874, DOI 10.1097/01.CCM.0000221921.71300.BF; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Snir O, 2013, GENES IMMUN, V14, P83, DOI 10.1038/gene.2012.56; Suh HW, 2007, MOL CELL BIOCHEM, V298, P187, DOI 10.1007/s11010-006-9365-6; Takahashi S, 2003, ENDOCR-RELAT CANCER, V10, P403, DOI 10.1677/erc.0.0100403; Tanaka T, 2014, BIOL-TARGETS THER, V8, P141, DOI 10.2147/BTT.S37509; TRUELOVE SC, 1955, BRIT MED J, V2, P1041, DOI 10.1136/bmj.2.4947.1041; van Horssen R, 2006, ONCOLOGIST, V11, P397, DOI 10.1634/theoncologist.11-4-397; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530	59	64	66	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31879	31890		10.1074/jbc.M114.593855	http://dx.doi.org/10.1074/jbc.M114.593855			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25231984	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000345314700019
J	Bailey, TA; Luan, HT; Tom, E; Bielecki, TA; Mohapatra, B; Ahmad, G; George, M; Kelly, DL; Natarajan, A; Raja, SM; Band, V; Band, H				Bailey, Tameka A.; Luan, Haitao; Tom, Eric; Bielecki, Timothy Alan; Mohapatra, Bhopal; Ahmad, Gulzar; George, Manju; Kelly, David L.; Natarajan, Amarnath; Raja, Srikumar M.; Band, Vimla; Band, Hamid			A Kinase Inhibitor Screen Reveals Protein Kinase C-dependent Endocytic Recycling of ErbB2 in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; INDUCED DOWN-REGULATION; TYROSINE PHOSPHORYLATION; TANESPIMYCIN 17-AAG; DEGRADATIVE PATHWAY; INDUCED APOPTOSIS; HSP90 INHIBITORS; PHOSPHOLIPASE-D; UP-REGULATION; EGF RECEPTOR	ErbB2 overexpression drives oncogenesis in 20-30% cases of breast cancer. Oncogenic potential of ErbB2 is linked to inefficient endocytic traffic into lysosomes and preferential recycling. However, regulation of ErbB2 recycling is incompletely understood. We used a high-content immunofluorescence imaging-based kinase inhibitor screen on SKBR-3 breast cancer cells to identify kinases whose inhibition alters the clearance of cell surface ErbB2 induced by Hsp90 inhibitor 17-AAG. Less ErbB2 clearance was observed with broad-spectrum PKC inhibitor Ro 31-8220. A similar effect was observed with Go 6976, a selective inhibitor of classical Ca2+-dependent PKCs (alpha, beta 1, beta II, and gamma). PKC activation by PMA promoted surface ErbB2 clearance but without degradation, and ErbB2 was observed to move into a juxtanuclear compartment where it colocalized with PKC-alpha and PKC-delta together with the endocytic recycling regulator Arf6. PKC-alpha knockdown impaired the juxtanuclear localization of ErbB2. ErbB2 transit to the recycling compartment was also impaired upon PKC-delta knockdown. PMA-induced Erkphosphorylation was reduced by ErbB2 inhibitor lapatinib, as well as by knockdown of PKC-delta but not that of PKC-alpha. Our results suggest that activation of PKC-alpha and -delta mediates a novel positive feedback loop by promoting ErbB2 entry into the endocytic recycling compartment, consistent with reported positive roles for these PKCs in ErbB2-mediated tumorigenesis. As the endocytic recycling compartment/pericentrion has emerged as a PKC-dependent signaling hub for G-protein-coupled receptors, our findings raise the possibility that oncogenesis by ErbB2 involves previously unexplored PKC-dependent endosomal signaling.	[Bailey, Tameka A.; Luan, Haitao; Tom, Eric; Bielecki, Timothy Alan; Mohapatra, Bhopal; Ahmad, Gulzar; George, Manju; Kelly, David L.; Natarajan, Amarnath; Raja, Srikumar M.; Band, Vimla; Band, Hamid] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Coll Med, Omaha, NE 68198 USA; [Luan, Haitao; Band, Vimla; Band, Hamid] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Coll Med, Omaha, NE 68198 USA; [Tom, Eric; Mohapatra, Bhopal; Band, Hamid] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Coll Med, Omaha, NE 68198 USA; [Kelly, David L.; Natarajan, Amarnath; Raja, Srikumar M.; Band, Vimla; Band, Hamid] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Band, H (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	hband@unmc.edu	Band, Hamid/AAF-4701-2020	Natarajan, Amarnath/0000-0001-5067-0203; Mohapatra, Bhopal/0000-0003-3434-4306; Bielecki, Timothy/0000-0003-4561-0892	National Institutes of Health [CA116552, CA105489, CA99163, CA87986, CA96844, CA144027, CA127239]; Dept. of Defense [W81WH-11-1-0167, W81XWH-07-1-0351, W81XWH-11-1-0171]; NE DHHS [LB506-2014-01]; Nebraska DHHS [LB606-18123-Y3]; Nebraska Center for Nanomedicine-Center for Biomedical Research Excellence (NCN-COBRE) seed grant; NCI Core Support Grant; NCI Institutional Cancer Biology Training Grant [CA009476]; Susan G. Komen Foundation for Cure postdoctoral Fellowship [KG091363]; UNMC Faculty Diversity Scholar award; NATIONAL CANCER INSTITUTE [R01CA096844, P30CA036727, R01CA087986, R01CA105489, R01CA099163, T32CA009476, R01CA127239, R01CA116552, R01CA144027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Defense(United States Department of Defense); NE DHHS; Nebraska DHHS; Nebraska Center for Nanomedicine-Center for Biomedical Research Excellence (NCN-COBRE) seed grant; NCI Core Support Grant; NCI Institutional Cancer Biology Training Grant; Susan G. Komen Foundation for Cure postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation); UNMC Faculty Diversity Scholar award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health Grants CA116552, CA105489, CA99163, CA87986, Dept. of Defense Grant W81WH-11-1-0167, NE DHHS LB506-2014-01, and Nebraska DHHS LB606-18123-Y3 (to H. B.); National Institutes of Health Grants CA96844 and CA144027, and Dept. of Defense Grants W81XWH-07-1-0351 and W81XWH-11-1-0171 (to V. B.); National Institutes of Health Grant CA127239 (to A. N.); Nebraska Center for Nanomedicine-Center for Biomedical Research Excellence (NCN-COBRE) seed grant (to S. M. R.); and the NCI Core Support Grant to the UNMC Buffett Cancer Center.; A postdoctoral trainee under the NCI Institutional Cancer Biology Training Grant (CA009476) and a recipient of the Susan G. Komen Foundation for Cure postdoctoral Fellowship (KG091363) and a UNMC Faculty Diversity Scholar award.	Alessi DR, 1997, FEBS LETT, V402, P121, DOI 10.1016/S0014-5793(96)01510-4; Allen-Petersen BL, 2014, ONCOGENE, V33, P1306, DOI 10.1038/onc.2013.59; Alvi F, 2007, CELL MOL LIFE SCI, V64, P263, DOI 10.1007/s00018-006-6363-5; Antonescu CN, 2010, MOL BIOL CELL, V21, P2944, DOI 10.1091/mbc.E10-05-0421; Austin CD, 2004, MOL BIOL CELL, V15, P5268, DOI 10.1091/mbc.E04-07-0591; Bao J, 2000, J BIOL CHEM, V275, P26178, DOI 10.1074/jbc.M002367200; Barr DJ, 2008, J CELL SCI, V121, P3155, DOI 10.1242/jcs.020404; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Baulida J, 1996, J BIOL CHEM, V271, P5251; Becker KP, 2003, J BIOL CHEM, V278, P52747, DOI 10.1074/jbc.M305228200; Beltman J, 1996, J BIOL CHEM, V271, P27018, DOI 10.1074/jbc.271.43.27018; Bonita DP, 1997, MOL CELL BIOL, V17, P4597, DOI 10.1128/MCB.17.8.4597; Cai JJ, 2010, J BIOL CHEM, V285, P6952, DOI 10.1074/jbc.M109.055731; Chung BM, 2009, ONCOGENE, V28, P1821, DOI 10.1038/onc.2009.31; Chung BM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-84; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cortese K, 2013, MOL BIOL CELL, V24, P129, DOI 10.1091/mbc.E12-04-0282; de Diesbach MT, 2010, EXP CELL RES, V316, P3239, DOI 10.1016/j.yexcr.2010.09.001; Feng X, 1998, J BIOL CHEM, V273, P10755, DOI 10.1074/jbc.273.17.10755; Friedman LM, 2005, P NATL ACAD SCI USA, V102, P1915, DOI 10.1073/pnas.0409610102; Gabriel L, 2012, J BIOL CHEM, V287, P32354, DOI 10.1074/jbc.M112.391458; Gordon LI, 2009, J BIOL CHEM, V284, P2080, DOI 10.1074/jbc.M804570200; Han Z, 2000, CELL DEATH DIFFER, V7, P521, DOI 10.1038/sj.cdd.4400681; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Hashizume T, 2008, CELL BIOL INT, V32, P814, DOI 10.1016/j.cellbi.2008.03.012; Helikar T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061757; Henriksen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058148; Idkowiak-Baldys J, 2006, J BIOL CHEM, V281, P22321, DOI 10.1074/jbc.M512540200; Idkowiak-Baldys J, 2009, J BIOL CHEM, V284, P22322, DOI 10.1074/jbc.M109.026765; Kaneko T, 2005, GENES CELLS, V10, P973, DOI 10.1111/j.1365-2443.2005.00895.x; Kasai A, 2005, GENES CELLS, V10, P1175, DOI 10.1111/j.1365-2443.2005.00909.x; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Keshamouni VG, 2002, J BIOL CHEM, V277, P22558, DOI 10.1074/jbc.M202351200; KING CR, 1988, EMBO J, V7, P1647, DOI 10.1002/j.1460-2075.1988.tb02991.x; Konopatskaya O, 2010, TRENDS PHARMACOL SCI, V31, P8, DOI 10.1016/j.tips.2009.10.006; Lanzetti L, 2008, TRAFFIC, V9, P2011, DOI 10.1111/j.1600-0854.2008.00816.x; Le XF, 2001, ONCOGENE, V20, P8258, DOI 10.1038/sj.onc.1205039; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lerdrup M, 2006, J CELL SCI, V119, P85, DOI 10.1242/jcs.02707; Lerdrup M, 2007, MOL BIOL CELL, V18, P3656, DOI 10.1091/mbc.e07-01-0025; Li-Ping Z., 2010, REPROD BIOL ENDOCRIN, V8, P1; Li-Ping Z., 2010, REPROD BIOL ENDOCRIN, V8, P7827; Liu Y, 2007, BIOCHEM BIOPH RES CO, V354, P505, DOI 10.1016/j.bbrc.2007.01.009; Llado A, 2004, MOL BIOL CELL, V15, P4877, DOI 10.1091/mbc.E04-02-0127; Llado A, 2008, MOL BIOL CELL, V19, P17, DOI 10.1091/mbc.E07-05-0411; Lonne GK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-76; Lu XY, 2012, BIOCHEM PHARMACOL, V83, P995, DOI 10.1016/j.bcp.2011.11.011; Lum MA, 2013, J BIOL CHEM, V288, P27112, DOI 10.1074/jbc.M112.437095; Lum MA, 2013, J BIOL CHEM, V288, P13093, DOI 10.1074/jbc.M112.437061; Magnifico A, 1998, FEBS LETT, V422, P129, DOI 10.1016/S0014-5793(97)01612-8; Magnifico A, 2007, CANCER RES, V67, P5308, DOI 10.1158/0008-5472.CAN-06-3936; Mahlknecht G, 2013, P NATL ACAD SCI USA, V110, P8170, DOI 10.1073/pnas.1302594110; MAIER LA, 1991, CANCER RES, V51, P5361; Marcotte R, 2009, MOL CELL BIOL, V29, P5858, DOI 10.1128/MCB.01731-08; Marx C, 2010, CANCER RES, V70, P3709, DOI 10.1158/0008-5472.CAN-09-3768; Meijer IMJ, 2012, CELL SIGNAL, V24, P1981, DOI 10.1016/j.cellsig.2012.07.006; Melendez AJ, 2001, CURR BIOL, V11, P869, DOI 10.1016/S0960-9822(01)00260-3; Modi S, 2007, J CLIN ONCOL, V25, P5410, DOI 10.1200/JCO.2007.11.7960; Modi S, 2011, CLIN CANCER RES, V17, P5132, DOI 10.1158/1078-0432.CCR-11-0072; Mohapatra B, 2013, BBA-MOL CELL RES, V1833, P122, DOI 10.1016/j.bbamcr.2012.10.010; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Munster PN, 2001, CLIN CANCER RES, V7, P2228; Neckers L, 2003, CURR MED CHEM, V10, P733, DOI 10.2174/0929867033457818; Nishimura M, 2009, MOL CELL BIOL, V29, P5529, DOI 10.1128/MCB.00375-09; Nishimura Y, 2006, HISTOCHEM CELL BIOL, V126, P627, DOI 10.1007/s00418-006-0198-x; Norambuena A, 2010, MOL BIOL CELL, V21, P2916, DOI 10.1091/mbc.E10-02-0167; Ohba S, 2010, J NEUROSURG, V112, P33, DOI 10.3171/2009.3.JNS081146; Ouyang XM, 1998, CARCINOGENESIS, V19, P2013, DOI 10.1093/carcin/19.11.2013; Padival AK, 2004, MOL CELL BIOCHEM, V258, P129, DOI 10.1023/B:MCBI.0000012847.86529.07; Park SK, 2001, J CELL BIOL, V154, P1245, DOI 10.1083/jcb.200104025; Pedersen NM, 2008, MOL CANCER RES, V6, P491, DOI 10.1158/1541-7786.MCR-07-0191; Rafn B, 2012, MOL CELL, V45, P764, DOI 10.1016/j.molcel.2012.01.029; Raja SM, 2008, CANCER BIOL THER, V7, P1629; Raja SM, 2011, CANCER BIOL THER, V11, P263, DOI 10.4161/cbt.11.2.13959; Recktenwald CV, 2012, J BIOL CHEM, V287, P24320, DOI 10.1074/jbc.M111.334425; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Rusin A, 2010, ACTA BIOCHIM POL, V57, P23; Salazar G, 2002, MOL BIOL CELL, V13, P1677, DOI 10.1091/mbc.01-08-0403; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Schweitzer JK, 2011, SEMIN CELL DEV BIOL, V22, P39, DOI 10.1016/j.semcdb.2010.09.002; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; Shen YJ, 2001, MOL CELL BIOL, V21, P595, DOI 10.1128/MCB.21.2.595-602.2001; Sidiropoulos PNM, 2012, BRAIN, V135, P1395, DOI 10.1093/brain/aws061; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; SORKIN A, 1993, ONCOGENE, V8, P3021; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Standaert ML, 1999, ENDOCRINOLOGY, V140, P2145, DOI 10.1210/en.140.5.2145; STERN DF, 1986, MOL CELL BIOL, V6, P1729, DOI 10.1128/MCB.6.5.1729; Tan M, 2006, ONCOGENE, V25, P3286, DOI 10.1038/sj.onc.1209361; Tonetti DA, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/740353; Tong JF, 2009, MOL CELL PROTEOMICS, V8, P2131, DOI 10.1074/mcp.M900148-MCP200; Vuong TT, 2013, EXP CELL RES, V319, P32, DOI 10.1016/j.yexcr.2012.10.010; Ursini-Siegel J, 2007, NAT REV CANCER, V7, P389, DOI 10.1038/nrc2127; Urtreger AJ, 2012, IUBMB LIFE, V64, P18, DOI 10.1002/iub.574; Vaidyanath A, 2011, J CELL MOL MED, V15, P2525, DOI 10.1111/j.1582-4934.2011.01277.x; Vartanian T, 1997, J CELL BIOL, V137, P211, DOI 10.1083/jcb.137.1.211; Wang XQ, 2007, CANCER RES, V67, P9986, DOI 10.1158/0008-5472.CAN-07-1300; Wang ZX, 1999, MOL BIOL CELL, V10, P1621, DOI 10.1091/mbc.10.5.1621; Ware MF, 1997, J BIOL CHEM, V272, P30185, DOI 10.1074/jbc.272.48.30185; Watanabe TM, 2007, BIOPHYS J, V92, P4109, DOI 10.1529/biophysj.106.094649; Waterman H, 1998, J BIOL CHEM, V273, P13819, DOI 10.1074/jbc.273.22.13819; Widakowich C, 2008, ANTI-CANCER AGENT ME, V8, P488, DOI 10.2174/187152008784533062; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; Worthylake R, 1999, J BIOL CHEM, V274, P8865, DOI 10.1074/jbc.274.13.8865; Worthylake R, 1997, J BIOL CHEM, V272, P8594, DOI 10.1074/jbc.272.13.8594; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yang XL, 2005, MOL CELL NEUROSCI, V28, P335, DOI 10.1016/j.mcn.2004.10.001; Zeng LL, 2012, ADV EXP MED BIOL, V740, P639, DOI 10.1007/978-94-007-2888-2_28; Zhong CB, 2008, J NEUROSCI, V28, P9111, DOI 10.1523/JNEUROSCI.0381-08.2008; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200; Zhu WL, 2007, CANCER BIOL THER, V6, P1960, DOI 10.4161/cbt.6.12.4979; Zsebik B, 2006, IMMUNOL LETT, V104, P146, DOI 10.1016/j.imlet.2005.11.018; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	116	25	26	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30443	30458		10.1074/jbc.M114.608992	http://dx.doi.org/10.1074/jbc.M114.608992			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25225290	hybrid, Green Published			2022-12-25	WOS:000344549700025
J	Li, X; Niu, JZ; Xie, BY				Li, Xiang; Niu, Jianzhi; Xie, Baoyuan			The Effect of Leaf Litter Cover on Surface Runoff and Soil Erosion in Northern China	PLOS ONE			English	Article							INFILTRATION; SEDIMENT; SLOPE; MULCHES; STRAW	The role of leaf litter in hydrological processes and soil erosion of forest ecosystems is poorly understood. A field experiment was conducted under simulated rainfall in runoff plots with a slope of 10%. Two common types of litter in North China (from Quercus variabilis, representing broadleaf litter, and Pinus tabulaeformis, representing needle leaf litter), four amounts of litter, and five rainfall intensities were tested. Results revealed that the litter reduced runoff and delayed the beginning of runoff, but significantly reduced soil loss (p<0.05). Average runoff yield was 29.5% and 31.3% less than bare-soil plot, and for Q. variabilis and P. tabulaeformis, respectively, and average sediment yield was 85.1% and 79.9% lower. Rainfall intensity significantly affected runoff (R = 0.99, p<0.05), and the efficiency in runoff reduction by litter decreased considerably. Runoff yield and the runoff coefficient increased dramatically by 72.9 and 5.4 times, respectively. The period of time before runoff appeared decreased approximately 96.7% when rainfall intensity increased from 5.7 to 75.6 mm h(-1). Broadleaf and needle leaf litter showed similarly relevant effects on runoff and soil erosion control, since no significant differences (p <= 0.05) were observed in runoff and sediment variables between two litter-covered plots. In contrast, litter mass was probably not a main factor in determining runoff and sediment because a significant correlation was found only with sediment in Q. variabilis litter plot. Finally, runoff yield was significantly correlated (p<0.05) with sediment yield. These results suggest that the protective role of leaf litter in runoff and erosion processes was crucial, and both rainfall intensity and litter characteristics had an impact on these processes.	[Li, Xiang; Niu, Jianzhi; Xie, Baoyuan] Beijing Forestry Univ, Educ Minist, Key Lab Soil & Water Conservat & Desertificat Com, Beijing, Peoples R China	Beijing Forestry University	Niu, JZ (corresponding author), Beijing Forestry Univ, Educ Minist, Key Lab Soil & Water Conservat & Desertificat Com, Beijing, Peoples R China.	nexk@bjfu.edu.cn			Fundamental Research Funds for the Central Universities [BLYJ201406]; National Natural Science Fund of China [41171028]; National Advanced Project of the 12th Plan, China [2011BAD38B05]; National Forestry Public Welfare Industry Research Project [201104005]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); National Advanced Project of the 12th Plan, China; National Forestry Public Welfare Industry Research Project	This study was supported by the Fundamental Research Funds for the Central Universities (No.BLYJ201406); National Natural Science Fund of China (41171028); National Advanced Project of the 12th Plan, China (2011BAD38B05); and National Forestry Public Welfare Industry Research Project (201104005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS AD, 1991, J HYDROL, V122, P49, DOI 10.1016/0022-1694(91)90171-D; ADAMS JE, 1966, SOIL SCI SOC AM PRO, V30, P110, DOI 10.2136/sssaj1966.03615995003000010036x; Adekalu KO, 2007, BIORESOURCE TECHNOL, V98, P912, DOI 10.1016/j.biortech.2006.02.044; Battany MC, 2000, HYDROL PROCESS, V14, P1289, DOI 10.1002/(SICI)1099-1085(200005)14:7&lt;1289::AID-HYP43&gt;3.0.CO;2-R; BENKOBI L, 1993, J ENVIRON QUAL, V22, P657, DOI 10.2134/jeq1993.00472425002200040003x; Bhattacharyya R, 2010, CATENA, V81, P184, DOI 10.1016/j.catena.2010.03.003; Blake G. R., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P363; Bochet E, 2006, EARTH SURF PROC LAND, V31, P536, DOI 10.1002/esp.1351; Carter MC, 2008, SOIL SAMPING METHODS, P173; Carter MC, 2008, SOIL SAMPLING METHOD, P743; Cerda A, 2008, CATENA, V74, P256, DOI 10.1016/j.catena.2008.03.010; DICKEY EC, 1985, T ASAE, V28, P1124; Dunjo G, 2004, J ARID ENVIRON, V57, P239, DOI 10.1016/S0140-1963(03)00097-1; Zuazo VHD, 2009, SUSTAINABLE AGRICULTURE, P785, DOI 10.1007/978-90-481-2666-8_48; Findeling A, 2003, J HYDROL, V275, P49, DOI 10.1016/S0022-1694(03)00021-0; Geddes N, 1999, CATENA, V36, P303, DOI 10.1016/S0341-8162(99)00050-8; Gee G.W., 1986, METHODS SOIL ANAL PA, P383, DOI DOI 10.2136/SSSAB00KSER5.1.2ED.C15; Ghahramani A, 2011, HYDROL PROCESS, V25, P2471, DOI 10.1002/hyp.8086; Ghahramani A, 2011, CATENA, V85, P34, DOI 10.1016/j.catena.2010.11.005; Gholami L, 2013, SOIL SCI SOC AM J, V77, P268, DOI 10.2136/sssaj2012.0271; Guevara-Escobar A, 2007, HYDROL EARTH SYST SC, V11, P1703, DOI 10.5194/hess-11-1703-2007; IMESON AC, 1983, CATENA, P79; Jean JS, 2000, HYDROL PROCESS, V14, P1829, DOI [10.1002/1099-1085(200007)14:10<1829::AID-HYP66>3.0.CO;2-#, 10.1002/1099-1085(200007)14:10&lt;1829::AID-HYP66&gt;3.0.CO;2-#]; Kim KH, 1996, SOIL TECHNOL, V9, P173, DOI 10.1016/S0933-3630(96)00011-6; Kimoto A, 2002, CATENA, V48, P217, DOI 10.1016/S0341-8162(02)00029-2; LAL R, 1981, GEODERMA, V25, P215, DOI 10.1016/0016-7061(81)90037-9; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060338; Li Z.G., 2008, SCI SOIL WATER CONSE, V6, P57, DOI [10.16843/j.sswc.2008.01.010, DOI 10.16843/J.SSWC.2008.01.010]; LOWDERMILK W. C., 1930, JOUR FOREST, V28, P474; [马京津 Ma Jingjin], 2012, [气象, Meteorological Monthly], V38, P569; Mandal UK, 2005, EUR J SOIL SCI, V56, P435, DOI 10.1111/j.1365-2389.2004.00687.x; MCGREGOR KC, 1988, T ASAE, V31, P111; Ministry of Environmental Protection of the P.R. China, 1993, DET SPEC COND WET PR; Miyata S, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007270; Mohammad AG, 2010, CATENA, V81, P97, DOI 10.1016/j.catena.2010.01.008; Morgan RPC, 2005, SOIL CONSERV, P3; Neris J, 2013, CATENA, V108, P50, DOI 10.1016/j.catena.2012.04.011; NETTO ALC, 1987, CATENA, V14, P213, DOI 10.1016/S0341-8162(87)80019-X; Pan CZ, 2006, J HYDROL, V331, P178, DOI 10.1016/j.jhydrol.2006.05.011; Pan CZ, 2010, EARTH SURF PROC LAND, V35, P1006, DOI 10.1002/esp.1997; Pannkuk CD, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002318; Pierce SP, 1967, INT S FOREST HYDROL, V25, P247; POESEN JW, 1994, CATENA, V23, P141, DOI 10.1016/0341-8162(94)90058-2; Putuhena WM, 1996, J HYDROL, V180, P283, DOI 10.1016/0022-1694(95)02883-8; RGCST, 2001, CHINESE SOIL TAXONOM; Robichaud PR, 2013, CATENA, V105, P75, DOI 10.1016/j.catena.2012.11.015; Ruxton BP, 1967, LANDFORM STUDIES AUS, P85; Sato Y, 2004, HYDROL PROCESS, V18, P3007, DOI 10.1002/hyp.5746; Satoru Miura, 2003, Journal of Forest Research, V8, P27, DOI 10.1007/s103100300003; Savenije HHG, 1996, J HYDROL, V176, P219, DOI 10.1016/0022-1694(95)02776-9; Sayer EJ, 2006, BIOL REV, V81, P1, DOI 10.1017/S1464793105006846; Shi XZ, 2006, PEDOSPHERE, V16, P147, DOI 10.1016/S1002-0160(06)60037-4; SINGER MJ, 1978, SOIL SCI SOC AM J, V42, P481, DOI 10.2136/sssaj1978.03615995004200030022x; Smets T, 2008, PROG PHYS GEOG, V32, P654, DOI 10.1177/0309133308101473; Smets T, 2008, EARTH-SCI REV, V89, P1, DOI 10.1016/j.earscirev.2008.04.001; Tang J., 2000, ACTA SCI CIRCUMSTANT, V20, P420; VALENTIN C, 1992, SOIL SCI SOC AM J, V56, P1667, DOI 10.2136/sssaj1992.03615995005600060002x; WALSH RPD, 1977, J BIOGEOGR, V4, P253, DOI 10.2307/3038060; Wan Y, 1999, SOIL TILL RES, V52, P29, DOI 10.1016/S0167-1987(99)00055-0; Wang H, 2008, URBAN GEOL, V3, P18; [王佳丽 Wang Jiali], 2012, [应用气象学报, Journal of Applied Meteorolgical Science], V23, P265; Wu Z., 2001, RES SOIL WATER CONSE, V8, P67; [谢云 XIE YUN], 2008, [水土保持通报, Bulletin of Soil and Water Conservation], V28, P1; [张光辉 ZHANG Guanghui], 2007, [水土保持通报, Bulletin of Soil and Water Conservation], V27, P56; Zhang HJ, 2008, SOIL EROSION THEORY; [钟一丹 Zhong Yidan], 2013, [水文, Hydrology], V33, P32	66	75	79	6	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107789	10.1371/journal.pone.0107789	http://dx.doi.org/10.1371/journal.pone.0107789			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232858	Green Published, Green Submitted, gold			2022-12-25	WOS:000342921200050
J	Fledderjohann, J; Agrawal, S; Vellakkal, S; Basu, S; Campbell, O; Doyle, P; Ebrahim, S; Stuckler, D				Fledderjohann, Jasmine; Agrawal, Sutapa; Vellakkal, Sukumar; Basu, Sanjay; Campbell, Oona; Doyle, Pat; Ebrahim, Shah; Stuckler, David			Do Girls Have a Nutritional Disadvantage Compared with Boys? Statistical Models of Breastfeeding and Food Consumption Inequalities among Indian Siblings	PLOS ONE			English	Article							SON PREFERENCE; SEX DIFFERENTIALS; BIRTH-ORDER; HEALTH-CARE; RURAL INDIA; MORTALITY; GENDER; CHILDREN; SURVIVAL; FAMILY	Background: India is the only nation where girls have greater risks of under-5 mortality than boys. We test whether female disadvantage in breastfeeding and food allocation accounts for gender disparities in mortality. Methods and Findings: Secondary, publicly available anonymized and de-identified data were used; no ethics committee review was required. Multivariate regression and Cox models were performed using Round 3 of India's National Family and Health Survey (2005-2006; response rate = 93.5%). Models were disaggregated by birth order and sibling gender, and adjusted for maternal age, education, and fixed effects, urban residence, household deprivation, and other sociodemographics. Mothers' reported practices of WHO/UNICEF recommendations for breastfeeding initiation, exclusivity, and total duration (ages 0-59 months), children's consumption of 24 food items (6-59 months), and child survival (0-59 months) were examined for first-and secondborns (n = 20,395). Girls were breastfed on average for 0.45 months less than boys (95% CI: = 0.15 months to 0.75 months, p = 0.004). There were no gender differences in breastfeeding initiation (OR = 1.04, 95% CI: 0.97 to 1.12) or exclusivity (OR = 1.06, 95% CI: 0.99 to 1.14). Differences in breastfeeding cessation emerged between 12 and 36 months in secondborn females. Compared with boys, girls had lower consumption of fresh milk by 14% (95% CI: 79% to 94%, p = 0.001) and breast milk by 21% (95% CI: 70% to 90%, p<0.000). Each additional month of breastfeeding was associated with a 24% lower risk of mortality (OR = 0.76, 95% CI: 0.73 to 0.79, p<0.000). Girls' shorter breastfeeding duration accounted for an 11% increased probability of dying before age 5, accounting for about 50% of their survival disadvantage compared with other low-income countries. Conclusions: Indian girls are breastfed for shorter periods than boys and consume less milk. Future research should investigate the role of additional factors driving India's female survival disadvantage.	[Fledderjohann, Jasmine; Vellakkal, Sukumar; Stuckler, David] Univ Oxford, Dept Sociol, Oxford, England; [Agrawal, Sutapa; Vellakkal, Sukumar; Ebrahim, Shah; Stuckler, David] Publ Hlth Fdn India, South Asia Chron Dis Network, New Delhi, India; [Basu, Sanjay] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Campbell, Oona; Doyle, Pat; Ebrahim, Shah] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England	University of Oxford; Public Health Foundation of India; Stanford University; University of London; London School of Hygiene & Tropical Medicine	Fledderjohann, J (corresponding author), Univ Oxford, Dept Sociol, Oxford, England.	jasmine.fledderjohann@sociology.ox.ac.uk	Vellakkal, Sukumar/AAD-4893-2020	Vellakkal, Sukumar/0000-0003-2635-1944; Fledderjohann, Jasmine/0000-0003-4952-7658; Campbell, Oona/0000-0002-9311-0115; Vellakkal, Sukumar/0000-0002-0594-1454; Stuckler, David/0000-0002-1288-8401	Economic and Social Research Council; NWO-WOTRO; Population Reference Bureau; Population, Reproductive Health, and Economic Development; RCN foundation joint research scheme [ES/K13130/1]; Wellcome Trust Investigator Award; ESRC [ES/K013130/1] Funding Source: UKRI; Economic and Social Research Council [ES/K013130/1] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NWO-WOTRO(Netherlands Organization for Scientific Research (NWO)); Population Reference Bureau; Population, Reproductive Health, and Economic Development; RCN foundation joint research scheme; Wellcome Trust Investigator Award(Wellcome Trust); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Support for this project was provided by a grant from the Economic and Social Research Council, NWO-WOTRO, Population Reference Bureau, and Population, Reproductive Health, and Economic Development, and the RCN foundation joint research scheme (Grant number: ES/K13130/1). DS is supported by a Wellcome Trust Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada TSJ, 2001, SOC SCI MED, V52, P71, DOI 10.1016/S0277-9536(00)00123-4; Agampodi Suneth B, BREASTFEEDING PRACTI; Agnihotri SB, 2001, ECON POLIT WEEKLY, P228; Arnold F, 1998, POP STUD-J DEMOG, V52, P301, DOI 10.1080/0032472031000150486; Arokiasamy P, 2008, J BIOSOC SCI, V40, P183, DOI 10.1017/S0021932007002623; BASU AM, 1989, POP STUD-J DEMOG, V43, P193, DOI 10.1080/0032472031000144086; BEHRMAN JR, 1988, J DEV ECON, V28, P43, DOI 10.1016/0304-3878(88)90013-2; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bloom SS, 2001, DEMOGRAPHY, V38, P67, DOI 10.1353/dem.2001.0001; CHOE MK, 1995, SOC BIOL, V42, P50; Clark S, 2000, DEMOGRAPHY, V37, P95, DOI 10.2307/2648099; CLELAND JG, 1988, SOC SCI MED, V27, P1357, DOI 10.1016/0277-9536(88)90201-8; Das Gupta M, 2003, J DEV STUD, V40, P153, DOI 10.1080/00220380412331293807; Engle PL, 2002, NUTR REV, V60, pS109, DOI 10.1301/00296640260130849; Gragnolati M, 2005, INDIAS UNDERNOURISHE; Griffiths P, 2002, SOC SCI MED, V55, P775, DOI 10.1016/S0277-9536(01)00202-7; HABICHT JP, 1986, AM J EPIDEMIOL, V123, P279, DOI 10.1093/oxfordjournals.aje.a114236; Huffman SL, 1984, POPUL DEV REV, V10, P93, DOI 10.2307/2807957; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jayachandran S, 2011, Q J ECON, V126, P1485, DOI 10.1093/qje/qjr029; Maitra P., 2006, EUR SOC POP EC ANN C; Mishra V, 2004, POPUL DEV REV, V30, P269, DOI 10.1111/j.1728-4457.2004.013_1.x; Pal S, 1999, WORLD DEV, V27, P1151, DOI 10.1016/S0305-750X(99)00048-0; Pande RP, 2003, DEMOGRAPHY, V40, P395, DOI 10.1353/dem.2003.0029; SEN A, 1983, ECON POLIT WEEKLY, V18, P855; SEN A, 1992, BRIT MED J, V304, P587, DOI 10.1136/bmj.304.6827.587; Sen A, 2003, BMJ-BRIT MED J, V327, P1297, DOI 10.1136/bmj.327.7427.1297; Shrinivasan R., 2012, TIMES INDIA; Svedberg P, 2009, CHILD MALNUTRITION I, P91; UN Inter-agency Group for Child Mortality Estimation, 2013, CHILD MORT EST; UN Inter-agency Group for Child Mortality Estimation, 2013, MORT RAT INF FEM PER; United Nations-Department of Economic and Social Affairs (DESA), 2011, SEX DIFF CHILDH MORT; WHO, 2003, GLOB STRAT INF YOUNG; WHO/UNICEF, 2010, IND ASS INF YOUNG 3	35	48	47	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107172	10.1371/journal.pone.0107172	http://dx.doi.org/10.1371/journal.pone.0107172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP5MS	25229235	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000342123900028
J	Igarashi, H; Maeda, S; Ohno, K; Horigome, A; Odamaki, T; Tsujimoto, H				Igarashi, Hirotaka; Maeda, Shingo; Ohno, Koichi; Horigome, Ayako; Odamaki, Toshitaka; Tsujimoto, Hajime			Effect of Oral Administration of Metronidazole or Prednisolone on Fecal Microbiota in Dogs	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ANTIBIOTIC-ASSOCIATED DIARRHEA; INVASIVE ESCHERICHIA-COLI; TOLL-LIKE RECEPTORS; CHAIN FATTY-ACID; PHYLOGENETIC CHARACTERIZATION; CLOSTRIDIUM-DIFFICILE; BACTERIAL MICROBIOTA; MOLECULAR ANALYSIS; SMALL-INTESTINE	Gastrointestinal microbiota have been implicated in the pathogenesis of various gastrointestinal disorders in dogs, including acute diarrhea and chronic enteropathy. Metronidazole and prednisolone are commonly prescribed for the treatment of these diseases; however, their effects on gastrointestinal microbiota have not been investigated. The objective of this study was to evaluate the effects of these drugs on the gastrointestinal microbiota of dogs. Metronidazole was administered twice daily at 12.5 mg/kg to a group of five healthy dogs, and prednisolone at 1.0 mg/kg daily to a second group of five healthy dogs for 14 days. Fecal samples were collected before and after administration (day 0 and 14), and 14 and 28 days after cessation (day 28 and 42). DNA was extracted, and the bacterial diversity and composition of each sample were determined based on 16S ribosomal RNA (rRNA) gene sequences using next-generation sequencing (Illumina MiSeq). In the group administered metronidazole, bacterial diversity indices significantly decreased at day 14, and recovered after the cessation. Principal coordinates analysis and hierarchical dendrogram construction based on unweighted and weighted UniFrac distance matrices revealed that bacterial composition was also significantly altered by metronidazole at day 14 compared with the other time points. The proportions of Bacteroidaceae, Clostridiaceae, Fusobacteriaceae, Lachnospiraceae, Ruminococcaceae, Turicibacteraceae, and Veillonellaceae decreased, while Bifidobacteriaceae, Enterobacteriaceae, Enterococcaceae, and Streptococcaceae increased at day 14 and returned to their initial proportions by day 42. Conversely, no effect of prednisolone was observed on either the bacterial diversity or composition. Reducing pathogenic bacteria such as Fusobacteria and increasing beneficial bacteria such as Bifidobacterium through the administration of metronidazole may be beneficial for promoting gastrointestinal health; however, further investigations into the effects on diseased dogs are needed.	[Igarashi, Hirotaka; Maeda, Shingo; Ohno, Koichi; Tsujimoto, Hajime] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Internal Med, Tokyo, Japan; [Horigome, Ayako; Odamaki, Toshitaka] Morinaga Milk Ind Co Ltd, Food Sci & Technol Inst, Tokyo, Kanagawa, Japan	University of Tokyo; Morinaga Milk Industry Company, Ltd	Ohno, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Internal Med, Tokyo, Japan.	aohno@mail.ecc.u-tokyo.ac.jp		Igarashi, Hirotaka/0000-0002-0870-8586; Tsujimoto, Hajime/0000-0002-3771-6235	Japan Society for the Promotion of Science (KAKENHI) [23380182]	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by the Grant-in-Aid for Scientific Research of the Japan Society for the Promotion of Science (KAKENHI 23380182). Veterinary Medical Center of the University of Tokyo supplied metronidazole and prednisolone, and Hill's-Colgate (JAPAN) Ltd. supplied diet used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abujamel T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076269; Allen-Vercoe E, 2011, GUT MICROBES, V2, P294, DOI 10.4161/gmic.2.5.18603; Allenspach K, 2007, J VET INTERN MED, V21, P700, DOI 10.1892/0891-6640(2007)21[700:CEIDEO]2.0.CO;2; Allenspach K, 2010, VET MICROBIOL, V146, P326, DOI 10.1016/j.vetmic.2010.05.025; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Ayyagari A, 2003, Indian J Med Microbiol, V21, P6; Baldwin K, 2010, J AM ANIM HOSP ASSOC, V46, P285, DOI 10.5326/0460285; Beloshapka AN, 2013, FEMS MICROBIOL ECOL, V84, P532, DOI 10.1111/1574-6941.12081; BORRIELLO SP, 1995, CLIN INFECT DIS, V20, pS242, DOI 10.1093/clinids/20.Supplement_2.S242; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Cave NJ, 2002, J AM VET MED ASSOC, V221, P52, DOI 10.2460/javma.2002.221.52; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chrzastowska M, 2009, POL J VET SCI, V12, P279; Citron DM, 2002, CLIN INFECT DIS, V35, pS22, DOI 10.1086/341916; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Craven M, 2004, J SMALL ANIM PRACT, V45, P336, DOI 10.1111/j.1748-5827.2004.tb00245.x; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; De La Cochetiere MF, 2005, J CLIN MICROBIOL, V43, P5588, DOI 10.1128/JCM.43.11.5588-5592.2005; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; DION YM, 1980, ANN SURG, V192, P221, DOI 10.1097/00000658-198008000-00016; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Garcia-Mazcorro JF, 2012, MICROBIOLOGYOPEN, V1, P340, DOI 10.1002/mbo3.36; Garcia-Mazcorro JF, 2011, FEMS MICROBIOL ECOL, V78, P542, DOI 10.1111/j.1574-6941.2011.01185.x; Garcia-Sancho M, 2007, J VET INTERN MED, V21, P11, DOI 10.1892/0891-6640(2007)21[11:EOCMAH]2.0.CO;2; Gupta V, 2009, INDIAN J MED MICROBI, V27, P202, DOI 10.4103/0255-0857.53201; Hang I, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-90; Hempel S, 2012, JAMA-J AM MED ASSOC, V307, P1959, DOI 10.1001/jama.2012.3507; Hooda Seema, 2012, Animal Health Research Reviews, V13, P78, DOI 10.1017/S1466252312000059; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jergens AE, 2010, J VET INTERN MED, V24, P269, DOI 10.1111/j.1939-1676.2009.0447.x; JERGENS AE, 1994, J AM ANIM HOSP ASSOC, V30, P123; Jiang T, 1997, DIGEST DIS SCI, V42, P2370, DOI 10.1023/A:1018895524114; Kahn CM, 2010, MERCK VET MANUAL, DOI DOI 10.1071/RD9910501; Kanauchi O, 2005, CURR PHARM DESIGN, V11, P1047, DOI 10.2174/1381612053381675; Kanizaj TF, 2014, WORLD J GASTROENTERO, V20, P699, DOI 10.3748/wjg.v20.i3.699; Kennedy NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088982; Kerr KR, 2013, J ANIM SCI, V91, P2504, DOI 10.2527/jas.2012-6225; Liu CX, 2008, INT J SYST EVOL MICR, V58, P1896, DOI 10.1099/ijs.0.65208-0; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Malewska K, 2011, POL J VET SCI, V14, P165, DOI 10.2478/v10181-011-0026-7; Marks SL, 2011, J VET INTERN MED, V25, P1195, DOI 10.1111/j.1939-1676.2011.00821.x; Marks SL, 2003, VET CLIN N AM-SMALL, V33, P1029, DOI 10.1016/S0195-5616(03)00091-3; Martin Steven J, 2011, J Pharm Pract, V24, P35, DOI 10.1177/0897190010388906; McFarland LV, 2006, AM J GASTROENTEROL, V101, P812, DOI 10.1111/j.1572-0241.2006.00465.x; Middelbos IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009768; Munster M, 2006, BERL MUNCH TIERARZTL, V119, P493; Nitzan O, 2013, WORLD J GASTROENTERO, V19, P7577, DOI 10.3748/wjg.v19.i43.7577; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Relman DA, 2012, NUTR REV, V70, pS2, DOI 10.1111/j.1753-4887.2012.00489.x; ROE FJC, 1977, J ANTIMICROB CHEMOTH, V3, P205, DOI 10.1093/jac/3.3.205; Rossi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094699; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sharma Rashmi, 2005, Indian J Med Sci, V59, P120; Simpson KW, 2006, INFECT IMMUN, V74, P4778, DOI 10.1128/IAI.00067-06; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Suchodolski JS, 2011, J ANIM SCI, V89, P1520, DOI 10.2527/jas.2010-3377; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039333; Suchodolski JS, 2010, VET MICROBIOL, V142, P394, DOI 10.1016/j.vetmic.2009.11.002; Suchodolski JS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-210; SUNVOLD GD, 1995, J ANIM SCI, V73, P1110; Tanabe S, 2008, INT J MOL MED, V22, P181, DOI 10.3892/ijmm_00000006; Tsukamoto A, 2012, J VET MED SCI, V74, P1103, DOI 10.1292/jvms.12-0066; Upcroft P, 2001, CLIN MICROBIOL REV, V14, P150, DOI 10.1128/CMR.14.1.150-164.2001; Vasquez N, 2009, APPL ENVIRON MICROB, V75, P381, DOI 10.1128/AEM.01731-08; Vieira AT, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00445; Willard MD, 1998, J AM VET MED ASSOC, V213, P1775; Xenoulis PG, 2008, FEMS MICROBIOL ECOL, V66, P579, DOI 10.1111/j.1574-6941.2008.00556.x	72	72	73	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107909	10.1371/journal.pone.0107909	http://dx.doi.org/10.1371/journal.pone.0107909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229475	Green Published, Green Submitted, gold			2022-12-25	WOS:000342123900087
J	Miksis-Olds, JL; Madden, LE				Miksis-Olds, Jennifer L.; Madden, Laura E.			Environmental Predictors of Ice Seal Presence in the Bering Sea	PLOS ONE			English	Article							UNDERWATER SOUND; RIBBON SEAL; AMPHIBIOUS HEARING; VOCALIZATIONS; ORIENTATION; VARIABILITY; ABUNDANCE; SENSITIVITY; FREQUENCY; TRENDS	Ice seals overwintering in the Bering Sea are challenged with foraging, finding mates, and maintaining breathing holes in a dark and ice covered environment. Due to the difficulty of studying these species in their natural environment, very little is known about how the seals navigate under ice. Here we identify specific environmental parameters, including components of the ambient background sound, that are predictive of ice seal presence in the Bering Sea. Multi-year mooring deployments provided synoptic time series of acoustic and oceanographic parameters from which environmental parameters predictive of species presence were identified through a series of mixed models. Ice cover and 10 kHz sound level were significant predictors of seal presence, with 40 kHz sound and prey presence (combined with ice cover) as potential predictors as well. Ice seal presence showed a strong positive correlation with ice cover and a negative association with 10 kHz environmental sound. On average, there was a 20-30 dB difference between sound levels during solid ice conditions compared to open water or melting conditions, providing a salient acoustic gradient between open water and solid ice conditions by which ice seals could orient. By constantly assessing the acoustic environment associated with the seasonal ice movement in the Bering Sea, it is possible that ice seals could utilize aspects of the soundscape to gauge their safe distance to open water or the ice edge by orienting in the direction of higher sound levels indicative of open water, especially in the frequency range above 1 kHz. In rapidly changing Arctic and sub-Arctic environments, the seasonal ice conditions and soundscapes are likely to change which may impact the ability of animals using ice presence and cues to successfully function during the winter breeding season.	[Miksis-Olds, Jennifer L.; Madden, Laura E.] Penn State Univ, Appl Res Lab, State Coll, PA 16804 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Miksis-Olds, JL (corresponding author), Penn State Univ, Appl Res Lab, State Coll, PA 16804 USA.	jlm91@arl.psu.edu			Office of Naval Research Award [N000140810391]	Office of Naval Research Award(Office of Naval Research)	Funding was provided by the Office of Naval Research Award N000140810391. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able K.P., 1980, P283; Berta A, 2012, MAMMAL REV, V42, P207, DOI 10.1111/j.1365-2907.2011.00193.x; Bormpoudakis D, 2013, LANDSCAPE ECOL, V28, P495, DOI 10.1007/s10980-013-9849-1; Boyd IL, 2011, OCEANOGRAPHY, V24, P174, DOI 10.5670/oceanog.2011.37; Bradbury Jack W., 1998, pi; Brierley AS, 2006, LIMNOL OCEANOGR-METH, V4, P18, DOI 10.4319/lom.2006.4.18; Burns J.J., 1981, P145; Chatterjee S., 2006, REGRESSION ANAL EXAM, DOI DOI 10.1002/0470055464; CLEATOR HJ, 1989, CAN J ZOOL, V67, P1900, DOI 10.1139/z89-272; CLEATOR HJ, 1990, CAN J FISH AQUAT SCI, V47, P1071, DOI 10.1139/f90-123; De Robertis A, 2010, CAN J FISH AQUAT SCI, V67, P1459, DOI 10.1139/F10-075; Demer DA, 2003, ICES J MAR SCI, V60, P625, DOI 10.1016/S1054-3139(03)00063-8; Friedlaender AS, 2006, MAR ECOL PROG SER, V317, P297, DOI 10.3354/meps317297; Gordon JCD, 2002, MARINE MAMMALS BIOL, P293; Jeffs A, 2003, MAR FRESHWATER RES, V54, P841, DOI 10.1071/MF03007; Jones JM, 2014, ARCTIC, V67, P203, DOI 10.14430/arctic4388; Joseph JE, 2010, J ACOUST SOC AM, V128, pEL144, DOI 10.1121/1.3425738; Kenney Robert D., 2001, Journal of Cetacean Research and Management Special Issue, V2, P251; Kunze E, 2006, SCIENCE, V313, P1768, DOI 10.1126/science.1129378; Lillis A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079337; Madsen PT, 2013, PHYSIOLOGY, V28, P276, DOI 10.1152/physiol.00008.2013; Mate Bruce R., 2003, Journal of Cetacean Research and Management, V5, P155; McCullagh P, 1989, GEN LINEAR MODELS; McWilliam JN, 2013, J EXP MAR BIOL ECOL, V446, P166, DOI 10.1016/j.jembe.2013.05.012; Miksis-Olds JL, 2013, PROG OCEANOGR, V111, P38, DOI 10.1016/j.pocean.2012.10.010; Miksis-Olds JL, 2011, AQUAT MAMM, V37, P464, DOI 10.1578/AM.37.4.2011.464; Miksis-Olds JL, 2010, APPL ACOUST, V71, P1087, DOI 10.1016/j.apacoust.2010.05.010; Norris KS, 1967, ANIMAL ORIENTATION N, P101; Nystuen JA, 1998, J ATMOS OCEAN TECH, V15, P1253, DOI 10.1175/1520-0426(1998)015<1253:TSRFAR>2.0.CO;2; Nystuen JA, 2008, J ACOUST SOC AM, V123, P1952, DOI 10.1121/1.2871485; Pijanowski BC, 2011, BIOSCIENCE, V61, P203, DOI 10.1525/bio.2011.61.3.6; Poulter TC, 1968, ANIMAL COMMUNICATION, P405; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Radford CA, 2011, CORAL REEFS, V30, P295, DOI 10.1007/s00338-010-0710-6; Radford CA, 2010, MAR ECOL PROG SER, V401, P21, DOI 10.3354/meps08451; RAY C, 1969, ZOOLOGICA-N Y, V54, P79; Reichmuth C, 2013, J COMP PHYSIOL A, V199, P491, DOI 10.1007/s00359-013-0813-y; Reiss CS, 2008, ICES J MAR SCI, V65, P497, DOI 10.1093/icesjms/fsn033; Rodriguez A, 2014, ECOL INFORM, V21, P133, DOI 10.1016/j.ecoinf.2013.12.006; Sills JM, 2014, J EXP BIOL, V217, P726, DOI 10.1242/jeb.097469; Simpson SD, 2008, ANIM BEHAV, V75, P1861, DOI 10.1016/j.anbehav.2007.11.004; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Slabbekoorn H, 2008, ANIM BEHAV, V76, pE5, DOI 10.1016/j.anbehav.2008.06.010; Smith PE, 1985, EGG PRODUCTION METHO, V36, P23; Sonafrank N, 1983, 5 BIENN C BIOL MAR M; Sousa-Lima RS, 2013, AQUAT MAMM, V39, P23, DOI 10.1578/AM.39.1.2013.23; Stabeno P, 2010, PROG OCEANOGR, V85, P180, DOI 10.1016/j.pocean.2010.02.010; Stanley JA, 2012, P ROY SOC B-BIOL SCI, V279, P3622, DOI 10.1098/rspb.2012.0697; Stanley JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028572; STIRLING I, 1983, ARCTIC, V36, P262; Sueur J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004065; TERHUNE JM, 1975, CAN J ZOOL, V53, P227, DOI 10.1139/z75-028; TERHUNE JM, 1988, CAN J ZOOL, V66, P1578, DOI 10.1139/z88-230; Tolimieri N, 2004, CORAL REEFS, V23, P184, DOI 10.1007/s00338-004-0383-0; van Opzeeland I, 2012, ADV EXP MED BIOL, V730, P357, DOI 10.1007/978-1-4419-7311-5_80; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Wagner T, 2011, N AM J FISH MANAGE, V31, P340, DOI 10.1080/02755947.2011.574081; Watkins JL, 2002, ICES J MAR SCI, V59, P1326, DOI 10.1006/jmsc.2002.1309; WATKINS WA, 1977, FISH B-NOAA, V75, P450; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J ROY STAT SOC B; Zuur AF, 2010, AED DATA FILES USED; Zuur Alain F., 2009, P1	63	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e106998	10.1371/journal.pone.0106998	http://dx.doi.org/10.1371/journal.pone.0106998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229453	Green Submitted, Green Published, gold			2022-12-25	WOS:000342123900020
J	Saito, AC; Ogura, T; Fujiwara, K; Murata, S; Nomura, SM				Saito, Akira C.; Ogura, Toshihiko; Fujiwara, Kei; Murata, Satoshi; Nomura, Shin-ichiro M.			Introducing Micrometer-Sized Artificial Objects into Live Cells: A Method for Cell-Giant Unilamellar Vesicle Electrofusion	PLOS ONE			English	Article							DNA ORIGAMI; DELIVERY; PATHWAYS; FUSION	Here, we report a method for introducing large objects of up to a micrometer in diameter into cultured mammalian cells by electrofusion of giant unilamellar vesicles. We prepared GUVs containing various artificial objects using a water-in-oil (w/o) emulsion centrifugation method. GUVs and dispersed HeLa cells were exposed to an alternating current (AC) field to induce a linear cell-GUV alignment, and then a direct current (DC) pulse was applied to facilitate transient electrofusion. With uniformly sized fluorescent beads as size indexes, we successfully and efficiently introduced beads of 1 mu m in diameter into living cells along with a plasmid mammalian expression vector. Our electrofusion did not affect cell viability. After the electrofusion, cells proliferated normally until confluence was reached, and the introduced fluorescent beads were inherited during cell division. Analysis by both confocal microscopy and flow cytometry supported these findings. As an alternative approach, we also introduced a designed nanostructure (DNA origami) into live cells. The results we report here represent a milestone for designing artificial symbiosis of functionally active objects (such as micro-machines) in living cells. Moreover, our technique can be used for drug delivery, tissue engineering, and cell manipulation.	[Saito, Akira C.; Murata, Satoshi; Nomura, Shin-ichiro M.] Tohoku Univ, Dept Bioengn & Robot, Aoba Ku, Sendai, Miyagi 980, Japan; [Ogura, Toshihiko] Tohoku Univ, Inst Dev Aging & Canc, Dept Dev Neurobiol, Aoba Ku, Sendai, Miyagi 980, Japan; [Ogura, Toshihiko] Tohoku Univ, JST, CREST, Sendai, Miyagi 980, Japan; [Fujiwara, Kei] Keio Univ, Dept Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 223, Japan; [Fujiwara, Kei] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan	Tohoku University; Tohoku University; Japan Science & Technology Agency (JST); Tohoku University; Keio University; Japan Society for the Promotion of Science	Nomura, SM (corresponding author), Tohoku Univ, Dept Bioengn & Robot, Aoba Ku, Sendai, Miyagi 980, Japan.	nomura@molbot.mech.tohoku.ac.jp	nomura, Shinichiro/AAD-9593-2019; FUJIWARA, KEI/U-8308-2019; FUJIWARA, KEI/G-5467-2010	FUJIWARA, KEI/0000-0001-7308-774X; FUJIWARA, KEI/0000-0001-7308-774X; NOMURA, Shin-ichiro/0000-0002-0346-130X; Saito, Akira/0000-0003-4204-1487	Core Research for Evolutional Science and Technology for Toshihiko Ogura;  [24104004];  [22220001];  [25610117];  [23.3718]; Grants-in-Aid for Scientific Research [22220001] Funding Source: KAKEN	Core Research for Evolutional Science and Technology for Toshihiko Ogura(Core Research for Evolutional Science and Technology (CREST)); ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (#24104004, #22220001 for Satoshi Murata and Shin-ichiro M. Nomura, #25610117 for Shin-ichiro M. Nomura, and #23.3718 for Kei Fujiwara), and Core Research for Evolutional Science and Technology for Toshihiko Ogura. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayollo DV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008027; Bath J, 2007, NAT NANOTECHNOL, V2, P275, DOI 10.1038/nnano.2007.104; de Lima MCP, 2001, ADV DRUG DELIVER REV, V47, P277, DOI 10.1016/S0169-409X(01)00110-7; Falcone S, 2006, J CELL SCI, V119, P4758, DOI 10.1242/jcs.03238; Futaki S, 2006, BIOPOLYMERS, V84, P241, DOI 10.1002/bip.20421; Hamada T, 2008, J PHYS CHEM B, V112, P14678, DOI 10.1021/jp807784j; Jiang Q, 2012, J AM CHEM SOC, V134, P13396, DOI 10.1021/ja304263n; Kuribayashi K, 2006, MEAS SCI TECHNOL, V17, P3121, DOI 10.1088/0957-0233/17/12/S01; Kusumi A, 2010, FEBS LETT, V584, P1814, DOI 10.1016/j.febslet.2010.02.047; Modi S, 2013, NAT NANOTECHNOL, V8, P459, DOI [10.1038/nnano.2013.92, 10.1038/NNANO.2013.92]; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Murase K, 2004, BIOPHYS J, V86, P4075, DOI 10.1529/biophysj.103.035717; Murata S, 2013, NEW GENERAT COMPUT, V31, P27, DOI 10.1007/s00354-012-0121-z; Natsume Y, 2013, CHEM LETT, V42, P295, DOI 10.1246/cl.2013.295; Pautot S, 2003, P NATL ACAD SCI USA, V100, P10718, DOI 10.1073/pnas.1931005100; Ranade VV, 2011, DRUG DELIVERY SYSTEMS, 3RD EDITION, P451; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Saito H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1157; Shirakashi R, 2004, INT J HEAT MASS TRAN, V47, P4517, DOI 10.1016/j.ijheatmasstransfer.2004.04.007; Shirakashi R, 2012, J THERM SCI TECH-JPN, V7, P589, DOI 10.1299/jtst.7.589; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Terasawa H, 2012, P NATL ACAD SCI USA, V109, P5942, DOI 10.1073/pnas.1120327109; Wagner V, 2006, NAT BIOTECHNOL, V24, P1211, DOI 10.1038/nbt1006-1211; Walde P, 2010, CHEMBIOCHEM, V11, P848, DOI 10.1002/cbic.201000010; Zhao F, 2011, SMALL, V7, P1322, DOI 10.1002/smll.201100001; Zhao YX, 2012, ACS NANO, V6, P8684, DOI 10.1021/nn3022662; Zuhorn IS, 2002, J MEMBRANE BIOL, V189, P167, DOI 10.1007/s00232-002-1015-7	28	21	21	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e106853	10.1371/journal.pone.0106853	http://dx.doi.org/10.1371/journal.pone.0106853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229561	gold, Green Published, Green Submitted			2022-12-25	WOS:000342123900013
J	Simpson, SD; Harrison, HB; Claereboudt, MR; Planes, S				Simpson, Stephen D.; Harrison, Hugo B.; Claereboudt, Michel R.; Planes, Serge			Long-Distance Dispersal via Ocean Currents Connects Omani Clownfish Populations throughout Entire Species Range	PLOS ONE			English	Article							LARVAL CONNECTIVITY; FISH POPULATIONS; MARINE RESERVES; PERSISTENCE; MANAGEMENT; MODEL; REPLENISHMENT; RECRUITMENT; RETENTION; PATTERNS	Dispersal is a crucial ecological process, driving population dynamics and defining the structure and persistence of populations. Measuring demographic connectivity between discreet populations remains a long-standing challenge for most marine organisms because it involves tracking the movement of pelagic larvae. Recent studies demonstrate local connectivity of reef fish populations via the dispersal of planktonic larvae, while biogeography indicates some larvae must disperse 100-1000 s kilometres. To date, empirical measures of long-distance dispersal are lacking and the full scale of dispersal is unknown. Here we provide the first measure of long-distance dispersal in a coral reef fish, the Omani clownfish Amphiprion omanensis, throughout its entire species range. Using genetic assignment tests we demonstrate bidirectional exchange of first generation migrants, with subsequent social and reproductive integration, between two populations separated by over 400 km. Immigration was 5.4% and 0.7% in each region, suggesting a biased southward exchange, and matched predictions from a physically-coupled dispersal model. This rare opportunity to measure long-distance dispersal demonstrates connectivity of isolated marine populations over distances of 100 s of kilometres and provides a unique insight into the processes of biogeography, speciation and adaptation.	[Simpson, Stephen D.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Harrison, Hugo B.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Claereboudt, Michel R.] Sultan Qaboos Univ, Dept Marine Sci & Fisheries, Al Khoud, Oman; [Planes, Serge] Univ Perpignan, Ctr Biol & Ecol Trop & Mediterraneenne, F-66025 Perpignan, Pyrenees Orient, France; [Planes, Serge] Ctr Rech Insulaires & Observ Environm, Lab Excellence CORAIL, Moorea, France	University of Exeter; James Cook University; Sultan Qaboos University; Universite Perpignan Via Domitia	Simpson, SD (corresponding author), Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England.	S.Simpson@exeter.ac.uk	Harrison, Hugo/F-6830-2012; PLANES, Serge/ABF-1360-2021	Harrison, Hugo/0000-0001-8831-0086; Simpson, Stephen/0000-0002-4856-6164	NERC [NE/B501720/1, NE/J500616/2]; Royal Society Exchange grant; EPHE Fellowship; Davis Trust; University of Edinburgh Development Trust; Carnegie Trust; BS-AC Jubilee Trust; Weir Trust; Genetics Society; British Association; Shell Oman; Natural Environment Research Council [NE/B501720/1, NE/J500616/2] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society Exchange grant(Royal Society of London); EPHE Fellowship; Davis Trust; University of Edinburgh Development Trust; Carnegie Trust(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); BS-AC Jubilee Trust; Weir Trust; Genetics Society; British Association; Shell Oman; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	SDS was supported by a NERC Postdoctorate Fellowship (NE/B501720/1), a NERC Knowledge Exchange Fellowship (NE/J500616/2), a Royal Society Exchange grant and an EPHE Fellowship. The Project NEMO Expedition Team was funded by the Davis Trust, University of Edinburgh Development Trust, Carnegie Trust, BS-AC Jubilee Trust, Weir Trust, Genetics Society, British Association and Shell Oman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Almany GR, 2013, CURR BIOL, V23, P626, DOI 10.1016/j.cub.2013.03.006; Berumen ML, 2012, ECOL EVOL, V2, P444, DOI 10.1002/ece3.208; Buston PM, 2007, MOL ECOL, V16, P3671, DOI 10.1111/j.1365-294X.2007.03421.x; Carson HS, 2011, ECOLOGY, V92, P1972, DOI 10.1890/11-0488.1; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Cornuet JM, 1999, GENETICS, V153, P1989; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Davies NB, 2012, INTRO BEHAV ECOLOGY; Excoffier L, 2005, GENETICS, V169, P1727, DOI 10.1534/genetics.104.036236; Foster NL, 2012, MOL ECOL, V21, P1143, DOI 10.1111/j.1365-294X.2012.05455.x; Gaither MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028913; Gaither MR, 2010, MOL ECOL, V19, P1107, DOI 10.1111/j.1365-294X.2010.04535.x; Galarza JA, 2009, P NATL ACAD SCI USA, V106, P1473, DOI 10.1073/pnas.0806804106; Gonzalez A, 1998, SCIENCE, V281, P2045, DOI 10.1126/science.281.5385.2045; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Green AL, 2014, COAST MANAGE, V42, P143, DOI 10.1080/08920753.2014.877763; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Hanski I., 1999, METAPOPULATION ECOLO; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hastings A, 2006, P NATL ACAD SCI USA, V103, P6067, DOI 10.1073/pnas.0506651103; Hill MF, 2002, AM NAT, V160, P389, DOI 10.1086/341526; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Kool JT, 2011, GLOBAL ECOL BIOGEOGR, V20, P695, DOI 10.1111/j.1466-8238.2010.00637.x; Leis JM, 2009, MAR ECOL PROG SER, V379, P163, DOI 10.3354/meps07904; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; McCook LJ, 2009, CORAL REEFS, V28, P353, DOI 10.1007/s00338-008-0463-7; Mooney H.A., 2000, INVASIVE SPECIES CHA; Mora C, 2012, ECOGRAPHY, V35, P89, DOI 10.1111/j.1600-0587.2011.06874.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nichols J., 2001, DISPERSAL; Nielsen EE, 2006, MOL ECOL NOTES, V6, P971, DOI 10.1111/j.1471-8286.2006.01433.x; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; Pritchard JK, 2000, GENETICS, V155, P945; Purcell JFH, 2006, P ROY SOC B-BIOL SCI, V273, P1483, DOI 10.1098/rspb.2006.3470; Quenouille B, 2004, MOL ECOL NOTES, V4, P291, DOI 10.1111/j.1471-8286.2004.00646.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Saenz-Agudelo P, 2012, MOL ECOL, V21, P4695, DOI 10.1111/j.1365-294X.2012.05726.x; Saenz-Agudelo P, 2011, P ROY SOC B-BIOL SCI, V278, P2954, DOI 10.1098/rspb.2010.2780; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Schils T, 2003, J BIOGEOGR, V30, P1339, DOI 10.1046/j.1365-2699.2003.00933.x; Shanks AL, 2009, BIOL BULL-US, V216, P373; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; Simpson SD, 2011, CURR BIOL, V21, P1565, DOI 10.1016/j.cub.2011.08.016; Trakhtenbrot A, 2005, DIVERS DISTRIB, V11, P173, DOI 10.1111/j.1366-9516.2005.00156.x; Treml EA, 2008, LANDSCAPE ECOL, V23, P19, DOI 10.1007/s10980-007-9138-y; Underwood JN, 2012, ECOL EVOL, V2, P666, DOI 10.1002/ece3.80; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Wood S, 2014, GLOBAL ECOL BIOGEOGR, V23, P1, DOI 10.1111/geb.12101	54	43	43	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107610	10.1371/journal.pone.0107610	http://dx.doi.org/10.1371/journal.pone.0107610			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229550	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900055
J	Wang, H; Fang, M; Gu, X; Ji, Q; Li, DD; Cheng, SQ; Shen, F; Gao, CF				Wang, Hui; Fang, Meng; Gu, Xing; Ji, Qiang; Li, Dongdi; Cheng, Shu-Qun; Shen, Feng; Gao, Chun-Fang			The Intracellular HBV DNAs as Novel and Sensitive Biomarkers for the Clinical Diagnosis of Occult HBV Infection in HBeAg Negative Hepatocellular Carcinoma in China	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; SURFACE-ANTIGEN; LIVER-DISEASE; PATIENT; IMPACT; RISK	This study aimed to investigate the virological status in liver (both tumor and adjacent non-tumor tissue), the clinical features and the contribution of occult HBV infection (OBI) to postoperative prognosis in HBeAg-negative(-) hepatocellular carcinoma (HCC) patients in China. Using quantitative TaqMan fluorescent real-time PCR assays, HBV covalently closed circular DNA (cccDNA) and total DNA (tDNA) were both quantified in 11 (HBsAg(-)) and 57 (HBsAg-positive(+)) pairs of tumor tissue (TT) and adjacent non-tumor tissue (ANTT) obtained from HBeAg(-) HCC patients who received no antiviral treatment and were negative for anti-HCV before surgical treatment. Of 11 HBsAg(-) patients, 36% were with HBsAb(+) HBeAb(+) HBcAb(+). However, only 9% of the HBsAg(-) patients were HBsAb(-) HBeAb(+) HBcAb(+), which accounted for the majority (93%) in the HBsAg(+) group. TT and ANTT HBV tDNAs in 11 HCC patients with HBsAg (-) and HBeAg (-) were all detectable. HBV cccDNA and tDNA were all lower in the HBsAg(-) group than those in the HBsAg(+) group. By Kaplan-Meier analysis, patients with OBI were associated with a lower risk of cirrhosis and better overall survival (OS). The intracellular HBV DNAs, such as HBV cccDNA and tDNA are valuable biological markers for the diagnosis of occult HBV infection in HCC patients. This would assist the clinical implementation of a more personalized therapy for viral re-activation control and improve the survival rate of OBI patients.	[Wang, Hui; Fang, Meng; Gu, Xing; Ji, Qiang; Gao, Chun-Fang] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Lab Med, Shanghai, Peoples R China; [Li, Dongdi] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia; [Cheng, Shu-Qun] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg 6, Shanghai, Peoples R China; [Shen, Feng] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg 4, Shanghai, Peoples R China	Naval Medical University; Australian National University; Naval Medical University; Naval Medical University	Gao, CF (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Lab Med, Shanghai, Peoples R China.	gaocf1115@163.com	cheng, sq/GPT-4112-2022; Shen, Feng/GSD-2508-2022	Wang, Hui/0000-0001-7899-7144	China National Key Projects for Infectious Disease [2012ZX10002-016]; National Natural Science Foundation of China [81271925, 81171664]; Key Projects of Science and Technology Commission of Shanghai Municipality [10411955200]	China National Key Projects for Infectious Disease; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects of Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by China National Key Projects for Infectious Disease (No. 2012ZX10002-016); National Natural Science Foundation of China (No. 81271925, No. 81171664); Key Projects of Science and Technology Commission of Shanghai Municipality (No. 10411955200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou A, 2004, J CLIN MICROBIOL, V42, P2861, DOI 10.1128/JCM.42.6.2861-2865.2004; Blackberg J, 2000, J HEPATOL, V33, P992, DOI 10.1016/S0168-8278(00)80134-8; Brechot C, 2001, HEPATOLOGY, V34, P194, DOI 10.1053/jhep.2001.25172; BRECHOT C, 1980, NATURE, V286, P533, DOI 10.1038/286533a0; BRECHOT C, 1981, P NATL ACAD SCI-BIOL, V78, P3906, DOI 10.1073/pnas.78.6.3906; Center MM, 2011, CANCER EPIDEM BIOMAR, V20, P2362, DOI 10.1158/1055-9965.EPI-11-0643; Chemin I, 2006, HEPATOLOGY, V43, P195, DOI 10.1002/hep.21008; Chemin I, 2005, J CLIN VIROL, V34, pS15, DOI 10.1016/S1386-6532(05)80005-8; De Maria N, 2000, AM J GASTROENTEROL, V95, P3529, DOI 10.1111/j.1572-0241.2000.03371.x; De Mitri MS, 2010, EUR J CANCER, V46, P2178, DOI 10.1016/j.ejca.2010.03.034; Dervite I, 2001, NEW ENGL J MED, V344, P68, DOI 10.1056/NEJM200101043440120; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gunther S, 1999, ADV VIRUS RES, V52, P25, DOI 10.1016/S0065-3527(08)60298-5; Hui CK, 2006, GASTROENTEROLOGY, V131, P59, DOI 10.1053/j.gastro.2006.04.015; Inuzuka T, 2014, J HEPATOL; Jeantet D, 2004, J MED VIROL, V73, P508, DOI 10.1002/jmv.20119; Jeantet D, 2002, HEPATOLOGY, V35, P1215, DOI 10.1053/jhep.2002.32710; Nguyen VTT, 2009, J VIRAL HEPATITIS, V16, P453, DOI 10.1111/j.1365-2893.2009.01117.x; Pollicino T, 2004, GASTROENTEROLOGY, V126, P102, DOI 10.1053/j.gastro.2003.10.048; Pollicino T, 2007, HEPATOLOGY, V45, P277, DOI 10.1002/hep.21529; Pollicino T, 2011, CARCINOGENESIS, V32, P1122, DOI 10.1093/carcin/bgr108; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Raimondo G, 2013, SEMIN IMMUNOPATHOL, V35, P39, DOI 10.1007/s00281-012-0327-7; Rodriguez-Inigo E, 2003, J MED VIROL, V70, P571, DOI 10.1002/jmv.10432; Sagnelli E, 2001, J MED VIROL, V64, P350, DOI 10.1002/jmv.1057; Saito T, 1999, J MED VIROL, V58, P325, DOI 10.1002/(SICI)1096-9071(199908)58:4&lt;325::AID-JMV2&gt;3.0.CO;2-L; SHAFRITZ DA, 1981, NEW ENGL J MED, V305, P1067, DOI 10.1056/NEJM198110293051807; Wagner AA, 2004, AIDS, V18, P569, DOI 10.1097/00002030-200402200-00028; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wong DKH, 2011, HEPATOLOGY, V54, P829, DOI 10.1002/hep.24551; Wong DKH, 2006, J HEPATOL, V45, P553, DOI 10.1016/j.jhep.2006.05.014	31	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107162	10.1371/journal.pone.0107162	http://dx.doi.org/10.1371/journal.pone.0107162			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229710	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900027
J	Bresson, J; Vasseur, F; Dauzat, M; Labadie, M; Varoquaux, F; Touraine, B; Vile, D				Bresson, Justine; Vasseur, Francois; Dauzat, Myriam; Labadie, Marc; Varoquaux, Fabrice; Touraine, Bruno; Vile, Denis			Interact to Survive: Phyllobacterium brassicacearum Improves Arabidopsis Tolerance to Severe Water Deficit and Growth Recovery	PLOS ONE			English	Article							PLANT-GROWTH; DROUGHT TOLERANCE; CHLOROPHYLL FLUORESCENCE; LEAF SENESCENCE; COLD-ACCLIMATION; STRESS; MECHANISMS; THALIANA; BACTERIA; SOIL	Mutualistic bacteria can alter plant phenotypes and confer new abilities to plants. Some plant growth-promoting rhizobacteria (PGPR) are known to improve both plant growth and tolerance to multiple stresses, including drought, but reports on their effects on plant survival under severe water deficits are scarce. We investigated the effect of Phyllobacterium brassicacearum STM196 strain, a PGPR isolated from the rhizosphere of oilseed rape, on survival, growth and physiological responses of Arabidopsis thaliana to severe water deficits combining destructive and non-destructive high-throughput phenotyping. Soil inoculation with STM196 greatly increased the survival rate of A. thaliana under several scenarios of severe water deficit. Photosystem II efficiency, assessed at the whole-plant level by high-throughput fluorescence imaging (Fv/Fm), was related to the probability of survival and revealed that STM196 delayed plant mortality. Inoculated surviving plants tolerated more damages to the photosynthetic tissues through a delayed dehydration and a better tolerance to low water status. Importantly, STM196 allowed a better recovery of plant growth after rewatering and stressed plants reached a similar biomass at flowering than non-stressed plants. Our results highlight the importance of plant-bacteria interactions in plant responses to severe drought and provide a new avenue of investigations to improve drought tolerance in agriculture.	[Bresson, Justine; Vasseur, Francois; Dauzat, Myriam; Labadie, Marc; Vile, Denis] Inst Natl Rech Agron SupAgro, UMR759, LEPSE, Montpellier, France; [Bresson, Justine; Labadie, Marc; Varoquaux, Fabrice; Touraine, Bruno] Univ Montpellier 2, UMR113, LSTM, IRD,CIRAD,INRA,SupAgro, Montpellier, France; [Vasseur, Francois] Max Planck Inst Dev Biol, Tubingen, Germany	INRAE; Institut Agro; Montpellier SupAgro; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Max Planck Society	Vile, D (corresponding author), Inst Natl Rech Agron SupAgro, UMR759, LEPSE, Montpellier, France.	denis.vile@supagro.inra.fr	LABADIE, Marc/AAC-8431-2019; Vile, Denis/A-5637-2008	LABADIE, Marc/0000-0001-9923-8817; Vile, Denis/0000-0002-7948-1462; BRESSON, Justine/0000-0003-2365-5985; VASSEUR, Francois/0000-0002-0575-6216	French Ministry of Higher Education and Research	French Ministry of Higher Education and Research	JB was funded by French Ministry of Higher Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzanesh MH, 2011, WORLD J MICROB BIOT, V27, P197, DOI 10.1007/s11274-010-0444-1; Babalola OO, 2010, BIOTECHNOL LETT, V32, P1559, DOI 10.1007/s10529-010-0347-0; Belimov AA, 2009, NEW PHYTOL, V181, P413, DOI 10.1111/j.1469-8137.2008.02657.x; BENGTSON C, 1977, PHYSIOL PLANTARUM, V41, P149, DOI 10.1111/j.1399-3054.1977.tb05548.x; Bertrand H, 2001, BIOL FERT SOILS, V33, P152, DOI 10.1007/s003740000305; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Bresson J, 2013, NEW PHYTOL, V200, P558, DOI 10.1111/nph.12383; CHAVES MM, 1991, J EXP BOT, V42, P1, DOI 10.1093/jxb/42.1.1; Cheng HP, 1998, J BACTERIOL, V180, P5183, DOI 10.1128/JB.180.19.5183-5191.1998; Contesto C, 2010, PLANTA, V232, P1455, DOI 10.1007/s00425-010-1264-0; Creus CM, 2004, CAN J BOT, V82, P273, DOI [10.1139/b03-119, 10.1139/B03-119]; Diaz C, 2005, PLANT PHYSIOL, V138, P898, DOI 10.1104/pp.105.060764; Dimkpa C, 2009, PLANT CELL ENVIRON, V32, P1682, DOI 10.1111/j.1365-3040.2009.02028.x; Ehlert B, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-12; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Fabre J, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-77; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI [10.1007/978-90-481-2666-8_12, 10.1051/agro:2008021]; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Figueiredo MVB, 2008, APPL SOIL ECOL, V40, P182, DOI 10.1016/j.apsoil.2008.04.005; Galland M, 2012, PLANT SCI, V190, P74, DOI 10.1016/j.plantsci.2012.03.008; Galmes J, 2007, PHYSIOL PLANTARUM, V130, P495, DOI 10.1111/j.1399-3054.2007.00919.x; Granier C, 2006, NEW PHYTOL, V169, P623, DOI 10.1111/j.1469-8137.2005.01609.x; Gray GR, 2003, PHYSIOL PLANTARUM, V119, P365, DOI 10.1034/j.1399-3054.2003.00224.x; Grayson Michelle, 2013, Nature, V501, pS1, DOI 10.1038/501S1a; Vendruscolo ECG, 2007, J PLANT PHYSIOL, V164, P1367, DOI 10.1016/j.jplph.2007.05.001; Halvorson HO, 1933, J BACTERIOL, V25, P101, DOI 10.1128/JB.25.2.101-121.1933; Heidari M., 2012, Journal of the Saudi Society of Agricultural Sciences, V11, P57; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P1, DOI DOI 10.1007/S12374-010-9112-0; Jansen M, 2009, FUNCT PLANT BIOL, V36, P902, DOI 10.1071/FP09095; Poupin MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069435; Kechid M, 2013, NEW PHYTOL, V198, P514, DOI 10.1111/nph.12158; Kohler J, 2008, FUNCT PLANT BIOL, V35, P141, DOI 10.1071/FP07218; Kranner I, 2002, PLANT J, V31, P13, DOI 10.1046/j.1365-313X.2002.01329.x; Kursar TA, 2009, FUNCT ECOL, V23, P93, DOI 10.1111/j.1365-2435.2008.01483.x; Larcher M, 2003, NEW PHYTOL, V160, P119, DOI 10.1046/j.1469-8137.2003.00862.x; Lawlor DW, 2013, J EXP BOT, V64, P83, DOI 10.1093/jxb/ers326; Lechner L, 2008, ANN BOT-LONDON, V101, P1007, DOI 10.1093/aob/mcn029; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Liu F, 2013, APPL MICROBIOL BIOT, P1; Lucy M, 2004, ANTON LEEUW INT J G, V86, P1, DOI 10.1023/B:ANTO.0000024903.10757.6e; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Mantelin S, 2006, INT J SYST EVOL MICR, V56, P827, DOI 10.1099/ijs.0.63911-0; Mantelin S, 2006, PLANTA, V223, P591, DOI 10.1007/s00425-005-0106-y; Marulanda A, 2009, J PLANT GROWTH REGUL, V28, P115, DOI 10.1007/s00344-009-9079-6; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; McDowell NG, 2011, PLANT PHYSIOL, V155, P1051, DOI 10.1104/pp.110.170704; Moore JP, 2009, TRENDS PLANT SCI, V14, P110, DOI 10.1016/j.tplants.2008.11.007; Morgan PW, 1990, STRESS RESPONSES PLA, P113; Munne-Bosch S, 2004, FUNCT PLANT BIOL, V31, P203, DOI 10.1071/FP03236; Murchie E., 2013, J EXP BOT; Ono K, 2001, PLANT BIOLOGY, V3, P234, DOI 10.1055/s-2001-15201; Padilla FM, 2007, FUNCT ECOL, V21, P489, DOI 10.1111/j.1365-2435.2007.01267.x; R Development Core Team, 2009, R FDN STAT COMP; Rincon A, 2008, TREE PHYSIOL, V28, P1693, DOI 10.1093/treephys/28.11.1693; Rivero RM, 2007, P NATL ACAD SCI USA, V104, P19631, DOI 10.1073/pnas.0709453104; Rodriguez-Salazar J, 2009, FEMS MICROBIOL LETT, V296, P52, DOI 10.1111/j.1574-6968.2009.01614.x; Ruiz-Sanchez M, 2010, J PLANT PHYSIOL, V167, P862, DOI 10.1016/j.jplph.2010.01.018; Sakamoto A, 2002, PLANT CELL ENVIRON, V25, P163, DOI 10.1046/j.0016-8025.2001.00790.x; Salomon MV, 2013, PHYSL PLANTARUM; Selosse MA, 2004, CR BIOL, V327, P639, DOI 10.1016/j.crvi.2003.12.008; Skirycz A, 2011, NAT BIOTECHNOL, V29, P212, DOI 10.1038/nbt.1800; Sperdouli I, 2012, PLANT BIOLOGY, V14, P118, DOI 10.1111/j.1438-8677.2011.00473.x; Suarez R, 2008, MOL PLANT MICROBE IN, V21, P958, DOI 10.1094/MPMI-21-7-0958; Taiz L., 2018, FUNDAMENTALS PLANT P; Timmusk S, 2013, J FOOD SECURITY, V1, P6, DOI DOI 10.12691/JFS-1-1-2; Tyree MT, 2003, PLANT PHYSIOL, V132, P1439, DOI 10.1104/pp.102.018937; Vardharajula S, 2011, J PLANT INTERACT, V6, P1, DOI 10.1080/17429145.2010.535178; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Wang C, 2012, PLOS ONE, V7; Wingler A, 2006, J EXP BOT, V57, P391, DOI 10.1093/jxb/eri279; Woo NS, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-27; Xu ZZ, 2009, J EXP BOT, V60, P3737, DOI 10.1093/jxb/erp216; Yang J, 2009, TRENDS PLANT SCI, V14, P1, DOI 10.1016/j.tplants.2008.10.004	74	31	32	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107607	10.1371/journal.pone.0107607	http://dx.doi.org/10.1371/journal.pone.0107607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226036	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700066
J	Batchelder, KA; Tanenbaum, AB; Albert, S; Guimond, L; Kestener, P; Arneodo, A; Khalil, A				Batchelder, Kendra A.; Tanenbaum, Aaron B.; Albert, Seth; Guimond, Lyne; Kestener, Pierre; Arneodo, Alain; Khalil, Andre			Wavelet-Based 3D Reconstruction of Microcalcification Clusters from Two Mammographic Views: New Evidence That Fractal Tumors Are Malignant and Euclidean Tumors Are Benign	PLOS ONE			English	Article							COMPUTER-AIDED DETECTION; MULTIFRACTAL IMAGE-ANALYSIS; BREAST-CANCER DIAGNOSIS; AUTOMATED DETECTION; MASS DETECTION; SEGMENTATION; FORMALISM; FEATURES; TEXTURE; SHAPE	The 2D Wavelet-Transform Modulus Maxima (WTMM) method was used to detect microcalcifications (MC) in human breast tissue seen in mammograms and to characterize the fractal geometry of benign and malignant MC clusters. This was done in the context of a preliminary analysis of a small dataset, via a novel way to partition the wavelet-transform space-scale skeleton. For the first time, the estimated 3D fractal structure of a breast lesion was inferred by pairing the information from two separate 2D projected mammographic views of the same breast, i.e. the cranial-caudal (CC) and mediolateral-oblique (MLO) views. As a novelty, we define the "CC-MLO fractal dimension plot", where a "fractal zone" and "Euclidean zones" (non-fractal) are defined. 118 images (59 cases, 25 malignant and 34 benign) obtained from a digital databank of mammograms with known radiologist diagnostics were analyzed to determine which cases would be plotted in the fractal zone and which cases would fall in the Euclidean zones. 92% of malignant breast lesions studied (23 out of 25 cases) were in the fractal zone while 88% of the benign lesions were in the Euclidean zones (30 out of 34 cases). Furthermore, a Bayesian statistical analysis shows that, with 95% credibility, the probability that fractal breast lesions are malignant is between 74% and 98%. Alternatively, with 95% credibility, the probability that Euclidean breast lesions are benign is between 76% and 96%. These results support the notion that the fractal structure of malignant tumors is more likely to be associated with an invasive behavior into the surrounding tissue compared to the less invasive, Euclidean structure of benign tumors. Finally, based on indirect 3D reconstructions from the 2D views, we conjecture that all breast tumors considered in this study, benign and malignant, fractal or Euclidean, restrict their growth to 2-dimensional manifolds within the breast tissue.	[Batchelder, Kendra A.; Tanenbaum, Aaron B.; Albert, Seth; Guimond, Lyne; Khalil, Andre] Univ Maine, CompuMAINE Lab, Orono, ME 04469 USA; [Batchelder, Kendra A.; Tanenbaum, Aaron B.; Albert, Seth; Guimond, Lyne; Khalil, Andre] Univ Maine, Dept Math & Stat, Orono, ME USA; [Batchelder, Kendra A.; Tanenbaum, Aaron B.; Albert, Seth; Guimond, Lyne; Khalil, Andre] Univ Maine, Inst Mol Biophys, Orono, ME USA; [Kestener, Pierre] Comis Energia Atom, Gif Sur Yvette, France; [Arneodo, Alain] Ecole Normale Super Lyon, Phys Lab, F-69364 Lyon, France; [Arneodo, Alain] Ecole Normale Super Lyon, CNRS, F-69364 Lyon, France	University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; CEA; Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Khalil, A (corresponding author), Univ Maine, CompuMAINE Lab, Orono, ME 04469 USA.	andre.khalil@maine.edu	Arneodo, Alain/I-4412-2017	Arneodo, Alain/0000-0002-3690-2108	Maine Cancer Foundation; Institute for Molecular Biophysics; Department of Mathematics at the University of Maine	Maine Cancer Foundation; Institute for Molecular Biophysics; Department of Mathematics at the University of Maine	This work was funded through a grant from the Maine Cancer Foundation, as well as funds from the Institute for Molecular Biophysics and the Department of Mathematics at the University of Maine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlZubi S, 2011, INT J BIOMED IMAGING, V2011, DOI 10.1155/2011/136034; Amaral LAN, 2001, PHYS REV LETT, V86, P6026, DOI 10.1103/PhysRevLett.86.6026; [Anonymous], 2013, TEXTS STAT SCI SERIE; [Anonymous], 1999, WAVELET TOUR SIGNAL, DOI DOI 10.1016/B978-012466606-1/50016-7; ARGOUL F, 1988, PHYS REV LETT, V61, P2558, DOI 10.1103/PhysRevLett.61.2558; Arnedo A, 2000, EUR PHYS J B, V15, P567, DOI 10.1007/s100510051161; ARNEODO A, 1995, PHYSICA A, V213, P232, DOI 10.1016/0378-4371(94)00163-N; Arneodo A, 2003, ADV IMAG ELECT PHYS, V126, P1, DOI 10.1016/S1076-5670(03)80014-9; Autier P, 2011, ANN ONCOL, V22, P1726, DOI 10.1093/annonc/mdq633; Ayer Turgay, 2010, Imaging Med, V2, P313, DOI 10.2217/iim.10.24; Baish JW, 2000, CANCER RES, V60, P3683; Bizzarri M, 2011, SEMIN CANCER BIOL, V21, P175, DOI 10.1016/j.semcancer.2011.04.002; Bocchi L, 2004, MED ENG PHYS, V26, P303, DOI 10.1016/j.medengphy.2003.11.009; Bunk W, 2002, SCI DISASTERS, P282; Caddle LB, 2007, CHROMOSOME RES, V15, P1061, DOI 10.1007/s10577-007-1181-7; Chan HP, 2008, MED PHYS, V35, P4087, DOI 10.1118/1.2968098; Chan HP, 2005, RADIOLOGY, V237, P1075, DOI 10.1148/radiol.2373041657; CLARIDGE E, 1992, J BIOMED ENG, V14, P229, DOI 10.1016/0141-5425(92)90057-R; Cross SS, 1997, J PATHOL, V182, P1; CROSS SS, 1995, AM J DERMATOPATH, V17, P374, DOI 10.1097/00000372-199508000-00012; D'Anselmi F, 2011, INT J BIOCHEM CELL B, V43, P1052, DOI 10.1016/j.biocel.2010.05.002; Decoster N, 2000, EUR PHYS J B, V15, P739, DOI 10.1007/s100510051179; Eadie LH, 2012, EUR J RADIOL, V81, pE70, DOI 10.1016/j.ejrad.2011.01.098; Eberl MM, 2006, J AM BOARD FAM MED, V19, P161, DOI 10.3122/jabfm.19.2.161; Eid R, 2003, PATHOL RES PRACT, V199, P475; Eltoukhy MM, 2012, COMPUT BIOL MED, V42, P123, DOI 10.1016/j.compbiomed.2011.10.016; Eltoukhy MM, 2010, COMPUT BIOL MED, V40, P384, DOI 10.1016/j.compbiomed.2010.02.002; England NHS, 2013, CCG PROGR BUDG BENCH; Fenton JJ, 2007, NEW ENGL J MED, V356, P1399, DOI 10.1056/NEJMoa066099; Fenton JJ, 2013, ANN INTERN MED, V158, P580, DOI 10.7326/0003-4819-158-8-201304160-00002; Fenton JJ, 2011, J NATL CANCER I, V103, P1152, DOI 10.1093/jnci/djr206; GAZIT Y, 1995, PHYS REV LETT, V75, P2428, DOI 10.1103/PhysRevLett.75.2428; Georgian-Smith D, 2007, AM J ROENTGENOL, V189, P1135, DOI 10.2214/AJR.07.2393; Gerasimova E, 2013, EPL-EUROPHYS LETT, V104, DOI 10.1209/0295-5075/104/68001; Gerasimova E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00176; Gilbert FJ, 2008, NEW ENGL J MED, V359, P1675, DOI 10.1056/NEJMoa0803545; Goody MF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001409; Goody MF, 2010, DEV BIOL, V344, P809, DOI 10.1016/j.ydbio.2010.05.513; Grant J, 2010, CHROMOSOME RES, V18, P873, DOI 10.1007/s10577-010-9175-2; Haberle L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3163; Heath M, 1998, COMP IMAG VIS, V13, P457; Heath M, 2001, DIGITAL DATABASE SCR, P212; Horsch A, 2011, INT J COMPUT ASS RAD, V6, P749, DOI 10.1007/s11548-011-0553-9; Hunt BR, 1997, NONLINEARITY, V10, P1031, DOI 10.1088/0951-7715/10/5/002; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; Ivanov PC, 2001, CHAOS, V11, P641, DOI 10.1063/1.1395631; Jorgensen KJ, 2013, INT J CANCER, V132, P1725, DOI 10.1002/ijc.27808; Jorgensen KJ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3212; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Karahaliou AN, 2008, IEEE T INF TECHNOL B, V12, P731, DOI 10.1109/TITB.2008.920634; Ke L, 2009, IEEE ENG MED BIO, P5760, DOI 10.1109/IEMBS.2009.5332615; Kestener P, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.194501; Kestener P, 2010, ASTROPHYS J, V717, P995, DOI 10.1088/0004-637X/717/2/995; Kestener P., 2001, IMAGE ANAL STEREOL, V20, P169, DOI 10.5566/ias.v20.p169-174; Khalil A, 2007, CHROMOSOME RES, V15, P899, DOI 10.1007/s10577-007-1172-8; Khalil A, 2006, ASTROPHYS J SUPPL S, V165, P512, DOI 10.1086/505144; Khalil A, 2009, MED ENG PHYS, V31, P775, DOI 10.1016/j.medengphy.2009.02.007; Kilic N, 2010, J MED SYST, V34, P1083, DOI 10.1007/s10916-009-9326-1; Kim SJ, 2009, ACTA RADIOL, V50, P999, DOI 10.3109/02841850903216700; Kruschke J. K., 2011, DOING BAYESIAN DATA; KUHN A, 1994, PHYS REV LETT, V73, P2998, DOI 10.1103/PhysRevLett.73.2998; Lacquement MA, 1999, J AM COLL SURGEONS, V189, P34, DOI 10.1016/S1072-7515(99)00080-0; Landini G, 1996, J PATHOL, V179, P210; LEFEBVRE F, 1995, MED PHYS, V22, P381, DOI 10.1118/1.597473; Li H, 1997, IEEE T MED IMAGING, V16, P785, DOI 10.1109/42.650875; LOSA GA, 2002, FRACTALS BIOL MED; Ma Li, 2008, 2008 2nd International Conference on Bioinformatics and Biomedical Engineering (ICBBE '08), P361; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; Manduca A, 2009, CANCER EPIDEM BIOMAR, V18, P837, DOI 10.1158/1055-9965.EPI-08-0631; McAteer RTJ, 2010, SOL PHYS, V262, P387, DOI 10.1007/s11207-010-9530-7; Michaelson JS, 2005, BRIT J CANCER, V93, P1244, DOI 10.1038/sj.bjc.6602848; MUZY JF, 1993, PHYS REV E, V47, P875, DOI 10.1103/PhysRevE.47.875; MUZY JF, 1994, INT J BIFURCAT CHAOS, V4, P245, DOI 10.1142/S0218127494000204; MUZY JF, 1991, PHYS REV LETT, V67, P3515, DOI 10.1103/PhysRevLett.67.3515; Niwas SI, 2012, J MED SYST, V36, P3091, DOI 10.1007/s10916-011-9788-9; Noble M, 2009, ARCH GYNECOL OBSTET, V279, P881, DOI 10.1007/s00404-008-0841-y; Onega T, 2013, ACAD RADIOL, V20, P731, DOI 10.1016/j.acra.2013.01.012; Orel SG, 1999, RADIOLOGY, V211, P845, DOI 10.1148/radiology.211.3.r99jn31845; Raguso G, 2010, IEEE ENG MED BIO, P3182, DOI 10.1109/IEMBS.2010.5627180; Rangayyan RM, 2007, J DIGIT IMAGING, V20, P223, DOI 10.1007/s10278-006-0860-9; Rangayyan RM, 2010, IEEE ENG MED BIO, P6737, DOI 10.1109/IEMBS.2010.5626017; Reiser I, 2008, MED PHYS, V35, P1486, DOI 10.1118/1.2885366; Reiser I, 2006, MED PHYS, V33, P482, DOI 10.1118/1.2163390; Reiser I, 2004, TECHNOL CANCER RES T, V3, P437, DOI 10.1177/153303460400300504; Reiser I, 2011, MED PHYS, V38, P5303, DOI 10.1118/1.3633905; Roland T, 2009, SURF SCI, V603, P3307, DOI 10.1016/j.susc.2009.09.021; Roux SG, 2000, EUR PHYS J B, V15, P765, DOI 10.1007/s100510051180; Sankar D, 2010, J DIGIT IMAGING, V23, P538, DOI 10.1007/s10278-009-9224-6; Singh S, 2008, MED PHYS, V35, P3626, DOI 10.1118/1.2953562; Snow CJ, 2008, DEV DYNAM, V237, P2542, DOI 10.1002/dvdy.21670; Snow CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000219; Stotzka R, 1998, P SOC PHOTO-OPT INS, V3338, P513, DOI 10.1117/12.310930; Thangavel K, 2012, Int J Bioinform Res Appl, V8, P436, DOI 10.1504/IJBRA.2012.049626; Tracqui P, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/5/056701; Tsai NC, 2011, COMPUT MED IMAG GRAP, V35, P1, DOI 10.1016/j.compmedimag.2010.08.005; Velayutham C., 2012, International Journal of Computational Biology and Drug Design, V5, P16, DOI 10.1504/IJCBDD.2012.045949; WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400; Zanca F, 2009, MED PHYS, V36, P765, DOI 10.1118/1.3077121	98	25	25	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107580	10.1371/journal.pone.0107580	http://dx.doi.org/10.1371/journal.pone.0107580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222610	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774800084
J	Si, YH; Li, JG; Niu, YQ; Liu, XY; Ren, LL; Guo, L; Cheng, M; Zhou, HL; Wang, JW; Jin, Q; Yang, W				Si, Youhui; Li, Jianguo; Niu, Yuqiang; Liu, Xiuying; Ren, Lili; Guo, Li; Cheng, Min; Zhou, Hongli; Wang, Jianwei; Jin, Qi; Yang, Wei			Entry Properties and Entry Inhibitors of a Human H7N9 Influenza Virus	PLOS ONE			English	Article							AVIAN INFLUENZA; A VIRUS; CLEAVAGE SITE; HEMAGGLUTININ; CELLS; PATHOGENICITY; CHLOROQUINE; INFECTION; PEPTIDE; FUSION	The recently identified human infections with a novel avian influenza H7N9 virus in China raise important questions regarding possible risk to humans. However, the entry properties and tropism of this H7N9 virus were poorly understood. Moreover, neuraminidase inhibitor resistant H7N9 isolates were recently observed in two patients and correlated with poor clinical outcomes. In this study, we aimed to elucidate the entry properties of H7N9 virus, design and evaluate inhibitors for H7N9 virus entry. We optimized and developed an H7N9-pseudotyped particle system (H7N9pp) that could be neutralized by anti-H7 antibodies and closely mimicked the entry process of the H7N9 virus. Avian, human and mouse-derived cultured cells showed high, moderate and low permissiveness to H7N9pp, respectively. Based on influenza virus membrane fusion mechanisms, a potent anti-H7N9 peptide (P155-185-chol) corresponding to the C-terminal ectodomain of the H7N9 hemagglutinin protein was successfully identified. P155-185-chol demonstrated H7N9pp-specific inhibition of infection with IC50 of 0.19 mu M. Importantly, P155-185-chol showed significant suppression of A/Anhui/1/2013 H7N9 live virus propagation in MDCK cells and additive effects with NA inhibitors Oseltamivir and Zanamivir. These findings expand our knowledge of the entry properties of the novel H7N9 viruses, and they highlight the potential for developing a new class of inhibitors targeting viral entry for use in the next pandemic.	[Wang, Jianwei] Chinese Acad Med Sci, Inst Pathogen Biol, Key Lab Syst Biol Pathogens, Minist Hlth, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, JW (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, Key Lab Syst Biol Pathogens, Minist Hlth, Beijing 100730, Peoples R China.	wangjw28@163.com; zdsys@vip.sina.com; wyang@ipb.pumc.edu.cn	Wang, Jianwei/W-5916-2019; Wang, Jianwei/AAW-9499-2020; Si, Youhui/O-6274-2017; Li, Jianguo/T-3372-2019	Wang, Jianwei/0000-0002-1116-4559; Li, Jianguo/0000-0002-2251-8308; Si, Youhui/0000-0001-8909-221X	National Science and Technology Major Project of China [2012ZX10002007-003]; National Basic Research Program of China [2011CB504800]; National Natural Science Foundation of China [81271831, 81301442]; Institute of Pathogen Biology [2013IPB103]	National Science and Technology Major Project of China; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Institute of Pathogen Biology	This work was supported by grants from National Science and Technology Major Project of China (2012ZX10002007-003), National Basic Research Program of China (2011CB504800), National Natural Science Foundation of China (81271831 and 81301442) and an intramural grant from the Institute of Pathogen Biology (2013IPB103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Y, 2013, LANCET; de Vries E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001329; Di Trani L, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-39; Dong G, 2011, PLOS ONE, V6; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Garten W, 1999, TRENDS MICROBIOL, V7, P99, DOI 10.1016/S0966-842X(99)01460-2; Guo Y, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-39; HORIMOTO T, 1994, J VIROL, V68, P3120, DOI 10.1128/JVI.68.5.3120-3128.1994; Hu Y., 2013, LANCET; Huang IC, 2008, J VIROL, V82, P4834, DOI 10.1128/JVI.00079-08; Jones JC, 2006, J VIROL, V80, P11960, DOI 10.1128/JVI.01678-06; Jones JC, 2011, ANTIMICROB AGENTS CH, V55, P1810, DOI 10.1128/AAC.01428-10; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Kido Hiroshi, 2008, J Mol Genet Med, V3, P167; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Lee KK, 2011, J BIOL CHEM, V286, P42141, DOI 10.1074/jbc.M111.254243; Li RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041956; Liu XY, 2013, J VIROL, V87, P1649, DOI 10.1128/JVI.02201-12; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; OCHIAI H, 1995, ANTIVIR RES, V27, P425, DOI 10.1016/0166-3542(95)00040-S; Oh HLJ, 2010, J VIROL, V84, P8275, DOI 10.1128/JVI.02593-09; Ooi EE, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-39; Park HE, 2003, NAT STRUCT BIOL, V10, P1048, DOI 10.1038/nsb1012; Pasick J, 2009, REV SCI TECH OIE, V28, P349, DOI 10.20506/rst.28.1.1875; Ramos I, 2013, J GEN VIROL; Senne DA, 1996, AVIAN DIS, V40, P425, DOI 10.2307/1592241; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; Trock SC, 2010, AVIAN DIS, V54, P340, DOI 10.1637/8728-032409-ResNote.1; Wang HL, 2009, SCI CHINA SER C, V52, P464, DOI 10.1007/s11427-009-0061-0; Watanabe T, 2013, NATURE; Xiong X., 2013, NATURE; Yen HL, 2013, MBIO, V16, P4, DOI DOI 10.1128/MBI0.00396-13; Zhao RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023374	34	5	7	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107235	10.1371/journal.pone.0107235	http://dx.doi.org/10.1371/journal.pone.0107235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222852	Green Submitted, Green Published, gold			2022-12-25	WOS:000341774800054
J	Wang, XF; Jiang, FL; Liang, Y; Xu, LN; Li, HB; Liu, YL; Liu, SG; Ye, YH				Wang, Xuefeng; Jiang, Fengli; Liang, Yu; Xu, Lina; Li, Hongbo; Liu, Yali; Liu, Shiguo; Ye, Yuanhua			Interleukin-1 beta-31C/T and-511T/C Polymorphisms Were Associated with Preeclampsia in Chinese Han Population	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SINGLE NUCLEOTIDE POLYMORPHISMS; SERUM-LEVELS; INFLAMMATORY RESPONSE; CYTOKINES; GENE; INTERLEUKIN-6; HYPERTENSION; EXPRESSION; PREGNANCY	Objective: The purpose of our study is to investigate the relationship between IL-1 beta -31C/T (rs1143627) and -511T/C (rs16944) polymorphisms and the preeclampsia (PE), and analyze the Linkage disequilibrium (LD) and haplotype frequency of the two polymorphism loci. Methods: Polymorphisms at -31C/T and -511T/C of IL-1 beta were genotyped with the method of polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in 232 PE and 447 control subjects. Genotype and allele frequencies between case-control groups were compared by chi-square(chi(2)) tests. Two-point LD and haplotype frequency analyses were done with the software Haploview4.2. Results: Significant statistical differences were found between PE and control groups regarding genotype and allele frequencies of the two polymorphisms of IL-1 beta (For IL-1 beta -31C/T: chi(2) = 11.478, P = 0.003; For IL-1 beta-511T/C: chi(2) = 9.687, P = 0.008). LD analysis revealed that the IL-1 beta -31C/T SNP was in high LD with the IL-1 beta-511C/T SNP(D' = 0.92, r(2) = 0.79). Both CT and TC haplotypes showed significant differences between case and control groups. Only the plasma level of Prothrombin Time had a significantly statistical difference among TT, CT and CC groups of the preeclamptic two polymorphisms of IL-1 beta-31C/T and -511T/C (for IL-1 beta-31C/T, F = 1.644, P = 0.01; F = 1.587, P = 0.016). Conclusion: Our results revealed IL-1 beta was associated with the PE in Chinese Han population. The CT haplotype may increase the risk of PE, while haplotype TC could be considered as a protective haplotype of PE.	[Wang, Xuefeng; Liu, Shiguo; Ye, Yuanhua] Qingdao Univ, Affiliated Hosp, Prenatal Diag Ctr, Qingdao 266071, Peoples R China; [Wang, Xuefeng; Liu, Shiguo] Qingdao Univ, Affiliated Hosp, Shandong Prov Key Lab Metab Dis, Qingdao 266071, Peoples R China; [Jiang, Fengli] Qingdao Univ, Coll Med, Dept Clin Lab Diag, Qingdao 266071, Peoples R China; [Liang, Yu] Qingdao Univ, Affiliated Hosp, Dept Intervent Radiol, Qingdao 266071, Peoples R China; [Xu, Lina] Heze Med Coll, Dept Resp Med, Heze, Peoples R China; [Li, Hongbo] Qingdao Univ, Songshan Hosp, Coll Med, Dept Intervent Radiol, Qingdao 266071, Peoples R China; [Liu, Yali] Qingdao Fuwai Cardiovasc Hosp, Qingdao, Peoples R China	Qingdao University; Qingdao University; Qingdao University; Qingdao University; Qingdao University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Liu, SG (corresponding author), Qingdao Univ, Affiliated Hosp, Prenatal Diag Ctr, Qingdao 266071, Peoples R China.	liushiguo2002@126.com; yeyuanhua8067@126.com	xu, li/GNH-3667-2022		National Natural Science Foundation of China [81371499, 30971586]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81371499 and 30971586). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanbay I, 2012, ARCH GYNECOL OBSTET, V285, P1505, DOI 10.1007/s00404-011-2157-6; Amash A, 2012, J INTERF CYTOK RES, V32, P432, DOI 10.1089/jir.2012.0013; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Chen HM, 2006, HUM MOL GENET, V15, P519, DOI 10.1093/hmg/ddi469; Diaz L, 2009, J REPROD IMMUNOL, V81, P17, DOI 10.1016/j.jri.2009.02.005; Dundar O, 2008, PRENATAL DIAG, V28, P1052, DOI 10.1002/pd.2126; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Freitas LG, 2013, HEMATOLOGY, V18, P359, DOI 10.1179/1607845413Y.0000000098; Golboni F., 2011, Eastern Mediterranean Health Journal, V17, P744; Gurdol F, 2012, ARCH GYNECOL OBSTET, V286, P51, DOI 10.1007/s00404-012-2244-3; Hefler LA, 2001, OBSTET GYNECOL, V97, P664, DOI 10.1016/S0029-7844(01)01128-0; Huang SJ, 2008, J PATHOL, V214, P328, DOI 10.1002/path.2257; Kalinderis M, 2011, AM J REPROD IMMUNOL, V66, P468, DOI 10.1111/j.1600-0897.2011.01019.x; Kang L, 2012, TAIWAN J OBSTET GYNE, V51, P240, DOI 10.1016/j.tjog.2012.04.014; Kocyigit Y, 2004, GYNECOL ENDOCRINOL, V19, P267, DOI 10.1080/09513590400018108; Lachmeijer AMA, 2002, HYPERTENS PREGNANCY, V21, P23, DOI 10.1081/PRG-120002907; LaMarca BD, 2007, CURR HYPERTENS REP, V9, P480, DOI 10.1007/s11906-007-0088-1; Lockwood CJ, 2008, BIOL REPROD, V78, P1064, DOI 10.1095/biolreprod.107.063743; Luppi P, 2006, CLIN IMMUNOL, V118, P268, DOI 10.1016/j.clim.2005.11.001; Mohajertehran F, 2012, IRAN J ALLERGY ASTHM, V11, P224, DOI 011.03/ijaai.224229; Ramma W, 2011, BIOCHEM SOC T, V39, P1619, DOI 10.1042/BST20110672; Redman CWG, 2009, PLACENTA, V30, pS38, DOI 10.1016/j.placenta.2008.11.021; Redman CWG, 2003, PLACENTA, V24, pS21, DOI 10.1053/plac.2002.0930; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Rinehart BK, 1999, AM J OBSTET GYNECOL, V181, P915, DOI 10.1016/S0002-9378(99)70325-X; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Szarka A, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-59; Tosun M, 2010, J MATERN-FETAL NEO M, V23, P880, DOI 10.3109/14767051003774942; van Pampus MG, 1999, AM J OBSTET GYNECOL, V180, P1146, DOI 10.1016/S0002-9378(99)70608-3; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1	31	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e106919	10.1371/journal.pone.0106919	http://dx.doi.org/10.1371/journal.pone.0106919			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222025	gold, Green Published, Green Submitted			2022-12-25	WOS:000341774800033
J	Sood, R; Minzel, W; Rimon, G; Tal, S; Barki-Harrington, L				Sood, Rapita; Minzel, Waleed; Rimon, Gilad; Tal, Sharon; Barki-Harrington, Liza			Down-regulation of Cyclooxygenase-2 by the Carboxyl Tail of the Angiotensin II Type 1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEGRADATION; PROTEIN; EXPRESSION; BETA-ARRESTIN-2; UBIQUITINATION; ACTIVATION; INTERACTS; KINASE-1; PATHWAYS; AT(1)	The enzyme cyclooxygenase-2 (COX-2) plays an important role in the kidney by up-regulating the production of the vasoconstrictor hormone angiotensin II (AngII), which in turn down-regulates COX-2 expression via activation of the angiotensin II type 1 receptor (AT(1)) receptor. Chemical inhibition of the catalytic activity of COX-2 is a well-established strategy for treating inflammation but little is known of cellular mechanisms that dispose of the protein itself. Here we show that in addition to its indirect negative feedback on COX-2, AT1 also down-regulates the expression of the COX-2 protein via a pathway that does not involve G-protein or beta-arrestin-dependent signaling. Instead, AT(1) enhances the ubiquitination and subsequent degradation of the enzyme in the proteasome through elements in its cytosolic carboxyl tail (CT). We find that a mutant receptor that lacks the last 35 amino acids of its CT (Delta 324) is devoid of its ability to reduce COX-2, and that expression of the CT sequence alone is sufficient to down-regulate COX-2. Collectively these results propose a new role for AT(1) in regulating COX-2 expression in a mechanism that deviates from its canonical signaling pathways. Down-regulation of COX-2 by a short peptide that originates from AT(1) may present as a basis for novel therapeutic means of eliminating excess COX-2 protein.	[Sood, Rapita; Minzel, Waleed; Tal, Sharon; Barki-Harrington, Liza] Univ Haifa, Fac Nat Sci, Dept Human Biol, IL-3498838 Haifa, Israel; [Rimon, Gilad] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, IL-84105 Beer Sheva, Israel	University of Haifa; Ben Gurion University	Barki-Harrington, L (corresponding author), Univ Haifa, Fac Nat Sci, Dept Human Biol, 199 Aba Khoushy Ave Mt Carmel, IL-3498838 Haifa, Israel.	lbarki@psy.haifa.ac.il			United States Israel Binational Science Foundation [2009246]	United States Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This work was supported by the United States Israel Binational Science Foundation Grant 2009246 (to L.B.H.).	Ali MS, 1997, J BIOL CHEM, V272, P23382, DOI 10.1074/jbc.272.37.23382; Brender S, 2014, BIOCHEM BIOPH RES CO, V451, P319, DOI 10.1016/j.bbrc.2014.07.123; Chen SF, 2013, J BIOL CHEM, V288, P33462, DOI 10.1074/jbc.M113.521799; Cheng HF, 1999, J CLIN INVEST, V103, P953, DOI 10.1172/JCI5505; Daviet L, 1999, J BIOL CHEM, V274, P17058, DOI 10.1074/jbc.274.24.17058; Haddad A, 2012, J BIOL CHEM, V287, P17214, DOI 10.1074/jbc.M111.304220; Harris RC, 2004, ACTA PHYSIOL SCAND, V181, P543, DOI 10.1111/j.1365-201X.2004.01329.x; HARRIS RC, 1994, J CLIN INVEST, V94, P2504, DOI 10.1172/JCI117620; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; Mbonye UR, 2009, BMB REP, V42, P552, DOI 10.5483/BMBRep.2009.42.9.552; Neuss H, 2007, J MOL MED-JMM, V85, P961, DOI 10.1007/s00109-007-0197-y; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Spector-Chotiner A, 2014, BIOCHEM BIOPH RES CO, V443, P738, DOI 10.1016/j.bbrc.2013.12.038; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; Wei HJ, 2004, J BIOL CHEM, V279, P48255, DOI 10.1074/jbc.M406205200; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Zhang MZ, 2006, P NATL ACAD SCI USA, V103, P16045, DOI 10.1073/pnas.0602176103	21	6	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31473	31479		10.1074/jbc.M114.587576	http://dx.doi.org/10.1074/jbc.M114.587576			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25231994	Green Published, hybrid			2022-12-25	WOS:000344549900049
J	Grenier, K; Kontogiannea, M; Fon, EA				Grenier, Karl; Kontogiannea, Maria; Fon, Edward A.			Short Mitochondrial ARF Triggers Parkin/PINK1-dependent Mitophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitochondria; Mitophagy; Parkin; Parkinson Disease; PTEN-induced Putative Kinase 1 (PINK1); smARF	PARKINSONS-DISEASE; DAMAGED MITOCHONDRIA; ACTIVATE PARKIN; MITOFUSIN 1; PINK1; UBIQUITIN; NEURONS; DEGRADATION; AUTOPHAGY; P19(ARF)	Background: PINK1 and Parkin promote mitochondrial autophagy upon loss of mitochondrial membrane potential. Results: smARF induces Parkin/PINK1-mitochondrial autophagy in neurons. Conclusion: smARF is upstream of Parkin and PINK1 in mitochondrial autophagy. Significance: Parkin/PINK1-mitochondrial autophagy can be triggered by intrinsic signaling. Parkinson disease (PD) is a complex neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra. Multiple genes have been associated with PD, including Parkin and PINK1. Recent studies have established that the Parkin and PINK1 proteins function in a common mitochondrial quality control pathway, whereby disruption of the mitochondrial membrane potential leads to PINK1 stabilization at the mitochondrial outer surface. PINK1 accumulation leads to Parkin recruitment from the cytosol, which in turn promotes the degradation of the damaged mitochondria by autophagy (mitophagy). Most studies characterizing PINK1/Parkin mitophagy have relied on high concentrations of chemical uncouplers to trigger mitochondrial depolarization, a stimulus that has been difficult to adapt to neuronal systems and one unlikely to faithfully model the mitochondrial damage that occurs in PD. Here, we report that the short mitochondrial isoform of ARF (smARF), previously identified as an alternate translation product of the tumor suppressor p19ARF, depolarizes mitochondria and promotes mitophagy in a Parkin/PINK1-dependent manner, both in cell lines and in neurons. The work positions smARF upstream of PINK1 and Parkin and demonstrates that mitophagy can be triggered by intrinsic signaling cascades.	McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; McGill Univ, Montreal Neurol Inst, McGill Parkinson Program, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Fon, EA (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St,Rm MP038, Montreal, PQ H3A 2B4, Canada.	ted.fon@mcgill.ca			Graduate Student Award from Parkinson Society Canada; Canadian Institutes of Health Research [MOP-62714]	Graduate Student Award from Parkinson Society Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Graduate Student Award from Parkinson Society Canada (to K. G.) and an operating grant (MOP-62714) from the Canadian Institutes of Health Research (to E. A. F.).	Abdouh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031870; Abida WM, 2008, CANCER RES, V68, P352, DOI 10.1158/0008-5472.CAN-07-2069; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Cai Q, 2012, CURR BIOL, V22, P545, DOI 10.1016/j.cub.2012.02.005; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Corti O, 2013, CURR OPIN NEUROBIOL, V23, P100, DOI 10.1016/j.conb.2012.11.002; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Grenier K, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00100; Hulleman E, 2005, ADV CANCER RES, V94, P1, DOI 10.1016/S0065-230X(05)94001-3; Joselin AP, 2012, HUM MOL GENET, V21, P4888, DOI 10.1093/hmg/dds325; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Koyano F, 2013, GENES CELLS, V18, P672, DOI 10.1111/gtc.12066; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Moore PS, 2010, NAT REV CANCER, V10, P878, DOI 10.1038/nrc2961; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pimkina J, 2009, J BIOL CHEM, V284, P2803, DOI 10.1074/jbc.M804705200; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; Rakovic A, 2013, J BIOL CHEM, V288, P2223, DOI 10.1074/jbc.M112.391680; Reef S, 2008, AUTOPHAGY, V4, P866, DOI 10.4161/auto.6691; Reef S, 2006, MOL CELL, V22, P463, DOI 10.1016/j.molcel.2006.04.014; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Spratt DE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2983; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Van Laar VS, 2011, HUM MOL GENET, V20, P927, DOI 10.1093/hmg/ddq531; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	48	22	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29519	29530		10.1074/jbc.M114.607150	http://dx.doi.org/10.1074/jbc.M114.607150			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25217637	hybrid, Green Published			2022-12-25	WOS:000344370800005
J	Junges, A; Boldo, JT; Souza, BK; Guedes, RLM; Sbaraini, N; Kmetzsch, L; Thompson, CE; Staats, CC; de Almeida, LGP; de Vasconcelos, ATR; Vainstein, MH; Schrank, A				Junges, Angela; Boldo, Juliano Tomazzoni; Souza, Barbara Kunzler; Muniz Guedes, Rafael Lucas; Sbaraini, Nicolau; Kmetzsch, Livia; Thompson, Claudia Elizabeth; Staats, Charley Christian; Paula de Almeida, Luis Gonzaga; Ribeiro de Vasconcelos, Ana Tereza; Vainstein, Marilene Henning; Schrank, Augusto			Genomic Analyses and Transcriptional Profiles of the Glycoside Hydrolase Family 18 Genes of the Entomopathogenic Fungus Metarhizium anisopliae	PLOS ONE			English	Article							EXTRACELLULAR CHITINASE; ASPERGILLUS-NIDULANS; BEAUVERIA-BASSIANA; ESCHERICHIA-COLI; QUANTITATIVE PCR; SIGNAL PEPTIDES; IDENTIFICATION; EXPRESSION; PROTEINS; SEQUENCE	Fungal chitin metabolism involves diverse processes such as metabolically active cell wall maintenance, basic nutrition, and different aspects of virulence. Chitinases are enzymes belonging to the glycoside hydrolase family 18 (GH18) and 19 (GH19) and are responsible for the hydrolysis of beta-1,4-linkages in chitin. This linear homopolymer of N-acetyl-beta-D-glucosamine is an essential constituent of fungal cell walls and arthropod exoskeletons. Several chitinases have been directly implicated in structural, morphogenetic, autolytic and nutritional activities of fungal cells. In the entomopathogen Metarhizium anisopliae, chitinases are also involved in virulence. Filamentous fungi genomes exhibit a higher number of chitinase-coding genes than bacteria or yeasts. The survey performed in the M. anisopliae genome has successfully identified 24 genes belonging to glycoside hydrolase family 18, including three previously experimentally determined chitinase-coding genes named chit1, chi2 and chi3. These putative chitinases were classified based on domain organization and phylogenetic analysis into the previously described A, B and C chitinase subgroups, and into a new subgroup D. Moreover, three GH18 proteins could be classified as putative endo-N-acetyl-beta-D-glucosaminidases, enzymes that are associated with deglycosylation and were therefore assigned to a new subgroup E. The transcriptional profile of the GH18 genes was evaluated by qPCR with RNA extracted from eight culture conditions, representing different stages of development or different nutritional states. The transcripts from the GH18 genes were detected in at least one of the different M. anisopliae developmental stages, thus validating the proposed genes. Moreover, not all members from the same chitinase subgroup presented equal patterns of transcript expression under the eight distinct conditions studied. The determination of M. anisopliae chitinases and ENGases and a more detailed study concerning the enzymes' roles in morphological or nutritional functions will allow comprehensive insights into the chitinolytic potential of this highly infective entomopathogenic fungus.	[Junges, Angela; Boldo, Juliano Tomazzoni; Souza, Barbara Kunzler; Sbaraini, Nicolau; Kmetzsch, Livia; Thompson, Claudia Elizabeth; Staats, Charley Christian; Vainstein, Marilene Henning; Schrank, Augusto] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil; [Muniz Guedes, Rafael Lucas; Paula de Almeida, Luis Gonzaga; Ribeiro de Vasconcelos, Ana Tereza] Lab Nacl Comp Cient, Petropolis, Brazil	Universidade Federal do Rio Grande do Sul; Laboratorio Nacional de Computacao Cientifica (LNCC)	Schrank, A (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil.	aschrank@cbiot.ufrgs.br	Thompson, Claudia/C-3203-2014; Almeida, Luiz GP/G-5829-2012; Staats, Charley Christian/J-4283-2014; Sbaraini, Nicolau/H-5484-2019; Kmetzsch, Livia/H-4033-2015; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Vainstein, Marilene H/J-5452-2014; Schrank, Augusto/G-4688-2012; Vasconcelos, Ana Tereza R/I-1011-2012	Thompson, Claudia/0000-0003-3639-1851; Almeida, Luiz GP/0000-0002-7124-2715; Staats, Charley Christian/0000-0002-2433-6903; Kmetzsch, Livia/0000-0003-3766-5869; Vainstein, Marilene H/0000-0002-3914-2300; Schrank, Augusto/0000-0002-5248-4620; Vasconcelos, Ana Tereza R/0000-0002-4632-2086; Muniz Guedes, Rafael Lucas/0000-0002-9163-6674; Tomazzoni Boldo, Juliano/0000-0002-7920-6364	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Programa de Aperfeicoamento Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do RS (FAPERGS); Fundacao de Amparo a Pesquisa do Estado do RJ (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa de Aperfeicoamento Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do RS (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Fundacao de Amparo a Pesquisa do Estado do RJ (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was supported by grants and fellowships from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Programa de Aperfeicoamento Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado do RS (FAPERGS) and Fundacao de Amparo a Pesquisa do Estado do RJ (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar-Fuoli L, 2011, FUNGAL GENET BIOL, V48, P418, DOI 10.1016/j.fgb.2010.12.007; Baratto CM, 2006, CURR MICROBIOL, V53, P217, DOI 10.1007/s00284-006-0078-6; Barreto CC, 2004, CURR MICROBIOL, V48, P102, DOI 10.1007/s00284-003-4063-z; Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Bogo MR, 1998, CURR MICROBIOL, V37, P221, DOI 10.1007/s002849900368; Boldo JT, 2010, GENE, V462, P1, DOI 10.1016/j.gene.2010.04.005; Boldo JT, 2009, CURR GENET, V55, P551, DOI 10.1007/s00294-009-0267-5; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CARSOLIO C, 1994, P NATL ACAD SCI USA, V91, P10903, DOI 10.1073/pnas.91.23.10903; da Silva MV, 2005, RES MICROBIOL, V156, P382, DOI 10.1016/j.resmic.2004.10.013; Deising HB, 2000, MICROBES INFECT, V2, P1631, DOI 10.1016/S1286-4579(00)01319-8; Duo-Chuan L, 2006, MYCOPATHOLOGIA, V161, P345, DOI 10.1007/s11046-006-0024-y; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Fan YH, 2007, PROTEIN EXPRES PURIF, V56, P93, DOI 10.1016/j.pep.2007.06.012; Fuglsang CC, 2000, J BIOL CHEM, V275, P2009, DOI 10.1074/jbc.275.3.2009; Funkhouser JD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-96; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Geng JM, 2002, MOL BIOCHEM PARASIT, V124, P11, DOI 10.1016/S0166-6851(02)00155-X; Gruber S, 2012, MICROBIOL-SGM, V158, P26, DOI 10.1099/mic.0.052613-0; Gruber S, 2011, GLYCOBIOLOGY, V21, P122, DOI 10.1093/glycob/cwq142; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hamaguchi T, 2010, GLYCOBIOLOGY, V20, P420, DOI 10.1093/glycob/cwp188; Hartl L, 2012, APPL MICROBIOL BIOT, V93, P533, DOI 10.1007/s00253-011-3723-3; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hoell IA, 2010, BIOTECHNOL GENET ENG, V27, P331, DOI 10.1080/02648725.2010.10648156; Honda Y, 2008, APPL MICROBIOL BIOT, V78, P627, DOI 10.1007/s00253-008-1352-2; Jaques AK, 2003, MICROBIOL-SGM, V149, P2931, DOI 10.1099/mic.0.26476-0; Karlsson M, 2008, EVOL BIOINFORM, V4, P47; Karlsson M, 2009, J MOL MICROB BIOTECH, V16, P208, DOI 10.1159/000151220; Kong LA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002526; Kruszewska JS, 2008, ACTA BIOCHIM POL, V55, P447, DOI 10.18388/abp.2008_3050; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu ZH, 2008, APPL MICROBIOL BIOT, V80, P241, DOI 10.1007/s00253-008-1543-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubeck I, 2008, FUNGAL ECOL, V1, P78, DOI 10.1016/j.funeco.2008.09.002; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Merzendorfer H, 2011, EUR J CELL BIOL, V90, P759, DOI 10.1016/j.ejcb.2011.04.014; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nielsen CB, 2004, PLOS BIOL, V2, P2234, DOI 10.1371/journal.pbio.0020422; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Patil RS, 2000, ENZYME MICROB TECH, V26, P473, DOI 10.1016/S0141-0229(00)00134-4; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Peterson ME, 2009, PROTEIN SCI, V18, P1306, DOI 10.1002/pro.143; Pinto ADS, 1997, CAN J MICROBIOL, V43, P322, DOI 10.1139/m97-045; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santi L, 2010, FUNGAL BIOL-UK, V114, P312, DOI 10.1016/j.funbio.2010.01.006; Santi L, 2009, RES MICROBIOL, V160, P824, DOI 10.1016/j.resmic.2009.09.012; Schrank A, 2010, TOXICON, V56, P1267, DOI 10.1016/j.toxicon.2010.03.008; Seidl V, 2005, FEBS J, V272, P5923, DOI 10.1111/j.1742-4658.2005.04994.x; Seidl Verena, 2008, Fungal Biology Reviews, V22, P36, DOI 10.1016/j.fbr.2008.03.002; Shin KS, 2009, EUKARYOT CELL, V8, P738, DOI 10.1128/EC.00368-08; Staats CC, 2013, FUNGAL BIOL-UK, V117, P137, DOI 10.1016/j.funbio.2012.12.006; Stals I, 2010, FEMS MICROBIOL LETT, V303, P9, DOI 10.1111/j.1574-6968.2009.01849.x; STLEGER RJ, 1993, J INVERTEBR PATHOL, V61, P81, DOI 10.1006/jipa.1993.1014; Synstad B, 2004, EUR J BIOCHEM, V271, P253, DOI 10.1046/j.1432-1033.2003.03923.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tharanathan RN, 2003, CRIT REV FOOD SCI, V43, P61, DOI 10.1080/10408690390826455; Truong NH, 2003, BIOSCI BIOTECH BIOCH, V67, P1063, DOI 10.1271/bbb.67.1063; Tzelepis G, 2014, BIOCHEM BIOPH RES CO, V449, P256, DOI 10.1016/j.bbrc.2014.05.017; Tzelepis GD, 2014, FUNGAL GENET BIOL, V64, P58, DOI 10.1016/j.fgb.2013.12.009; Ueda M, 2003, EUR J BIOCHEM, V270, P2513, DOI 10.1046/j.1432-1033.2003.03624.x; Vaaje-Kolstad G, 2013, FEBS J, V280, P3028, DOI 10.1111/febs.12181; van Munster JM, 2012, MICROBIOL-SGM, V158, P2168, DOI 10.1099/mic.0.054650-0; Yamazaki H, 2008, FUNGAL GENET BIOL, V45, P963, DOI 10.1016/j.fgb.2008.02.008; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhao ZT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-6; Zheng P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r116	75	17	19	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107864	10.1371/journal.pone.0107864	http://dx.doi.org/10.1371/journal.pone.0107864			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232743	gold, Green Published, Green Submitted			2022-12-25	WOS:000342921200056
J	Lew, WYW; Bayna, E; Molle, ED; Contu, R; Condorelli, G; Tang, T				Lew, Wilbur Y. W.; Bayna, Evelyn; Molle, Erminia Dalle; Contu, Riccardo; Condorelli, Gianluigi; Tang, Tong			Myocardial Fibrosis Induced by Exposure to Subclinical Lipopolysaccharide Is Associated with Decreased miR-29c and Enhanced NOX2 Expression in Mice	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; HEART-FAILURE; CARDIOVASCULAR-DISEASE; MICRORNA THERAPEUTICS; CARDIAC FIBROSIS; NADPH OXIDASES; ENDOTOXEMIA; RESPONSES; REVEALS; OBESITY	Background: Exposure to subclinical levels of lipopolysaccharide (LPS) occurs commonly and is seemingly well tolerated. However, recurrent LPS exposure induces cardiac fibrosis over 2 to 3 months in a murine model, not mediated by the renin-angiotensin system. Subclinical LPS induces cardiac fibrosis by unique mechanisms. Methods: In C57/Bl6 mice, LPS (10 mg/kg) or saline (control) were injected intraperitoneally once a week for 1-4 weeks. Mice showed no signs of distress, change in activity, appetite, or weight loss. Mice were euthanized after 3 days, 1, 2, or 4 weeks to measure cardiac expression of fibrosis-related genes and potential mediators (measured by QRT-PCR), including micro-RNA (miR) and NADPH oxidase (NOX). Collagen fraction area of the left ventricle was measured with picrosirius red staining. Cardiac fibroblasts isolated from adult mouse hearts were incubated with 0, 0.1, 1.0 or 10 ng/ml LPS for 48 hours. Results: Cardiac miR expression profiling demonstrated decreased miR-29c after 3 and 7 days following LPS, which were confirmed by QRT-PCR. The earliest changes in fibrosis-related genes and mediators that occurred 3 days after LPS were increased cardiac expression of TIMP-1 and NOX-2 (but not of NOX-4). This persisted at 1 and 2 weeks, with additional increases in collagen I alpha 1, collagen III alpha 1, MMP2, MMP9, TIMP1, TIMP2, and periostin. There was no change in TGF-beta or connective tissue growth factor. Collagen fraction area of the left ventricle increased after 2 and 4 weeks of LPS. LPS decreased miR-29c and increased NOX-2 in isolated cardiac fibroblasts. Conclusions: Recurrent exposure to subclinical LPS induces cardiac fibrosis after 2-4 weeks. Early changes 3 days after LPS were decreased miR-29c and increased NOX2 and TIMP1, which persisted at 1 and 2 weeks, along with widespread activation of fibrosis-related genes. Decreased miR-29c and increased NOX2, which induce cardiac fibrosis in other conditions, may uniquely mediate LPS-induced cardiac fibrosis.	[Lew, Wilbur Y. W.; Bayna, Evelyn; Molle, Erminia Dalle; Contu, Riccardo; Tang, Tong] Vet Adm San Diego Healthcare Syst, Dept Med, Cardiol Sect, San Diego, CA 92161 USA; [Lew, Wilbur Y. W.; Bayna, Evelyn; Molle, Erminia Dalle; Contu, Riccardo; Tang, Tong] Vet Adm San Diego Healthcare Syst, Res Serv, San Diego, CA USA; [Lew, Wilbur Y. W.; Bayna, Evelyn; Molle, Erminia Dalle; Contu, Riccardo; Tang, Tong] Univ Calif San Diego, San Diego, CA 92103 USA; [Condorelli, Gianluigi] Univ Milan, Humanitas Res Hosp, Milan, Italy	University of California System; University of California San Diego; University of Milan	Lew, WYW (corresponding author), Vet Adm San Diego Healthcare Syst, Dept Med, Cardiol Sect, San Diego, CA 92161 USA.	wlew@ucsd.edu	Condorelli, Gianluigi/Q-6736-2017	Condorelli, Gianluigi/0000-0003-0481-6843	Medical Research Service, Department of Veterans Affairs [0007]; Veterans Medical Research Foundation, San Diego, California [08254]; American Heart Association [11GRNT17390014]	Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Medical Research Foundation, San Diego, California; American Heart Association(American Heart Association)	This research was supported by the Medical Research Service, Department of Veterans Affairs (0007, P.I. WYWL) www.research.va.gov; the Veterans Medical Research Foundation, San Diego, California (08254, P.I. WYWL) www.vmrf.org; and the American Heart Association (11GRNT17390014, P.I. WYWL) www.heart.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Burgoyne JR, 2012, CIRC RES, V111, P1091, DOI 10.1161/CIRCRESAHA.111.255216; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Dangwal S, 2014, ANNU REV PHARMACOL, V54, P185, DOI 10.1146/annurev-pharmtox-011613-135957; Dobaczewski M, 2010, CIRC RES, V107, P418, DOI 10.1161/CIRCRESAHA.109.216101; Doerries C, 2007, CIRC RES, V100, P894, DOI 10.1161/01.RES.0000261657.76299.ff; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286; Fang Y, 2013, AM J PHYSIOL-RENAL, V304, pF1274, DOI 10.1152/ajprenal.00287.2012; Gandhirajan RK, 2013, J CLIN INVEST, V123, P887, DOI 10.1172/JCI65647; Ghanim H, 2009, DIABETES CARE, V32, P2281, DOI 10.2337/dc09-0979; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; Johar S, 2006, FASEB J, V20, P1546, DOI 10.1096/fj.05-4642fje; Kim SY, 2010, IMMUNOL CELL BIOL, V88, P197, DOI 10.1038/icb.2009.87; Komajda M, 2014, EUR HEART J, V35, P1022, DOI 10.1093/eurheartj/ehu067; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P237, DOI 10.1152/physiolgenomics.00141.2011; Lew WYW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061057; Looi YH, 2008, HYPERTENSION, V51, P319, DOI 10.1161/HYPERTENSIONAHA.107.101980; Maejima Y, 2011, J MOL CELL CARDIOL, V50, P408, DOI 10.1016/j.yjmcc.2010.12.018; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Ngkelo A, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-1; Niebauer J, 1999, LANCET, V353, P1838, DOI 10.1016/S0140-6736(98)09286-1; Pan ZW, 2012, CIRCULATION, V126, P840, DOI 10.1161/CIRCULATIONAHA.112.094524; Park HS, 2006, CARDIOVASC RES, V72, P447, DOI 10.1016/j.cardiores.2006.09.012; Parker MW, 2014, J CLIN INVEST, V124, P1622, DOI 10.1172/JCI71386; Pussinen PJ, 2007, ARTERIOSCL THROM VAS, V27, P1433, DOI 10.1161/ATVBAHA.106.138743; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Roncarati R, 2014, J AM COLL CARDIOL, V63, P920, DOI 10.1016/j.jacc.2013.09.041; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; Thum T, 2012, EMBO MOL MED, V4, P3, DOI 10.1002/emmm.201100191; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; van Rooij E, 2009, CIRC RES, V104, P138, DOI 10.1161/CIRCRESAHA.108.192492; Weber KT, 2013, NAT REV CARDIOL, V10, P15, DOI 10.1038/nrcardio.2012.158; Westermann D, 2008, CIRCULATION, V117, P2051, DOI 10.1161/CIRCULATIONAHA.107.716886; Wiedermann CJ, 1999, J AM COLL CARDIOL, V34, P1975, DOI 10.1016/S0735-1097(99)00448-9; Zhang M, 2013, ANTIOXID REDOX SIGN, V18, P1024, DOI 10.1089/ars.2012.4550	47	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107556	10.1371/journal.pone.0107556	http://dx.doi.org/10.1371/journal.pone.0107556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233448	Green Published, gold, Green Submitted			2022-12-25	WOS:000342921200035
J	Nassar, FJ; El Sabban, M; Zgheib, NK; Tfayli, A; Boulos, F; Jabbour, M; El Saghir, NS; Talhouk, R; Bazarbachi, A; Calin, GA; Nasr, R				Nassar, Farah J.; El Sabban, Maya; Zgheib, Nathalie K.; Tfayli, Arafat; Boulos, Fouad; Jabbour, Mark; El Saghir, Nagi S.; Talhouk, Rabih; Bazarbachi, Ali; Calin, George A.; Nasr, Rihab			miRNA as Potential Biomarkers of Breast Cancer in the Lebanese Population and in Young Women: A Pilot Study	PLOS ONE			English	Article							MICRORNA-21 TARGETS; ESTROGEN-RECEPTOR; EXPRESSION; METASTASIS; PROGNOSIS; EPIDEMIOLOGY; SURVIVAL; INVASION; MIR-155; RISK	Relative to western populations, the percentage of women diagnosed with breast cancer at a young age in Lebanon is high. While the younger age of the Lebanese population compared to the West certainly contributes to this difference, potential genetic, reproductive and/or biological factors likely play an important role. The objective of this study is to investigate the contribution of miRNAs in this setting through the analysis of the expression of five reported dysregulated miRNAs, miR-148b, miR-10b, miR-21, miR-221, and miR-155 in 20 normal and 57 cancerous breast tissues from Lebanese breast cancer patients. After finding their relative expression by quantitative reverse transcription real time PCR, the results were analyzed with respect to the patients' clinical and histopathology presentations. Compared to normal breast tissues, significant upregulation of miR-155, miR-21 and miR-148b, notable downregulation of miR-10b and non-significant expression of miR-221 were observed in tumor tissues. Moreover, miR-10b was significantly underexpressed in estrogen/progesterone receptor (ER/PR) negative tumors relative to ER/PR positive tumor tissues. miR-155 was also significantly overexpressed in postmenopausal patients and in those of age at diagnosis greater than 40 years old as well as in PR negative or in human epidermal growth factor 2 (Her2) positive tissues. This study is the first one to report miRNA expression patterns in Lebanese breast cancer patients. We found that differential miRNA expression in breast cancer could be variable between Lebanese and Western populations. miR-10b was positively correlated with the ER and PR status and miR-155 could be a noteworthy biomarker for the menopausal state, age at diagnosis, PR and Her2 status. Hence, miRNA can be used as biomarkers for early breast cancer detection.	[Nassar, Farah J.; Talhouk, Rabih] Amer Univ Beirut, Fac Arts & Sci, Dept Biol, Beirut, Lebanon; [El Sabban, Maya; Nasr, Rihab] Amer Univ Beirut, Dept Anat Cell Biol & Physiol Sci, Fac Med, Beirut, Lebanon; [Zgheib, Nathalie K.] Amer Univ Beirut, Dept Pharmacol, Fac Med, Beirut, Lebanon; [Tfayli, Arafat; El Saghir, Nagi S.; Bazarbachi, Ali] Amer Univ Beirut, Dept Internal Med, Fac Med, Beirut, Lebanon; [Boulos, Fouad; Jabbour, Mark] Amer Univ Beirut, Dept Pathol, Fac Med, Beirut, Lebanon; [Calin, George A.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Div Canc Med, Houston, TX 77030 USA	American University of Beirut; American University of Beirut; American University of Beirut; American University of Beirut; American University of Beirut; University of Texas System; UTMD Anderson Cancer Center	Nasr, R (corresponding author), Amer Univ Beirut, Dept Anat Cell Biol & Physiol Sci, Fac Med, Beirut, Lebanon.	rn03@aub.edu.lb	Boulos, Fouad/AAL-9299-2021; Nassar, Farah Jihad/GYA-5024-2022; Zgheib, Nathalie Khoueiry/ABA-8902-2020; Nassar, Farah/AAJ-4792-2020; Calin, George/E-9390-2011; Nasr, Rihab/AAF-1606-2020; Nasr, Rihab/ABE-4068-2020	Nassar, Farah Jihad/0000-0002-4092-2531; Zgheib, Nathalie Khoueiry/0000-0002-0571-768X; Nassar, Farah/0000-0002-4092-2531; Nasr, Rihab/0000-0003-1166-4999; Calin, George/0000-0001-6704-5615; Calin, George/0000-0002-7427-0578; Bazarbachi, Ali/0000-0002-7171-4997	Medical Practice Plan at the American University of Beirut	Medical Practice Plan at the American University of Beirut	This work was supported by the Medical Practice Plan at the American University of Beirut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; Assi HA, 2013, J THORAC DIS, V5, pS2, DOI 10.3978/j.issn.2072-1439.2013.05.24; Azim HA, 2012, CLIN CANCER RES, V18, P1341, DOI 10.1158/1078-0432.CCR-11-2599; Chang H, 2012, MOL MED REP, V5, P1277, DOI 10.3892/mmr.2012.794; Chen WX, 2013, TUMOR BIOL, V34, P1361, DOI 10.1007/s13277-013-0750-y; Cimino D, 2013, FASEB J, V27, P1223, DOI 10.1096/fj.12-214692; Cuk K, 2013, INT J CANCER, V132, P1602, DOI 10.1002/ijc.27799; El Saghir NS, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-194; El Saghir Nagi S, 2007, Int J Surg, V5, P225; Falkenberg N, 2013, BR J CANC; Ha Tai-You, 2011, Immune Netw, V11, P11, DOI [10.4110/in.2011.11.3.135, 10.4110/in.2011.11.1.11]; Han ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039520; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li CI, 2013, BREAST CANCER RES TR, V137, P579, DOI 10.1007/s10549-012-2365-1; Li LH, 2012, EXPERT REV PROTEOMIC, V9, P615, DOI [10.1586/epr.12.64, 10.1586/EPR.12.64]; Li Yu, 2012, Genomics Proteomics & Bioinformatics, V10, P246, DOI 10.1016/j.gpb.2012.07.005; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu ZD, 2012, ONCOL LETT, V4, P1027, DOI 10.3892/ol.2012.841; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2720; Mattiske S, 2012, CANCER EPIDEM BIOMAR, V21, P1236, DOI 10.1158/1055-9965.EPI-12-0173; Qian BY, 2009, BREAST CANCER RES TR, V117, P131, DOI 10.1007/s10549-008-0219-7; Shamseddine AI, 2010, MIDDLE EAST J CANCER, V1, P41; Singh R, 2013, CANC BIOL THER; Singletary SE, 2006, CA-CANCER J CLIN, V56, P37, DOI 10.3322/canjclin.56.1.37; Song Chuan-gui, 2012, Zhonghua Wai Ke Za Zhi, V50, P1011; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Zgheib NK, 2013, MUTAT RES-FUND MOL M, V747, P40, DOI 10.1016/j.mrfmmm.2013.04.004; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	35	25	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107566	10.1371/journal.pone.0107566	http://dx.doi.org/10.1371/journal.pone.0107566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232827	Green Published, gold, Green Submitted			2022-12-25	WOS:000342921200037
J	Zaborowska, J; Baumli, S; Laitem, C; O'Reilly, D; Thomas, PH; O'Hare, P; Murphy, S				Zaborowska, Justyna; Baumli, Sonja; Laitem, Clelia; O'Reilly, Dawn; Thomas, Peter H.; O'Hare, Peter; Murphy, Shona			Herpes Simplex Virus 1 (HSV-1) ICP22 Protein Directly Interacts with Cyclin-Dependent Kinase (CDK) 9 to Inhibit RNA Polymerase II Transcription Elongation	PLOS ONE			English	Article							CARBOXYL-TERMINAL DOMAIN; INFECTED-CELL PROTEIN-22; GENE-EXPRESSION; TYPE-1 ICP22; U2 SNRNA; P-TEFB; TYROSINE PHOSPHORYLATION; DELETION MUTANT; ALPHA-GENE; CTD	The Herpes Simplex Virus 1 (HSV-1)-encoded ICP22 protein plays an important role in viral infection and affects expression of host cell genes. ICP22 is known to reduce the global level of serine (Ser) 2 phosphorylation of the Tyr1Ser2Pro3Thr4Ser5Pro6Ser7 heptapeptide repeats comprising the carboxy-terminal domain (CTD) of the large subunit of RNA polymerase (pol) II. Accordingly, ICP22 is thought to associate with and inhibit the activity of the positive-transcription elongation factor b (P-TEFb) pol II CTD Ser2 kinase. We show here that ICP22 causes loss of CTD Ser2 phosphorylation from pol II engaged in transcription of protein-coding genes following ectopic expression in HeLa cells and that recombinant ICP22 interacts with the CDK9 subunit of recombinant P-TEFb. ICP22 also interacts with pol II in vitro. Residues 193 to 256 of ICP22 are sufficient for interaction with CDK9 and inhibition of pol II CTD Ser2 phosphorylation but do not interact with pol II. These results indicate that discrete regions of ICP22 interact with either CDK9 or pol II and that ICP22 interacts directly with CDK9 to inhibit expression of host cell genes.	[Zaborowska, Justyna; Laitem, Clelia; O'Reilly, Dawn; Murphy, Shona] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Baumli, Sonja] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Thomas, Peter H.] Univ Oxford, John Radcliffe Hosp, Dept Oncol, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [O'Hare, Peter] Univ London Imperial Coll Sci Technol & Med, St Marys Med Sch, Fac Med, Virol Sect, London, England	University of Oxford; Newcastle University - UK; University of Oxford; Imperial College London	Murphy, S (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	shona.murphy@path.ox.ac.uk		Murphy, Shona/0000-0001-5276-9645; O'Hare, Peter/0000-0003-4508-5602	Wellcome Trust [088542/Z/09/Z, 092483/Z/10/Z]; EPA Trust [RF202]; Medical Research Council [G0901526, MR/L000148/1]; Rosetrees Trust [A459]; Oxford Martin School [LC0910-004]; MRC [G0400653, G0901526] Funding Source: UKRI; Medical Research Council [G0400653] Funding Source: researchfish; Rosetrees Trust [M319] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); EPA Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rosetrees Trust(Rosetrees Trust); Oxford Martin School; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust)	SM was supported by Wellcome Trust (088542/Z/09/Z, 092483/Z/10/Z) www.wellcome.ac.uk; EPA Trust (RF202). SB was supported by Medical Research Council (G0901526) www.mrc.ac.uk. POH was supported by Medical Research Council (MR/L000148/1) www.mrc.ac.uk. JZ was supported by Rosetrees Trust (A459) www.rosetreestrust.co.uk. DOR was supported by Oxford Martin School (LC0910-004) www.oxfordmartin.ox.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN M, 1985, J VIROL, V56, P207, DOI 10.1128/JVI.56.1.207-215.1985; Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; BASKARAN R, 1993, P NATL ACAD SCI USA, V90, P11167, DOI 10.1073/pnas.90.23.11167; Bastian TW, 2009, J VIROL, V83, P128, DOI 10.1128/JVI.01954-08; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Bowman JJ, 2009, J VIROL, V83, P9183, DOI 10.1128/JVI.00984-09; Bowman JJ, 2009, J VIROL, V83, P8733, DOI 10.1128/JVI.00810-09; Cabart P, 2004, ONCOGENE, V23, P5316, DOI 10.1038/sj.onc.1207684; Carter KL, 1996, J VIROL, V70, P172, DOI 10.1128/JVI.70.1.172-178.1996; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Cun W, 2006, J BIOCHEM, V140, P67, DOI 10.1093/jb/mvj135; Descostes N, 2014, ELIFE, V3, DOI 10.7554/eLife.02105; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Durand LO, 2005, J VIROL, V79, P6757, DOI 10.1128/JVI.79.11.6757-6762.2005; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Egloff S, 2012, MOL CELL, V45, P111, DOI 10.1016/j.molcel.2011.11.006; Egloff S, 2010, J BIOL CHEM, V285, P20564, DOI 10.1074/jbc.M110.132530; Egloff S, 2009, MOL CELL BIOL, V29, P4002, DOI 10.1128/MCB.00189-09; Fraser KA, 2005, J VIROL, V79, P11323, DOI 10.1128/JVI.79.17.11323-11334.2005; Fraser KA, 2007, J VIROL, V81, P5091, DOI 10.1128/JVI.00184-07; Galdiero S, 2013, J PEPT SCI, V19, P148, DOI 10.1002/psc.2489; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Guo L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045749; KEMP LM, 1988, EUR J BIOCHEM, V174, P443, DOI 10.1111/j.1432-1033.1988.tb14118.x; Kimberlin DW, 2004, CLIN MICROBIOL REV, V17, P1, DOI 10.1128/CMR.17.1.1-13.2004; Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794; Kolb AW, 2011, INVEST OPHTH VIS SCI, V52, P4630, DOI 10.1167/iovs.10-7032; Liesegang TJ, 2001, CORNEA, V20, P1, DOI 10.1097/00003226-200101000-00001; Mayer A, 2012, SCIENCE, V336, P1723, DOI 10.1126/science.1219651; Medlin J, 2005, EMBO J, V24, P4154, DOI 10.1038/sj.emboj.7600876; Medlin JE, 2003, EMBO J, V22, P925, DOI 10.1093/emboj/cdg077; Mostafa HH, 2013, J VIROL, V87, P13510, DOI 10.1128/JVI.02424-13; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Ogle WO, 1999, J VIROL, V73, P4305, DOI 10.1128/JVI.73.5.4305-4315.1999; Orlando JS, 2006, J VIROL, V80, P9381, DOI 10.1128/JVI.01061-06; Orlando JS, 2006, J VIROL, V80, P4005, DOI 10.1128/JVI.80.8.4005-4016.2006; POFFENBERGER KL, 1994, ARCH VIROL, V139, P111, DOI 10.1007/BF01309458; Poon APW, 2000, J VIROL, V74, P11210, DOI 10.1128/JVI.74.23.11210-11214.2000; Rice SA, 2013, FUTURE MICROBIOL, V8, P311, DOI [10.2217/FMB.13.4, 10.2217/fmb.13.4]; Riedl T, 2000, GENE EXPRESSION, V9, P3; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SEARS AE, 1985, J VIROL, V55, P338, DOI 10.1128/JVI.55.2.338-346.1985; Stelz G, 2002, VIROLOGY, V295, P360, DOI 10.1006/viro.2002.1384	46	27	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107654	10.1371/journal.pone.0107654	http://dx.doi.org/10.1371/journal.pone.0107654			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233083	Green Published, Green Submitted, gold			2022-12-25	WOS:000342921200039
J	Zhang, JP; Wang, J; Pang, L; Xie, GR; Welte, T; Saxena, V; Wicker, J; Mann, B; Soong, L; Barrett, A; Born, W; O'Brien, R; Wang, T				Zhang, Jinping; Wang, Jia; Pang, Lan; Xie, Guorui; Welte, Thomas; Saxena, Vandana; Wicker, Jason; Mann, Brian; Soong, Lynn; Barrett, Alan; Born, Willi; O'Brien, Rebecca; Wang, Tian			The Co-Stimulatory Effects of MyD88-Dependent Toll-Like Receptor Signaling on Activation of Murine gamma delta T Cells	PLOS ONE			English	Article							WEST-NILE-VIRUS; IMMUNE-RESPONSE; DENDRITIC CELLS; BORRELIA-BURGDORFERI; MOLECULAR-PATTERNS; ADAPTIVE IMMUNITY; LYMPHOCYTES-T; IN-VIVO; INFECTION; RECOGNITION	gamma delta T cells express several different toll-like receptor (TLR)s. The role of MyD88-dependent TLR signaling in TCR activation of murine gamma delta T cells is incompletely defined. Here, we report that Pam3CSK4 (PAM, TLR2 agonist) and CL097 (TLR7 agonist), but not lipopolysaccharide (TLR4 agonist), increased CD69 expression and Th1-type cytokine production upon anti-CD3 stimulation of gamma delta T cells from young adult mice (6-to 10-week-old). However, these agonists alone did not induce gamma delta T cell activation. Additionally, we noted that neither PAM nor CL097 synergized with anti-CD3 in inducing CD69 expression on gamma delta T cells of aged mice (21-to 22-month-old). Compared to young gamma delta T cells, PAM and CL097 increased Th-1 type cytokine production with a lower magnitude from anti-CD3-stimulated, aged gamma delta T cells. V gamma 1(+) and V gamma 4(+) cells are two subpopulations of splenic gamma delta T cells. PAM had similar effects in anti-CD3-activated control and V gamma 4(+) subset-depleted gamma delta T cells; whereas CL097 induced more IFN-gamma production from V gamma 4(+) subset-depleted gamma delta T cells than from the control group. Finally, we studied the role of MyD88-dependent TLRs in gamma delta T cell activation during West Nile virus (WNV) infection. gamma delta T cell, in particular, V gamma 1(+) subset expansion was significantly reduced in both MyD88- and TLR7-deficient mice. Treatment with TLR7 agonist induced more V gamma 1(+) cell expansion in wild-type mice during WNV infection. In summary, these results suggest that MyD88-dependent TLRs provide co-stimulatory signals during TCR activation of gamma delta T cells and these have differential effects on distinct subsets.	[Zhang, Jinping; Wang, Jia; Pang, Lan; Xie, Guorui; Welte, Thomas; Saxena, Vandana; Soong, Lynn; Barrett, Alan; Wang, Tian] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Wicker, Jason; Mann, Brian; Soong, Lynn; Barrett, Alan; Wang, Tian] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Born, Willi; O'Brien, Rebecca] Natl Jewish Hlth Ctr, Integrated Dept Immunol, Denver, CO USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; National Jewish Health	Wang, T (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.	ti1wang@utmb.edu	zhang, jin/GXV-9154-2022	Xie, Guorui/0000-0002-2414-1241	NIH [R01AI072060]; Sealy Center for Vaccine Development at UTMB; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072060] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sealy Center for Vaccine Development at UTMB; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a NIH grant to T.W. (R01AI072060). G.X. was supported by a fellowship from the Sealy Center for Vaccine Development at UTMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Alvarez-Rodriguez L, 2012, CELL IMMUNOL, V273, P124, DOI 10.1016/j.cellimm.2012.01.001; Argentati K, 2002, J LEUKOCYTE BIOL, V72, P65; BARNES PF, 1992, J INFECT DIS, V165, P506, DOI 10.1093/infdis/165.3.506; Beetz S, 2008, IMMUNOBIOLOGY, V213, P173, DOI 10.1016/j.imbio.2007.10.006; Beetz S, 2007, IMMUNOL RES, V37, P97, DOI 10.1007/BF02685893; Born WK, 2009, ARCH IMMUNOL THER EX, V57, P129, DOI 10.1007/s00005-009-0017-x; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; CARDILLO F, 1993, EUR J IMMUNOL, V23, P2597, DOI 10.1002/eji.1830231033; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Collins C, 2008, J IMMUNOL, V181, P2392, DOI 10.4049/jimmunol.181.4.2392; Colonna-Romano G, 2002, EXP GERONTOL, V37, P205, DOI 10.1016/S0531-5565(01)00185-1; Dechanet J, 1999, J CLIN INVEST, V103, P1437, DOI 10.1172/JCI5409; Deetz CO, 2006, INFECT IMMUN, V74, P4505, DOI 10.1128/IAI.00088-06; Devilder MC, 2009, J IMMUNOL, V183, P3625, DOI 10.4049/jimmunol.0901571; Dieude M, 2011, J IMMUNOL, V186, P4771, DOI 10.4049/jimmunol.1000921; Doyle KP, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-62; Fang H, 2010, FEMS IMMUNOL MED MIC, V59, P71, DOI 10.1111/j.1574-695X.2010.00663.x; Ferrick DA, 2000, SPRINGER SEMIN IMMUN, V22, P283, DOI 10.1007/s002810000047; Hahn YS, 2004, J IMMUNOL, V172, P2894, DOI 10.4049/jimmunol.172.5.2894; Hao JL, 2011, J IMMUNOL, V187, P4979, DOI 10.4049/jimmunol.1101389; HARA T, 1992, J CLIN INVEST, V90, P204, DOI 10.1172/JCI115837; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hayes SM, 2002, IMMUNITY, V16, P827, DOI 10.1016/S1074-7613(02)00320-5; HEILIG JS, 1986, NATURE, V322, P836, DOI 10.1038/322836a0; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kabelitz D, 2001, EUR J MED RES, V6, P169; Kong KF, 2008, J VIROL, V82, P7613, DOI 10.1128/JVI.00618-08; Kunzmann V, 2004, IMMUNOLOGY, V112, P369, DOI 10.1111/j.1365-2567.2004.01908.x; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Martino A, 2005, J CLIN IMMUNOL, V25, P230, DOI 10.1007/s10875-005-4080-8; O'Brien RL, 2009, EUR J IMMUNOL, V39, P662, DOI 10.1002/eji.200839120; Panda A, 2010, J IMMUNOL, V184, P2518, DOI 10.4049/jimmunol.0901022; Peng G, 2007, IMMUNITY, V27, P334, DOI 10.1016/j.immuni.2007.05.020; PERERA MK, 1994, J EXP MED, V179, P311, DOI 10.1084/jem.179.1.311; Pietschmann K, 2009, SCAND J IMMUNOL, V70, P245, DOI 10.1111/j.1365-3083.2009.02290.x; Roark CL, 2007, J IMMUNOL, V179, P5576, DOI 10.4049/jimmunol.179.8.5576; Roark CL, 2013, IMMUNOL RES, V55, P217, DOI 10.1007/s12026-012-8364-9; Schmolka N, 2013, NAT IMMUNOL, V14, P1093, DOI 10.1038/ni.2702; Schwacha MG, 2014, INNATE IMMUN-LONDON, V20, P261, DOI 10.1177/1753425913488969; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Shaw AC, 2011, AGEING RES REV, V10, P346, DOI 10.1016/j.arr.2010.10.007; Shi CX, 2011, INFECT IMMUN, V79, P3940, DOI 10.1128/IAI.00148-11; Shimura H, 2005, J DERMATOL SCI, V37, P101, DOI 10.1016/j.jdermsci.2004.11.006; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Shrestha B, 2006, J VIROL, V80, P5338, DOI 10.1128/JVI.00274-06; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012; VIDOVIC D, 1989, NATURE, V340, P646, DOI 10.1038/340646a0; Wang LS, 2001, J CLIN INVEST, V108, P1349, DOI 10.1172/JCI13584; Wang T, 2003, J IMMUNOL, V171, P2524, DOI 10.4049/jimmunol.171.5.2524; Wang T, 2006, J IMMUNOL, V177, P1825, DOI 10.4049/jimmunol.177.3.1825; Weerkamp F, 2005, J ALLERGY CLIN IMMUN, V115, P834, DOI 10.1016/j.jaci.2004.10.031; Welte T, 2008, FEMS IMMUNOL MED MIC, V53, P275, DOI 10.1111/j.1574-695X.2008.00430.x; Welte T, 2011, FEMS IMMUNOL MED MIC, V63, P183, DOI 10.1111/j.1574-695X.2011.00840.x; Welte T, 2009, J GEN VIROL, V90, P2660, DOI 10.1099/vir.0.011783-0; Wesch D, 2006, J IMMUNOL, V176, P1348, DOI 10.4049/jimmunol.176.3.1348; Wicker JA, 2012, VIROLOGY, V426, P22, DOI 10.1016/j.virol.2011.11.022; Xie GR, 2013, VACCINE, V31, P4143, DOI 10.1016/j.vaccine.2013.06.093; Zeng X, 2012, IMMUNITY, V37, P524, DOI 10.1016/j.immuni.2012.06.011; Zuo AJ, 2012, MOL IMMUNOL, V50, P125, DOI 10.1016/j.molimm.2011.12.013	63	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e108156	10.1371/journal.pone.0108156	http://dx.doi.org/10.1371/journal.pone.0108156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232836	Green Published, gold, Green Submitted			2022-12-25	WOS:000342921200085
J	Colosimo, G; Knapp, CR; Wallace, LE; Welch, ME				Colosimo, Giuliano; Knapp, Charles R.; Wallace, Lisa E.; Welch, Mark E.			Inferred vs Realized Patterns of Gene Flow: An Analysis of Population Structure in the Andros Island Rock Iguana	PLOS ONE			English	Article							POLYMORPHIC MICROSATELLITE LOCI; FRAGMENTED LANDSCAPE; MIGRATION RATES; CYCLURA-CYCHLURA; NESTING-BEHAVIOR; F-STATISTICS; CONSERVATION; DISPERSAL; DIVERSITY; SOFTWARE	Ecological data, the primary source of information on patterns and rates of migration, can be integrated with genetic data to more accurately describe the realized connectivity between geographically isolated demes. In this paper we implement this approach and discuss its implications for managing populations of the endangered Andros Island Rock Iguana, Cyclura cychlura cychlura. This iguana is endemic to Andros, a highly fragmented landmass of large islands and smaller cays. Field observations suggest that geographically isolated demes were panmictic due to high, inferred rates of gene flow. We expand on these observations using 16 polymorphic microsatellites to investigate the genetic structure and rates of gene flow from 188 Andros Iguanas collected across 23 island sites. Bayesian clustering of specimens assigned individuals to three distinct genotypic clusters. An analysis of molecular variance (AMOVA) indicates that allele frequency differences are responsible for a significant portion of the genetic variance across the three defined clusters (F-st = 0.117, p << 0.01). These clusters are associated with larger islands and satellite cays isolated by broad water channels with strong currents. These findings imply that broad water channels present greater obstacles to gene flow than was inferred from field observation alone. Additionally, rates of gene flow were indirectly estimated using BAYESASS 3.0. The proportion of individuals originating from within each identified cluster varied from 94.5 to 98.7%, providing further support for local isolation. Our assessment reveals a major disparity between inferred and realized gene flow. We discuss our results in a conservation perspective for species inhabiting highly fragmented landscapes.	[Colosimo, Giuliano; Wallace, Lisa E.; Welch, Mark E.] Mississippi State Univ, Mississippi State, MS 39762 USA; [Knapp, Charles R.] John G Shedd Aquarium, Daniel P Haerter Ctr Conservat & Res, Chicago, IL USA	Mississippi State University	Colosimo, G (corresponding author), Mississippi State Univ, Mississippi State, MS 39762 USA.	gc460@msstate.edu		Colosimo, Giuliano/0000-0002-0485-9758	Shedd Aquarium; Mohamed bin Zayed Species Conservation Fund [12054368, 11253150]; Department of Biological Sciences at Mississippi State University	Shedd Aquarium; Mohamed bin Zayed Species Conservation Fund; Department of Biological Sciences at Mississippi State University	Samples were collected with financial support provided by Shedd Aquarium and Mohamed bin Zayed Species Conservation Fund (Proj. # 12054368). Samples were analyzed with funds provided by the Mohamed bin Zayed Species Conservation Fund (Proj. #s 11253150, 12054368), John G. Shedd Aquarium and the Department of Biological Sciences at Mississippi State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F., 2007, CONSERVATION GENETIC; An JH, 2004, CONSERV GENET, V5, P121, DOI 10.1023/B:COGE.0000014062.86556.e3; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bertrand JAM, 2014, HEREDITY, V112, P190, DOI 10.1038/hdy.2013.91; Bryan JJ, 2007, COPEIA, P734; Censky EJ, 1998, NATURE, V395, P556, DOI 10.1038/26886; Dever JA, 2007, J HERPETOL, V41, P168, DOI 10.1670/0022-1511(2007)41[168:FGSITT]2.0.CO;2; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Faubet P, 2007, MOL ECOL, V16, P1149, DOI 10.1111/j.1365-294X.2007.03218.x; Frankham R., 2010, CONSERVATION GENETIC; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Glor R, 2005, MOL ECOL, V5, P184; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; GREIG JC, 1979, S AFR J WILDL RES, V9, P57; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Haasl RJ, 2011, HEREDITY, V106, P158, DOI 10.1038/hdy.2010.21; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hedrick PW, 1996, CONSERV BIOL, V10, P1312, DOI 10.1046/j.1523-1739.1996.10051312.x; HOLM S, 1979, SCAND J STAT, V6, P65; Janecka JE, 2011, ANIM CONSERV, V14, P608, DOI 10.1111/j.1469-1795.2011.00475.x; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Knapp CR, 2006, CAN J ZOOL, V84, P1566, DOI 10.1139/Z06-157; Knapp CR, 2008, J HERPETOL, V42, P46, DOI 10.1670/07-098.1; Knapp CR, 2010, COPEIA, P62, DOI 10.1643/CE-09-014; Knapp CR, 2005, ANIM CONSERV, V8, P269, DOI 10.1017/S1367943005002222; KNAPP CR, 2004, 2004 IUCN RED LIST T; Knapp CR, 2005, THESIS U FLORIDA; Lanterbecq D, 2010, J HERED, V101, P663, DOI 10.1093/jhered/esq067; Lau J, 2009, MOL ECOL RESOUR, V9, P1412, DOI 10.1111/j.1755-0998.2009.02683.x; Layman CA, 2011, ECOL APPL, V21, P343, DOI 10.1890/10-1339.1; Longmire Jonathan L., 1997, Occasional Papers the Museum Texas Tech University, V163, P1; Malone CL, 2000, MOL PHYLOGENET EVOL, V17, P269, DOI 10.1006/mpev.2000.0836; Malone CL, 2003, CONSERV GENET, V4, P1, DOI 10.1023/A:1021885323539; Mattila ALK, 2012, PNAS, V109, P2496; Meirmans PG, 2014, MOL ECOL RESOUR, V14, P726, DOI 10.1111/1755-0998.12216; Moore JA, 2008, MOL ECOL, V17, P4630, DOI 10.1111/j.1365-294X.2008.03951.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Ng J, 2011, MOL ECOL, V20, P4302, DOI 10.1111/j.1365-294X.2011.05267.x; Nowak C, 2007, AQUAT TOXICOL, V85, P278, DOI 10.1016/j.aquatox.2007.04.015; Pagni L, 2011, ANDROS IGUANA CONSER; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Price TD, 2010, SPECIATION BIRDS; Pritchard JK, 2000, GENETICS, V155, P945; Purrenhage JL, 2009, MOL ECOL, V18, P235, DOI 10.1111/j.1365-294X.2008.04024.x; R Foundation for Statistical Computing, R LANG ENV STAT COMP; Rambaut A, 2004, TRACER V1 6; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Rosas KG, 2008, MOL ECOL RESOUR, V8, P825, DOI 10.1111/j.1755-0998.2007.02080.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Row JR, 2010, MOL ECOL, V19, P5157, DOI 10.1111/j.1365-294X.2010.04872.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Rutz C, 2012, NATURWISSENSCHAFTEN, V99, P313, DOI 10.1007/s00114-012-0904-6; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Steinfartz S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-297; Wang IJ, 2013, ECOL LETT, V16, P175, DOI 10.1111/ele.12025; Wang IJ, 2009, MOL ECOL, V18, P1365, DOI 10.1111/j.1365-294X.2009.04122.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Welch Mark E., 2004, P58; Welch ME, 2011, CONSERV GENET RESOUR, V3, P209, DOI 10.1007/s12686-010-9324-0; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Wilson GA, 2003, GENETICS, V163, P1177; Wright S, 1931, GENETICS, V16, P0097; Wright S., 1969, THEORY GENE FREQUENC, V2, P520	73	13	13	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e106963	10.1371/journal.pone.0106963	http://dx.doi.org/10.1371/journal.pone.0106963			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229344	Green Published, gold			2022-12-25	WOS:000342123900018
J	Cornelis, MC; Chiuve, SE; Glymour, MM; Chang, SC; Tchetgen, EJT; Liang, L; Koenen, KC; Rimm, EB; Kawachi, I; Kubzansky, LD				Cornelis, Marilyn C.; Chiuve, Stephanie E.; Glymour, M. Maria; Chang, Shun-Chiao; Tchetgen, Eric J. Tchetgen; Liang, Liming; Koenen, Karestan C.; Rimm, Eric B.; Kawachi, Ichiro; Kubzansky, Laura D.			Bachelors, Divorcees, and Widowers: Does Marriage Protect Men from Type 2 Diabetes?	PLOS ONE			English	Article							MARITAL-STATUS; PHYSICAL-ACTIVITY; ALCOHOL-CONSUMPTION; HEALTH BEHAVIORS; RISK; ASSOCIATIONS; PREVALENCE; DIETARY; DISEASE; SELECTION	While research has suggested that being married may confer a health advantage, few studies to date have investigated the role of marital status in the development of type 2 diabetes. We examined whether men who are not married have increased risk of incident type 2 diabetes in the Health Professionals Follow-up Study. Men (n = 41,378) who were free of T2D in 1986, were followed for <= 22 years with biennial reports of T2D, marital status and covariates. Cox proportional hazard models were used to compare risk of incident T2D by marital status (married vs unmarried and married vs never married, divorced/separated, or widowed). There were 2,952 cases of incident T2D. Compared to married men, unmarried men had a 16% higher risk of developing T2D (95%CI: 1.04,1.30), adjusting for age, family history of diabetes, ethnicity, lifestyle and body mass index (BMI). Relative risks (RR) for developing T2D differed for divorced/separated (1.09 [95%CI: 0.94,1.27]), widowed (1.29 [95%CI: 1.06,1.57]), and never married (1.17 [95%CI: 0.91,1.52]) after adjusting for age, family history of diabetes and ethnicity. Adjusting for lifestyle and BMI, the RR for T2D associated with widowhood was no longer significant (RR: 1.16 [95%CI: 0.95,1.41]). When allowing for a 2-year lag period between marital status and disease, RRs of T2D for widowers were augmented and borderline significant (RR:1.24 [95%CI: 1.00,1.54]) after full adjustment. In conclusion, not being married, and more specifically, widowhood was more consistently associated with an increased risk of type 2 diabetes in men and this may be mediated, in part, through unfavorable changes in lifestyle, diet and adiposity.	[Cornelis, Marilyn C.; Chiuve, Stephanie E.; Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Glymour, M. Maria] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Chang, Shun-Chiao; Kawachi, Ichiro; Kubzansky, Laura D.] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Tchetgen, Eric J. Tchetgen; Liang, Liming; Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Koenen, Karestan C.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA	Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Columbia University	Cornelis, MC (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	mcorneli@hsph.harvard.edu	Tchetgen, Eric Tchetgen/AAF-6160-2021	Glymour, M. Maria/0000-0001-9644-3081; Chiuve, Stephanie/0000-0002-3524-8917	National Institutes of Diabetes and Digestive and Kidney Disease [DK58845]; National Institutes of Mental Health [1RC4 MH092707]; Robert Wood Johnson Foundation's Pioneer Portfolio; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC4MH092707] Funding Source: NIH RePORTER	National Institutes of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Robert Wood Johnson Foundation's Pioneer Portfolio(Robert Wood Johnson Foundation (RWJF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Diabetes and Digestive and Kidney Disease (DK58845), the National Institutes of Mental Health (1RC4 MH092707, LDK), and The Robert Wood Johnson Foundation's Pioneer Portfolio ("Exploring Concepts of Positive Health", LDK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Azimi-Nezhad M, 2008, SINGAP MED J, V49, P571; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Cole SR, 2002, INT J EPIDEMIOL, V31, P163, DOI 10.1093/ije/31.1.163; Eng PM, 2005, J EPIDEMIOL COMMUN H, V59, P56, DOI 10.1136/jech.2004.020073; Espinosa J, 2008, J HEALTH ECON, V27, P1326, DOI 10.1016/j.jhealeco.2008.04.001; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Friedrich N, 2013, J OBES, V2013, DOI 10.1155/2013/762012; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; HARRIS M, 1979, DIABETES, V28, P1039; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hiltunen L. A., 2005, Central European Journal of Public Health, V13, P187; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; International Diabetes Federation, 2011, IDF DIABETES ATLAS; Jeffery RW, 2002, OBES RES, V10, P809, DOI 10.1038/oby.2002.109; JOUNG IMA, 1995, J EPIDEMIOL COMMUN H, V49, P482, DOI 10.1136/jech.49.5.482; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; Koh-Banerjee P, 2003, AM J CLIN NUTR, V78, P719, DOI 10.1093/ajcn/78.4.719; Martin SA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-261; Moon JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023465; Mostofsky E, 2012, CIRCULATION, V125, P491, DOI 10.1161/CIRCULATIONAHA.111.061770; Murray JE, 2000, DEMOGRAPHY, V37, P511, DOI 10.1353/dem.2000.0010; Ortega FB, 2011, AM J EPIDEMIOL, V173, P337, DOI 10.1093/aje/kwq362; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Sobal J, 2003, SOC SCI MED, V56, P1543, DOI 10.1016/S0277-9536(02)00155-7; Stephens MAP, 2013, HEALTH PSYCHOL, V32, P1029, DOI 10.1037/a0030018; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Sun Q, 2009, DIABETES CARE, V32, P629, DOI 10.2337/dc08-1913; The NS, 2009, OBESITY, V17, P1441, DOI 10.1038/oby.2009.97; U.S. Census Bureau HaHESD, 2011, FERT FAM STAT BRANCH; UMBERSON D, 1992, SOC SCI MED, V34, P907, DOI 10.1016/0277-9536(92)90259-S; Willett W., 2012, NUTR EPIDEMIOLOGY	38	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e106720	10.1371/journal.pone.0106720	http://dx.doi.org/10.1371/journal.pone.0106720			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP5MS	25229473	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900010
J	Ito, T; Yoshikawa, N; Inui, T; Miyazaki, N; Schaffer, SW; Azuma, J				Ito, Takashi; Yoshikawa, Natsumi; Inui, Takaaki; Miyazaki, Natsuko; Schaffer, Stephen W.; Azuma, Junichi			Tissue Depletion of Taurine Accelerates Skeletal Muscle Senescence and Leads to Early Death in Mice	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; LIFE-SPAN; TRANSPORTER KNOCKOUT; ANGIOTENSIN-II; COMPLEX I; ER STRESS; LONGEVITY; KINASE; CARDIOMYOPATHY; DEGENERATION	Taurine (2-aminoethanesulfonic acid) is found in milimolar concentrations in mammalian tissues. One of its main functions is osmoregulation; however, it also exhibits cytoprotective activity by diminishing injury caused by stress and disease. Taurine depletion is associated with several defects, many of which are found in the aging animal, suggesting that taurine might exert anti-aging actions. Therefore, in the present study, we examined the hypothesis that taurine depletion accelerates aging by reducing longevity and accelerating aging-associated tissue damage. Tissue taurine depletion in taurine transporter knockout (TauTKO) mouse was found to shorten lifespan and accelerate skeletal muscle histological and functional defects, including an increase in central nuclei containing myotubes, a reduction in mitochondrial complex 1 activity and an induction in an aging biomarker, Cyclin-dependent kinase 4 inhibitor A (p16INK4a). Tissue taurine depletion also enhances unfolded protein response (UPR), which may be associated with an improvement in protein folding by taurine. Our data reveal that tissue taurine depletion affects longevity and cellular senescence; an effect possibly linked to a disturbance in protein folding.	[Ito, Takashi; Yoshikawa, Natsumi; Inui, Takaaki; Miyazaki, Natsuko; Azuma, Junichi] Hyogo Univ Hlth Sci, Dept Clin Pharmacogen, Coll Pharm, Kobe, Hyogo, Japan; [Schaffer, Stephen W.] Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA	University of South Alabama	Ito, T (corresponding author), Hyogo Univ Hlth Sci, Dept Clin Pharmacogen, Coll Pharm, Kobe, Hyogo, Japan.	tito@huhs.ac.jp; azuma@huhs.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25750368, 22790097]; Uehara Memorial Foundation; Taisho Phamaceutical Co. Ltd.	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Taisho Phamaceutical Co. Ltd.	This work was funded by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (TI: 25750368, 22790097), Uehara Memorial Foundation (TI, http://www.ueharazaidan.or.jp/), and a research grant from Taisho Phamaceutical Co. Ltd. (for JA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Anisimov VN, 2011, AGING-US, V3, P148, DOI 10.18632/aging.100273; Anisimov VN, 2010, AGING-US, V2, P945, DOI 10.18632/aging.100245; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bandyopadhyay A, 2012, NAT CHEM BIOL, V8, P238, DOI [10.1038/NCHEMBIO.768, 10.1038/nchembio.768]; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Berger E, 2011, BIOCHEM BIOPH RES CO, V409, P610, DOI 10.1016/j.bbrc.2011.05.043; Campisi J, 2014, NATURE, V505, P35, DOI 10.1038/nature12844; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Han XB, 2012, AMINO ACIDS, V43, P2249, DOI 10.1007/s00726-012-1314-y; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; HAYES KC, 1975, SCIENCE, V188, P949, DOI 10.1126/science.1138364; Heller-Stilb B, 2001, FASEB J, V15, P231, DOI 10.1096/fj.01-0691fje; Henis-Korenblit S, 2010, P NATL ACAD SCI USA, V107, P9730, DOI 10.1073/pnas.1002575107; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Ito T, 2012, CARDIOMYOPATHIES BAS; Ito T, 2008, J MOL CELL CARDIOL, V44, P927, DOI 10.1016/j.yjmcc.2008.03.001; Ito T, 2007, J BIOL CHEM, V282, P1152, DOI 10.1074/jbc.M609547200; Ito T, 2014, AMINO ACIDS, V46, P111, DOI 10.1007/s00726-013-1507-z; Ito T, 2012, AMINO ACIDS, V42, P1529, DOI 10.1007/s00726-011-0883-5; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Lee-Young RS, 2009, J BIOL CHEM, V284, P23925, DOI 10.1074/jbc.M109.021048; Lenaz G, 1997, MOL CELL BIOCHEM, V174, P329, DOI 10.1023/A:1006854619336; Lexell J, 1997, J NUTR, V127, pS1011, DOI 10.1093/jn/127.5.1011S; Liu S, 2011, MOL ENDOCRINOL, V25, P1301, DOI 10.1210/me.2010-0455; Menzie J, 2014, AMINO ACIDS, V46, P31, DOI 10.1007/s00726-012-1382-z; Miyazaki T, 2014, AMINO ACIDS, V46, P101, DOI 10.1007/s00726-012-1381-0; Neff F, 2013, J CLIN INVEST, V123, P3272, DOI 10.1172/JCI67674; Nonaka H, 2001, CIRCULATION, V104, P1165, DOI 10.1161/hc3601.093976; Pan CL, 2012, AMINO ACIDS, V43, P845, DOI 10.1007/s00726-011-1141-6; Pierno S, 1998, J PHARMACOL EXP THER, V286, P1183; PION PD, 1987, SCIENCE, V237, P764, DOI 10.1126/science.3616607; Rader EP, 2006, J APPL PHYSIOL, V101, P887, DOI 10.1152/japplphysiol.00380.2006; Rajesh D, 2003, J BIOL CHEM, V278, P35968, DOI 10.1074/jbc.M303280200; Romero-Suarez S, 2010, AGING-US, V2, P504, DOI 10.18632/aging.100190; SAKS VA, 1985, J BIOL CHEM, V260, P7757; Schaffer S, 2000, AMINO ACIDS, V19, P527, DOI 10.1007/s007260070004; Schaffer SW, 2014, AMINO ACIDS, V46, P47, DOI [10.1007/s00726-012-1414-8, 10.1007/s00726-013-1632-8]; Schaffer SW, 2014, AMINO ACIDS, V46, P21, DOI 10.1007/s00726-012-1378-8; Schaffer SW, 2009, CAN J PHYSIOL PHARM, V87, P91, DOI 10.1139/Y08-110; Schaffer SW, 2000, AMINO ACIDS, V18, P305, DOI 10.1007/PL00010320; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Stenesen D, 2013, CELL METAB, V17, P101, DOI 10.1016/j.cmet.2012.12.006; Strong R, 2008, AGING CELL, V7, P641, DOI 10.1111/j.1474-9726.2008.00414.x; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; Takatani T, 2004, AM J PHYSIOL-CELL PH, V287, pC949, DOI 10.1152/ajpcell.00042.2004; Taylor R.C., 2011, COLD SPRING HARB PER, V3; Warskulat U, 2006, FASEB J, V20, P574, DOI 10.1096/fj.05-5016fje; Warskulat U, 2004, FASEB J, V18, P577, DOI 10.1096/fj.03-0496fje; Wojcik OP, 2010, ATHEROSCLEROSIS, V208, P19, DOI 10.1016/j.atherosclerosis.2009.06.002; Yamori Y, 2001, HYPERTENS RES, V24, P453, DOI 10.1291/hypres.24.453; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730	57	58	60	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107409	10.1371/journal.pone.0107409	http://dx.doi.org/10.1371/journal.pone.0107409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229346	Green Submitted, Green Published, gold			2022-12-25	WOS:000342123900040
J	Ren, ZH; Wang, YN; Jiang, WH; Dai, W; Jiang, YP				Ren, Zhihua; Wang, Yanan; Jiang, Wenhong; Dai, Wei; Jiang, Yongping			Anti-Tumor Effect of a Novel Soluble Recombinant Human Endostatin: Administered as a Single Agent or in Combination with Chemotherapy Agents in Mouse Tumor Models	PLOS ONE			English	Article							IN-VITRO ACTIVITY; ANTIANGIOGENIC THERAPY; CLINICAL-TRIAL; ANTI-ANGIOGENESIS; ENDOTHELIAL-CELLS; GROWTH; CANCER; METASTASIS; CARCINOMA; INHIBITION	Background: Angiogenesis has become an attractive target in cancer treatment. Endostatin is one of the potent anti-angiogenesis agents. Its recombinant form expressed in the yeast system is currently under clinical trials. Endostatin suppresses tumor formation through the inhibition of blood vessel growth. It is anticipated that combined therapy using endostatin and cytotoxic compounds may exert an additive effect. In the present study, we expressed and purified recombinant human endostatin (rhEndostatin) that contained 3 additional amino acid residues (arginine, glycine, and serine) at the amino-terminus and 6 histidine residues in its carboxyl terminus. The recombinant protein was expressed in E. Coli and refolded into a soluble form in a large scale purification process. The protein exhibited a potent anti-tumor activity in bioassays. Furthermore, rhEndostatin showed an additive effect with chemotherapy agents including cyclophosphamide (CTX) and cisplatin (DDP). Methods: rhEndostatin cDNA was cloned into PQE vector and expressed in E. Coli. The protein was refolded through dialysis with an optimized protocol. To establish tumor models, nude mice were subcutaneously injected with human cancer cells (lung carcinoma A549, hepatocellular carcinoma QGY-7703, or breast cancer Bcap37). rhEndostatin and/or DDP was administered peritumorally to evaluate the rate of growth inhibition of A549 tumors. For the tumor metastasis model, mice were injected intravenously with mouse melanoma B16 cells. One day after tumor cell injection, a single dose of rhEndostatin, or in combination with CTX, was administered intravenously or at a site close to the tumor. Results: rhEndostatin reduced the growth of A549, QGY-7703, and Bcap37 xenograft tumors in a dose dependent manner. When it was administered peritumorally, rhEndostatin exhibited a more potent inhibitory activity. Furthermore, rhEndostatin displayed an additive effect with CTX or DDP on the inhibition of metastasis of B16 tumors or growth of A549 tumors. Conclusion: Soluble rhEndostatin exhibits a potent anti-tumor activity in mouse xenograft models and it also has an additive effect with CTX and DDP, implying possible applications in clinical settings.	[Ren, Zhihua; Jiang, Wenhong; Jiang, Yongping] Biopharmagen Corp, Suzhou, Peoples R China; [Wang, Yanan] Nanjing Med Univ, Suzhou Municipal Hosp, Dept Lab Diag, Suzhou, Peoples R China; [Ren, Zhihua; Dai, Wei; Jiang, Yongping] Chinese Acad Med Sci, Biopharmaceut R&D Ctr, Suzhou, Peoples R China; [Ren, Zhihua; Dai, Wei; Jiang, Yongping] Peking Union Med Coll, Suzhou, Peoples R China; [Dai, Wei] NYU, Langone Med Ctr, Dept Environm Med, Tuxedo Pk, NY USA	Nanjing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; New York University; NYU Langone Medical Center	Dai, W (corresponding author), Chinese Acad Med Sci, Biopharmaceut R&D Ctr, Suzhou, Peoples R China.	wei.dai@nyumc.org; yjiang@biopharmagen.com		Dai, Wei/0000-0003-0169-8327	Key State projects of China [2011ZX09401-027, 2011ZX09102-010-04]	Key State projects of China	This study was supported in all by the Key State projects of China (2011ZX09401-027) and (2011ZX09102-010-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2005, DRUG RESIST UPDATE, V8, P59, DOI 10.1016/j.drup.2005.03.001; Boehm T, 1998, BIOCHEM BIOPH RES CO, V252, P190, DOI 10.1006/bbrc.1998.9617; Boehm T, 1999, YEAST, V15, P563, DOI 10.1002/(SICI)1097-0061(199905)15:7<563::AID-YEA398>3.0.CO;2-R; Boehm T, 1997, NATURE, V390, P404, DOI 10.1038/37126; Brandwijk RJMGE, 2006, BIOCHEM BIOPH RES CO, V349, P1073, DOI 10.1016/j.bbrc.2006.08.154; BREM H, 1975, J EXP MED, V141, P427, DOI 10.1084/jem.141.2.427; BRILES EB, 1978, J NATL CANCER I, V60, P1217, DOI 10.1093/jnci/60.6.1217; Cabebe Elwyn, 2007, Curr Treat Options Oncol, V8, P15, DOI 10.1007/s11864-007-0022-4; Calvo A, 2002, CANCER RES, V62, P3934; Capillo M, 2003, CLIN CANCER RES, V9, P377; Choudhury SR, 2012, J ONCOL, V2012, DOI 10.1155/2012/782020; Cui C, MOL THER, V21, P1456; Dhanabal M, 1999, BIOCHEM BIOPH RES CO, V258, P345, DOI 10.1006/bbrc.1999.0595; Dhanabal M, 1999, CANCER RES, V59, P189; Dome B, 2007, AM J PATHOL, V170, P1, DOI 10.2353/ajpath.2007.060302; Dong XP, ASIAN PAC J CANC PRE, V14, P3079; Eder JP, 2002, J CLIN ONCOL, V20, P3772, DOI 10.1200/JCO.2002.02.082; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Folkman J, 1996, EUR J CANCER, V32A, P2534, DOI 10.1016/S0959-8049(96)00423-6; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; Fu XH, CANC LETT, V312, P109; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Hagedorn M, 2000, CRIT REV ONCOL HEMAT, V34, P89, DOI 10.1016/S1040-8428(00)00056-1; Harris AL, 1998, RECENT RES CANCER, V152, P341; Hawtin SR, 2006, J BIOL CHEM, V281, P38478, DOI 10.1074/jbc.M607639200; Herbst RS, 2002, J CLIN ONCOL, V20, P3804, DOI 10.1200/JCO.2002.05.102; HOSHI H, 1984, P NATL ACAD SCI-BIOL, V81, P6413, DOI 10.1073/pnas.81.20.6413; Huang XJ, 2001, CANCER RES, V61, P478; Jia Y, PATHOL ONCOL RES, V18, P315; Jiang Y, J HEMATOL ONCOL, V4, P28; Joseph MK, 2004, ONCOGENE, V23, P835, DOI 10.1038/sj.onc.1207141; Kaya M, 2007, J ORTHOP SCI, V12, P562, DOI 10.1007/s00776-007-1179-1; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Kerbel RS, 2000, EUR J CANCER, V36, P1248, DOI 10.1016/S0959-8049(00)00092-7; Kisker O, 2001, CANCER RES, V61, P7669; Klement G, 2000, J CLIN INVEST, V105, pR15, DOI 10.1172/JCI8829; Kulke MH, 2006, J CLIN ONCOL, V24, P3555, DOI 10.1200/JCO.2006.05.6762; Luo D, 1999, TUMOR BIOL, V20, P331, DOI 10.1159/000030097; Ma J, 2008, MOL CANCER THER, V7, P3670, DOI 10.1158/1535-7163.MCT-08-0715; Morioka H, 2003, CLIN CANCER RES, V9, P1211; Mundhenke C, 2001, CLIN CANCER RES, V7, P3366; OReilly MS, 1996, NAT MED, V2, P689, DOI 10.1038/nm0696-689; OREILLY MS, 1994, COLD SPRING HARB SYM, V59, P471, DOI 10.1101/SQB.1994.059.01.052; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Plum SM, 2003, CLIN CANCER RES, V9, P4619; Prokopiou EM, 2013, ANGIOGENESIS, V16, P503, DOI 10.1007/s10456-013-9347-8; Rao JS, 2005, MOL CANCER THER, V4, P1399, DOI 10.1158/1535-7163.MCT-05-0082; Saphir A, 1997, J NATL CANCER I, V89, P1658; Scheer A, 2000, MOL PHARMACOL, V57, P219; [宋爽 Song Shuang], 2012, [中国生物医学工程学报, Chinese Journal of Biomedical Engineering], V31, P552; Sun L, 2007, WORLD J GASTROENTERO, V13, P6115, DOI 10.3748/wjg.13.6115; WEIDNER N, 1993, AM J PATHOL, V143, P401; Wu Y, 2005, ANTI-CANCER DRUG, V16, P551, DOI 10.1097/00001813-200506000-00011; Xiang XX, 2007, CANCER BIOL THER, V6, P1067, DOI 10.4161/cbt.6.7.4323; Xu M, 2013, BONE, V57, P111, DOI 10.1016/j.bone.2013.07.035; Zetter BR, 1998, ANNU REV MED, V49, P407, DOI 10.1146/annurev.med.49.1.407; Zhang LP, ASIAN PAC J CANC PRE, V14, P4255	57	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107823	10.1371/journal.pone.0107823	http://dx.doi.org/10.1371/journal.pone.0107823			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229620	Green Published, gold			2022-12-25	WOS:000342123900078
J	Shu, Q; Li, WJ; Li, JN; Wang, WS; Liu, C; Sun, K				Shu, Qun; Li, Wenjiao; Li, Jianneng; Wang, Wangsheng; Liu, Chao; Sun, Kang			Cross-Talk between cAMP and MAPK Pathways in HSD11B2 Induction by hCG in Placental Trophoblasts	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2; HUMAN CHORIONIC-GONADOTROPIN; CYCLIC ADENOSINE 5'-MONOPHOSPHATE; BETA-HYDROXYSTEROID DEHYDROGENASE; DIFFERENTIAL REGULATION; INDUCED APOPTOSIS; CELLS; EXPRESSION; P38; KINASE	Overexposure of the fetus to glucocorticoids in gestation is detrimental to fetal development. The passage of maternal glucocorticoids into the fetal circulation is governed by 11beta-Hydroxysteroid Dehydrogenase Type 2 (HSD11B2) in the placental syncytiotrophoblasts. Human chorionic gonadotropin (hCG) plays an important role in maintaining placental HSD11B2 expression via activation of the cAMP pathway. In this study, we investigated the relationship between the activation of the cAMP pathway by hCG and subsequent phosphorylation of extracellular signal-regulated kinase1/2 (ERK1/2) or p38 mitogen-activated protein kinase (MAPK) pathways in the regulation of placental HSD11B2 expression in human placental syncytiotrophoblasts. We found that treatment of the placental syncytiotrophoblasts with either hCG or dibutyl cAMP (dbcAMP) could promote the phosphorylation of p38 and ERK1/2. Inhibition of p38 MAPK with SB203580 not only reduced the basal HSD11B2 mRNA and protein levels but also attenuated HSD11B2 levels induced by either hCG or dbcAMP. By contrast, inhibition of ERK1/2 with PD98059 increased the basal mRNA and protein levels of HSD11B2 and had no effect on HSD11B2 mRNA and protein levels induced by either hCG or dbcAMP. These data suggest that p38 MAPK is involved in both basal and hCG/cAMP-induced expression of HSD11B2, and ERK1/2 may play a role opposite to p38 MAPK at least in the basal expression of HSD11B2 in human placental syncytiotrophoblasts and that there is complicated cross-talk between hCG/cAMP and MAPK cascades in the regulation of placental HSD11B2 expression.	[Sun, Kang] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Ctr Reprod Med,Shanghai Key Lab Assisted Reprod &, Shanghai 200030, Peoples R China; [Shu, Qun; Li, Wenjiao] Changning Matern & Infant Hlth Hosp, Shanghai, Peoples R China; [Li, Jianneng; Wang, Wangsheng; Liu, Chao] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Fudan University	Sun, K (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Ctr Reprod Med,Shanghai Key Lab Assisted Reprod &, Shanghai 200030, Peoples R China.	sungangrenji@hotmail.com	Wang, Wang-sheng/E-9811-2017	Wang, Wang-sheng/0000-0003-1429-9237; Sun, Kang/0000-0003-2727-141X	Natural Science Foundation of China [81330018, 81270704]; National Key Basic Research Program of China [2011CB944403]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported by the Natural Science Foundation of China (81330018, 81270704) and the National Key Basic Research Program of China (2011CB944403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 1996, MOL CELL ENDOCRINOL, V121, P93, DOI 10.1016/0303-7207(96)03855-5; Benediktsson R, 1997, CLIN ENDOCRINOL, V46, P161, DOI 10.1046/j.1365-2265.1997.1230939.x; Bhat NR, 2007, NEUROCHEM RES, V32, P293, DOI 10.1007/s11064-006-9274-9; BRORASMUSSEN F, 1962, ACTA ENDOCRINOL-COP, V40, P571, DOI 10.1530/acta.0.0400571; Burton PJ, 1999, BIOL REPROD, V60, P234, DOI 10.1095/biolreprod60.2.234; CAMPBELL AL, 1977, J CLIN ENDOCR METAB, V45, P435, DOI 10.1210/jcem-45-3-435; Cole LA, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-8; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; CRONIER L, 1994, ENDOCRINOLOGY, V135, P402, DOI 10.1210/en.135.1.402; Daoud G, 2005, J PHYSIOL-LONDON, V566, P409, DOI 10.1113/jphysiol.2005.089326; Dhingra S, 2007, AM J PHYSIOL-HEART C, V293, pH3524, DOI 10.1152/ajpheart.00919.2007; Fan YM, 2007, MOL CELLS, V23, P30; Fitzgerald JS, 2005, CHEM IMMUNOL ALLERGY, V88, P181, DOI 10.1159/000087834; Ge YC, 2011, REPRODUCTION, V142, P369, DOI 10.1530/REP-11-0053; Guan HY, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110924; Handschuh K, 2007, ENDOCRINOLOGY, V148, P5011, DOI 10.1210/en.2007-0286; Hardy DB, 1999, BIOL REPROD, V61, P40, DOI 10.1095/biolreprod61.1.40; Homan A, 2006, PLACENTA, V27, P832, DOI 10.1016/j.placenta.2005.09.006; Ki MR, 2008, AM J PHYSIOL-GASTR L, V294, pG635, DOI 10.1152/ajpgi.00281.2007; Kirkegaard I, 2011, ULTRASOUND OBST GYN, V37, P341, DOI 10.1002/uog.8808; Kitanaka S, 1996, CLIN ENDOCRINOL, V44, P353, DOI 10.1046/j.1365-2265.1996.677500.x; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; KRAIEM Z, 1994, J CLIN ENDOCR METAB, V79, P595, DOI 10.1210/jc.79.2.595; KROZOWSKI Z, 1995, J CLIN ENDOCR METAB, V80, P2203, DOI 10.1210/jc.80.7.2203; Kurtzman JT, 2001, SEMIN REPROD MED, V19, P63, DOI 10.1055/s-2001-13912; Li JN, 2011, J CLIN ENDOCR METAB, V96, pE899, DOI 10.1210/jc.2010-2852; Liu MG, 2011, BRAIN RES, V1382, P57, DOI 10.1016/j.brainres.2011.01.076; Ma XH, 2003, AM J OBSTET GYNECOL, V188, P13, DOI 10.1067/mob.2003.62; Maymo JL, 2010, ENDOCRINOLOGY, V151, P3738, DOI 10.1210/en.2010-0064; Maymo JL, 2009, ENDOCRINOLOGY, V150, P304, DOI 10.1210/en.2008-0522; Mesiano S, 1997, ENDOCR REV, V18, P378, DOI 10.1210/er.18.3.378; Nawrocki AR, 2002, J BIOL CHEM, V277, P14647, DOI 10.1074/jbc.M111549200; Ni XT, 2009, PLACENTA, V30, P1023, DOI 10.1016/j.placenta.2009.10.005; Nordstrom E, 2009, FASEB J, V23, P613, DOI 10.1096/fj.08-115360; Pepe GJ, 1999, PLACENTA, V20, P575, DOI 10.1053/plac.1999.0416; Pepe GJ, 2001, ENDOCRINOLOGY, V142, P4496, DOI 10.1210/en.142.10.4496; Perez-Perez A, 2008, ARCH BIOCHEM BIOPHYS, V477, P390, DOI 10.1016/j.abb.2008.06.015; Rey A, 2007, BONE, V41, P59, DOI 10.1016/j.bone.2007.02.031; Seckl JR, 2004, EUR J ENDOCRINOL, V151, pU49, DOI 10.1530/eje.0.151u049; Seckl JR, 2001, MOL CELL ENDOCRINOL, V185, P61, DOI 10.1016/S0303-7207(01)00633-5; Sengupta N, 2007, BIOPHYS CHEM, V125, P59, DOI 10.1016/j.bpc.2006.06.012; Sharma A, 2009, ENDOCRINOLOGY, V150, P4278, DOI 10.1210/en.2009-0479; SHI QJ, 1993, ENDOCRINOLOGY, V132, P1387, DOI 10.1210/en.132.3.1387; STRAUSS JF, 1992, PLACENTA, V13, P389, DOI 10.1016/0143-4004(92)90047-W; Sun K, 1997, ENDOCRINOLOGY, V138, P4912, DOI 10.1210/en.138.11.4912; Sun K, 1999, PLACENTA, V20, P13, DOI 10.1053/plac.1998.0352; Sun K, 1998, BIOL REPROD, V58, P1379, DOI 10.1095/biolreprod58.6.1379; Wagener J, 2013, MOL HUM REPROD, V19, P237, DOI 10.1093/molehr/gas061; Wyrwoll CS, 2009, ENDOCRINOLOGY, V150, P1287, DOI 10.1210/en.2008-1100; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang K, 1997, Rev Reprod, V2, P129, DOI 10.1530/ror.0.0020129; Yang KP, 2006, AM J PHYSIOL-ENDOC M, V290, pE135, DOI 10.1152/ajpendo.00356.2005; Zhang J, 2008, CELL DEATH DIFFER, V15, P1654, DOI 10.1038/cdd.2008.87	53	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107938	10.1371/journal.pone.0107938	http://dx.doi.org/10.1371/journal.pone.0107938			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229504	Green Submitted, Green Published, gold			2022-12-25	WOS:000342123900088
J	Son, KY; Kim, DS; Kwon, J; Choi, JS; Kang, MI; Belsham, GJ; Cho, KO				Son, Kyu-Yeol; Kim, Deok-Song; Kwon, Joseph; Choi, Jong-Soon; Kang, Mun-Il; Belsham, Graham J.; Cho, Kyoung-Oh			Full-Length Genomic Analysis of Korean Porcine Sapelovirus Strains	PLOS ONE			English	Article							ACTING REPLICATION ELEMENT; RIBOSOME ENTRY SITES; MOUTH-DISEASE VIRUS; HEPATITIS-C VIRUS; RNA REPLICATION; TRANSLATION INITIATION; SEQUENCE-ANALYSIS; LEADER PROTEIN; POLIOVIRUS RNA; IDENTIFICATION	Porcine sapelovirus (PSV), a species of the genus Sapelovirus within the family Picornaviridae, is associated with diarrhea, pneumonia, severe neurological disorders, and reproductive failure in pigs. However, the structural features of the complete PSV genome remain largely unknown. To analyze the structural features of PSV genomes, the full-length nucleotide sequences of three Korean PSV strains were determined and analyzed using bioinformatic techniques in comparison with other known PSV strains. The Korean PSV genomes ranged from 7,542 to 7,566 nucleotides excluding the 3' poly(A) tail, and showed the typical picornavirus genome organization; 5'untranslated region (UTR)-L-VP4-VP2-VP3-VP1-2A-2B-2C-3A-3B-3C3D-3'UTR. Three distinct cis-active RNA elements, the internal ribosome entry site (IRES) in the 5'UTR, a cis-replication element (CRE) in the 2C coding region and 3'UTR were identified and their structures were predicted. Interestingly, the structural features of the CRE and 3'UTR were different between PSV strains. The availability of these first complete genome sequences for PSV strains will facilitate future investigations of the molecular pathogenesis and evolutionary characteristics of PSV.	[Son, Kyu-Yeol; Kim, Deok-Song; Kang, Mun-Il; Cho, Kyoung-Oh] Chonnam Natl Univ, Coll Vet Med, Lab Vet Pathol, Kwangju, South Korea; [Kwon, Joseph; Choi, Jong-Soon] Korea Basic Sci Inst, Div Life Sci, Taejon, South Korea; [Belsham, Graham J.] Tech Univ Denmark, Natl Vet Inst, Kalvehave, Denmark	Chonnam National University; Korea Basic Science Institute (KBSI); Technical University of Denmark	Belsham, GJ (corresponding author), Tech Univ Denmark, Natl Vet Inst, Kalvehave, Denmark.	grbe@vet.dtu.dk; choko@chonnam.ac.kr	Belsham, Graham/J-3132-2019; Belsham, Graham J./H-8589-2019	Belsham, Graham/0000-0003-1187-4873; Belsham, Graham J./0000-0003-1187-4873; Kang, Munil/0000-0003-1595-1717; kang, munil/0000-0003-2140-4234	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2012R1A1A2041530]; Korea Basic Science Institute, Republic of Korea [C33730]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; Korea Basic Science Institute, Republic of Korea	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2012R1A1A2041530) and the Korea Basic Science Institute grant (C33730), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2011, VIRUS GENES, V43, P243, DOI 10.1007/s11262-011-0628-2; Al-Sunaidi M, 2007, J VIROL, V81, P1013, DOI 10.1128/JVI.00584-06; Belsham GJ, 2000, COLD SPRING HARBOR M, V39, P869; Belsham GJ, 2009, VIRUS RES, V139, P183, DOI 10.1016/j.virusres.2008.07.001; Buitrago D, 2010, J VET DIAGN INVEST, V22, P763, DOI 10.1177/104063871002200519; Chard LS, 2006, J GEN VIROL, V87, P927, DOI 10.1099/vir.0.81546-0; Chard LS, 2006, J VIROL, V80, P1271, DOI 10.1128/JVI.80.3.1271-1279.2006; CHEN CY, 1995, SCIENCE, V268, P415, DOI 10.1126/science.7536344; Chen JW, 2012, J VIROL, V86, P10898, DOI 10.1128/JVI.01799-12; Cordey S, 2008, RNA, V14, P1568, DOI 10.1261/rna.1031408; CRAWFORD NM, 1983, P NATL ACAD SCI-BIOL, V80, P7452, DOI 10.1073/pnas.80.24.7452; DEVANEY MA, 1988, J VIROL, V62, P4407, DOI 10.1128/JVI.62.11.4407-4409.1988; Dvorak CMT, 2001, VIROLOGY, V290, P261, DOI 10.1006/viro.2001.1193; FORSS S, 1984, NUCLEIC ACIDS RES, V12, P6587, DOI 10.1093/nar/12.16.6587; Gerber K, 2001, J VIROL, V75, P10979, DOI 10.1128/JVI.75.22.10979-10990.2001; Goodfellow I, 2000, J VIROL, V74, P4590, DOI 10.1128/JVI.74.10.4590-4600.2000; Goodfellow IG, 2003, J GEN VIROL, V84, P2359, DOI 10.1099/vir.0.19132-0; GORBALENYA AE, 1991, FEBS LETT, V288, P201, DOI 10.1016/0014-5793(91)81034-6; Gradi A, 2004, J VIROL, V78, P3271, DOI 10.1128/JVI.78.7.3271-3278.2004; Hales LM, 2008, J GEN VIROL, V89, P1265, DOI 10.1099/vir.0.83570-0; Hellen CUT, 2007, J VIROL, V81, P5850, DOI 10.1128/JVI.02403-06; HONDA E, 1990, JPN J VET SCI, V52, P85; International Committee on Taxonomy of viruses ICTV, 2013, MAST SPEC LIST; Knowles N.J., 2006, DIS SWINE, P337; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; Krumbholz A, 2002, J VIROL, V76, P5813, DOI 10.1128/JVI.76.11.5813-5821.2002; Lan DL, 2011, ARCH VIROL, V156, P1567, DOI 10.1007/s00705-011-1035-7; Le Gall O, 2008, ARCH VIROL, V153, P715, DOI 10.1007/s00705-008-0041-x; Lobert PE, 1999, P NATL ACAD SCI USA, V96, P11560, DOI 10.1073/pnas.96.20.11560; Mason PW, 2002, J VIROL, V76, P9686, DOI 10.1128/JVI.76.19.9686-9694.2002; McKnight KL, 1998, RNA, V4, P1569, DOI 10.1017/S1355838298981006; Melchers WJG, 1997, J VIROL, V71, P686, DOI 10.1128/JVI.71.1.686-696.1997; Melchers WJG, 2000, RNA, V6, P976, DOI 10.1017/S1355838200000480; Nayak A, 2005, J VIROL, V79, P7698, DOI 10.1128/JVI.79.12.7698-7706.2005; Oberste MS, 2003, VIROLOGY, V314, P283, DOI 10.1016/S0042-6822(03)00420-3; Oberste MS, 2002, J VIROL, V76, P1244, DOI 10.1128/JVI.76.3.1244-1251.2002; Paul Aniko V., 2002, P227; Paul AV, 2000, J VIROL, V74, P10359, DOI 10.1128/JVI.74.22.10359-10370.2000; Paul AV, 2003, J BIOL CHEM, V278, P43951, DOI 10.1074/jbc.M307441200; Pilipenko EV, 1996, EMBO J, V15, P5428, DOI 10.1002/j.1460-2075.1996.tb00926.x; Pisarev AV, 2004, J VIROL, V78, P4487, DOI 10.1128/JVI.78.9.4487-4497.2004; Prodelalova J, 2012, INFECT GENET EVOL, V12, P1447, DOI 10.1016/j.meegid.2012.04.025; Racaniello VR, 2007, FIELDS VIROLOGY, P795; Son KY, 2014, ARCH VIROL, V159, P1175, DOI 10.1007/s00705-013-1901-6; Sozzi E, 2010, TRANSBOUND EMERG DIS, V57, P434, DOI 10.1111/j.1865-1682.2010.01170.x; Steil BP, 2009, VIRUS RES, V139, P240, DOI 10.1016/j.virusres.2008.07.027; Sweeney TR, 2012, J VIROL, V86, P1468, DOI 10.1128/JVI.05862-11; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thiviyanathan V, 2004, P NATL ACAD SCI USA, V101, P12688, DOI 10.1073/pnas.0403079101; Tseng CH, 2007, VIRUS RES, V129, P104, DOI 10.1016/j.virusres.2007.06.023; van Ooij MJM, 2006, NUCLEIC ACIDS RES, V34, P2953, DOI 10.1093/nar/gkl349; Wang JH, 1999, NUCLEIC ACIDS RES, V27, P485, DOI 10.1093/nar/27.2.485; Yang Y, 2004, J BIOL CHEM, V279, P12659, DOI 10.1074/jbc.M312992200; Yang Y, 2002, J VIROL, V76, P7485, DOI 10.1128/JVI.76.15.7485-7494.2002	54	24	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107860	10.1371/journal.pone.0107860	http://dx.doi.org/10.1371/journal.pone.0107860			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229940	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900082
J	Lukoshe, A; Hokken-Koelega, AC; van der Lugt, A; White, T				Lukoshe, Akvile; Hokken-Koelega, Anita C.; van der Lugt, Aad; White, Tonya			Reduced Cortical Complexity in Children with Prader-Willi Syndrome and Its Association with Cognitive Impairment and Developmental Delay	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; AUTISM SPECTRUM DISORDERS; MAGNETIC-RESONANCE IMAGES; GROWTH-HORMONE TREATMENT; MENTAL-RETARDATION; HUMAN BRAIN; GENETIC SUBTYPES; GYRIFICATION; MRI; SCHIZOPHRENIA	Background: Prader-Willi Syndrome (PWS) is a complex neurogenetic disorder with symptoms involving not only hypothalamic, but also a global, central nervous system dysfunction. Previously, qualitative studies reported polymicrogyria in adults with PWS. However, there have been no quantitative neuroimaging studies of cortical morphology in PWS and no studies to date in children with PWS. Thus, our aim was to investigate and quantify cortical complexity in children with PWS compared to healthy controls. In addition, we investigated differences between genetic subtypes of PWS and the relationship between cortical complexity and intelligence within the PWS group. Methods: High-resolution structural magnetic resonance images were acquired in 24 children with genetically confirmed PWS (12 carrying a deletion (DEL), 12 with maternal uniparental disomy (mUPD)) and 11 age-and sex-matched typically developing siblings as healthy controls. Local gyrification index (lGI) was obtained using the FreeSurfer software suite. Results: Four large clusters, two in each hemisphere, comprising frontal, parietal and temporal lobes, had lower lGI in children with PWS, compared to healthy controls. Clusters with lower lGI also had significantly lower cortical surface area in children with PWS. No differences in cortical thickness of the clusters were found between the PWS and healthy controls. lGI correlated significantly with cortical surface area, but not with cortical thickness. Within the PWS group, lGI in both hemispheres correlated with Total IQ and Verbal IQ, but not with Performance IQ. Children with mUPD, compared to children with DEL, had two small clusters with lower lGI in the right hemisphere. lGI of these clusters correlated with cortical surface area, but not with cortical thickness or IQ. Conclusions: These results suggest that lower cortical complexity in children with PWS partially underlies cognitive impairment and developmental delay, probably due to alterations in gene networks that play a prominent role in early brain development.	[Lukoshe, Akvile; Hokken-Koelega, Anita C.] Dutch Growth Res Fdn, Rotterdam, Netherlands; [Lukoshe, Akvile; Hokken-Koelega, Anita C.] Sophia Childrens Univ Hosp, Erasmus Med Ctr Rotterdam, Dept Pediat, Rotterdam, Netherlands; [White, Tonya] Sophia Childrens Univ Hosp, Erasmus Med Ctr Rotterdam, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands; [van der Lugt, Aad; White, Tonya] Erasmus MC, Dept Radiol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC	Lukoshe, A (corresponding author), Dutch Growth Res Fdn, Rotterdam, Netherlands.	a.lukose@kindengroei.nl	White, Tonya/AAU-2226-2021	White, Tonya/0000-0003-0271-1896	Foundation for Prader-Willi Research; Dutch Growth Research Foundation	Foundation for Prader-Willi Research; Dutch Growth Research Foundation	This study was financially supported by the Foundation for Prader-Willi Research and Dutch Growth Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bearden CE, 2009, CEREB CORTEX, V19, P115, DOI 10.1093/cercor/bhn064; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Bonnici HM, 2007, NEUROIMAGE, V35, P648, DOI 10.1016/j.neuroimage.2006.11.031; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Casanova MF, 2004, J CHILD NEUROL, V19, P275, DOI 10.1177/088307380401900407; Cassidy SB, 1997, AM J MED GENET, V68, P433; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Festen DAM, 2008, CLIN ENDOCRINOL, V68, P919, DOI 10.1111/j.1365-2265.2007.03126.x; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Harris JM, 2004, BIOL PSYCHIAT, V56, P182, DOI 10.1016/j.biopsych.2004.04.007; Herzing LBK, 2002, HUM MOL GENET, V11, P1707, DOI 10.1093/hmg/11.15.1707; Hilgetag CC, 2006, PLOS COMPUT BIOL, V2, P146, DOI 10.1371/journal.pcbi.0020022; Honea RA, 2012, AM J MED GENET B, V159B, P243, DOI 10.1002/ajmg.b.32022; Judson MC, 2013, J COMP NEUROL; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Kates WR, 2009, AUTISM RES, V2, P267, DOI 10.1002/aur.98; Kuwajima T, 2010, J NEUROSCI, V30, P3709, DOI 10.1523/JNEUROSCI.5797-09.2010; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; LIM SH, 1994, ELECTROEN CLIN NEURO, V91, P179, DOI 10.1016/0013-4694(94)90068-X; Lu YB, 2009, HUM MOL GENET, V18, P454, DOI 10.1093/hmg/ddn373; Luders E, 2008, CEREB CORTEX, V18, P2019, DOI 10.1093/cercor/bhm227; Lukoshe A, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-31; Magnotta VA, 1999, CEREB CORTEX, V9, P151, DOI 10.1093/cercor/9.2.151; Miller JL, 2007, AM J MED GENET A, V143A, P476, DOI 10.1002/ajmg.a.31508; Minamide R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084460; Mous SE, 2014, PSYCHIAT RES-NEUROIM, V221, P169, DOI 10.1016/j.pscychresns.2013.12.002; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; Ogura K, 2011, HUM BRAIN MAPP, V32, P1059, DOI 10.1002/hbm.21089; Piven J, 1990, AM J PSYCHIAT; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Roof E, 2000, J INTELL DISABIL RES, V44, P25, DOI 10.1046/j.1365-2788.2000.00250.x; Samaco RC, 2005, HUM MOL GENET, V14, P483, DOI 10.1093/hmg/ddi045; Schaer M, 2006, PSYCHIAT RES-NEUROIM, V146, P1, DOI 10.1016/j.pscychresns.2005.10.002; Schaer M, 2008, IEEE T MED IMAGING, V27, P161, DOI 10.1109/TMI.2007.903576; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Siemensma EPC, 2012, J CLIN ENDOCR METAB, V97, P2307, DOI 10.1210/jc.2012-1182; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Su S, 2013, HUM BRAIN MAPP, V34, P1230, DOI 10.1002/hbm.21510; Tennese AA, 2008, DEV DYNAM, V237, P1935, DOI 10.1002/dvdy.21615; Toro R, 2008, CEREB CORTEX, V18, P2352, DOI 10.1093/cercor/bhm261; Vandersteene G., 1986, NEDERLANDSTALIGE UIT; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Veltman MWM, 2005, PSYCHIAT GENET, V15, P243, DOI 10.1097/00041444-200512000-00006; Vogels A, 2003, J MED GENET, V40, P72, DOI 10.1136/jmg.40.1.72; Wallace GL, 2006, J CHILD PSYCHOL PSYC, V47, P987, DOI 10.1111/j.1469-7610.2006.01676.x; Wallace GL, 2013, BRAIN, V136, P1956, DOI 10.1093/brain/awt106; White T, 2003, BIOL PSYCHIAT, V54, P418, DOI 10.1016/S0006-3223(03)00065-9; White T, 2013, EUR J EPIDEMIOL, V28, P99, DOI 10.1007/s10654-013-9768-0; White T, 2010, BRAIN COGNITION, V72, P36, DOI 10.1016/j.bandc.2009.10.009; Zhang Y, 2010, AM J NEURORADIOL, V31, P1063, DOI 10.3174/ajnr.A1984; ZILLES K, 1988, ANAT EMBRYOL, V179, P173, DOI 10.1007/BF00304699; Zilles K, 2013, TRENDS NEUROSCI, V36, P275, DOI 10.1016/j.tins.2013.01.006	60	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107320	10.1371/journal.pone.0107320	http://dx.doi.org/10.1371/journal.pone.0107320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226172	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700043
J	Ruaux, CG; Stang, BV				Ruaux, Craig G.; Stang, Bernadette V.			Prevalence of Blastocystis in Shelter-Resident and Client-Owned Companion Animals in the US Pacific Northwest	PLOS ONE			English	Article							GENETIC DIVERSITY; ZOO ANIMALS; DOGS; INFECTION; SUBTYPES; CATS; IDENTIFICATION; TRANSMISSION	Domestic dogs and cats are commonly infected with a variety of protozoan enteric parasites, including Blastocystis spp. In addition, there is growing interest in Blastocystis as a potential enteric pathogen, and the possible role of domestic and incontact animals as reservoirs for human infection. Domestic animals in shelter environments are commonly recognized to be at higher risk for carriage of enteropathogens. The purpose of this study was to determine the frequency of infection of shelter-resident and client-owned domestic dogs and cats with Blastocystis spp in the Pacific Northwest region of the USA. Fecal samples were collected from 103 shelter-resident dogs, 105 shelter-resident cats, 51 client-owned dogs and 52 clientowned cats. Blastocystis were detected and subtypes assigned using a nested PCR based on small subunit ribosomal DNA sequences. Shelter-resident animals were significantly more likely to test positive for Blastocystis (P < 0.05 for dogs, P = 0.009 for cats). Sequence analysis indicated that shelter-resident animals were carrying a variety of Blastocystis subtypes. No relationship was seen between Blastocystis carriage and the presence of gastrointestinal disease signs in either dogs or cats. These data suggest that, as previously reported for other enteric pathogens, shelter-resident companion animals are a higher risk for carriage of Blastocystis spp. The lack of relationship between Blastocystis carriage and intestinal disease in shelter-resident animals suggests that this organism is unlikely to be a major enteric pathogen in these species.	[Ruaux, Craig G.; Stang, Bernadette V.] Oregon State Univ, Coll Vet Med, Dept Clin Sci, Corvallis, OR 97331 USA	Oregon State University	Ruaux, CG (corresponding author), Oregon State Univ, Coll Vet Med, Dept Clin Sci, Corvallis, OR 97331 USA.	craig.ruaux@oregonstate.edu	Ruaux, Craig G./AAK-1538-2021	Ruaux, Craig G./0000-0001-9443-0682	Maddie's Fund	Maddie's Fund	This study was supported by a grant from The Maddie's Fund (http://www.maddiesfund.org/Grant_Giving/Colleges_of_Veterinary_Medicine.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfellani MA, 2013, PROTIST, V164, P497, DOI 10.1016/j.protis.2013.05.003; Bissett SA, 2009, J FELINE MED SURG, V11, P803, DOI 10.1016/j.jfms.2009.02.001; Boorom KF, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-40; Boreham RE, 1996, LANCET, V348, P272, DOI 10.1016/S0140-6736(05)65587-0; Bybee SN, 2011, J VET INTERN MED, V25, P856, DOI 10.1111/j.1939-1676.2011.0738.x; Duda A, 1998, VET PARASITOL, V76, P9, DOI 10.1016/S0304-4017(97)00224-0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esch KJ, 2013, CLIN MICROBIOL REV, V26, P58, DOI 10.1128/CMR.00067-12; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Little SE, 2009, VET PARASITOL, V166, P144, DOI 10.1016/j.vetpar.2009.07.044; MARKELL EK, 1995, CLIN INFECT DIS, V21, P104, DOI 10.1093/clinids/21.1.104; Nagel R, 2012, INTERN MED J, V42, P1187, DOI 10.1111/j.1445-5994.2011.02626.x; Noel C, 2005, J CLIN MICROBIOL, V43, P348, DOI 10.1128/JCM.43.1.348-355.2005; Parkar U, 2007, PARASITOLOGY, V134, P359, DOI 10.1017/S0031182006001582; Puthia MK, 2008, EUKARYOT CELL, V7, P435, DOI 10.1128/EC.00371-07; Robben SRM, 2004, TIJDSCHR DIERGENEESK, V129, P2; Scaramozzino P, 2009, VET J, V182, P231, DOI 10.1016/j.tvjl.2008.07.003; Scicluna SM, 2006, PROTIST, V157, P77, DOI 10.1016/j.protis.2005.12.001; Souppart L, 2009, PARASITOL RES, V105, P413, DOI 10.1007/s00436-009-1398-9; Stensvold CR, 2008, ANN TROP MED PARASIT, V102, P271, DOI 10.1179/136485908X278847; Stensvold CR, 2007, TRENDS PARASITOL, V23, P93, DOI 10.1016/j.pt.2007.01.004; Stensvold CR, 2009, INT J PARASITOL, V39, P473, DOI 10.1016/j.ijpara.2008.07.006; Stenzel DJ, 1996, CLIN MICROBIOL REV, V9, P563, DOI 10.1128/CMR.9.4.563; Teo JDW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089036; Traub RJ, 2004, PARASITOLOGY, V128, P253, DOI 10.1017/S0031182003004505; Wang WQ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-215; Whipps CM, 2010, PARASITOL RES, V106, P827, DOI 10.1007/s00436-010-1739-8	27	40	42	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107496	10.1371/journal.pone.0107496	http://dx.doi.org/10.1371/journal.pone.0107496			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226285	Green Published, Green Submitted, gold			2022-12-25	WOS:000344317700060
J	Wang, SL; Chang, CH; Hu, LY; Tsai, SJ; Yang, AC; You, ZH				Wang, Shu-Li; Chang, Cheng-Ho; Hu, Li-Yu; Tsai, Shih-Jen; Yang, Albert C.; You, Zi-Hong			Risk of Developing Depressive Disorders following Rheumatoid Arthritis: A Nationwide Population-Based Study	PLOS ONE			English	Article							PSYCHOLOGICAL ADJUSTMENT; PRIMARY FIBROMYALGIA; COMORBID DEPRESSION; CHRONIC PAIN; INFLAMMATION; ASSOCIATION; PREVALENCE; SYMPTOMS; ANXIETY; DISEASE	Background & Aims: To evaluate the risk of depressive disorders among rheumatoid arthritis (RA) by using the Taiwan National Health Insurance Research Database (NHIRD). Methods: We conducted a retrospective study of a matched cohort of 18 285 participants (3 657 RA patients and 14 628 control patients) who were selected from the NHIRD. Patients were observed for a maximum of 10 years to determine the rates of newly diagnosed depressive disorders, and Cox regression was used to identify the risk factors associated with depressive disorders in RA patients. Results: During the 10-year follow-up period, 205 (11.2 per 1000 person-years) RA patients and 384 (5.1 per 1000 person-years) control patients were diagnosed with depressive disorders. In RA patients, most depressive disorders (n = 163, 80%) developed with five years of being diagnosed with RA. The incidence risk ratio of depressive disorders between RA patients and control patients was 2.20 (95% confidence interval [CI], 1.84-2.61, P<.001). After adjusting for age, sex, and comorbidities, RA patients were 2.06 times more likely to develop depressive disorders (95% CI, 1.73-2.44, P<.001) compared with the control patients. Hyperthyroidism (HR = 1.67) was an independent risk factor for depressive disorders in patients with RA. Conclusions: The likelihood of developing depressive disorders is greater among RA patients than among patients without RA. Symptoms of depression should be sought in patients with RA.	[Chang, Cheng-Ho; Hu, Li-Yu] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Wang, Shu-Li] Cent Taiwan Univ Sci & Technol, Dept Dent Lab Technol, Taichung, Taiwan; [Tsai, Shih-Jen; Yang, Albert C.] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Tsai, Shih-Jen; Yang, Albert C.] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Yang, Albert C.] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Chungli 32054, Taiwan; [You, Zi-Hong] Taichung Vet Gen Hosp, Chia Yi Branch, Div Nephrol, Dept Internal Med, Chiayi, Taiwan; [You, Zi-Hong] Chung Shan Med Univ, Inst Med, Taichung, Taiwan	Kaohsiung Veterans General Hospital; Central Taiwan University Science & Technology; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Central University; Taichung Veterans General Hospital; Chung Shan Medical University	You, ZH (corresponding author), Taichung Vet Gen Hosp, Chia Yi Branch, Div Nephrol, Dept Internal Med, Chiayi, Taiwan.	zihongyou@gmail.com	Tsai, Shih-Jen/AAK-7944-2020	Tsai, Shih-Jen/0000-0002-9987-022X; Yang, Albert Chih-Chieh/0000-0003-2794-9649	Taipei Veterans General Hospital [V101D-001-2]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study was supported by a grant from the Taipei Veterans General Hospital (V101D-001-2) and SJT received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLES TA, 1991, AM J PSYCHIAT, V148, P1721; ALLAIRE SH, 1991, ARTHRITIS RHEUM, V34, P669, DOI 10.1002/art.1780340607; Ang DC, 2005, J RHEUMATOL, V32, P1013; Becofsky K, 2013, ARTHRITIS, DOI 10.1155/2013/525761; Bednarek PH, 2011, NEW ENGL J MED, V364, P2208, DOI 10.1056/NEJMoa1011600; BELZA BL, 1995, J RHEUMATOL, V22, P639; Callahan L F, 1991, Arthritis Care Res, V4, P3, DOI 10.1002/art.1790040103; Chuang Cynthia H, 2012, Ment Health Fam Med, V9, P107; Coskun B, 2013, UROL J, V10, P1081; Covic T, 2003, RHEUMATOLOGY, V42, P1287, DOI 10.1093/rheumatology/keg369; Cross M, 2014, ANN RHEUM DIS; Curtis R, 2005, PATIENT EDUC COUNS, V59, P192, DOI 10.1016/j.pec.2004.10.015; D'Mello C, 2011, AM J PHYSIOL-GASTR L, V301, pG749, DOI 10.1152/ajpgi.00184.2011; Ribeiro NPD, 2013, COMPR PSYCHIAT, V54, P1185, DOI 10.1016/j.comppsych.2013.05.010; Demet MM, 2002, ARCH MED RES, V33, P552, DOI 10.1016/S0188-4409(02)00410-1; Dickens C, 2002, PSYCHOSOM MED, V64, P52, DOI 10.1097/00006842-200201000-00008; Dickens C, 2001, RHEUMATOLOGY, V40, P1327, DOI 10.1093/rheumatology/40.12.1327; Freedland KE, 2003, PSYCHOSOM MED, V65, P119, DOI 10.1097/01.PSY.0000038938.67401.85; Gothe F, 2012, PANMINERVA MED, V54, P161; Hashmi AM, 2013, PAK J MED SCI, V29, P877, DOI 10.12669/pjms.293.3357; Hassett AL, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0436-1; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Hooley JM, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0435-2; Johansen A, 2012, EUR J EPIDEMIOL, V27, P63, DOI [10.1007/s10654-011-9641-y, 10.1007/s10654-011-9639-5]; KASL SV, 1969, J CHRON DIS, V22, P239, DOI 10.1016/0021-9681(69)90017-4; KATHOL RG, 1986, PSYCHOSOMATICS, V27, P501, DOI 10.1016/S0033-3182(86)72656-X; Katz P P, 1994, Arthritis Care Res, V7, P69, DOI 10.1002/art.1790070205; Katz PP, 2001, ARTHRITIS RHEUM, V44, P1194, DOI 10.1002/1529-0131(200105)44:5<1194::AID-ANR203>3.3.CO;2-Y; Kaur G, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-69; Kop WJ, 2002, AM J CARDIOL, V89, P419, DOI 10.1016/S0002-9149(01)02264-0; Lee Hun, 2010, Korean J Ophthalmol, V24, P65, DOI 10.3341/kjo.2010.24.2.65; Li JX, 2014, BEHAV BRAIN RES; Lisitsyna TA, 2013, TERAPEVT ARKH, V85, P8; Lisitsyna TA, 2012, ZH NEVROL PSIKHIATR, V112, P96; Lowe B, 2004, PSYCHOSOM MED, V66, P395, DOI 10.1097/01.psy.0000126203.89941.a3; Lu Y, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-53; Manavathongchai S, 2013, J RHEUMATOL, V40, P1806, DOI 10.3899/jrheum.130394; Monroe SM, 2013, J PSYCHIAT RES; Musselman DL, 1996, BRIT J PSYCHIAT, V168, P123; Guimaraes JMN, 2009, J AFFECT DISORDERS, V117, P120, DOI 10.1016/j.jad.2008.12.012; Nicola PJ, 2005, ARTHRITIS RHEUM-US, V52, P412, DOI 10.1002/art.20855; Pasco JA, 2010, BRIT J PSYCHIAT, V197, P372, DOI 10.1192/bjp.bp.109.076430; PECK JR, 1989, ARTHRITIS RHEUM, V32, P1100, DOI 10.1002/anr.1780320908; Placidi GPA, 1998, NEUROPSYCHOBIOLOGY, V38, P222, DOI 10.1159/000026545; Pollard L, 2005, CLIN EXP RHEUMATOL, V23, pS43; Psaltopoulou T, 2013, ANN NEUROL; Ramjeet J, 2005, RHEUMATOLOGY, V44, P1166, DOI 10.1093/rheumatology/keh699; Raterman HG, 2008, ANN RHEUM DIS, V67, P229, DOI 10.1136/ard.2006.068130; Rezvani A, 2014, INT J RHEUM DIS, V17, P34, DOI 10.1111/1756-185X.12033; Rosenblat J.D., 2014, PROG NEUROPSYCHOPHAR; Scheidt CE, 2014, NORD J PSYCHIAT, V68, P88, DOI 10.3109/08039488.2013.782566; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; SERBO B, 1991, CLIN RHEUMATOL, V10, P419, DOI 10.1007/BF02206663; Sheehy C, 2006, RHEUMATOLOGY, V45, P1325, DOI 10.1093/rheumatology/kel231; Shimbo D, 2005, AM J CARDIOL, V96, P1016, DOI 10.1016/j.amjcard.2005.05.064; Su CC, 2013, J RHEUMATOL, V40, P1513, DOI 10.3899/jrheum.121259; Tenev VT, 2009, AM J GERIAT PSYCHIAT, V17, P276, DOI 10.1097/JGP.0b013e3181953b6e; van den Hoek J, 2013, ARTHRIT CARE RES, V65, P1157, DOI 10.1002/acr.21950; VILHJALMSSON R, 1993, SOC SCI MED, V37, P331, DOI 10.1016/0277-9536(93)90264-5; Wolfe F, 2003, J RHEUMATOL, V30, P36; WOLFE F, 1993, J RHEUMATOL, V20, P2032; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975	62	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107791	10.1371/journal.pone.0107791	http://dx.doi.org/10.1371/journal.pone.0107791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS5NP	25226167	Green Submitted, gold, Green Published			2022-12-25	WOS:000344317700083
J	Brodie, SA; Lombardo, C; Li, G; Kowalski, J; Gandhi, K; You, SJ; Khuri, FR; Marcus, A; Vertino, PM; Brandes, JC				Brodie, Seth A.; Lombardo, Courtney; Li, Ge; Kowalski, Jeanne; Gandhi, Khanjan; You, Shaojin; Khuri, Fadlo R.; Marcus, Adam; Vertino, Paula M.; Brandes, Johann C.			Aberrant Promoter Methylation of Caveolin-1 Is Associated with Favorable Response to Taxane-Platinum Combination Chemotherapy in Advanced NSCLC	PLOS ONE			English	Article							CELL LUNG-CANCER; EPIGENETIC INACTIVATION; MESENCHYMAL TRANSITION; POOR-PROGNOSIS; GENE; SENSITIVITY; EXPRESSION; RESISTANCE; INHIBITORS; CHEMORESISTANCE	Purpose: Aberrant promoter DNA methylation can serve as a predictive biomarker for improved clinical responses to certain chemotherapeutics. One of the major advantages of methylation biomarkers is the ease of detection and clinical application. In order to identify methylation biomarkers predictive of a response to a taxane-platinum based chemotherapy regimen in advanced NSCLC we performed an unbiased methylation analysis of 1,536 CpG dinucleotides in cancer-associated gene loci and correlated results with clinical outcomes. Methods: We studied a cohort of 49 patients (median age 62 years) with advanced NSCLC treated at the Atlanta VAMC between 1999 and 2010. Methylation analysis was done on the Illumina GoldenGate Cancer panel 1 methylation microarray platform. Methylation data were correlated with clinical response and adjusted for false discovery rates. Results: Cav1 methylation emerged as a powerful predictor for achieving disease stabilization following platinum taxane based chemotherapy (p = 1.21E-05, FDR significance = 0.018176). In Cox regression analysis after multivariate adjustment for age, performance status, gender, histology and the use of bevacizumab, CAV1 methylation was significantly associated with improved overall survival (HR 0.18 (95% CI: 0.03-0.94)). Silencing of CAV1 expression in lung cancer cell lines(A549, EKVX) by shRNA led to alterations in taxane retention. Conclusions: CAV1 methylation is a predictor of disease stabilization and improved overall survival following chemotherapy with a taxane-platinum combination regimen in advanced NSCLC. CAV1 methylation may predict improved outcomes for other chemotherapeutic agents which are subject to cellular clearance mediated by caveolae.	[Brodie, Seth A.; You, Shaojin; Brandes, Johann C.] Atlanta VA Med Ctr, Atlanta, GA 30345 USA; [Brodie, Seth A.; Lombardo, Courtney; Li, Ge; Khuri, Fadlo R.; Marcus, Adam; Brandes, Johann C.] Emory Univ, Sch Med, Dept Hematol, Atlanta, GA USA; [Brodie, Seth A.; Lombardo, Courtney; Li, Ge; Khuri, Fadlo R.; Marcus, Adam; Brandes, Johann C.] Emory Univ, Sch Med, Dept Med Oncol, Atlanta, GA USA; [Vertino, Paula M.] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA USA; [Gandhi, Khanjan] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [You, Shaojin] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Brodie, Seth A.; Lombardo, Courtney; Li, Ge; Kowalski, Jeanne; Gandhi, Khanjan; Khuri, Fadlo R.; Marcus, Adam; Vertino, Paula M.; Brandes, Johann C.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Kowalski, Jeanne; Gandhi, Khanjan] Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; Rollins School Public Health	Brandes, JC (corresponding author), Atlanta VA Med Ctr, Atlanta, GA 30345 USA.	johann.brandes@emory.edu	Khuri, Fadlo R./AAU-4942-2020; Brodie, Seth/U-9035-2019	Khuri, Fadlo R./0000-0002-8638-7618; Kowalski, Jeanne/0000-0003-3458-3024	Veterans' Health Administration Career Development Award [7-IK2BX001283-03]; Career Development Project [NCI-5 P50 CA128613-02]; CHEST Foundation/Lungevity Foundation Clinical Lung Cancer Research Award; Uniting against Lung Cancer / Lungevity Foundation Research Award; SunTrust Scholar Award; Cohen Family Scholar Award; Elsa U Pardee Foundation Research Award; Emory University Integrated Cellular Imaging Microscopy Core; Biostatistics and Bioinformatics Shared Resource of the Winship Cancer Institute of Emory University [P30CA138292];  [NCI-P30CA138292]; NATIONAL CANCER INSTITUTE [P30CA138292, P50CA128613, R01CA077337] Funding Source: NIH RePORTER	Veterans' Health Administration Career Development Award; Career Development Project; CHEST Foundation/Lungevity Foundation Clinical Lung Cancer Research Award; Uniting against Lung Cancer / Lungevity Foundation Research Award; SunTrust Scholar Award; Cohen Family Scholar Award; Elsa U Pardee Foundation Research Award; Emory University Integrated Cellular Imaging Microscopy Core; Biostatistics and Bioinformatics Shared Resource of the Winship Cancer Institute of Emory University; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support was provided by the Veterans' Health Administration Career Development Award 7-IK2BX001283-03 to JCB; NCI-5 P50 CA128613-02 Career Development Project to JCB; NCI-P30CA138292 pilot grant to JCB; CHEST Foundation/Lungevity Foundation Clinical Lung Cancer Research Award to JCB; Uniting against Lung Cancer / Lungevity Foundation Research Award to JCB; SunTrust Scholar Award to JCB; Cohen Family Scholar Award to JCB; and Elsa U Pardee Foundation Research Award to JCB. This research project was supported in part by the Emory University Integrated Cellular Imaging Microscopy Core and the Biostatistics and Bioinformatics Shared Resource of the Winship Cancer Institute of Emory University under award number P30CA138292. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banno K, 2007, INT J ONCOL, V31, P713; Belanger MM, 2004, CANCER BIOL THER, V3, P954, DOI 10.4161/cbt.3.10.1112; Canadas I, 2014, CLIN CANCER RES, V20, P938, DOI 10.1158/1078-0432.CCR-13-1330; DAVIS S, 2012, METHYLUMI HANDLE ILL; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Ho CC, 2008, LUNG CANCER, V59, P105, DOI 10.1016/j.lungcan.2007.07.024; Marcus AI, 2006, CANCER RES, V66, P8838, DOI 10.1158/0008-5472.CAN-06-0699; Pelosof L, 2014, INT J CANCER, V134, P596, DOI 10.1002/ijc.28390; Pillai RN, 2013, CLIN CANC RES; Ren J, 2013, J CELL BIOCHEM, V114, P1395, DOI 10.1002/jcb.24481; Rigas JR, 2004, ONCOLOGIST, V9, P16, DOI 10.1634/theoncologist.9-suppl_2-16; Satoh A, 2003, CANCER RES, V63, P8606; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Song Y, 2012, BIOMED PHARMACOTHER, V66, P439, DOI 10.1016/j.biopha.2012.03.001; Sunaga N, 2004, CANCER RES, V64, P4277, DOI 10.1158/0008-5472.CAN-03-3941; Takezawa K, 2011, BRIT J CANCER, V104, P1594, DOI 10.1038/bjc.2011.129; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; Wang H, 2014, EUR J PHARMACOL, V723, P156, DOI 10.1016/j.ejphar.2013.12.004; Yang CPH, 1998, FEBS LETT, V439, P368, DOI 10.1016/S0014-5793(98)01354-4; Yoo SH, 2003, LUNG CANCER, V42, P195, DOI 10.1016/S0169-5002(03)00287-3; Zhan P, 2012, ONCOL REP, V27, P1072, DOI 10.3892/or.2011.1605	26	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107124	10.1371/journal.pone.0107124	http://dx.doi.org/10.1371/journal.pone.0107124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222296	gold, Green Published, Green Submitted			2022-12-25	WOS:000341774800043
J	Genetos, DC; Wong, A; Weber, TJ; Karin, NJ; Yellowley, CE				Genetos, Damian C.; Wong, Alice; Weber, Thomas J.; Karin, Norman J.; Yellowley, Clare E.			Impaired Osteoblast Differentiation in Annexin A2-and-A5-Deficient Cells	PLOS ONE			English	Article							GROWTH-PLATE CARTILAGE; INCREASES OSTEOCLAST FORMATION; MATRIX VESICLES; PROSTATE-CANCER; II-RECEPTOR; EXPRESSION; MINERALIZATION; BONE; A2; STIMULATION	Annexins are a class of calcium-binding proteins with diverse functions in the regulation of lipid rafts, inflammation, fibrinolysis, transcriptional programming and ion transport. Within bone, they are well-characterized as components of mineralizing matrix vesicles, although little else is known as to their function during osteogenesis. We employed shRNA to generate annexin A2 (AnxA2)- or annexin A5 (AnxA5)-knockdown pre-osteoblasts, and determined whether proliferation or osteogenic differentiation was altered in knockdown cells, compared to pSiren (Si) controls. We report that DNA content, a marker of proliferation, was significantly reduced in both AnxA2 and AnxA5 knockdown cells. Alkaline phosphatase expression and activity were also suppressed in AnxA2- or AnxA5-knockdown after 14 days of culture. The pattern of osteogenic gene expression was altered in knockdown cells, with Col1a1 expressed more rapidly in knock-down cells, compared to pSiren. In contrast, Runx2, Ibsp, and Bglap all revealed decreased expression after 14 days of culture. In both AnxA2- and AnxA5-knockdown, interleukin-induced STAT6 signaling was markedly attenuated compared to pSiren controls. These data suggest that AnxA2 and AnxA5 can influence bone formation via regulation of osteoprogenitor proliferation, differentiation, and responsiveness to cytokines in addition to their well-studied function in matrix vesicles.	[Genetos, Damian C.; Wong, Alice; Yellowley, Clare E.] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA; [Weber, Thomas J.; Karin, Norman J.] Pacific NW Natl Lab, Syst Toxicol, Richland, WA 99352 USA	University of California System; University of California Davis; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Yellowley, CE (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA.	cyellowley@ucdavis.edu	Genetos, Damian C/A-6480-2012; Genetos, Damian/AAF-5953-2021	Genetos, Damian/0000-0002-8599-2867	National Institute of Arthritis and Musculoskeletal and Skin Diseases (DCG) [R03AR057547]	National Institute of Arthritis and Musculoskeletal and Skin Diseases (DCG)	This work was supported by Award Number R03AR057547 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (DCG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao HY, 2009, INT J HEMATOL, V90, P177, DOI 10.1007/s12185-009-0356-8; Belluoccio D, 2010, J BONE MINER RES, V25, P141, DOI 10.1359/jbmr.090710; Bist P, 2011, ONCOGENE, V30, P3174, DOI 10.1038/onc.2011.28; Brachvogel B, 2003, MOL CELL BIOL, V23, P2907, DOI 10.1128/MCB.23.8.2907-2913.2003; CAO X, 1993, BIOCHEM BIOPH RES CO, V197, P556, DOI 10.1006/bbrc.1993.2515; Collette NM, 2010, DEV BIOL, V342, P169, DOI 10.1016/j.ydbio.2010.03.021; Das S, 2010, BIOCHEMISTRY-US, V49, P2216, DOI 10.1021/bi9013038; Devarajan-Ketha H, 2012, BIOCHEM BIOPH RES CO, V417, P830, DOI 10.1016/j.bbrc.2011.12.048; Dolmetsch R, 1997, NATURE; Donahue TLH, 2004, BONE, V35, P656, DOI 10.1016/j.bone.2004.04.025; Genetos DC, 2010, BONE, V47, P1013, DOI 10.1016/j.bone.2010.08.024; Genetos DC, 2010, J CELL BIOCHEM, V110, P457, DOI 10.1002/jcb.22559; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gillette JM, 2004, J CELL SCI, V117, P441, DOI 10.1242/jcs.00909; Jeon YJ, 2010, CELL MOL LIFE SCI, V67, P2271, DOI 10.1007/s00018-010-0331-9; Jung YH, 2007, BLOOD, V110, P82, DOI 10.1182/blood-2006-05-021352; Jung YH, 2011, EXP HEMATOL, V39, P151, DOI 10.1016/j.exphem.2010.11.007; KIRSCH T, 1994, J BIOL CHEM, V269, P11462; Kirsch T, 2000, J BIOL CHEM, V275, P35577, DOI 10.1074/jbc.M005648200; Kirsch T, 1997, J CELL BIOL, V137, P1149, DOI 10.1083/jcb.137.5.1149; Li FH, 2005, J BONE MINER RES, V20, P1161, DOI 10.1359/JBMR.050207; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu GW, 2006, J BIOL CHEM, V281, P30542, DOI 10.1074/jbc.M607072200; Machaca K, 2011, CELL CALCIUM, V49, P323, DOI 10.1016/j.ceca.2011.05.004; Menaa C, 1999, J CLIN INVEST, V103, P1605, DOI 10.1172/JCI6374; MIKUNITAKAGAKI Y, 1995, J BONE MINER RES, V10, P231, DOI 10.1002/jbmr.5650100209; Mohiti J, 1995, MOL MEMBR BIOL, V12, P321, DOI 10.3109/09687689509072434; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; NOHTOMI K, 1994, BONE MINER, V27, P69, DOI 10.1016/S0169-6009(08)80188-2; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Shiozawa Y, 2008, J CELL BIOCHEM, V105, P370, DOI 10.1002/jcb.21835; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; SUAREZ F, 1993, J BONE MINER RES, V8, P1201; TAKAHASHI S, 1994, J BIOL CHEM, V269, P28696; Thouverey C, 2009, J CELL BIOCHEM, V106, P127, DOI 10.1002/jcb.21992; UENO K, 1992, BIOCHEM BIOPH RES CO, V189, P1521, DOI 10.1016/0006-291X(92)90248-J; Wang YX, 2012, PATHOL ONCOL RES, V18, P183, DOI 10.1007/s12253-011-9427-2; Waters KM, 2013, RADIAT RES, V179, P53, DOI 10.1667/RR3056.1; Weber TJ, 2009, RADIAT RES, V172, P96, DOI 10.1667/RR1220.1; Widdicombe JH, 2000, AM J RESP CELL MOL, V22, P11, DOI 10.1165/ajrcmb.22.1.f177; Woods A, 2007, J CELL PHYSIOL, V213, P1, DOI 10.1002/jcp.21110; Wu LNY, 1997, J BIOL CHEM, V272, P4404, DOI 10.1074/jbc.272.7.4404; Xiao Z, 2007, J CELL PHYSIOL, V210, P325, DOI 10.1002/jcp.20826; Zhang J, 2010, SAUDI MED J, V31, P374	45	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107482	10.1371/journal.pone.0107482	http://dx.doi.org/10.1371/journal.pone.0107482			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222280	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774800073
J	van Alphen, LB; Dorleans, F; Schultz, AC; Fonager, J; Ethelberg, S; Dalgaard, C; Adelhardt, M; Engberg, JH; Fischer, TK; Lassen, SG				van Alphen, Lieke B.; Dorleans, Frederique; Schultz, Anna Charlotte; Fonager, Jannik; Ethelberg, Steen; Dalgaard, Camilla; Adelhardt, Marianne; Engberg, Jorgen H.; Fischer, Thea Kolsen; Lassen, Sofie Gillesberg			The Application of New Molecular Methods in the Investigation of a Waterborne Outbreak of Norovirus in Denmark, 2012	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; NORWALK-LIKE VIRUSES; VIRAL GASTROENTERITIS; GENETIC DIVERSITY; DRINKING-WATER; ASSAY; QUANTIFICATION; INFECTIONS; SAPOVIRUS; CHILDREN	In December 2012, an outbreak of acute gastrointestinal illness occurred in a geographical distinct area in Denmark covering 368 households. A combined microbiological, epidemiological and environmental investigation was initiated to understand the outbreak magnitude, pathogen(s) and vehicle in order to control the outbreak. Norovirus GII.4 New Orleans 2009 variant was detected in 15 of 17 individual stool samples from 14 households. Norovirus genomic material from water samples was detected and quantified and sequencing of longer parts of the viral capsid region (>1000 nt) were applied to patient and water samples. All five purposely selected water samples tested positive for norovirus GII in levels up to 1.8 x 10(4) genomic units per 200 ml. Identical norovirus sequences were found in all 5 sequenced stool samples and 1 sequenced water sample, a second sequenced water sample showed 1 nt (<0.1%) difference. In a cohort study, including 256 participants, cases were defined as residents of the area experiencing diarrhoea or vomiting onset on 12-14 December 2012. We found an attack rate of 51%. Being a case was associated with drinking tap-water on 12-13 December (relative risk = 6.0, 95%CI: 1.6-22) and a dose-response relation for the mean glasses of tap-water consumed was observed. Environmental investigations suggested contamination from a sewage pipe to the drinking water due to fall in pressure during water supply system renovations. The combined microbiological, epidemiological and environmental investigations strongly indicates the outbreak was caused by norovirus contamination of the water supply system.	[van Alphen, Lieke B.; Fonager, Jannik; Dalgaard, Camilla; Fischer, Thea Kolsen] Statens Serum Inst, Dept Microbiol Diagnost & Virol, DK-2300 Copenhagen, Denmark; [van Alphen, Lieke B.] European Ctr Dis Prevent & Control ECDC, European Programme Publ Hlth Microbiol EUPHEM, Stockholm, Sweden; [Dorleans, Frederique; Ethelberg, Steen; Lassen, Sofie Gillesberg] Statens Serum Inst, Dept Infect Dis Epidemiol, DK-2300 Copenhagen, Denmark; [Dorleans, Frederique] European Ctr Dis Prevent & Control ECDC, European Programme Intervent Epidemiol Training E, Stockholm, Sweden; [Schultz, Anna Charlotte] DTU, Natl Food Inst, Div Food Microbiol, Lyngby, Denmark; [Adelhardt, Marianne] Danish Hlth & Med Author, Publ Hlth Med Officers East, Glostrup, Denmark	Statens Serum Institut; European Centre for Disease Prevention & Control; Statens Serum Institut; European Centre for Disease Prevention & Control; Technical University of Denmark	van Alphen, LB (corresponding author), Statens Serum Inst, Dept Microbiol Diagnost & Virol, DK-2300 Copenhagen, Denmark.	lieke.vanalphen@mumc.nl	Fischer, Thea K/AAH-9892-2019; Fonager, Jannik/AAJ-8292-2020; Lassen, Sofie Gillesberg/AAL-2876-2021; Schultz, Anna C/N-4898-2016	Fischer, Thea K/0000-0003-4812-980X; Lassen, Sofie Gillesberg/0000-0001-6226-5416; Schultz, Anna C/0000-0003-1484-9120; Engberg, Jorgen/0000-0001-9042-1631; Fonager, Jannik/0000-0003-1688-1482; Ethelberg, Steen/0000-0002-9709-356X	VISK (EU Interreg IV A); Aquavalens (EU) [FP7-KBBE-2012-6]	VISK (EU Interreg IV A); Aquavalens (EU)	Financial support of the viral analyses of water was provided by: VISK (EU Interreg IV A) and Aquavalens (EU FP7-KBBE-2012-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ANN REPORT ZOONOSES; [Anonymous], 2013, 1521612013 ISOTS; Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; Borchardt MA, 2013, APPL ENVIRON MICROB, V79, P5418, DOI 10.1128/AEM.01430-13; Carrique-Mas J, 2003, EPIDEMIOL INFECT, V131, P737, DOI 10.1017/S0950268803008604; Costafreda MI, 2006, APPL ENVIRON MICROB, V72, P3846, DOI 10.1128/AEM.02660-05; Dai YC, 2011, ARCH VIROL, V156, P1641, DOI 10.1007/s00705-011-1010-3; Di Pasquale S, 2010, J VIROL METHODS, V165, P57, DOI 10.1016/j.jviromet.2010.01.003; Engberg Jorgen, 1998, Clin Microbiol Infect, V4, P648, DOI 10.1111/j.1469-0691.1998.tb00348.x; Ferreira MSR, 2010, J MED VIROL, V82, P1442, DOI 10.1002/jmv.21831; Fonager J, 2005, EUROSURVEILLANCE, V18, P10; Gallimore CI, 2005, INT J FOOD MICROBIOL, V103, P323, DOI 10.1016/j.ijfoodmicro.2005.02.003; Gentry J, 2009, J VIROL METHODS, V156, P59, DOI 10.1016/j.jviromet.2008.11.001; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Gubbels SM, 2012, SCAND J INFECT DIS, V44, P586, DOI 10.3109/00365548.2012.655773; Hansman GS, 2007, EMERG INFECT DIS, V13, P786, DOI 10.3201/eid1305.070049; Haramoto E, 2007, J VIROL METHODS, V142, P169, DOI 10.1016/j.jviromet.2007.01.024; Harwood VJ, 2005, APPL ENVIRON MICROB, V71, P3163, DOI 10.1128/AEM.71.6.3163-3170.2005; Hoebe CJPA, 2004, J INFECT DIS, V189, P699, DOI 10.1086/381534; Johnsen CK, 2009, J CLIN VIROL, V46, P265, DOI 10.1016/j.jcv.2009.07.008; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Kuusi M, 2002, EPIDEMIOL INFECT, V129, P133, DOI 10.1017/S0950268802007276; Laine J, 2011, EPIDEMIOL INFECT, V139, P1105, DOI 10.1017/S0950268810002141; LAURSEN E, 1994, J EPIDEMIOL COMMUN H, V48, P453, DOI 10.1136/jech.48.5.453; Le Cann P, 2004, RES MICROBIOL, V155, P11, DOI 10.1016/j.resmic.2003.09.013; Le Guyader FS, 2009, APPL ENVIRON MICROB, V75, P618, DOI 10.1128/AEM.01507-08; LeGuyader F, 1996, APPL ENVIRON MICROB, V62, P4268, DOI 10.1128/AEM.62.11.4268-4272.1996; Logan C, 2006, J CLIN MICROBIOL, V44, P3189, DOI 10.1128/JCM.00915-06; Lysen M, 2009, J CLIN MICROBIOL, V47, P2411, DOI 10.1128/JCM.02168-08; Matthews JE, 2012, EPIDEMIOL INFECT, V140, P1161, DOI 10.1017/S0950268812000234; Maunula L, 2005, EMERG INFECT DIS, V11, P1716, DOI 10.3201/eid1111.050487; Medici MC, 2006, J MED VIROL, V78, P1486, DOI 10.1002/jmv.20723; Nygard K, 2007, INT J EPIDEMIOL, V36, P873, DOI 10.1093/ije/dym029; Oka T, 2006, J MED VIROL, V78, P1347, DOI 10.1002/jmv.20699; Pang XLL, 2004, J MED VIROL, V72, P496, DOI 10.1002/jmv.20009; Parashar UD, 2001, REV MED VIROL, V11, P243, DOI 10.1002/rmv.321; Persson S, 2011, DIAGN MICR INFEC DIS, V69, P240, DOI 10.1016/j.diagmicrobio.2010.09.023; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Stensvold CR, 2012, J CLIN MICROBIOL, V50, P540, DOI 10.1128/JCM.06012-11; Sukhrie FHA, 2011, J CLIN MICROBIOL, V49, P602, DOI 10.1128/JCM.01443-10; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; ter Waarbeek HLG, 2010, J CLIN VIROL, V47, P268, DOI 10.1016/j.jcv.2009.12.002; Vantarakis A, 2011, INT J ENV RES PUB HE, V8, P3468, DOI 10.3390/ijerph8083468; Vennema H, 2002, J CLIN VIROL, V25, P233, DOI 10.1016/S1386-6532(02)00126-9; Vestergaard L, 2007, EUROSURVEILLANCE, V12; Victoria M, 2009, J VIROL METHODS, V156, P73, DOI 10.1016/j.jviromet.2008.11.003; Vinje J, 2004, J VIROL METHODS, V116, P109, DOI 10.1016/j.jviromet.2003.11.001; Vinje J, 2003, J CLIN MICROBIOL, V41, P1423, DOI 10.1128/JCM.41.4.1423-1433.2003; Werber D, 2009, EPIDEMIOL INFECT, V137, P1713, DOI 10.1017/S095026880999015X; Xerry J, 2008, J CLIN MICROBIOL, V46, P947, DOI 10.1128/JCM.02240-07; Zhou X, 2012, EPIDEMIOL INFECT, V140, P2282, DOI 10.1017/S0950268812000374	53	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e105053	10.1371/journal.pone.0105053	http://dx.doi.org/10.1371/journal.pone.0105053			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222495	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774800004
J	Lee, YJ; Son, SJ; Paick, JS; Kim, SW				Lee, Young Ju; Son, Seung Jun; Paick, Jae-Seung; Kim, Soo Woong			Preoperative CT Voiding Cystourethrography Using 16-Multidetector CT in Female Urethral Diverticulum	PLOS ONE			English	Article							DIAGNOSIS; WOMEN; EXPERIENCE; OUTCOMES; MRI	Purpose: To evaluate the clinical usefulness of preoperative CT voiding cystourethrography (CT-VCUG) using 16-multidetector computed tomography for female urethral diverticula. Materials and Methods: Preoperative CT-VCUG was performed in 15 consecutive patients who underwent urethral diverticulectomy from May 2004 to December 2012. The result of preoperative cystourethroscopy and surgical findings were recorded by a single surgeon and CT-VCUG findings including the location of osita were retrospectively reviewed by another urologist who was blinded to the surgical finding. The location of the ostium detected on CT-VCUG was compared descriptively with the intraoperative surgical and preoperative cystourethroscopic findings. Results: A total of 14 consecutive patients who underwent preoperative CT-VCUG and urethral diverticulectomy were included in the analysis. Ostia were detected on CT-VCUG in all cases, whereas ostia were identified in 10 patients (71.4%) by cystourethroscopy. Ostia were located between the 4 and 8 o'clock direction. Mean distance from the bladder neck to the ostium was 24.2 mm. Circumferential and horseshoe shaped diverticula were observed in 6 and 4 patients, respectively. The surgical findings correlated well with the CT findings. Conclusions: Preoperative CT-VCUG can be useful in identifying the ostia of urethral diverticula in patients scheduled for urethral diverticulectomy and can provide structural information, useful to establish surgical strategy.	[Lee, Young Ju; Son, Seung Jun; Paick, Jae-Seung; Kim, Soo Woong] Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital	Kim, SW (corresponding author), Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea.	swkim@snu.ac.kr						ANDERSEN MJ, 1967, J UROLOGY, V98, P96; Antosh DD, 2011, FEMALE PELVIC MED RE, V17, P264, DOI 10.1097/SPV.0b013e318234a242; Bennett SJ, 2000, EUR J OBSTET GYN R B, V89, P135, DOI 10.1016/S0301-2115(99)00210-9; Blander DS, 2001, UROLOGY, V57, P660, DOI 10.1016/S0090-4295(00)01082-7; Chou CP, 2005, AM J ROENTGENOL, V184, P1889, DOI 10.2214/ajr.184.6.01841889; Chung DE, 2010, J UROLOGY, V183, P2265, DOI 10.1016/j.juro.2010.02.016; DAVIS HJ, 1958, J UROLOGY, V80, P34, DOI 10.1016/S0022-5347(17)66126-3; Dwarkasing RS, 2011, AM J ROENTGENOL, V197, P676, DOI 10.2214/AJR.10.6144; Fortunato P, 2001, INT UROGYNECOL J, V12, P51, DOI 10.1007/s001920170095; Han DH, 2007, EUR UROL, V51, P1664, DOI 10.1016/j.eururo.2007.01.103; Ingber MS, 2011, UROLOGY, V77, P65, DOI 10.1016/j.urology.2010.06.004; Jeffrey M, 2004, FEMALE URETHRAL DIVE, P370; KIM B, 1993, AM J ROENTGENOL, V161, P809, DOI 10.2214/ajr.161.4.8372765; Kim SH, 2005, AM J ROENTGENOL, V184, P1594, DOI 10.2214/ajr.184.5.01841594; Lee JWS, 2005, BEST PRACT RES CL OB, V19, P875, DOI 10.1016/j.bpobgyn.2005.08.008; Leng WW, 1998, J UROLOGY, V160, P1297, DOI 10.1016/S0022-5347(01)62520-5; Ockrim JL, 2009, BJU INT, V103, P1550, DOI 10.1111/j.1464-410X.2009.08348.x; Patel AK, 2006, CURR OPIN UROL, V16, P248, DOI 10.1097/01.mou.0000232045.80180.2f; Portnoy O, 2013, EUR J RADIOL, V82, P2183, DOI 10.1016/j.ejrad.2013.08.005; Romanzi LJ, 2000, J UROLOGY, V164, P428, DOI 10.1016/S0022-5347(05)67377-6	20	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107448	10.1371/journal.pone.0107448	http://dx.doi.org/10.1371/journal.pone.0107448			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216189	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774300067
J	Bookwalter, CS; Kelsen, A; Leung, JM; Ward, GE; Trybus, KM				Bookwalter, Carol S.; Kelsen, Anne; Leung, Jacqueline M.; Ward, Gary E.; Trybus, Kathleen M.			A Toxoplasma gondii Class XIV Myosin, Expressed in Sf9 Cells with a Parasite Co-chaperone, Requires Two Light Chains for Fast Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTING-PROTEIN MTIP; NECK REGION; TPR DOMAIN; UCS DOMAIN; MOTOR; TAIL; COMPLEX; UNC-45; DROSOPHILA; MECHANISM	Many diverse myosin classes can be expressed using the baculovirus/Sf9 insect cell expression system, whereas others have been recalcitrant. We hypothesized that most myosins utilize Sf9 cell chaperones, but others require an organism-specific cochaperone. TgMyoA, a class XIVa myosin from the parasite Toxoplasma gondii, is required for the parasite to efficiently move and invade host cells. The T. gondii genome contains one UCS family myosin co-chaperone (TgUNC). TgMyoA expressed in Sf9 cells was soluble and functional only if the heavy and light chain(s) were co-expressed with TgUNC. The tetratricopeptide repeat domain of TgUNC was not essential to obtain functional myosin, implying that there are other mechanisms to recruit Hsp90. Purified TgMyoA heavy chain complexed with its regulatory light chain (TgMLC1) moved actin in a motility assay at a speed of similar to 1.5 mu m/s. When a putative essential light chain (TgELC1) was also bound, TgMyoA moved actin at more than twice that speed (similar to 3.4 mu m/s). This result implies that two light chains bind to and stabilize the lever arm, the domain that amplifies small motions at the active site into the larger motions that propel actin at fast speeds. Our results show that the TgMyoA domain structure is more similar to other myosins than previously appreciated and provide a molecular explanation for how it moves actin at fast speeds. The ability to express milligram quantities of a class XIV myosin in a heterologous system paves the way for detailed structure-function analysis of TgMyoA and identification of small molecule inhibitors.	[Bookwalter, Carol S.; Trybus, Kathleen M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Kelsen, Anne; Leung, Jacqueline M.; Ward, Gary E.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Ward, GE (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Stafford 316, Burlington, VT 05405 USA.	gary.ward@uvm.edu; kathleen.trybus@uvm.edu		Ward, Gary/0000-0003-4138-3055	National Institutes of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI054961, R01AI054961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496, R01GM078097] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Marc-Jan Gubbels for providing the T. gondii cosmid number p559 and Dr. Con Beckers for providing the anti-TgMLC1 antibody. We acknowledge the early efforts of Aoife Heaslip and Michelle Shepard in attempting to express functional TgMyoA in Sf9 cells without the chaperone. We thank Susan Lowey for helpful comments on the manuscript. T. gondii genome sequence information was obtained from the Toxoplasma Genome Database. ToxoDB is a component of the Eukaryotic Pathogen Genomics Resource, a Bioinformatics Resource Center supported by the National Institutes of Allergy and Infectious Diseases; we gratefully acknowledge the staff responsible for developing and maintaining this resource.	Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; BECKINGHAM K, 1991, J BIOL CHEM, V266, P6027; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Bird JE, 2014, P NATL ACAD SCI USA, V111, P12390, DOI 10.1073/pnas.1409459111; Bosch J, 2007, J MOL BIOL, V372, P77, DOI 10.1016/j.jmb.2007.06.016; Chow D, 2002, J BIOL CHEM, V277, P36799, DOI 10.1074/jbc.M204101200; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Douse CH, 2012, J BIOL CHEM, V287, P36968, DOI 10.1074/jbc.M112.379842; Egarter S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091819; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Frenal K, 2008, MYOS SUP MOL MOT, P421; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gazda L, 2013, CELL, V152, P183, DOI 10.1016/j.cell.2012.12.025; Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539; Heaslip AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000720; Heintzelman MB, 1997, J MOL BIOL, V271, P139, DOI 10.1006/jmbi.1997.1167; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Hettmann C, 2000, MOL BIOL CELL, V11, P1385, DOI 10.1091/mbc.11.4.1385; Kinose F, 1996, J CELL BIOL, V134, P895, DOI 10.1083/jcb.134.4.895; Lee CF, 2011, STRUCTURE, V19, P397, DOI 10.1016/j.str.2011.01.002; Leung JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085763; Liu L, 2008, J BIOL CHEM, V283, P13185, DOI 10.1074/jbc.M800757200; LOWEY S, 1993, NATURE, V365, P454, DOI 10.1038/365454a0; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Mishra M, 2005, EUKARYOT CELL, V4, P567, DOI 10.1128/EC.4.3.567-576.2005; Moore JR, 2004, J MUSCLE RES CELL M, V25, P29, DOI 10.1023/B:JURE.0000021394.48560.71; Nebl T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002222; Ni WM, 2011, J CELL SCI, V124, P3164, DOI 10.1242/jcs.087320; Pato MD, 1996, J BIOL CHEM, V271, P2689, DOI 10.1074/jbc.271.5.2689; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; SHEFFIELD HG, 1968, J PARASITOL, V54, P209, DOI 10.2307/3276925; Shi H, 2010, P NATL ACAD SCI USA, V107, P21382, DOI 10.1073/pnas.1013038107; Srikakulam R, 2004, J CELL SCI, V117, P641, DOI 10.1242/jcs.00899; Srikakulam R, 1999, J BIOL CHEM, V274, P27265, DOI 10.1074/jbc.274.38.27265; Srikakulam R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002137; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Trybus KM, 2000, METHODS, V22, P327, DOI 10.1006/meth.2000.1085; TRYBUS KM, 1994, J BIOL CHEM, V269, P20819; Turley S, 2013, MOL BIOCHEM PARASIT, V190, P56, DOI 10.1016/j.molbiopara.2013.06.004; Tyska MJ, 2002, CELL MOTIL CYTOSKEL, V51, P1, DOI 10.1002/cm.10014; Uyeda TQP, 1996, P NATL ACAD SCI USA, V93, P4459, DOI 10.1073/pnas.93.9.4459; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Warshaw DM, 2000, J BIOL CHEM, V275, P37167, DOI 10.1074/jbc.M006438200; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Yang Y, 2005, J BIOL CHEM, V280, P32061, DOI 10.1074/jbc.M506765200	51	27	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30832	30841		10.1074/jbc.M114.572453	http://dx.doi.org/10.1074/jbc.M114.572453			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25231988	hybrid, Green Published			2022-12-25	WOS:000344549700057
J	Kiskin, NI; Babich, V; Knipe, L; Hannah, MJ; Carter, T				Kiskin, Nikolai I.; Babich, Victor; Knipe, Laura; Hannah, Matthew J.; Carter, Tom			Differential Cargo Mobilisation within Weibel-Palade Bodies after Transient Fusion with the Plasma Membrane	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; HUMAN ENDOTHELIAL-CELLS; NORMAL-MODE ANALYSIS; COMPOUND EXOCYTOSIS; SECRETORY GRANULES; CUMULATIVE FUSION; LATERAL DIFFUSION; CHROMAFFIN CELLS; RELEASE; BODY	Inflammatory chemokines can be selectively released from Weibel-Palade bodies (WPBs) during kiss-and-run exocytosis. Such selectivity may arise from molecular size filtering by the fusion pore, however differential intra-WPB cargo remobilisation following fusion-induced structural changes within the WPB may also contribute to this process. To determine whether WPB cargo molecules are differentially re-mobilised, we applied FRAP to residual post-fusion WPB structures formed after transient exocytosis in which some or all of the fluorescent cargo was retained. Transient fusion resulted in WPB collapse from a rod to a spheroid shape accompanied by substantial swelling (>2 times by surface area) and membrane mixing between the WPB and plasma membranes. Post-fusion WPBs supported cumulative WPB exocytosis. To quantify diffusion inside rounded organelles we developed a method of FRAP analysis based on image moments. FRAP analysis showed that von Willebrand factor-EGFP (VWF-EGFP) and the VWF-propolypeptide-EGFP (Pro-EGFP) were immobile in post-fusion WPBs. Because Eotaxin-3-EGFP and ssEGFP (small soluble cargo proteins) were largely depleted from post-fusion WPBs, we studied these molecules in cells preincubated in the weak base NH4Cl which caused WPB alkalinisation and rounding similar to that produced by plasma membrane fusion. In these cells we found a dramatic increase in mobilities of Eotaxin-3-EGFP and ssEGFP that exceeded the resolution of our method (similar to 2.4 mu m(2)/s mean). In contrast, the membrane mobilities of EGFP-CD63 and EGFP-Rab27A in post-fusion WPBs were unchanged, while P-selectin-EGFP acquired mobility. Our data suggest that selective re-mobilisation of chemokines during transient fusion contributes to selective chemokine secretion during transient WPB exocytosis. Selective secretion provides a mechanism to regulate intravascular inflammatory processes with reduced risk of thrombosis.	[Kiskin, Nikolai I.; Knipe, Laura; Carter, Tom] Natl Inst Med Res, MRC, Div Phys Biochem, London NW7 1AA, England; [Kiskin, Nikolai I.] Natl Inst Med Res, MRC, Div Neurophysiol, London NW7 1AA, England; [Babich, Victor] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Hannah, Matthew J.] Publ Hlth England, Microbiol Serv Colindale, London, England; [Carter, Tom] St Georges Univ, Cardiovasc & Cell Sci Res Inst, London, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research; University System of Maryland; University of Maryland Baltimore; Public Health England; St Georges University London	Carter, T (corresponding author), Natl Inst Med Res, MRC, Div Phys Biochem, London NW7 1AA, England.	tcarter@nimr.mrc.ac.uk	Kiskin, Nikolai/AAJ-1984-2020; Carter, Tom/E-5035-2016	Carter, Tom/0000-0002-6248-7278; Kiskin, Nikolai/0000-0003-1017-180X	United Kingdom Medical Research Council [U117573808, U117570589]; Medical Research Council [MC_PC_13053] Funding Source: researchfish; MRC [MC_PC_13053] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the United Kingdom Medical Research Council (reference code U117573808 and U117570589). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatore C, 2000, BIOCHIMIE, V82, P481, DOI 10.1016/S0300-9084(00)00213-3; Babich V, 2008, BLOOD, V111, P5282, DOI 10.1182/blood-2007-09-113746; Babich V, 2009, J BIOL CHEM, V284, P12459, DOI 10.1074/jbc.M809235200; Berriman JA, 2009, P NATL ACAD SCI USA, V106, P17407, DOI 10.1073/pnas.0902977106; Bierings R, 2007, J THROMB HAEMOST, V5, P2512, DOI 10.1111/j.1538-7836.2007.02768.x; Bierings R, 2012, BLOOD, V120, P2757, DOI 10.1182/blood-2012-05-429936; Braun M, 2007, J GEN PHYSIOL, V129, P221, DOI 10.1085/jgp.200609658; BRECKENRIDGE LJ, 1987, P NATL ACAD SCI USA, V84, P1945, DOI 10.1073/pnas.84.7.1945; Cochilla AJ, 2000, J CELL BIOL, V150, P839, DOI 10.1083/jcb.150.4.839; Cookson EA, 2013, J CELL SCI, V126, P5490, DOI 10.1242/jcs.138438; Cowan AE, 2004, P NATL ACAD SCI USA, V101, P7733, DOI 10.1073/pnas.0306859101; Erent A, 2007, J PHYSIOL-LONDON, V583, P195, DOI 10.1113/jphysiol.2007.132993; GHEZ R, 1985, J ELECTROCHEM SOC, V132, P2759, DOI 10.1149/1.2113659; Hafez I, 2003, J BIOL CHEM, V278, P44921, DOI 10.1074/jbc.M306013200; Hannah MJ, 2005, J BIOL CHEM, V280, P22827, DOI 10.1074/jbc.M412547200; Hartmann J, 2003, J BIOL CHEM, V278, P44929, DOI 10.1074/jbc.M306014200; Hol J, 2009, J BIOL CHEM, V284, P23532, DOI 10.1074/jbc.M900874200; Huang RH, 2008, P NATL ACAD SCI USA, V105, P482, DOI 10.1073/pnas.0710079105; Kelly ML, 2004, CELL BIOL INT, V28, P709, DOI 10.1016/j.cellbi.2004.07.005; Kishimoto T, 2006, EMBO J, V25, P673, DOI 10.1038/sj.emboj.7600983; Kiskin NI, 2010, J CELL SCI, V123, P2964, DOI 10.1242/jcs.073593; Knipe L, 2010, BLOOD, V116, P2183, DOI 10.1182/blood-2010-03-276170; KOPPEL DE, 1980, BIOPHYS J, V30, P187, DOI 10.1016/S0006-3495(80)85087-9; KOPPEL DE, 1985, BIOPHYS J, V47, P337, DOI 10.1016/S0006-3495(85)83924-2; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Manneville JB, 2003, J CELL SCI, V116, P3927, DOI 10.1242/jcs.00672; Marszalek P, 1996, SOC GEN PHY, V51, P211; Marszalek PE, 1997, BIOPHYS J, V73, P1169, DOI 10.1016/S0006-3495(97)78149-9; Mourik MJ, 2013, J THROMB HAEMOST, V11, P2009, DOI 10.1111/jth.12401; NANAVATI C, 1993, SCIENCE, V259, P963, DOI 10.1126/science.8438154; Nemoto T, 2001, NAT CELL BIOL, V3, P253, DOI 10.1038/35060042; Nightingale TD, 2011, J CELL BIOL, V194, P613, DOI 10.1083/jcb.201011119; Obermuller S, 2005, J CELL SCI, V118, P4271, DOI 10.1242/jcs.02549; Ozisik M.N., 1993, HEAT CONDUCTION; Parsons TD, 2003, NEURON, V37, P379, DOI 10.1016/S0896-6273(03)00062-X; Perrais D, 2004, J PHYSIOL-LONDON, V560, P413, DOI 10.1113/jphysiol.2004.064410; Rahamimoff R, 1997, NEURON, V18, P17, DOI 10.1016/S0896-6273(01)80043-X; Reigada D, 2003, P NATL ACAD SCI USA, V100, P3485, DOI 10.1073/pnas.0336914100; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; Sadler JE, 2005, J THROMB HAEMOST, V3, P1702, DOI 10.1111/j.1538-7836.2005.01369.x; SCEPEK S, 1993, EMBO J, V12, P1811, DOI 10.1002/j.1460-2075.1993.tb05829.x; Soekmadji C, 2010, CLIN EXP PHARMACOL P, V37, P218, DOI 10.1111/j.1440-1681.2009.05298.x; Vardjan N, 2007, J NEUROSCI, V27, P4737, DOI 10.1523/JNEUROSCI.0351-07.2007; VERDUGO P, 1990, ANNU REV PHYSIOL, V52, P157, DOI 10.1146/annurev.ph.52.030190.001105; WEIBEL ER, 1964, J CELL BIOL, V23, P101, DOI 10.1083/jcb.23.1.101; Weiss M, 2004, TRAFFIC, V5, P662, DOI 10.1111/j.1600-0854.2004.00215.x; Weiss T.F., 1996, TRANSPORT BRADFORD B, V1; Zenner HL, 2007, J CELL SCI, V120, P2117, DOI 10.1242/jcs.007781; ZIMMERBERG J, 1987, P NATL ACAD SCI USA, V84, P1585, DOI 10.1073/pnas.84.6.1585; Zupancic G, 2002, J PHYSIOL-LONDON, V544, P741, DOI 10.1113/jphysiol.2002.027490	50	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e108093	10.1371/journal.pone.0108093	http://dx.doi.org/10.1371/journal.pone.0108093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233365	Green Accepted, gold, Green Published			2022-12-25	WOS:000342921200082
J	Kritzberg, ES; Villanueva, AB; Jung, M; Reader, HE				Kritzberg, Emma S.; Villanueva, Ana Bedmar; Jung, Marco; Reader, Heather E.			Importance of Boreal Rivers in Providing Iron to Marine Waters	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; SURFACE WATERS; SIZE DISTRIBUTION; HUMIC SUBSTANCES; SEA; ELEMENTS; FE(III); FLOW; FRACTIONATION; CYANOBACTERIA	This study reports increasing iron concentrations in rivers draining into the Baltic Sea. Given the decisive role of iron to the structure and biogeochemical function of aquatic ecosystems, this trend is likely one with far reaching consequences to the receiving system. What those consequences may be depends on the fate of the iron in estuarine mixing. We here assess the stability of riverine iron by mixing water from seven boreal rivers with artificial sea salts. The results show a gradual loss of iron from suspension with increasing salinity. However, the capacity of the different river waters to maintain iron in suspension varied greatly, i.e. between 1 and 54% of iron was in suspension at a salinity of 30. The variability was best explained by iron: organic carbon ratios in the riverine waters - the lower the ratio the more iron remained in suspension. Water with an initially low iron: organic carbon ratio could keep even higher than ambient concentrations of Fe in suspension across the salinity gradient, as shown in experiments with iron amendments. Moreover, there was a positive relationship between the molecular size of the riverine organic matter and the amount of iron in suspension. In all, the results point towards a remarkably high transport capacity of iron from boreal rivers, suggesting that increasing concentrations of iron in river mouths may result in higher concentrations of potentially bioavailable iron in the marine system.	[Kritzberg, Emma S.; Villanueva, Ana Bedmar; Jung, Marco; Reader, Heather E.] Lund Univ, Dept Biol Aquat Ecol, Lund, Sweden	Lund University	Kritzberg, ES (corresponding author), Lund Univ, Dept Biol Aquat Ecol, Lund, Sweden.	Emma.Kritzberg@biol.lu.se			Swedish Research Council [2010-4081]; Swedish Research Council Formas through the Strong Research Environment Managing multiple stressors in the Baltic Sea [217-2010-126]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council Formas through the Strong Research Environment Managing multiple stressors in the Baltic Sea	This research was performed with funding from The Swedish Research Council (http://www.vr.se/grant number 2010-4081) and The Swedish Research Council Formas (http://www.formas.se/grant number 217-2010-126) through the Strong Research Environment Managing multiple stressors in the Baltic Sea to ESK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batchelli S, 2010, ENVIRON SCI TECHNOL, V44, P8485, DOI 10.1021/es101081c; Boyanapalli R, 2007, APPL ENVIRON MICROB, V73, P1019, DOI 10.1128/AEM.01670-06; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; BOYLE EA, 1977, GEOCHIM COSMOCHIM AC, V41, P1313, DOI 10.1016/0016-7037(77)90075-8; Breitbarth E, 2009, BIOGEOSCIENCES, V6, P2397, DOI 10.5194/bg-6-2397-2009; Bruland KW, 2001, LIMNOL OCEANOGR, V46, P1661, DOI 10.4319/lo.2001.46.7.1661; Cabaj A, 2009, MICROBIOL RES, V164, P570, DOI 10.1016/j.micres.2007.07.001; Chen M, 2008, AQUAT BIOL, V3, P155, DOI 10.3354/ab00064; Cory RM, 2010, LIMNOL OCEANOGR-METH, V8, P67; DAI MH, 1995, EARTH PLANET SC LETT, V131, P127, DOI 10.1016/0012-821X(95)00021-4; de Baar H.J.W., 2001, BIOGEOCHEMISTRY IRON, P123; de Baar HJW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002601; Erlandsson M, 2008, GLOBAL CHANGE BIOL, V14, P1191, DOI 10.1111/j.1365-2486.2008.01551.x; Fujii M, 2008, GEOCHIM COSMOCHIM AC, V72, P1335, DOI 10.1016/j.gca.2007.12.017; Geiss U, 2004, ENVIRON MICROBIOL, V6, P377, DOI 10.1111/j.1462-2920.2004.00569.x; Gelting J, 2010, BIOGEOSCIENCES, V7, P2489, DOI 10.5194/bg-7-2489-2010; Gustafsson O, 2000, MAR CHEM, V71, P1, DOI 10.1016/S0304-4203(00)00035-9; Helms JR, 2008, LIMNOL OCEANOGR, V53, P955, DOI 10.4319/lo.2008.53.3.0955; Ingri J, 2006, EARTH PLANET SC LETT, V245, P792, DOI 10.1016/j.epsl.2006.03.031; Jaffe R, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000683; Jirsa F, 2013, LIMNOLOGICA, V43, P239, DOI 10.1016/j.limno.2012.09.006; Johnson KS, 1997, MAR CHEM, V57, P137, DOI 10.1016/S0304-4203(97)00043-1; Johnson MS, 2011, BIOGEOCHEMISTRY, V105, P149, DOI 10.1007/s10533-011-9595-x; Karlsson T, 2012, CHEM ECOL, V364, P93; Knorr KH, 2013, BIOGEOSCIENCES, V10, P891, DOI 10.5194/bg-10-891-2013; Krachler R, 2005, BIOGEOSCIENCES, V2, P311, DOI 10.5194/bg-2-311-2005; Krachler R, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2012GB004294; Krachler R, 2010, SCI TOTAL ENVIRON, V408, P2402, DOI 10.1016/j.scitotenv.2010.02.018; Kritzberg ES, 2012, BIOGEOSCIENCES, V9, P1465, DOI 10.5194/bg-9-1465-2012; Kuma K, 1998, ESTUAR COAST SHELF S, V47, P275, DOI 10.1006/ecss.1998.0355; Kustka A, 2002, RES MICROBIOL, V153, P255, DOI 10.1016/S0923-2508(02)01325-6; Kustka AB, 2005, LIMNOL OCEANOGR, V50, P1172, DOI 10.4319/lo.2005.50.4.1172; Laglera LM, 2009, LIMNOL OCEANOGR, V54, P610, DOI 10.4319/lo.2009.54.2.0610; Lalonde K, 2012, NATURE, V483, P198, DOI 10.1038/nature10855; Lepisto A, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003175; Liu XW, 1999, GEOCHIM COSMOCHIM AC, V63, P3487, DOI 10.1016/S0016-7037(99)00270-7; MARTIN JH, 1990, NATURE, V345, P156, DOI 10.1038/345156a0; McKnight DM, 2001, LIMNOL OCEANOGR, V46, P38, DOI 10.4319/lo.2001.46.1.0038; Millero FJ, 1998, EARTH PLANET SC LETT, V154, P323, DOI 10.1016/S0012-821X(97)00179-9; Moore JK, 2001, DEEP-SEA RES PT II, V49, P463; Neal C, 2008, AQUAT GEOCHEM, V14, P263, DOI 10.1007/s10498-008-9036-1; Neubauer E, 2013, ENVIRON SCI TECHNOL, V47, P7120, DOI 10.1021/es401193j; Nowostawska U, 2008, MAR CHEM, V110, P205, DOI 10.1016/j.marchem.2008.03.001; Peuravuori J, 1997, ANAL CHIM ACTA, V337, P133, DOI 10.1016/S0003-2670(96)00412-6; Pokrovsky OS, 2014, OCEAN SCI, V10, P107, DOI 10.5194/os-10-107-2014; Pokrovsky OS, 2002, CHEM GEOL, V190, P141, DOI 10.1016/S0009-2541(02)00115-8; Rose AL, 2003, MAR CHEM, V84, P85, DOI 10.1016/S0304-4203(03)00113-0; Saitoh Y, 2008, J OCEANOGR, V64, P815, DOI 10.1007/s10872-008-0068-3; Saleh N, 2008, ENVIRON SCI TECHNOL, V42, P3349, DOI 10.1021/es071936b; Sarkkola S, 2013, SCI TOTAL ENVIRON, V463, P683, DOI 10.1016/j.scitotenv.2013.06.072; Schubert B, 2008, J MARINE SYST, V74, pS97, DOI 10.1016/j.jmarsys.2008.03.026; SENESI N, 1989, SCI TOTAL ENVIRON, V81-2, P143, DOI 10.1016/0048-9697(89)90120-4; SHAPIRO J, 1966, LIMNOL OCEANOGR, V11, P293, DOI 10.4319/lo.1966.11.2.0293; SHILLER AM, 1991, GEOCHIM COSMOCHIM AC, V55, P3241, DOI 10.1016/0016-7037(91)90486-O; SHOLKOVITZ ER, 1978, EARTH PLANET SC LETT, V40, P130, DOI 10.1016/0012-821X(78)90082-1; SHOLKOVITZ ER, 1976, GEOCHIM COSMOCHIM AC, V40, P831, DOI 10.1016/0016-7037(76)90035-1; Slomp CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062386; Sondergaard M, 2003, OPHELIA, V57, P161, DOI 10.1080/00785236.2003.10409512; Stal LJ, 1999, AQUAT MICROB ECOL, V18, P165, DOI 10.3354/ame018165; Stolpe B, 2007, GEOCHIM COSMOCHIM AC, V71, P3292, DOI 10.1016/j.gca.2007.04.025; Stolte W, 2006, MAR ECOL PROG SER, V327, P71, DOI 10.3354/meps327071; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Stumm W., 1996, AQUATIC CHEM CHEM EQ; TIPPING E, 1981, GEOCHIM COSMOCHIM AC, V45, P191, DOI 10.1016/0016-7037(81)90162-9; Turner A, 2004, MAR CHEM, V88, P179, DOI 10.1016/j.marchem.2004.03.008; Turner A, 2002, ESTUAR COAST SHELF S, V55, P857, DOI 10.1006/ecss.2002.1033; Viollier E, 2000, APPL GEOCHEM, V15, P785, DOI 10.1016/S0883-2927(99)00097-9; Vrede T, 2006, ECOSYSTEMS, V9, P1094, DOI 10.1007/s10021-006-0167-1; Wang WX, 2003, AQUAT MICROB ECOL, V33, P247, DOI 10.3354/ame033247; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x; Weyhenmeyer GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088104; Xiao YH, 2013, LIMNOL OCEANOGR, V58, P653, DOI 10.4319/lo.2013.58.2.0653; Yoshimura T, 2010, DEEP-SEA RES PT I, V57, P1454, DOI 10.1016/j.dsr.2010.08.003	73	50	50	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107500	10.1371/journal.pone.0107500	http://dx.doi.org/10.1371/journal.pone.0107500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233197	Green Published, Green Submitted, gold			2022-12-25	WOS:000342921200033
J	Valdez, CA; Leif, RN; Mayer, BP				Valdez, Carlos A.; Leif, Roald N.; Mayer, Brian P.			An Efficient, Optimized Synthesis of Fentanyl and Related Analogs	PLOS ONE			English	Article							EPIDURAL INTRATHECAL ROUTE; MOSCOW THEATER SIEGE; OPIOID-RECEPTOR; CLINICAL USE; TOLERANCE; EFFICACY; COMPLEX	The alternate and optimized syntheses of the parent opioid fentanyl and its analogs are described. The routes presented exhibit high-yielding transformations leading to these powerful analgesics after optimization studies were carried out for each synthetic step. The general three-step strategy produced a panel of four fentanyls in excellent yields (73-78%) along with their more commonly encountered hydrochloride and citric acid salts. The following strategy offers the opportunity for the gram-scale, efficient production of this interesting class of opioid alkaloids.	[Valdez, Carlos A.; Leif, Roald N.; Mayer, Brian P.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA; [Valdez, Carlos A.; Leif, Roald N.; Mayer, Brian P.] Lawrence Livermore Natl Lab, Forens Sci Ctr, Livermore, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Mayer, BP (corresponding author), Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA.	mayer22@llnl.gov		Valdez, Carlos A./0000-0002-8641-9077; Mayer, Brian/0000-0003-1967-9802	Lawrence Livermore National Laboratory (llnl.gov) under the Laboratory Directed Research and Development (LDRD) program [14-ERD-048]	Lawrence Livermore National Laboratory (llnl.gov) under the Laboratory Directed Research and Development (LDRD) program	The authors (CAV, BPM, and RNL) received funding from Lawrence Livermore National Laboratory (llnl.gov) under the Laboratory Directed Research and Development (LDRD) program, project number 14-ERD-048. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese D, 2008, ORG PROCESS RES DEV, V12, P736, DOI 10.1021/op800001d; Balannik V, 2009, BIOCHEMISTRY-US, V48, P11872, DOI 10.1021/bi9014488; Burova SA, 2007, SYNTHETIC COMMUN, V37, P3029, DOI 10.1080/00397910701542996; Chauhan S, 2008, ENVIRON TOXICOL PHAR, V26, P113, DOI 10.1016/j.etap.2008.03.003; Coupland RM, 2003, LANCET, V362, P1346, DOI 10.1016/S0140-6736(03)14684-3; DUTTAROY A, 1995, ANESTHESIOLOGY, V82, P1226, DOI 10.1097/00000542-199505000-00018; Friedrichsdorf SJ, 2014, J PAIN RES, V7, P117, DOI 10.2147/JPR.S58862; Gant T. G., 2010, Patent No. [US2010/0016365Al, 20100016365]; George AV, 2010, AM J EMERG MED, V28, P530, DOI 10.1016/j.ajem.2010.03.003; Ghaffarzadeh M, 2012, TETRAHEDRON LETT, V53, P203, DOI 10.1016/j.tetlet.2011.11.018; Gordon DB, 2006, ONCOL NURS FORUM, V33, P257, DOI 10.1188/06.ONF.257-264; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Grass J A, 2000, Anesthesiol Clin North Am, V18, P407, DOI 10.1016/S0889-8537(05)70170-X; GRASS JA, 1992, J PAIN SYMPTOM MANAG, V7, P271, DOI 10.1016/0885-3924(92)90061-L; GRASS JA, 1992, J PAIN SYMPTOM MANAG, V7, P419, DOI 10.1016/0885-3924(92)90022-A; Gupta PK, 2005, J CHEM RES, P452; JANSSEN PA, 1961, J PHARM PHARMACOL, V13, P513, DOI 10.1111/j.2042-7158.1961.tb11864.x; JANSSEN PAJ, 1960, J MED PHARMACEUT CH, V2, P31; Kronstrand R, 1997, FORENSIC SCI INT, V88, P185, DOI 10.1016/S0379-0738(97)00068-6; Lee SK, 2014, INT J GEN MED, V7, P49, DOI 10.2147/IJGM.S42187; Lehmann KA, 2005, J PAIN SYMPTOM MANAG, V29, pS72, DOI 10.1016/j.jpainsymman.2005.01.005; Maciejewski D, 2012, ANAESTH INTENSIVE TH, V44, P35; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mercadante S, 2011, CURR PAIN HEADACHE R, V15, P244, DOI 10.1007/s11916-011-0191-5; Ogilvie L, 2013, MMWR-MORBID MORTAL W, V62, P703; Rieder J, 2003, LANCET, V361, P1131, DOI 10.1016/S0140-6736(03)12869-3; Sirohi S, 2008, PHARMACOL BIOCHEM BE, V91, P115, DOI 10.1016/j.pbb.2008.06.019; STANLEY TH, 1992, J PAIN SYMPTOM MANAG, V7, pS3, DOI 10.1016/0885-3924(92)90047-L; Stanley TH, 2005, J PAIN SYMPTOM MANAG, V29, pS67, DOI 10.1016/j.jpainsymman.2005.01.009; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Vardanyan RS, 2014, FUTURE MED CHEM, V6, P385, DOI 10.4155/fmc.13.215; Watson AJA, 2011, J ORG CHEM, V76, P2328, DOI 10.1021/jo102521a; Wax PM, 2003, ANN EMERG MED, V41, P700, DOI 10.1067/mem.2003.148; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939	34	55	56	5	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e108250	10.1371/journal.pone.0108250	http://dx.doi.org/10.1371/journal.pone.0108250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233364	Green Submitted, Green Published, gold			2022-12-25	WOS:000342921200089
J	Castellanos-Joya, M; Delgado-Sanchez, G; Ferreyra-Reyes, L; Cruz-Hervert, P; Ferreira-Guerrero, E; Ortiz-Solis, G; Jimenez, MI; Salazar, LL; Montero-Campos, R; Mongua-Rodriguez, N; Baez-Saldana, R; Bobadilla-del-Valle, M; Gonzalez-Roldan, JF; Ponce-de-Leon, A; Sifuentes-Osornio, J; Garcia-Garcia, L				Castellanos-Joya, Martin; Delgado-Sanchez, Guadalupe; Ferreyra-Reyes, Leticia; Cruz-Hervert, Pablo; Ferreira-Guerrero, Elizabeth; Ortiz-Solis, Gabriela; Irene Jimenez, Mirtha; Lorena Salazar, Leslie; Montero-Campos, Rogelio; Mongua-Rodriguez, Norma; Baez-Saldana, Renata; Bobadilla-del-Valle, Miriam; Felipe Gonzalez-Roldan, Jesus; Ponce-de-Leon, Alfredo; Sifuentes-Osornio, Jose; Garcia-Garcia, Lourdes			Results of the Implementation of a Pilot Model for the Bidirectional Screening and Joint Management of Patients with Pulmonary Tuberculosis and Diabetes Mellitus in Mexico	PLOS ONE			English	Article							IMPACT; ASSOCIATION	Background: Recently, the World Health Organisation and the International Union Against Tuberculosis and Lung Disease published a Collaborative Framework for the Care and Control of Tuberculosis (TB) and Diabetes (DM) (CFTB/DM) proposing bidirectional screening and joint management. Objective: To evaluate the feasibility and effectiveness of the CFTB/DM in Mexico. Design. Prospective observational cohort. Setting. 15 primary care units in 5 states in Mexico. Participants: Patients aged >= 20 years diagnosed with DM or pulmonary TB who sought care at participating clinics. Intervention: The WHO/Union CFTB/DM was adapted and implemented according to official Mexican guidelines. We recruited participants from July 2012 to April 2013 and followed up until March 2014. Bidirectional screening was performed. Patients diagnosed with TB and DM were invited to receive TB treatment under joint management. Main outcome measures. Diagnoses of TB among DM, of DM among TB, and treatment outcomes among patients with DM and TB. Results: Of 783 DM patients, 11 (1.4%) were unaware of their TB. Of 361 TB patients, 16 (4.4%) were unaware of their DM. 95 TB/DM patients accepted to be treated under joint management, of whom 85 (89.5%) successfully completed treatment. Multiple linear regression analysis with change in HbA1c and random capillary glucose as dependent variables revealed significant decrease with time (regression coefficients (beta) = -0.660, (95% confidence interval (CI), -0.96 to -0.35); and beta = -1.889 (95% CI, -2.77 to -1.01, respectively)) adjusting by sex, age and having been treated for a previous TB episode. Patients treated under joint management were more likely to experience treatment success than patients treated under routine DM and TB programs as compared to historical (adjusted OR (aOR), 2.8, 95%CI 1.28-6.13) and same period (aOR 2.37, 95% CI 1.13-4.96) comparison groups. Conclusions: Joint management of TB and DM is feasible and appears to improve clinical outcomes.	[Castellanos-Joya, Martin; Irene Jimenez, Mirtha; Lorena Salazar, Leslie] Ctr Nacl Programas Prevent & Control Enfermedades, Direcc Programa Micobacteriosis, Mexico City, DF, Mexico; [Delgado-Sanchez, Guadalupe; Ferreyra-Reyes, Leticia; Cruz-Hervert, Pablo; Ferreira-Guerrero, Elizabeth; Montero-Campos, Rogelio; Mongua-Rodriguez, Norma; Baez-Saldana, Renata; Garcia-Garcia, Lourdes] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico; [Ortiz-Solis, Gabriela] Ctr Nacl Programas Prevent & Control Enfermedades, Direcc Programa Salud Adulto & Anciano, Mexico City, DF, Mexico; [Bobadilla-del-Valle, Miriam; Ponce-de-Leon, Alfredo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Microbiol Lab, Mexico City, DF, Mexico; [Felipe Gonzalez-Roldan, Jesus] Ctr Nacl Programas Prevent & Control Enfermedades, Direcc Gen, Mexico City, DF, Mexico; [Sifuentes-Osornio, Jose] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Direcc Med, Mexico City, DF, Mexico	Instituto Nacional de Salud Publica; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Garcia-Garcia, L (corresponding author), Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.	garcigarml@gmail.com	Cruz-Hervert, Luis Pablo/AEI-4595-2022; Bobadilla-del-Valle, Miriam/AAD-6418-2020; García, Maria de Lourdes/I-2724-2019	Cruz-Hervert, Luis Pablo/0000-0002-6094-958X; García, Maria de Lourdes/0000-0001-5262-1157; BOBADILLA-DEL VALLE, MIRIAM/0000-0003-1184-827X; Sifuentes-Osornio, Jose/0000-0001-9584-1360; Ponce-de-Leon, Alfredo/0000-0003-2640-2916				Achanta S, 2013, PUBLIC HEALTH ACTION, V3, pS43, DOI 10.5588/pha.13.0033; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc12-s064, 10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc11-S062]; [Anonymous], REV ASOCIACION LATIN; [Anonymous], GLOB TUB CONTR WHO R; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Dave P, 2013, PUBLIC HEALTH ACTION, V3, pS29, DOI 10.5588/pha.13.0027; DOLHOFER R, 1985, BIOL CHEM H-S, V366, P361, DOI 10.1515/bchm3.1985.366.1.361; Dudley L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003318.pub3; Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756; Gomez DI, 2013, TUBERCULOSIS, V93, P192, DOI 10.1016/j.tube.2012.10.003; Hernandez-Avila M, 2013, SALUD PUBLICA MEXICO, V55, pS129, DOI 10.21149/spm.v55s2.5108; Jali MV, 2013, DIABETES METAB J, V37, P291, DOI 10.4093/dmj.2013.37.4.291; Jeon CY, 2010, TROP MED INT HEALTH, V15, P1300, DOI 10.1111/j.1365-3156.2010.02632.x; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kumpatla S, 2013, PUBLIC HEALTH ACTION, V3, pS23, DOI 10.5588/pha.13.0035; Laniado-Laborin R, 2006, INFECT CONT HOSP EP, V27, P449, DOI 10.1086/503641; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lin Y, 2012, TROP MED INT HEALTH, V17, P1302, DOI 10.1111/j.1365-3156.2012.03069.x; Macias AE, 2005, ARCH MED RES, V36, P637, DOI 10.1016/j.arcmed.2005.05.004; Nair S, 2013, PUBLIC HEALTH ACTION, V3, pS38, DOI 10.5588/pha.13.0037; Peyffer GE, 2011, MANUAL CLIN MICROBIO, V1, P472, DOI DOI 10.1128/9781555816728.CH28; Ponce-De-Leon A, 2004, DIABETES CARE, V27, P1584, DOI 10.2337/diacare.27.7.1584; Prakash BC, 2013, PUBLIC HEALTH ACTION, V3, pS18, DOI 10.5588/pha.13.0032; Raviglione M, 2001, INT J TUBERC LUNG D, V5, P213; Renders CM, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858.CD001481]; Restrepo BI, 2008, CLIN INFECT DIS, V47, P634, DOI 10.1086/590565; Secretaria de salud, 2010, DIARIO OFICIAL FEDER; Secretaria de Salud, 2013, DIARIO OFICIAL FEDER; Secretaria de Salud, 2000, DIARIO OFICIAL FEDER; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; Tsukaguchi Katsuhiko, 2002, Kekkaku, V77, P409; Watterson SA, 2000, J CLIN PATHOL, V53, P727, DOI 10.1136/jcp.53.10.727; World Health Organization International Union against Tuberculosis and Lung Disease, 2011, COLL FRAM CAR CONTR	33	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e106961	10.1371/journal.pone.0106961	http://dx.doi.org/10.1371/journal.pone.0106961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229236	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900017
J	Elsner, JB; Jagger, TH; Elsner, IJ				Elsner, James B.; Jagger, Thomas H.; Elsner, Ian J.			Tornado Intensity Estimated from Damage Path Dimensions	PLOS ONE			English	Article							UNITED-STATES; CLIMATOLOGY; FUTURE; WINDS	The Newcastle/Moore and El Reno tornadoes of May 2013 are recent reminders of the destructive power of tornadoes. A direct estimate of a tornado's power is difficult and dangerous to get. An indirect estimate on a categorical scale is available from a post-storm survery of the damage. Wind speed bounds are attached to the scale, but the scale is not adequate for analyzing trends in tornado intensity separate from trends in tornado frequency. Here tornado intensity on a continuum is estimated from damage path length and width, which are measured on continuous scales and correlated to the EF rating. The wind speeds on the EF scale are treated as interval censored data and regressed onto the path dimensions and fatalities. The regression model indicates a 25% increase in expected intensity over a threshold intensity of 29 m s(-1) for a 100 km increase in path length and a 17% increase in expected intensity for a one km increase in path width. The model shows a 43% increase in the expected intensity when fatalities are observed controlling for path dimensions. The estimated wind speeds correlate at a level of .77 (.34, .93) [95% confidence interval] with a small sample of wind speeds estimated independently from a doppler radar calibration. The estimated wind speeds allow analyses to be done on the tornado database that are not possible with the categorical scale. The modeled intensities can be used in climatology and in environmental and engineering applications. Research is needed to understand the upward trends in path length and width.	[Elsner, James B.; Jagger, Thomas H.] Florida State Univ, Dept Geog, Tallahassee, FL 32306 USA; [Elsner, Ian J.] Univ Florida, Digital Worlds Inst, Gainesville, FL USA	State University System of Florida; Florida State University; State University System of Florida; University of Florida	Elsner, JB (corresponding author), Florida State Univ, Dept Geog, Tallahassee, FL 32306 USA.	jelsner@fsu.edu		Elsner, James/0000-0001-6805-7431	Department of Geography at Florida State University; Climatek, Inc.	Department of Geography at Florida State University; Climatek, Inc.	Partial support for this work came from the Department of Geography at Florida State University and from Climatek, Inc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks HE, 2004, WEATHER FORECAST, V19, P310, DOI 10.1175/1520-0434(2004)019<0310:OTROTP>2.0.CO;2; Brooks HE, 2001, WEATHER FORECAST, V16, P168, DOI 10.1175/1520-0434(2001)016<0168:NDFMTI>2.0.CO;2; Brown PJ, 2013, J APPL METEOROL CLIM, V52, P147, DOI 10.1175/JAMC-D-12-035.1; Diffenbaugh NS, 2013, P NATL ACAD SCI; DOSWELL CA, 1988, MON WEATHER REV, V116, P495, DOI 10.1175/1520-0493(1988)116<0495:OSIOUS>2.0.CO;2; Doswell CA, 2009, ATMOS RES, V93, P554, DOI 10.1016/j.atmosres.2008.11.003; Edwards R, 2013, B AM METEOROL SOC, V94, P641, DOI 10.1175/BAMS-D-11-00006.1; Feuerstein B, 2005, J CLIMATE, V18, P585, DOI 10.1175/JCLI-3285.1; Francis JA, 2012, GEOPHYS RES LETT; Fujita T, 1973, 8 C SEV LOC STORMS D, P142; FUJITA TT, 1981, J ATMOS SCI, V38, P1511, DOI 10.1175/1520-0469(1981)038<1511:TADITC>2.0.CO;2; Grazulis T. P., 1990, SIGNIFICANT TORNADOE; Jagger T, 2001, J APPL METEOROL, V40, P853, DOI 10.1175/1520-0450(2001)040<0853:ADPMOH>2.0.CO;2; Ramsdell Jr J. V., 2007, NUREGCR4461 PAC NW N; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Simmons KM, 2012, B AM METEOROL SOC, V93, P959, DOI 10.1175/BAMS-D-11-00126.1; Toth M, 2013, WEATHER FORECAST, V28, P418, DOI 10.1175/WAF-D-12-00019.1; Trapp RJ, 2007, P NATL ACAD SCI USA, V104, P19719, DOI 10.1073/pnas.0705494104; Wurman J, 2005, MON WEATHER REV, V133, P97, DOI 10.1175/MWR-2856.1	19	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107571	10.1371/journal.pone.0107571	http://dx.doi.org/10.1371/journal.pone.0107571			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229242	Green Published, gold			2022-12-25	WOS:000342123900050
J	Rodriguez, M; Alhassan, A; Ord, RL; Cursino-Santos, JR; Singh, M; Gray, J; Lobo, CA				Rodriguez, Marilis; Alhassan, Andy; Ord, Rosalynn L.; Cursino-Santos, Jeny R.; Singh, Manpreet; Gray, Jeremy; Lobo, Cheryl A.			Identification and Characterization of the RouenBd1987 Babesia divergens Rhopty-Associated Protein 1	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; ERYTHROCYTE INVASION; PARASITE INVASION; BOVIS; GENES; MALARIA; EXPRESSION; LOCALIZATION; ORGANELLES; RECEPTORS	Human babesiosis is caused by one of several babesial species transmitted by ixodid ticks that have distinct geographical distributions based on the presence of competent animal hosts. The pathology of babesiosis, like malaria, is a consequence of the parasitaemia which develops through the cyclical replication of Babesia parasites in a patient's red blood cells, though symptoms typically are nonspecific. We have identified the gene encoding Rhoptry-Associated Protein -1 (RAP-1) from a human isolate of B. divergens, Rouen1987 and characterized its protein product at the molecular and cellular level. Consistent with other Babesia RAP-1 homologues, BdRAP-1 is expressed as a 46 kDa protein in the parasite rhoptries, suggesting a possible role in red cell invasion. Native BdRAP-1 binds to an unidentified red cell receptor(s) that appears to be non-sialylated and non-proteinacious in nature, but we do not find significant reduction in growth with anti-rRAP1 antibodies in vitro, highlighting the possibility the B. divergens is able to use alternative pathways for invasion, or there is an alternative, complementary, role for BdRAP-1 during the invasion process. As it is the parasite's ability to recognize and then invade host cells which is central to clinical disease, characterising and understanding the role of Babesia-derived proteins involved in these steps are of great interest for the development of an effective prophylaxis.	[Rodriguez, Marilis; Alhassan, Andy; Ord, Rosalynn L.; Cursino-Santos, Jeny R.; Singh, Manpreet; Lobo, Cheryl A.] New York Blood Ctr, Dept Blood Borne Parasites, New York, NY 10021 USA; [Gray, Jeremy] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland	New York Blood Center; University College Dublin	Lobo, CA (corresponding author), New York Blood Ctr, Dept Blood Borne Parasites, New York, NY 10021 USA.	clobo@nybloodcenter.org			National Institutes of Health (NIH) [RO1-HL105694]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105694] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this study was provided by a grant from the National Institutes of Health (NIH) to CAL: RO1-HL105694. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besteiro S, 2011, CELL MICROBIOL, V13, P797, DOI 10.1111/j.1462-5822.2011.01597.x; DALRYMPLE BP, 1993, MOL BIOCHEM PARASIT, V57, P181, DOI 10.1016/0166-6851(93)90194-3; DAMMIN GJ, 1981, HUM PATHOL, V12, P398, DOI 10.1016/S0046-8177(81)80020-2; Florin-Christensen M, 2002, INFECT IMMUN, V70, P3566, DOI 10.1128/IAI.70.7.3566-3575.2002; GARNHAM PCC, 1980, T ROY SOC TROP MED H, V74, P153, DOI 10.1016/0035-9203(80)90232-1; GORENFLOT A, 1991, PARASITOL RES, V77, P3, DOI 10.1007/BF00934377; Gray J, 2010, TICKS TICK-BORNE DIS, V1, P3, DOI 10.1016/j.ttbdis.2009.11.003; Gubernot DM, 2009, CLIN INFECT DIS, V48, P25, DOI 10.1086/595010; Homer MJ, 2000, CLIN MICROBIOL REV, V13, P451, DOI 10.1128/CMR.13.3.451-469.2000; Hotzel I, 1997, MOL BIOCHEM PARASIT, V90, P479, DOI 10.1016/S0166-6851(97)00182-5; HOWARD RF, 1990, EXP PARASITOL, V71, P330, DOI 10.1016/0014-4894(90)90038-E; Howard RF, 1998, MOL BIOCHEM PARASIT, V92, P111, DOI 10.1016/S0166-6851(97)00238-7; Ikadai H, 1999, J CLIN MICROBIOL, V37, P3475, DOI 10.1128/JCM.37.11.3475-3480.1999; Kaneko O, 2007, PARASITOL INT, V56, P255, DOI 10.1016/j.parint.2007.05.003; KANIA SA, 1995, EXP PARASITOL, V80, P76, DOI 10.1006/expr.1995.1009; Kats LM, 2006, TRENDS PARASITOL, V22, P269, DOI 10.1016/j.pt.2006.04.001; Kjemtrup AM, 2000, INT J PARASITOL, V30, P1323, DOI 10.1016/S0020-7519(00)00137-5; Lantos PM, 2002, PEDIATR ANN, V31, P192, DOI 10.3928/0090-4481-20020301-10; Ling IT, 2004, MOL MICROBIOL, V52, P107, DOI 10.1111/j.1365-2958.2003.03969.x; Lobo CA, 2005, INFECT IMMUN, V73, P649, DOI 10.1128/IAI.73.1.649-651.2005; Lobo CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003387; MACHADO RZ, 1993, EXP PARASITOL, V77, P315, DOI 10.1006/expr.1993.1089; MISHRA VS, 1992, MOL BIOCHEM PARASIT, V53, P149, DOI 10.1016/0166-6851(92)90017-E; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Preiser P, 2000, MICROBES INFECT, V2, P1461, DOI 10.1016/S1286-4579(00)01301-0; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; RUEBUSH TK, 1977, NEW ENGL J MED, V297, P825, DOI 10.1056/NEJM197710132971511; SamYellowe TY, 1996, PARASITOL TODAY, V12, P308, DOI 10.1016/0169-4758(96)10030-2; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Skuce PJ, 1996, MOL BIOCHEM PARASIT, V77, P99, DOI 10.1016/0166-6851(96)02570-4; SPIELMAN A, 1985, ANNU REV ENTOMOL, V30, P439, DOI 10.1146/annurev.en.30.010185.002255; Suarez CE, 2011, PARASITOLOGY, V138, P809, DOI 10.1017/S0031182011000321; Suarez CE, 2003, MOL BIOCHEM PARASIT, V127, P101, DOI 10.1016/S0166-6851(02)00311-0; Suarez CE, 2000, INFECT IMMUN, V68, P6865, DOI 10.1128/IAI.68.12.6865-6870.2000; SUAREZ CE, 1991, MOL BIOCHEM PARASIT, V46, P45, DOI 10.1016/0166-6851(91)90197-E; Vannier Edouard, 2009, Interdiscip Perspect Infect Dis, V2009, P984568, DOI 10.1155/2009/984568; WITTNER M, 1982, ANN INTERN MED, V96, P601, DOI 10.7326/0003-4819-96-5-601; Yokoyama N, 2002, INFECT IMMUN, V70, P5822, DOI 10.1128/IAI.70.10.5822-5826.2002; Yokoyama N, 2006, VET PARASITOL, V138, P22, DOI 10.1016/j.vetpar.2006.01.037; Zintl A, 2003, CLIN MICROBIOL REV, V16, P622, DOI 10.1128/CMR.16.4.622-636.2003	40	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107727	10.1371/journal.pone.0107727	http://dx.doi.org/10.1371/journal.pone.0107727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226276	gold, Green Submitted, Green Published			2022-12-25	WOS:000344317700076
J	Babin, D; Vogel, C; Zuhlke, S; Schloter, M; Pronk, GJ; Heister, K; Spiteller, M; Kogel-Knabner, I; Smalla, K				Babin, Doreen; Vogel, Cordula; Zuehlke, Sebastian; Schloter, Michael; Pronk, Geertje Johanna; Heister, Katja; Spiteller, Michael; Koegel-Knabner, Ingrid; Smalla, Kornelia			Soil Mineral Composition Matters: Response of Microbial Communities to Phenanthrene and Plant Litter Addition in Long-Term Matured Artificial Soils	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; GRADIENT GEL-ELECTROPHORESIS; ACCUMULATING POTATO PLANTS; CLAY-MINERALS; BIOGEOCHEMICAL INTERFACES; MICROBIOLOGICAL PROCESSES; BACTERIAL COMMUNITIES; MONTMORILLONITE CLAY; CHARCOAL DETERMINE; CONTAMINATED SOIL	The fate of polycyclic aromatic hydrocarbons (PAHs) in soil is determined by a suite of biotic and abiotic factors, and disentangling their role in the complex soil interaction network remains challenging. Here, we investigate the influence of soil composition on the microbial community structure and its response to the spiked model PAH compound phenanthrene and plant litter. We used long-term matured artificial soils differing in type of clay mineral (illite, montmorillonite) and presence of charcoal or ferrihydrite. The soils received an identical soil microbial fraction and were incubated for more than two years with two sterile manure additions. The matured artificial soils and a natural soil were subjected to the following spiking treatments: (I) phenanthrene, (II) litter, (III) litter + phenanthrene, (IV) unspiked control. Total community DNA was extracted from soil sampled on the day of spiking, 7, 21, and 63 days after spiking. Bacterial 16S rRNA gene and fungal internal transcribed spacer amplicons were quantified by qPCR and subjected to denaturing gradient gel electrophoresis (DGGE). DGGE analysis revealed that the bacterial community composition, which was strongly shaped by clay minerals after more than two years of incubation, changed in response to spiked phenanthrene and added litter. DGGE and qPCR showed that soil composition significantly influenced the microbial response to spiking. While fungal communities responded only in presence of litter to phenanthrene spiking, the response of the bacterial communities to phenanthrene was less pronounced when litter was present. Interestingly, microbial communities in all artificial soils were more strongly affected by spiking than in the natural soil, which might indicate the importance of higher microbial diversity to compensate perturbations. This study showed the influence of soil composition on the microbiota and their response to phenanthrene and litter, which may increase our understanding of complex interactions in soils for bioremediation applications.	[Babin, Doreen; Smalla, Kornelia] Julius Kuhn Inst, Inst Epidemiol & Pathogen Diagnost, Fed Res Ctr Cultivated Plants, Braunschweig, Germany; [Vogel, Cordula; Pronk, Geertje Johanna; Heister, Katja; Koegel-Knabner, Ingrid] Tech Univ Munich, Lehrstuhl Bodenkunde, Freising Weihenstephan, Germany; [Zuehlke, Sebastian; Spiteller, Michael] Tech Univ Dortmund, Fak Chem & Chem Biol, Inst Umweltforsch INFU, Lehrstuhl Umweltchem & Analyt Chem, Dortmund, Germany; [Schloter, Michael] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Environm Genom, Neuherberg, Germany; [Pronk, Geertje Johanna; Koegel-Knabner, Ingrid] Tech Univ Munich, Inst Adv Study, Garching, Germany	Julius Kuhn-Institut; Technical University of Munich; Dortmund University of Technology; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Smalla, K (corresponding author), Julius Kuhn Inst, Inst Epidemiol & Pathogen Diagnost, Fed Res Ctr Cultivated Plants, Braunschweig, Germany.	kornelia.smalla@jki.bund.de	Schloter, 1Michael/H-9151-2013; Babin, Doreen/G-1312-2015; Smalla, Kornelia/H-4002-2011; Pronk, Geertje/S-1981-2016; Kögel-Knabner, Ingrid/A-7905-2008; Babin, Doreen/J-3640-2019; Heister, Katja/M-1497-2014; Vogel, Cordula/AAA-4966-2020	Pronk, Geertje/0000-0003-3881-4934; Kögel-Knabner, Ingrid/0000-0002-7216-8326; Babin, Doreen/0000-0001-7144-8898; Vogel, Cordula/0000-0002-6525-2634	Deutsche Forschungsgemeinschaft [SPP1315, SM59/8-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by Deutsche Forschungsgemeinschaft within the framework of the priority program SPP1315 "Biogeochemical Interfaces in Soil'' (SM59/8-2) (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander M., 1999, BIODEGRADATION BIORE; Amellal N, 2001, BIODEGRADATION, V12, P49, DOI 10.1023/A:1011909107858; Babin D, 2013, FEMS MICROBIOL ECOL, V86, P3, DOI 10.1111/1574-6941.12058; Baran S, 2002, POL J ENVIRON STUD, V11, P609; Bundy JG, 2002, J APPL MICROBIOL, V92, P276, DOI 10.1046/j.1365-2672.2002.01528.x; Carson JK, 2009, FEMS MICROBIOL ECOL, V67, P381, DOI 10.1111/j.1574-6941.2008.00645.x; Chaerun SK, 2005, CLAY MINER, V40, P105, DOI 10.1180/0009855054010159; Chang W, 2013, CHEMOSPHERE, V91, P1620, DOI 10.1016/j.chemosphere.2012.12.058; Chenu C, 2002, IUPAC S ANAL PHYS CH, V8, P3; Cornelissen G, 2005, ENVIRON SCI TECHNOL, V39, P6881, DOI 10.1021/es050191b; Ding GC, 2013, FEMS MICROBIOL ECOL, V86, P15, DOI 10.1111/1574-6941.12070; Ding GC, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00290; Ding GC, 2010, APPL ENVIRON MICROB, V76, P4765, DOI 10.1128/AEM.00047-10; ENSIGN JC, 1970, J BACTERIOL, V103, P569, DOI 10.1128/JB.103.3.569-577.1970; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Griffiths BS, 2000, OIKOS, V90, P279, DOI 10.1034/j.1600-0706.2000.900208.x; Gschwendtner S, 2010, PLANT SOIL, V335, P413, DOI 10.1007/s11104-010-0430-2; Guenet B, 2011, APPL SOIL ECOL, V48, P243, DOI 10.1016/j.apsoil.2011.04.002; Haritash AK, 2009, J HAZARD MATER, V169, P1, DOI 10.1016/j.jhazmat.2009.03.137; HATZINGER PB, 1995, ENVIRON SCI TECHNOL, V29, P537, DOI 10.1021/es00002a033; Heuer H, 2001, ENVIRONMENTAL MOLECULAR MICROBIOLOGY : PROTOCOLS AND APPLICATIONS, P177; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Holden PA, 1997, J ENVIRON QUAL, V26, P32, DOI 10.2134/jeq1997.00472425002600010006x; Hwang S, 1997, BIOL FERT SOILS, V24, P335, DOI 10.1007/s003740050253; Hwang S, 1997, BIOL FERT SOILS, V25, P36, DOI 10.1007/s003740050276; Hwang S, 2003, ENVIRON SCI POLLUT R, V10, P277, DOI 10.1065/espr2003.08.167; Jeon CO, 2013, CURR OPIN BIOTECH, V24, P474, DOI 10.1016/j.copbio.2012.09.001; Jones D, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P945, DOI 10.1007/0-387-30743-5_36; KAAL EEJ, 1995, BIORESOURCE TECHNOL, V53, P133, DOI 10.1016/0960-8524(95)00066-N; Kropfa S, 2004, J MICROBIOL METH, V57, P187, DOI 10.1016/j.mimet.2004.01.002; Lahlou M, 1999, ENVIRON TOXICOL CHEM, V18, P2729, DOI [10.1897/1551-5028(1999)018&lt;2729:BOLADR&gt;2.3.CO;2, 10.1002/etc.5620181212]; LINDSTROM JE, 1991, APPL ENVIRON MICROB, V57, P2514, DOI 10.1128/AEM.57.9.2514-2522.1991; Madhok MR, 1937, SOIL SCI, V44, P319, DOI 10.1097/00010694-193710000-00006; Milling A, 2004, PLANT SOIL, V266, P23; Muller S, 2007, EUR J SOIL SCI, V58, P918, DOI 10.1111/j.1365-2389.2007.00930.x; Nam K, 1998, ENVIRON SCI TECHNOL, V32, P3785, DOI 10.1021/es980428m; Nam K, 2003, ENVIRON POLLUT, V121, P147, DOI 10.1016/S0269-7491(02)00181-1; Nam K, 1998, ENVIRON SCI TECHNOL, V32, P71, DOI 10.1021/es9705304; Nocentini M, 2001, SOIL SEDIMENT CONTAM, V10, P211, DOI 10.1080/20015891109220; OECD, 1984, GUID TEST CHEM NO 20, P9; Pronk GJ, 2012, GEODERMA, V189, P585, DOI 10.1016/j.geoderma.2012.05.020; Ryan RP, 2009, NAT REV MICROBIOL, V7, P514, DOI 10.1038/nrmicro2163; SACK U, 1993, J BASIC MICROB, V33, P269, DOI 10.1002/jobm.3620330411; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; STOTZKY G, 1966, CAN J MICROBIOL, V12, P547, DOI 10.1139/m66-078; Stotzky G., 1986, SOIL SCI SOC AM J, V17, P305, DOI DOI 10.2136/SSSASPECPUB17.C10; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Theng BKG, 2001, SOIL BIOL BIOCHEM, V33, P845, DOI 10.1016/S0038-0717(00)00222-4; Totsche KU, 2010, J PLANT NUTR SOIL SC, V173, P88, DOI 10.1002/jpln.200900105; van Bruggen AHC, 2000, APPL SOIL ECOL, V15, P13, DOI 10.1016/S0929-1393(00)00068-8; Vogel C, 2014, SOIL BIOL BIOCHEM, V79, P57, DOI 10.1016/j.soilbio.2014.07.012; Warr LN, 2009, APPL CLAY SCI, V46, P337, DOI 10.1016/j.clay.2009.09.012; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; WEISSENFELS WD, 1992, APPL MICROBIOL BIOT, V36, P689, DOI 10.1007/BF00183251; Williams CM, 1999, POULTRY SCI, V78, P956, DOI 10.1093/ps/78.7.956; Wischmann H, 1997, CHEMOSPHERE, V35, P1681, DOI 10.1016/S0045-6535(97)00249-X; Wong JWC, 2002, ENVIRON TECHNOL, V23, P15, DOI 10.1080/09593332508618438; Yateem A, 1998, ENVIRON INT, V24, P181, DOI 10.1016/S0160-4120(97)00134-7; Zhang XX, 2006, PEDOSPHERE, V16, P555, DOI 10.1016/S1002-0160(06)60088-X	60	12	12	7	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e106865	10.1371/journal.pone.0106865	http://dx.doi.org/10.1371/journal.pone.0106865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222697	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774800029
J	Fritz, JM; Weaver, TE				Fritz, Jill M.; Weaver, Timothy E.			The BiP Cochaperone ERdj4 Is Required for B Cell Development and Function	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; TRANSCRIPTION FACTOR XBP-1; TOLL-LIKE RECEPTORS; BONE-MARROW; ER STRESS; MASTER CHAPERONE; STEM-CELLS; GP96; DIFFERENTIATION; IMMUNOGLOBULIN	ERdj4 is a BiP cochaperone regulated by the unfolded protein response to facilitate degradation of unfolded and/or misfolded proteins in the endoplasmic reticulum. As the unfolded protein response plays a critical role in B cell maturation and antibody production, ERdj4 gene trap mice were generated to determine if this chaperone was required for B cell homeostasis. Homozygosity for the trapped allele resulted in hypomorphic expression of ERdj4 in bone marrow cells and abnormal development of hematopoietic lineages in the bone marrow. The number of myeloid cells was increased, while the number of erythroid and B lymphoid cells was reduced in ERdj4 gene trap mice compared to controls. An intrinsic B cell defect was identified that decreased survival of B cell precursors including large and small pre-B, and immature B cells. Consistent with impaired B lymphopoiesis, the number of mature follicular B cells was reduced in both the bone marrow and spleen of ERdj4 gene trap mice. Paradoxically, unchallenged ERdj4 gene trap mice showed non-specific hypergammaglobulinemia and gene trap B cells exhibited increased proliferation, survival and isotype switching in response to LPS stimulation. Although ERdj4 gene trap mice responded normally to T cell-independent antigen, they failed to mount a specific antibody response to T cell-dependent antigen in vivo. Collectively, these findings demonstrate that the chaperone activity of ERdj4 is required for survival of B cell progenitors and normal antibody production.	[Weaver, Timothy E.] Perinatal & Pulm Biol Cincinnati Childrens Hosp, Med Ctr, Perinatal Inst, Sect Neonatol, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Weaver, TE (corresponding author), Perinatal & Pulm Biol Cincinnati Childrens Hosp, Med Ctr, Perinatal Inst, Sect Neonatol, Cincinnati, OH 45229 USA.	tim.weaver@cchmc.org			National Institutes of Health [HL103923, HL086492]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086492, R01HL103923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health Grants HL103923 (T.E.W.) and HL086492 (T.E.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; Anthony BA, 2014, TRENDS IMMUNOL, V35, P32, DOI 10.1016/j.it.2013.10.002; Benhamron S, 2014, EUR J IMMUNOL, V44, P867, DOI 10.1002/eji.201343953; Berger BJ, 2003, EXP CELL RES, V290, P82, DOI 10.1016/S0014-4827(03)00316-1; Brunsing R, 2008, J BIOL CHEM, V283, P17954, DOI 10.1074/jbc.M801395200; Cariappa A, 2007, BLOOD, V109, P2339, DOI 10.1182/blood-2006-05-021089; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Clark MR, 2014, NAT REV IMMUNOL, V14, P69, DOI 10.1038/nri3570; Dong M, 2008, MOL BIOL CELL, V19, P2620, DOI 10.1091/mbc.E07-07-0674; Fritz JM, 2014, MOL BIOL CELL, V25, P431, DOI 10.1091/mbc.E13-06-0319; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hu CCA, 2009, EMBO J, V28, P1624, DOI 10.1038/emboj.2009.117; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Kurisu J, 2003, GENES CELLS, V8, P189, DOI 10.1046/j.1365-2443.2003.00625.x; Lai CW, 2012, J BIOL CHEM, V287, P7969, DOI 10.1074/jbc.M111.311290; Lindsley RC, 2007, BLOOD, V109, P2521, DOI 10.1182/blood-2006-04-018085; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; McGehee AM, 2009, J IMMUNOL, V183, P3690, DOI 10.4049/jimmunol.0900953; Patterson ST, 2009, J BIOL CHEM, V284, P14547, DOI 10.1074/jbc.M809076200; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Shen Y, 2002, J BIOL CHEM, V277, P15947, DOI 10.1074/jbc.M112214200; Skalet AH, 2005, J BIOL CHEM, V280, P39762, DOI 10.1074/jbc.M502640200; Staron M, 2010, BLOOD, V115, P2380, DOI 10.1182/blood-2009-07-233031; Todd DJ, 2009, J EXP MED, V206, P2151, DOI 10.1084/jem.20090738; van Zelm MC, 2007, J EXP MED, V204, P645, DOI 10.1084/jem.20060964; Xu ZM, 2012, NAT REV IMMUNOL, V12, P517, DOI 10.1038/nri3216; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848	38	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107473	10.1371/journal.pone.0107473	http://dx.doi.org/10.1371/journal.pone.0107473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222125	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774800072
J	Liu, ZB; Cheng, RM; Xiao, WF; Guo, QS; Wang, N				Liu, Zebin; Cheng, Ruimei; Xiao, Wenfa; Guo, Quanshui; Wang, Na			Effect of Off-Season Flooding on Growth, Photosynthesis, Carbohydrate Partitioning, and Nutrient Uptake in Distylium chinense	PLOS ONE			English	Article							END RULE PATHWAY; LEAF GAS-EXCHANGE; CHLOROPHYLL FLUORESCENCE; RESPONSES; SEEDLINGS; OXYGEN; TOLERANCE; CONDUCTANCE; SUBMERGENCE; METABOLISM	Distylium chinense is an evergreen shrub used for the vegetation recovery of floodplain and riparian areas in Three Gorges Reservoir Region. To clarify the morphological and physiological responses and tolerance of Distylium chinense to off-season flooding, a simulation flooding experiment was conducted during autumn and winter. Results indicated that the survival rate of seedlings was 100%, and that plant height and stem diameter were not significantly affected by flooding. Adventitious roots and hypertrophic lenticels were observed in flooded seedlings after 30 days of flooding. Flooding significantly reduced the plant biomass of roots, net photosynthetic rate (P-n), stomatal conductance (g(s)), transpiration rate (T-r), maximum photochemical efficiency (Fv/Fm), photochemical quenching (qP), and electron transport rate (ETR) in leaves, and also affected the allocation and transport of carbohydrate and nutrients. However, D. chinense was able to maintain stable levels of P-n, Fv/Fm, qP, ETR, and nutrient content (N and P) in leaves and to store a certain amount of carbohydrate in roots over prolonged durations of flooding. Based on these results, we conclude that there is a high flooding tolerance in D. chinense, and the high survival rate of D. chinense may be attributable to a combination of morphological and physiological responses to flooding.	[Liu, Zebin; Cheng, Ruimei; Xiao, Wenfa; Guo, Quanshui; Wang, Na] Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Key Lab Forest Ecol & Environm, State Forestry Adm, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Liu, ZB (corresponding author), Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Key Lab Forest Ecol & Environm, State Forestry Adm, Beijing, Peoples R China.	binarystar1989@163.com; chengrm@caf.ac.cn			Program of Forestry Science and Technology Support [2011BAD30BO4]	Program of Forestry Science and Technology Support	This project was funded by the Program of Forestry Science and Technology Support (2011BAD30BO4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS WW, 1995, AUST J PLANT PHYSIOL, V22, P261, DOI 10.1071/PP9950261; [Anonymous], 2003, FLORA CHINA; Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; BECKMAN TG, 1992, HORTSCIENCE, V27, P1297, DOI 10.21273/HORTSCI.27.12.1297; Berry JA, 1982, PHOTOSYNTHESIS, VII; Boem FHG, 1996, FIELD CROP RES, V47, P175, DOI 10.1016/0378-4290(96)00025-1; Chen Fang-qing, 2008, Yingyong Shengtai Xuebao, V19, P1229; Chen GF, 2008, J SW FOR COLL, V28, P42; Chen HJ, 2005, AQUAT BOT, V82, P250, DOI 10.1016/j.aquabot.2005.02.013; Colmer TD, 2006, NEW PHYTOL, V170, P767, DOI 10.1111/j.1469-8137.2006.01725.x; Das KK, 2005, PLANT SCI, V168, P131, DOI 10.1016/j.plantsci.2004.07.023; Davanso VM, 2002, BRAZ ARCH BIOL TECHN, V45, P375, DOI 10.1590/S1516-89132002000300016; de Oliveira VC, 2010, TREES-STRUCT FUNCT, V24, P185, DOI 10.1007/s00468-009-0392-2; Edwards D, 1982, TOLERANCE CROP PASTU; Elcan JM, 2002, PHOTOSYNTHETICA, V40, P177, DOI 10.1023/A:1021381204684; Enriquez S, 2005, OECOLOGIA, V145, P235, DOI 10.1007/s00442-005-0111-7; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gibbs DJ, 2011, NATURE, V479, P415, DOI 10.1038/nature10534; Gravatt DA, 1998, TREE PHYSIOL, V18, P411; Greenway H., 1996, Physiology of stress tolerance in rice: Proceedings of the International Conference on Stress Physiology of Rice, Lucknow, U.P., India, 28 February-5 March 1994., P11; Han GY, 2005, J CHONGQING FOR SCI, V71, P22; HENDRY GAF, 1985, NEW PHYTOL, V101, P199, DOI 10.1111/j.1469-8137.1985.tb02826.x; Horchani F., 2011, International Journal of Agricultural Research, V6, P227, DOI 10.3923/ijar.2011.227.237; Jing YX, 2009, PHOTOSYNTHETICA, V47, P595, DOI 10.1007/s11099-009-0085-5; Kozlowski TT, 1997, TREE PHYSL MONOGR, V1, P1, DOI [DOI 10.1093/TREEPHYS/17.7.490, 10.1093/treephys/17.7.490]; Kreuzwieser J, 2004, PLANT BIOLOGY, V6, P299, DOI 10.1055/s-2004-817882; [李娅 LI Ya], 2008, [生态学报, Acta Ecologica Sinica], V28, P1923; Liao CT, 1996, ENVIRON EXP BOT, V36, P167, DOI 10.1016/0098-8472(96)01009-X; Licausi F, 2011, NATURE, V479, P419, DOI 10.1038/nature10536; Lima ALS, 2002, ENVIRON EXP BOT, V47, P239, DOI 10.1016/S0098-8472(01)00130-7; Liu Ze-bin, 2013, Shengtaixue Zazhi, V32, P2015; Liu ZeBin, 2013, World Forestry Research, V26, P33; Lopez OR, 1999, TREE PHYSIOL, V19, P925; Luo FL, 2007, J PLANT ECOL, V42, P1; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Medina CL, 2009, ANN BOT-LONDON, V104, P671, DOI 10.1093/aob/mcp159; Miao SL, 2012, ECOL ENG, V42, P10, DOI 10.1016/j.ecoleng.2012.01.009; Mielke Marcelo S., 2005, Acta Bot. Bras., V19, P905, DOI 10.1590/S0102-33062005000400025; Mielke MS, 2003, ENVIRON EXP BOT, V50, P221, DOI 10.1016/S0098-8472(03)00036-4; Peng X, 2006, J SICHUAN FOR SCI TE, V2, P17; Pezeshki SR, 2001, ENVIRON EXP BOT, V46, P299, DOI 10.1016/S0098-8472(01)00107-1; Pociecha E, 2008, ACTA PHYSIOL PLANT, V30, P529, DOI 10.1007/s11738-008-0151-9; REGEHR DL, 1975, PHOTOSYNTHETICA, V9, P52; Rengifo E, 2005, PHOTOSYNTHETICA, V43, P203, DOI 10.1007/s11099-005-0034-x; Rosa M, 2009, PLANT SIGNAL BEHAV, V4, P388, DOI 10.4161/psb.4.5.8294; Sasidharan R, 2011, PLANT CELL, V23, P4173, DOI 10.1105/tpc.111.093880; Smethurst CF, 2005, PLANT SOIL, V270, P31, DOI 10.1007/s11104-004-1082-x; Tan SD, 2010, ACTA PHYSIOL PLANT, V32, P133, DOI 10.1007/s11738-009-0388-y; Wang Chao-ying, 2013, Yingyong Shengtai Xuebao, V24, P675; Wang Xiao-rong, 2009, Yingyong Shengtai Xuebao, V20, P2891; Wu JG, 2004, FRONT ECOL ENVIRON, V2, P241, DOI 10.2307/3868264; Ye XiaoQi, 2013, Acta Hydrobiologica Sinica, V37, P450; Yi Ying-Hua, 2006, Zhiwu Shengtai Xuebao, V30, P960; Yu JG, 1994, METHOD MODERN PRACTI; Zhou Jun, 2012, Shengtaixue Zazhi, V31, P30	56	44	51	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107636	10.1371/journal.pone.0107636	http://dx.doi.org/10.1371/journal.pone.0107636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222006	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774800088
J	Nie, JX; Ardern, CI				Nie, Jason X.; Ardern, Chris I.			Association between Obesity and Cardiometabolic Health Risk in Asian-Canadian Sub-Groups	PLOS ONE			English	Article							BODY-MASS INDEX; VISCERAL ADIPOSE-TISSUE; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; INCIDENT HYPERTENSION; DIABETES PREVALENCE; WAIST CIRCUMFERENCE; INSULIN-RESISTANCE; ETHNIC-DIFFERENCES; CUTOFF VALUES	Objectives: To quantify and compare the association between the World Health Organizations' Asian-specific trigger points for public health action ['increased risk': body mass index (BMI) >= 23 kg/m(2), and; 'high risk': BMI >= 27.5 kg/m(2)] with self-reported cardiovascular-related conditions in Asian-Canadian sub-groups. Methods: Six cycles of the Canadian Community Health Survey (2001-2009) were pooled to examine BMI and health in Asian sub-groups (South Asians, Chinese, Filipino, Southeast Asians, Arabs, West Asians, Japanese and Korean; N = 18 794 participants, ages 18-64 y). Multivariable logistic regression, adjusting for demographic, lifestyle characteristics and acculturation measures, was used to estimate the odds of cardiovascular-related health (high blood pressure, heart disease, diabetes, 'at least one cardiometabolic condition') outcomes across all eight Asian sub-groups. Results: Compared to South Asians (OR = 1.00), Filipinos had higher odds of having 'at least one cardiometabolic condition' (OR = 1.29, 95% CI: 1.04-1.62), whereas Chinese (0.63, 0.474-0.9) and Arab-Canadians had lower odds (0.38, 0.28-0.51). In ethnic-specific analyses (with 'acceptable' risk weight as the referent), 'increased' and 'high' risk weight categories were the most highly associated with 'at least one cardiometabolic condition' in Chinese ('increased': 3.6, 2.34-5.63; 'high': 8.9, 3.6-22.01). Compared to normal weight South Asians, being in the 'high' risk weight category in all but the Southeast Asian, Arab, and Japanese ethnic groups was associated with approximately 3-times the likelihood of having 'at least one cardiometabolic condition'. Conclusion: Differences in the association between obesity and cardiometabolic health risks were seen among Asian sub-groups in Canada. The use of WHO's lowered Asian-specific BMI cut-offs identified obesity-related risks in South Asian, Filipino and Chinese sub-groups that would have been masked by traditional BMI categories. These findings have implications for public health messaging, especially for ethnic groups at higher odds of obesity-related health risks.	[Nie, Jason X.; Ardern, Chris I.] York Univ, Bethune Coll, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada	York University - Canada	Ardern, CI (corresponding author), York Univ, Bethune Coll, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	cardern@yorku.ca						Anand S S, 2000, Indian Heart J, V52, pS35; Anand SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022112; Araneta MRG, 2002, DIABETES CARE, V25, P494, DOI 10.2337/diacare.25.3.494; Bainey KR, 2009, ATHEROSCLEROSIS, V204, P1, DOI 10.1016/j.atherosclerosis.2008.09.023; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Barnes Patricia M, 2008, Adv Data, P1; Bell AC, 2002, AM J EPIDEMIOL, V155, P346, DOI 10.1093/aje/155.4.346; Bes-Rastrollo M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-213; Boyko EJ, 2000, DIABETES CARE, V23, P465, DOI 10.2337/diacare.23.4.465; Brenner DR, 2011, CLIN INVEST MED, V34, pE377; Charbonneau-Roberts Guylaine, 2005, Int J Circumpolar Health, V64, P163; Chen Y, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5446; Chiu M, 2010, CMAJ, V182, P774; Chiu M, 2011, DIABETES CARE, V34, P1741, DOI 10.2337/dc10-2300; Davis J, 2013, ETHNIC DIS, V23, P65; Deurenberg P, 1999, INT J OBESITY, V23, P537, DOI 10.1038/sj.ijo.0800868; Deurenberg P, 2003, ACTA DIABETOL, V40, pS246, DOI 10.1007/s00592-003-0077-z; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Deurenberg-Yap M, 2003, NUTR REV, V61, pS80, DOI 10.1301/nr.2003.may.S80-S87; Dogra Shilpa, 2010, Int J Behav Nutr Phys Act, V7, P75, DOI 10.1186/1479-5868-7-75; Dulloo AG, 2012, OBES REV, V13, P1, DOI 10.1111/j.1467-789X.2012.01032.x; Dulloo AG, 2010, INT J OBESITY, V34, pS4, DOI 10.1038/ijo.2010.234; Forouhi NG, 2006, ATHEROSCLEROSIS SUPP, V7, P11, DOI 10.1016/j.atherosclerosissup.2006.01.003; Foulds HJA, 2012, J HYPERTENS, V30, P359, DOI 10.1097/HJH.0b013e32834f0b86; GARN SM, 1986, AM J CLIN NUTR, V44, P996, DOI 10.1093/ajcn/44.6.996; Gholap N, 2011, PRIM CARE DIABETES, V5, P45, DOI 10.1016/j.pcd.2010.08.002; Gordon-Larsen P, 2013, OBESITY, V21, pE166, DOI 10.1002/oby.20409; Grandinetti A, 2005, ETHNIC DIS, V15, P233; Gurrici S, 1998, EUR J CLIN NUTR, V52, P779, DOI 10.1038/sj.ejcn.1600637; Hayashi T, 2004, ANN INTERN MED, V140, P992, DOI 10.7326/0003-4819-140-12-200406150-00008; Health Canada, CAN GUID BOD WEIGHT; Hou Feng, 2004, CANADIAN SOCIAL TREN, V72, P8; Kadowaki T, 2006, INT J OBESITY, V30, P1163, DOI 10.1038/sj.ijo.0803248; Kanaya AM, 2011, DIABETES CARE, V34, P930, DOI 10.2337/dc10-1964; Katz EG, 2013, ASIA PAC J CLIN NUTR, V22, P626, DOI 10.6133/apjcn.2013.22.4.12; Lear SA, 2007, OBESITY, V15, P2817, DOI 10.1038/oby.2007.334; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Lee JWR, 2011, DIABETES CARE, V34, P353, DOI 10.2337/dc10-0746; Liu Richard, 2010, Open Med, V4, pe143; Low S, 2009, ANN ACAD MED SINGAP, V38, P66; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; McNeely MJ, 2004, DIABETES CARE, V27, P66, DOI 10.2337/diacare.27.1.66; Misra A, 2007, NUTRITION, V23, P696, DOI 10.1016/j.nut.2007.06.008; Narayan KMV, 2010, J AM COLL CARDIOL, V55, P966, DOI 10.1016/j.jacc.2009.07.075; Niu JJ, 2014, PREV MED, V62, P113, DOI 10.1016/j.ypmed.2014.02.012; O'Loughlin J, 2007, ETHNIC DIS, V17, P657; Oza-Frank R, 2009, DIABETES CARE, V32, P1644, DOI 10.2337/dc09-0573; Palaniappan L, 2004, ANN EPIDEMIOL, V14, P499, DOI 10.1016/j.annepidem.2003.12.001; Palaniappan LP, 2007, METABOLISM, V56, P899, DOI 10.1016/j.metabol.2007.01.020; Palaniappan LP, 2010, CIRCULATION, V122, P1242, DOI 10.1161/CIR.0b013e3181f22af4; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; Rothman KJ, 2008, INT J OBESITY, V32, pS56, DOI 10.1038/ijo.2008.87; Sarafin C, 2007, SSC ANN M P SURV MET; Sebo P, 2008, PREV MED, V47, P389, DOI 10.1016/j.ypmed.2008.06.012; Shaw PKC, 2007, DIABETES CARE, V30, P1840, DOI 10.2337/dc07-0028; Snehalatha C, 2003, DIABETES CARE, V26, P1380, DOI 10.2337/diacare.26.5.1380; Srinivasan S, 2000, AM J PUBLIC HEALTH, V90, P1731, DOI 10.2105/AJPH.90.11.1731; Statistic Canada, 2011, IMM ETHN DIV CAN; Statistics Canada, 2013, OTH REF PER CAN COMM; Statistics Canada, 2010, STUD PROJ DIV CAN PO; Statistics Canada, 2007, CAN COMM HLTH SURV C; Statistics Canada, CAN COMM HLTH SURV C; Statistics Canada, 2009, CAN COMM HLTH SURV C; Stevens J, 2003, INT J OBESITY, V27, P1297, DOI 10.1038/sj.ijo.0802417; Stevens J, 2002, AM J CLIN NUTR, V75, P986, DOI 10.1093/ajcn/75.6.986; Stevens J, 2008, AM J EPIDEMIOL, V167, P1365, DOI 10.1093/aje/kwn060; STUNKARD AJ, 1981, AM J CLIN NUTR, V34, P1593, DOI 10.1093/ajcn/34.8.1593; Thomas Steven, 2009, Health Rep, V20, P53; Tremblay Mark S, 2005, Health Rep, V16, P23; Tuan NT, 2009, AM J CLIN NUTR, V89, P1905, DOI 10.3945/ajcn.2008.26809; Villanueva EV, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-11; Wang DY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019629, 10.1371/journal.pone.0019835]; WANG J, 1994, AM J CLIN NUTR, V60, P23, DOI 10.1093/ajcn/60.1.23; Wulan SN, 2010, MATURITAS, V65, P315, DOI 10.1016/j.maturitas.2009.12.012	74	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107548	10.1371/journal.pone.0107548	http://dx.doi.org/10.1371/journal.pone.0107548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222283	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774800082
J	Saxena, MS; Bajaj, D; Kujur, A; Das, S; Badoni, S; Kumar, V; Singh, M; Bansal, KC; Tyagi, AK; Parida, SK				Saxena, Maneesha S.; Bajaj, Deepak; Kujur, Alice; Das, Shouvik; Badoni, Saurabh; Kumar, Vinod; Singh, Mohar; Bansal, Kailash C.; Tyagi, Akhilesh K.; Parida, Swarup K.			Natural Allelic Diversity, Genetic Structure and Linkage Disequilibrium Pattern in Wild Chickpea	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE NUCLEOTIDE POLYMORPHISMS; TRANSCRIPTION FACTOR GENES; CICER-ARIETINUM L.; GENUS CICER; MICROSATELLITE MARKERS; COMPLEX TRAITS; CULTIVATED CHICKPEA; SEQUENCE; MAP	Characterization of natural allelic diversity and understanding the genetic structure and linkage disequilibrium (LD) pattern in wild germplasm accessions by large-scale genotyping of informative microsatellite and single nucleotide polymorphism (SNP) markers is requisite to facilitate chickpea genetic improvement. Large-scale validation and high-throughput genotyping of genome-wide physically mapped 478 genic and genomic microsatellite markers and 380 transcription factor gene-derived SNP markers using gel-based assay, fluorescent dye-labelled automated fragment analyser and matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass array have been performed. Outcome revealed their high genotyping success rate (97.5%) and existence of a high level of natural allelic diversity among 94 wild and cultivated Cicer accessions. High intra- and inter-specific polymorphic potential and wider molecular diversity (11-94%) along with a broader genetic base (13-78%) specifically in the functional genic regions of wild accessions was assayed by mapped markers. It suggested their utility in monitoring introgression and transferring target trait-specific genomic (gene) regions from wild to cultivated gene pool for the genetic enhancement. Distinct species/gene pool-wise differentiation, admixed domestication pattern, and differential genome-wide recombination and LD estimates/decay observed in a six structured population of wild and cultivated accessions using mapped markers further signifies their usefulness in chickpea genetics, genomics and breeding.	[Saxena, Maneesha S.; Bajaj, Deepak; Kujur, Alice; Das, Shouvik; Badoni, Saurabh; Tyagi, Akhilesh K.; Parida, Swarup K.] NIPGR, New Delhi, India; [Kumar, Vinod] NRCPB, New Delhi, India; [Singh, Mohar; Bansal, Kailash C.] NBPGR, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB); Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources	Parida, SK (corresponding author), NIPGR, Aruna Asaf Ali Marg, New Delhi, India.	swarup@nipgr.ac.in	Badoni, Saurabh/AAN-2997-2020; das, shouvik/AAD-4293-2019; Kujur, Alice/AAK-5786-2021	Badoni, Saurabh/0000-0001-6969-5662; Das, Shouvik/0000-0002-0451-1401; Kumar, Vinod/0000-0003-0843-1342	Department of Biotechnology (DBT), Government of India [102/IFD/SAN/2161/2013-14]; Council of Scientific and Industrial Research (CSIR); Department of Biotechnology (DBT)	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India)	The authors gratefully acknowledge the financial support by the Department of Biotechnology (DBT), Government of India, through their research grant (102/IFD/SAN/2161/2013-14) for this research work. Alice Kujur and Shouvik Das acknowledges the Council of Scientific and Industrial Research (CSIR) and Department of Biotechnology (DBT) for the award of Junior/Senior Research Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbo S, 2003, FUNCT PLANT BIOL, V30, P1081, DOI 10.1071/FP03084; Agarwal G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052443; Agarwal P, 2011, BIOESSAYS, V33, P189, DOI 10.1002/bies.201000107; AHMAD F, 1989, CYTOLOGIA, V54, P753, DOI 10.1508/cytologia.54.753; Ahmad F, 1999, THEOR APPL GENET, V98, P657, DOI 10.1007/s001220051117; AHMAD F, 1992, THEOR APPL GENET, V83, P620, DOI 10.1007/BF00226907; AHMAD F, 1992, THEOR APPL GENET, V84, P688, DOI 10.1007/BF00224169; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Berger J, 2003, CROP SCI, V43, P1076, DOI 10.2135/cropsci2003.1076; Berger JD, 2005, AUST J AGR RES, V56, P1191, DOI 10.1071/AR05089; Bharadwaj C, 2011, J GENET, V90, pE94, DOI 10.1007/s12041-011-0114-6; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Branca A, 2011, P NATL ACAD SCI USA, V108, pE864, DOI 10.1073/pnas.1104032108; Buhariwalla HK, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-16; Choudhary P, 2012, GENET MOL RES, V11, P891, DOI 10.4238/2012.April.10.5; Choudhary S, 2009, THEOR APPL GENET, V118, P591, DOI 10.1007/s00122-008-0923-z; Choumane W, 2000, THEOR APPL GENET, V101, P269, DOI 10.1007/s001220051479; Chowdhury MA, 2002, EUPHYTICA, V127, P317, DOI 10.1023/A:1020366819075; Cingilli H, 2005, BIOLOGIA, V60, P93; Collard BCY, 2003, THEOR APPL GENET, V107, P719, DOI 10.1007/s00122-003-1297-x; Dwivedi SL, 2006, PL BRED RE, V26, P171; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gaur R, 2012, DNA RES, V19, P357, DOI 10.1093/dnares/dss018; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Gujaria N, 2011, THEOR APPL GENET, V122, P1577, DOI 10.1007/s00122-011-1556-1; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; Haseneyer G, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-5; Hiremath PJ, 2012, PLANT BIOTECHNOL J, V10, P716, DOI 10.1111/j.1467-7652.2012.00710.x; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Hyten DL, 2007, GENETICS, V175, P1937, DOI 10.1534/genetics.106.069740; Iruela M, 2002, THEOR APPL GENET, V104, P643, DOI 10.1007/s001220100751; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Jhanwar S, 2012, PLANT BIOTECHNOL J, V10, P690, DOI 10.1111/j.1467-7652.2012.00712.x; KAZAN K, 1991, PLANT SYST EVOL, V175, P11, DOI 10.1007/BF00942142; Kujur A, 2013, DNA RES, V20, P355, DOI 10.1093/dnares/dst015; Kumar J, 2000, J HERED, V91, P67, DOI 10.1093/jhered/91.1.67; Kumar J, 2001, ADV AGRON, V72, P107, DOI 10.1016/S0065-2113(01)72012-3; Labdi M, 1996, EUPHYTICA, V88, P181, DOI 10.1007/BF00023889; LADIZINSKY G, 1976, THEOR APPL GENET, V48, P197, DOI 10.1007/BF00527371; LADIZINSKY G, 1975, ISRAEL J BOT, V24, P183; LADIZINSKY G, 1976, EUPHYTICA, V25, P211, DOI 10.1007/BF00041547; Ladizinsky G, 1998, PLANT EVOLUTION DOME; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lev-Yadun S, 2000, SCIENCE, V288, P1602, DOI 10.1126/science.288.5471.1602; Libault M, 2009, PLANT PHYSIOL, V151, P991, DOI 10.1104/pp.109.144105; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; MANTEL N, 1967, CANCER RES, V27, P209; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; Nayak SN, 2010, THEOR APPL GENET, V120, P1415, DOI 10.1007/s00122-010-1265-1; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nguyen TT, 2004, PLANT BREEDING, V123, P173, DOI 10.1046/j.1439-0523.2003.00942.x; Ocampo B., 1992, Journal of Genetics and Breeding, V46, P229; Orjuela J, 2010, THEOR APPL GENET, V120, P563, DOI 10.1007/s00122-009-1176-1; Parida SK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-251; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perez-de-Castro AM, 2012, CURR GENOMICS, V13, P179, DOI 10.2174/138920212800543084; Pritchard JK, 2000, GENETICS, V155, P945; Rajesh PN, 2002, THEOR APPL GENET, V105, P604, DOI 10.1007/s00122-002-0930-4; Riedelsheimer C, 2012, P NATL ACAD SCI USA, V109, P8872, DOI 10.1073/pnas.1120813109; Robertson LD, 1997, EUPHYTICA, V95, P309, DOI 10.1023/A:1003004516921; Roorkiwal M, 2013, PLANT GEN, V6, P1, DOI DOI 10.3835/PLANTGENOME2013.05.0017; SAEED A, 2011, PLANT MOL BIOL REP, V29, P848, DOI DOI 10.1007/s11105-011-0294-5; Sakiroglu M, 2012, THEOR APPL GENET, V125, P577, DOI 10.1007/s00122-012-1854-2; Sethy NK, 2006, THEOR APPL GENET, V112, P347, DOI 10.1007/s00122-005-0135-8; Shah TM, 2005, PAK J BOT, V37, P431; Shan F, 2005, THEOR APPL GENET, V110, P381, DOI 10.1007/s00122-004-1849-8; SINGH KB, 1995, CROP SCI, V35, P1491, DOI 10.2135/cropsci1995.0011183X003500050037x; Singh R, 2008, BIOTECHNOL GENET ENG, V25, P267, DOI 10.5661/bger-25-267; Sudupak MA, 2004, THEOR APPL GENET, V108, P937, DOI 10.1007/s00122-003-1505-8; Sudupak MA, 2002, THEOR APPL GENET, V105, P1220, DOI 10.1007/s00122-002-1060-8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanno K, 2006, VEG HIST ARCHAEOBOT, V15, P197, DOI 10.1007/s00334-005-0027-5; Tayyar RI, 1996, THEOR APPL GENET, V92, P245, DOI 10.1007/BF00223381; TAYYAR RI, 1994, GENOME, V37, P656, DOI 10.1139/g94-093; Toker C, 2009, GENET RESOUR CROP EV, V56, P7, DOI 10.1007/s10722-008-9336-8; Udvardi MK, 2007, PLANT PHYSIOL, V144, P538, DOI 10.1104/pp.107.098061; Upadhyaya HD, 2011, PLANT GENET RESOUR-C, V9, P45, DOI 10.1017/S1479262110000468; Upadhyaya HD, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-106; Varshney RK, 2007, THEOR APPL GENET, V114, P1105, DOI 10.1007/s00122-007-0504-6; Varshney RK, 2012, FIELD CROP RES, V126, P171, DOI 10.1016/j.fcr.2011.10.008; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Xiao YJ, 2012, THEOR APPL GENET, V125, P437, DOI 10.1007/s00122-012-1843-5; Yan WG, 2009, MOL BREEDING, V24, P277, DOI 10.1007/s11032-009-9290-y; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zohary D, 2000, DOMESTICATION PLANTS, P108	86	43	43	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107484	10.1371/journal.pone.0107484	http://dx.doi.org/10.1371/journal.pone.0107484			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222488	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774800074
J	Xu, HT; Ebner, L; Jiang, SM; Wu, Y; Christe, A; Zhang, SX; Zhang, XM; Luo, ZL; Tian, FZ				Xu, Haotong; Ebner, Lukas; Jiang, Shiming; Wu, Yi; Christe, Andreas; Zhang, Shaoxiang; Zhang, Xiaoming; Luo, Zhulin; Tian, Fuzhou			Retrocrural Space Involvement on Computed Tomography as a Predictor of Mortality and Disease Severity in Acute Pancreatitis	PLOS ONE			English	Article							PLEURAL EFFUSION; CT; COMPLICATIONS; RESOLUTION; AREA	Background: Because computed tomography (CT) has advantages for visualizing the manifestation of necrosis and local complications, a series of scoring systems based on CT manifestations have been developed for assessing the clinical outcomes of acute pancreatitis (AP), including the CT severity index (CTSI), modified CTSI, etc. Despite the internationally accepted CTSI having been successfully used to predict the overall mortality and disease severity of AP, recent literature has revealed the limitations of the CTSI. Using the Delphi method, we establish a new scoring system based on retrocrural space involvement (RCSI), and compared its effectiveness at evaluating the mortality and severity of AP with that of the CTSI. Methods: We reviewed CT images of 257 patients with AP taken within 3-5 days of admission in 2012. The RCSI scoring system, which includes assessment of infectious conditions involving the retrocrural space and the adjacent pleural cavity, was established using the Delphi method. Two radiologists independently assessed the RCSI and CTSI scores. The predictive points of the RCSI and CTSI scoring systems in evaluating the mortality and severity of AP were estimated using receiver operating characteristic (ROC) curves. Principal Findings: The RCSI score can accurately predict the mortality and disease severity. The area under the ROC curve for the RCSI versus CTSI score was 0.962 +/- 0.011 versus 0.900 +/- 0.021 for predicting the mortality, and 0.888 +/- 0.025 versus 0.904 +/- 0.020 for predicting the severity of AP. Applying ROC analysis to our data showed that a RCSI score of 4 was the best cutoff value, above which mortality could be identified. Conclusion: The Delphi method was innovatively adopted to establish a scoring system to predict the clinical outcome of AP. The RCSI scoring system can predict the mortality of AP better than the CTSI system, and the severity of AP equally as well.	[Xu, Haotong; Luo, Zhulin; Tian, Fuzhou] Chengdu Army Gen Hosp, Peoples Liberat Army, Gen Surg Ctr, Chengdu, Sichuan, Peoples R China; [Xu, Haotong] Sichuan Prov Peoples Hosp Supo, Dept Radiol, Chengdu, Sichuan, Peoples R China; [Ebner, Lukas; Christe, Andreas] Univ Bern, Inselspital, Dept Radiol, CH-3010 Bern, Switzerland; [Jiang, Shiming] Nanchong Cent Hosp, North Sichuan Med Coll, Dept Radiol, Nanchong, Sichuan, Peoples R China; [Wu, Yi; Zhang, Shaoxiang] Third Mil Med Univ, Inst Comp Med, Chongqing, Peoples R China; [Zhang, Xiaoming] Affiliated Hosp, North Sichuan Med Coll, Dept Radiol, Sichuan Key Lab Med Imaging, Nanchong, Sichuan, Peoples R China	Sichuan Provincial People's Hospital; University of Bern; University Hospital of Bern; North Sichuan Medical University; Army Medical University; North Sichuan Medical University	Xu, HT (corresponding author), Chengdu Army Gen Hosp, Peoples Liberat Army, Gen Surg Ctr, Chengdu, Sichuan, Peoples R China.	xuliangxman@hotmail.com; tfz3006@yahoo.com	Zhang, Xiao Ming/H-7104-2019	Zhang, Xiao Ming/0000-0001-5327-8506; Ebner, Lukas/0000-0001-5117-6047; Xu, Haotong/0000-0001-6416-9970; Xu, Hao-tong/0000-0003-0352-1795	National Science Foundation of China [61190122, 81100480]; Military Twelfth-five Major Research Project of China [BWS12J020]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Military Twelfth-five Major Research Project of China	This work was supported by the National Science Foundation of China (No. 61190122 and 81100480) (http://www.nsfc.gov.cn). This work was also supported by the Military Twelfth-five Major Research Project of China (BWS12J020) (http://211.162.67.9/Depart/Desc/20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, INT CLASS DIS 9 REV; BALTHAZAR EJ, 1990, RADIOLOGY, V174, P331, DOI 10.1148/radiology.174.2.2296641; Balthazar EJ, 2002, RADIOL CLIN N AM, V40, P1211, DOI 10.1016/S0033-8389(02)00043-X; BALTHAZAR EJ, 1994, RADIOLOGY, V193, P297, DOI 10.1148/radiology.193.2.7972730; BECMEUR F, 1995, EUR J PEDIATR SURG, V5, P43, DOI 10.1055/s-2008-1066162; Bollen FL, 2008, BRIT J SURG, V95, P6, DOI 10.1002/bjs.6010; Browne GW, 2006, WORLD J GASTROENTERO, V12, P7087, DOI 10.3748/wjg.v12.i44.7087; De Waele JJ, 2007, PANCREAS, V34, P185, DOI 10.1097/mpa.0b013e31802d4136; Francois CJ, 2005, ABDOM IMAGING, V30, P761, DOI 10.1007/s00261-005-0320-x; Gore RM, 2000, AM J ROENTGENOL, V175, P363, DOI 10.2214/ajr.175.2.1750363; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Heller SJ, 1997, PANCREAS, V15, P222, DOI 10.1097/00006676-199710000-00002; IM JG, 1989, RADIOLOGY, V171, P125, DOI 10.1148/radiology.171.1.2928515; Ishikawa K, 2006, EUR J RADIOL, V60, P445, DOI 10.1016/j.ejrad.2006.06.014; Lecesne R, 1999, RADIOLOGY, V211, P727, DOI 10.1148/radiology.211.3.r99jn08727; Lenhart DK, 2008, AM J ROENTGENOL, V190, P643, DOI 10.2214/AJR.07.2761; Liu ZY, 2008, EUR RADIOL, V18, P1611, DOI 10.1007/s00330-008-0935-8; MCLOUD TC, 1991, AM J ROENTGENOL, V156, P1145, DOI 10.2214/ajr.156.6.2028857; Molmenti EP, 1996, RADIOLOGY, V200, P95, DOI 10.1148/radiology.200.1.8657951; Mortele KJ, 2004, AM J ROENTGENOL, V183, P1261, DOI 10.2214/ajr.183.5.1831261; Mortele KJ, 2000, ABDOM IMAGING, V25, P272, DOI 10.1007/s002610000032; Ouchi F, 2003, LIT REV USE EXPERT O; Restrepo CS, 2008, RADIOGRAPHICS, V28, P1289, DOI 10.1148/rg.285075187; Ricke J, 2001, EUR J RADIOL, V37, P8, DOI 10.1016/S0720-048X(00)00187-X; Rowe G, 1999, INT J FORECASTING, V15, P353, DOI 10.1016/S0169-2070(99)00018-7; Rowe G., 2001, PRINCIPLES FORECASTI; Singh P, 1996, DIGEST DIS SCI, V41, P1966, DOI 10.1007/BF02093597; Tang W, 2011, EUR J RADIOL, V80, P637, DOI 10.1016/j.ejrad.2010.08.020; Xu HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062025; Xu HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027166; Zhang SX, 2004, J ANAT, V204, P165, DOI 10.1111/j.0021-8782.2004.00274.x; Zhou X H, 1998, Stat Methods Med Res, V7, P337, DOI 10.1191/096228098676485370	32	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107378	10.1371/journal.pone.0107378	http://dx.doi.org/10.1371/journal.pone.0107378			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222846	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774800062
J	Brown, TI; Collie, DS; Shaw, DJ; Rzechorzek, NM; Sallenave, JM				Brown, Thomas I.; Collie, David S.; Shaw, Darren J.; Rzechorzek, Nina M.; Sallenave, Jean-Michel			Sheep Lung Segmental Delivery Strategy Demonstrates Adenovirus Priming of Local Lung Responses to Bacterial LPS and the Role of Elafin as a Response Modulator	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; GENE-THERAPY; IN-VITRO; PASTEURELLA-HAEMOLYTICA; VIRUS-INFECTION; EXPRESSION; PNEUMONIA; LIPOPOLYSACCHARIDE; INHIBITOR; VECTORS	Viral lung infections increase susceptibility to subsequent bacterial infection. We questioned whether local lung administration of recombinant adenoviral vectors in the sheep would alter the susceptibility of the lung to subsequent challenge with bacterial lipopolysaccharide (LPS). We further questioned whether local lung expression of elafin, a locally produced alarm anti-LPS/anti-bacterial molecule, would modulate the challenge response. We established that adenoviral vector treatment primed the lung for an enhanced response to bacterial LPS. Whereas this local effect appeared to be independent of the transgene used (Ad-o-elafin or Ad-GFP), Ad-o-elafin treated sheep demonstrated a more profound lymphopenia in response to local lung administration of LPS. The local influence of elafin in modulating the response to LPS was restricted to maintaining neutrophil myeloperoxidase activity, and levels of alveolar macrophage and neutrophil phagocytosis at higher levels post-LPS. Adenoviral vector-bacterial synergism exists in the ovine lung and elafin expression modulates such synergism both locally and systemically.	[Brown, Thomas I.; Sallenave, Jean-Michel] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; [Brown, Thomas I.; Collie, David S.; Shaw, Darren J.; Rzechorzek, Nina M.] Univ Edinburgh, Easter Bush Vet Ctr, Roslin Inst & RD SVS, Roslin, Midlothian, Scotland	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Collie, DS (corresponding author), Univ Edinburgh, Easter Bush Vet Ctr, Roslin Inst & RD SVS, Roslin, Midlothian, Scotland.	david.collie@ed.ac.uk	SALLENAVE, Jean-Michel/J-3746-2017	SALLENAVE, Jean-Michel/0000-0002-8595-6970; Collie, David/0000-0001-9313-8137; Rzechorzek, Nina/0000-0003-3209-5019; Shaw, Darren/0000-0003-2016-1541	Wellcome Trust (Clinical Research Training Award in Veterinary Medicine) [046712]	Wellcome Trust (Clinical Research Training Award in Veterinary Medicine)(Wellcome Trust)	The authors acknowledge the Wellcome Trust (http://www.wellcome.ac.uk/) for funding this work (Clinical Research Training Award in Veterinary Medicine for T. Brown; 046712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams A, 1919, LANCET, V1, P1; Albelda SM, 2000, ANN INTERN MED, V132, P649, DOI 10.7326/0003-4819-132-8-200004180-00008; Brogden KA, 1998, VET RES, V29, P233; Brown TI, 2004, PHYSIOL GENOMICS, V19, P11, DOI 10.1152/physiolgenomics.00113.2004; Chang HW, 2006, VET IMMUNOL IMMUNOP, V110, P207, DOI 10.1016/j.vetimm.2005.09.016; Collie D David S, 2006, Int J Chron Obstruct Pulmon Dis, V1, P189, DOI 10.2147/copd.2006.1.2.189; Collie DDS, 2001, CLIN EXP ALLERGY, V31, P1636, DOI 10.1046/j.1365-2222.2001.01225.x; Curiel DT, 1996, AM J RESP CELL MOL, V14, P1; Driskell RA, 2003, ANNU REV PHYSIOL, V65, P585, DOI 10.1146/annurev.physiol.65.092101.142426; Emerson M, 2003, MOL THER, V8, P646, DOI 10.1016/S1525-0016(03)00233-8; Fasbender A, 1998, J CLIN INVEST, V102, P184, DOI 10.1172/JCI2732; Fejer G, 2005, J IMMUNOL, V175, P1498, DOI 10.4049/jimmunol.175.3.1498; Fejer G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000208; FRANKEULLMANN G, 1995, J IMMUNOL, V154, P268; Frevert CW, 2004, SEMIN RESP CRIT CARE, V25, P85, DOI 10.1055/s-2004-822308; Frevert CW, 1998, EXP LUNG RES, V24, P745, DOI 10.3109/01902149809099593; HAKANSSON A, 1994, INFECT IMMUN, V62, P2707; HERS JFP, 1958, LANCET, V2, P1141; Hodgson PD, 2005, COMP FUNCT GENOM, V6, P244, DOI 10.1002/cfg.474; Kopcha M, 1998, MERCK VET MANUAL, P1107; Labarque G, 2002, VET MICROBIOL, V88, P1, DOI 10.1016/S0378-1135(02)00104-9; Lee JH, 1999, HUM GENE THER, V10, P603, DOI 10.1089/10430349950018670; LEHMKUHL HD, 1989, AM J VET RES, V50, P671; McMichael JW, 2005, INFECT IMMUN, V73, P3609, DOI 10.1128/IAI.73.6.3609-3617.2005; McMichael JW, 2005, AM J RESP CELL MOL, V32, P443, DOI 10.1165/rcmb.2004-0250OC; Miller-Jensen K, 2006, J CELL SCI, V119, P3788, DOI 10.1242/jcs.03102; Muruve DA, 2004, HUM GENE THER, V15, P1157, DOI 10.1089/hum.2004.15.1157; Muruve DA, 2004, J VIROL, V78, P5966, DOI 10.1128/JVI.78.11.5966-5972.2004; Nalubarnba KS, 2007, VET IMMUNOL IMMUNOP, V118, P252, DOI 10.1016/j.vetimm.2007.05.018; NICKERSON CL, 1990, INFECT IMMUN, V58, P2809, DOI 10.1128/IAI.58.9.2809-2814.1990; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Roghanian A, 2006, AM J RESP CELL MOL, V34, P634, DOI 10.1165/rcmb.2005-0405OC; Sallenave JM, 1999, EUR RESPIR J, V13, P1029, DOI 10.1183/09031936.99.13510299; Sallenave JM, 1997, THORAX, V52, P742, DOI 10.1136/thx.52.8.742; SCHWARZMANN SW, 1971, ARCH INTERN MED, V127, P1037, DOI 10.1001/archinte.127.6.1037; Seki M, 2004, CLIN EXP IMMUNOL, V137, P35, DOI 10.1111/j.1365-2249.2004.02481.x; Shayakhmetov DM, 2005, J IMMUNOL, V174, P7310, DOI 10.4049/jimmunol.174.11.7310; Simpson AJ, 2001, HUM GENE THER, V12, P1395, DOI 10.1089/104303401750298553; Simpson AJ, 2001, J IMMUNOL, V167, P1778, DOI 10.4049/jimmunol.167.3.1778; Stark JM, 2006, J MED VIROL, V78, P829, DOI 10.1002/jmv.20631; Tamanini A, 2003, VIROLOGY, V307, P228, DOI 10.1016/S0042-6822(02)00078-8; Thorne PS, 1999, AM J RESP CELL MOL, V20, P1155, DOI 10.1165/ajrcmb.20.6.3632; Tremblay GM, 1996, AM J RESP CRIT CARE, V154, P1092, DOI 10.1164/ajrccm.154.4.8887613; Tripp RA, 1999, J VIROL, V73, P7099, DOI 10.1128/JVI.73.9.7099-7107.1999; Van Gucht S, 2003, J CLIN MICROBIOL, V41, P960, DOI 10.1128/JCM.41.3.960-966.2003; vanBergen BH, 1996, ARCH DERMATOL RES, V288, P458, DOI 10.1007/s004030050083; Verrier T, 2012, INT J BIOCHEM CELL B, V44, P1377, DOI 10.1016/j.biocel.2012.05.007; Walters RW, 1999, GENE THER, V6, P1845, DOI 10.1038/sj.gt.3301020; Wang ZX, 2008, AM J RESP CELL MOL, V38, P724, DOI 10.1165/rcmb.2007-0354OC; WELSH MD, 1995, VET IMMUNOL IMMUNOP, V46, P195, DOI 10.1016/0165-2427(94)05366-Z; YATES WDG, 1983, CAN J COMP MED, V47, P257; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06	52	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107590	10.1371/journal.pone.0107590	http://dx.doi.org/10.1371/journal.pone.0107590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216250	Green Submitted, Green Published, gold			2022-12-25	WOS:000341774300084
J	Crane, MJ; Lindenmayer, DB; Cunningham, RB				Crane, Mason J.; Lindenmayer, David B.; Cunningham, Ross B.			The Value of Countryside Elements in the Conservation of a Threatened Arboreal Marsupial Petaurus norfolcensis in Agricultural Landscapes of South-Eastern Australia-The Disproportional Value of Scattered Trees	PLOS ONE			English	Article							SQUIRREL GLIDER; HOME-RANGE; VARIEGATED LANDSCAPE; FEEDING-BEHAVIOR; PROTECTED AREAS; PADDOCK TREES; HABITAT; BIRDS; VEGETATION; NETWORK	Human activities, particularly agriculture, have transformed much of the world's terrestrial environment. Within these anthropogenic landscapes, a variety of relictual and semi-natural habitats exist, which we term countryside elements. The habitat value of countryside elements (hereafter termed 'elements') is increasingly recognised. We quantify the relative value of four kinds of such 'elements' (linear roadside remnants, native vegetation patches, scattered trees and tree plantings) used by a threatened Australian arboreal marsupial, the squirrel glider (Petaurus norfolcensis). We examined relationships between home range size and the availability of each 'element' and whether the usage was relative to predicted levels of use. The use of 'elements' by gliders was largely explained by their availability, but there was a preference for native vegetation patches and scattered trees. We found home range size was significantly smaller with increasing area of scattered trees and a contrasting effect with increasing area of linear roadside remnants or native vegetation patches. Our work showed that each 'element' was used and as such had a role in the conservation of the squirrel glider, but their relative value varied. We illustrate the need to assess the conservation value of countryside elements so they can be incorporated into the holistic management of agricultural landscapes. This work demonstrates the disproportional value of scattered trees, underscoring the need to specifically incorporate and/or enhance the protection and recruitment of scattered trees in biodiversity conservation policy and management.	[Crane, Mason J.; Lindenmayer, David B.; Cunningham, Ross B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia	Australian National University	Crane, MJ (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	mason.crane@anu.edu.au	Lindenmayer, David B/P-7183-2017; Crane, Mason/AAQ-1810-2021	Lindenmayer, David B/0000-0002-4766-4088; 				Anderson RH, 1961, CONTRIBUTIONS NEW S, V1-18, P1; Arnaud JF, 2003, LANDSCAPE ECOL, V18, P333, DOI 10.1023/A:1024409116214; Aung UM, 2007, J ENVIRON MANAGE, V84, P188, DOI 10.1016/j.jenvman.2006.05.016; Ball T, 2009, AUST J ZOOL, V57, P295, DOI 10.1071/ZO08095; Bennett A. F., 1999, LINKAGES LANDSCAPE R; Benson J. S., 2008, Cunninghamia, V10, P599; Burel F, 1996, CRIT REV PLANT SCI, V15, P169, DOI 10.1080/713608130; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Collard S, 2009, BIODIVERS CONSERV, V18, P1649, DOI 10.1007/s10531-008-9548-4; Crane MJ, 2008, WILDLIFE RES, V35, P663, DOI 10.1071/WR07142; Crane MJ, 2012, AUST J ZOOL, V60, P320, DOI 10.1071/ZO12080; CUMMINGS JR, 1994, AM MIDL NAT, V132, P209, DOI 10.2307/2426575; Cunningham RB, 2008, CONSERV BIOL, V22, P742, DOI 10.1111/j.1523-1739.2008.00924.x; Cunningham RB, 2007, ECOL APPL, V17, P609, DOI 10.1890/05-1892; Daily GC, 2003, CONSERV BIOL, V17, P1814, DOI 10.1111/j.1523-1739.2003.00298.x; Daily GC, 2001, ECOL APPL, V11, P1, DOI 10.1890/1051-0761(2001)011[0001:CBUOHD]2.0.CO;2; Ellis EC, 2011, PHILOS T R SOC A, V369, P1010, DOI 10.1098/rsta.2010.0331; Fischer J, 2002, BIODIVERS CONSERV, V11, P833, DOI 10.1023/A:1015318328007; Fischer J, 2002, BIODIVERS CONSERV, V11, P807, DOI 10.1023/A:1015371511169; Fischer J, 2002, BIOL CONSERV, V106, P129, DOI 10.1016/S0006-3207(01)00241-5; Fischer J, 2010, BIOL CONSERV, V143, P1564, DOI 10.1016/j.biocon.2010.03.030; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; GETZ LL, 1978, J MAMMAL, V59, P208, DOI 10.2307/1379900; Gibbons P, 2008, CONSERV BIOL, V22, P1309, DOI 10.1111/j.1523-1739.2008.00997.x; Haslem A, 2008, AGR ECOSYST ENVIRON, V125, P191, DOI 10.1016/j.agee.2008.01.001; Hazell D, 2001, BIOL CONSERV, V102, P155, DOI 10.1016/S0006-3207(01)00096-9; Holland GJ, 2007, WILDLIFE RES, V34, P288, DOI 10.1071/WR06104; Ioja CI, 2010, BIOL CONSERV, V143, P2468, DOI 10.1016/j.biocon.2010.06.013; Lindenmayer D, 2012, LAND USE INTENSIFICATION: EFFECTS ON AGRICULTURE, BIODIVERSITY AND ECOLOGICAL PROCESSES, P1; Lindenmayer DB, 2014, CONSERV LETT, V7, P61, DOI 10.1111/conl.12013; Lindenmayer David B., 2010, Ecological Management & Restoration, V11, P27, DOI 10.1111/j.1442-8903.2010.00509.x; LINDENMAYER DB, 1993, BIOL CONSERV, V66, P207, DOI 10.1016/0006-3207(93)90006-M; Lumsden LF, 2005, BIOL CONSERV, V122, P205, DOI 10.1016/j.biocon.2004.07.006; Manning AD, 2004, BIOL CONSERV, V120, P363, DOI 10.1016/j.biocon.2004.03.008; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Maron M, 2007, BIOL CONSERV, V135, P587, DOI 10.1016/j.biocon.2006.10.051; Martin JK, 2007, AUSTRAL ECOL, V32, P686, DOI 10.1111/j.1442-9993.2007.01763.x; McCullagh P, 1989, GEN LINEAR MODELS; McLoughlin PD, 2003, ECOSCIENCE, V10, P11, DOI 10.1080/11956860.2003.11682744; Michael DR, 2008, J APPL ECOL, V45, P1742, DOI 10.1111/j.1365-2664.2008.01567.x; Mitchell MS, 2004, ECOL MODEL, V177, P209, DOI 10.1016/j.ecolmodel.2004.01.015; Munro NT, 2011, RESTOR ECOL, V19, P223, DOI 10.1111/j.1526-100X.2010.00703.x; Ockinger E, 2007, J APPL ECOL, V44, P50, DOI 10.1111/j.1365-2664.2006.01250.x; Pacheco R, 2013, BIODIVERS CONSERV, V22, P983, DOI 10.1007/s10531-013-0463-y; PRESSEY RL, 1994, AUST J ECOL, V19, P375, DOI 10.1111/j.1442-9993.1994.tb00503.x; Prober SM, 1996, AUST J BOT, V44, P57, DOI 10.1071/BT9960057; Recher H.F., 1987, P177; Renjifo LM, 2001, ECOL APPL, V11, P14, DOI 10.1890/1051-0761(2001)011[0014:EONAAL]2.0.CO;2; Rouget M, 2003, BIOL CONSERV, V112, P129, DOI 10.1016/S0006-3207(02)00396-8; Sarre A., 2002, TREES WATER SALT AUS; Sharpe DJ, 1998, WILDLIFE RES, V25, P243, DOI 10.1071/WR97037; Soderstrom B, 2003, AGR ECOSYST ENVIRON, V99, P113, DOI 10.1016/S0167-8809(03)00144-0; Spooner PG, 2005, AUST GEOGR, V36, P55, DOI 10.1080/00049180500050870; van Beest FM, 2011, J ANIM ECOL, V80, P771, DOI 10.1111/j.1365-2656.2011.01829.x; van der Ree R, 2004, BIOL CONSERV, V115, P241, DOI 10.1016/S0006-3207(03)00142-3; van der Ree R, 2003, J ZOOL, V259, P327, DOI 10.1017/S0952836902003229; van der Ree R, 2002, WILDLIFE RES, V29, P329, DOI 10.1071/WR01095; White G.C., 1990, ANAL WILDLIFE RADIO	58	17	17	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107178	10.1371/journal.pone.0107178	http://dx.doi.org/10.1371/journal.pone.0107178			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216045	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774300050
J	Ikeda, DH; Grady, KC; Shuster, SM; Whitham, TG				Ikeda, Dana H.; Grady, Kevin C.; Shuster, Stephen M.; Whitham, Thomas G.			Incorporating Climate Change and Exotic Species into Forecasts of Riparian Forest Distribution	PLOS ONE			English	Article							INVASIVE TAMARISK TAMARIX; PLANT INVASIONS; CHANGE IMPACTS; WATER SOURCES; BIODIVERSITY; RESTORATION; VEGETATION; RIVER; COMMUNITY; DROUGHT	We examined the impact climate change (CC) will have on the availability of climatically suitable habitat for three native and one exotic riparian species. Due to its increasing prevalence in arid regions throughout the western US, we predicted that an exotic species, Tamarix, would have the greatest increase in suitable habitat relative to native counterparts under CC. We used an ecological niche model to predict range shifts of Populus fremontii, Salix gooddingii, Salix exigua and Tamarix, from present day to 2080s, under five general circulation models and one climate change scenario (A1B). Four major findings emerged. 1) Contrary to our original hypothesis, P. fremontii is projected to have the greatest increase in suitable habitat under CC, followed closely by Tamarix. 2) Of the native species, S. gooddingii and S. exigua showed the greatest loss in predicted suitable habitat due to CC. 3) Nearly 80 percent of future P. fremontii and Salix habitat is predicted to be affected by either CC or Tamarix by the 2080s. 4) By the 2080s, 20 percent of S. gooddingii habitat is projected to be affected by both Tamarix and CC concurrently, followed by S. exigua (19 percent) and P. fremontii (13 percent). In summary, while climate change alone will negatively impact both native willow species, Tamarix is likely to affect a larger portion of all three native species' distributions. We discuss these and other results in the context of prioritizing restoration and conservation efforts to optimize future productivity and biodiversity. As we are accounting for only direct effects of CC and Tamarix on native habitat, we present a possible hierarchy of effects- from the direct to the indirect- and discuss the potential for the indirect to outweigh the direct effects. Our results highlight the need to account for simultaneous challenges in the face of CC.	[Ikeda, Dana H.; Shuster, Stephen M.; Whitham, Thomas G.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Ikeda, Dana H.; Grady, Kevin C.; Shuster, Stephen M.; Whitham, Thomas G.] No Arizona Univ, Merriam Powell Ctr Environm Res, Flagstaff, AZ 86011 USA; [Grady, Kevin C.] No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA	Northern Arizona University; Northern Arizona University; Northern Arizona University	Ikeda, DH (corresponding author), No Arizona Univ, Dept Biol Sci, Box 5640, Flagstaff, AZ 86011 USA.	Dana.Ikeda@nau.edu			National Science Foundation (NSF) Integrative Graduate Education Research Traineeship (IGERT); Frontiers in Integrative Biological Research (FIBR) grant [DEB-0425908]; NSF Macrosystems grant [DEB-1340852]; Northern Arizona University TRIF program; Bureau of Land Management Challenge Cost Share grant [L12AC20606]	National Science Foundation (NSF) Integrative Graduate Education Research Traineeship (IGERT)(National Science Foundation (NSF)); Frontiers in Integrative Biological Research (FIBR) grant; NSF Macrosystems grant(National Science Foundation (NSF)); Northern Arizona University TRIF program; Bureau of Land Management Challenge Cost Share grant	This work was supported by the National Science Foundation (NSF) Integrative Graduate Education Research Traineeship (IGERT), Frontiers in Integrative Biological Research (FIBR) grant DEB-0425908, NSF Macrosystems grant DEB-1340852, the Northern Arizona University TRIF program, and Bureau of Land Management Challenge Cost Share grant L12AC20606. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderson B, 2004, RIPARIAN REVEGETATIO; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Bailey JK, 2001, WETLANDS, V21, P442, DOI 10.1672/0277-5212(2001)021[0442:SCNABO]2.0.CO;2; Bangert R, 2013, RESTOR ECOL, V21, P447, DOI 10.1111/j.1526-100X.2012.00910.x; Barve N, 2008, TOOL PARTIAL ROC; Bay RF, 2008, RESTOR ECOL, V16, P113, DOI 10.1111/j.1526-100X.2007.00359.x; Bell DM, 2014, GLOBAL ECOL BIOGEOGR, V23, P168, DOI 10.1111/geb.12109; Bradley BA, 2009, GLOBAL CHANGE BIOL, V15, P1511, DOI 10.1111/j.1365-2486.2008.01824.x; Brand AL, 2008, CONDOR, P110; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Brusca RC, 2013, ECOL EVOL, V3, P3307, DOI 10.1002/ece3.720; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; BUSCH DE, 1995, ECOL MONOGR, V65, P347, DOI 10.2307/2937064; Cox G, 2005, WEST N AM NATURALIST, V65, P175; Davies PM, 2010, RESTOR ECOL, V18, P261, DOI 10.1111/j.1526-100X.2009.00648.x; Dominguez F, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050762; Durst SL, 2008, J ARID ENVIRON, V72, P1644, DOI 10.1016/j.jaridenv.2008.04.003; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Ellis LM, 1997, SOUTHWEST NAT, V42, P13; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; ESRI, 2009, ARCGIS DESKT REL 9 3; Evangelista PH, 2008, DIVERS DISTRIB, V14, P808, DOI 10.1111/j.1472-4642.2008.00486.x; Evangelista PH, 2009, REMOTE SENS-BASEL, V1, P519, DOI 10.3390/rs1030519; Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7; Felde VA, 2012, ECOGRAPHY, V35, P922, DOI 10.1111/j.1600-0587.2011.07057.x; Flory AR, 2012, J APPL ECOL, V49, P680, DOI 10.1111/j.1365-2664.2012.02129.x; Friedman JM, 2005, BIOL INVASIONS, V7, P747, DOI 10.1007/s10530-004-5849-z; Friedman JM, 2008, EVOL APPL, V1, P598, DOI 10.1111/j.1752-4571.2008.00044.x; Garfin G, 2013, NCA REGION INPUT REP, P1, DOI 10.5822/978-1-61091-484-0; Garfin GM, 2010, COLORADO PLATEAU, P22; Gaskin JF, 2002, P NATL ACAD SCI USA, V99, P11256, DOI 10.1073/pnas.132403299; Gaskin John F., 2005, Madrono, V52, P1, DOI 10.3120/0024-9637(2005)52[1:HOTRAT]2.0.CO;2; Gaskin JF, 2009, BIOL INVASIONS, V11, P1121, DOI 10.1007/s10530-008-9384-1; Gitlin AR, 2006, CONSERV BIOL, V20, P1477, DOI 10.1111/j.1523-1739.2006.00424.x; Glenn EP, 2012, J ARID ENVIRON, V79, P56, DOI 10.1016/j.jaridenv.2011.11.025; Goergen EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018145; Grady KC, 2011, GLOBAL CHANGE BIOL, P1; Grady KC, 2013, FUNCT ECOL, V27, P428, DOI 10.1111/1365-2435.12060; GRAF WL, 1978, GEOL SOC AM BULL, V89, P1491, DOI 10.1130/0016-7606(1978)89<1491:FATTSO>2.0.CO;2; Harms RS, 2006, RESTOR ECOL, V14, P461, DOI 10.1111/j.1526-100X.2006.00154.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Horton JL, 2001, ECOL APPL, V11, P1046, DOI 10.1890/1051-0761(2001)011[1046:PRTGDV]2.0.CO;2; HOWE WH, 1991, SOUTHWEST NAT, V36, P218, DOI 10.2307/3671924; Hultine KR, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010317; Hultine KR, 2010, ECOL APPL, V20, P347, DOI 10.1890/09-0492.1; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Ikeda DH, 2014, FUNCT ECOL, V28, P65, DOI 10.1111/1365-2435.12151; Jarnevich CS, 2011, WEST N AM NATURALIST, V71, P164, DOI 10.3398/064.071.0204; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Kerns BK, 2009, INVAS PLANT SCI MANA, V2, P200, DOI 10.1614/IPSM-08-120.1; Kim HY, 2013, GLOBAL CHANGE BIOL, V19, P548, DOI 10.1111/gcb.12047; Kolb TE, 1997, TREE PHYSIOL, V17, P151; Kumar S, 2009, FRONT ECOL ENVIRON, V7, P415, DOI 10.1890/080054; Meinhardt KA, 2012, ECOL APPL, V22, P532, DOI 10.1890/11-1247.1; Merritt DM, 2010, ECOL APPL, V20, P135, DOI 10.1890/08-2251.1; Morisette JT, 2006, FRONT ECOL ENVIRON, V4, P11, DOI 10.1890/1540-9295(2006)004[0012:ATHSMF]2.0.CO;2; Noss RF, 1995, 28 USDI NAT BIOL SER; O'Neill GA, 2008, J APPL ECOL, V45, P1040, DOI 10.1111/j.1365-2664.2008.01472.x; Ochoa-Ochoa L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006878; Oney B, 2013, ECOL EVOL, V3, P437, DOI 10.1002/ece3.426; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Pendleton RL, 2011, NATURAL RESOURCES EN, V1, P1; Perry LG, 2012, GLOBAL CHANGE BIOL, V18, P821, DOI 10.1111/j.1365-2486.2011.02588.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pockman WT, 2000, AM J BOT, V87, P1287, DOI 10.2307/2656722; Ramirez-Villegas J, 2010, 1 CTR TROP AGR COL; Ramirez-Villegas J, 2012, J NAT CONSERV, V20, P337, DOI 10.1016/j.jnc.2012.07.006; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Richardson DM, 2007, DIVERS DISTRIB, V13, P126, DOI 10.1111/j.1366-9516.2006.00314.x; Rood SB, 2005, FRONT ECOL ENVIRON, V3, P193, DOI 10.1890/1540-9295(2005)003[0193:MRFTRF]2.0.CO;2; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sahlean TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091994; Sanchez-Salguero R, 2012, FOREST ECOL MANAG, V271, P158, DOI 10.1016/j.foreco.2012.01.040; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Sher A., 2013, TAMARIX CASE STUDY E; Sher AA, 2002, ECOL APPL, V12, P760, DOI 10.2307/3060987; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Snyder KA, 2000, AGR FOREST METEOROL, V105, P227, DOI 10.1016/S0168-1923(00)00193-3; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stella JC, 2010, OECOLOGIA, V164, P579, DOI 10.1007/s00442-010-1657-6; Strudley S, 2009, THESIS U DENVER CO; Taylor JP, 1999, WETLANDS, V19, P372, DOI 10.1007/BF03161769; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; VanDerWal J, 2009, J BIOGEOGR, V36, P291, DOI 10.1111/j.1365-2699.2008.01993.x; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Walther GR, 2005, P ROY SOC B-BIOL SCI, V272, P1427, DOI 10.1098/rspb.2005.3119; Wang TL, 2010, ECOL APPL, V20, P153, DOI 10.1890/08-2257.1; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Williams AP, 2013, NAT CLIM CHANGE, V3, P292, DOI [10.1038/nclimate1693, 10.1038/NCLIMATE1693]; Yesson C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001124	103	20	19	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107037	10.1371/journal.pone.0107037	http://dx.doi.org/10.1371/journal.pone.0107037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216285	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774300037
J	Cui, HX; Wang, YQ; Huang, HZ; Yu, WJ; Bai, M; Zhang, L; Bryan, BA; Wang, Y; Luo, J; Li, DL; Ma, YL; Liu, MY				Cui, Hengxiang; Wang, Yeqi; Huang, Huizhe; Yu, Wenjie; Bai, Min; Zhang, Long; Bryan, Brad A.; Wang, Yuan; Luo, Jian; Li, Dali; Ma, Yanlin; Liu, Mingyao			GPR126 Protein Regulates Developmental and Pathological Angiogenesis through Modulation of VEGFR2 Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Endothelial Cell; G Protein-coupled Receptor (GPCR); Protein Kinase A (PKA); Vascular Endothelial Growth Factor (VEGF); VEGFR2	HEMATOPOIETIC STEM-CELLS; COUPLED RECEPTOR; ENDOTHELIAL-CELLS; IN-VITRO; ACTIVATION; GENE; ZEBRAFISH; TRANSCRIPTION; MYELINATION; GENERATION	Background: GPR126 plays critical roles in development, but its function in vessels is not well characterized. Results: GPR126 regulates angiogenesis by modulating endothelial cell proliferation and migration via regulation of Vegfr2 expression. Conclusion: GPR126 is important for physiological and pathological angiogenesis. Significance: This finding provides a new functional mechanism for the regulation of angiogenesis. Angiogenesis, the formation of new blood vessels from pre-existing ones, is essential for development, wound healing, and tumor progression. The VEGF pathway plays irreplaceable roles during angiogenesis, but how other signals cross-talk with and modulate VEGF cascades is not clearly elucidated. Here, we identified that Gpr126, an endothelial cell-enriched gene, plays an important role in angiogenesis by regulating endothelial cell proliferation, migration, and tube formation. Knockdown of Gpr126 in the mouse retina resulted in the inhibition of hypoxia-induced angiogenesis. Interference of Gpr126 expression in zebrafish embryos led to defects in intersegmental vessel formation. Finally, we identified that GPR126 regulated the expression of VEGFR2 by targeting STAT5 and GATA2 through the cAMP-PKA-cAMP-response element-binding protein signaling pathway during angiogenesis. Our findings illustrate that GPR126 modulates both physiological and pathological angiogenesis through VEGF signaling, providing a potential target for the treatment of angiogenesis-related diseases.	[Cui, Hengxiang; Yu, Wenjie; Zhang, Long; Wang, Yuan; Luo, Jian; Li, Dali; Liu, Mingyao] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Cui, Hengxiang; Yu, Wenjie; Zhang, Long; Wang, Yuan; Luo, Jian; Li, Dali; Liu, Mingyao] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Bai, Min; Ma, Yanlin] Hainan Med Univ, Affiliated Hosp, Hainan Reprod Med Ctr, Hainan Prov Key Lab Human Reprod Med & Genet Res, Haikou 570102, Peoples R China; [Wang, Yeqi] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Huang, Huizhe] Chongqing Med Univ, Sch Basic Med, Core Facil Zebrafish Res, Chongqing 400016, Peoples R China; [Bryan, Brad A.] Texas Tech Univ, Hlth Sci Ctr, Ctr Excellence Canc Res, El Paso, TX 79905 USA; [Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA	East China Normal University; East China Normal University; Hainan Medical University; Yale University; Chongqing Medical University; Texas Tech University System; Texas Tech University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Li, DL (corresponding author), E China Normal Univ, Inst Biomed Sci, Shanghai 200241, Peoples R China.	dlli@bio.ecnu.edu.cn; mayl1990@foxmail.com; mlliu@bio.ecnu.edu.cn	CUI, Hengxiang/AAO-1326-2021; Ma, Yanlin/CAH-2185-2022; Wang, Yeqi/V-8445-2019; Luo, Jian/H-3362-2016	Ma, Yanlin/0000-0001-9668-0204; Wang, Yeqi/0000-0003-2881-4607; Yu, Wenjie/0000-0002-3013-1218; Li, Dali/0000-0002-0046-8493; Luo, Jian/0000-0003-3583-0154; wang, Yuan/0000-0002-0939-1269; Liu, Mingyao/0000-0001-7339-5048	National Institutes of Health from NHLBI [R15HL098931]; State Key Development Programs of China [2012CB910400, 2010CB945403]; National Natural Science Foundation of China [30800627, 30930055, 31171318]; Science and Technology Commission of Shanghai Municipality [14140900300]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL098931] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); State Key Development Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R15HL098931 from NHLBI. This work was also supported in part by State Key Development Programs of China grants 2012CB910400 and 2010CB945403), National Natural Science Foundation of China Grants 30800627, 30930055, and 31171318, and Science and Technology Commission of Shanghai Municipality Grant 14140900300.	Anderson KD, 2011, P NATL ACAD SCI USA, V108, P2807, DOI 10.1073/pnas.1019761108; Childs S, 2002, DEVELOPMENT, V129, P973; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Cullen M, 2011, P NATL ACAD SCI USA, V108, P5759, DOI 10.1073/pnas.1017192108; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; Dentelli P, 2009, ARTERIOSCL THROM VAS, V29, P114, DOI 10.1161/ATVBAHA.108.172247; Dudley AC, 2005, BIOCHEM J, V390, P427, DOI 10.1042/BJ20050351; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Hidaka M, 1999, P NATL ACAD SCI USA, V96, P7370, DOI 10.1073/pnas.96.13.7370; Jackson TA, 2005, J BIOL CHEM, V280, P29856, DOI 10.1074/jbc.M500335200; Kaur B, 2005, ONCOGENE, V24, P3632, DOI 10.1038/sj.onc.1208317; Kohler EE, 2011, BLOOD, V117, P1761, DOI 10.1182/blood-2010-07-295261; Korpelainen EI, 1999, ONCOGENE, V18, P1, DOI 10.1038/sj.onc.1202288; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Leung T, 2006, BLOOD, V108, P160, DOI 10.1182/blood-2005-09-3706; Li DL, 2009, NUCLEIC ACIDS RES, V37, P7059, DOI 10.1093/nar/gkp773; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Meissner M, 2004, CIRC RES, V94, P324, DOI 10.1161/01.RES.0000113781.08139.81; Minami T, 2001, J BIOL CHEM, V276, P5395, DOI 10.1074/jbc.M008798200; Monk KR, 2011, DEVELOPMENT, V138, P2673, DOI 10.1242/dev.062224; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Nishimori H, 1997, ONCOGENE, V15, P2145, DOI 10.1038/sj.onc.1201542; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P17692, DOI 10.1073/pnas.0707045104; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Rompler H, 2007, MOL INTERV, V7, P17, DOI 10.1124/mi.7.1.5; Schmidt A, 2007, CIRC RES, V101, P125, DOI 10.1161/CIRCRESAHA.107.148932; Schuringa JJ, 2004, STEM CELLS, V22, P1191, DOI 10.1634/stemcells.2004-0033; STAINIER DYR, 1994, TRENDS CARDIOVAS MED, V4, P207, DOI 10.1016/1050-1738(94)90036-1; Stehlik C, 2004, FEBS LETT, V569, P149, DOI 10.1016/j.febslet.2004.05.038; Sumida H, 2010, BLOOD, V116, P5060, DOI 10.1182/blood-2010-03-272443; Tanaka A, 2010, BLOOD, V115, P4138, DOI 10.1182/blood-2009-05-223057; Tsopanoglou NE, 1999, J BIOL CHEM, V274, P23969, DOI 10.1074/jbc.274.34.23969; Vittet D, 1996, BLOOD, V88, P3424, DOI 10.1182/blood.V88.9.3424.bloodjournal8893424; Waller-Evans H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014047; Wang T, 2005, BLOOD, V105, P2836, DOI 10.1182/blood-2004-07-2878; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Wang YQ, 2011, J BIOL CHEM, V286, P41095, DOI 10.1074/jbc.M111.296806; Xu M, 2003, EMBO J, V22, P893, DOI 10.1093/emboj/cdg094; Yamamizu K, 2009, BLOOD, V114, P3707, DOI 10.1182/blood-2008-12-195750; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yang LV, 2007, MOL CELL BIOL, V27, P1334, DOI 10.1128/MCB.01909-06; Yang XH, 2009, CANCER RES, V69, P1668, DOI 10.1158/0008-5472.CAN-07-6385; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Zeng HY, 2003, J BIOL CHEM, V278, P20738, DOI 10.1074/jbc.M209712200; Zeoli A, 2008, BLOOD, V112, P350, DOI 10.1182/blood-2007-12-128215	50	35	35	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34871	34885		10.1074/jbc.M114.571000	http://dx.doi.org/10.1074/jbc.M114.571000			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25217645	hybrid, Green Published			2022-12-25	WOS:000346260800038
J	Xing, GL; Gan, GM; Chen, DD; Sun, MK; Yi, JK; Lv, HH; Han, JH; Xie, W				Xing, Guanglin; Gan, Guangming; Chen, Dandan; Sun, Mingkuan; Yi, Jukang; Lv, Huihui; Han, Junhai; Xie, Wei			Drosophila Neuroligin3 Regulates Neuromuscular Junction Development and Synaptic Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; Electron Microscopy (EM); Glutamate Receptor; Synapse; Synaptic Plasticity	GLUTAMATE-RECEPTOR SUBUNIT; INHIBITORY SYNAPSES; CELL-ADHESION; VESICLE SIZE; PROTEIN; ENDOCYTOSIS; MUTATIONS; NEUREXIN; TRANSMISSION; DOMAIN	Background: Postsynaptic neuroligins play essential roles in synaptic maturation and function. Results:Drosophila Neuroligin3 regulates neuromuscular junction growth, GluRIIA recruitment, synaptic vesicle recycling, and postsynaptic density maturation. Conclusion: This elucidates the in vivo roles of Drosophila Neuroligin3 in development and synaptic differentiation of NMJs. Significance: This highlights that Drosophila can be used to understand and uncover functional diversity in neuroligins. Neuroligins (Nlgs) are a family of cell adhesion molecules thought to be important for synapse maturation and function. Mammalian studies have shown that different Nlgs have different roles in synaptic maturation and function. In Drosophila melanogaster, the roles of Drosophila neuroligin1 (DNlg1), neuroligin2, and neuroligin4 have been examined. However, the roles of neuroligin3 (dnlg3) in synaptic development and function have not been determined. In this study, we used the Drosophila neuromuscular junctions (NMJs) as a model system to investigate the in vivo role of dnlg3. We showed that DNlg3 was expressed in both the CNS and NMJs where it was largely restricted to the postsynaptic site. We generated dnlg3 mutants and showed that these mutants exhibited an increased bouton number and reduced bouton size compared with the wild-type (WT) controls. Consistent with alterations in bouton properties, pre- and postsynaptic differentiations were affected in dnlg3 mutants. This included abnormal synaptic vesicle endocytosis, increased postsynaptic density length, and reduced GluRIIA recruitment. In addition to impaired synaptic development and differentiation, we found that synaptic transmission was reduced in dnlg3 mutants. Altogether, our data showed that DNlg3 was required for NMJ development, synaptic differentiation, and function.	[Xing, Guanglin; Gan, Guangming; Chen, Dandan; Sun, Mingkuan; Yi, Jukang; Lv, Huihui; Han, Junhai; Xie, Wei] Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Nanjing 210096, Jiangsu, Peoples R China	Southeast University - China	Xie, W (corresponding author), Southeast Univ, Inst Life Sci, 2 Sipailou Rd, Nanjing 210096, Jiangsu, Peoples R China.	wei.xie@seu.edu.cn	SUN, Mingkuan/I-7186-2016; Chen, Dandan/X-6286-2019; Sun, Mingkuan/H-6191-2019	SUN, Mingkuan/0000-0002-4511-5894; Sun, Mingkuan/0000-0002-4511-5894; Xing, Guanglin/0000-0002-8258-0293	Natural Science Foundation of China [31171041]; National Basic Research Program (973 Program) [2012CB517903]; Natural Science Foundation of China; Canadian Institutes of Health Research [81161120543]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Natural Science Foundation of China Grant 31171041, National Basic Research Program (973 Program) Grant 2012CB517903, and Natural Science Foundation of China and Canadian Institutes of Health Research Joint Health Research Initiative Program Grant 81161120543 (to W. X.).	Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Banovic D, 2010, NEURON, V66, P724, DOI 10.1016/j.neuron.2010.05.020; Blundell J, 2009, GENES BRAIN BEHAV, V8, P114, DOI 10.1111/j.1601-183X.2008.00455.x; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Chen YC, 2012, J NEUROSCI, V32, P16018, DOI 10.1523/JNEUROSCI.1685-12.2012; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; DiAntonio A, 1999, J NEUROSCI, V19, P3023; DiAntonio A, 2006, INT REV NEUROBIOL, V75, P165, DOI 10.1016/S0074-7742(06)75008-5; Fabrichny IP, 2007, NEURON, V56, P979, DOI 10.1016/j.neuron.2007.11.013; Featherstone DE, 2005, J NEUROSCI, V25, P3199, DOI 10.1523/JNEUROSCI.4201-04.2005; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jedlicka P, 2011, CEREB CORTEX, V21, P357, DOI 10.1093/cercor/bhq100; Koh TW, 2007, J CELL BIOL, V178, P309, DOI 10.1083/jcb.200701030; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Kwon HB, 2012, NAT NEUROSCI, V15, P1667, DOI 10.1038/nn.3256; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Li Y, 2013, J NEUROSCI, V33, P15545, DOI 10.1523/JNEUROSCI.0819-13.2013; Liebl FLW, 2008, BIOINFORM BIOL INSIG, V2, P369; Marrus SB, 2004, CURR BIOL, V14, P924, DOI 10.1016/j.cub.2004.05.047; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; Mondin M, 2011, J NEUROSCI, V31, P13500, DOI 10.1523/JNEUROSCI.6439-10.2011; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Poskanzer KE, 2006, NEURON, V50, P49, DOI 10.1016/j.neuron.2006.02.021; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; Salazar AM, 2010, J NEUROSCI, V30, P515, DOI 10.1523/JNEUROSCI.2523-09.2010; Sand P, 2006, SCHIZOPHR RES, V82, P277, DOI 10.1016/j.schres.2005.11.003; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SCHUSTER CM, 1991, SCIENCE, V254, P112, DOI 10.1126/science.1681587; Stevens RJ, 2012, J NEUROSCI, V32, P18054, DOI 10.1523/JNEUROSCI.2668-12.2012; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sun CC, 2011, HUM MOL GENET, V20, P3042, DOI 10.1093/hmg/ddr208; Sun MK, 2011, J NEUROSCI, V31, P687, DOI 10.1523/JNEUROSCI.3854-10.2011; Suzuki K, 2012, NEURON, V76, P410, DOI 10.1016/j.neuron.2012.10.003; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Verstreken Patrik, 2008, V440, P349, DOI 10.1007/978-1-59745-178-9_26; Verstreken P, 2009, NEURON, V63, P203, DOI 10.1016/j.neuron.2009.06.017; Wang D, 2010, J CELL SCI, V123, P1546, DOI 10.1242/jcs.060251; Wermter AK, 2008, AM J MED GENET B, V147B, P535, DOI 10.1002/ajmg.b.30618; Zeng XK, 2007, FEBS LETT, V581, P2509, DOI 10.1016/j.febslet.2007.04.068; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zhao L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003450	51	34	35	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31867	31877		10.1074/jbc.M114.574897	http://dx.doi.org/10.1074/jbc.M114.574897			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25228693	Green Published, hybrid			2022-12-25	WOS:000345314700018
J	Al-Fotawei, R; Ayoub, AF; Heath, N; Naudi, KB; Tanner, KE; Dalby, MJ; McMahon, J				Al-Fotawei, Randa; Ayoub, Ashraf F.; Heath, Neil; Naudi, Kurt B.; Tanner, K. Elizabeth; Dalby, Matthew J.; McMahon, Jeremy			Radiological Assessment of Bioengineered Bone in a Muscle Flap for the Reconstruction of Critical-Size Mandibular Defect	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; MARROW STEM-CELLS; RADIOGRAPHIC ASSESSMENT; DENSITY; REPAIR; BMP-2; GRAFT	This study presents a comprehensive radiographic evaluation of bone regeneration within a pedicled muscle flap for the reconstruction of critical size mandibular defect. The surgical defect (20 mmx15 mm) was created in the mandible of ten experimental rabbits. The masseter muscle was adapted to fill the surgical defect, a combination of calcium sulphate/hydroxyapatite cement (CERAMENT (TM) vertical bar SPINE SUPPORT), BMP-7 and rabbit mesenchymal stromal cells (rMSCs) was injected inside the muscle tissue. Radiographic assessment was carried out on the day of surgery and at 4, 8, and 12 weeks postoperatively. At 12 weeks, the animals were sacrificed and cone beam computerized tomography (CBCT) scanning and micro-computed tomography (mu-CT) were carried out. Clinically, a clear layer of bone tissue was identified closely adherent to the border of the surgical defect. Sporadic radio-opaque areas within the surgical defect were detected radiographically. In comparison with the opposite non operated control side, the estimated quantitative scoring of the radio-opacity was 46.6% +/- 15, the mean volume of the radio-opaque areas was 63.4% +/- 20. Areas of a bone density higher than that of the mandibular bone (+/- 35% +/- 25%) were detected at the borders of the surgical defect. The micro-CT analysis revealed thinner trabeculae of the regenerated bone with a more condensed trabecular pattern than the surrounding native bone. These findings suggest a rapid deposition rate of the mineralised tissue and an active remodelling process of the newly regenerated bone within the muscle flap. The novel surgical model of this study has potential clinical application; the assessment of bone regeneration using the presented radiolographic protocol is descriptive and comprehensive. The findings of this research confirm the remarkable potential of local muscle flaps as local bioreactors to induce bone formation for reconstruction of maxillofacial bony defects.	[Al-Fotawei, Randa; Ayoub, Ashraf F.] Univ Glasgow, Glasgow, Lanark, Scotland; [Heath, Neil; Naudi, Kurt B.] Univ Glasgow, Dent Hosp & Sch, Glasgow, Lanark, Scotland; [Tanner, K. Elizabeth] Univ Glasgow, Sch Engn, Glasgow, Lanark, Scotland; [Dalby, Matthew J.] Univ Glasgow, Ctr Cell Engn, Glasgow, Lanark, Scotland; [McMahon, Jeremy] So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland	University of Glasgow; University of Glasgow; University of Glasgow; University of Glasgow; University of Glasgow	Ayoub, AF (corresponding author), Univ Glasgow, Glasgow, Lanark, Scotland.	Ashraf.Ayoub@glasgow.ac.uk	ALFOTAWI, RANDA A/F-6014-2017; Tanner, Elizabeth/E-9242-2010; ALFOTAWI, RANDA/N-2623-2019	ALFOTAWI, RANDA A/0000-0003-4556-4099; Tanner, Elizabeth/0000-0003-2257-0218; ALFOTAWI, RANDA/0000-0003-4556-4099; Ayoub, Ashraf/0000-0002-2760-6008; Dalby, Matthew/0000-0002-0528-3359	Biotechnology and Biological Sciences Research Council [BB/G008868/1, JF20604] Funding Source: Medline; BBSRC [BB/G008868/1] Funding Source: UKRI; EPSRC [EP/G048703/1, EP/K034898/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Abu Serriah M, 2006, J CRANIO MAXILLOFAC, V34, P62; Alfotawi R, J CRANIOMAX IN PRESS; Alfotawi R, 2013, J TISSUE ENG, V4, DOI 10.1177/2041731413509645; Ayoub A, 2007, INT J ORAL MAX SURG, V36, P1183, DOI 10.1016/j.ijom.2007.07.012; Berglund JD, 2003, BRIT J PHARMACOL, V140, P627, DOI 10.1038/sj.bjp.0705457; Burkus JK, 2003, SPINE, V28, P372, DOI 10.1097/00007632-200302150-00012; Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023; Cook SD, 2005, J BIOMED MATER RES B, V75B, P137, DOI 10.1002/jbm.b.30271; Das A, 2013, BIOMATERIALS, V34, P9853, DOI 10.1016/j.biomaterials.2013.08.015; Eck KR, 2000, J SPINAL DISORD, V13, P501, DOI 10.1097/00002517-200012000-00006; Frost HM, 1999, J BONE MINER RES, V14, P1816, DOI 10.1359/jbmr.1999.14.11.1816; Gauthier O, 2003, J BIOMED MATER RES A, V66A, P47, DOI 10.1002/jbm.a.10506; Gimbel M, 2007, J CRANIOFAC SURG, V18, P895, DOI 10.1097/scs.0b013e3180a771af; Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x; Hamada Y, 2005, CLEFT PALATE-CRAN J, V42, P128, DOI 10.1597/03-035.1; Heliotis M, 2006, INT J ORAL MAX SURG, V35, P265, DOI 10.1016/j.ijom.2005.07.013; Ito K, 2001, CLIN ORAL IMPLAN RES, V12, P539, DOI 10.1034/j.1600-0501.2001.120516.x; Jeffcoat MK, 2000, PERIODONTOL 2000, V23, P94, DOI 10.1034/j.1600-0757.2000.2230109.x; Kim BC, 2013, J CRANIOFAC SURG, V24, pE409, DOI 10.1097/SCS.0b013e318292c91d; KINNEY JH, 1995, J BONE MINER RES, V10, P264; Kothari M, 1998, BONE, V22, P437, DOI 10.1016/S8756-3282(98)00031-3; Lagravere MO, 2006, DENTOMAXILLOFAC RAD, V35, P407, DOI 10.1259/dmfr/55276404; Liu FJ, 2012, J ORTHOP RES, V30, P1095, DOI 10.1002/jor.22038; Lu M, 2003, BRIT J ORAL MAX SURG, V41, P385, DOI 10.1016/S0266-4356(03)00169-4; Lu M, 2013, CLIN ORTHOP RELAT R, V471, P2987, DOI 10.1007/s11999-013-3021-8; Meijer GJ, 2008, BIOMATERIALS, V29, P3053, DOI 10.1016/j.biomaterials.2008.03.012; Meirelles LD, 2009, TISSUE ENG PT A, V15, P221, DOI 10.1089/ten.tea.2008.0103; Mulconrey DS, 2008, SPINE, V33, P2153, DOI 10.1097/BRS.0b013e31817bd91e; Muller R, 1997, ST HEAL T, V40, P61; Muller R, 1998, BONE, V23, P59, DOI 10.1016/S8756-3282(98)00068-4; Nilsson M, 2003, INJECTABLE CALCIUM S; Oberoi S, 2009, CLEFT PALATE-CRAN J, V46, P503, DOI 10.1597/08-153.1; Su JS, 2013, INT J MOL SCI, V14, P12714, DOI 10.3390/ijms140612714; TURNER CH, 1995, BONE, V17, P85, DOI 10.1016/8756-3282(95)00148-7; Warnke PH, 2006, BIOMATERIALS, V27, P3163, DOI 10.1016/j.biomaterials.2006.01.050; Weldon E, 2008, CONE BEAM CT IN VITR	36	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107403	10.1371/journal.pone.0107403	http://dx.doi.org/10.1371/journal.pone.0107403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226170	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000344317700051
J	Ortega, A; Rosello-Lleti, E; Tarazon, E; Molina-Navarro, MM; Martinez-Dolz, L; Gonzalez-Juanatey, JR; Lago, F; Montoro-Mateos, JD; Salvador, A; Rivera, M; Portoles, M				Ortega, Ana; Rosello-Lleti, Esther; Tarazon, Estefania; Micaela Molina-Navarro, Maria; Martinez-Dolz, Luis; Ramon Gonzalez-Juanatey, Jose; Lago, Francisca; David Montoro-Mateos, Jose; Salvador, Antonio; Rivera, Miguel; Portoles, Manuel			Endoplasmic Reticulum Stress Induces Different Molecular Structural Alterations in Human Dilated and Ischemic Cardiomyopathy	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; HEART-FAILURE; ER-STRESS; NUCLEOCYTOPLASMIC TRANSPORT; MEMBRANE-PROTEINS; FAILING HEART; EXPRESSION; GUIDELINES; PHOSPHORYLATION; CARDIOMYOCYTES	Background: The endoplasmic reticulum (ER) is a multifunctional organelle responsible for the synthesis and folding of proteins as well as for signalling and calcium storage, that has been linked to the contraction-relaxation process. Perturbations of its homeostasis activate a stress response in diseases such as heart failure (HF). To elucidate the alterations in ER molecular components, we analyze the levels of ER stress and structure proteins in human dilated (DCM) and ischemic (ICM) cardiomyopathies, and its relationship with patient's functional status. Methods and Results: We examined 52 explanted human hearts from DCM (n = 21) and ICM (n = 21) subjects and 10 nonfailing hearts as controls. Our results showed specific changes in stress (IRE1, p < 0.05; p-IRE1, p < 0.05) and structural (Reticulon 1, p < 0.01) protein levels. The stress proteins GRP78, XBP1 and ATF6 as well as the structural proteins RRBP1, kinectin, and Nogo A and B, were upregulated in both DCM and ICM patients. Immunofluorescence results were concordant with quantified Western blot levels. Moreover, we show a novel relationship between stress and structural proteins. RRBP1, involved in procollagen synthesis and remodeling, was related with left ventricular function. Conclusions: In the present study, we report the existence of alterations in ER stress response and shaping proteins. We show a plausible effect of the ER stress on ER structure in a suitable sample of DCM and ICM subjects. Patients with higher values of RRBP1 had worse left ventricular function.	[Ortega, Ana; Rosello-Lleti, Esther; Tarazon, Estefania; Micaela Molina-Navarro, Maria; David Montoro-Mateos, Jose; Rivera, Miguel; Portoles, Manuel] La Fe Univ Hosp, Cardiocirculatory Unit, Hlth Res Inst, Valencia, Spain; [Martinez-Dolz, Luis; Salvador, Antonio] La Fe Univ Hosp, Dept Cardiol, Heart Failure & Transplantat Unit, Valencia, Spain; [Ramon Gonzalez-Juanatey, Jose; Lago, Francisca] Univ Clin Hosp, Dept Cardiol, Cellular & Mol Cardiol Res Unit, Santiago De Compostela, Spain; [Ramon Gonzalez-Juanatey, Jose; Lago, Francisca] Univ Clin Hosp, Inst Biomed Res, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Portoles, M (corresponding author), La Fe Univ Hosp, Cardiocirculatory Unit, Hlth Res Inst, Valencia, Spain.	portoles_man@gva.es	Roselló Lletí, Esther/ABG-8503-2020; Ortega, Ana/AAG-5941-2020; Dolz, Luis Martinez/X-4627-2018; Tarazón, Estefanía/D-6950-2017; Roselló-Lletí, Esther/B-2695-2017; Ortega, Ana AO/D-3027-2017; PORTOLES, MANUEL/B-4789-2009	Roselló Lletí, Esther/0000-0003-2627-6104; Ortega, Ana/0000-0002-9763-0505; Dolz, Luis Martinez/0000-0001-5145-8191; Tarazón, Estefanía/0000-0003-3466-2558; Roselló-Lletí, Esther/0000-0003-2627-6104; Ortega, Ana AO/0000-0002-9763-0505; PORTOLES, MANUEL/0000-0002-4415-7160; , Micaela/0000-0002-2103-0351; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388	NIH "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III" [RETICS 12/0042/0003]; NIH "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III" [FIS Project] [PI10/00275]	NIH "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III"; NIH "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III" [FIS Project]	This work was supported by grants from the NIH "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III". [RETICS 12/0042/0003, FIS Project PI10/00275]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam S, 2012, J CELL MOL MED, V16, P2176, DOI 10.1111/j.1582-4934.2012.01526.x; Becker F, 1999, J CELL BIOL, V146, P273, DOI 10.1083/jcb.146.2.273; Benyamini P, 2009, MOL BIOL CELL, V20, P732, DOI 10.1091/mbc.E08-07-0682; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Cortes R, 2010, CARDIOVASC RES, V85, P464, DOI 10.1093/cvr/cvp336; Davis RC, 2000, BRIT MED J, V320, P39, DOI 10.1136/bmj.320.7226.39; Dickstein K, 2010, EUROPACE, V12, P1526, DOI 10.1093/europace/euq392; Doroudgar S, 2013, J MOL CELL CARDIOL, V55, P85, DOI 10.1016/j.yjmcc.2012.10.006; Doroudgar S, 2009, J BIOL CHEM, V284, P29735, DOI 10.1074/jbc.M109.018036; Fu HY, 2008, CARDIOVASC RES, V79, P600, DOI 10.1093/cvr/cvn128; Garcia-Rua V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037505; Goyal U, 2013, BBA-MOL CELL RES, V1833, P2492, DOI 10.1016/j.bbamcr.2013.04.009; Hamada H, 2004, MOL CELL BIOL, V24, P8007, DOI 10.1128/MCB.24.18.8007-8017.2004; Hein S, 2000, CARDIOVASC RES, V45, P273, DOI 10.1016/S0008-6363(99)00268-0; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Liu XH, 2008, SHOCK, V30, P422, DOI 10.1097/SHK.0b013e318164ca29; Macrae Duncan J, 2007, Proc Am Thorac Soc, V4, P176, DOI 10.1513/pats.200701-011GC; Molina-Navarro MM, 2013, INT J CARDIOL, V168, P2837, DOI 10.1016/j.ijcard.2013.03.192; Minamino T, 2010, J MOL CELL CARDIOL, V48, P1105, DOI 10.1016/j.yjmcc.2009.10.026; Oikawa D, 2007, J CELL SCI, V120, P1681, DOI 10.1242/jcs.002808; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Pawlak A, 2013, AM J CARDIOL, V111, P393, DOI 10.1016/j.amjcard.2012.09.036; Remme WJ, 2002, EUR J HEART FAIL, V4, P11, DOI 10.1016/S1388-9842(01)00231-8; Rosca MG, 2008, CARDIOVASC RES, V80, P30, DOI 10.1093/cvr/cvn184; Rosca MG, 2010, CARDIOVASC RES, V88, P40, DOI 10.1093/cvr/cvq240; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Sun YY, 2008, ACTA BIOCHIM POL, V55, P511, DOI 10.18388/abp.2008_3057; Szegezdi E, 2003, ANN NY ACAD SCI, V1010, P186, DOI 10.1196/annals.1299.032; Tarazon E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048957; TOYOSHIMA I, 1992, J CELL BIOL, V118, P1121, DOI 10.1083/jcb.118.5.1121; Tumanovs'ka L V, 2008, Fiziol Zh, V54, P10; Ueno T, 2012, NUCLEIC ACIDS RES, V40, P3006, DOI 10.1093/nar/gkr1197; Ueno T, 2010, J BIOL CHEM, V285, P29941, DOI 10.1074/jbc.M109.094607; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Winters AL, 2005, ANAL BIOCHEM, V346, P43, DOI 10.1016/j.ab.2005.07.041; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x	37	39	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107635	10.1371/journal.pone.0107635	http://dx.doi.org/10.1371/journal.pone.0107635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226522	Green Submitted, Green Published, gold			2022-12-25	WOS:000344317700070
J	Due, MR; Yang, XF; Allette, YM; Randolph, AL; Ripsch, MS; Wilson, SM; Dustrude, ET; Khanna, R; White, FA				Due, Michael R.; Yang, Xiao-Fang; Allette, Yohance M.; Randolph, Aaron L.; Ripsch, Matthew S.; Wilson, Sarah M.; Dustrude, Erik T.; Khanna, Rajesh; White, Fletcher A.			Carbamazepine Potentiates the Effectiveness of Morphine in a Rodent Model of Neuropathic Pain	PLOS ONE			English	Article							GATED SODIUM-CHANNELS; DORSAL-ROOT GANGLION; RECEPTOR 4; MECHANICAL ALLODYNIA; DIABETIC-NEUROPATHY; NERVE INJURY; DRG NEURONS; EXPRESSION; HYPERALGESIA; GABAPENTIN	Approximately 60% of morphine is glucuronidated to morphine-3-glucuronide (M3G) which may aggravate preexisting pain conditions. Accumulating evidence indicates that M3G signaling through neuronal Toll-like receptor 4 (TLR4) may be central to this proalgesic signaling event. These events are known to include elevated neuronal excitability, increased voltage-gated sodium (NaV) current, tactile allodynia and decreased opioid analgesic efficacy. Using an in vitro ratiometric-based calcium influx analysis of acutely dissociated small and medium-diameter neurons derived from lumbar dorsal root ganglion (DRG), we observed that M3G-sensitive neurons responded to lipopolysaccharide (LPS) and over 35% of these M3G/LPS-responsive cells exhibited sensitivity to capsaicin. In addition, M3G-exposed sensory neurons significantly increased excitatory activity and potentiated NaV current as measured by current and voltage clamp, when compared to baseline level measurements. The M3G-dependent excitability and potentiation of NaV current in these sensory neurons could be reversed by the addition of carbamazepine (CBZ), a known inhibitor of several NaV currents. We then compared the efficacy between CBZ and morphine as independent agents, to the combined treatment of both drugs simultaneously, in the tibial nerve injury (TNI) model of neuropathic pain. The potent anti-nociceptive effects of morphine (5 mg/kg, i.p.) were observed in TNI rodents at post-injury day (PID) 7-14 and absent at PID21-28, while administration of CBZ (10 mg/kg, i.p.) alone failed to produce anti-nociceptive effects at any time following TNI (PID 7-28). In contrast to either drug alone at PID28, the combination of morphine and CBZ completely attenuated tactile hyperalgesia in the rodent TNI model. The basis for the potentiation of morphine in combination with CBZ may be due to the effects of a latent upregulation of NaV1.7 in the DRG following TNI. Taken together, our observations demonstrate a potential therapeutic use of morphine and CBZ as a combinational treatment for neuropathic pain.	[Due, Michael R.; Randolph, Aaron L.; Ripsch, Matthew S.; White, Fletcher A.] Indiana Univ, Sch Med, Dept Anesthesia, Indianapolis, IN 46202 USA; [Yang, Xiao-Fang; Khanna, Rajesh] Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA; [Allette, Yohance M.; Dustrude, Erik T.] Indiana Univ, Sch Med, Dept Cell Biol & Anat, Indianapolis, IN USA; [Wilson, Sarah M.] Indiana Univ, Sch Med, Paul & Carole Stark Neurosci Res Inst, Program Med Neurosci, Indianapolis, IN USA; [Khanna, Rajesh; White, Fletcher A.] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; University of Arizona; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	White, FA (corresponding author), Indiana Univ, Sch Med, Dept Anesthesia, Indianapolis, IN 46202 USA.	fawhite@iupui.edu	White, Fletcher/F-3203-2015	White, Fletcher/0000-0002-8408-9262; Due, Michael/0000-0001-6771-7100; Khanna, Rajesh/0000-0002-9066-2969	NIH NIDA [R01DA026040]; NIDDK [DK100905]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM077229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026040] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002209] Funding Source: NIH RePORTER	NIH NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NIH NIDA R01DA026040 and NIDDK DK100905. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Allette YM, 2014, BRAIN BEHAV IMMUN, V42, P169, DOI 10.1016/j.bbi.2014.06.199; Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; Bhangoo S, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-38; Black JA, 2009, GLIA, V57, P1072, DOI 10.1002/glia.20830; Brittain JM, 2011, NAT MED, V17, P822, DOI 10.1038/nm.2345; Decosterd I, 2004, ANESTH ANALG, V99, P457; Devor M, 2006, J PAIN, V7, pS3, DOI 10.1016/j.jpain.2005.09.006; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Diogenes A, 2011, J DENT RES, V90, P759, DOI 10.1177/0022034511400225; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; Due MR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-200; Eidson LN, 2013, J NEUROSCI, V33, P15952, DOI 10.1523/JNEUROSCI.1609-13.2013; Eisenberg E, 2005, JAMA-J AM MED ASSOC, V293, P3043, DOI 10.1001/jama.293.24.3043; Erichsen HK, 2002, PAIN, V98, P151, DOI 10.1016/S0304-3959(02)00039-8; Feldman P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-180; Fischer TZ, 2009, ANN NEUROL, V65, P733, DOI 10.1002/ana.21678; Gilron I, 2005, NEW ENGL J MED, V352, P1324, DOI 10.1056/NEJMoa042580; Heinl C, 2011, J NEUROSCI, V31, P16748, DOI 10.1523/JNEUROSCI.3491-11.2011; Hou LF, 2001, J NEUROSCI RES, V66, P592, DOI 10.1002/jnr.1249; Hutchinson MR, 2011, PHARMACOL REV, V63, P772, DOI 10.1124/pr.110.004135; Hutchinson MR, 2010, BRAIN BEHAV IMMUN, V24, P83, DOI 10.1016/j.bbi.2009.08.004; Inturrisi CE, 2010, OPIOID ANALGESICS; Jo S, 2014, MOL PHARMACOL, V85, P381, DOI 10.1124/mol.113.090472; Ju WN, 2013, J NEUROCHEM, V124, P869, DOI 10.1111/jnc.12070; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Laedermann CJ, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-19; Laedermann CJ, 2013, J CLIN INVEST, V123, P3002, DOI 10.1172/JCI68996; Lee BH, 2000, NEUROREPORT, V11, P657, DOI 10.1097/00001756-200003200-00002; Lewis SS, 2013, BRAIN BEHAV IMMUN, V30, P24, DOI 10.1016/j.bbi.2013.01.005; Ma C, 2005, PAIN, V113, P106, DOI 10.1016/j.pain.2004.10.001; Ma C, 2003, J NEUROPHYSIOL, V89, P1588, DOI 10.1152/jn.00855.2002; Ma C, 2007, J NEUROSCI, V27, P14059, DOI 10.1523/JNEUROSCI.3699-07.2007; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Minett MS, 2014, CELL REP, V6, P301, DOI 10.1016/j.celrep.2013.12.033; Miyazaki R, 2012, ANESTH ANALG, V115, P182, DOI 10.1213/ANE.0b013e31824f94ca; O'Connor AB, 2009, AM J MED, V122, pS22, DOI 10.1016/j.amjmed.2009.04.007; Ochoa-Cortes F, 2010, AM J PHYSIOL-GASTR L, V299, pG723, DOI 10.1152/ajpgi.00494.2009; Ossipov MH, 2004, J NEUROBIOL, V61, P126, DOI 10.1002/neu.20091; Ossipov MH, 2005, BIOPOLYMERS, V80, P319, DOI 10.1002/bip.20254; Raouf R, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-21; Sheets PL, 2008, J PHARMACOL EXP THER, V326, P89, DOI 10.1124/jpet.107.133413; Sorge RE, 2011, J NEUROSCI, V31, P15450, DOI 10.1523/JNEUROSCI.3859-11.2011; Stokes JA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-148; Suter MR, 2013, ANESTHESIOLOGY, V118, P160, DOI 10.1097/ALN.0b013e318278cade; Theile JW, 2011, MOL PHARMACOL, V80, P724, DOI 10.1124/mol.111.072751; Tse KH, 2014, NEUROSCIENCE, V267, P241, DOI 10.1016/j.neuroscience.2014.02.041; Vanderah TW, 2001, J NEUROSCI, V21, P279, DOI 10.1523/JNEUROSCI.21-01-00279.2001; Wang SY, 2010, ANESTHESIOLOGY, V113, P655, DOI 10.1097/ALN.0b013e3181e89a93; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Wang YY, 2011, ACS CHEM NEUROSCI, V2, P317, DOI 10.1021/cn200024z; Watson CPN, 2003, PAIN, V105, P71, DOI 10.1016/S0304-3959(03)00160-X; Waxman SG, 2014, NAT NEUROSCI, V17, P153, DOI 10.1038/nn.3602; YAKSH TL, 1986, ANESTHESIOLOGY, V64, P590, DOI 10.1097/00000542-198605000-00008; Zhang JL, 2013, BRAIN RES, V1493, P13, DOI 10.1016/j.brainres.2012.11.032	55	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107399	10.1371/journal.pone.0107399	http://dx.doi.org/10.1371/journal.pone.0107399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25221944	gold, Green Published, Green Submitted			2022-12-25	WOS:000341774800063
J	Sako, H; Fukuda, K; Saikawa, Y; Nakamura, R; Takahashi, T; Wada, N; Kawakubo, H; Takeuchi, H; Ohmori, T; Kitagawa, Y				Sako, Hiroyuki; Fukuda, Kazumasa; Saikawa, Yoshiro; Nakamura, Rieko; Takahashi, Tsunehiro; Wada, Norihito; Kawakubo, Hirohumi; Takeuchi, Hiroya; Ohmori, Tai; Kitagawa, Yuko			Antitumor Effect of the Tyrosine Kinase Inhibitor Nilotinib on Gastrointestinal Stromal Tumor (GIST) and Imatinib-Resistant GIST Cells	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; HIGH-DOSE IMATINIB; SARCOMA-GROUP; PHASE-III; WILD-TYPE; KIT GENE; C-KIT; SORAFENIB; SUNITINIB; MUTATION	Despite the benefits of imatinib for treating gastrointestinal stromal tumors (GIST), the prognosis for high risk GIST and imatinib-resistant (IR) GIST remains poor. The mechanisms of imatinib resistance have not yet been fully clarified. The aim of the study was to establish imatinib-resistant cell lines and investigate nilotinib, a second generation tyrosine kinase inhibitor (TKI), in preclinical models of GIST and imatinib-resistant GIST. For a model of imatinib-resistant GIST, we generated resistant cells from GK1C and GK3C cell lines by exposing them to imatinib for 6 months. The parent cell lines GK1C and GK3C showed imatinib sensitivity with IC50 of 4.59 +/- 0.97 mu M and 11.15 +/- 1.48 mu M, respectively. The imatinib-resistant cell lines GK1C-IR and GK3C-IR showed imatinib resistance with IC50 values of 11.74 +/- 0.17 mu M (P<0.001) and 41.37 +/- 1.07 mu M (P<0.001), respectively. The phosphorylation status of key cell signaling pathways, receptor tyrosine kinase KIT (CD117), platelet-derived growth factor receptor alpha (PDGFRA) and downstream signaling kinases: serine-threonine kinase Akt (AKT) and extracellular signal-regulated kinase 1/2 (ERK1/2) or the non-receptor tyrosine kinase: proto-oncogene tyrosine-protein kinase Src (SRC), was analyzed in established cell lines and ERK1/2 phosphorylation was found to be increased compared to the parental cells. Nilotinib demonstrated significant antitumor efficacy against GIST xenograft lines and imatinib-resistant GIST cell lines. Thus, nilotinib may have clinical potential for patients with GIST or imatinib-resistant GIST.	[Sako, Hiroyuki; Fukuda, Kazumasa; Saikawa, Yoshiro; Nakamura, Rieko; Takahashi, Tsunehiro; Wada, Norihito; Kawakubo, Hirohumi; Takeuchi, Hiroya; Ohmori, Tai; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 160, Japan	Keio University	Saikawa, Y (corresponding author), Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 160, Japan.	saiky@z8.keio.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22791302]; Novartis Pharma [21-133]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Novartis Pharma	Funding provided by a Grant-in-Aid for Young Scientists (B), The Ministry of Education, Culture, Sports, Science and Technology (MEXT). Grant Number: 22791302, URL: http://www.jsps.go.jp/j-grantsinaid/. Novartis Pharma funded research. Grant Number: 21-133, URL: NOT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonescu CR, 2005, LAB INVEST, V85, p11A; Blanke CD, 2008, J CLIN ONCOL, V26, P626, DOI 10.1200/JCO.2007.13.4452; Blay JY, 2007, J CLIN ONCOL, V25, P1107, DOI 10.1200/JCO.2006.09.0183; Blay JY, 2005, ANN ONCOL, V16, P566, DOI 10.1093/annonc/mdi127; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Debiec-Rychter M, 2004, EUR J CANCER, V40, P689, DOI 10.1016/j.ejca.2003.11.025; DeMatteo RP, 2000, ANN SURG, V231, P51, DOI 10.1097/00000658-200001000-00008; Demetri GD, 2013, LANCET, V381, P295, DOI 10.1016/S0140-6736(12)61857-1; Fletcher CDM, 2002, HUM PATHOL, V33, P459, DOI 10.1053/hupa.2002.123545; Fukuda K, 2013, ONCOL REP, V30, P71, DOI 10.3892/or.2013.2425; Ganjoo KN, 2014, ANN ONCOL, V25, P236, DOI 10.1093/annonc/mdt484; Guo T, 2007, CLIN CANCER RES, V13, P4874, DOI 10.1158/1078-0432.CCR-07-0484; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hou XW, 2013, ONCOL LETT, V5, P552, DOI 10.3892/ol.2012.1019; Huynh H, 2009, MOL CANCER THER, V8, P152, DOI 10.1158/1535-7163.MCT-08-0553; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kindblom LG, 1998, AM J PATHOL, V152, P1259; Le Cesne A, 2010, LANCET ONCOL, V11, P942, DOI 10.1016/S1470-2045(10)70222-9; Manley PW, 2010, BBA-PROTEINS PROTEOM, V1804, P445, DOI 10.1016/j.bbapap.2009.11.008; Martin J, 2005, J CLIN ONCOL, V23, P6190, DOI 10.1200/JCO.2005.19.554; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Montemurro M, 2013, EUR J CANCER, V49, P1027, DOI 10.1016/j.ejca.2012.10.009; Nishida T, 2008, INT J CLIN ONCOL, V13, P244, DOI 10.1007/s10147-007-0746-y; Nishida T, 2008, CANCER SCI, V99, P799, DOI 10.1111/j.1349-7006.2008.00727.x; Pantaleo MA, 2012, ANTI-CANCER DRUG, V23, P567, DOI 10.1097/CAD.0b013e328352cc50; Quattrone A, 2014, MODERN PATHOLOGY, V18; Rankin C, 2004, J CLIN ONCOL, V22, p819S; Sawaki A, 2011, CANCER-AM CANCER SOC, V117, P4633, DOI 10.1002/cncr.26120; Schittenhelm MM, 2006, CANCER RES, V66, P473, DOI 10.1158/0008-5472.CAN-05-2050; Shinomura Y, 2005, J GASTROENTEROL, V40, P775, DOI 10.1007/s00535-005-1674-0; Sleijfer S, 2008, NAT CLIN PRACT ONCOL, V5, P102, DOI 10.1038/ncponc1037; Takahashi T, 2013, INT J CANCER, V133, P2737, DOI 10.1002/ijc.28282; Thao LB, 2009, CANCER BIOL THER, V8, P683, DOI 10.4161/cbt.8.8.7779; Tornillo L, 2006, J CLIN PATHOL, V59, P557, DOI 10.1136/jcp.2005.031112; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0; Wardelmann E, 2007, VIRCHOWS ARCH, V451, P743, DOI 10.1007/s00428-007-0473-9; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Weisberg E, 2006, GASTROENTEROLOGY, V131, P1734, DOI 10.1053/j.gastro.2006.09.017; White DL, 2012, HAEMATOL-HEMATOL J, V97, P907, DOI 10.3324/haematol.2011.056457; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055	42	10	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107613	10.1371/journal.pone.0107613	http://dx.doi.org/10.1371/journal.pone.0107613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25221952	gold, Green Submitted, Green Published			2022-12-25	WOS:000341774800087
J	Song, E; Fu, JL; Xia, XM; Su, CY; Song, Y				Song, Erqun; Fu, Juanli; Xia, Xiaomin; Su, Chuanyang; Song, Yang			Bazhen Decoction Protects against Acetaminophen Induced Acute Liver Injury by Inhibiting Oxidative Stress, Inflammation and Apoptosis in Mice	PLOS ONE			English	Article							CELL-DEATH; ENDOTHELIAL-CELLS; TNF-ALPHA; HEPATOTOXICITY; ANTIOXIDANT; PAEONIFLORIN; DAMAGE; LPS; MITOCHONDRIA; MECHANISMS	Bazhen decoction is a widely used traditional Chinese medicinal decoction, but the scientific validation of its therapeutic potential is lacking. The objective of this study was to investigate corresponding anti-oxidative, anti-inflammatory and antiapoptosis activities of Bazhen decoction, using acetaminophen-treated mice as a model system. A total of 48 mice were divided into four groups. Group I, negative control, treated with vehicle only. Group II, fed with 500 mg/kg/day Bazhen decoction for 10 continuous days. Group III, received a single dose of 900 mg/kg acetaminophen. Group IV, fed with 500 mg/kg/day Bazhen decoction for 10 continuous days and a single dose of 900 mg/kg acetaminophen 30 min before last Bazhen decoction administration. Bazhen decoction administration significantly decrease acetaminophen-induced serum ALT, AST, ALP, LDH, TNF-alpha, IL-1 beta, ROS, TBARS and protein carbonyl group levels, as well as GSH depletion and loss of MMP. Bazhen decoction restore SOD, CAT, GR and GPx activities and depress the expression of pro-inflammatory factors, such as iNOS, COX-2, TNF-alpha, NF-kappa B, IL-1 beta and IL-6, respectively. Moreover, Bazhen decoction down-regulate acetaminophen-induced Bax/Bcl-2 ratio, caspase 3, caspase 8 and caspase 9. These results suggest the anti-oxidative, anti-inflammatory and anti-apoptosis properties of Bazhen decoction towards acetaminophen-induced liver injury in mice.	[Song, Erqun; Fu, Juanli; Xia, Xiaomin; Su, Chuanyang; Song, Yang] Southwest Univ, Coll Pharmaceut Sci, Key Lab Luminescence & Real Time Analyt Chem, Minist Educ, Chongqing, Peoples R China	Southwest University - China	Song, Y (corresponding author), Southwest Univ, Coll Pharmaceut Sci, Key Lab Luminescence & Real Time Analyt Chem, Minist Educ, Chongqing, Peoples R China.	songyangwenrong@hotmail.com	Song, Yang/HGU-4953-2022; Song, Yang/ABE-9615-2021		Fundamental Research Funds for the Central Universities [XDJK2014A020, XDJK2013B009]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Fundamental Research Funds for the Central Universities (XDJK2014A020, XDJK2013B009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ML, 2001, MOL PHARMACOL, V60, P907, DOI 10.1124/mol.60.5.907; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; ARNAIZ SL, 1995, FREE RADICAL BIO MED, V19, P303, DOI 10.1016/0891-5849(95)00023-Q; Botta D, 2006, J BIOL CHEM, V281, P28865, DOI 10.1074/jbc.M605143200; Boulares AH, 2002, PHARMACOL TOXICOL, V90, P38, DOI 10.1034/j.1600-0773.2002.900108.x; Brown JM, 2012, TOXICOL LETT, V212, P320, DOI 10.1016/j.toxlet.2012.05.018; Cheng Y, 2005, ACTA PHARMACOL SIN, V26, P143, DOI 10.1111/j.1745-7254.2005.00034.x; Choi JH, 2009, J MED FOOD, V12, P320, DOI 10.1089/jmf.2007.0691; Colle D, 2012, J MED FOOD, V15, P549, DOI 10.1089/jmf.2011.0282; El-Hassan H, 2003, TOXICOL APPL PHARM, V191, P118, DOI 10.1016/S0041-008X(03)00240-0; Ghosh J, 2010, TOXICOLOGY, V268, P8, DOI 10.1016/j.tox.2009.11.011; Gujral JS, 2002, TOXICOL SCI, V67, P322, DOI 10.1093/toxsci/67.2.322; Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12; Huang ZF, 2000, BIOCHEM PHARMACOL, V59, P187, DOI 10.1016/S0006-2952(99)00312-3; Jaeschke Hartmut, 2005, Expert Opin Drug Metab Toxicol, V1, P389, DOI 10.1517/17425255.1.3.389; Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688; Jaeschke H, 2012, LIVER INT, V32, P8, DOI 10.1111/j.1478-3231.2011.02501.x; Jaeschke H, 2011, LIFE SCI, V88, P737, DOI 10.1016/j.lfs.2011.01.025; Ji QL, 2012, TOXICOL IN VITRO, V26, P455, DOI 10.1016/j.tiv.2012.01.016; Kim ID, 2010, ARCH PHARM RES, V33, P959, DOI 10.1007/s12272-010-0620-8; Kim TG, 2013, J ENDODONT, V39, P461, DOI 10.1016/j.joen.2012.11.022; Kim TW, 2012, INT IMMUNOPHARMACOL, V12, P110, DOI 10.1016/j.intimp.2011.10.023; Kumari A, 2012, FOOD CHEM TOXICOL, V50, P1781, DOI 10.1016/j.fct.2012.02.042; Kumari A, 2012, LIFE SCI, V90, P561, DOI 10.1016/j.lfs.2012.01.012; Lee KJ, 2001, CANCER LETT, V174, P73, DOI 10.1016/S0304-3835(01)00678-4; Li G, 2013, WORLD J GASTROENTERO, V19, P7440, DOI 10.3748/wjg.v19.i42.7440; Li WenLan, 2012, Journal of Medicinal Plants Research, V6, P2601; Liu WX, 2012, WORLD J GASTROENTERO, V18, P2197, DOI 10.3748/wjg.v18.i18.2197; Liu Y, 2006, J PHARMACEUT BIOMED, V41, P1642, DOI 10.1016/j.jpba.2006.02.033; Muir KW, 2007, CURR OPIN NEUROL, V20, P334, DOI 10.1097/WCO.0b013e32813ba151; O'Brien PJ, 2000, HUM EXP TOXICOL, V19, P277, DOI 10.1191/096032700678815918; Olaleye MT, 2008, EXP TOXICOL PATHOL, V59, P319, DOI 10.1016/j.etp.2007.10.003; Ray SD, 1996, J PHARMACOL EXP THER, V279, P1470; Sener G, 2006, HEPATOL RES, V35, P62, DOI 10.1016/j.hepres.2006.02.005; Shang XF, 2010, J ETHNOPHARMACOL, V128, P279, DOI 10.1016/j.jep.2010.01.006; Su SL, 2013, CHIN MED-UK, V8, DOI 10.1186/1749-8546-8-5; Sun YX, 2010, J ASIAN NAT PROD RES, V12, P1051, DOI 10.1080/10286020.2010.535520; Wang L, 2012, CAN J PHYSIOL PHARM, V90, P229, DOI [10.1139/Y11-127, 10.1139/y11-127]; Wang YH, 2008, BRIT J PHARMACOL, V154, P1327, DOI 10.1038/bjp.2008.202; Williams CD, 2010, TOXICOL APPL PHARM, V247, P169, DOI 10.1016/j.taap.2010.07.004; Wu YL, 2010, PHYTOMEDICINE, V17, P475, DOI 10.1016/j.phymed.2009.07.011; Xu YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068757; Yu J, 2013, TOXICOL LETT, V218, P224, DOI 10.1016/j.toxlet.2013.01.028; Yuan HD, 2010, J ETHNOPHARMACOL, V127, P528, DOI 10.1016/j.jep.2009.10.002	44	47	51	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107405	10.1371/journal.pone.0107405	http://dx.doi.org/10.1371/journal.pone.0107405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222049	Green Submitted, Green Published, gold			2022-12-25	WOS:000341774800065
J	Ju, YI; Sone, T; Ohnaru, K; Tanaka, K; Yamaguchi, H; Fukunaga, M				Ju, Yong-In; Sone, Teruki; Ohnaru, Kazuhiro; Tanaka, Kensuke; Yamaguchi, Hidetaka; Fukunaga, Masao			Effects of Different Types of Jump Impact on Trabecular Bone Mass and Microarchitecture in Growing Rats	PLOS ONE			English	Article							EXERCISE; RESISTANCE; STRENGTH; ENERGY; REMOBILIZATION; ARCHITECTURE; SUSPENSION; TURNOVER; CHILDREN; FORCES	Substantial evidence from animal studies indicates that jumping increases bone mass and strength. However, most studies have focused on the take-off, rather than the landing phase of jumps. Thus, we compared the effects of landing and upward jump impact on trabecular bone mass and microarchitecture. Male Wistar rats aged 10 weeks were randomly assigned to the following groups: sedentary control (CON), 40-cm upward jumps (40UJ); 40-cm drop jumps (40DJ); and 60-cm drop jumps (60DJ) (n = 10 each). The upward jump protocol comprised 10 upward jumps/day, 5 days/week for 8 weeks to a height of 40 cm. The drop jump protocol comprised dropping rats from a height of 40 or 60 cm at the same frequency and time period as the 40UJ group. Trabecular bone mass, architecture, and mineralization at the distal femoral metaphysis were evaluated using microcomputed tomography. Ground reaction force (GRF) was measured using a force platform. Bone mass was significantly higher in the 40UJ group compared with the DJ groups (+ 49.1% and + 28.3%, respectively), although peak GRF (-57.8% and -122.7%, respectively) and unit time force (-21.6% and -36.2%, respectively) were significantly lower in the 40UJ group. These results showed that trabecular bone mass in growing rats is increased more effectively by the takeoff than by the landing phases of jumps and suggest that mechanical stress accompanied by muscle contraction would be more important than GRF as an osteogenic stimulus. However, the relevance of these findings to human bone physiology is unclear and requires further study.	[Ju, Yong-In] Kawasaki Univ Med Welf, Dept Hlth & Sports Sci, Kurashiki, Okayama, Japan; [Sone, Teruki; Tanaka, Kensuke] Kawasaki Med Sch, Dept Nucl Med, Kurashiki, Okayama, Japan; [Ohnaru, Kazuhiro] Kawasaki Med Sch, Dept Orthoped Surg, Kurashiki, Okayama, Japan; [Yamaguchi, Hidetaka] KIBI Int Univ, Sports Hlth Course Sch Social Sci, Dept Sports Social Management, Takahashi, Okayama, Japan; [Fukunaga, Masao] Kawasaki Med Sch, Kurashiki, Okayama, Japan	Kawasaki Medical School; Kawasaki Medical School; Kawasaki Medical School	Ju, YI (corresponding author), Kawasaki Univ Med Welf, Dept Hlth & Sports Sci, Kurashiki, Okayama, Japan.	jyi.k@mw.kawasaki-m.ac.jp			Kawasaki University of Medical Welfare Scientific Research Fund	Kawasaki University of Medical Welfare Scientific Research Fund	This study was supported by Kawasaki University of Medical Welfare Scientific Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian MJ, 1983, BIOMECHANICS B, P903; Carroll AM, 2008, J APPL PHYSIOL, V105, P1262, DOI 10.1152/japplphysiol.01316.2007; Chiba K, 2012, J BONE MINER RES, V27, P1511, DOI 10.1002/jbmr.1609; Decker MJ, 2003, CLIN BIOMECH, V18, P662, DOI 10.1016/S0268-0033(03)00090-1; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Forwood MR, 1996, AM J PHYSIOL-ENDOC M, V270, pE419, DOI 10.1152/ajpendo.1996.270.3.E419; Fuchs RK, 2001, J BONE MINER RES, V16, P148, DOI 10.1359/jbmr.2001.16.1.148; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Honda A, 2001, J BONE MINER RES, V16, P1688, DOI 10.1359/jbmr.2001.16.9.1688; Johannsen N, 2003, BONE, V33, P533, DOI 10.1016/S8756-3282(03)00220-5; Ju YI, 2008, J APPL PHYSIOL, V104, P1594, DOI 10.1152/japplphysiol.01004.2007; Ju YI, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-35; Ju YI, 2012, J APPL PHYSIOL, V112, P766, DOI 10.1152/japplphysiol.01219.2011; Judex S, 2000, J APPL PHYSIOL, V88, P2183, DOI 10.1152/jappl.2000.88.6.2183; Kato T, 2006, J APPL PHYSIOL, V100, P839, DOI 10.1152/japplphysiol.00666.2005; Kohrt WM, 2004, MED SCI SPORT EXER, V36, P1985, DOI 10.1249/01.MSS.0000142662.21767.58; Konow N, 2012, P ROY SOC B-BIOL SCI, V279, P1108, DOI 10.1098/rspb.2011.1435; Lin HS, 2013, J SPORT SCI MED, V12, P1; Lu TW, 1997, J BIOMECH, V30, P1101, DOI 10.1016/S0021-9290(97)00090-0; McGowan CP, 2005, J EXP BIOL, V208, P41, DOI 10.1242/jeb.01305; Notomi T, 2000, EUR J APPL PHYSIOL, V82, P268, DOI 10.1007/s004210000195; Notomi T, 2000, EUR J APPL PHYSIOL, V83, P469, DOI 10.1007/s004210000316; Richard DP, 1996, AM J SPORT MED, V24, P676, DOI 10.1177/036354659602400520; Rittweger J., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P174; Swift JM, 2010, J APPL PHYSIOL, V109, P1600, DOI 10.1152/japplphysiol.00596.2010; Umemura Y, 1997, J BONE MINER RES, V12, P1480, DOI 10.1359/jbmr.1997.12.9.1480; UMEMURA Y, 1995, INT J SPORTS MED, V16, P364, DOI 10.1055/s-2007-973021; Welch JM, 2008, BONE, V42, P660, DOI 10.1016/j.bone.2007.12.220; Welch JM, 2004, J APPL PHYSIOL, V97, P1859, DOI 10.1152/japplphysiol.00438.2004; Wu J, 1998, J BONE MINER RES, V13, P900, DOI 10.1359/jbmr.1998.13.5.900; Yeow CH, 2009, KNEE, V16, P381, DOI 10.1016/j.knee.2009.02.002	31	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107953	10.1371/journal.pone.0107953	http://dx.doi.org/10.1371/journal.pone.0107953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233222	Green Submitted, gold, Green Published			2022-12-25	WOS:000342921200067
J	Radigan, KA; Morales-Nebreda, L; Soberanes, S; Nicholson, T; Nigdelioglu, R; Cho, T; Chi, M; Hamanaka, RB; Misharin, AV; Perlman, H; Budinger, GRS; Mutlu, GM				Radigan, Kathryn A.; Morales-Nebreda, Luisa; Soberanes, Saul; Nicholson, Trevor; Nigdelioglu, Recep; Cho, Takugo; Chi, Monica; Hamanaka, Robert B.; Misharin, Alexander V.; Perlman, Harris; Budinger, G. R. Scott; Mutlu, Goekhan M.			Impaired Clearance of Influenza A Virus in Obese, Leptin Receptor Deficient Mice Is Independent of Leptin Signaling in the Lung Epithelium and Macrophages	PLOS ONE			English	Article							PROGENITOR-CELL PROLIFERATION; DOSAGE-SENSITIVE REGULATOR; BODY-MASS INDEX; ALVEOLAR MACROPHAGES; MEDIATED-IMMUNITY; NMYC PLAYS; OUTCOMES; WEIGHT; ADULTS; MORTALITY	Rationale: During the recent H1N1 outbreak, obese patients had worsened lung injury and increased mortality. We used a murine model of influenza A pneumonia to test the hypothesis that leptin receptor deficiency might explain the enhanced mortality in obese patients. Methods: We infected wild-type, obese mice globally deficient in the leptin receptor (db/db) and non-obese mice with tissue specific deletion of the leptin receptor in the lung epithelium (SPC-Cre/LepR(fl/fl)) or macrophages and alveolar type II cells (LysM-Cre/Lepr(fl/fl)) with influenza A virus (A/WSN/33 [H1N1]) (500 and 1500 pfu/mouse) and measured mortality, viral clearance and several markers of lung injury severity. Results: The clearance of influenza A virus from the lungs of mice was impaired in obese mice globally deficient in the leptin receptor (db/db) compared to normal weight wild-type mice. In contrast, non-obese, SP-C-Cre(+/+)/LepR(fl/fl) and LysM-Cre(+/+)/LepR(fl/fl) had improved viral clearance after influenza A infection. In obese mice, mortality was increased compared with wildtype mice, while the SP-C-Cre(+/+)/LepR(fl/fl) and LysM-Cre(+/+)/LepR(fl/fl) mice exhibited improved survival. Conclusions: Global loss of the leptin receptor results in reduced viral clearance and worse outcomes following influenza A infection. These findings are not the result of the loss of leptin signaling in lung epithelial cells or macrophages. Our results suggest that factors associated with obesity or with leptin signaling in non-myeloid populations such as natural killer and T cells may be associated with worsened outcomes following influenza A infection.	[Radigan, Kathryn A.; Morales-Nebreda, Luisa; Soberanes, Saul; Nicholson, Trevor; Nigdelioglu, Recep; Cho, Takugo; Chi, Monica; Hamanaka, Robert B.; Budinger, G. R. Scott; Mutlu, Goekhan M.] Northwestern Univ, Dept Med, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Misharin, Alexander V.; Perlman, Harris] Northwestern Univ, Dept Med, Div Rheumatol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Radigan, KA (corresponding author), Northwestern Univ, Dept Med, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA.	k-radigan@northwestern.edu	Misharin, Alexander/AAD-6456-2019	Misharin, Alexander/0000-0003-2879-3789; Nicholson, Trevor/0000-0003-3187-1493; Morales-Nebreda, Luisa/0000-0002-7126-0518	Parker B. Francis Fellowship; NRSA [1F32AI094976, T32HL076139]; Northwestern Memorial Foundation Dixon Young Investigator Grant [NIH ES015024, ES013995, HL071643]; VA Merit Award; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL071643, T32HL076139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI094976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013995, R01ES015024] Funding Source: NIH RePORTER	Parker B. Francis Fellowship; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern Memorial Foundation Dixon Young Investigator Grant; VA Merit Award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by The Parker B. Francis Fellowship, NRSA 1F32AI094976, T32HL076139, The Northwestern Memorial Foundation Dixon Young Investigator Grant, NIH ES015024, ES013995, HL071643, and VA Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, MMWR-MORBID MORTAL W, V58, P749; Bellmeyer A, 2007, AM J RESP CRIT CARE, V175, P587, DOI 10.1164/rccm.200603-312OC; CHANDRA RK, 1980, PEDIATR RES, V14, P544, DOI 10.1093/ajcn/33.1.13; Chiang DAJ, 2011, AM J PHYSIOL-GASTR L, V300, pG697, DOI 10.1152/ajpgi.00426.2010; Chiarella SE, 2014, J CLIN INVEST, V124, P2935, DOI 10.1172/JCI75157; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cohen P, 2001, J CLIN INVEST, V108, P1113, DOI 10.1172/JCI200113914; Garcia MC, 2012, J INFECTION, V64, P218, DOI 10.1016/j.jinf.2011.11.022; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Finfer S, 2009, CRIT CARE RESUSC, V11, P46; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hashimoto Y, 2007, J IMMUNOL, V178, P2448, DOI 10.4049/jimmunol.178.4.2448; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; Hume DA, 2011, J LEUKOCYTE BIOL, V89, P525, DOI 10.1189/jlb.0810472; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jing XH, 2008, P NATL ACAD SCI USA, V105, P10967, DOI 10.1073/pnas.0804958105; Kim HM, 2008, J VIROL, V82, P4265, DOI 10.1128/JVI.02602-07; Kordonowy LL, 2012, AM J RESP CELL MOL, V47, P120, DOI 10.1165/rcmb.2011-0334OC; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mancuso P, 2002, J IMMUNOL, V168, P4018, DOI 10.4049/jimmunol.168.8.4018; MANDEL MA, 1978, J IMMUNOL, V120, P1375; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694; Morris AE, 2007, CHEST, V131, P342, DOI 10.1378/chest.06-1709; Mutlu GM, 2007, J CLIN INVEST, V117, P2952, DOI 10.1172/JCI30639; Mutlu GM, 2006, AM J RESP CELL MOL, V34, P670, DOI 10.1165/rcmb.2005-0329OC; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; O'Brien JM, 2006, CRIT CARE MED, V34, P738, DOI 10.1097/01.CCM.0000202207.87891.FC; O'Brien JM, 2004, ANN INTERN MED, V140, P338, DOI 10.7326/0003-4819-140-5-200403020-00009; Okubo T, 2005, DEV BIOL, V283, P680; Okubo T, 2005, DEVELOPMENT, V132, P1363, DOI 10.1242/dev.01678; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Radigan KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035788; Riscili BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018166; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Shulga N, 2012, J CELL SCI, V125, P2995, DOI 10.1242/jcs.103093; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; Tian ZG, 2002, BIOCHEM BIOPH RES CO, V298, P297, DOI 10.1016/S0006-291X(02)02462-2; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Vaillant L, 2009, EUROSURVEILLANCE, V14, P2; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Vernooy JHJ, 2010, J IMMUNOL, V184, P7169, DOI 10.4049/jimmunol.0900963; VOGEL SN, 1979, J IMMUNOL, V122, P619; Zhang AJX, 2013, J INFECT DIS, V207, P1270, DOI 10.1093/infdis/jit031; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou L, 1996, J HISTOCHEM CYTOCHEM, V44, P1183, DOI 10.1177/44.10.8813084	51	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e108138	10.1371/journal.pone.0108138	http://dx.doi.org/10.1371/journal.pone.0108138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232724	Green Published, Green Submitted, gold			2022-12-25	WOS:000342921200084
J	Ye, XP; Skidmore, AK; Wang, TJ				Ye, Xinping; Skidmore, Andrew K.; Wang, Tiejun			Joint Effects of Habitat Heterogeneity and Species' Life-History Traits on Population Dynamics in Spatially Structured Landscapes	PLOS ONE			English	Article							EFFECT SIZE; DISPERSAL; QUALITY; AUTOCORRELATION; VARIABILITY; PERSISTENCE; MODELS; FRAGMENTATION; COMPETITION; STATISTICS	Both habitat heterogeneity and species' life-history traits play important roles in driving population dynamics, yet there is little scientific consensus around the combined effect of these two factors on populations in complex landscapes. Using a spatially explicit agent-based model, we explored how interactions between habitat spatial structure (defined here as the scale of spatial autocorrelation in habitat quality) and species life-history strategies (defined here by species environmental tolerance and movement capacity) affect population dynamics in spatially heterogeneous landscapes. We compared the responses of four hypothetical species with different life-history traits to four landscape scenarios differing in the scale of spatial autocorrelation in habitat quality. The results showed that the population size of all hypothetical species exhibited a substantial increase as the scale of spatial autocorrelation in habitat quality increased, yet the pattern of population increase was shaped by species' movement capacity. The increasing scale of spatial autocorrelation in habitat quality promoted the resource share of individuals, but had little effect on the mean mortality rate of individuals. Species' movement capacity also determined the proportion of individuals in high-quality cells as well as the proportion of individuals experiencing competition in response to increased spatial autocorrelation in habitat quality. Positive correlations between the resource share of individuals and the proportion of individuals experiencing competition indicate that large-scale spatial autocorrelation in habitat quality may mask the density-dependent effect on populations through increasing the resource share of individuals, especially for species with low mobility. These findings suggest that low-mobility species may be more sensitive to habitat spatial heterogeneity in spatially structured landscapes. In addition, localized movement in combination with spatial autocorrelation may increase the population size, despite increased density effects.	[Ye, Xinping; Skidmore, Andrew K.; Wang, Tiejun] Univ Twente, Dept Nat Resources, Fac Geoinformat Sci & Earth Observat ITC, POB 217, NL-7500 AE Enschede, Netherlands; [Ye, Xinping] Foping Natl Nat Reserve, Jinan, Jiangxi, Peoples R China	University of Twente	Ye, XP; Wang, TJ (corresponding author), Univ Twente, Dept Nat Resources, Fac Geoinformat Sci & Earth Observat ITC, POB 217, NL-7500 AE Enschede, Netherlands.	ye17188@itc.nl; t.wang@utwente.nl	Wang, Tiejun/A-4671-2010; Skidmore, Andrew K/C-7441-2011	Wang, Tiejun/0000-0002-1138-8464; Skidmore, Andrew K/0000-0002-7446-8429	EU Erasmus Mundus External Co-operation Window Programme [L14a0900029]; ITC Research Fund [RC201003/PD]	EU Erasmus Mundus External Co-operation Window Programme; ITC Research Fund	This work was supported by the following grants: EU Erasmus Mundus External Co-operation Window Programme (L14a0900029 XY) and ITC Research Fund (RC201003/PD XY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armsworth PR, 2009, THEOR ECOL-NETH, V2, P105, DOI 10.1007/s12080-008-0032-2; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Boeye J, 2014, LANDSCAPE ECOL, V29, P593, DOI 10.1007/s10980-014-0010-6; Bolker BM, 2003, THEOR POPUL BIOL, V64, P255, DOI 10.1016/S0040-5809(03)00090-X; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Brachet S, 1999, J THEOR BIOL, V198, P479, DOI 10.1006/jtbi.1999.0926; Burgess MD, 2011, J ANIM ECOL, V80, P688, DOI 10.1111/j.1365-2656.2011.01816.x; Chipperfield JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017040; Clarke RT, 1997, P ROY SOC B-BIOL SCI, V264, P347, DOI 10.1098/rspb.1997.0050; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; DHONDT AA, 1992, J ANIM ECOL, V61, P643, DOI 10.2307/5619; DUTILLEUL P, 1993, OIKOS, V66, P152, DOI 10.2307/3545210; Fahrig L, 1998, ECOL MODEL, V105, P273, DOI 10.1016/S0304-3800(97)00163-4; Fleishman E, 2002, CONSERV BIOL, V16, P706, DOI 10.1046/j.1523-1739.2002.00539.x; Getz WM, 2008, P NATL ACAD SCI USA, V105, P19066, DOI 10.1073/pnas.0801732105; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Gonzalez A, 2002, P NATL ACAD SCI USA, V99, P14872, DOI 10.1073/pnas.232589299; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; HAEFNER JW, 1991, ECOL MODEL, V56, P221, DOI 10.1016/0304-3800(91)90201-B; Harrison S, 1999, ECOGRAPHY, V22, P225, DOI 10.1111/j.1600-0587.1999.tb00496.x; HASSELL MP, 1975, J ANIM ECOL, V44, P283, DOI 10.2307/3863; Hiebeler D, 2004, THEOR POPUL BIOL, V66, P205, DOI 10.1016/j.tpb.2004.06.004; Humphries NE, 2013, METHODS ECOL EVOL, V4, P930, DOI 10.1111/2041-210X.12096; Itakura J, 2010, BIOSYSTEMS, V99, P70, DOI 10.1016/j.biosystems.2009.09.001; Jacobson B, 2010, LANDSCAPE ECOL, V25, P495, DOI 10.1007/s10980-009-9442-9; Jager HI, 2001, ECOL MODEL, V144, P61, DOI 10.1016/S0304-3800(01)00362-3; Jonsen ID, 1997, LANDSCAPE ECOL, V12, P185, DOI 10.1023/A:1007961006232; Kendall BE, 1998, THEOR POPUL BIOL, V54, P11, DOI 10.1006/tpbi.1998.1365; Kolasa J, 2003, P ROY SOC B-BIOL SCI, V270, pS198, DOI 10.1098/rsbl.2003.0059; Lawrence M. A., 2011, EZ EASY ANAL VISUALI; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Lou Y, 2006, J DIFFER EQUATIONS, V223, P400, DOI 10.1016/j.jde.2005.05.010; Lovett GM, 2005, Ecosystem Function in Heterogeneous Landscapes, P1, DOI 10.1007/0-387-24091-8_1; Mortelliti A, 2010, OECOLOGIA, V163, P535, DOI 10.1007/s00442-010-1623-3; Nevoux M, 2010, P ROYAL SOC B, V278, P2173; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Parrott L, 2000, COMPLEXITY INT, P7; Pearson SM, 2011, SOURCES SINKS SUSTAI; Petchey OL, 1997, P ROY SOC B-BIOL SCI, V264, P1841, DOI 10.1098/rspb.1997.0254; Pigliucci M, 2001, ENV HETEROGENEITY TE; Pike N, 2004, P ROY SOC B-BIOL SCI, V271, P2143, DOI 10.1098/rspb.2004.2834; Pinto SM, 2010, AM NAT, V175, P675, DOI 10.1086/652467; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; PULLIAM HR, 1992, ECOL APPL, V2, P165, DOI 10.2307/1941773; R Core Team, 2021, R LANG ENV STAT COMP; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Rodenhouse NL, 1997, ECOLOGY, V78, P2025, DOI 10.2307/2265942; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; Schiegg K, 2003, TRENDS ECOL EVOL, V18, P212, DOI 10.1016/S0169-5347(03)00074-0; Schooley RL, 2007, ECOSYSTEMS, V10, P846, DOI 10.1007/s10021-007-9062-7; Skelsey P, 2013, THEOR ECOL-NETH, V6, P203, DOI 10.1007/s12080-012-0171-3; Snyder RE, 2003, ECOL LETT, V6, P301, DOI 10.1046/j.1461-0248.2003.00434.x; Stoddard ST, 2010, ECOL MODEL, V221, P2409, DOI 10.1016/j.ecolmodel.2010.06.024; White JW, 2014, OIKOS, V123, P385, DOI 10.1111/j.1600-0706.2013.01073.x; Wiegand T, 1999, AM NAT, V154, P605, DOI 10.1086/303272; WIENS JA, 1993, OIKOS, V66, P369, DOI 10.2307/3544931; With KA, 1999, CONSERV BIOL, V13, P314, DOI 10.1046/j.1523-1739.1999.013002314.x; Wu J., 2007, KEY TOPICS LANDSCAPE; Wu JG, 2002, LANDSCAPE ECOL, V17, P355, DOI 10.1023/A:1020561630963; Ye XP, 2013, ECOL RES, V28, P949, DOI 10.1007/s11284-013-1077-2; Zajac T, 2008, J AVIAN BIOL, V39, P206, DOI 10.1111/j.0908-8857.2008.04183.x	63	52	54	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107742	10.1371/journal.pone.0107742	http://dx.doi.org/10.1371/journal.pone.0107742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V43LR	25232739	Green Published, Green Submitted, gold			2022-12-25	WOS:000209683400001
J	Yue, QY; Wu, KL; Qiu, DY; Hu, J; Liu, DX; Wei, XY; Chen, J; Cook, CE				Yue, Qiaoyun; Wu, Keliang; Qiu, Deyi; Hu, Jia; Liu, Dexing; Wei, Xiaoya; Chen, Jian; Cook, Charles E.			A Formal Re-Description of the Cockroach Hebardina concinna Anchored on DNA Barcodes Confirms Wing Polymorphism and Identifies Morphological Characters for Field Identification	PLOS ONE			English	Article							GEN. NOV.; DIPTERA; EVOLUTION	Background: Hebardina concinna is a domestic pest and potential vector of pathogens throughout East and Southeast Asia, yet identification of this species has been difficult due to a lack of diagnostic morphological characters, and to uncertainty in the relationship between macroptyrous (long-winged) and brachypterous (small-winged) morphotypes. In insects male genital structures are typically species-specific and are frequently used to identify species. However, male genital structures in H. concinna had not previously been described, in part due to difficulty in identifying conspecifics. Methods/Principal Findings: We collected 15 putative H. concinna individuals, from Chinese populations, of both wing morphotypes and both sexes and then generated mitochondrial COI (the standard barcode region) and COII sequences from five of these individuals. These confirmed that both morphotypes of both sexes are the same species. We then dissected male genitalia and compared genital structures from macropterous and brachypterous individuals, which we showed to be identical, and present here for the first time a detailed description of H. concinna male genital structures. We also present a complete re-description of the morphological characters of this species, including both wing morphs. Conclusions/Significance: This work describes a practical application of DNA barcoding to confirm that putatively polymorphic insects are conspecific and then to identify species-specific characters that can be used in the field to identify individuals and to obviate the delay and cost of returning samples to a laboratory for DNA sequencing.	[Yue, Qiaoyun; Wu, Keliang; Qiu, Deyi; Liu, Dexing; Wei, Xiaoya; Chen, Jian] Zhongshan Entry Exit Inspect & Quarantine Bur Tec, Zhongshan, Guangdong, Peoples R China; [Hu, Jia] Guangdong Entry Exit Inspect & Quarantine Bur Tec, Guangzhou, Guangdong, Peoples R China; [Cook, Charles E.] EMBL European Bioinformat Inst, Cambridge, England	European Molecular Biology Laboratory (EMBL)	Yue, QY (corresponding author), Zhongshan Entry Exit Inspect & Quarantine Bur Tec, Zhongshan, Guangdong, Peoples R China.	yueqy@zs.gdciq.gov.cn	Wu, Ke/HCQ-3503-2022	Cook, Charles E/0000-0002-4145-8048	National Science and Technology support program [2012BAK11B05]; AQSIQ (Administration of Quality Supervision, Inspection and Quarantine) support program [2012IK223]; GDCIQ (Guangdong Entry-Exit Inspection and Quarantine Bureau) support program [2013GDK39, 2013GDK36]; Zhongshan City support program [20123A298]	National Science and Technology support program; AQSIQ (Administration of Quality Supervision, Inspection and Quarantine) support program; GDCIQ (Guangdong Entry-Exit Inspection and Quarantine Bureau) support program; Zhongshan City support program	This work was financially supported by the National Science and Technology support program "2012BAK11B05 (http://program.most.gov.cn/)", AQSIQ (Administration of Quality Supervision, Inspection and Quarantine) support program "2012IK223 (http://zjkygl.aqsiq.gov.cn)'', GDCIQ (Guangdong Entry-Exit Inspection and Quarantine Bureau) support program "2013GDK39 (http://www.gdciq.gov.cn)" and "2013GDK36 (http://www.gdciq.gov.cn)" and Zhongshan City support program "20123A298 (http://www.zskj.gov.cn/).'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisyutkin LN, 2013, ZOOTAXA, V3635, P520, DOI 10.11646/zootaxa.3635.5.2; Anisyutkin LN, 2010, ENTOMOLOGICAL REV, V90, P871, DOI DOI 10.1134/S0013873810070055; Anisyutkin LN, 2000, ZOOSYSTEMATICA ROSSI, V8, P251; Asahina S, 1983, PROMOTION PROVINCIAL, V5, P1; Beccaloni G, 2007, BLATTODEA SPECIES FI; Bell WJ, 2007, COCKROACHES ECOLOGY, P37; Bergsten J, 2012, DNA BARCODES, V1, P1, DOI DOI 10.2478/DNA-2012-0001; BEY-BIENKO G., 1938, ANN AND MAG NAT HIST, V1, P230; BRUIJNING C. F. A., 1948, ZOOL MEDEDEEL LEYDEN, V29, P1; Cochran DG, 1999, COCKROACHES THEIR BI, P1; Cook CE, 2005, P ROY SOC B-BIOL SCI, V272, P1295, DOI 10.1098/rspb.2004.3042; Corsaro D, 2006, INT J INFECT DIS, V10, pS85, DOI 10.1016/S1201-9712(06)80149-9; Corsaro D, 2007, SYST APPL MICROBIOL, V30, P221, DOI 10.1016/j.syapm.2006.06.001; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; de Haan W, 1842, VERHANDLINGEN NATURL, P50; Ding T, 2011, J MOL DIAGNOSIS THER, V3, P249; Evangelista D, 2013, ENTOMOLOGICAL SOC AM, V106, P2267; Feng PZ, 1997, CHINA COCKROACH SPEC; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Grandcolas P, 1996, CAN J ZOOL, V74, P508, DOI 10.1139/z96-059; Gullan PJ, 2005, INSECTS OUTLINE ENTO, V3; Hajibabaei M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-24; Hamilton CA, 2014, MOL PHYLOGENET EVOL, V71, P79, DOI 10.1016/j.ympev.2013.11.007; HARRISON RG, 1980, ANNU REV ECOL SYST, V11, P95, DOI 10.1146/annurev.es.11.110180.000523; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; HEBARD MORGAN, 1929, PROC ACAD NAT SCI PHILADELPHIA, V81, P1; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; IWANAGA K, 1985, ENTOMOL EXP APPL, V38, P101, DOI 10.1007/BF00361919; McKittrick FA, 1964, CORNELL U AGR EXPT S; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Princis K, 1966, ORTHOPTERORUM CATALO, P402; Renaud AK, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-24; Rivera J, 2009, MOL ECOL RESOUR, V9, P224, DOI 10.1111/j.1755-0998.2009.02648.x; ROFF DA, 1991, AM ZOOL, V31, P243; ROFF DA, 1994, AM NAT, V144, P772, DOI 10.1086/285706; ROTH L M, 1990, Memoirs of the Museum of Victoria, V50, P357; Roth LM, 1998, ORIENT INSECTS, V32, P1; Saglam IK, 2008, J EVOLUTION BIOL, V21, P997, DOI 10.1111/j.1420-9101.2008.01548.x; Schuehli GSE, 2007, INVERTEBR SYST, V21, P263, DOI 10.1071/IS06026; Shiraki Tokuichi, 1906, Annotationes Zoologicae Japonenses, V6, P17; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; STEK M, 1982, T ROY SOC TROP MED H, V76, P566, DOI 10.1016/0035-9203(82)90166-3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Wallman JF, 2001, FORENSIC SCI INT, V120, P60, DOI 10.1016/S0379-0738(01)00426-1; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zeng Jian, 2006, Journal of Sichuan Agricultural University, V24, P369; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207; Zhu Dao-Hong, 2009, Chinese Bulletin of Entomology, V46, P11	51	14	18	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e106789	10.1371/journal.pone.0106789	http://dx.doi.org/10.1371/journal.pone.0106789			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232993	Green Submitted, gold, Green Published			2022-12-25	WOS:000342921200010
J	Ardin, AC; Fujita, K; Nagayama, K; Takashima, Y; Nomura, R; Nakano, K; Ooshima, T; Matsumoto-Nakano, M				Ardin, Arifah Chieko; Fujita, Kazuyo; Nagayama, Kayoko; Takashima, Yukiko; Nomura, Ryota; Nakano, Kazuhiko; Ooshima, Takashi; Matsumoto-Nakano, Michiyo			Identification and Functional Analysis of an Ammonium Transporter in Streptococcus mutans	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; P-II PROTEIN; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; CORYNEBACTERIUM-GLUTAMICUM; SACCHAROMYCES-CEREVISIAE; NITROGEN-METABOLISM; BIOFILM FORMATION; ENTERIC BACTERIA; GENE-EXPRESSION	Streptococcus mutans, a Gram-positive bacterium, is considered to be a major etiologic agent of human dental caries and reported to form biofilms known as dental plaque on tooth surfaces. This organism is also known to possess a large number of transport proteins in the cell membrane for export and import of molecules. Nitrogen is an essential nutrient for Grampositive bacteria, though alternative sources such as ammonium can also be utilized. In order to obtain nitrogen for macromolecular synthesis, nitrogen-containing compounds must be transported into the cell. However, the ammonium transporter in S. mutans remains to be characterized. The present study focused on characterizing the ammonium transporter gene of S. mutans and its operon, while related regulatory genes were also analyzed. The SMU. 1658 gene corresponding to nrgA in S. mutans is homologous to the ammonium transporter gene in Bacillus subtilis and SMU. 1657, located upstream of the nrgA gene and predicted to be glnB, is a member of the PII protein family. Using a nrgA-deficient mutant strain (NRGD), we examined bacterial growth in the presence of ammonium, calcium chloride, and manganese sulfate. Fluorescent efflux assays were also performed to reveal export molecules associated with the ammonium transporter. The growth rate of NRGD was lower, while its fluorescent intensity was much higher as compared to the parental strain. In addition, confocal laser scanning microscopy revealed that the structure of biofilms formed by NRGD was drastically different than that of the parental strain. Furthermore, transcriptional analysis showed that the nrgA gene was co-transcribed with the glnB gene. These results suggest that the nrgA gene in S. mutans is essential for export of molecules and biofilm formation.	[Ardin, Arifah Chieko; Nagayama, Kayoko; Nomura, Ryota; Nakano, Kazuhiko; Ooshima, Takashi] Osaka Univ, Dept Pediat Dent, Grad Sch Dent, Suita, Osaka, Japan; [Fujita, Kazuyo; Takashima, Yukiko; Matsumoto-Nakano, Michiyo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pediat Dent, Okayama, Japan	Osaka University; Okayama University	Matsumoto-Nakano, M (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pediat Dent, Okayama, Japan.	mnakano@cc.okayama-u.ac.jp			Japan Society for the Promotion of Science [2339047315]; Asahi Glass Scholarship; Terayama Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Asahi Glass Scholarship; Terayama Foundation	This study was supported by a Grant-in Aid for Scientific Research (B) 2339047315 from the Japan Society for the Promotion of Science, and Asahi Glass Scholarship and Terayama Foundation for their financial support granted throughout my PhD studies in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Amon J, 2010, FEMS MICROBIOL REV, V34, P588, DOI 10.1111/j.1574-6976.2010.00216.x; Arcondeguy T, 2001, MICROBIOL MOL BIOL R, V65, P80, DOI 10.1128/MMBR.65.1.80-105.2001; Biswas S, 2011, ANTIMICROB AGENTS CH, V55, P1460, DOI 10.1128/AAC.01094-10; BUENO R, 1985, J BACTERIOL, V164, P816, DOI 10.1128/JB.164.2.816-822.1985; Burkovski A, 2003, ARCH MICROBIOL, V179, P83, DOI 10.1007/s00203-002-0505-4; Chen PM, 2010, APPL ENVIRON MICROB, V76, P2478, DOI 10.1128/AEM.02622-09; Coutts G, 2002, EMBO J, V21, P536, DOI 10.1093/emboj/21.4.536; DASHPER SG, 1995, ORAL MICROBIOL IMMUN, V10, P183, DOI 10.1111/j.1399-302X.1995.tb00140.x; Detsch C, 2003, MICROBIOL-SGM, V149, P3289, DOI 10.1099/mic.0.26512-0; Doroshchuk NA, 2006, MOL BIOL+, V40, P829, DOI 10.1134/S0026893306050190; DUNNY GM, 1991, APPL ENVIRON MICROB, V57, P1194, DOI 10.1128/AEM.57.4.1194-1201.1991; Howitt SM, 2000, BBA-BIOMEMBRANES, V1465, P152, DOI 10.1016/S0005-2736(00)00136-X; Hsieh MH, 1998, P NATL ACAD SCI USA, V95, P13965, DOI 10.1073/pnas.95.23.13965; Hu P, 1999, J BACTERIOL, V181, P5042, DOI 10.1128/JB.181.16.5042-5050.1999; JAYAKUMAR A, 1989, J BACTERIOL, V171, P996, DOI 10.1128/jb.171.2.996-1001.1989; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; KLEINER D, 1985, FEMS MICROBIOL LETT, V32, P87, DOI 10.1016/0378-1097(85)90059-X; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Krastel K, 2010, J BACTERIOL, V192, P984, DOI 10.1128/JB.01169-09; Kuboniwa M, 2006, MOL MICROBIOL, V60, P121, DOI 10.1111/j.1365-2958.2006.05099.x; KUHRY JG, 1983, CELL BIOPHYS, V5, P129, DOI 10.1007/BF02796139; Larsen R, 2006, J BACTERIOL, V188, P4978, DOI 10.1128/JB.00025-06; Leigh JA, 2007, ANNU REV MICROBIOL, V61, P349, DOI 10.1146/annurev.micro.61.080706.093409; Lemos JAC, 2005, CURR ISSUES MOL BIOL, V7, P95; Lemos JA, 2008, MICROBIOL-SGM, V154, P3247, DOI 10.1099/mic.0.2008/023770-0; LINDLER LE, 1986, J BACTERIOL, V166, P658, DOI 10.1128/jb.166.2.658-665.1986; Linton KJ, 1998, MOL MICROBIOL, V28, P5, DOI 10.1046/j.1365-2958.1998.00764.x; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Matsumoto M, 2003, FEMS MICROBIOL LETT, V228, P73, DOI 10.1016/S0378-1097(03)00723-7; Matsumoto-Nakano M, 2007, ORAL MICROBIOL IMMUN, V22, P30; Matsumoto-Nakano M, 2011, CARIES RES, V45, P56, DOI 10.1159/000323376; Matsumoto-Nakano M, 2006, J BACTERIOL, V188, P8095, DOI 10.1128/JB.00908-06; McDonald TR, 2012, MOL BIOL EVOL, V29, P51, DOI 10.1093/molbev/msr123; Merrick M, 2006, TRANSFUS CLIN BIOL, V13, P97, DOI 10.1016/j.tracli.2006.02.015; MERRICK MJ, 1995, MICROBIOL REV, V59, P604, DOI 10.1128/MMBR.59.4.604-622.1995; Mitchell BA, 1999, J BIOL CHEM, V274, P3541, DOI 10.1074/jbc.274.6.3541; Nakano K, 2002, J DENT RES, V81, P376, DOI 10.1177/154405910208100604; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; Ocaktan A, 1997, J BIOL CHEM, V272, P21964, DOI 10.1074/jbc.272.35.21964; OKAHASHI N, 1984, INFECT IMMUN, V44, P617, DOI 10.1128/IAI.44.3.617-622.1984; OKAHASHI N, 1989, MOL MICROBIOL, V3, P673, DOI 10.1111/j.1365-2958.1989.tb00215.x; OOSHIMA T, 1983, INFECT IMMUN, V39, P43, DOI 10.1128/IAI.39.1.43-49.1983; Padan E, 2009, SUPERFAMILIES TRANSP, P1; Peyyala R, 2011, APPL ENVIRON MICROB, V77, P3413, DOI 10.1128/AEM.00039-11; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Reitzer L.J., 1987, E COLI SALMONELLA CE, P302; Saier MH, 1999, J CELL BIOCHEM, P84; SCHREIER HJ, 1989, J MOL BIOL, V210, P51, DOI 10.1016/0022-2836(89)90290-8; Siewe RM, 1996, J BIOL CHEM, V271, P5398, DOI 10.1074/jbc.271.10.5398; Soupene E, 1998, P NATL ACAD SCI USA, V95, P7030, DOI 10.1073/pnas.95.12.7030; Thomas G, 2000, TRENDS GENET, V16, P11, DOI 10.1016/S0168-9525(99)01887-9; Tremblay PL, 2009, MOL MICROBIOL, V71, P12, DOI 10.1111/j.1365-2958.2008.06514.x; Van Dommelen A, 1998, J BACTERIOL, V180, P2652, DOI 10.1128/JB.180.10.2652-2659.1998; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; vanHeeswijk WC, 1996, MOL MICROBIOL, V21, P133, DOI 10.1046/j.1365-2958.1996.6281349.x; Wolfe DM, 2007, J BACTERIOL, V189, P6861, DOI 10.1128/JB.00759-07; WRAY LV, 1994, J BACTERIOL, V176, P108, DOI 10.1128/JB.176.1.108-114.1994; Yoshida A, 2002, MICROBIOL-SGM, V148, P3385, DOI 10.1099/00221287-148-11-3385; Yoshida A, 2002, APPL ENVIRON MICROB, V68, P6283, DOI 10.1128/AEM.68.12.6283-6291.2002; Young J, 1999, BBA-BIOMEMBRANES, V1461, P177, DOI 10.1016/S0005-2736(99)00158-3	63	13	13	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107569	10.1371/journal.pone.0107569	http://dx.doi.org/10.1371/journal.pone.0107569			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229891	Green Submitted, gold, Green Published			2022-12-25	WOS:000342123900049
J	Mehrali, M; Moghaddam, E; Shirazi, SFS; Baradaran, S; Mehrali, M; Latibari, ST; Metselaar, HSC; Kadri, NA; Zandi, K; Abu Osman, NA				Mehrali, Mehdi; Moghaddam, Ehsan; Shirazi, Seyed Farid Seyed; Baradaran, Saeid; Mehrali, Mohammad; Latibari, Sara Tahan; Metselaar, Hendrik Simon Cornelis; Kadri, Nahrizul Adib; Zandi, Keivan; Abu Osman, Noor Azuan			Mechanical and In Vitro Biological Performance of Graphene Nanoplatelets Reinforced Calcium Silicate Composite	PLOS ONE			English	Article							THERMAL-CONDUCTIVITY; BIOMEDICAL APPLICATIONS; RAMAN-SPECTROSCOPY; FORMATION ABILITY; APATITE-FORMATION; OXIDE; WOLLASTONITE; COATINGS; BIOCOMPATIBILITY; OSTEOBLASTS	Calcium silicate (CaSiO3, CS) ceramic composites reinforced with graphene nanoplatelets (GNP) were prepared using hot isostatic pressing (HIP) at 1150 degrees C. Quantitative microstructural analysis suggests that GNP play a role in grain size and is responsible for the improved densification. Raman spectroscopy and scanning electron microscopy showed that GNP survived the harsh processing conditions of the selected HIP processing parameters. The uniform distribution of 1 wt.% GNP in the CS matrix, high densification and fine CS grain size help to improve the fracture toughness by similar to 130%, hardness by similar to 30% and brittleness index by similar to 40% as compared to the CS matrix without GNP. The toughening mechanisms, such as crack bridging, pull-out, branching and deflection induced by GNP are observed and discussed. The GNP/CS composites exhibit good apatite-forming ability in the simulated body fluid (SBF). Our results indicate that the addition of GNP decreased pH value in SBF. Effect of addition of GNP on early adhesion and proliferation of human osteoblast cells (hFOB) was measured in vitro. The GNP/CS composites showed good biocompatibility and promoted cell viability and cell proliferation. The results indicated that the cell viability and proliferation are affected by time and concentration of GNP in the CS matrix.	[Mehrali, Mehdi; Shirazi, Seyed Farid Seyed; Baradaran, Saeid; Mehrali, Mohammad; Latibari, Sara Tahan; Metselaar, Hendrik Simon Cornelis] Univ Malaya, Dept Mech Engn, Kuala Lumpur, Malaysia; [Mehrali, Mehdi; Shirazi, Seyed Farid Seyed; Baradaran, Saeid; Mehrali, Mohammad; Latibari, Sara Tahan; Metselaar, Hendrik Simon Cornelis] Univ Malaya, Ctr Adv Mat, Kuala Lumpur, Malaysia; [Moghaddam, Ehsan] Univ Malay, Fac Med, Dept Med Microbiol, Trop Infect Dis Res & Educ Ctr, Kuala Lumpur, Malaysia; [Kadri, Nahrizul Adib; Zandi, Keivan; Abu Osman, Noor Azuan] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Mehrali, M (corresponding author), Univ Malaya, Dept Mech Engn, Kuala Lumpur, Malaysia.	m.mehrali@siswa.um.edu.my; f.shirazi@siswa.um.edu.my; h.metselaar@um.edu.my	mehrali, mohammad/A-7328-2018; Mehrali, Mehdi/G-6395-2011; Shirazi, Farid/M-8518-2014; KADRI, NAHRIZUL ADIB/W-1531-2019; Baradaran, Saeid/M-3077-2013; Mehrali, Mohammad/ABE-7990-2020; ABU OSMAN, NOOR AZUAN/B-9265-2010; Kadri, Nahrizul Adib/D-4400-2009; Metselaar, Hendrik/B-5324-2010; ZANDI, KEIVAN ZANDI KEIVAN/B-8762-2010; Tahan Latibari, Sara/C-4657-2013	mehrali, mohammad/0000-0001-6667-9368; Mehrali, Mehdi/0000-0002-5084-1823; KADRI, NAHRIZUL ADIB/0000-0001-9694-4337; Mehrali, Mohammad/0000-0001-6667-9368; ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421; Kadri, Nahrizul Adib/0000-0001-9694-4337; Metselaar, Hendrik/0000-0003-1047-654X; Tahan Latibari, Sara/0000-0003-4012-6006; Zandi, Keivan/0000-0001-9728-5038	Ministry of Higher Education (MOHE) of Malaysia [UM.C/HIR/MOHE/ENG/ 10D000010-16001]; Ministry of Higher Education (MOHE) of Malaysia through FRGS [FP007/2013A]	Ministry of Higher Education (MOHE) of Malaysia; Ministry of Higher Education (MOHE) of Malaysia through FRGS	This work was financially supported by the Ministry of Higher Education (MOHE) of Malaysia through the UM.C/HIR/MOHE/ENG/10 D000010-16001 and FRGS (FP007/2013A) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan O, 2012, BIOMATERIALS, V33, P8017, DOI 10.1016/j.biomaterials.2012.07.040; Akhavan O, 2010, ACS NANO, V4, P5731, DOI 10.1021/nn101390x; Askari E, 2012, J MECH BEHAV BIOMED, V12, P144, DOI 10.1016/j.jmbbm.2012.02.029; Baradaran S, 2014, CARBON, V69, P32, DOI 10.1016/j.carbon.2013.11.054; Boccaccini AR, 1997, J MATER PROCESS TECH, V65, P302, DOI 10.1016/S0924-0136(96)02275-3; Bose S, 2010, ACTA BIOMATER, V6, P3782, DOI 10.1016/j.actbio.2010.03.016; Boskey AL, 1998, J CELL BIOCHEM, P83, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<83::AID-JCB12>3.0.CO;2-F; Bruinink A, 2014, J BIOMED MATER RES A, V102, P275, DOI 10.1002/jbm.a.34691; Colomban P, 2004, APPL PHYS A-MATER, V79, P167, DOI 10.1007/s00339-004-2512-6; Dasgupta S, 2013, MAT SCI ENG C-MATER, V33, P2846, DOI 10.1016/j.msec.2013.03.004; Ferrari AC, 2013, NAT NANOTECHNOL, V8, P235, DOI 10.1038/nnano.2013.46; Garbev K, 2007, J AM CERAM SOC, V90, P900, DOI 10.1111/j.1551-2916.2006.01428.x; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Gurunathan S, 2013, COLLOID SURFACE B, V105, P58, DOI 10.1016/j.colsurfb.2012.12.036; Hu WB, 2010, ACS NANO, V4, P4317, DOI 10.1021/nn101097v; Kalbacova M, 2010, CARBON, V48, P4323, DOI 10.1016/j.carbon.2010.07.045; Kaur G, 2014, J BIOMED MATER RES A, V102, P254, DOI 10.1002/jbm.a.34690; Kobayashi T, 2012, CRYSTENGCOMM, V14, P1143, DOI 10.1039/c1ce06114c; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; Krishnamoorthy K, 2013, ULTRASON SONOCHEM, V20, P644, DOI 10.1016/j.ultsonch.2012.09.007; Lahiri D, 2012, MAT SCI ENG C-MATER, V32, P1727, DOI 10.1016/j.msec.2012.05.010; Lahiri D, 2012, ACS APPL MATER INTER, V4, P2234, DOI 10.1021/am300244s; Lahiri D, 2011, J BIOMED MATER RES A, V96A, P1, DOI 10.1002/jbm.a.32952; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Li M, 2014, CARBON, V67, P185, DOI 10.1016/j.carbon.2013.09.080; Li SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043328; Liu HY, 2012, J PHYS CHEM C, V116, P3334, DOI 10.1021/jp2102226; Liu J, 2013, CERAM INT, V39, P6215, DOI 10.1016/j.ceramint.2013.01.041; Liu J, 2012, J EUR CERAM SOC, V32, P4185, DOI 10.1016/j.jeurceramsoc.2012.07.007; Liu XY, 2004, BIOMATERIALS, V25, P1755, DOI 10.1016/j.biomaterials.2003.08.024; Liu Y, 2014, CARBON, V67, P250, DOI 10.1016/j.carbon.2013.09.088; Long LH, 2006, J EUR CERAM SOC, V26, P1701, DOI 10.1016/j.jeurceramsoc.2005.03.247; Long LH, 2008, J EUR CERAM SOC, V28, P2883, DOI 10.1016/j.jeurceramsoc.2008.05.006; Mehrali M, 2014, ULTRASON SONOCHEM, V21, P735, DOI 10.1016/j.ultsonch.2013.08.012; Mehrali M, 2013, J BIOMED MATER RES A, V101, P3046, DOI 10.1002/jbm.a.34588; Mehrali M, 2014, J MATER SCI, V49, P7156, DOI 10.1007/s10853-014-8424-8; Mehrali M, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-15; Mehrali M, 2013, APPL THERM ENG, V61, P633, DOI 10.1016/j.applthermaleng.2013.08.035; Mehrali M, 2013, ENERGY, V58, P628, DOI 10.1016/j.energy.2013.05.050; Nieto A, 2013, MAT SCI ENG A-STRUCT, V582, P338, DOI 10.1016/j.msea.2013.06.006; Nieto A, 2012, CARBON, V50, P4068, DOI 10.1016/j.carbon.2012.04.054; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Pan HB, 2010, ACTA BIOMATER, V6, P4181, DOI 10.1016/j.actbio.2010.05.013; Pattanayak DK, 2006, J AM CERAM SOC, V89, P2172, DOI 10.1111/j.1551-2916.2006.01068.x; Porwal H, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/5/055007; Richet P, 1998, PHYS CHEM MINER, V25, P401, DOI 10.1007/s002690050130; Sadeghinezhad E, 2014, IND ENG CHEM RES, V53, P12455, DOI 10.1021/ie501947u; Shen YH, 2011, LANGMUIR, V27, P2701, DOI 10.1021/la104876w; Shirazi FS, 2014, J BIOMED MATER RES A, V102, P3973, DOI 10.1002/jbm.a.35074; Shirazi FS, 2014, J MECH BEHAV BIOMED, V30, P168, DOI 10.1016/j.jmbbm.2013.10.024; Shirazi FS, 2015, INT J APPL CERAM TEC, V12, P371, DOI 10.1111/ijac.12151; Siddique YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080944; Silver IA, 2001, BIOMATERIALS, V22, P175, DOI 10.1016/S0142-9612(00)00173-3; Singh V, 2011, PROG MATER SCI, V56, P1178, DOI 10.1016/j.pmatsci.2011.03.003; Tsoukleri G, 2009, SMALL, V5, P2397, DOI 10.1002/smll.200900802; Walker LS, 2011, ACS NANO, V5, P3182, DOI 10.1021/nn200319d; Wei J, 2009, BIOMATERIALS, V30, P1080, DOI 10.1016/j.biomaterials.2008.10.046; Wu CT, 2007, BIOMATERIALS, V28, P3171, DOI 10.1016/j.biomaterials.2007.04.002; Xue WC, 2005, BIOMATERIALS, V26, P3455, DOI 10.1016/j.biomaterials.2004.09.027; Zhang L, 2013, CARBON, V61, P105, DOI 10.1016/j.carbon.2013.04.074; Zhang X, 2013, J BIOMED MAT RES A, pn/a; Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038; Zhao SJ, 2008, MATER TRANS, V49, P2310, DOI 10.2320/matertrans.MRA2008064; Zhao XJ, 2011, J EUR CERAM SOC, V31, P883, DOI 10.1016/j.jeurceramsoc.2010.11.014; Zhao Y, 2013, CERAM INT, V39, P7627, DOI 10.1016/j.ceramint.2013.03.018	65	45	48	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e106802	10.1371/journal.pone.0106802	http://dx.doi.org/10.1371/journal.pone.0106802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229540	Green Submitted, Green Published, gold			2022-12-25	WOS:000342123900012
J	Hughes, E; Middleton, DA				Hughes, Eleri; Middleton, David A.			Comparison of the Structure and Function of Phospholamban and the Arginine-14 Deficient Mutant Associated with Dilated Cardiomyopathy	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; DEPENDENT PROTEIN-KINASE; ADENOSINE-TRIPHOSPHATASE; MONOMERIC PHOSPHOLAMBAN; CYTOPLASMIC DOMAIN; CALCIUM-TRANSPORT; HYBRID SOLUTION; LIPID-BILAYERS; WILD-TYPE; STATE	Phospholamban (PLB) is a pentameric protein that plays an important role in regulating cardiac contractility via a reversible inhibitory association with the sarcoplasmic reticulum Ca(2+)ATPase (SERCA), the enzyme responsible for maintaining correct calcium homeostasis. Here we study the functional and biophysical characteristics of a PLB mutant associated with human dilated cardiomyopathy (DCM), with a deletion of arginine at position 14 (PLBR14 Delta). In agreement with recent findings, we find that PLBR14 Delta has a reduced inhibitory effect on SERCA compared to wild type PLB (PLBWT) when reconstituted into lipid membranes. The mutation also leads to a large reduction in the protein kinase A-catalysed phosphorylation of Ser-16 in the cytoplasmic domain of PLBR14 Delta. Measurements on SERCA co-reconstituted with an equimolar mixture of PLBWT and PLBR14 Delta (representing the lethal heterozygous state associated with DCM) indicates that the loss-of-function mutation has a dominant effect on PLBWT functionality and phosphorylation capacity, suggesting that mixed PLBWT/PLBR14 Delta pentamers are formed that have characteristics typical of the mutant protein. Structural and biophysical analysis of PLBR14 Delta indicates that the mutation perturbs slightly the helical structure of the PLB cytoplasmic domain and reduces its affinity for the phospholipid bilayer surface, thereby altering the orientation of the cytoplasmic domain relative to the wild-type protein. These results indicate that the structure and function consequences of the R14 deletion have profound effects on the regulation of SERCA which may contribute to the aetiology of DCM.	[Hughes, Eleri; Middleton, David A.] Univ Lancaster, Dept Chem, Lancaster LA1 4YA, England	Lancaster University	Middleton, DA (corresponding author), Univ Lancaster, Dept Chem, Lancaster LA1 4YA, England.	d.middleton@lancaster.ac.uk		Middleton, David/0000-0002-3227-7632; Hughes, Eleri/0000-0001-5123-7524	British Heart Foundation [PG/10/004]; British Heart Foundation [PG/10/004/28174, PG/13/20/30070] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was funded by the British Heart Foundation (grant number PG/10/004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Baker S, 2007, PROTEIN SCI, V16, P2345, DOI 10.1110/ps.072977707; Akin BL, 2010, J BIOL CHEM, V285, P28540, DOI 10.1074/jbc.M110.151779; Andronesi OC, 2005, J AM CHEM SOC, V127, P12965, DOI 10.1021/ja0530164; Buck B, 2003, PROTEIN EXPRES PURIF, V30, P253, DOI 10.1016/S1046-5928(03)00127-X; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; Ceholski DK, 2012, J BIOL CHEM, V287, P26596, DOI 10.1074/jbc.M112.382713; Ceholski DK, 2012, J BIOL CHEM, V287, P16521, DOI 10.1074/jbc.M112.360859; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; Dalton KA, 1999, BIOCHEM J, V342, P431, DOI 10.1042/0264-6021:3420431; Douglas JL, 2005, PROTEIN EXPRES PURIF, V40, P118, DOI 10.1016/j.pep.2004.11.015; EAST JM, 1982, BIOCHEMISTRY-US, V21, P4144, DOI 10.1021/bi00260a035; FUJII J, 1987, J CLIN INVEST, V79, P301, DOI 10.1172/JCI112799; Gruber SJ, 2012, BIOCHEM BIOPH RES CO, V420, P236, DOI 10.1016/j.bbrc.2012.02.125; Gustavsson M, 2011, J MOL BIOL, V408, P755, DOI 10.1016/j.jmb.2011.03.015; Ha KN, 2011, P NATL ACAD SCI USA, V108, P2735, DOI 10.1073/pnas.1013987108; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Haghighi K, 2012, J MOL CELL CARDIOL, V52, P773, DOI 10.1016/j.yjmcc.2011.11.012; Hu J, 2007, PROTEIN SCI, V16, P2153, DOI 10.1110/ps.072996707; Hughes E, 2003, J BIOL CHEM, V278, P20835, DOI 10.1074/jbc.M212208200; Hughes E, 2010, BIOCHEM BIOPH RES CO, V401, P370, DOI 10.1016/j.bbrc.2010.09.056; Hughes E, 2009, BBA-BIOMEMBRANES, V1788, P559, DOI 10.1016/j.bbamem.2008.10.029; Hughes G, 1996, BIOCHEM J, V318, P973, DOI 10.1042/bj3180973; Jackson WA, 1996, BIOCHEM J, V316, P201, DOI 10.1042/bj3160201; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Koss KL, 1996, CIRC RES, V79, P1059, DOI 10.1161/01.RES.79.6.1059; LEVY D, 1992, BIOCHIM BIOPHYS ACTA, V1107, P283, DOI 10.1016/0005-2736(92)90415-I; Li M, 1998, BIOCHEMISTRY-US, V37, P7869, DOI 10.1021/bi9801053; Lockamy EL, 2011, BIOCHEM BIOPH RES CO, V408, P388, DOI 10.1016/j.bbrc.2011.04.023; Mahaney JE, 2000, BIOPHYS J, V78, P1306, DOI 10.1016/S0006-3495(00)76686-0; Masterson LR, 2011, J MOL BIOL, V412, P155, DOI 10.1016/j.jmb.2011.06.041; Negash S, 2000, BIOCHEM J, V351, P195, DOI 10.1042/0264-6021:3510195; Reddy LG, 2003, BIOCHEMISTRY-US, V42, P4585, DOI 10.1021/bi026995a; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; Sayadi M, 2010, BIOPHYS J, V98, P805, DOI 10.1016/j.bpj.2009.11.015; Schmitt JP, 2009, CIRCULATION, V119, P436, DOI 10.1161/CIRCULATIONAHA.108.783506; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Sharma P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011496; TADA M, 1983, J MOL CELL CARDIOL, V15, P565, DOI 10.1016/0022-2828(83)90267-5; TOYOFUKU T, 1994, J BIOL CHEM, V269, P3088; Traaseth NJ, 2009, P NATL ACAD SCI USA, V106, P10165, DOI 10.1073/pnas.0904290106; van der Zwaag PA, 2012, EUR J HEART FAIL, V14, P1199, DOI 10.1093/eurjhf/hfs119; Verardi R, 2011, P NATL ACAD SCI USA, V108, P9101, DOI 10.1073/pnas.1016535108; Waggoner JR, 2007, BIOCHEMISTRY-US, V46, P1999, DOI 10.1021/bi061365k; WEGENER AD, 1984, J BIOL CHEM, V259, P1834; YODA A, 1970, BIOCHEM BIOPH RES CO, V40, P880, DOI 10.1016/0006-291X(70)90985-X; Zamoon J, 2003, BIOPHYS J, V85, P2589, DOI 10.1016/S0006-3495(03)74681-5; Zvaritch E, 2000, J BIOL CHEM, V275, P14985, DOI 10.1074/jbc.275.20.14985	49	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e106746	10.1371/journal.pone.0106746	http://dx.doi.org/10.1371/journal.pone.0106746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225809	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000344317700016
J	Ndiwa, TC; Nyingi, DW; Agnese, JF				Ndiwa, Titus Chemandwa; Nyingi, Dorothy Wanja; Agnese, Jean-Francois			An Important Natural Genetic Resource of Oreochromis niloticus (Linnaeus, 1758) Threatened by Aquaculture Activities in Loboi Drainage, Kenya	PLOS ONE			English	Article							SEX DETERMINATION; DNA; TILAPIA; SOFTWARE; INFERENCE; NILE; MICROSATELLITE; ENVIRONMENT; DIVERSITY; WETLANDS	The need to improve food security in Africa through culture of tilapias has led to transfer of different species from their natural ranges causing negative impacts on wild fish genetic resources. Loboi swamp in Kenya is fed by three hot springs: Lake Bogoria Hotel, Chelaba and Turtle Springs, hosting natural populations of Oreochromis niloticus. The present study aimed at better genetic characterization of these threatened populations. Partial mtDNA sequences of the D-loop region and variations at 16 microsatellite loci were assessed in the three hot spring populations and compared with three other natural populations of O. niloticus in the region. Results obtained indicated that the hot spring populations had mitochondrial and nuclear genetic variability similar to or higher than the large closely related populations. This may be attributed to the perennial nature of the hot springs, which do not depend on rainfall but rather receive permanent water supply from deep aquifers. The study also revealed that gene flow between the three different hot spring populations was sufficiently low thus allowing their differentiation. This differentiation was unexpected considering the very close proximity of the springs to each other. It is possible that the swamp creates a barrier to free movement of fish from one spring to the other thereby diminishing gene flow. Finally, the most surprising and worrying results were that the three hot spring populations are introgressed by mtDNA genes of O. leucostictus, while microsatellite analysis suggested that some nuclear genes may also have crossed the species barrier. It is very likely that the recent intensification of aquaculture activities in the Loboi drainage may be responsible for these introgressions. Taking into account the importance of these new genetic resources, protection and management actions of the Loboi swamp should be accorded top priority to prevent the loss of these spring populations.	[Ndiwa, Titus Chemandwa; Nyingi, Dorothy Wanja] Natl Museums Kenya, Kenya Wetlands Biodivers Res Grp, Ichthyol Sect, Nairobi, Kenya; [Ndiwa, Titus Chemandwa; Agnese, Jean-Francois] Univ Montpellier 2, CNRS 5554, Dept Conservat & Domesticat, UMR IRD 226, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Nyingi, DW (corresponding author), Natl Museums Kenya, Kenya Wetlands Biodivers Res Grp, Ichthyol Sect, Nairobi, Kenya.	dorothynyingi@yahoo.com	Agnèse, jean-François/J-8302-2016	Agnèse, jean-François/0000-0002-6883-551X; Ndiwa, Titus Chemandwa/0000-0001-5262-6142	IRD (Institut de Recherche pour le Developpement); MAE (French Ministry of Foreign Affairs); Kenya Wetlands Research; National Museums of Kenya (NMK); IRD; NMK	IRD (Institut de Recherche pour le Developpement); MAE (French Ministry of Foreign Affairs); Kenya Wetlands Research; National Museums of Kenya (NMK); IRD; NMK	TCN received a personal grant from IRD (Institut de Recherche pour le Developpement) and MAE (French Ministry of Foreign Affairs). Field work was funded by Kenya Wetlands Research and National Museums of Kenya (NMK). Laboratory work was funded 50% by IRD and 50% by NMK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnese J-F, 2009, MAR GENOM, V1, P103; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Anderson EC, 2002, GENETICS, V160, P1217; Anderson EC, 2008, PHILOS T R SOC B, V363, P2841, DOI 10.1098/rstb.2008.0043; Angienda PO, 2011, CONSERV GENET, V12, P243, DOI 10.1007/s10592-010-0136-2; [Anonymous], 1983, TILAPIINE FISHES GEN; Ashley GM, 2004, SEDIMENTOLOGY, V51, P1301, DOI 10.1111/j.1365-3091.2004.00671.x; Ashley GM, 2002, WETLANDS, V22, P686, DOI 10.1672/0277-5212(2002)022[0686:ABWAPW]2.0.CO;2; Baroiller JF, 2009, COMP BIOCHEM PHYS A, V153, P30, DOI 10.1016/j.cbpa.2008.11.018; Baroiller J.-F., 1989, Aquatic Living Resources, V2, P105, DOI 10.1051/alr:1989013; Baroiller JF, 2001, COMP BIOCHEM PHYS C, V130, P399, DOI 10.1016/S1532-0456(01)00267-8; Beardmore JA, 2001, AQUACULTURE, V197, P283, DOI 10.1016/S0044-8486(01)00590-7; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Bezault E, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-102; CHAKRABORTY S.B., 2009, WORLD J FISH MARINE, V1, P212; Chapman LJ, 2002, COMP BIOCHEM PHYS A, V133, P421, DOI 10.1016/S1095-6433(02)00195-2; Crispo E, 2008, MOL ECOL, V17, P2134, DOI 10.1111/j.1365-294X.2008.03729.x; Deocampo DM., 2002, SPECIAL PUBLICATION, V73, P295, DOI DOI 10.2110/PEC.02.73.0295; Eknath AE, 2009, REV AQUACULT, V1, P197, DOI 10.1111/j.1753-5131.2009.01017.x; Falush D, 2003, GENETICS, V164, P1567; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FUCHS V. E., 1950, GEOL MAG, V87, P149; Grammer GL, 2012, AQUAT INVASIONS, V7, P367, DOI 10.3391/ai.2012.7.3.008; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lind CE, 2012, REV AQUACULT, V4, P125, DOI 10.1111/j.1753-5131.2012.01068.x; MUASYA AM, 2004, J E AFRICAN NATURAL, V93, P39, DOI DOI 10.2982/0012-8317(2004)93[39:DADOMI]2.0.CO;2; Mumba M, 2008, ADAPTING CLIMATE CHA; Nei M., 1987, MOL EVOLUTIONARY GEN; Nevado B, 2011, MOL BIOL EVOL, V28, P2253, DOI 10.1093/molbev/msr043; Nyingi DW, 2007, J FISH BIOL, V70, P148, DOI 10.1111/j.1095-8649.2007.01327.x; Nyingi D.W., 2011, P76; Nyingi D, 2009, AQUACULTURE, V297, P57, DOI 10.1016/j.aquaculture.2009.09.017; Owen RB, 2004, HYDROBIOLOGIA, V518, P59, DOI 10.1023/B:HYDR.0000025057.62967.2c; Pritchard JK, 2000, GENETICS, V155, P945; Rognon X, 2003, MOL ECOL, V12, P435, DOI 10.1046/j.1365-294X.2003.01739.x; Romana-Eguia MRR, 2004, AQUACULTURE, V236, P131, DOI 10.1016/j.aquaculture.2004.01.026; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ryman N, 1991, J FISH BIOL, V39, P1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shelton WL, 2002, P INT FOR TIL FARM 2, P1; TAJIMA F, 1983, GENETICS, V105, P437; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tessema M, 2006, AQUACULTURE, V258, P270, DOI 10.1016/j.aquaculture.2006.04.041; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]	51	23	23	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e106972	10.1371/journal.pone.0106972	http://dx.doi.org/10.1371/journal.pone.0106972			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222491	gold, Green Published, Green Submitted			2022-12-25	WOS:000341774800036
J	Bai, JH; Xiao, R; Zhao, QQ; Lu, QQ; Wang, JJ; Reddy, KR				Bai, Junhong; Xiao, Rong; Zhao, Qingqing; Lu, Qiongqiong; Wang, Junjing; Reddy, K. Ramesh			Seasonal Dynamics of Trace Elements in Tidal Salt Marsh Soils as Affected by the Flow-Sediment Regulation Regime	PLOS ONE			English	Article							HEAVY-METAL CONTAMINATION; POLYCYCLIC AROMATIC-HYDROCARBONS; RIVER INTERTIDAL ZONE; LOW-MOLECULAR-WEIGHT; VERTICAL-DISTRIBUTION; SURFACE SEDIMENTS; CHINA; WETLAND; PROFILE; DELTA	Soil profiles were collected in three salt marshes with different plant species (i.e. Phragmites australis, Tamarix chinensis and Suaeda salsa) in the Yellow River Delta (YRD) of China during three seasons (summer and fall of 2007 and the following spring of 2008) after the flow-sediment regulation regime. Total elemental contents of As, Cd, Cu, Pb and Zn were determined using inductively coupled plasma atomic absorption spectrometry to investigate temporal variations in trace elements in soil profiles of the three salt marshes, assess the enrichment levels and ecological risks of these trace elements in three sampling seasons and identify their influencing factors. Trace elements did not change significantly along soil profiles at each site in each sampling season. The highest value for each sampling site was observed in summer and the lowest one in fall. Soils in both P. australis and S. salsa wetlands tended to have higher trace element levels than those in T. chinensis wetland. Compared to other elements, both Cd and As had higher enrichment factors exceeding moderate enrichment levels. However, the toxic unit (TU) values of these trace elements did not exceed probable effect levels. Correlation analysis showed that these trace elements were closely linked to soil properties such as moisture, sulfur, salinity, soil organic matter, soil texture and pH values. Principal component analysis showed that the sampling season affected by the flow-sediment regulation regime was the dominant factor influencing the distribution patterns of these trace elements in soils, and plant community type was another important factor. The findings of this study could contribute to wetland conservation and management in coastal regions affected by the hydrological engineering.	[Bai, Junhong; Xiao, Rong; Zhao, Qingqing; Lu, Qiongqiong; Wang, Junjing] Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Stimulat, Beijing 100875, Peoples R China; [Bai, Junhong; Reddy, K. Ramesh] Univ Florida, Soil & Water Sci Dept, Wetland Biogeochem Lab, Gainesville, FL USA	Beijing Normal University; State University System of Florida; University of Florida	Bai, JH (corresponding author), Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Stimulat, Beijing 100875, Peoples R China.	junhongbai@163.com	Bai, Junhong/V-1993-2019	Bai, Junhong/0000-0003-2613-2143	National Basic Research Program [2013CB430406]; National Natural Science Foundation of China [51379012, 51179006]; Program for New Century Excellent Talents in University [NECT-10-0235]; Fok Ying Tung Foundation [132009]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fok Ying Tung Foundation(Fok Ying Tung Education Foundation)	This work was financially supported by the National Basic Research Program (2013CB430406), the National Natural Science Foundation of China (51379012 and 51179006), the Program for New Century Excellent Talents in University (NECT-10-0235) and the Fok Ying Tung Foundation (132009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, BIOGEOCHEMISTRY WETL; [Anonymous], 1990, CHIN EL BACKGR VAL S; Audet P, 2008, ENVIRON POLLUT, V156, P290, DOI 10.1016/j.envpol.2008.02.010; Bai JH, 2012, J HYDROL, V450, P244, DOI 10.1016/j.jhydrol.2012.05.006; Bai JH, 2011, ENVIRON POLLUT, V159, P817, DOI 10.1016/j.envpol.2010.11.004; Bai JH, 2010, SOIL TILL RES, V106, P344, DOI 10.1016/j.still.2009.11.003; Bai JH, 2009, ENVIRON ENG SCI, V26, P941, DOI 10.1089/ees.2008.0136; Beth R, 2003, ESTUARIES, V26, P465; Bragato C, 2009, DESALINATION, V246, P35, DOI 10.1016/j.desal.2008.02.036; Brandt SA, 2000, CATENA, V40, P375, DOI 10.1016/S0341-8162(00)00093-X; Carpenter B, 1997, J WATER ENV TECHNOLO, V9, P47; Chabukdhara M, 2012, CHEMOSPHERE, V87, P945, DOI 10.1016/j.chemosphere.2012.01.055; Chiang PN, 2006, ENVIRON TOXICOL, V21, P479, DOI 10.1002/tox.20210; Cui BS, 2009, J NAT CONSERV, V17, P129, DOI 10.1016/j.jnc.2009.01.003; DONER HE, 1978, SOIL SCI SOC AM J, V42, P882, DOI 10.2136/sssaj1978.03615995004200060008x; Du Laing G, 2008, ESTUAR COAST SHELF S, V77, P589, DOI 10.1016/j.ecss.2007.10.017; Ehlken S, 2002, J ENVIRON RADIOACTIV, V58, P97, DOI 10.1016/S0265-931X(01)00060-1; Feng H, 2004, MAR POLLUT BULL, V49, P910, DOI 10.1016/j.marpolbul.2004.06.014; GAMBRELL RP, 1994, J ENVIRON QUAL, V23, P883, DOI 10.2134/jeq1994.00472425002300050005x; Gao XL, 2012, WATER RES, V46, P1901, DOI 10.1016/j.watres.2012.01.007; Gonzalez ZI, 2006, ENVIRON SCI TECHNOL, V40, P6568, DOI 10.1021/es061080v; Grabowski LA, 2001, CHEMOSPHERE, V45, P643, DOI 10.1016/S0045-6535(01)00037-6; Gregorauskiene V, 2006, GEOL Q, V50, P229; Han YM, 2006, SCI TOTAL ENVIRON, V355, P176, DOI 10.1016/j.scitotenv.2005.02.026; Hartley W, 2004, ENVIRON POLLUT, V131, P495, DOI 10.1016/j.envpol.2004.02.017; Hollert Henner, 2003, Journal of Soils and Sediments, V3, P197, DOI 10.1065/jss2003.09.085; Kumpiene J, 2008, WASTE MANAGE, V28, P215, DOI 10.1016/j.wasman.2006.12.012; Lacutusu R, 2000, 4 EUR SOIL BUR; Lassabatere L, 2004, ENVIRON SCI TECHNOL, V38, P4215, DOI 10.1021/es035029s; Li SN, 2009, ECOL ENG, V35, P1719, DOI 10.1016/j.ecoleng.2009.07.009; Long ER, 1998, HUM ECOL RISK ASSESS, V4, P1019, DOI 10.1080/10807039891284956; Madejon P, 2003, SCI TOTAL ENVIRON, V307, P239, DOI 10.1016/S0048-9697(02)00609-5; Manousaki E, 2009, J CHEM TECHNOL BIOT, V84, P877, DOI 10.1002/jctb.2177; MENCH M, 1988, J SOIL SCI, V39, P521, DOI 10.1111/j.1365-2389.1988.tb01236.x; Mitsch W.J., 2007, WETLANDS, V4th ed., DOI DOI 10.1017/CBO9781107415324.004; National Standard of PR China, 2002, GB186682002; Neumann G, 2001, RELEASE ROOT EXUDATE; Nie M, 2010, J HAZARD MATER, V174, P156, DOI 10.1016/j.jhazmat.2009.09.030; Page AL, 1982, METHODS SOIL ANAL 2, P539; Pedersen F, 1998, WATER SCI TECHNOL, V37, P233, DOI 10.1016/S0273-1223(98)00203-0; Peng J, 2010, CATENA, V83, P135, DOI 10.1016/j.catena.2010.08.006; Prusty BAK, 2007, AUST J SOIL RES, V45, P533, DOI 10.1071/SR07041; Roychoudhury AN, 2007, ESTUAR COAST SHELF S, V72, P675, DOI 10.1016/j.ecss.2006.12.003; Selvaraj K, 2004, MAR POLLUT BULL, V49, P174, DOI 10.1016/j.marpolbul.2004.02.006; Soil Survey Staff, 2010, KEYS SOIL TAX; Tixier G, 2012, WATER RES, V46, P6671, DOI 10.1016/j.watres.2011.12.031; Ullrich SM, 1999, APPL GEOCHEM, V14, P187, DOI 10.1016/S0883-2927(98)00042-0; Wang LL, 2009, J HAZARD MATER, V169, P460, DOI 10.1016/j.jhazmat.2009.03.125; Yeloff DE, 2005, J PALEOLIMNOL, V34, P339, DOI 10.1007/s10933-005-5013-5; Zehetner F, 2009, WATER AIR SOIL POLL, V198, P125, DOI 10.1007/s11270-008-9831-8; ZHANG J, 1988, ESTUAR COAST SHELF S, V26, P499, DOI 10.1016/0272-7714(88)90003-0; Zhang WG, 2009, ENVIRON POLLUT, V157, P1533, DOI 10.1016/j.envpol.2009.01.007; Zhao YM, 1995, SCI SURVEY YELLOW RI, P26	53	40	40	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107738	10.1371/journal.pone.0107738	http://dx.doi.org/10.1371/journal.pone.0107738			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216278	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774300093
J	Codrons, E; Bernardi, NF; Vandoni, M; Bernardi, L				Codrons, Erwan; Bernardi, Nicolo F.; Vandoni, Matteo; Bernardi, Luciano			Spontaneous Group Synchronization of Movements and Respiratory Rhythms	PLOS ONE			English	Article							HEART-RATE; PERCEPTION; ENTRAINMENT; RESPONSES; DYNAMICS; RAPPORT; MUSIC	We tested whether pre-assigned arm movements performed in a group setting spontaneously synchronized and whether synchronization extended to heart and respiratory rhythms. We monitored arm movements, respiration and electrocardiogram at rest and during spontaneous, music and metronome-associated arm-swinging. No directions were given on whether or how the arm swinging were to be synchronized between participants or with the external cues. Synchronization within 3 groups of 10 participants studied collectively was compared with pseudo-synchronization of 3 groups of 10 participants that underwent an identical protocol but in an individual setting. Motor synchronization was found to be higher in the collective groups than in the individuals for the metronome-associated condition. On a repetition of the protocol on the following day, motor synchronization in the collective groups extended to the spontaneous, un-cued condition. Breathing was also more synchronized in the collective groups than in the individuals, particularly at rest and in the music-associated condition. Group synchronization occurs without explicit instructions, and involves both movements and respiratory control rhythms.	[Codrons, Erwan; Vandoni, Matteo] Univ Pavia, Dept Publ Hlth & Neurosci, I-27100 Pavia, Italy; [Codrons, Erwan] Univ Pavia, Dept Brain & Behav Sci, I-27100 Pavia, Italy; [Bernardi, Nicolo F.] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Bernardi, Luciano] Univ Pavia, Dept Internal Med, I-27100 Pavia, Italy; [Bernardi, Luciano] Univ Helsinki, Folkhalsan Res Ctr, Helsinki, Finland	University of Pavia; University of Pavia; McGill University; University of Pavia; Folkhalsan Research Center; University of Helsinki	Bernardi, L (corresponding author), Univ Pavia, Dept Internal Med, Via Palestro 3, I-27100 Pavia, Italy.	lbern1ps@unipv.it	vandoni, matteo/AAS-7299-2021	vandoni, matteo/0000-0002-3405-9364; Bernardi, Nicolo Francesco/0000-0002-1250-1916	Department of Public Health and Neuroscience, University of Pavia, Italy; Signe and Ane Gyllenberg Foundation, Helsinki, Finland	Department of Public Health and Neuroscience, University of Pavia, Italy; Signe and Ane Gyllenberg Foundation, Helsinki, Finland	The authors acknowledge the financial support of the Department of Public Health and Neuroscience, University of Pavia, Italy (E.C.) and of the Signe and Ane Gyllenberg Foundation, Helsinki, Finland (L.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, DIGITAL SPECTRAL ANA; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Baccala LA, 2007, PROCEEDINGS OF THE 2007 15TH INTERNATIONAL CONFERENCE ON DIGITAL SIGNAL PROCESSING, P163, DOI 10.1109/ICDSP.2007.4288544; Bernardi L, 2006, HEART, V92, P445, DOI 10.1136/hrt.2005.064600; Bernardi L, 2011, DIABETES-METAB RES, V27, P654, DOI 10.1002/dmrr.1224; Bernardi L, 2009, CIRCULATION, V119, P3171, DOI 10.1161/CIRCULATIONAHA.108.806174; BERNIERI FJ, 1988, J NONVERBAL BEHAV, V12, P120, DOI 10.1007/BF00986930; Blinowska KJ, 2011, MED BIOL ENG COMPUT, V49, P521, DOI 10.1007/s11517-011-0739-x; Chartrand Tanya L, 2003, SOCIAL JUDGMENTS IMP, P290; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Chiel HJ, 1997, TRENDS NEUROSCI, V20, P553, DOI 10.1016/S0166-2236(97)01149-1; Critchley HD, 2009, INT J PSYCHOPHYSIOL, V73, P88, DOI 10.1016/j.ijpsycho.2009.01.012; D'Ausilio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035757; Demos AP, 2012, J EXP PSYCHOL GEN, V141, P49, DOI 10.1037/a0023843; DIMASCIO A, 1957, PSYCHOSOM MED, V19, P99, DOI 10.1097/00006842-195703000-00002; Egermann H, 2013, COGN AFFECT BEHAV NE, V13, P533, DOI 10.3758/s13415-013-0161-y; Feldman R, 2007, J CHILD PSYCHOL PSYC, V48, P329, DOI 10.1111/j.1469-7610.2006.01701.x; FIELD T, 1989, INFANT BEHAV DEV, V12, P357, DOI 10.1016/0163-6383(89)90044-1; Gibson JJ, 1979, ECOLOGICAL APPROACH; Giese MA, 1996, BIOL CYBERN, V74, P427, DOI 10.1007/BF00206709; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Helm JL, 2012, EMOTION, V12, P748, DOI 10.1037/a0025036; Henning RA, 2009, APPL ERGON, V40, P1004, DOI 10.1016/j.apergo.2009.04.009; Issartel J, 2007, NEUROSCI LETT, V411, P174, DOI 10.1016/j.neulet.2006.09.086; KELSO JAS, 1990, ATTENTION PERFORM, V8, P139; Kelso S., 1995, DYNAMIC PATTERNS SEL; Konvalinka I, 2011, P NATL ACAD SCI USA, V108, P8514, DOI 10.1073/pnas.1016955108; Kugler P.N., 1980, ADV PSYCHOL, P3, DOI [10.1016/S0166-4115, DOI 10.1016/S0166-4115, 10.1016/S0166-4115(08)61936]; Laczika K, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-23; Lopresti-Goodman SM, 2008, J MOTOR BEHAV, V40, P3, DOI 10.3200/JMBR.40.1.3-10; McNeill W. H., 1995, KEEPING TOGETHER TIM; Miles LK, 2009, J EXP SOC PSYCHOL, V45, P585, DOI 10.1016/j.jesp.2009.02.002; Muller V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024893; Nagasaka Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01151; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Pellegrini Raffaella, 2012, REV PSYCHOL, V19, P17; Philippot P, 2002, COGNITION EMOTION, V16, P605, DOI 10.1080/02699930143000392; Radcliffe-Brown, 2013, ANDAMAN ISLANDERS; Repp BH, 2004, PSYCHOL RES-PSYCH FO, V68, P252, DOI 10.1007/s00426-003-0143-8; Richardson M. J., 2010, MIND CONTEXT, P307; Richardson MJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00405; Schelter B, 2009, J NEUROSCI METH, V179, P121, DOI 10.1016/j.jneumeth.2009.01.006; Schlogl A, 2006, SIGNAL PROCESS, V86, P2426, DOI 10.1016/j.sigpro.2005.11.007; Schmidt RC, 2007, J EXP PSYCHOL HUMAN, V33, P860, DOI 10.1037/0096-1523.33.4.860; Schmidt RC, 2008, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-3-540-74479-5_14; Shockley K, 2003, J EXP PSYCHOL HUMAN, V29, P326, DOI 10.1037/0096-1523.29.2.326; Spadacini G, 2006, INT J CARDIOL, V107, P171, DOI 10.1016/j.ijcard.2005.03.011; STANEK B, 1973, PSYCHOTHER PSYCHOSOM, V22, P289, DOI 10.1159/000286534; Valdesolo P, 2011, EMOTION, V11, P262, DOI 10.1037/a0021302; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; Van Leeuwen P, 2009, P NATL ACAD SCI USA, V106, P13661, DOI 10.1073/pnas.0901049106; Vickhoff B, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00334; Warren WH, 2006, PSYCHOL REV, V113, P358, DOI 10.1037/0033-295X.113.2.358; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x	55	61	62	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107538	10.1371/journal.pone.0107538	http://dx.doi.org/10.1371/journal.pone.0107538			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP0SM	25216280	gold, Green Published, Green Submitted			2022-12-25	WOS:000341774300077
J	Kalahroudi, VG; Kamalidehghan, B; Kani, AA; Aryani, O; Tondar, M; Ahmadipour, F; Chung, LY; Houshmand, M				Kalahroudi, Vadieh Ghodsinejad; Kamalidehghan, Behnam; Kani, Ahoura Arasteh; Aryani, Omid; Tondar, Mahdi; Ahmadipour, Fatemeh; Chung, Lip Yong; Houshmand, Massoud			Two Novel Tyrosinase (TYR) Gene Mutations with Pathogenic Impact on Oculocutaneous Albinism Type 1 (OCA1)	PLOS ONE			English	Article							RECESSIVE OCULAR ALBINISM; ENDOPLASMIC-RETICULUM; MISSENSE MUTATIONS; PIGMENTATION; POLYMORPHISM; TEMPERATURE; RETENTION; PROTEINS; SPECTRUM; DISEASES	Oculocutaneous albinism (OCA) is a heterogeneous group of autosomal recessive disorders resulting from mutations of the tyrosinase (TYR) gene and presents with either complete or partial absence of pigment in the skin, hair and eyes due to a defect in an enzyme involved in the production of melanin. In this study, mutations in the TYR gene of 30 unrelated Iranian OCA1 patients and 100 healthy individuals were examined using PCR-sequencing. Additionally, in order to predict the possible effects of new mutations on the structure and function of tyrosinase, these mutations were analyzed by SIFT, PolyPhen and I-Mutant 2 software. Here, two new pathogenic p.C89S and p.H180R mutations were detected in two OCA1 patients. Moreover, the R402Q and S192Y variants, which are common non-pathogenic polymorphisms, were detected in 17.5% and 35% of the patients, respectively. The outcome of this study has extended the genotypic spectrum of OCA1 patients, which paves the way for more efficient carrier detection and genetic counseling.	[Kalahroudi, Vadieh Ghodsinejad] Kharazmi Univ, Dept Biol, Tehran, Iran; [Kalahroudi, Vadieh Ghodsinejad; Kani, Ahoura Arasteh; Aryani, Omid; Tondar, Mahdi; Houshmand, Massoud] Special Med Ctr, Dept Med Genet, Tehran, Iran; [Kamalidehghan, Behnam; Ahmadipour, Fatemeh; Chung, Lip Yong] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Tondar, Mahdi] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC USA; [Houshmand, Massoud] Natl Inst Genet Engn & Biotechnol NIGEB, Dept Med Genet, Tehran, Iran	Kharazmi University; Universiti Malaya; Georgetown University	Houshmand, M (corresponding author), Special Med Ctr, Dept Med Genet, Tehran, Iran.	massoudh@nigeb.ac.ir	CHUNG, LIP YONG/B-7764-2010; Houshmand, Massoud/AEG-9909-2022; Kamalidehghan, Behnam/B-5401-2013	CHUNG, LIP YONG/0000-0002-3596-768X; Kamalidehghan, Behnam/0000-0001-8530-8124; Houshmand, Massoud/0000-0002-2198-223X; , Masoud/0000-0001-7687-7464	University of Malaya Research [RG084-13BIO]; IPPP [PG0822013B]; BKP [BK020-2012]; Malaysian Ministry of Higher Education's MOHE-HIR [UM.C/625/1/MOHE/MED/17, UM.C/625/1/MOHE/MED/33]	University of Malaya Research(Universiti Malaya); IPPP; BKP; Malaysian Ministry of Higher Education's MOHE-HIR	The authors would like to thank all the participants for the blood donation from the Medical Genetics Department at the Special Medical Center, Tehran, Iran. The authors would like to express their utmost gratitude and appreciation to University of Malaya Research Grant (RG084-13BIO), IPPP grant (PG0822013B), BKP grant (BK020-2012) and Malaysian Ministry of Higher Education's MOHE-HIR Grants (UM.C/625/1/MOHE/MED/17 and UM.C/625/1/MOHE/MED/33) for providing partial financial supports to conduct this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Berson JF, 2000, J BIOL CHEM, V275, P12281, DOI 10.1074/jbc.275.16.12281; Chaki M, 2005, HUM MUTAT, V26, P53, DOI 10.1002/humu.20171; Chiang PW, 2008, AM J MED GENET A, V146A, P2968, DOI 10.1002/ajmg.a.32539; Chiang PW, 2008, AM J MED GENET A, V146A, P2427, DOI 10.1002/ajmg.a.32453; Chiang PW, 2009, AM J MED GENET A, V149A, P1590, DOI 10.1002/ajmg.a.32939; Desmet FO, 2012, METHODS MOL BIOL, V867, P17, DOI 10.1007/978-1-61779-767-5_2; FUKAI K, 1995, NAT GENET, V9, P92, DOI 10.1038/ng0195-92; Garcia-Borron JC, 2002, PIGM CELL RES, V15, P162, DOI 10.1034/j.1600-0749.2002.02012.x; Gargiulo A, 2011, INVEST OPHTH VIS SCI, V52, P1281, DOI 10.1167/iovs.10-6091; GIEBEL LB, 1991, AM J HUM GENET, V48, P1159; GIEBEL LB, 1991, GENOMICS, V9, P435, DOI 10.1016/0888-7543(91)90409-8; Gronskov K, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-43; Gronskov K, 2009, INVEST OPHTH VIS SCI, V50, P1058, DOI 10.1167/iovs.08-2639; Halaban R, 2000, P NATL ACAD SCI USA, V97, P5889, DOI 10.1073/pnas.97.11.5889; Hutton SM, 2008, INVEST OPHTH VIS SCI, V49, P868, DOI 10.1167/iovs.07-0791; Karaman Ali, 2008, Dermatol Online J, V14, P13; King R., 1995, METABOLIC MOL BASES, P4353; KING RA, 1991, MOL BIOL MED, V8, P19; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; KWON BS, 1987, P NATL ACAD SCI USA, V84, P7473, DOI 10.1073/pnas.84.21.7473; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Landsverk ML, 2012, GENET MED, V14, P877, DOI 10.1038/gim.2012.58; Lin YY, 2011, CHINESE MED J-PEKING, V124, P3358, DOI 10.3760/cma.j.issn.0366-6999.2011.20.027; Liu J, 2010, CLIN EXP OPHTHALMOL, V38, P37, DOI 10.1111/j.1442-9071.2009.02220.x; MULLER G, 1988, EMBO J, V7, P2723, DOI 10.1002/j.1460-2075.1988.tb03126.x; Nakamura E, 2002, J DERMATOL SCI, V28, P102, DOI 10.1016/S0923-1811(01)00141-4; Oetting WS, 2009, AM J MED GENET A, V149A, P466, DOI 10.1002/ajmg.a.32654; Oetting WS, 2003, PIGM CELL RES, V16, P307, DOI 10.1034/j.1600-0749.2003.00045.x; OETTING WS, 1993, AM J HUM GENET, V52, P17; OETTING WS, 1994, ELECTROPHORESIS, V15, P159, DOI 10.1002/elps.1150150127; OKORO AN, 1975, BRIT J DERMATOL, V92, P485; Park SH, 2012, JPN J OPHTHALMOL, V56, P98, DOI 10.1007/s10384-011-0098-z; Preising MN, 2011, MOL VIS, V17, P939; Ray K, 2007, PROG RETIN EYE RES, V26, P323, DOI 10.1016/j.preteyeres.2007.01.001; Rooryck C, 2008, PIGM CELL MELANOMA R, V21, P583, DOI 10.1111/j.1755-148X.2008.00496.x; Rundshagen U, 2004, HUM MUTAT, V23, P106, DOI 10.1002/humu.10311; Schnur RE, 1996, J INVEST DERMATOL, V106, P1137, DOI 10.1111/1523-1747.ep12340185; Simeonov DR, 2013, HUM MUTAT, V34, P827, DOI 10.1002/humu.22315; SPRITZ RA, 1991, AM J HUM GENET, V48, P318; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; TOMITA Y, 1989, BIOCHEM BIOPH RES CO, V164, P990, DOI 10.1016/0006-291X(89)91767-1; Toyofuku K, 2001, FASEB J, V15, P2149, DOI 10.1096/fj.01-0216com; TRIPATHI RK, 1991, GENE EXPRESSION, V1, P103; TRIPATHI RK, 1992, AM J MED GENET, V43, P865, DOI 10.1002/ajmg.1320430523; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Wei AH, 2010, J INVEST DERMATOL, V130, P716, DOI 10.1038/jid.2009.339; YAMAMOTO H, 1987, JPN J GENET, V62, P271, DOI 10.1266/jjg.62.271; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	50	24	25	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106656	10.1371/journal.pone.0106656	http://dx.doi.org/10.1371/journal.pone.0106656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216246	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774300020
J	Lee, YH; Bang, H; Park, YM; Bae, JC; Lee, BW; Kang, ES; Cha, BS; Lee, HC; Balkau, B; Lee, WY; Kim, DJ				Lee, Yong-ho; Bang, Heejung; Park, Young Min; Bae, Ji Cheol; Lee, Byung-Wan; Kang, Eun Seok; Cha, Bong Soo; Lee, Hyun Chul; Balkau, Beverley; Lee, Won-Young; Kim, Dae Jung			Non-Laboratory-Based Self-Assessment Screening Score for Non-Alcoholic Fatty Liver Disease: Development, Validation and Comparison with Other Scores	PLOS ONE			English	Article							RISK-FACTORS; HEPATIC STEATOSIS; PREVALENCE; NAFLD; STEATOHEPATITIS; MANAGEMENT; PREDICTOR; DIAGNOSIS; OBESITY; COMMON	Background: Non-alcoholic fatty liver disease (NAFLD) is a prevalent and rapidly increasing disease worldwide; however, no widely accepted screening models to assess the risk of NAFLD are available. Therefore, we aimed to develop and validate a self-assessment score for NAFLD in the general population using two independent cohorts. Methods: The development cohort comprised 15676 subjects (8313 males and 7363 females) who visited the National Health Insurance Service Ilsan Hospital in Korea in 2008-2010. Anthropometric, clinical, and laboratory data were examined during regular health check-ups and fatty liver diagnosed by abdominal ultrasound. Logistic regression analysis was conducted to determine predictors of prevalent NAFLD and to derive risk scores/models. We validated our models and compared them with other existing methods using an external cohort (N = 66868). Results: The simple self-assessment score consists of age, sex, waist circumference, body mass index, history of diabetes and dyslipidemia, alcohol intake, physical activity and menopause status, which are independently associated with NAFLD, and has a value of 0-15. A cut-off point of >= 8 defined 58% of males and 36% of females as being at high-risk of NAFLD, and yielded a sensitivity of 80% in men (77% in women), a specificity of 67% (81%), a positive predictive value of 72% (63%), a negative predictive value of 76% (89%) and an AUC of 0.82 (0.88). Comparable results were obtained using the validation dataset. The comprehensive NAFLD score, which includes additional laboratory parameters, has enhanced discrimination ability, with an AUC of 0.86 for males and 0.91 for females. Both simple and comprehensive NAFLD scores were significantly increased in subjects with higher fatty liver grades or severity of liver conditions (e.g., simple steatosis, steatohepatitis). Conclusions: The new non-laboratory-based self-assessment score may be useful for identifying individuals at high-risk of NAFLD. Further studies are warranted to evaluate the utility and feasibility of the scores in various settings.	[Lee, Yong-ho; Lee, Byung-Wan; Kang, Eun Seok; Cha, Bong Soo; Lee, Hyun Chul] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Bang, Heejung] Univ Calif Davis, Sch Med, Dept Publ Hlth Sci, Div Biostat, Davis, CA 95616 USA; [Park, Young Min] Natl Hlth Insurance Corp Ilsan Hosp, Dept Family Med, Goyang, South Korea; [Bae, Ji Cheol] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med,Div Endocrinol & Metab, Seoul, South Korea; [Balkau, Beverley] INSERM, Ctr Res Epidemiol & Populat Hlth CESP, U1018, Epidemiol Diabet Obes & Chron Renal Dis Lifecours, Villejuif, France; [Balkau, Beverley] Univ Paris 11, UMRS 1018, Villejuif, France; [Lee, Won-Young] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med,Beijing Mil Command, Seoul, South Korea; [Kim, Dae Jung] Ajou Univ, Sch Med, Dept Endocrinol & Metab, Suwon 441749, South Korea; [Kim, Dae Jung] Ajou Univ, Sch Med, Inst Aging, Suwon 441749, South Korea	Yonsei University; Yonsei University Health System; University of California System; University of California Davis; Sungkyunkwan University (SKKU); Samsung Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Sungkyunkwan University (SKKU); Samsung Medical Center; Ajou University; Ajou University	Lee, WY (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med,Beijing Mil Command, Seoul, South Korea.	drlwy@hanmail.net; djkim@ajou.ac.kr	LEE, WON-YOUNG/C-7249-2018; Lee, Yong-ho/AAT-4106-2020	LEE, WON-YOUNG/0000-0002-1082-7592; Lee, Yong-ho/0000-0002-6219-4942; Kim, Dae Jung/0000-0003-1025-2044; Cha, Bong-Soo/0000-0003-0542-2854; Kang, Eun Seok/0000-0002-0364-4675; Lee, Byung-Wan/0000-0002-9899-4992	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C0715]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This paper is supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C0715). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal NH, 2012, JAMA-J AM MED ASSOC, V308, P608, DOI 10.1001/jama.2012.8402; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; [Anonymous], 2013, LANCET, V381, P508, DOI 10.1016/S0140-6736(13)60263-9; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Bae JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046819; Bang HJ, 2009, ANN INTERN MED, V151, P775, DOI 10.7326/0003-4819-151-11-200912010-00005; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bedogni G, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-98; Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Claridge LC, 2011, LANCET, V377, P2179, DOI 10.1016/S0140-6736(11)60962-8; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Farrell GC, 2013, NAT REV GASTRO HEPAT, V10, P307, DOI 10.1038/nrgastro.2013.34; Gonen M, 2007, ANAL RECEIVER OPERAT; Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005; Lee JW, 2010, GUT LIVER, V4, P378, DOI 10.5009/gnl.2010.4.3.378; Lee JH, 2010, DIGEST LIVER DIS, V42, P503, DOI 10.1016/j.dld.2009.08.002; Lee JY, 2007, J HEPATOL, V47, P239, DOI 10.1016/j.jhep.2007.02.007; Lee YH, 2012, DIABETES CARE, V35, P1723, DOI 10.2337/dc11-2347; Leung CM, 2009, J GASTROEN HEPATOL, V24, P1786, DOI 10.1111/j.1440-1746.2009.05914.x; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Oh SW, 2011, DIABETES METAB J, V35, P561, DOI 10.4093/dmj.2011.35.6.561; Ong JP, 2008, J HEPATOL, V49, P608, DOI 10.1016/j.jhep.2008.06.018; Park Young Jin, 2011, Korean J Hepatol, V17, P19, DOI 10.3350/kjhep.2011.17.1.19; Ramos-De la Medina A, 2008, J GASTROINTEST SURG, V12, P2097, DOI 10.1007/s11605-008-0704-7; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Soderberg C, 2010, HEPATOLOGY, V51, P595, DOI 10.1002/hep.23314; Suzuki A, 2009, WOMENS HEALTH, V5, P191, DOI 10.2217/17455057.5.2.191; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wieckowska A, 2007, HEPATOLOGY, V46, P582, DOI 10.1002/hep.21768; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020; Zhang H, 2013, J LIPID RES, V54, P345, DOI 10.1194/jlr.M028969; Zhou YJ, 2012, J DIGEST DIS, V13, P153, DOI 10.1111/j.1751-2980.2011.00571.x	40	71	70	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107584	10.1371/journal.pone.0107584	http://dx.doi.org/10.1371/journal.pone.0107584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216184	Green Published, Green Submitted, gold			2022-12-25	WOS:000341774300083
J	Korkmaz, G; Holm, M; Wiens, T; Sanyal, S				Korkmaz, Gurkan; Holm, Mikael; Wiens, Tobias; Sanyal, Suparna			Comprehensive Analysis of Stop Codon Usage in Bacteria and Its Correlation with Release Factor Abundance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENT GROWTH-RATES; ESCHERICHIA-COLI; TRANSLATION TERMINATION; MYCOPLASMA-GENITALIUM; IN-VIVO; EVOLUTION; EFFICIENCY; CONTEXT; SIGNALS; PREDICT	We present a comprehensive analysis of stop codon usage in bacteria by analyzing over eight million coding sequences of 4684 bacterial sequences. Using a newly developed program called "stop codon counter," the frequencies of the three classical stop codons TAA, TAG, and TGA were analyzed, and a publicly available stop codon database was built. Our analysis shows that with increasing genomic GC content the frequency of the TAA codon decreases and that of the TGA codon increases in a reciprocal manner. Interestingly, the release factor 1-specific codon TAG maintains a more or less uniform frequency (similar to 20%) irrespective of the GC content. The low abundance of TAG is also valid with respect to expression level of the genes ending with different stop codons. In contrast, the highly expressed genes predominantly end with TAA, ensuring termination with either of the two release factors. Using three model bacteria with different stop codon usage (Escherichia coli, Mycobacterium smegmatis, and Bacillus subtilis), we show that the frequency of TAG and TGA codons correlates well with the relative steady state amount of mRNA and protein for release factors RF1 and RF2 during exponential growth. Furthermore, using available microarray data for gene expression, we show that in both fast growing and contrasting biofilm formation conditions, the relative level of RF1 is nicely correlated with the expression level of the genes ending with TAG.	[Korkmaz, Gurkan; Holm, Mikael; Wiens, Tobias; Sanyal, Suparna] Uppsala Univ, Dept Cell & Mol Biol, BMC, S-75124 Uppsala, Sweden	Uppsala University	Sanyal, S (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, BMC, Box 596, S-75124 Uppsala, Sweden.	suparna.sanyal@icm.uu.se		Korkmaz, Gurkan/0000-0003-1911-027X	Swedish Research Council [2010-2619, 2011-6088, 2008-6593]; Carl-Tryggers Foundation [CTS 09:341, 10:330]; Wenner-Gren Foundation; Knut and Alice Wallenberg Foundation [KAW 2011.0081]; Sven and Lilly Lawski Foundation for Scientific Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl-Tryggers Foundation; Wenner-Gren Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Sven and Lilly Lawski Foundation for Scientific Research	This work was supported by Swedish Research Council Research Grants 2010-2619 Medicin, 2011-6088 (Natural Science) and 2008-6593, a Linnaeus grant to the Uppsala RNA Research Center (all to S. S.); Carl-Tryggers Foundation Grants CTS 09:341 and 10:330; the Wenner-Gren Foundation; and Knut and Alice Wallenberg Foundation Grant KAW 2011.0081 (to RiboCORE).; Supported by a scholarship from the Sven and Lilly Lawski Foundation for Scientific Research.	ADAMSKI FM, 1994, J MOL BIOL, V238, P302, DOI 10.1006/jmbi.1994.1293; BONETTI B, 1995, J MOL BIOL, V251, P334, DOI 10.1006/jmbi.1995.0438; BROWN CM, 1993, NUCLEIC ACIDS RES, V21, P3119, DOI 10.1093/nar/21.13.3119; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Cridge AG, 2006, NUCLEIC ACIDS RES, V34, P1959, DOI 10.1093/nar/gkl074; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Duarte I, 2012, MOL BIOL EVOL, V29, P3497, DOI 10.1093/molbev/mss157; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Gao HX, 2007, CELL, V129, P929, DOI 10.1016/j.cell.2007.03.050; Gilchrist MA, 2007, MOL BIOL EVOL, V24, P2362, DOI 10.1093/molbev/msm169; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; INAMINE JM, 1990, J BACTERIOL, V172, P504, DOI 10.1128/JB.172.1.504-506.1990; Ivanova NN, 2014, SCIENCE, V344, P909, DOI 10.1126/science.1250691; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Lind C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3940; Major LL, 2002, FEBS LETT, V514, P84, DOI 10.1016/S0014-5793(02)02301-3; Margus T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-15; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mora L, 2007, J BIOL CHEM, V282, P35638, DOI 10.1074/jbc.M706076200; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; Pavlov MY, 1998, J MOL BIOL, V284, P579, DOI 10.1006/jmbi.1998.2220; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; Povolotskaya IS, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-30; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santos MAS, 2004, TRENDS GENET, V20, P95, DOI 10.1016/j.tig.2003.12.009; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; SHARP PM, 1988, GENE, V63, P141, DOI 10.1016/0378-1119(88)90553-7; Sun JC, 2005, J MOL EVOL, V61, P437, DOI 10.1007/s00239-004-0277-3; Tate WP, 1999, BIOCHEMISTRY-MOSCOW+, V64, P1342; Yang XO, 2008, APPL ENVIRON MICROB, V74, P2690, DOI 10.1128/AEM.02809-07; Zhang G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005036	35	39	40	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30334	30342		10.1074/jbc.M114.606632	http://dx.doi.org/10.1074/jbc.M114.606632			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25217634	Green Published, hybrid			2022-12-25	WOS:000344549700016
J	Wogenstein, KL; Szabo, S; Lunova, M; Wiche, G; Haybaeck, J; Strnad, P; Boor, P; Wagner, M; Fuchs, P				Woegenstein, Karl L.; Szabo, Sandra; Lunova, Mariia; Wiche, Gerhard; Haybaeck, Johannes; Strnad, Pavel; Boor, Peter; Wagner, Martin; Fuchs, Peter			Epiplakin Deficiency Aggravates Murine Caerulein-Induced Acute Pancreatitis and Favors the Formation of Acinar Keratin Granules	PLOS ONE			English	Article							HUMAN EPIDERMAL AUTOANTIGEN; DISRUPTION; EXPRESSION; CELLS; MICE; ACCELERATION; CYTOKERATINS; EPITHELIA; MIGRATION; NETWORKS	Epiplakin, a member of the plakin protein family, is exclusively expressed in epithelial tissues and was shown to bind to keratins. Epiplakin- deficient (EPPK-/-) mice showed no obvious spontaneous phenotype, however, EPPK-/- keratinocytes displayed faster keratin network breakdown in response to stress. The role of epiplakin in pancreas, a tissue with abundant keratin expression, was not yet known. We analyzed epiplakin's expression in healthy and inflamed pancreatic tissue and compared wild-type and EPPK-/- mice during caerulein-induced acute pancreatitis. We found that epiplakin was expressed primarily in ductal cells of the pancreas and colocalized with apicolateral keratin bundles in murine pancreatic acinar cells. Epiplakin's diffuse subcellular localization in keratin filament-free acini of K8-deficient mice indicated that its filament-associated localization in acinar cells completely depends on its binding partner keratin. During acute pancreatitis, epiplakin was upregulated in acinar cells and its redistribution closely paralleled keratin reorganization. EPPK-/- mice suffered from aggravated pancreatitis but showed no obvious regeneration phenotype. At the most severe stage of the disease, EPPK-/- acinar cells displayed more keratin aggregates than those of wild-type mice. Our data propose epiplakin to be a protective protein during acute pancreatitis, and that its loss causes impaired disease-associated keratin reorganization.	[Woegenstein, Karl L.; Szabo, Sandra; Wiche, Gerhard; Fuchs, Peter] Univ Vienna, Dept Biochem & Cell Biol, Max F Perutz Labs, Vienna, Austria; [Lunova, Mariia; Strnad, Pavel] Univ Hosp Aachen, Dept Internal Med 3, Aachen, Germany; [Lunova, Mariia; Strnad, Pavel] Univ Hosp Aachen, IZKF, Aachen, Germany; [Haybaeck, Johannes] Med Univ Graz, Inst Pathol, Graz, Austria; [Boor, Peter] Rhein Westfal TH Aachen, Div Nephrol, Aachen, Germany; [Boor, Peter] Rhein Westfal TH Aachen, Inst Pathol, Aachen, Germany; [Wagner, Martin] Univ Med Ctr Ulm, Dept Internal Med 1, Ulm, Germany	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Medical University of Graz; RWTH Aachen University; RWTH Aachen University; Ulm University	Fuchs, P (corresponding author), Univ Vienna, Dept Biochem & Cell Biol, Max F Perutz Labs, Vienna, Austria.	peter.fuchs@univie.ac.at	WICHE, Gerhard/AAA-3227-2021; Lunova, Mariia/G-8447-2014; Boor, Peter/C-7707-2011	Boor, Peter/0000-0001-9921-4284; Lunova, Mariia/0000-0002-5795-7781; Fuchs, Peter/0000-0003-3933-7674; Wiche, Gerhard/0000-0001-9550-5463	Austrian Science Fund (FWF) [P 22604-B12]; DFG [TP25, SFB/Transregio 57, BO 3755/1-1, STR 1095/4-1]; Else-Kroner Fresenius Stiftung [EKFS 2012_A216]; Austrian Science Fund (FWF) [P 23729, P 22604] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); DFG(German Research Foundation (DFG)); Else-Kroner Fresenius Stiftung; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grant P 22604-B12 from the Austrian Science Fund (FWF) (to PF) and the financial research grants TP25 and Q1 of the SFB/Transregio 57 "Mechanisms of organ fibrosis" (to PB), BO 3755/1-1 (to PB), and STR 1095/4-1 (to PS), all of the DFG, and by the Else-Kroner Fresenius Stiftung (EKFS 2012_A216 to PB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOLLER K, 1987, EUR J CELL BIOL, V43, P459; Casanova ML, 1999, J CLIN INVEST, V103, P1587, DOI 10.1172/JCI5343; Fujiwara S, 2001, J BIOL CHEM, V276, P13340, DOI 10.1074/jbc.M011386200; FUJIWARA S, 1994, DERMATOLOGY, V189, P120, DOI 10.1159/000246950; Fujiwara S, 1996, J INVEST DERMATOL, V106, P1125, DOI 10.1111/1523-1747.ep12340171; Goto M, 2006, MOL CELL BIOL, V26, P548, DOI 10.1128/MCB.26.2.548-558.2006; Jang SI, 2005, J CELL SCI, V118, P781, DOI 10.1242/jcs.01647; Kokado M, 2013, INVEST OPHTH VIS SCI, V54, P3780, DOI 10.1167/iovs.12-11077; Ku NO, 2002, J BIOL CHEM, V277, P10775, DOI 10.1074/jbc.M107623200; Matsuo A, 2011, GENE EXPR PATTERNS, V11, P255, DOI 10.1016/j.gep.2011.01.001; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; SCHEELE GA, 1975, J BIOL CHEM, V250, P2660; SCHMIDT J, 1992, INT J PANCREATOL, V12, P41; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Spazierer D, 2006, MOL CELL BIOL, V26, P559, DOI 10.1128/MCB.26.2.559-568.2006; Spazierer D, 2003, J BIOL CHEM, V278, P31657, DOI 10.1074/jbc.M303055200; Spazierer D, 2008, J CELL SCI, V121, P825, DOI 10.1242/jcs.013755; Toivola DM, 2008, AM J PATHOL, V172, P882, DOI 10.2353/ajpath.2008.070830; Toivola DM, 2000, AM J PHYSIOL-GASTR L, V279, pG1343, DOI 10.1152/ajpgi.2000.279.6.G1343; Toivola DM, 2000, EXP CELL RES, V255, P156, DOI 10.1006/excr.1999.4787; Wang WQ, 2006, J DERMATOL, V33, P518, DOI 10.1111/j.1346-8138.2006.00127.x; Watson ED, 2007, DEVELOPMENT, V134, P1809, DOI 10.1242/dev.02843; Williams JA, 2010, DATABASE PANCREAPEDI; Yoshida T, 2008, GENES CELLS, V13, P667, DOI 10.1111/j.1365-2443.2008.01196.x	24	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e108323	10.1371/journal.pone.0108323	http://dx.doi.org/10.1371/journal.pone.0108323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232867	Green Submitted, gold, Green Published			2022-12-25	WOS:000342921200092
J	Ring, J; Hoerr, V; Tuchscherr, L; Kuhlmann, MT; Loffler, B; Faber, C				Ring, Janine; Hoerr, Verena; Tuchscherr, Lorena; Kuhlmann, Michael T.; Loeffler, Bettina; Faber, Cornelius			MRI Visualization of Staphyloccocus aureus-Induced Infective Endocarditis in Mice	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; IRON-OXIDE PARTICLES; STAPHYLOCOCCUS-AUREUS; MAGNETIC-RESONANCE; PATHOGENESIS; CRITERIA; MODEL; THIGH	Infective endocarditis (IE) is a severe and often fatal disease, lacking a fast and reliable diagnostic procedure. The purpose of this study was to establish a mouse model of Staphylococcus aureus-induced IE and to develop a MRI technology to characterize and diagnose IE. To establish the mouse model of hematogenous IE, aortic valve damage was induced by placing a permanent catheter into right carotid artery. 24 h after surgery, mice were injected intravenously with either iron particle-labeled or unlabeled S. aureus (strain 6850). To distinguish the effect of IE from mere tissue injury or recruited macrophages, subgroups of mice received sham surgery prior to infection (n = 17), received surgery without infection (n = 8), or obtained additionally injection of free iron particles to label macrophages (n = 17). Cardiac MRI was performed 48 h after surgery using a self-gated ultra-short echo time (UTE) sequence (TR/TE, 5/0.31 ms; in-plane/slice, 0.125/1 mm; duration, 12: 08 min) to obtain high-resolution, artifact-free cinematographic images of the valves. After MRI, valves were either homogenized and plated on blood agar plates for determination of bacterial titers, or sectioned and stained for histology. In the animal model, both severity of the disease and mortality increased with bacterial numbers. Infection with 10 5 S. aureus bacteria reliably caused endocarditis with vegetations on the valves. Cinematographic UTE MRI visualised the aortic valve over the cardiac cycle and allowed for detection of bacterial vegetations, while mere tissue trauma or labeled macrophages were not detected. Iron labeling of S. aureus was not required for detection. MRI results were consistent with histology and microbial assessment. These data showed that S. aureus-induced IE in mice can be detected by MRI. The established mouse model allows for investigation of the pathophysiology of IE, testing of novel drugs and may serve for the development of a clinical diagnostic strategy.	[Ring, Janine; Hoerr, Verena; Faber, Cornelius] Univ Hosp Munster, Dept Clin Radiol, Munster, Germany; [Tuchscherr, Lorena; Loeffler, Bettina] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany; [Kuhlmann, Michael T.] Univ Munster, European Inst Mol Imaging, D-48149 Munster, Germany	University of Munster; University of Munster; University of Munster	Faber, C (corresponding author), Univ Hosp Munster, Dept Clin Radiol, Munster, Germany.	faberc@uni-muenster.de	Faber, Cornelius/Q-2689-2016	Faber, Cornelius/0000-0001-7683-7710; Tuchscherr, Lorena/0000-0002-9328-5302	German Research Foundation [SFBTR34-Z3, SFBTR34-C12, SFB656-PM16, SFB656-Z2, SFB656-A10, EXC 1003]; Interdisciplinary center for clinical research (IZKF) Munster: PIX	German Research Foundation(German Research Foundation (DFG)); Interdisciplinary center for clinical research (IZKF) Munster: PIX	This work was supported by: German Research Foundation grant Nos SFBTR34-Z3 to CF; SFBTR34-C12 to BL; SFB656-PM16 to BL and CF; SFB656-Z2 to CF and MK; SFB656-A10 to BL; EXC 1003 to CF and BL (www.dfg.de); and Interdisciplinary center for clinical research (IZKF) Munster: PIX (campus.uni-muenster.de/izkf.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANNERMAN TL, 1995, J CLIN MICROBIOL, V33, P551, DOI 10.1128/JCM.33.3.551-555.1995; Bensimhon L, 2011, CLIN MICROBIOL INFEC, V17, P836, DOI 10.1111/j.1469-0691.2010.03312.x; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; Dousset V, 1999, MAGNET RESON MED, V41, P329, DOI 10.1002/(SICI)1522-2594(199902)41:2<329::AID-MRM17>3.0.CO;2-Z; ENTENZA JM, 1995, ANTIMICROB AGENTS CH, V39, P1419, DOI 10.1128/AAC.39.7.1419; Fernandez Guerrero ML, 2009, MEDICINE, V88, P1, DOI 10.1097/MD.0b013e318194da65; Gibson GW, 2007, COMPARATIVE MED, V57, P563; Hertlein T, 2014, ANTIMICROB AGENTS CH, V58, P1630, DOI 10.1128/AAC.01422-13; Hertlein T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064440; Hertlein T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018246; Hoen B, 2013, NEW ENGL J MED, V368, P1425, DOI 10.1056/NEJMcp1206782; Hoerr V, 2013, J PHARM BIOMED ANAL, V93, P136; Hoerr V, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-59; Hoerr V, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-63; Kaim AH, 2002, RADIOLOGY, V225, P808, DOI 10.1148/radiol.2253011485; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lutz AM, 2005, RADIOLOGY, V234, P765, DOI 10.1148/radiol.2343031172; Marzola P, 1999, MAGN RESON MATER PHY, V9, P21; Millar BC, 2004, EMERG INFECT DIS, V10, P1110; Moreillon P, 2002, INFECT DIS CLIN N AM, V16, P297, DOI 10.1016/S0891-5520(01)00009-5; MOREILLON P, 1995, INFECT IMMUN, V63, P4738, DOI 10.1128/IAI.63.12.4738-4743.1995; Panizzi P, 2011, NAT MED, V17, P1142, DOI 10.1038/nm.2423; PROCTOR RA, 1984, J LAB CLIN MED, V104, P455; Roosens B, 2013, INT J CARDIOL, V165, P398, DOI 10.1016/j.ijcard.2012.03.065; Strobel K, 2012, MAGN RESON MED, V68, P1924, DOI 10.1002/mrm.24180; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Thuny F, 2013, ARCH CARDIOVASC DIS, V106, P52, DOI 10.1016/j.acvd.2012.09.004; Thuny F, 2012, LANCET, V379, P965, DOI 10.1016/S0140-6736(11)60755-1; Van Riet J, 2010, EUR J NUCL MED MOL I, V37, P1189, DOI 10.1007/s00259-010-1380-x; Werdan K, 2014, NAT REV CARDIOL, V11, P35, DOI 10.1038/nrcardio.2013.174; Winter P, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-88	31	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107179	10.1371/journal.pone.0107179	http://dx.doi.org/10.1371/journal.pone.0107179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229324	Green Published, Green Submitted, gold			2022-12-25	WOS:000342123900029
J	Ripple, MJ; Struckhoff, AP; Trillo-Tinoco, J; Li, L; Margolin, DA; McGoey, R; Del Valle, L				Ripple, Michael J.; Struckhoff, Amanda Parker; Trillo-Tinoco, Jimena; Li, Li; Margolin, David A.; McGoey, Robin; Del Valle, Luis			Activation of c-Myc and Cyclin D1 by JCV T-Antigen and beta-Catenin in Colon Cancer	PLOS ONE			English	Article							HUMAN POLYOMAVIRUS JC; VIRUS-DNA SEQUENCES; BRAIN-TUMORS; COLORECTAL-CANCER; CHROMOSOMAL INSTABILITY; GROWTH-FACTOR; GENE-PRODUCT; BK-VIRUS; EXPRESSION; WNT	During the last decade, mounting evidence has implicated the human neurotropic virus JC virus in the pathology of colon cancer. However, the mechanisms of JC virus-mediated oncogenesis are still not fully determined. One candidate to mediate these effects is the viral early transcriptional product T-Antigen, which has the ability to inactivate cell cycle regulatory proteins such as p53. In medulloblastomas, T-Antigen has been shown to bind the Wnt signaling pathway protein beta-catenin; however, the effects of this interaction on downstream cell cycle regulatory proteins remain unknown. In light of these observations, we investigated the association of T-Antigen and nuclear beta-catenin in colon cancer cases and the effects of this complex in the activation of the transcription and cell cycle regulators c-Myc and Cyclin D1 in vitro. Gene amplification demonstrated the presence of viral sequences in 82.4% of cases and we detected expression of T-Antigen in 64.6% of cases by immunohistochemistry. Further, we found that T-Antigen and beta-catenin co-localized in the nuclei of tumor cells and we confirmed the physical binding between these two proteins in vitro. The nuclear presence of T-Antigen and beta-catenin resulted in the significant enhancement of TCF-dependent promoter activity and activation of the b-catenin downstream targets, c-Myc and Cyclin D1. These observations provide further evidence for a role of JCV T-Antigen in the dysregulation of the Wnt signaling pathway and in the pathogenesis of colon cancer.	[Ripple, Michael J.; Struckhoff, Amanda Parker; Trillo-Tinoco, Jimena; Del Valle, Luis] Louisiana State Univ, Dept Med, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA; [Ripple, Michael J.] Louisiana State Univ, Dept Genet, Hlth Sci Ctr, New Orleans, LA USA; [Li, Li] Ochsner Clin Fdn, Inst Translat Res, New Orleans, LA USA; [Margolin, David A.] Ochsner Clin Fdn, Dept Colorectal Surg, New Orleans, LA USA; [McGoey, Robin; Del Valle, Luis] Louisiana State Univ, Hlth Sci Ctr, Dept Pathol, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Ochsner Health System; Ochsner Health System; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Del Valle, L (corresponding author), Louisiana State Univ, Dept Med, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA.	Ldelva@lsuhsc.edu	Del Valle, Luis/J-4085-2015; Margolin, David/A-6017-2011	Del Valle, Luis/0000-0003-3894-9206; Trillo-Tinoco, Jimena/0000-0002-1240-9650	National Institutes of Health [P20 RR021970]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM114732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was possible thanks to grant P20 RR021970 from the National Institutes of Health, to LDV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTHUR RR, 1989, J CLIN MICROBIOL, V27, P1174, DOI 10.1128/JCM.27.6.1174-1179.1989; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Bhattacharyya R, 2007, ONCOGENE, V26, P7628, DOI 10.1038/sj.onc.1210576; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bofill-Mas S, 2001, J VIROL, V75, P10290, DOI 10.1128/JVI.75.21.10290-10299.2001; Bofill-Mas S, 2000, APPL ENVIRON MICROB, V66, P238, DOI 10.1128/AEM.66.1.238-245.2000; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Brodsky JL, 1998, J VIROL, V72, P5329, DOI 10.1128/JVI.72.7.5329-5334.1998; Chen L, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-157; Coelho TR, 2013, J MED VIROL, V85, P2119, DOI 10.1002/jmv.23705; Colangelo AM, 1998, P NATL ACAD SCI USA, V95, P10920, DOI 10.1073/pnas.95.18.10920; Dang CV, 1999, MOL CELL BIOL, V19, P1; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Del Valle L, 2006, FRONT BIOSCI-LANDMRK, V11, P718, DOI 10.2741/1830; Del Valle L, 2005, CANCER-AM CANCER SOC, V103, P516, DOI 10.1002/cncr.20806; Del Valle L, 2001, CANCER RES, V61, P4287; Del Valle L, 2002, JNCI-J NATL CANCER I, V94, P267, DOI 10.1093/jnci/94.4.267; Del Valle L, 2008, J NEUROPATH EXP NEUR, V67, P729, DOI 10.1097/NEN.0b013e318180e631; Egli A, 2009, J INFECT DIS, V199, P837, DOI 10.1086/597126; Enam S, 2002, CANCER RES, V62, P7093; Frisque RJ, 2006, ADV EXP MED BIOL, V577, P288; FRISQUE RJ, 1984, J VIROL, V51, P458, DOI 10.1128/JVI.51.2.458-469.1984; Fumian TM, 2010, J WATER HEALTH, V8, P438, DOI 10.2166/wh.2010.090; Gan DD, 2004, ONCOGENE, V23, P483, DOI 10.1038/sj.onc.1207018; Gan DD, 2001, ONCOGENE, V20, P4864, DOI 10.1038/sj.onc.1204670; Hernandez JM, 2011, CLIN COLORECTAL CANC, V10, P188, DOI 10.1016/j.clcc.2011.03.014; Hori R, 2005, VIRCHOWS ARCH, V447, P723, DOI 10.1007/s00428-005-0014-3; Jung WT, 2008, CANCER-AM CANCER SOC, V112, P1028, DOI 10.1002/cncr.23266; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Kobayashi M, 2000, BRIT J CANCER, V82, P1689; Krynska B, 1999, ONCOGENE, V18, P39, DOI 10.1038/sj.onc.1202278; Ksiaa F, 2010, MODERN PATHOL, V23, P522, DOI 10.1038/modpathol.2009.184; Laghi L, 1999, P NATL ACAD SCI USA, V96, P7484, DOI 10.1073/pnas.96.13.7484; Lassak A, 2002, J BIOL CHEM, V277, P17231, DOI 10.1074/jbc.M110885200; Lin PY, 2008, J MED VIROL, V80, P1828, DOI 10.1002/jmv.21296; Link A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008146; LONDON WT, 1978, SCIENCE, V201, P1246, DOI 10.1126/science.211583; Major EO, 2010, ANNU REV MED, V61, P35, DOI 10.1146/annurev.med.080708.082655; Morikawa T, 2011, CLIN CANCER RES, V17, P1452, DOI 10.1158/1078-0432.CCR-10-2694; Murai Y, 2007, CANCER SCI, V98, P25, DOI 10.1111/j.1349-7006.2006.00354.x; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Niv Y, 2010, J CLIN GASTROENTEROL, V44, P489, DOI 10.1097/MCG.0b013e3181d7a347; Nosho K, 2009, NEOPLASIA, V11, P87, DOI 10.1593/neo.81188; OHSUMI S, 1985, JPN J CANCER RES, V76, P429; Ricciardiello L, 2000, GASTROENTEROLOGY, V119, P1228, DOI 10.1053/gast.2000.19269; Ricciardiello L, 2003, CANCER RES, V63, P7256; Ricciardiello L, 2001, J VIROL, V75, P1996, DOI 10.1128/JVI.75.4.1996-2001.2001; Saif MW, 2010, CANCER J, V16, P196, DOI 10.1097/PPO.0b013e3181e076af; Shin SK, 2006, CANCER-AM CANCER SOC, V107, P481, DOI 10.1002/cncr.22028; Shollar D, 2004, ONCOGENE, V23, P5459, DOI 10.1038/sj.onc.1207728; Simard EP, 2012, CA CANC J CLIN; Suraweera N, 2006, INT J CANCER, V119, P1837, DOI 10.1002/ijc.22046; TAGUCHI F, 1982, MICROBIOL IMMUNOL, V26, P1057, DOI 10.1111/j.1348-0421.1982.tb00254.x; Theodoropoulos G, 2005, DIS COLON RECTUM, V48, P86, DOI 10.1007/s10350-004-0737-2; Tyagarajan SK, 2006, J VIROL, V80, P2083, DOI 10.1128/JVI.80.5.2083-2091.2006; Vilkin A, 2012, DIGEST DIS SCI, V57, P79, DOI 10.1007/s10620-011-1855-z; WALKER DL, 1973, SCIENCE, V181, P674, DOI 10.1126/science.181.4100.674; Wang JP, 2012, ONCOL LETT, V3, P1073, DOI 10.3892/ol.2012.627; YOGO Y, 1990, J VIROL, V64, P3139, DOI 10.1128/JVI.64.6.3139-3143.1990; Zhang T, 2001, CANCER RES, V61, P8664; Zhang XB, 2001, CANCER RES, V61, P6050; Zheng H, 2007, J PATHOL, V212, P306, DOI 10.1002/path.2188; Zur Hausen H, 2001, ONCOGENE, V20, P7820, DOI 10.1038/sj.onc.1204958	63	45	47	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e106257	10.1371/journal.pone.0106257	http://dx.doi.org/10.1371/journal.pone.0106257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229241	gold, Green Submitted, Green Published			2022-12-25	WOS:000342123900006
J	Han, DS; Tang, H; Lu, J; Wang, GZ; Zhou, L; Min, LF; Han, CX				Han, Dongsheng; Tang, Hui; Lu, Jun; Wang, Guangzhou; Zhou, Lin; Min, Lingfeng; Han, Chongxu			Population Structure of Clinical Vibrio parahaemolyticus from 17 Coastal Countries, Determined through Multilocus Sequence Analysis	PLOS ONE			English	Article							THERMOSTABLE DIRECT HEMOLYSIN; SEROVARS O3-K6; UNITED-STATES; STRAINS; MOZAMBIQUE; EMERGENCE; OUTBREAKS; THAILAND; DIARRHEA; DISTINCT	Vibrio parahaemolyticus is a leading cause of food-borne gastroenteritis worldwide. Although this bacterium has been the subject of much research, the population structure of clinical strains from worldwide collections remains largely undescribed, and the recorded outbreaks of V. parahaemolyticus gastroenteritis highlight the need for the subtyping of this species. We present a broad phylogenetic analysis of 490 clinical V. parahaemolyticus isolates from 17 coastal countries through multilocus sequence analysis (MLST). The 490 tested isolates fell into 161 sequence types (STs). The eBURST algorithm revealed that the 161 clinically relevant STs belonged to 8 clonal complexes, 11 doublets, and 94 singletons, showing a high level of genetic diversity. CC3 was found to be a global epidemic clone of V. parahaemolyticus, and ST-3 was the only ST with an international distribution. recA was observed to be evolving more rapidly, exhibiting the highest degree of nucleotide diversity (0.028) and the largest number of polymorphic nucleotide sites (177). We also found that the high variability of recA was an important cause of differences between the results of the eBURST and ME tree analyses, suggesting that recA has a much greater influence on the apparent evolutionary classification of V. parahaemolyticus based on the current MLST scheme. In conclusion, it is evident that a high degree of genetic diversity within the V. parahaemolyticus population and multiple sequence types are contributing to the burden of disease around the world. MLST, with a fully extractable database, is a powerful system for analysis of the clonal relationships of strains at a global scale. With the addition of more strains, the pubMLST database will provide more detailed and accurate information, which will be conducive to our future research on the population structure of V. parahaemolyticus.	[Han, Dongsheng; Wang, Guangzhou; Zhou, Lin; Han, Chongxu] Northern Jiangsu Peoples Hosp, Clin Med Examinat Ctr, Yangzhou, Jiangsu, Peoples R China; [Tang, Hui; Lu, Jun] Northern Jiangsu Peoples Hosp, Biobank Dept, Yangzhou, Jiangsu, Peoples R China; [Min, Lingfeng] Northern Jiangsu Peoples Hosp, Dept Resp Med, Yangzhou, Jiangsu, Peoples R China		Han, CX (corresponding author), Northern Jiangsu Peoples Hosp, Clin Med Examinat Ctr, Yangzhou, Jiangsu, Peoples R China.	huisheng113905@163.com		Han, Dongsheng/0000-0002-1892-8603	National Natural Science Foundation of China [81400899]; Science & Technology Foundation Program of Jiangsu Province, China [BK2007072]; Northern Jiangsu People's Hospital, Yangzhou, China [yzucms201425]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Foundation Program of Jiangsu Province, China; Northern Jiangsu People's Hospital, Yangzhou, China	This study was jointly supported by grant NO.81400899 from the National Natural Science Foundation of China, grant No. BK2007072 from the Science & Technology Foundation Program of Jiangsu Province, China, and a research project (NO: yzucms201425) of Northern Jiangsu People's Hospital, Yangzhou, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaruzzaman M, 2008, J MED MICROBIOL, V57, P1502, DOI 10.1099/jmm.0.2008/004275-0; Ansaruzzaman M, 2005, J CLIN MICROBIOL, V43, P2559, DOI 10.1128/JCM.43.6.2559-2562.2005; Bhuiyan NA, 2002, J CLIN MICROBIOL, V40, P284, DOI 10.1128/JCM.40.1.284-286.2002; Chao GX, 2011, INT J FOOD MICROBIOL, V145, P459, DOI 10.1016/j.ijfoodmicro.2011.01.022; Chen WY, 2012, INT J FOOD MICROBIOL, V153, P402, DOI 10.1016/j.ijfoodmicro.2011.12.001; Chowdhury A, 2004, MICROBIOL IMMUNOL, V48, P319, DOI 10.1111/j.1348-0421.2004.tb03513.x; Chowdhury NR, 2000, EPIDEMIOL INFECT, V125, P17, DOI 10.1017/S0950268899004070; Chowdhury NR, 2004, J CLIN MICROBIOL, V42, P1280, DOI 10.1128/JCM.42.3.1280-1282.2004; Dauros P, 2011, J INFECT DEV COUNTR, V5, P502; Ellis CN, 2012, APPL ENVIRON MICROB, V78, P3778, DOI 10.1128/AEM.07794-11; [范艳艳 Fan Yanyan], 2013, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V36, P548; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Gonzalez-Escalona N, 2008, J BACTERIOL, V190, P2831, DOI 10.1128/JB.01808-07; [韩东升 Han Dongsheng], 2012, [环境与健康杂志, Journal of Environment and Health], V29, P917; Harth E, 2009, EMERG INFECT DIS, V15, P163, DOI 10.3201/eid1502.071269; HONDA T, 1988, INFECT IMMUN, V56, P961, DOI 10.1128/IAI.56.4.961-965.1988; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; JOSEPH SW, 1982, CRC CR REV MICROBIOL, V10, P77, DOI 10.3109/10408418209113506; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Marshall S, 1999, J CLIN MICROBIOL, V37, P2473, DOI 10.1128/JCM.37.8.2473-2478.1999; Martinez-Urtaza J, 2004, J CLIN MICROBIOL, V42, P4672, DOI 10.1128/JCM.42.10.4672-4678.2004; Martinez-Urtaza J, 2005, EMERG INFECT DIS, V11, P1319, DOI 10.3201/eid1108.050322; Matsumoto C, 2000, J CLIN MICROBIOL, V38, P578, DOI 10.1128/JCM.38.2.578-585.2000; NISHIBUCHI M, 1995, INFECT IMMUN, V63, P2093, DOI 10.1128/IAI.63.6.2093-2099.1995; Okuda J, 1997, J CLIN MICROBIOL, V35, P1965, DOI 10.1128/JCM.35.8.1965-1971.1997; Okuda Jun, 1997, Journal of Clinical Microbiology, V35, P3150; Pal D, 2010, EUR REV MED PHARMACO, V14, P545; SAKURAI J, 1974, INFECT IMMUN, V9, P777, DOI 10.1128/IAI.9.5.777-780.1974; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; [石晓路 Shi Xiaolu], 2013, [中华流行病学杂志, Chinese Journal of Epidemiology], V34, P609; Theethakaew C, 2013, APPL ENVIRON MICROB, V79, P2358, DOI 10.1128/AEM.03067-12; Turner JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055726; Wong HC, 2000, J FOOD PROTECT, V63, P900, DOI 10.4315/0362-028X-63.7.900; Yan YF, 2011, INT J FOOD MICROBIOL, V145, P106, DOI 10.1016/j.ijfoodmicro.2010.11.038; Yu Y, 2011, FOODBORNE PATHOG DIS, V8, P1169, DOI 10.1089/fpd.2011.0865	36	63	66	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107371	10.1371/journal.pone.0107371	http://dx.doi.org/10.1371/journal.pone.0107371			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225911	gold, Green Published, Green Submitted			2022-12-25	WOS:000344317700049
J	Watabe, T; Naka, S; Ikeda, H; Horitsugi, G; Kanai, Y; Isohashi, K; Ishibashi, M; Kato, H; Shimosegawa, E; Watabe, H; Hatazawa, J				Watabe, Tadashi; Naka, Sadahiro; Ikeda, Hayato; Horitsugi, Genki; Kanai, Yasukazu; Isohashi, Kayako; Ishibashi, Mana; Kato, Hiroki; Shimosegawa, Eku; Watabe, Hiroshi; Hatazawa, Jun			Distribution of Intravenously Administered Acetylcholinesterase Inhibitor and Acetylcholinesterase Activity in the Adrenal land: C-11-Donepezil PET Study in the Normal Rat	PLOS ONE			English	Article							IN-VIVO VISUALIZATION; ALZHEIMERS-DISEASE; BRAIN ACETYLCHOLINESTERASE; DONEPEZIL; GALANTAMINE; BINDING; TRACER	Purpose: Acetylcholinesterase (AChE) inhibitors have been used for patients with Alzheimer's disease. However, its pharmacokinetics in non-target organs other than the brain has not been clarified yet. The purpose of this study was to evaluate the relationship between the whole-body distribution of intravenously administered C-11-Donepezil (DNP) and the AChE activity in the normal rat, with special focus on the adrenal glands. Methods: The distribution of C-11-DNP was investigated by PET/ CT in 6 normal male Wistar rats (8 weeks old, body weight = 220 +/- 8.9 g). A 30-min dynamic scan was started simultaneously with an intravenous bolus injection of C-11-DNP (45.0 +/- 10.7 MBq). The whole-body distribution of the C-11-DNP PET was evaluated based on the Vt (total distribution volume) by Logan-plot analysis. A fluorometric assay was performed to quantify the AChE activity in homogenized tissue solutions of the major organs. Results: The PET analysis using Vt showed that the adrenal glands had the 2nd highest level of C-11-DNP in the body (following the liver) (13.33 +/- 1.08 and 19.43 +/- 1.29 ml/ cm(3), respectively), indicating that the distribution of C-11-DNP was the highest in the adrenal glands, except for that in the excretory organs. The AChE activity was the third highest in the adrenal glands (following the small intestine and the stomach) (24.9 +/- 1.6, 83.1 +/- 3.0, and 38.5 +/- 8.1 mU/ mg, respectively), indicating high activity of AChE in the adrenal glands. Conclusions: We demonstrated the whole-body distribution of C-11-DNP by PET and the AChE activity in the major organs by fluorometric assay in the normal rat. High accumulation of C-11-DNP was observed in the adrenal glands, which suggested the risk of enhanced cholinergic synaptic transmission by the use of AChE inhibitors.	[Watabe, Tadashi; Kanai, Yasukazu; Watabe, Hiroshi] Osaka Univ, Grad Sch Med, Dept Mol Imaging Med, Suita, Osaka, Japan; [Watabe, Tadashi; Kanai, Yasukazu; Isohashi, Kayako; Kato, Hiroki; Shimosegawa, Eku; Watabe, Hiroshi; Hatazawa, Jun] Osaka Univ, Grad Sch Med, PET Mol Imaging Ctr, Suita, Osaka, Japan; [Naka, Sadahiro] Osaka Univ Hosp, Suita, Osaka, Japan; [Ikeda, Hayato; Horitsugi, Genki; Isohashi, Kayako; Ishibashi, Mana; Kato, Hiroki; Shimosegawa, Eku; Hatazawa, Jun] Osaka Univ, Grad Sch Med, Dept Nucl Med & Tracer Kinet, Suita, Osaka, Japan; [Hatazawa, Jun] Osaka Univ, Immunol Frontier Res Ctr, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University	Watabe, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Imaging Med, Suita, Osaka, Japan.	twatabe@mi.med.osaka-u.ac.jp	Watabe, Tadashi/AHD-6866-2022; Isohashi, Kayako/AAA-7379-2022	Watabe, Tadashi/0000-0001-8658-2395; Isohashi, Kayako/0000-0002-2081-3020; Ikeda, Hayato/0000-0003-4167-1284; Watabe, Hiroshi/0000-0001-6257-7735	KAKENHI from Ministry of Education, Culture, Sports, Science and Technology [24229008, 25861099, 10048012]	KAKENHI from Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by KAKENHI Grant-in-Aid for Scientific Research (S) (No. 24229008), Grant-in-Aid for Young Scientists (B) (No. 25861099), and Molecular Imaging Research Strategic Program, a grant (No. 10048012) from Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2003, AUTON NEUROSCI-BASIC, V107, P65, DOI 10.1016/S1566-0702(03)00129-2; Bao Q, 2009, J NUCL MED, V50, P401, DOI 10.2967/jnumed.108.056374; Bergstrom M, 2003, EUR J CLIN PHARMACOL, V59, P357, DOI 10.1007/s00228-003-0643-x; De Vos F, 2000, NUCL MED BIOL, V27, P745, DOI 10.1016/S0969-8051(00)00166-9; FINKELSTEIN Y, 1988, ANN NEUROL, V24, P252, DOI 10.1002/ana.410240212; Francis PT, 1999, J NEUROL NEUROSUR PS, V66, P137, DOI 10.1136/jnnp.66.2.137; Funaki Y, 2003, J PHARMACOL SCI, V91, P105; Gorfe AA, 2009, BIOPHYS J, V97, P897, DOI 10.1016/j.bpj.2009.05.033; Hansen RA, 2008, CLIN INTERV AGING, V3, P211; Howes LG, 2014, DRUG SAFETY, V37, P391, DOI 10.1007/s40264-014-0161-z; IRIE T, 1994, NUCL MED BIOL, V21, P801, DOI 10.1016/0969-8051(94)90159-7; Kar S, 2004, J PSYCHIATR NEUROSCI, V29, P427; Kikuchi T, 2010, SYNAPSE, V64, P209, DOI 10.1002/syn.20720; Kosasa T, 1999, EUR J PHARMACOL, V386, P7, DOI 10.1016/S0014-2999(99)00741-4; Matsui K, 1999, DRUG METAB DISPOS, V27, P1406; McCorry LK, 2007, AM J PHARM EDUC, V71, DOI 10.5688/aj710478; Okamura N, 2008, BRIT J CLIN PHARMACO, V65, P472, DOI 10.1111/j.1365-2125.2007.03063.x; Paes AMA, 2006, INT J NEUROSCI, V116, P1295, DOI 10.1080/00207450600920910; Ramakrishnan NK, 2014, PSYCHOPHARMACOLOGY B; Regitz-Zagrosek Vera, 2012, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-30726-3_1; van Beijsterveldt L, 2004, ARZNEIMITTEL-FORSCH, V54, P85	21	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107427	10.1371/journal.pone.0107427	http://dx.doi.org/10.1371/journal.pone.0107427			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225806	gold, Green Published, Green Submitted			2022-12-25	WOS:000344317700056
J	Ko, YC; Liu, CJ; Hwang, DK; Chen, TJ; Liu, CJ				Ko, Yu-Chieh; Liu, Chia-Jen; Hwang, De-Kuang; Chen, Tzeng-Ji; Liu, Catherine J.			Increased Risk of Acute Angle Closure in Retinitis Pigmentosa: A Population-Based Case-Control Study	PLOS ONE			English	Article							RECESSIVE SYNDROME; GLAUCOMA; TAIWAN; NANOPHTHALMOS; PREVALENCE; LENS; FOVEOSCHISIS; ADMISSIONS; SECONDARY; MUTATION	Purpose: To investigate the association between retinitis pigmentosa (RP) and acute angle closure during a 15-year follow-up period. Methods: Using the Taiwan Longitudinal Health Insurance Database 2000, we identified 382 RP patients based on the diagnostic code of RP (International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) 362.74) made during 1996-2010, excluding subjects under age of 20 years at diagnosis or subjects undergoing lens extraction before the index date. The control group included 3820 randomly selected non-RP subjects matched with the RP patients in age, gender and the index date of diagnosis. The incidence of acute angle closure during the study period was observed based on an ICD-9-CM code of 365.22. Cochran-Mantel-Haenszel test was used to determine the odds ratio (OR) of having acute angle closure in RP patients. Results: The mean age at the diagnosis of RP was 51.1years (standard deviation [SD] 16.7). Acute angle closure occurred in 5 RP patients (1.3%) and in 15 controls (0.4%). The mean age with the acute angle closure was 53.3 years (SD 8.0) in RP patients and 64.6 years (SD 8.4) in controls (P = 0.015). After adjusting for age, gender and comorbid disorders, RP patients had 3.64-fold (95% confidence interval [CI], 1.29-10.25, P<0.001) greater odds of having acute angle closure. After stratification for gender and age, the risk of acute angle closure in RP was higher in patients under age of 60 years (adjusted OR 11.84; 95% CI, 2.84-49.48) and male patients (adjusted OR 19.36; 95% CI, 3.43-109.40)(both P = 0.001). Conclusions: RP patients had increased risk of acute angle closure than controls. Contrary to the fact that angle closure disease is more prevalent in elderly females in general population, acute angle closure attack occurred earlier in life and the risk was higher in males among RP patients.	[Ko, Yu-Chieh; Liu, Catherine J.] Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Ko, Yu-Chieh; Liu, Catherine J.] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan; [Ko, Yu-Chieh] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Liu, Chia-Jen] Taipei Vet Gen Hosp, Div Hematol & Oncol, Taipei, Taiwan; [Liu, Chia-Jen] Natl Yang Ming Univ, Sch Med, Inst Publ Hlth, Taipei 112, Taiwan; [Hwang, De-Kuang] Taichung Vet Gen Hosp, Dept Ophthalmol, Taichung, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Taipei Veterans General Hospital	Liu, CJ (corresponding author), Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan.	jlliu@vghtpe.gov.tw	Chen, TJ/AAH-8430-2021; Hwang, DK De-Kuang/J-3931-2016	Hwang, DK De-Kuang/0000-0001-6346-8485	Taipei Veterans General Hospital, Taipei, Taiwan [VGH 102C-186, 103C-192]	Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital)	This research was supported by grants VGH 102C-186, and 103C-192 from Taipei Veterans General Hospital, Taipei, Taiwan (http://www.vghtpe.gov.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, J POPUL STUD; Ayala-Ramirez R, 2006, MOL VIS, V12, P1483; BADEEB O, 1993, ACTA OPHTHALMOL, V71, P727; BOUGHMAN JA, 1980, AM J HUM GENET, V32, P223; Chen YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045189; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheng JW, 2013, J GLAUCOMA, V22, P301, DOI 10.1097/IJG.0b013e31824083ca; Crespi J, 2008, AM J OPHTHALMOL, V146, P323, DOI 10.1016/j.ajo.2008.04.029; Damji KF, 2009, CAN J OPHTHALMOL, V44, P70, DOI 10.3129/i08-181; Dikopf MS, 2013, AM J OPHTHALMOL, V156, P82, DOI 10.1016/j.ajo.2013.02.002; GARTNER S, 1949, AM J OPHTHALMOL, V32, P1337, DOI 10.1016/S0002-9394(49)91752-3; GHOSE S, 1985, BRIT J OPHTHALMOL, V69, P624, DOI 10.1136/bjo.69.8.624; Grunwald JE, 1996, AM J OPHTHALMOL, V122, P502, DOI 10.1016/S0002-9394(14)72109-9; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Hartong Dyonne T, 2006, Lancet, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hu CC, 2008, ACTA OPHTHALMOL, V86, P440, DOI 10.1111/j.1600-0420.2007.01066.x; Hu CC, 2008, OPHTHAL EPIDEMIOL, V15, P66, DOI 10.1080/09286580701771997; HU DN, 1987, J MED GENET, V24, P584, DOI 10.1136/jmg.24.10.584; Inatani M, 2000, J CATARACT REFR SURG, V26, P1533, DOI 10.1016/S0886-3350(00)00471-5; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lin JC, 2007, J GLAUCOMA, V16, P268, DOI 10.1097/IJG.0b013e31802d6e00; MACKAY CJ, 1987, ARCH OPHTHALMOL-CHIC, V105, P366, DOI 10.1001/archopht.1987.01060030086032; Peng T, 1990, Yan Ke Xue Bao, V6, P17; Quek DTL, 2011, AM J OPHTHALMOL, V152, P463, DOI 10.1016/j.ajo.2011.02.023; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ritch R, 2003, OPHTHALMOLOGY, V110, P1880, DOI 10.1016/S0161-6420(03)00563-3; Sato H, 2002, ARCH OPHTHALMOL-CHIC, V120, P852; Sira M, 2005, EYE, V19, P472, DOI 10.1038/sj.eye.6701527; Sposato V, 2008, GRAEF ARCH CLIN EXP, V246, P1553, DOI 10.1007/s00417-008-0903-7; Tarongoy P, 2009, SURV OPHTHALMOL, V54, P211, DOI 10.1016/j.survophthal.2008.12.002; Walia S, 2007, INVEST OPHTH VIS SCI, V48, P4748, DOI 10.1167/iovs.07-0404; Wang D, 2013, CLIN EXPT OPHTHALMOL, V40, P542; Wang M, 2011, CHINESE MED J-PEKING, V124, P1270, DOI 10.3760/cma.j.issn.0366-6999.2011.08.029	33	13	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107660	10.1371/journal.pone.0107660	http://dx.doi.org/10.1371/journal.pone.0107660			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222486	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774800091
J	Ghosh, S; More, P; Derle, A; Patil, AB; Markad, P; Asok, A; Kumbhar, N; Shaikh, ML; Ramanamurthy, B; Shinde, VS; Dhavale, DD; Chopade, BA				Ghosh, Sougata; More, Piyush; Derle, Abhishek; Patil, Ajay B.; Markad, Pramod; Asok, Adersh; Kumbhar, Navanath; Shaikh, Mahemud L.; Ramanamurthy, Boppana; Shinde, Vaishali S.; Dhavale, Dilip D.; Chopade, Balu A.			Diosgenin from Dioscorea bulbifera: Novel Hit for Treatment of Type II Diabetes Mellitus with Inhibitory Activity against alpha-Amylase and alpha-Glucosidase	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ANTIDIABETIC ACTIVITY; BITTER YAM; EXTRACT; TARGETS; METABOLISM; COMPLEX	Diabetes mellitus is a multifactorial metabolic disease characterized by post-prandial hyperglycemia (PPHG). alpha-amylase and alpha-glucosidase inhibitors aim to explore novel therapeutic agents. Herein we report the promises of Dioscorea bulbifera and its bioactive principle, diosgenin as novel alpha-amylase and alpha-glucosidase inhibitor. Among petroleum ether, ethyl acetate, methanol and 70% ethanol (v/v) extracts of bulbs of D. bulbifera, ethyl acetate extract showed highest inhibition upto 72.06 +/- 0.51% and 82.64 +/- 2.32% against alpha-amylase and alpha-glucosidase respectively. GC-TOF-MS analysis of ethyl acetate extract indicated presence of high diosgenin content. Diosgenin was isolated and identified by FTIR, H-1 NMR and C-13 NMR and confirmed by HPLC which showed an alpha-amylase and alpha-glucosidase inhibition upto 70.94 +/- 1.24% and 81.71 +/- 3.39%, respectively. Kinetic studies confirmed the uncompetitive mode of binding of diosgenin to alpha-amylase indicated by lowering of both Km and Vm. Interaction studies revealed the quenching of intrinsic fluorescence of alpha-amylase in presence of diosgenin. Similarly, circular dichroism spectrometry showed diminished negative humped peaks at 208 nm and 222 nm. Molecular docking indicated hydrogen bonding between carboxyl group of Asp300, while hydrophobic interactions between Tyr62, Trp58, Trp59, Val163, His305 and Gln63 residues of alpha-amylase. Diosgenin interacted with two catalytic residues (Asp352 and Glu411) from alpha-glucosidase. This is the first report of its kind that provides an intense scientific rationale for use of diosgenin as novel drug candidate for type II diabetes mellitus.	[Ghosh, Sougata; More, Piyush; Derle, Abhishek; Kumbhar, Navanath] Univ Pune, Inst Bioinformat & Biotechnol, Pune, Maharashtra, India; [Patil, Ajay B.; Markad, Pramod; Shinde, Vaishali S.; Dhavale, Dilip D.] Univ Pune, Garware Res Ctr, Dept Chem, Pune, Maharashtra, India; [Asok, Adersh] Indian Inst Technol, Ctr Res Nanotechnol & Sci, Mumbai 400076, Maharashtra, India; [Shaikh, Mahemud L.; Ramanamurthy, Boppana] Univ Pune Campus, Natl Ctr Cell Sci, Pune, Maharashtra, India; [Chopade, Balu A.] Univ Pune, Dept Microbiol, Pune, Maharashtra, India	Savitribai Phule Pune University; Savitribai Phule Pune University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Savitribai Phule Pune University	Chopade, BA (corresponding author), Univ Pune, Dept Microbiol, Pune, Maharashtra, India.	chopade@unipune.ac.in	Asok, Adersh/F-4670-2010; Shinde, Vaishali S/J-6570-2018; Ghosh, Sougata/GOH-0726-2022; Asok, Adersh/AAH-9098-2019; Ghosh, Sougata/AFV-4012-2022; Ghosh, Sougata/C-6409-2018; Ghosh, Sougata/AAX-9774-2020; Asok, Adersh/F-4670-2010	Asok, Adersh/0000-0001-8718-9974; Ghosh, Sougata/0000-0001-8631-0357; Asok, Adersh/0000-0001-8718-9974; Ghosh, Sougata/0000-0003-0077-1318; Ghosh, Sougata/0000-0003-0077-1318; Patil, Ajay B./0000-0003-0509-4926; Asok, Adersh/0000-0001-6331-470X; Shinde, Vaishali/0000-0001-8800-7247; Kumbhar, Navanath/0000-0003-3543-5664; Dhavale, Dilip/0000-0001-8221-6347	Council of Scientific and Industrial Research (CSIR, Government of India) [09/137(0516)/2012-EMR-I]; UGC, New Delhi, India	Council of Scientific and Industrial Research (CSIR, Government of India)(Council of Scientific & Industrial Research (CSIR) - India); UGC, New Delhi, India(University Grants Commission, India)	S. Ghosh thanks Council of Scientific and Industrial Research (CSIR, Government of India) for Senior Research Fellowship (09/137(0516)/2012-EMR-I). The authors acknowledge financial support for UPE Phase II-Focus Area Biotechnology, for 2012-2017 by UGC, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Zabeer, 2009, Diabetologia Croatica, V38, P63; Alwan AD, 2011, B WORLD HEALTH ORGAN, V89, P546, DOI 10.2471/BLT.11.091074; Bharatam PV, 2005, J MED CHEM, V48, P7615, DOI 10.1021/jm050602z; Bhat M, 2008, EVID-BASED COMPL ALT, V2011; CAYEN MN, 1979, J LIPID RES, V20, P162; de Melo EB, 2006, TETRAHEDRON, V62, P10277, DOI 10.1016/j.tet.2006.08.055; Geldenhuys WJ, 2010, BIOORG MED CHEM LETT, V20, P819, DOI 10.1016/j.bmcl.2009.12.088; Ghosh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082529; Ghosh S, 2012, INT J NANOMED, V7, P483, DOI 10.2147/IJN.S24793; Ghosh S, 2011, J NANOMATER, V2011, DOI 10.1155/2011/354793; Ghosh S, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/929051; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gupta AK, 2005, INDIAN J CHEM, V3, P195; Hehre WJ, 1986, AB INITIO MOL ORBITA, V7, P548; Hunyadi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050619; JUAREZOROPEZA MA, 1987, INT J BIOCHEM, V19, P679, DOI 10.1016/0020-711X(87)90080-2; Khajeh K, 2001, ENZYME MICROB TECH, V28, P543, DOI 10.1016/S0141-0229(01)00296-4; Kitture R, 2013, J NANOSCI N IN PRESS; Kosters A, 2005, HEPATOLOGY, V41, P141, DOI 10.1002/hep.20540; Larson SB, 2010, BIOCHEMISTRY-US, V49, P3101, DOI 10.1021/bi902183w; Li EY, 2013, OPHTHALMOLOGY, V120, P2176, DOI 10.1016/j.ophtha.2013.04.003; Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068; Mane RS, 2011, BIOORGAN MED CHEM, V19, P6720, DOI 10.1016/j.bmc.2011.09.046; Mane RS, 2011, J ORG CHEM, V76, P2892, DOI 10.1021/jo102193q; McAnuff MA, 2005, FOOD CHEM TOXICOL, V43, P1667, DOI 10.1016/j.fct.2005.05.008; McAnuff-Harding MA, 2006, LIFE SCI, V78, P2595, DOI 10.1016/j.lfs.2005.10.046; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; Narula A, 2007, BIOTECHNOL LETT, V29, P623, DOI 10.1007/s10529-006-9276-3; Nguelefack TB, 2010, EVID-BASED COMPL ALT, V2011; Oubre AY, 1997, DIABETOLOGIA, V40, P614, DOI 10.1007/s001250050724; Patil VS, 2013, EUR J MED CHEM, V59, P304, DOI 10.1016/j.ejmech.2012.11.020; Patil VS, 2012, BIOORG MED CHEM LETT, V22, P7011, DOI 10.1016/j.bmcl.2012.10.025; Pawar VU, 2010, BIOORG MED CHEM LETT, V20, P7243, DOI 10.1016/j.bmcl.2010.10.100; Ponnusamy S, 2013, J NAT PRODUCTS, V3, P15; Ponnusamy S, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/515647; Qian MX, 2001, BIOCHEMISTRY-US, V40, P7700, DOI 10.1021/bi0102050; Qian MX, 1997, PROTEIN SCI, V6, P2285; Ramasubbu N, 2004, EUR J BIOCHEM, V271, P2517, DOI 10.1111/j.1432-1033.2004.04182.x; Rawel HM, 2006, MOL NUTR FOOD RES, V50, P705, DOI 10.1002/mnfr.200600013; Rocha GB, 2006, J COMPUT CHEM, V27, P1101, DOI 10.1002/jcc.20425; Sanap SP, 2010, ORG BIOMOL CHEM, V8, P3307, DOI 10.1039/c004690f; Sato K, 2014, J STEROID BIOCHEM, V143, P152, DOI 10.1016/j.jsbmb.2014.02.020; Shirai T, 2008, PROTEINS, V73, P126, DOI 10.1002/prot.22044; Son IS, 2007, BIOSCI BIOTECH BIOCH, V71, P3063, DOI 10.1271/bbb.70472; Sontakke V, 2013, ISRN ORG CHEM, V2013, DOI DOI 10.1155/2013/453682; Srinivasan S, 2009, INT J CANCER, V125, P961, DOI 10.1002/ijc.24419; Sudha P, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-5; TAL B, 1984, BIOCHEM J, V219, P619, DOI 10.1042/bj2190619; Temel RE, 2009, J LIPID RES, V50, P915, DOI 10.1194/jlr.M800631-JLR200; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Uemura T, 2010, MOL NUTR FOOD RES, V54, P1596, DOI 10.1002/mnfr.200900609; Vila-Carriles WH, 2007, FASEB J, V21, P18, DOI 10.1096/fj.06-6730hyp; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071144; Wawer I, 2001, SOLID STATE NUCL MAG, V20, P35, DOI 10.1006/snmr.2001.0028; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; WIEGAND G, 1995, J MOL BIOL, V247, P99, DOI 10.1006/jmbi.1994.0125; Yamamoto K, 2010, FEBS J, V277, P4205, DOI 10.1111/j.1742-4658.2010.07810.x	59	68	69	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106039	10.1371/journal.pone.0106039	http://dx.doi.org/10.1371/journal.pone.0106039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216353	Green Submitted, gold, Green Published			2022-12-25	WOS:000341774300005
J	Pinto, JT; Krasnikov, BF; Alcutt, S; Jones, ME; Dorai, T; Villar, MT; Artigues, A; Li, JY; Cooper, AJL				Pinto, John T.; Krasnikov, Boris F.; Alcutt, Steven; Jones, Melanie E.; Dorai, Thambi; Villar, Maria T.; Artigues, Antonio; Li, Jianyong; Cooper, Arthur J. L.			Kynurenine Aminotransferase III and Glutamine Transaminase L Are Identical Enzymes that have Cysteine S-Conjugate beta-Lyase Activity and Can Transaminate L-Selenomethionine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-KETO ACID; MITOCHONDRIAL ASPARTATE-AMINOTRANSFERASE; GLUTATHIONE-DEPENDENT BIOACTIVATION; PREVENTION TRIAL SELECT; RAT-KIDNEY; PROSTATE-CANCER; VITAMIN-E; ORGANOSELENIUM COMPOUNDS; SUBSTRATE-SPECIFICITY; SELENIUM METABOLISM	Three of the four kynurenine aminotransferases (KAT I, II, and IV) that synthesize kynurenic acid, a neuromodulator, are identical to glutamine transaminase K (GTK), alpha-aminoadipate aminotransferase, and mitochondrial aspartate aminotransferase, respectively. GTK/KAT I and aspartate aminotransferase/KAT IV possess cysteine S-conjugate beta-lyase activity. The gene for the former enzyme, GTK/KAT I, is listed in mammalian genome data banks as CCBL1 (cysteine conjugate beta-lyase 1). Also listed, despite the fact that no beta-lyase activity has been assigned to the encoded protein in the genome data bank, is a CCBL2 (synonym KAT III). We show that human KAT III/CCBL2 possesses cysteine S-conjugate beta-lyase activity, as does mouse KAT II. Thus, depending on the nature of the substrate, all four KATs possess cysteine S-conjugate beta-lyase activity. These present studies show that KAT III and glutamine transaminase L are identical enzymes. This report also shows that KAT I, II, and III differ in their ability to transaminate methyl-L-selenocysteine (MSC) and L-selenomethionine (SM) to beta-methylselenopyruvate (MSP) and alpha-ketomethylselenobutyrate, respectively. Previous studies have identified these seleno-alpha-keto acids as potent histone deacetylase inhibitors. Methylselenol (CH3SeH), also purported to have chemopreventive properties, is the gamma-elimination product of SM and the beta-elimination product of MSC catalyzed by cystathionine gamma-lyase (gamma-cystathionase). KAT I, II, and III, in part, can catalyze beta-elimination reactions with MSC generating CH3SeH. Thus, the anticancer efficacy of MSC and SM will depend, in part, on the endogenous expression of various KAT enzymes and cystathionine gamma-lyase present in target tissue coupled with the ability of cells to synthesize in situ either CH3SeH and/or seleno-keto acid metabolites.	[Pinto, John T.; Krasnikov, Boris F.; Alcutt, Steven; Jones, Melanie E.; Cooper, Arthur J. L.] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA; [Dorai, Thambi] New York Med Coll, Dept Urol, Valhalla, NY 10595 USA; [Villar, Maria T.; Artigues, Antonio] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Li, Jianyong] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA	New York Medical College; New York Medical College; University of Kansas; University of Kansas Medical Center; Virginia Polytechnic Institute & State University	Pinto, JT (corresponding author), New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA.	john_pinto@nymc.edu; arthur_cooper@nymc.edu	Krasnikov, Boris/R-2244-2019; Cooper, Arthur J.L./H-5171-2016; Krasnikov, Boris F/GZG-7807-2022	Krasnikov, Boris F/0000-0001-9525-4385	National Institutes of Health [CA111842, ES8421]; NATIONAL CANCER INSTITUTE [R01CA111842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA111842 (to J. T. P.) and ES8421 (to A. J. L. C.).	Abraham DG, 1996, ARCH BIOCHEM BIOPHYS, V335, P311, DOI 10.1006/abbi.1996.0512; Anders MW, 2004, DRUG METAB REV, V36, P583, DOI 10.1081/DMR-200033451; Anders MW, 1998, ANNU REV PHARMACOL, V38, P501, DOI 10.1146/annurev.pharmtox.38.1.501; Birner G, 1997, ARCH TOXICOL, V72, P1, DOI 10.1007/s002040050461; BLARZINO C, 1994, BIOCHEM MOL BIOL INT, V32, P79; BRAUNSTEIN AE, 1984, ADV ENZYMOL RAMB, V56, P1; Bruning T, 2000, CRIT REV TOXICOL, V30, P253, DOI 10.1080/10408440091159202; Commandeur JNM, 2000, J PHARMACOL EXP THER, V294, P753; Cooper AJL, 2005, BIOCHEM PHARMACOL, V69, P209, DOI 10.1016/j.bcp.2004.08.034; Cooper AJL, 2004, NEUROCHEM INT, V44, P557, DOI 10.1016/j.neuint.2003.12.002; Cooper AJL, 2003, BIOCHEM PHARMACOL, V65, P181, DOI 10.1016/S0006-2952(02)01513-7; Cooper AJL, 2002, BIOCHEM J, V368, P253, DOI 10.1042/BJ20020531; COOPER AJL, 1981, COMP BIOCHEM PHYS B, V69, P137, DOI 10.1016/0305-0491(81)90223-6; COOPER AJL, 1972, BIOCHEMISTRY-US, V11, P661; Cooper AJL, 2001, BIOCHEM PHARMACOL, V62, P1345, DOI 10.1016/S0006-2952(01)00802-4; COOPER AJL, 1974, J BIOL CHEM, V249, P2554; COOPER AJL, 1985, METHOD ENZYMOL, V113, P338; COOPER AJL, 1973, J BIOL CHEM, V248, P8499; Cooper AJL., GLUTAMINE GLUTAMATE, VVol. 1, P33; Cooper AJL, 2008, ARCH BIOCHEM BIOPHYS, V474, P72, DOI 10.1016/j.abb.2008.02.038; Cooper AJL, 2011, AMINO ACIDS, V41, P7, DOI 10.1007/s00726-010-0552-0; Dantzler WH, 1998, J PHARMACOL EXP THER, V286, P52; Dekant W, 2003, TOXICOL LETT, V144, P49, DOI 10.1016/S0378-4274(02)00338-7; ELFARRA AA, 1990, DRUG METAB DISPOS, V18, P917; Gammelgaard B, 2008, ANAL BIOANAL CHEM, V390, P1691, DOI 10.1007/s00216-007-1788-8; Guidetti P, 1997, J NEUROSCI RES, V50, P457; Guidetti P, 2007, J NEUROCHEM, V102, P103, DOI 10.1111/j.1471-4159.2007.04556.x; Han Q, 2004, EUR J BIOCHEM, V271, P4804, DOI 10.1111/j.1432-1033.2004.04446.x; Han Q, 2011, BIOSCIENCE REP, V31, P323, DOI 10.1042/BSR20100117; Han Q, 2009, J MED CHEM, V52, P2786, DOI 10.1021/jm9000874; Han Q, 2009, MOL CELL BIOL, V29, P784, DOI 10.1128/MCB.01272-08; HAYDEN PJ, 1990, MOL PHARMACOL, V37, P468; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Lee JI, 2009, CANCER PREV RES, V2, P683, DOI 10.1158/1940-6207.CAPR-09-0047; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; MALHERBE P, 1995, FEBS LETT, V367, P141, DOI 10.1016/0014-5793(95)00546-L; Marshall JR, 2001, NUTR CANCER, V40, P74, DOI 10.1207/S15327914NC401_13; MATSUO Y, 1958, J BIOL CHEM, V230, P545; MEISTER A, 1953, J BIOL CHEM, V200, P571; MEISTER A, 1955, J BIOL CHEM, V215, P441; MEISTER A, 1952, J BIOL CHEM, V197, P319; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Newman D, 2007, DRUG METAB DISPOS, V35, P43, DOI 10.1124/dmd.106.012062; Nian H, 2009, CARCINOGENESIS, V30, P1416, DOI 10.1093/carcin/bgp147; Okuno T, 2006, BIOL TRACE ELEM RES, V109, P155, DOI 10.1385/BTER:109:2:155; OTANI TT, 1957, J BIOL CHEM, V224, P137; PERRY SJ, 1993, MOL PHARMACOL, V43, P660; Pinto JT, 2011, AMINO ACIDS, V41, P29, DOI 10.1007/s00726-010-0578-3; Pinto JT, 2009, J CHROMATOGR B, V877, P3434, DOI 10.1016/j.jchromb.2009.05.041; Pinto JT, 2006, J NUTR, V136, p835S, DOI 10.1093/jn/136.3.835S; Potter MC, 2010, NEUROPSYCHOPHARMACOL, V35, P1734, DOI 10.1038/npp.2010.39; Rossi F, 2008, J BIOL CHEM, V283, P3559, DOI 10.1074/jbc.M707925200; Saito K, 2000, AM J PHYSIOL-RENAL, V279, pF565, DOI 10.1152/ajprenal.2000.279.3.F565; SHRAWDER E, 1972, J BIOL CHEM, V247, P2486; STEVENS JL, 1986, J BIOL CHEM, V261, P5529; STEVENS JL, 1988, J BIOL CHEM, V263, P3395; Suzuki KT, 2008, TOXICOL APPL PHARM, V227, P76, DOI 10.1016/j.taap.2007.10.001; Suzuki KT, 2007, BBA-GEN SUBJECTS, V1770, P1053, DOI 10.1016/j.bbagen.2007.03.007; Taylor PR, 2003, J NATL CANCER I, V95, P1414, DOI 10.1093/jnci/djg044; Tsuji Y, 2009, J TOXICOL SCI, V34, P191, DOI 10.2131/jts.34.191; Wei WQ, 2004, AM J CLIN NUTR, V79, P80; Wessjohann LA, 2007, BIOL CHEM, V388, P997, DOI 10.1515/BC.2007.138; Yu P, 2006, GENE, V365, P111, DOI 10.1016/J.gene.2005.09.034	64	23	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					30950	30961		10.1074/jbc.M114.591461	http://dx.doi.org/10.1074/jbc.M114.591461			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25231977	Green Published, hybrid			2022-12-25	WOS:000344549900007
J	Good, ME; Ek-Vitorin, JF; Burt, JM				Good, Miranda E.; Ek-Vitorin, Jose F.; Burt, Janis M.			Structural Determinants and Proliferative Consequences of Connexin 37 Hemichannel Function in Insulinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION CHANNELS; CX37; GROWTH; PHOSPHORYLATION; OLIGOMERIZATION; PERMEABILITY; SUPPRESSION; EXPRESSION; INTERFACE; MUTANT	Connexin (Cx) 37 suppresses vascular and cancer cell proliferation. The C terminus and a channel able to function are necessary, and neither by itself is sufficient, for Cx37 to mediate growth suppression. Cx37 supports transmembrane and intercellular signaling by forming functional hemichannels (HCs) and gap junction channels (GJCs), respectively. Here we determined whether Cx37 with HC, but not GJC, functionality would suppress proliferation of rat insulinoma (Rin) cells comparably to wild-type Cx37 (Cx37-WT). We mutated extracellular loop residues hypothesized to compromise HC docking but not HC function (six cysteines mutated to alanine, C54A, C61A, C65A, C187A, C192A, C198A (designated as C(6)A); N55I; and Q58L). All three mutants trafficked to the plasma membrane and formed protein plaques comparably to Cx37-WT. None of the mutants formed functional GJCs, and Cx37-C6A did not form functional HCs. Cx37-N55I and-Q58L formed HCs with behavior and permeation properties similar to Cx37-WT (especially Q58L), but none of the mutants suppressed Rin cell proliferation. The data indicate that determinants of Cx37 HC function differ from other Cxs and that HC functions with associated HC-supported protein-protein interactions are not sufficient for Cx37 to suppress Rin cell proliferation. Together with previously published data, these results suggest that Cx37 suppresses Rin cell proliferation only when in a specific conformation achieved by interaction of the C terminus with a Cx37 poreforming domain able to open as a GJC.	[Good, Miranda E.; Ek-Vitorin, Jose F.; Burt, Janis M.] Univ Arizona, Dept Physiol, Tucson, AZ 85724 USA	University of Arizona	Burt, JM (corresponding author), Univ Arizona, Dept Physiol, POB 245051, Tucson, AZ 85724 USA.	jburt@u.arizona.edu	Ek-Vitorin, Jose F./AAF-8533-2020	Good, Miranda/0000-0001-7775-1863	National Institutes of Health [R01 HL058732, T32HL007249]; Finley and Florence Brown Endowed Research Award from the Sarver Heart Center, University of Arizona; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007249, R01HL058732, F32HL131399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Finley and Florence Brown Endowed Research Award from the Sarver Heart Center, University of Arizona; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL058732 (to J. M. B.) and T32HL007249 (to M. E. G. and J. M. B.). This work was also supported by The Finley and Florence Brown Endowed Research Award from the Sarver Heart Center, University of Arizona (to M. E. G.).	Bao XY, 2004, J BIOL CHEM, V279, P9689, DOI 10.1074/jbc.M311438200; Bednarczyk D, 2000, PFLUG ARCH EUR J PHY, V440, P184, DOI 10.1007/s004240051038; BUEHLER LK, 1995, BIOPHYS J, V68, P1767, DOI 10.1016/S0006-3495(95)80353-X; Burt JM, 2008, AM J PHYSIOL-CELL PH, V295, pC1103, DOI 10.1152/ajpcell.299.2008; DAHL G, 1991, EUR J BIOCHEM, V197, P141, DOI 10.1111/j.1432-1033.1991.tb15892.x; Das S, 2009, MOL BIOL CELL, V20, P2593, DOI 10.1091/mbc.E08-07-0790; Derouette JP, 2009, J MOL CELL CARDIOL, V46, P499, DOI 10.1016/j.yjmcc.2008.12.018; Ek-Vitorin JF, 2005, AM J PHYSIOL-CELL PH, V289, pC1535, DOI 10.1152/ajpcell.00182.2005; Ek-Vitorin JF, 2013, BBA-BIOMEMBRANES, V1828, P51, DOI 10.1016/j.bbamem.2012.02.003; Fang JS, 2011, AM J PHYSIOL-HEART C, V301, pH1872, DOI 10.1152/ajpheart.00683.2011; Foote CI, 1998, J CELL BIOL, V140, P1187, DOI 10.1083/jcb.140.5.1187; Gong XQ, 2013, J CELL SCI, V126, P3113, DOI 10.1242/jcs.123430; Good ME, 2012, J MEMBRANE BIOL, V245, P369, DOI 10.1007/s00232-012-9459-x; Good ME, 2011, J CELL SCI, V124, P2448, DOI 10.1242/jcs.081695; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Grosely R, 2013, J BIOL CHEM, V288, P24857, DOI 10.1074/jbc.M113.454389; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Herve JC, 2013, CELL TISSUE RES, V352, P21, DOI 10.1007/s00441-012-1485-6; Kardami E, 2007, PROG BIOPHYS MOL BIO, V94, P245, DOI 10.1016/j.pbiomolbio.2007.03.009; Koval M, 2014, FEBS LETT, V588, P1193, DOI 10.1016/j.febslet.2014.02.025; Larson D. M., 2000, Molecular Cell Biology Research Communications, V3, P115, DOI 10.1006/mcbr.2000.0200; Larson DM, 1997, AM J PHYSIOL-CELL PH, V272, pC405, DOI 10.1152/ajpcell.1997.272.2.C405; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Morel S, 2010, CARCINOGENESIS, V31, P1922, DOI 10.1093/carcin/bgq170; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; Nakagawa S, 2010, CURR OPIN STRUC BIOL, V20, P423, DOI 10.1016/j.sbi.2010.05.003; Nelson TK, 2013, AM J PHYSIOL-CELL PH, V305, pC1246, DOI 10.1152/ajpcell.00159.2013; Simon AM, 2006, CELL COMMUN ADHES, V13, P61, DOI 10.1080/15419060600631748; Smith TD, 2012, J MEMBRANE BIOL, V245, P221, DOI 10.1007/s00232-012-9443-5; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Tong D, 2007, J CELL SCI, V120, P4016, DOI 10.1242/jcs.011775; Vinken M, 2012, BBA-BIOMEMBRANES, V1818, P2002, DOI 10.1016/j.bbamem.2011.06.011; Vinken M, 2011, BBA-REV CANCER, V1815, P13, DOI 10.1016/j.bbcan.2010.08.004; Weber PA, 2004, BIOPHYS J, V87, P958, DOI 10.1529/biophysj.103.036350	34	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30379	30386		10.1074/jbc.M114.583054	http://dx.doi.org/10.1074/jbc.M114.583054			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25217644	Green Published, hybrid			2022-12-25	WOS:000344549700020
J	Han, B; Li, W; Sun, YL; Zhou, LP; Xu, Y; Zhao, XH				Han, Bo; Li, Wei; Sun, Yulin; Zhou, Lanping; Xu, Yang; Zhao, Xiaohang			A Prolyl-Hydroxylase Inhibitor, Ethyl-3,4-Dihydroxybenzoate, Induces Cell Autophagy and Apoptosis in Esophageal Squamous Cell Carcinoma Cells via Up-Regulation of BNIP3 and N-myc Downstream-Regulated Gene-1	PLOS ONE			English	Article							BECLIN 1; CANCER; EXPRESSION; PROTEIN; TRIAL; DEATH; EPIDEMIOLOGY; HYPOXIA; IDENTIFICATION; MECHANISMS	The protocatechuic acid ethyl ester ethyl-3,4-dihydroxybenzoate is an antioxidant found in the testa of peanut seeds. Previous studies have shown that ethyl-3,4-dihydroxybenzoate can effectively reduce breast cancer cell metastasis by inhibiting prolyl-hydroxylase. In this study, we investigated the cytotoxic effect of ethyl-3,4-dihydroxybenzoate on esophageal squamous cell carcinoma cells in vitro and identified key regulators of ethyl-3,4-dihydroxybenzoate-induced esophageal cancer cell death through transcription expression profiling. Using flow cytometry analysis, we found that ethyl-3,4-dihydroxybenzoate induced S phase accumulation, a loss in mitochondrial membrane permeabilization, and caspase-dependent apoptosis. Moreover, an expression profile analysis identified 46 up- and 9 down-regulated genes in esophageal cancer KYSE 170 cells treated with ethyl-3,4-dihydroxybenzoate. These differentially expressed genes are involved in several signaling pathways associated with cell cycle regulation and cellular metabolism. Consistent with the expression profile results, the transcriptional and protein expression levels of candidate genes NDRG1, BNIP3, AKR1C1, CCNG2 and VEGFA were found to be significantly increased in treated KYSE 170 cells by reverse-transcription PCR and western blot analysis. We also found that protein levels of hypoxia-inducible factor-1 alpha, BNIP3, Beclin and NDRG1 were increased and that enriched expression of BNIP3 and Beclin caused autophagy mediated by microtubule-associated protein 1 light chain 3 in the treated cells. Autophagy and apoptosis were activated together in esophageal cancer cells after exposed to ethyl-3,4-dihydroxybenzoate. Furthermore, knock-down of NDRG1 expression by siRNA significantly attenuated apoptosis in the cancer cells, implying that NDRG1 may be required for ethyl-3,4-dihydroxybenzoate-induced apoptosis. Together, these results suggest that the cytotoxic effects of ethyl-3,4-dihydroxybenzoate were mediated by the up-regulation of NDRG1, BNIP3, Beclin and hypoxia-inducible factor-1 alpha, initiating BNIP3 and Beclin mediated autophagy at an early stage and ultimately resulting in esophageal cancer cell apoptosis.	[Han, Bo; Li, Wei; Sun, Yulin; Zhou, Lanping; Xu, Yang; Zhao, Xiaohang] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Han, Bo; Li, Wei; Sun, Yulin; Zhou, Lanping; Xu, Yang; Zhao, Xiaohang] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Xu, Y (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China.	xuyang@cicams.ac.cn; zhaoxh@cicams.ac.cn			High-tech R D Program [2012AA020206, 2012AA02A503]; State Key Projects for Basic Research of China [2011CB910703, 2014CBA02001]; NSFC [81372591, 81372385, 81321091]	High-tech R D Program; State Key Projects for Basic Research of China; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by grants of the High-tech R & D Program (2012AA020206, 2012AA02A503), State Key Projects for Basic Research (2011CB910703, 2014CBA02001) of China and NSFC (81372591, 81372385, 81321091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar MB, 2012, INT J MOL SCI, V13, P15054, DOI 10.3390/ijms131115054; Baay-Guzman GJ, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-60; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Chen T, 2006, CARCINOGENESIS, V27, P2301, DOI 10.1093/carcin/bgl109; Chen T, 2012, CANCER PREV RES, V5, P41, DOI 10.1158/1940-6207.CAPR-11-0469; Chu PWY, 2010, EUR J PHARMACOL, V633, P24, DOI 10.1016/j.ejphar.2010.02.008; Chung LC, 2012, AM J PHYSIOL-CELL PH, V302, pC676, DOI 10.1152/ajpcell.00180.2011; Ding YJ, 2013, NUTRIENTS, V5, P2173, DOI 10.3390/nu5062173; George J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023395; Gilkes DM, 2013, CANCER RES, V73, P3285, DOI 10.1158/0008-5472.CAN-12-3963; Han YH, 2006, PROTEOMICS, V6, P3262, DOI 10.1002/pmic.200500754; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Henning SM, 2011, MOL NUTR FOOD RES, V55, P905, DOI 10.1002/mnfr.201000648; Huang SC, 2003, J AGR FOOD CHEM, V51, P2380, DOI 10.1021/jf0210019; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jung KA, 2013, TOXICOL LETT, V218, P39, DOI 10.1016/j.toxlet.2012.12.026; Kanzawa T, 2005, ONCOGENE, V24, P980, DOI 10.1038/sj.onc.1208095; Khan KH, 2014, CRIT REV ONCOL HEMAT, V90, P200, DOI 10.1016/j.critrevonc.2013.12.012; Li XL, 2013, INFECT IMMUN, V81, P271, DOI 10.1128/IAI.00834-12; Limburg PJ, 2005, GASTROENTEROLOGY, V129, P863, DOI 10.1053/j.gastro.2005.06.024; Liu MN, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-142; Muley MM, 2013, LIFE SCI, V93, P51, DOI 10.1016/j.lfs.2013.05.020; Muley MM, 2012, PHARMACOL BIOCHEM BE, V102, P286, DOI 10.1016/j.pbb.2012.05.004; Myllyharju J, 2013, ACTA PHYSIOL, V208, P148, DOI 10.1111/apha.12096; Qian WB, 2007, LEUKEMIA RES, V31, P329, DOI 10.1016/j.leukres.2006.06.021; Qiao YL, 2009, JNCI-J NATL CANCER I, V101, P507, DOI 10.1093/jnci/djp037; Ryan AM, 2011, CANCER EPIDEMIOL, V35, P309, DOI 10.1016/j.canep.2011.03.001; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Smith DM, 2010, CELL DEATH DIFFER, V17, P1867, DOI 10.1038/cdd.2010.53; Stoner GD, 2006, NUTR CANCER, V54, P33, DOI 10.1207/s15327914nc5401_5; Stoner GD, 2010, PHARM RES-DORDR, V27, P1138, DOI 10.1007/s11095-010-0102-1; Stoner GD, 2005, CARCINOGENESIS, V26, P1590, DOI 10.1093/carcin/bgi111; Sullivan KD, 2012, BBA-REV CANCER, V1825, P229, DOI 10.1016/j.bbcan.2012.01.004; Tang H, 2009, HEPATOLOGY, V49, P60, DOI 10.1002/hep.22581; Wang Q, 2013, MOL BIOL REP, V40, P3723, DOI 10.1007/s11033-012-2448-4; Wheeler JB, 2012, SURG CLIN N AM, V92, P1077, DOI 10.1016/j.suc.2012.07.008; Worni M, 2012, J AM COLL SURGEONS, V215, P643, DOI 10.1016/j.jamcollsurg.2012.07.006; Xu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100127	40	29	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107204	10.1371/journal.pone.0107204	http://dx.doi.org/10.1371/journal.pone.0107204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232961	gold, Green Submitted, Green Published			2022-12-25	WOS:000342921200017
J	Ostfeld, RS; Levi, T; Jolles, AE; Martin, LB; Hosseini, PR; Keesing, F				Ostfeld, Richard S.; Levi, Taal; Jolles, Anna E.; Martin, Lynn B.; Hosseini, Parviez R.; Keesing, Felicia			Life History and Demographic Drivers of Reservoir Competence for Three Tick-Borne Zoonotic Pathogens	PLOS ONE			English	Article							TROPICAL HOUSE SPARROWS; IMMUNE-RESPONSES; BABESIA-MICROTI; TRADE-OFFS; DISEASE; HOSTS; TRANSMISSION; PREVALENCE; ECOLOGY; BIODIVERSITY	Animal and plant species differ dramatically in their quality as hosts for multi-host pathogens, but the causes of this variation are poorly understood. A group of small mammals, including small rodents and shrews, are among the most competent natural reservoirs for three tick-borne zoonotic pathogens, Borrelia burgdorferi, Babesia microti, and Anaplasma phagocytophilum, in eastern North America. For a group of nine commonly-infected mammals spanning >2 orders of magnitude in body mass, we asked whether life history features or surrogates for (unknown) encounter rates with ticks, predicted reservoir competence for each pathogen. Life history features associated with a fast pace of life generally were positively correlated with reservoir competence. However, a model comparison approach revealed that host population density, as a proxy for encounter rates between hosts and pathogens, generally received more support than did life history features. The specific life history features and the importance of host population density differed somewhat between the different pathogens. We interpret these results as supporting two alternative but non-exclusive hypotheses for why ecologically widespread, synanthropic species are often the most competent reservoirs for multi-host pathogens. First, multi-host pathogens might adapt to those hosts they are most likely to experience, which are likely to be the most abundant and/or frequently bitten by tick vectors. Second, species with fast life histories might allocate less to certain immune defenses, which could increase their reservoir competence. Results suggest that of the host species that might potentially be exposed, those with comparatively high population densities, small bodies, and fast pace of life will often be keystone reservoirs that should be targeted for surveillance or management.	[Ostfeld, Richard S.] Cary Inst Ecosyst Studies, Millbrook, NY 12545 USA; [Levi, Taal] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Jolles, Anna E.] Oregon State Univ, Dept Biomed Sci, Corvallis, OR 97331 USA; [Jolles, Anna E.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Martin, Lynn B.] Univ S Florida, Dept Integrat Biol, Tampa, FL USA; [Hosseini, Parviez R.] EcoHealth Alliance, New York, NY USA; [Keesing, Felicia] Bard Coll, Biol Program, Annandale on Hudson, NY 12504 USA	Cary Institute of Ecosystem Studies; Oregon State University; Oregon State University; Oregon State University; State University System of Florida; University of South Florida	Ostfeld, RS (corresponding author), Cary Inst Ecosyst Studies, Millbrook, NY 12545 USA.	rostfeld@caryinstitute.org	; Martin, Lynn/C-2037-2009	Levi, Taal/0000-0003-1853-8311; Martin, Lynn/0000-0002-5887-4937; Jolles, Anna/0000-0003-3074-9912; Ostfeld, Richard/0000-0002-3707-9301	National Science Foundation [DEB 0949702, EF 0813035, 0920475, 1257773]	National Science Foundation(National Science Foundation (NSF))	Funding provided by National Science Foundation DEB 0949702 RSO CDC. National Science Foundation EF 0813035 FK RSO. National Science Foundation 0920475 and 1257773 LBM. National Science Foundation postdoctoral fellowship TL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beldomenico Pablo M, 2010, Trends Ecol Evol, V25, P21, DOI 10.1016/j.tree.2009.06.015; Brunner JL, 2008, ECOLOGY, V89, P2259, DOI 10.1890/07-0665.1; Brunner JL, 2008, J MED ENTOMOL, V45, P139, DOI 10.1603/0022-2585(2008)45[139:ERCOBB]2.0.CO;2; Cronin JP, 2010, ECOL LETT, V13, P1221, DOI 10.1111/j.1461-0248.2010.01513.x; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Gray J, 2002, J CLIN MICROBIOL, V40, P1259, DOI 10.1128/JCM.40.4.1259-1263.2002; Hawley DM, 2011, FUNCT ECOL, V25, P48, DOI 10.1111/j.1365-2435.2010.01753.x; Hersh MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099348; Hersh MH, 2012, EMERG INFECT DIS, V18, P1951, DOI 10.3201/eid1812.111392; Huang ZYX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054341; Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Keesing F, 2009, P ROY SOC B-BIOL SCI, V276, P3911, DOI 10.1098/rspb.2009.1159; Keesing F, 2014, AM J TROP MED HYG, V91, P302, DOI 10.4269/ajtmh.13-0525; Keesing F, 2012, EMERG INFECT DIS, V18, P2013, DOI 10.3201/eid1812.120919; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Knowles SCL, 2009, FUNCT ECOL, V23, P405, DOI 10.1111/j.1365-2435.2008.01507.x; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V310, P1110, DOI 10.1001/jama.2013.278331; Lee KA, 2008, J ANIM ECOL, V77, P356, DOI 10.1111/j.1365-2656.2007.01347.x; Lee KA, 2006, OECOLOGIA, V150, P383, DOI 10.1007/s00442-006-0537-6; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Martin LB, 2006, FUNCT ECOL, V20, P630, DOI 10.1111/j.1365-2435.2006.01138.x; Martin LB, 2005, GEN COMP ENDOCR, V140, P126, DOI 10.1016/j.ygcen.2004.10.010; Martin LB, 2004, ECOLOGY, V85, P2323, DOI 10.1890/03-0365; Martin LB, 2008, PHILOS T R SOC B, V363, P321, DOI 10.1098/rstb.2007.2142; Martin LB, 2008, FUNCT ECOL, V22, P68, DOI 10.1111/j.1365-2435.2007.01347.x; Martin LB, 2007, ECOLOGY, V88, P2516, DOI 10.1890/07-0060.1; Miller BLW, 2007, J EVOLUTION BIOL, V20, P1554, DOI 10.1111/j.1420-9101.2007.01331.x; OLIVEIRA MR, 1979, J PARASITOL, V65, P816, DOI 10.2307/3280370; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Ostfeld R. S., 2011, LYME DIS ECOLOGY COM; Patrican LA, 1997, J MED ENTOMOL, V34, P52, DOI 10.1093/jmedent/34.1.52; Previtali MA, 2012, OIKOS, V121, P1483, DOI 10.1111/j.1600-0706.2012.020215.x; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Sears BF, 2011, TRENDS PARASITOL, V27, P382, DOI 10.1016/j.pt.2011.05.004; Stearns S.C., 1992, pi; Tompkins DM, 2011, J ANIM ECOL, V80, P19, DOI 10.1111/j.1365-2656.2010.01742.x; Viney ME, 2005, TRENDS ECOL EVOL, V20, P665, DOI 10.1016/j.tree.2005.10.003; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775	43	77	79	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107387	10.1371/journal.pone.0107387	http://dx.doi.org/10.1371/journal.pone.0107387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232722	Green Published, gold			2022-12-25	WOS:000342921200029
J	Rafiq, K; Nishiyama, A; Konishi, Y; Morikawa, T; Kitabayashi, C; Kohno, M; Masaki, T; Mori, H; Kobori, H; Imanishi, M				Rafiq, Kazi; Nishiyama, Akira; Konishi, Yoshio; Morikawa, Takashi; Kitabayashi, Chizuko; Kohno, Masakazu; Masaki, Tsutomu; Mori, Hirohito; Kobori, Hiroyuki; Imanishi, Masahito			Regression of Glomerular and Tubulointerstitial Injuries by Dietary Salt Reduction with Combination Therapy of Angiotensin II Receptor Blocker and Calcium Channel Blocker in Dahl Salt-Sensitive Rats	PLOS ONE			English	Article							KALLIKREIN GENE DELIVERY; TYPE-2 DIABETIC-RATS; INDUCED RENAL INJURY; OXIDATIVE STRESS; PODOCYTE INJURY; IGA NEPHROPATHY; HYPERTENSION; FIBROSIS; REVERSAL; KINASE	A growing body of evidence indicates that renal tissue injuries are reversible. We investigated whether dietary salt reduction with the combination therapy of angiotensin II type 1 receptor blocker (ARB) plus calcium channel blocker (CCB) reverses renal tissue injury in Dahl salt-sensitive (DSS) hypertensive rats. DSS rats were fed a high-salt diet (HS; 4% NaCl) for 4 weeks. Then, DSS rats were given one of the following for 10 weeks: HS diet; normal-salt diet (NS; 0.5% NaCl), NS + an ARB (olmesartan, 10 mg/kg/day), NS + a CCB (azelnidipine, 3 mg/kg/day), NS + olmesartan + azelnidipine or NS + hydralazine (50 mg/kg/day). Four weeks of treatment with HS diet induced hypertension, proteinuria, glomerular sclerosis and hypertrophy, glomerular podocyte injury, and tubulointerstitial fibrosis in DSS rats. A continued HS diet progressed hypertension, proteinuria and renal tissue injury, which was associated with inflammatory cell infiltration and increased proinflammatory cytokine mRNA levels, NADPH oxidase activity and NADPH oxidase-dependent superoxide production in the kidney. In contrast, switching to NS halted the progression of hypertension, renal glomerular and tubular injuries. Dietary salt reduction with ARB or with CCB treatment further reduced blood pressure and partially reversed renal tissues injury. Furthermore, dietary salt reduction with the combination of ARB plus CCB elicited a strong recovery from HS-induced renal tissue injury including the attenuation of inflammation and oxidative stress. These data support the hypothesis that dietary salt reduction with combination therapy of an ARB plus CCB restores glomerular and tubulointerstitial injury in DSS rats.	[Rafiq, Kazi; Nishiyama, Akira; Kobori, Hiroyuki] Kagawa Univ, Fac Med, Dept Pharmacol, Takamatsu, Kagawa 760, Japan; [Konishi, Yoshio; Morikawa, Takashi; Kitabayashi, Chizuko; Imanishi, Masahito] Osaka City Gen Hosp, Div Nephrol & Hypertens, Osaka, Japan; [Kohno, Masakazu] Kagawa Univ, Fac Med, Dept Cardiorenal & Cerebrovasc Med, Takamatsu, Kagawa 760, Japan; [Masaki, Tsutomu; Mori, Hirohito] Kagawa Univ, Fac Med, Dept Gastroenterol, Takamatsu, Kagawa 760, Japan	Kagawa University; Osaka City General Hospital; Kagawa University; Kagawa University	Rafiq, K (corresponding author), Kagawa Univ, Fac Med, Dept Pharmacol, Takamatsu, Kagawa 760, Japan.	krafiq73@yahoo.com	Rafiq, Kazi/AEU-4834-2022	Nishiyama, Akira/0000-0001-5971-820X	Japan Society for the Promotion of Science (JSPS) (KAKENHI) [23590303, 24.02420]; Osaka City; JSPS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072408] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS) (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Osaka City; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) (23590303 and 24.02420 to Akira Nishiyama) and a research fund from Osaka City (to Masahito Imanishi). Kazi Rafiq is a recipient of a JSPS Postdoctoral Fellowship for Foreign Researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2011, HYPERTENS RES, V34, P935, DOI 10.1038/hr.2011.67; Adamczak M, 2003, J AM SOC NEPHROL, V14, P2833, DOI 10.1097/01.ASN.0000095248.91994.D3; Bledsoe G, 2006, HUM GENE THER, V17, P545, DOI 10.1089/hum.2006.17.545; Carew RM, 2012, CELL TISSUE RES, V347, P103, DOI 10.1007/s00441-011-1227-1; Chao J, 1998, HUM GENE THER, V9, P21, DOI 10.1089/hum.1998.9.1-21; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Fan YY, 2009, J HYPERTENS, V27, P1855, DOI 10.1097/HJH.0b013e32832dda6f; Fioretto P, 1998, NEW ENGL J MED, V339, P69, DOI 10.1056/NEJM199807093390202; Hayashi W, 2012, NEPHRON EXP NEPHROL, V122, P13, DOI 10.1159/000346954; Hotta O, 2002, AM J KIDNEY DIS, V39, P493, DOI 10.1053/ajkd.2002.31399; Ihara G, 2010, J HYPERTENS, V28, P2289, DOI 10.1097/HJH.0b013e32833dfcda; IKOMA M, 1991, KIDNEY INT, V40, P195, DOI 10.1038/ki.1991.200; Jaffe IZ, 2005, CIRC RES, V96, P643, DOI 10.1161/01.RES.0000159937.05502.d1; Ji C, 2001, J BIOL CHEM, V276, P18223, DOI 10.1074/jbc.M101266200; Jinno T, 2004, HYPERTENSION, V43, P263, DOI 10.1161/01.HYP.0000113627.08110.6f; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Karlsen FM, 1997, HYPERTENSION, V30, P975, DOI 10.1161/01.HYP.30.4.975; Kawarazaki H, 2011, AM J PHYSIOL-RENAL, V300, pF1402, DOI 10.1152/ajprenal.00691.2010; Kim-Mitsuyama S, 2013, KIDNEY INT, V83, P167, DOI 10.1038/ki.2012.326; KLAHR S, 1988, NEW ENGL J MED, V318, P1657; Kobori H, 2001, J AM SOC NEPHROL, V12, P431, DOI 10.1681/ASN.V123431; Kobori H, 2007, BIOCHEM BIOPH RES CO, V358, P156, DOI 10.1016/j.bbrc.2007.04.105; Lv ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022806; Ma LJ, 2005, J AM SOC NEPHROL, V16, P966, DOI 10.1681/ASN.2004060492; Nagasu H, 2011, KIDNEY BLOOD PRESS R, V34, P87, DOI 10.1159/000323535; Nakaya H, 2002, NEPHRON, V91, P710, DOI 10.1159/000065035; Nishiyama A, 2004, KIDNEY INT, V65, P972, DOI 10.1111/j.1523-1755.2004.00476.x; Nishiyama A, 2010, J PHARMACOL EXP THER, V332, P1072, DOI 10.1124/jpet.109.158113; Ohashi N, 2010, HYPERTENS RES, V33, P1174, DOI 10.1038/hr.2010.143; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Pichaiwong W, 2013, J AM SOC NEPHROL, V24, P1088, DOI 10.1681/ASN.2012050445; Rafiq K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082082; Rafiq K, 2012, CIRCULATION, V125, P1402, DOI 10.1161/CIRCULATIONAHA.111.064097; Rafiq K, 2011, J HYPERTENS, V29, P290, DOI 10.1097/HJH.0b013e32834103a9; Rodriguez-Iturbe B, 2004, AM J PHYSIOL-RENAL, V286, pF606, DOI 10.1152/ajprenal.00269.2003; Shen B, 2008, HYPERTENSION, V51, P1358, DOI 10.1161/HYPERTENSIONAHA.107.108514; Smadel JE, 1937, J EXP MED, V65, P541, DOI 10.1084/jem.65.4.541; Sugimoto H, 2012, NAT MED, V18, P396, DOI 10.1038/nm.2629; Taylor NE, 2006, HYPERTENSION, V47, P692, DOI 10.1161/01.HYP.0000203161.02046.8d; Teles F, 2009, KIDNEY INT, V75, P72, DOI 10.1038/ki.2008.528; Trolliet MR, 2001, KIDNEY BLOOD PRESS R, V24, P116, DOI 10.1159/000054217; Vallon V, 2005, CURR OPIN NEPHROL HY, V14, P59, DOI 10.1097/00041552-200501000-00010; WAJCHENBERG BL, 1983, ACTA DIABETOL LAT, V20, P1, DOI 10.1007/BF02629124; Yamamoto E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039162; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	45	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107853	10.1371/journal.pone.0107853	http://dx.doi.org/10.1371/journal.pone.0107853			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233358	Green Submitted, Green Published, gold			2022-12-25	WOS:000342921200054
J	Thygesen, LG; Thybring, EE; Johansen, KS; Felby, C				Thygesen, Lisbeth G.; Thybring, Emil E.; Johansen, Katja S.; Felby, Claus			The Mechanisms of Plant Cell Wall Deconstruction during Enzymatic Hydrolysis	PLOS ONE			English	Article							PULP FIBERS; LIQUEFACTION; CELLULASE; SACCHARIFICATION; LENGTH	Mechanical agitation during enzymatic hydrolysis of insoluble plant biomass at high dry matter contents is indispensable for the initial liquefaction step in biorefining. It is known that particle size reduction is an important part of liquefaction, but the mechanisms involved are poorly understood. Here we put forward a simple model based on mechanical principles capable of capturing the result of the interaction between mechanical forces and cell wall weakening via hydrolysis of glucosidic bonds. This study illustrates that basic material science insights are relevant also within biochemistry, particularly when it comes to up-scaling of processes based on insoluble feed stocks.	[Thygesen, Lisbeth G.; Felby, Claus] Univ Copenhagen, Dept Geosci & Nat Management, Fac Sci, Frederiksberg C, Denmark; [Thybring, Emil E.] EMPA, Swiss Fed Labs Mat Sci & Technol, Dubendorf, Switzerland; [Thybring, Emil E.] ETH, Swiss Fed Inst Technol, Inst Bldg Mat, Zurich, Switzerland; [Johansen, Katja S.] Novozymes AS, Bagsvaerd, Denmark	University of Copenhagen; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Swiss Federal Institutes of Technology Domain; ETH Zurich; Novozymes	Thygesen, LG (corresponding author), Univ Copenhagen, Dept Geosci & Nat Management, Fac Sci, Frederiksberg C, Denmark.	lgt@ign.ku.dk	Johansen, Katja/J-7939-2016; Thybring, Emil Engelund/I-5477-2012; Thygesen, Lisbeth Garbrecht/P-5085-2014	Johansen, Katja/0000-0002-7587-5990; Thybring, Emil Engelund/0000-0003-0471-6922; Felby, Claus/0000-0002-6537-0155; Thygesen, Lisbeth Garbrecht/0000-0001-9685-7460	company Novozymes A/S; University of Copenhagen; Novozymes A/S	company Novozymes A/S; University of Copenhagen; Novozymes A/S	The study was financed by the company Novozymes A/S and by the University of Copenhagen. Novozymes A/S provided support in the form of salaries for author KSJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Ander P, 2005, NORD PULP PAP RES J, V20, P115, DOI 10.3183/npprj-2005-20-01-p115-121; Arantes V, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-87; Baley C, 2004, J MATER SCI, V39, P331, DOI 10.1023/B:JMSC.0000007768.63055.ae; Baley C, 2002, COMPOS PART A-APPL S, V33, P939, DOI 10.1016/S1359-835X(02)00040-4; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; Forgacs OL, 1961, TAPPI, V44, P112; Frolander U, 1969, CELL CHEM TECHNOL, V3, P499; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hsieh CWC, 2014, J AGR FOOD CHEM, V62, P3800, DOI 10.1021/jf5012962; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Jorgensen H, 2007, BIOTECHNOL BIOENG, V96, P862, DOI 10.1002/bit.21115; Kristensen JB, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-11; Lapierre L, 2009, HOLZFORSCHUNG, V63, P402, DOI 10.1515/HF.2009.072; Lavenson DM, 2012, BIORESOURCE TECHNOL, V111, P240, DOI 10.1016/j.biortech.2012.01.167; PAGE DH, 1972, PULP PAPER MAG CAN, V73, P72; Roberts KM, 2011, CELLULOSE, V18, P759, DOI 10.1007/s10570-011-9509-z; Selig MJ, 2012, BIOTECHNOL PROGR, V28, P1478, DOI 10.1002/btpr.1617; Skovgaard PA, 2014, BIOTECHNOL PROGR, V30, P923, DOI 10.1002/btpr.1893; Thygesen LG, 2008, J MATER SCI, V43, P1311, DOI 10.1007/s10853-007-2284-4; Thygesen LG, 2011, J IND MICROBIOL BIOT, V38, P975, DOI 10.1007/s10295-010-0870-y; Wallace JT, 2006, THESIS N CAROLINA ST	22	15	15	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e108313	10.1371/journal.pone.0108313	http://dx.doi.org/10.1371/journal.pone.0108313			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25232741	Green Submitted, Green Published, gold			2022-12-25	WOS:000342921200091
J	Visser, JH; Bennett, NC; van Vuuren, BJ				Visser, Jacobus H.; Bennett, Nigel C.; van Vuuren, Bettine Jansen			Local and Regional Scale Genetic Variation in the Cape Dune Mole-Rat, Bathyergus suillus	PLOS ONE			English	Article							SUBTERRANEAN RODENT CTENOMYS; MITOCHONDRIAL-DNA VARIATION; SOUTHERN ROCK AGAMA; CRYPTOMYS-HOTTENTOTUS; SEQUENCE VARIATION; SPECIES COMPLEX; GENUS CRYPTOMYS; SEA-LEVEL; CLIMATIC OSCILLATIONS; BURROW ARCHITECTURE	The distribution of genetic variation is determined through the interaction of life history, morphology and habitat specificity of a species in conjunction with landscape structure. While numerous studies have investigated this interplay of factors in species inhabiting aquatic, riverine, terrestrial, arboreal and saxicolous systems, the fossorial system has remained largely unexplored. In this study we attempt to elucidate the impacts of a subterranean lifestyle coupled with a heterogeneous landscape on genetic partitioning by using a subterranean mammal species, the Cape dune mole-rat (Bathyergus suillus), as our model. Bathyergus suillus is one of a few mammal species endemic to the Cape Floristic Region (CFR) of the Western Cape of South Africa. Its distribution is fragmented by rivers and mountains; both geographic phenomena that may act as geographical barriers to gene-flow. Using two mitochondrial fragments (cytochrome b and control region) as well as nine microsatellite loci, we determined the phylogeographic structure and gene-flow patterns at two different spatial scales (local and regional). Furthermore, we investigated genetic differentiation between populations and applied Bayesian clustering and assignment approaches to our data. Nearly every population formed a genetically unique entity with significant genetic structure evident across geographic barriers such as rivers (Berg, Verlorenvlei, Breede and Gourits Rivers), mountains (Piketberg and Hottentots Holland Mountains) and with geographic distance at both spatial scales. Surprisingly, B. suillus was found to be paraphyletic with respect to its sister species, B. janetta-a result largely overlooked by previous studies on these taxa. A systematic revision of the genus Bathyergus is therefore necessary. This study provides a valuable insight into how the biology, life-history and habitat specificity of animals inhabiting a fossorial system may act in concert with the structure of the surrounding landscape to influence genetic distinctiveness and ultimately speciation.	[Visser, Jacobus H.; van Vuuren, Bettine Jansen] Univ Johannesburg, Dept Zool, Auckland Pk, South Africa; [Bennett, Nigel C.] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa	University of Johannesburg; University of Pretoria	van Vuuren, BJ (corresponding author), Univ Johannesburg, Dept Zool, Auckland Pk, South Africa.	bettinevv@uj.ac.za	Jansen van Vuuren, Bettine/E-6227-2013; Bennett, Nigel/E-4238-2010	Jansen van Vuuren, Bettine/0000-0002-5334-5358; Bennett, Nigel/0000-0001-9748-2947	Centre for Invasion Biology	Centre for Invasion Biology	The work was supported by a Centre for Invasion Biology stipend to BJVV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; ALLARD MW, 1992, MOL BIOL EVOL, V9, P27; ANDERSEN DC, 1981, ECOL MONOGR, V51, P179, DOI 10.2307/2937262; Avise John C., 1994, pi; Bennett N.C., 2000, AFRICAN MOLE RATS EC; Bishop JM, 2004, MOL ECOL, V13, P1217, DOI 10.1111/j.1365-294X.2004.02131.x; Bray TC, 2011, CONSERV GENET RESOUR, V3, P221, DOI 10.1007/s12686-010-9327-x; Bray TC, 2013, BIOL J LINN SOC, V110, P890, DOI 10.1111/bij.12175; Bray TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039866; Brown M, 2006, AUST J ZOOL, V54, P305, DOI 10.1071/ZO06034; Burda H., 2000, SMALL AFRICAN MAMMAL; Burland TM, 2001, MOL ECOL NOTES, V1, P311, DOI 10.1046/j.1471-8278 .2001.00121.x; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Colangelo P, 2013, BIOL J LINN SOC, V108, P901, DOI 10.1111/bij.12013; Conrad J, 2004, WATER SA, V30, P623; Cook BD, 2006, MOL ECOL, V15, P1083, DOI 10.1111/j.1365-294X.2006.02852.x; Cook JA, 1998, EVOLUTION, V52, P1521, DOI 10.1111/j.1558-5646.1998.tb02035.x; Cornuet JM, 1996, GENETICS, V144, P2001; Cotterill F.P.D., 2003, P59; Coulon A, 2006, MOL ECOL, V15, P1669, DOI 10.1111/j.1365-294X.2006.02861.x; Da Silva Cecilia C., 2009, Open Evolution Journal, V3, P17; Da Silva MNF, 1998, MOL ECOL, V7, P475, DOI 10.1046/j.1365-294x.1998.00276.x; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Daniels SR, 2010, ANIM CONSERV, V13, P237, DOI 10.1111/j.1469-1795.2009.00323.x; Daniels SR, 2009, ZOOL SCR, V38, P449, DOI 10.1111/j.1463-6409.2009.00387.x; DASILVA MNF, 1993, MOL PHYLOGENET EVOL, V2, P243, DOI 10.1006/mpev.1993.1023; DAVIES KC, 1986, J ZOOL, V209, P125, DOI 10.1111/j.1469-7998.1986.tb03570.x; Deuve JL, 2008, CHROMOSOME RES, V16, P57, DOI 10.1007/s10577-007-1200-8; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Engelbrecht HM, 2013, J BIOGEOGR, V40, P492, DOI 10.1111/jbi.12024; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Faulkes CG, 2011, J ZOOL, V285, P324, DOI 10.1111/j.1469-7998.2011.00863.x; Faulkes CG, 1997, P ROY SOC B-BIOL SCI, V264, P1619, DOI 10.1098/rspb.1997.0226; Faulkes CG, 2004, MOL ECOL, V13, P613, DOI 10.1046/j.1365-294X.2004.02099.x; Faulkes CG, 2010, BIOL J LINN SOC, V100, P337, DOI 10.1111/j.1095-8312.2010.01418.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fu YX, 1997, GENETICS, V147, P915; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Hadid Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030043; Hart L, 2006, J MAMMAL, V87, P1078, DOI 10.1644/05-MAMM-A-411R2.1; Hart L, 2006, PHYSIOL BEHAV, V88, P615, DOI 10.1016/j.physbeh.2006.05.020; Heideman NJL, 2011, MOL PHYLOGENET EVOL, V61, P823, DOI 10.1016/j.ympev.2011.08.021; HENDEY QB, 1983, FYNBOS PALAEOECOLOGY, P35; Herbst M, 2006, J ZOOL, V270, P420, DOI 10.1111/j.1469-7998.2006.00151.x; Holderegger R, 2008, BIOSCIENCE, V58, P199, DOI 10.1641/B580306; Holderegger R, 2006, LANDSCAPE ECOL, V21, P793, DOI 10.1007/s10980-005-6058-6; HONEYCUTT RL, 1987, SYST ZOOL, V36, P280, DOI 10.2307/2413067; Huchon D, 2000, P R SOC LONDON, V267, P339; Hughes JM, 2009, BIOSCIENCE, V59, P573, DOI 10.1525/bio.2009.59.7.8; Ingram CM, 2004, MOL PHYLOGENET EVOL, V31, P997, DOI 10.1016/j.ympev.2003.11.004; Ingram CM, 2005, THESIS TEXAS A M U T; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Jackson CR, 2008, J ZOOL, V274, P13, DOI 10.1111/j.1469-7998.2007.00351.x; JANECEK LL, 1992, BIOCHEM SYST ECOL, V20, P401, DOI 10.1016/0305-1978(92)90081-N; Jarvis JUM, 1998, OECOLOGIA, V113, P290, DOI 10.1007/s004420050380; Johns GC, 1998, MOL BIOL EVOL, V15, P1481, DOI 10.1093/oxfordjournals.molbev.a025875; Joly S, 2007, SYST BIOL, V56, P857, DOI 10.1080/10635150701633153; Karsten M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054281; Katongo C, 2005, HYDROBIOLOGIA, V542, P221, DOI 10.1007/s10750-004-1389-x; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Krystufek B, 2012, BIOL J LINN SOC, V105, P446, DOI 10.1111/j.1095-8312.2011.01795.x; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Lambeck K, 2004, CR GEOSCI, V336, P677, DOI 10.1016/j.crte.2003.12.017; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Low AB, 2004, GREATER CEDERBERG BI, P1; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Maddison D. R., 2003, MACCLADE VERSION 4 0; Mapelli FJ, 2009, LANDSCAPE ECOL, V24, P723, DOI 10.1007/s10980-009-9352-x; Matthee CA, 2002, MOL ECOL, V11, P465, DOI 10.1046/j.0962-1083.2001.01458.x; Matthee CA, 1996, HEREDITY, V76, P514, DOI 10.1038/hdy.1996.74; MILLER RS, 1964, ECOLOGY, V45, P256, DOI 10.2307/1933839; Mirol P, 2010, BIOL J LINN SOC, V100, P368, DOI 10.1111/j.1095-8312.2010.01409.x; Montgelard C, 2012, ACTA OECOL, V42, P50, DOI 10.1016/j.actao.2012.02.001; Mortimer E, 2011, P ROY SOC B-BIOL SCI, V278, P1247, DOI 10.1098/rspb.2010.1779; Nevo, 1999, MOSAIC EVOLUTION SUB; NEVO E, 1987, BIOCHEM SYST ECOL, V15, P489, DOI 10.1016/0305-1978(87)90066-4; Nevo E, 2000, EVOLUTION, V54, P586, DOI 10.1111/j.0014-3820.2000.tb00061.x; NEVO E, 1991, COPEIA, P565, DOI 10.2307/1446386; NEVO E, 1992, J EXP ZOOL, V263, P430, DOI 10.1002/jez.1402630411; NEVO E, 1979, ANNU REV ECOL SYST, V10, P269, DOI 10.1146/annurev.es.10.110179.001413; NEVO E, 1976, EXPERIENTIA, V32, P858, DOI 10.1007/BF02003729; Nevo EN, 1997, PHILOS T R SOC B, V352, P381, DOI 10.1098/rstb.1997.0028; Patterson BD, 2008, J MAMM EVOL, V15, P181, DOI 10.1007/s10914-007-9070-6; PATTON JL, 1994, EVOLUTION, V48, P1314, DOI 10.1111/j.1558-5646.1994.tb05315.x; Patzenhauerova H, 2010, BEHAV ECOL SOCIOBIOL, V64, P757, DOI 10.1007/s00265-009-0893-4; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pelc RA, 2009, J BIOGEOGR, V36, P1881, DOI 10.1111/j.1365-2699.2009.02138.x; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; PRINSLOO P, 1992, MOL BIOL EVOL, V9, P447; Rambaut A., 2003, TRACER; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; REICHMAN OJ, 1982, ECOLOGY, V63, P687, DOI 10.2307/1936789; Reyes A, 2003, MOL BIOL EVOL, V20, P622, DOI 10.1093/molbev/msg061; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosi MI, 2000, ACTA THERIOL, V45, P491, DOI 10.4098/AT.arch.00-49; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SIESSER WG, 1981, J GEOL, V89, P523, DOI 10.1086/628618; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; Skliba J, 2009, ETHOLOGY, V115, P217, DOI 10.1111/j.1439-0310.2008.01604.x; Smit HA, 2007, MOL ECOL, V16, P2680, DOI 10.1111/j.1365-294X.2007.03334.x; Smit HA, 2011, J ZOOL, V284, P133, DOI 10.1111/j.1469-7998.2011.00790.x; Spinks AC, 2000, OECOLOGIA, V125, P341, DOI 10.1007/s004420000460; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Sumbera R, 2008, J ZOOL, V274, P77, DOI 10.1111/j.1469-7998.2007.00359.x; Swart BL, 2009, J BIOGEOGR, V36, P78, DOI 10.1111/j.1365-2699.2008.01988.x; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Teske PR, 2011, S AFR J SCI, V107, P43, DOI 10.4102/sajs.v107i5/6.514; THAELER CS, 1968, CHROMOSOMA, V25, P172, DOI 10.1007/BF00327176; Thomas HG, 2012, J ZOOL, V288, P214, DOI 10.1111/j.1469-7998.2012.00944.x; Thomas HG, 2009, J ZOOL, V279, P277, DOI 10.1111/j.1469-7998.2009.00616.x; Van Daele PAAG, 2004, J ZOOL, V264, P317, DOI 10.1017/S0952836904005825; Van Daele PAAG, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P357; Van Daele PAAG, 2007, MOL PHYLOGENET EVOL, V45, P142, DOI 10.1016/j.ympev.2007.04.008; van Vuuren BJ, 2007, POLAR BIOL, V30, P327, DOI 10.1007/s00300-006-0188-4; VLECK D, 1979, PHYSIOL ZOOL, V52, P122, DOI 10.1086/physzool.52.2.30152558; Walton AH, 2000, MOL PHYLOGENET EVOL, V16, P467, DOI 10.1006/mpev.2000.0808; Waters JM, 2005, MOL ECOL, V14, P2789, DOI 10.1111/j.1365-294X.2005.02635.x	120	7	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107226	10.1371/journal.pone.0107226	http://dx.doi.org/10.1371/journal.pone.0107226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229558	Green Published, Green Submitted, gold			2022-12-25	WOS:000342123900034
J	Eilertsen, M; Andersen, S; Al-Saad, S; Kiselev, Y; Donnem, T; Stenvold, H; Pettersen, I; Al-Shibli, K; Richardsen, E; Busund, LT; Bremnes, RM				Eilertsen, Marte; Andersen, Sigve; Al-Saad, Samer; Kiselev, Yury; Donnem, Tom; Stenvold, Helge; Pettersen, Ingvild; Al-Shibli, Khalid; Richardsen, Elin; Busund, Lill-Tove; Bremnes, Roy M.			Monocarboxylate Transporters 1-4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival	PLOS ONE			English	Article							LUNG-CANCER; SQUAMOUS-CELL; STROMAL CELLS; TUMOR-CELLS; METABOLISM; EXPRESSION; LACTATE; COEXPRESSION; CARCINOMAS; HYPOXIA	Introduction: Monocarboxylate transporters (MCTs) 1-4 are lactate transporters crucial for cancers cells adaption to upregulated glycolysis. Herein, we aimed to explore their prognostic impact on disease-specific survival (DSS) in both cancer and tumor stromal cells in NSCLC. Methods: Tissue micro arrays (TMAs) were constructed, representing both cancer and stromal tumor tissue from 335 unselected patients diagnosed with stage I-IIIA NSCLC. Immunohistochemistry was used to evaluate the expression of MCT1-4. Results: In univariate analyses; down arrow MCT1 (P = 0.021) and up arrow MCT4 (P = 0.027) expression in cancer cells, and up arrow MCT1 (P = 0.003), down arrow MCT2 (P = 0.006), down arrow MCT3 (P = 0.020) expression in stromal cells correlated significantly with a poor DSS. In multivariate analyses; down arrow MCT1 expression in cancer cells (HR: 1.9, CI 95%: 1.3-2.8, P = 0.001), down arrow MCT2 (HR: 2.4, CI 95%: 1.5-3.9, P<0.001), down arrow MCT3 (HR: 1.9, CI 95%: 1.1-3.5, P = 0.031) and up arrow MCT1 expression in stromal cells (HR: 1.7, CI 95%: 1.1-2.7, P = 0.016) were significant independent poor prognostic markers for DSS. Conclusions: We provide novel information of MCT1 as a candidate marker for prognostic stratification in NSCLC. Interestingly, MCT1 shows diverging, independent prognostic impact in the cancer cell and stromal cell compartments.	[Eilertsen, Marte; Andersen, Sigve; Donnem, Tom; Stenvold, Helge; Pettersen, Ingvild; Bremnes, Roy M.] Univ Tromso, Dept Clin Med, Tromso, Norway; [Andersen, Sigve; Donnem, Tom; Stenvold, Helge; Bremnes, Roy M.] Univ Hosp North Norway, Dept Oncol, Tromso, Norway; [Al-Saad, Samer; Kiselev, Yury; Al-Shibli, Khalid; Richardsen, Elin; Busund, Lill-Tove] Univ Tromso, Dept Med Biol, Tromso, Norway; [Al-Saad, Samer; Richardsen, Elin; Busund, Lill-Tove] Univ Hosp North Norway, Dept Clin Pathol, Tromso, Norway; [Al-Shibli, Khalid] Nordland Cent Hosp, Dept Pathol, Bodo, Norway; [Kiselev, Yury] Univ Tromso, Dept Pharm, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Eilertsen, M (corresponding author), Univ Tromso, Dept Clin Med, Tromso, Norway.	marte.eilertsen@uit.no		Kiselev, Yury/0000-0002-6753-8572	University of Tromso	University of Tromso	This work was funded by the University of Tromso. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023847; Andersen S, 2011, ANTICANCER RES, V31, P1603; Andersen S, 2011, LUNG CANCER, V72, P294, DOI 10.1016/j.lungcan.2010.10.006; Boidot R, 2012, CANCER RES, V72, P939, DOI 10.1158/0008-5472.CAN-11-2474; Busk M, 2011, RADIOTHER ONCOL, V99, P404, DOI 10.1016/j.radonc.2011.05.053; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chen HC, 2010, INTEGR SER INFORM SY, V21, P147, DOI 10.1007/978-1-4419-1278-7_10; Chen JLY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000293; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; Donnem T, 2007, CLIN CANCER RES, V13, P6649, DOI 10.1158/1078-0432.CCR-07-0414; Eilertsen M, 2012, ANTICANCER RES, V32, P4729; Fang J, 2006, MOL PHARMACOL, V70, P2108, DOI 10.1124/mol.106.026245; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Izumi H, 2011, CANCER SCI, V102, P1007, DOI 10.1111/j.1349-7006.2011.01908.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Koukourakis MI, 2006, CANCER RES, V66, P632, DOI 10.1158/0008-5472.CAN-05-3260; Koukourakis MI, 2007, CANCER BIOL THER, V6, P1476, DOI 10.4161/cbt.6.9.4635; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Meijer TWH, 2012, LUNG CANCER, V76, P316, DOI 10.1016/j.lungcan.2011.11.006; Pinheiro C, 2012, J BIOENERG BIOMEMBR, V44, P127, DOI 10.1007/s10863-012-9428-1; Rattigan YL, 2012, EXP CELL RES, V318, P326, DOI 10.1016/j.yexcr.2011.11.014; Sonveaux P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033418; de Oliveira ATT, 2012, J BIOENERG BIOMEMBR, V44, P171, DOI 10.1007/s10863-012-9408-5; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064	26	42	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e105038	10.1371/journal.pone.0105038	http://dx.doi.org/10.1371/journal.pone.0105038			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225794	Green Submitted, Green Published, gold			2022-12-25	WOS:000344317700008
J	Giuliani, AL; Colognesi, D; Ricco, T; Roncato, C; Capece, M; Amoroso, F; Wang, QG; De Marchi, E; Gartland, A; Di Virgilio, F; Adinolfi, E				Giuliani, Anna Lisa; Colognesi, Davide; Ricco, Tiziana; Roncato, Carlotta; Capece, Marina; Amoroso, Francesca; Wang, Qi Guang; De Marchi, Elena; Gartland, Allison; Di Virgilio, Francesco; Adinolfi, Elena			Trophic Activity of Human P2X7 Receptor Isoforms A and B in Osteosarcoma	PLOS ONE			English	Article							BONE-MINERAL DENSITY; P2X(7) RECEPTOR; EXTRACELLULAR ATP; HUMAN OSTEOBLASTS; ACTIVATION; EXPRESSION; CANCER; POLYMORPHISMS; PROLIFERATION; GENE	The P2X7 receptor (P2X7R) is attracting increasing attention for its involvement in cancer. Several recent studies have shown a crucial role of P2X7R in tumour cell growth, angiogenesis and invasiveness. In this study, we investigated the role of the two known human P2X7R functional splice variants, the full length P2X7RA and the truncated P2X7RB, in osteosarcoma cell growth. Immunohistochemical analysis of a tissue array of human osteosarcomas showed that forty-four, of a total fifty-four tumours (81.4%), stained positive for both P2X7RA and B, thirty-one (57.4%) were positive using an anti-P2X7RA antibody, whereas fifteen of the total number (27.7%) expressed only P2X7RB. P2X7RB positive tumours showed increased cell density, at the expense of extracellular matrix. The human osteosarcoma cell line Te85, which lacks endogenous P2X7R expression, was stably transfected with either P2X7RA, P2X7RB, or both. Receptor expression was a powerful stimulus for cell growth, the most efficient growth-promoting isoform being P2X7RB alone. Growth stimulation was matched by increased Ca2+ mobilization and enhanced NFATc1 activity. Te85 P2X7RA+B cells presented pore formation as well as spontaneous extracellular ATP release. The ATP release was sustained in all clones by P2X7R agonist (BzATP) and reduced following P2X7R antagonist (A740003) application. BzATP also increased cell growth and activated NFATc1 levels. On the other hand cyclosporin A (CSA) affected both NFATc1 activation and cell growth, definitively linking P2X7R stimulation to NFATc1 and cell proliferation. All transfected clones also showed reduced RANK-L expression, and an overall decreased RANK-L/OPG ratio. Mineralization was increased in Te85 P2X7RA+ B cells while it was significantly diminished in Te85 P2X7RB clones, in agreement with immunohistochemical results. In summary, our data show that the majority of human osteosarcomas express P2X7RA and B and suggest that expression of either isoform is differently coupled to cell growth or activity.	[Giuliani, Anna Lisa; Colognesi, Davide; Ricco, Tiziana; Roncato, Carlotta; Capece, Marina; Amoroso, Francesca; De Marchi, Elena; Di Virgilio, Francesco; Adinolfi, Elena] Univ Ferrara, Dept Morphol Surg & Expt Med, Sect Expt Pathol Oncol & Biol, I-44100 Ferrara, Italy; [Wang, Qi Guang] Univ Manchester, Ctr Tissue Injury & Repair, Manchester, Lancs, England; [Gartland, Allison] Univ Sheffield, Mellanby Ctr Bone Res, Sheffield, S Yorkshire, England	University of Ferrara; University of Manchester; University of Sheffield	Adinolfi, E (corresponding author), Univ Ferrara, Dept Morphol Surg & Expt Med, Sect Expt Pathol Oncol & Biol, I-44100 Ferrara, Italy.	elena.adinolfi@unife.it	Giuliani, Anna Lisa/HHS-0401-2022; Wang, Qiguang/AAK-9010-2021; Adinolfi, Elena/F-9169-2010; DI VIRGILIO, Francesco/O-4634-2019; Di Virgilio, Francesco/J-3754-2018	Adinolfi, Elena/0000-0001-8129-9929; DI VIRGILIO, Francesco/0000-0003-3566-1362; Di Virgilio, Francesco/0000-0003-3566-1362; Giuliani, Anna Lisa/0000-0003-4988-9181; Amoroso, Francesca Saveria/0000-0002-5946-2491; Gartland, Alison/0000-0002-3712-2437; De Marchi, Elena/0000-0003-0064-4335	AIRC Grant from the Italian Association of Cancer Research [MFAG 11630]; Region Emilia Romagna (Bando Alessandro Liberati); Italian Association for Cancer Research [IG 5354]; Telethon of Italy [GGP06070]; ERA-NET Neuron Joint Transnational Project "Nanostroke'', Ministry of Health of Italy) [RF-2011-02348435]; University of Ferrara; Versus Arthritis [18753] Funding Source: researchfish	AIRC Grant from the Italian Association of Cancer Research(Fondazione AIRC per la ricerca sul cancro); Region Emilia Romagna (Bando Alessandro Liberati); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Telethon of Italy(Fondazione Telethon); ERA-NET Neuron Joint Transnational Project "Nanostroke'', Ministry of Health of Italy); University of Ferrara; Versus Arthritis(Versus Arthritis)	EA is a recipient of a my first AIRC Grant (MFAG 11630) from the Italian Association of Cancer Research (http://www.airc.it/) and of Young Researcher Grant from the Region Emilia Romagna (Bando Alessandro Liberati). FDV is supported by grants from the Italian Association for Cancer Research (n. IG 5354), Telethon of Italy (n. GGP06070), ERA-NET Neuron Joint Transnational Project "Nanostroke'', Ministry of Health of Italy (n. RF-2011-02348435, and institutional funds from the University of Ferrara. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Adinolfi E, 2012, J OSTEOPOROS, V2012, DOI 10.1155/2012/637863; Adinolfi E, 2012, CANCER RES, V72, P2957, DOI 10.1158/0008-5472.CAN-11-1947; Adinolfi E, 2010, FASEB J, V24, P3393, DOI 10.1096/fj.09-153601; Adinolfi E, 2009, J BIOL CHEM, V284, P10120, DOI 10.1074/jbc.M805805200; Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Alqallaf SM, 2009, BRIT J PHARMACOL, V156, P1124, DOI 10.1111/j.1476-5381.2009.00119.x; Baricordi OR, 1999, J BIOL CHEM, V274, P33206, DOI 10.1074/jbc.274.47.33206; Beristain AG, 2012, J CELL SCI, V125, P943, DOI 10.1242/jcs.094029; Bianco F, 2006, J NEUROCHEM, V99, P745, DOI 10.1111/j.1471-4159.2006.04101.x; Brandao-Burch Andrea, 2012, Front Endocrinol (Lausanne), V3, P41, DOI 10.3389/fendo.2012.00041; Buckley KA, 2002, BONE, V31, P582, DOI 10.1016/S8756-3282(02)00877-3; Buell G, 1998, BLOOD, V92, P3521, DOI 10.1182/blood.V92.10.3521.422k50_3521_3528; Cheewatrakoolpong B, 2005, BIOCHEM BIOPH RES CO, V332, P17, DOI 10.1016/j.bbrc.2005.04.087; Chong JH, 2010, BIOCHEM BIOPH RES CO, V391, P498, DOI 10.1016/j.bbrc.2009.11.087; Costa HM, 2011, PURINERG SIGNAL, V7, P7, DOI 10.1007/s11302-011-9215-1; Di Virgilio F, 2009, PURINERG SIGNAL, V5, P251, DOI 10.1007/s11302-009-9145-3; Feng YH, 2006, J BIOL CHEM, V281, P17228, DOI 10.1074/jbc.M602999200; Gartland A, 2003, CRIT REV EUKAR GENE, V13, P237; Gartland A, 2003, CALCIFIED TISSUE INT, V73, P361, DOI 10.1007/s00223-002-2098-y; Gartland A, 2001, J BONE MINER RES, V16, P846, DOI 10.1359/jbmr.2001.16.5.846; Gartland A, 2012, EUR J HUM GENET, V20, P559, DOI 10.1038/ejhg.2011.245; Gorlick R, 2013, PEDIATR BLOOD CANCER, V60, P1009, DOI 10.1002/pbc.24429; Grol MW, 2012, AM J PHYSIOL-ENDOC M, V302, pE561, DOI 10.1152/ajpendo.00209.2011; Grol MW, 2009, PURINERG SIGNAL; Hameed M, 2011, SEMIN DIAGN PATHOL, V28, P86, DOI 10.1053/j.semdp.2011.02.002; Hattori F, 2012, EUR J PHARMACOL, V695, P20, DOI 10.1016/j.ejphar.2012.09.001; Hill LM, 2010, J IMMUNOL, V185, P3028, DOI 10.4049/jimmunol.1001298; Husted LB, 2013, OSTEOPOROSIS INT, V24, P949, DOI 10.1007/s00198-012-2035-5; Jelassi B, 2011, ONCOGENE, V30, P2108, DOI 10.1038/onc.2010.593; Jelassi B, 2013, CARCINOGENESIS, V34, P1487, DOI 10.1093/carcin/bgt099; Jiang LH, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00055; Jorgensen NR, 2012, EUR J HUM GENET, V20, P675, DOI 10.1038/ejhg.2011.253; Jorgensen NR, 2002, J BIOL CHEM, V277, P7574, DOI 10.1074/jbc.M104608200; Ke HZ, 2003, MOL ENDOCRINOL, V17, P1356, DOI 10.1210/me.2003-0021; Li JL, 2005, J BIOL CHEM, V280, P42952, DOI 10.1074/jbc.M506415200; Liu DW, 2008, BONE, V42, P644, DOI 10.1016/j.bone.2007.09.058; Liu PS, 2010, TOXICOL APPL PHARM, V244, P308, DOI 10.1016/j.taap.2010.01.007; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Monif M, 2009, J NEUROSCI, V29, P3781, DOI 10.1523/JNEUROSCI.5512-08.2009; Ohlendorff SD, 2007, PHARMACOGENET GENOM, V17, P555, DOI 10.1097/FPC.0b013e3280951625; Okumura H, 2008, BIOCHEM BIOPH RES CO, V372, P486, DOI 10.1016/j.bbrc.2008.05.066; Orriss IR, 2006, BONE, V39, P300, DOI 10.1016/j.bone.2006.02.063; Orriss IR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069057; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Panupinthu N, 2008, J CELL BIOL, V181, P859, DOI 10.1083/jcb.200708037; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; RHIM JS, 1977, INT J CANCER, V19, P505, DOI 10.1002/ijc.2910190411; Rumney RMH, 2012, J BIOMECH, V45, P549, DOI 10.1016/j.jbiomech.2011.11.036; Salinas-Souza C, 2013, HUM PATHOL, V44, P2188, DOI 10.1016/j.humpath.2013.04.013; Schumacher D, 2013, CANCER CELL, V24, P130, DOI 10.1016/j.ccr.2013.05.008; Slater M, 2004, HISTOPATHOLOGY, V44, P206, DOI 10.1111/j.0309-0167.2004.01798.x; Slater M, 2004, BREAST CANCER RES TR, V83, P1, DOI 10.1023/B:BREA.0000010670.85915.0f; Solini A, 2008, ENDOCRINOLOGY, V149, P389, DOI 10.1210/en.2007-1223; Stern PH, 2006, MOL INTERV, V6, P193, DOI 10.1124/mi.6.4.4; Wesselius A, 2013, OSTEOPOROSIS INT, V24, P1235, DOI 10.1007/s00198-012-2059-x; Wesselius A, 2011, FRONT BIOSCI-LANDMRK, V16, P2572, DOI 10.2741/3873; Yasuda H, 2013, WORLD J ORTHOP, V4, P207, DOI 10.5312/wjo.v4.i4.207	59	65	65	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107224	10.1371/journal.pone.0107224	http://dx.doi.org/10.1371/journal.pone.0107224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226385	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000344317700036
J	Ozdemir, B; Shi, B; Bantleon, HP; Moritz, A; Rausch-Fan, X; Andrukhov, O				Ozdemir, Burcu; Shi, Bin; Bantleon, Hans Peter; Moritz, Andreas; Rausch-Fan, Xiaohui; Andrukhov, Oleh			Endocannabinoids and Inflammatory Response in Periodontal Ligament Cells	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS; ANANDAMIDE; SYSTEM; PROLIFERATION; CANNABINOIDS; DISEASES; 2-ARACHIDONOYLGLYCEROL; FIBROBLASTS; INVOLVEMENT; CHEMOKINES	Endocannabinoids are associated with multiple regulatory functions in several tissues. The main endocannabinoids, anandamide (AEA) and 2-arachidonylglycerol (2-AG), have been detected in the gingival crevicular fluid of periodontitis patients, but the association between periodontal disease or human periodontal ligament cells (hPdLCs) and endocannabinoids still remain unclear. The aim of the present study was to examine the effects of AEA and 2-AG on the proliferation/viability and cytokine/chemokine production of hPdLCs in the presence/absence of Porphyromonas gingivalis lipopolysaccharide (P. gingivalis LPS). The proliferation/viability of hPdLCs was measured using 3,4,5-dimethylthiazol-2-yl-2,5- diphenyl tetrazolium bromide (MTT)-assay. Interleukin-6 (IL-6), interleukin-8 (IL-8), and monocyte chemotactic protein-1 (MCP-1) levels were examined at gene expression and protein level by real-time PCR and ELISA, respectively. AEA and 2-AG did not reveal any significant effects on proliferation/viability of hPdLCs in the absence of P. gingivalis LPS. However, hPdLCs viability was significantly increased by 10-20 mu M AEA in the presence of P. gingivalis LPS (1 mu g/ml). In the absence of P. gingivalis LPS, AEA and 2-AG did not exhibit any significant effect on the expression of IL-8 and MCP-1 expression in hPdLCs, whereas IL-6 expression was slightly enhanced by 10 mM 2-AG and not affected by AEA. In P. gingivalis LPS stimulated hPdLCs, 10 mu M AEA down-regulated gene-expression and protein production of IL-6, IL-8, and MCP-1. In contrast, 10 mu M 2AG had an opposite effect and induced a significant up-regulation of gene and protein expression of IL-6 and IL-8 (P<0.05) as well as gene-expression of MCP-1 in P. gingivalis LPS stimulated hPdLCs. Our data suggest that AEA appears to have an anti-inflammatory and immune suppressive effect on hPdLCs' host response to P. gingivalis LPS, whereas 2-AG appears to promote detrimental inflammatory processes. In conclusion, AEA and 2-AG might play an important role in the modulation of periodontal inflammation.	[Ozdemir, Burcu] Gazi Univ, Fac Dent, Dept Periodontol, Ankara, Turkey; [Ozdemir, Burcu; Shi, Bin; Rausch-Fan, Xiaohui; Andrukhov, Oleh] Med Univ, Bernhard Gottlieb Sch Dent, Div Oral Biol, Vienna, Austria; [Bantleon, Hans Peter; Rausch-Fan, Xiaohui] Med Univ, Bernhard Gottlieb Sch Dent, Div Orthodont, Vienna, Austria; [Moritz, Andreas] Med Univ, Bernhard Gottlieb Sch Dent, Div Conservat Dent Periodontol & Prophylaxis, Vienna, Austria; [Shi, Bin] Fujian Med Univ, Affiliated Hosp 1, Dept Oral Surg, Fuzhou, Peoples R China	Gazi University; Fujian Medical University	Ozdemir, B (corresponding author), Gazi Univ, Fac Dent, Dept Periodontol, Ankara, Turkey.	cburcu@gazi.edu.tr; oleh.andrukhov@meduniwien.ac.at	Andrukhov, Oleh/H-9851-2018	Andrukhov, Oleh/0000-0002-0485-2142; Rausch-Fan, Xiaohui/0000-0002-8010-1914; OZDEMIR, BURCU/0000-0003-0356-7769	Bernhard Gottlieb School of Dentistry, Medical University of Vienna; Ministry of Science and Technology of China under contract International Science & Technology Cooperation Program foundation [1019]	Bernhard Gottlieb School of Dentistry, Medical University of Vienna; Ministry of Science and Technology of China under contract International Science & Technology Cooperation Program foundation	This work was supported by the authors' institution, Bernhard Gottlieb School of Dentistry, Medical University of Vienna and by Ministry of Science and Technology of China under contract International Science & Technology Cooperation Program foundation (Nr. 1019). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	An N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096942; Andrukhov O, 2013, ACTA ODONTOL SCAND; Andrukhov O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090301; Andrukhov O, 2010, ACTA ODONTOL SCAND, V68, P329, DOI 10.3109/00016357.2010.514717; Antonietta R, 2012, CYTOKINE, V60, P197, DOI 10.1016/j.cyto.2012.06.004; Bab I, 2008, J NEUROENDOCRINOL, V20, P69, DOI 10.1111/j.1365-2826.2008.01675.x; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Cencioni MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008688; Chang YH, 2001, J CELL BIOCHEM, V81, P715, DOI 10.1002/jcb.1103; Croxford JL, 2005, J NEUROIMMUNOL, V166, P3, DOI 10.1016/j.jneuroim.2005.04.023; Czifra G, 2012, J INVEST DERMATOL, V132, P1967, DOI 10.1038/jid.2012.118; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; GENCO RJ, 1992, J PERIODONTOL, V63, P338, DOI 10.1902/jop.1992.63.4s.338; Graves DT, 1999, CLIN INFECT DIS, V28, P482, DOI 10.1086/515178; Idris AI, 2010, CALCIFIED TISSUE INT, V87, P285, DOI 10.1007/s00223-010-9378-8; Itaya T, 2009, J PERIODONTAL RES, V44, P425, DOI 10.1111/j.1600-0765.2008.01137.x; Jonsson D, 2011, J PERIODONTAL RES, V46, P153, DOI 10.1111/j.1600-0765.2010.01331.x; Jonsson D, 2008, ARCH ORAL BIOL, V53, P896, DOI 10.1016/j.archoralbio.2008.05.001; Kishimoto S, 2004, J BIOCHEM, V135, P517, DOI 10.1093/jb/mvh063; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; Kozono S, 2010, BIOCHEM BIOPH RES CO, V394, P928, DOI 10.1016/j.bbrc.2010.03.080; Kreitzer FR, 2009, PHARMACOL THERAPEUT, V122, P83, DOI 10.1016/j.pharmthera.2009.01.005; Kurtis B, 2005, J PERIODONTOL, V76, P1849, DOI 10.1902/jop.2005.76.11.1849; Loesche WJ, 2001, CLIN MICROBIOL REV, V14, P727, DOI 10.1128/CMR.14.4.727-752.2001; Morandini ACF, 2013, J PERIODONTOL, V84, P535, DOI 10.1902/jop.2012.120177; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakajima Y, 2006, FEBS LETT, V580, P613, DOI 10.1016/j.febslet.2005.12.079; Nibali L, 2012, ORAL DIS, V18, P236, DOI 10.1111/j.1601-0825.2011.01867.x; Opitz CA, 2007, FEBS LETT, V581, P4927, DOI 10.1016/j.febslet.2007.09.032; Ossola CA, 2012, INFLAMM RES, V61, P941, DOI 10.1007/s00011-012-0485-z; Pandey R, 2009, PHARMACOL RES, V60, P85, DOI 10.1016/j.phrs.2009.03.019; Pathirana RD, 2010, PERIODONTOL 2000, V52, P218, DOI 10.1111/j.1600-0757.2009.00330.x; Qian H, 2010, J PERIODONTAL RES, V45, P504, DOI 10.1111/j.1600-0765.2009.01265.x; Qian H, 2013, OPEN J STOMATOLOGY, V3, P44; Rettori E, 2012, NEUROIMMUNOMODULAT, V19, P293, DOI 10.1159/000339113; Ridge FL, 2007, CALCIF TISSUE INT; Scheres N, 2010, J PERIODONTAL RES, V45, P262, DOI 10.1111/j.1600-0765.2009.01229.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sooampon S, 2013, J PERIODONTAL RES, V48, P22, DOI 10.1111/j.1600-0765.2012.01493.x; Tanasescu R, 2010, IMMUNOBIOLOGY, V215, P588, DOI 10.1016/j.imbio.2009.12.005; Teng YTA, 2006, J DENT RES, V85, P198, DOI 10.1177/154405910608500301; Wang YP, 2013, CLIN VACCINE IMMUNOL, V20, P1008, DOI 10.1128/CVI.00674-12; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	43	32	32	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107407	10.1371/journal.pone.0107407	http://dx.doi.org/10.1371/journal.pone.0107407			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226300	Green Submitted, Green Published, gold			2022-12-25	WOS:000344317700052
J	Sowa, M; Grossmann, K; Knutter, I; Hiemann, R; Rober, N; Anderer, U; Csernok, E; Bogdanos, DP; Borghi, MO; Meroni, PL; Schierack, P; Reinhold, D; Conrad, K; Roggenbuck, D				Sowa, Mandy; Grossmann, Kai; Knuetter, Ilka; Hiemann, Rico; Roeber, Nadja; Anderer, Ursula; Csernok, Elena; Bogdanos, Dimitrios P.; Borghi, Maria Orietta; Meroni, Pier Luigi; Schierack, Peter; Reinhold, Dirk; Conrad, Karsten; Roggenbuck, Dirk			Simultaneous Automated Screening and Confirmatory Testing for Vasculitis-Specific ANCA	PLOS ONE			English	Article							ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; INTERNATIONAL CONSENSUS STATEMENT; INFLAMMATORY-BOWEL-DISEASE; LINKED-IMMUNOSORBENT-ASSAY; INDIRECT IMMUNOFLUORESCENCE; WEGENERS-GRANULOMATOSIS; ANTINUCLEAR ANTIBODIES; HEP-2 CELLS; AUTOANTIBODIES; PROTEINASE-3	Anti-neutrophil cytoplasmic antibodies (ANCA) are the serological hallmark of small vessel vasculitis, so called ANCA-associated vasculitis. The international consensus requires testing by indirect immunofluorescence (IIF) on human ethanol-fixed neutrophils (ethN) as screening followed by confirmation with enzyme-linked immunosorbent assays (ELISAs). This study evaluates the combination of cell- and microbead-based digital IIF analysis of ANCA in one reaction environment by the novel multiplexing CytoBead technology for simultaneous screening and confirmatory ANCA testing. Sera of 592 individuals including 118 patients with ANCA-associated vasculitis, 133 with rheumatoid arthritis, 49 with infectious diseases, 77 with inflammatory bowel syndrome, 20 with autoimmune liver diseases, 70 with primary sclerosing cholangitis and 125 blood donors were tested for cytoplasmic ANCA (C-ANCA) and perinuclear ANCA (P-ANCA) by classical IIF and ANCA to proteinase 3 (PR3) and myeloperoxidase (MPO) by ELISA. These findings were compared to respective ANCA results determined by automated multiplex CytoBead technology using ethN and antigen-coated microbeads for microbead immunoassays. There was a good agreement for PR3- and MPO-ANCA and a very good one for P-ANCA and C-ANCA by classical and multiplex analysis (Cohen's kappa [kappa] = 0.775, 0.720, 0.876, 0.820, respectively). The differences between classical testing and CytoBead analysis were not significant for PR3-ANCA, P-ANCA, and C-ANCA (p<0.05, respectively). The prevalence of confirmed positive ANCA findings by classical testing (IIF and ELISA) compared with multiplex CytoBead analysis (IIF and microbead immunoassay positive) resulted in a very good agreement (kappa = 0.831) with no significant difference of both methods (p = 0.735). Automated endpoint-ANCA titer detection in one dilution demonstrated a very good agreement with classical analysis requiring dilution of samples (kappa = 0.985). Multiplexing by CytoBead technology can be employed for simultaneous screening and quantitative confirmation of ANCA. This novel technique provides fast and cost-effective ANCA analysis by automated digital IIF for the first time.	[Sowa, Mandy; Grossmann, Kai; Knuetter, Ilka; Roggenbuck, Dirk] GA Gener Assays GmbH, Dept Res & Dev, Dahlewitz Berlin, Germany; [Hiemann, Rico; Anderer, Ursula; Schierack, Peter; Roggenbuck, Dirk] Brandenburg Univ Technol Cottbus Senftenberg, Fac Sci, Senftenberg, Germany; [Roeber, Nadja; Conrad, Karsten] Tech Univ Dresden, Inst Immunol, D-01062 Dresden, Germany; [Csernok, Elena] Univ Schleswig Holstein Campus Lubeck, Dept Rheumatol, Bad Bramstedt, Germany; [Csernok, Elena] Rheumaklin Bad Bramstedt, Bad Bramstedt, Germany; [Bogdanos, Dimitrios P.] Kings Univ Coll, Div Transplantat Immunol & Mucosal Biol, London, England; [Borghi, Maria Orietta; Meroni, Pier Luigi] Univ Milan, Dept Rheumatol, Milan, Italy; [Reinhold, Dirk] Univ Magdeburg, Inst Mol & Clin Immunol, D-39106 Magdeburg, Germany	Brandenburg University of Technology Cottbus; Technische Universitat Dresden; University of Kiel; Schleswig Holstein University Hospital; University of London; King's College London; University of Milan; Otto von Guericke University	Roggenbuck, D (corresponding author), GA Gener Assays GmbH, Dept Res & Dev, Dahlewitz Berlin, Germany.	dirk.roggenbuck@hs-lausitz.de	Bogdanos, Dimitrios/AAF-8620-2020; Borghi, Maria Orietta/K-8768-2016; meroni, pier luigi/K-8473-2016	Bogdanos, Dimitrios/0000-0002-9697-7902; Borghi, Maria Orietta/0000-0001-8967-9678; meroni, pier luigi/0000-0002-3394-1451; Roggenbuck, Dirk/0000-0002-6861-6827	Federal Ministry of Economics and Technology Central Innovation Programme SME ZIM-KOOP [KF2379003AJ0, KF2379004AJ1]; Federal Ministry of Education [03IP611, 03IPT611A, 03IP611X]	Federal Ministry of Economics and Technology Central Innovation Programme SME ZIM-KOOP; Federal Ministry of Education	This work was supported by the Federal Ministry of Economics and Technology Central Innovation Programme SME ZIM-KOOP (grants KF2379003AJ0, KF2379004AJ1) and the Federal Ministry of Education (Research projects InnoProfile 03IP611, InnoProfile-Transfer 03IPT611A and InnoProfile-Transfer 03IP611X). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon-Levin N, 2014, ANN RHEUM DIS, V73, P17, DOI 10.1136/annrheumdis-2013-203863; Bonroy C, 2013, CLIN CHEM LAB MED, V51, P1771, DOI 10.1515/cclm-2013-0016; Boomsma MM, 2003, J IMMUNOL METHODS, V274, P27, DOI 10.1016/S0022-1759(02)00273-9; Bosch X, 2006, LANCET, V368, P404, DOI 10.1016/S0140-6736(06)69114-9; Bossuyt X, 2013, CLIN CHIM ACTA, V415, P101, DOI 10.1016/j.cca.2012.09.021; Conrad K, 2014, AUTOIMMUN REV, V13, P463, DOI 10.1016/j.autrev.2014.01.028; Conrad K, 2012, AUTOIMMUN REV, V11, P207, DOI 10.1016/j.autrev.2011.05.014; Conrad K, 2010, AUTOIMMUN REV, V9, P431, DOI 10.1016/j.autrev.2009.11.017; Csernok E, 2002, RHEUMATOLOGY, V41, P1313, DOI 10.1093/rheumatology/41.11.1313; Csernok E, 2010, AUTOIMMUN HIGHLIGHTS, V1, P39, DOI 10.1007/s13317-010-0007-3; Damoiseaux J, 2009, ANN RHEUM DIS, V68, P228, DOI 10.1136/ard.2007.086579; Damoiseaux J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/762874; Damoiseaux J, 2009, J IMMUNOL METHODS, V348, P67, DOI 10.1016/j.jim.2009.07.001; Egerer K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2949; Falk RJ, 2011, ARTHRITIS RHEUM-US, V63, P863, DOI 10.1002/art.30286; Fritzler MJ, 2003, ARTHRITIS RES THER, V5, P192, DOI 10.1186/ar782; George S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083924; Giraldo J, 2002, PHARMACOL THERAPEUT, V95, P21, DOI 10.1016/S0163-7258(02)00223-1; Gou SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060530; Grossmann K, 2011, CYTOM PART A, V79A, P118, DOI 10.1002/cyto.a.21009; Hiemann R, 2009, AUTOIMMUN REV, V9, P17, DOI 10.1016/j.autrev.2009.02.033; Holle JU, 2010, ANN RHEUM DIS, V69, P468, DOI 10.1136/ard.2009.109868; HOLLE JU, 2012, EXPT RHEUMATOL, P1; Jennette JC, 2013, CLIN EXP NEPHROL, V17, P603, DOI 10.1007/s10157-013-0869-6; Jennette JC, 2013, ANNU REV PATHOL-MECH, V8, P139, DOI 10.1146/annurev-pathol-011811-132453; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Kivity S, 2012, CLIN RHEUMATOL, V31, P503, DOI 10.1007/s10067-011-1884-1; Knutter I, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4119; Melegari A, 2012, AUTOIMMUN REV, V11, P713, DOI 10.1016/j.autrev.2011.12.010; Merkel PA, 1997, ANN INTERN MED, V126, P866, DOI 10.7326/0003-4819-126-11-199706010-00003; Meroni PL, 2010, ANN RHEUM DIS, V69, P1420, DOI 10.1136/ard.2009.127100; Muller A, 2007, ANN NY ACAD SCI, V1109, P84, DOI 10.1196/annals.1398.010; Radice A, 2013, CLIN CHEM LAB MED, V51, P2141, DOI 10.1515/cclm-2013-0308; Rodiger S, 2013, ADV BIOCHEM ENG BIOT, V133, P35, DOI 10.1007/10_2011_132; Roggenbuck D, 2014, CLIN CHEM LAB MED, V52, pE9, DOI 10.1515/cclm-2013-0543; Roggenbuck D, 2013, CLIN CHIM ACTA, V421, P168, DOI 10.1016/j.cca.2013.03.019; Roggenbuck D, 2012, AUTOIMMUN REV, V11, P821, DOI 10.1016/j.autrev.2012.02.016; Roggenbuck D, 2011, CLIN CHIM ACTA, V412, P2011, DOI 10.1016/j.cca.2011.07.005; Roggenbuck D, 2009, ANN NY ACAD SCI, V1173, P41, DOI 10.1111/j.1749-6632.2009.04649.x; Ruffatti A, 2002, J RHEUMATOL, V29, P918; Sack U, 2009, ANN NY ACAD SCI, V1173, P166, DOI 10.1111/j.1749-6632.2009.04735.x; Savige J, 2000, KIDNEY INT, V57, P846, DOI 10.1046/j.1523-1755.2000.057003846.x; Savige J, 2003, AM J CLIN PATHOL, V120, P312, DOI 10.1309/WAEPADW0K4LPUHFN; Savige J, 1999, AM J CLIN PATHOL, V111, P507; Arias-Loste MT, 2013, CLIN REV ALLERG IMMU, V45, P109, DOI 10.1007/s12016-012-8349-4; TOZZOLI R, 2012, CLIN CHEM LAB MED, V51, P1; Tsiveriotis K, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/626495; Van Biervliet S, 2013, J PEDIATR GASTR NUTR, V57, P489, DOI 10.1097/MPG.0b013e31829d4e9e; VANDERWOUDE FJ, 1985, LANCET, V1, P425; Willitzki A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/284740; Ying CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089777; Zophel K, 2009, CLIN CHIM ACTA, V403, P266, DOI 10.1016/j.cca.2009.01.022	52	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107743	10.1371/journal.pone.0107743	http://dx.doi.org/10.1371/journal.pone.0107743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25225805	Green Published, gold			2022-12-25	WOS:000344317700080
J	Iglesias, MJ; Terrile, MC; Windels, D; Lombardo, MC; Bartoli, CG; Vazquez, F; Estelle, M; Casalongue, CA				Jose Iglesias, Maria; Cecilia Terrile, Maria; Windels, David; Cristina Lombardo, Maria; Guillermo Bartoli, Carlos; Vazquez, Franck; Estelle, Mark; Anahi Casalongue, Claudia			MiR393 Regulation of Auxin Signaling and Redox-Related Components during Acclimation to Salinity in Arabidopsis	PLOS ONE			English	Article							INDUCED MORPHOGENIC RESPONSE; LATERAL ROOT DEVELOPMENT; SALT STRESS-RESPONSE; OXYGEN GENE NETWORK; BOX PROTEIN TIR1; OXIDATIVE STRESS; ABIOTIC STRESS; PROFILING REVEALS; GROWTH-REGULATION; CELL-DEATH	One of the most striking aspects of plant plasticity is the modulation of development in response to environmental changes. Plant growth and development largely depend on the phytohormone auxin that exerts its function through a partially redundant family of F-box receptors, the TIR1-AFBs. We have previously reported that the Arabidopsis double mutant tir1 afb2 is more tolerant to salt stress than wild-type plants and we hypothesized that down-regulation of auxin signaling might be part of Arabidopsis acclimation to salinity. In this work, we show that NaCl-mediated salt stress induces miR393 expression by enhancing the transcription of AtMIR393A and leads to a concomitant reduction in the levels of the TIR1 and AFB2 receptors. Consequently, NaCl triggers stabilization of Aux/IAA repressors leading to down-regulation of auxin signaling. Further, we report that miR393 is likely involved in repression of lateral root (LR) initiation, emergence and elongation during salinity, since the mir393ab mutant shows reduced inhibition of emergent and mature LR number and length upon NaCl-treatment. Additionally, mir393ab mutant plants have increased levels of reactive oxygen species (ROS) in LRs, and reduced ascorbate peroxidase (APX) enzymatic activity compared with wild-type plants during salinity. Thus, miR393 regulation of the TIR1 and AFB2 receptors could be a critical checkpoint between auxin signaling and specfic redox-associated components in order to coordinate tissue and time-specific growth responses and tolerance during acclimation to salinity in Arabidopsis.	[Jose Iglesias, Maria; Cecilia Terrile, Maria; Cristina Lombardo, Maria; Anahi Casalongue, Claudia] Univ Nacl Mar Del Plata, UE CONICET UNMDP, Fac Ciencias Exactas & Nat, Inst Invest Biol, Mar Del Plata, Argentina; [Cristina Lombardo, Maria] Univ Nacl Mar Del Plata, UE CONICET UNMDP, Fac Ciencias Exactas & Nat, Dept Biol, Mar Del Plata, Argentina; [Vazquez, Franck] Univ Basel, Zurich Basel Plant Sci Ctr, Inst Bot, Dept Environm Sci, Basel, Switzerland; [Guillermo Bartoli, Carlos] Univ Nacl La Plata, CCT La Plata, CONICET, Fac Ciencias Nat,Inst Fisiol Vegetal, La Plata, Argentina; [Estelle, Mark] Univ Calif San Diego, Sect Cell & Dev Biol, San Diego, CA 92103 USA; [Estelle, Mark] Univ Calif San Diego, Howard Hughes Med Inst, San Diego, CA 92103 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Mar del Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Mar del Plata; University of Basel; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Casalongue, CA (corresponding author), Univ Nacl Mar Del Plata, UE CONICET UNMDP, Fac Ciencias Exactas & Nat, Inst Invest Biol, Mar Del Plata, Argentina.	casalong@mdp.edu.ar	Iglesias, MariaJ/AAE-5047-2019; Estelle, Mark/ABD-6742-2021	Iglesias, MariaJ/0000-0002-6007-5069; Terrile, Maria Cecilia/0000-0003-4929-4540; Vazquez, Franck/0000-0002-7967-3798	CONICET [PIP 0292, PIP 0202]; Mar del Plata National University; ANPCyT-Ministry of Science and Technology, Argentina [PICT 1167]; Swiss National Science Foundation [PZ00P3_126329, PZ00P3_142106]; National Institutes of Health (NIH) [GM 43644]; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043644] Funding Source: NIH RePORTER	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Mar del Plata National University; ANPCyT-Ministry of Science and Technology, Argentina; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work in the laboratory of CAC is supported by CONICET (grant PIP 0292 to CAC; grant PIP 0202 to MCT), Mar del Plata National University and ANPCyT-Ministry of Science and Technology (grant PICT 1167 to MCT), Argentina. The work in the laboratory of FV is supported by grants of the Swiss National Science Foundation (PZ00P3_126329 and PZ00P3_142106). Work in the laboratory of ME is supported by grants from the National Institutes of Health (NIH) (GM 43644), The Howard Hughes Medical Institute and the Gordon and Betty Moore Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bai MY, 2012, PLANT CELL, V24, P4917, DOI 10.1105/tpc.112.105163; Barth C, 2004, PLANT PHYSIOL, V134, P1784, DOI 10.1104/pp.103.032185; Bellincampi D, 2000, PLANT PHYSIOL, V122, P1379, DOI 10.1104/pp.122.4.1379; Blomster T, 2011, PLANT PHYSIOL, V157, P1866, DOI 10.1104/pp.111.181883; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burssens S, 2000, PLANTA, V211, P632, DOI 10.1007/s004250000334; Villalobos LIAC, 2012, NAT CHEM BIOL, V8, P477, DOI [10.1038/NCHEMBIO.926, 10.1038/nchembio.926]; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; Chen ZH, 2011, PLANT MOL BIOL, V77, P619, DOI 10.1007/s11103-011-9838-1; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Correa-Aragunde N, 2013, J EXP BOT, V64, P3339, DOI 10.1093/jxb/ert172; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Duan LN, 2013, PLANT CELL, V25, P324, DOI 10.1105/tpc.112.107227; Dubrovsky JG, 2008, P NATL ACAD SCI USA, V105, P8790, DOI 10.1073/pnas.0712307105; Estelle M, 2008, COLD SPRING HARBOR P, V2008; Feng XM, 2010, ACTA PHYSIOL PLANT, V32, P997, DOI 10.1007/s11738-010-0490-1; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Geng Y, 2013, PLANT CELL, V25, P2132, DOI 10.1105/tpc.113.112896; Gergoff G, 2010, PLANT SCI, V178, P207, DOI 10.1016/j.plantsci.2009.12.003; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Guan QM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003755; Gustafson AM, 2005, NUCLEIC ACIDS RES, V33, pD637, DOI 10.1093/nar/gki127; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853; Jain M, 2009, FEBS J, V276, P3148, DOI 10.1111/j.1742-4658.2009.07033.x; Joo JH, 2001, PLANT PHYSIOL, V126, P1055, DOI 10.1104/pp.126.3.1055; Joo JH, 2005, PLANT CELL, V17, P957, DOI 10.1105/tpc.104.029603; Iglesias MJ, 2010, PLANT MOL BIOL, V74, P215, DOI 10.1007/s11103-010-9667-7; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kruszka K, 2012, J PLANT PHYSIOL, V169, P1664, DOI 10.1016/j.jplph.2012.03.009; Li SW, 2009, ENVIRON EXP BOT, V66, P442, DOI 10.1016/j.envexpbot.2009.03.005; Ma F, 2013, IEEE POW EN SOC GEN, P1, DOI DOI 10.1109/PESMG.2013.6672379; Malamy JE, 1997, DEVELOPMENT, V124, P33; Mallory A, 2010, PLANT CELL, V22, P3879, DOI 10.1105/tpc.110.080671; Mendoza-Soto AB, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00105; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Oono Y, 1998, PLANT CELL, V10, P1649, DOI 10.1105/tpc.10.10.1649; Park JE, 2007, J BIOL CHEM, V282, P10036, DOI 10.1074/jbc.M610524200; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Peer WA, 2013, J EXP BOT, V64, P2629, DOI 10.1093/jxb/ert152; Potters G, 2007, TRENDS PLANT SCI, V12, P98, DOI 10.1016/j.tplants.2007.01.004; Potters G, 2010, PLANT PHYSIOL BIOCH, V48, P292, DOI 10.1016/j.plaphy.2009.12.007; Rahman A, 2007, PLANT J, V50, P514, DOI 10.1111/j.1365-313X.2007.03068.x; Reed RC, 1998, PLANT PHYSIOL, V118, P1369, DOI 10.1104/pp.118.4.1369; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Savaldi-Goldstein S, 2008, P NATL ACAD SCI USA, V105, P15190, DOI 10.1073/pnas.0806324105; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Si-Ammour A, 2011, PLANT PHYSIOL, V157, P683, DOI 10.1104/pp.111.180083; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Takeda S, 2008, NAT REV GENET, V9, P444, DOI 10.1038/nrg2342; Terrile MC, 2012, PLANT J, V70, P492, DOI 10.1111/j.1365-313X.2011.04885.x; Tognetti VB, 2012, PLANT CELL ENVIRON, V35, P321, DOI 10.1111/j.1365-3040.2011.02324.x; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Van Breusegem F, 2006, PLANT PHYSIOL, V141, P384, DOI 10.1104/pp.106.078295; Van Hoewyk D, 2008, PHYSIOL PLANTARUM, V132, P236, DOI 10.1111/j.1399-3054.2007.01002.x; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Vidal EA, 2010, P NATL ACAD SCI USA, V107, P4477, DOI 10.1073/pnas.0909571107; Wang PC, 2010, PLANT CELL, V22, P2981, DOI 10.1105/tpc.109.072959; Wang YN, 2009, J PLANT PHYSIOL, V166, P1637, DOI 10.1016/j.jplph.2009.04.009; WILSON AK, 1990, MOL GEN GENET, V222, P377, DOI 10.1007/BF00633843; Windels D, 2011, PLANT SIGNAL BEHAV, V6, P1672, DOI 10.4161/psb.6.11.17900; Windels D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095972; Wolters H, 2009, NAT REV GENET, V10, P305, DOI 10.1038/nrg2558; Zhang SW, 2009, PLANT PHYSIOL, V151, P1889, DOI 10.1104/pp.109.146803; Zhang ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057472; Zhao YK, 2011, NEW PHYTOL, V189, P1122, DOI 10.1111/j.1469-8137.2010.03545.x; Zolla G, 2010, J EXP BOT, V61, P211, DOI 10.1093/jxb/erp290	77	82	91	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107678	10.1371/journal.pone.0107678	http://dx.doi.org/10.1371/journal.pone.0107678			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222737	Green Published, gold, Green Submitted			2022-12-25	WOS:000341774800093
J	Brown, JB; Ramaiya, K; Besancon, S; Rheeder, P; Tassou, CM; Mbanya, JC; Kissimova-Skarbek, K; Njenga, EW; Muchemi, EW; Wanjiru, HK; Schneider, E				Brown, Jonathan Betz; Ramaiya, Kaushik; Besancon, Stephane; Rheeder, Paul; Tassou, Clarisse Mapa; Mbanya, Jean-Claude; Kissimova-Skarbek, Katarzyna; Njenga, Eva Wangechi; Muchemi, Eva Wangui; Wanjiru, Harrison Kiambuthi; Schneider, Erin			Use of Medical Services and Medicines Attributable to Diabetes in Sub-Saharan Africa	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; COST-EFFECTIVENESS; BLOOD-PRESSURE; RISK-FACTORS; FOLLOW-UP; CARE; PREVALENCE; PREVENTION; EXPENDITURE; MELLITUS	Background: Although the large majority of persons with diabetes and other non-communicable diseases (NCDs) lives and dies in low- and middle-income countries, the prevention and treatment of diabetes and other NCDs is widely neglected in these areas. A contributing reason may be that, unlike the impacts of acute and communicable diseases, the demands on resources imposed by diabetes is not superficially obvious, and studies capable of detecting these impacts have not be done. Methods: To ascertain recent use of medical services and medicines and other information about the impact of ill-health, we in 2008-2009 conducted structured, personal interviews with 1,780 persons with diagnosed diabetes (DMs) and 1,770 matched comparison subjects (MCs) without diabetes in Cameroon, Mali, Tanzania and South Africa. We sampled DMs from diabetes registries and, in Cameroon and South Africa, from attendees at outpatient diabetes clinics. To recruit MCs, we asked subjects with diabetes to identify five persons living nearest to them who were of the same sex and approximate age. We estimated diabetes impact on medical services use by calculating ratios and differences between DMs and MCs, testing for statistical significance using two-stage multivariable hurdle models. Findings: DMs consumed 12.95 times more days of inpatient treatment, 7.54 times more outpatient visits, and 5.61 times more medications than MCs (all p<0.001). DMs used an estimated 3.44 inpatient days per person per year, made 10.72 outpatient visits per person per year (excluding traditional healers), and were taking an average of 2.49 prescribed medicines when interviewed. Conclusions: In Sub-Saharan Africa, the relative incremental use of medical care and medicines associated with diagnosed diabetes is much greater than in industrialized countries and in China. Published calculations of the health-system impact of diabetes in Africa are dramatic underestimates. Although non-communicable diseases like diabetes are commonly thought to be minor problems for health systems and patients in Africa, our data demonstrate the opposite.	[Brown, Jonathan Betz] Kaiser Permanente, Ctr Hlth Res, Portland, OR USA; [Ramaiya, Kaushik] Shree Hindu Mandal Hosp, Dar Es Salaam, Tanzania; [Besancon, Stephane] NGO Sante Diabet, Bamako, Mali; [Rheeder, Paul] Univ Pretoria, Fac Hlth Sci, Sch Hlth Syst & Publ Hlth, ZA-0002 Pretoria, South Africa; [Tassou, Clarisse Mapa] Univ Yaounde, Fac Med & Biomed Sci, Hlth Populat Transit Res Grp, Yaounde, Cameroon; [Mbanya, Jean-Claude] Univ Yaounde, Fac Med & Biomed Sci, Dept Internal Med & Specialties, Yaounde, Cameroon; [Mbanya, Jean-Claude] Univ Yaounde, Ctr Biotechnol, Lab Mol & Metab Med, Yaounde, Cameroon; [Kissimova-Skarbek, Katarzyna] Jagiellonian Univ, Coll Med, Inst Publ Hlth, Krakow, Poland; [Kissimova-Skarbek, Katarzyna; Schneider, Erin] Int Diabet Federat, Brussels, Belgium; [Njenga, Eva Wangechi; Muchemi, Eva Wangui] Kenya Diabet Management & Informat Ctr DMI, Nairobi, Kenya; [Wanjiru, Harrison Kiambuthi] WHO, Hlth Syst Management, Nairobi, Kenya; [Schneider, Erin] MAX Fdn, Edmonds, WA USA	Kaiser Permanente; University of Pretoria; University of Yaounde I; University of Yaounde I; University of Yaounde I; Jagiellonian University; Collegium Medicum Jagiellonian University; World Health Organization	Brown, JB (corresponding author), Kaiser Permanente, Ctr Hlth Res, Portland, OR USA.	jonabrown@gmail.com	Mbanya, Jean Claude N/T-5147-2018	Mbanya, Jean Claude N/0000-0001-9651-8653; Kissimova-Skarbek, Katarzyna/0000-0003-4624-0918; Rheeder, Paul/0000-0002-1573-4985; Besancon, Stephane/0000-0002-3779-3441	Economic Study Fund of the International Diabetes Federation (IDF); NGO headquartered in Brussels, Belgium	Economic Study Fund of the International Diabetes Federation (IDF); NGO headquartered in Brussels, Belgium	This study was funded by allocations from the Economic Study Fund of the International Diabetes Federation (IDF), a not-for-profit NGO headquartered in Brussels, Belgium. The IDF's Economic Studies Fund was created from contributions that IDF solicited from Merck and Co., Novo Nordisk, Eli Lilly and Co., Takeda Pharmaceuticals North America, and GSK, Inc. These funders had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript, or selection of countries in which economic impact studies were conducted.	ADAMS PF, 1999, VITAL HLTH STAT, V10; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Aspray TJ, 2009, T R SOC TROP MED HYG, V94, P637; Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Bonham G. S, 1983, DHHS PUB, V83-20001; Brown JB, 1999, DIABETES CARE, V22, P1116, DOI 10.2337/diacare.22.7.1116; BROWN JB, 1992, MED CARE, V30, P400, DOI 10.1097/00005650-199205000-00003; CHALE SS, 1992, BRIT MED J, V304, P1215, DOI 10.1136/bmj.304.6836.1215; Corsi DJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000895; Franks PW, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/482186; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Hussain A, 2005, DIABETIC MED, V22, P931, DOI 10.1111/j.1464-5491.2005.01558.x; International Diabetes Federation, 2011, IDF DIABETES ATLAS; Jonsson B, 1998, DIABETES CARE, V21, pC7, DOI 10.2337/diacare.21.3.C7; Koster I, 2006, DIABETOLOGIA, V49, P1498, DOI 10.1007/s00125-006-0277-5; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Leibbrandt Murray, 2010, OECD SOCIAL EMPLOYME, V101; Li R, 2010, DIABETES CARE, V33, P1872, DOI 10.2337/dc10-0843; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Mohan V, 2006, DIABETOLOGIA, V49, P1175, DOI 10.1007/s00125-006-0219-2; Nkegoum A. V., 2002, THESIS U YAOUNDE 1 C; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Peer N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043336; Peters A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00047; Raina P, 2002, HEALTH SERV RES, V37, P751, DOI 10.1111/1475-6773.00047; Ringborg A, 2009, INT J CLIN PRACT, V63, P997, DOI 10.1111/j.1742-1241.2009.02098.x; RIVEST LP, 1994, BIOMETRIKA, V81, P373, DOI 10.2307/2336967; Roberts RO, 1996, J CLIN EPIDEMIOL, V49, P989, DOI 10.1016/0895-4356(96)00143-6; Roseboom TJ, 2011, MATURITAS, V70, P141, DOI 10.1016/j.maturitas.2011.06.017; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; Statistics South Africa, 2012, CENS 2011 CENS BRIEF; Stringhini S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5452; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Weichle T, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-614; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wolinsky FD, 2007, MED CARE, V45, P300, DOI 10.1097/01.mlr.0000254576.26353.09; World Bank, 2008, DAT GNI PER CAP ATL; Yang WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039513; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026; Zuvekas SH, 2009, HEALTH SERV RES, V44, P1679, DOI 10.1111/j.1475-6773.2009.00995.x	48	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106716	10.1371/journal.pone.0106716	http://dx.doi.org/10.1371/journal.pone.0106716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216268	Green Published, gold			2022-12-25	WOS:000341774300021
J	Coelho, FR; Iqbal, A; Linares, E; Silva, DF; Lima, FS; Cuccovia, IM; Augusto, O				Coelho, Fernando R.; Iqbal, Asif; Linares, Edlaine; Silva, Daniel F.; Lima, Filipe S.; Cuccovia, Iolanda M.; Augusto, Ohara			Oxidation of the Tryptophan 32 Residue of Human Superoxide Dismutase 1 Caused by Its Bicarbonate-dependent Peroxidase Activity Triggers the Non-amyloid Aggregation of the Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PROTEIN SECONDARY STRUCTURE; CU,ZN-SUPEROXIDE DISMUTASE; WILD-TYPE; COVALENT AGGREGATION; RADICAL-ANION; HUMAN COPPER; MUTANT; SOD1; MECHANISM	The role of oxidative post-translational modifications of human superoxide dismutase 1 (hSOD1) in the amyotrophic lateral sclerosis (ALS) pathology is an attractive hypothesis to explore based on several lines of evidence. Among them, the remarkable stability of hSOD1(WT) and several of its ALS-associated mutants suggests that hSOD1 oxidation may precede its conversion to the unfolded and aggregated forms found in ALS patients. The bicarbonate-dependent peroxidase activity of hSOD1 causes oxidation of its own solvent-exposed Trp(32) residue. The resulting products are apparently different from those produced in the absence of bicarbonate and are most likely specific for simian SOD1s, which contain the Trp(32) residue. The aims of this work were to examine whether the bicarbonate-dependent peroxidase activity of hSOD1 ( hSOD1WT and hSOD1(G93A) mutant) triggers aggregation of the enzyme and to comprehend the role of the Trp(32) residue in the process. The results showed that Trp(32) residues of both enzymes are oxidized to a similar extent to hSOD1-derived tryptophanyl radicals. These radicals decayed to hSOD1-N-formylkynurenine and hSOD1-kynurenine or to a hSOD1 covalent dimer cross-linked by a ditryptophan bond, causing hSOD1 unfolding, oligomerization, and non-amyloid aggregation. The latter process was inhibited by tempol, which recombines with the hSOD1-derived tryptophanyl radical, and did not occur in the absence of bicarbonate or with enzymes that lack the Trp(32) residue (bovine SOD1 and hSOD1(W32F) mutant). The results support a role for the oxidation products of the hSOD1-Trp(32) residue, particularly the covalent dimer, in triggering the non-amyloid aggregation of hSOD1.	[Coelho, Fernando R.; Iqbal, Asif; Linares, Edlaine; Silva, Daniel F.; Lima, Filipe S.; Cuccovia, Iolanda M.; Augusto, Ohara] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05513970 Sao Paulo, Brazil	Universidade de Sao Paulo	Augusto, O (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05513970 Sao Paulo, Brazil.	oaugusto@iq.usp.br	Lima, Filipe S/E-7740-2012; Augusto, Ohara/D-3839-2012; Silva, Daniel/N-7754-2015; Linares, Edlaine/AAR-8753-2020	Lima, Filipe S/0000-0002-3420-8155; Augusto, Ohara/0000-0002-7220-4286; Linares, Edlaine/0000-0001-8164-3013	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/57721-3, 2013/07937-8]; Conselho Nacional de Desenvolvimento Cientifico Tecnologico (CNPq) [573530/2008-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Pro-Reitoria de Pesquisa da Universidade de Sao Paulo (PRPUSP) [2011.1.9352.1.8]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Pro-Reitoria de Pesquisa da Universidade de Sao Paulo (PRPUSP)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grants 2008/57721-3 and 2013/07937-8, Conselho Nacional de Desenvolvimento Cientifico Tecnologico (CNPq) Grant 573530/2008-4, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Pro-Reitoria de Pesquisa da Universidade de Sao Paulo (PRPUSP) Grant 2011.1.9352.1.8. The authors are members of INCT Redoxoma (FAPESP/CNPq/CAPES), NAP Redoxoma (PRPUSP), and the CEPID Redoxoma (FAPESP).	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; Bonini MG, 2004, BIOCHEMISTRY-US, V43, P344, DOI 10.1021/bi035606p; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Ehrenshaft M, 2009, FREE RADICAL BIO MED, V46, P1260, DOI 10.1016/j.freeradbiomed.2009.01.020; Elam JS, 2003, J BIOL CHEM, V278, P21032, DOI 10.1074/jbc.M300484200; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; Graffmo KS, 2013, HUM MOL GENET, V22, P51, DOI 10.1093/hmg/dds399; Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020; Guareschi S, 2012, P NATL ACAD SCI USA, V109, P5074, DOI 10.1073/pnas.1115402109; HODGSON EK, 1975, BIOCHEMISTRY-US, V14, P5294, DOI 10.1021/bi00695a010; Hwang YM, 2010, J BIOL CHEM, V285, P41701, DOI 10.1074/jbc.M110.113696; Jewett SL, 1999, FREE RADICAL BIO MED, V26, P905, DOI 10.1016/S0891-5849(98)00274-3; Karunakaran C, 2004, J BIOL CHEM, V279, P32534, DOI 10.1074/jbc.M314272200; Kerman A, 2010, ACTA NEUROPATHOL, V119, P335, DOI 10.1007/s00401-010-0646-5; Liochev SI, 2004, P NATL ACAD SCI USA, V101, P743, DOI 10.1073/pnas.0307635100; Medinas DB, 2010, FREE RADICAL BIO MED, V49, P1046, DOI 10.1016/j.freeradbiomed.2010.06.018; Medinas DB, 2009, CHEM RES TOXICOL, V22, P639, DOI 10.1021/tx800287m; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Munch C, 2010, J MOL BIOL, V399, P512, DOI 10.1016/j.jmb.2010.04.019; Mulligan VK, 2012, J MOL BIOL, V421, P631, DOI 10.1016/j.jmb.2012.04.016; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P8397, DOI 10.1021/bi0105983; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Poon HF, 2005, FREE RADICAL BIO MED, V39, P453, DOI 10.1016/j.freeradbiomed.2005.03.030; Proctor EA, 2011, J MOL BIOL, V408, P555, DOI 10.1016/j.jmb.2011.03.004; Queiroz RF, 2013, BIOCHEM J, V455, P37, DOI 10.1042/BJ20130180; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Ranguelova K, 2012, FREE RADICAL BIO MED, V53, P589, DOI 10.1016/j.freeradbiomed.2012.04.029; Redler RL, 2011, BIOCHEMISTRY-US, V50, P7057, DOI 10.1021/bi200614y; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTILIO G, 1972, BIOCHEMISTRY-US, V11, P2187, DOI 10.1021/bi00761a028; Sankarapandi S, 1999, J BIOL CHEM, V274, P1226, DOI 10.1074/jbc.274.3.1226; Seetharaman SV, 2009, EXP BIOL MED, V234, P1140, DOI 10.3181/0903-MR-104; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Strange RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044811; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Toichi K, 2013, J BIOL CHEM, V288, P4970, DOI 10.1074/jbc.M112.414235; Toledo JC, 2011, FREE RADICAL BIO MED, V50, P1032, DOI 10.1016/j.freeradbiomed.2011.02.020; Trumbull KA, 2009, ANTIOXID REDOX SIGN, V11, P1627, DOI 10.1089/ARS.2009.2574; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wilcox KC, 2009, J BIOL CHEM, V284, P13940, DOI 10.1074/jbc.M809687200; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Zhang H, 2004, FREE RADICAL BIO MED, V36, P1355, DOI 10.1016/j.freeradbiomed.2004.02.038; Zhang H, 2003, J BIOL CHEM, V278, P24078, DOI 10.1074/jbc.M302051200; ZILBER LA, 1963, B WORLD HEALTH ORGAN, V29, P449	58	29	29	0	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30690	30701		10.1074/jbc.M114.586370	http://dx.doi.org/10.1074/jbc.M114.586370			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25237191	hybrid, Green Published			2022-12-25	WOS:000344549700045
J	Zhu, X; Zhang, J; Sun, HY; Jiang, CC; Dong, YS; Shan, Q; Su, SY; Xie, YY; Xu, NZ; Lou, XM; Liu, SQ				Zhu, Xu; Zhang, Ju; Sun, Huiying; Jiang, Cuicui; Dong, Yusheng; Shan, Qiang; Su, Siyuan; Xie, Yingying; Xu, Ningzhi; Lou, Xiaomin; Liu, Siqi			Ubiquitination of Inositol-requiring Enzyme 1 (IRE1) by the E3 Ligase CHIP Mediates the IRE1/TRAF2/JNK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOPLASMIC-RETICULUM STRESS; C-TERMINUS; PROTEASOMAL DEGRADATION; CELLULAR SENESCENCE; QUALITY-CONTROL; ER-STRESS; ACTIVATION; APOPTOSIS	Deciphering the inositol-requiring enzyme 1 (IRE1) signaling pathway is fundamentally important for understanding the unfolded protein response (UPR). The ubiquitination of proteins residing on the endoplasmic reticulum (ER) membrane has been reported to be involved in the UPR, although the mechanism has yet to be fully elucidated. Using immunoprecipitation and mass spectrometry, IRE1 was identified as a substrate of the E3 ligase CHIP (carboxyl terminus of HSC70-interacting protein) in HEK293 cells under geldanamycin-induced ER stress. Two residues of IRE1, Lys(545) and Lys(828), were targeted for Lys(63)-linked ubiquitination. Moreover, in CHIP knockdown cells, IRE1 phosphorylation and the IRE1-TRAF2 interaction were nearly abolished under ER stress, which may be due to lacking ubiquitination of IRE1 on Lys545 and Lys828, respectively. The cellular responses were evaluated, and the data indicated that CHIP-regulated IRE1/TRAF2/JNK signaling antagonized the senescence process. Therefore, our findings suggest that CHIP-mediated ubiquitination of IRE1 contributes to the dynamic regulation of the UPR.	[Zhu, Xu; Zhang, Ju; Sun, Huiying; Shan, Qiang; Su, Siyuan; Xie, Yingying; Lou, Xiaomin; Liu, Siqi] Chinese Acad Sci, Beijing Inst Genom, Beijing 100101, Peoples R China; [Zhu, Xu; Su, Siyuan; Xie, Yingying; Liu, Siqi] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Jiang, Cuicui; Dong, Yusheng] Beijing Prot Innovat, Beijing 101318, Peoples R China; [Xu, Ningzhi] Chinese Acad Med Sci, Lab Cell & Mol Biol, Inst Canc, Beijing 100021, Peoples R China; [Xu, Ningzhi] Chinese Acad Med Sci, Canc Hosp, Beijing 100021, Peoples R China; [Xu, Ningzhi] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Lou, XM (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Beijing 100101, Peoples R China.	louxm@big.ac.cn; siqiliu@big.ac.cn		Zhu, Xu/0000-0003-2531-2820; Shan, Qiang/0000-0002-7089-0278; Su, Siyuan/0000-0002-8816-9577	National High Technology Research and Development Program [2012AA020206]; National Basic Research Program of China [2011CB910704]	National High Technology Research and Development Program(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National High Technology Research and Development Program Grant 2012AA020206 and National Basic Research Program of China Grant 2011CB910704.	Ahmed SF, 2012, J BIOL CHEM, V287, P15996, DOI 10.1074/jbc.M111.321083; Ali MMU, 2011, EMBO J, V30, P894, DOI 10.1038/emboj.2011.18; Arshad M, 2013, J BIOL CHEM, V288, P8726, DOI 10.1074/jbc.M112.368829; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Davenport EL, 2007, BLOOD, V110, P2641, DOI 10.1182/blood-2006-11-053728; Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919; Demidenko ZN, 2009, CELL CYCLE, V8, P1888, DOI 10.4161/cc.8.12.8606; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; El Khouri E, 2013, J BIOL CHEM, V288, P31177, DOI 10.1074/jbc.M113.470500; Gao BX, 2008, EMBO REP, V9, P480, DOI 10.1038/embor.2008.37; Jwa M, 2012, NAT CELL BIOL, V14, P1223, DOI 10.1038/ncb2593; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee JJ, 2010, ONCOGENE, V29, P561, DOI 10.1038/onc.2009.355; Li XN, 2008, J CELL BIOL, V181, P959, DOI 10.1083/jcb.200711044; Lim KL, 2011, NEUROBIOL DIS, V43, P9, DOI 10.1016/j.nbd.2010.08.001; Lu G, 2013, MOL METAB, V2, P405, DOI 10.1016/j.molmet.2013.07.005; Merksamer PI, 2010, J CELL SCI, V123, P1003, DOI 10.1242/jcs.035832; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Pabarcus MK, 2009, ARCH BIOCHEM BIOPHYS, V483, P66, DOI 10.1016/j.abb.2008.12.001; Raciti M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.167; Schmidt BZ, 2009, J BIOL CHEM, V284, P4168, DOI 10.1074/jbc.M806485200; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Sisoula C, 2011, FREE RADICAL BIO MED, V50, P157, DOI 10.1016/j.freeradbiomed.2010.10.701; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Thorpe JA, 2010, CELL STRESS CHAPERON, V15, P497, DOI 10.1007/s12192-009-0163-4; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Woo CH, 2010, FASEB J, V24, P4917, DOI 10.1096/fj.10-162636; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yang MJ, 2011, J EXP MED, V208, P2099, DOI 10.1084/jem.20102667; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	37	48	51	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30567	30577		10.1074/jbc.M114.562868	http://dx.doi.org/10.1074/jbc.M114.562868			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25225294	Green Published, hybrid			2022-12-25	WOS:000344549700034
J	Chang, YW; Huang, YS				Chang, Yu-Wei; Huang, Yi-Shuian			Arsenite-Activated JNK Signaling Enhances CPEB4-Vinexin Interaction to Facilitate Stress Granule Assembly and Cell Survival	PLOS ONE			English	Article							BINDING PROTEIN; TRANSLATIONAL CONTROL; ADAPTER PROTEIN; MESSENGER-RNA; VINEXIN; KINASE; CPEB3; EXPRESSION; PHOSPHORYLATION; ADHESION	Stress granules (SGs) are compartmentalized messenger ribonucleoprotein particles (mRNPs) where translationally repressed mRNAs are stored when cells encounter environmental stress. Cytoplasmic polyadenylation element-binding protein (CPEB) 4 is a sequence-specific RNA-binding protein and translational regulator. In keeping with the results obtained from the study of other RNA-binding proteins, we found CPEB4 localized in SGs in various arsenite-treated cells. In this study, we identified that Vinexin, a CPEB4-interacting protein, is a novel component of SGs. Vinexin is a SH3-domain-containing adaptor protein and affects cell migration through its association with Vinculin to localize at focal adhesions (FAs). Unexpectedly, Vinexin is translocated from FAs to SGs under arsenite-induced stress. The recruitment of Vinexin to SGs depends on its interaction with CPEB4 and influences SG formation and cell survival. Arsenite-activated c-Jun N-terminal kinase (JNK) signaling enhances the association between CPEB4 and Vinexin, which consequently facilitates SG localization of Vinexin. Taken together, this study uncovers a novel interaction between a translational regulator and an adaptor protein to influence SG assembly and cell survival.	[Chang, Yu-Wei; Huang, Yi-Shuian] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chang, Yu-Wei; Huang, Yi-Shuian] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center	Huang, YS (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	yishuian@ibms.sinica.edu.tw	Huang, Yi-Shuian/P-2824-2018	Huang, Yi-Shuian/0000-0001-9000-7748	National Science Council [NSC 102-2628 B-001-007-MY3, NSC102-2321-B-001-058]; Academia Sinica in Taiwan [AS-103-TP-B05]	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica in Taiwan(Academia Sinica - Taiwan)	This work was supported by grants from the National Science Council [NSC 102-2628 B-001-007-MY3, NSC102-2321-B-001-058] and Academia Sinica [AS-103-TP-B05] in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu M, 1999, J BIOL CHEM, V274, P35933, DOI 10.1074/jbc.274.50.35933; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Bentmann E, 2013, FEBS J, V280, P4348, DOI 10.1111/febs.12287; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Bour G, 2005, J BIOL CHEM, V280, P17027, DOI 10.1074/jbc.M501344200; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Cargnello M, 2012, MOL CELL BIOL, V32, P4572, DOI 10.1128/MCB.00544-12; Chao HW, 2013, J NEUROSCI, V 33, P17008, DOI 10.1523/JNEUROSCI.3043-13.2013; Chao HW, 2012, NUCLEIC ACIDS RES, V40, P8484, DOI 10.1093/nar/gks598; Chen PJ, 2012, EMBO J, V31, P959, DOI 10.1038/emboj.2011.448; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; D'Ambrogio A, 2013, NAT REV CANCER, V13, P283, DOI 10.1038/nrc3485; Darnell JC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012344; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Ernoult-Lange M, 2009, MOL BIOL CELL, V20, P176, DOI 10.1091/mbc.E08-09-0904; Ferraro E, 2007, NUCLEIC ACIDS RES, V35, pW451, DOI 10.1093/nar/gkm296; GEIGER B, 1992, COLD SPRING HARB SYM, V57, P631, DOI 10.1101/SQB.1992.057.01.069; Higashi S, 2013, J NEUROCHEM, V126, P288, DOI 10.1111/jnc.12194; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; Igea A, 2010, EMBO J, V29, P2182, DOI 10.1038/emboj.2010.111; JOHNSON KA, 1995, NUCLEIC ACIDS RES, V23, P1273, DOI 10.1093/nar/23.7.1273; Jones KJ, 2008, GLIA, V56, P1401, DOI 10.1002/glia.20707; Kan MC, 2010, MOL CELL BIOL, V30, P5658, DOI 10.1128/MCB.00716-10; Kawauchi T, 2001, MECH DEVELOP, V106, P147, DOI 10.1016/S0925-4773(01)00421-X; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kim B, 2012, DEVELOPMENT, V139, P568, DOI 10.1242/dev.075846; Kimura A, 2001, P NATL ACAD SCI USA, V98, P9098, DOI 10.1073/pnas.151252898; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; Kioka N, 2002, CELL STRUCT FUNCT, V27, P1, DOI 10.1247/csf.27.1; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Lin CL, 2010, RNA, V16, P338, DOI 10.1261/rna.1779810; Liu YS, 1996, FREE RADICAL BIO MED, V21, P771, DOI 10.1016/0891-5849(96)00176-1; Matsuyama M, 2005, GENES CELLS, V10, P421, DOI 10.1111/j.1365-2443.2005.00844.x; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Mitsushima M, 2006, GENES CELLS, V11, P281, DOI 10.1111/j.1365-2443.2006.00932.x; Nagata K, 2009, MED MOL MORPHOL, V42, P9, DOI 10.1007/s00795-008-0433-8; Ortiz-Zapater E, 2012, NAT MED, V18, P83, DOI 10.1038/nm.2540; Pavlopoulos E, 2011, CELL, V147, P1369, DOI 10.1016/j.cell.2011.09.056; Paz M, 2007, BIOL REPROD, V77, P605, DOI 10.1095/biolreprod.107.060020; Peng SC, 2010, NUCLEIC ACIDS RES, V38, P7446, DOI 10.1093/nar/gkq634; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Shelkovnikova TA, 2013, CELL CYCLE, V12, P3194, DOI 10.4161/cc.26241; Takahashi H, 2005, BIOCHEM BIOPH RES CO, V336, P239, DOI 10.1016/j.bbrc.2005.08.064; Takahashi M, 2013, MOL CELL BIOL, V33, P815, DOI 10.1128/MCB.00763-12; Thedieck K, 2013, CELL, V154, P859, DOI 10.1016/j.cell.2013.07.031; Thumkeo D, 2013, EUR J CELL BIOL, V92, P303, DOI 10.1016/j.ejcb.2013.09.002; Tsai LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084978; Tsai NP, 2010, CELL SIGNAL, V22, P668, DOI 10.1016/j.cellsig.2009.12.001; Wang CF, 2012, MOL CELL BIOL, V32, P3321, DOI 10.1128/MCB.00296-12; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Yancy SL, 2005, TOXICOL SCI, V84, P278, DOI 10.1093/toxsci/kfi032	52	14	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107961	10.1371/journal.pone.0107961	http://dx.doi.org/10.1371/journal.pone.0107961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25237887	Green Published, gold, Green Submitted			2022-12-25	WOS:000342491600068
J	Ligon, TS; Leonhardt, C; Radler, JO				Ligon, Thomas S.; Leonhardt, Carolin; Raedler, Joachim O.			Multi-Level Kinetic Model of mRNA Delivery via Transfection of Lipoplexes	PLOS ONE			English	Article							SYNTHETIC GENE DELIVERY; LIPID-DNA COMPLEXES; CHROMOPHORE FORMATION; ENDOSOMAL ESCAPE; DRUG-DELIVERY; GREEN; EXPRESSION; DYNAMICS; THERAPY; ABSTRACTION	Recent work on the use of mRNA lipoplexes for gene delivery demonstrates the need for a mathematical model that simulates and predicts kinetics and transfection efficiency. The small copy numbers involved make it necessary to use stochastic models and include statistical analysis of the variation observed in the experimental data. The modeling requirements are further complicated by the multi-level nature of the problem, where mRNA molecules are contained in lipoplexes, which are in turn contained in endosomes, where each of these entities displays a behavior of its own. We have created a mathematical model that reproduces both the time courses and the statistical variance observed in recent experiments using single-cell tracking of GFP expression after transfection. By applying a few key simplifications and assumptions, we have limited the number of free parameters to five, which we optimize to match five experimental determinants by means of a simulated annealing algorithm. The models demonstrate the need for modeling of nested species in order to reproduce the shape of the dose-response and expression-level curves.	[Ligon, Thomas S.] Univ Munich, Fac Phys, Munich, Germany; Univ Munich, Ctr NanoSci CeNS, Munich, Germany	University of Munich; University of Munich	Ligon, TS (corresponding author), Univ Munich, Fac Phys, Munich, Germany.	Thomas.Ligon@physik.uni-muenchen.de	Rädler, Joachim/AAD-8747-2019	Rädler, Joachim/0000-0002-5846-1489; Ligon, Thomas/0000-0002-4067-876X	Deutsche Forschungsgemeinschaft (DFG) [SFB 1032]; Excellence Cluster 'Nanosystems Initiative Munich (NIM)'; FP7 EU	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Excellence Cluster 'Nanosystems Initiative Munich (NIM)'; FP7 EU	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) via project B1 within the SFB 1032, the Excellence Cluster 'Nanosystems Initiative Munich (NIM)', and FP7 EU grants NanoTransKinetics and Nano-MILE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andries O, 2012, MOL PHARMACEUT, V9, P2136, DOI 10.1021/mp200604h; Chan CL, 2012, BIOMATERIALS, V33, P4928, DOI 10.1016/j.biomaterials.2012.03.038; Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; de Lima MCP, 2001, ADV DRUG DELIVER REV, V47, P277, DOI 10.1016/S0169-409X(01)00110-7; Debus H, 2010, J CONTROL RELEASE, V148, P334, DOI 10.1016/j.jconrel.2010.09.007; Dinh AT, 2007, BIOPHYS J, V92, P831, DOI 10.1529/biophysj.106.095521; Dobay MPD, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0821-9; Dominska M, 2010, J CELL SCI, V123, P1183, DOI 10.1242/jcs.066399; Faeder JR, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-68; Faeder James R., 2009, V500, P113, DOI 10.1007/978-1-59745-525-1_5; Fisher J, 2007, NAT BIOTECHNOL, V25, P1239, DOI 10.1038/nbt1356; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Gao HJ, 2005, P NATL ACAD SCI USA, V102, P9469, DOI 10.1073/pnas.0503879102; Guerriero ML, 2007, LECT NOTES COMPUT SC, V4545, P247; Guerriero ML, 2006, BETA BINDERS STATIC; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hucka M, 2010, NATURE PRECEDINGS; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Nguyen J, 2012, ACCOUNTS CHEM RES, V45, P1153, DOI 10.1021/ar3000162; Kamiya H, 2003, DRUG DISCOV TODAY, V8, P990, DOI 10.1016/S1359-6446(03)02889-7; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Kremers GJ, 2007, BIOCHEMISTRY-US, V46, P3775, DOI 10.1021/bi0622874; Leonhardt C, 2013, NANOMEDICINE NANOTEC; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Mac Gabhann F, 2010, CURR OPIN MOL THER, V12, P570; Mahmutovic A, 2012, NAT METHODS, V9, P1163, DOI 10.1038/nmeth.2253; MALONE RW, 1989, P NATL ACAD SCI USA, V86, P6077, DOI 10.1073/pnas.86.16.6077; Maus C, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-166; Megerle JA, 2008, BIOPHYS J, V95, P2103, DOI 10.1529/biophysj.107.127191; Milner R, 2009, SPACE MOTION COMMUNI; Morille M, 2008, BIOMATERIALS, V29, P3477, DOI 10.1016/j.biomaterials.2008.04.036; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Phillips A, 2007, LECT NOTES COMPUT SC, V4695, P184; Priami C, 2005, LECT NOTES COMPUT SC, V3082, P20; Priami C, 2001, INFORM PROCESS LETT, V80, P25, DOI 10.1016/S0020-0190(01)00214-9; Priami C, 1995, COMPUT J, V38, P578, DOI 10.1093/comjnl/38.7.578; Radler JO, 1997, SCIENCE, V275, P810, DOI 10.1126/science.275.5301.810; Rantala JK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-162; Regev A, 2004, NAT COMPUT SER, P219; Regev A, 2004, THEOR COMPUT SCI, V325, P141, DOI 10.1016/j.tcs.2004.03.061; Regev A, 2002, NATURE, V419, P343, DOI 10.1038/419343a; Regev A, 2001, REPRESENTATION SIMUL, P459; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Safinya CR, 2001, CURR OPIN STRUC BIOL, V11, P440, DOI 10.1016/S0959-440X(00)00230-X; Sauer AM, 2009, J CONTROL RELEASE, V137, P136, DOI 10.1016/j.jconrel.2009.04.003; Sauer AM, 2010, NANO LETT, V10, P3684, DOI 10.1021/nl102180s; Schaffert D, 2008, GENE THER, V15, P1131, DOI 10.1038/gt.2008.105; Schlossbauer A, 2012, ADV HEALTHC MATER, V1, P316, DOI 10.1002/adhm.201100033; Schwake G, 2010, BIOTECHNOL BIOENG, V105, P805, DOI 10.1002/bit.22604; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Sneddon MW, 2011, NAT METHODS, V8, P177, DOI [10.1038/nmeth.1546, 10.1038/NMETH.1546]; Sniegowski JA, 2005, J BIOL CHEM, V280, P26248, DOI 10.1074/jbc.M412327200; Summers HD, 2011, NAT NANOTECHNOL, V6, P170, DOI [10.1038/nnano.2010.277, 10.1038/NNANO.2010.277]; Tachibana R, 2001, ADV DRUG DELIVER REV, V52, P219, DOI 10.1016/S0169-409X(01)00211-3; Tavernier G, 2011, J CONTROL RELEASE, V150, P238, DOI 10.1016/j.jconrel.2010.10.020; Tseng YC, 2009, ADV DRUG DELIVER REV, V61, P721, DOI 10.1016/j.addr.2009.03.003; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Varga CM, 2005, GENE THER, V12, P1023, DOI 10.1038/sj.gt.3302495; Varga CM, 2001, MOL THER, V4, P438, DOI 10.1006/mthe.2001.0475; Xu YH, 1996, BIOCHEMISTRY-US, V35, P5616, DOI 10.1021/bi9602019; Zhou JY, 2007, PHARM RES, V24, P1079, DOI 10.1007/s11095-006-9229-5	63	23	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2014	9	9							e107148	10.1371/journal.pone.0107148	http://dx.doi.org/10.1371/journal.pone.0107148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0RY	25237886	Green Submitted, Green Published, gold			2022-12-25	WOS:000342491600020
J	Chang, KC; Wu, JF; Hsu, WC; Lin, BR; Chen, HL; Ni, YH				Chang, Kai-Chi; Wu, Jia-Feng; Hsu, Wei-Chung; Lin, Bor-Ru; Chen, Huey-Ling; Ni, Yen-Hsuan			Impacts of Endoscopic Gastroesophageal Flap Valve Grading on Pediatric Gastroesophageal Reflux Disease	PLOS ONE			English	Article							INTRALUMINAL IMPEDANCE TECHNIQUE; ESOPHAGITIS; MECHANISMS; SYMPTOMS; JUNCTION; CHILDREN; INFANTS	Background: Gastroesophageal flap valve (GEFV) endoscopic grading is reported to be associated with gastroesophageal reflux disease (GERD) in adults; however its role in pediatric groups remains unknown. This study aimed to investigate the significance of GEFV grading and the associations to multichannel intraluminal impedance and pH monitoring (MII-pH) in children with GERD. Methods: A total of 48 children with GERD symptoms who received esophagogastroduodenoscopy and MII-pH monitoring were enrolled. The degree of GEFV was graded from I to IV according to the Hill classification, and classified into two groups: normal GEFV (Hill grades I and II), and abnormal GEFV (Hill grades III and VI). Endoscopic findings and MII-pH monitoring were analyzed among the groups. Results: Thirty-six patients had normal GEFV while 12 had abnormal GEFV. The presence of erosive esophagitis was significantly more common in the patients with abnormal GEFV (p = 0.037, OR 9.84, 95% CI 1.15-84.42). Pathological acidic gastroesophageal reflux (GER) determined by MII-pH was more prevalent in the patients with loosened GEFV geometry (p = 0.01, OR 7.0, 95% CI 1.67-27.38). There were significant positive correlations between GEFV Hill grading I to IV and the severity of erosive esophagitis (r = 0.49, p<0.001), percentage of supine acid reflux (r = 0.37, p = 0.009), percentage of total acid reflux (r = 0.3284, p = 0.023), and DeMeester score (r = 0.36, p = 0.01) detected by pH monitoring. In the impedance study, GEFV Hill grading also positively correlated to median number of acid reflux events (r = 0.3015, p = 0.037). Conclusions: GEFV dysfunction highly associated with acid GER and severe erosive esophagitis. An abnormal GEFV is a sign of acid GER in children.	[Chang, Kai-Chi; Wu, Jia-Feng; Chen, Huey-Ling; Ni, Yen-Hsuan] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Chang, Kai-Chi; Wu, Jia-Feng; Hsu, Wei-Chung; Lin, Bor-Ru; Chen, Huey-Ling; Ni, Yen-Hsuan] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Hsu, Wei-Chung] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Lin, Bor-Ru] Natl Taiwan Univ Hosp, Dept Integrated Diagnost & Therapeut, Taipei, Taiwan; [Lin, Bor-Ru] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Ni, YH (corresponding author), Natl Taiwan Univ Hosp, Dept Pediat, 1 Chang Te St, Taipei 10016, Taiwan.	yhni@ntu.edu.tw	Wu, Jia-Feng/H-8125-2019	Wu, Jia-Feng/0000-0001-6343-1658; Ni, Yen-Hsuan/0000-0002-1158-5249; LIN, BOR-RU/0000-0001-9545-7393; CHANG, KAI-CHI/0000-0002-9720-3810; Hsu, Wei-Chung/0000-0001-8583-8459	National Taiwan University Hospital [NTUH.100-M1671, NTUH.103-S2320]	National Taiwan University Hospital(National Taiwan University)	This work was supported by grant awards from National Taiwan University Hospital (NTUH.100-M1671, NTUH.103-S2320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheong JH, 2011, SCAND J GASTROENTERO, V46, P789, DOI 10.3109/00365521.2011.579154; Contractor QQ, 1999, J CLIN GASTROENTEROL, V28, P233, DOI 10.1097/00004836-199904000-00009; DELATTRE JF, 1985, ANAT CLIN, V7, P271, DOI 10.1007/BF01784644; DEMEESTER TR, 1976, ANN SURG, V184, P459, DOI 10.1097/00000658-197610000-00009; El-Serag HB, 2013, GUT; Hill LD, 1999, J CLIN GASTROENTEROL, V28, P194, DOI 10.1097/00004836-199904000-00002; Hill LD, 1996, GASTROINTEST ENDOSC, V44, P541, DOI 10.1016/S0016-5107(96)70006-8; Hoppo T, 2012, WORLD J SURG, V36, P1623, DOI 10.1007/s00268-012-1537-9; JOHNSON LF, 1974, AM J GASTROENTEROL, V62, P325; Kahrilas PJ, 1996, GASTROENTEROLOGY, V110, P1982, DOI 10.1053/gast.1996.1101982; Kayaoglu HA, 2012, SURG ENDOSC; Kim GH, 2008, J GASTROEN HEPATOL, V23, P208, DOI 10.1111/j.1440-1746.2007.05038.x; Kim GH, 2006, J GASTROENTEROL, V41, P654, DOI 10.1007/s00535-006-1819-9; LIEBERMANNMEFFERT D, 1979, GASTROENTEROLOGY, V76, P31; Lin BR, 2006, J GASTROEN HEPATOL, V21, P556, DOI 10.1111/j.1440-1746.2005.04003.x; Liu XL, 2012, HONG KONG MED J, V18, P421; Mittal RK, 1997, NEW ENGL J MED, V336, P924, DOI 10.1056/NEJM199703273361306; Mousa HM, 2011, J PEDIATR GASTR NUTR, V52, P129, DOI 10.1097/MPG.0b013e3181ffde67; Oberg S, 1999, SURG ENDOSC-ULTRAS, V13, P1184, DOI 10.1007/PL00009617; Orlando RC, 2001, AM J MED, V111, P174, DOI 10.1016/S0002-9343(01)00828-2; Paterson W G, 2001, Chest Surg Clin N Am, V11, P473; Shay S, 2004, AM J GASTROENTEROL, V99, P1020, DOI 10.1111/j.1572-0241.2004.40119.x; Sifrim D, 2004, GUT, V53, P1024, DOI 10.1136/gut.2003.033290; Skopnik H, 1996, J PEDIATR GASTR NUTR, V23, P591, DOI 10.1097/00005176-199612000-00014; Takeuchi R, 2004, HELICOBACTER, V9, P1, DOI 10.1111/j.1083-4389.2004.00193.x; THOR KBA, 1987, ACTA CHIR SCAND, V153, P25; Vandenplas Y, 2009, J PEDIATR GASTR NUTR, V49, P498, DOI 10.1097/MPG.0b013e3181b7f563; Velepic M, 2000, INT J PEDIATR OTORHI, V55, P187, DOI 10.1016/S0165-5876(00)00396-7; Wenzl TG, 2001, PEDIATR PULM, V31, P144, DOI 10.1002/1099-0496(200102)31:2<144::AID-PPUL1023>3.0.CO;2-Z; Wenzl TG, 2012, J PEDIATR GASTR NUTR, V55, P230, DOI 10.1097/MPG.0b013e3182592b65; Xirouchakis E, 2009, DIGEST DIS SCI, V54, P328, DOI 10.1007/s10620-008-0347-2	31	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2014	9	9							e107954	10.1371/journal.pone.0107954	http://dx.doi.org/10.1371/journal.pone.0107954			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ6KR	25233350	Green Submitted, Green Published, gold			2022-12-25	WOS:000342921200068
J	Nguyen, KA; Hamzeh-Cognasse, H; Palle, S; Anselme-Bertrand, I; Arthaud, CA; Chavarin, P; Pozzetto, B; Garraud, O; Cognasse, F				Kim Anh Nguyen; Hamzeh-Cognasse, Hind; Palle, Sabine; Anselme-Bertrand, Isabelle; Arthaud, Charles-Antoine; Chavarin, Patricia; Pozzetto, Bruno; Garraud, Olivier; Cognasse, Fabrice			Role of Siglec-7 in Apoptosis in Human Platelets	PLOS ONE			English	Article							ACTIVATION MARKERS; IMMUNE-RESPONSES; STORAGE LESION; RECEPTOR; TRANSFUSION; DISEASE; INFLAMMATION; EXPRESSION; INNATE; VIVO	Background: Platelets participate in tissue repair and innate immune responses. Sialic acid-binding immunoglobulin-like lectins (Siglecs) are well-characterized I-type lectins, which control apoptosis. Methodology/Principal Findings: We characterized the expression of Siglec-7 in human platelets isolated from healthy volunteers using flow cytometry and confocal microscopy. Siglec-7 is primarily expressed on alpha granular membranes and colocalized with CD62P. Siglec-7 expression was increased upon platelet activation and correlated closely with CD62P expression. Cross-linking Siglec-7 with its ligand, ganglioside, resulted in platelet apoptosis without any significant effects on activation, aggregation, cell morphology by electron microscopy analysis or secretion. We show that ganglioside triggered four key pathways leading to apoptosis in human platelets: (i) mitochondrial inner transmembrane potential (Delta psi m) depolarization; (ii) elevated expression of pro-apoptotic Bax and Bak proteins with reduced expression of antiapoptotic Bcl-2 protein; (iii) phosphatidylserine exposure and (iv), microparticle formation. Inhibition of NAPDH oxidase, PI3K, or PKC rescued platelets from apoptosis induced by Siglec-7 recruitment, suggesting that the platelet receptors P2Y1 and GPIIbIIIa are essential for ganglioside-induced platelet apoptosis. Conclusions/Significance: The present work characterizes the role of Siglec-7 and platelet receptors in regulating apoptosis and death. Because some platelet pathology involves apoptosis (idiopathic thrombocytopenic purpura and possibly storage lesions), Siglec-7 might be a molecular target for therapeutic intervention/prevention.	[Kim Anh Nguyen; Hamzeh-Cognasse, Hind; Pozzetto, Bruno; Garraud, Olivier; Cognasse, Fabrice] Univ Lyon, GIMAP EA3064, St Etienne, France; [Palle, Sabine] Univ Lyon, Hubert Curien Lab, Multiphoton Confocal Microscopy Platform 4D, St Etienne, France; [Palle, Sabine] Univ Lyon, UMR CNRS 5516, St Etienne, France; [Anselme-Bertrand, Isabelle] Univ Lyon, Ctr Microscopie Elect Stephanois CMES St Etienne, St Etienne, France; [Arthaud, Charles-Antoine; Chavarin, Patricia; Garraud, Olivier; Cognasse, Fabrice] EFS Auvergne Loire, St Etienne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite Jean Monnet	Cognasse, F (corresponding author), Univ Lyon, GIMAP EA3064, St Etienne, France.	fabrice.cognasse@univ-st-etienne.fr	Cognasse, Fabrice/Z-4401-2019	POZZETTO, Bruno/0000-0002-2603-8467	National and Regional Blood Bank-EFS Auvergne-Loire, France; French "Agence Nationale de la Recherche'' (ANR) [ANR-12-JSV1-0012-01]; National Safety Agency for Drug and Health Products (ANSM) [AAP-2012-011]; Association Recherche Transfusion; Association "Les Amis de Remi''	National and Regional Blood Bank-EFS Auvergne-Loire, France; French "Agence Nationale de la Recherche'' (ANR)(French National Research Agency (ANR)); National Safety Agency for Drug and Health Products (ANSM); Association Recherche Transfusion; Association "Les Amis de Remi''	Financial support was received through grants from the National and Regional Blood Bank-EFS Auvergne-Loire, France, the French "Agence Nationale de la Recherche'' (ANR) under reference ANR-12-JSV1-0012-01, The National Safety Agency for Drug and Health Products (ANSM - AAP-2012-011), and the "Association Recherche Transfusion'' and the Association "Les Amis de Remi.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandru N, 2010, TRENDS CARDIOVAS MED, V20, P232, DOI 10.1016/j.tcm.2011.11.007; Andonegui G, 2005, BLOOD, V106, P2417, DOI 10.1182/blood-2005-03-0916; Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01; Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202; Benson AB, 2009, BRIT J HAEMATOL, V147, P431, DOI 10.1111/j.1365-2141.2009.07840.x; Berthet J, 2012, CLIN IMMUNOL, V145, P189, DOI 10.1016/j.clim.2012.09.004; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Brunetta E, 2009, BLOOD, V114, P3822, DOI 10.1182/blood-2009-06-226332; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Cognasse F, 2005, IMMUNOL CELL BIOL, V83, P196, DOI 10.1111/j.1440-1711.2005.01314.x; Cognasse F, 2006, TRANSFUSION, V46, P1184, DOI 10.1111/j.1537-2995.2006.00869.x; Crocker P R, 1998, Glycobiology, V8, pv; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Crocker PR, 2012, ANN NY ACAD SCI, V1253, P102, DOI 10.1111/j.1749-6632.2011.06449.x; Elzey BD, 2003, IMMUNITY, V19, P9, DOI 10.1016/S1074-7613(03)00177-8; Freedman JE, 2003, CIRC RES, V92, P944, DOI 10.1161/01.RES.0000074030.98009.FF; Garraud O, 2013, CRIT CARE, V17, DOI 10.1186/cc12716; Gyulkhandanyan AV, 2012, J THROMB THROMBOLYS, V33, P397, DOI 10.1007/s11239-012-0688-8; Gyulkhandanyan AV, 2013, BR J HAEMATOL; Hellum M, 2012, BLOOD COAGUL FIBRIN, V23, P520, DOI 10.1097/MBC.0b013e328354a256; Jackson SP, 2010, BLOOD, V116, P2011, DOI 10.1182/blood-2010-01-261669; Kuter DJ, 2002, VOX SANG, V83, P311, DOI 10.1111/j.1423-0410.2002.tb05325.x; Leytin V, 2006, J THROMB HAEMOST, V4, P2656, DOI 10.1111/j.1538-7836.2006.02200.x; Leytin V, 2004, BIOCHEM BIOPH RES CO, V320, P303, DOI 10.1016/j.bbrc.2004.05.166; Leytin V, 2008, BRIT J HAEMATOL, V142, P494, DOI 10.1111/j.1365-2141.2008.07209.x; Leytin V, 2012, BLOOD REV, V26, P51, DOI 10.1016/j.blre.2011.10.002; Li JZ, 2000, TRANSFUSION, V40, P1320, DOI 10.1046/j.1537-2995.2000.40111320.x; Macaulay IC, 2005, J CLIN INVEST, V115, P3370, DOI 10.1172/JCI26885; Marquardt L, 2002, STROKE, V33, P2570, DOI 10.1161/01.STR.0000034398.34938.20; Martini F, 2002, BBA-MOL CELL BIOL L, V1583, P297, DOI 10.1016/S1388-1981(02)00250-0; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; McMillan SJ, 2008, CARBOHYD RES, V343, P2050, DOI 10.1016/j.carres.2008.01.009; Morrell CN, 2011, HEMATOL-AM SOC HEMAT, P470, DOI 10.1182/asheducation-2011.1.470; Ohto H, 2011, TRANSFUS APHER SCI, V44, P321, DOI 10.1016/j.transci.2011.03.008; Paulson JC, 2012, ANN NY ACAD SCI, V1253, P37, DOI 10.1111/j.1749-6632.2011.06362.x; Perrotta PL, 2003, TRANSFUSION, V43, P526, DOI 10.1046/j.1537-2995.2003.00349.x; Rambaruth NDS, 2011, ACTA HISTOCHEM, V113, P591, DOI 10.1016/j.acthis.2011.03.001; Rondina MT, 2013, CIRC RES, V112, P1506, DOI 10.1161/CIRCRESAHA.113.300512; Schubert P, 2010, J PROTEOMICS, V73, P436, DOI 10.1016/j.jprot.2009.08.002; Seghatchian J, 2006, TRANSFUS APHER SCI, V34, P125, DOI 10.1016/j.transci.2005.09.002; Seghatchian J, 2012, TRANSFUS APHER SCI, V47, P235, DOI 10.1016/j.transci.2012.06.001; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Shiraki R, 2004, THROMB RES, V113, P379, DOI 10.1016/j.thromres.2004.03.023; Thon JN, 2012, J CELL BIOL, V198, P561, DOI 10.1083/jcb.201111136; Ulyanova T, 2001, J BIOL CHEM, V276, P14451, DOI 10.1074/jbc.M011650200; van Velzen JF, 2012, THROMB RES, V130, P92, DOI 10.1016/j.thromres.2012.02.041; Vanags DM, 1997, BRIT J HAEMATOL, V99, P824, DOI 10.1046/j.1365-2141.1997.4813284.x; Varchetta S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045821; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Watson SP, 1998, IMMUNOL TODAY, V19, P260, DOI 10.1016/S0167-5699(98)01267-5; Weber AA, 2001, BRIT J CLIN PHARMACO, V52, P333, DOI 10.1046/j.0306-5251.2001.01453.x; Zhang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040641	52	31	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e106239	10.1371/journal.pone.0106239	http://dx.doi.org/10.1371/journal.pone.0106239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25230315	gold, Green Submitted, Green Published			2022-12-25	WOS:000342123900005
J	Neven, E; De Schutter, TM; Dams, G; Gundlach, K; Steppan, S; Buchel, J; Passlick-Deetjen, J; D'Haese, PC; Behets, GJ				Neven, Ellen; De Schutter, Tineke M.; Dams, Geert; Gundlach, Kristina; Steppan, Sonja; Buechel, Janine; Passlick-Deetjen, Jutta; D'Haese, Patrick C.; Behets, Geert J.			A Magnesium Based Phosphate Binder Reduces Vascular Calcification without Affecting Bone in Chronic Renal Failure Rats	PLOS ONE			English	Article							CALCIUM ACETATE/MAGNESIUM CARBONATE; LANTHANUM CARBONATE; SEVELAMER-HYDROCHLORIDE; HEMODIALYSIS-PATIENTS; ALUMINUM TOXICITY; HIGH PREVALENCE; DISEASE; HISTOMORPHOMETRY; OSTEOMALACIA; POPULATION	The alternative phosphate binder calcium acetate/magnesium carbonate (CaMg) effectively reduces hyperphosphatemia, the most important inducer of vascular calcification, in chronic renal failure (CRF). In this study, the effect of low dose CaMg on vascular calcification and possible effects of CaMg on bone turnover, a persistent clinical controversy, were evaluated in chronic renal failure rats. Adenine-induced CRF rats were treated daily with 185 mg/kg CaMg or vehicle for 5 weeks. The aortic calcium content and area% calcification were measured to evaluate the effect of CaMg. To study the effect of CaMg on bone remodeling, rats underwent 5/6th nephrectomy combined with either a normal phosphorus diet or a high phosphorus diet to differentiate between possible bone effects resulting from either CaMg-induced phosphate deficiency or a direct effect of Mg. Vehicle or CaMg was administered at doses of 185 and 375 mg/kg/day for 8 weeks. Bone histomorphometry was performed. Aortic calcium content was significantly reduced by 185 mg/kg/day CaMg. CaMg ameliorated features of hyperparathyroid bone disease. In CRF rats on a normal phosphorus diet, the highest CaMg dose caused an increase in osteoid area due to phosphate depletion. The high phosphorus diet combined with the highest CaMg dose prevented the phosphate depletion and thus the rise in osteoid area. CaMg had no effect on osteoblast/osteoclast or dynamic bone parameters, and did not alter bone Mg levels. CaMg at doses that reduce vascular calcification did not show any harmful effect on bone turnover.	[Neven, Ellen; De Schutter, Tineke M.; Dams, Geert; D'Haese, Patrick C.; Behets, Geert J.] Univ Antwerp, Dept Biomed Sci, Lab Pathophysiol, B-2020 Antwerp, Belgium; [Gundlach, Kristina; Steppan, Sonja; Buechel, Janine] Fresenius Med Care, Bad Homburg, Germany; [Passlick-Deetjen, Jutta] Univ Dusseldorf, Dept Nephrol, Dusseldorf, Germany	University of Antwerp; Heinrich Heine University Dusseldorf	D'Haese, PC (corresponding author), Univ Antwerp, Dept Biomed Sci, Lab Pathophysiol, B-2020 Antwerp, Belgium.	patrick.dhaese@uantwerpen.be	D'Haese, Patrick C/C-9599-2019; Neven, Ellen/GVR-7948-2022	Behets, Geert/0000-0001-8697-433X	Fresenius Medical Care Deutschland GmbH (Bad Homburg, Germany) [A11/0819]	Fresenius Medical Care Deutschland GmbH (Bad Homburg, Germany)	This study was supported by a research grant (grant number: A11/0819) from Fresenius Medical Care Deutschland GmbH (Bad Homburg, Germany). K. Gundlach, S. Steppan and J. Buchel are current employees of Fresenius Medical Care Deutschland GmbH and contributed to the study design and proofreading of the manuscript.	ANDRESS DL, 1986, J BONE MINER RES, V1, P391; ANDRESS DL, 1987, J CLIN ENDOCR METAB, V65, P11, DOI 10.1210/jcem-65-1-11; Barreto DV, 2008, AM J KIDNEY DIS, V52, P1139, DOI 10.1053/j.ajkd.2008.06.024; Behets GJ, 2005, RENAL FAILURE, V27, P475, DOI 10.1081/JDI-200065423; Behets GJ, 2004, J AM SOC NEPHROL, V15, P2219, DOI 10.1097/01.ASN.0000133022.32912.95; Bellows CG, 1999, CALCIFIED TISSUE INT, V65, P59, DOI 10.1007/s002239900658; Bervoets ARJ, 2006, BONE, V38, P803, DOI 10.1016/j.bone.2005.11.022; Brancaccio D, 2007, KIDNEY INT, V71, P190, DOI 10.1038/sj.ki.5002079; Couttenye MM, 1997, NEPHROL DIAL TRANSPL, V12, P2144, DOI 10.1093/ndt/12.10.2144; Covic A, 2013, NEPHROL DIAL TRANSPL, V28, P2383, DOI 10.1093/ndt/gft203; de Francisco ALM, 2010, NEPHROL DIAL TRANSPL, V25, P3707, DOI 10.1093/ndt/gfq292; De Schutter TM, 2013, KIDNEY INT, V83, P1109, DOI 10.1038/ki.2013.34; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; DHaese PC, 1996, NEPHROL DIAL TRANSPL, V11, P74; Firling CE, 1999, ARCH TOXICOL, V73, P359, DOI 10.1007/s002040050674; Jablonski G, 1996, BIOSCIENCE REP, V16, P49, DOI 10.1007/BF01201001; London GM, 2004, J AM SOC NEPHROL, V15, P1943, DOI 10.1097/01.asn.0000129337.50739.48; Oste L, 2007, RENAL FAILURE, V29, P1, DOI 10.1080/08860220601038637; Persy VP, 2006, SEMIN DIALYSIS, V19, P195, DOI 10.1111/j.1525-139X.2006.00169.x; RODRIGUEZ M, 1989, J BONE MINER RES, V4, P687; Vetter T, 2002, CURR OPIN NEPHROL HY, V11, P403, DOI 10.1097/00041552-200207000-00006	21	28	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107067	10.1371/journal.pone.0107067	http://dx.doi.org/10.1371/journal.pone.0107067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229549	Green Published, Green Submitted, gold			2022-12-25	WOS:000342123900023
J	Prabakaran, M; Leyrer, S; He, F; Auer, S; Kumar, SR; Kindsmueller, K; Mytle, N; Schneider, J; Lockhart, S; Kwang, J				Prabakaran, Mookkan; Leyrer, Sonja; He, Fang; Auer, Sebastian; Kumar, Subaschandrabose R.; Kindsmueller, Kathrin; Mytle, Nutan; Schneider, Joerg; Lockhart, Stephen; Kwang, Jimmy			Progress toward a Universal H5N1 Vaccine: A Recombinant Modified Vaccinia Virus Ankara-Expressing Trivalent Hemagglutinin Vaccine	PLOS ONE			English	Article							INFLUENZA-VIRUS; EFFICACY; EPITOPE; ANTIBODY	Background: The rapid evolution of new sublineages of H5N1 influenza poses the greatest challenge in control of H5N1 infection by currently existing vaccines. To overcome this, an MVAtor vector expressing three H5HA antigens A/Vietnam/1203/04, A/Indonesia/669/06 and A/Anhui/01/05 (MVAtor-tri-HA vector) was developed to elicit broad cross-protection against diverse clades by covering amino acid variations in the major neutralizing epitopes of HA among H5N1 subtypes. Methods: BALB/c mice and guinea pigs were immunized i.m. with 8x10(7) TCID50/animal of MVAtor-tri-HA vector. The immunogenicity and cross-protective immunity of the MVAtor-tri-HA vector was evaluated against diverse clades of H5N1 strains. Results: The results showed that mice immunized with MVAtor-tri-HA vector induced robust cross-neutralizing immunity to diverse H5N1 clades. In addition, the MVAtor-tri-HA vector completely protected against 10 MLD50 of a divergent clade of H5N1 infection (clade 7). Importantly, the serological surveillance of post-vaccinated guinea pig sera demonstrated that MVAtor-tri-HA vector was able to elicit strong cross-clade neutralizing immunity against twenty different H5N1 strains from six clades that emerged between 1997 and 2012. Conclusions: The present findings revealed that incorporation of carefully selected HA genes from divergent H5N1 strains within a single vector could be an effective approach in developing a vaccine with broad coverage to prevent infection during a pandemic situation.	[Prabakaran, Mookkan; He, Fang; Kumar, Subaschandrabose R.; Kwang, Jimmy] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore; [Leyrer, Sonja; Auer, Sebastian; Kindsmueller, Kathrin; Mytle, Nutan; Schneider, Joerg; Lockhart, Stephen] Emergent BioSolut Inc, Rockville, MD 20850 USA	National University of Singapore	Leyrer, S (corresponding author), Emergent BioSolut Inc, Rockville, MD 20850 USA.	leyrers@ebsi.com; kwang@tll.org.sg		Lockhart, Stephen/0000-0002-0805-2193; Prabakaran, Mookkan/0000-0002-9816-5908	EPIC BIO Pte Ltd; Emergent BioSolutions Inc., USA; Temasek LifeSciences Ventures Pte Ltd., Singapore; Temasek LifeSciences Ventures Pte Ltd.; STFC [ST/J001465/1] Funding Source: UKRI	EPIC BIO Pte Ltd; Emergent BioSolutions Inc., USA; Temasek LifeSciences Ventures Pte Ltd., Singapore; Temasek LifeSciences Ventures Pte Ltd.; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported by EPIC BIO Pte Ltd, a joint venture of Emergent BioSolutions Inc., USA and Temasek LifeSciences Ventures Pte Ltd., Singapore. S. Leyrer, SA, KK, NM, JS and S. Lockhart were employed with the commercial company Emergent BioSolutions Inc., USA. MP, FH, SRK, JK are affiliated with Temasek LifeSciences Laboratory, a non-profitable organization funded by Temasek LifeSciences Ventures Pte Ltd. All members of each funding party participated in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2014, SUMM STAT DEV AV A H; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Casimiro DR, 2010, J VIROL, V84, P2996, DOI 10.1128/JVI.00969-09; Centers for Disease Control and Prevention National Institutes of Health, 1999, BIOSAFETY MICROBIOLO; Chen MW, 2008, P NATL ACAD SCI USA, V105, P13538, DOI 10.1073/pnas.0806901105; Ducatez MF, 2011, P NATL ACAD SCI USA, V108, P349, DOI 10.1073/pnas.1012457108; He F., 2013, INFLUENZA RES TREAT, V2013, P1; Hu HX, 2012, J VIROL, V86, P2978, DOI 10.1128/JVI.06665-11; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; KING DJ, 1991, AVIAN DIS, V35, P505, DOI 10.2307/1591214; McCurdy LH, 2004, CLIN INFECT DIS, V38, P1749, DOI 10.1086/421266; Poon LLM, 2009, J IMMUNOL, V182, P3063, DOI 10.4049/jimmunol.0803467; Prabakaran M, 2013, VACCINE, V31, P1385, DOI 10.1016/j.vaccine.2013.01.003; Prabakaran M, 2010, J VIROL, V84, P11822, DOI 10.1128/JVI.00891-10; Prabakaran M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004566; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rollier CS, 2011, CURR OPIN IMMUNOL, V23, P377, DOI 10.1016/j.coi.2011.03.006; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Wang GQ, 2014, J INFECT DIS, V209, P676, DOI 10.1093/infdis/jit414; WEBSTER RG, 1991, VACCINE, V9, P303, DOI 10.1016/0264-410X(91)90055-B; WHO, 2013, CUM NUMB CONF HUM CA	21	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107316	10.1371/journal.pone.0107316	http://dx.doi.org/10.1371/journal.pone.0107316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229722	Green Published, gold, Green Submitted			2022-12-25	WOS:000342123900037
J	Tamas, G; Gulacsi, L; Bereczki, D; Baji, P; Takats, A; Brodszky, V; Pentek, M				Tamas, Gertrud; Gulacsi, Laszlo; Bereczki, Daniel; Baji, Petra; Takats, Annamaria; Brodszky, Valentin; Pentek, Marta			Quality of Life and Costs in Parkinson's Disease: A Cross Sectional Study in Hungary	PLOS ONE			English	Article							EUROPE; DISORDERS; IMPACT; BRAIN	Background: Patient reported outcomes and costs of illness are useful to capture some of the multiple effects of a disease and its treatments. Our aim was to assess quality of life (QoL) and costs of Parkinson's disease (PD) in Hungary, and to analyze their associations. Methods: A cross-sectional questionnaire survey was conducted in one neurology university clinic. Clinical characteristics, PD related resource utilizations and productivity loss in the past 12 months were recorded; the Hoehn&Yahr (HY) scale, PDQ-39 and EQ-5D questionnaires were applied. Cost calculation was performed from the societal perspective. Results: 110 patients (34.5% female) were involved with mean age of 63.3 (SD = 11.3) and disease duration of 8.2 (SD = 5.8) years. PDQ-39 summary score was 48.1 (SD = 13.4). The average EQ-5D score was 0.59 (SD = 0.28), and was significantly lower than the population norm in age-groups 45-74. The correlation was significant between EQ-5D and PDQ-39 (20.47, p = 0.000), the HY scale and EQ-5D (-0.3416, p = 0.0008) and PDQ-39 (0.3419, p = 0.0006) scores. The total mean cost was is an element of 6030.2 (SD = 6163.0)/patient/year (direct medical 35.7%, direct non-medical 29.4%, indirect cost 34.9%). A one year increase in disease duration and 0.1 decrease of the EQ-5D utility score increase the yearly costs by 8 to 10%, and 7.8%, respectively. The effect of the PDQ-39 score on total cost was not significant. Conclusions: Disease severity and public health importance of PD are clearly demonstrated by the magnitude of QoL loss. PD-related costs are substantial, but are much lower in Hungary than in Western European countries. Disease duration and EQ-5D score are significant proxy of costs.	[Tamas, Gertrud; Bereczki, Daniel; Takats, Annamaria] Semmelweis Univ, Dept Neurol, H-1085 Budapest, Hungary; [Gulacsi, Laszlo; Baji, Petra; Brodszky, Valentin; Pentek, Marta] Corvinus Univ Budapest, Dept Hlth Econ, Budapest, Hungary; [Pentek, Marta] Flor Ferenc Cty Hosp, Kistarcsa, Hungary	Semmelweis University; Corvinus University Budapest	Tamas, G (corresponding author), Semmelweis Univ, Dept Neurol, H-1085 Budapest, Hungary.	tamas.gertrud@med.semmelweis-univ.hu	Tamas, Gertrud/X-9756-2019; Brodszky, Valentin/AFN-4112-2022; Bereczki, Daniel/AAL-9886-2020	Tamas, Gertrud/0000-0001-8054-3678; Brodszky, Valentin/0000-0002-6095-2295; Gulacsi, Laszlo/0000-0002-9285-8746; Baji, Petra/0000-0003-2899-8557	Tarsadalmi Megujulas Operativ Program [TAMOP 4.2.1.B-09/1/KMR]	Tarsadalmi Megujulas Operativ Program	Funding source of the study: Tarsadalmi Megujulas Operativ Program'', TAMOP 4.2.1.B-09/1/KMR grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokor M, 2001, PARKINSONS DIS OTHER, P59; Chapuis S, 2005, MOVEMENT DISORD, V20, P224, DOI 10.1002/mds.20279; Costa N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/852368; Cubo E, 2002, EUR J NEUROL, V9, P589, DOI 10.1046/j.1468-1331.2002.00484.x; Dodel R, 2014, MOVEMENT DISORD, V29, P169, DOI 10.1002/mds.25571; Ersek K, 2010, J NUTR HEALTH AGING, V14, P633, DOI 10.1007/s12603-010-0309-1; Findley Leslie J, 2011, J Med Econ, V14, P130, DOI 10.3111/13696998.2010.551164; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Herlofson K, 2003, ACTA NEUROL SCAND, V107, P1, DOI 10.1034/j.1600-0404.2003.02033.x; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Jenkinson C, 1997, AGE AGEING, V26, P353, DOI 10.1093/ageing/26.5.353; Jennum P, 2011, J NEUROL, V258, P1497, DOI 10.1007/s00415-011-5969-1; Klepac N, 2007, EUR J NEUROL, V14, P194, DOI 10.1111/j.1468-1331.2006.01604.x; Lokk J, 2012, ACTA NEUROL SCAND, V125, P142, DOI 10.1111/j.1600-0404.2011.01517.x; Martinez-Martin P, 2009, NEUROLOGY, V73, P1584, DOI 10.1212/WNL.0b013e3181c0d416; Michatowska M, 2005, FUNCT NEUROL, V20, P163; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Pentek M, 2012, IDEGGYOGY SZEMLE, V65, P316; Pentek Marta, 2012, Psychiatr Hung, V27, P4; Reuther M, 2007, PARKINSONISM RELAT D, V13, P108, DOI 10.1016/j.parkreldis.2006.07.009; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P67, DOI 10.1136/jnnp.69.1.67; Soh SE, 2011, PARKINSONISM RELAT D, V17, P1, DOI 10.1016/j.parkreldis.2010.08.012; Szende A, 2004, EUROQOL GROUP MONOGR, V1; von Campenhausen S, 2011, EUR NEUROPSYCHOPHARM, V21, P180, DOI 10.1016/j.euroneuro.2010.08.002; Winter Y, 2010, PARKINSONISM RELAT D, V16, P51, DOI 10.1016/j.parkreldis.2009.07.005; 1990, HLTH POLICY, V16, P199	26	23	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2014	9	9							e107704	10.1371/journal.pone.0107704	http://dx.doi.org/10.1371/journal.pone.0107704			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP5MS	25229404	Green Submitted, Green Published, gold			2022-12-25	WOS:000342123900063
J	Falahati-Anbaran, M; Lundemo, S; Ansell, SW; Stenoien, HK				Falahati-Anbaran, Mohsen; Lundemo, Sverre; Ansell, Stephen W.; Stenoien, Hans K.			Contrasting Patterns of Genetic Structuring in Natural Populations of Arabidopsis lyrata Subsp petraea across Different Regions in Northern Europe	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; LOCAL ADAPTATION; METABOLIC PHENOTYPES; SELF-INCOMPATIBILITY; MICROSATELLITE LOCI; LANDSCAPE GENETICS; GLACIAL SURVIVAL; COMPUTER-PROGRAM; MIGRATION RATES; ARABIS PETRAEA	Level and partitioning of genetic diversity is expected to vary between contrasting habitats, reflecting differences in strength of ecological and evolutionary processes. Therefore, it is necessary to consider processes acting on different time scales when trying to explain diversity patterns in different parts of species' distributions. To explore how historical and contemporary factors jointly may influence patterns of genetic diversity and population differentiation, we compared genetic composition in the perennial herb Arabidopsis lyrata ssp. petraea from the northernmost parts of its distribution range on Iceland to that previously documented in Scandinavia. Leaf tissue and soil were sampled from ten Icelandic populations of A. lyrata. Seedlings were grown from soil samples, and tissue from above-ground and seed bank individuals were genotyped with 21 microsatellite markers. Seed bank density in Icelandic populations was low but not significantly different from that observed in Norwegian populations. While within-population genetic diversity was relatively high on Iceland (H-E = 0.35), among-population differentiation was low (F-ST = 0.10) compared to Norwegian and Swedish populations. Population differentiation was positively associated with geographical distance in both Iceland and Scandinavia, but the strength of this relationship varied between regions. Although topography and a larger distribution range may explain the higher differentiation between mountainous Norwegian relative to lowland populations in Sweden, these factors cannot explain the lower differentiation in Icelandic compared to Swedish populations. We propose that low genetic differentiation among Icelandic populations is not caused by differences in connectivity, but is rather due to large historical effective population sizes. Thus, rather than contemporary processes, historical factors such as survival of Icelandic lineages in northern refugia during the last glacial period may have contributed to the observed pattern.	[Falahati-Anbaran, Mohsen] Norwegian Univ Sci & Technol NTNU, Dept Biol, Trondheim, Norway; [Falahati-Anbaran, Mohsen; Lundemo, Sverre; Stenoien, Hans K.] Norwegian Univ Sci & Technol, NTNU Univ Museum, N-7034 Trondheim, Norway; [Falahati-Anbaran, Mohsen] Univ Tehran, Sch Biol, Tehran, Iran; [Falahati-Anbaran, Mohsen] Univ Tehran, Ctr Excellence Phylogeny Living Organisms, Tehran, Iran; [Lundemo, Sverre] Uppsala Univ, Evolutionary Biol Ctr, Dept Ecol & Genet, Uppsala, Sweden; [Ansell, Stephen W.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Tehran; University of Tehran; Uppsala University; Natural History Museum London	Falahati-Anbaran, M (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Biol, Trondheim, Norway.	falahati@ntnu.no	Falahati Anbaran, Mohsen/C-7182-2012; Falahati-Anbaran, Mohsen/A-7864-2018	Falahati-Anbaran, Mohsen/0000-0001-6215-6498	Swedish Research Council [VR 21-2004-3314]; Research Council of Norway [NFR 10298100]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Research Council of Norway(Research Council of Norway)	This work was financially supported by grants to HKS from the Swedish Research Council (VR 21-2004-3314) and the Research Council of Norway (NFR 10298100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell SW, 2010, HEREDITY, V105, P543, DOI 10.1038/hdy.2010.10; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2004, MOL ECOL, V13, P827, DOI 10.1111/j.1365-294X.2004.02101.x; Bergelson J, 2010, NAT REV GENET, V11, P867, DOI 10.1038/nrg2896; BRANTJES NBM, 1981, ECOL ENTOMOL, V6, P361, DOI 10.1111/j.1365-2311.1981.tb00626.x; Brown AO, 2009, AM J BOT, V96, P1096, DOI 10.3732/ajb.0800102; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Castric V, 2003, GENETICS, V163, P983; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Clauss MJ, 2006, MOL ECOL, V15, P2753, DOI 10.1111/j.1365-294X.2006.02973.x; Cornuet JM, 1999, GENETICS, V153, P1989; Cornuet JM, 1996, GENETICS, V144, P2001; Coulson T, 1999, EVOLUTION, V53, P1951, DOI 10.1111/j.1558-5646.1999.tb04575.x; Crispo E, 2005, CONSERV GENET, V6, P665, DOI 10.1007/s10592-005-9026-4; Davey MP, 2008, NEW PHYTOL, V177, P380, DOI 10.1111/j.1469-8137.2007.02282.x; Davey MP, 2009, METABOLOMICS, V5, P138, DOI 10.1007/s11306-008-0127-1; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falahati-Anbaran M, 2011, AM J BOT, V98, P1475, DOI 10.3732/ajb.1100021; Falush D, 2003, GENETICS, V164, P1567; Garnier S, 2004, MOL ECOL, V13, P1883, DOI 10.1111/j.1365-294X.2004.02212.x; Gaudeul M, 2007, AM J BOT, V94, P1146, DOI 10.3732/ajb.94.7.1146; Gonzalez-Wevar CA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-139; Gotelli NJ, 2001, GARYENTSMINGER WEBSI; He TH, 2010, ANN BOT-LONDON, V106, P457, DOI 10.1093/aob/mcq140; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Holderegger R, 2010, TRENDS PLANT SCI, V15, P675, DOI 10.1016/j.tplants.2010.09.002; Honnay O, 2008, OIKOS, V117, P1, DOI 10.1111/j.2007.0030-1299.16188.x; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; JALAS J, 1994, ATLAS FLORAE EUROPAE, V10; Jessen K, 1938, P R IR ACAD, V60, P1; Jonsell B, 1995, ECOGRAPHY, V18, P321, DOI 10.1111/j.1600-0587.1995.tb00135.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kamau E, 2007, GENETICS, V176, P2357, DOI 10.1534/genetics.107.072231; Karkkainen K, 2004, EVOLUTION, V58, P2831, DOI 10.1111/j.0014-3820.2004.tb01634.x; KIMURA M, 1964, GENETICS, V49, P561; Leinonen PH, 2011, EVOLUTION, V65, P90, DOI 10.1111/j.1558-5646.2010.01119.x; Leinonen PH, 2009, AM J BOT, V96, P1129, DOI 10.3732/ajb.0800080; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Lundemo S, 2010, ANN BOT-LONDON, V106, P243, DOI 10.1093/aob/mcq102; Lundemo S, 2009, MOL ECOL, V18, P2798, DOI 10.1111/j.1365-294X.2009.04236.x; Mable BK, 2005, EVOLUTION, V59, P1437, DOI 10.1111/j.0014-3820.2005.tb01794.x; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; MANICACCI D, 1992, LANDSCAPE ECOL, V6, P147; Marko PB, 2004, MOL ECOL, V13, P597, DOI 10.1046/j.1365-294X.2004.02096.x; Marteinsdottir B, 2010, J VEG SCI, V21, P531, DOI 10.1111/j.1654-1103.2009.01161.x; Moyle LC, 2006, MOL ECOL, V15, P1067, DOI 10.1111/j.1365-294X.2006.02840.x; Muller MH, 2008, HEREDITY, V100, P47, DOI 10.1038/sj.hdy.6801057; Neff BD, 2004, J HERED, V95, P165, DOI 10.1093/jhered/esh021; Parducci L, 2012, SCIENCE, V335, P1083, DOI 10.1126/science.1216043; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R., 2012, BIOINFORMATICS; Peterson MA, 1998, AM NAT, V152, P428, DOI 10.1086/286180; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Ross-Ibarra J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002411; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Roux C, 2013, MOL BIOL EVOL, V30, P435, DOI 10.1093/molbev/mss246; Rundgren M, 1999, J BIOGEOGR, V26, P387, DOI 10.1046/j.1365-2699.1999.00296.x; Sandring S, 2009, EVOLUTION, V63, P1292, DOI 10.1111/j.1558-5646.2009.00624.x; Schierup MH, 2006, GENETICS, V172, P477, DOI 10.1534/genetics.105.045682; Schierup MH, 1998, HEREDITAS, V128, P21, DOI 10.1111/j.1601-5223.1998.00021.x; Schierup MH, 2008, GENETICS, V180, P1051, DOI 10.1534/genetics.108.088799; Schmickl R, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-98; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Sork VL, 1999, TRENDS ECOL EVOL, V14, P219, DOI 10.1016/S0169-5347(98)01585-7; Sousa VC, 2013, GENETICS, V194, P211, DOI 10.1534/genetics.113.149211; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Toivainen T, 2014, MOL ECOL, V23, P1040, DOI 10.1111/mec.12682; TOTLAND O, 1994, ARCTIC ALPINE RES, V26, P66, DOI 10.2307/1551879; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; Turner TL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003183; Vergeer P, 2013, NEW PHYTOL, V197, P989, DOI 10.1111/nph.12060; Vergeer P, 2011, OIKOS, V120, P979, DOI 10.1111/j.1600-0706.2010.18944.x; Vigueira CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058916; Westergaard KB, 2011, MOL ECOL, V20, P376, DOI 10.1111/j.1365-294X.2010.04928.x; Wright S, 1943, GENETICS, V28, P114; Wright SI, 2003, MOL ECOL, V12, P1247, DOI 10.1046/j.1365-294X.2003.01743.x	88	2	2	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107479	10.1371/journal.pone.0107479	http://dx.doi.org/10.1371/journal.pone.0107479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226024	Green Published, gold, Green Submitted			2022-12-25	WOS:000344317700058
J	Jonsson, JM; Johansson, I; Dominguez-Valentin, M; Kimbung, S; Jonsson, M; Bonde, JH; Kannisto, P; Masback, A; Malander, S; Nilbert, M; Hedenfalk, I				Jonsson, Jenny-Maria; Johansson, Ida; Dominguez-Valentin, Mev; Kimbung, Siker; Jonsson, Mats; Bonde, Jesper Hansen; Kannisto, Paivi; Masback, Anna; Malander, Susanne; Nilbert, Mef; Hedenfalk, Ingrid			Molecular Subtyping of Serous Ovarian Tumors Reveals Multiple Connections to Intrinsic Breast Cancer Subtypes	PLOS ONE			English	Article							GENE-EXPRESSION; CARCINOMA; GRADE; PATHOGENESIS; PORTRAITS; PATTERNS; DISEASES; THERAPY; ORIGIN; TRIAL	Objective: Transcriptional profiling of epithelial ovarian cancer has revealed molecular subtypes correlating to biological and clinical features. We aimed to determine gene expression differences between malignant, benign and borderline serous ovarian tumors, and investigate similarities with the well-established intrinsic molecular subtypes of breast cancer. Methods: Global gene expression profiling using Illumina's HT12 Bead Arrays was applied to 59 fresh-frozen serous ovarian malignant, benign and borderline tumors. Nearest centroid classification was performed applying previously published gene profiles for the ovarian and breast cancer subtypes. Correlations to gene expression modules representing key biological breast cancer features were also sought. Validation was performed using an independent, publicly available dataset. Results: 5,944 genes were significantly differentially expressed between benign and malignant serous ovarian tumors, with cell cycle processes enriched in the malignant subgroup. Borderline tumors were split between the two clusters. Significant correlations between the malignant serous tumors and the highly aggressive ovarian cancer signatures, and the basal-like breast cancer subtype were found. The benign and borderline serous tumors together were significantly correlated to the normal-like breast cancer subtype and the ovarian cancer signature derived from borderline tumors. The borderline tumors in the study dataset, in addition, also correlated significantly to the luminal A breast cancer subtype. These findings remained when analyzed in an independent dataset, supporting links between the molecular subtypes of ovarian cancer and breast cancer beyond those recently acknowledged. Conclusions: These data link the transcriptional profiles of serous ovarian cancer to the intrinsic molecular subtypes of breast cancer, in line with the shared clinical and molecular features between high-grade serous ovarian cancer and basal-like breast cancer, and suggest that biomarkers and targeted therapies may overlap between these tumor subsets. The link between benign and borderline ovarian cancer and luminal breast cancer may indicate endocrine responsiveness in a subset of ovarian cancers.	[Jonsson, Jenny-Maria; Johansson, Ida; Dominguez-Valentin, Mev; Kimbung, Siker; Jonsson, Mats; Masback, Anna; Malander, Susanne; Nilbert, Mef; Hedenfalk, Ingrid] Lund Univ, Dept Clin Sci, Div Oncol Pathol, Skane Univ Hosp, Lund, Sweden; [Johansson, Ida; Kimbung, Siker; Hedenfalk, Ingrid] Lund Univ, CREATE Hlth Strateg Ctr Translat Canc Res, Lund, Sweden; [Bonde, Jesper Hansen] Univ Copenhagen, Hvidovre Hosp, Dept Pathol, Clin Res Ctr, DK-2650 Hvidovre, Denmark; [Kannisto, Paivi] Lund Univ, Dept Clin Sci, Div Obstet & Gynecol, Skane Univ Hosp, Lund, Sweden; [Dominguez-Valentin, Mev; Nilbert, Mef] Univ Copenhagen, Hvdiovre Hosp, Clin Res Ctr, Hvidovre, Denmark	Lund University; Skane University Hospital; Lund University; University of Copenhagen; Lund University; Skane University Hospital; University of Copenhagen	Jonsson, JM (corresponding author), Lund Univ, Dept Clin Sci, Div Oncol Pathol, Skane Univ Hosp, Lund, Sweden.	jenny-maria.jonsson@med.lu.se	Bonde, Jesper H/F-1478-2013; Bonde, Jesper/AAN-5930-2020	Dominguez-Valentin, Mev/0000-0001-7856-0057; Hedenfalk, Ingrid/0000-0002-6840-3397; Nilbert, Mef/0000-0003-2717-1937; Bonde, Jesper/0000-0003-4853-6747; Kannisto, Paivi/0000-0002-5517-1494	National Health Services; Swedish Cancer Society; Swedish Research Council; Swedish Society of Gynecologic Oncology - Roche	National Health Services; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Gynecologic Oncology - Roche	Financial support was granted from a governmental funding of clinical research within the National Health Services (JMJ), the Swedish Cancer Society (MN, IH), the Swedish Research Council (MN, IH) and an unrestricted educational grant from the Swedish Society of Gynecologic Oncology sponsored by Roche (JMJ). Funding has neither influenced study design, data collection nor analysis or manuscript writing.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Anglesio MS, 2008, MOL CANCER RES, V6, P1678, DOI 10.1158/1541-7786.MCR-08-0193; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berns EMJJ, 2012, CANCER RES, V72, P2701, DOI 10.1158/0008-5472.CAN-11-3911; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; Bookman MA, 2009, J CLIN ONCOL, V27, P1419, DOI 10.1200/JCO.2008.19.1684; Burges A, 2010, ARCH GYNECOL OBSTET, V281, P511, DOI 10.1007/s00404-009-1185-y; Chan KKL, 2008, OBSTET GYNECOL, V111, P144, DOI 10.1097/01.AOG.0000296715.07705.e9; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; Curry EW, 2013, MOD PATHOL; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Hauptmann S, 2001, VIRCHOWS ARCH, V438, P539, DOI 10.1007/s004280100435; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Johansson I, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3116; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Li J, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-8; Marchini S, 2008, CLIN CANCER RES, V14, P7850, DOI 10.1158/1078-0432.CCR-08-0523; Marquez RT, 2005, CLIN CANCER RES, V11, P6116, DOI 10.1158/1078-0432.CCR-04-2509; McCluggage WG, 2011, PATHOLOGY, V43, P420, DOI 10.1097/PAT.0b013e328348a6e7; Meinhold-Heerlein I, 2005, ONCOGENE, V24, P1053, DOI 10.1038/sj.onc.1208298; Perez-Gracia JL, 2002, GYNECOL ONCOL, V84, P201, DOI 10.1006/gyno.2001.6489; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Piek JMJ, 2001, J PATHOL, V195, P451, DOI 10.1002/path.1000; Prat J, 2012, VIRCHOWS ARCH, V460, P237, DOI 10.1007/s00428-012-1203-5; Saad Antonio F., 2010, Hormones & Cancer, V1, P277, DOI 10.1007/s12672-010-0054-2; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Sieh W, 2013, LANCET ONCOL, V14, P853, DOI 10.1016/S1470-2045(13)70253-5; Silverberg SG, 2000, INT J GYNECOL PATHOL, V19, P7, DOI 10.1097/00004347-200001000-00003; Smyth JF, 2007, CLIN CANCER RES, V13, P3617, DOI 10.1158/1078-0432.CCR-06-2878; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tavassoli FA, 2003, WHO CLASSIFICATION T; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Winter-Roach BA, 2009, COCHRANE DATABASE SY; Yoshihara K, 2012, CLIN CANCER RES, V18, P1374, DOI 10.1158/1078-0432.CCR-11-2725	43	10	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107643	10.1371/journal.pone.0107643	http://dx.doi.org/10.1371/journal.pone.0107643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226589	gold, Green Published, Green Submitted			2022-12-25	WOS:000344317700071
J	Krikavova, R; Hosek, J; Vanco, J; Hutyra, J; Dvorak, Z; Travnicek, Z				Krikavova, Radka; Hosek, Jan; Vanco, Jan; Hutyra, Jakub; Dvorak, Zdenek; Travnicek, Zdenek			Gold(I)-Triphenylphosphine Complexes with Hypoxanthine-Derived Ligands: In Vitro Evaluations of Anticancer and Anti-Inflammatory Activities	PLOS ONE			English	Article							BIOLOGICAL-ACTIVITY; RHEUMATOID-ARTHRITIS; GOLD; AURANOFIN; CYTOTOXICITY; DERIVATIVES; AGENTS; INHIBITION; COPPER(II); PHOSPHINE	A series of gold(I) complexes involving triphenylphosphine (PPh3) and one N-donor ligand derived from deprotonated mono-or disubstituted hypoxanthine (HLn) of the general composition [Au(L-n)(PPh3)] (1-9) is reported. The complexes were thoroughly characterized, including multinuclear high resolution NMR spectroscopy as well as single crystal X-ray analysis (for complexes 1 and 3). The complexes were screened for their in vitro cytotoxicity against human cancer cell lines MCF7 (breast carcinoma), HOS (osteosarcoma) and THP-1 (monocytic leukaemia), which identified the complexes 4-6 as the most promising representatives, who antiproliferative activity was further tested against A549 (lung adenocarcinoma), G-361 (melanoma), HeLa (cervical cancer), A2780 (ovarian carcinoma), A2780R (ovarian carcinoma resistant to cisplatin), 22Rv1 (prostate cancer) cell lines. Complexes 4-6 showed a significantly higher in vitro anticancer effect against the employed cancer cells, except for G-361, as compared with the commercially used anticancer drug cisplatin, with IC50 approximate to 1-30 mu M. Antiinflammatory activity was evaluated in vitro by the assessment of the ability of the complexes to modulate secretion of the pro-inflammatory cytokines, i.e. tumour necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta), in the lipopolysaccharide-activated macrophage-like THP-1 cell model. The results of this study identified the complexes as auspicious antiinflammatory agents with similar or better activity as compared with the clinically applied gold-based antiarthritic drug Auranofin. In an effort to explore the possible mechanisms responsible for the biological effect, the products of interactions of selected complexes with sulfur-containing biomolecules (L-cysteine and reduced glutathione) were studied by means of the mass-spectrometry study.	[Krikavova, Radka; Hosek, Jan; Vanco, Jan; Hutyra, Jakub; Dvorak, Zdenek; Travnicek, Zdenek] Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic; [Krikavova, Radka; Hosek, Jan; Vanco, Jan; Hutyra, Jakub; Travnicek, Zdenek] Palacky Univ, Fac Sci, Dept Inorgan Chem, CR-77147 Olomouc, Czech Republic; [Dvorak, Zdenek] Palacky Univ, Fac Sci, Dept Cell Biol & Genet, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc	Travnicek, Z (corresponding author), Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic.	zdenek.travnicek@upol.cz	Vanco, Jan/H-2705-2013; Hosek, Jan/B-6274-2009; KŘIKAVOVÁ, Radka/CAG-6109-2022	Vanco, Jan/0000-0003-3351-1192; Hosek, Jan/0000-0003-0975-1671; KŘIKAVOVÁ, Radka/0000-0002-8466-4829; Travnicek, Zdenek/0000-0002-5890-7874; Dvorak, Zdenek/0000-0002-3938-3585	Operational Program Research and Development for Innovations - European Regional Development Fund [CZ.1.05/2.1.00/03.0058]; National Program of Sustainability I of the Ministry of Education, Youth and Sports of the Czech Republic [LO1305]; Palacky University in Olomouc [IGA_PrF_2014009]	Operational Program Research and Development for Innovations - European Regional Development Fund; National Program of Sustainability I of the Ministry of Education, Youth and Sports of the Czech Republic; Palacky University in Olomouc	The authors gratefully thank the Operational Program Research and Development for Innovations - European Regional Development Fund (CZ.1.05/2.1.00/03.0058), the National Program of Sustainability I (LO1305) of the Ministry of Education, Youth and Sports of the Czech Republic and Palacky University in Olomouc (IGA_PrF_2014009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbehausen C, 2013, INORG CHEM, V52, P11280, DOI 10.1021/ic401535s; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Arris CE, 2000, J MED CHEM, V43, P2797, DOI 10.1021/jm990628o; Barreiro E, 2008, J INORG BIOCHEM, V102, P184, DOI 10.1016/j.jinorgbio.2007.07.034; Berners-Price S.J., 2011, BIOINORGANIC MED CHE, P197, DOI DOI 10.1002/9783527633104.CH7; Berners-Price SJ, 2011, METALLOMICS, V3, P863, DOI 10.1039/c1mt00062d; Brandenburg K., 2011, DIAMOND RELEASE 3 2I; BRUCE MI, 1989, INORG SYN, V26, P324, DOI 10.1002/9780470132579.ch59; Buchtik R, 2012, J INORG BIOCHEM, V116, P163, DOI 10.1016/j.jinorgbio.2012.07.009; Craig S, 2012, J MED CHEM, V55, P2437, DOI 10.1021/jm2005942; FAGGIANI R, 1987, CAN J CHEM, V65, P1568, DOI 10.1139/v87-264; Galassi R, 2012, DALTON T, V41, P5307, DOI 10.1039/c2dt11781a; Gandin V, 2010, BIOCHEM PHARMACOL, V79, P90, DOI 10.1016/j.bcp.2009.07.023; Gibson AE, 2002, J MED CHEM, V45, P3381, DOI 10.1021/jm020056z; Griffin RJ, 2000, J MED CHEM, V43, P4071, DOI 10.1021/jm000961o; Han S, 2008, ARCH PHARM RES, V31, P67, DOI 10.1007/s12272-008-1122-9; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ho S.Y., 2005, METALLOTHERAPEUTIC D; Hosek J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082441; Iqbal MS, 2009, BIOL TRACE ELEM RES, V130, P204, DOI 10.1007/s12011-009-8330-0; Jeon KI, 2000, J IMMUNOL, V164, P5981, DOI 10.4049/jimmunol.164.11.5981; Kean WF, 1997, BRIT J RHEUMATOL, V36, P560; Kouroulis KN, 2009, DALTON T, P10446, DOI 10.1039/b909587j; Krikavova R, 2014, J INORG BIOCHEM, V134, P92, DOI 10.1016/j.jinorgbio.2014.02.002; LEWIS D, 1983, ANN RHEUM DIS, V42, P566, DOI 10.1136/ard.42.5.566; Macrae CF, 2008, J APPL CRYSTALLOGR, V41, P466, DOI 10.1107/S0021889807067908; Madeira J. M., 2012, Inflammopharmacology, V20, P297, DOI 10.1007/s10787-012-0149-1; Mann FG, 1937, J CHEM SOC, P1828, DOI 10.1039/jr9370001828; Nakamoto K., 1997, INFRARED SPECTRA I B; Ott I, 2005, J MED CHEM, V48, P622, DOI 10.1021/jm049326z; Ott I, 2009, COORDIN CHEM REV, V253, P1670, DOI 10.1016/j.ccr.2009.02.019; Ott I, 2009, J MED CHEM, V52, P763, DOI 10.1021/jm8012135; Oxford Diffraction, CRYSALIS RED CRYSALI; Rau R, 2005, CLIN RHEUMATOL, V24, P189, DOI 10.1007/s10067-004-0869-8; Saccoccia F, 2012, J INORG BIOCHEM, V108, P105, DOI 10.1016/j.jinorgbio.2011.11.005; Salemi G, 2009, NEUROL SCI, V30, P361, DOI 10.1007/s10072-009-0090-2; Schirrmacher R, 2005, CURR ORG SYNTH, V2, P215, DOI 10.2174/1570179053545369; Seitz M, 2003, J CLIN IMMUNOL, V23, P477, DOI 10.1023/B:JOCI.0000010424.41475.17; Shaw CF, 1999, CHEM REV, V99, P2589, DOI 10.1021/cr980431o; SHAW CF, 1988, J AM CHEM SOC, V110, P729, DOI 10.1021/ja00211a011; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SIGLER JW, 1974, ANN INTERN MED, V80, P21, DOI 10.7326/0003-4819-80-1-21; SMITH B.C., 1999, INFRARED SPECTRAL IN; Starha P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090341; Travnicek Z, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-160; Travnicek Z, 2012, J MED CHEM, V55, P4568, DOI 10.1021/jm201416p; Travnicek Z, 2011, J INORG BIOCHEM, V105, P937, DOI 10.1016/j.jinorgbio.2011.04.002; Vanco J, 2008, J INORG BIOCHEM, V102, P595, DOI 10.1016/j.jinorgbio.2007.10.003; Vrzal R, 2010, J INORG BIOCHEM, V104, P1130, DOI 10.1016/j.jinorgbio.2010.07.002; WILLIAMS HJ, 1992, ARTHRITIS RHEUM, V35, P259, DOI 10.1002/art.1780350304	50	20	20	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107373	10.1371/journal.pone.0107373	http://dx.doi.org/10.1371/journal.pone.0107373			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226034	gold, Green Submitted, Green Published			2022-12-25	WOS:000344317700050
J	Lepperhof, V; Polchynski, O; Kruttwig, K; Bruggemann, C; Neef, K; Drey, F; Zheng, YJ; Ackermann, JP; Choi, YH; Wunderlich, TF; Hoehn, M; Hescheler, J; Saric, T				Lepperhof, Vera; Polchynski, Olga; Kruttwig, Klaus; Brueggemann, Chantal; Neef, Klaus; Drey, Florian; Zheng, Yunjie; Ackermann, Justus P.; Choi, Yeong-Hoon; Wunderlich, Thomas F.; Hoehn, Mathias; Hescheler, Juergen; Saric, Tomo			Bioluminescent Imaging of Genetically Selected Induced Pluripotent Stem Cell-Derived Cardiomyocytes after Transplantation into Infarcted Heart of Syngeneic Recipients	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; IN-VIVO BIOLUMINESCENCE; COLLAGEN MATRICES; PROGENITOR CELLS; CARDIAC-FUNCTION; REPORTER GENES; SURVIVAL; ENGRAFTMENT; EXPRESSION; FIBROBLASTS	Cell loss after transplantation is a major limitation for cell replacement approaches in regenerative medicine. To assess the survival kinetics of induced pluripotent stem cell (iPSC)-derived cardiomyocytes (CM) we generated transgenic murine iPSC lines which, in addition to CM-specific expression of puromycin N-acetyl-transferase and enhanced green fluorescent protein (EGFP), also constitutively express firefly luciferase (FLuc) for bioluminescence (BL) in vivo imaging. While undifferentiated iPSC lines generated by random integration of the transgene into the genome retained stable FLuc activity over many passages, the BL signal intensity was strongly decreased in purified iPS-CM compared to undifferentiated iPSC. Targeted integration of FLuc-expression cassette into the ROSA26 genomic locus using zinc finger nuclease (ZFN) technology strongly reduced transgene silencing in iPS-CM, leading to a several-fold higher BL compared to iPS-CM expressing FLuc from random genomic loci. To investigate the survival kinetics of iPS-CM in vivo, purified CM obtained from iPSC lines expressing FLuc from a random or the ROSA26 locus were transplanted into cryoinfarcted hearts of syngeneic mice. Engraftment of viable cells was monitored by BL imaging over 4 weeks. Transplanted iPS-CM were poorly retained in the myocardium independently of the cell line used. However, up to 8% of cells survived for 28 days at the site of injection, which was confirmed by immunohistological detection of EGFP-positive iPS-CM in the host tissue. Transplantation of iPS-CM did not affect the scar formation or capillary density in the periinfarct region of host myocardium. This report is the first to determine the survival kinetics of drug-selected iPS-CM in the infarcted heart using BL imaging and demonstrates that transgene silencing in the course of iPSC differentiation can be greatly reduced by employing genome editing technology. FLuc-expressing iPS-CM generated in this study will enable further studies to reduce their loss, increase long-term survival and functional integration upon transplantation.	[Lepperhof, Vera; Polchynski, Olga; Zheng, Yunjie; Hescheler, Juergen; Saric, Tomo] Univ Cologne, Fac Med, Inst Neurophysiol, D-50931 Cologne, Germany; [Kruttwig, Klaus; Brueggemann, Chantal; Hoehn, Mathias] Max Planck Inst Neurol Res, In Vivo NMR Lab, D-50931 Cologne, Germany; [Neef, Klaus; Drey, Florian; Choi, Yeong-Hoon] Univ Cologne, Ctr Heart, Dept Cardiothorac Surg, D-50931 Cologne, Germany; [Neef, Klaus; Choi, Yeong-Hoon; Wunderlich, Thomas F.] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Ackermann, Justus P.; Wunderlich, Thomas F.] Max Planck Inst Metab Res, Cologne, Germany; [Ackermann, Justus P.; Wunderlich, Thomas F.] Univ Cologne, Inst Genet, Cologne, Germany; [Wunderlich, Thomas F.] Cologne Cluster Excellence Cellular Stress Respon, Cologne, Germany	University of Cologne; Max Planck Society; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Cologne; University of Cologne; University of Cologne	Saric, T (corresponding author), Univ Cologne, Fac Med, Inst Neurophysiol, D-50931 Cologne, Germany.	tomo.saric@uni-koeln.de	Saric, Tomo/B-3415-2015	Saric, Tomo/0000-0001-8344-1095	Federal Ministry for Education and Research (BMBF) [01GN0947]; Else-Kroner-Fresenius Stiftung [A93/2008]; Maria Pesch Stiftung; Koln-Fortune Program; Volkswagen Foundation [I/83 443]	Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Else-Kroner-Fresenius Stiftung; Maria Pesch Stiftung; Koln-Fortune Program; Volkswagen Foundation(Volkswagen)	This study was supported by the grants from the Federal Ministry for Education and Research (BMBF, http://www.bmbf.de/) to T.S. (grant No. 01GN0947) and from the Else-Kroner-Fresenius Stiftung (http://www.ekfs.de/de/start.html) to T.S. and K.N. (grant No. A93/2008). Further funding was provided by the Maria Pesch Stiftung and Koln-Fortune Program (http://www.medfak.uni-koeln.de/index.php?id=195) to T.S. and by the Volkswagen Foundation (http://www.volkswagenstiftung.de/) to M.H. (I/83 443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RPH, 2011, CIRC RES, V109, P60, DOI 10.1161/CIRCRESAHA.110.240010; Assmus B, 2010, CIRC-HEART FAIL, V3, P89, DOI 10.1161/CIRCHEARTFAILURE.108.843243; Bai XW, 2011, MOL IMAGING BIOL, V13, P633, DOI 10.1007/s11307-010-0392-z; Boheler KR, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/214203; Burt RK, 2012, CIRC RES, V111, P1286, DOI 10.1161/CIRCRESAHA.111.262584; Cao F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003474; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Chang C, 2013, CIRC RES, V112, P441, DOI 10.1161/CIRCRESAHA.112.273375; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023376; Chen X, 1999, MOL CELL BIOL, V19, P4695; de Almeida PE, 2011, AM J PHYSIOL-HEART C, V301, pH663, DOI 10.1152/ajpheart.00337.2011; Didie M, 2013, J CLIN INVEST, V123, P1285, DOI 10.1172/JCI66854; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Gherghiceanu M, 2011, J CELL MOL MED, V15, P2539, DOI 10.1111/j.1582-4934.2011.01417.x; Gupta MK, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-98; Haider HK, 2008, J MOL CELL CARDIOL, V45, P554, DOI 10.1016/j.yjmcc.2008.05.004; He J, 2005, J VIROL, V79, P13497, DOI 10.1128/JVI.79.21.13497-13508.2005; Herbst F, 2012, MOL THER, V20, P1014, DOI 10.1038/mt.2012.46; Hino S, 2004, GENE THER, V11, P819, DOI 10.1038/sj.gt.3302227; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hu SJ, 2011, CIRCULATION, V124, pS27, DOI 10.1161/CIRCULATIONAHA.111.017954; Kammili RK, 2010, STEM CELLS DEV, V19, P1437, DOI 10.1089/scd.2009.0308; Kearns-Jonker M, 2012, J STEM CELL RES TH S, VS1; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; Krishnan M, 2005, FASEB J, V19, P106, DOI 10.1096/fj.05-4551fje; Kutschka I, 2006, CIRCULATION, V114, pI167, DOI 10.1161/CIRCULATIONAHA.105.001297; Kuzmenkin A, 2009, FASEB J, V23, P4168, DOI 10.1096/fj.08-128546; Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lan F, 2012, CIRCULATION, V126, pS20, DOI 10.1161/CIRCULATIONAHA.111.084913; Lee AS, 2009, CELL CYCLE, V8, P2608, DOI 10.4161/cc.8.16.9353; Li SH, 2009, J THORAC CARDIOV SUR, V137, P1225, DOI 10.1016/j.jtcvs.2008.11.001; Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029; Li Z, 2007, CIRCULATION, V116, pI46, DOI 10.1161/CIRCULATIONAHA.106.680561; Li ZJ, 2009, J AM COLL CARDIOL, V53, P1229, DOI 10.1016/j.jacc.2008.12.036; Liu Y, 2013, CARDIOVASC RES, V97, P208, DOI 10.1093/cvr/cvs314; MacArthur CC, 2012, STEM CELLS DEV, V21, P191, DOI 10.1089/scd.2011.0163; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Matsuura K, 2009, J CLIN INVEST, V119, P2204, DOI 10.1172/JCI37456; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Miki K, 2012, STEM CELL TRANSL MED, V1, P430, DOI 10.5966/sctm.2011-0038; Min JJ, 2006, ANN NUCL MED, V20, P165, DOI 10.1007/BF03027425; Mohsin S, 2012, J AM COLL CARDIOL, V60, P1278, DOI 10.1016/j.jacc.2012.04.047; Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491; Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154; Perez-Pinera P, 2012, NUCLEIC ACIDS RES, V40, P3741, DOI 10.1093/nar/gkr1214; Pfaff N, 2013, STEM CELLS, V31, P488, DOI 10.1002/stem.1316; Pfannkuche K, 2010, STEM CELLS DEV, V19, P1589, DOI 10.1089/scd.2009.0255; Pfannkuche K, 2009, CELL PHYSIOL BIOCHEM, V24, P73, DOI 10.1159/000227815; Rodriguez-Porcel M, 2010, MOL IMAGING BIOL, V12, P325, DOI 10.1007/s11307-009-0274-4; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sekine H, 2011, TISSUE ENG PT A, V17, P2973, DOI 10.1089/ten.tea.2010.0659; Sheikh AY, 2007, STEM CELLS, V25, P2677, DOI 10.1634/stemcells.2007-0041; Sheikh AY, 2012, ARTERIOSCL THROM VAS, V32, P92, DOI 10.1161/ATVBAHA.111.238618; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Singla DK, 2007, AM J PHYSIOL-HEART C, V293, pH1308, DOI 10.1152/ajpheart.01277.2006; Swijnenburg RJ, 2010, CIRC-CARDIOVASC IMAG, V3, P77, DOI 10.1161/CIRCIMAGING.109.872085; Templin C, 2012, CIRCULATION, V126, P430, DOI 10.1161/CIRCULATIONAHA.111.087684; Terrovitis JV, 2010, CIRC RES, V106, P479, DOI 10.1161/CIRCRESAHA.109.208991; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van der Bogt KEA, 2008, CIRCULATION, V118, pS121, DOI 10.1161/CIRCULATIONAHA.107.759480; van der Bogt KEA, 2009, TRANSPLANTATION, V87, P642, DOI 10.1097/TP.0b013e31819609d9; Wang YM, 2012, CIRC RES, V111, P1494, DOI 10.1161/CIRCRESAHA.112.274969; Westrich J, 2010, CELL TRANSPLANT, V19, P937, DOI 10.3727/096368910X494911; Wu JC, 2006, PHYSIOL GENOMICS, V25, P29, DOI 10.1152/physiolgenomics.00254.2005; Wu JC, 2003, CIRCULATION, V108, P1302, DOI 10.1161/01.CIR.0000091252.20010.6E; Wu JC, 2006, PROTEOMICS, V6, P6234, DOI 10.1002/pmic.200600150; Wu KH, 2011, ANN THORAC SURG, V92, P1917, DOI 10.1016/j.athoracsur.2011.07.012; Xie XY, 2007, CLONING STEM CELLS, V9, P549, DOI 10.1089/clo.2007.0032; Yan BB, 2011, MOL PHARMACEUT, V8, P1602, DOI 10.1021/mp2003576; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhang WY, 2011, J CARDIOVASC TRANSL, V4, P514, DOI 10.1007/s12265-011-9281-3	74	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2014	9	9							e107363	10.1371/journal.pone.0107363	http://dx.doi.org/10.1371/journal.pone.0107363			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS5NP	25226590	gold, Green Published, Green Submitted			2022-12-25	WOS:000344317700047
J	Del Carpio, DP; Basnet, RK; Arends, D; Lin, K; De Vos, RCH; Muth, D; Kodde, J; Boutilier, K; Bucher, J; Wang, XW; Jansen, R; Bonnema, G				Del Carpio, Dunia Pino; Basnet, Ram Kumar; Arends, Danny; Lin, Ke; De Vos, Ric C. H.; Muth, Dorota; Kodde, Jan; Boutilier, Kim; Bucher, Johan; Wang, Xiaowu; Jansen, Ritsert; Bonnema, Guusje			Regulatory Network of Secondary Metabolism in Brassica rapa: Insight into the Glucosinolate Pathway	PLOS ONE			English	Article							GENETIC GENOMICS; ARABIDOPSIS; BIOSYNTHESIS; METABOLOMICS; IDENTIFICATION; FRUIT; INTEGRATION; QTLS; AFLP	Brassica rapa studies towards metabolic variation have largely been focused on the profiling of the diversity of metabolic compounds in specific crop types or regional varieties, but none aimed to identify genes with regulatory function in metabolite composition. Here we followed a genetical genomics approach to identify regulatory genes for six biosynthetic pathways of health-related phytochemicals, i.e carotenoids, tocopherols, folates, glucosinolates, flavonoids and phenylpropanoids. Leaves from six weeks-old plants of a Brassica rapa doubled haploid population, consisting of 92 genotypes, were profiled for their secondary metabolite composition, using both targeted and LC-MS-based untargeted metabolomics approaches. Furthermore, the same population was profiled for transcript variation using a microarray containing EST sequences mainly derived from three Brassica species: B. napus, B. rapa and B. oleracea. The biochemical pathway analysis was based on the network analyses of both metabolite QTLs (mQTLs) and transcript QTLs (eQTLs). Co-localization of mQTLs and eQTLs lead to the identification of candidate regulatory genes involved in the biosynthesis of carotenoids, tocopherols and glucosinolates. We subsequently focused on the well-characterized glucosinolate pathway and revealed two hotspots of co-localization of eQTLs with mQTLs in linkage groups A03 and A09. Our results indicate that such a large-scale genetical genomics approach combining transcriptomics and metabolomics data can provide new insights into the genetic regulation of metabolite composition of Brassica vegetables.	[Del Carpio, Dunia Pino; Basnet, Ram Kumar; Lin, Ke; Bucher, Johan; Bonnema, Guusje] Wageningen Univ & Res Ctr, Wageningen UR Plant Breeding, NL-6700 AP Wageningen, Netherlands; [De Vos, Ric C. H.; Muth, Dorota; Kodde, Jan; Boutilier, Kim] BU Biosci, Plant Res Int, Wageningen, Netherlands; [De Vos, Ric C. H.; Muth, Dorota; Bonnema, Guusje] Ctr BioSyst Genom, Wageningen, Netherlands; [De Vos, Ric C. H.; Muth, Dorota] Netherlands Metabol Ctr, Leiden, Netherlands; [Arends, Danny; Jansen, Ritsert] Univ Groningen, Groningen Bioinformat Ctr, Groningen Biomol Sci & Biotechnol Inst, Haren, Netherlands; [Wang, Xiaowu; Bonnema, Guusje] Chinese Acad Agr Sci, IVF, Beijing 100193, Peoples R China	Wageningen University & Research; Centre for BioSystems Genomics; University of Groningen; Chinese Academy of Agricultural Sciences	Bonnema, G (corresponding author), Wageningen Univ & Res Ctr, Wageningen UR Plant Breeding, NL-6700 AP Wageningen, Netherlands.	guusje.bonnema@wur.nl	De Vos, Ric/F-5012-2017; Muth-Pawlak, Dorota/AAA-9410-2021; Arends, Danny/C-5368-2012; Wang, Xiaowu/L-2579-2019	Arends, Danny/0000-0001-8738-0162; Muth-Pawlak, Dorota/0000-0001-7005-2007	IOP genomics program: Brassica Vegetable Nutrigenomics; Netherlands Metabolomics Centre, Netherlands Genomics Initiative/Netherlands Organization for Scientific Research; Centre for BioSystems Genomics, Netherlands Genomics Initiative/Netherlands Organization for Scientific Research	IOP genomics program: Brassica Vegetable Nutrigenomics; Netherlands Metabolomics Centre, Netherlands Genomics Initiative/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Centre for BioSystems Genomics, Netherlands Genomics Initiative/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	DPDC and JK were supported by a grant of the IOP genomics program: Brassica Vegetable Nutrigenomics. RCHDV, GB and DM acknowledge the Netherlands Metabolomics Centre and the Centre for BioSystems Genomics, both of which are part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research, for additional funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arends D, 2010, BIOINFORMATICS, V26, P2990, DOI 10.1093/bioinformatics/btq565; Cheng F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-136; Cohen JH, 2000, JNCI-J NATL CANCER I, V92, P61, DOI 10.1093/jnci/92.1.61; Coventry J, 1988, MANUAL MICROSCOPE CU; CUSTERS JBM, 1994, PLANT CELL REP, V13, P267, DOI 10.1007/BF00233317; Custers JBM, 2001, CURRENT TRENDS EMBRY, P451, DOI DOI 10.1007/978-94-017-1203-3_18; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Del Carpio DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019624; Del Carpio DP, 2011, THEOR APPL GENET, V122, P1105, DOI 10.1007/s00122-010-1516-1; DellaPenna D, 2008, ANNU REV PLANT BIOL, V57, P711; Fernie AR, 2009, TRENDS GENET, V25, P39, DOI 10.1016/j.tig.2008.10.010; Fu JY, 2007, NAT PROTOC, V2, P685, DOI 10.1038/nprot.2007.96; Fu JY, 2006, GENETICS, V172, P1993, DOI 10.1534/genetics.105.047001; Gachon CMM, 2005, PLANT MOL BIOL, V58, P229, DOI 10.1007/s11103-005-5346-5; Gigolashvili T, 2008, NEW PHYTOL, V177, P627, DOI 10.1111/j.1469-8137.2007.02295.x; Gigolashvili T, 2007, PLANT J, V51, P247, DOI 10.1111/j.1365-313X.2007.03133.x; Goossens A, 2003, P NATL ACAD SCI USA, V100, P8595, DOI 10.1073/pnas.1032967100; Halkier BA, 1997, TRENDS PLANT SCI, V2, P425, DOI 10.1016/S1360-1385(97)01128-X; Hanson AD, 2011, ANNU REV PLANT BIOL, V62, P105, DOI 10.1146/annurev-arplant-042110-103819; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Hirai MY, 2005, J BIOL CHEM, V280, P25590, DOI 10.1074/jbc.M502332200; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Kliebenstein DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-308; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Kroymann J, 2001, PLANT PHYSIOL, V127, P1077, DOI 10.1104/pp.010416; Leoni O, 1997, BIOORGAN MED CHEM, V5, P1799, DOI 10.1016/S0968-0896(97)00112-0; Li F, 2014, DNA RES, V21, P355, DOI 10.1093/dnares/dsu002; Liang YS, 2006, J CHROMATOGR A, V1112, P148, DOI 10.1016/j.chroma.2005.11.114; Lou P, 2008, NEW PHYTOL, V179, P1017, DOI 10.1111/j.1469-8137.2008.02530.x; Mene-Saffrane L, 2010, PLANT PHYSIOL BIOCH, V48, P301, DOI 10.1016/j.plaphy.2009.11.004; Mithen RF, 2000, J SCI FOOD AGR, V80, P967, DOI [10.1002/(SICI)1097-0010(20000515)80:7<967::AID-JSFA597>3.0.CO;2-V, 10.1002/(SICI)1097-0010(20000515)80:7&lt;967::AID-JSFA597&gt;3.0.CO;2-V]; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Onyilagha J, 2003, BIOCHEM SYST ECOL, V31, P1309, DOI 10.1016/S0305-1978(03)00074-7; Padilla G, 2007, PHYTOCHEMISTRY, V68, P536, DOI 10.1016/j.phytochem.2006.11.017; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Podsedek A, 2007, LWT-FOOD SCI TECHNOL, V40, P1, DOI 10.1016/j.lwt.2005.07.023; Rohrmann J, 2011, PLANT J, V68, P999, DOI 10.1111/j.1365-313X.2011.04750.x; Rowe HC, 2008, PLANT CELL, V20, P1199, DOI 10.1105/tpc.108.058131; Saito K, 2008, TRENDS PLANT SCI, V13, P36, DOI 10.1016/j.tplants.2007.10.006; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Tikunov Y, 2005, PLANT PHYSIOL, V139, P1125, DOI 10.1104/pp.105.068130; Tikunov YM, 2012, METABOLOMICS, V8, P714, DOI 10.1007/s11306-011-0368-2; Trick M, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-50; Vallejo F, 2004, J CHROMATOGR A, V1054, P181, DOI 10.1016/j.chroma.2004.05.045; Verpoorte R., 2008, Phytochemistry Reviews, V7, P525, DOI 10.1007/s11101-008-9091-7; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang H, 2011, GENE, V487, P135, DOI 10.1016/j.gene.2011.07.021; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wentzell AM, 2007, PLOS GENET, V3, P1687, DOI 10.1371/journal.pgen.0030162; Xiao D, 2014, PLANT PHYSIOL, V164, P1309, DOI 10.1104/pp.113.227348; Xiao D, 2013, J EXP BOT, V64, P4503, DOI 10.1093/jxb/ert264; Zang YX, 2009, FEBS J, V276, P3559, DOI 10.1111/j.1742-4658.2009.07076.x; Zhao JJ, 2005, THEOR APPL GENET, V110, P1301, DOI 10.1007/s00122-005-1967-y	57	18	18	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107123	10.1371/journal.pone.0107123	http://dx.doi.org/10.1371/journal.pone.0107123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25222144	Green Submitted, gold, Green Published			2022-12-25	WOS:000341774800042
J	Hirooka, S; Higuchi, S; Uzuka, A; Nozaki, H; Miyagishima, SY				Hirooka, Shunsuke; Higuchi, Sumio; Uzuka, Akihiro; Nozaki, Hisayoshi; Miyagishima, Shin-ya			Acidophilic Green Alga Pseudochlorella sp YKT1 Accumulates High Amount of Lipid Droplets under a Nitrogen-Depleted Condition at a Low-pH	PLOS ONE			English	Article							MICROALGAE; CHLORELLA; BIODIESEL; ENVIRONMENTS; CHLOROPHYTA; DIVERSITY; COMMUNITY; ALIGNMENT; BIOFUELS; POSITION	Microalgal storage lipids are considered to be a promising source for next-generation biofuel feedstock. However, microalgal biodiesel is not yet economically feasible due to the high cost of production. One of the reasons for this is that the use of a low-cost open pond system is currently limited because of the unavoidable contamination with undesirable organisms. Extremophiles have an advantage in culturing in an open pond system because they grow in extreme environments toxic to other organisms. In this study, we isolated the acidophilic green alga Pseudochlorella sp. YKT1 from sulfuric acid mine drainage in Nagano Prefecture, Japan. The vegetative cells of YKT1 display the morphological characteristics of Trebouxiophyceae and molecular phylogenetic analyses indicated it to be most closely related to Pseudochlorella pringsheimii. The optimal pH and temperature for the growth of YKT1 are pH 3.0-5.0 and a temperature 20-25 degrees C, respectively. Further, YKT1 is able to grow at pH 2.0 and at 32 degrees C, which corresponds to the usual water temperature in the outdoors in summer in many countries. YKT1 accumulates a large amount of storage lipids (similar to 30% of dry weigh) under a nitrogen-depleted condition at low-pH (pH 3.0). These results show that acidophilic green algae will be useful for industrial applications by acidic open culture systems.	[Hirooka, Shunsuke; Uzuka, Akihiro; Miyagishima, Shin-ya] Natl Inst Genet, Frontier Res Ctr, Mishima, Shizuoka 411, Japan; [Hirooka, Shunsuke; Miyagishima, Shin-ya] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Uzuka, Akihiro; Miyagishima, Shin-ya] Grad Univ Adv Studies SOKENDAI, Dept Genet, Mishima, Shizuoka, Japan; [Nozaki, Hisayoshi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Science & Technology Agency (JST); Graduate University for Advanced Studies - Japan; University of Tokyo	Hirooka, S (corresponding author), Natl Inst Genet, Frontier Res Ctr, Mishima, Shizuoka 411, Japan.	shirooka@nig.ac.jp		Nozaki, Hisayoshi/0000-0002-9308-4498; Miyagishima, Shin-ya/0000-0002-9111-0832	Core Research for Evolutional Science and Technology (CREST) Program of Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science [25251039]; Grants-in-Aid for Scientific Research [25251039] Funding Source: KAKEN	Core Research for Evolutional Science and Technology (CREST) Program of Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Core Research for Evolutional Science and Technology (CREST) Program of Japan Science and Technology Agency (JST, http://www.jst.go.jp/EN/index.html) to SYM and Grant-in-aid for Scientific Research from Japan Society for the Promotion of Science (no. 25251039 to SYM, http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2007, SYST APPL MICROBIOL, V30, P531, DOI 10.1016/j.syapm.2007.05.003; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bai LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054966; Benemann J, 2013, ENERGIES, V6, P5869, DOI 10.3390/en6115869; Brennan L, 2010, RENEW SUST ENERG REV, V14, P557, DOI 10.1016/j.rser.2009.10.009; Carvalho AP, 2006, BIOTECHNOL PROGR, V22, P1490, DOI 10.1021/bp060065r; Chen W, 2009, J MICROBIOL METH, V77, P41, DOI 10.1016/j.mimet.2009.01.001; Chisti Y, 2008, TRENDS BIOTECHNOL, V26, P126, DOI 10.1016/j.tibtech.2007.12.002; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Darienko T, 2010, EUR J PHYCOL, V45, P79, DOI 10.1080/09670260903362820; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Garcia-Gonzalez M, 2003, J APPL PHYCOL, V15, P177, DOI 10.1023/A:1023892520443; Harris E.H, 2009, INTRO CHLAMYDOMONAS; Heidelberg KB, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00115; Higuchi S, 2003, J PLANT RES, V116, P461, DOI 10.1007/s10265-003-0125-3; Huss VAR, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-13; Kitto M.R., 2011, J ALGAL BIOMASS UTIL, V2, P14; Kuroiwa T, 2012, CYTOLOGIA, V77, P289, DOI 10.1508/cytologia.77.289; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lopez-Archilla AI, 2001, MICROB ECOL, V41, P20; Merchant SS, 2012, CURR OPIN BIOTECH, V23, P352, DOI 10.1016/j.copbio.2011.12.001; Minoda A, 2004, PLANT CELL PHYSIOL, V45, P667, DOI 10.1093/pcp/pch087; Nakazawa Atsushi, 2004, Journal of Japanese Botany, V79, P255; Nancucheo I, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00325; Nevoigt E, 2008, MICROBIOL MOL BIOL R, V72, P379, DOI 10.1128/MMBR.00025-07; Nielsen SL, 2006, J PLANKTON RES, V28, P489, DOI 10.1093/plankt/fbi134; Novis Phil, 2007, V11; Pedrozo F, 2001, HYDROBIOLOGIA, V452, P129, DOI 10.1023/A:1011984212798; Pribyl P, 2012, APPL MICROBIOL BIOT, V94, P549, DOI 10.1007/s00253-012-3915-5; Priyadarshani I., 2012, J ALGAL BIOMASS UTIL, V3, P89; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schenk PM, 2008, BIOENERG RES, V1, P20, DOI 10.1007/s12155-008-9008-8; Shihira I., 1965, CHLORELLA PHYSL TAXO, P1, DOI DOI 10.1016/J.ADDR.2016.09.0041965; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; Yamamoto M, 2007, PLANTA, V226, P917, DOI 10.1007/s00425-007-0538-7; Zettler LAA, 2002, NATURE, V417, P137; Zhang JM, 2008, EUR J PHYCOL, V43, P185, DOI 10.1080/09670260701718462	39	26	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2014	9	9							e107702	10.1371/journal.pone.0107702	http://dx.doi.org/10.1371/journal.pone.0107702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SR	25221913	gold, Green Published, Green Submitted			2022-12-25	WOS:000341774800095
J	Zhang, WN; Liu, T; Yang, Y; Cao, LJ; Zhang, Y; Ji, RR				Zhang, Wei-Nan; Liu, Ting; Yang, Yang; Cao, Liujuan; Zhang, Yu; Ji, Rongrong			A Topic Clustering Approach to Finding Similar Questions from Large Question and Answer Archives	PLOS ONE			English	Article							WORDNET	With the blooming of Web 2.0, Community Question Answering (CQA) services such as Yahoo! Answers (http://answers.yahoo.com), WikiAnswer (http://wiki.answers.com), and Baidu Zhidao (http://zhidao.baidu.com), etc., have emerged as alternatives for knowledge and information acquisition. Over time, a large number of question and answer (Q&A) pairs with high quality devoted by human intelligence have been accumulated as a comprehensive knowledge base. Unlike the search engines, which return long lists of results, searching in the CQA services can obtain the correct answers to the question queries by automatically finding similar questions that have already been answered by other users. Hence, it greatly improves the efficiency of the online information retrieval. However, given a question query, finding the similar and well-answered questions is a non-trivial task. The main challenge is the word mismatch between question query (query) and candidate question for retrieval (question). To investigate this problem, in this study, we capture the word semantic similarity between query and question by introducing the topic modeling approach. We then propose an unsupervised machine-learning approach to finding similar questions on CQA Q&A archives. The experimental results show that our proposed approach significantly outperforms the state-of-the-art methods.	[Zhang, Wei-Nan; Liu, Ting; Zhang, Yu] Harbin Inst Technol, Res Ctr Social Comp & Informat Retrieval, Harbin 150006, Heilongjiang, Peoples R China; [Yang, Yang] Natl Univ Singapore, Sch Comp, Singapore 117548, Singapore; [Cao, Liujuan] Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Fujian, Peoples R China; [Ji, Rongrong] Xiamen Univ, Dept Cognit Sci, Xiamen, Fujian, Peoples R China	Harbin Institute of Technology; National University of Singapore; Xiamen University; Xiamen University	Cao, LJ (corresponding author), Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Fujian, Peoples R China.	caoliujuan@gmail.com; zhangyu@ir.hit.edu.cn			Natural Science Foundation of China [61133012, 61202277, 61073126]; Fundamental Research Funds for the Central Universities [2013121026, 2011121052]; Xiamen University 985 Project	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Xiamen University 985 Project	This work was supported by the Natural Science Foundation of China (Grant No. 61133012, 61202277, 61073126) and the Fundamental Research Funds for the Central Universities (No. 2013121026 and No. 2011121052) and Xiamen University 985 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan James, 2003, P 26 ANN INT ACM SIG, P314, DOI DOI 10.1145/860435.860493; Banerjee Satanjeev., 2003, P 18 INT JOINT C ART, P805; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Budanitsky A, 2006, COMPUT LINGUIST, V32, P13, DOI 10.1162/coli.2006.32.1.13; Chen TC, 2009, PROC EUR SOLID-STATE, P1; Cheng MM, 2014, VISUAL COMPUT, V30, P443, DOI 10.1007/s00371-013-0867-4; Cheng MM, 2011, TPAMI2011100753; Cui H., 2005, P 28 ANN INT ACM SIG, P400, DOI [10. 1145/1076034.1076103, DOI 10.1145/1076034.1076103]; Duan H., 2008, ACL, V8, P156; Gao Y, 2012, IEEE T IMAGE PROCESS, V21, P4290, DOI 10.1109/TIP.2012.2199502; Gao Y, 2012, IEEE T IMAGE PROCESS, V21, P2269, DOI 10.1109/TIP.2011.2170081; Gehler P, 2009, IEEE I CONF COMP VIS, P221, DOI 10.1109/ICCV.2009.5459169; Hoad TC, 2003, J AM SOC INF SCI TEC, V54, P203, DOI 10.1002/asi.10170; Jeon J., 2005, P 14 ACM INT C INF K, P84, DOI DOI 10.1145/1099554.1099572; Ji RR, 2012, INT J COMPUT VISION, V96, P290, DOI 10.1007/s11263-011-0472-9; Ji RR, 2012, IEEE T IMAGE PROCESS, V21, P2282, DOI 10.1109/TIP.2011.2176950; Ji RR, 2011, ACM T MULTIM COMPUT, V7, DOI 10.1145/2037676.2037688; Jiwoon Jeon, 2005, SIGIR 2005. Proceedings of the Twenty-Eighth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P617, DOI 10.1145/1076034.1076156; Landauer TK, 1997, PROCEEDINGS OF THE NINETEENTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P412; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Lin D, 1998, P INT C MACH LEARN; Mandreoli F., 2002, Proceedings of the Eleventh International Conference on Information and Knowledge Management. CIKM 2002, P635, DOI 10.1145/584792.584904; Metzler Donald, 2005, P 14 ACM INT C INF K, P517; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Min Chen, 2011, IEEE INFOCOM 2011 - IEEE Conference on Computer Communications. Workshops, P409, DOI 10.1109/INFCOMW.2011.5928847; Ming ZY, 2010, P 19 ACM INT C INF K, P1605; Park JH, 2010, SIGIR 2010: PROCEEDINGS OF THE 33RD ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH DEVELOPMENT IN INFORMATION RETRIEVAL, P829; Park JH, 2011, P 20 ACM INT C INF K, P17, DOI DOI 10.1145/2063576.2063585; Ponte J. M., 1998, P 21 ANN INT ACM SIG, P275, DOI DOI 10.1145/290941.291008; Robertson S. E., 1995, Text REtrieval Conference (TREC-3) (NIST SP 500-225), P109; Sparck-Jones K, 2000, INFORM PROCESS MANAG, V36, P779, DOI 10.1016/S0306-4573(00)00015-7; Wang K, 2009, PROCEEDINGS 32ND ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P187, DOI 10.1145/1571941.1571975; Xue X., 2008, P 31 ANN INT ACM SIG, P475, DOI 10.1145/1390334.1390416; Zhang ST, 2010, PROC CVPR IEEE, P3312, DOI 10.1109/CVPR.2010.5540036; Zhang W.N., 2012, COLING, P3105; Zhang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064601, 10.1371/journal.pone.0071243, 10.1371/journal.pone.0067564]	37	61	64	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e71511	10.1371/journal.pone.0071511	http://dx.doi.org/10.1371/journal.pone.0071511			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595052	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500001
J	Martin-Serra, A; Figueirido, B; Palmqvist, P				Martin-Serra, Alberto; Figueirido, Borja; Palmqvist, Paul			A Three-Dimensional Analysis of Morphological Evolution and Locomotor Performance of the Carnivoran Forelimb	PLOS ONE			English	Article							FUNCTIONAL TRADE-OFFS; GEOMETRIC MORPHOMETRICS; BODY-SIZE; PREDATORY BEHAVIOR; LIMB MUSCLES; LATE MIOCENE; SKULL SHAPE; MAMMALIA; EXTANT; EXTINCT	In this study, three-dimensional landmark-based methods of geometric morphometrics are used for estimating the influence of phylogeny, allometry and locomotor performance on forelimb shape in living and extinct carnivorans (Mammalia, Carnivora). The main objective is to investigate morphological convergences towards similar locomotor strategies in the shape of the major forelimb bones. Results indicate that both size and phylogeny have strong effects on the anatomy of all forelimb bones. In contrast, bone shape does not correlate in the living taxa with maximum running speed or daily movement distance, two proxies closely related to locomotor performance. A phylomorphospace approach showed that shape variation in forelimb bones mainly relates to changes in bone robustness. This indicates the presence of biomechanical constraints resulting from opposite demands for energetic efficiency in locomotion -which would require a slender forelimb-and resistance to stress -which would be satisfied by a robust forelimb-. Thus, we interpret that the need of maintaining a trade-off between both functional demands would limit shape variability in forelimb bones. Given that different situations can lead to one or another morphological solution, depending on the specific ecology of taxa, the evolution of forelimb morphology represents a remarkable "one-to-many mapping'' case between anatomy and ecology.	[Martin-Serra, Alberto; Figueirido, Borja; Palmqvist, Paul] Univ Malaga, Fac Ciencias, Dept Ecol & Geol, E-29071 Malaga, Spain	Universidad de Malaga	Martin-Serra, A (corresponding author), Univ Malaga, Fac Ciencias, Dept Ecol & Geol, E-29071 Malaga, Spain.	almarse@uma.es	Figueirido, Borja/AAV-7882-2020; Martín-Serra, Alberto/C-3460-2015; Figueirido, Borja/G-9665-2015; Palmqvist, Paul/B-5378-2013; Simoes, Nuno/D-9974-2011	Figueirido, Borja/0000-0003-2542-3977; Martín-Serra, Alberto/0000-0003-0221-1103; Figueirido, Borja/0000-0003-2542-3977; Palmqvist, Paul/0000-0002-6630-6956; Martinez, Ana/0000-0002-0515-1946; Simoes, Nuno/0000-0001-7490-3147; Castillo Hernandez, Tania/0000-0002-9492-855X; Mascaro, Maite/0000-0003-3614-4383; Lopez-Rull, Isabel/0000-0002-3255-0459	Spanish Ministry of Education PhD Research Fellowship (FPU); Spanish Ministry of Science and Innovation [CGL2008-04896, CGL2011-30334, CGL2012-37866]; Junta de Andalucia [Hum-7248]	Spanish Ministry of Education PhD Research Fellowship (FPU)(German Research Foundation (DFG)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia)	This study was supported by the Spanish Ministry of Education PhD Research Fellowship (FPU) to AMS, projects CGL2008-04896, CGL2011-30334 and CGL2012-37866 from the Spanish Ministry of Science and Innovation, and project Hum-7248 from Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; ALBERCH P, 1980, AM ZOOL, V20, P653; Alexander RM, 2005, J EXP BIOL, V208, P1645, DOI 10.1242/jeb.01484; Alexander RM., 2003, PRINCIPLES ANIMAL LO; Andersson K, 2005, PALEOBIOLOGY, V31, P56, DOI 10.1666/0094-8373(2005)031<0056:WTPCIT>2.0.CO;2; Andersson K, 2003, P ROY SOC B-BIOL SCI, V270, pS163, DOI 10.1098/rsbl.2003.0070; Andersson K, 2003, THESIS U UPPSALA SWE; Anton M, 2004, J VERTEBR PALEONTOL, V24, P957, DOI 10.1671/0272-4634(2004)024[0957:FKCSOT]2.0.CO;2; Anton M, 2004, ZOOL J LINN SOC-LOND, V140, P207, DOI 10.1111/j.1096-3642.2003.00093.x; Anyonge W, 1996, J ZOOL, V238, P395, DOI 10.1111/j.1469-7998.1996.tb05402.x; Argot C, 2001, J MORPHOL, V247, P51, DOI 10.1002/1097-4687(200101)247:1<51::AID-JMOR1003>3.0.CO;2-#; Barone R, 1986, ANATOMIE COMP MAMMIF, V1; Beisiegel Beatriz de Mello, 2005, Mammalian Species, P1, DOI 10.1644/783.1; BERTRAM JEA, 1990, J MORPHOL, V204, P157, DOI 10.1002/jmor.1052040205; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; BIEWENER AA, 1983, J EXP BIOL, V105, P147; BIEWENER AA, 1983, J EXP BIOL, V103, P131; Biewener AA., 2003, ANIMAL LOCOMOTION; Christiansen P, 2002, ZOOL J LINN SOC-LOND, V136, P685, DOI 10.1046/j.1096-3642.2002.00041.x; Ercoli MD, 2012, ZOOL J LINN SOC-LOND, V165, P224, DOI 10.1111/j.1096-3642.2011.00793.x; Day LM, 2007, J EXP BIOL, V210, P642, DOI 10.1242/jeb.02703; Diaz-Uriarte R, 1998, SYST BIOL, V47, P654, DOI 10.1080/106351598260653; Doube M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004742; Drake AG, 2008, P ROY SOC B-BIOL SCI, V275, P71, DOI 10.1098/rspb.2007.1169; Dryden IL, 1998, STAT ANAL SHAPE; Ewer, 1998, CARNIVORES; Fabre AC, 2013, J EVOLUTION BIOL, V26, P1521, DOI 10.1111/jeb.12161; Fabre AC, 2013, BIOL J LINN SOC, V110, P91, DOI 10.1111/bij.12103; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Figueirido B, 2010, J EVOLUTION BIOL, V23, P2579, DOI 10.1111/j.1420-9101.2010.02117.x; Figueirido B, 2013, EVOLUTION, V67, P1975, DOI 10.1111/evo.12059; Figueirido B, 2011, BIOL LETTERS, V7, P937, DOI 10.1098/rsbl.2011.0364; Figueirido B, 2011, PALEOBIOLOGY, V37, P490, DOI 10.1666/09062.1; Finarelli JA, 2006, SYST BIOL, V55, P301, DOI 10.1080/10635150500541698; GARLAND T, 1993, J ZOOL, V229, P133, DOI 10.1111/j.1469-7998.1993.tb02626.x; GARLAND T, 1983, AM NAT, V121, P571, DOI 10.1086/284084; Gidaszewski NA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-110; GONYEA WJ, 1978, ACTA ANAT, V102, P111, DOI 10.1159/000145627; GOSLOW GE, 1981, J EXP BIOL, V94, P15; GUNNELL GF, 1998, EVOLUTION TERTIARY M, V1, P91; Halenar LB, 2011, ANAT REC, V294, P2048, DOI 10.1002/ar.21499; Hanna JB, 2006, AM J PHYS ANTHROPOL, V130, P529, DOI 10.1002/ajpa.20385; Harris MA, 1997, J ZOOL, V241, P381, DOI 10.1111/j.1469-7998.1997.tb01966.x; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hildebrand M., 1985, P38; Homberger DG, 2004, VERTEBRATE DISSECTIO; Hunt Robert M. Jr, 1998, P196; Iriarte-Diaz J, 2002, J EXP BIOL, V205, P2897; Iwaniuk AN, 1999, BEHAV BRAIN RES, V99, P35, DOI 10.1016/S0166-4328(98)00067-9; Janis CM, 2012, J VERTEBR PALEONTOL, V32, P433, DOI 10.1080/02724634.2012.635737; Janis Christine M., 1993, Journal of Mammalian Evolution, V1, P103, DOI 10.1007/BF01041590; Janis CM, 2008, EVOLUTION OF TERTIARY MAMMALS OF NORTH AMERICA, VOL 2, P1, DOI 10.1017/CBO9780511541438; Kardong K., 2006, VERTEBRATES COMP ANA; Kemp TJ, 2005, J EXP BIOL, V208, P3475, DOI 10.1242/jeb.01814; Klingenberg CP, 2012, J EVOLUTION BIOL, V25, P115, DOI 10.1111/j.1420-9101.2011.02410.x; Klingenberg CP, 2013, HYSTRIX, V24, P15, DOI 10.4404/hystrix-24.1-7691; Klingenberg CP, 2013, SYST BIOL, V62, P591, DOI 10.1093/sysbio/syt025; Klingenberg CP, 2010, SYST BIOL, V59, P245, DOI 10.1093/sysbio/syp106; Klingenberg CP, 1996, BIOL J LINN SOC, V59, P143; Klingenberg CP, 2011, MORPHOJ; Koepfli KP, 2007, MOL PHYLOGENET EVOL, V43, P1076, DOI 10.1016/j.ympev.2006.10.003; KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0; Krause J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-220; Krausman Paul R., 2005, Mammalian Species, P1; Laurin M, 2004, SYST BIOL, V53, P594, DOI 10.1080/10635150490445706; Lee DV, 1999, J EXP BIOL, V202, P3565; MacLeod N, 2001, PALEOBIOLOGY, V27, P226, DOI 10.1666/0094-8373(2001)027<0226:TROPIQ>2.0.CO;2; MACLEOD N, 1993, AM J SCI, V293A, P300, DOI 10.2475/ajs.293.A.300; MADDISON WP, 1991, SYST ZOOL, V40, P304, DOI 10.2307/2992324; Maddison WP, 2011, MESQUITE MODULAR SYS; Martin LD, 1998, EVOLUTION TERTIARY M, P228; McLellan B, 1994, BEARS THEIR BIOL MAN, P85; MCMAHON T, 1973, SCIENCE, V179, P1201, DOI 10.1126/science.179.4079.1201; Meachen-Samuels J, 2009, J MORPHOL, V270, P729, DOI 10.1002/jmor.10712; Meachen-Samuels JA, 2012, PALEOBIOLOGY, V38, P1, DOI 10.1666/10036.1; Meachen-Samuels JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011412; Meloro C, 2013, PALEOBIOLOGY, V39, P323, DOI 10.1666/12001; Midford P.E., 2008, PDAP PACKAGE MESQUIT; Monteiro LR, 1999, SYST BIOL, V48, P192, DOI 10.1080/106351599260526; Morlo M, 2004, ZOOL J LINN SOC-LOND, V140, P43, DOI 10.1111/j.1096-3642.2004.00087.x; Nyakatura K, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-12; Osborn HF, 1900, B AM MUS NAT HIST, V13, P269; Pasi BM, 2003, J EVOLUTION BIOL, V16, P324, DOI 10.1046/j.1420-9101.2003.00512.x; Peigne S, 2003, ZOOL SCR, V32, P199, DOI 10.1046/j.1463-6409.2003.00116.x; Polly P. David, 2008, P167, DOI 10.1007/978-1-4020-6997-0_9; Polly PD, 2001, AM NAT, V157, P596, DOI 10.1086/320622; Raichlen DA, 2009, AM J PHYS ANTHROPOL, V138, P395, DOI 10.1002/ajpa.20952; REYNOLDS TR, 1985, AM J PHYS ANTHROPOL, V67, P335, DOI 10.1002/ajpa.1330670406; Rohlf F. James, 2002, VVolume 64, P175; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rothwell T, 2003, AM MUS NOV, V3403; Salesa MJ, 2011, RED PANDA: BIOLOGY AND CONSERVATION OF THE FIRST PANDA, P27, DOI 10.1016/B978-1-4377-7813-7.00003-3; Salesa MJ, 2010, J ANAT, V216, P381, DOI 10.1111/j.1469-7580.2009.01178.x; Samuels JX, 2008, J MORPHOL, V269, P1387, DOI 10.1002/jmor.10662; Samuels JX, 2013, J MORPHOL, V274, P121, DOI 10.1002/jmor.20077; Sanger TJ, 2012, EVOLUTION, V66, P1525, DOI 10.1111/j.1558-5646.2011.01519.x; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Schmitt D, 2002, AM J PHYS ANTHROPOL, V118, P231, DOI 10.1002/ajpa.10048; Schoenebeck JJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002849; Schutz H, 2007, ZOOL J LINN SOC-LOND, V150, P895, DOI 10.1111/j.1096-3642.2007.00303.x; Schwenk K, 2003, KEYWORDS CONCEPTS EV, P52; Singleton M, 2012, EVOL BIOL, V39, P499, DOI 10.1007/s11692-011-9153-4; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Sorkin B, 2008, LETHAIA, V41, P333, DOI 10.1111/j.1502-3931.2007.00091.x; SPOOR CF, 1986, ANAT ANZEIGER, V161, P375; Stein BR, 1997, J ZOOL, V242, P185, DOI 10.1111/j.1469-7998.1997.tb02939.x; STEUDEL K, 1993, J MORPHOL, V217, P55, DOI 10.1002/jmor.1052170105; STRANG KT, 1990, J ZOOL, V221, P343, DOI 10.1111/j.1469-7998.1990.tb04006.x; Taylor M.E., 1989, P382; Turner A., 1997, BIG CATS THEIR FOSSI; van Valkenburgh B., 1987, Journal of Vertebrate Paleontology, V7, P162; Van Valkenburgh B, 2007, INTEGR COMP BIOL, V47, P147, DOI 10.1093/icb/icm016; VANVALKENBURGH B, 1991, PALEOBIOLOGY, V17, P340, DOI 10.1017/S0094837300010691; VANVALKENBURGH B, 1985, PALEOBIOLOGY, V11, P406, DOI 10.1017/S0094837300011702; Wallace SC, 2011, RED PANDA: BIOLOGY AND CONSERVATION OF THE FIRST PANDA, P43, DOI 10.1016/B978-1-4377-7813-7.00004-5; Walmsley A, 2012, J MORPHOL, V273, P1424, DOI 10.1002/jmor.20084; Walter RM, 2007, J EXP BIOL, V210, P208, DOI 10.1242/jeb.02645; Wang XM, 1999, B AM MUS NAT HIST, P1; Wiley DF, 2005, IEEE VISUALIZATION 2005, PROCEEDINGS, P431; Wilson DE, 2009, HDB MAMMALS WORLD, V1; Wortman, 1894, B AM MUS NAT HIST, V6, P129; Wroe S, 2008, J ZOOL, V274, P332, DOI 10.1111/j.1469-7998.2007.00389.x; Wroe S, 2007, P ROY SOC B-BIOL SCI, V274, P2819, DOI 10.1098/rspb.2007.0906; Wroe S, 2007, EVOLUTION, V61, P1251, DOI 10.1111/j.1558-5646.2007.00101.x	126	64	64	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85574	10.1371/journal.pone.0085574	http://dx.doi.org/10.1371/journal.pone.0085574			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	25229639	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100101
J	Choi, BY; Kim, J; Chung, J; Kim, AR; Mun, SJ; Kang, SI; Lee, SH; Kim, N; Oh, SH				Choi, Byung Yoon; Kim, Jiwoong; Chung, Juyong; Kim, Ah Reum; Mun, Sue Jean; Kang, Seong Il; Lee, Sang-Heon; Kim, Namshin; Oh, Seung-Ha			Whole-Exome Sequencing Identifies a Novel Genotype-Phenotype Correlation in the Entactin Domain of the Known Deafness Gene TECTA	PLOS ONE			English	Article							NONSYNDROMIC HEARING IMPAIRMENT; TECTORIAL MEMBRANE; MUTATIONS; PROTEIN; EXPRESSION; CONFIRMS; DELETION; FAMILIES; OTOGELIN; DFNA12	Postlingual progressive hearing loss, affecting primarily the high frequencies, is the clinical finding in most cases of autosomal dominant nonsyndromic hearing loss (ADNSHL). The molecular genetic etiology of ADNSHL is extremely heterogeneous. We applied whole-exome sequencing to reveal the genetic etiology of high-frequency hearing loss in a mid-sized Korean family without any prior linkage data. Whole-exome sequencing of four family members (two affected and two unaffected), together with our filtering strategy based on comprehensive bioinformatics analyses, identified 21 potential pathogenic candidates. Sanger validation of an additional five family members excluded 20 variants, leaving only one novel variant, TECTA c.710C>T (p.T237I), as the strongest candidate. This variant resides in the entactin (ENT) domain and co-segregated perfectly with non-progressive high-frequency hearing loss in the family. It was absent among 700 ethnically matched control chromosomes, and the T237 residue is conserved among species, which supports its pathogenicity. Interestingly, this finding contrasted with a previously proposed genotype-phenotype correlation in which variants of the ENT domain of TECTA were associated with mid-frequency hearing loss. Based upon what we observed, we propose a novel "genotype to phenotype'' correlation in the ENT domain of TECTA. Our results shed light on another important application of whole-exome sequencing: the establishment of a novel genotype-phenotype in the molecular genetic diagnosis of autosomal dominant hearing loss.	[Choi, Byung Yoon] Seoul Natl Univ, Dept Otorhinolaryngol, Bundang Hosp, Songnam, South Korea; [Kim, Jiwoong; Lee, Sang-Heon; Kim, Namshin] KRIBB, Korean Bioinformat Ctr, Taejon, South Korea; [Chung, Juyong] Ajou Univ, Dept Otolaryngol, Sch Med, Suwon 441749, South Korea; [Kim, Ah Reum; Mun, Sue Jean; Kang, Seong Il; Oh, Seung-Ha] Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Lee, Sang-Heon; Kim, Namshin] Univ Sci & Technol, Dept Bioinformat, Taejon, South Korea	Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Ajou University; Seoul National University (SNU)	Kim, N (corresponding author), KRIBB, Korean Bioinformat Ctr, Taejon, South Korea.	n@rna.kr; shaoh@snu.ac.kr	Kim, Namshin/Q-6491-2017	Kim, Namshin/0000-0001-6361-274X	Ministry for Health, Welfare and Family Affairs, Republic of Korea [A080588, A111377]; National Research Foundation of Korea - Korean government (Ministry of Education, Science, and Technology) [20120009215]	Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea - Korean government (Ministry of Education, Science, and Technology)	This study was supported by the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (Nos. A080588 and A111377), and the National Research Foundation of Korea grant funded by the Korean government (Ministry of Education, Science, and Technology; No. 20120009215). The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alasti F, 2008, INT J PEDIATR OTORHI, V72, P249, DOI 10.1016/j.ijporl.2007.09.023; Alloisio N, 1999, EUR J HUM GENET, V7, P255, DOI 10.1038/sj.ejhg.5200273; Balciuniene J, 1999, HUM GENET, V105, P211, DOI 10.1007/s004390051091; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; CHUNG AE, 1993, KIDNEY INT, V43, P13, DOI 10.1038/ki.1993.4; Collin RWJ, 2008, EUR J HUM GENET, V16, P1430, DOI 10.1038/ejhg.2008.110; Delmaghani S, 2012, HUM MOL GENET, V21, P3835, DOI 10.1093/hmg/dds212; DURKIN ME, 1988, J CELL BIOL, V107, P2749, DOI 10.1083/jcb.107.6.2749; DZIADEK M, 1985, EMBO J, V4, P2513, DOI 10.1002/j.1460-2075.1985.tb03964.x; Govaerts PJ, 1998, AM J OTOL, V19, P718; Hildebrand MS, 2011, HUM MUTAT, V32, P825, DOI 10.1002/humu.21512; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Huygen PL, 2007, GENES HEARING DEAFNE, P185; Iwasaki S, 2002, ARCH OTOLARYNGOL, V128, P913, DOI 10.1001/archotol.128.8.913; King KA, 2010, LARYNGOSCOPE, V120, P384, DOI 10.1002/lary.20722; Knipper M, 2001, J BIOL CHEM, V276, P39046, DOI 10.1074/jbc.M103385200; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Legan PK, 2005, NAT NEUROSCI, V8, P1035, DOI 10.1038/nn1496; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; Lezirovitz K, 2012, GENE, V511, P280, DOI 10.1016/j.gene.2012.09.023; Maeda Y, 2001, NEUROREPORT, V12, P3223, DOI 10.1097/00001756-200110290-00016; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer NC, 2007, CLIN GENET, V72, P130, DOI 10.1111/j.1399-0004.2007.00828.x; Meyer NC, 2007, AM J MED GENET A, V143A, P1623, DOI 10.1002/ajmg.a.31718; Moreno-Pelayo M A, 2001, J Med Genet, V38, pE13, DOI 10.1136/jmg.38.5.e13; Mustapha M, 1999, HUM MOL GENET, V8, P409, DOI 10.1093/hmg/8.3.409; Naz S, 2003, J MED GENET, V40, P360, DOI 10.1136/jmg.40.5.360; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Pfister M, 2004, CELL PHYSIOL BIOCHEM, V14, P369, DOI 10.1159/000080347; Plantinga RF, 2006, JARO-J ASSOC RES OTO, V7, P173, DOI 10.1007/s10162-006-0033-z; Rau A, 1999, J COMP NEUROL, V405, P271; Rehman AU, 2014, AM J HUM GENET, V94, P144, DOI 10.1016/j.ajhg.2013.12.004; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Sagong B, 2012, GENE, V492, P239, DOI 10.1016/j.gene.2011.10.022; Sagong B, 2010, ANN CLIN LAB SCI, V40, P380; Santos-Cortez RLP, 2013, AM J HUM GENET, V93, P132, DOI 10.1016/j.ajhg.2013.05.018; Schraders M, 2012, AM J HUM GENET, V91, P883, DOI 10.1016/j.ajhg.2012.09.012; Schraders M, 2011, AM J HUM GENET, V88, P628, DOI 10.1016/j.ajhg.2011.04.012; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Tekin M, 2013, J CLIN INVEST, V123, P2094, DOI 10.1172/JCI65853; Verhoeven K, 1997, AM J HUM GENET, V60, P1168; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Yariz KO, 2012, AM J HUM GENET, V91, P872, DOI 10.1016/j.ajhg.2012.09.011	46	37	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e97040	10.1371/journal.pone.0097040	http://dx.doi.org/10.1371/journal.pone.0097040			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	25226504	gold, Green Published, Green Submitted			2022-12-25	WOS:000336838000097
J	Cousins, SAO; Kaligaric, M; Bakan, B; Lindborg, R				Cousins, Sara A. O.; Kaligaric, Mitja; Bakan, Branko; Lindborg, Regina			Political Systems Affect Mobile and Sessile Species Diversity - A Legacy from the Post-WWII Period	PLOS ONE			English	Article							LAND-USE CHANGE; EXTINCTION DEBT; LANDSCAPE PERSPECTIVES; HABITAT HETEROGENEITY; DRIVING FORCES; USE HISTORY; BIODIVERSITY; CONSERVATION; GRASSLANDS; RICHNESS	Political ideologies, policies and economy affect land use which in turn may affect biodiversity patterns and future conservation targets. However, few studies have investigated biodiversity in landscapes with similar physical properties but governed by different political systems. Here we investigate land use and biodiversity patterns, and number and composition of birds and plants, in the borderland of Austria, Slovenia and Hungary. It is a physically uniform landscape but managed differently during the last 70 years as a consequence of the political "map" of Europe after World War I and II. We used a historical map from 1910 and satellite data to delineate land use within three 10-kilometre transects starting from the point where the three countries meet. There was a clear difference between countries detectable in current biodiversity patterns, which relates to land use history. Mobile species richness was associated with current land use whereas diversity of sessile species was more associated with past land use. Heterogeneous landscapes were positively and forest cover was negatively correlated to bird species richness. Our results provide insights into why landscape history is important to understand present and future biodiversity patterns, which is crucial for designing policies and conservation strategies across the world.	[Cousins, Sara A. O.; Lindborg, Regina] Stockholm Univ, Dept Phys Geog & Quaternary Geol, Landscape Ecol, S-10691 Stockholm, Sweden; [Kaligaric, Mitja; Bakan, Branko] Univ Maribor, Fac Nat Sci & Math, Dept Biol, Maribor, Slovenia; [Kaligaric, Mitja] Univ Maribor, Fac Agr & Life Sci, Hoce, Slovenia	Stockholm University; University of Maribor; University of Maribor	Cousins, SAO (corresponding author), Stockholm Univ, Dept Phys Geog & Quaternary Geol, Landscape Ecol, S-10691 Stockholm, Sweden.	sara.cousins@natgeo.su.se	Cousins, Sara/A-2437-2012; Staab, Jeffrey/B-8792-2015	Cousins, Sara/0000-0003-2656-2645; Seemungal, Barry/0000-0002-6578-0904; Staab, Jeffrey/0000-0002-1516-3131; Kaski, Diego/0000-0002-0591-646X	program group "Biodiversity" [P1-0078]; Slovenian Research Agency; FORMAS; Slovenian Research Agency [P1-0164]	program group "Biodiversity"; Slovenian Research Agency(Slovenian Research Agency - Slovenia); FORMAS(Swedish Research Council Formas); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	Funding was provided by the program group "Biodiversity" (P1-0078) and granted by Slovenian Research Agency to MK and by FORMAS to SC and RL. MK was supported by program group P1-0164, funded by Slovenian Research Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggemyr E, 2012, J BIOGEOGR, V39, P1645, DOI 10.1111/j.1365-2699.2012.02733.x; [Anonymous], 2002, PRAVILNIK UVRSTITVI; Bakan B, 2006, SLIKOVNI PREGLAD VIS; Baldi A, 2011, IBIS, V153, P875, DOI 10.1111/j.1474-919X.2011.01169.x; Balmford A, 2005, GLOBAL CHANGE BIOL, V11, P1594, DOI 10.1111/j.1365-2486.2005.001035.x; Batary P, 2011, FRONT ECOL ENVIRON, V9, P152, DOI 10.1890/11.WB.006; Bender O, 2005, LANDSCAPE ECOL, V20, P149, DOI 10.1007/s10980-003-1506-7; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bignal EM, 1996, J APPL ECOL, V33, P413, DOI 10.2307/2404973; Bommarco R, 2014, DIVERS DISTRIB, V20, P591, DOI 10.1111/ddi.12187; Burgi M, 2004, LANDSCAPE ECOL, V19, P857, DOI 10.1007/s10980-004-0245-8; Cousins SAO, 2007, LANDSCAPE ECOL, V22, P723, DOI 10.1007/s10980-006-9067-1; Cousins SAO, 2009, BIOL CONSERV, V142, P2752, DOI 10.1016/j.biocon.2009.07.001; Cousins SAO, 2009, J VEG SCI, V20, P3, DOI 10.1111/j.1654-1103.2009.05647.x; Cousins SAO, 2008, APPL VEG SCI, V11, P365, DOI 10.3170/2008-7-18480; Donlan CJ, 2006, AM NAT, V168, P660, DOI 10.1086/508027; Eriksson O, 1996, OIKOS, V77, P248, DOI 10.2307/3546063; Eriksson O, 2014, LAND-BASEL, V3, P300, DOI 10.3390/land3010300; Ewers RM, 2013, ECOL LETT, V16, P1221, DOI 10.1111/ele.12160; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Fischer J, 2008, DIVERS DISTRIB, V14, P38, DOI 10.1111/j.1472-4642.2007.00411.x; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Franklin JF, 2009, P NATL ACAD SCI USA, V106, P349, DOI 10.1073/pnas.0812016105; Geister I., 1995, ORNITOLOSKI ATLAS SL; Gergely K, 2007, VOROS LISTA MAGYAROR; Gobster PH, 2007, LANDSCAPE ECOL, V22, P959, DOI 10.1007/s10980-007-9110-x; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Hooftman DAP, 2012, BIOL CONSERV, V145, P30, DOI 10.1016/j.biocon.2011.09.015; Ibbe M, 2011, FOREST ECOL MANAG, V261, P1885, DOI 10.1016/j.foreco.2011.02.011; Katoh K, 2009, BIOL CONSERV, V142, P1930, DOI 10.1016/j.biocon.2009.02.030; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Kuemmerle T, 2008, ECOSYSTEMS, V11, P614, DOI 10.1007/s10021-008-9146-z; Kuemmerle T, 2009, REG ENVIRON CHANGE, V9, P1, DOI 10.1007/s10113-008-0050-z; KULL K, 1991, J VEG SCI, V2, P715, DOI 10.2307/3236182; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Liira J, 2008, J VEG SCI, V19, P3, DOI 10.3170/2007-8-18308; Lindborg R, 2004, ECOLOGY, V85, P1840, DOI 10.1890/04-0367; Lindborg R, 2008, AGR ECOSYST ENVIRON, V125, P213, DOI 10.1016/j.agee.2008.01.006; Martincic A, 2007, MALA FLORA SLOVENIJE; Mikusinski G, 1998, CONSERV BIOL, V12, P200, DOI 10.1046/j.1523-1739.1998.96310.x; Navarro LM, 2012, ECOSYSTEMS, V15, P900, DOI 10.1007/s10021-012-9558-7; Niklfeld H, 1986, ROTE LISTEN GEFAHRDE; Ockinger E, 2012, ECOGRAPHY, V35, P259, DOI 10.1111/j.1600-0587.2011.06870.x; Plieninger T, 2006, ENVIRON SCI POLICY, V9, P317, DOI 10.1016/j.envsci.2006.03.001; Primdahl J., 2010, GLOBALISATION AGR LA; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Serra P, 2008, APPL GEOGR, V28, P189, DOI 10.1016/j.apgeog.2008.02.001; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Sutherland WJ, 2002, TRENDS ECOL EVOL, V17, P148, DOI 10.1016/S0169-5347(01)02421-1; Svensson L., 2009, BIRDS EUROPE; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Vandermeer J, 2007, CONSERV BIOL, V21, P274, DOI 10.1111/j.1523-1739.2006.00582.x; Vellend M, 2006, ECOLOGY, V87, P542, DOI 10.1890/05-1182; Wilson JB, 2012, J VEG SCI, V23, P796, DOI 10.1111/j.1654-1103.2012.01400.x; Zurita GA, 2010, LANDSCAPE ECOL, V25, P147, DOI 10.1007/s10980-009-9410-4; [No title captured]	59	22	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103367	10.1371/journal.pone.0103367	http://dx.doi.org/10.1371/journal.pone.0103367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4JL	25084154	gold, Green Submitted, Green Published			2022-12-25	WOS:000339819800034
J	Erickson, ZT; Falkenberg, EA; Metz, GAS				Erickson, Zachary T.; Falkenberg, Erin A.; Metz, Gerlinde A. S.			Lifespan Psychomotor Behaviour Profiles of Multigenerational Prenatal Stress and Artificial Food Dye Effects in Rats	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RAT; ADHD SYMPTOMS; DISORDER ADHD; ANIMAL-MODEL; ANXIETY; CORTICOSTERONE; HYPERACTIVITY; ADDITIVES; DOPAMINE; TOXICITY	The consumption of artificial food dye (AFD) during childhood and adolescence has been linked to behavioural changes, such as hyperactivity. It is possible that the vulnerability to AFDs is modified by prenatal stress. Common consequences of prenatal stress include hyperactivity, thus potentially leading to synergistic actions with AFDs. Here, we investigated the compounding effect of multigenerational prenatal stress (MPS) and AFD consumption on the development of hyperactivity and anxiety-related behaviours across the lifespan in male rats. MPS treatment involved a family history of four consecutive generations of prenatal stress (F4 generation). AFD treatment included a 4%-concentration of FD&C Red 40, FD&C Yellow 5, FD&C Yellow 6, and FD&C Blue 1 in the drinking water from postnatal days 22 to 50 to resemble juvenile and adolescent dietary exposure. Using several exploration tasks, animals were tested in motor activity and anxiety-like behaviours from adolescence to 13 months of age. MPS resulted in hyperactivity both early (50 days) and later in life (13 months), with normalized activity patterns at reproductive age. AFD consumption resulted in hyperactivity during consumption, which subsided following termination of treatment. Notably, both MPS and AFD promoted risk-taking behaviour in young adults (3 months). There were few synergistic effects between MPS and AFD in this study. The findings suggest that AFDs exert the most noticeable effects at the time of exposure. MPS, however, results in a characteristic lifespan profile of behavioural changes, indicating that development and aging represent particularly vulnerable periods in life during which a family history of prenatal stress may precipitate.	[Erickson, Zachary T.; Falkenberg, Erin A.; Metz, Gerlinde A. S.] Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Metz, GAS (corresponding author), Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada.	gerlinde.metz@uleth.ca			Alberta Innovates-Health Solutions [200700595]; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research [102652]	Alberta Innovates-Health Solutions; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors acknowledge support by the Alberta Innovates-Health Solutions Interdisciplinary Team Grant #200700595 "Preterm Birth and Healthy Outcomes" (GM), grants from Alberta Innovates-Health Solutions (GM), the Natural Sciences and Engineering Research Council of Canada (GM), and the Canadian Institutes of Health Research #102652 (GM). GM is an AHFMR Senior Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold LE, 2012, NEUROTHERAPEUTICS, V9, P599, DOI 10.1007/s13311-012-0133-x; Bateman B, 2004, ARCH DIS CHILD, V89, P506, DOI 10.1136/adc.2003.031435; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Crespi EJ, 2005, AM J HUM BIOL, V17, P44, DOI 10.1002/ajhb.20098; Fernandez F, 2004, NEUROPSYCHOPHARMACOL, V29, P59, DOI 10.1038/sj.npp.1300308; Field T, 2008, INFANT BEHAV DEV, V31, P590, DOI 10.1016/j.infbeh.2008.07.007; FLORES CM, 1990, J NEUROIMMUNOL, V28, P219, DOI 10.1016/0165-5728(90)90015-F; Food and Drug Administration/Center for Food Safety and Applied Nutrition, 2011, BACKGR INF FOOD ADV; Gatzke-Kopp LM, 2011, NEUROSCI BIOBEHAV R, V35, P794, DOI 10.1016/j.neubiorev.2010.09.013; Glover V, 2011, J CHILD PSYCHOL PSYC, V52, P356, DOI 10.1111/j.1469-7610.2011.02371.x; Hao Y, 2013, NONGENETIC INHERITAN, V1, P9, DOI DOI 10.2478/NGI-2013-0001; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Holmes MC, 2006, J NEUROSCI, V26, P3840, DOI 10.1523/JNEUROSCI.4464-05.2006; Jadavji NM, 2011, NEUROENDOCRINOLOGY, V94, P278, DOI 10.1159/000329988; Jankord R, 2011, ENDOCRINOLOGY, V152, P629, DOI 10.1210/en.2010-0658; Kanarek RB, 2011, NUTR REV, V69, P385, DOI 10.1111/j.1753-4887.2011.00385.x; Korosi A, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.027.2009; Laloux C, 2012, PSYCHONEUROENDOCRINO, V37, P1646, DOI 10.1016/j.psyneuen.2012.02.010; Lau K, 2006, TOXICOL SCI, V90, P178, DOI 10.1093/toxsci/kfj073; Li Q, 2007, NEUROCHEM INT, V50, P848, DOI 10.1016/j.neuint.2007.02.005; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Matthews SG, 2010, ENDOCRINOLOGY, V151, P7, DOI 10.1210/en.2009-0916; McCann D, 2007, LANCET, V370, P1560, DOI 10.1016/S0140-6736(07)61306-3; Metz GA, 2005, EUR J NEUROSCI, V22, P1190, DOI 10.1111/j.1460-9568.2005.04285.x; Metz GA, 2007, REV NEUROSCIENCE, V18, P209; Nosek K, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-23; O'Connor TG, 2003, J CHILD PSYCHOL PSYC, V44, P1025, DOI 10.1111/1469-7610.00187; Park M, 2009, J TOXICOL ENV HEAL A, V72, P1412, DOI 10.1080/15287390903212816; Prediger RDS, 2005, INT J NEUROPSYCHOPH, V8, P583, DOI 10.1017/S1461145705005341; REISEN CA, 1986, NEUROTOXICOL TERATOL, V8, P317; Sagvolden T, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-6; Sandman CA, 2013, J PSYCHOSOM RES, V75, P327, DOI 10.1016/j.jpsychores.2013.07.009; Schab DW, 2004, J DEV BEHAV PEDIATR, V25, P423, DOI 10.1097/00004703-200412000-00007; Smith LK, 2008, EUR J NEUROSCI, V27, P2133, DOI 10.1111/j.1460-9568.2008.06177.x; Stevens LJ, 2011, CLIN PEDIATR, V50, P279, DOI 10.1177/0009922810384728; Tanaka T, 2006, FOOD CHEM TOXICOL, V44, P179, DOI 10.1016/j.fct.2005.06.011; Tanaka T, 2008, REPROD TOXICOL, V26, P156, DOI 10.1016/j.reprotox.2008.07.001; Vallee M, 1999, EUR J NEUROSCI, V11, P2906, DOI 10.1046/j.1460-9568.1999.00705.x; Van den Bergh BRH, 2004, CHILD DEV, V75, P1085, DOI 10.1111/j.1467-8624.2004.00727.x; VORHEES CV, 1983, TOXICOLOGY, V28, P207, DOI 10.1016/0300-483X(83)90118-X; Ward ID, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S9; Wilson CA, 2013, BEHAV BRAIN RES, V238, P279, DOI 10.1016/j.bbr.2012.10.003; Zucchi Fabiola C. R., 2012, Frontiers in Genetics, V3, P96, DOI 10.3389/fgene.2012.00096	43	44	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e92132	10.1371/journal.pone.0092132	http://dx.doi.org/10.1371/journal.pone.0092132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	25222738	Green Published, Green Submitted, gold			2022-12-25	WOS:000338503400001
J	Chen, C; Sia, I; Ma, HM; Tai, BC; Cheong, A; Fong, NP; Tan, SYJ; Chan, KM; Tan, BY; Menon, E; Ee, CH; Lee, KK; Ng, YS; Teo, YY; Ma, S; Heng, D; Koh, GCH				Chen, Cynthia; Sia, Isaac; Ma, Hon-Ming; Tai, Bee Choo; Cheong, Angela; Fong, Ngan Phoon; Tan, Shi Yu Julia; Chan, Kin Ming; Tan, Boon Yeow; Menon, Edward; Ee, Chye Hua; Lee, Kok Keng; Ng, Yee Sien; Teo, Yik Ying; Ma, Stefan; Heng, Derrick; Koh, Gerald Choon-Huat			The Synergistic Effect of Functional Status and Comorbidity Burden on Mortality: A 16-Year Survival Analysis	PLOS ONE			English	Article							NURSING-HOME USE; OLDER-ADULTS; BARTHEL INDEX; HIP FRACTURE; FRAILTY; PREVALENCE; DISABILITY; ACCUMULATION; MORBIDITY; DISEASES	Objectives: The relationship between disability and comorbidity on mortality is widely perceived as additive in clinical models of frailty. Design: National data were retrospectively extracted from medical records of community hospital. Data Sources: There were of 12,804 acutely-disabled patients admitted for inpatient rehabilitation in Singapore rehabilitation community hospitals from 1996 through 2005 were followed up for death till 31 December 2011. Outcome Measure: Cox proportional-hazards regression to assess the interaction of comorbidity and disability at discharge on all-cause mortality. Results: During a median follow-up of 10.9 years, there were 8,565 deaths (66.9%). The mean age was 73.0 (standard deviation: 11.5) years. Independent risk factors of mortality were higher comorbidity (p<0.001), severity of disability at discharge (p<0.001), being widowed (adjusted hazard ratio [aHR]: 1.38, 95% confidence interval [CI]:1.25-1.53), low socioeconomic status (aHR: 1.40, 95%CI:1.29-1.53), discharge to nursing home (aHR: 1.14, 95%CI:1.05-1.22) and re-admission into acute care (aHR: 1.54, 95%CI:1.45-1.65). In the main effects model, those with high comorbidity had an aHR = 2.41 (95%CI:2.13-2.72) whereas those with total disability had an aHR = 2.28 (95%CI:2.12-2.46). In the interaction model, synergistic interaction existed between comorbidity and disability (p<0.001) where those with high comorbidity and total disability had much higher aHR = 6.57 (95%CI:5.15-8.37). Conclusions: Patients with greater comorbidity and disability at discharge, discharge to nursing home or re-admission into acute care, lower socioeconomic status and being widowed had higher mortality risk. Our results identified predictive variables of mortality that map well onto the frailty cascade model. Increasing comorbidity and disability interacted synergistically to increase mortality risk.	[Chen, Cynthia; Tai, Bee Choo; Cheong, Angela; Fong, Ngan Phoon; Teo, Yik Ying; Koh, Gerald Choon-Huat] Natl Univ Singapore, Natl Univ Hlth Syst, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Sia, Isaac] Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Ma, Hon-Ming] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Ma, Hon-Ming] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Therapeut, Hong Kong, Hong Kong, Peoples R China; [Tan, Shi Yu Julia; Koh, Gerald Choon-Huat] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Chan, Kin Ming] Ang Mo Kio Thye Hua Kwan Hosp, Med Serv, Singapore, Singapore; [Tan, Boon Yeow] St Lukes Hosp, Med Serv, Singapore, Singapore; [Menon, Edward] St Andrews Community Hosp, Med Serv, Singapore, Singapore; [Ee, Chye Hua; Lee, Kok Keng] Bright Vis Hosp, Singapore, Singapore; [Ng, Yee Sien] Singapore Gen Hosp, Dept Rehabil Med, Singapore, Singapore; [Teo, Yik Ying] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Ma, Stefan; Heng, Derrick] Minist Hlth, Singapore, Singapore	National University of Singapore; State University System of Florida; University of Florida; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; National University of Singapore; Singapore General Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Ministry of Health-Singapore	Koh, GCH (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.	gerald_koh@nuhs.edu.sg	CHEN, CYNTHIA/O-6203-2016; Chen, Chien-Yi/A-9680-2015; Chou, Hung-Chieh/AGZ-5161-2022; Rogawski, Michael/B-6353-2009	Chen, Chien-Yi/0000-0002-6030-2655; CHOU, HUNG-CHIEH/0000-0002-8932-9472; Chang, Mei Hwei/0000-0002-3648-9261; HSIEH, WU-SHIUN/0000-0002-0609-3311; Koh, Choon Huat Gerald/0000-0002-6453-6897; TSAO, PO-NIEN/0000-0002-6114-1769; Matt, Lucas/0000-0003-3235-5140; Rogawski, Michael/0000-0002-3296-8193; Sia, Isaac/0000-0001-8449-1799; Ng, Yee-Sien/0000-0003-1377-5852	National University of Singapore (NUS) Start-Up Grant; NUS Provost Matching Grant; NUS Academic Research Fund, Ministry of Health (Singapore) Health Services Research Competitive Research [HSRG/0006/2013]; Singapore National Medical Research Council Research Fellowship; Schulich Graduate Scholarship, University of Western Ontario	National University of Singapore (NUS) Start-Up Grant(National University of Singapore); NUS Provost Matching Grant; NUS Academic Research Fund, Ministry of Health (Singapore) Health Services Research Competitive Research(Ministry of Education, SingaporeNational University of Singapore); Singapore National Medical Research Council Research Fellowship(National Medical Research Council, Singapore); Schulich Graduate Scholarship, University of Western Ontario	This study was supported by a National University of Singapore (NUS) Start-Up Grant, the NUS Provost Matching Grant, the NUS Academic Research Fund, Ministry of Health (Singapore) Health Services Research Competitive Research Grant Number HSRG/0006/2013, Singapore National Medical Research Council Research Fellowship and Schulich Graduate Scholarship, University of Western Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, PRINCIPLES GERIATRIC; Bernardini Judith, 2004, Adv Perit Dial, V20, P125; Braithwaite RS, 2003, J AM GERIATR SOC, V51, P364, DOI 10.1046/j.1532-5415.2003.51110.x; Caughey GE, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-221; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fried LP, 1997, J AM GERIATR SOC, V45, P92, DOI 10.1111/j.1532-5415.1997.tb00986.x; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Gobbens RJJ, 2010, J AM MED DIR ASSOC, V11, P356, DOI 10.1016/j.jamda.2009.11.008; Hubbard RE, 2009, J NUTR HEALTH AGING, V13, P468, DOI 10.1007/s12603-009-0085-y; Lee J, 2007, NEUROCHEM RES, V32, P635, DOI 10.1007/s11064-006-9138-3; Leibson CL, 2002, J AM GERIATR SOC, V50, P1644, DOI 10.1046/j.1532-5415.2002.50455.x; Ministry of Health (MOH), 2004, HEALTHC SERV ELD INF; Mitnitski A, 2005, J AM GERIATR SOC, V53, P2184, DOI 10.1111/j.1532-5415.2005.00506.x; Morley JE, 2006, MED CLIN N AM, V90, P837, DOI 10.1016/j.mcna.2006.05.019; Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022; Ravindrarajah R, ARCH GERONTOLOGY GER; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Rochon PA, 1996, MED CARE, V34, P1093, DOI 10.1097/00005650-199611000-00004; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Rockwood K, 2011, CLIN GERIATR MED, V27, P17, DOI 10.1016/j.cger.2010.08.008; Rodriguez-Manas L, 2013, J GERONTOL A-BIOL, V68, P62, DOI 10.1093/gerona/gls119; ROY CW, 1988, INT J REHABIL RES, V11, P67, DOI 10.1097/00004356-198803000-00010; Rudberg MA, 1996, J GERONTOL A-BIOL, V51, pM189, DOI 10.1093/gerona/51A.5.M189; Schiller JS, 2012, VITAL HLTH STAT, V10, P67; Seo Nam Sook, 2006, Taehan Kanho Hakhoe Chi, V36, P514; Shah S, 2000, CLIN REHABIL, V14, P551, DOI 10.1191/0269215500cr360oa; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SHINAR D, 1987, ARCH PHYS MED REHAB, V68, P723; Slot KB, 2008, BRIT MED J, V336, P376, DOI 10.1136/bmj.39456.688333.BE; Song XW, 2007, AGING CLIN EXP RES, V19, P145; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; Van Kan GA, 2008, J NUTR HEALTH AGING, V12, P29, DOI 10.1007/BF02982161; van Kan GA, 2008, J AM MED DIR ASSOC, V9, P71, DOI 10.1016/j.jamda.2007.11.005; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Woo J, 2014, AGE, V36, P923, DOI 10.1007/s11357-013-9590-3	41	94	94	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2014	9	8							e106248	10.1371/journal.pone.0106248	http://dx.doi.org/10.1371/journal.pone.0106248			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO2EE	25229608	Green Published, gold, Green Submitted			2022-12-25	WOS:000341127500134
J	Liu, Y; Wang, FY; Wu, Y; Tan, SN; Wen, QL; Wang, J; Zhu, XM; Wang, X; Li, CM; Ma, X; Pan, H				Liu, Yan; Wang, Fengyu; Wu, Yuan; Tan, Sainan; Wen, Qiaolian; Wang, Jing; Zhu, Xiaomei; Wang, Xi; Li, Congmin; Ma, Xu; Pan, Hong			Variations of CITED2 Are Associated with Congenital Heart Disease (CHD) in Chinese Population	PLOS ONE			English	Article							PITX2C EXPRESSION; DEFECTS; MUTATIONS; MICE; MALFORMATIONS; HIF-1-ALPHA; ATRIAL; GROWTH; CELLS; GATA4	CITED2 was identified as a cardiac transcription factor which is essential to the heart development. Cited2-deficient mice showed cardiac malformations, adrenal agenesis and neural crest defects. To explore the potential impact of mutations in CITED2 on congenital heart disease (CHD) in humans, we screened the coding region of CITED2 in a total of 700 Chinese people with congenital heart disease and 250 healthy individuals as controls. We found five potential disease-causing mutations, p.P140S, p.S183L, p.S196G, p.Ser161delAGC and p.Ser192_Gly193delAGCGGC. Two mammalian two-hybrid assays showed that the last four mutations significantly affected the interaction between p300CH1 and CITED2 or HIF1A. Further studies showed that four CITED2 mutations recovered the promoter activity of VEGF by decreasing its competitiveness with HIF1A for binding to p300CH1 and three mutations decreased the consociation of TFAP2C and CITED2 in the transactivation of PITX2C. Both VEGF and PITX2C play very important roles in cardiac development. In conclusion, we demonstrated that CITED2 has a potential causative impact on congenital heart disease.	[Liu, Yan; Wen, Qiaolian; Zhu, Xiaomei; Wang, Xi; Ma, Xu; Pan, Hong] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Liu, Yan; Wen, Qiaolian; Zhu, Xiaomei; Wang, Xi; Ma, Xu; Pan, Hong] Natl Res Inst Family Planning, Beijing, Peoples R China; [Wang, Fengyu; Li, Congmin] Henan Res Inst Populat & Family Planning, Key Lab Populat Defects Intervent Technol Henan P, Zhengzhou, Peoples R China; [Wu, Yuan] Xiamen Univ, Dept Cardiac Surg, Xiamen Heart Ctr, Organ Transplantat Inst, Xiamen, Peoples R China; [Tan, Sainan] Family Planning Inst Hunan Prov, Key Lab Genet & Birth Hlth Hunan Prov, Chang Sha, Peoples R China; [Wang, Jing] Capital Med Univ, Sch Basic Med Sci, Dept Med Genet, Beijing, Peoples R China; [Ma, Xu] World Hlth Org, Collaborating Ctr Res Human Reprod, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Research Institute for Family Planning - China; Xiamen University; Capital Medical University; World Health Organization	Li, CM (corresponding author), Henan Res Inst Populat & Family Planning, Key Lab Populat Defects Intervent Technol Henan P, Zhengzhou, Peoples R China.	13838377996@163.com; nicgr@263.net; 13174483538@126.com		Liu, Yali/0000-0003-0037-6326; Zhang, Junjie/0000-0001-8809-1485; Liu, Yehao/0000-0002-6381-6440; Li, Yuhui/0000-0002-9778-4512	National Basic Research Program of China [2010CB529504]; National Natural Science Foundation of China [81300131]; Applied Basic Research Program of Qinghai Province [QH2013-z-744]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research Program of Qinghai Province	This work was supported by the National Basic Research Program of China (2010CB529504), the National Natural Science Foundation of China (81300131) and the Applied Basic Research Program of Qinghai Province (QH2013-z-744). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2008, ARTHRITIS RHEUM-US, V58, P3798, DOI 10.1002/art.24073; Amati F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-497; Andrews JE, 2000, MECH DEVELOP, V95, P305, DOI 10.1016/S0925-4773(00)00362-2; Bamforth SD, 2004, NAT GENET, V36, P1189, DOI 10.1038/ng1446; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Bentham J, 2010, HUM MOL GENET, V19, P3394, DOI 10.1093/hmg/ddq251; Bhattacherjee V, 2009, INT J DEV BIOL, V53, P1097, DOI 10.1387/ijdb.072489vb; Blue GM, 2012, MED J AUSTRALIA, V197, P155, DOI 10.5694/mja12.10811; Campione M, 2001, DEV BIOL, V231, P252, DOI 10.1006/dbio.2000.0133; Chen CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046256; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; Crider KS, 2011, GENOME MED, V3, DOI 10.1186/gm223; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Li DY, 2010, STROKE, V41, pS92, DOI 10.1161/STROKEAHA.110.594929; Li Q, 2012, BIOCHEM BIOPH RES CO, V423, P895, DOI 10.1016/j.bbrc.2012.06.099; MacDonald ST, 2013, EUR HEART J, V34, P2557, DOI 10.1093/eurheartj/ehs056; Ruiz-Perez VL, 2007, DEVELOPMENT, V134, P2903, DOI 10.1242/dev.007542; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Sperling S, 2005, HUM MUTAT, V26, P575, DOI 10.1002/humu.20262; Xiong F, 2013, CARDIOVASC PATHOL, V22, P141, DOI 10.1016/j.carpath.2012.07.001; Xu B, 2007, DEV BIOL, V301, P130, DOI 10.1016/j.ydbio.2006.08.072; Xu M, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-7; Yang Xiao-fei, 2010, Zhonghua Er Ke Za Zhi, V48, P293; Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799	26	255	264	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e98157	10.1371/journal.pone.0098157	http://dx.doi.org/10.1371/journal.pone.0098157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	25237849	gold, Green Published, Green Submitted			2022-12-25	WOS:000336730600093
J	Chen, CY; Chen, HL; Chou, HC; Tsao, PN; Hsieh, WS; Chang, MH				Chen, Chien-Yi; Chen, Huey-Ling; Chou, Hung-Chieh; Tsao, Po-Nien; Hsieh, Wu-Shiun; Chang, Mei-Hwei			Weight-Based Policy of Hepatitis B Vaccination in Very Low Birth Weight Infants in Taiwan: A Retrospective Cross-Sectional Study	PLOS ONE			English	Article							FOLLOW-UP; HEPATOCELLULAR-CARCINOMA; IMMUNE-RESPONSE; PRETERM INFANTS; INFECTION; PREVENTION; EFFICACY; IMMUNOGENICITY; GLOBULIN; BORN	Background: The current recommendation of giving the first dose of hepatitis B vaccine to very low birth weight (VLBW) infants at 30 days of chronologic age usually is not practical, because most VLBW infants are not medically stable at that age. We use an alternative body-weight-based protocol, and evaluate its efficacy in an endemic area under a universal immunization program. Methods: The immunogenicity of the current hepatitis B vaccination strategy in 155 VLBW preterm infants was evaluated at age 2 to 13 years, with parental consent. All of the infants were born between 1995 and 2006, and received their first dose of hepatitis B vaccine when they reached 2,000-2,200 g, irrespective of chronological age. Hepatitis B immunoglobulin (HBIG) was given at birth to infants born to HBsAg(+)/HBeAg(+) mothers. Results: All 155 of the recruited children were HBsAg and anti-HBc negative. The anti-HBs seropositivity rate (geometric mean titer) was 84.1% (146.5 mIU/mL) for children under 3 years, 73.5% (68.8 mIU/mL) for 4-to 7-year-olds, 27.7% (55.4 mIU/mL) for 8-to 11-year-olds and 20% (6.0 mIU/mL) for children >= 12 years of age. More than 90% of these children received the first vaccination after 30 days of age, half (51%) at 60 to 90 days, and 29 children (18.6%) after 90 days of age. Of the 26 infants born to HBsAg(+) mothers, 6/6 infants of HBeAg(+) mothers received HBIG at birth, and 12/20 infants of HBeAg(-) mothers received HBIG. None of the 26 infants became infected. Conclusions: Delaying hepatitis B vaccinations in VLBW preterm infants until they reach a weight of 2,000 g, with the administration of HBIG at birth for infants of HBsAg(+) mothers provided adequate immunogenicity and protection in a highly endemic area. Weight-based policy of hepatitis B vaccination is an effective and practical alternative strategy for VLBW infants.	[Chen, Chien-Yi] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Chen, Chien-Yi; Chen, Huey-Ling; Chou, Hung-Chieh; Tsao, Po-Nien; Hsieh, Wu-Shiun; Chang, Mei-Hwei] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Chen, Chien-Yi; Chen, Huey-Ling; Chou, Hung-Chieh; Tsao, Po-Nien; Hsieh, Wu-Shiun; Chang, Mei-Hwei] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chang, MH (corresponding author), Natl Taiwan Univ Hosp, Dept Pediat, 1 Chang Te St, Taipei 10016, Taiwan.	changmh@ntu.edu.tw	CHEN, CYNTHIA/O-6203-2016; Chen, Chien-Yi/A-9680-2015; Chou, Hung-Chieh/AGZ-5161-2022; Rogawski, Michael/B-6353-2009	Chen, Chien-Yi/0000-0002-6030-2655; CHOU, HUNG-CHIEH/0000-0002-8932-9472; Chang, Mei Hwei/0000-0002-3648-9261; HSIEH, WU-SHIUN/0000-0002-0609-3311; Koh, Choon Huat Gerald/0000-0002-6453-6897; TSAO, PO-NIEN/0000-0002-6114-1769; Matt, Lucas/0000-0003-3235-5140; Rogawski, Michael/0000-0002-3296-8193; Sia, Isaac/0000-0001-8449-1799; Ng, Yee-Sien/0000-0003-1377-5852	National Taiwan University Hospital [NTUH.98-M1230]; Center for Disease Control, Department of Health, Taiwan [DOH98-DC-10181]	National Taiwan University Hospital(National Taiwan University); Center for Disease Control, Department of Health, Taiwan	This study was supported by grant from the National Taiwan University Hospital (NTUH.98-M1230), and partially from the Center for Disease Control, Department of Health, Taiwan (DOH98-DC-10181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEASLEY RP, 1983, HEPATOLOGY, V3, P135; BEASLEY RP, 1983, LANCET, V2, P1099; Chang MH, 2009, JNCI-J NATL CANCER I, V101, P1348, DOI 10.1093/jnci/djp288; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Chen HL, 2004, HEPATOLOGY, V39, P58, DOI 10.1002/hep.20006; HALL CB, 1994, PEDIATRICS, V94, P403; HALL CB, 1992, PEDIATRICS, V89, P795; Hsu HM, 1999, J INFECT DIS, V179, P367, DOI 10.1086/314585; Huang FY, 1997, ARCH DIS CHILD-FETAL, V77, pF135, DOI 10.1136/fn.77.2.F135; Kesler K, 1998, PEDIATR INFECT DIS J, V17, P116, DOI 10.1097/00006454-199802000-00007; Khalak R, 1998, PEDIATRICS, V101, P597, DOI 10.1542/peds.101.4.597; Kim SC, 1997, PEDIATRICS, V99, P534, DOI 10.1542/peds.99.4.534; Kirmani KI, 2002, PEDIATRICS, V109, P498, DOI 10.1542/peds.109.3.498; LAU YL, 1992, J PEDIATR-US, V121, P962, DOI 10.1016/S0022-3476(05)80352-X; LEE CY, 1991, PEDIATR INFECT DIS J, V10, P299, DOI 10.1097/00006454-199104000-00007; LEE PI, 1995, J PEDIATR-US, V126, P716, DOI 10.1016/S0022-3476(95)70398-5; Linder N, 2002, INFECTION, V30, P136, DOI 10.1007/s15010-002-2068-3; Linder N, 2000, ARCH DIS CHILD-FETAL, V83, pF24, DOI 10.1136/fn.83.1.F24; Losonsky GA, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.2.e14; Ni YH, 2007, GASTROENTEROLOGY, V132, P1287, DOI 10.1053/j.gastro.2007.02.055; Ni YH, 2012, J HEPATOL, V57, P730, DOI 10.1016/j.jhep.2012.05.021; Patel DM, 1997, J PEDIATR-US, V131, P641, DOI 10.1016/S0022-3476(97)70078-7; Poland GA, 2004, NEW ENGL J MED, V351, P2832, DOI 10.1056/NEJMcp041507; Saari TN, 2003, PEDIATRICS, V112, P193, DOI 10.1542/peds.112.1.193	24	94	94	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92271	10.1371/journal.pone.0092271	http://dx.doi.org/10.1371/journal.pone.0092271			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	25229608	Green Published, gold, Green Submitted			2022-12-25	WOS:000333254100136
J	Wang, LL; Sun, XY; Li, SY; Zhang, T; Zhang, W; Zhai, PH				Wang, Linlin; Sun, Xiangyang; Li, Suyan; Zhang, Tao; Zhang, Wei; Zhai, Penghui			Application of Organic Amendments to a Coastal Saline Soil in North China: Effects on Soil Physical and Chemical Properties and Tree Growth	PLOS ONE			English	Article							BIOLOGICAL-PROPERTIES; MICROBIAL COMMUNITIES; CATION-EXCHANGE; SEWAGE-SLUDGE; BEET VINASSE; SODIC SOILS; NITROGEN; RECLAMATION; PHOSPHORUS; POTASSIUM	The ability of the following four organic amendments to ameliorate saline soil in coastal northern China was investigated from April 2010 to October 2012 in a field experiment: green waste compost (GWC), sedge peat (SP), furfural residue (FR), and a mixture of GWC, SP and FR (1: 1: 1 by volume) (GSF). Compared to a non-amended control (CK), the amendments, which were applied at 4.5 kg organic matter m(-3), dramatically promoted plant growth; improved soil structure; increased the cation exchange capacity (CEC), organic carbon, and available nutrients; and reduced the salt content, electrical conductivity (EC), and exchangeable sodium percentage (ESP). At the end of the experiment in soil amended with GSF, bulk density, EC, and ESP had decreased by 11, 87, and 71%, respectively, and total porosity and organic carbon had increased by 25 and 96% respectively, relative to the CK. The GSF treatment resulted in a significantly lower Na++K+ content than the other treatments. CEC and the contents of available N, P, and K were significantly higher in the GSF-treated soil than in the CK and were the highest in all treatments. The FR treatment resulted in the lowest pH value and Ca2+ concentration, which decreased by 8% and 39%, respectively, relative to the CK. Overall, the results indicate that a combination of green waste compost, sedge peat and furfural residue (GSF treatment) has substantial potential for ameliorating saline soils in the coastal areas of northern China, and it works better than each amendment alone. Utilization of GWC and FR can be an alternative organic amendment to substitute the nonrenewable SP in saline soil amelioration.	[Wang, Linlin; Sun, Xiangyang; Li, Suyan; Zhang, Tao; Zhang, Wei; Zhai, Penghui] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China; [Wang, Linlin] Forestry Res Inst Hulun Buir, Hulun Buir, Inner Mongolia, Peoples R China	Beijing Forestry University	Sun, XY (corresponding author), Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China.	sunxy1965@126.com; lisuyan@bjfu.edu.cn	; Williams, Robert W./H-8789-2016	Habibovic, Pamela/0000-0001-8249-5155; Williams, Robert W./0000-0001-8924-4447; Deng, Hong-Wen/0000-0002-0387-8818; Farber, Charles/0000-0002-6748-4711; Wang, Cong-Yi/0000-0001-7914-168X	Eleventh Five-Year Plan of the National Scientific and Technical Supporting Programs [2009BADB2B0504]; Fundamental Research Funds for the Central Universities; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR050496, R01AR057049, R01AR050066, R01AR064825, R01AR051190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG020321, R01AG026564, P01AG018397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662] Funding Source: NIH RePORTER	Eleventh Five-Year Plan of the National Scientific and Technical Supporting Programs; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the Eleventh Five-Year Plan of the National Scientific and Technical Supporting Programs (No. 2009BADB2B0504), and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi MK, 2007, COMMUN SOIL SCI PLAN, V38, P1691, DOI 10.1080/00103620701435464; Amezketa E, 2005, AGRON J, V97, P983, DOI 10.2134/agronj2004.0236; Antil Rajinder Singh, 2007, Archives of Agronomy and Soil Science, V53, P519, DOI 10.1080/03650340701571033; BAO SD, 2005, ANAL SOIL AGROCHEMIS; BARKHAM JP, 1993, BIODIVERS CONSERV, V2, P556, DOI 10.1007/BF00056749; Barzegar AR, 1997, SOIL SCI SOC AM J, V61, P1131, DOI 10.2136/sssaj1997.03615995006100040020x; Bhattacharyya P, 2007, CHEMOSPHERE, V66, P1789, DOI 10.1016/j.chemosphere.2006.07.062; Brady AC, 2002, NATURE PROPERTIES SO; Clark GJ, 2007, SOIL BIOL BIOCHEM, V39, P2806, DOI 10.1016/j.soilbio.2007.06.003; Cooperband L., 2002, BUILDING SOIL ORGANI; David R, 2002, GEODERMA, V107, P271, DOI 10.1016/S0016-7061(01)00152-5; Feng YJ, 2006, PEDOSPHERE, V16, P668, DOI 10.1016/S1002-0160(06)60101-X; Hahn AS, 2013, PLANT SOIL, V363, P331, DOI 10.1007/s11104-012-1306-4; Hanay A, 2004, COMPOST SCI UTIL, V12, P175, DOI 10.1080/1065657x.2004.10702177; Hyvonen R, 2008, BIOGEOCHEMISTRY, V89, P121, DOI 10.1007/s10533-007-9121-3; JACKSON M. L., 1958, Soil Chemical Analysis.; Kahlown MA, 2003, AGR WATER MANAGE, V62, P127, DOI 10.1016/S0378-3774(03)00096-9; Kaya C, 2001, J PLANT NUTR, V24, P357, DOI 10.1081/PLN-100001394; Larney FJ, 2012, CAN J SOIL SCI, V92, P19, DOI [10.4141/cjss2010-064, 10.4141/CJSS2010-064]; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; Liang YC, 2003, GEODERMA, V115, P149, DOI 10.1016/S0016-7061(03)00084-3; Liu GQ, 2009, BIORESOURCE TECHNOL, V100, P5103, DOI 10.1016/j.biortech.2009.03.081; Mamedov AI, 2002, SOIL TILL RES, V68, P121, DOI 10.1016/S0167-1987(02)00115-0; Melero S, 2007, EUR J AGRON, V26, P327, DOI 10.1016/j.eja.2006.11.004; Oo AN, 2013, LAND DEGRAD DEV, DOI 101002/ldr2208; Page A.L., 1982, AGRONOMY SERIES, V9, DOI DOI 10.1002/JP1N.19851480319; Pocknee S, 1997, SOIL SCI SOC AM J, V61, P86, DOI 10.2136/sssaj1997.03615995006100010014x; Qadir M, 2007, ADV AGRON, V96, P197, DOI 10.1016/S0065-2113(07)96006-X; Qadir M, 2004, SCI TOTAL ENVIRON, V323, P1, DOI 10.1016/j.scitotenv.2003.10.012; Qadir M, 1998, SOIL TILL RES, V45, P119, DOI 10.1016/S0933-3630(96)00130-4; Qadir M, 2000, LAND DEGRAD DEV, V11, P501, DOI 10.1002/1099-145X(200011/12)11:6<501::AID-LDR405>3.0.CO;2-S; RICHARDS LA, 1954, AGR HDB, V60, P98; Rietz DN, 2003, SOIL BIOL BIOCHEM, V35, P845, DOI 10.1016/S0038-0717(03)00125-1; Roca-Perez L, 2009, CHEMOSPHERE, V75, P781, DOI 10.1016/j.chemosphere.2008.12.058; Ros M, 2003, SOIL BIOL BIOCHEM, V35, P463, DOI 10.1016/S0038-0717(02)00298-5; Sumner M.E., 2000, HDB SOIL SCI; Sun R, 2011, BIORESOURCES, V6, P317; Tejada M, 2008, BIORESOURCE TECHNOL, V99, P1758, DOI 10.1016/j.biortech.2007.03.052; Tejada M, 2006, SOIL BIOL BIOCHEM, V38, P1413, DOI 10.1016/j.soilbio.2005.10.017; Tejada M, 2006, SOIL SCI SOC AM J, V70, P900, DOI 10.2136/sssaj2005.0271; Tejada M, 2005, EUR J AGRON, V23, P336, DOI 10.1016/j.eja.2005.02.005; TUCKER BM, 1954, AUST J AGR RES, V5, P706, DOI 10.1071/AR9540706; Wang Z.Q., 1993, SALINE SOIL IN CHINA; Warman PR, 2005, BIORESOURCE TECHNOL, V96, P955, DOI 10.1016/j.biortech.2004.08.003; Wichern J, 2006, GEODERMA, V137, P100, DOI 10.1016/j.geoderma.2006.08.001; Withers PJA, 2003, SOIL USE MANAGE, V19, P28, DOI 10.1111/j.1475-2743.2003.tb00276.x; Wong VNL, 2009, APPL SOIL ECOL, V41, P29, DOI 10.1016/j.apsoil.2008.08.006; Xing Y, 2012, CELL CHEM TECHNOL, V46, P249; Yazdanpanah N, 2013, AGR WATER MANAGE, V120, P39, DOI 10.1016/j.agwat.2012.08.017; Zhang L, 2013, BIORESOURCE TECHNOL, V131, P68, DOI 10.1016/j.biortech.2012.10.059; Zhang XC, 2002, J HYDROL, V260, P194, DOI 10.1016/S0022-1694(01)00612-6	51	125	145	10	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89185	10.1371/journal.pone.0089185	http://dx.doi.org/10.1371/journal.pone.0089185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	25229501	gold, Green Published, Green Submitted			2022-12-25	WOS:000331706700132
J	Wang, LS; Lu, WL; Zhang, L; Huang, Y; Scheib, R; Liu, XY; Myers, L; Lu, L; Farber, CR; Liu, GF; Wang, CY; Deng, HW; Williams, RW; Wang, YJ; Gu, WK; Jiao, Y				Wang, Lishi; Lu, Wenli; Zhang, Lei; Huang, Yue; Scheib, Rachel; Liu, Xiaoyun; Myers, Linda; Lu, Lu; Farber, Charles R.; Liu, Gaifen; Wang, Cong-Yi; Deng, Hongwen; Williams, Robert W.; Wang, Yongjun; Gu, Weikuan; Jiao, Yan			Trps1 Differentially Modulates the Bone Mineral Density between Male and Female Mice and Its Polymorphism Associates with BMD Differently between Women and Men	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; TRICHORHINOPHALANGEAL-SYNDROME; MISSENSE MUTATION; GENE-EXPRESSION; POPULATION; IDENTIFICATION; METAANALYSIS; NETWORKS; LINKAGE; GROWTH	The objective of our study was to identify genetic factors that regulate bone mineral density (BMD) in mice using well defined recombinant inbred strains. For this purpose we chose the BXD recombinant inbred (RI) strains derived from progeny of the C57BL/6J (B6) and DBA/2J (D2) progenitor strains. We sampled both male and female mice (similar to 4 each) of 46 strains at 3 months-of-age, measured their BMD, and conducted QTL mapping. The data were analyzed to identify candidates genes contained within the most significant quantitative trait locus (QTL). Evaluation of candidate genes included functional assessment, single nucleotide polymorphism (SNP) genotyping and direct sequencing. We established that there was a QTL for BMD in males on chromosome 15 that has the impact larger than QTLs on all other chromosomes. The QTL on chromosome 15 was narrowed to a genomic region between 38 Mbp and 52 Mbp. By examining transcripts within this region, we found an important candidate gene: trichorhinophalangeal syndrome, type I (Trps1). SNP analysis identified a nonsynonymous SNP (rs32398060) in Trps1 that co-segregated with bone mineral density. Analysis of association between this SNP within TRPS1 and BMD in a human population confirmed its significance.	[Wang, Lishi; Lu, Wenli; Huang, Yue; Scheib, Rachel; Liu, Xiaoyun; Gu, Weikuan; Jiao, Yan] Univ Tennessee, Hlth Sci Ctr, Campbell Clin, Dept Orthoped Surg & BioMed Engn, Memphis, TN 38163 USA; [Wang, Lishi] Inner Mongolia Med Univ, Dept Basic Med, Hohhot, Inner Mongolia, Peoples R China; [Zhang, Lei; Deng, Hongwen] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat & Bioinformat, New Orleans, LA USA; [Myers, Linda] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN USA; [Lu, Lu; Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN USA; [Farber, Charles R.] Univ Virginia, Dept Med, Div Cardiol, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Farber, Charles R.] Univ Virginia, Dept Biochem & Mol Genet, Div Cardiol, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Liu, Gaifen; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, Cong-Yi] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Ctr Biomed Res, Wuhan 430074, Hubei, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; Inner Mongolia Medical University; Tulane University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Virginia; University of Virginia; Capital Medical University; Huazhong University of Science & Technology	Gu, WK (corresponding author), Univ Tennessee, Hlth Sci Ctr, Campbell Clin, Dept Orthoped Surg & BioMed Engn, Memphis, TN 38163 USA.	wgu@uthsc.edu; yjiao2@utusc.edu	; Williams, Robert W./H-8789-2016	Habibovic, Pamela/0000-0001-8249-5155; Williams, Robert W./0000-0001-8924-4447; Deng, Hong-Wen/0000-0002-0387-8818; Farber, Charles/0000-0002-6748-4711; Wang, Cong-Yi/0000-0001-7914-168X	National Institute of Arthritis (NIA); Musculoskeletal and Skin Diseases, National Institutes of Health (NIH) [R01 AR51190]; Genediscovery Core at UTHSC; Veterans Administration Medical Center in Memphis, Tennessee; NIH [P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, R03TW008221, R01 AR/AG 41398, R01 AR050066, R03 AG20321]; Franklin D. Dickson/Missouri Endowment; Edward G. Schlieder Endowment; National Natural Science Foundation of China [31100902]; National Heart, Lung, and Blood Institute (NHLBI); Boston University [N01-HC-25195]; NHLBI [N02-HL-64278]; NIA Division of Geriatrics and Clinical Gerontology; Genetic Determinants of Bone Fragility [P01-AG018397]; NIH NIA; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR050496, R01AR057049, R01AR050066, R01AR064825, R01AR051190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG020321, R01AG026564, P01AG018397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662] Funding Source: NIH RePORTER	National Institute of Arthritis (NIA); Musculoskeletal and Skin Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genediscovery Core at UTHSC; Veterans Administration Medical Center in Memphis, Tennessee; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Franklin D. Dickson/Missouri Endowment; Edward G. Schlieder Endowment; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA Division of Geriatrics and Clinical Gerontology; Genetic Determinants of Bone Fragility; NIH NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The study was partially supported by grants from the National Institute of Arthritis (NIA) and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH)(R01 AR51190 to W.G.), Genediscovery Core at UTHSC, and the Veterans Administration Medical Center in Memphis, Tennessee. H. W. D. was partially supported by grants from NIH (P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, and R03TW008221), the Franklin D. Dickson/Missouri Endowment and the Edward G. Schlieder Endowment. L.Z. was partially supported by National Natural Science Foundation of China (project 31100902). The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University (Contract No. N01-HC-25195). This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or views of the Framingham Heart Study, Boston University, or NHLBI. Funding for SHARe genotyping was provided by NHLBI Contract N02-HL-64278. Funding support for the Framingham Bone Mineral Density datasets was provided by NIH grants R01 AR/AG 41398, R01 AR050066 and R03 AG20321. Funding support for the Genetic Determinants of Bone Fragility (the Indiana fragility study) was provided through the NIA Division of Geriatrics and Clinical Gerontology. Genetic Determinants of Bone Fragility is a genome-wide association studies funded as part of the NIA Division of Geriatrics and Clinical Gerontology. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the NIA Division of Geriatrics and Clinical Gerontology and the NIA Division of Aging Biology. Support for the collection of datasets and samples were provided by the parent grant, Genetic Determinants of Bone Fragility (P01-AG018397). Funding support for the genotyping which was performed at the Johns Hopkins University Center for Inherited Diseases Research was provided by the NIH NIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackert-Bicknell CL, 2012, BONE; Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Beamer WG, 1999, MAMM GENOME, V10, P1043, DOI 10.1007/s003359901159; BONJOUR JP, 1994, OSTEOPOROSIS INT, V4, P7; Calabrese G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003150; CARRINGTON PR, 1994, J AM ACAD DERMATOL, V31, P331, DOI 10.1016/S0190-9622(94)70166-0; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Garnero P., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P50; Geisert EE, 2009, MOL VIS, V15, P1730; Grubb SC, 2004, BIOINFORMATICS, V20, P2857, DOI 10.1093/bioinformatics/bth299; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ishimori N, 2008, J BONE MINER RES, V23, P1529, DOI 10.1359/JBMR.080414; Jiao Y, 2008, GENOMICS, V91, P407, DOI 10.1016/j.ygeno.2007.12.010; Klein RF, 1998, J BONE MINER RES, V13, P1648, DOI 10.1359/jbmr.1998.13.11.1648; Kolta S, 2003, J CLIN DENSITOM, V6, P251, DOI 10.1385/JCD:6:3:251; Li GHY, 2011, HUM GENET, V130, P539, DOI 10.1007/s00439-011-0972-2; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu EY, 2013, GENET EPIDEMIOL, V37, P25, DOI 10.1002/gepi.21690; Lynch RM, 2010, PHYSIOL GENOMICS, V41, P244, DOI 10.1152/physiolgenomics.00020.2010; Milner LC, 2010, INT REV NEUROBIOL, V91, P173, DOI 10.1016/S0074-7742(10)91006-4; NOLTORP S, 1986, ANN RHEUM DIS, V45, P31, DOI 10.1136/ard.45.1.31; Orwoll ES, 2001, J BONE MINER RES, V16, P1962, DOI 10.1359/jbmr.2001.16.11.1962; Pei YF, 2013, HUM MOL GENET; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Rossi A, 2007, BRIT J DERMATOL, V157, P1021, DOI 10.1111/j.1365-2133.2007.08158.x; Sarafoglou K, 2010, CLIN GENET, V78, P591, DOI 10.1111/j.1399-0004.2010.01434.x; SCHNITZLER CM, 1993, CALCIFIED TISSUE INT, V53, pS27, DOI 10.1007/BF01673398; Soon G, 2006, CALCIFIED TISSUE INT, V78, P186, DOI 10.1007/s00223-005-0191-8; Suwanwela J, 2011, J BONE MINER RES, V26, P747, DOI 10.1002/jbmr.271; Tariq M, 2008, BRIT J DERMATOL, V159, P476, DOI 10.1111/j.1365-2133.2008.08658.x; Tremollieres F, 2010, MATURITAS, V65, P348, DOI 10.1016/j.maturitas.2009.12.023; Vaccaro M, 2009, PEDIATR DERMATOL, V26, P171, DOI 10.1111/j.1525-1470.2009.00905.x; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Xiong Q, 2008, BIOINFORMATICS, V24, P1011, DOI 10.1093/bioinformatics/btn002; Xiong Q, 2009, GENOMICS, V93, P401, DOI 10.1016/j.ygeno.2008.12.008; Yu H, 2007, CALCIFIED TISSUE INT, V80, P103, DOI 10.1007/s00223-006-0187-z; Zhang L, 2009, ANN HUM GENET, V73, P601, DOI 10.1111/j.1469-1809.2009.00539.x	42	125	145	10	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84485	10.1371/journal.pone.0084485	http://dx.doi.org/10.1371/journal.pone.0084485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	25229501	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500131
